EU-1-00-129_h_a_dec_0.pdf@EU-1-00-129_h_a_dec_0.pdf@2000-09-03 00:00:00@Azopt@brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_0.pdf@EU-1-00-130_h_a_dec_0.pdf@2000-05-17 00:00:00@Orgalutran@Ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_0.pdf@EU-1-00-141_h_a_dec_0.pdf@2000-07-13 00:00:00@MYOCET@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@The Liposome Company Ltd@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_0.pdf@EU-1-00-135_h_a_dec_0.pdf@2000-07-27 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_0.pdf@EU-1-00-140_h_a_dec_0.pdf@2000-07-27 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@CIBA Vision Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_0.pdf@EU-1-00-149_h_a_dec_0.pdf@2000-11-10 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_0.pdf@EU-1-00-150_h_a_dec_0.pdf@2000-10-13 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_0.pdf@EU-1-00-145_h_a_dec_0.pdf@2000-08-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_0.pdf@EU-1-00-133_h_a_dec_0.pdf@2000-06-27 00:00:00@OPTISULIN insulin glargine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_0.pdf@EU-1-00-152_h_a_dec_0.pdf@2000-10-23 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae   type b vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_0.pdf@EU-1-00-155_h_a_dec_0.pdf@2000-11-29 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd.@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_0.pdf@EU-1-00-142_h_a_dec_0.pdf@2000-01-08 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_0.pdf@EU-1-00-134_h_a_dec_0.pdf@2000-09-06 00:00:00@Lantus@insulin glargin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_0.pdf@EU-1-00-156_h_a_dec_0.pdf@2000-12-28 00:00:00@TRIZIVIR@abacavir / lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_0.pdf@EU-1-00-157_h_a_dec_0.pdf@2001-01-15 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-162_h_a_dec_0.pdf@EU-1-00-162_h_a_dec_0.pdf@2001-01-29 00:00:00@Prandin@repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_0.pdf@EU-1-00-160_h_a_dec_0.pdf@2001-01-15 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_0.pdf@EU-1-00-146_h_a_dec_0.pdf@2000-09-29 00:00:00@Keppra@levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_0.pdf@EU-1-00-164_h_a_dec_0.pdf@2001-02-16 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_0.pdf@EU-1-00-161_h_a_dec_0.pdf@2001-01-15 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_0.pdf@EU-1-00-166_h_a_dec_0.pdf@2001-01-22 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_0.pdf@EU-1-00-170_h_a_dec_0.pdf@2001-02-23 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-01-173_h_a_dec_0.pdf@EU-1-01-173_h_a_dec_0.pdf@2001-03-20 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_0.pdf@EU-1-00-163_h_a_dec_0.pdf@2001-02-02 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_0.pdf@EU-1-00-169_h_a_dec_0.pdf@2001-02-23 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_0.pdf@EU-1-00-143_h_a_dec_0.pdf@2000-04-08 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@NA before 2000@Bayer AG@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_0.pdf@EU-1-01-178_h_a_dec_0.pdf@2001-03-29 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_0.pdf@EU-1-00-165_h_a_dec_0.pdf@2001-02-02 00:00:00@OVIDRELLE@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-01-177_h_a_dec_0.pdf@EU-1-01-177_h_a_dec_0.pdf@2001-03-26 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_0.pdf@EU-1-01-188_h_a_dec_0.pdf@2001-03-08 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@adopted@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_0.pdf@EU-1-01-183_h_a_dec_0.pdf@2001-04-27 00:00:00@HBVAXPRO@Hepatitis B (Recombinant) vaccine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA not available before 2006@Parsed
EU-1-01-190_h_a_dec_0.pdf@EU-1-01-190_h_a_dec_0.pdf@2001-07-16 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_0.pdf@EU-1-01-176_h_a_dec_0.pdf@2001-03-20 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_0.pdf@EU-1-01-189_h_a_dec_0.pdf@2001-03-08 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@adopted@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_0.pdf@EU-1-01-194_h_a_dec_0.pdf@2001-01-08 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-197_h_a_dec_0.pdf@EU-1-01-197_h_a_dec_0.pdf@2001-10-24 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Scotia Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_0.pdf@EU-1-01-199_h_a_dec_0.pdf@2001-11-27 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_0.pdf@EU-1-01-196_h_a_dec_0.pdf@2001-10-24 00:00:00@Caspofungin MSD@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_0.pdf@EU-1-01-171_h_a_dec_0.pdf@2001-03-13 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_0.pdf@EU-1-02-201_h_a_dec_0.pdf@2002-02-28 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_0.pdf@EU-1-02-203_h_a_dec_0.pdf@2002-08-03 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_0.pdf@EU-1-02-204_h_a_dec_0.pdf@2002-05-03 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-02-205_h_a_dec_0.pdf@EU-1-02-205_h_a_dec_0.pdf@2002-08-03 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_0.pdf@EU-1-01-195_h_a_dec_0.pdf@2001-01-08 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_0.pdf@EU-1-01-172_h_a_dec_0.pdf@2001-03-20 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_0.pdf@EU-1-01-200_h_a_dec_0.pdf@2002-05-02 00:00:00@Viread@Tenofovir disoproxil (as fumarate)@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_0.pdf@EU-1-01-198_h_a_dec_0.pdf@2001-07-11 00:00:00@Glivec@imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_0.pdf@EU-1-02-206_h_a_dec_0.pdf@2002-03-21 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_0.pdf@EU-1-02-213_h_a_dec_0.pdf@2002-04-19 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-216_h_a_dec_0.pdf@EU-1-02-216_h_a_dec_0.pdf@2002-04-18 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_0.pdf@EU-1-02-209_h_a_dec_0.pdf@2002-03-22 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_0.pdf@EU-1-02-214_h_a_dec_0.pdf@2002-04-19 00:00:00@BolusacPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_0.pdf@EU-1-02-218_h_a_dec_0.pdf@2002-05-17 00:00:00@Memantine Merz Pharmaceuticals GmbH@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_0.pdf@EU-1-02-215_h_a_dec_0.pdf@2002-04-22 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_0.pdf@EU-1-02-219_h_a_dec_0.pdf@2002-05-15 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-224_h_a_dec_0.pdf@EU-1-02-224_h_a_dec_0.pdf@2002-08-30 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA not available before 2006@Parsed
EU-1-02-223_h_a_dec_0.pdf@EU-1-02-223_h_a_dec_0.pdf@2002-08-22 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_0.pdf@EU-1-02-226_h_a_dec_0.pdf@2002-09-09 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_0.pdf@EU-1-02-220_h_a_dec_0.pdf@2002-05-15 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_0.pdf@EU-1-02-227_h_a_dec_0.pdf@2002-08-22 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_0.pdf@EU-1-02-212_h_a_dec_0.pdf@2002-03-19 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_0.pdf@EU-1-01-185_h_a_dec_0.pdf@2001-08-06 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_0.pdf@EU-1-02-222_h_a_dec_0.pdf@2002-06-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_0.pdf@EU-1-02-230_h_a_dec_0.pdf@2002-07-10 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_0.pdf@EU-1-02-238_h_a_dec_0.pdf@2002-11-20 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@adopted@Oxford GlycoSciences (UK) Ltd@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_0.pdf@EU-1-02-233_h_a_dec_0.pdf@2002-07-10 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_0.pdf@EU-1-02-229_h_a_dec_0.pdf@2002-07-10 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-246_h_a_dec_0.pdf@EU-1-02-246_h_a_dec_0.pdf@2003-01-24 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_0.pdf@EU-1-02-237_h_a_dec_0.pdf@2002-12-11 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_0.pdf@EU-1-02-231_h_a_dec_0.pdf@2002-07-10 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_0.pdf@EU-1-02-240_h_a_dec_0.pdf@2002-11-13 00:00:00@ Somavert Pegvisomant @Active Substance Not Found@NAS before 2012@NA before 2012@adopted@Pharmacia Enterprises S.A@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_0.pdf@EU-1-02-221_h_a_dec_0.pdf@2002-06-20 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_0.pdf@EU-1-03-247_h_a_dec_0.pdf@2003-10-06 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-02-234_h_a_dec_0.pdf@EU-1-02-234_h_a_dec_0.pdf@2002-07-10 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_0.pdf@EU-1-03-253_h_a_dec_0.pdf@2003-10-06 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_0.pdf@EU-1-03-254_h_a_dec_0.pdf@2003-09-07 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@adopted@Pierre Fabre Médicament@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_0.pdf@EU-1-03-251_h_a_dec_0.pdf@2003-06-03 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_0.pdf@EU-1-03-255_h_a_dec_0.pdf@2003-09-16 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@adopted@Schering AG@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_0.pdf@EU-1-03-252_h_a_dec_0.pdf@2003-05-27 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_0.pdf@EU-1-03-249_h_a_dec_0.pdf@2003-04-03 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-263_h_a_dec_0.pdf@EU-1-03-263_h_a_dec_0.pdf@2004-04-28 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@NA before 2012@OD Not Found@SBL Vaccin AB@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_0.pdf@EU-1-03-248_h_a_dec_0.pdf@2003-06-03 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_0.pdf@EU-1-03-261_h_a_dec_0.pdf@2003-10-24 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-268_h_a_dec_0.pdf@EU-1-03-268_h_a_dec_0.pdf@2004-10-03 00:00:00@Cholestagel@colesevelam hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_0.pdf@EU-1-03-264_h_a_dec_0.pdf@2004-01-16 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_0.pdf@EU-1-03-260_h_a_dec_0.pdf@2003-10-17 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-03-269_h_a_dec_0.pdf@EU-1-03-269_h_a_dec_0.pdf@2004-10-03 00:00:00@Faslodex@Fulvestrant@NAS before 2012@NA before 2012@OD Not Found@AstraZeneca UK Limited@CMA not available before 2006@Parsed
EU-1-03-265_h_a_dec_0.pdf@EU-1-03-265_h_a_dec_0.pdf@2004-02-23 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@appointed@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-270_h_a_dec_0.pdf@EU-1-03-270_h_a_dec_0.pdf@2004-06-15 00:00:00@Oxybutynin Nicobrand@Oxybutynin@NAS before 2012@NA before 2012@OD Not Found@Nicobrand Limited@CMA not available before 2006@Parsed
EU-1-04-273_h_a_dec_0.pdf@EU-1-04-273_h_a_dec_0.pdf@2004-04-28 00:00:00@Lysodren@Mitotane@NAS before 2012@NA before 2012@adopted@Laboratoire HRA Pharma@CMA not available before 2006@Parsed
EU-1-04-275_h_a_dec_0.pdf@EU-1-04-275_h_a_dec_0.pdf@2004-04-14 00:00:00@Litak@Cladribine@NAS before 2012@NA before 2012@adopted@Lipomed GmbH@CMA not available before 2006@Parsed
EU-1-04-277_h_a_dec_0.pdf@EU-1-04-277_h_a_dec_0.pdf@2004-08-06 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_0.pdf@EU-1-03-262_h_a_dec_0.pdf@2003-11-11 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_0.pdf@EU-1-04-274_h_a_dec_0.pdf@2004-04-26 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@appointed@Millenium Pharmaceuticals, Ltd@CMA not available before 2006@Parsed
EU-1-03-271_h_a_dec_0.pdf@EU-1-03-271_h_a_dec_0.pdf@2004-02-03 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-04-280_h_a_dec_0.pdf@EU-1-04-280_h_a_dec_0.pdf@2004-11-08 00:00:00@YENTREVE@Duloxetine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_0.pdf@EU-1-04-281_h_a_dec_0.pdf@2004-06-29 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA not available before 2006@Parsed
EU-1-04-284_h_a_dec_0.pdf@EU-1-04-284_h_a_dec_0.pdf@2004-07-29 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-04-278_h_a_dec_0.pdf@EU-1-04-278_h_a_dec_0.pdf@2004-01-06 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-04-286_h_a_dec_0.pdf@EU-1-04-286_h_a_dec_0.pdf@2004-10-13 00:00:00@Wilzin@Zinc acetate dihydrate@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_0.pdf@EU-1-04-279_h_a_dec_0.pdf@2004-06-07 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-290_h_a_dec_0.pdf@EU-1-04-290_h_a_dec_0.pdf@2004-09-20 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_0.pdf@EU-1-03-267_h_a_dec_0.pdf@2004-02-03 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-04-294_h_a_dec_0.pdf@EU-1-04-294_h_a_dec_0.pdf@2004-10-22 00:00:00@EMSELEX@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-295_h_a_dec_0.pdf@EU-1-04-295_h_a_dec_0.pdf@2004-11-16 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@adopted@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-04-285_h_a_dec_0.pdf@EU-1-04-285_h_a_dec_0.pdf@2004-09-27 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-04-282_h_a_dec_0.pdf@EU-1-04-282_h_a_dec_0.pdf@2004-12-07 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-299_h_a_dec_0.pdf@EU-1-04-299_h_a_dec_0.pdf@2005-02-02 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-04-292_h_a_dec_0.pdf@EU-1-04-292_h_a_dec_0.pdf@2004-10-22 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-04-303_h_a_dec_0.pdf@EU-1-04-303_h_a_dec_0.pdf@2005-02-21 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@adopted@Swedish Orphan International AB@CMA not available before 2006@Parsed
EU-1-04-296_h_a_dec_0.pdf@EU-1-04-296_h_a_dec_0.pdf@2004-12-17 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-298_h_a_dec_0.pdf@EU-1-04-298_h_a_dec_0.pdf@2004-12-17 00:00:00@Kivexa@abacavir / lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-04-304_h_a_dec_0.pdf@EU-1-04-304_h_a_dec_0.pdf@2005-02-21 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA not available before 2006@Parsed
EU-1-04-302_h_a_dec_0.pdf@EU-1-04-302_h_a_dec_0.pdf@2005-02-21 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@adopted@Elan Pharma International Ltd@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_0.pdf@EU-1-04-276_h_a_dec_0.pdf@2004-04-06 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-306_h_a_dec_0.pdf@EU-1-04-306_h_a_dec_0.pdf@2005-03-22 00:00:00@Aloxi@Palonosetron@NAS before 2012@NA before 2012@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA not available before 2006@Parsed
EU-1-05-308_h_a_dec_0.pdf@EU-1-05-308_h_a_dec_0.pdf@2005-04-15 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-305_h_a_dec_0.pdf@EU-1-04-305_h_a_dec_0.pdf@2005-02-21 00:00:00@Truvada@Emtricitabine / Tenofovir Disoproxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-05-310_h_a_dec_0.pdf@EU-1-05-310_h_a_dec_0.pdf@2005-08-24 00:00:00@FOSAVANCE@Alendronate Sodium / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_0.pdf@EU-1-04-300_h_a_dec_0.pdf@2005-12-01 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-05-312_h_a_dec_0.pdf@EU-1-05-312_h_a_dec_0.pdf@2005-10-13 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@adopted@UCB Pharma Ltd.@CMA not available before 2006@Parsed
EU-1-05-316_h_a_dec_0.pdf@EU-1-05-316_h_a_dec_0.pdf@2005-10-25 00:00:00@Procoralan@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-05-317_h_a_dec_0.pdf@EU-1-05-317_h_a_dec_0.pdf@2005-10-25 00:00:00@Corlentor@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-04-307_h_a_dec_0.pdf@EU-1-04-307_h_a_dec_0.pdf@2005-10-03 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma@CMA not available before 2006@Parsed
EU-1-05-311_h_a_dec_0.pdf@EU-1-05-311_h_a_dec_0.pdf@2005-09-19 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-05-322_h_a_dec_0.pdf@EU-1-05-322_h_a_dec_0.pdf@2006-01-19 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@NA before 2012@OD Not Found@AEA Technology QSA GmbH@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_0.pdf@EU-1-05-324_h_a_dec_0.pdf@2006-01-24 00:00:00@Naglazyme@Recombinant human N-acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@NA before 2012@adopted@BioMarin Europe Limited@exceptional@Parsed
EU-1-05-315_h_a_dec_0.pdf@EU-1-05-315_h_a_dec_0.pdf@2005-10-25 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-05-320_h_a_dec_0.pdf@EU-1-05-320_h_a_dec_0.pdf@2005-10-25 00:00:00@Noxafil@Posaconazole@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-05-323_h_a_dec_0.pdf@EU-1-05-323_h_a_dec_0.pdf@2006-06-04 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_0.pdf@EU-1-05-329_h_a_dec_0.pdf@2006-01-19 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_0.pdf@EU-1-05-318_h_a_dec_0.pdf@2005-10-28 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@adopted@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-05-319_h_a_dec_0.pdf@EU-1-05-319_h_a_dec_0.pdf@2005-10-25 00:00:00@Xolair@omalizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-05-328_h_a_dec_0.pdf@EU-1-05-328_h_a_dec_0.pdf@2006-01-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Limited@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_0.pdf@EU-1-06-333_h_a_dec_0.pdf@2006-03-29 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_0.pdf@EU-1-06-334_h_a_dec_0.pdf@2006-05-29 00:00:00@Evoltra@clofarabine@NAS before 2012@NA before 2012@adopted@Bioenvision Limited@exceptional@Parsed
EU-1-06-336_h_a_dec_0.pdf@EU-1-06-336_h_a_dec_0.pdf@2006-04-24 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_0.pdf@EU-1-06-338_h_a_dec_0.pdf@2006-04-24 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_0.pdf@EU-1-06-337_h_a_dec_0.pdf@2006-05-05 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_0.pdf@EU-1-06-332_h_a_dec_0.pdf@2006-12-04 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_0.pdf@EU-1-05-330_h_a_dec_0.pdf@2006-02-21 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_0.pdf@EU-1-06-340_h_a_dec_0.pdf@2006-05-19 00:00:00@Ganfort@bimatoprost/timolol@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_0.pdf@EU-1-06-342_h_a_dec_0.pdf@2006-07-19 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@adopted@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_0.pdf@EU-1-06-341_h_a_dec_0.pdf@2006-05-19 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_0.pdf@EU-1-06-350_h_a_dec_0.pdf@2006-07-28 00:00:00@Savene@Dexrazoxane@NAS before 2012@NA before 2012@adopted@TopoTarget A/S@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_0.pdf@EU-1-06-346_h_a_dec_0.pdf@2006-06-27 00:00:00@Tysabri@Natalizumab@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_0.pdf@EU-1-06-348_h_a_dec_0.pdf@2006-06-27 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_0.pdf@EU-1-06-343_h_a_dec_0.pdf@2006-06-26 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_0.pdf@EU-1-06-354_h_a_dec_0.pdf@2006-07-28 00:00:00@Competact@Pioglitazone /  metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_0.pdf@EU-1-06-359_h_a_dec_0.pdf@2006-09-26 00:00:00@Suboxone@buprenorphine /  naloxone@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_0.pdf@EU-1-03-256_h_a_dec_0.pdf@2003-08-09 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-06-361_h_a_dec_0.pdf@EU-1-06-361_h_a_dec_0.pdf@2006-09-20 00:00:00@Luminity@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_0.pdf@EU-1-06-357_h_a_dec_0.pdf@2006-09-20 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_0.pdf@EU-1-05-331_h_a_dec_0.pdf@2006-02-15 00:00:00@Neupro@Rotigotine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_0.pdf@EU-1-06-347_h_a_dec_0.pdf@2006-07-19 00:00:00@SUTENT@sunitinib@NAS before 2012@NA before 2012@adopted@Pfizer Ltd@conditional@Parsed
EU-1-06-360_h_a_dec_0.pdf@EU-1-06-360_h_a_dec_0.pdf@2006-09-26 00:00:00@Champix@varenicline tartrate@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_0.pdf@EU-1-06-356_h_a_dec_0.pdf@2006-08-28 00:00:00@Exjade@deferasirox@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_0.pdf@EU-1-06-365_h_a_dec_0.pdf@2007-08-01 00:00:00@Elaprase@Idursulfase@NAS before 2012@NA before 2012@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-364_h_a_dec_0.pdf@EU-1-06-364_h_a_dec_0.pdf@2007-04-01 00:00:00@ADROVANCE@Alendronate sodium  / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_0.pdf@EU-1-06-362_h_a_dec_0.pdf@2006-11-20 00:00:00@BYETTA@exenatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_0.pdf@EU-1-06-367_h_a_dec_0.pdf@2007-04-01 00:00:00@Diacomit@Stiripentol@NAS before 2012@NA before 2012@adopted@Biocodex@conditional@Parsed
EU-1-06-366_h_a_dec_0.pdf@EU-1-06-366_h_a_dec_0.pdf@2007-08-01 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_0.pdf@EU-1-06-370_h_a_dec_0.pdf@2007-01-17 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_0.pdf@EU-1-06-371_h_a_dec_0.pdf@2007-01-16 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_0.pdf@EU-1-06-372_h_a_dec_0.pdf@2007-01-16 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_0.pdf@EU-1-06-379_h_a_dec_0.pdf@2007-02-15 00:00:00@Cystadane@Betaine anhydrous@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_0.pdf@EU-1-06-378_h_a_dec_0.pdf@2007-01-16 00:00:00@Inovelon@Rufinamide@NAS before 2012@NA before 2012@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_0.pdf@EU-1-06-374_h_a_dec_0.pdf@2007-01-22 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_0.pdf@EU-1-07-386_h_a_dec_0.pdf@2007-04-20 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_0.pdf@EU-1-06-376_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_0.pdf@EU-1-07-382_h_a_dec_0.pdf@2007-03-21 00:00:00@Xelevia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_0.pdf@EU-1-07-383_h_a_dec_0.pdf@2007-03-21 00:00:00@Januvia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_0.pdf@EU-1-06-363_h_a_dec_0.pdf@2006-11-20 00:00:00@Sprycel@Dasatinib@NAS before 2012@NA before 2012@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_0.pdf@EU-1-07-392_h_a_dec_0.pdf@2007-06-29 00:00:00@Circadin@melatonin@NAS before 2012@NA before 2012@OD Not Found@Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_0.pdf@EU-1-06-377_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_0.pdf@EU-1-07-389_h_a_dec_0.pdf@2007-05-21 00:00:00@ORENCIA@abatacept@NAS before 2012@NA before 2012@OD Not Found@BRISTOL MYERS SQUIBB PHARMA  EEIG@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_0.pdf@EU-1-07-387_h_a_dec_0.pdf@2007-04-23 00:00:00@Advagraf@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_0.pdf@EU-1-07-396_h_a_dec_0.pdf@2007-06-25 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_0.pdf@EU-1-07-399_h_a_dec_0.pdf@2007-07-30 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_0.pdf@EU-1-07-393_h_a_dec_0.pdf@2007-06-20 00:00:00@Soliris@Eculizumab@NAS before 2012@NA before 2012@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_0.pdf@EU-1-07-397_h_a_dec_0.pdf@2007-06-29 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@NA before 2012@adopted@OTL Pharma/Addmedica@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_0.pdf@EU-1-07-403_h_a_dec_0.pdf@2007-08-22 00:00:00@Atriance@nelarabine@NAS before 2012@NA before 2012@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-401_h_a_dec_0.pdf@EU-1-07-401_h_a_dec_0.pdf@2007-07-23 00:00:00@Orlistat GSK@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_0.pdf@EU-1-07-402_h_a_dec_0.pdf@2007-03-08 00:00:00@INCRELEX@Mecasermin@NAS before 2012@NA before 2012@adopted@Tercica Europe Limited@exceptional@Parsed
EU-1-07-404_h_a_dec_0.pdf@EU-1-07-404_h_a_dec_0.pdf@2007-08-23 00:00:00@Flebogammadif@human normal  immunoglobulin@NAS before 2012@NA before 2012@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_0.pdf@EU-1-07-395_h_a_dec_0.pdf@2007-06-25 00:00:00@Invega@paliperidone@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_0.pdf@EU-1-07-405_h_a_dec_0.pdf@2007-08-22 00:00:00@Rasilez@aliskiren@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_0.pdf@EU-1-07-413_h_a_dec_0.pdf@2007-07-09 00:00:00@Gliolan@5-aminolevulinic acid hydrochloride@NAS before 2012@NA before 2012@adopted@Medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_0.pdf@EU-1-07-414_h_a_dec_0.pdf@2007-09-26 00:00:00@Galvus@vildagliptin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_0.pdf@EU-1-07-400_h_a_dec_0.pdf@2007-07-20 00:00:00@MIRCERA@methoxy polyethylene glycol-epoetin  beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_0.pdf@EU-1-07-416_h_a_dec_0.pdf@2007-09-20 00:00:00@ECALTA@anidulafungin@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_0.pdf@EU-1-06-380_h_a_dec_0.pdf@2007-12-02 00:00:00@Prezista@darunavir”, a  medicinal product for human use  (Text with EEA relevance)   THE COMMISSION OF THE EUROPEAN COMMUNITIES,  Having regard to the Treaty establishing the European Community,     Having regard to Regulation (EC) No 726/2004  the European Parliament and  the  Council  31 March 2004 laying down Community procedures for the authorisation and  supervision  medicinal products for human and veterinary use and establishing a  European Medicines Agency 1, and in particular Article 10(2) and 14(7) thereof, Having regard to Commission Regulation (EC) No 507/2006 on the conditional  marketing authorisation for medicinal products for human use falling within the scope   Regulation (EC) No 726/2004  the European Parliament and  the Council 2, Having regard to the application submitted by Janssen-Cilag International NV on 1  February 2006 under Article 4(1)  Regulation (EC) No 726/2004,   Having regard to the opinion  the European Medicines Agency, formulated by the  Committee for Medicinal Products for Human Use on 14 December 2006,   Whereas:   (1)@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-07-410_h_a_dec_0.pdf@EU-1-07-410_h_a_dec_0.pdf@2007-08-28 00:00:00@Binocrit@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_0.pdf@EU-1-07-391_h_a_dec_0.pdf@2007-06-14 00:00:00@Revlimid@lenalidomide@NAS before 2012@NA before 2012@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_0.pdf@EU-1-07-411_h_a_dec_0.pdf@2007-08-28 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@HEXAL Biotech ForschungsGmbH@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_0.pdf@EU-1-07-420_h_a_dec_0.pdf@2007-11-23 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@NA before 2012@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_0.pdf@EU-1-07-417_h_a_dec_0.pdf@2007-09-17 00:00:00@Yondelis@Trabectedin@NAS before 2012@NA before 2012@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-412_h_a_dec_0.pdf@EU-1-07-412_h_a_dec_0.pdf@2007-08-28 00:00:00@Abseamed@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_0.pdf@EU-1-07-418_h_a_dec_0.pdf@2007-09-17 00:00:00@CELSENTRI@maraviroc@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_0.pdf@EU-1-07-415_h_a_dec_0.pdf@2007-09-27 00:00:00@Zalasta@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_0.pdf@EU-1-07-423_h_a_dec_0.pdf@2007-03-12 00:00:00@Vectibix@panitumumab@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-419_h_a_dec_0.pdf@EU-1-07-419_h_a_dec_0.pdf@2007-09-20 00:00:00@Cervarix@16 and Human Papilloma Virus 18 L1 proteins@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_0.pdf@EU-1-07-425_h_a_dec_0.pdf@2007-11-14 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_0.pdf@EU-1-07-424_h_a_dec_0.pdf@2007-11-19 00:00:00@TORISEL@Temsirolimus@NAS before 2012@NA before 2012@adopted@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_0.pdf@EU-1-07-433_h_a_dec_0.pdf@2007-11-12 00:00:00@NEVANAC@nepafenac@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_0.pdf@EU-1-07-434_h_a_dec_0.pdf@2008-11-01 00:00:00@Avamys@Flucticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_0.pdf@EU-1-07-428_h_a_dec_0.pdf@2008-01-14 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_0.pdf@EU-1-07-422_h_a_dec_0.pdf@2007-11-19 00:00:00@Tasigna@Nilotinib@NAS before 2012@NA before 2012@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_0.pdf@EU-1-07-437_h_a_dec_0.pdf@2008-11-01 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_0.pdf@EU-1-07-438_h_a_dec_0.pdf@2008-02-21 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_0.pdf@EU-1-07-435_h_a_dec_0.pdf@2008-10-01 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_0.pdf@EU-1-07-439_h_a_dec_0.pdf@2008-02-21 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_0.pdf@EU-1-07-431_h_a_dec_0.pdf@2007-12-18 00:00:00@Retacrit@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_0.pdf@EU-1-07-432_h_a_dec_0.pdf@2007-12-18 00:00:00@Silapo@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_0.pdf@EU-1-07-427_h_a_dec_0.pdf@2007-12-12 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_0.pdf@EU-1-07-440_h_a_dec_0.pdf@2008-10-06 00:00:00@Tyverb@lapatinib@NAS before 2012@True@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-436_h_a_dec_0.pdf@EU-1-07-436_h_a_dec_0.pdf@2007-12-20 00:00:00@ISENTRESS@raltegravir@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Limited@conditional@Parsed
EU-1-08-446_h_a_dec_0.pdf@EU-1-08-446_h_a_dec_0.pdf@2008-04-25 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_0.pdf@EU-1-08-445_h_a_dec_0.pdf@2008-09-15 00:00:00@Tevagrastim@filgrastim@NAS before 2012@True@OD Not Found@Teva Generics GmbH@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_0.pdf@EU-1-08-444_h_a_dec_0.pdf@2008-09-15 00:00:00@Ratiograstim@filgrastim@NAS before 2012@True@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_0.pdf@EU-1-08-443_h_a_dec_0.pdf@2008-04-16 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@adopted@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_0.pdf@EU-1-08-447_h_a_dec_0.pdf@2008-04-21 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Ipsen Manufacturing Ireland Ltd (IMIL),@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_0.pdf@EU-1-08-448_h_a_dec_0.pdf@2008-04-25 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_0.pdf@EU-1-08-441_h_a_dec_0.pdf@2008-04-04 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_0.pdf@EU-1-08-454_h_a_dec_0.pdf@2008-05-20 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_0.pdf@EU-1-08-451_h_a_dec_0.pdf@2008-04-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_0.pdf@EU-1-08-461_h_a_dec_0.pdf@2008-11-07 00:00:00@Firazyr@icatibant@NAS before 2012@True@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_0.pdf@EU-1-08-455_h_a_dec_0.pdf@2008-07-16 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_0.pdf@EU-1-08-456_h_a_dec_0.pdf@2008-07-16 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_0.pdf@EU-1-08-457_h_a_dec_0.pdf@2008-07-16 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_0.pdf@EU-1-08-466_h_a_dec_0.pdf@2008-07-25 00:00:00@Bridion@sugammadex@NAS before 2012@True@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_0.pdf@EU-1-08-463_h_a_dec_0.pdf@2008-02-07 00:00:00@RELISTOR@methylnaltrexone  bromide@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_0.pdf@EU-1-08-462_h_a_dec_0.pdf@2008-09-07 00:00:00@Latixa@ranolazine@NAS before 2012@True@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_0.pdf@EU-1-08-465_h_a_dec_0.pdf@2008-07-16 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_0.pdf@EU-1-08-473_h_a_dec_0.pdf@2008-06-10 00:00:00@EVICEL@human fibrinogen / human  thrombin@NAS before 2012@True@OD Not Found@OMRIX biopharmaceuticals S.A.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_0.pdf@EU-1-08-442_h_a_dec_0.pdf@2008-03-18 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_0.pdf@EU-1-08-476_h_a_dec_0.pdf@2008-01-10 00:00:00@Tadalafil Lilly@tadalafil@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_0.pdf@EU-1-08-469_h_a_dec_0.pdf@2008-12-09 00:00:00@Oprymea@Pramipexole@NAS before 2012@True@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_0.pdf@EU-1-08-477_h_a_dec_0.pdf@2008-07-10 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@True@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-468_h_a_dec_0.pdf@EU-1-08-468_h_a_dec_0.pdf@2008-08-28 00:00:00@INTELENCE@etravirine@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-481_h_a_dec_0.pdf@EU-1-08-481_h_a_dec_0.pdf@2008-02-12 00:00:00@Kuvan@sapropterin  dihydrochloride@NAS before 2012@False@adopted@Merck KGaA@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_0.pdf@EU-1-08-480_h_a_dec_0.pdf@2008-01-12 00:00:00@Irbesartan Krka@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_0.pdf@EU-1-08-482_h_a_dec_0.pdf@2008-11-25 00:00:00@AZARGA@brinzolamide / timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_0.pdf@EU-1-08-475_h_a_dec_0.pdf@2008-07-10 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@True@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_0.pdf@EU-1-08-479_h_a_dec_0.pdf@2008-11-19 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_0.pdf@EU-1-08-483_h_a_dec_0.pdf@2008-01-12 00:00:00@Zomarist@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_0.pdf@EU-1-08-485_h_a_dec_0.pdf@2008-11-19 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_0.pdf@EU-1-08-486_h_a_dec_0.pdf@2008-11-19 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_0.pdf@EU-1-08-484_h_a_dec_0.pdf@2008-01-12 00:00:00@Vildagliptin/metformin  hydrochloride Novartis@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_0.pdf@EU-1-08-488_h_a_dec_0.pdf@2008-12-17 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_0.pdf@EU-1-08-490_h_a_dec_0.pdf@2008-12-18 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_0.pdf@EU-1-08-495_h_a_dec_0.pdf@2009-06-02 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_0.pdf@EU-1-08-470_h_a_dec_0.pdf@2008-08-29 00:00:00@Vimpat@lacosamide@NAS before 2012@True@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_0.pdf@EU-1-08-496_h_a_dec_0.pdf@2009-06-02 00:00:00@Filgrastim Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_0.pdf@EU-1-08-498_h_a_dec_0.pdf@2009-02-19 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_0.pdf@EU-1-08-499_h_a_dec_0.pdf@2009-02-19 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_0.pdf@EU-1-08-501_h_a_dec_0.pdf@2009-03-31 00:00:00@IXIARO@Japanese Encephalitis  vaccine (inactivated, adsorbed)@NAS before 2012@False@adopted@Intercell AG@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_0.pdf@EU-1-08-502_h_a_dec_0.pdf@2009-06-03 00:00:00@MEPACT@mifamurtide@NAS before 2012@False@adopted@IDM Pharma S.A.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_0.pdf@EU-1-08-472_h_a_dec_0.pdf@2008-09-30 00:00:00@Xarelto@rivaroxaban@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_0.pdf@EU-1-08-503_h_a_dec_0.pdf@2009-02-25 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_0.pdf@EU-1-08-504_h_a_dec_0.pdf@2009-02-17 00:00:00@FIRMAGON@degarelix (as acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_0.pdf@EU-1-09-511_h_a_dec_0.pdf@2009-04-17 00:00:00@CONBRIZA@bazedoxifene@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_0.pdf@EU-1-09-515_h_a_dec_0.pdf@2009-12-06 00:00:00@CONTROLOC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_0.pdf@EU-1-09-516_h_a_dec_0.pdf@2009-12-06 00:00:00@SOMAC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_0.pdf@EU-1-08-497_h_a_dec_0.pdf@2009-04-02 00:00:00@Nplate@romiplostim@NAS before 2012@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_0.pdf@EU-1-08-492_h_a_dec_0.pdf@2009-01-16 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_0.pdf@EU-1-09-517_h_a_dec_0.pdf@2009-12-06 00:00:00@PANTOZOL Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_0.pdf@EU-1-09-508_h_a_dec_0.pdf@2009-03-30 00:00:00@Synflorix@Pneumococcal  polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_0.pdf@EU-1-09-522_h_a_dec_0.pdf@2009-05-15 00:00:00@Ellaone@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_0.pdf@EU-1-09-524_h_a_dec_0.pdf@2009-05-15 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@NeurogesX UK Limited@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_0.pdf@EU-1-09-521_h_a_dec_0.pdf@2009-10-06 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_0.pdf@EU-1-09-523_h_a_dec_0.pdf@2009-05-15 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_0.pdf@EU-1-09-528_h_a_dec_0.pdf@2009-02-07 00:00:00@Nymusa@Caffeine citrate@NAS before 2012@False@adopted@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_0.pdf@EU-1-09-526_h_a_dec_0.pdf@2009-06-24 00:00:00@IRESSA@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_0.pdf@EU-1-09-530_h_a_dec_0.pdf@2009-06-29 00:00:00@Repaglinide Teva@Repaglinide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_0.pdf@EU-1-09-525_h_a_dec_0.pdf@2009-11-05 00:00:00@Nimvastid@Rivastigmine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_0.pdf@EU-1-09-533_h_a_dec_0.pdf@2009-07-24 00:00:00@Vedrop@tocofersolan@NAS before 2012@False@OD Not Found@Orphan Europe SARL@exceptional@Parsed
EU-1-09-535_h_a_dec_0.pdf@EU-1-09-535_h_a_dec_0.pdf@2009-07-28 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_0.pdf@EU-1-09-514_h_a_dec_0.pdf@2009-04-21 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_0.pdf@EU-1-08-494_h_a_dec_0.pdf@2009-01-16 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_0.pdf@EU-1-09-537_h_a_dec_0.pdf@2009-07-31 00:00:00@Mozobil@plerixafor@NAS before 2012@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_0.pdf@EU-1-09-539_h_a_dec_0.pdf@2009-03-08 00:00:00@Samsca@tolvaptan@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_0.pdf@EU-1-09-529_h_a_dec_0.pdf@2009-06-30 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_0.pdf@EU-1-09-540_h_a_dec_0.pdf@2009-07-28 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_0.pdf@EU-1-09-543_h_a_dec_0.pdf@2009-09-21 00:00:00@Cayston@aztreonam@NAS before 2012@False@adopted@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-550_h_a_dec_0.pdf@EU-1-09-550_h_a_dec_0.pdf@2009-09-21 00:00:00@Javlor@vinflunine ditartrate@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_0.pdf@EU-1-09-538_h_a_dec_0.pdf@2009-03-08 00:00:00@Afinitor@everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_0.pdf@EU-1-09-531_h_a_dec_0.pdf@2009-07-20 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_0.pdf@EU-1-09-553_h_a_dec_0.pdf@2009-09-28 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_0.pdf@EU-1-09-555_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_0.pdf@EU-1-09-545_h_a_dec_0.pdf@2009-01-10 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_0.pdf@EU-1-09-556_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_0.pdf@EU-1-09-551_h_a_dec_0.pdf@2009-09-21 00:00:00@Vizarsin@sildenafil@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_0.pdf@EU-1-09-558_h_a_dec_0.pdf@2009-09-21 00:00:00@Zylagren@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_0.pdf@EU-1-09-566_h_a_dec_0.pdf@2009-10-23 00:00:00@Lamivudine Teva@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_0.pdf@EU-1-09-562_h_a_dec_0.pdf@2009-09-21 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_0.pdf@EU-1-09-559_h_a_dec_0.pdf@2009-09-21 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_0.pdf@EU-1-09-544_h_a_dec_0.pdf@2009-01-10 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_0.pdf@EU-1-09-571_h_a_dec_0.pdf@2009-10-16 00:00:00@PANDEMIC  INFLUENZA VACCINE H5N1 BAXTER@Pandemic influenza vaccine (H5N1  whole virion, Vero cell derived, inactivated)@NAS before 2012@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-568_h_a_dec_0.pdf@EU-1-09-568_h_a_dec_0.pdf@2009-10-16 00:00:00@Clopidogrel MYLAN Pharma@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_0.pdf@EU-1-09-572_h_a_dec_0.pdf@2009-10-16 00:00:00@ALENDRONATE SODIUM AND  COLECALCIFEROL, MSD@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_0.pdf@EU-1-09-565_h_a_dec_0.pdf@2009-10-23 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_0.pdf@EU-1-09-564_h_a_dec_0.pdf@2009-10-23 00:00:00@ILARIS@canakinumab@NAS before 2012@False@adopted@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-573_h_a_dec_0.pdf@EU-1-09-573_h_a_dec_0.pdf@2009-10-29 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_0.pdf@EU-1-09-576_h_a_dec_0.pdf@2009-10-30 00:00:00@Irbesartan Teva@Irbesartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_0.pdf@EU-1-09-577_h_a_dec_0.pdf@2009-10-19 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@exceptional@Parsed
EU-1-09-578_h_a_dec_0.pdf@EU-1-09-578_h_a_dec_0.pdf@2009-10-19 00:00:00@Pandemic  influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline  Biologicals@Pandemic influenza vaccine (H5N1) (split virion, inactivated,  adjuvanted) A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@exceptional@Parsed
EU-1-09-579_h_a_dec_0.pdf@EU-1-09-579_h_a_dec_0.pdf@2009-04-11 00:00:00@Repaglinide Krka@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_0.pdf@EU-1-09-580_h_a_dec_0.pdf@2009-10-14 00:00:00@Enyglid@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_0.pdf@EU-1-09-581_h_a_dec_0.pdf@2009-10-15 00:00:00@Resolor@prucalopride@NAS before 2012@False@OD Not Found@Movetis NV@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_0.pdf@EU-1-09-546_h_a_dec_0.pdf@2009-01-10 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_0.pdf@EU-1-09-569_h_a_dec_0.pdf@2009-10-16 00:00:00@Exforge HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_0.pdf@EU-1-09-584_h_a_dec_0.pdf@2009-11-30 00:00:00@Sildenafil Teva@sildenafil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_0.pdf@EU-1-09-583_h_a_dec_0.pdf@2009-11-26 00:00:00@Irbesartan / Hydrochlorothiazide  Teva@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_0.pdf@EU-1-09-574_h_a_dec_0.pdf@2009-04-11 00:00:00@Dafiro HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_0.pdf@EU-1-09-585_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@NAS before 2012@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_0.pdf@EU-1-09-586_h_a_dec_0.pdf@2009-11-30 00:00:00@Oslif Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_0.pdf@EU-1-09-575_h_a_dec_0.pdf@2009-04-11 00:00:00@Copalia HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_0.pdf@EU-1-09-588_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark Europe@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_0.pdf@EU-1-09-589_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine HEXAL@Rivastigmine@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_0.pdf@EU-1-09-591_h_a_dec_0.pdf@2009-11-26 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_0.pdf@EU-1-09-587_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_0.pdf@EU-1-09-595_h_a_dec_0.pdf@2009-10-12 00:00:00@Sildenafil Actavis@Sildenafil@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_0.pdf@EU-1-09-596_h_a_dec_0.pdf@2009-10-12 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_0.pdf@EU-1-09-590_h_a_dec_0.pdf@2009-09-12 00:00:00@Prevenar 13@Pneumococcal  polysaccharide conjugate vaccine (13-valent, adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_0.pdf@EU-1-09-593_h_a_dec_0.pdf@2009-11-30 00:00:00@Onbrez Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_0.pdf@EU-1-09-592_h_a_dec_0.pdf@2009-10-12 00:00:00@Olazax Disperzi@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_0.pdf@EU-1-09-594_h_a_dec_0.pdf@2009-11-30 00:00:00@Hirobriz Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_0.pdf@EU-1-09-600_h_a_dec_0.pdf@2009-11-30 00:00:00@Zutectra@Human Hepatitis B  Immunoglobulin@NAS before 2012@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_0.pdf@EU-1-09-598_h_a_dec_0.pdf@2009-11-30 00:00:00@Nevirapine Teva@nevirapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_0.pdf@EU-1-09-602_h_a_dec_0.pdf@2010-11-01 00:00:00@Scintimun@besilesomab@NAS before 2012@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_0.pdf@EU-1-09-601_h_a_dec_0.pdf@2009-12-23 00:00:00@Zenas@amifampridine@NAS before 2012@False@adopted@EUSA Pharma SAS@exceptional@Parsed
EU-1-09-603_h_a_dec_0.pdf@EU-1-09-603_h_a_dec_0.pdf@2009-12-23 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_0.pdf@EU-1-09-597_h_a_dec_0.pdf@2009-11-12 00:00:00@Olazax@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_0.pdf@EU-1-09-607_h_a_dec_0.pdf@2010-01-29 00:00:00@Silodyx@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_0.pdf@EU-1-09-599_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine Sandoz@Rivastigmine@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_0.pdf@EU-1-09-608_h_a_dec_0.pdf@2010-01-29 00:00:00@Urorec@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_0.pdf@EU-1-09-604_h_a_dec_0.pdf@2010-08-01 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_0.pdf@EU-1-09-609_h_a_dec_0.pdf@2010-01-25 00:00:00@Elonva@corifollitropin alfa@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_0.pdf@EU-1-10-614_h_a_dec_0.pdf@2010-03-15 00:00:00@Menveo@Meningococcal Group A, C,  W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_0.pdf@EU-1-09-606_h_a_dec_0.pdf@2010-01-28 00:00:00@Temozolomide Teva@Temozolomide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_0.pdf@EU-1-09-605_h_a_dec_0.pdf@2010-01-25 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@ALFRED E. TIEFENBACHER, (GmbH  & Co. KG)@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_0.pdf@EU-1-10-619_h_a_dec_0.pdf@2010-03-15 00:00:00@DuoPlavin@clopidogrel /  acetylsalicylic acid@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_0.pdf@EU-1-10-627_h_a_dec_0.pdf@2010-04-29 00:00:00@Raloxifene Teva@Raloxifene  hydrochloride@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_0.pdf@EU-1-10-620_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristfor@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_0.pdf@EU-1-10-618_h_a_dec_0.pdf@2010-05-26 00:00:00@Prolia@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_0.pdf@EU-1-10-622_h_a_dec_0.pdf@2010-03-15 00:00:00@TEPADINA@Thiotepa@NAS before 2012@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_0.pdf@EU-1-10-615_h_a_dec_0.pdf@2010-03-15 00:00:00@Temozolomide Hospira@Temozolomide@NAS before 2012@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_0.pdf@EU-1-10-633_h_a_dec_0.pdf@2010-10-06 00:00:00@Topotecan Hospira@Topotecan@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_0.pdf@EU-1-10-621_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_0.pdf@EU-1-10-632_h_a_dec_0.pdf@2010-04-06 00:00:00@Tolura@telmisartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_0.pdf@EU-1-10-612_h_a_dec_0.pdf@2010-11-03 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@adopted@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_0.pdf@EU-1-10-631_h_a_dec_0.pdf@2010-08-06 00:00:00@Nivestim@Filgrastim@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_0.pdf@EU-1-10-636_h_a_dec_0.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_0.pdf@EU-1-10-637_h_a_dec_0.pdf@2010-07-27 00:00:00@Leflunomide medac@leflunomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_0.pdf@EU-1-10-639_h_a_dec_0.pdf@2010-09-30 00:00:00@Telmisartan Actavis@telmisartan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_0.pdf@EU-1-10-638_h_a_dec_0.pdf@2010-07-27 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_0.pdf@EU-1-10-641_h_a_dec_0.pdf@2010-10-28 00:00:00@Ruconest@conestat alfa@NAS before 2012@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_0.pdf@EU-1-10-642_h_a_dec_0.pdf@2010-09-17 00:00:00@Ibandronic Acid Teva@Ibandronic  acid@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_0.pdf@EU-1-10-628_h_a_dec_0.pdf@2010-06-14 00:00:00@Votrient@Pazopanib  hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-643_h_a_dec_0.pdf@EU-1-10-643_h_a_dec_0.pdf@2010-06-09 00:00:00@Rapiscan@regadenoson@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_0.pdf@EU-1-10-645_h_a_dec_0.pdf@2010-01-09 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_0.pdf@EU-1-10-640_h_a_dec_0.pdf@2010-01-09 00:00:00@Sycrest@asenapine@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_0.pdf@EU-1-10-646_h_a_dec_0.pdf@2010-08-26 00:00:00@VPRIV@Velaglucerase alfa@NAS before 2012@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_0.pdf@EU-1-10-647_h_a_dec_0.pdf@2010-07-10 00:00:00@Myclausen@mycophenolate mofetil@NAS before 2012@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_0.pdf@EU-1-10-644_h_a_dec_0.pdf@2010-08-31 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_0.pdf@EU-1-10-635_h_a_dec_0.pdf@2010-10-06 00:00:00@Olanzapine Apotex@Olanzapine@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_0.pdf@EU-1-10-652_h_a_dec_0.pdf@2011-07-20 00:00:00@TOBI Podhaler@Tobramycin@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_0.pdf@EU-1-10-654_h_a_dec_0.pdf@2010-11-29 00:00:00@Leflunomide ratiopharm@leflunomide@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_0.pdf@EU-1-10-660_h_a_dec_0.pdf@2011-06-01 00:00:00@Potactasol@topotecan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_0.pdf@EU-1-10-665_h_a_dec_0.pdf@2011-02-18 00:00:00@Entacapone Teva@entacapone@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_0.pdf@EU-1-10-658_h_a_dec_0.pdf@2010-11-29 00:00:00@Aflunov@Prepandemic influenza  vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_0.pdf@EU-1-10-663_h_a_dec_0.pdf@2011-02-28 00:00:00@Lamivudine / Zidovudine Teva@lamivudine, zidovudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_0.pdf@EU-1-10-659_h_a_dec_0.pdf@2011-01-21 00:00:00@Iasibon@Ibandronic acid@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_0.pdf@EU-1-11-673_h_a_dec_0.pdf@2011-04-03 00:00:00@Ifirmacombi@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_0.pdf@EU-1-10-648_h_a_dec_0.pdf@2010-07-10 00:00:00@Twynsta@telmisartan / amlodipine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_0.pdf@EU-1-10-655_h_a_dec_0.pdf@2010-03-12 00:00:00@Brilique@ticagrelor@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_0.pdf@EU-1-11-667_h_a_dec_0.pdf@2011-02-28 00:00:00@Esbriet@Pirfenidone@NAS before 2012@False@adopted@InterMune Europe Ltd@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_0.pdf@EU-1-11-679_h_a_dec_0.pdf@2011-04-14 00:00:00@Pravafenix@fenofibrate /  pravastatin@NAS before 2012@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_0.pdf@EU-1-11-682_h_a_dec_0.pdf@2011-06-05 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@NAS before 2012@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_0.pdf@EU-1-11-676_h_a_dec_0.pdf@2011-03-17 00:00:00@JEVTANA@cabazitaxel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_0.pdf@EU-1-11-685_h_a_dec_0.pdf@2011-07-26 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_0.pdf@EU-1-11-669_h_a_dec_0.pdf@2011-03-14 00:00:00@Teysuno@Tegafur/gimeracil/oteracil@NAS before 2012@False@OD Not Found@Taiho Pharma Europe, Limited@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_0.pdf@EU-1-11-678_h_a_dec_0.pdf@2011-03-17 00:00:00@HALAVEN@eribulin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_0.pdf@EU-1-11-687_h_a_dec_0.pdf@2011-04-14 00:00:00@Hizentra@human normal immunoglobulin@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_0.pdf@EU-1-11-692_h_a_dec_0.pdf@2011-05-18 00:00:00@Yellox@bromfenac@NAS before 2012@False@OD Not Found@Croma-Pharma GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_0.pdf@EU-1-11-688_h_a_dec_0.pdf@2011-06-15 00:00:00@Cinryze@C1 inhibitor, human@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_0.pdf@EU-1-11-672_h_a_dec_0.pdf@2011-04-03 00:00:00@Xeplion@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_0.pdf@EU-1-11-690_h_a_dec_0.pdf@2011-07-27 00:00:00@Zoely@nomegestrol/estradiol@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_0.pdf@EU-1-11-693_h_a_dec_0.pdf@2011-06-16 00:00:00@Rivastigmine Actavis@Rivastigmine@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_0.pdf@EU-1-11-677_h_a_dec_0.pdf@2011-03-17 00:00:00@GILENYA@Fingolimod@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_0.pdf@EU-1-11-694_h_a_dec_0.pdf@2011-06-17 00:00:00@NULOJIX@belatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_0.pdf@EU-1-11-691_h_a_dec_0.pdf@2011-05-18 00:00:00@Eliquis@apixaban@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_0.pdf@EU-1-11-699_h_a_dec_0.pdf@2011-07-20 00:00:00@Fampyra@fampridine@NAS before 2012@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-701_h_a_dec_0.pdf@EU-1-11-701_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam Teva@Levetiracetam@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_0.pdf@EU-1-11-697_h_a_dec_0.pdf@2011-07-13 00:00:00@Temozolomide Sun@Temozolomide@NAS before 2012@False@OD Not Found@Sun Pharmaceuticals Industries Europe  B.V.@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_0.pdf@EU-1-11-702_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam ratiopharm@Levetiracetam@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_0.pdf@EU-1-11-703_h_a_dec_0.pdf@2011-07-13 00:00:00@Xgeva@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_0.pdf@EU-1-11-708_h_a_dec_0.pdf@2011-08-18 00:00:00@Entacapone Orion@entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_0.pdf@EU-1-11-700_h_a_dec_0.pdf@2011-07-13 00:00:00@Benlysta@belimumab@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_0.pdf@EU-1-11-696_h_a_dec_0.pdf@2011-06-17 00:00:00@BYDUREON@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_0.pdf@EU-1-11-706_h_a_dec_0.pdf@2011-08-24 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_0.pdf@EU-1-11-707_h_a_dec_0.pdf@2011-08-24 00:00:00@Trajenta@linagliptin@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_0.pdf@EU-1-11-698_h_a_dec_0.pdf@2011-07-13 00:00:00@Yervoy@ipilimumab@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_0.pdf@EU-1-11-709_h_a_dec_0.pdf@2011-05-09 00:00:00@Buccolam@Midazolam@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_0.pdf@EU-1-11-712_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Accord@Levetiracetam@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_0.pdf@EU-1-11-713_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Actavis@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_0.pdf@EU-1-11-715_h_a_dec_0.pdf@2011-03-11 00:00:00@Plenadren@Hydrocortisone@NAS before 2012@False@adopted@DuoCort Pharma AB@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_0.pdf@EU-1-11-711_h_a_dec_0.pdf@2011-03-10 00:00:00@Matever@Levetiracetam@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_0.pdf@EU-1-11-717_h_a_dec_0.pdf@2011-11-16 00:00:00@Vyndaqel@tafamidis@NAS before 2012@False@adopted@Pfizer Specialty UK Limited@exceptional@Parsed
EU-1-11-718_h_a_dec_0.pdf@EU-1-11-718_h_a_dec_0.pdf@2011-09-16 00:00:00@Dexdor@dexmedetomidine@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_0.pdf@EU-1-11-722_h_a_dec_0.pdf@2012-03-21 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_0.pdf@EU-1-11-732_h_a_dec_0.pdf@2011-11-24 00:00:00@Desloratadine Teva@desloratadine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_0.pdf@EU-1-11-716_h_a_dec_0.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_0.pdf@EU-1-11-727_h_a_dec_0.pdf@2012-09-03 00:00:00@Mercaptopurine Nova Laboratories@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_0.pdf@EU-1-11-719_h_a_dec_0.pdf@2011-03-10 00:00:00@Telmisartan Teva Pharma@telmisartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_0.pdf@EU-1-11-733_h_a_dec_0.pdf@2011-05-12 00:00:00@Dificlir@fidaxomicin@NAS before 2012@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_0.pdf@EU-1-11-714_h_a_dec_0.pdf@2011-05-09 00:00:00@Zytiga@abiraterone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_0.pdf@EU-1-11-734_h_a_dec_0.pdf@2011-07-12 00:00:00@Edarbi@azilsartan medoxomil@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_0.pdf@EU-1-11-739_h_a_dec_0.pdf@2011-11-28 00:00:00@Dasselta@desloratadine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_0.pdf@EU-1-11-736_h_a_dec_0.pdf@2011-11-28 00:00:00@EDURANT@rilpivirine@NAS before 2012@False@OD Not Found@Janssen Cilag International NV@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_0.pdf@EU-1-11-738_h_a_dec_0.pdf@2011-05-12 00:00:00@Levetiracetam Actavis Group@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_0.pdf@EU-1-11-731_h_a_dec_0.pdf@2011-11-24 00:00:00@Komboglyze@saxagliptin / metformin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_0.pdf@EU-1-11-740_h_a_dec_0.pdf@2011-12-14 00:00:00@Ameluz@5-aminolevulinic acid@NAS before 2012@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_0.pdf@EU-1-11-741_h_a_dec_0.pdf@2011-12-14 00:00:00@Levetiracetam SUN@Levetiracetam@NAS before 2012@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_0.pdf@EU-1-11-745_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_0.pdf@EU-1-11-743_h_a_dec_0.pdf@2011-12-22 00:00:00@Repaglinide Accord@Repaglinide@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_0.pdf@EU-1-11-746_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_0.pdf@EU-1-11-742_h_a_dec_0.pdf@2012-09-01 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma BV@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_0.pdf@EU-1-11-747_h_a_dec_0.pdf@2012-02-13 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_0.pdf@EU-1-11-737_h_a_dec_0.pdf@2011-11-28 00:00:00@Eviplera@emtricitabine / rilpivirine (as  hydrochloride) / tenofovir disoproxil (as fumarate)@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_0.pdf@EU-1-12-755_h_a_dec_0.pdf@2012-03-15 00:00:00@Pioglitazone Actavis@Pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_0.pdf@EU-1-12-750_h_a_dec_0.pdf@2012-02-23 00:00:00@Esmya@ulipristal@False@False@OD Not Found@PregLem France SAS.@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_0.pdf@EU-1-12-757_h_a_dec_0.pdf@2012-03-26 00:00:00@Pioglitazone Teva@Pioglitazone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_0.pdf@EU-1-12-751_h_a_dec_0.pdf@2012-02-17 00:00:00@Zelboraf@vemurafenib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_0.pdf@EU-1-11-749_h_a_dec_0.pdf@2012-02-17 00:00:00@Caprelsa@Vandetanib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-759_h_a_dec_0.pdf@EU-1-12-759_h_a_dec_0.pdf@2012-04-20 00:00:00@Zoledronic acid Actavis@Zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_0.pdf@EU-1-11-710_h_a_dec_0.pdf@2011-02-09 00:00:00@Votubia@Everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-12-761_h_a_dec_0.pdf@EU-1-12-761_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Teva@Capecitabine@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_0.pdf@EU-1-12-753_h_a_dec_0.pdf@2012-04-24 00:00:00@Signifor@Pasireotide@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_0.pdf@EU-1-12-766_h_a_dec_0.pdf@2012-04-20 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_0.pdf@EU-1-12-760_h_a_dec_0.pdf@2012-04-13 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_0.pdf@EU-1-12-768_h_a_dec_0.pdf@2012-07-05 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_0.pdf@EU-1-12-763_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Krka@capecitabine@False@False@OD Not Found@KRKA, d.d@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_0.pdf@EU-1-12-764_h_a_dec_0.pdf@2012-10-05 00:00:00@Pixuvri@Pixantrone@True@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-762_h_a_dec_0.pdf@EU-1-12-762_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_0.pdf@EU-1-12-775_h_a_dec_0.pdf@2012-03-09 00:00:00@NovoThirteen@catridecacog@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_0.pdf@EU-1-12-771_h_a_dec_0.pdf@2012-08-16 00:00:00@Zoledronic acid Teva@Zoledronic acid@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_0.pdf@EU-1-12-767_h_a_dec_0.pdf@2012-04-20 00:00:00@Nimenrix@Meningococcal Group A, C, W-135 and  Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_0.pdf@EU-1-12-778_h_a_dec_0.pdf@2012-07-20 00:00:00@Eklira Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_0.pdf@EU-1-12-769_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_0.pdf@EU-1-12-773_h_a_dec_0.pdf@2012-08-23 00:00:00@Jakavi@ruxolitinib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_0.pdf@EU-1-12-777_h_a_dec_0.pdf@2012-03-09 00:00:00@Inlyta@Axitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_0.pdf@EU-1-12-779_h_a_dec_0.pdf@2012-03-08 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_0.pdf@EU-1-12-776_h_a_dec_0.pdf@2012-07-23 00:00:00@Fycompa@Perampanel@True@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_0.pdf@EU-1-12-783_h_a_dec_0.pdf@2012-08-23 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_0.pdf@EU-1-12-784_h_a_dec_0.pdf@2012-08-23 00:00:00@Cuprymina@Copper  64Cu chloride@True@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_0.pdf@EU-1-12-781_h_a_dec_0.pdf@2012-07-20 00:00:00@Bretaris Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_0.pdf@EU-1-12-780_h_a_dec_0.pdf@2012-07-20 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_0.pdf@EU-1-12-785_h_a_dec_0.pdf@2012-08-23 00:00:00@Zinforo@ceftaroline fosamil@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_0.pdf@EU-1-12-786_h_a_dec_0.pdf@2012-08-23 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_0.pdf@EU-1-12-788_h_a_dec_0.pdf@2012-09-28 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_0.pdf@EU-1-12-792_h_a_dec_0.pdf@2012-09-20 00:00:00@Dacogen@Decitabine@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_0.pdf@EU-1-12-789_h_a_dec_0.pdf@2012-09-28 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_0.pdf@EU-1-12-790_h_a_dec_0.pdf@2012-09-28 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_0.pdf@EU-1-12-787_h_a_dec_0.pdf@2012-08-30 00:00:00@Revestive@teduglutide@True@False@adopted@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_0.pdf@EU-1-12-770_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_0.pdf@EU-1-12-782_h_a_dec_0.pdf@2012-07-23 00:00:00@Kalydeco@ivacaftor@True@False@adopted@Vertex Pharmaceuticals (U.K.) Limited,@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_0.pdf@EU-1-12-798_h_a_dec_0.pdf@2012-11-19 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_0.pdf@EU-1-12-799_h_a_dec_0.pdf@2012-11-22 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_0.pdf@EU-1-12-801_h_a_dec_0.pdf@2012-11-26 00:00:00@Constella@linaclotide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_0.pdf@EU-1-12-800_h_a_dec_0.pdf@2012-11-19 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_0.pdf@EU-1-12-794_h_a_dec_0.pdf@2012-10-25 00:00:00@Adcetris@Brentuximab vedotin@True@False@adopted@Takeda Global Research and Development  Centre (Europe) Ltd.@conditional@Parsed
EU-1-12-802_h_a_dec_0.pdf@EU-1-12-802_h_a_dec_0.pdf@2012-11-19 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_0.pdf@EU-1-12-793_h_a_dec_0.pdf@2012-10-23 00:00:00@XALKORI@crizotinib@True@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-795_h_a_dec_0.pdf@EU-1-12-795_h_a_dec_0.pdf@2012-12-11 00:00:00@Forxiga@dapagliflozin@True@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_0.pdf@EU-1-12-803_h_a_dec_0.pdf@2012-12-18 00:00:00@NexoBrid@Concentrate  proteolytic enzymes  enriched in bromelain@False@False@adopted@TEVA Pharma GmbH@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_0.pdf@EU-1-12-805_h_a_dec_0.pdf@2013-01-14 00:00:00@Amyvid@Florbetapir (18F)@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_0.pdf@EU-1-12-797_h_a_dec_0.pdf@2012-11-22 00:00:00@Eylea@aflibercept@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_0.pdf@EU-1-12-812_h_a_dec_0.pdf@2013-01-14 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA,  component, adsorbed)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_0.pdf@EU-1-12-809_h_a_dec_0.pdf@2012-12-20 00:00:00@Betmiga@mirabegron@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_0.pdf@EU-1-12-811_h_a_dec_0.pdf@2013-01-02 00:00:00@Lyxumia@lixisenatide@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_0.pdf@EU-1-12-806_h_a_dec_0.pdf@2013-01-21 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_0.pdf@EU-1-12-814_h_a_dec_0.pdf@2013-01-02 00:00:00@ZALTRAP@aflibercept@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_0.pdf@EU-1-12-815_h_a_dec_0.pdf@2013-02-25 00:00:00@Selincro@nalmefene@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_0.pdf@EU-1-12-807_h_a_dec_0.pdf@2013-01-21 00:00:00@Tresiba@Insulin degludec@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_0.pdf@EU-1-13-820_h_a_dec_0.pdf@2013-04-29 00:00:00@Maruxa@Memantine@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_0.pdf@EU-1-12-808_h_a_dec_0.pdf@2013-08-01 00:00:00@Imatinib Teva@imatinib@False@False@appointed@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-817_h_a_dec_0.pdf@EU-1-13-817_h_a_dec_0.pdf@2013-03-13 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_0.pdf@EU-1-13-822_h_a_dec_0.pdf@2013-07-31 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_0.pdf@EU-1-13-826_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-823_h_a_dec_0.pdf@EU-1-13-823_h_a_dec_0.pdf@2013-02-20 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd.@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_0.pdf@EU-1-13-819_h_a_dec_0.pdf@2013-03-13 00:00:00@JETREA@OCRIPLASMIN@True@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_0.pdf@EU-1-13-821_h_a_dec_0.pdf@2013-03-13 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_0.pdf@EU-1-13-827_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_0.pdf@EU-1-13-813_h_a_dec_0.pdf@2013-04-03 00:00:00@Perjeta@pertuzumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_0.pdf@EU-1-13-824_h_a_dec_0.pdf@2013-04-22 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_0.pdf@EU-1-13-818_h_a_dec_0.pdf@2013-03-27 00:00:00@Bosulif@Bosutinib@True@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-834_h_a_dec_0.pdf@EU-1-13-834_h_a_dec_0.pdf@2014-01-16 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_0.pdf@EU-1-13-828_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexacima@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_0.pdf@EU-1-13-836_h_a_dec_0.pdf@2013-06-13 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_0.pdf@EU-1-13-829_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_0.pdf@EU-1-13-832_h_a_dec_0.pdf@2013-06-24 00:00:00@Stayveer@bosentan@False@False@adopted@Marklas Nederland BV@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_0.pdf@EU-1-13-835_h_a_dec_0.pdf@2013-05-16 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_0.pdf@EU-1-13-840_h_a_dec_0.pdf@2013-05-16 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_0.pdf@EU-1-13-830_h_a_dec_0.pdf@2013-05-24 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine /  tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_0.pdf@EU-1-13-837_h_a_dec_0.pdf@2014-01-30 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_0.pdf@EU-1-13-838_h_a_dec_0.pdf@2013-08-26 00:00:00@AUBAGIO@Teriflunomide@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_0.pdf@EU-1-13-841_h_a_dec_0.pdf@2013-06-13 00:00:00@Spedra@avanafil@True@False@OD Not Found@VIVUS BV@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_0.pdf@EU-1-13-839_h_a_dec_0.pdf@2013-01-07 00:00:00@Iclusig@ponatinib@True@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_0.pdf@EU-1-13-842_h_a_dec_0.pdf@2013-09-19 00:00:00@Incresync@alogliptin / pioglitazone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_0.pdf@EU-1-13-844_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipidia@alogliptin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_0.pdf@EU-1-13-843_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipdomet@alogliptin / metformin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-852_h_a_dec_0.pdf@EU-1-13-852_h_a_dec_0.pdf@2013-07-31 00:00:00@Atosiban SUN@atosiban@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_0.pdf@EU-1-13-845_h_a_dec_0.pdf@2013-01-07 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_0.pdf@EU-1-13-848_h_a_dec_0.pdf@2013-12-07 00:00:00@Erivedge@vismodegib@True@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-855_h_a_dec_0.pdf@EU-1-13-855_h_a_dec_0.pdf@2013-07-31 00:00:00@Imvanex@modified  vaccinia ankara virus@True@False@appointed@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-846_h_a_dec_0.pdf@EU-1-13-846_h_a_dec_0.pdf@2013-06-21 00:00:00@Xtandi@enzalutamide@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_0.pdf@EU-1-13-854_h_a_dec_0.pdf@2013-10-09 00:00:00@Inflectra@infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_0.pdf@EU-1-13-851_h_a_dec_0.pdf@2013-07-31 00:00:00@Lojuxta@Lomitapide@True@False@appointed@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-856_h_a_dec_0.pdf@EU-1-13-856_h_a_dec_0.pdf@2013-07-25 00:00:00@Lonquex@lipegfilgrastim@True@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_0.pdf@EU-1-13-859_h_a_dec_0.pdf@2013-11-11 00:00:00@Levodopa-Carbidopa-Entacapone Sandoz@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_0.pdf@EU-1-13-861_h_a_dec_0.pdf@2013-06-09 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Raptor Pharmaceuticals Europe BV@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_0.pdf@EU-1-13-853_h_a_dec_0.pdf@2013-10-09 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_0.pdf@EU-1-13-860_h_a_dec_0.pdf@2013-08-26 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_0.pdf@EU-1-13-858_h_a_dec_0.pdf@2013-08-26 00:00:00@Stivarga@regorafenib@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_0.pdf@EU-1-13-857_h_a_dec_0.pdf@2013-12-08 00:00:00@Voncento@human coagulation factor VIII / human  von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_0.pdf@EU-1-13-850_h_a_dec_0.pdf@2013-05-08 00:00:00@Pomalidomidea Celgene@Pomalidomide@True@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_0.pdf@EU-1-13-870_h_a_dec_0.pdf@2012-05-25 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS (Cell Therapies Research &  Services)@exceptional@Parsed
EU-1-13-862_h_a_dec_0.pdf@EU-1-13-862_h_a_dec_0.pdf@2013-09-19 00:00:00@Ultibro Breezhaler@Indacaterol  maleate/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_0.pdf@EU-1-13-863_h_a_dec_0.pdf@2013-09-19 00:00:00@Xoterna Breezhaler@indacaterol / glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_0.pdf@EU-1-13-871_h_a_dec_0.pdf@2013-09-27 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_0.pdf@EU-1-13-866_h_a_dec_0.pdf@2013-08-26 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Abbott Healthcare Products Ltd@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_0.pdf@EU-1-13-873_h_a_dec_0.pdf@2013-11-13 00:00:00@Xofigo@Radium Ra 223 dichloride@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_0.pdf@EU-1-13-869_h_a_dec_0.pdf@2013-12-09 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_0.pdf@EU-1-13-865_h_a_dec_0.pdf@2013-08-26 00:00:00@Tafinlar@DABRAFENIB@True@False@OD Not Found@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_0.pdf@EU-1-13-872_h_a_dec_0.pdf@2013-09-19 00:00:00@Tybost@cobicistat@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_0.pdf@EU-1-13-878_h_a_dec_0.pdf@2013-10-18 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.p.A.@exceptional@Parsed
EU-1-13-875_h_a_dec_0.pdf@EU-1-13-875_h_a_dec_0.pdf@2014-04-28 00:00:00@Deltyba@delamanid@True@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-880_h_a_dec_0.pdf@EU-1-13-880_h_a_dec_0.pdf@2013-04-12 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_0.pdf@EU-1-13-877_h_a_dec_0.pdf@2013-10-18 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_0.pdf@EU-1-13-881_h_a_dec_0.pdf@2013-11-15 00:00:00@Lidocaine/Prilocaine Plethora@lidocaine /  prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-879_h_a_dec_0.pdf@EU-1-13-879_h_a_dec_0.pdf@2013-09-25 00:00:00@Giotrif@afatinib@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_0.pdf@EU-1-13-887_h_a_dec_0.pdf@2013-04-12 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated,  nasal)@True@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_0.pdf@EU-1-13-885_h_a_dec_0.pdf@2013-11-15 00:00:00@Kadcyla@Trastuzumab emtansine@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_0.pdf@EU-1-13-889_h_a_dec_0.pdf@2014-08-01 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_0.pdf@EU-1-13-882_h_a_dec_0.pdf@2013-11-15 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_0.pdf@EU-1-13-888_h_a_dec_0.pdf@2013-11-13 00:00:00@NovoEight@turoctocog alfa@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_0.pdf@EU-1-13-884_h_a_dec_0.pdf@2013-11-15 00:00:00@Invokana@canagliflozin@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_0.pdf@EU-1-13-896_h_a_dec_0.pdf@2014-07-04 00:00:00@Para-aminosalicylic acid Lucane@aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_0.pdf@EU-1-13-893_h_a_dec_0.pdf@2013-12-20 00:00:00@Opsumit@macitentan@True@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_0.pdf@EU-1-13-886_h_a_dec_0.pdf@2013-11-13 00:00:00@Relvar Elllipta@fluticasone furoate/vilanterol  trifenatate@True@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_0.pdf@EU-1-13-890_h_a_dec_0.pdf@2014-03-21 00:00:00@Cometriq@cabozantinib@True@False@adopted@TMC Pharma Services Ltd.@conditional@Parsed
EU-1-13-892_h_a_dec_0.pdf@EU-1-13-892_h_a_dec_0.pdf@2014-01-16 00:00:00@Tivicay@dolutegravir@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_0.pdf@EU-1-13-901_h_a_dec_0.pdf@2014-05-03 00:00:00@Sirturo@bedaquiline@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-894_h_a_dec_0.pdf@EU-1-13-894_h_a_dec_0.pdf@2014-01-16 00:00:00@Sovaldi@sofosbuvir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-905_h_a_dec_0.pdf@EU-1-13-905_h_a_dec_0.pdf@2014-02-20 00:00:00@Izba@travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_0.pdf@EU-1-13-891_h_a_dec_0.pdf@2013-12-18 00:00:00@Brintellix@vortioxetine@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_0.pdf@EU-1-13-904_h_a_dec_0.pdf@2014-02-21 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International Tour Europlaza,  20 avenue André Prothin, La Défense 4, La Défense Cedex 92927, France@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_0.pdf@EU-1-13-900_h_a_dec_0.pdf@2014-01-16 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_0.pdf@EU-1-13-906_h_a_dec_0.pdf@2014-02-20 00:00:00@Neuraceq@florbetaben (18F)@True@False@OD Not Found@Piramal Imaging GmbH@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_0.pdf@EU-1-13-907_h_a_dec_0.pdf@2014-03-27 00:00:00@Adempas@riociguat@True@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_0.pdf@EU-1-13-902_h_a_dec_0.pdf@2014-07-31 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics, Limited@conditional@Parsed
EU-1-14-898_h_a_dec_0.pdf@EU-1-14-898_h_a_dec_0.pdf@2014-08-05 00:00:00@Anoro@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_0.pdf@EU-1-14-914_h_a_dec_0.pdf@2014-04-28 00:00:00@Vimizim@elosulfase alfa@True@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-13-909_h_a_dec_0.pdf@EU-1-13-909_h_a_dec_0.pdf@2014-03-27 00:00:00@Bemfola@Follitropin alfa@False@False@OD Not Found@FINOX Biotech AG@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_0.pdf@EU-1-14-919_h_a_dec_0.pdf@2014-04-23 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@PIERRE FABRE DERMATOLOGIE@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_0.pdf@EU-1-14-917_h_a_dec_0.pdf@2014-04-23 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_0.pdf@EU-1-14-916_h_a_dec_0.pdf@2014-10-04 00:00:00@Pregabalin Pfizer@Pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-915_h_a_dec_0.pdf@EU-1-14-915_h_a_dec_0.pdf@2014-05-22 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_0.pdf@EU-1-14-899_h_a_dec_0.pdf@2014-08-05 00:00:00@Laventair@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_0.pdf@EU-1-14-913_h_a_dec_0.pdf@2014-03-21 00:00:00@Latuda@lurasidone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_0.pdf@EU-1-14-920_h_a_dec_0.pdf@2014-04-28 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_0.pdf@EU-1-14-921_h_a_dec_0.pdf@2014-04-28 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_0.pdf@EU-1-14-928_h_a_dec_0.pdf@2014-05-22 00:00:00@Sylvant@siltuximab@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_0.pdf@EU-1-14-918_h_a_dec_0.pdf@2014-04-23 00:00:00@Vokanamet@canagliflozin / metformin  hydrochloride@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_0.pdf@EU-1-14-922_h_a_dec_0.pdf@2014-04-28 00:00:00@Incruse@umeclidinium bromide@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_0.pdf@EU-1-14-923_h_a_dec_0.pdf@2014-05-22 00:00:00@Entyvio@vedolizumab@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_0.pdf@EU-1-14-933_h_a_dec_0.pdf@2014-07-18 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_0.pdf@EU-1-14-930_h_a_dec_0.pdf@2014-05-22 00:00:00@Jardiance@empagliflozin@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_0.pdf@EU-1-14-929_h_a_dec_0.pdf@2014-02-05 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_0.pdf@EU-1-14-935_h_a_dec_0.pdf@2014-07-18 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_0.pdf@EU-1-14-934_h_a_dec_0.pdf@2014-07-18 00:00:00@Plegridy@peginterferon beta-1a@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_0.pdf@EU-1-14-941_h_a_dec_0.pdf@2014-08-22 00:00:00@Vizamyl@flutemetamol ( 18F)@True@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_0.pdf@EU-1-14-931_h_a_dec_0.pdf@2014-06-30 00:00:00@Mekinist@trametinib@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_0.pdf@EU-1-14-937_h_a_dec_0.pdf@2014-07-23 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_0.pdf@EU-1-14-940_h_a_dec_0.pdf@2014-01-09 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_0.pdf@EU-1-14-943_h_a_dec_0.pdf@2014-08-26 00:00:00@Velphoro@oxyhydroxide, sucrose and starches@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_0.pdf@EU-1-14-951_h_a_dec_0.pdf@2014-09-22 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_0.pdf@EU-1-14-938_h_a_dec_0.pdf@2014-09-18 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_0.pdf@EU-1-14-936_h_a_dec_0.pdf@2014-07-22 00:00:00@Nuwiq@simoctocog alfa@True@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_0.pdf@EU-1-14-944_h_a_dec_0.pdf@2014-09-09 00:00:00@ABASRIA@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_0.pdf@EU-1-14-955_h_a_dec_0.pdf@2014-11-19 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Navidea Biopharmaceuticals Limited@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_0.pdf@EU-1-14-952_h_a_dec_0.pdf@2015-01-15 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_0.pdf@EU-1-14-947_h_a_dec_0.pdf@2014-09-18 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_0.pdf@EU-1-14-954_h_a_dec_0.pdf@2014-11-21 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_0.pdf@EU-1-14-946_h_a_dec_0.pdf@2014-09-18 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_0.pdf@EU-1-14-960_h_a_dec_0.pdf@2014-12-16 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_0.pdf@EU-1-14-957_h_a_dec_0.pdf@2014-12-19 00:00:00@Cyramza@ramucirumab@False@False@adopted@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_0.pdf@EU-1-14-961_h_a_dec_0.pdf@2014-11-21 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_0.pdf@EU-1-14-958_h_a_dec_0.pdf@2014-11-17 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_0.pdf@EU-1-14-962_h_a_dec_0.pdf@2014-08-12 00:00:00@Moventig@naloxegol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_0.pdf@EU-1-14-956_h_a_dec_0.pdf@2014-11-21 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_0.pdf@EU-1-14-959_h_a_dec_0.pdf@2014-12-16 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_0.pdf@EU-1-14-965_h_a_dec_0.pdf@2014-11-19 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_0.pdf@EU-1-14-945_h_a_dec_0.pdf@2014-10-21 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_0.pdf@EU-1-14-967_h_a_dec_0.pdf@2014-11-19 00:00:00@REZOLSTA@DARUNAVIR / COBICISTAT@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_0.pdf@EU-1-14-969_h_a_dec_0.pdf@2014-12-22 00:00:00@Scenesse@afamelanotide@False@False@adopted@Clinuvel UK Limited@exceptional@Parsed
EU-1-14-963_h_a_dec_0.pdf@EU-1-14-963_h_a_dec_0.pdf@2014-11-19 00:00:00@Brimica Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_0.pdf@EU-1-14-964_h_a_dec_0.pdf@2014-11-19 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_0.pdf@EU-1-14-972_h_a_dec_0.pdf@2014-08-12 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-970_h_a_dec_0.pdf@EU-1-14-970_h_a_dec_0.pdf@2014-12-19 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_0.pdf@EU-1-14-977_h_a_dec_0.pdf@2015-12-01 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_0.pdf@EU-1-14-974_h_a_dec_0.pdf@2015-01-19 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_0.pdf@EU-1-14-971_h_a_dec_0.pdf@2014-05-12 00:00:00@Paliperidone Janssen@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_0.pdf@EU-1-14-975_h_a_dec_0.pdf@2015-02-19 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_0.pdf@EU-1-14-978_h_a_dec_0.pdf@2015-01-15 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_0.pdf@EU-1-14-973_h_a_dec_0.pdf@2015-03-26 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Aptalis Pharma SAS@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_0.pdf@EU-1-14-984_h_a_dec_0.pdf@2015-02-24 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_0.pdf@EU-1-14-981_h_a_dec_0.pdf@2015-01-15 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-14-986_h_a_dec_0.pdf@EU-1-14-986_h_a_dec_0.pdf@2015-02-19 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Durata Therapeutics International B.V.@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_0.pdf@EU-1-14-987_h_a_dec_0.pdf@2015-02-17 00:00:00@Holoclar@Ex vivo expanded autologous  human corneal epithelial cells containing stem cells@True@True@adopted@Chiesi Farmaceutici S.P.A.@conditional@Parsed
EU-1-14-979_h_a_dec_0.pdf@EU-1-14-979_h_a_dec_0.pdf@2015-01-15 00:00:00@Ofev@Nintedanib@True@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_0.pdf@EU-1-14-983_h_a_dec_0.pdf@2015-01-15 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_0.pdf@EU-1-15-1000_h_a_dec_0.pdf@2015-05-27 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_0.pdf@EU-1-14-988_h_a_dec_0.pdf@2015-03-26 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_0.pdf@EU-1-15-1001_h_a_dec_0.pdf@2015-05-27 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_0.pdf@EU-1-15-1002_h_a_dec_0.pdf@2015-05-28 00:00:00@Lenvima@Lenvatinib@False@False@adopted@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_0.pdf@EU-1-15-1004_h_a_dec_0.pdf@2015-05-27 00:00:00@Voriconazole Hospira@voriconazole@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_0.pdf@EU-1-15-1005_h_a_dec_0.pdf@2015-06-30 00:00:00@Aripiprazole Pharmathen@aripiprazole@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_0.pdf@EU-1-15-1008_h_a_dec_0.pdf@2015-03-07 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_0.pdf@EU-1-15-1003_h_a_dec_0.pdf@2015-05-27 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_0.pdf@EU-1-15-1010_h_a_dec_0.pdf@2015-06-19 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_0.pdf@EU-1-15-1007_h_a_dec_0.pdf@2015-10-06 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine  (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_0.pdf@EU-1-15-1013_h_a_dec_0.pdf@2015-06-19 00:00:00@Lumark@lutetium, isotope  mass 177@True@False@OD Not Found@IDB Radiopharmacy B.V.@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_0.pdf@EU-1-15-1009_h_a_dec_0.pdf@2015-06-25 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_0.pdf@EU-1-15-1011_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1018_h_a_dec_0.pdf@EU-1-15-1018_h_a_dec_0.pdf@2015-07-28 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_0.pdf@EU-1-15-1012_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_0.pdf@EU-1-15-1015_h_a_dec_0.pdf@2015-08-28 00:00:00@Strensiq@asfotase alfa@True@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1020_h_a_dec_0.pdf@EU-1-15-1020_h_a_dec_0.pdf@2015-08-09 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland)  GmbH@exceptional@Parsed
EU-1-14-980_h_a_dec_0.pdf@EU-1-14-980_h_a_dec_0.pdf@2015-01-15 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_0.pdf@EU-1-15-1021_h_a_dec_0.pdf@2015-07-17 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_0.pdf@EU-1-15-1019_h_a_dec_0.pdf@2015-07-20 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1016_h_a_dec_0.pdf@EU-1-15-1016_h_a_dec_0.pdf@2015-07-17 00:00:00@Repatha@Evolocumab@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_0.pdf@EU-1-15-1027_h_a_dec_0.pdf@2015-08-28 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_0.pdf@EU-1-15-1028_h_a_dec_0.pdf@2015-08-20 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_0.pdf@EU-1-15-1023_h_a_dec_0.pdf@2015-08-28 00:00:00@Farydak@panobinostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_0.pdf@EU-1-15-1025_h_a_dec_0.pdf@2015-07-13 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_0.pdf@EU-1-15-1029_h_a_dec_0.pdf@2015-08-20 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_0.pdf@EU-1-15-1030_h_a_dec_0.pdf@2015-08-14 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_0.pdf@EU-1-15-1032_h_a_dec_0.pdf@2015-09-18 00:00:00@Zerbaxa@ceftolozane / tazobactam@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_0.pdf@EU-1-15-1033_h_a_dec_0.pdf@2015-08-28 00:00:00@Kanuma@sebelipase alfa@True@False@adopted@Synageva BioPharma Ltd@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_0.pdf@EU-1-15-1035_h_a_dec_0.pdf@2015-11-11 00:00:00@Obizur@susoctocog alfa@True@False@adopted@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1038_h_a_dec_0.pdf@EU-1-15-1038_h_a_dec_0.pdf@2015-11-27 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_0.pdf@EU-1-15-1031_h_a_dec_0.pdf@2015-09-23 00:00:00@Praluent@alirocumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_0.pdf@EU-1-15-1037_h_a_dec_0.pdf@2015-09-18 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_0.pdf@EU-1-15-1041_h_a_dec_0.pdf@2015-08-09 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne  S.A.@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_0.pdf@EU-1-15-1040_h_a_dec_0.pdf@2015-09-17 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_0.pdf@EU-1-15-1036_h_a_dec_0.pdf@2015-10-15 00:00:00@Cresemba@isavuconazole@True@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_0.pdf@EU-1-15-1045_h_a_dec_0.pdf@2015-11-16 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1049_h_a_dec_0.pdf@EU-1-15-1049_h_a_dec_0.pdf@2017-01-19 00:00:00@Cystadrops@mercaptamine@False@False@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_0.pdf@EU-1-15-1046_h_a_dec_0.pdf@2015-11-19 00:00:00@Elocta@efmoroctocog alfa@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-15-1048_h_a_dec_0.pdf@EU-1-15-1048_h_a_dec_0.pdf@2015-11-20 00:00:00@Cotellic@cobimetinib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_0.pdf@EU-1-15-1043_h_a_dec_0.pdf@2015-02-12 00:00:00@Nucala@mepolizumab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_0.pdf@EU-1-15-1051_h_a_dec_0.pdf@2015-11-16 00:00:00@Ebymect@dapagliflozin / metfomin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_0.pdf@EU-1-15-1047_h_a_dec_0.pdf@2015-11-23 00:00:00@Blincyto@blinatumomab@True@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1053_h_a_dec_0.pdf@EU-1-15-1053_h_a_dec_0.pdf@2016-03-16 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_0.pdf@EU-1-15-1054_h_a_dec_0.pdf@2015-11-19 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_0.pdf@EU-1-15-1052_h_a_dec_0.pdf@2015-09-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_0.pdf@EU-1-15-1055_h_a_dec_0.pdf@2015-02-12 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_0.pdf@EU-1-15-1057_h_a_dec_0.pdf@2015-11-20 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_0.pdf@EU-1-15-1056_h_a_dec_0.pdf@2015-11-20 00:00:00@Praxbind@Idarucizumab@True@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_0.pdf@EU-1-15-1058_h_a_dec_0.pdf@2015-11-19 00:00:00@Entresto@sacubitril / valsartan@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_0.pdf@EU-1-15-1014_h_a_dec_0.pdf@2015-06-19 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_0.pdf@EU-1-15-1063_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Actavis@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_0.pdf@EU-1-15-1059_h_a_dec_0.pdf@2015-11-19 00:00:00@Orkambi@Lumacaftor / Ivacaftor@True@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_0.pdf@EU-1-15-1062_h_a_dec_0.pdf@2015-11-27 00:00:00@Ravicti@Glycerol phenylbutyrate@True@False@adopted@Horizon Therapeutics Limited@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_0.pdf@EU-1-15-1065_h_a_dec_0.pdf@2016-11-01 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_0.pdf@EU-1-15-1064_h_a_dec_0.pdf@2015-12-16 00:00:00@Imlygic@talimogene laherparepvec@True@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_0.pdf@EU-1-15-1060_h_a_dec_0.pdf@2015-11-19 00:00:00@Kyprolis@carfilzomib@True@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_0.pdf@EU-1-15-1061_h_a_dec_0.pdf@2015-11-19 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine /  tenofovir alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_0.pdf@EU-1-15-1066_h_a_dec_0.pdf@2016-06-24 00:00:00@Ongentys@opicapone@True@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_0.pdf@EU-1-15-1067_h_a_dec_0.pdf@2016-01-14 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_0.pdf@EU-1-15-1068_h_a_dec_0.pdf@2016-03-31 00:00:00@Wakix@Pitolisant hydrochloride@True@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_0.pdf@EU-1-15-1071_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_0.pdf@EU-1-15-1070_h_a_dec_0.pdf@2016-01-14 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_0.pdf@EU-1-15-1075_h_a_dec_0.pdf@2016-02-18 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Iron Therapeutics (UK) Ltd@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_0.pdf@EU-1-15-1072_h_a_dec_0.pdf@2016-01-14 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_0.pdf@EU-1-15-1076_h_a_dec_0.pdf@2016-02-18 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_0.pdf@EU-1-15-1079_h_a_dec_0.pdf@2016-02-15 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b  conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_0.pdf@EU-1-15-1082_h_a_dec_0.pdf@2016-05-26 00:00:00@Galafold@migalastat@True@False@adopted@Amicus Therapeutics UK Ltd@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_0.pdf@EU-1-15-1083_h_a_dec_0.pdf@2016-12-05 00:00:00@Uptravi@selexipag@True@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_0.pdf@EU-1-15-1078_h_a_dec_0.pdf@2017-04-24 00:00:00@Natpar@parathyroid hormone@False@False@adopted@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1073_h_a_dec_0.pdf@EU-1-15-1073_h_a_dec_0.pdf@2016-01-14 00:00:00@Briviact@brivaracetam@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_0.pdf@EU-1-15-990_h_a_dec_0.pdf@2015-03-19 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@SANTEN S.A.S.@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_0.pdf@EU-1-15-989_h_a_dec_0.pdf@2015-03-19 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_0.pdf@EU-1-15-991_h_a_dec_0.pdf@2015-03-23 00:00:00@Sivextro@tedizolid phosphate@True@False@OD Not Found@Cubist (UK) Ltd@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_0.pdf@EU-1-15-1074_h_a_dec_0.pdf@2016-01-14 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-994_h_a_dec_0.pdf@EU-1-15-994_h_a_dec_0.pdf@2015-03-23 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_0.pdf@EU-1-15-992_h_a_dec_0.pdf@2015-03-23 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_0.pdf@EU-1-15-1024_h_a_dec_0.pdf@2015-07-17 00:00:00@KEYTRUDA@pembrolizumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1087_h_a_dec_0.pdf@EU-1-16-1087_h_a_dec_0.pdf@2016-03-16 00:00:00@Coagadex@human coagulation factor X@False@False@adopted@Bio Products Laboratory Ltd@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_0.pdf@EU-1-15-1085_h_a_dec_0.pdf@2016-04-25 00:00:00@Taltz@ixekizumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_0.pdf@EU-1-15-993_h_a_dec_0.pdf@2015-06-19 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_0.pdf@EU-1-15-997_h_a_dec_0.pdf@2015-06-25 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-16-1090_h_a_dec_0.pdf@EU-1-16-1090_h_a_dec_0.pdf@2016-04-04 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_0.pdf@EU-1-16-1088_h_a_dec_0.pdf@2016-11-05 00:00:00@Empliciti@elotuzumab@True@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-16-1093_h_a_dec_0.pdf@EU-1-16-1093_h_a_dec_0.pdf@2016-03-31 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_0.pdf@EU-1-16-1089_h_a_dec_0.pdf@2016-05-20 00:00:00@Pandemic influenza vaccine H5N1  MedImmune@Pandemic influenza vaccine (H5N1) (live attenuated, nasal)@True@False@OD Not Found@MedImmune, LLC@conditional@Parsed
EU-1-16-1092_h_a_dec_0.pdf@EU-1-16-1092_h_a_dec_0.pdf@2016-03-22 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_0.pdf@EU-1-16-1086_h_a_dec_0.pdf@2016-02-02 00:00:00@TAGRISSO@osimertinib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1091_h_a_dec_0.pdf@EU-1-16-1091_h_a_dec_0.pdf@2016-08-22 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_0.pdf@EU-1-16-1096_h_a_dec_0.pdf@2016-04-25 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_0.pdf@EU-1-15-999_h_a_dec_0.pdf@2015-06-05 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-16-1097_h_a_dec_0.pdf@EU-1-16-1097_h_a_dec_0.pdf@2016-05-26 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction  that contains CD34+ cells transduced with retroviral vector that encodes for the human  ADA cDNA sequence@True@True@adopted@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_0.pdf@EU-1-16-1095_h_a_dec_0.pdf@2016-11-05 00:00:00@IDELVION@albutrepenonacog alfa@True@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1104_h_a_dec_0.pdf@EU-1-16-1104_h_a_dec_0.pdf@2016-05-26 00:00:00@Palonosetron Accord@palonosetron@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_0.pdf@EU-1-16-1094_h_a_dec_0.pdf@2016-11-21 00:00:00@Ninlaro@ixazomib@True@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1098_h_a_dec_0.pdf@EU-1-16-1098_h_a_dec_0.pdf@2016-12-05 00:00:00@ALPROLIX@eftrenonacog alfa@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_0.pdf@EU-1-16-1102_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_0.pdf@EU-1-16-1103_h_a_dec_0.pdf@2016-05-26 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_0.pdf@EU-1-16-1105_h_a_dec_0.pdf@2016-06-07 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_0.pdf@EU-1-16-1110_h_a_dec_0.pdf@2017-10-04 00:00:00@Chenodeoxycholic acid  sigma-tau@chenodeoxycholic acid@False@False@adopted@sigma-tau Arzeimittel GmbH@exceptional@Parsed
EU-1-16-1109_h_a_dec_0.pdf@EU-1-16-1109_h_a_dec_0.pdf@2016-06-24 00:00:00@Zavicefta@ceftazidime/avibactam@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_0.pdf@EU-1-16-1108_h_a_dec_0.pdf@2016-07-15 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_0.pdf@EU-1-16-1099_h_a_dec_0.pdf@2016-04-21 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_0.pdf@EU-1-16-1114_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_0.pdf@EU-1-16-1106_h_a_dec_0.pdf@2016-05-26 00:00:00@Flixabi@Infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_0.pdf@EU-1-16-1101_h_a_dec_0.pdf@2016-05-20 00:00:00@Darzalex@daratumumab@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1112_h_a_dec_0.pdf@EU-1-16-1112_h_a_dec_0.pdf@2016-06-21 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir  alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_0.pdf@EU-1-16-1115_h_a_dec_0.pdf@2016-07-22 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_0.pdf@EU-1-16-1119_h_a_dec_0.pdf@2016-07-22 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_0.pdf@EU-1-16-1125_h_a_dec_0.pdf@2016-08-16 00:00:00@Cinqaero@reslizumab@True@False@OD Not Found@Teva Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_0.pdf@EU-1-16-1116_h_a_dec_0.pdf@2016-06-07 00:00:00@Epclusa@sofosbuvir/velpatasvir@True@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_0.pdf@EU-1-16-1127_h_a_dec_0.pdf@2016-09-15 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_0.pdf@EU-1-16-1134_h_a_dec_0.pdf@2016-09-15 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_0.pdf@EU-1-16-1130_h_a_dec_0.pdf@2016-10-14 00:00:00@Onivyde@irinotecan@False@False@adopted@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_0.pdf@EU-1-16-1128_h_a_dec_0.pdf@2016-08-25 00:00:00@Kisplyx@Lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_0.pdf@EU-1-16-1124_h_a_dec_0.pdf@2016-08-18 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_0.pdf@EU-1-16-1133_h_a_dec_0.pdf@2016-12-16 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_0.pdf@EU-1-16-1137_h_a_dec_0.pdf@2016-11-14 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_0.pdf@EU-1-16-1129_h_a_dec_0.pdf@2016-08-12 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@MYLAN S.A.S@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_0.pdf@EU-1-16-1135_h_a_dec_0.pdf@2016-09-15 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1141_h_a_dec_0.pdf@EU-1-16-1141_h_a_dec_0.pdf@2016-08-12 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1142_h_a_dec_0.pdf@EU-1-16-1142_h_a_dec_0.pdf@2016-11-11 00:00:00@Parsabiv@etelcalcetide@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_0.pdf@EU-1-16-1139_h_a_dec_0.pdf@2016-12-12 00:00:00@OCALIVA@obeticholic acid@True@False@adopted@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1136_h_a_dec_0.pdf@EU-1-16-1136_h_a_dec_0.pdf@2016-09-09 00:00:00@CABOMETYX@cabozantinib@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_0.pdf@EU-1-16-1138_h_a_dec_0.pdf@2016-05-12 00:00:00@Venclyxto@venetoclax@True@False@adopted@AbbVie Ltd@conditional@Parsed
EU-1-16-1144_h_a_dec_0.pdf@EU-1-16-1144_h_a_dec_0.pdf@2016-11-11 00:00:00@Ivabradine Zentiva@Ivabradine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_0.pdf@EU-1-16-1146_h_a_dec_0.pdf@2016-11-11 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_0.pdf@EU-1-16-1148_h_a_dec_0.pdf@2016-09-11 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_0.pdf@EU-1-16-1151_h_a_dec_0.pdf@2016-08-12 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_0.pdf@EU-1-16-1153_h_a_dec_0.pdf@2017-09-01 00:00:00@Tadalafil Generics@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1150_h_a_dec_0.pdf@EU-1-16-1150_h_a_dec_0.pdf@2016-12-12 00:00:00@Rekovelle@follitropin delta@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_0.pdf@EU-1-16-1147_h_a_dec_0.pdf@2016-09-11 00:00:00@IBRANCE@palbociclib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-16-1152_h_a_dec_0.pdf@EU-1-16-1152_h_a_dec_0.pdf@2017-04-20 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-16-1156_h_a_dec_0.pdf@EU-1-16-1156_h_a_dec_0.pdf@2017-01-18 00:00:00@ZINPLAVA@bezlotoxumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_0.pdf@EU-1-16-1155_h_a_dec_0.pdf@2017-07-17 00:00:00@Kyntheum@brodalumab@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_0.pdf@EU-1-16-1159_h_a_dec_0.pdf@2017-04-01 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_0.pdf@EU-1-16-1158_h_a_dec_0.pdf@2017-04-01 00:00:00@AFSTYLA@lonoctocog alfa@True@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_0.pdf@EU-1-16-1154_h_a_dec_0.pdf@2017-09-01 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_0.pdf@EU-1-16-1161_h_a_dec_0.pdf@2017-11-01 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_0.pdf@EU-1-16-1140_h_a_dec_0.pdf@2017-04-01 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_0.pdf@EU-1-16-1166_h_a_dec_0.pdf@2017-02-27 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_0.pdf@EU-1-16-1157_h_a_dec_0.pdf@2017-11-01 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_0.pdf@EU-1-16-1168_h_a_dec_0.pdf@2017-02-13 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_0.pdf@EU-1-16-1171_h_a_dec_0.pdf@2017-03-03 00:00:00@Ledaga@chlormethine@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_0.pdf@EU-1-16-1160_h_a_dec_0.pdf@2017-09-01 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_0.pdf@EU-1-16-1132_h_a_dec_0.pdf@2016-09-15 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_0.pdf@EU-1-16-1169_h_a_dec_0.pdf@2017-02-16 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-17-1173_h_a_dec_0.pdf@EU-1-17-1173_h_a_dec_0.pdf@2018-03-22 00:00:00@Lokelma@sodium zirconium cyclosilicate@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_0.pdf@EU-1-16-1170_h_a_dec_0.pdf@2017-02-13 00:00:00@Olumiant@baricitinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_0.pdf@EU-1-17-1174_h_a_dec_0.pdf@2017-03-20 00:00:00@Rolufta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_0.pdf@EU-1-17-1172_h_a_dec_0.pdf@2017-03-29 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind Ltd@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_0.pdf@EU-1-17-1175_h_a_dec_0.pdf@2017-03-22 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_0.pdf@EU-1-17-1176_h_a_dec_0.pdf@2017-03-22 00:00:00@Yargesa@miglustat@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_0.pdf@EU-1-16-1164_h_a_dec_0.pdf@2017-03-22 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1177_h_a_dec_0.pdf@EU-1-17-1177_h_a_dec_0.pdf@2017-03-22 00:00:00@Tadalafil Lilly@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_0.pdf@EU-1-17-1179_h_a_dec_0.pdf@2017-07-19 00:00:00@Veltassa@patiromer@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_0.pdf@EU-1-17-1182_h_a_dec_0.pdf@2017-04-28 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA, d.d.@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_0.pdf@EU-1-17-1181_h_a_dec_0.pdf@2017-10-07 00:00:00@Spherox@associated chondrocytes@True@True@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_0.pdf@EU-1-16-1167_h_a_dec_0.pdf@2017-02-17 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_0.pdf@EU-1-17-1186_h_a_dec_0.pdf@2017-05-22 00:00:00@Axumin@fluciclovine (18F)@True@False@OD Not Found@Blue Earth Diagnostics Ltd@CMA Not Found@Parsed
EU-1-17-1190_h_a_dec_0.pdf@EU-1-17-1190_h_a_dec_0.pdf@2017-05-22 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_0.pdf@EU-1-17-1187_h_a_dec_0.pdf@2017-05-24 00:00:00@Trumenba@meningococcal group B vaccine  (recombinant, adsorbed)@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_0.pdf@EU-1-17-1189_h_a_dec_0.pdf@2017-02-06 00:00:00@Elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_0.pdf@EU-1-17-1188_h_a_dec_0.pdf@2017-05-30 00:00:00@Spinraza@nusinersen@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_0.pdf@EU-1-17-1184_h_a_dec_0.pdf@2017-06-15 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_0.pdf@EU-1-17-1191_h_a_dec_0.pdf@2017-08-05 00:00:00@Dinutuximab beta Apeiron@dinutuximab beta@False@False@adopted@APEIRON Biologics AG@exceptional@Parsed
EU-1-17-1185_h_a_dec_0.pdf@EU-1-17-1185_h_a_dec_0.pdf@2017-06-15 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_0.pdf@EU-1-17-1192_h_a_dec_0.pdf@2017-05-30 00:00:00@Brineura@cerliponase  alfa@True@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1194_h_a_dec_0.pdf@EU-1-17-1194_h_a_dec_0.pdf@2017-06-15 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1193_h_a_dec_0.pdf@EU-1-17-1193_h_a_dec_0.pdf@2017-02-06 00:00:00@Refixia@nonacog beta pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1199_h_a_dec_0.pdf@EU-1-17-1199_h_a_dec_0.pdf@2017-05-09 00:00:00@Cuprior@trientine@False@False@adopted@gmp-orphan SA@CMA Not Found@Parsed
EU-1-17-1197_h_a_dec_0.pdf@EU-1-17-1197_h_a_dec_0.pdf@2017-06-07 00:00:00@OXERVATE@cenegermin@True@False@adopted@Dompé farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_0.pdf@EU-1-17-1202_h_a_dec_0.pdf@2017-06-23 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-17-1201_h_a_dec_0.pdf@EU-1-17-1201_h_a_dec_0.pdf@2017-06-23 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_0.pdf@EU-1-17-1200_h_a_dec_0.pdf@2017-06-29 00:00:00@Besponsa@inotuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_0.pdf@EU-1-17-1195_h_a_dec_0.pdf@2017-06-23 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_0.pdf@EU-1-17-1203_h_a_dec_0.pdf@2017-07-19 00:00:00@Insulin lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_0.pdf@EU-1-17-1178_h_a_dec_0.pdf@2017-03-22 00:00:00@Xeljanz@Tofacitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_0.pdf@EU-1-17-1211_h_a_dec_0.pdf@2017-09-26 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_0.pdf@EU-1-17-1196_h_a_dec_0.pdf@2017-06-23 00:00:00@Kevzara@sarilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1209_h_a_dec_0.pdf@EU-1-17-1209_h_a_dec_0.pdf@2017-07-13 00:00:00@Reagila@cariprazine@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_0.pdf@EU-1-17-1208_h_a_dec_0.pdf@2017-07-17 00:00:00@Trimbow@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_0.pdf@EU-1-17-1210_h_a_dec_0.pdf@2017-07-17 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_0.pdf@EU-1-17-1212_h_a_dec_0.pdf@2017-08-22 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_0.pdf@EU-1-17-1217_h_a_dec_0.pdf@2017-08-24 00:00:00@Nitisinone MendeliKABS@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_0.pdf@EU-1-17-1205_h_a_dec_0.pdf@2017-07-17 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1215_h_a_dec_0.pdf@EU-1-17-1215_h_a_dec_0.pdf@2017-08-24 00:00:00@Fotivda@tivozanib@True@False@OD Not Found@EUSA Pharma (UK) Limited@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_0.pdf@EU-1-17-1218_h_a_dec_0.pdf@2017-09-18 00:00:00@Rydapt@Midostaurin@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_0.pdf@EU-1-17-1219_h_a_dec_0.pdf@2018-06-07 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_0.pdf@EU-1-17-1213_h_a_dec_0.pdf@2017-07-26 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_0.pdf@EU-1-17-1214_h_a_dec_0.pdf@2017-09-18 00:00:00@Bavencio@avelumab@True@False@adopted@Merck Serono Europe Limited@conditional@Parsed
EU-1-17-1222_h_a_dec_0.pdf@EU-1-17-1222_h_a_dec_0.pdf@2017-05-09 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_0.pdf@EU-1-17-1225_h_a_dec_0.pdf@2017-09-21 00:00:00@Symtuza@Darunavir ethanolate/ cobistat/  emtricitabine/ tenofovir alafenamide fumarate@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_0.pdf@EU-1-17-1221_h_a_dec_0.pdf@2017-08-22 00:00:00@Kisqali@ribociclib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_0.pdf@EU-1-17-1224_h_a_dec_0.pdf@2017-09-18 00:00:00@Xermelo@telotristat@True@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_0.pdf@EU-1-17-1227_h_a_dec_0.pdf@2017-09-18 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_0.pdf@EU-1-17-1223_h_a_dec_0.pdf@2017-07-26 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_0.pdf@EU-1-17-1228_h_a_dec_0.pdf@2017-10-11 00:00:00@TOOKAD@padeliporfin@True@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_0.pdf@EU-1-17-1226_h_a_dec_0.pdf@2017-09-26 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@True@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_0.pdf@EU-1-17-1232_h_a_dec_0.pdf@2020-04-28 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_0.pdf@EU-1-17-1216_h_a_dec_0.pdf@2017-08-24 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_0.pdf@EU-1-17-1230_h_a_dec_0.pdf@2017-09-18 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_0.pdf@EU-1-17-1233_h_a_dec_0.pdf@2017-10-11 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_0.pdf@EU-1-17-1231_h_a_dec_0.pdf@2018-08-01 00:00:00@Ocrevus@ocrelizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_0.pdf@EU-1-17-1236_h_a_dec_0.pdf@2017-11-15 00:00:00@Trelegy Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_0.pdf@EU-1-17-1238_h_a_dec_0.pdf@2017-10-11 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_0.pdf@EU-1-17-1237_h_a_dec_0.pdf@2017-11-15 00:00:00@Elebrato Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_0.pdf@EU-1-17-1235_h_a_dec_0.pdf@2017-11-16 00:00:00@Zejula@niraparib@True@False@adopted@TESARO UK LIMITED@CMA Not Found@Parsed
EU-1-17-1239_h_a_dec_0.pdf@EU-1-17-1239_h_a_dec_0.pdf@2017-10-11 00:00:00@VeraSeal@human fibrinogen / human thrombin@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_0.pdf@EU-1-17-1234_h_a_dec_0.pdf@2017-10-11 00:00:00@Tremfya@Guselkumab@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_0.pdf@EU-1-17-1244_h_a_dec_0.pdf@2017-08-12 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_0.pdf@EU-1-17-1242_h_a_dec_0.pdf@2017-10-11 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_0.pdf@EU-1-17-1241_h_a_dec_0.pdf@2017-11-15 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_0.pdf@EU-1-17-1220_h_a_dec_0.pdf@2017-09-21 00:00:00@Tecentriq@atezolizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1247_h_a_dec_0.pdf@EU-1-17-1247_h_a_dec_0.pdf@2018-08-01 00:00:00@ADYNOVI@rurioctocog alfa pegol@True@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-17-1249_h_a_dec_0.pdf@EU-1-17-1249_h_a_dec_0.pdf@2018-01-26 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_0.pdf@EU-1-17-1245_h_a_dec_0.pdf@2018-08-01 00:00:00@PREVYMIS@letermovir@True@False@adopted@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1253_h_a_dec_0.pdf@EU-1-17-1253_h_a_dec_0.pdf@2018-08-01 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_0.pdf@EU-1-17-1246_h_a_dec_0.pdf@2018-01-15 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1254_h_a_dec_0.pdf@EU-1-17-1254_h_a_dec_0.pdf@2018-08-01 00:00:00@Jorveza@budesonide@False@False@adopted@Dr. Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_0.pdf@EU-1-17-1229_h_a_dec_0.pdf@2017-09-26 00:00:00@Dupixent@dupilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1256_h_a_dec_0.pdf@EU-1-17-1256_h_a_dec_0.pdf@2018-02-15 00:00:00@Anagrelide Mylan@anagrelide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_0.pdf@EU-1-17-1250_h_a_dec_0.pdf@2018-05-24 00:00:00@Rubraca@rucaparib@True@False@adopted@Clovis Oncology UK Limited@conditional@Parsed
EU-1-17-1255_h_a_dec_0.pdf@EU-1-17-1255_h_a_dec_0.pdf@2018-08-01 00:00:00@Intrarosa@Prasterone@False@False@OD Not Found@Endoceutics Ltd.@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_0.pdf@EU-1-17-1251_h_a_dec_0.pdf@2018-08-02 00:00:00@Ozempic@semaglutide@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_0.pdf@EU-1-17-1260_h_a_dec_0.pdf@2018-09-02 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Ltd@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_0.pdf@EU-1-17-1252_h_a_dec_0.pdf@2018-08-01 00:00:00@Fasenra@benralizumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1257_h_a_dec_0.pdf@EU-1-17-1257_h_a_dec_0.pdf@2018-09-02 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1258_h_a_dec_0.pdf@EU-1-17-1258_h_a_dec_0.pdf@2018-03-23 00:00:00@Lamzede@velmanase alfa@True@False@adopted@Chiesi Farmaceutici S.p.A.@exceptional@Parsed
EU-1-17-1261_h_a_dec_0.pdf@EU-1-17-1261_h_a_dec_0.pdf@2018-03-23 00:00:00@Alofisel@Darvadstrocel@True@True@adopted@TiGenix S.A.U.@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_0.pdf@EU-1-17-1263_h_a_dec_0.pdf@2018-08-02 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-18-1269_h_a_dec_0.pdf@EU-1-18-1269_h_a_dec_0.pdf@2018-04-13 00:00:00@Alpivab@peramivir@True@False@OD Not Found@BioCryst UK Ltd.@CMA Not Found@Parsed
EU-1-18-1264_h_a_dec_0.pdf@EU-1-18-1264_h_a_dec_0.pdf@2018-11-22 00:00:00@Alunbrig@brigatinib@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_0.pdf@EU-1-18-1267_h_a_dec_0.pdf@2018-03-21 00:00:00@Steglatro@ertugliflozin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1266_h_a_dec_0.pdf@EU-1-18-1266_h_a_dec_0.pdf@2018-03-23 00:00:00@Steglujan@ertugliflozin / sitagliptin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_0.pdf@EU-1-18-1265_h_a_dec_0.pdf@2018-03-23 00:00:00@Segluromet@ertugliflozin / metformin  hydrochloride@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_0.pdf@EU-1-17-1262_h_a_dec_0.pdf@2018-02-19 00:00:00@CRYSVITA@Burosumab@True@False@adopted@Kyowa Kirin Limited@conditional@Parsed
EU-1-18-1273_h_a_dec_0.pdf@EU-1-18-1273_h_a_dec_0.pdf@2018-05-16 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1275_h_a_dec_0.pdf@EU-1-18-1275_h_a_dec_0.pdf@2018-04-23 00:00:00@Riarify@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_0.pdf@EU-1-18-1270_h_a_dec_0.pdf@2018-03-23 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_0.pdf@EU-1-18-1274_h_a_dec_0.pdf@2018-04-26 00:00:00@Trydonis@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_0.pdf@EU-1-18-1278_h_a_dec_0.pdf@2018-07-19 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_0.pdf@EU-1-18-1272_h_a_dec_0.pdf@2018-03-21 00:00:00@Shingrix@herpes zoster vaccine (recombinant,  adjuvanted)@True@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-18-1279_h_a_dec_0.pdf@EU-1-18-1279_h_a_dec_0.pdf@2018-05-24 00:00:00@AMGLIDIA@glibenclamide@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1283_h_a_dec_0.pdf@EU-1-18-1283_h_a_dec_0.pdf@2018-05-22 00:00:00@Pemetrexed Krka@pemetrexed@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1280_h_a_dec_0.pdf@EU-1-18-1280_h_a_dec_0.pdf@2018-05-18 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_0.pdf@EU-1-18-1281_h_a_dec_0.pdf@2018-05-16 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_0.pdf@EU-1-18-1276_h_a_dec_0.pdf@2018-07-30 00:00:00@Myalepta@metreleptin@True@False@adopted@Aegerion Pharmaceuticals B.V.@exceptional@Parsed
EU-1-18-1277_h_a_dec_0.pdf@EU-1-18-1277_h_a_dec_0.pdf@2018-04-19 00:00:00@Mylotarg@gemtuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-18-1290_h_a_dec_0.pdf@EU-1-18-1290_h_a_dec_0.pdf@2018-07-26 00:00:00@Nityr@nitisinone@False@False@OD Not Found@Cycle Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-18-1284_h_a_dec_0.pdf@EU-1-18-1284_h_a_dec_0.pdf@2018-06-25 00:00:00@Dzuveo@sufentanil@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_0.pdf@EU-1-18-1282_h_a_dec_0.pdf@2018-05-16 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_0.pdf@EU-1-18-1292_h_a_dec_0.pdf@2018-11-20 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_0.pdf@EU-1-18-1289_h_a_dec_0.pdf@2018-06-21 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir  alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_0.pdf@EU-1-18-1293_h_a_dec_0.pdf@2018-07-26 00:00:00@Aimovig@erenumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1291_h_a_dec_0.pdf@EU-1-18-1291_h_a_dec_0.pdf@2019-02-18 00:00:00@Rizmoic@naldemedine@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_0.pdf@EU-1-18-1271_h_a_dec_0.pdf@2018-02-23 00:00:00@Hemlibra@emicizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_0.pdf@EU-1-18-1295_h_a_dec_0.pdf@Date is blank@Trazimera@trastuzumab@NAS before 2012@NA before 2012@NA before 2000@Pfizer Europe MA EEIG@CMA not available before 2006@Parsed
EU-1-18-1294_h_a_dec_0.pdf@EU-1-18-1294_h_a_dec_0.pdf@2018-07-26 00:00:00@RXULTI@brexpiprazole@True@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_0.pdf@EU-1-18-1286_h_a_dec_0.pdf@2018-07-26 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_0.pdf@EU-1-18-1287_h_a_dec_0.pdf@2018-07-26 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1298_h_a_dec_0.pdf@EU-1-18-1298_h_a_dec_0.pdf@2018-08-31 00:00:00@VEYVONDI@vonicog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-18-1301_h_a_dec_0.pdf@EU-1-18-1301_h_a_dec_0.pdf@2018-08-23 00:00:00@Mepsevii@vestronidase  alfa@True@False@adopted@Ultragenyx Germany GmbH@exceptional@Parsed
EU-1-18-1302_h_a_dec_0.pdf@EU-1-18-1302_h_a_dec_0.pdf@2018-09-20 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-18-1305_h_a_dec_0.pdf@EU-1-18-1305_h_a_dec_0.pdf@2018-08-31 00:00:00@Cablivi@caplacizumab@True@False@adopted@Ablynx N.V.@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_0.pdf@EU-1-18-1296_h_a_dec_0.pdf@2018-06-07 00:00:00@Tegsedi@inotersen@True@False@adopted@IONIS USA Limited@CMA Not Found@Parsed
EU-1-18-1310_h_a_dec_0.pdf@EU-1-18-1310_h_a_dec_0.pdf@2018-09-20 00:00:00@Deferiprone Lipomed@Deferiprone@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_0.pdf@EU-1-18-1299_h_a_dec_0.pdf@2018-08-23 00:00:00@Yescarta@axicabtagene ciloleucel@True@True@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_0.pdf@EU-1-18-1297_h_a_dec_0.pdf@2018-08-23 00:00:00@Kymriah@tisagenlecleucel@True@True@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1308_h_a_dec_0.pdf@EU-1-18-1308_h_a_dec_0.pdf@2018-08-23 00:00:00@Vyxeos@daunorubicin / cytarabine@False@False@adopted@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_0.pdf@EU-1-18-1307_h_a_dec_0.pdf@2018-09-27 00:00:00@Verzenios@abemaciclib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_0.pdf@EU-1-18-1306_h_a_dec_0.pdf@2018-10-31 00:00:00@Symkevi@tezacaftor/ivacaftor@True@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_0.pdf@EU-1-18-1312_h_a_dec_0.pdf@2018-09-20 00:00:00@Xerava@Eravacycline@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_0.pdf@EU-1-18-1311_h_a_dec_0.pdf@2018-08-31 00:00:00@Nerlynx@neratinib@True@False@OD Not Found@Puma Biotechnology, Ltd.@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_0.pdf@EU-1-18-1317_h_a_dec_0.pdf@2019-06-05 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_0.pdf@EU-1-18-1313_h_a_dec_0.pdf@2018-09-21 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_0.pdf@EU-1-18-1318_h_a_dec_0.pdf@2018-09-20 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited,@CMA Not Found@Parsed
EU-1-18-1321_h_a_dec_0.pdf@EU-1-18-1321_h_a_dec_0.pdf@2018-09-27 00:00:00@Gefitinib Mylan@gefitinib@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_0.pdf@EU-1-18-1320_h_a_dec_0.pdf@2018-08-27 00:00:00@Onpattro@patisiran@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1315_h_a_dec_0.pdf@EU-1-18-1315_h_a_dec_0.pdf@2018-09-20 00:00:00@Mektovi@binimetinib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_0.pdf@EU-1-18-1314_h_a_dec_0.pdf@2018-09-20 00:00:00@Braftovi@encorafenib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1324_h_a_dec_0.pdf@EU-1-18-1324_h_a_dec_0.pdf@2018-11-22 00:00:00@Jivi@damoctocog alfa pegol@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_0.pdf@EU-1-18-1316_h_a_dec_0.pdf@2018-09-20 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1325_h_a_dec_0.pdf@EU-1-18-1325_h_a_dec_0.pdf@2018-12-18 00:00:00@Namuscla@Mexiletine@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_0.pdf@EU-1-18-1323_h_a_dec_0.pdf@2018-09-17 00:00:00@Ilumetri@tildrakizumab@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_0.pdf@EU-1-18-1326_h_a_dec_0.pdf@2018-12-12 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen,  inactivated, prepared in cell cultures)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_0.pdf@EU-1-18-1329_h_a_dec_0.pdf@2018-11-20 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1327_h_a_dec_0.pdf@EU-1-18-1327_h_a_dec_0.pdf@2018-11-22 00:00:00@Ziextenzo@pegfilgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_0.pdf@EU-1-18-1328_h_a_dec_0.pdf@2018-11-20 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Cinfa Biotech S.L.@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_0.pdf@EU-1-18-1331_h_a_dec_0.pdf@2018-11-22 00:00:00@Luxturna@voretigene neparvovec@True@True@adopted@Spark Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_0.pdf@EU-1-18-1322_h_a_dec_0.pdf@2018-09-21 00:00:00@Imfinzi@durvalumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_0.pdf@EU-1-18-1330_h_a_dec_0.pdf@2018-11-14 00:00:00@Emgality@galcanezumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1332_h_a_dec_0.pdf@EU-1-18-1332_h_a_dec_0.pdf@2018-11-22 00:00:00@Pifeltro@doravirine@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1334_h_a_dec_0.pdf@EU-1-18-1334_h_a_dec_0.pdf@2018-11-20 00:00:00@Vabomere@meropenem/vaborbactam@True@False@OD Not Found@Rempex London Limited@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_0.pdf@EU-1-18-1333_h_a_dec_0.pdf@2018-11-22 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir  disoproxil@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1335_h_a_dec_0.pdf@EU-1-18-1335_h_a_dec_0.pdf@2018-11-22 00:00:00@Poteligeo@Mogamulizumab@True@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1337_h_a_dec_0.pdf@EU-1-18-1337_h_a_dec_0.pdf@2019-11-01 00:00:00@Macimorelin Aeterna Zentaris@macimorelin@True@False@OD Not Found@Æterna Zentaris GmbH@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_0.pdf@EU-1-18-1319_h_a_dec_0.pdf@2018-09-17 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1339_h_a_dec_0.pdf@EU-1-18-1339_h_a_dec_0.pdf@2018-12-18 00:00:00@Bevespi Aerosphere@glycopyrronium bromide /  formoterol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1343_h_a_dec_0.pdf@EU-1-18-1343_h_a_dec_0.pdf@2019-07-01 00:00:00@Silodosin Recordati@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1338_h_a_dec_0.pdf@EU-1-18-1338_h_a_dec_0.pdf@2018-12-12 00:00:00@Dengvaxia@dengue tetravalent vaccine (live,  attenuated)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_0.pdf@EU-1-18-1340_h_a_dec_0.pdf@2018-11-22 00:00:00@TAKHZYRO@lanadelumab@True@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1346_h_a_dec_0.pdf@EU-1-18-1346_h_a_dec_0.pdf@2019-02-18 00:00:00@Miglustat Dipharma@miglustat@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-18-1342_h_a_dec_0.pdf@EU-1-18-1342_h_a_dec_0.pdf@2019-01-14 00:00:00@Erleada@apalutamide@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_0.pdf@EU-1-18-1336_h_a_dec_0.pdf@2018-11-20 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1347_h_a_dec_0.pdf@EU-1-18-1347_h_a_dec_0.pdf@2019-03-28 00:00:00@Febuxostat Krka@febuxostat@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1350_h_a_dec_0.pdf@EU-1-18-1350_h_a_dec_0.pdf@2019-02-18 00:00:00@Tobramycin PARI@tobramycin@False@False@adopted@PARI Pharma GmbH@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_0.pdf@EU-1-18-1345_h_a_dec_0.pdf@2019-04-26 00:00:00@Ondexxya@andexanet alfa@True@False@OD Not Found@Portola Netherlands B.V.@conditional@Parsed
EU-1-18-1341_h_a_dec_0.pdf@EU-1-18-1341_h_a_dec_0.pdf@2018-12-12 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1349_h_a_dec_0.pdf@EU-1-18-1349_h_a_dec_0.pdf@2019-04-26 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@exceptional@Parsed
EU-1-19-1353_h_a_dec_0.pdf@EU-1-19-1353_h_a_dec_0.pdf@2019-03-25 00:00:00@Atazanavir Krka@atazanavir@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1344_h_a_dec_0.pdf@EU-1-18-1344_h_a_dec_0.pdf@2019-02-14 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1348_h_a_dec_0.pdf@EU-1-18-1348_h_a_dec_0.pdf@2019-02-18 00:00:00@Lusutrombopag Shionogi@lusutrombopag@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1352_h_a_dec_0.pdf@EU-1-18-1352_h_a_dec_0.pdf@2019-02-15 00:00:00@Besremi@ropeginterferon alfa-2b@True@False@OD Not Found@AOP Orphan Pharmaceuticals AG@CMA Not Found@Parsed
EU-1-18-1351_h_a_dec_0.pdf@EU-1-18-1351_h_a_dec_0.pdf@2019-06-20 00:00:00@Trecondi@treosulfan@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_0.pdf@EU-1-19-1355_h_a_dec_0.pdf@2019-06-05 00:00:00@Lorviqua@lorlatinib@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-19-1354_h_a_dec_0.pdf@EU-1-19-1354_h_a_dec_0.pdf@2019-02-04 00:00:00@Vizimpro@dacomitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1359_h_a_dec_0.pdf@EU-1-19-1359_h_a_dec_0.pdf@2019-09-26 00:00:00@Trogarzo@ibalizumab@True@False@OD Not Found@Theratechnologies International Limited@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_0.pdf@EU-1-19-1358_h_a_dec_0.pdf@2019-03-28 00:00:00@AJOVY@fremanezumab@True@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_0.pdf@EU-1-19-1360_h_a_dec_0.pdf@2019-03-05 00:00:00@Waylivra@volanesorsen@True@False@adopted@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1365_h_a_dec_0.pdf@EU-1-19-1365_h_a_dec_0.pdf@2019-07-25 00:00:00@Cufence@trientine dihydrochloride@False@False@OD Not Found@Univar BV@CMA Not Found@Parsed
EU-1-19-1368_h_a_dec_0.pdf@EU-1-19-1368_h_a_dec_0.pdf@2019-06-20 00:00:00@Ambrisentan Mylan@ambrisentan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1364_h_a_dec_0.pdf@EU-1-19-1364_h_a_dec_0.pdf@2019-09-27 00:00:00@NUCEIVA@botulinum toxin type A@False@False@OD Not Found@Evolus Pharma Limited@CMA Not Found@Parsed
EU-1-19-1362_h_a_dec_0.pdf@EU-1-19-1362_h_a_dec_0.pdf@2019-03-05 00:00:00@Palynziq@pegvaliase@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1361_h_a_dec_0.pdf@EU-1-19-1361_h_a_dec_0.pdf@2019-04-26 00:00:00@Skyrizi@risankizumab@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1372_h_a_dec_0.pdf@EU-1-19-1372_h_a_dec_0.pdf@2019-06-25 00:00:00@Striascan@ioflupane ( 123I)@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-19-1366_h_a_dec_0.pdf@EU-1-19-1366_h_a_dec_0.pdf@2019-01-07 00:00:00@Xromi@hydroxycarbamide@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-19-1369_h_a_dec_0.pdf@EU-1-19-1369_h_a_dec_0.pdf@2019-06-20 00:00:00@Sixmo@buprenorphine@False@False@OD Not Found@L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A,@CMA Not Found@Parsed
EU-1-19-1370_h_a_dec_0.pdf@EU-1-19-1370_h_a_dec_0.pdf@2019-01-07 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1374_h_a_dec_0.pdf@EU-1-19-1374_h_a_dec_0.pdf@2019-06-20 00:00:00@Esperoct@turoctocog alfa pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-19-1373_h_a_dec_0.pdf@EU-1-19-1373_h_a_dec_0.pdf@2019-06-20 00:00:00@Doptelet@avatrombopag@True@False@OD Not Found@Dova Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-19-1375_h_a_dec_0.pdf@EU-1-19-1375_h_a_dec_0.pdf@2019-06-20 00:00:00@Grasustek@pegfilgrastim@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1379_h_a_dec_0.pdf@EU-1-19-1379_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole Accord@posaconazole@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1380_h_a_dec_0.pdf@EU-1-19-1380_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole AHCL@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1381_h_a_dec_0.pdf@EU-1-19-1381_h_a_dec_0.pdf@2019-07-25 00:00:00@LysaKare@arginine / lysine@False@False@OD Not Found@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_0.pdf@EU-1-19-1371_h_a_dec_0.pdf@2019-02-07 00:00:00@Ultomiris@Ravulizumab@True@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1377_h_a_dec_0.pdf@EU-1-19-1377_h_a_dec_0.pdf@2019-06-20 00:00:00@Talzenna@talazoparib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1387_h_a_dec_0.pdf@EU-1-19-1387_h_a_dec_0.pdf@2019-11-14 00:00:00@Senstend@lidocaine / prilocaine@False@False@OD Not Found@Plethora Pharma Solutions Ltd.@CMA Not Found@Parsed
EU-1-19-1386_h_a_dec_0.pdf@EU-1-19-1386_h_a_dec_0.pdf@2019-09-26 00:00:00@Deferasirox Mylan@deferasirox@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1356_h_a_dec_0.pdf@EU-1-19-1356_h_a_dec_0.pdf@2019-02-04 00:00:00@Idacio@adalimumab@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1384_h_a_dec_0.pdf@EU-1-19-1384_h_a_dec_0.pdf@2019-08-23 00:00:00@Giapreza@angiotensin II acetate@True@False@OD Not Found@La Jolla Pharmaceutical II B.V.@CMA Not Found@Parsed
EU-1-19-1390_h_a_dec_0.pdf@EU-1-19-1390_h_a_dec_0.pdf@2019-09-19 00:00:00@Inbrija@levodopa@False@False@OD Not Found@Acorda Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-19-1383_h_a_dec_0.pdf@EU-1-19-1383_h_a_dec_0.pdf@2019-08-26 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1393_h_a_dec_0.pdf@EU-1-19-1393_h_a_dec_0.pdf@2019-12-16 00:00:00@Quofenix@delafloxacin@True@False@OD Not Found@A. Menarini - Industrie Farmaceutiche Riunite  - s.r.l.@CMA Not Found@Parsed
EU-1-19-1394_h_a_dec_0.pdf@EU-1-19-1394_h_a_dec_0.pdf@2020-04-17 00:00:00@Tigecycline Accord@tigecycline@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1392_h_a_dec_0.pdf@EU-1-19-1392_h_a_dec_0.pdf@2019-11-11 00:00:00@Ervebo@ZEBOV-GP, live)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1376_h_a_dec_0.pdf@EU-1-19-1376_h_a_dec_0.pdf@2019-06-28 00:00:00@LIBTAYO@cemiplimab@True@False@OD Not Found@Regeneron Ireland U.C.@conditional@Parsed
EU-1-19-1388_h_a_dec_0.pdf@EU-1-19-1388_h_a_dec_0.pdf@2020-01-16 00:00:00@Polivy@polatuzumab vedotin@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-19-1389_h_a_dec_0.pdf@EU-1-19-1389_h_a_dec_0.pdf@2019-09-19 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1398_h_a_dec_0.pdf@EU-1-19-1398_h_a_dec_0.pdf@2019-11-14 00:00:00@Arsenic Trioxide Accord@arsenic trioxide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_0.pdf@EU-1-19-1396_h_a_dec_0.pdf@2019-11-14 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1395_h_a_dec_0.pdf@EU-1-19-1395_h_a_dec_0.pdf@2020-09-01 00:00:00@Clopidogrel/Acetylsalicylic acid Mylan@clopidogrel /  acetylsalicylic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1400_h_a_dec_0.pdf@EU-1-19-1400_h_a_dec_0.pdf@2019-11-19 00:00:00@Rhokiinsa@netarsudil@True@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1397_h_a_dec_0.pdf@EU-1-19-1397_h_a_dec_0.pdf@2019-11-14 00:00:00@Bortezomib Fresenius Kabi@bortezomib@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1403_h_a_dec_0.pdf@EU-1-19-1403_h_a_dec_0.pdf@2020-03-04 00:00:00@Budesonide/Formoterol Teva Pharma B.V.@budesonide / formoterol fumarate dihydrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-19-1385_h_a_dec_0.pdf@EU-1-19-1385_h_a_dec_0.pdf@2019-09-19 00:00:00@VITRAKVI@larotrectinib@True@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1407_h_a_dec_0.pdf@EU-1-19-1407_h_a_dec_0.pdf@2020-09-01 00:00:00@Isturisa@osilodrostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1399_h_a_dec_0.pdf@EU-1-19-1399_h_a_dec_0.pdf@2019-10-24 00:00:00@Xospata@gilteritinib@True@False@adopted@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-19-1406_h_a_dec_0.pdf@EU-1-19-1406_h_a_dec_0.pdf@2019-12-16 00:00:00@Baqsimi@Glucagon@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1409_h_a_dec_0.pdf@EU-1-19-1409_h_a_dec_0.pdf@2019-12-19 00:00:00@Pegfilgrastim Mundipharma@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-19-1408_h_a_dec_0.pdf@EU-1-19-1408_h_a_dec_0.pdf@2020-01-16 00:00:00@Sunosi@solriamfetol@True@False@OD Not Found@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1412_h_a_dec_0.pdf@EU-1-19-1412_h_a_dec_0.pdf@2020-09-01 00:00:00@Deferasirox Accord@deferasirox@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1413_h_a_dec_0.pdf@EU-1-19-1413_h_a_dec_0.pdf@2020-02-13 00:00:00@Azacitidine Accord@Azacitidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1416_h_a_dec_0.pdf@EU-1-19-1416_h_a_dec_0.pdf@2020-03-24 00:00:00@Azacitidine Betapharm@Azacitidine@False@False@OD Not Found@betapharm Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_0.pdf@EU-1-19-1405_h_a_dec_0.pdf@2020-09-01 00:00:00@TAVLESSE@fostamatinib@True@False@OD Not Found@Rigel Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_0.pdf@EU-1-19-1404_h_a_dec_0.pdf@2019-12-16 00:00:00@Rinvoq@upadacitinib@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1418_h_a_dec_0.pdf@EU-1-19-1418_h_a_dec_0.pdf@2020-02-13 00:00:00@Dexmedetomidine Accord@dexmedetomidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_0.pdf@EU-1-19-1410_h_a_dec_0.pdf@2019-12-18 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1411_h_a_dec_0.pdf@EU-1-19-1411_h_a_dec_0.pdf@2019-09-12 00:00:00@Evenity@romosozumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1419_h_a_dec_0.pdf@EU-1-19-1419_h_a_dec_0.pdf@2020-03-04 00:00:00@Trepulmix@treprostinil sodium@False@False@adopted@SciPharm Sàrl@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_0.pdf@EU-1-19-1417_h_a_dec_0.pdf@2020-02-13 00:00:00@Beovu@brolucizumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_0.pdf@EU-1-19-1414_h_a_dec_0.pdf@2020-01-13 00:00:00@Mayzent@siponimod@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_0.pdf@EU-1-19-1420_h_a_dec_0.pdf@2020-02-13 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-20-1423_h_a_dec_0.pdf@EU-1-20-1423_h_a_dec_0.pdf@2020-01-04 00:00:00@Vaxchora@Cholera vaccine (recombinant, live,  oral)@True@False@OD Not Found@Emergent Netherlands B.V.@CMA Not Found@Parsed
EU-1-19-1421_h_a_dec_0.pdf@EU-1-19-1421_h_a_dec_0.pdf@2020-03-27 00:00:00@Staquis@crisaborole@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1427_h_a_dec_0.pdf@EU-1-20-1427_h_a_dec_0.pdf@2020-01-04 00:00:00@Arsenic trioxide Mylan@arsenic trioxide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1426_h_a_dec_0.pdf@EU-1-20-1426_h_a_dec_0.pdf@2020-03-27 00:00:00@Azacitidine Mylan@Azacitidine@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1425_h_a_dec_0.pdf@EU-1-20-1425_h_a_dec_0.pdf@2020-01-04 00:00:00@Nilemdo@bempedoic acid@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1429_h_a_dec_0.pdf@EU-1-20-1429_h_a_dec_0.pdf@2020-03-04 00:00:00@Cinacalcet Accordpharma@cinacalcet@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1424_h_a_dec_0.pdf@EU-1-20-1424_h_a_dec_0.pdf@2020-03-27 00:00:00@Nustendi@bempedoic acid / ezetimibe@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1428_h_a_dec_0.pdf@EU-1-20-1428_h_a_dec_0.pdf@2020-02-03 00:00:00@Givlaari@givosiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1422_h_a_dec_0.pdf@EU-1-20-1422_h_a_dec_0.pdf@2020-03-24 00:00:00@Liumjev@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-20-1430_h_a_dec_0.pdf@EU-1-20-1430_h_a_dec_0.pdf@2020-03-04 00:00:00@Rybelsus@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1431_h_a_dec_0.pdf@EU-1-20-1431_h_a_dec_0.pdf@2020-01-04 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1432_h_a_dec_0.pdf@EU-1-20-1432_h_a_dec_0.pdf@2020-03-27 00:00:00@NUBEQA@darolutamide@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-20-1433_h_a_dec_0.pdf@EU-1-20-1433_h_a_dec_0.pdf@2020-05-20 00:00:00@Fluad Tetra@influenza vaccine (surface antigen,  inactivated, adjuvanted)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1434_h_a_dec_0.pdf@EU-1-20-1434_h_a_dec_0.pdf@2020-04-23 00:00:00@Fetcroja@cefiderocol@True@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-20-1436_h_a_dec_0.pdf@EU-1-20-1436_h_a_dec_0.pdf@2020-05-20 00:00:00@Nepexto@etanercept@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_0.pdf@EU-1-20-1437_h_a_dec_0.pdf@2020-07-31 00:00:00@Pretomanid FGK@pretomanid@True@False@adopted@FGK Representative Service GmbH@conditional@Parsed
EU-1-20-1435_h_a_dec_0.pdf@EU-1-20-1435_h_a_dec_0.pdf@2020-05-30 00:00:00@Sarclisa@isatuximab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1441_h_a_dec_0.pdf@EU-1-20-1441_h_a_dec_0.pdf@2020-05-30 00:00:00@Bemrist Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1438_h_a_dec_0.pdf@EU-1-20-1438_h_a_dec_0.pdf@2020-03-07 00:00:00@Enerzair Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1440_h_a_dec_0.pdf@EU-1-20-1440_h_a_dec_0.pdf@2020-03-07 00:00:00@Zimbus Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1439_h_a_dec_0.pdf@EU-1-20-1439_h_a_dec_0.pdf@2020-05-30 00:00:00@Atectura Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1444_h_a_dec_0.pdf@EU-1-20-1444_h_a_dec_0.pdf@2020-01-07 00:00:00@Zabdeno@Ebola vaccine  (Ad26.ZEBOV-GP [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1448_h_a_dec_0.pdf@EU-1-20-1448_h_a_dec_0.pdf@2020-08-28 00:00:00@Cabazitaxel Accord@cabazitaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1442_h_a_dec_0.pdf@EU-1-20-1442_h_a_dec_0.pdf@2020-05-20 00:00:00@Zeposia@ozanimod@True@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1445_h_a_dec_0.pdf@EU-1-20-1445_h_a_dec_0.pdf@2020-01-07 00:00:00@Mvabea@Ebola vaccine  (MVA-BN-Filo [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1447_h_a_dec_0.pdf@EU-1-20-1447_h_a_dec_0.pdf@2020-06-25 00:00:00@Insulin aspart Sanofi@insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1450_h_a_dec_0.pdf@EU-1-20-1450_h_a_dec_0.pdf@2020-06-25 00:00:00@Fingolimod Accord@fingolimod@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_0.pdf@EU-1-20-1443_h_a_dec_0.pdf@2020-05-18 00:00:00@Zolgensma@onasemnogene  abeparvovec@True@False@adopted@AveXis EU Limited@conditional@Parsed
EU-1-20-1446_h_a_dec_0.pdf@EU-1-20-1446_h_a_dec_0.pdf@2020-07-31 00:00:00@Hepcludex@bulevirtide@True@False@adopted@Myr GmbH@conditional@Parsed
EU-1-20-1453_h_a_dec_0.pdf@EU-1-20-1453_h_a_dec_0.pdf@2020-06-18 00:00:00@Paliperidone Janssen-Cilag International@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1451_h_a_dec_0.pdf@EU-1-20-1451_h_a_dec_0.pdf@2020-06-26 00:00:00@Daurismo@glasdegib@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1415_h_a_dec_0.pdf@EU-1-19-1415_h_a_dec_0.pdf@2020-02-13 00:00:00@Amsparity@adalimumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1452_h_a_dec_0.pdf@EU-1-20-1452_h_a_dec_0.pdf@2020-06-25 00:00:00@Reblozyl@luspatercept@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1458_h_a_dec_0.pdf@EU-1-20-1458_h_a_dec_0.pdf@2020-07-23 00:00:00@Apixaban Accord@apixaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1454_h_a_dec_0.pdf@EU-1-20-1454_h_a_dec_0.pdf@2020-08-19 00:00:00@Aybintio@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1457_h_a_dec_0.pdf@EU-1-20-1457_h_a_dec_0.pdf@2020-07-27 00:00:00@Xenleta@lefamulin@True@False@OD Not Found@Nabriva Therapeutics Ireland DAC@CMA Not Found@Parsed
EU-1-20-1462_h_a_dec_0.pdf@EU-1-20-1462_h_a_dec_0.pdf@2020-08-27 00:00:00@Livogiva@teriparatide@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-20-1465_h_a_dec_0.pdf@EU-1-20-1465_h_a_dec_0.pdf@2020-08-19 00:00:00@Gencebok@caffeine citrate@False@False@OD Not Found@Gennisium Pharma@CMA Not Found@Parsed
EU-1-20-1456_h_a_dec_0.pdf@EU-1-20-1456_h_a_dec_0.pdf@2020-07-27 00:00:00@Zercepac@trastuzumab@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1455_h_a_dec_0.pdf@EU-1-20-1455_h_a_dec_0.pdf@2020-07-27 00:00:00@Piqray@alpelisib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1469_h_a_dec_0.pdf@EU-1-20-1469_h_a_dec_0.pdf@2020-10-27 00:00:00@ARIKAYCE liposomal@amikacin@False@False@adopted@Insmed Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1470_h_a_dec_0.pdf@EU-1-20-1470_h_a_dec_0.pdf@2020-08-19 00:00:00@Methylthioninium chloride Cosmo@methylthioninium chloride@False@False@OD Not Found@Cosmo Technologies Ltd@CMA Not Found@Parsed
EU-1-20-1471_h_a_dec_0.pdf@EU-1-20-1471_h_a_dec_0.pdf@2020-08-25 00:00:00@Idefirix@imlifidase@True@False@adopted@Hansa Biopharma AB@conditional@Parsed
EU-1-20-1468_h_a_dec_0.pdf@EU-1-20-1468_h_a_dec_0.pdf@2020-08-21 00:00:00@Kaftrio@ivacaftor / tezacaftor / elexacaftor@True@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-20-1475_h_a_dec_0.pdf@EU-1-20-1475_h_a_dec_0.pdf@2020-09-17 00:00:00@Arsenic trioxide medac@arsenic trioxide@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_0.pdf@EU-1-20-1459_h_a_dec_0.pdf@2020-03-07 00:00:00@Veklury@remdesivir@True@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1460_h_a_dec_0.pdf@EU-1-20-1460_h_a_dec_0.pdf@2020-07-31 00:00:00@Rozlytrek@entrectinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1477_h_a_dec_0.pdf@EU-1-20-1477_h_a_dec_0.pdf@2020-09-24 00:00:00@Fampridine Accord@fampridine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1474_h_a_dec_0.pdf@EU-1-20-1474_h_a_dec_0.pdf@2020-08-25 00:00:00@BLENREP@belantamab mafodotin@True@False@adopted@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1476_h_a_dec_0.pdf@EU-1-20-1476_h_a_dec_0.pdf@2020-10-28 00:00:00@Adakveo@crizanlizumab@True@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1473_h_a_dec_0.pdf@EU-1-20-1473_h_a_dec_0.pdf@2020-09-24 00:00:00@AYVAKYT@avapritinib@True@False@adopted@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1478_h_a_dec_0.pdf@EU-1-20-1478_h_a_dec_0.pdf@2020-09-24 00:00:00@Zynrelef@bupivacaine/meloxicam@False@False@OD Not Found@Heron Therapeutics, B.V.@CMA Not Found@Parsed
EU-1-20-1479_h_a_dec_0.pdf@EU-1-20-1479_h_a_dec_0.pdf@2020-05-11 00:00:00@Calquence@acalabrutinib@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1484_h_a_dec_0.pdf@EU-1-20-1484_h_a_dec_0.pdf@2020-11-16 00:00:00@Supemtek@quadrivalent influenza vaccine  (recombinant, prepared in cell culture)@True@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1480_h_a_dec_0.pdf@EU-1-20-1480_h_a_dec_0.pdf@2020-09-24 00:00:00@Jyseleca@filgotinib@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1485_h_a_dec_0.pdf@EU-1-20-1485_h_a_dec_0.pdf@2020-11-18 00:00:00@Obiltoxaximab SFL@obiltoxaximab@True@False@adopted@the applicant@exceptional@Parsed
EU-1-20-1483_h_a_dec_0.pdf@EU-1-20-1483_h_a_dec_0.pdf@2020-11-18 00:00:00@MenQuadfi@Meningococcal group A, C, W and Y  conjugate vaccine@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1486_h_a_dec_0.pdf@EU-1-20-1486_h_a_dec_0.pdf@2020-11-18 00:00:00@Nyvepria@pegfilgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1487_h_a_dec_0.pdf@EU-1-20-1487_h_a_dec_0.pdf@2020-11-16 00:00:00@PHELINUN@melphalan@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-20-1489_h_a_dec_0.pdf@EU-1-20-1489_h_a_dec_0.pdf@2020-11-16 00:00:00@EXPAREL liposomal@bupivacaine@False@False@OD Not Found@Pacira Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1482_h_a_dec_0.pdf@EU-1-20-1482_h_a_dec_0.pdf@2020-12-17 00:00:00@REKAMBYS@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1491_h_a_dec_0.pdf@EU-1-20-1491_h_a_dec_0.pdf@2020-12-18 00:00:00@Fintepla@fenfluramine@False@False@adopted@Zogenix ROI Limited@CMA Not Found@Parsed
EU-1-20-1488_h_a_dec_0.pdf@EU-1-20-1488_h_a_dec_0.pdf@2020-11-16 00:00:00@Rivaroxaban Accord@rivaroxaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_0.pdf@EU-1-20-1481_h_a_dec_0.pdf@2020-12-17 00:00:00@Vocabria@cabotegravir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1490_h_a_dec_0.pdf@EU-1-20-1490_h_a_dec_0.pdf@2020-12-18 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_0.pdf@EU-1-20-1492_h_a_dec_0.pdf@2020-12-14 00:00:00@Tecartus@autologous anti-CD19-transduced  CD3+ cells@True@True@adopted@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1495_h_a_dec_0.pdf@EU-1-20-1495_h_a_dec_0.pdf@2020-12-17 00:00:00@Palforzia@defatted powder  Arachis hypogaea L.,  semen (peanuts)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-20-1496_h_a_dec_0.pdf@EU-1-20-1496_h_a_dec_0.pdf@2020-11-19 00:00:00@Oxlumo@lumasiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1494_h_a_dec_0.pdf@EU-1-20-1494_h_a_dec_0.pdf@2020-09-12 00:00:00@Leqvio@inclisiran@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1493_h_a_dec_0.pdf@EU-1-20-1493_h_a_dec_0.pdf@2020-12-17 00:00:00@Libmeldy@autologous CD34+ cell enriched population  that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral  vector encoding the human arylsulfatase A gene@True@True@adopted@Orchard Therapeutics (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-20-1503_h_a_dec_0.pdf@EU-1-20-1503_h_a_dec_0.pdf@2021-02-18 00:00:00@Heplisav B@hepatitis B surface antigen@False@False@OD Not Found@Dynavax GmbH@CMA Not Found@Parsed
EU-1-20-1497_h_a_dec_0.pdf@EU-1-20-1497_h_a_dec_0.pdf@2020-12-21 00:00:00@Phesgo@pertuzumab / trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1500_h_a_dec_0.pdf@EU-1-20-1500_h_a_dec_0.pdf@2021-07-01 00:00:00@Xofluza@baloxavir marboxil@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1501_h_a_dec_0.pdf@EU-1-20-1501_h_a_dec_0.pdf@2021-03-31 00:00:00@Sogroya@somapacitan@True@False@adopted@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1499_h_a_dec_0.pdf@EU-1-20-1499_h_a_dec_0.pdf@2021-11-01 00:00:00@Onbevzi@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1502_h_a_dec_0.pdf@EU-1-20-1502_h_a_dec_0.pdf@2021-07-01 00:00:00@Roclanda@Latanoprost / netarsudil@False@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1506_h_a_dec_0.pdf@EU-1-20-1506_h_a_dec_0.pdf@2021-05-02 00:00:00@Kixelle@Insulin aspart@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1505_h_a_dec_0.pdf@EU-1-20-1505_h_a_dec_0.pdf@2021-03-26 00:00:00@Byfavo@remimazolam@True@False@OD Not Found@PAION Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1504_h_a_dec_0.pdf@EU-1-20-1504_h_a_dec_0.pdf@2021-07-01 00:00:00@ELZONRIS@tagraxofusp@True@False@adopted@Stemline Therapeutics B.V.@exceptional@Parsed
EU-1-20-1511_h_a_dec_0.pdf@EU-1-20-1511_h_a_dec_0.pdf@2021-11-02 00:00:00@Sunitinib Accord@sunitinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1509_h_a_dec_0.pdf@EU-1-20-1509_h_a_dec_0.pdf@2021-03-26 00:00:00@Alymsys@bevacizumab@False@False@OD Not Found@Mabxience Research SL@CMA Not Found@Parsed
EU-1-20-1498_h_a_dec_0.pdf@EU-1-20-1498_h_a_dec_0.pdf@2020-09-12 00:00:00@TRIXEO AEROSPHERE@Formoterol /  glycopyrronium bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1512_h_a_dec_0.pdf@EU-1-20-1512_h_a_dec_0.pdf@2021-04-26 00:00:00@Abiraterone Accord@abiraterone acetate@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1510_h_a_dec_0.pdf@EU-1-20-1510_h_a_dec_0.pdf@2021-03-26 00:00:00@Oyavas@bevacizumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-20-1508_h_a_dec_0.pdf@EU-1-20-1508_h_a_dec_0.pdf@2021-01-18 00:00:00@Enhertu@trastuzumab deruxtecan@True@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1517_h_a_dec_0.pdf@EU-1-20-1517_h_a_dec_0.pdf@2021-04-30 00:00:00@Sibnayal@potassium citrate/potassium hydrogen  carbonate@False@False@OD Not Found@ADVICENNE@CMA Not Found@Parsed
EU-1-20-1518_h_a_dec_0.pdf@EU-1-20-1518_h_a_dec_0.pdf@2021-04-02 00:00:00@Rukobia@fostemsavir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1514_h_a_dec_0.pdf@EU-1-20-1514_h_a_dec_0.pdf@2021-08-02 00:00:00@Inrebic@fedratinib@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_0.pdf@EU-1-20-1507_h_a_dec_0.pdf@2021-06-01 00:00:00@COVID-19 Vaccine Moderna@COVID-19 mRNA Vaccine (nucleoside modified)@True@False@OD Not Found@MODERNA BIOTECH SPAIN, S.L.@conditional@Parsed
EU-1-20-1515_h_a_dec_0.pdf@EU-1-20-1515_h_a_dec_0.pdf@2021-04-21 00:00:00@Abevmy@bevacizumab@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1519_h_a_dec_0.pdf@EU-1-20-1519_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka d.d. Novo mesto@lenalidomide@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1521_h_a_dec_0.pdf@EU-1-20-1521_h_a_dec_0.pdf@2021-12-02 00:00:00@Lenalidomide Krka d.d.@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1520_h_a_dec_0.pdf@EU-1-20-1520_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1513_h_a_dec_0.pdf@EU-1-20-1513_h_a_dec_0.pdf@2021-11-02 00:00:00@Yuflyma@adalimumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-20-1524_h_a_dec_0.pdf@EU-1-20-1524_h_a_dec_0.pdf@2021-03-26 00:00:00@Vazkepa@icosapent ethyl@True@False@OD Not Found@Amarin Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1523_h_a_dec_0.pdf@EU-1-20-1523_h_a_dec_0.pdf@2021-11-02 00:00:00@Ogluo@glucagon@False@False@OD Not Found@Xeris Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-21-1530_h_a_dec_0.pdf@EU-1-21-1530_h_a_dec_0.pdf@2021-03-26 00:00:00@Ontozry@cenobamate@True@False@OD Not Found@Arvelle Therapeutics Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1531_h_a_dec_0.pdf@EU-1-21-1531_h_a_dec_0.pdf@2021-03-26 00:00:00@Evrysdi@risdiplam@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1527_h_a_dec_0.pdf@EU-1-20-1527_h_a_dec_0.pdf@2021-11-02 00:00:00@Retsevmo@selpercatinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@conditional@Parsed
EU-1-21-1533_h_a_dec_0.pdf@EU-1-21-1533_h_a_dec_0.pdf@2021-03-26 00:00:00@Seffalair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-20-1526_h_a_dec_0.pdf@EU-1-20-1526_h_a_dec_0.pdf@2021-11-02 00:00:00@TUKYSA@tucatinib@False@False@OD Not Found@Seagen B.V.@CMA Not Found@Parsed
EU-1-21-1536_h_a_dec_0.pdf@EU-1-21-1536_h_a_dec_0.pdf@2021-03-26 00:00:00@Thiotepa Riemser@thiotepa@False@False@OD Not Found@RIEMSER Pharma GmbH@CMA Not Found@Parsed
EU-1-21-1532_h_a_dec_0.pdf@EU-1-21-1532_h_a_dec_0.pdf@2021-03-26 00:00:00@Kesimpta@ofatumumab@False@False@OD Not Found@Novartis Ireland Limited@CMA Not Found@Parsed
EU-1-21-1535_h_a_dec_0.pdf@EU-1-21-1535_h_a_dec_0.pdf@2021-03-26 00:00:00@Pemazyre@pemigatinib@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1529_h_a_dec_0.pdf@EU-1-21-1529_h_a_dec_0.pdf@2021-01-29 00:00:00@COVID-19 Vaccine AstraZeneca@COVID-19 Vaccine (ChAdOx1-S [recombinant])@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-21-1540_h_a_dec_0.pdf@EU-1-21-1540_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accord@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1541_h_a_dec_0.pdf@EU-1-21-1541_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accordpharma@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_0.pdf@EU-1-20-1525_h_a_dec_0.pdf@2021-11-03 00:00:00@COVID-19 Vaccine Janssen@19 vaccine (Ad26.COV2-S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1537_h_a_dec_0.pdf@EU-1-21-1537_h_a_dec_0.pdf@2021-03-26 00:00:00@NEXPOVIO@selinexor@True@False@OD Not Found@Karyopharm Europe GmbH@conditional@Parsed
EU-1-21-1534_h_a_dec_0.pdf@EU-1-21-1534_h_a_dec_0.pdf@2021-03-26 00:00:00@BroPair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1538_h_a_dec_0.pdf@EU-1-21-1538_h_a_dec_0.pdf@2021-04-21 00:00:00@JEMPERLI@dostarlimab@True@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-21-1546_h_a_dec_0.pdf@EU-1-21-1546_h_a_dec_0.pdf@2021-07-22 00:00:00@Ozawave@pitolisant@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-21-1547_h_a_dec_0.pdf@EU-1-21-1547_h_a_dec_0.pdf@2021-05-19 00:00:00@Drovelis@drospirenone / estetrol@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1539_h_a_dec_0.pdf@EU-1-21-1539_h_a_dec_0.pdf@2021-08-18 00:00:00@Abecma@idecabtagene vicleucel@True@True@adopted@Celgene Europe B.V.@conditional@Parsed
EU-1-21-1549_h_a_dec_0.pdf@EU-1-21-1549_h_a_dec_0.pdf@2021-05-27 00:00:00@Efmody@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
EU-1-21-1551_h_a_dec_0.pdf@EU-1-21-1551_h_a_dec_0.pdf@2021-06-17 00:00:00@Evkeeza@evinacumab@True@False@OD Not Found@Regeneron Ireland Designated Activity  Company (DAC)@exceptional@Parsed
EU-1-21-1548_h_a_dec_0.pdf@EU-1-21-1548_h_a_dec_0.pdf@2021-05-19 00:00:00@Lydisilka@drospirenone / estetrol@False@False@OD Not Found@Estetra SRL@CMA Not Found@Parsed
EU-1-21-1554_h_a_dec_0.pdf@EU-1-21-1554_h_a_dec_0.pdf@2021-06-17 00:00:00@Adtralza@tralokinumab@True@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-21-1553_h_a_dec_0.pdf@EU-1-21-1553_h_a_dec_0.pdf@2021-06-24 00:00:00@Abiraterone Krka@abiraterone acetate@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-21-1544_h_a_dec_0.pdf@EU-1-21-1544_h_a_dec_0.pdf@2021-04-30 00:00:00@Orladeyo@berotralstat@True@False@OD Not Found@Biocryst Ireland Limited@CMA Not Found@Parsed
EU-1-21-1542_h_a_dec_0.pdf@EU-1-21-1542_h_a_dec_0.pdf@2021-05-19 00:00:00@Copiktra@duvelisib@True@False@OD Not Found@Verastem Europe GmbH@CMA Not Found@Parsed
EU-1-21-1557_h_a_dec_0.pdf@EU-1-21-1557_h_a_dec_0.pdf@2021-06-21 00:00:00@Jayempi@azathioprine@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-21-1558_h_a_dec_0.pdf@EU-1-21-1558_h_a_dec_0.pdf@2021-07-16 00:00:00@Klisyri@tirbanibulin@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-21-1550_h_a_dec_0.pdf@EU-1-21-1550_h_a_dec_0.pdf@2021-05-19 00:00:00@Ponvory@ponesimod@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-21-1560_h_a_dec_0.pdf@EU-1-21-1560_h_a_dec_0.pdf@2021-06-17 00:00:00@Celsunax@ioflupane (123I)@False@False@OD Not Found@Pinax Pharma GmbH@CMA Not Found@Parsed
EU-1-21-1552_h_a_dec_0.pdf@EU-1-21-1552_h_a_dec_0.pdf@2021-06-17 00:00:00@Koselugo@selumetinib@True@False@adopted@AstraZeneca AB@conditional@Parsed
EU-1-21-1556_h_a_dec_0.pdf@EU-1-21-1556_h_a_dec_0.pdf@2021-06-17 00:00:00@Onureg@azacitidine@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-21-1555_h_a_dec_0.pdf@EU-1-21-1555_h_a_dec_0.pdf@2021-11-18 00:00:00@Gavreto@pralsetinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-21-1561_h_a_dec_0.pdf@EU-1-21-1561_h_a_dec_0.pdf@2021-07-16 00:00:00@Verquvo@vericiguat@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1559_h_a_dec_0.pdf@EU-1-21-1559_h_a_dec_0.pdf@2021-06-24 00:00:00@Enspryng@satralizumab@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1562_h_a_dec_0.pdf@EU-1-21-1562_h_a_dec_0.pdf@2021-12-17 00:00:00@Xevudy@sotrovimab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-21-1567_h_a_dec_0.pdf@EU-1-21-1567_h_a_dec_0.pdf@2021-07-16 00:00:00@Icatibant Accord@icatibant@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1568_h_a_dec_0.pdf@EU-1-21-1568_h_a_dec_0.pdf@2021-09-22 00:00:00@Imatinib Koanaa@imatinib@False@False@OD Not Found@Koanaa Healthcare GmbH@CMA Not Found@Parsed
EU-1-21-1566_h_a_dec_0.pdf@EU-1-21-1566_h_a_dec_0.pdf@2021-07-16 00:00:00@Bylvay@odevixibat@True@False@adopted@Albireo AB@exceptional@Parsed
EU-1-21-1564_h_a_dec_0.pdf@EU-1-21-1564_h_a_dec_0.pdf@2021-07-16 00:00:00@Imcivree@setmelanotide@True@False@adopted@Rhythm Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-21-1571_h_a_dec_0.pdf@EU-1-21-1571_h_a_dec_0.pdf@2021-08-20 00:00:00@Abiraterone Mylan@abiraterone acetate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1573_h_a_dec_0.pdf@EU-1-21-1573_h_a_dec_0.pdf@2021-08-18 00:00:00@Fingolimod Mylan@fingolimod@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1569_h_a_dec_0.pdf@EU-1-21-1569_h_a_dec_0.pdf@2021-11-18 00:00:00@QINLOCK@ripretinib@True@False@adopted@Deciphera Pharmaceuticals (Netherlands)  B.V.@CMA Not Found@Parsed
EU-1-21-1570_h_a_dec_0.pdf@EU-1-21-1570_h_a_dec_0.pdf@2021-08-26 00:00:00@Minjuvi@tafasitamab@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1574_h_a_dec_0.pdf@EU-1-21-1574_h_a_dec_0.pdf@2021-08-18 00:00:00@Evrenzo@roxadustat@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1565_h_a_dec_0.pdf@EU-1-21-1565_h_a_dec_0.pdf@2021-07-16 00:00:00@Ryeqo@relugolix / estradiol / norethisterone  acetate@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1578_h_a_dec_0.pdf@EU-1-21-1578_h_a_dec_0.pdf@2022-02-21 00:00:00@Ontilyv@opicapone@False@False@OD Not Found@Bial - Portela & Cª, SA@CMA Not Found@Parsed
EU-1-21-1572_h_a_dec_0.pdf@EU-1-21-1572_h_a_dec_0.pdf@2021-08-18 00:00:00@Byooviz@ranibizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-21-1583_h_a_dec_0.pdf@EU-1-21-1583_h_a_dec_0.pdf@2021-11-15 00:00:00@Sugammadex Mylan@sugammadex@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1575_h_a_dec_0.pdf@EU-1-21-1575_h_a_dec_0.pdf@2021-08-20 00:00:00@Bimzelx@bimekizumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-21-1577_h_a_dec_0.pdf@EU-1-21-1577_h_a_dec_0.pdf@2021-08-26 00:00:00@Voxzogo@vosoritide@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-21-1582_h_a_dec_0.pdf@EU-1-21-1582_h_a_dec_0.pdf@2021-11-22 00:00:00@Artesunate Amivas@artesunate@True@False@adopted@Amivas Ireland Limited@CMA Not Found@Parsed
EU-1-21-1576_h_a_dec_0.pdf@EU-1-21-1576_h_a_dec_0.pdf@2021-11-22 00:00:00@Brukinsa@zanubrutinib@True@False@OD Not Found@BeiGene Ireland Limited@CMA Not Found@Parsed
EU-1-21-1587_h_a_dec_0.pdf@EU-1-21-1587_h_a_dec_0.pdf@2022-08-17 00:00:00@RAYVOW@lasmiditan@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-21-1585_h_a_dec_0.pdf@EU-1-21-1585_h_a_dec_0.pdf@2021-11-15 00:00:00@Vumerity@diroximel fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1579_h_a_dec_0.pdf@EU-1-21-1579_h_a_dec_0.pdf@2022-06-24 00:00:00@Nexviadyme@avalglucosidase alfa@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-21-1588_h_a_dec_0.pdf@EU-1-21-1588_h_a_dec_0.pdf@2021-12-11 00:00:00@Rivaroxaban Mylan@rivaroxaban@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1592_h_a_dec_0.pdf@EU-1-21-1592_h_a_dec_0.pdf@2021-11-22 00:00:00@Trodelvy@sacituzumab govitecan@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-21-1586_h_a_dec_0.pdf@EU-1-21-1586_h_a_dec_0.pdf@2022-11-01 00:00:00@Voraxaze@glucarpidase@True@False@adopted@the applicant@exceptional@Parsed
EU-1-21-1589_h_a_dec_0.pdf@EU-1-21-1589_h_a_dec_0.pdf@2021-11-15 00:00:00@Hukyndra@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1590_h_a_dec_0.pdf@EU-1-21-1590_h_a_dec_0.pdf@2021-12-11 00:00:00@Libmyris@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1594_h_a_dec_0.pdf@EU-1-21-1594_h_a_dec_0.pdf@2021-09-12 00:00:00@Rybrevant@amivantamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1591_h_a_dec_0.pdf@EU-1-21-1591_h_a_dec_0.pdf@2021-12-13 00:00:00@Vaxneuvance@Pneumococcal polysaccharide  conjugate vaccine (15 ‑ valent, adsorbed)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-21-1593_h_a_dec_0.pdf@EU-1-21-1593_h_a_dec_0.pdf@2021-09-12 00:00:00@Cibinqo@abrocitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1598_h_a_dec_0.pdf@EU-1-21-1598_h_a_dec_0.pdf@2021-09-12 00:00:00@Sitagliptin SUN@sitagliptin fumarate@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-21-1595_h_a_dec_0.pdf@EU-1-21-1595_h_a_dec_0.pdf@2021-12-13 00:00:00@ASPAVELI@pegcetacoplan@True@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-21-1596_h_a_dec_0.pdf@EU-1-21-1596_h_a_dec_0.pdf@2022-02-16 00:00:00@Tepmetko@tepotinib@True@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-21-1600_h_a_dec_0.pdf@EU-1-21-1600_h_a_dec_0.pdf@2022-06-01 00:00:00@Tecovirimat SIGA@tecovirimat@True@False@OD Not Found@SIGA Technologies Netherlands B.V.@exceptional@Parsed
EU-1-21-1597_h_a_dec_0.pdf@EU-1-21-1597_h_a_dec_0.pdf@2021-12-11 00:00:00@Regkirona@regdanvimab@True@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-21-1599_h_a_dec_0.pdf@EU-1-21-1599_h_a_dec_0.pdf@2022-01-24 00:00:00@Vyepti@eptinezumab@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-21-1602_h_a_dec_0.pdf@EU-1-21-1602_h_a_dec_0.pdf@2022-04-25 00:00:00@Uplizna@inebilizumab@True@False@adopted@Viela Bio B.V.@CMA Not Found@Parsed
EU-1-21-1603_h_a_dec_0.pdf@EU-1-21-1603_h_a_dec_0.pdf@2022-06-01 00:00:00@Lumykras@sotorasib@True@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-21-1601_h_a_dec_0.pdf@EU-1-21-1601_h_a_dec_0.pdf@2021-12-11 00:00:00@Ronapreve@casirivimab / imdevimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1605_h_a_dec_0.pdf@EU-1-21-1605_h_a_dec_0.pdf@2022-11-01 00:00:00@Tavneos@avacopan@True@False@adopted@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-21-1611_h_a_dec_0.pdf@EU-1-21-1611_h_a_dec_0.pdf@2022-03-24 00:00:00@Vildagliptin/Metformin hydrochloride Accord@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1606_h_a_dec_0.pdf@EU-1-21-1606_h_a_dec_0.pdf@2022-06-14 00:00:00@Yselty@linzagolix choline@True@False@OD Not Found@ObsEva Ireland Ltd.@CMA Not Found@Parsed
EU-1-21-1604_h_a_dec_0.pdf@EU-1-21-1604_h_a_dec_0.pdf@2022-06-01 00:00:00@Riltrava Aerosphere@formoterol / glycopyrronium  bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-21-1607_h_a_dec_0.pdf@EU-1-21-1607_h_a_dec_0.pdf@2022-11-01 00:00:00@Lonapegsomatropin Ascendis Pharma@Lonapegsomatropin@True@False@adopted@Ascendis Pharma Endocrinology Division A/S,@CMA Not Found@Parsed
EU-1-21-1612_h_a_dec_0.pdf@EU-1-21-1612_h_a_dec_0.pdf@2022-02-14 00:00:00@Apexxnar@pneumococcal polysaccharide conjugate  vaccine (20-valent, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1619_h_a_dec_0.pdf@EU-1-21-1619_h_a_dec_0.pdf@2022-02-16 00:00:00@Sitagliptin/Metformin hydrochloride Mylan@sitagliptin/metformin hydrochloride@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1617_h_a_dec_0.pdf@EU-1-21-1617_h_a_dec_0.pdf@2022-02-14 00:00:00@Ngenla@somatrogon@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1616_h_a_dec_0.pdf@EU-1-21-1616_h_a_dec_0.pdf@2022-02-16 00:00:00@Kerendia@finerenone@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1608_h_a_dec_0.pdf@EU-1-21-1608_h_a_dec_0.pdf@2022-06-01 00:00:00@Wegovy@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-21-1620_h_a_dec_0.pdf@EU-1-21-1620_h_a_dec_0.pdf@2022-02-16 00:00:00@Sapropterin Dipharma@sapropterin@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-21-1615_h_a_dec_0.pdf@EU-1-21-1615_h_a_dec_0.pdf@2022-04-13 00:00:00@Padcev@enfortumab vedotin@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1621_h_a_dec_0.pdf@EU-1-21-1621_h_a_dec_0.pdf@2022-02-14 00:00:00@OKEDI@risperidone@False@False@OD Not Found@Laboratorios Farmacéuticos Rovi, S.A.@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_0.pdf@EU-1-21-1618_h_a_dec_0.pdf@2021-12-20 00:00:00@Nuvaxovid@COVID-19 Vaccine  (recombinant, adjuvanted)@True@False@OD Not Found@Novavax CZ, a.s.@conditional@Parsed
EU-1-22-1628_h_a_dec_0.pdf@EU-1-22-1628_h_a_dec_0.pdf@2022-03-24 00:00:00@Sondelbay@teriparatide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1629_h_a_dec_0.pdf@EU-1-22-1629_h_a_dec_0.pdf@2022-05-31 00:00:00@ZOLSKETIL pegylated liposomal@doxorubicin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1622_h_a_dec_0.pdf@EU-1-21-1622_h_a_dec_0.pdf@2022-02-14 00:00:00@Oxbryta@voxelotor@True@False@adopted@Global Blood Therapeutics Netherlands B.V.,@CMA Not Found@Parsed
EU-1-21-1624_h_a_dec_0.pdf@EU-1-21-1624_h_a_dec_0.pdf@2022-06-24 00:00:00@COVID-19 Vaccine (inactivated, adjuvanted)  Valneva@COVID-19 vaccine (inactivated, adjuvanted, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-21-1623_h_a_dec_0.pdf@EU-1-21-1623_h_a_dec_0.pdf@2022-02-14 00:00:00@Saphnelo@anifrolumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1625_h_a_dec_0.pdf@EU-1-22-1625_h_a_dec_0.pdf@2022-01-28 00:00:00@Paxlovid@trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide /  ritonavir@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-22-1633_h_a_dec_0.pdf@EU-1-22-1633_h_a_dec_0.pdf@2022-04-25 00:00:00@Sitagliptin Accord@Sitagliptin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_0.pdf@EU-1-20-1528_h_a_dec_0.pdf@2020-12-21 00:00:00@Comirnaty@COVID-19 mRNA  Vaccine (nucleoside modified)@True@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-22-1632_h_a_dec_0.pdf@EU-1-22-1632_h_a_dec_0.pdf@2022-03-28 00:00:00@Stimufend@pegfilgrastim@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1635_h_a_dec_0.pdf@EU-1-22-1635_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumerate Polpharma@dimethyl  fumarate@False@False@OD Not Found@Zakłady Farmaceutyczne POLPHARMA S.A.,@CMA Not Found@Parsed
EU-1-22-1634_h_a_dec_0.pdf@EU-1-22-1634_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Mylan@dimethyl fumarate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-22-1637_h_a_dec_0.pdf@EU-1-22-1637_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Neuraxpharm@dimethyl  fumarate@False@False@OD Not Found@Laboratorios Lesvi, S.L.@CMA Not Found@Parsed
EU-1-22-1640_h_a_dec_0.pdf@EU-1-22-1640_h_a_dec_0.pdf@2022-05-05 00:00:00@Amversio@betaine anhydrous@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-22-1641_h_a_dec_0.pdf@EU-1-22-1641_h_a_dec_0.pdf@2022-04-25 00:00:00@PreHevbri@Hepatitis B vaccine (recombinant,  adsorbed)@False@False@OD Not Found@VBI Vaccines B.V.@CMA Not Found@Parsed
EU-1-22-1639_h_a_dec_0.pdf@EU-1-22-1639_h_a_dec_0.pdf@2022-04-25 00:00:00@Truvelog Mix 30@Insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-22-1638_h_a_dec_0.pdf@EU-1-22-1638_h_a_dec_0.pdf@2022-04-29 00:00:00@QUVIVIQ@daridorexant@True@False@OD Not Found@Idorsia Pharmaceuticals Deutschland GmbH,@CMA Not Found@Parsed
EU-1-22-1630_h_a_dec_0.pdf@EU-1-22-1630_h_a_dec_0.pdf@2022-01-04 00:00:00@KIMMTRAK@tebentafusp@True@False@adopted@Immunocore Ireland Limited@CMA Not Found@Parsed
EU-1-22-1646_h_a_dec_0.pdf@EU-1-22-1646_h_a_dec_0.pdf@2022-05-19 00:00:00@Amifampridine SERB@amifampridine@False@False@OD Not Found@SERB S.A.@CMA Not Found@Parsed
EU-1-22-1643_h_a_dec_0.pdf@EU-1-22-1643_h_a_dec_0.pdf@2022-04-25 00:00:00@Kapruvia@difelikefalin@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-22-1631_h_a_dec_0.pdf@EU-1-22-1631_h_a_dec_0.pdf@2022-04-04 00:00:00@Breyanzi@lisocabtagene maraleucel@True@True@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-22-1644_h_a_dec_0.pdf@EU-1-22-1644_h_a_dec_0.pdf@2022-04-25 00:00:00@Inpremzia@insulin human (rDNA)@False@False@OD Not Found@Baxter Holding B.V.@CMA Not Found@Parsed
EU-1-22-1650_h_a_dec_0.pdf@EU-1-22-1650_h_a_dec_0.pdf@2022-06-20 00:00:00@Tabrecta@capmatinib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-22-1642_h_a_dec_0.pdf@EU-1-22-1642_h_a_dec_0.pdf@2022-04-29 00:00:00@Orgovyx@relugolix@False@False@OD Not Found@Myovant Sciences Ireland Limited@CMA Not Found@Parsed
EU-1-22-1647_h_a_dec_0.pdf@EU-1-22-1647_h_a_dec_0.pdf@2022-05-24 00:00:00@Camcevi@leuprorelin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1645_h_a_dec_0.pdf@EU-1-22-1645_h_a_dec_0.pdf@2022-04-25 00:00:00@Vydura@rimegepant@True@False@OD Not Found@Biohaven Pharmaceutical Ireland DAC@CMA Not Found@Parsed
EU-1-22-1656_h_a_dec_0.pdf@EU-1-22-1656_h_a_dec_0.pdf@2022-07-15 00:00:00@Ertapenem SUN@ertapenem@False@False@OD Not Found@Sun Pharmaceutical Industries Europe B.V.@CMA Not Found@Parsed
EU-1-22-1648_h_a_dec_0.pdf@EU-1-22-1648_h_a_dec_0.pdf@2022-05-25 00:00:00@CARVYKTI@ciltacabtagene  autoleucel@True@True@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1652_h_a_dec_0.pdf@EU-1-22-1652_h_a_dec_0.pdf@2022-06-21 00:00:00@Filsuvez@birch bark extract@False@False@adopted@Amryt Pharmaceuticals DAC@CMA Not Found@Parsed
EU-1-22-1658_h_a_dec_0.pdf@EU-1-22-1658_h_a_dec_0.pdf@2022-07-15 00:00:00@Ganirelix Gedeon Richter@ganirelix@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-22-1655_h_a_dec_0.pdf@EU-1-22-1655_h_a_dec_0.pdf@2022-06-20 00:00:00@Pirfenidone AET@pirfenidone@False@False@OD Not Found@Alfred E. Tiefenbacher (GmbH & Co. KG)@CMA Not Found@Parsed
EU-1-22-1661_h_a_dec_0.pdf@EU-1-22-1661_h_a_dec_0.pdf@2022-07-22 00:00:00@Sitagliptin/Metformin hydrochloride Accord@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1653_h_a_dec_0.pdf@EU-1-22-1653_h_a_dec_0.pdf@2022-07-18 00:00:00@Upstaza@eladocagene  exuparvovec@True@True@adopted@PTC Therapeutics International Limited@exceptional@Parsed
EU-1-22-1663_h_a_dec_0.pdf@EU-1-22-1663_h_a_dec_0.pdf@2022-07-15 00:00:00@Sugammadex Fresenius Kabi@sugammadex@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1649_h_a_dec_0.pdf@EU-1-22-1649_h_a_dec_0.pdf@2022-03-06 00:00:00@Lunsumio@mosunetuzumab@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-22-1651_h_a_dec_0.pdf@EU-1-22-1651_h_a_dec_0.pdf@2022-03-25 00:00:00@EVUSHELD@tixagevimab / cilgavimab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1666_h_a_dec_0.pdf@EU-1-22-1666_h_a_dec_0.pdf@2022-09-15 00:00:00@Celdoxome pegylated liposomal@doxorubicin  hydrochloride@False@False@OD Not Found@YES Pharmaceutical Development Services  GmbH@CMA Not Found@Parsed
EU-1-22-1664_h_a_dec_0.pdf@EU-1-22-1664_h_a_dec_0.pdf@2022-07-15 00:00:00@Cevenfacta@eptacog beta (activated)@False@False@OD Not Found@Laboratoire français du Fractionnement et des  Biotechnologies@CMA Not Found@Parsed
EU-1-22-1668_h_a_dec_0.pdf@EU-1-22-1668_h_a_dec_0.pdf@2022-08-24 00:00:00@Roctavian@valoctocogene  roxaparvovec@True@True@adopted@BioMarin International Limited@conditional@Parsed
EU-1-22-1657_h_a_dec_0.pdf@EU-1-22-1657_h_a_dec_0.pdf@2022-07-15 00:00:00@Kinpeygo@budesonide@False@False@adopted@Calliditas Therapeutics AB@conditional@Parsed
EU-1-22-1659_h_a_dec_0.pdf@EU-1-22-1659_h_a_dec_0.pdf@2022-06-24 00:00:00@Xenpozyme@olipudase alfa@True@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-22-1667_h_a_dec_0.pdf@EU-1-22-1667_h_a_dec_0.pdf@2022-08-17 00:00:00@VEGZELMA@bevacizumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-22-1670_h_a_dec_0.pdf@EU-1-22-1670_h_a_dec_0.pdf@2022-08-25 00:00:00@Scemblix@asciminib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-22-1660_h_a_dec_0.pdf@EU-1-22-1660_h_a_dec_0.pdf@2022-07-18 00:00:00@Zokinvy@lonafarnib@True@False@adopted@EigerBio Europe Limited@exceptional@Parsed
EU-1-22-1674_h_a_dec_0.pdf@EU-1-22-1674_h_a_dec_0.pdf@2022-10-08 00:00:00@Vyvgart@efgartigimod alfa@True@False@adopted@argenx BV@CMA Not Found@Parsed
EU-1-22-1675_h_a_dec_0.pdf@EU-1-22-1675_h_a_dec_0.pdf@2022-08-23 00:00:00@TECVAYLI@teclistamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1676_h_a_dec_0.pdf@EU-1-22-1676_h_a_dec_0.pdf@2022-09-19 00:00:00@Thalidomide Lipomed@Thalidomide@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-22-1673_h_a_dec_0.pdf@EU-1-22-1673_h_a_dec_0.pdf@2022-08-25 00:00:00@Ranivisio@ranibizumab@False@False@OD Not Found@Midas Pharma GmbH@CMA Not Found@Parsed
EU-1-22-1678_h_a_dec_0.pdf@EU-1-22-1678_h_a_dec_0.pdf@2022-09-15 00:00:00@Lupkynis@voclosporin@True@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1679_h_a_dec_0.pdf@EU-1-22-1679_h_a_dec_0.pdf@2022-09-15 00:00:00@Opdualag@nivolumab/relatlimab@True@False@OD Not Found@Bristol Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-22-1680_h_a_dec_0.pdf@EU-1-22-1680_h_a_dec_0.pdf@2022-09-15 00:00:00@ilLuzyce@lutetium ( 177Lu) chloride@False@False@OD Not Found@Billev Pharma ApS@CMA Not Found@Parsed
EU-1-22-1681_h_a_dec_0.pdf@EU-1-22-1681_h_a_dec_0.pdf@2022-09-15 00:00:00@Amvuttra@vutrisiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1683_h_a_dec_0.pdf@EU-1-22-1683_h_a_dec_0.pdf@2022-09-15 00:00:00@Vabysmo@Faricimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-22-1671_h_a_dec_0.pdf@EU-1-22-1671_h_a_dec_0.pdf@2022-08-17 00:00:00@Sunlenca@lenacapavir@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-22-1684_h_a_dec_0.pdf@EU-1-22-1684_h_a_dec_0.pdf@2022-09-15 00:00:00@NULIBRY@fosdenopterin@True@False@adopted@the applicant@exceptional@Parsed
EU-1-22-1685_h_a_dec_0.pdf@EU-1-22-1685_h_a_dec_0.pdf@2022-09-15 00:00:00@Mounjaro@tirzepatide@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-22-1677_h_a_dec_0.pdf@EU-1-22-1677_h_a_dec_0.pdf@2022-09-19 00:00:00@Tezspire@tezepelumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-96-004_h_a_dec_0.pdf@EU-1-96-004_h_a_dec_0.pdf@1996-02-14 00:00:00@FARESTON@toremifene@NAS before 2012@NA before 2012@NA before 2000@Ercopharm A/S@CMA not available before 2006@Parsed
EU-1-22-1669_h_a_dec_0.pdf@EU-1-22-1669_h_a_dec_0.pdf@2022-08-17 00:00:00@Pepaxti@melphalan flufenamide@False@False@OD Not Found@Oncopeptides AB (publ)@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_0.pdf@EU-1-96-010_h_a_dec_0.pdf@Date is blank@Rilutek®@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_0.pdf@EU-1-95-003_h_a_dec_0.pdf@Date is blank@BETAFERON@Interferon beta-lb@NAS before 2012@NA before 2012@NA before 2000@Schering  Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_0.pdf@EU-1-96-011_h_a_dec_0.pdf@1996-06-21 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Sequus Pharmaceuticals, Incorporated@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_0.pdf@EU-1-96-012_h_a_dec_0.pdf@Date is blank@Bondronat®@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_0.pdf@EU-1-96-018_h_a_dec_0.pdf@1996-08-29 00:00:00@Rapilysin®@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_0.pdf@EU-1-96-020_h_a_dec_0.pdf@1996-09-20 00:00:00@TWINRIX ADULT@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_0.pdf@EU-1-96-015_h_a_dec_0.pdf@1996-08-08 00:00:00@1COMMISSION DECISION   8 August 1996   granting the marketing authorization for the medicinal    product for human use,    “EPIVIR ®”@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo  Group  Ltd.@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_0.pdf@EU-1-96-008_h_a_dec_0.pdf@1996-05-03 00:00:00@Puregon®@Follitropin ß@NAS before 2012@NA before 2012@NA before 2000@Organon (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_0.pdf@EU-1-96-027_h_a_dec_0.pdf@1996-12-11 00:00:00@HYCAMTIN@Topotecan hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_0.pdf@EU-1-97-029_h_a_dec_0.pdf@1997-02-10 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_0.pdf@EU-1-96-026_h_a_dec_0.pdf@Date is blank@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_0.pdf@EU-1-96-007_h_a_dec_0.pdf@1996-04-30 00:00:00@HUMALOG®@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_0.pdf@EU-1-96-016_h_a_dec_0.pdf@Date is blank@Norvir®@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott laboratories Limited@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_0.pdf@EU-1-97-039_h_a_dec_0.pdf@1997-06-23 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_0.pdf@EU-1-97-045_h_a_dec_0.pdf@1997-08-14 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@NA before 2000@INFAI@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_0.pdf@EU-1-97-044_h_a_dec_0.pdf@1997-08-27 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_0.pdf@EU-1-96-022_h_a_dec_0.pdf@1996-09-27 00:00:00@ZYPREXA@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_0.pdf@EU-1-97-033_h_a_dec_0.pdf@1997-03-13 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_0.pdf@EU-1-97-046_h_a_dec_0.pdf@1997-08-27 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_0.pdf@EU-1-97-049_h_a_dec_0.pdf@1997-08-27 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_0.pdf@EU-1-97-053_h_a_dec_0.pdf@1997-11-17 00:00:00@CEREZYME@imiglucerase@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_0.pdf@EU-1-97-057_h_a_dec_0.pdf@1998-02-05 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@NA before 2000@CIS bio international@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_0.pdf@EU-1-97-047_h_a_dec_0.pdf@1997-08-27 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe, B.V.@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_0.pdf@EU-1-98-058_h_a_dec_0.pdf@2022-03-18 00:00:00@COMBIVIR@lamivudine/zidovudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_0.pdf@EU-1-97-050_h_a_dec_0.pdf@1997-10-14 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_0.pdf@EU-1-98-064_h_a_dec_0.pdf@1998-07-05 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@NA before 2000@B.S.I.A. Limited@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_0.pdf@EU-1-97-051_h_a_dec_0.pdf@1998-02-23 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_0.pdf@EU-1-98-065_h_a_dec_0.pdf@1980-01-01 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@NA before 2000@MAH Not Found@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_0.pdf@EU-1-97-031_h_a_dec_0.pdf@1998-02-04 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_0.pdf@EU-1-98-070_h_a_dec_0.pdf@2022-10-15 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_0.pdf@EU-1-98-069_h_a_dec_0.pdf@1998-07-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_0.pdf@EU-1-98-073_h_a_dec_0.pdf@1998-05-08 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_0.pdf@EU-1-98-071_h_a_dec_0.pdf@1998-07-29 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_0.pdf@EU-1-98-063_h_a_dec_0.pdf@1998-05-04 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_0.pdf@EU-1-98-074_h_a_dec_0.pdf@1998-05-08 00:00:00@CELVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_0.pdf@EU-1-97-055_h_a_dec_0.pdf@1998-05-02 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_0.pdf@EU-1-98-076_h_a_dec_0.pdf@1998-08-17 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_0.pdf@EU-1-98-066_h_a_dec_0.pdf@2022-05-12 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_0.pdf@EU-1-98-081_h_a_dec_0.pdf@1998-09-22 00:00:00@COMTAN@entacapone@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_0.pdf@EU-1-98-080_h_a_dec_0.pdf@1998-09-18 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@NA before 2000@Laboratoires 3M Santé@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_0.pdf@EU-1-98-082_h_a_dec_0.pdf@1998-09-16 00:00:00@COMTESS@entacapone@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_0.pdf@EU-1-98-084_h_a_dec_0.pdf@1998-09-10 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_0.pdf@EU-1-98-077_h_a_dec_0.pdf@1998-09-14 00:00:00@VIAGRA@sildenafil@NAS before 2012@NA before 2012@NA before 2000@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_0.pdf@EU-1-98-089_h_a_dec_0.pdf@1998-11-12 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_0.pdf@EU-1-98-090_h_a_dec_0.pdf@1998-12-16 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_0.pdf@EU-1-98-067_h_a_dec_0.pdf@1998-02-06 00:00:00@MABTHERA@Rituximab@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_0.pdf@EU-1-98-091_h_a_dec_0.pdf@1998-12-16 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_0.pdf@EU-1-98-095_h_a_dec_0.pdf@1999-01-27 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@NA before 2000@Alcon Laboratories (UK) Ltd@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_0.pdf@EU-1-99-097_h_a_dec_0.pdf@1999-04-13 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_0.pdf@EU-1-99-100_h_a_dec_0.pdf@1999-04-13 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@NA before 2000@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_0.pdf@EU-1-98-085_h_a_dec_0.pdf@1998-10-16 00:00:00@KARVEZIDE@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Bristol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_0.pdf@EU-1-98-086_h_a_dec_0.pdf@1998-10-15 00:00:00@COAPROVEL@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_0.pdf@EU-1-98-092_h_a_dec_0.pdf@1998-04-12 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_0.pdf@EU-1-99-108_h_a_dec_0.pdf@1999-08-25 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@NA before 2000@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_0.pdf@EU-1-99-103_h_a_dec_0.pdf@1999-04-13 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_0.pdf@EU-1-99-109_h_a_dec_0.pdf@1999-01-07 00:00:00@INTEGRILIN@Eptifibatide@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_0.pdf@EU-1-99-107_h_a_dec_0.pdf@1999-07-05 00:00:00@REBETOL@ribavirin@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_0.pdf@EU-1-98-096_h_a_dec_0.pdf@1999-01-26 00:00:00@TEMODAL@Temozolomide@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_0.pdf@EU-1-99-114_h_a_dec_0.pdf@1999-07-29 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_0.pdf@EU-1-99-117_h_a_dec_0.pdf@1999-08-13 00:00:00@SYNAGIS@palivizumab@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_0.pdf@EU-1-99-112_h_a_dec_0.pdf@1999-08-07 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_0.pdf@EU-1-97-030_h_a_dec_0.pdf@1997-02-21 00:00:00@INSUMAN@Insulin human@NAS before 2012@NA before 2012@NA before 2000@HOECHST AG@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_0.pdf@EU-1-99-120_h_a_dec_0.pdf@1999-08-12 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_0.pdf@EU-1-99-116_h_a_dec_0.pdf@1999-08-13 00:00:00@REMICADE@infliximab@NAS before 2012@NA before 2012@NA before 2000@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_0.pdf@EU-1-99-122_h_a_dec_0.pdf@2000-09-03 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_0.pdf@EU-1-99-124_h_a_dec_0.pdf@2000-01-20 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@NA before 2000@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_0.pdf@EU-1-99-118_h_a_dec_0.pdf@1999-02-09 00:00:00@ARAVA@leflunomide@NAS before 2012@NA before 2012@NA before 2000@Hoechst marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_0.pdf@EU-1-99-123_h_a_dec_0.pdf@2000-01-28 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_0.pdf@EU-1-99-119_h_a_dec_0.pdf@1999-07-09 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_0.pdf@EU-1-99-125_h_a_dec_0.pdf@2000-03-02 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_0.pdf@EU-1-99-110_h_a_dec_0.pdf@1999-05-28 00:00:00@SUSTIVA@efavirenz@NAS before 2012@NA before 2012@NA before 2000@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_0.pdf@EU-1-99-111_h_a_dec_0.pdf@1999-05-28 00:00:00@STOCRIN@efavirenz@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_0.pdf@EU-1-99-126_h_a_dec_0.pdf@2000-03-02 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@NA before 2000@Wyeth Research (UK) Limited@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_0.pdf@EU-1-00-129_h_a_dec_0.pdf@2000-09-03 00:00:00@Azopt@brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_0.pdf@EU-1-00-130_h_a_dec_0.pdf@2000-05-17 00:00:00@Orgalutran@Ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_0.pdf@EU-1-00-133_h_a_dec_0.pdf@2000-06-27 00:00:00@OPTISULIN insulin glargine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_0.pdf@EU-1-00-140_h_a_dec_0.pdf@2000-07-27 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@CIBA Vision Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_0.pdf@EU-1-00-141_h_a_dec_0.pdf@2000-07-13 00:00:00@MYOCET@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@The Liposome Company Ltd@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_0.pdf@EU-1-00-143_h_a_dec_0.pdf@2000-04-08 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@NA before 2000@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_0.pdf@EU-1-00-134_h_a_dec_0.pdf@2000-09-06 00:00:00@Lantus@insulin glargin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_0.pdf@EU-1-00-142_h_a_dec_0.pdf@2000-01-08 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_0.pdf@EU-1-00-135_h_a_dec_0.pdf@2000-07-27 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_0.pdf@EU-1-00-145_h_a_dec_0.pdf@2000-08-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_0.pdf@EU-1-00-146_h_a_dec_0.pdf@2000-09-29 00:00:00@Keppra@levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_0.pdf@EU-1-00-149_h_a_dec_0.pdf@2000-11-10 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_0.pdf@EU-1-00-150_h_a_dec_0.pdf@2000-10-13 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_0.pdf@EU-1-00-152_h_a_dec_0.pdf@2000-10-23 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae   type b vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_0.pdf@EU-1-00-155_h_a_dec_0.pdf@2000-11-29 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd.@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_0.pdf@EU-1-00-156_h_a_dec_0.pdf@2000-12-28 00:00:00@TRIZIVIR@abacavir / lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_0.pdf@EU-1-00-157_h_a_dec_0.pdf@2001-01-15 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_0.pdf@EU-1-00-160_h_a_dec_0.pdf@2001-01-15 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_0.pdf@EU-1-00-161_h_a_dec_0.pdf@2001-01-15 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-162_h_a_dec_0.pdf@EU-1-00-162_h_a_dec_0.pdf@2001-01-29 00:00:00@Prandin@repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_0.pdf@EU-1-00-163_h_a_dec_0.pdf@2001-02-02 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_0.pdf@EU-1-00-164_h_a_dec_0.pdf@2001-02-16 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_0.pdf@EU-1-00-166_h_a_dec_0.pdf@2001-01-22 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_0.pdf@EU-1-00-170_h_a_dec_0.pdf@2001-02-23 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_0.pdf@EU-1-00-165_h_a_dec_0.pdf@2001-02-02 00:00:00@OVIDRELLE@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_0.pdf@EU-1-00-169_h_a_dec_0.pdf@2001-02-23 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-01-173_h_a_dec_0.pdf@EU-1-01-173_h_a_dec_0.pdf@2001-03-20 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_0.pdf@EU-1-01-171_h_a_dec_0.pdf@2001-03-13 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_0.pdf@EU-1-01-172_h_a_dec_0.pdf@2001-03-20 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-177_h_a_dec_0.pdf@EU-1-01-177_h_a_dec_0.pdf@2001-03-26 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_0.pdf@EU-1-01-176_h_a_dec_0.pdf@2001-03-20 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_0.pdf@EU-1-01-178_h_a_dec_0.pdf@2001-03-29 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_0.pdf@EU-1-01-183_h_a_dec_0.pdf@2001-04-27 00:00:00@HBVAXPRO@Hepatitis B (Recombinant) vaccine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_0.pdf@EU-1-01-185_h_a_dec_0.pdf@2001-08-06 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_0.pdf@EU-1-01-188_h_a_dec_0.pdf@2001-03-08 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@adopted@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-01-190_h_a_dec_0.pdf@EU-1-01-190_h_a_dec_0.pdf@2001-07-16 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_0.pdf@EU-1-01-194_h_a_dec_0.pdf@2001-01-08 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_0.pdf@EU-1-01-196_h_a_dec_0.pdf@2001-10-24 00:00:00@Caspofungin MSD@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_0.pdf@EU-1-01-189_h_a_dec_0.pdf@2001-03-08 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@adopted@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_0.pdf@EU-1-01-198_h_a_dec_0.pdf@2001-07-11 00:00:00@Glivec@imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_0.pdf@EU-1-01-195_h_a_dec_0.pdf@2001-01-08 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_0.pdf@EU-1-01-200_h_a_dec_0.pdf@2002-05-02 00:00:00@Viread@Tenofovir disoproxil (as fumarate)@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-197_h_a_dec_0.pdf@EU-1-01-197_h_a_dec_0.pdf@2001-10-24 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Scotia Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_0.pdf@EU-1-02-203_h_a_dec_0.pdf@2002-08-03 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_0.pdf@EU-1-02-204_h_a_dec_0.pdf@2002-05-03 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_0.pdf@EU-1-02-206_h_a_dec_0.pdf@2002-03-21 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-205_h_a_dec_0.pdf@EU-1-02-205_h_a_dec_0.pdf@2002-08-03 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_0.pdf@EU-1-01-199_h_a_dec_0.pdf@2001-11-27 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_0.pdf@EU-1-02-212_h_a_dec_0.pdf@2002-03-19 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_0.pdf@EU-1-02-214_h_a_dec_0.pdf@2002-04-19 00:00:00@BolusacPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_0.pdf@EU-1-02-201_h_a_dec_0.pdf@2002-02-28 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_0.pdf@EU-1-02-218_h_a_dec_0.pdf@2002-05-17 00:00:00@Memantine Merz Pharmaceuticals GmbH@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_0.pdf@EU-1-02-209_h_a_dec_0.pdf@2002-03-22 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_0.pdf@EU-1-02-222_h_a_dec_0.pdf@2002-06-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_0.pdf@EU-1-02-226_h_a_dec_0.pdf@2002-09-09 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_0.pdf@EU-1-02-219_h_a_dec_0.pdf@2002-05-15 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_0.pdf@EU-1-02-227_h_a_dec_0.pdf@2002-08-22 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_0.pdf@EU-1-02-215_h_a_dec_0.pdf@2002-04-22 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_0.pdf@EU-1-02-220_h_a_dec_0.pdf@2002-05-15 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_0.pdf@EU-1-02-229_h_a_dec_0.pdf@2002-07-10 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_0.pdf@EU-1-02-230_h_a_dec_0.pdf@2002-07-10 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-216_h_a_dec_0.pdf@EU-1-02-216_h_a_dec_0.pdf@2002-04-18 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-223_h_a_dec_0.pdf@EU-1-02-223_h_a_dec_0.pdf@2002-08-22 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-234_h_a_dec_0.pdf@EU-1-02-234_h_a_dec_0.pdf@2002-07-10 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-224_h_a_dec_0.pdf@EU-1-02-224_h_a_dec_0.pdf@2002-08-30 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_0.pdf@EU-1-02-213_h_a_dec_0.pdf@2002-04-19 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_0.pdf@EU-1-02-231_h_a_dec_0.pdf@2002-07-10 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-246_h_a_dec_0.pdf@EU-1-02-246_h_a_dec_0.pdf@2003-01-24 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_0.pdf@EU-1-02-221_h_a_dec_0.pdf@2002-06-20 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_0.pdf@EU-1-02-238_h_a_dec_0.pdf@2002-11-20 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@adopted@Oxford GlycoSciences (UK) Ltd@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_0.pdf@EU-1-03-247_h_a_dec_0.pdf@2003-10-06 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_0.pdf@EU-1-02-237_h_a_dec_0.pdf@2002-12-11 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_0.pdf@EU-1-02-240_h_a_dec_0.pdf@2002-11-13 00:00:00@ Somavert Pegvisomant @Active Substance Not Found@NAS before 2012@NA before 2012@adopted@Pharmacia Enterprises S.A@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_0.pdf@EU-1-03-248_h_a_dec_0.pdf@2003-06-03 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_0.pdf@EU-1-03-252_h_a_dec_0.pdf@2003-05-27 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_0.pdf@EU-1-03-256_h_a_dec_0.pdf@2003-08-09 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_0.pdf@EU-1-03-260_h_a_dec_0.pdf@2003-10-17 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_0.pdf@EU-1-03-253_h_a_dec_0.pdf@2003-10-06 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_0.pdf@EU-1-03-249_h_a_dec_0.pdf@2003-04-03 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_0.pdf@EU-1-03-264_h_a_dec_0.pdf@2004-01-16 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_0.pdf@EU-1-02-233_h_a_dec_0.pdf@2002-07-10 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_0.pdf@EU-1-03-254_h_a_dec_0.pdf@2003-09-07 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@adopted@Pierre Fabre Médicament@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_0.pdf@EU-1-03-261_h_a_dec_0.pdf@2003-10-24 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-265_h_a_dec_0.pdf@EU-1-03-265_h_a_dec_0.pdf@2004-02-23 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@appointed@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_0.pdf@EU-1-03-255_h_a_dec_0.pdf@2003-09-16 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@adopted@Schering AG@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_0.pdf@EU-1-03-251_h_a_dec_0.pdf@2003-06-03 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-268_h_a_dec_0.pdf@EU-1-03-268_h_a_dec_0.pdf@2004-10-03 00:00:00@Cholestagel@colesevelam hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_0.pdf@EU-1-03-267_h_a_dec_0.pdf@2004-02-03 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_0.pdf@EU-1-03-262_h_a_dec_0.pdf@2003-11-11 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-269_h_a_dec_0.pdf@EU-1-03-269_h_a_dec_0.pdf@2004-10-03 00:00:00@Faslodex@Fulvestrant@NAS before 2012@NA before 2012@OD Not Found@AstraZeneca UK Limited@CMA not available before 2006@Parsed
EU-1-04-273_h_a_dec_0.pdf@EU-1-04-273_h_a_dec_0.pdf@2004-04-28 00:00:00@Lysodren@Mitotane@NAS before 2012@NA before 2012@adopted@Laboratoire HRA Pharma@CMA not available before 2006@Parsed
EU-1-03-270_h_a_dec_0.pdf@EU-1-03-270_h_a_dec_0.pdf@2004-06-15 00:00:00@Oxybutynin Nicobrand@Oxybutynin@NAS before 2012@NA before 2012@OD Not Found@Nicobrand Limited@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_0.pdf@EU-1-04-276_h_a_dec_0.pdf@2004-04-06 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_0.pdf@EU-1-04-274_h_a_dec_0.pdf@2004-04-26 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@appointed@Millenium Pharmaceuticals, Ltd@CMA not available before 2006@Parsed
EU-1-03-271_h_a_dec_0.pdf@EU-1-03-271_h_a_dec_0.pdf@2004-02-03 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-04-280_h_a_dec_0.pdf@EU-1-04-280_h_a_dec_0.pdf@2004-11-08 00:00:00@YENTREVE@Duloxetine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-03-263_h_a_dec_0.pdf@EU-1-03-263_h_a_dec_0.pdf@2004-04-28 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@NA before 2012@OD Not Found@SBL Vaccin AB@CMA not available before 2006@Parsed
EU-1-04-284_h_a_dec_0.pdf@EU-1-04-284_h_a_dec_0.pdf@2004-07-29 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-04-275_h_a_dec_0.pdf@EU-1-04-275_h_a_dec_0.pdf@2004-04-14 00:00:00@Litak@Cladribine@NAS before 2012@NA before 2012@adopted@Lipomed GmbH@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_0.pdf@EU-1-04-281_h_a_dec_0.pdf@2004-06-29 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA not available before 2006@Parsed
EU-1-04-285_h_a_dec_0.pdf@EU-1-04-285_h_a_dec_0.pdf@2004-09-27 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-04-290_h_a_dec_0.pdf@EU-1-04-290_h_a_dec_0.pdf@2004-09-20 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-292_h_a_dec_0.pdf@EU-1-04-292_h_a_dec_0.pdf@2004-10-22 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-04-282_h_a_dec_0.pdf@EU-1-04-282_h_a_dec_0.pdf@2004-12-07 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-296_h_a_dec_0.pdf@EU-1-04-296_h_a_dec_0.pdf@2004-12-17 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-286_h_a_dec_0.pdf@EU-1-04-286_h_a_dec_0.pdf@2004-10-13 00:00:00@Wilzin@Zinc acetate dihydrate@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_0.pdf@EU-1-04-300_h_a_dec_0.pdf@2005-12-01 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-04-304_h_a_dec_0.pdf@EU-1-04-304_h_a_dec_0.pdf@2005-02-21 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA not available before 2006@Parsed
EU-1-04-294_h_a_dec_0.pdf@EU-1-04-294_h_a_dec_0.pdf@2004-10-22 00:00:00@EMSELEX@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-298_h_a_dec_0.pdf@EU-1-04-298_h_a_dec_0.pdf@2004-12-17 00:00:00@Kivexa@abacavir / lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-04-305_h_a_dec_0.pdf@EU-1-04-305_h_a_dec_0.pdf@2005-02-21 00:00:00@Truvada@Emtricitabine / Tenofovir Disoproxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-04-295_h_a_dec_0.pdf@EU-1-04-295_h_a_dec_0.pdf@2004-11-16 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@adopted@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-04-277_h_a_dec_0.pdf@EU-1-04-277_h_a_dec_0.pdf@2004-08-06 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA not available before 2006@Parsed
EU-1-05-308_h_a_dec_0.pdf@EU-1-05-308_h_a_dec_0.pdf@2005-04-15 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-278_h_a_dec_0.pdf@EU-1-04-278_h_a_dec_0.pdf@2004-01-06 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-04-299_h_a_dec_0.pdf@EU-1-04-299_h_a_dec_0.pdf@2005-02-02 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-05-315_h_a_dec_0.pdf@EU-1-05-315_h_a_dec_0.pdf@2005-10-25 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-04-302_h_a_dec_0.pdf@EU-1-04-302_h_a_dec_0.pdf@2005-02-21 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@adopted@Elan Pharma International Ltd@CMA not available before 2006@Parsed
EU-1-04-306_h_a_dec_0.pdf@EU-1-04-306_h_a_dec_0.pdf@2005-03-22 00:00:00@Aloxi@Palonosetron@NAS before 2012@NA before 2012@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA not available before 2006@Parsed
EU-1-05-317_h_a_dec_0.pdf@EU-1-05-317_h_a_dec_0.pdf@2005-10-25 00:00:00@Corlentor@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-05-310_h_a_dec_0.pdf@EU-1-05-310_h_a_dec_0.pdf@2005-08-24 00:00:00@FOSAVANCE@Alendronate Sodium / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-04-307_h_a_dec_0.pdf@EU-1-04-307_h_a_dec_0.pdf@2005-10-03 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma@CMA not available before 2006@Parsed
EU-1-04-303_h_a_dec_0.pdf@EU-1-04-303_h_a_dec_0.pdf@2005-02-21 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@adopted@Swedish Orphan International AB@CMA not available before 2006@Parsed
EU-1-05-318_h_a_dec_0.pdf@EU-1-05-318_h_a_dec_0.pdf@2005-10-28 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@adopted@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_0.pdf@EU-1-04-279_h_a_dec_0.pdf@2004-06-07 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-05-322_h_a_dec_0.pdf@EU-1-05-322_h_a_dec_0.pdf@2006-01-19 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@NA before 2012@OD Not Found@AEA Technology QSA GmbH@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_0.pdf@EU-1-05-311_h_a_dec_0.pdf@2005-09-19 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-05-316_h_a_dec_0.pdf@EU-1-05-316_h_a_dec_0.pdf@2005-10-25 00:00:00@Procoralan@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-05-328_h_a_dec_0.pdf@EU-1-05-328_h_a_dec_0.pdf@2006-01-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_0.pdf@EU-1-05-323_h_a_dec_0.pdf@2006-06-04 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_0.pdf@EU-1-05-319_h_a_dec_0.pdf@2005-10-25 00:00:00@Xolair@omalizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-05-329_h_a_dec_0.pdf@EU-1-05-329_h_a_dec_0.pdf@2006-01-19 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_0.pdf@EU-1-06-333_h_a_dec_0.pdf@2006-03-29 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_0.pdf@EU-1-05-312_h_a_dec_0.pdf@2005-10-13 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@adopted@UCB Pharma Ltd.@CMA not available before 2006@Parsed
EU-1-06-337_h_a_dec_0.pdf@EU-1-06-337_h_a_dec_0.pdf@2006-05-05 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_0.pdf@EU-1-05-330_h_a_dec_0.pdf@2006-02-21 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_0.pdf@EU-1-05-324_h_a_dec_0.pdf@2006-01-24 00:00:00@Naglazyme@Recombinant human N-acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@NA before 2012@adopted@BioMarin Europe Limited@exceptional@Parsed
EU-1-06-334_h_a_dec_0.pdf@EU-1-06-334_h_a_dec_0.pdf@2006-05-29 00:00:00@Evoltra@clofarabine@NAS before 2012@NA before 2012@adopted@Bioenvision Limited@exceptional@Parsed
EU-1-06-341_h_a_dec_0.pdf@EU-1-06-341_h_a_dec_0.pdf@2006-05-19 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_0.pdf@EU-1-06-346_h_a_dec_0.pdf@2006-06-27 00:00:00@Tysabri@Natalizumab@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_0.pdf@EU-1-06-338_h_a_dec_0.pdf@2006-04-24 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_0.pdf@EU-1-05-331_h_a_dec_0.pdf@2006-02-15 00:00:00@Neupro@Rotigotine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_0.pdf@EU-1-05-320_h_a_dec_0.pdf@2005-10-25 00:00:00@Noxafil@Posaconazole@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-06-340_h_a_dec_0.pdf@EU-1-06-340_h_a_dec_0.pdf@2006-05-19 00:00:00@Ganfort@bimatoprost/timolol@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_0.pdf@EU-1-06-336_h_a_dec_0.pdf@2006-04-24 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_0.pdf@EU-1-06-342_h_a_dec_0.pdf@2006-07-19 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@adopted@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_0.pdf@EU-1-06-347_h_a_dec_0.pdf@2006-07-19 00:00:00@SUTENT@sunitinib@NAS before 2012@NA before 2012@adopted@Pfizer Ltd@conditional@Parsed
EU-1-06-350_h_a_dec_0.pdf@EU-1-06-350_h_a_dec_0.pdf@2006-07-28 00:00:00@Savene@Dexrazoxane@NAS before 2012@NA before 2012@adopted@TopoTarget A/S@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_0.pdf@EU-1-06-354_h_a_dec_0.pdf@2006-07-28 00:00:00@Competact@Pioglitazone /  metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_0.pdf@EU-1-06-343_h_a_dec_0.pdf@2006-06-26 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_0.pdf@EU-1-06-361_h_a_dec_0.pdf@2006-09-20 00:00:00@Luminity@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_0.pdf@EU-1-06-357_h_a_dec_0.pdf@2006-09-20 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_0.pdf@EU-1-06-365_h_a_dec_0.pdf@2007-08-01 00:00:00@Elaprase@Idursulfase@NAS before 2012@NA before 2012@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-362_h_a_dec_0.pdf@EU-1-06-362_h_a_dec_0.pdf@2006-11-20 00:00:00@BYETTA@exenatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_0.pdf@EU-1-06-356_h_a_dec_0.pdf@2006-08-28 00:00:00@Exjade@deferasirox@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_0.pdf@EU-1-06-366_h_a_dec_0.pdf@2007-08-01 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_0.pdf@EU-1-06-359_h_a_dec_0.pdf@2006-09-26 00:00:00@Suboxone@buprenorphine /  naloxone@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_0.pdf@EU-1-06-370_h_a_dec_0.pdf@2007-01-17 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_0.pdf@EU-1-06-363_h_a_dec_0.pdf@2006-11-20 00:00:00@Sprycel@Dasatinib@NAS before 2012@NA before 2012@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_0.pdf@EU-1-06-348_h_a_dec_0.pdf@2006-06-27 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_0.pdf@EU-1-06-367_h_a_dec_0.pdf@2007-04-01 00:00:00@Diacomit@Stiripentol@NAS before 2012@NA before 2012@adopted@Biocodex@conditional@Parsed
EU-1-06-360_h_a_dec_0.pdf@EU-1-06-360_h_a_dec_0.pdf@2006-09-26 00:00:00@Champix@varenicline tartrate@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_0.pdf@EU-1-06-377_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_0.pdf@EU-1-06-374_h_a_dec_0.pdf@2007-01-22 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_0.pdf@EU-1-07-382_h_a_dec_0.pdf@2007-03-21 00:00:00@Xelevia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_0.pdf@EU-1-06-332_h_a_dec_0.pdf@2006-12-04 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_0.pdf@EU-1-06-371_h_a_dec_0.pdf@2007-01-16 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_0.pdf@EU-1-06-376_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_0.pdf@EU-1-07-386_h_a_dec_0.pdf@2007-04-20 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_0.pdf@EU-1-06-378_h_a_dec_0.pdf@2007-01-16 00:00:00@Inovelon@Rufinamide@NAS before 2012@NA before 2012@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_0.pdf@EU-1-07-383_h_a_dec_0.pdf@2007-03-21 00:00:00@Januvia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_0.pdf@EU-1-07-389_h_a_dec_0.pdf@2007-05-21 00:00:00@ORENCIA@abatacept@NAS before 2012@NA before 2012@OD Not Found@BRISTOL MYERS SQUIBB PHARMA  EEIG@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_0.pdf@EU-1-06-372_h_a_dec_0.pdf@2007-01-16 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_0.pdf@EU-1-06-364_h_a_dec_0.pdf@2007-04-01 00:00:00@ADROVANCE@Alendronate sodium  / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_0.pdf@EU-1-07-387_h_a_dec_0.pdf@2007-04-23 00:00:00@Advagraf@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_0.pdf@EU-1-06-379_h_a_dec_0.pdf@2007-02-15 00:00:00@Cystadane@Betaine anhydrous@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_0.pdf@EU-1-07-393_h_a_dec_0.pdf@2007-06-20 00:00:00@Soliris@Eculizumab@NAS before 2012@NA before 2012@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_0.pdf@EU-1-06-380_h_a_dec_0.pdf@2007-12-02 00:00:00@Prezista@darunavir”, a  medicinal product for human use  (Text with EEA relevance)   THE COMMISSION OF THE EUROPEAN COMMUNITIES,  Having regard to the Treaty establishing the European Community,     Having regard to Regulation (EC) No 726/2004  the European Parliament and  the  Council  31 March 2004 laying down Community procedures for the authorisation and  supervision  medicinal products for human and veterinary use and establishing a  European Medicines Agency 1, and in particular Article 10(2) and 14(7) thereof, Having regard to Commission Regulation (EC) No 507/2006 on the conditional  marketing authorisation for medicinal products for human use falling within the scope   Regulation (EC) No 726/2004  the European Parliament and  the Council 2, Having regard to the application submitted by Janssen-Cilag International NV on 1  February 2006 under Article 4(1)  Regulation (EC) No 726/2004,   Having regard to the opinion  the European Medicines Agency, formulated by the  Committee for Medicinal Products for Human Use on 14 December 2006,   Whereas:   (1)@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-07-397_h_a_dec_0.pdf@EU-1-07-397_h_a_dec_0.pdf@2007-06-29 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@NA before 2012@adopted@OTL Pharma/Addmedica@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_0.pdf@EU-1-07-391_h_a_dec_0.pdf@2007-06-14 00:00:00@Revlimid@lenalidomide@NAS before 2012@NA before 2012@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_0.pdf@EU-1-07-401_h_a_dec_0.pdf@2007-07-23 00:00:00@Orlistat GSK@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_0.pdf@EU-1-07-405_h_a_dec_0.pdf@2007-08-22 00:00:00@Rasilez@aliskiren@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_0.pdf@EU-1-07-399_h_a_dec_0.pdf@2007-07-30 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_0.pdf@EU-1-07-410_h_a_dec_0.pdf@2007-08-28 00:00:00@Binocrit@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_0.pdf@EU-1-07-402_h_a_dec_0.pdf@2007-03-08 00:00:00@INCRELEX@Mecasermin@NAS before 2012@NA before 2012@adopted@Tercica Europe Limited@exceptional@Parsed
EU-1-07-400_h_a_dec_0.pdf@EU-1-07-400_h_a_dec_0.pdf@2007-07-20 00:00:00@MIRCERA@methoxy polyethylene glycol-epoetin  beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_0.pdf@EU-1-07-395_h_a_dec_0.pdf@2007-06-25 00:00:00@Invega@paliperidone@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_0.pdf@EU-1-07-403_h_a_dec_0.pdf@2007-08-22 00:00:00@Atriance@nelarabine@NAS before 2012@NA before 2012@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-413_h_a_dec_0.pdf@EU-1-07-413_h_a_dec_0.pdf@2007-07-09 00:00:00@Gliolan@5-aminolevulinic acid hydrochloride@NAS before 2012@NA before 2012@adopted@Medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_0.pdf@EU-1-07-404_h_a_dec_0.pdf@2007-08-23 00:00:00@Flebogammadif@human normal  immunoglobulin@NAS before 2012@NA before 2012@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_0.pdf@EU-1-07-414_h_a_dec_0.pdf@2007-09-26 00:00:00@Galvus@vildagliptin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_0.pdf@EU-1-07-396_h_a_dec_0.pdf@2007-06-25 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_0.pdf@EU-1-07-411_h_a_dec_0.pdf@2007-08-28 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@HEXAL Biotech ForschungsGmbH@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_0.pdf@EU-1-07-422_h_a_dec_0.pdf@2007-11-19 00:00:00@Tasigna@Nilotinib@NAS before 2012@NA before 2012@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_0.pdf@EU-1-07-417_h_a_dec_0.pdf@2007-09-17 00:00:00@Yondelis@Trabectedin@NAS before 2012@NA before 2012@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-415_h_a_dec_0.pdf@EU-1-07-415_h_a_dec_0.pdf@2007-09-27 00:00:00@Zalasta@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_0.pdf@EU-1-07-392_h_a_dec_0.pdf@2007-06-29 00:00:00@Circadin@melatonin@NAS before 2012@NA before 2012@OD Not Found@Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_0.pdf@EU-1-07-425_h_a_dec_0.pdf@2007-11-14 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_0.pdf@EU-1-07-431_h_a_dec_0.pdf@2007-12-18 00:00:00@Retacrit@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_0.pdf@EU-1-07-434_h_a_dec_0.pdf@2008-11-01 00:00:00@Avamys@Flucticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_0.pdf@EU-1-07-418_h_a_dec_0.pdf@2007-09-17 00:00:00@CELSENTRI@maraviroc@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_0.pdf@EU-1-07-423_h_a_dec_0.pdf@2007-03-12 00:00:00@Vectibix@panitumumab@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-416_h_a_dec_0.pdf@EU-1-07-416_h_a_dec_0.pdf@2007-09-20 00:00:00@ECALTA@anidulafungin@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_0.pdf@EU-1-07-412_h_a_dec_0.pdf@2007-08-28 00:00:00@Abseamed@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_0.pdf@EU-1-07-435_h_a_dec_0.pdf@2008-10-01 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_0.pdf@EU-1-07-427_h_a_dec_0.pdf@2007-12-12 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_0.pdf@EU-1-07-424_h_a_dec_0.pdf@2007-11-19 00:00:00@TORISEL@Temsirolimus@NAS before 2012@NA before 2012@adopted@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_0.pdf@EU-1-07-419_h_a_dec_0.pdf@2007-09-20 00:00:00@Cervarix@16 and Human Papilloma Virus 18 L1 proteins@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_0.pdf@EU-1-07-438_h_a_dec_0.pdf@2008-02-21 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_0.pdf@EU-1-07-432_h_a_dec_0.pdf@2007-12-18 00:00:00@Silapo@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_0.pdf@EU-1-07-436_h_a_dec_0.pdf@2007-12-20 00:00:00@ISENTRESS@raltegravir@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Limited@conditional@Parsed
EU-1-08-442_h_a_dec_0.pdf@EU-1-08-442_h_a_dec_0.pdf@2008-03-18 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_0.pdf@EU-1-07-439_h_a_dec_0.pdf@2008-02-21 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_0.pdf@EU-1-07-420_h_a_dec_0.pdf@2007-11-23 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@NA before 2012@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_0.pdf@EU-1-07-428_h_a_dec_0.pdf@2008-01-14 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_0.pdf@EU-1-08-446_h_a_dec_0.pdf@2008-04-25 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_0.pdf@EU-1-07-433_h_a_dec_0.pdf@2007-11-12 00:00:00@NEVANAC@nepafenac@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_0.pdf@EU-1-07-440_h_a_dec_0.pdf@2008-10-06 00:00:00@Tyverb@lapatinib@NAS before 2012@True@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-08-451_h_a_dec_0.pdf@EU-1-08-451_h_a_dec_0.pdf@2008-04-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_0.pdf@EU-1-07-437_h_a_dec_0.pdf@2008-11-01 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_0.pdf@EU-1-08-447_h_a_dec_0.pdf@2008-04-21 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Ipsen Manufacturing Ireland Ltd (IMIL),@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_0.pdf@EU-1-08-461_h_a_dec_0.pdf@2008-11-07 00:00:00@Firazyr@icatibant@NAS before 2012@True@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_0.pdf@EU-1-08-454_h_a_dec_0.pdf@2008-05-20 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_0.pdf@EU-1-08-462_h_a_dec_0.pdf@2008-09-07 00:00:00@Latixa@ranolazine@NAS before 2012@True@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_0.pdf@EU-1-08-441_h_a_dec_0.pdf@2008-04-04 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_0.pdf@EU-1-08-448_h_a_dec_0.pdf@2008-04-25 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_0.pdf@EU-1-08-443_h_a_dec_0.pdf@2008-04-16 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@adopted@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_0.pdf@EU-1-08-466_h_a_dec_0.pdf@2008-07-25 00:00:00@Bridion@sugammadex@NAS before 2012@True@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_0.pdf@EU-1-08-455_h_a_dec_0.pdf@2008-07-16 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_0.pdf@EU-1-08-470_h_a_dec_0.pdf@2008-08-29 00:00:00@Vimpat@lacosamide@NAS before 2012@True@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_0.pdf@EU-1-08-468_h_a_dec_0.pdf@2008-08-28 00:00:00@INTELENCE@etravirine@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-463_h_a_dec_0.pdf@EU-1-08-463_h_a_dec_0.pdf@2008-02-07 00:00:00@RELISTOR@methylnaltrexone  bromide@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_0.pdf@EU-1-08-444_h_a_dec_0.pdf@2008-09-15 00:00:00@Ratiograstim@filgrastim@NAS before 2012@True@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_0.pdf@EU-1-08-475_h_a_dec_0.pdf@2008-07-10 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@True@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_0.pdf@EU-1-08-479_h_a_dec_0.pdf@2008-11-19 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_0.pdf@EU-1-08-465_h_a_dec_0.pdf@2008-07-16 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_0.pdf@EU-1-08-456_h_a_dec_0.pdf@2008-07-16 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_0.pdf@EU-1-08-445_h_a_dec_0.pdf@2008-09-15 00:00:00@Tevagrastim@filgrastim@NAS before 2012@True@OD Not Found@Teva Generics GmbH@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_0.pdf@EU-1-08-469_h_a_dec_0.pdf@2008-12-09 00:00:00@Oprymea@Pramipexole@NAS before 2012@True@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_0.pdf@EU-1-08-480_h_a_dec_0.pdf@2008-01-12 00:00:00@Irbesartan Krka@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_0.pdf@EU-1-08-476_h_a_dec_0.pdf@2008-01-10 00:00:00@Tadalafil Lilly@tadalafil@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_0.pdf@EU-1-08-482_h_a_dec_0.pdf@2008-11-25 00:00:00@AZARGA@brinzolamide / timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_0.pdf@EU-1-08-477_h_a_dec_0.pdf@2008-07-10 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@True@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-472_h_a_dec_0.pdf@EU-1-08-472_h_a_dec_0.pdf@2008-09-30 00:00:00@Xarelto@rivaroxaban@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_0.pdf@EU-1-08-481_h_a_dec_0.pdf@2008-02-12 00:00:00@Kuvan@sapropterin  dihydrochloride@NAS before 2012@False@adopted@Merck KGaA@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_0.pdf@EU-1-08-492_h_a_dec_0.pdf@2009-01-16 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_0.pdf@EU-1-08-486_h_a_dec_0.pdf@2008-11-19 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_0.pdf@EU-1-08-457_h_a_dec_0.pdf@2008-07-16 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_0.pdf@EU-1-08-483_h_a_dec_0.pdf@2008-01-12 00:00:00@Zomarist@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_0.pdf@EU-1-08-496_h_a_dec_0.pdf@2009-06-02 00:00:00@Filgrastim Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_0.pdf@EU-1-08-501_h_a_dec_0.pdf@2009-03-31 00:00:00@IXIARO@Japanese Encephalitis  vaccine (inactivated, adsorbed)@NAS before 2012@False@adopted@Intercell AG@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_0.pdf@EU-1-08-488_h_a_dec_0.pdf@2008-12-17 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_0.pdf@EU-1-08-497_h_a_dec_0.pdf@2009-04-02 00:00:00@Nplate@romiplostim@NAS before 2012@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_0.pdf@EU-1-08-484_h_a_dec_0.pdf@2008-01-12 00:00:00@Vildagliptin/metformin  hydrochloride Novartis@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_0.pdf@EU-1-08-502_h_a_dec_0.pdf@2009-06-03 00:00:00@MEPACT@mifamurtide@NAS before 2012@False@adopted@IDM Pharma S.A.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_0.pdf@EU-1-08-504_h_a_dec_0.pdf@2009-02-17 00:00:00@FIRMAGON@degarelix (as acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_0.pdf@EU-1-08-490_h_a_dec_0.pdf@2008-12-18 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_0.pdf@EU-1-08-494_h_a_dec_0.pdf@2009-01-16 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_0.pdf@EU-1-08-485_h_a_dec_0.pdf@2008-11-19 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_0.pdf@EU-1-08-503_h_a_dec_0.pdf@2009-02-25 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_0.pdf@EU-1-09-508_h_a_dec_0.pdf@2009-03-30 00:00:00@Synflorix@Pneumococcal  polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_0.pdf@EU-1-09-516_h_a_dec_0.pdf@2009-12-06 00:00:00@SOMAC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_0.pdf@EU-1-08-498_h_a_dec_0.pdf@2009-02-19 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_0.pdf@EU-1-09-514_h_a_dec_0.pdf@2009-04-21 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_0.pdf@EU-1-09-517_h_a_dec_0.pdf@2009-12-06 00:00:00@PANTOZOL Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_0.pdf@EU-1-09-521_h_a_dec_0.pdf@2009-10-06 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_0.pdf@EU-1-09-524_h_a_dec_0.pdf@2009-05-15 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@NeurogesX UK Limited@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_0.pdf@EU-1-08-499_h_a_dec_0.pdf@2009-02-19 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_0.pdf@EU-1-08-473_h_a_dec_0.pdf@2008-06-10 00:00:00@EVICEL@human fibrinogen / human  thrombin@NAS before 2012@True@OD Not Found@OMRIX biopharmaceuticals S.A.@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_0.pdf@EU-1-09-511_h_a_dec_0.pdf@2009-04-17 00:00:00@CONBRIZA@bazedoxifene@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_0.pdf@EU-1-09-528_h_a_dec_0.pdf@2009-02-07 00:00:00@Nymusa@Caffeine citrate@NAS before 2012@False@adopted@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_0.pdf@EU-1-08-495_h_a_dec_0.pdf@2009-06-02 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_0.pdf@EU-1-09-533_h_a_dec_0.pdf@2009-07-24 00:00:00@Vedrop@tocofersolan@NAS before 2012@False@OD Not Found@Orphan Europe SARL@exceptional@Parsed
EU-1-09-525_h_a_dec_0.pdf@EU-1-09-525_h_a_dec_0.pdf@2009-11-05 00:00:00@Nimvastid@Rivastigmine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_0.pdf@EU-1-09-522_h_a_dec_0.pdf@2009-05-15 00:00:00@Ellaone@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_0.pdf@EU-1-09-537_h_a_dec_0.pdf@2009-07-31 00:00:00@Mozobil@plerixafor@NAS before 2012@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_0.pdf@EU-1-09-529_h_a_dec_0.pdf@2009-06-30 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_0.pdf@EU-1-09-515_h_a_dec_0.pdf@2009-12-06 00:00:00@CONTROLOC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_0.pdf@EU-1-09-535_h_a_dec_0.pdf@2009-07-28 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_0.pdf@EU-1-09-540_h_a_dec_0.pdf@2009-07-28 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_0.pdf@EU-1-09-544_h_a_dec_0.pdf@2009-01-10 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_0.pdf@EU-1-09-543_h_a_dec_0.pdf@2009-09-21 00:00:00@Cayston@aztreonam@NAS before 2012@False@adopted@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-526_h_a_dec_0.pdf@EU-1-09-526_h_a_dec_0.pdf@2009-06-24 00:00:00@IRESSA@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_0.pdf@EU-1-09-523_h_a_dec_0.pdf@2009-05-15 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_0.pdf@EU-1-09-538_h_a_dec_0.pdf@2009-03-08 00:00:00@Afinitor@everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_0.pdf@EU-1-09-530_h_a_dec_0.pdf@2009-06-29 00:00:00@Repaglinide Teva@Repaglinide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_0.pdf@EU-1-09-550_h_a_dec_0.pdf@2009-09-21 00:00:00@Javlor@vinflunine ditartrate@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_0.pdf@EU-1-09-553_h_a_dec_0.pdf@2009-09-28 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_0.pdf@EU-1-09-531_h_a_dec_0.pdf@2009-07-20 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_0.pdf@EU-1-09-556_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_0.pdf@EU-1-09-562_h_a_dec_0.pdf@2009-09-21 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_0.pdf@EU-1-09-545_h_a_dec_0.pdf@2009-01-10 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_0.pdf@EU-1-09-551_h_a_dec_0.pdf@2009-09-21 00:00:00@Vizarsin@sildenafil@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_0.pdf@EU-1-09-555_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_0.pdf@EU-1-09-539_h_a_dec_0.pdf@2009-03-08 00:00:00@Samsca@tolvaptan@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_0.pdf@EU-1-09-564_h_a_dec_0.pdf@2009-10-23 00:00:00@ILARIS@canakinumab@NAS before 2012@False@adopted@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-558_h_a_dec_0.pdf@EU-1-09-558_h_a_dec_0.pdf@2009-09-21 00:00:00@Zylagren@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_0.pdf@EU-1-09-559_h_a_dec_0.pdf@2009-09-21 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_0.pdf@EU-1-09-546_h_a_dec_0.pdf@2009-01-10 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_0.pdf@EU-1-09-573_h_a_dec_0.pdf@2009-10-29 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_0.pdf@EU-1-09-569_h_a_dec_0.pdf@2009-10-16 00:00:00@Exforge HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_0.pdf@EU-1-09-577_h_a_dec_0.pdf@2009-10-19 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@exceptional@Parsed
EU-1-09-581_h_a_dec_0.pdf@EU-1-09-581_h_a_dec_0.pdf@2009-10-15 00:00:00@Resolor@prucalopride@NAS before 2012@False@OD Not Found@Movetis NV@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_0.pdf@EU-1-09-585_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@NAS before 2012@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_0.pdf@EU-1-09-565_h_a_dec_0.pdf@2009-10-23 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_0.pdf@EU-1-09-578_h_a_dec_0.pdf@2009-10-19 00:00:00@Pandemic  influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline  Biologicals@Pandemic influenza vaccine (H5N1) (split virion, inactivated,  adjuvanted) A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@exceptional@Parsed
EU-1-09-583_h_a_dec_0.pdf@EU-1-09-583_h_a_dec_0.pdf@2009-11-26 00:00:00@Irbesartan / Hydrochlorothiazide  Teva@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_0.pdf@EU-1-09-586_h_a_dec_0.pdf@2009-11-30 00:00:00@Oslif Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_0.pdf@EU-1-09-579_h_a_dec_0.pdf@2009-04-11 00:00:00@Repaglinide Krka@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_0.pdf@EU-1-09-574_h_a_dec_0.pdf@2009-04-11 00:00:00@Dafiro HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_0.pdf@EU-1-09-566_h_a_dec_0.pdf@2009-10-23 00:00:00@Lamivudine Teva@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_0.pdf@EU-1-09-580_h_a_dec_0.pdf@2009-10-14 00:00:00@Enyglid@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_0.pdf@EU-1-09-589_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine HEXAL@Rivastigmine@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_0.pdf@EU-1-09-584_h_a_dec_0.pdf@2009-11-30 00:00:00@Sildenafil Teva@sildenafil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_0.pdf@EU-1-09-587_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_0.pdf@EU-1-09-571_h_a_dec_0.pdf@2009-10-16 00:00:00@PANDEMIC  INFLUENZA VACCINE H5N1 BAXTER@Pandemic influenza vaccine (H5N1  whole virion, Vero cell derived, inactivated)@NAS before 2012@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-568_h_a_dec_0.pdf@EU-1-09-568_h_a_dec_0.pdf@2009-10-16 00:00:00@Clopidogrel MYLAN Pharma@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_0.pdf@EU-1-09-597_h_a_dec_0.pdf@2009-11-12 00:00:00@Olazax@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_0.pdf@EU-1-09-593_h_a_dec_0.pdf@2009-11-30 00:00:00@Onbrez Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_0.pdf@EU-1-09-572_h_a_dec_0.pdf@2009-10-16 00:00:00@ALENDRONATE SODIUM AND  COLECALCIFEROL, MSD@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_0.pdf@EU-1-09-590_h_a_dec_0.pdf@2009-09-12 00:00:00@Prevenar 13@Pneumococcal  polysaccharide conjugate vaccine (13-valent, adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_0.pdf@EU-1-09-601_h_a_dec_0.pdf@2009-12-23 00:00:00@Zenas@amifampridine@NAS before 2012@False@adopted@EUSA Pharma SAS@exceptional@Parsed
EU-1-09-594_h_a_dec_0.pdf@EU-1-09-594_h_a_dec_0.pdf@2009-11-30 00:00:00@Hirobriz Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_0.pdf@EU-1-09-605_h_a_dec_0.pdf@2010-01-25 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@ALFRED E. TIEFENBACHER, (GmbH  & Co. KG)@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_0.pdf@EU-1-09-588_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark Europe@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_0.pdf@EU-1-09-602_h_a_dec_0.pdf@2010-11-01 00:00:00@Scintimun@besilesomab@NAS before 2012@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_0.pdf@EU-1-09-598_h_a_dec_0.pdf@2009-11-30 00:00:00@Nevirapine Teva@nevirapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_0.pdf@EU-1-09-591_h_a_dec_0.pdf@2009-11-26 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_0.pdf@EU-1-09-575_h_a_dec_0.pdf@2009-04-11 00:00:00@Copalia HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_0.pdf@EU-1-09-603_h_a_dec_0.pdf@2009-12-23 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_0.pdf@EU-1-09-609_h_a_dec_0.pdf@2010-01-25 00:00:00@Elonva@corifollitropin alfa@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_0.pdf@EU-1-09-599_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine Sandoz@Rivastigmine@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_0.pdf@EU-1-09-595_h_a_dec_0.pdf@2009-10-12 00:00:00@Sildenafil Actavis@Sildenafil@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_0.pdf@EU-1-09-606_h_a_dec_0.pdf@2010-01-28 00:00:00@Temozolomide Teva@Temozolomide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_0.pdf@EU-1-09-592_h_a_dec_0.pdf@2009-10-12 00:00:00@Olazax Disperzi@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_0.pdf@EU-1-09-604_h_a_dec_0.pdf@2010-08-01 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_0.pdf@EU-1-10-612_h_a_dec_0.pdf@2010-11-03 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@adopted@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_0.pdf@EU-1-09-596_h_a_dec_0.pdf@2009-10-12 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_0.pdf@EU-1-10-614_h_a_dec_0.pdf@2010-03-15 00:00:00@Menveo@Meningococcal Group A, C,  W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_0.pdf@EU-1-09-600_h_a_dec_0.pdf@2009-11-30 00:00:00@Zutectra@Human Hepatitis B  Immunoglobulin@NAS before 2012@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_0.pdf@EU-1-10-618_h_a_dec_0.pdf@2010-05-26 00:00:00@Prolia@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_0.pdf@EU-1-10-621_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_0.pdf@EU-1-10-627_h_a_dec_0.pdf@2010-04-29 00:00:00@Raloxifene Teva@Raloxifene  hydrochloride@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_0.pdf@EU-1-09-607_h_a_dec_0.pdf@2010-01-29 00:00:00@Silodyx@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_0.pdf@EU-1-10-615_h_a_dec_0.pdf@2010-03-15 00:00:00@Temozolomide Hospira@Temozolomide@NAS before 2012@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_0.pdf@EU-1-09-576_h_a_dec_0.pdf@2009-10-30 00:00:00@Irbesartan Teva@Irbesartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_0.pdf@EU-1-10-628_h_a_dec_0.pdf@2010-06-14 00:00:00@Votrient@Pazopanib  hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-09-608_h_a_dec_0.pdf@EU-1-09-608_h_a_dec_0.pdf@2010-01-29 00:00:00@Urorec@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_0.pdf@EU-1-10-631_h_a_dec_0.pdf@2010-08-06 00:00:00@Nivestim@Filgrastim@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_0.pdf@EU-1-10-619_h_a_dec_0.pdf@2010-03-15 00:00:00@DuoPlavin@clopidogrel /  acetylsalicylic acid@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_0.pdf@EU-1-10-633_h_a_dec_0.pdf@2010-10-06 00:00:00@Topotecan Hospira@Topotecan@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_0.pdf@EU-1-10-637_h_a_dec_0.pdf@2010-07-27 00:00:00@Leflunomide medac@leflunomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_0.pdf@EU-1-10-622_h_a_dec_0.pdf@2010-03-15 00:00:00@TEPADINA@Thiotepa@NAS before 2012@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_0.pdf@EU-1-10-635_h_a_dec_0.pdf@2010-10-06 00:00:00@Olanzapine Apotex@Olanzapine@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_0.pdf@EU-1-10-632_h_a_dec_0.pdf@2010-04-06 00:00:00@Tolura@telmisartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_0.pdf@EU-1-10-641_h_a_dec_0.pdf@2010-10-28 00:00:00@Ruconest@conestat alfa@NAS before 2012@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_0.pdf@EU-1-10-638_h_a_dec_0.pdf@2010-07-27 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_0.pdf@EU-1-10-620_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristfor@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_0.pdf@EU-1-10-652_h_a_dec_0.pdf@2011-07-20 00:00:00@TOBI Podhaler@Tobramycin@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_0.pdf@EU-1-10-645_h_a_dec_0.pdf@2010-01-09 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_0.pdf@EU-1-10-639_h_a_dec_0.pdf@2010-09-30 00:00:00@Telmisartan Actavis@telmisartan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_0.pdf@EU-1-10-642_h_a_dec_0.pdf@2010-09-17 00:00:00@Ibandronic Acid Teva@Ibandronic  acid@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_0.pdf@EU-1-10-654_h_a_dec_0.pdf@2010-11-29 00:00:00@Leflunomide ratiopharm@leflunomide@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_0.pdf@EU-1-10-640_h_a_dec_0.pdf@2010-01-09 00:00:00@Sycrest@asenapine@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_0.pdf@EU-1-10-646_h_a_dec_0.pdf@2010-08-26 00:00:00@VPRIV@Velaglucerase alfa@NAS before 2012@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_0.pdf@EU-1-10-658_h_a_dec_0.pdf@2010-11-29 00:00:00@Aflunov@Prepandemic influenza  vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_0.pdf@EU-1-10-636_h_a_dec_0.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_0.pdf@EU-1-10-643_h_a_dec_0.pdf@2010-06-09 00:00:00@Rapiscan@regadenoson@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_0.pdf@EU-1-10-663_h_a_dec_0.pdf@2011-02-28 00:00:00@Lamivudine / Zidovudine Teva@lamivudine, zidovudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_0.pdf@EU-1-11-667_h_a_dec_0.pdf@2011-02-28 00:00:00@Esbriet@Pirfenidone@NAS before 2012@False@adopted@InterMune Europe Ltd@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_0.pdf@EU-1-10-655_h_a_dec_0.pdf@2010-03-12 00:00:00@Brilique@ticagrelor@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_0.pdf@EU-1-10-659_h_a_dec_0.pdf@2011-01-21 00:00:00@Iasibon@Ibandronic acid@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_0.pdf@EU-1-10-665_h_a_dec_0.pdf@2011-02-18 00:00:00@Entacapone Teva@entacapone@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_0.pdf@EU-1-10-647_h_a_dec_0.pdf@2010-07-10 00:00:00@Myclausen@mycophenolate mofetil@NAS before 2012@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_0.pdf@EU-1-10-644_h_a_dec_0.pdf@2010-08-31 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_0.pdf@EU-1-11-672_h_a_dec_0.pdf@2011-04-03 00:00:00@Xeplion@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_0.pdf@EU-1-11-679_h_a_dec_0.pdf@2011-04-14 00:00:00@Pravafenix@fenofibrate /  pravastatin@NAS before 2012@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_0.pdf@EU-1-11-676_h_a_dec_0.pdf@2011-03-17 00:00:00@JEVTANA@cabazitaxel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_0.pdf@EU-1-10-660_h_a_dec_0.pdf@2011-06-01 00:00:00@Potactasol@topotecan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_0.pdf@EU-1-10-648_h_a_dec_0.pdf@2010-07-10 00:00:00@Twynsta@telmisartan / amlodipine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_0.pdf@EU-1-11-669_h_a_dec_0.pdf@2011-03-14 00:00:00@Teysuno@Tegafur/gimeracil/oteracil@NAS before 2012@False@OD Not Found@Taiho Pharma Europe, Limited@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_0.pdf@EU-1-11-682_h_a_dec_0.pdf@2011-06-05 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@NAS before 2012@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_0.pdf@EU-1-11-685_h_a_dec_0.pdf@2011-07-26 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_0.pdf@EU-1-11-688_h_a_dec_0.pdf@2011-06-15 00:00:00@Cinryze@C1 inhibitor, human@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_0.pdf@EU-1-11-692_h_a_dec_0.pdf@2011-05-18 00:00:00@Yellox@bromfenac@NAS before 2012@False@OD Not Found@Croma-Pharma GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_0.pdf@EU-1-11-677_h_a_dec_0.pdf@2011-03-17 00:00:00@GILENYA@Fingolimod@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_0.pdf@EU-1-11-687_h_a_dec_0.pdf@2011-04-14 00:00:00@Hizentra@human normal immunoglobulin@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_0.pdf@EU-1-11-690_h_a_dec_0.pdf@2011-07-27 00:00:00@Zoely@nomegestrol/estradiol@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_0.pdf@EU-1-11-693_h_a_dec_0.pdf@2011-06-16 00:00:00@Rivastigmine Actavis@Rivastigmine@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_0.pdf@EU-1-11-673_h_a_dec_0.pdf@2011-04-03 00:00:00@Ifirmacombi@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_0.pdf@EU-1-11-696_h_a_dec_0.pdf@2011-06-17 00:00:00@BYDUREON@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_0.pdf@EU-1-11-700_h_a_dec_0.pdf@2011-07-13 00:00:00@Benlysta@belimumab@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_0.pdf@EU-1-11-691_h_a_dec_0.pdf@2011-05-18 00:00:00@Eliquis@apixaban@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_0.pdf@EU-1-11-708_h_a_dec_0.pdf@2011-08-18 00:00:00@Entacapone Orion@entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_0.pdf@EU-1-11-706_h_a_dec_0.pdf@2011-08-24 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_0.pdf@EU-1-11-678_h_a_dec_0.pdf@2011-03-17 00:00:00@HALAVEN@eribulin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_0.pdf@EU-1-11-694_h_a_dec_0.pdf@2011-06-17 00:00:00@NULOJIX@belatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_0.pdf@EU-1-11-709_h_a_dec_0.pdf@2011-05-09 00:00:00@Buccolam@Midazolam@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_0.pdf@EU-1-11-697_h_a_dec_0.pdf@2011-07-13 00:00:00@Temozolomide Sun@Temozolomide@NAS before 2012@False@OD Not Found@Sun Pharmaceuticals Industries Europe  B.V.@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_0.pdf@EU-1-11-712_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Accord@Levetiracetam@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_0.pdf@EU-1-11-716_h_a_dec_0.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_0.pdf@EU-1-11-701_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam Teva@Levetiracetam@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_0.pdf@EU-1-11-707_h_a_dec_0.pdf@2011-08-24 00:00:00@Trajenta@linagliptin@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_0.pdf@EU-1-11-722_h_a_dec_0.pdf@2012-03-21 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_0.pdf@EU-1-11-710_h_a_dec_0.pdf@2011-02-09 00:00:00@Votubia@Everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-713_h_a_dec_0.pdf@EU-1-11-713_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Actavis@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_0.pdf@EU-1-11-727_h_a_dec_0.pdf@2012-09-03 00:00:00@Mercaptopurine Nova Laboratories@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_0.pdf@EU-1-11-698_h_a_dec_0.pdf@2011-07-13 00:00:00@Yervoy@ipilimumab@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_0.pdf@EU-1-11-731_h_a_dec_0.pdf@2011-11-24 00:00:00@Komboglyze@saxagliptin / metformin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_0.pdf@EU-1-11-717_h_a_dec_0.pdf@2011-11-16 00:00:00@Vyndaqel@tafamidis@NAS before 2012@False@adopted@Pfizer Specialty UK Limited@exceptional@Parsed
EU-1-11-736_h_a_dec_0.pdf@EU-1-11-736_h_a_dec_0.pdf@2011-11-28 00:00:00@EDURANT@rilpivirine@NAS before 2012@False@OD Not Found@Janssen Cilag International NV@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_0.pdf@EU-1-11-702_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam ratiopharm@Levetiracetam@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_0.pdf@EU-1-11-714_h_a_dec_0.pdf@2011-05-09 00:00:00@Zytiga@abiraterone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_0.pdf@EU-1-11-718_h_a_dec_0.pdf@2011-09-16 00:00:00@Dexdor@dexmedetomidine@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_0.pdf@EU-1-11-737_h_a_dec_0.pdf@2011-11-28 00:00:00@Eviplera@emtricitabine / rilpivirine (as  hydrochloride) / tenofovir disoproxil (as fumarate)@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_0.pdf@EU-1-11-732_h_a_dec_0.pdf@2011-11-24 00:00:00@Desloratadine Teva@desloratadine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_0.pdf@EU-1-11-715_h_a_dec_0.pdf@2011-03-11 00:00:00@Plenadren@Hydrocortisone@NAS before 2012@False@adopted@DuoCort Pharma AB@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_0.pdf@EU-1-11-699_h_a_dec_0.pdf@2011-07-20 00:00:00@Fampyra@fampridine@NAS before 2012@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-703_h_a_dec_0.pdf@EU-1-11-703_h_a_dec_0.pdf@2011-07-13 00:00:00@Xgeva@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_0.pdf@EU-1-11-733_h_a_dec_0.pdf@2011-05-12 00:00:00@Dificlir@fidaxomicin@NAS before 2012@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_0.pdf@EU-1-11-719_h_a_dec_0.pdf@2011-03-10 00:00:00@Telmisartan Teva Pharma@telmisartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_0.pdf@EU-1-11-739_h_a_dec_0.pdf@2011-11-28 00:00:00@Dasselta@desloratadine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_0.pdf@EU-1-11-743_h_a_dec_0.pdf@2011-12-22 00:00:00@Repaglinide Accord@Repaglinide@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_0.pdf@EU-1-11-740_h_a_dec_0.pdf@2011-12-14 00:00:00@Ameluz@5-aminolevulinic acid@NAS before 2012@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_0.pdf@EU-1-11-738_h_a_dec_0.pdf@2011-05-12 00:00:00@Levetiracetam Actavis Group@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_0.pdf@EU-1-11-745_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_0.pdf@EU-1-11-747_h_a_dec_0.pdf@2012-02-13 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_0.pdf@EU-1-11-711_h_a_dec_0.pdf@2011-03-10 00:00:00@Matever@Levetiracetam@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_0.pdf@EU-1-11-746_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_0.pdf@EU-1-12-751_h_a_dec_0.pdf@2012-02-17 00:00:00@Zelboraf@vemurafenib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_0.pdf@EU-1-11-734_h_a_dec_0.pdf@2011-07-12 00:00:00@Edarbi@azilsartan medoxomil@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_0.pdf@EU-1-12-755_h_a_dec_0.pdf@2012-03-15 00:00:00@Pioglitazone Actavis@Pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_0.pdf@EU-1-11-741_h_a_dec_0.pdf@2011-12-14 00:00:00@Levetiracetam SUN@Levetiracetam@NAS before 2012@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_0.pdf@EU-1-12-759_h_a_dec_0.pdf@2012-04-20 00:00:00@Zoledronic acid Actavis@Zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_0.pdf@EU-1-12-757_h_a_dec_0.pdf@2012-03-26 00:00:00@Pioglitazone Teva@Pioglitazone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_0.pdf@EU-1-12-760_h_a_dec_0.pdf@2012-04-13 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_0.pdf@EU-1-11-749_h_a_dec_0.pdf@2012-02-17 00:00:00@Caprelsa@Vandetanib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-753_h_a_dec_0.pdf@EU-1-12-753_h_a_dec_0.pdf@2012-04-24 00:00:00@Signifor@Pasireotide@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_0.pdf@EU-1-12-763_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Krka@capecitabine@False@False@OD Not Found@KRKA, d.d@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_0.pdf@EU-1-12-767_h_a_dec_0.pdf@2012-04-20 00:00:00@Nimenrix@Meningococcal Group A, C, W-135 and  Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_0.pdf@EU-1-12-771_h_a_dec_0.pdf@2012-08-16 00:00:00@Zoledronic acid Teva@Zoledronic acid@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_0.pdf@EU-1-11-742_h_a_dec_0.pdf@2012-09-01 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma BV@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_0.pdf@EU-1-12-773_h_a_dec_0.pdf@2012-08-23 00:00:00@Jakavi@ruxolitinib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_0.pdf@EU-1-12-761_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Teva@Capecitabine@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_0.pdf@EU-1-12-764_h_a_dec_0.pdf@2012-10-05 00:00:00@Pixuvri@Pixantrone@True@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-775_h_a_dec_0.pdf@EU-1-12-775_h_a_dec_0.pdf@2012-03-09 00:00:00@NovoThirteen@catridecacog@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_0.pdf@EU-1-12-750_h_a_dec_0.pdf@2012-02-23 00:00:00@Esmya@ulipristal@False@False@OD Not Found@PregLem France SAS.@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_0.pdf@EU-1-12-762_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_0.pdf@EU-1-12-766_h_a_dec_0.pdf@2012-04-20 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_0.pdf@EU-1-12-768_h_a_dec_0.pdf@2012-07-05 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_0.pdf@EU-1-12-779_h_a_dec_0.pdf@2012-03-08 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_0.pdf@EU-1-12-776_h_a_dec_0.pdf@2012-07-23 00:00:00@Fycompa@Perampanel@True@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_0.pdf@EU-1-12-783_h_a_dec_0.pdf@2012-08-23 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_0.pdf@EU-1-12-769_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_0.pdf@EU-1-12-787_h_a_dec_0.pdf@2012-08-30 00:00:00@Revestive@teduglutide@True@False@adopted@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_0.pdf@EU-1-12-792_h_a_dec_0.pdf@2012-09-20 00:00:00@Dacogen@Decitabine@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_0.pdf@EU-1-12-784_h_a_dec_0.pdf@2012-08-23 00:00:00@Cuprymina@Copper  64Cu chloride@True@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_0.pdf@EU-1-12-780_h_a_dec_0.pdf@2012-07-20 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_0.pdf@EU-1-12-795_h_a_dec_0.pdf@2012-12-11 00:00:00@Forxiga@dapagliflozin@True@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_0.pdf@EU-1-12-785_h_a_dec_0.pdf@2012-08-23 00:00:00@Zinforo@ceftaroline fosamil@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_0.pdf@EU-1-12-788_h_a_dec_0.pdf@2012-09-28 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_0.pdf@EU-1-12-793_h_a_dec_0.pdf@2012-10-23 00:00:00@XALKORI@crizotinib@True@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-770_h_a_dec_0.pdf@EU-1-12-770_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_0.pdf@EU-1-12-777_h_a_dec_0.pdf@2012-03-09 00:00:00@Inlyta@Axitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_0.pdf@EU-1-12-789_h_a_dec_0.pdf@2012-09-28 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_0.pdf@EU-1-12-786_h_a_dec_0.pdf@2012-08-23 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_0.pdf@EU-1-12-781_h_a_dec_0.pdf@2012-07-20 00:00:00@Bretaris Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_0.pdf@EU-1-12-797_h_a_dec_0.pdf@2012-11-22 00:00:00@Eylea@aflibercept@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_0.pdf@EU-1-12-799_h_a_dec_0.pdf@2012-11-22 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_0.pdf@EU-1-12-790_h_a_dec_0.pdf@2012-09-28 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_0.pdf@EU-1-12-778_h_a_dec_0.pdf@2012-07-20 00:00:00@Eklira Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_0.pdf@EU-1-12-794_h_a_dec_0.pdf@2012-10-25 00:00:00@Adcetris@Brentuximab vedotin@True@False@adopted@Takeda Global Research and Development  Centre (Europe) Ltd.@conditional@Parsed
EU-1-12-782_h_a_dec_0.pdf@EU-1-12-782_h_a_dec_0.pdf@2012-07-23 00:00:00@Kalydeco@ivacaftor@True@False@adopted@Vertex Pharmaceuticals (U.K.) Limited,@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_0.pdf@EU-1-12-800_h_a_dec_0.pdf@2012-11-19 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_0.pdf@EU-1-12-803_h_a_dec_0.pdf@2012-12-18 00:00:00@NexoBrid@Concentrate  proteolytic enzymes  enriched in bromelain@False@False@adopted@TEVA Pharma GmbH@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_0.pdf@EU-1-12-798_h_a_dec_0.pdf@2012-11-19 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_0.pdf@EU-1-12-807_h_a_dec_0.pdf@2013-01-21 00:00:00@Tresiba@Insulin degludec@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_0.pdf@EU-1-12-811_h_a_dec_0.pdf@2013-01-02 00:00:00@Lyxumia@lixisenatide@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_0.pdf@EU-1-13-813_h_a_dec_0.pdf@2013-04-03 00:00:00@Perjeta@pertuzumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_0.pdf@EU-1-13-820_h_a_dec_0.pdf@2013-04-29 00:00:00@Maruxa@Memantine@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_0.pdf@EU-1-12-805_h_a_dec_0.pdf@2013-01-14 00:00:00@Amyvid@Florbetapir (18F)@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_0.pdf@EU-1-12-801_h_a_dec_0.pdf@2012-11-26 00:00:00@Constella@linaclotide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_0.pdf@EU-1-13-821_h_a_dec_0.pdf@2013-03-13 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_0.pdf@EU-1-12-806_h_a_dec_0.pdf@2013-01-21 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_0.pdf@EU-1-12-812_h_a_dec_0.pdf@2013-01-14 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA,  component, adsorbed)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_0.pdf@EU-1-13-824_h_a_dec_0.pdf@2013-04-22 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_0.pdf@EU-1-12-808_h_a_dec_0.pdf@2013-08-01 00:00:00@Imatinib Teva@imatinib@False@False@appointed@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-817_h_a_dec_0.pdf@EU-1-13-817_h_a_dec_0.pdf@2013-03-13 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_0.pdf@EU-1-13-822_h_a_dec_0.pdf@2013-07-31 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_0.pdf@EU-1-12-802_h_a_dec_0.pdf@2012-11-19 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_0.pdf@EU-1-13-826_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_0.pdf@EU-1-13-828_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexacima@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_0.pdf@EU-1-12-814_h_a_dec_0.pdf@2013-01-02 00:00:00@ZALTRAP@aflibercept@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_0.pdf@EU-1-13-827_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_0.pdf@EU-1-13-832_h_a_dec_0.pdf@2013-06-24 00:00:00@Stayveer@bosentan@False@False@adopted@Marklas Nederland BV@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_0.pdf@EU-1-13-818_h_a_dec_0.pdf@2013-03-27 00:00:00@Bosulif@Bosutinib@True@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-823_h_a_dec_0.pdf@EU-1-13-823_h_a_dec_0.pdf@2013-02-20 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd.@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_0.pdf@EU-1-12-815_h_a_dec_0.pdf@2013-02-25 00:00:00@Selincro@nalmefene@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_0.pdf@EU-1-13-836_h_a_dec_0.pdf@2013-06-13 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_0.pdf@EU-1-13-834_h_a_dec_0.pdf@2014-01-16 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_0.pdf@EU-1-13-829_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_0.pdf@EU-1-13-840_h_a_dec_0.pdf@2013-05-16 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_0.pdf@EU-1-13-844_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipidia@alogliptin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_0.pdf@EU-1-12-809_h_a_dec_0.pdf@2012-12-20 00:00:00@Betmiga@mirabegron@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_0.pdf@EU-1-13-837_h_a_dec_0.pdf@2014-01-30 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_0.pdf@EU-1-13-835_h_a_dec_0.pdf@2013-05-16 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_0.pdf@EU-1-13-819_h_a_dec_0.pdf@2013-03-13 00:00:00@JETREA@OCRIPLASMIN@True@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_0.pdf@EU-1-13-841_h_a_dec_0.pdf@2013-06-13 00:00:00@Spedra@avanafil@True@False@OD Not Found@VIVUS BV@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_0.pdf@EU-1-13-845_h_a_dec_0.pdf@2013-01-07 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_0.pdf@EU-1-13-838_h_a_dec_0.pdf@2013-08-26 00:00:00@AUBAGIO@Teriflunomide@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_0.pdf@EU-1-13-848_h_a_dec_0.pdf@2013-12-07 00:00:00@Erivedge@vismodegib@True@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-830_h_a_dec_0.pdf@EU-1-13-830_h_a_dec_0.pdf@2013-05-24 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine /  tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_0.pdf@EU-1-13-842_h_a_dec_0.pdf@2013-09-19 00:00:00@Incresync@alogliptin / pioglitazone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_0.pdf@EU-1-13-846_h_a_dec_0.pdf@2013-06-21 00:00:00@Xtandi@enzalutamide@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-852_h_a_dec_0.pdf@EU-1-13-852_h_a_dec_0.pdf@2013-07-31 00:00:00@Atosiban SUN@atosiban@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_0.pdf@EU-1-13-856_h_a_dec_0.pdf@2013-07-25 00:00:00@Lonquex@lipegfilgrastim@True@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_0.pdf@EU-1-13-839_h_a_dec_0.pdf@2013-01-07 00:00:00@Iclusig@ponatinib@True@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_0.pdf@EU-1-13-853_h_a_dec_0.pdf@2013-10-09 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_0.pdf@EU-1-13-843_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipdomet@alogliptin / metformin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_0.pdf@EU-1-13-850_h_a_dec_0.pdf@2013-05-08 00:00:00@Pomalidomidea Celgene@Pomalidomide@True@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_0.pdf@EU-1-13-860_h_a_dec_0.pdf@2013-08-26 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_0.pdf@EU-1-13-865_h_a_dec_0.pdf@2013-08-26 00:00:00@Tafinlar@DABRAFENIB@True@False@OD Not Found@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_0.pdf@EU-1-13-857_h_a_dec_0.pdf@2013-12-08 00:00:00@Voncento@human coagulation factor VIII / human  von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_0.pdf@EU-1-13-869_h_a_dec_0.pdf@2013-12-09 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_0.pdf@EU-1-13-873_h_a_dec_0.pdf@2013-11-13 00:00:00@Xofigo@Radium Ra 223 dichloride@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_0.pdf@EU-1-13-861_h_a_dec_0.pdf@2013-06-09 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Raptor Pharmaceuticals Europe BV@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_0.pdf@EU-1-13-858_h_a_dec_0.pdf@2013-08-26 00:00:00@Stivarga@regorafenib@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_0.pdf@EU-1-13-854_h_a_dec_0.pdf@2013-10-09 00:00:00@Inflectra@infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_0.pdf@EU-1-13-866_h_a_dec_0.pdf@2013-08-26 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Abbott Healthcare Products Ltd@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_0.pdf@EU-1-13-862_h_a_dec_0.pdf@2013-09-19 00:00:00@Ultibro Breezhaler@Indacaterol  maleate/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_0.pdf@EU-1-13-870_h_a_dec_0.pdf@2012-05-25 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS (Cell Therapies Research &  Services)@exceptional@Parsed
EU-1-13-875_h_a_dec_0.pdf@EU-1-13-875_h_a_dec_0.pdf@2014-04-28 00:00:00@Deltyba@delamanid@True@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-851_h_a_dec_0.pdf@EU-1-13-851_h_a_dec_0.pdf@2013-07-31 00:00:00@Lojuxta@Lomitapide@True@False@appointed@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-855_h_a_dec_0.pdf@EU-1-13-855_h_a_dec_0.pdf@2013-07-31 00:00:00@Imvanex@modified  vaccinia ankara virus@True@False@appointed@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-871_h_a_dec_0.pdf@EU-1-13-871_h_a_dec_0.pdf@2013-09-27 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_0.pdf@EU-1-13-863_h_a_dec_0.pdf@2013-09-19 00:00:00@Xoterna Breezhaler@indacaterol / glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_0.pdf@EU-1-13-859_h_a_dec_0.pdf@2013-11-11 00:00:00@Levodopa-Carbidopa-Entacapone Sandoz@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_0.pdf@EU-1-13-878_h_a_dec_0.pdf@2013-10-18 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.p.A.@exceptional@Parsed
EU-1-13-882_h_a_dec_0.pdf@EU-1-13-882_h_a_dec_0.pdf@2013-11-15 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_0.pdf@EU-1-13-872_h_a_dec_0.pdf@2013-09-19 00:00:00@Tybost@cobicistat@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_0.pdf@EU-1-13-877_h_a_dec_0.pdf@2013-10-18 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_0.pdf@EU-1-13-886_h_a_dec_0.pdf@2013-11-13 00:00:00@Relvar Elllipta@fluticasone furoate/vilanterol  trifenatate@True@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-13-879_h_a_dec_0.pdf@EU-1-13-879_h_a_dec_0.pdf@2013-09-25 00:00:00@Giotrif@afatinib@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_0.pdf@EU-1-13-890_h_a_dec_0.pdf@2014-03-21 00:00:00@Cometriq@cabozantinib@True@False@adopted@TMC Pharma Services Ltd.@conditional@Parsed
EU-1-13-894_h_a_dec_0.pdf@EU-1-13-894_h_a_dec_0.pdf@2014-01-16 00:00:00@Sovaldi@sofosbuvir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_0.pdf@EU-1-13-901_h_a_dec_0.pdf@2014-05-03 00:00:00@Sirturo@bedaquiline@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-884_h_a_dec_0.pdf@EU-1-13-884_h_a_dec_0.pdf@2013-11-15 00:00:00@Invokana@canagliflozin@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_0.pdf@EU-1-13-906_h_a_dec_0.pdf@2014-02-20 00:00:00@Neuraceq@florbetaben (18F)@True@False@OD Not Found@Piramal Imaging GmbH@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_0.pdf@EU-1-13-887_h_a_dec_0.pdf@2013-04-12 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated,  nasal)@True@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-880_h_a_dec_0.pdf@EU-1-13-880_h_a_dec_0.pdf@2013-04-12 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_0.pdf@EU-1-13-891_h_a_dec_0.pdf@2013-12-18 00:00:00@Brintellix@vortioxetine@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_0.pdf@EU-1-13-907_h_a_dec_0.pdf@2014-03-27 00:00:00@Adempas@riociguat@True@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_0.pdf@EU-1-13-896_h_a_dec_0.pdf@2014-07-04 00:00:00@Para-aminosalicylic acid Lucane@aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_0.pdf@EU-1-13-885_h_a_dec_0.pdf@2013-11-15 00:00:00@Kadcyla@Trastuzumab emtansine@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_0.pdf@EU-1-13-881_h_a_dec_0.pdf@2013-11-15 00:00:00@Lidocaine/Prilocaine Plethora@lidocaine /  prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_0.pdf@EU-1-13-902_h_a_dec_0.pdf@2014-07-31 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics, Limited@conditional@Parsed
EU-1-13-888_h_a_dec_0.pdf@EU-1-13-888_h_a_dec_0.pdf@2013-11-13 00:00:00@NovoEight@turoctocog alfa@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_0.pdf@EU-1-13-900_h_a_dec_0.pdf@2014-01-16 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-13-909_h_a_dec_0.pdf@EU-1-13-909_h_a_dec_0.pdf@2014-03-27 00:00:00@Bemfola@Follitropin alfa@False@False@OD Not Found@FINOX Biotech AG@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_0.pdf@EU-1-14-898_h_a_dec_0.pdf@2014-08-05 00:00:00@Anoro@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_0.pdf@EU-1-14-913_h_a_dec_0.pdf@2014-03-21 00:00:00@Latuda@lurasidone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_0.pdf@EU-1-13-889_h_a_dec_0.pdf@2014-08-01 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_0.pdf@EU-1-13-892_h_a_dec_0.pdf@2014-01-16 00:00:00@Tivicay@dolutegravir@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_0.pdf@EU-1-13-904_h_a_dec_0.pdf@2014-02-21 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International Tour Europlaza,  20 avenue André Prothin, La Défense 4, La Défense Cedex 92927, France@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_0.pdf@EU-1-14-899_h_a_dec_0.pdf@2014-08-05 00:00:00@Laventair@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_0.pdf@EU-1-14-917_h_a_dec_0.pdf@2014-04-23 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-905_h_a_dec_0.pdf@EU-1-13-905_h_a_dec_0.pdf@2014-02-20 00:00:00@Izba@travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_0.pdf@EU-1-14-921_h_a_dec_0.pdf@2014-04-28 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_0.pdf@EU-1-14-928_h_a_dec_0.pdf@2014-05-22 00:00:00@Sylvant@siltuximab@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_0.pdf@EU-1-14-918_h_a_dec_0.pdf@2014-04-23 00:00:00@Vokanamet@canagliflozin / metformin  hydrochloride@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_0.pdf@EU-1-14-914_h_a_dec_0.pdf@2014-04-28 00:00:00@Vimizim@elosulfase alfa@True@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_0.pdf@EU-1-14-929_h_a_dec_0.pdf@2014-02-05 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_0.pdf@EU-1-14-933_h_a_dec_0.pdf@2014-07-18 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_0.pdf@EU-1-14-922_h_a_dec_0.pdf@2014-04-28 00:00:00@Incruse@umeclidinium bromide@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_0.pdf@EU-1-13-893_h_a_dec_0.pdf@2013-12-20 00:00:00@Opsumit@macitentan@True@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_0.pdf@EU-1-14-936_h_a_dec_0.pdf@2014-07-22 00:00:00@Nuwiq@simoctocog alfa@True@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-915_h_a_dec_0.pdf@EU-1-14-915_h_a_dec_0.pdf@2014-05-22 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_0.pdf@EU-1-14-934_h_a_dec_0.pdf@2014-07-18 00:00:00@Plegridy@peginterferon beta-1a@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_0.pdf@EU-1-14-930_h_a_dec_0.pdf@2014-05-22 00:00:00@Jardiance@empagliflozin@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_0.pdf@EU-1-14-919_h_a_dec_0.pdf@2014-04-23 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@PIERRE FABRE DERMATOLOGIE@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_0.pdf@EU-1-14-940_h_a_dec_0.pdf@2014-01-09 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_0.pdf@EU-1-14-923_h_a_dec_0.pdf@2014-05-22 00:00:00@Entyvio@vedolizumab@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_0.pdf@EU-1-14-937_h_a_dec_0.pdf@2014-07-23 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_0.pdf@EU-1-14-916_h_a_dec_0.pdf@2014-10-04 00:00:00@Pregabalin Pfizer@Pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_0.pdf@EU-1-14-935_h_a_dec_0.pdf@2014-07-18 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_0.pdf@EU-1-14-931_h_a_dec_0.pdf@2014-06-30 00:00:00@Mekinist@trametinib@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_0.pdf@EU-1-14-920_h_a_dec_0.pdf@2014-04-28 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_0.pdf@EU-1-14-941_h_a_dec_0.pdf@2014-08-22 00:00:00@Vizamyl@flutemetamol ( 18F)@True@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_0.pdf@EU-1-14-944_h_a_dec_0.pdf@2014-09-09 00:00:00@ABASRIA@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_0.pdf@EU-1-14-938_h_a_dec_0.pdf@2014-09-18 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_0.pdf@EU-1-14-951_h_a_dec_0.pdf@2014-09-22 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_0.pdf@EU-1-14-943_h_a_dec_0.pdf@2014-08-26 00:00:00@Velphoro@oxyhydroxide, sucrose and starches@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_0.pdf@EU-1-14-952_h_a_dec_0.pdf@2015-01-15 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_0.pdf@EU-1-14-956_h_a_dec_0.pdf@2014-11-21 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_0.pdf@EU-1-14-960_h_a_dec_0.pdf@2014-12-16 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_0.pdf@EU-1-14-964_h_a_dec_0.pdf@2014-11-19 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-970_h_a_dec_0.pdf@EU-1-14-970_h_a_dec_0.pdf@2014-12-19 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_0.pdf@EU-1-14-954_h_a_dec_0.pdf@2014-11-21 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_0.pdf@EU-1-14-961_h_a_dec_0.pdf@2014-11-21 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_0.pdf@EU-1-14-971_h_a_dec_0.pdf@2014-05-12 00:00:00@Paliperidone Janssen@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_0.pdf@EU-1-14-945_h_a_dec_0.pdf@2014-10-21 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_0.pdf@EU-1-14-965_h_a_dec_0.pdf@2014-11-19 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_0.pdf@EU-1-14-974_h_a_dec_0.pdf@2015-01-19 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_0.pdf@EU-1-14-955_h_a_dec_0.pdf@2014-11-19 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Navidea Biopharmaceuticals Limited@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_0.pdf@EU-1-14-957_h_a_dec_0.pdf@2014-12-19 00:00:00@Cyramza@ramucirumab@False@False@adopted@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_0.pdf@EU-1-14-962_h_a_dec_0.pdf@2014-08-12 00:00:00@Moventig@naloxegol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_0.pdf@EU-1-14-972_h_a_dec_0.pdf@2014-08-12 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_0.pdf@EU-1-14-967_h_a_dec_0.pdf@2014-11-19 00:00:00@REZOLSTA@DARUNAVIR / COBICISTAT@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_0.pdf@EU-1-14-978_h_a_dec_0.pdf@2015-01-15 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_0.pdf@EU-1-14-973_h_a_dec_0.pdf@2015-03-26 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Aptalis Pharma SAS@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_0.pdf@EU-1-14-975_h_a_dec_0.pdf@2015-02-19 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_0.pdf@EU-1-14-963_h_a_dec_0.pdf@2014-11-19 00:00:00@Brimica Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_0.pdf@EU-1-14-977_h_a_dec_0.pdf@2015-12-01 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_0.pdf@EU-1-14-979_h_a_dec_0.pdf@2015-01-15 00:00:00@Ofev@Nintedanib@True@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_0.pdf@EU-1-14-946_h_a_dec_0.pdf@2014-09-18 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_0.pdf@EU-1-14-969_h_a_dec_0.pdf@2014-12-22 00:00:00@Scenesse@afamelanotide@False@False@adopted@Clinuvel UK Limited@exceptional@Parsed
EU-1-14-986_h_a_dec_0.pdf@EU-1-14-986_h_a_dec_0.pdf@2015-02-19 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Durata Therapeutics International B.V.@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_0.pdf@EU-1-15-1001_h_a_dec_0.pdf@2015-05-27 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_0.pdf@EU-1-14-958_h_a_dec_0.pdf@2014-11-17 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_0.pdf@EU-1-14-987_h_a_dec_0.pdf@2015-02-17 00:00:00@Holoclar@Ex vivo expanded autologous  human corneal epithelial cells containing stem cells@True@True@adopted@Chiesi Farmaceutici S.P.A.@conditional@Parsed
EU-1-15-1005_h_a_dec_0.pdf@EU-1-15-1005_h_a_dec_0.pdf@2015-06-30 00:00:00@Aripiprazole Pharmathen@aripiprazole@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_0.pdf@EU-1-14-980_h_a_dec_0.pdf@2015-01-15 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_0.pdf@EU-1-14-947_h_a_dec_0.pdf@2014-09-18 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_0.pdf@EU-1-14-988_h_a_dec_0.pdf@2015-03-26 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_0.pdf@EU-1-15-1007_h_a_dec_0.pdf@2015-10-06 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine  (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_0.pdf@EU-1-14-983_h_a_dec_0.pdf@2015-01-15 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_0.pdf@EU-1-14-959_h_a_dec_0.pdf@2014-12-16 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_0.pdf@EU-1-15-1002_h_a_dec_0.pdf@2015-05-28 00:00:00@Lenvima@Lenvatinib@False@False@adopted@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_0.pdf@EU-1-15-1009_h_a_dec_0.pdf@2015-06-25 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_0.pdf@EU-1-15-1000_h_a_dec_0.pdf@2015-05-27 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_0.pdf@EU-1-15-1008_h_a_dec_0.pdf@2015-03-07 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_0.pdf@EU-1-15-1010_h_a_dec_0.pdf@2015-06-19 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_0.pdf@EU-1-15-1013_h_a_dec_0.pdf@2015-06-19 00:00:00@Lumark@lutetium, isotope  mass 177@True@False@OD Not Found@IDB Radiopharmacy B.V.@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_0.pdf@EU-1-14-984_h_a_dec_0.pdf@2015-02-24 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_0.pdf@EU-1-15-1003_h_a_dec_0.pdf@2015-05-27 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1018_h_a_dec_0.pdf@EU-1-15-1018_h_a_dec_0.pdf@2015-07-28 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_0.pdf@EU-1-15-1021_h_a_dec_0.pdf@2015-07-17 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_0.pdf@EU-1-14-981_h_a_dec_0.pdf@2015-01-15 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_0.pdf@EU-1-15-1025_h_a_dec_0.pdf@2015-07-13 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_0.pdf@EU-1-15-1011_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_0.pdf@EU-1-15-1023_h_a_dec_0.pdf@2015-08-28 00:00:00@Farydak@panobinostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_0.pdf@EU-1-15-1019_h_a_dec_0.pdf@2015-07-20 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_0.pdf@EU-1-15-1014_h_a_dec_0.pdf@2015-06-19 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_0.pdf@EU-1-15-1004_h_a_dec_0.pdf@2015-05-27 00:00:00@Voriconazole Hospira@voriconazole@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_0.pdf@EU-1-15-1029_h_a_dec_0.pdf@2015-08-20 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_0.pdf@EU-1-15-1012_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_0.pdf@EU-1-15-1020_h_a_dec_0.pdf@2015-08-09 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland)  GmbH@exceptional@Parsed
EU-1-15-1024_h_a_dec_0.pdf@EU-1-15-1024_h_a_dec_0.pdf@2015-07-17 00:00:00@KEYTRUDA@pembrolizumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_0.pdf@EU-1-15-1033_h_a_dec_0.pdf@2015-08-28 00:00:00@Kanuma@sebelipase alfa@True@False@adopted@Synageva BioPharma Ltd@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_0.pdf@EU-1-15-1030_h_a_dec_0.pdf@2015-08-14 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_0.pdf@EU-1-15-1037_h_a_dec_0.pdf@2015-09-18 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_0.pdf@EU-1-15-1027_h_a_dec_0.pdf@2015-08-28 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_0.pdf@EU-1-15-1041_h_a_dec_0.pdf@2015-08-09 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne  S.A.@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_0.pdf@EU-1-15-1031_h_a_dec_0.pdf@2015-09-23 00:00:00@Praluent@alirocumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1038_h_a_dec_0.pdf@EU-1-15-1038_h_a_dec_0.pdf@2015-11-27 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_0.pdf@EU-1-15-1043_h_a_dec_0.pdf@2015-02-12 00:00:00@Nucala@mepolizumab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_0.pdf@EU-1-15-1035_h_a_dec_0.pdf@2015-11-11 00:00:00@Obizur@susoctocog alfa@True@False@adopted@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1040_h_a_dec_0.pdf@EU-1-15-1040_h_a_dec_0.pdf@2015-09-17 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_0.pdf@EU-1-15-1028_h_a_dec_0.pdf@2015-08-20 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_0.pdf@EU-1-15-1045_h_a_dec_0.pdf@2015-11-16 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1049_h_a_dec_0.pdf@EU-1-15-1049_h_a_dec_0.pdf@2017-01-19 00:00:00@Cystadrops@mercaptamine@False@False@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_0.pdf@EU-1-15-1036_h_a_dec_0.pdf@2015-10-15 00:00:00@Cresemba@isavuconazole@True@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_0.pdf@EU-1-15-1032_h_a_dec_0.pdf@2015-09-18 00:00:00@Zerbaxa@ceftolozane / tazobactam@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_0.pdf@EU-1-15-1053_h_a_dec_0.pdf@2016-03-16 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_0.pdf@EU-1-15-1051_h_a_dec_0.pdf@2015-11-16 00:00:00@Ebymect@dapagliflozin / metfomin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_0.pdf@EU-1-15-1046_h_a_dec_0.pdf@2015-11-19 00:00:00@Elocta@efmoroctocog alfa@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_0.pdf@EU-1-15-1054_h_a_dec_0.pdf@2015-11-19 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_0.pdf@EU-1-15-1055_h_a_dec_0.pdf@2015-02-12 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_0.pdf@EU-1-15-1015_h_a_dec_0.pdf@2015-08-28 00:00:00@Strensiq@asfotase alfa@True@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1047_h_a_dec_0.pdf@EU-1-15-1047_h_a_dec_0.pdf@2015-11-23 00:00:00@Blincyto@blinatumomab@True@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1057_h_a_dec_0.pdf@EU-1-15-1057_h_a_dec_0.pdf@2015-11-20 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_0.pdf@EU-1-15-1056_h_a_dec_0.pdf@2015-11-20 00:00:00@Praxbind@Idarucizumab@True@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1016_h_a_dec_0.pdf@EU-1-15-1016_h_a_dec_0.pdf@2015-07-17 00:00:00@Repatha@Evolocumab@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_0.pdf@EU-1-15-1052_h_a_dec_0.pdf@2015-09-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_0.pdf@EU-1-15-1058_h_a_dec_0.pdf@2015-11-19 00:00:00@Entresto@sacubitril / valsartan@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_0.pdf@EU-1-15-1065_h_a_dec_0.pdf@2016-11-01 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_0.pdf@EU-1-15-1061_h_a_dec_0.pdf@2015-11-19 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine /  tenofovir alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1048_h_a_dec_0.pdf@EU-1-15-1048_h_a_dec_0.pdf@2015-11-20 00:00:00@Cotellic@cobimetinib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_0.pdf@EU-1-15-1070_h_a_dec_0.pdf@2016-01-14 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_0.pdf@EU-1-15-1066_h_a_dec_0.pdf@2016-06-24 00:00:00@Ongentys@opicapone@True@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_0.pdf@EU-1-15-1073_h_a_dec_0.pdf@2016-01-14 00:00:00@Briviact@brivaracetam@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_0.pdf@EU-1-15-1059_h_a_dec_0.pdf@2015-11-19 00:00:00@Orkambi@Lumacaftor / Ivacaftor@True@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_0.pdf@EU-1-15-1071_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_0.pdf@EU-1-15-1078_h_a_dec_0.pdf@2017-04-24 00:00:00@Natpar@parathyroid hormone@False@False@adopted@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1067_h_a_dec_0.pdf@EU-1-15-1067_h_a_dec_0.pdf@2016-01-14 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_0.pdf@EU-1-15-1082_h_a_dec_0.pdf@2016-05-26 00:00:00@Galafold@migalastat@True@False@adopted@Amicus Therapeutics UK Ltd@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_0.pdf@EU-1-15-1074_h_a_dec_0.pdf@2016-01-14 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_0.pdf@EU-1-15-1062_h_a_dec_0.pdf@2015-11-27 00:00:00@Ravicti@Glycerol phenylbutyrate@True@False@adopted@Horizon Therapeutics Limited@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_0.pdf@EU-1-15-1072_h_a_dec_0.pdf@2016-01-14 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_0.pdf@EU-1-15-1060_h_a_dec_0.pdf@2015-11-19 00:00:00@Kyprolis@carfilzomib@True@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_0.pdf@EU-1-15-1079_h_a_dec_0.pdf@2016-02-15 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b  conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_0.pdf@EU-1-15-1068_h_a_dec_0.pdf@2016-03-31 00:00:00@Wakix@Pitolisant hydrochloride@True@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_0.pdf@EU-1-15-1083_h_a_dec_0.pdf@2016-12-05 00:00:00@Uptravi@selexipag@True@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_0.pdf@EU-1-15-1085_h_a_dec_0.pdf@2016-04-25 00:00:00@Taltz@ixekizumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_0.pdf@EU-1-15-992_h_a_dec_0.pdf@2015-03-23 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_0.pdf@EU-1-15-1063_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Actavis@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_0.pdf@EU-1-15-1075_h_a_dec_0.pdf@2016-02-18 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Iron Therapeutics (UK) Ltd@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_0.pdf@EU-1-15-997_h_a_dec_0.pdf@2015-06-25 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_0.pdf@EU-1-16-1086_h_a_dec_0.pdf@2016-02-02 00:00:00@TAGRISSO@osimertinib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-15-1064_h_a_dec_0.pdf@EU-1-15-1064_h_a_dec_0.pdf@2015-12-16 00:00:00@Imlygic@talimogene laherparepvec@True@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_0.pdf@EU-1-15-993_h_a_dec_0.pdf@2015-06-19 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_0.pdf@EU-1-15-989_h_a_dec_0.pdf@2015-03-19 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_0.pdf@EU-1-15-1076_h_a_dec_0.pdf@2016-02-18 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-16-1087_h_a_dec_0.pdf@EU-1-16-1087_h_a_dec_0.pdf@2016-03-16 00:00:00@Coagadex@human coagulation factor X@False@False@adopted@Bio Products Laboratory Ltd@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_0.pdf@EU-1-15-999_h_a_dec_0.pdf@2015-06-05 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-16-1090_h_a_dec_0.pdf@EU-1-16-1090_h_a_dec_0.pdf@2016-04-04 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_0.pdf@EU-1-16-1094_h_a_dec_0.pdf@2016-11-21 00:00:00@Ninlaro@ixazomib@True@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1091_h_a_dec_0.pdf@EU-1-16-1091_h_a_dec_0.pdf@2016-08-22 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_0.pdf@EU-1-16-1098_h_a_dec_0.pdf@2016-12-05 00:00:00@ALPROLIX@eftrenonacog alfa@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_0.pdf@EU-1-15-990_h_a_dec_0.pdf@2015-03-19 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@SANTEN S.A.S.@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_0.pdf@EU-1-16-1088_h_a_dec_0.pdf@2016-11-05 00:00:00@Empliciti@elotuzumab@True@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-994_h_a_dec_0.pdf@EU-1-15-994_h_a_dec_0.pdf@2015-03-23 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_0.pdf@EU-1-16-1102_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_0.pdf@EU-1-16-1095_h_a_dec_0.pdf@2016-11-05 00:00:00@IDELVION@albutrepenonacog alfa@True@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_0.pdf@EU-1-16-1099_h_a_dec_0.pdf@2016-04-21 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1092_h_a_dec_0.pdf@EU-1-16-1092_h_a_dec_0.pdf@2016-03-22 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_0.pdf@EU-1-15-991_h_a_dec_0.pdf@2015-03-23 00:00:00@Sivextro@tedizolid phosphate@True@False@OD Not Found@Cubist (UK) Ltd@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_0.pdf@EU-1-16-1089_h_a_dec_0.pdf@2016-05-20 00:00:00@Pandemic influenza vaccine H5N1  MedImmune@Pandemic influenza vaccine (H5N1) (live attenuated, nasal)@True@False@OD Not Found@MedImmune, LLC@conditional@Parsed
EU-1-16-1093_h_a_dec_0.pdf@EU-1-16-1093_h_a_dec_0.pdf@2016-03-31 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_0.pdf@EU-1-16-1106_h_a_dec_0.pdf@2016-05-26 00:00:00@Flixabi@Infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_0.pdf@EU-1-16-1096_h_a_dec_0.pdf@2016-04-25 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_0.pdf@EU-1-16-1110_h_a_dec_0.pdf@2017-10-04 00:00:00@Chenodeoxycholic acid  sigma-tau@chenodeoxycholic acid@False@False@adopted@sigma-tau Arzeimittel GmbH@exceptional@Parsed
EU-1-16-1103_h_a_dec_0.pdf@EU-1-16-1103_h_a_dec_0.pdf@2016-05-26 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_0.pdf@EU-1-16-1115_h_a_dec_0.pdf@2016-07-22 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_0.pdf@EU-1-16-1124_h_a_dec_0.pdf@2016-08-18 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1097_h_a_dec_0.pdf@EU-1-16-1097_h_a_dec_0.pdf@2016-05-26 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction  that contains CD34+ cells transduced with retroviral vector that encodes for the human  ADA cDNA sequence@True@True@adopted@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_0.pdf@EU-1-16-1108_h_a_dec_0.pdf@2016-07-15 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_0.pdf@EU-1-16-1112_h_a_dec_0.pdf@2016-06-21 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir  alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_0.pdf@EU-1-16-1101_h_a_dec_0.pdf@2016-05-20 00:00:00@Darzalex@daratumumab@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1116_h_a_dec_0.pdf@EU-1-16-1116_h_a_dec_0.pdf@2016-06-07 00:00:00@Epclusa@sofosbuvir/velpatasvir@True@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_0.pdf@EU-1-16-1109_h_a_dec_0.pdf@2016-06-24 00:00:00@Zavicefta@ceftazidime/avibactam@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_0.pdf@EU-1-16-1127_h_a_dec_0.pdf@2016-09-15 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1104_h_a_dec_0.pdf@EU-1-16-1104_h_a_dec_0.pdf@2016-05-26 00:00:00@Palonosetron Accord@palonosetron@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_0.pdf@EU-1-16-1125_h_a_dec_0.pdf@2016-08-16 00:00:00@Cinqaero@reslizumab@True@False@OD Not Found@Teva Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_0.pdf@EU-1-16-1128_h_a_dec_0.pdf@2016-08-25 00:00:00@Kisplyx@Lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_0.pdf@EU-1-16-1130_h_a_dec_0.pdf@2016-10-14 00:00:00@Onivyde@irinotecan@False@False@adopted@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_0.pdf@EU-1-16-1134_h_a_dec_0.pdf@2016-09-15 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_0.pdf@EU-1-16-1114_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_0.pdf@EU-1-16-1105_h_a_dec_0.pdf@2016-06-07 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_0.pdf@EU-1-16-1119_h_a_dec_0.pdf@2016-07-22 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_0.pdf@EU-1-16-1129_h_a_dec_0.pdf@2016-08-12 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@MYLAN S.A.S@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_0.pdf@EU-1-16-1132_h_a_dec_0.pdf@2016-09-15 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_0.pdf@EU-1-16-1135_h_a_dec_0.pdf@2016-09-15 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_0.pdf@EU-1-16-1138_h_a_dec_0.pdf@2016-05-12 00:00:00@Venclyxto@venetoclax@True@False@adopted@AbbVie Ltd@conditional@Parsed
EU-1-16-1146_h_a_dec_0.pdf@EU-1-16-1146_h_a_dec_0.pdf@2016-11-11 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1142_h_a_dec_0.pdf@EU-1-16-1142_h_a_dec_0.pdf@2016-11-11 00:00:00@Parsabiv@etelcalcetide@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_0.pdf@EU-1-16-1151_h_a_dec_0.pdf@2016-08-12 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_0.pdf@EU-1-16-1155_h_a_dec_0.pdf@2017-07-17 00:00:00@Kyntheum@brodalumab@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_0.pdf@EU-1-16-1147_h_a_dec_0.pdf@2016-09-11 00:00:00@IBRANCE@palbociclib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_0.pdf@EU-1-16-1136_h_a_dec_0.pdf@2016-09-09 00:00:00@CABOMETYX@cabozantinib@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1156_h_a_dec_0.pdf@EU-1-16-1156_h_a_dec_0.pdf@2017-01-18 00:00:00@ZINPLAVA@bezlotoxumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1152_h_a_dec_0.pdf@EU-1-16-1152_h_a_dec_0.pdf@2017-04-20 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_0.pdf@EU-1-16-1157_h_a_dec_0.pdf@2017-11-01 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1144_h_a_dec_0.pdf@EU-1-16-1144_h_a_dec_0.pdf@2016-11-11 00:00:00@Ivabradine Zentiva@Ivabradine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_0.pdf@EU-1-16-1139_h_a_dec_0.pdf@2016-12-12 00:00:00@OCALIVA@obeticholic acid@True@False@adopted@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1148_h_a_dec_0.pdf@EU-1-16-1148_h_a_dec_0.pdf@2016-09-11 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_0.pdf@EU-1-16-1153_h_a_dec_0.pdf@2017-09-01 00:00:00@Tadalafil Generics@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_0.pdf@EU-1-16-1159_h_a_dec_0.pdf@2017-04-01 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_0.pdf@EU-1-16-1137_h_a_dec_0.pdf@2016-11-14 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_0.pdf@EU-1-16-1158_h_a_dec_0.pdf@2017-04-01 00:00:00@AFSTYLA@lonoctocog alfa@True@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1150_h_a_dec_0.pdf@EU-1-16-1150_h_a_dec_0.pdf@2016-12-12 00:00:00@Rekovelle@follitropin delta@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_0.pdf@EU-1-16-1140_h_a_dec_0.pdf@2017-04-01 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_0.pdf@EU-1-16-1133_h_a_dec_0.pdf@2016-12-16 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_0.pdf@EU-1-16-1154_h_a_dec_0.pdf@2017-09-01 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_0.pdf@EU-1-16-1160_h_a_dec_0.pdf@2017-09-01 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_0.pdf@EU-1-16-1164_h_a_dec_0.pdf@2017-03-22 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_0.pdf@EU-1-16-1167_h_a_dec_0.pdf@2017-02-17 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_0.pdf@EU-1-16-1171_h_a_dec_0.pdf@2017-03-03 00:00:00@Ledaga@chlormethine@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_0.pdf@EU-1-17-1175_h_a_dec_0.pdf@2017-03-22 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_0.pdf@EU-1-16-1168_h_a_dec_0.pdf@2017-02-13 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_0.pdf@EU-1-17-1179_h_a_dec_0.pdf@2017-07-19 00:00:00@Veltassa@patiromer@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_0.pdf@EU-1-16-1161_h_a_dec_0.pdf@2017-11-01 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_0.pdf@EU-1-17-1172_h_a_dec_0.pdf@2017-03-29 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind Ltd@CMA Not Found@Parsed
EU-1-16-1141_h_a_dec_0.pdf@EU-1-16-1141_h_a_dec_0.pdf@2016-08-12 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_0.pdf@EU-1-17-1181_h_a_dec_0.pdf@2017-10-07 00:00:00@Spherox@associated chondrocytes@True@True@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_0.pdf@EU-1-17-1176_h_a_dec_0.pdf@2017-03-22 00:00:00@Yargesa@miglustat@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_0.pdf@EU-1-16-1169_h_a_dec_0.pdf@2017-02-16 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
ed
EU-1-17-1184_h_a_dec_0.pdf@EU-1-17-1184_h_a_dec_0.pdf@2017-06-15 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_0.pdf@EU-1-17-1187_h_a_dec_0.pdf@2017-05-24 00:00:00@Trumenba@meningococcal group B vaccine  (recombinant, adsorbed)@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_0.pdf@EU-1-17-1182_h_a_dec_0.pdf@2017-04-28 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA, d.d.@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_0.pdf@EU-1-17-1191_h_a_dec_0.pdf@2017-08-05 00:00:00@Dinutuximab beta Apeiron@dinutuximab beta@False@False@adopted@APEIRON Biologics AG@exceptional@Parsed
EU-1-17-1173_h_a_dec_0.pdf@EU-1-17-1173_h_a_dec_0.pdf@2018-03-22 00:00:00@Lokelma@sodium zirconium cyclosilicate@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_0.pdf@EU-1-16-1170_h_a_dec_0.pdf@2017-02-13 00:00:00@Olumiant@baricitinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1177_h_a_dec_0.pdf@EU-1-17-1177_h_a_dec_0.pdf@2017-03-22 00:00:00@Tadalafil Lilly@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_0.pdf@EU-1-17-1195_h_a_dec_0.pdf@2017-06-23 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_0.pdf@EU-1-17-1178_h_a_dec_0.pdf@2017-03-22 00:00:00@Xeljanz@Tofacitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_0.pdf@EU-1-17-1192_h_a_dec_0.pdf@2017-05-30 00:00:00@Brineura@cerliponase  alfa@True@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1188_h_a_dec_0.pdf@EU-1-17-1188_h_a_dec_0.pdf@2017-05-30 00:00:00@Spinraza@nusinersen@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_0.pdf@EU-1-17-1174_h_a_dec_0.pdf@2017-03-20 00:00:00@Rolufta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_0.pdf@EU-1-17-1200_h_a_dec_0.pdf@2017-06-29 00:00:00@Besponsa@inotuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_0.pdf@EU-1-17-1185_h_a_dec_0.pdf@2017-06-15 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1193_h_a_dec_0.pdf@EU-1-17-1193_h_a_dec_0.pdf@2017-02-06 00:00:00@Refixia@nonacog beta pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_0.pdf@EU-1-17-1189_h_a_dec_0.pdf@2017-02-06 00:00:00@Elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_0.pdf@EU-1-17-1196_h_a_dec_0.pdf@2017-06-23 00:00:00@Kevzara@sarilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_0.pdf@EU-1-17-1205_h_a_dec_0.pdf@2017-07-17 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1194_h_a_dec_0.pdf@EU-1-17-1194_h_a_dec_0.pdf@2017-06-15 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1197_h_a_dec_0.pdf@EU-1-17-1197_h_a_dec_0.pdf@2017-06-07 00:00:00@OXERVATE@cenegermin@True@False@adopted@Dompé farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_0.pdf@EU-1-17-1186_h_a_dec_0.pdf@2017-05-22 00:00:00@Axumin@fluciclovine (18F)@True@False@OD Not Found@Blue Earth Diagnostics Ltd@CMA Not Found@Parsed
EU-1-17-1190_h_a_dec_0.pdf@EU-1-17-1190_h_a_dec_0.pdf@2017-05-22 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1209_h_a_dec_0.pdf@EU-1-17-1209_h_a_dec_0.pdf@2017-07-13 00:00:00@Reagila@cariprazine@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_0.pdf@EU-1-17-1208_h_a_dec_0.pdf@2017-07-17 00:00:00@Trimbow@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_0.pdf@EU-1-17-1213_h_a_dec_0.pdf@2017-07-26 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_0.pdf@EU-1-17-1202_h_a_dec_0.pdf@2017-06-23 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-17-1199_h_a_dec_0.pdf@EU-1-17-1199_h_a_dec_0.pdf@2017-05-09 00:00:00@Cuprior@trientine@False@False@adopted@gmp-orphan SA@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_0.pdf@EU-1-17-1217_h_a_dec_0.pdf@2017-08-24 00:00:00@Nitisinone MendeliKABS@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_0.pdf@EU-1-17-1203_h_a_dec_0.pdf@2017-07-19 00:00:00@Insulin lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_0.pdf@EU-1-17-1225_h_a_dec_0.pdf@2017-09-21 00:00:00@Symtuza@Darunavir ethanolate/ cobistat/  emtricitabine/ tenofovir alafenamide fumarate@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_0.pdf@EU-1-17-1221_h_a_dec_0.pdf@2017-08-22 00:00:00@Kisqali@ribociclib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_0.pdf@EU-1-17-1210_h_a_dec_0.pdf@2017-07-17 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_0.pdf@EU-1-17-1229_h_a_dec_0.pdf@2017-09-26 00:00:00@Dupixent@dupilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_0.pdf@EU-1-17-1218_h_a_dec_0.pdf@2017-09-18 00:00:00@Rydapt@Midostaurin@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_0.pdf@EU-1-17-1226_h_a_dec_0.pdf@2017-09-26 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@True@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_0.pdf@EU-1-17-1214_h_a_dec_0.pdf@2017-09-18 00:00:00@Bavencio@avelumab@True@False@adopted@Merck Serono Europe Limited@conditional@Parsed
EU-1-17-1222_h_a_dec_0.pdf@EU-1-17-1222_h_a_dec_0.pdf@2017-05-09 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_0.pdf@EU-1-17-1211_h_a_dec_0.pdf@2017-09-26 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_0.pdf@EU-1-17-1233_h_a_dec_0.pdf@2017-10-11 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_0.pdf@EU-1-17-1219_h_a_dec_0.pdf@2018-06-07 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1215_h_a_dec_0.pdf@EU-1-17-1215_h_a_dec_0.pdf@2017-08-24 00:00:00@Fotivda@tivozanib@True@False@OD Not Found@EUSA Pharma (UK) Limited@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_0.pdf@EU-1-17-1212_h_a_dec_0.pdf@2017-08-22 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_0.pdf@EU-1-17-1227_h_a_dec_0.pdf@2017-09-18 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_0.pdf@EU-1-17-1223_h_a_dec_0.pdf@2017-07-26 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_0.pdf@EU-1-17-1234_h_a_dec_0.pdf@2017-10-11 00:00:00@Tremfya@Guselkumab@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_0.pdf@EU-1-17-1228_h_a_dec_0.pdf@2017-10-11 00:00:00@TOOKAD@padeliporfin@True@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_0.pdf@EU-1-17-1220_h_a_dec_0.pdf@2017-09-21 00:00:00@Tecentriq@atezolizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_0.pdf@EU-1-17-1237_h_a_dec_0.pdf@2017-11-15 00:00:00@Elebrato Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_0.pdf@EU-1-17-1216_h_a_dec_0.pdf@2017-08-24 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_0.pdf@EU-1-17-1241_h_a_dec_0.pdf@2017-11-15 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_0.pdf@EU-1-17-1224_h_a_dec_0.pdf@2017-09-18 00:00:00@Xermelo@telotristat@True@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_0.pdf@EU-1-17-1230_h_a_dec_0.pdf@2017-09-18 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_0.pdf@EU-1-17-1235_h_a_dec_0.pdf@2017-11-16 00:00:00@Zejula@niraparib@True@False@adopted@TESARO UK LIMITED@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_0.pdf@EU-1-17-1238_h_a_dec_0.pdf@2017-10-11 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_0.pdf@EU-1-17-1242_h_a_dec_0.pdf@2017-10-11 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_0.pdf@EU-1-17-1245_h_a_dec_0.pdf@2018-08-01 00:00:00@PREVYMIS@letermovir@True@False@adopted@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1239_h_a_dec_0.pdf@EU-1-17-1239_h_a_dec_0.pdf@2017-10-11 00:00:00@VeraSeal@human fibrinogen / human thrombin@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_0.pdf@EU-1-17-1244_h_a_dec_0.pdf@2017-08-12 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-17-1249_h_a_dec_0.pdf@EU-1-17-1249_h_a_dec_0.pdf@2018-01-26 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_0.pdf@EU-1-17-1236_h_a_dec_0.pdf@2017-11-15 00:00:00@Trelegy Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1253_h_a_dec_0.pdf@EU-1-17-1253_h_a_dec_0.pdf@2018-08-01 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1257_h_a_dec_0.pdf@EU-1-17-1257_h_a_dec_0.pdf@2018-09-02 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_0.pdf@EU-1-17-1231_h_a_dec_0.pdf@2018-08-01 00:00:00@Ocrevus@ocrelizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_0.pdf@EU-1-17-1246_h_a_dec_0.pdf@2018-01-15 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1254_h_a_dec_0.pdf@EU-1-17-1254_h_a_dec_0.pdf@2018-08-01 00:00:00@Jorveza@budesonide@False@False@adopted@Dr. Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_0.pdf@EU-1-17-1250_h_a_dec_0.pdf@2018-05-24 00:00:00@Rubraca@rucaparib@True@False@adopted@Clovis Oncology UK Limited@conditional@Parsed
EU-1-17-1258_h_a_dec_0.pdf@EU-1-17-1258_h_a_dec_0.pdf@2018-03-23 00:00:00@Lamzede@velmanase alfa@True@False@adopted@Chiesi Farmaceutici S.p.A.@exceptional@Parsed
EU-1-17-1262_h_a_dec_0.pdf@EU-1-17-1262_h_a_dec_0.pdf@2018-02-19 00:00:00@CRYSVITA@Burosumab@True@False@adopted@Kyowa Kirin Limited@conditional@Parsed
EU-1-18-1266_h_a_dec_0.pdf@EU-1-18-1266_h_a_dec_0.pdf@2018-03-23 00:00:00@Steglujan@ertugliflozin / sitagliptin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1255_h_a_dec_0.pdf@EU-1-17-1255_h_a_dec_0.pdf@2018-08-01 00:00:00@Intrarosa@Prasterone@False@False@OD Not Found@Endoceutics Ltd.@CMA Not Found@Parsed
EU-1-17-1247_h_a_dec_0.pdf@EU-1-17-1247_h_a_dec_0.pdf@2018-08-01 00:00:00@ADYNOVI@rurioctocog alfa pegol@True@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_0.pdf@EU-1-17-1232_h_a_dec_0.pdf@2020-04-28 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1256_h_a_dec_0.pdf@EU-1-17-1256_h_a_dec_0.pdf@2018-02-15 00:00:00@Anagrelide Mylan@anagrelide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_0.pdf@EU-1-18-1267_h_a_dec_0.pdf@2018-03-21 00:00:00@Steglatro@ertugliflozin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_0.pdf@EU-1-17-1260_h_a_dec_0.pdf@2018-09-02 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Ltd@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_0.pdf@EU-1-17-1251_h_a_dec_0.pdf@2018-08-02 00:00:00@Ozempic@semaglutide@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_0.pdf@EU-1-17-1263_h_a_dec_0.pdf@2018-08-02 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_0.pdf@EU-1-18-1271_h_a_dec_0.pdf@2018-02-23 00:00:00@Hemlibra@emicizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-18-1279_h_a_dec_0.pdf@EU-1-18-1279_h_a_dec_0.pdf@2018-05-24 00:00:00@AMGLIDIA@glibenclamide@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1275_h_a_dec_0.pdf@EU-1-18-1275_h_a_dec_0.pdf@2018-04-23 00:00:00@Riarify@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1261_h_a_dec_0.pdf@EU-1-17-1261_h_a_dec_0.pdf@2018-03-23 00:00:00@Alofisel@Darvadstrocel@True@True@adopted@TiGenix S.A.U.@CMA Not Found@Parsed
EU-1-18-1280_h_a_dec_0.pdf@EU-1-18-1280_h_a_dec_0.pdf@2018-05-18 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1264_h_a_dec_0.pdf@EU-1-18-1264_h_a_dec_0.pdf@2018-11-22 00:00:00@Alunbrig@brigatinib@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-18-1269_h_a_dec_0.pdf@EU-1-18-1269_h_a_dec_0.pdf@2018-04-13 00:00:00@Alpivab@peramivir@True@False@OD Not Found@BioCryst UK Ltd.@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_0.pdf@EU-1-18-1276_h_a_dec_0.pdf@2018-07-30 00:00:00@Myalepta@metreleptin@True@False@adopted@Aegerion Pharmaceuticals B.V.@exceptional@Parsed
EU-1-18-1283_h_a_dec_0.pdf@EU-1-18-1283_h_a_dec_0.pdf@2018-05-22 00:00:00@Pemetrexed Krka@pemetrexed@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_0.pdf@EU-1-18-1281_h_a_dec_0.pdf@2018-05-16 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_0.pdf@EU-1-17-1252_h_a_dec_0.pdf@2018-08-01 00:00:00@Fasenra@benralizumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_0.pdf@EU-1-18-1272_h_a_dec_0.pdf@2018-03-21 00:00:00@Shingrix@herpes zoster vaccine (recombinant,  adjuvanted)@True@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_0.pdf@EU-1-18-1270_h_a_dec_0.pdf@2018-03-23 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1284_h_a_dec_0.pdf@EU-1-18-1284_h_a_dec_0.pdf@2018-06-25 00:00:00@Dzuveo@sufentanil@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_0.pdf@EU-1-18-1265_h_a_dec_0.pdf@2018-03-23 00:00:00@Segluromet@ertugliflozin / metformin  hydrochloride@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1273_h_a_dec_0.pdf@EU-1-18-1273_h_a_dec_0.pdf@2018-05-16 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1277_h_a_dec_0.pdf@EU-1-18-1277_h_a_dec_0.pdf@2018-04-19 00:00:00@Mylotarg@gemtuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_0.pdf@EU-1-18-1286_h_a_dec_0.pdf@2018-07-26 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_0.pdf@EU-1-18-1282_h_a_dec_0.pdf@2018-05-16 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_0.pdf@EU-1-18-1292_h_a_dec_0.pdf@2018-11-20 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_0.pdf@EU-1-18-1289_h_a_dec_0.pdf@2018-06-21 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir  alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_0.pdf@EU-1-18-1274_h_a_dec_0.pdf@2018-04-26 00:00:00@Trydonis@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_0.pdf@EU-1-18-1293_h_a_dec_0.pdf@2018-07-26 00:00:00@Aimovig@erenumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_0.pdf@EU-1-18-1278_h_a_dec_0.pdf@2018-07-19 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1290_h_a_dec_0.pdf@EU-1-18-1290_h_a_dec_0.pdf@2018-07-26 00:00:00@Nityr@nitisinone@False@False@OD Not Found@Cycle Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-18-1301_h_a_dec_0.pdf@EU-1-18-1301_h_a_dec_0.pdf@2018-08-23 00:00:00@Mepsevii@vestronidase  alfa@True@False@adopted@Ultragenyx Germany GmbH@exceptional@Parsed
EU-1-18-1296_h_a_dec_0.pdf@EU-1-18-1296_h_a_dec_0.pdf@2018-06-07 00:00:00@Tegsedi@inotersen@True@False@adopted@IONIS USA Limited@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_0.pdf@EU-1-18-1287_h_a_dec_0.pdf@2018-07-26 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1305_h_a_dec_0.pdf@EU-1-18-1305_h_a_dec_0.pdf@2018-08-31 00:00:00@Cablivi@caplacizumab@True@False@adopted@Ablynx N.V.@CMA Not Found@Parsed
EU-1-18-1291_h_a_dec_0.pdf@EU-1-18-1291_h_a_dec_0.pdf@2019-02-18 00:00:00@Rizmoic@naldemedine@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1294_h_a_dec_0.pdf@EU-1-18-1294_h_a_dec_0.pdf@2018-07-26 00:00:00@RXULTI@brexpiprazole@True@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-18-1310_h_a_dec_0.pdf@EU-1-18-1310_h_a_dec_0.pdf@2018-09-20 00:00:00@Deferiprone Lipomed@Deferiprone@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_0.pdf@EU-1-18-1306_h_a_dec_0.pdf@2018-10-31 00:00:00@Symkevi@tezacaftor/ivacaftor@True@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-18-1302_h_a_dec_0.pdf@EU-1-18-1302_h_a_dec_0.pdf@2018-09-20 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_0.pdf@EU-1-18-1311_h_a_dec_0.pdf@2018-08-31 00:00:00@Nerlynx@neratinib@True@False@OD Not Found@Puma Biotechnology, Ltd.@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_0.pdf@EU-1-18-1295_h_a_dec_0.pdf@Date is blank@Trazimera@trastuzumab@NAS before 2012@NA before 2012@NA before 2000@Pfizer Europe MA EEIG@CMA not available before 2006@Parsed
EU-1-18-1313_h_a_dec_0.pdf@EU-1-18-1313_h_a_dec_0.pdf@2018-09-21 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_0.pdf@EU-1-18-1307_h_a_dec_0.pdf@2018-09-27 00:00:00@Verzenios@abemaciclib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_0.pdf@EU-1-18-1317_h_a_dec_0.pdf@2019-06-05 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_0.pdf@EU-1-18-1297_h_a_dec_0.pdf@2018-08-23 00:00:00@Kymriah@tisagenlecleucel@True@True@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_0.pdf@EU-1-18-1314_h_a_dec_0.pdf@2018-09-20 00:00:00@Braftovi@encorafenib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_0.pdf@EU-1-18-1312_h_a_dec_0.pdf@2018-09-20 00:00:00@Xerava@Eravacycline@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1321_h_a_dec_0.pdf@EU-1-18-1321_h_a_dec_0.pdf@2018-09-27 00:00:00@Gefitinib Mylan@gefitinib@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1325_h_a_dec_0.pdf@EU-1-18-1325_h_a_dec_0.pdf@2018-12-18 00:00:00@Namuscla@Mexiletine@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_0.pdf@EU-1-18-1322_h_a_dec_0.pdf@2018-09-21 00:00:00@Imfinzi@durvalumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1308_h_a_dec_0.pdf@EU-1-18-1308_h_a_dec_0.pdf@2018-08-23 00:00:00@Vyxeos@daunorubicin / cytarabine@False@False@adopted@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_0.pdf@EU-1-18-1326_h_a_dec_0.pdf@2018-12-12 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen,  inactivated, prepared in cell cultures)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_0.pdf@EU-1-18-1318_h_a_dec_0.pdf@2018-09-20 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited,@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_0.pdf@EU-1-18-1329_h_a_dec_0.pdf@2018-11-20 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1298_h_a_dec_0.pdf@EU-1-18-1298_h_a_dec_0.pdf@2018-08-31 00:00:00@VEYVONDI@vonicog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_0.pdf@EU-1-18-1333_h_a_dec_0.pdf@2018-11-22 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir  disoproxil@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1327_h_a_dec_0.pdf@EU-1-18-1327_h_a_dec_0.pdf@2018-11-22 00:00:00@Ziextenzo@pegfilgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_0.pdf@EU-1-18-1330_h_a_dec_0.pdf@2018-11-14 00:00:00@Emgality@galcanezumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1315_h_a_dec_0.pdf@EU-1-18-1315_h_a_dec_0.pdf@2018-09-20 00:00:00@Mektovi@binimetinib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_0.pdf@EU-1-18-1323_h_a_dec_0.pdf@2018-09-17 00:00:00@Ilumetri@tildrakizumab@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_0.pdf@EU-1-18-1319_h_a_dec_0.pdf@2018-09-17 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1334_h_a_dec_0.pdf@EU-1-18-1334_h_a_dec_0.pdf@2018-11-20 00:00:00@Vabomere@meropenem/vaborbactam@True@False@OD Not Found@Rempex London Limited@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_0.pdf@EU-1-18-1299_h_a_dec_0.pdf@2018-08-23 00:00:00@Yescarta@axicabtagene ciloleucel@True@True@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_0.pdf@EU-1-18-1328_h_a_dec_0.pdf@2018-11-20 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Cinfa Biotech S.L.@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_0.pdf@EU-1-18-1316_h_a_dec_0.pdf@2018-09-20 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1324_h_a_dec_0.pdf@EU-1-18-1324_h_a_dec_0.pdf@2018-11-22 00:00:00@Jivi@damoctocog alfa pegol@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-18-1335_h_a_dec_0.pdf@EU-1-18-1335_h_a_dec_0.pdf@2018-11-22 00:00:00@Poteligeo@Mogamulizumab@True@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1337_h_a_dec_0.pdf@EU-1-18-1337_h_a_dec_0.pdf@2019-11-01 00:00:00@Macimorelin Aeterna Zentaris@macimorelin@True@False@OD Not Found@Æterna Zentaris GmbH@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_0.pdf@EU-1-18-1336_h_a_dec_0.pdf@2018-11-20 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_0.pdf@EU-1-18-1331_h_a_dec_0.pdf@2018-11-22 00:00:00@Luxturna@voretigene neparvovec@True@True@adopted@Spark Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_0.pdf@EU-1-18-1341_h_a_dec_0.pdf@2018-12-12 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1338_h_a_dec_0.pdf@EU-1-18-1338_h_a_dec_0.pdf@2018-12-12 00:00:00@Dengvaxia@dengue tetravalent vaccine (live,  attenuated)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_0.pdf@EU-1-18-1320_h_a_dec_0.pdf@2018-08-27 00:00:00@Onpattro@patisiran@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_0.pdf@EU-1-18-1345_h_a_dec_0.pdf@2019-04-26 00:00:00@Ondexxya@andexanet alfa@True@False@OD Not Found@Portola Netherlands B.V.@conditional@Parsed
EU-1-19-1353_h_a_dec_0.pdf@EU-1-19-1353_h_a_dec_0.pdf@2019-03-25 00:00:00@Atazanavir Krka@atazanavir@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1342_h_a_dec_0.pdf@EU-1-18-1342_h_a_dec_0.pdf@2019-01-14 00:00:00@Erleada@apalutamide@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-18-1349_h_a_dec_0.pdf@EU-1-18-1349_h_a_dec_0.pdf@2019-04-26 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@exceptional@Parsed
EU-1-18-1339_h_a_dec_0.pdf@EU-1-18-1339_h_a_dec_0.pdf@2018-12-18 00:00:00@Bevespi Aerosphere@glycopyrronium bromide /  formoterol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1332_h_a_dec_0.pdf@EU-1-18-1332_h_a_dec_0.pdf@2018-11-22 00:00:00@Pifeltro@doravirine@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-19-1354_h_a_dec_0.pdf@EU-1-19-1354_h_a_dec_0.pdf@2019-02-04 00:00:00@Vizimpro@dacomitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_0.pdf@EU-1-19-1358_h_a_dec_0.pdf@2019-03-28 00:00:00@AJOVY@fremanezumab@True@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-18-1346_h_a_dec_0.pdf@EU-1-18-1346_h_a_dec_0.pdf@2019-02-18 00:00:00@Miglustat Dipharma@miglustat@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_0.pdf@EU-1-19-1355_h_a_dec_0.pdf@2019-06-05 00:00:00@Lorviqua@lorlatinib@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-19-1361_h_a_dec_0.pdf@EU-1-19-1361_h_a_dec_0.pdf@2019-04-26 00:00:00@Skyrizi@risankizumab@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-18-1347_h_a_dec_0.pdf@EU-1-18-1347_h_a_dec_0.pdf@2019-03-28 00:00:00@Febuxostat Krka@febuxostat@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1350_h_a_dec_0.pdf@EU-1-18-1350_h_a_dec_0.pdf@2019-02-18 00:00:00@Tobramycin PARI@tobramycin@False@False@adopted@PARI Pharma GmbH@CMA Not Found@Parsed
EU-1-18-1343_h_a_dec_0.pdf@EU-1-18-1343_h_a_dec_0.pdf@2019-07-01 00:00:00@Silodosin Recordati@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_0.pdf@EU-1-18-1340_h_a_dec_0.pdf@2018-11-22 00:00:00@TAKHZYRO@lanadelumab@True@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1344_h_a_dec_0.pdf@EU-1-18-1344_h_a_dec_0.pdf@2019-02-14 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1356_h_a_dec_0.pdf@EU-1-19-1356_h_a_dec_0.pdf@2019-02-04 00:00:00@Idacio@adalimumab@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1359_h_a_dec_0.pdf@EU-1-19-1359_h_a_dec_0.pdf@2019-09-26 00:00:00@Trogarzo@ibalizumab@True@False@OD Not Found@Theratechnologies International Limited@CMA Not Found@Parsed
EU-1-18-1351_h_a_dec_0.pdf@EU-1-18-1351_h_a_dec_0.pdf@2019-06-20 00:00:00@Trecondi@treosulfan@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-18-1348_h_a_dec_0.pdf@EU-1-18-1348_h_a_dec_0.pdf@2019-02-18 00:00:00@Lusutrombopag Shionogi@lusutrombopag@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_0.pdf@EU-1-19-1360_h_a_dec_0.pdf@2019-03-05 00:00:00@Waylivra@volanesorsen@True@False@adopted@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1362_h_a_dec_0.pdf@EU-1-19-1362_h_a_dec_0.pdf@2019-03-05 00:00:00@Palynziq@pegvaliase@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1365_h_a_dec_0.pdf@EU-1-19-1365_h_a_dec_0.pdf@2019-07-25 00:00:00@Cufence@trientine dihydrochloride@False@False@OD Not Found@Univar BV@CMA Not Found@Parsed
EU-1-19-1369_h_a_dec_0.pdf@EU-1-19-1369_h_a_dec_0.pdf@2019-06-20 00:00:00@Sixmo@buprenorphine@False@False@OD Not Found@L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A,@CMA Not Found@Parsed
EU-1-18-1352_h_a_dec_0.pdf@EU-1-18-1352_h_a_dec_0.pdf@2019-02-15 00:00:00@Besremi@ropeginterferon alfa-2b@True@False@OD Not Found@AOP Orphan Pharmaceuticals AG@CMA Not Found@Parsed
EU-1-19-1377_h_a_dec_0.pdf@EU-1-19-1377_h_a_dec_0.pdf@2019-06-20 00:00:00@Talzenna@talazoparib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1373_h_a_dec_0.pdf@EU-1-19-1373_h_a_dec_0.pdf@2019-06-20 00:00:00@Doptelet@avatrombopag@True@False@OD Not Found@Dova Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-19-1370_h_a_dec_0.pdf@EU-1-19-1370_h_a_dec_0.pdf@2019-01-07 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1381_h_a_dec_0.pdf@EU-1-19-1381_h_a_dec_0.pdf@2019-07-25 00:00:00@LysaKare@arginine / lysine@False@False@OD Not Found@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-19-1366_h_a_dec_0.pdf@EU-1-19-1366_h_a_dec_0.pdf@2019-01-07 00:00:00@Xromi@hydroxycarbamide@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-19-1379_h_a_dec_0.pdf@EU-1-19-1379_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole Accord@posaconazole@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1383_h_a_dec_0.pdf@EU-1-19-1383_h_a_dec_0.pdf@2019-08-26 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1374_h_a_dec_0.pdf@EU-1-19-1374_h_a_dec_0.pdf@2019-06-20 00:00:00@Esperoct@turoctocog alfa pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-19-1380_h_a_dec_0.pdf@EU-1-19-1380_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole AHCL@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1364_h_a_dec_0.pdf@EU-1-19-1364_h_a_dec_0.pdf@2019-09-27 00:00:00@NUCEIVA@botulinum toxin type A@False@False@OD Not Found@Evolus Pharma Limited@CMA Not Found@Parsed
EU-1-19-1385_h_a_dec_0.pdf@EU-1-19-1385_h_a_dec_0.pdf@2019-09-19 00:00:00@VITRAKVI@larotrectinib@True@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1368_h_a_dec_0.pdf@EU-1-19-1368_h_a_dec_0.pdf@2019-06-20 00:00:00@Ambrisentan Mylan@ambrisentan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1389_h_a_dec_0.pdf@EU-1-19-1389_h_a_dec_0.pdf@2019-09-19 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1394_h_a_dec_0.pdf@EU-1-19-1394_h_a_dec_0.pdf@2020-04-17 00:00:00@Tigecycline Accord@tigecycline@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1375_h_a_dec_0.pdf@EU-1-19-1375_h_a_dec_0.pdf@2019-06-20 00:00:00@Grasustek@pegfilgrastim@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_0.pdf@EU-1-19-1371_h_a_dec_0.pdf@2019-02-07 00:00:00@Ultomiris@Ravulizumab@True@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1386_h_a_dec_0.pdf@EU-1-19-1386_h_a_dec_0.pdf@2019-09-26 00:00:00@Deferasirox Mylan@deferasirox@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1395_h_a_dec_0.pdf@EU-1-19-1395_h_a_dec_0.pdf@2020-09-01 00:00:00@Clopidogrel/Acetylsalicylic acid Mylan@clopidogrel /  acetylsalicylic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1384_h_a_dec_0.pdf@EU-1-19-1384_h_a_dec_0.pdf@2019-08-23 00:00:00@Giapreza@angiotensin II acetate@True@False@OD Not Found@La Jolla Pharmaceutical II B.V.@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_0.pdf@EU-1-19-1376_h_a_dec_0.pdf@2019-06-28 00:00:00@LIBTAYO@cemiplimab@True@False@OD Not Found@Regeneron Ireland U.C.@conditional@Parsed
EU-1-19-1398_h_a_dec_0.pdf@EU-1-19-1398_h_a_dec_0.pdf@2019-11-14 00:00:00@Arsenic Trioxide Accord@arsenic trioxide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1390_h_a_dec_0.pdf@EU-1-19-1390_h_a_dec_0.pdf@2019-09-19 00:00:00@Inbrija@levodopa@False@False@OD Not Found@Acorda Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-19-1399_h_a_dec_0.pdf@EU-1-19-1399_h_a_dec_0.pdf@2019-10-24 00:00:00@Xospata@gilteritinib@True@False@adopted@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-19-1403_h_a_dec_0.pdf@EU-1-19-1403_h_a_dec_0.pdf@2020-03-04 00:00:00@Budesonide/Formoterol Teva Pharma B.V.@budesonide / formoterol fumarate dihydrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_0.pdf@EU-1-19-1396_h_a_dec_0.pdf@2019-11-14 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1387_h_a_dec_0.pdf@EU-1-19-1387_h_a_dec_0.pdf@2019-11-14 00:00:00@Senstend@lidocaine / prilocaine@False@False@OD Not Found@Plethora Pharma Solutions Ltd.@CMA Not Found@Parsed
EU-1-19-1392_h_a_dec_0.pdf@EU-1-19-1392_h_a_dec_0.pdf@2019-11-11 00:00:00@Ervebo@ZEBOV-GP, live)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1388_h_a_dec_0.pdf@EU-1-19-1388_h_a_dec_0.pdf@2020-01-16 00:00:00@Polivy@polatuzumab vedotin@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-19-1400_h_a_dec_0.pdf@EU-1-19-1400_h_a_dec_0.pdf@2019-11-19 00:00:00@Rhokiinsa@netarsudil@True@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1372_h_a_dec_0.pdf@EU-1-19-1372_h_a_dec_0.pdf@2019-06-25 00:00:00@Striascan@ioflupane ( 123I)@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-19-1407_h_a_dec_0.pdf@EU-1-19-1407_h_a_dec_0.pdf@2020-09-01 00:00:00@Isturisa@osilodrostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_0.pdf@EU-1-19-1404_h_a_dec_0.pdf@2019-12-16 00:00:00@Rinvoq@upadacitinib@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1397_h_a_dec_0.pdf@EU-1-19-1397_h_a_dec_0.pdf@2019-11-14 00:00:00@Bortezomib Fresenius Kabi@bortezomib@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1411_h_a_dec_0.pdf@EU-1-19-1411_h_a_dec_0.pdf@2019-09-12 00:00:00@Evenity@romosozumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1408_h_a_dec_0.pdf@EU-1-19-1408_h_a_dec_0.pdf@2020-01-16 00:00:00@Sunosi@solriamfetol@True@False@OD Not Found@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1415_h_a_dec_0.pdf@EU-1-19-1415_h_a_dec_0.pdf@2020-02-13 00:00:00@Amsparity@adalimumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1393_h_a_dec_0.pdf@EU-1-19-1393_h_a_dec_0.pdf@2019-12-16 00:00:00@Quofenix@delafloxacin@True@False@OD Not Found@A. Menarini - Industrie Farmaceutiche Riunite  - s.r.l.@CMA Not Found@Parsed
EU-1-19-1419_h_a_dec_0.pdf@EU-1-19-1419_h_a_dec_0.pdf@2020-03-04 00:00:00@Trepulmix@treprostinil sodium@False@False@adopted@SciPharm Sàrl@CMA Not Found@Parsed
EU-1-19-1412_h_a_dec_0.pdf@EU-1-19-1412_h_a_dec_0.pdf@2020-09-01 00:00:00@Deferasirox Accord@deferasirox@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1409_h_a_dec_0.pdf@EU-1-19-1409_h_a_dec_0.pdf@2019-12-19 00:00:00@Pegfilgrastim Mundipharma@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-20-1427_h_a_dec_0.pdf@EU-1-20-1427_h_a_dec_0.pdf@2020-01-04 00:00:00@Arsenic trioxide Mylan@arsenic trioxide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_0.pdf@EU-1-19-1420_h_a_dec_0.pdf@2020-02-13 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-20-1423_h_a_dec_0.pdf@EU-1-20-1423_h_a_dec_0.pdf@2020-01-04 00:00:00@Vaxchora@Cholera vaccine (recombinant, live,  oral)@True@False@OD Not Found@Emergent Netherlands B.V.@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_0.pdf@EU-1-19-1405_h_a_dec_0.pdf@2020-09-01 00:00:00@TAVLESSE@fostamatinib@True@False@OD Not Found@Rigel Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-19-1413_h_a_dec_0.pdf@EU-1-19-1413_h_a_dec_0.pdf@2020-02-13 00:00:00@Azacitidine Accord@Azacitidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1428_h_a_dec_0.pdf@EU-1-20-1428_h_a_dec_0.pdf@2020-02-03 00:00:00@Givlaari@givosiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_0.pdf@EU-1-19-1410_h_a_dec_0.pdf@2019-12-18 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_0.pdf@EU-1-19-1414_h_a_dec_0.pdf@2020-01-13 00:00:00@Mayzent@siponimod@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1406_h_a_dec_0.pdf@EU-1-19-1406_h_a_dec_0.pdf@2019-12-16 00:00:00@Baqsimi@Glucagon@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1416_h_a_dec_0.pdf@EU-1-19-1416_h_a_dec_0.pdf@2020-03-24 00:00:00@Azacitidine Betapharm@Azacitidine@False@False@OD Not Found@betapharm Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-20-1429_h_a_dec_0.pdf@EU-1-20-1429_h_a_dec_0.pdf@2020-03-04 00:00:00@Cinacalcet Accordpharma@cinacalcet@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1421_h_a_dec_0.pdf@EU-1-19-1421_h_a_dec_0.pdf@2020-03-27 00:00:00@Staquis@crisaborole@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1424_h_a_dec_0.pdf@EU-1-20-1424_h_a_dec_0.pdf@2020-03-27 00:00:00@Nustendi@bempedoic acid / ezetimibe@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1430_h_a_dec_0.pdf@EU-1-20-1430_h_a_dec_0.pdf@2020-03-04 00:00:00@Rybelsus@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_0.pdf@EU-1-19-1417_h_a_dec_0.pdf@2020-02-13 00:00:00@Beovu@brolucizumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1431_h_a_dec_0.pdf@EU-1-20-1431_h_a_dec_0.pdf@2020-01-04 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1422_h_a_dec_0.pdf@EU-1-20-1422_h_a_dec_0.pdf@2020-03-24 00:00:00@Liumjev@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1418_h_a_dec_0.pdf@EU-1-19-1418_h_a_dec_0.pdf@2020-02-13 00:00:00@Dexmedetomidine Accord@dexmedetomidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1435_h_a_dec_0.pdf@EU-1-20-1435_h_a_dec_0.pdf@2020-05-30 00:00:00@Sarclisa@isatuximab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1432_h_a_dec_0.pdf@EU-1-20-1432_h_a_dec_0.pdf@2020-03-27 00:00:00@NUBEQA@darolutamide@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-20-1439_h_a_dec_0.pdf@EU-1-20-1439_h_a_dec_0.pdf@2020-05-30 00:00:00@Atectura Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1425_h_a_dec_0.pdf@EU-1-20-1425_h_a_dec_0.pdf@2020-01-04 00:00:00@Nilemdo@bempedoic acid@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_0.pdf@EU-1-20-1443_h_a_dec_0.pdf@2020-05-18 00:00:00@Zolgensma@onasemnogene  abeparvovec@True@False@adopted@AveXis EU Limited@conditional@Parsed
EU-1-20-1433_h_a_dec_0.pdf@EU-1-20-1433_h_a_dec_0.pdf@2020-05-20 00:00:00@Fluad Tetra@influenza vaccine (surface antigen,  inactivated, adjuvanted)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1447_h_a_dec_0.pdf@EU-1-20-1447_h_a_dec_0.pdf@2020-06-25 00:00:00@Insulin aspart Sanofi@insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1440_h_a_dec_0.pdf@EU-1-20-1440_h_a_dec_0.pdf@2020-03-07 00:00:00@Zimbus Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1452_h_a_dec_0.pdf@EU-1-20-1452_h_a_dec_0.pdf@2020-06-25 00:00:00@Reblozyl@luspatercept@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1436_h_a_dec_0.pdf@EU-1-20-1436_h_a_dec_0.pdf@2020-05-20 00:00:00@Nepexto@etanercept@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1448_h_a_dec_0.pdf@EU-1-20-1448_h_a_dec_0.pdf@2020-08-28 00:00:00@Cabazitaxel Accord@cabazitaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1441_h_a_dec_0.pdf@EU-1-20-1441_h_a_dec_0.pdf@2020-05-30 00:00:00@Bemrist Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1434_h_a_dec_0.pdf@EU-1-20-1434_h_a_dec_0.pdf@2020-04-23 00:00:00@Fetcroja@cefiderocol@True@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-20-1450_h_a_dec_0.pdf@EU-1-20-1450_h_a_dec_0.pdf@2020-06-25 00:00:00@Fingolimod Accord@fingolimod@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1444_h_a_dec_0.pdf@EU-1-20-1444_h_a_dec_0.pdf@2020-01-07 00:00:00@Zabdeno@Ebola vaccine  (Ad26.ZEBOV-GP [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1453_h_a_dec_0.pdf@EU-1-20-1453_h_a_dec_0.pdf@2020-06-18 00:00:00@Paliperidone Janssen-Cilag International@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1442_h_a_dec_0.pdf@EU-1-20-1442_h_a_dec_0.pdf@2020-05-20 00:00:00@Zeposia@ozanimod@True@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1426_h_a_dec_0.pdf@EU-1-20-1426_h_a_dec_0.pdf@2020-03-27 00:00:00@Azacitidine Mylan@Azacitidine@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1454_h_a_dec_0.pdf@EU-1-20-1454_h_a_dec_0.pdf@2020-08-19 00:00:00@Aybintio@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_0.pdf@EU-1-20-1437_h_a_dec_0.pdf@2020-07-31 00:00:00@Pretomanid FGK@pretomanid@True@False@adopted@FGK Representative Service GmbH@conditional@Parsed
EU-1-20-1460_h_a_dec_0.pdf@EU-1-20-1460_h_a_dec_0.pdf@2020-07-31 00:00:00@Rozlytrek@entrectinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1456_h_a_dec_0.pdf@EU-1-20-1456_h_a_dec_0.pdf@2020-07-27 00:00:00@Zercepac@trastuzumab@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1451_h_a_dec_0.pdf@EU-1-20-1451_h_a_dec_0.pdf@2020-06-26 00:00:00@Daurismo@glasdegib@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1445_h_a_dec_0.pdf@EU-1-20-1445_h_a_dec_0.pdf@2020-01-07 00:00:00@Mvabea@Ebola vaccine  (MVA-BN-Filo [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1455_h_a_dec_0.pdf@EU-1-20-1455_h_a_dec_0.pdf@2020-07-27 00:00:00@Piqray@alpelisib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1468_h_a_dec_0.pdf@EU-1-20-1468_h_a_dec_0.pdf@2020-08-21 00:00:00@Kaftrio@ivacaftor / tezacaftor / elexacaftor@True@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-20-1446_h_a_dec_0.pdf@EU-1-20-1446_h_a_dec_0.pdf@2020-07-31 00:00:00@Hepcludex@bulevirtide@True@False@adopted@Myr GmbH@conditional@Parsed
EU-1-20-1438_h_a_dec_0.pdf@EU-1-20-1438_h_a_dec_0.pdf@2020-03-07 00:00:00@Enerzair Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1473_h_a_dec_0.pdf@EU-1-20-1473_h_a_dec_0.pdf@2020-09-24 00:00:00@AYVAKYT@avapritinib@True@False@adopted@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1457_h_a_dec_0.pdf@EU-1-20-1457_h_a_dec_0.pdf@2020-07-27 00:00:00@Xenleta@lefamulin@True@False@OD Not Found@Nabriva Therapeutics Ireland DAC@CMA Not Found@Parsed
EU-1-20-1476_h_a_dec_0.pdf@EU-1-20-1476_h_a_dec_0.pdf@2020-10-28 00:00:00@Adakveo@crizanlizumab@True@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1469_h_a_dec_0.pdf@EU-1-20-1469_h_a_dec_0.pdf@2020-10-27 00:00:00@ARIKAYCE liposomal@amikacin@False@False@adopted@Insmed Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1462_h_a_dec_0.pdf@EU-1-20-1462_h_a_dec_0.pdf@2020-08-27 00:00:00@Livogiva@teriparatide@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-20-1458_h_a_dec_0.pdf@EU-1-20-1458_h_a_dec_0.pdf@2020-07-23 00:00:00@Apixaban Accord@apixaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1484_h_a_dec_0.pdf@EU-1-20-1484_h_a_dec_0.pdf@2020-11-16 00:00:00@Supemtek@quadrivalent influenza vaccine  (recombinant, prepared in cell culture)@True@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1480_h_a_dec_0.pdf@EU-1-20-1480_h_a_dec_0.pdf@2020-09-24 00:00:00@Jyseleca@filgotinib@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1474_h_a_dec_0.pdf@EU-1-20-1474_h_a_dec_0.pdf@2020-08-25 00:00:00@BLENREP@belantamab mafodotin@True@False@adopted@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1485_h_a_dec_0.pdf@EU-1-20-1485_h_a_dec_0.pdf@2020-11-18 00:00:00@Obiltoxaximab SFL@obiltoxaximab@True@False@adopted@the applicant@exceptional@Parsed
EU-1-20-1465_h_a_dec_0.pdf@EU-1-20-1465_h_a_dec_0.pdf@2020-08-19 00:00:00@Gencebok@caffeine citrate@False@False@OD Not Found@Gennisium Pharma@CMA Not Found@Parsed
EU-1-20-1470_h_a_dec_0.pdf@EU-1-20-1470_h_a_dec_0.pdf@2020-08-19 00:00:00@Methylthioninium chloride Cosmo@methylthioninium chloride@False@False@OD Not Found@Cosmo Technologies Ltd@CMA Not Found@Parsed
EU-1-20-1477_h_a_dec_0.pdf@EU-1-20-1477_h_a_dec_0.pdf@2020-09-24 00:00:00@Fampridine Accord@fampridine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_0.pdf@EU-1-20-1459_h_a_dec_0.pdf@2020-03-07 00:00:00@Veklury@remdesivir@True@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1486_h_a_dec_0.pdf@EU-1-20-1486_h_a_dec_0.pdf@2020-11-18 00:00:00@Nyvepria@pegfilgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1488_h_a_dec_0.pdf@EU-1-20-1488_h_a_dec_0.pdf@2020-11-16 00:00:00@Rivaroxaban Accord@rivaroxaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_0.pdf@EU-1-20-1481_h_a_dec_0.pdf@2020-12-17 00:00:00@Vocabria@cabotegravir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1487_h_a_dec_0.pdf@EU-1-20-1487_h_a_dec_0.pdf@2020-11-16 00:00:00@PHELINUN@melphalan@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-20-1471_h_a_dec_0.pdf@EU-1-20-1471_h_a_dec_0.pdf@2020-08-25 00:00:00@Idefirix@imlifidase@True@False@adopted@Hansa Biopharma AB@conditional@Parsed
EU-1-20-1478_h_a_dec_0.pdf@EU-1-20-1478_h_a_dec_0.pdf@2020-09-24 00:00:00@Zynrelef@bupivacaine/meloxicam@False@False@OD Not Found@Heron Therapeutics, B.V.@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_0.pdf@EU-1-20-1492_h_a_dec_0.pdf@2020-12-14 00:00:00@Tecartus@autologous anti-CD19-transduced  CD3+ cells@True@True@adopted@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1475_h_a_dec_0.pdf@EU-1-20-1475_h_a_dec_0.pdf@2020-09-17 00:00:00@Arsenic trioxide medac@arsenic trioxide@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-20-1482_h_a_dec_0.pdf@EU-1-20-1482_h_a_dec_0.pdf@2020-12-17 00:00:00@REKAMBYS@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1500_h_a_dec_0.pdf@EU-1-20-1500_h_a_dec_0.pdf@2021-07-01 00:00:00@Xofluza@baloxavir marboxil@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1496_h_a_dec_0.pdf@EU-1-20-1496_h_a_dec_0.pdf@2020-11-19 00:00:00@Oxlumo@lumasiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1493_h_a_dec_0.pdf@EU-1-20-1493_h_a_dec_0.pdf@2020-12-17 00:00:00@Libmeldy@autologous CD34+ cell enriched population  that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral  vector encoding the human arylsulfatase A gene@True@True@adopted@Orchard Therapeutics (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-20-1479_h_a_dec_0.pdf@EU-1-20-1479_h_a_dec_0.pdf@2020-05-11 00:00:00@Calquence@acalabrutinib@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1497_h_a_dec_0.pdf@EU-1-20-1497_h_a_dec_0.pdf@2020-12-21 00:00:00@Phesgo@pertuzumab / trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1489_h_a_dec_0.pdf@EU-1-20-1489_h_a_dec_0.pdf@2020-11-16 00:00:00@EXPAREL liposomal@bupivacaine@False@False@OD Not Found@Pacira Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1504_h_a_dec_0.pdf@EU-1-20-1504_h_a_dec_0.pdf@2021-07-01 00:00:00@ELZONRIS@tagraxofusp@True@False@adopted@Stemline Therapeutics B.V.@exceptional@Parsed
EU-1-20-1501_h_a_dec_0.pdf@EU-1-20-1501_h_a_dec_0.pdf@2021-03-31 00:00:00@Sogroya@somapacitan@True@False@adopted@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1508_h_a_dec_0.pdf@EU-1-20-1508_h_a_dec_0.pdf@2021-01-18 00:00:00@Enhertu@trastuzumab deruxtecan@True@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1494_h_a_dec_0.pdf@EU-1-20-1494_h_a_dec_0.pdf@2020-09-12 00:00:00@Leqvio@inclisiran@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1502_h_a_dec_0.pdf@EU-1-20-1502_h_a_dec_0.pdf@2021-07-01 00:00:00@Roclanda@Latanoprost / netarsudil@False@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1505_h_a_dec_0.pdf@EU-1-20-1505_h_a_dec_0.pdf@2021-03-26 00:00:00@Byfavo@remimazolam@True@False@OD Not Found@PAION Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1483_h_a_dec_0.pdf@EU-1-20-1483_h_a_dec_0.pdf@2020-11-18 00:00:00@MenQuadfi@Meningococcal group A, C, W and Y  conjugate vaccine@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1498_h_a_dec_0.pdf@EU-1-20-1498_h_a_dec_0.pdf@2020-09-12 00:00:00@TRIXEO AEROSPHERE@Formoterol /  glycopyrronium bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1490_h_a_dec_0.pdf@EU-1-20-1490_h_a_dec_0.pdf@2020-12-18 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1503_h_a_dec_0.pdf@EU-1-20-1503_h_a_dec_0.pdf@2021-02-18 00:00:00@Heplisav B@hepatitis B surface antigen@False@False@OD Not Found@Dynavax GmbH@CMA Not Found@Parsed
EU-1-20-1509_h_a_dec_0.pdf@EU-1-20-1509_h_a_dec_0.pdf@2021-03-26 00:00:00@Alymsys@bevacizumab@False@False@OD Not Found@Mabxience Research SL@CMA Not Found@Parsed
EU-1-20-1506_h_a_dec_0.pdf@EU-1-20-1506_h_a_dec_0.pdf@2021-05-02 00:00:00@Kixelle@Insulin aspart@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1512_h_a_dec_0.pdf@EU-1-20-1512_h_a_dec_0.pdf@2021-04-26 00:00:00@Abiraterone Accord@abiraterone acetate@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1495_h_a_dec_0.pdf@EU-1-20-1495_h_a_dec_0.pdf@2020-12-17 00:00:00@Palforzia@defatted powder  Arachis hypogaea L.,  semen (peanuts)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-20-1499_h_a_dec_0.pdf@EU-1-20-1499_h_a_dec_0.pdf@2021-11-01 00:00:00@Onbevzi@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1510_h_a_dec_0.pdf@EU-1-20-1510_h_a_dec_0.pdf@2021-03-26 00:00:00@Oyavas@bevacizumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-20-1517_h_a_dec_0.pdf@EU-1-20-1517_h_a_dec_0.pdf@2021-04-30 00:00:00@Sibnayal@potassium citrate/potassium hydrogen  carbonate@False@False@OD Not Found@ADVICENNE@CMA Not Found@Parsed
EU-1-20-1513_h_a_dec_0.pdf@EU-1-20-1513_h_a_dec_0.pdf@2021-11-02 00:00:00@Yuflyma@adalimumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-20-1518_h_a_dec_0.pdf@EU-1-20-1518_h_a_dec_0.pdf@2021-04-02 00:00:00@Rukobia@fostemsavir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_0.pdf@EU-1-20-1507_h_a_dec_0.pdf@2021-06-01 00:00:00@COVID-19 Vaccine Moderna@COVID-19 mRNA Vaccine (nucleoside modified)@True@False@OD Not Found@MODERNA BIOTECH SPAIN, S.L.@conditional@Parsed
EU-1-20-1491_h_a_dec_0.pdf@EU-1-20-1491_h_a_dec_0.pdf@2020-12-18 00:00:00@Fintepla@fenfluramine@False@False@adopted@Zogenix ROI Limited@CMA Not Found@Parsed
EU-1-20-1520_h_a_dec_0.pdf@EU-1-20-1520_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1524_h_a_dec_0.pdf@EU-1-20-1524_h_a_dec_0.pdf@2021-03-26 00:00:00@Vazkepa@icosapent ethyl@True@False@OD Not Found@Amarin Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1511_h_a_dec_0.pdf@EU-1-20-1511_h_a_dec_0.pdf@2021-11-02 00:00:00@Sunitinib Accord@sunitinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1519_h_a_dec_0.pdf@EU-1-20-1519_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka d.d. Novo mesto@lenalidomide@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_0.pdf@EU-1-20-1525_h_a_dec_0.pdf@2021-11-03 00:00:00@COVID-19 Vaccine Janssen@19 vaccine (Ad26.COV2-S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_0.pdf@EU-1-20-1528_h_a_dec_0.pdf@2020-12-21 00:00:00@Comirnaty@COVID-19 mRNA  Vaccine (nucleoside modified)@True@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1521_h_a_dec_0.pdf@EU-1-20-1521_h_a_dec_0.pdf@2021-12-02 00:00:00@Lenalidomide Krka d.d.@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1514_h_a_dec_0.pdf@EU-1-20-1514_h_a_dec_0.pdf@2021-08-02 00:00:00@Inrebic@fedratinib@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-21-1536_h_a_dec_0.pdf@EU-1-21-1536_h_a_dec_0.pdf@2021-03-26 00:00:00@Thiotepa Riemser@thiotepa@False@False@OD Not Found@RIEMSER Pharma GmbH@CMA Not Found@Parsed
EU-1-21-1532_h_a_dec_0.pdf@EU-1-21-1532_h_a_dec_0.pdf@2021-03-26 00:00:00@Kesimpta@ofatumumab@False@False@OD Not Found@Novartis Ireland Limited@CMA Not Found@Parsed
EU-1-20-1523_h_a_dec_0.pdf@EU-1-20-1523_h_a_dec_0.pdf@2021-11-02 00:00:00@Ogluo@glucagon@False@False@OD Not Found@Xeris Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-21-1540_h_a_dec_0.pdf@EU-1-21-1540_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accord@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1515_h_a_dec_0.pdf@EU-1-20-1515_h_a_dec_0.pdf@2021-04-21 00:00:00@Abevmy@bevacizumab@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-21-1537_h_a_dec_0.pdf@EU-1-21-1537_h_a_dec_0.pdf@2021-03-26 00:00:00@NEXPOVIO@selinexor@True@False@OD Not Found@Karyopharm Europe GmbH@conditional@Parsed
EU-1-21-1533_h_a_dec_0.pdf@EU-1-21-1533_h_a_dec_0.pdf@2021-03-26 00:00:00@Seffalair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1541_h_a_dec_0.pdf@EU-1-21-1541_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accordpharma@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1538_h_a_dec_0.pdf@EU-1-21-1538_h_a_dec_0.pdf@2021-04-21 00:00:00@JEMPERLI@dostarlimab@True@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-21-1546_h_a_dec_0.pdf@EU-1-21-1546_h_a_dec_0.pdf@2021-07-22 00:00:00@Ozawave@pitolisant@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-21-1542_h_a_dec_0.pdf@EU-1-21-1542_h_a_dec_0.pdf@2021-05-19 00:00:00@Copiktra@duvelisib@True@False@OD Not Found@Verastem Europe GmbH@CMA Not Found@Parsed
EU-1-20-1527_h_a_dec_0.pdf@EU-1-20-1527_h_a_dec_0.pdf@2021-11-02 00:00:00@Retsevmo@selpercatinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@conditional@Parsed
EU-1-21-1534_h_a_dec_0.pdf@EU-1-21-1534_h_a_dec_0.pdf@2021-03-26 00:00:00@BroPair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1550_h_a_dec_0.pdf@EU-1-21-1550_h_a_dec_0.pdf@2021-05-19 00:00:00@Ponvory@ponesimod@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-21-1547_h_a_dec_0.pdf@EU-1-21-1547_h_a_dec_0.pdf@2021-05-19 00:00:00@Drovelis@drospirenone / estetrol@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1544_h_a_dec_0.pdf@EU-1-21-1544_h_a_dec_0.pdf@2021-04-30 00:00:00@Orladeyo@berotralstat@True@False@OD Not Found@Biocryst Ireland Limited@CMA Not Found@Parsed
EU-1-21-1535_h_a_dec_0.pdf@EU-1-21-1535_h_a_dec_0.pdf@2021-03-26 00:00:00@Pemazyre@pemigatinib@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1548_h_a_dec_0.pdf@EU-1-21-1548_h_a_dec_0.pdf@2021-05-19 00:00:00@Lydisilka@drospirenone / estetrol@False@False@OD Not Found@Estetra SRL@CMA Not Found@Parsed
EU-1-21-1554_h_a_dec_0.pdf@EU-1-21-1554_h_a_dec_0.pdf@2021-06-17 00:00:00@Adtralza@tralokinumab@True@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-21-1539_h_a_dec_0.pdf@EU-1-21-1539_h_a_dec_0.pdf@2021-08-18 00:00:00@Abecma@idecabtagene vicleucel@True@True@adopted@Celgene Europe B.V.@conditional@Parsed
EU-1-21-1558_h_a_dec_0.pdf@EU-1-21-1558_h_a_dec_0.pdf@2021-07-16 00:00:00@Klisyri@tirbanibulin@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-21-1551_h_a_dec_0.pdf@EU-1-21-1551_h_a_dec_0.pdf@2021-06-17 00:00:00@Evkeeza@evinacumab@True@False@OD Not Found@Regeneron Ireland Designated Activity  Company (DAC)@exceptional@Parsed
EU-1-21-1555_h_a_dec_0.pdf@EU-1-21-1555_h_a_dec_0.pdf@2021-11-18 00:00:00@Gavreto@pralsetinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-21-1559_h_a_dec_0.pdf@EU-1-21-1559_h_a_dec_0.pdf@2021-06-24 00:00:00@Enspryng@satralizumab@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1552_h_a_dec_0.pdf@EU-1-21-1552_h_a_dec_0.pdf@2021-06-17 00:00:00@Koselugo@selumetinib@True@False@adopted@AstraZeneca AB@conditional@Parsed
EU-1-21-1562_h_a_dec_0.pdf@EU-1-21-1562_h_a_dec_0.pdf@2021-12-17 00:00:00@Xevudy@sotrovimab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-21-1560_h_a_dec_0.pdf@EU-1-21-1560_h_a_dec_0.pdf@2021-06-17 00:00:00@Celsunax@ioflupane (123I)@False@False@OD Not Found@Pinax Pharma GmbH@CMA Not Found@Parsed
EU-1-21-1553_h_a_dec_0.pdf@EU-1-21-1553_h_a_dec_0.pdf@2021-06-24 00:00:00@Abiraterone Krka@abiraterone acetate@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-21-1549_h_a_dec_0.pdf@EU-1-21-1549_h_a_dec_0.pdf@2021-05-27 00:00:00@Efmody@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
 Found@AstraZeneca AB@conditional@Parsed
EU-1-21-1566_h_a_dec_0.pdf@EU-1-21-1566_h_a_dec_0.pdf@2021-07-16 00:00:00@Bylvay@odevixibat@True@False@adopted@Albireo AB@exceptional@Parsed
EU-1-21-1556_h_a_dec_0.pdf@EU-1-21-1556_h_a_dec_0.pdf@2021-06-17 00:00:00@Onureg@azacitidine@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-21-1561_h_a_dec_0.pdf@EU-1-21-1561_h_a_dec_0.pdf@2021-07-16 00:00:00@Verquvo@vericiguat@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1564_h_a_dec_0.pdf@EU-1-21-1564_h_a_dec_0.pdf@2021-07-16 00:00:00@Imcivree@setmelanotide@True@False@adopted@Rhythm Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-21-1574_h_a_dec_0.pdf@EU-1-21-1574_h_a_dec_0.pdf@2021-08-18 00:00:00@Evrenzo@roxadustat@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1570_h_a_dec_0.pdf@EU-1-21-1570_h_a_dec_0.pdf@2021-08-26 00:00:00@Minjuvi@tafasitamab@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1557_h_a_dec_0.pdf@EU-1-21-1557_h_a_dec_0.pdf@2021-06-21 00:00:00@Jayempi@azathioprine@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-21-1565_h_a_dec_0.pdf@EU-1-21-1565_h_a_dec_0.pdf@2021-07-16 00:00:00@Ryeqo@relugolix / estradiol / norethisterone  acetate@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1575_h_a_dec_0.pdf@EU-1-21-1575_h_a_dec_0.pdf@2021-08-20 00:00:00@Bimzelx@bimekizumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-21-1578_h_a_dec_0.pdf@EU-1-21-1578_h_a_dec_0.pdf@2022-02-21 00:00:00@Ontilyv@opicapone@False@False@OD Not Found@Bial - Portela & Cª, SA@CMA Not Found@Parsed
EU-1-21-1567_h_a_dec_0.pdf@EU-1-21-1567_h_a_dec_0.pdf@2021-07-16 00:00:00@Icatibant Accord@icatibant@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1585_h_a_dec_0.pdf@EU-1-21-1585_h_a_dec_0.pdf@2021-11-15 00:00:00@Vumerity@diroximel fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1568_h_a_dec_0.pdf@EU-1-21-1568_h_a_dec_0.pdf@2021-09-22 00:00:00@Imatinib Koanaa@imatinib@False@False@OD Not Found@Koanaa Healthcare GmbH@CMA Not Found@Parsed
EU-1-21-1579_h_a_dec_0.pdf@EU-1-21-1579_h_a_dec_0.pdf@2022-06-24 00:00:00@Nexviadyme@avalglucosidase alfa@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-21-1576_h_a_dec_0.pdf@EU-1-21-1576_h_a_dec_0.pdf@2021-11-22 00:00:00@Brukinsa@zanubrutinib@True@False@OD Not Found@BeiGene Ireland Limited@CMA Not Found@Parsed
EU-1-21-1589_h_a_dec_0.pdf@EU-1-21-1589_h_a_dec_0.pdf@2021-11-15 00:00:00@Hukyndra@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1569_h_a_dec_0.pdf@EU-1-21-1569_h_a_dec_0.pdf@2021-11-18 00:00:00@QINLOCK@ripretinib@True@False@adopted@Deciphera Pharmaceuticals (Netherlands)  B.V.@CMA Not Found@Parsed
EU-1-21-1571_h_a_dec_0.pdf@EU-1-21-1571_h_a_dec_0.pdf@2021-08-20 00:00:00@Abiraterone Mylan@abiraterone acetate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1530_h_a_dec_0.pdf@EU-1-21-1530_h_a_dec_0.pdf@2021-03-26 00:00:00@Ontozry@cenobamate@True@False@OD Not Found@Arvelle Therapeutics Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1577_h_a_dec_0.pdf@EU-1-21-1577_h_a_dec_0.pdf@2021-08-26 00:00:00@Voxzogo@vosoritide@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-21-1586_h_a_dec_0.pdf@EU-1-21-1586_h_a_dec_0.pdf@2022-11-01 00:00:00@Voraxaze@glucarpidase@True@False@adopted@the applicant@exceptional@Parsed
EU-1-21-1572_h_a_dec_0.pdf@EU-1-21-1572_h_a_dec_0.pdf@2021-08-18 00:00:00@Byooviz@ranibizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-21-1590_h_a_dec_0.pdf@EU-1-21-1590_h_a_dec_0.pdf@2021-12-11 00:00:00@Libmyris@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1531_h_a_dec_0.pdf@EU-1-21-1531_h_a_dec_0.pdf@2021-03-26 00:00:00@Evrysdi@risdiplam@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1587_h_a_dec_0.pdf@EU-1-21-1587_h_a_dec_0.pdf@2022-08-17 00:00:00@RAYVOW@lasmiditan@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-21-1593_h_a_dec_0.pdf@EU-1-21-1593_h_a_dec_0.pdf@2021-09-12 00:00:00@Cibinqo@abrocitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1582_h_a_dec_0.pdf@EU-1-21-1582_h_a_dec_0.pdf@2021-11-22 00:00:00@Artesunate Amivas@artesunate@True@False@adopted@Amivas Ireland Limited@CMA Not Found@Parsed
EU-1-21-1588_h_a_dec_0.pdf@EU-1-21-1588_h_a_dec_0.pdf@2021-12-11 00:00:00@Rivaroxaban Mylan@rivaroxaban@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1573_h_a_dec_0.pdf@EU-1-21-1573_h_a_dec_0.pdf@2021-08-18 00:00:00@Fingolimod Mylan@fingolimod@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1591_h_a_dec_0.pdf@EU-1-21-1591_h_a_dec_0.pdf@2021-12-13 00:00:00@Vaxneuvance@Pneumococcal polysaccharide  conjugate vaccine (15 ‑ valent, adsorbed)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-21-1601_h_a_dec_0.pdf@EU-1-21-1601_h_a_dec_0.pdf@2021-12-11 00:00:00@Ronapreve@casirivimab / imdevimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1597_h_a_dec_0.pdf@EU-1-21-1597_h_a_dec_0.pdf@2021-12-11 00:00:00@Regkirona@regdanvimab@True@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-21-1583_h_a_dec_0.pdf@EU-1-21-1583_h_a_dec_0.pdf@2021-11-15 00:00:00@Sugammadex Mylan@sugammadex@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1605_h_a_dec_0.pdf@EU-1-21-1605_h_a_dec_0.pdf@2022-11-01 00:00:00@Tavneos@avacopan@True@False@adopted@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-21-1594_h_a_dec_0.pdf@EU-1-21-1594_h_a_dec_0.pdf@2021-09-12 00:00:00@Rybrevant@amivantamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1611_h_a_dec_0.pdf@EU-1-21-1611_h_a_dec_0.pdf@2022-03-24 00:00:00@Vildagliptin/Metformin hydrochloride Accord@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1617_h_a_dec_0.pdf@EU-1-21-1617_h_a_dec_0.pdf@2022-02-14 00:00:00@Ngenla@somatrogon@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1592_h_a_dec_0.pdf@EU-1-21-1592_h_a_dec_0.pdf@2021-11-22 00:00:00@Trodelvy@sacituzumab govitecan@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-21-1612_h_a_dec_0.pdf@EU-1-21-1612_h_a_dec_0.pdf@2022-02-14 00:00:00@Apexxnar@pneumococcal polysaccharide conjugate  vaccine (20-valent, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1602_h_a_dec_0.pdf@EU-1-21-1602_h_a_dec_0.pdf@2022-04-25 00:00:00@Uplizna@inebilizumab@True@False@adopted@Viela Bio B.V.@CMA Not Found@Parsed
EU-1-21-1606_h_a_dec_0.pdf@EU-1-21-1606_h_a_dec_0.pdf@2022-06-14 00:00:00@Yselty@linzagolix choline@True@False@OD Not Found@ObsEva Ireland Ltd.@CMA Not Found@Parsed
EU-1-21-1598_h_a_dec_0.pdf@EU-1-21-1598_h_a_dec_0.pdf@2021-09-12 00:00:00@Sitagliptin SUN@sitagliptin fumarate@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-21-1621_h_a_dec_0.pdf@EU-1-21-1621_h_a_dec_0.pdf@2022-02-14 00:00:00@OKEDI@risperidone@False@False@OD Not Found@Laboratorios Farmacéuticos Rovi, S.A.@CMA Not Found@Parsed
EU-1-21-1595_h_a_dec_0.pdf@EU-1-21-1595_h_a_dec_0.pdf@2021-12-13 00:00:00@ASPAVELI@pegcetacoplan@True@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-21-1603_h_a_dec_0.pdf@EU-1-21-1603_h_a_dec_0.pdf@2022-06-01 00:00:00@Lumykras@sotorasib@True@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-21-1615_h_a_dec_0.pdf@EU-1-21-1615_h_a_dec_0.pdf@2022-04-13 00:00:00@Padcev@enfortumab vedotin@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_0.pdf@EU-1-21-1618_h_a_dec_0.pdf@2021-12-20 00:00:00@Nuvaxovid@COVID-19 Vaccine  (recombinant, adjuvanted)@True@False@OD Not Found@Novavax CZ, a.s.@conditional@Parsed
EU-1-21-1599_h_a_dec_0.pdf@EU-1-21-1599_h_a_dec_0.pdf@2022-01-24 00:00:00@Vyepti@eptinezumab@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-21-1607_h_a_dec_0.pdf@EU-1-21-1607_h_a_dec_0.pdf@2022-11-01 00:00:00@Lonapegsomatropin Ascendis Pharma@Lonapegsomatropin@True@False@adopted@Ascendis Pharma Endocrinology Division A/S,@CMA Not Found@Parsed
EU-1-21-1596_h_a_dec_0.pdf@EU-1-21-1596_h_a_dec_0.pdf@2022-02-16 00:00:00@Tepmetko@tepotinib@True@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-21-1622_h_a_dec_0.pdf@EU-1-21-1622_h_a_dec_0.pdf@2022-02-14 00:00:00@Oxbryta@voxelotor@True@False@adopted@Global Blood Therapeutics Netherlands B.V.,@CMA Not Found@Parsed
EU-1-21-1604_h_a_dec_0.pdf@EU-1-21-1604_h_a_dec_0.pdf@2022-06-01 00:00:00@Riltrava Aerosphere@formoterol / glycopyrronium  bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-21-1619_h_a_dec_0.pdf@EU-1-21-1619_h_a_dec_0.pdf@2022-02-16 00:00:00@Sitagliptin/Metformin hydrochloride Mylan@sitagliptin/metformin hydrochloride@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1616_h_a_dec_0.pdf@EU-1-21-1616_h_a_dec_0.pdf@2022-02-16 00:00:00@Kerendia@finerenone@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1608_h_a_dec_0.pdf@EU-1-21-1608_h_a_dec_0.pdf@2022-06-01 00:00:00@Wegovy@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-22-1631_h_a_dec_0.pdf@EU-1-22-1631_h_a_dec_0.pdf@2022-04-04 00:00:00@Breyanzi@lisocabtagene maraleucel@True@True@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-21-1600_h_a_dec_0.pdf@EU-1-21-1600_h_a_dec_0.pdf@2022-06-01 00:00:00@Tecovirimat SIGA@tecovirimat@True@False@OD Not Found@SIGA Technologies Netherlands B.V.@exceptional@Parsed
EU-1-21-1620_h_a_dec_0.pdf@EU-1-21-1620_h_a_dec_0.pdf@2022-02-16 00:00:00@Sapropterin Dipharma@sapropterin@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-22-1625_h_a_dec_0.pdf@EU-1-22-1625_h_a_dec_0.pdf@2022-01-28 00:00:00@Paxlovid@trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide /  ritonavir@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-22-1632_h_a_dec_0.pdf@EU-1-22-1632_h_a_dec_0.pdf@2022-03-28 00:00:00@Stimufend@pegfilgrastim@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1635_h_a_dec_0.pdf@EU-1-22-1635_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumerate Polpharma@dimethyl  fumarate@False@False@OD Not Found@Zakłady Farmaceutyczne POLPHARMA S.A.,@CMA Not Found@Parsed
EU-1-21-1623_h_a_dec_0.pdf@EU-1-21-1623_h_a_dec_0.pdf@2022-02-14 00:00:00@Saphnelo@anifrolumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1640_h_a_dec_0.pdf@EU-1-22-1640_h_a_dec_0.pdf@2022-05-05 00:00:00@Amversio@betaine anhydrous@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-22-1644_h_a_dec_0.pdf@EU-1-22-1644_h_a_dec_0.pdf@2022-04-25 00:00:00@Inpremzia@insulin human (rDNA)@False@False@OD Not Found@Baxter Holding B.V.@CMA Not Found@Parsed
EU-1-22-1637_h_a_dec_0.pdf@EU-1-22-1637_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Neuraxpharm@dimethyl  fumarate@False@False@OD Not Found@Laboratorios Lesvi, S.L.@CMA Not Found@Parsed
EU-1-22-1628_h_a_dec_0.pdf@EU-1-22-1628_h_a_dec_0.pdf@2022-03-24 00:00:00@Sondelbay@teriparatide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1641_h_a_dec_0.pdf@EU-1-22-1641_h_a_dec_0.pdf@2022-04-25 00:00:00@PreHevbri@Hepatitis B vaccine (recombinant,  adsorbed)@False@False@OD Not Found@VBI Vaccines B.V.@CMA Not Found@Parsed
EU-1-22-1633_h_a_dec_0.pdf@EU-1-22-1633_h_a_dec_0.pdf@2022-04-25 00:00:00@Sitagliptin Accord@Sitagliptin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1648_h_a_dec_0.pdf@EU-1-22-1648_h_a_dec_0.pdf@2022-05-25 00:00:00@CARVYKTI@ciltacabtagene  autoleucel@True@True@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1645_h_a_dec_0.pdf@EU-1-22-1645_h_a_dec_0.pdf@2022-04-25 00:00:00@Vydura@rimegepant@True@False@OD Not Found@Biohaven Pharmaceutical Ireland DAC@CMA Not Found@Parsed
EU-1-22-1638_h_a_dec_0.pdf@EU-1-22-1638_h_a_dec_0.pdf@2022-04-29 00:00:00@QUVIVIQ@daridorexant@True@False@OD Not Found@Idorsia Pharmaceuticals Deutschland GmbH,@CMA Not Found@Parsed
EU-1-21-1624_h_a_dec_0.pdf@EU-1-21-1624_h_a_dec_0.pdf@2022-06-24 00:00:00@COVID-19 Vaccine (inactivated, adjuvanted)  Valneva@COVID-19 vaccine (inactivated, adjuvanted, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-22-1649_h_a_dec_0.pdf@EU-1-22-1649_h_a_dec_0.pdf@2022-03-06 00:00:00@Lunsumio@mosunetuzumab@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-22-1629_h_a_dec_0.pdf@EU-1-22-1629_h_a_dec_0.pdf@2022-05-31 00:00:00@ZOLSKETIL pegylated liposomal@doxorubicin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1642_h_a_dec_0.pdf@EU-1-22-1642_h_a_dec_0.pdf@2022-04-29 00:00:00@Orgovyx@relugolix@False@False@OD Not Found@Myovant Sciences Ireland Limited@CMA Not Found@Parsed
EU-1-22-1646_h_a_dec_0.pdf@EU-1-22-1646_h_a_dec_0.pdf@2022-05-19 00:00:00@Amifampridine SERB@amifampridine@False@False@OD Not Found@SERB S.A.@CMA Not Found@Parsed
EU-1-22-1634_h_a_dec_0.pdf@EU-1-22-1634_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Mylan@dimethyl fumarate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-22-1639_h_a_dec_0.pdf@EU-1-22-1639_h_a_dec_0.pdf@2022-04-25 00:00:00@Truvelog Mix 30@Insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-22-1630_h_a_dec_0.pdf@EU-1-22-1630_h_a_dec_0.pdf@2022-01-04 00:00:00@KIMMTRAK@tebentafusp@True@False@adopted@Immunocore Ireland Limited@CMA Not Found@Parsed
EU-1-22-1647_h_a_dec_0.pdf@EU-1-22-1647_h_a_dec_0.pdf@2022-05-24 00:00:00@Camcevi@leuprorelin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1650_h_a_dec_0.pdf@EU-1-22-1650_h_a_dec_0.pdf@2022-06-20 00:00:00@Tabrecta@capmatinib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-22-1652_h_a_dec_0.pdf@EU-1-22-1652_h_a_dec_0.pdf@2022-06-21 00:00:00@Filsuvez@birch bark extract@False@False@adopted@Amryt Pharmaceuticals DAC@CMA Not Found@Parsed
EU-1-22-1643_h_a_dec_0.pdf@EU-1-22-1643_h_a_dec_0.pdf@2022-04-25 00:00:00@Kapruvia@difelikefalin@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-22-1657_h_a_dec_0.pdf@EU-1-22-1657_h_a_dec_0.pdf@2022-07-15 00:00:00@Kinpeygo@budesonide@False@False@adopted@Calliditas Therapeutics AB@conditional@Parsed
EU-1-22-1661_h_a_dec_0.pdf@EU-1-22-1661_h_a_dec_0.pdf@2022-07-22 00:00:00@Sitagliptin/Metformin hydrochloride Accord@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1667_h_a_dec_0.pdf@EU-1-22-1667_h_a_dec_0.pdf@2022-08-17 00:00:00@VEGZELMA@bevacizumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-22-1663_h_a_dec_0.pdf@EU-1-22-1663_h_a_dec_0.pdf@2022-07-15 00:00:00@Sugammadex Fresenius Kabi@sugammadex@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1671_h_a_dec_0.pdf@EU-1-22-1671_h_a_dec_0.pdf@2022-08-17 00:00:00@Sunlenca@lenacapavir@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-22-1664_h_a_dec_0.pdf@EU-1-22-1664_h_a_dec_0.pdf@2022-07-15 00:00:00@Cevenfacta@eptacog beta (activated)@False@False@OD Not Found@Laboratoire français du Fractionnement et des  Biotechnologies@CMA Not Found@Parsed
EU-1-22-1676_h_a_dec_0.pdf@EU-1-22-1676_h_a_dec_0.pdf@2022-09-19 00:00:00@Thalidomide Lipomed@Thalidomide@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-22-1651_h_a_dec_0.pdf@EU-1-22-1651_h_a_dec_0.pdf@2022-03-25 00:00:00@EVUSHELD@tixagevimab / cilgavimab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1677_h_a_dec_0.pdf@EU-1-22-1677_h_a_dec_0.pdf@2022-09-19 00:00:00@Tezspire@tezepelumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1666_h_a_dec_0.pdf@EU-1-22-1666_h_a_dec_0.pdf@2022-09-15 00:00:00@Celdoxome pegylated liposomal@doxorubicin  hydrochloride@False@False@OD Not Found@YES Pharmaceutical Development Services  GmbH@CMA Not Found@Parsed
EU-1-22-1668_h_a_dec_0.pdf@EU-1-22-1668_h_a_dec_0.pdf@2022-08-24 00:00:00@Roctavian@valoctocogene  roxaparvovec@True@True@adopted@BioMarin International Limited@conditional@Parsed
EU-1-22-1680_h_a_dec_0.pdf@EU-1-22-1680_h_a_dec_0.pdf@2022-09-15 00:00:00@ilLuzyce@lutetium ( 177Lu) chloride@False@False@OD Not Found@Billev Pharma ApS@CMA Not Found@Parsed
EU-1-22-1673_h_a_dec_0.pdf@EU-1-22-1673_h_a_dec_0.pdf@2022-08-25 00:00:00@Ranivisio@ranibizumab@False@False@OD Not Found@Midas Pharma GmbH@CMA Not Found@Parsed
EU-1-22-1658_h_a_dec_0.pdf@EU-1-22-1658_h_a_dec_0.pdf@2022-07-15 00:00:00@Ganirelix Gedeon Richter@ganirelix@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-22-1653_h_a_dec_0.pdf@EU-1-22-1653_h_a_dec_0.pdf@2022-07-18 00:00:00@Upstaza@eladocagene  exuparvovec@True@True@adopted@PTC Therapeutics International Limited@exceptional@Parsed
EU-1-22-1681_h_a_dec_0.pdf@EU-1-22-1681_h_a_dec_0.pdf@2022-09-15 00:00:00@Amvuttra@vutrisiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1678_h_a_dec_0.pdf@EU-1-22-1678_h_a_dec_0.pdf@2022-09-15 00:00:00@Lupkynis@voclosporin@True@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1674_h_a_dec_0.pdf@EU-1-22-1674_h_a_dec_0.pdf@2022-10-08 00:00:00@Vyvgart@efgartigimod alfa@True@False@adopted@argenx BV@CMA Not Found@Parsed
EU-1-22-1685_h_a_dec_0.pdf@EU-1-22-1685_h_a_dec_0.pdf@2022-09-15 00:00:00@Mounjaro@tirzepatide@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-22-1669_h_a_dec_0.pdf@EU-1-22-1669_h_a_dec_0.pdf@2022-08-17 00:00:00@Pepaxti@melphalan flufenamide@False@False@OD Not Found@Oncopeptides AB (publ)@CMA Not Found@Parsed
EU-1-22-1655_h_a_dec_0.pdf@EU-1-22-1655_h_a_dec_0.pdf@2022-06-20 00:00:00@Pirfenidone AET@pirfenidone@False@False@OD Not Found@Alfred E. Tiefenbacher (GmbH & Co. KG)@CMA Not Found@Parsed
EU-1-22-1683_h_a_dec_0.pdf@EU-1-22-1683_h_a_dec_0.pdf@2022-09-15 00:00:00@Vabysmo@Faricimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-22-1659_h_a_dec_0.pdf@EU-1-22-1659_h_a_dec_0.pdf@2022-06-24 00:00:00@Xenpozyme@olipudase alfa@True@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-22-1656_h_a_dec_0.pdf@EU-1-22-1656_h_a_dec_0.pdf@2022-07-15 00:00:00@Ertapenem SUN@ertapenem@False@False@OD Not Found@Sun Pharmaceutical Industries Europe B.V.@CMA Not Found@Parsed
EU-1-22-1675_h_a_dec_0.pdf@EU-1-22-1675_h_a_dec_0.pdf@2022-08-23 00:00:00@TECVAYLI@teclistamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1684_h_a_dec_0.pdf@EU-1-22-1684_h_a_dec_0.pdf@2022-09-15 00:00:00@NULIBRY@fosdenopterin@True@False@adopted@the applicant@exceptional@Parsed
EU-1-22-1679_h_a_dec_0.pdf@EU-1-22-1679_h_a_dec_0.pdf@2022-09-15 00:00:00@Opdualag@nivolumab/relatlimab@True@False@OD Not Found@Bristol Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-22-1670_h_a_dec_0.pdf@EU-1-22-1670_h_a_dec_0.pdf@2022-08-25 00:00:00@Scemblix@asciminib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-96-004_h_a_dec_0.pdf@EU-1-96-004_h_a_dec_0.pdf@1996-02-14 00:00:00@FARESTON@toremifene@NAS before 2012@NA before 2012@NA before 2000@Ercopharm A/S@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_0.pdf@EU-1-96-008_h_a_dec_0.pdf@1996-05-03 00:00:00@Puregon®@Follitropin ß@NAS before 2012@NA before 2012@NA before 2000@Organon (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_0.pdf@EU-1-96-012_h_a_dec_0.pdf@Date is blank@Bondronat®@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_0.pdf@EU-1-96-020_h_a_dec_0.pdf@1996-09-20 00:00:00@TWINRIX ADULT@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-22-1660_h_a_dec_0.pdf@EU-1-22-1660_h_a_dec_0.pdf@2022-07-18 00:00:00@Zokinvy@lonafarnib@True@False@adopted@EigerBio Europe Limited@exceptional@Parsed
EU-1-96-016_h_a_dec_0.pdf@EU-1-96-016_h_a_dec_0.pdf@Date is blank@Norvir®@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_0.pdf@EU-1-96-026_h_a_dec_0.pdf@Date is blank@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_0.pdf@EU-1-96-022_h_a_dec_0.pdf@1996-09-27 00:00:00@ZYPREXA@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_0.pdf@EU-1-96-015_h_a_dec_0.pdf@1996-08-08 00:00:00@1COMMISSION DECISION   8 August 1996   granting the marketing authorization for the medicinal    product for human use,    “EPIVIR ®”@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo  Group  Ltd.@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_0.pdf@EU-1-96-010_h_a_dec_0.pdf@Date is blank@Rilutek®@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_0.pdf@EU-1-96-027_h_a_dec_0.pdf@1996-12-11 00:00:00@HYCAMTIN@Topotecan hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_0.pdf@EU-1-96-011_h_a_dec_0.pdf@1996-06-21 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Sequus Pharmaceuticals, Incorporated@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_0.pdf@EU-1-97-029_h_a_dec_0.pdf@1997-02-10 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_0.pdf@EU-1-96-007_h_a_dec_0.pdf@1996-04-30 00:00:00@HUMALOG®@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_0.pdf@EU-1-97-030_h_a_dec_0.pdf@1997-02-21 00:00:00@INSUMAN@Insulin human@NAS before 2012@NA before 2012@NA before 2000@HOECHST AG@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_0.pdf@EU-1-96-018_h_a_dec_0.pdf@1996-08-29 00:00:00@Rapilysin®@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_0.pdf@EU-1-97-033_h_a_dec_0.pdf@1997-03-13 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_0.pdf@EU-1-97-039_h_a_dec_0.pdf@1997-06-23 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_0.pdf@EU-1-97-044_h_a_dec_0.pdf@1997-08-27 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_0.pdf@EU-1-97-049_h_a_dec_0.pdf@1997-08-27 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_0.pdf@EU-1-97-053_h_a_dec_0.pdf@1997-11-17 00:00:00@CEREZYME@imiglucerase@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_0.pdf@EU-1-97-045_h_a_dec_0.pdf@1997-08-14 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@NA before 2000@INFAI@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_0.pdf@EU-1-97-057_h_a_dec_0.pdf@1998-02-05 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@NA before 2000@CIS bio international@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_0.pdf@EU-1-97-055_h_a_dec_0.pdf@1998-05-02 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_0.pdf@EU-1-97-046_h_a_dec_0.pdf@1997-08-27 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_0.pdf@EU-1-98-058_h_a_dec_0.pdf@2022-03-18 00:00:00@COMBIVIR@lamivudine/zidovudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_0.pdf@EU-1-98-063_h_a_dec_0.pdf@1998-05-04 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_0.pdf@EU-1-97-050_h_a_dec_0.pdf@1997-10-14 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_0.pdf@EU-1-98-064_h_a_dec_0.pdf@1998-07-05 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@NA before 2000@B.S.I.A. Limited@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_0.pdf@EU-1-97-047_h_a_dec_0.pdf@1997-08-27 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe, B.V.@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_0.pdf@EU-1-98-065_h_a_dec_0.pdf@1980-01-01 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@NA before 2000@MAH Not Found@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_0.pdf@EU-1-98-066_h_a_dec_0.pdf@2022-05-12 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_0.pdf@EU-1-98-069_h_a_dec_0.pdf@1998-07-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_0.pdf@EU-1-95-003_h_a_dec_0.pdf@Date is blank@BETAFERON@Interferon beta-lb@NAS before 2012@NA before 2012@NA before 2000@Schering  Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_0.pdf@EU-1-98-073_h_a_dec_0.pdf@1998-05-08 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_0.pdf@EU-1-97-051_h_a_dec_0.pdf@1998-02-23 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_0.pdf@EU-1-98-074_h_a_dec_0.pdf@1998-05-08 00:00:00@CELVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_0.pdf@EU-1-98-070_h_a_dec_0.pdf@2022-10-15 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_0.pdf@EU-1-98-076_h_a_dec_0.pdf@1998-08-17 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_0.pdf@EU-1-98-067_h_a_dec_0.pdf@1998-02-06 00:00:00@MABTHERA@Rituximab@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_0.pdf@EU-1-98-080_h_a_dec_0.pdf@1998-09-18 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@NA before 2000@Laboratoires 3M Santé@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_0.pdf@EU-1-98-084_h_a_dec_0.pdf@1998-09-10 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_0.pdf@EU-1-98-077_h_a_dec_0.pdf@1998-09-14 00:00:00@VIAGRA@sildenafil@NAS before 2012@NA before 2012@NA before 2000@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_0.pdf@EU-1-98-071_h_a_dec_0.pdf@1998-07-29 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_0.pdf@EU-1-98-081_h_a_dec_0.pdf@1998-09-22 00:00:00@COMTAN@entacapone@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_0.pdf@EU-1-98-089_h_a_dec_0.pdf@1998-11-12 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_0.pdf@EU-1-98-085_h_a_dec_0.pdf@1998-10-16 00:00:00@KARVEZIDE@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Bristol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_0.pdf@EU-1-98-082_h_a_dec_0.pdf@1998-09-16 00:00:00@COMTESS@entacapone@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_0.pdf@EU-1-99-097_h_a_dec_0.pdf@1999-04-13 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_0.pdf@EU-1-98-092_h_a_dec_0.pdf@1998-04-12 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_0.pdf@EU-1-99-103_h_a_dec_0.pdf@1999-04-13 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_0.pdf@EU-1-99-100_h_a_dec_0.pdf@1999-04-13 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@NA before 2000@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_0.pdf@EU-1-98-090_h_a_dec_0.pdf@1998-12-16 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_0.pdf@EU-1-99-107_h_a_dec_0.pdf@1999-07-05 00:00:00@REBETOL@ribavirin@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_0.pdf@EU-1-99-109_h_a_dec_0.pdf@1999-01-07 00:00:00@INTEGRILIN@Eptifibatide@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_0.pdf@EU-1-99-114_h_a_dec_0.pdf@1999-07-29 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_0.pdf@EU-1-98-086_h_a_dec_0.pdf@1998-10-15 00:00:00@COAPROVEL@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_0.pdf@EU-1-97-031_h_a_dec_0.pdf@1998-02-04 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_0.pdf@EU-1-98-095_h_a_dec_0.pdf@1999-01-27 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@NA before 2000@Alcon Laboratories (UK) Ltd@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_0.pdf@EU-1-98-091_h_a_dec_0.pdf@1998-12-16 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_0.pdf@EU-1-99-110_h_a_dec_0.pdf@1999-05-28 00:00:00@SUSTIVA@efavirenz@NAS before 2012@NA before 2012@NA before 2000@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_0.pdf@EU-1-98-096_h_a_dec_0.pdf@1999-01-26 00:00:00@TEMODAL@Temozolomide@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_0.pdf@EU-1-99-116_h_a_dec_0.pdf@1999-08-13 00:00:00@REMICADE@infliximab@NAS before 2012@NA before 2012@NA before 2000@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_0.pdf@EU-1-99-108_h_a_dec_0.pdf@1999-08-25 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@NA before 2000@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_0.pdf@EU-1-99-117_h_a_dec_0.pdf@1999-08-13 00:00:00@SYNAGIS@palivizumab@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_0.pdf@EU-1-99-122_h_a_dec_0.pdf@2000-09-03 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_0.pdf@EU-1-99-123_h_a_dec_0.pdf@2000-01-28 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_0.pdf@EU-1-99-118_h_a_dec_0.pdf@1999-02-09 00:00:00@ARAVA@leflunomide@NAS before 2012@NA before 2012@NA before 2000@Hoechst marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_0.pdf@EU-1-99-125_h_a_dec_0.pdf@2000-03-02 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_0.pdf@EU-1-99-124_h_a_dec_0.pdf@2000-01-20 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@NA before 2000@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_0.pdf@EU-1-99-126_h_a_dec_0.pdf@2000-03-02 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@NA before 2000@Wyeth Research (UK) Limited@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_0.pdf@EU-1-99-119_h_a_dec_0.pdf@1999-07-09 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_0.pdf@EU-1-99-111_h_a_dec_0.pdf@1999-05-28 00:00:00@STOCRIN@efavirenz@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_0.pdf@EU-1-99-120_h_a_dec_0.pdf@1999-08-12 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_0.pdf@EU-1-99-112_h_a_dec_0.pdf@1999-08-07 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_0.pdf@EU-1-00-130_h_a_dec_0.pdf@2000-05-17 00:00:00@Orgalutran@Ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_0.pdf@EU-1-00-129_h_a_dec_0.pdf@2000-09-03 00:00:00@Azopt@brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_0.pdf@EU-1-00-140_h_a_dec_0.pdf@2000-07-27 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@CIBA Vision Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_0.pdf@EU-1-00-142_h_a_dec_0.pdf@2000-01-08 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_0.pdf@EU-1-00-141_h_a_dec_0.pdf@2000-07-13 00:00:00@MYOCET@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@The Liposome Company Ltd@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_0.pdf@EU-1-00-133_h_a_dec_0.pdf@2000-06-27 00:00:00@OPTISULIN insulin glargine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_0.pdf@EU-1-00-143_h_a_dec_0.pdf@2000-04-08 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@NA before 2000@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_0.pdf@EU-1-00-134_h_a_dec_0.pdf@2000-09-06 00:00:00@Lantus@insulin glargin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_0.pdf@EU-1-00-135_h_a_dec_0.pdf@2000-07-27 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_0.pdf@EU-1-00-145_h_a_dec_0.pdf@2000-08-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_0.pdf@EU-1-00-149_h_a_dec_0.pdf@2000-11-10 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_0.pdf@EU-1-00-146_h_a_dec_0.pdf@2000-09-29 00:00:00@Keppra@levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_0.pdf@EU-1-00-150_h_a_dec_0.pdf@2000-10-13 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_0.pdf@EU-1-00-152_h_a_dec_0.pdf@2000-10-23 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae   type b vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_0.pdf@EU-1-00-155_h_a_dec_0.pdf@2000-11-29 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd.@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_0.pdf@EU-1-00-156_h_a_dec_0.pdf@2000-12-28 00:00:00@TRIZIVIR@abacavir / lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_0.pdf@EU-1-00-157_h_a_dec_0.pdf@2001-01-15 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_0.pdf@EU-1-00-160_h_a_dec_0.pdf@2001-01-15 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-162_h_a_dec_0.pdf@EU-1-00-162_h_a_dec_0.pdf@2001-01-29 00:00:00@Prandin@repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_0.pdf@EU-1-00-161_h_a_dec_0.pdf@2001-01-15 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_0.pdf@EU-1-00-163_h_a_dec_0.pdf@2001-02-02 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_0.pdf@EU-1-00-164_h_a_dec_0.pdf@2001-02-16 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_0.pdf@EU-1-00-165_h_a_dec_0.pdf@2001-02-02 00:00:00@OVIDRELLE@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_0.pdf@EU-1-00-166_h_a_dec_0.pdf@2001-01-22 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_0.pdf@EU-1-00-169_h_a_dec_0.pdf@2001-02-23 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_0.pdf@EU-1-00-170_h_a_dec_0.pdf@2001-02-23 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_0.pdf@EU-1-01-171_h_a_dec_0.pdf@2001-03-13 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-173_h_a_dec_0.pdf@EU-1-01-173_h_a_dec_0.pdf@2001-03-20 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_0.pdf@EU-1-01-172_h_a_dec_0.pdf@2001-03-20 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_0.pdf@EU-1-01-176_h_a_dec_0.pdf@2001-03-20 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-177_h_a_dec_0.pdf@EU-1-01-177_h_a_dec_0.pdf@2001-03-26 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_0.pdf@EU-1-01-178_h_a_dec_0.pdf@2001-03-29 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_0.pdf@EU-1-01-183_h_a_dec_0.pdf@2001-04-27 00:00:00@HBVAXPRO@Hepatitis B (Recombinant) vaccine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_0.pdf@EU-1-01-185_h_a_dec_0.pdf@2001-08-06 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_0.pdf@EU-1-01-188_h_a_dec_0.pdf@2001-03-08 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@adopted@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_0.pdf@EU-1-01-189_h_a_dec_0.pdf@2001-03-08 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@adopted@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-190_h_a_dec_0.pdf@EU-1-01-190_h_a_dec_0.pdf@2001-07-16 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_0.pdf@EU-1-01-194_h_a_dec_0.pdf@2001-01-08 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_0.pdf@EU-1-01-196_h_a_dec_0.pdf@2001-10-24 00:00:00@Caspofungin MSD@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_0.pdf@EU-1-01-198_h_a_dec_0.pdf@2001-07-11 00:00:00@Glivec@imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_0.pdf@EU-1-01-195_h_a_dec_0.pdf@2001-01-08 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_0.pdf@EU-1-01-200_h_a_dec_0.pdf@2002-05-02 00:00:00@Viread@Tenofovir disoproxil (as fumarate)@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-197_h_a_dec_0.pdf@EU-1-01-197_h_a_dec_0.pdf@2001-10-24 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Scotia Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_0.pdf@EU-1-02-203_h_a_dec_0.pdf@2002-08-03 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_0.pdf@EU-1-02-204_h_a_dec_0.pdf@2002-05-03 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_0.pdf@EU-1-02-206_h_a_dec_0.pdf@2002-03-21 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-205_h_a_dec_0.pdf@EU-1-02-205_h_a_dec_0.pdf@2002-08-03 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_0.pdf@EU-1-02-209_h_a_dec_0.pdf@2002-03-22 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_0.pdf@EU-1-02-201_h_a_dec_0.pdf@2002-02-28 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_0.pdf@EU-1-01-199_h_a_dec_0.pdf@2001-11-27 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_0.pdf@EU-1-02-212_h_a_dec_0.pdf@2002-03-19 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_0.pdf@EU-1-02-214_h_a_dec_0.pdf@2002-04-19 00:00:00@BolusacPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-216_h_a_dec_0.pdf@EU-1-02-216_h_a_dec_0.pdf@2002-04-18 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_0.pdf@EU-1-02-218_h_a_dec_0.pdf@2002-05-17 00:00:00@Memantine Merz Pharmaceuticals GmbH@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_0.pdf@EU-1-02-220_h_a_dec_0.pdf@2002-05-15 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-224_h_a_dec_0.pdf@EU-1-02-224_h_a_dec_0.pdf@2002-08-30 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_0.pdf@EU-1-02-226_h_a_dec_0.pdf@2002-09-09 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_0.pdf@EU-1-02-219_h_a_dec_0.pdf@2002-05-15 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_0.pdf@EU-1-02-215_h_a_dec_0.pdf@2002-04-22 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_0.pdf@EU-1-02-229_h_a_dec_0.pdf@2002-07-10 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_0.pdf@EU-1-02-227_h_a_dec_0.pdf@2002-08-22 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_0.pdf@EU-1-02-221_h_a_dec_0.pdf@2002-06-20 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_0.pdf@EU-1-02-233_h_a_dec_0.pdf@2002-07-10 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_0.pdf@EU-1-02-240_h_a_dec_0.pdf@2002-11-13 00:00:00@ Somavert Pegvisomant @Active Substance Not Found@NAS before 2012@NA before 2012@adopted@Pharmacia Enterprises S.A@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_0.pdf@EU-1-02-237_h_a_dec_0.pdf@2002-12-11 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-246_h_a_dec_0.pdf@EU-1-02-246_h_a_dec_0.pdf@2003-01-24 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_0.pdf@EU-1-02-213_h_a_dec_0.pdf@2002-04-19 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_0.pdf@EU-1-03-251_h_a_dec_0.pdf@2003-06-03 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_0.pdf@EU-1-03-247_h_a_dec_0.pdf@2003-10-06 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_0.pdf@EU-1-02-230_h_a_dec_0.pdf@2002-07-10 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_0.pdf@EU-1-02-238_h_a_dec_0.pdf@2002-11-20 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@adopted@Oxford GlycoSciences (UK) Ltd@CMA not available before 2006@Parsed
EU-1-02-234_h_a_dec_0.pdf@EU-1-02-234_h_a_dec_0.pdf@2002-07-10 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_0.pdf@EU-1-03-248_h_a_dec_0.pdf@2003-06-03 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_0.pdf@EU-1-03-252_h_a_dec_0.pdf@2003-05-27 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_0.pdf@EU-1-03-260_h_a_dec_0.pdf@2003-10-17 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_0.pdf@EU-1-03-254_h_a_dec_0.pdf@2003-09-07 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@adopted@Pierre Fabre Médicament@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_0.pdf@EU-1-02-231_h_a_dec_0.pdf@2002-07-10 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_0.pdf@EU-1-03-255_h_a_dec_0.pdf@2003-09-16 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@adopted@Schering AG@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_0.pdf@EU-1-03-253_h_a_dec_0.pdf@2003-10-06 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_0.pdf@EU-1-03-262_h_a_dec_0.pdf@2003-11-11 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_0.pdf@EU-1-03-249_h_a_dec_0.pdf@2003-04-03 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_0.pdf@EU-1-03-261_h_a_dec_0.pdf@2003-10-24 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_0.pdf@EU-1-03-256_h_a_dec_0.pdf@2003-08-09 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_0.pdf@EU-1-02-222_h_a_dec_0.pdf@2002-06-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_0.pdf@EU-1-03-267_h_a_dec_0.pdf@2004-02-03 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-03-263_h_a_dec_0.pdf@EU-1-03-263_h_a_dec_0.pdf@2004-04-28 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@NA before 2012@OD Not Found@SBL Vaccin AB@CMA not available before 2006@Parsed
EU-1-03-270_h_a_dec_0.pdf@EU-1-03-270_h_a_dec_0.pdf@2004-06-15 00:00:00@Oxybutynin Nicobrand@Oxybutynin@NAS before 2012@NA before 2012@OD Not Found@Nicobrand Limited@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_0.pdf@EU-1-04-274_h_a_dec_0.pdf@2004-04-26 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@appointed@Millenium Pharmaceuticals, Ltd@CMA not available before 2006@Parsed
EU-1-04-278_h_a_dec_0.pdf@EU-1-04-278_h_a_dec_0.pdf@2004-01-06 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_0.pdf@EU-1-03-264_h_a_dec_0.pdf@2004-01-16 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-271_h_a_dec_0.pdf@EU-1-03-271_h_a_dec_0.pdf@2004-02-03 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-03-265_h_a_dec_0.pdf@EU-1-03-265_h_a_dec_0.pdf@2004-02-23 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@appointed@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-04-275_h_a_dec_0.pdf@EU-1-04-275_h_a_dec_0.pdf@2004-04-14 00:00:00@Litak@Cladribine@NAS before 2012@NA before 2012@adopted@Lipomed GmbH@CMA not available before 2006@Parsed
EU-1-02-223_h_a_dec_0.pdf@EU-1-02-223_h_a_dec_0.pdf@2002-08-22 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_0.pdf@EU-1-04-276_h_a_dec_0.pdf@2004-04-06 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_0.pdf@EU-1-04-279_h_a_dec_0.pdf@2004-06-07 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-282_h_a_dec_0.pdf@EU-1-04-282_h_a_dec_0.pdf@2004-12-07 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-273_h_a_dec_0.pdf@EU-1-04-273_h_a_dec_0.pdf@2004-04-28 00:00:00@Lysodren@Mitotane@NAS before 2012@NA before 2012@adopted@Laboratoire HRA Pharma@CMA not available before 2006@Parsed
EU-1-03-268_h_a_dec_0.pdf@EU-1-03-268_h_a_dec_0.pdf@2004-10-03 00:00:00@Cholestagel@colesevelam hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-04-286_h_a_dec_0.pdf@EU-1-04-286_h_a_dec_0.pdf@2004-10-13 00:00:00@Wilzin@Zinc acetate dihydrate@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-04-290_h_a_dec_0.pdf@EU-1-04-290_h_a_dec_0.pdf@2004-09-20 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-03-269_h_a_dec_0.pdf@EU-1-03-269_h_a_dec_0.pdf@2004-10-03 00:00:00@Faslodex@Fulvestrant@NAS before 2012@NA before 2012@OD Not Found@AstraZeneca UK Limited@CMA not available before 2006@Parsed
EU-1-04-294_h_a_dec_0.pdf@EU-1-04-294_h_a_dec_0.pdf@2004-10-22 00:00:00@EMSELEX@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-298_h_a_dec_0.pdf@EU-1-04-298_h_a_dec_0.pdf@2004-12-17 00:00:00@Kivexa@abacavir / lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-04-295_h_a_dec_0.pdf@EU-1-04-295_h_a_dec_0.pdf@2004-11-16 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@adopted@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-04-292_h_a_dec_0.pdf@EU-1-04-292_h_a_dec_0.pdf@2004-10-22 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-04-296_h_a_dec_0.pdf@EU-1-04-296_h_a_dec_0.pdf@2004-12-17 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-284_h_a_dec_0.pdf@EU-1-04-284_h_a_dec_0.pdf@2004-07-29 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-04-299_h_a_dec_0.pdf@EU-1-04-299_h_a_dec_0.pdf@2005-02-02 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-04-285_h_a_dec_0.pdf@EU-1-04-285_h_a_dec_0.pdf@2004-09-27 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-04-280_h_a_dec_0.pdf@EU-1-04-280_h_a_dec_0.pdf@2004-11-08 00:00:00@YENTREVE@Duloxetine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_0.pdf@EU-1-04-300_h_a_dec_0.pdf@2005-12-01 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-04-302_h_a_dec_0.pdf@EU-1-04-302_h_a_dec_0.pdf@2005-02-21 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@adopted@Elan Pharma International Ltd@CMA not available before 2006@Parsed
EU-1-04-306_h_a_dec_0.pdf@EU-1-04-306_h_a_dec_0.pdf@2005-03-22 00:00:00@Aloxi@Palonosetron@NAS before 2012@NA before 2012@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA not available before 2006@Parsed
EU-1-04-307_h_a_dec_0.pdf@EU-1-04-307_h_a_dec_0.pdf@2005-10-03 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_0.pdf@EU-1-04-281_h_a_dec_0.pdf@2004-06-29 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA not available before 2006@Parsed
EU-1-04-277_h_a_dec_0.pdf@EU-1-04-277_h_a_dec_0.pdf@2004-08-06 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA not available before 2006@Parsed
EU-1-04-303_h_a_dec_0.pdf@EU-1-04-303_h_a_dec_0.pdf@2005-02-21 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@adopted@Swedish Orphan International AB@CMA not available before 2006@Parsed
EU-1-05-311_h_a_dec_0.pdf@EU-1-05-311_h_a_dec_0.pdf@2005-09-19 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-05-315_h_a_dec_0.pdf@EU-1-05-315_h_a_dec_0.pdf@2005-10-25 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-05-319_h_a_dec_0.pdf@EU-1-05-319_h_a_dec_0.pdf@2005-10-25 00:00:00@Xolair@omalizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-304_h_a_dec_0.pdf@EU-1-04-304_h_a_dec_0.pdf@2005-02-21 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA not available before 2006@Parsed
EU-1-05-323_h_a_dec_0.pdf@EU-1-05-323_h_a_dec_0.pdf@2006-06-04 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_0.pdf@EU-1-04-305_h_a_dec_0.pdf@2005-02-21 00:00:00@Truvada@Emtricitabine / Tenofovir Disoproxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-05-308_h_a_dec_0.pdf@EU-1-05-308_h_a_dec_0.pdf@2005-04-15 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-05-312_h_a_dec_0.pdf@EU-1-05-312_h_a_dec_0.pdf@2005-10-13 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@adopted@UCB Pharma Ltd.@CMA not available before 2006@Parsed
EU-1-05-324_h_a_dec_0.pdf@EU-1-05-324_h_a_dec_0.pdf@2006-01-24 00:00:00@Naglazyme@Recombinant human N-acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@NA before 2012@adopted@BioMarin Europe Limited@exceptional@Parsed
EU-1-05-310_h_a_dec_0.pdf@EU-1-05-310_h_a_dec_0.pdf@2005-08-24 00:00:00@FOSAVANCE@Alendronate Sodium / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-05-320_h_a_dec_0.pdf@EU-1-05-320_h_a_dec_0.pdf@2005-10-25 00:00:00@Noxafil@Posaconazole@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-05-328_h_a_dec_0.pdf@EU-1-05-328_h_a_dec_0.pdf@2006-01-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Limited@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_0.pdf@EU-1-05-331_h_a_dec_0.pdf@2006-02-15 00:00:00@Neupro@Rotigotine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_0.pdf@EU-1-05-316_h_a_dec_0.pdf@2005-10-25 00:00:00@Procoralan@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-06-336_h_a_dec_0.pdf@EU-1-06-336_h_a_dec_0.pdf@2006-04-24 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_0.pdf@EU-1-06-340_h_a_dec_0.pdf@2006-05-19 00:00:00@Ganfort@bimatoprost/timolol@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_0.pdf@EU-1-05-317_h_a_dec_0.pdf@2005-10-25 00:00:00@Corlentor@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-06-337_h_a_dec_0.pdf@EU-1-06-337_h_a_dec_0.pdf@2006-05-05 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_0.pdf@EU-1-05-322_h_a_dec_0.pdf@2006-01-19 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@NA before 2012@OD Not Found@AEA Technology QSA GmbH@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_0.pdf@EU-1-06-343_h_a_dec_0.pdf@2006-06-26 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_0.pdf@EU-1-05-329_h_a_dec_0.pdf@2006-01-19 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_0.pdf@EU-1-06-341_h_a_dec_0.pdf@2006-05-19 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_0.pdf@EU-1-06-347_h_a_dec_0.pdf@2006-07-19 00:00:00@SUTENT@sunitinib@NAS before 2012@NA before 2012@adopted@Pfizer Ltd@conditional@Parsed
EU-1-06-338_h_a_dec_0.pdf@EU-1-06-338_h_a_dec_0.pdf@2006-04-24 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_0.pdf@EU-1-05-318_h_a_dec_0.pdf@2005-10-28 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@adopted@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-05-330_h_a_dec_0.pdf@EU-1-05-330_h_a_dec_0.pdf@2006-02-21 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_0.pdf@EU-1-06-354_h_a_dec_0.pdf@2006-07-28 00:00:00@Competact@Pioglitazone /  metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_0.pdf@EU-1-06-342_h_a_dec_0.pdf@2006-07-19 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@adopted@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_0.pdf@EU-1-06-346_h_a_dec_0.pdf@2006-06-27 00:00:00@Tysabri@Natalizumab@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_0.pdf@EU-1-06-356_h_a_dec_0.pdf@2006-08-28 00:00:00@Exjade@deferasirox@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_0.pdf@EU-1-06-359_h_a_dec_0.pdf@2006-09-26 00:00:00@Suboxone@buprenorphine /  naloxone@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_0.pdf@EU-1-06-363_h_a_dec_0.pdf@2006-11-20 00:00:00@Sprycel@Dasatinib@NAS before 2012@NA before 2012@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_0.pdf@EU-1-06-367_h_a_dec_0.pdf@2007-04-01 00:00:00@Diacomit@Stiripentol@NAS before 2012@NA before 2012@adopted@Biocodex@conditional@Parsed
EU-1-06-332_h_a_dec_0.pdf@EU-1-06-332_h_a_dec_0.pdf@2006-12-04 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_0.pdf@EU-1-06-348_h_a_dec_0.pdf@2006-06-27 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_0.pdf@EU-1-06-360_h_a_dec_0.pdf@2006-09-26 00:00:00@Champix@varenicline tartrate@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_0.pdf@EU-1-06-371_h_a_dec_0.pdf@2007-01-16 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_0.pdf@EU-1-06-370_h_a_dec_0.pdf@2007-01-17 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_0.pdf@EU-1-06-350_h_a_dec_0.pdf@2006-07-28 00:00:00@Savene@Dexrazoxane@NAS before 2012@NA before 2012@adopted@TopoTarget A/S@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_0.pdf@EU-1-06-357_h_a_dec_0.pdf@2006-09-20 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_0.pdf@EU-1-06-333_h_a_dec_0.pdf@2006-03-29 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_0.pdf@EU-1-06-376_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_0.pdf@EU-1-06-361_h_a_dec_0.pdf@2006-09-20 00:00:00@Luminity@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_0.pdf@EU-1-06-372_h_a_dec_0.pdf@2007-01-16 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_0.pdf@EU-1-06-334_h_a_dec_0.pdf@2006-05-29 00:00:00@Evoltra@clofarabine@NAS before 2012@NA before 2012@adopted@Bioenvision Limited@exceptional@Parsed
EU-1-06-379_h_a_dec_0.pdf@EU-1-06-379_h_a_dec_0.pdf@2007-02-15 00:00:00@Cystadane@Betaine anhydrous@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_0.pdf@EU-1-06-362_h_a_dec_0.pdf@2006-11-20 00:00:00@BYETTA@exenatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_0.pdf@EU-1-06-364_h_a_dec_0.pdf@2007-04-01 00:00:00@ADROVANCE@Alendronate sodium  / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_0.pdf@EU-1-06-380_h_a_dec_0.pdf@2007-12-02 00:00:00@Prezista@darunavir”, a  medicinal product for human use  (Text with EEA relevance)   THE COMMISSION OF THE EUROPEAN COMMUNITIES,  Having regard to the Treaty establishing the European Community,     Having regard to Regulation (EC) No 726/2004  the European Parliament and  the  Council  31 March 2004 laying down Community procedures for the authorisation and  supervision  medicinal products for human and veterinary use and establishing a  European Medicines Agency 1, and in particular Article 10(2) and 14(7) thereof, Having regard to Commission Regulation (EC) No 507/2006 on the conditional  marketing authorisation for medicinal products for human use falling within the scope   Regulation (EC) No 726/2004  the European Parliament and  the Council 2, Having regard to the application submitted by Janssen-Cilag International NV on 1  February 2006 under Article 4(1)  Regulation (EC) No 726/2004,   Having regard to the opinion  the European Medicines Agency, formulated by the  Committee for Medicinal Products for Human Use on 14 December 2006,   Whereas:   (1)@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-07-383_h_a_dec_0.pdf@EU-1-07-383_h_a_dec_0.pdf@2007-03-21 00:00:00@Januvia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_0.pdf@EU-1-07-387_h_a_dec_0.pdf@2007-04-23 00:00:00@Advagraf@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_0.pdf@EU-1-06-374_h_a_dec_0.pdf@2007-01-22 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_0.pdf@EU-1-06-377_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_0.pdf@EU-1-06-365_h_a_dec_0.pdf@2007-08-01 00:00:00@Elaprase@Idursulfase@NAS before 2012@NA before 2012@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-07-391_h_a_dec_0.pdf@EU-1-07-391_h_a_dec_0.pdf@2007-06-14 00:00:00@Revlimid@lenalidomide@NAS before 2012@NA before 2012@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_0.pdf@EU-1-06-366_h_a_dec_0.pdf@2007-08-01 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_0.pdf@EU-1-07-389_h_a_dec_0.pdf@2007-05-21 00:00:00@ORENCIA@abatacept@NAS before 2012@NA before 2012@OD Not Found@BRISTOL MYERS SQUIBB PHARMA  EEIG@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_0.pdf@EU-1-07-386_h_a_dec_0.pdf@2007-04-20 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_0.pdf@EU-1-07-395_h_a_dec_0.pdf@2007-06-25 00:00:00@Invega@paliperidone@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_0.pdf@EU-1-07-399_h_a_dec_0.pdf@2007-07-30 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_0.pdf@EU-1-07-403_h_a_dec_0.pdf@2007-08-22 00:00:00@Atriance@nelarabine@NAS before 2012@NA before 2012@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-400_h_a_dec_0.pdf@EU-1-07-400_h_a_dec_0.pdf@2007-07-20 00:00:00@MIRCERA@methoxy polyethylene glycol-epoetin  beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_0.pdf@EU-1-07-410_h_a_dec_0.pdf@2007-08-28 00:00:00@Binocrit@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_0.pdf@EU-1-06-378_h_a_dec_0.pdf@2007-01-16 00:00:00@Inovelon@Rufinamide@NAS before 2012@NA before 2012@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_0.pdf@EU-1-07-404_h_a_dec_0.pdf@2007-08-23 00:00:00@Flebogammadif@human normal  immunoglobulin@NAS before 2012@NA before 2012@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_0.pdf@EU-1-07-396_h_a_dec_0.pdf@2007-06-25 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_0.pdf@EU-1-07-405_h_a_dec_0.pdf@2007-08-22 00:00:00@Rasilez@aliskiren@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_0.pdf@EU-1-07-382_h_a_dec_0.pdf@2007-03-21 00:00:00@Xelevia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_0.pdf@EU-1-07-411_h_a_dec_0.pdf@2007-08-28 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@HEXAL Biotech ForschungsGmbH@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_0.pdf@EU-1-07-397_h_a_dec_0.pdf@2007-06-29 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@NA before 2012@adopted@OTL Pharma/Addmedica@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_0.pdf@EU-1-07-392_h_a_dec_0.pdf@2007-06-29 00:00:00@Circadin@melatonin@NAS before 2012@NA before 2012@OD Not Found@Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_0.pdf@EU-1-07-415_h_a_dec_0.pdf@2007-09-27 00:00:00@Zalasta@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_0.pdf@EU-1-07-401_h_a_dec_0.pdf@2007-07-23 00:00:00@Orlistat GSK@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_0.pdf@EU-1-07-419_h_a_dec_0.pdf@2007-09-20 00:00:00@Cervarix@16 and Human Papilloma Virus 18 L1 proteins@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_0.pdf@EU-1-07-393_h_a_dec_0.pdf@2007-06-20 00:00:00@Soliris@Eculizumab@NAS before 2012@NA before 2012@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_0.pdf@EU-1-07-423_h_a_dec_0.pdf@2007-03-12 00:00:00@Vectibix@panitumumab@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-402_h_a_dec_0.pdf@EU-1-07-402_h_a_dec_0.pdf@2007-03-08 00:00:00@INCRELEX@Mecasermin@NAS before 2012@NA before 2012@adopted@Tercica Europe Limited@exceptional@Parsed
EU-1-07-427_h_a_dec_0.pdf@EU-1-07-427_h_a_dec_0.pdf@2007-12-12 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_0.pdf@EU-1-07-420_h_a_dec_0.pdf@2007-11-23 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@NA before 2012@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_0.pdf@EU-1-07-412_h_a_dec_0.pdf@2007-08-28 00:00:00@Abseamed@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_0.pdf@EU-1-07-432_h_a_dec_0.pdf@2007-12-18 00:00:00@Silapo@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_0.pdf@EU-1-07-424_h_a_dec_0.pdf@2007-11-19 00:00:00@TORISEL@Temsirolimus@NAS before 2012@NA before 2012@adopted@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_0.pdf@EU-1-07-422_h_a_dec_0.pdf@2007-11-19 00:00:00@Tasigna@Nilotinib@NAS before 2012@NA before 2012@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_0.pdf@EU-1-07-416_h_a_dec_0.pdf@2007-09-20 00:00:00@ECALTA@anidulafungin@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_0.pdf@EU-1-07-436_h_a_dec_0.pdf@2007-12-20 00:00:00@ISENTRESS@raltegravir@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Limited@conditional@Parsed
EU-1-07-417_h_a_dec_0.pdf@EU-1-07-417_h_a_dec_0.pdf@2007-09-17 00:00:00@Yondelis@Trabectedin@NAS before 2012@NA before 2012@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-425_h_a_dec_0.pdf@EU-1-07-425_h_a_dec_0.pdf@2007-11-14 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_0.pdf@EU-1-07-433_h_a_dec_0.pdf@2007-11-12 00:00:00@NEVANAC@nepafenac@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_0.pdf@EU-1-07-428_h_a_dec_0.pdf@2008-01-14 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_0.pdf@EU-1-07-418_h_a_dec_0.pdf@2007-09-17 00:00:00@CELSENTRI@maraviroc@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_0.pdf@EU-1-07-440_h_a_dec_0.pdf@2008-10-06 00:00:00@Tyverb@lapatinib@NAS before 2012@True@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-434_h_a_dec_0.pdf@EU-1-07-434_h_a_dec_0.pdf@2008-11-01 00:00:00@Avamys@Flucticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_0.pdf@EU-1-07-413_h_a_dec_0.pdf@2007-07-09 00:00:00@Gliolan@5-aminolevulinic acid hydrochloride@NAS before 2012@NA before 2012@adopted@Medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_0.pdf@EU-1-07-437_h_a_dec_0.pdf@2008-11-01 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_0.pdf@EU-1-08-444_h_a_dec_0.pdf@2008-09-15 00:00:00@Ratiograstim@filgrastim@NAS before 2012@True@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_0.pdf@EU-1-07-435_h_a_dec_0.pdf@2008-10-01 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_0.pdf@EU-1-07-414_h_a_dec_0.pdf@2007-09-26 00:00:00@Galvus@vildagliptin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_0.pdf@EU-1-07-431_h_a_dec_0.pdf@2007-12-18 00:00:00@Retacrit@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_0.pdf@EU-1-07-438_h_a_dec_0.pdf@2008-02-21 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_0.pdf@EU-1-08-441_h_a_dec_0.pdf@2008-04-04 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_0.pdf@EU-1-08-445_h_a_dec_0.pdf@2008-09-15 00:00:00@Tevagrastim@filgrastim@NAS before 2012@True@OD Not Found@Teva Generics GmbH@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_0.pdf@EU-1-08-448_h_a_dec_0.pdf@2008-04-25 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_0.pdf@EU-1-08-454_h_a_dec_0.pdf@2008-05-20 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_0.pdf@EU-1-07-439_h_a_dec_0.pdf@2008-02-21 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_0.pdf@EU-1-08-446_h_a_dec_0.pdf@2008-04-25 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_0.pdf@EU-1-08-456_h_a_dec_0.pdf@2008-07-16 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_0.pdf@EU-1-08-461_h_a_dec_0.pdf@2008-11-07 00:00:00@Firazyr@icatibant@NAS before 2012@True@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_0.pdf@EU-1-08-442_h_a_dec_0.pdf@2008-03-18 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_0.pdf@EU-1-08-455_h_a_dec_0.pdf@2008-07-16 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_0.pdf@EU-1-08-451_h_a_dec_0.pdf@2008-04-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_0.pdf@EU-1-08-447_h_a_dec_0.pdf@2008-04-21 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Ipsen Manufacturing Ireland Ltd (IMIL),@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_0.pdf@EU-1-08-462_h_a_dec_0.pdf@2008-09-07 00:00:00@Latixa@ranolazine@NAS before 2012@True@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_0.pdf@EU-1-08-465_h_a_dec_0.pdf@2008-07-16 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_0.pdf@EU-1-08-457_h_a_dec_0.pdf@2008-07-16 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_0.pdf@EU-1-08-468_h_a_dec_0.pdf@2008-08-28 00:00:00@INTELENCE@etravirine@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-476_h_a_dec_0.pdf@EU-1-08-476_h_a_dec_0.pdf@2008-01-10 00:00:00@Tadalafil Lilly@tadalafil@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_0.pdf@EU-1-08-472_h_a_dec_0.pdf@2008-09-30 00:00:00@Xarelto@rivaroxaban@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_0.pdf@EU-1-08-463_h_a_dec_0.pdf@2008-02-07 00:00:00@RELISTOR@methylnaltrexone  bromide@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_0.pdf@EU-1-08-466_h_a_dec_0.pdf@2008-07-25 00:00:00@Bridion@sugammadex@NAS before 2012@True@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_0.pdf@EU-1-08-477_h_a_dec_0.pdf@2008-07-10 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@True@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-480_h_a_dec_0.pdf@EU-1-08-480_h_a_dec_0.pdf@2008-01-12 00:00:00@Irbesartan Krka@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_0.pdf@EU-1-08-484_h_a_dec_0.pdf@2008-01-12 00:00:00@Vildagliptin/metformin  hydrochloride Novartis@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_0.pdf@EU-1-08-479_h_a_dec_0.pdf@2008-11-19 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_0.pdf@EU-1-08-490_h_a_dec_0.pdf@2008-12-18 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_0.pdf@EU-1-08-443_h_a_dec_0.pdf@2008-04-16 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@adopted@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_0.pdf@EU-1-08-469_h_a_dec_0.pdf@2008-12-09 00:00:00@Oprymea@Pramipexole@NAS before 2012@True@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_0.pdf@EU-1-08-481_h_a_dec_0.pdf@2008-02-12 00:00:00@Kuvan@sapropterin  dihydrochloride@NAS before 2012@False@adopted@Merck KGaA@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_0.pdf@EU-1-08-492_h_a_dec_0.pdf@2009-01-16 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_0.pdf@EU-1-08-494_h_a_dec_0.pdf@2009-01-16 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_0.pdf@EU-1-08-485_h_a_dec_0.pdf@2008-11-19 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_0.pdf@EU-1-08-482_h_a_dec_0.pdf@2008-11-25 00:00:00@AZARGA@brinzolamide / timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_0.pdf@EU-1-08-498_h_a_dec_0.pdf@2009-02-19 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_0.pdf@EU-1-08-470_h_a_dec_0.pdf@2008-08-29 00:00:00@Vimpat@lacosamide@NAS before 2012@True@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_0.pdf@EU-1-08-486_h_a_dec_0.pdf@2008-11-19 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_0.pdf@EU-1-08-483_h_a_dec_0.pdf@2008-01-12 00:00:00@Zomarist@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_0.pdf@EU-1-08-473_h_a_dec_0.pdf@2008-06-10 00:00:00@EVICEL@human fibrinogen / human  thrombin@NAS before 2012@True@OD Not Found@OMRIX biopharmaceuticals S.A.@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_0.pdf@EU-1-08-499_h_a_dec_0.pdf@2009-02-19 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_0.pdf@EU-1-08-475_h_a_dec_0.pdf@2008-07-10 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@True@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_0.pdf@EU-1-08-488_h_a_dec_0.pdf@2008-12-17 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_0.pdf@EU-1-08-502_h_a_dec_0.pdf@2009-06-03 00:00:00@MEPACT@mifamurtide@NAS before 2012@False@adopted@IDM Pharma S.A.@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_0.pdf@EU-1-09-508_h_a_dec_0.pdf@2009-03-30 00:00:00@Synflorix@Pneumococcal  polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_0.pdf@EU-1-08-495_h_a_dec_0.pdf@2009-06-02 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_0.pdf@EU-1-08-501_h_a_dec_0.pdf@2009-03-31 00:00:00@IXIARO@Japanese Encephalitis  vaccine (inactivated, adsorbed)@NAS before 2012@False@adopted@Intercell AG@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_0.pdf@EU-1-08-503_h_a_dec_0.pdf@2009-02-25 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_0.pdf@EU-1-09-511_h_a_dec_0.pdf@2009-04-17 00:00:00@CONBRIZA@bazedoxifene@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_0.pdf@EU-1-08-496_h_a_dec_0.pdf@2009-06-02 00:00:00@Filgrastim Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_0.pdf@EU-1-09-514_h_a_dec_0.pdf@2009-04-21 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_0.pdf@EU-1-08-504_h_a_dec_0.pdf@2009-02-17 00:00:00@FIRMAGON@degarelix (as acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_0.pdf@EU-1-09-521_h_a_dec_0.pdf@2009-10-06 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_0.pdf@EU-1-09-522_h_a_dec_0.pdf@2009-05-15 00:00:00@Ellaone@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_0.pdf@EU-1-09-526_h_a_dec_0.pdf@2009-06-24 00:00:00@IRESSA@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_0.pdf@EU-1-09-530_h_a_dec_0.pdf@2009-06-29 00:00:00@Repaglinide Teva@Repaglinide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_0.pdf@EU-1-08-497_h_a_dec_0.pdf@2009-04-02 00:00:00@Nplate@romiplostim@NAS before 2012@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_0.pdf@EU-1-09-523_h_a_dec_0.pdf@2009-05-15 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_0.pdf@EU-1-09-535_h_a_dec_0.pdf@2009-07-28 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_0.pdf@EU-1-09-531_h_a_dec_0.pdf@2009-07-20 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_0.pdf@EU-1-09-538_h_a_dec_0.pdf@2009-03-08 00:00:00@Afinitor@everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_0.pdf@EU-1-09-528_h_a_dec_0.pdf@2009-02-07 00:00:00@Nymusa@Caffeine citrate@NAS before 2012@False@adopted@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_0.pdf@EU-1-09-524_h_a_dec_0.pdf@2009-05-15 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@NeurogesX UK Limited@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_0.pdf@EU-1-09-537_h_a_dec_0.pdf@2009-07-31 00:00:00@Mozobil@plerixafor@NAS before 2012@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_0.pdf@EU-1-09-529_h_a_dec_0.pdf@2009-06-30 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_0.pdf@EU-1-09-515_h_a_dec_0.pdf@2009-12-06 00:00:00@CONTROLOC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_0.pdf@EU-1-09-543_h_a_dec_0.pdf@2009-09-21 00:00:00@Cayston@aztreonam@NAS before 2012@False@adopted@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-533_h_a_dec_0.pdf@EU-1-09-533_h_a_dec_0.pdf@2009-07-24 00:00:00@Vedrop@tocofersolan@NAS before 2012@False@OD Not Found@Orphan Europe SARL@exceptional@Parsed
EU-1-09-539_h_a_dec_0.pdf@EU-1-09-539_h_a_dec_0.pdf@2009-03-08 00:00:00@Samsca@tolvaptan@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_0.pdf@EU-1-09-525_h_a_dec_0.pdf@2009-11-05 00:00:00@Nimvastid@Rivastigmine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_0.pdf@EU-1-09-516_h_a_dec_0.pdf@2009-12-06 00:00:00@SOMAC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_0.pdf@EU-1-09-546_h_a_dec_0.pdf@2009-01-10 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_0.pdf@EU-1-09-555_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_0.pdf@EU-1-09-550_h_a_dec_0.pdf@2009-09-21 00:00:00@Javlor@vinflunine ditartrate@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_0.pdf@EU-1-09-540_h_a_dec_0.pdf@2009-07-28 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_0.pdf@EU-1-09-517_h_a_dec_0.pdf@2009-12-06 00:00:00@PANTOZOL Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_0.pdf@EU-1-09-544_h_a_dec_0.pdf@2009-01-10 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_0.pdf@EU-1-09-556_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_0.pdf@EU-1-09-558_h_a_dec_0.pdf@2009-09-21 00:00:00@Zylagren@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_0.pdf@EU-1-09-566_h_a_dec_0.pdf@2009-10-23 00:00:00@Lamivudine Teva@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_0.pdf@EU-1-09-562_h_a_dec_0.pdf@2009-09-21 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_0.pdf@EU-1-09-551_h_a_dec_0.pdf@2009-09-21 00:00:00@Vizarsin@sildenafil@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_0.pdf@EU-1-09-571_h_a_dec_0.pdf@2009-10-16 00:00:00@PANDEMIC  INFLUENZA VACCINE H5N1 BAXTER@Pandemic influenza vaccine (H5N1  whole virion, Vero cell derived, inactivated)@NAS before 2012@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-559_h_a_dec_0.pdf@EU-1-09-559_h_a_dec_0.pdf@2009-09-21 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_0.pdf@EU-1-09-568_h_a_dec_0.pdf@2009-10-16 00:00:00@Clopidogrel MYLAN Pharma@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_0.pdf@EU-1-09-572_h_a_dec_0.pdf@2009-10-16 00:00:00@ALENDRONATE SODIUM AND  COLECALCIFEROL, MSD@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_0.pdf@EU-1-09-564_h_a_dec_0.pdf@2009-10-23 00:00:00@ILARIS@canakinumab@NAS before 2012@False@adopted@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-545_h_a_dec_0.pdf@EU-1-09-545_h_a_dec_0.pdf@2009-01-10 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_0.pdf@EU-1-09-575_h_a_dec_0.pdf@2009-04-11 00:00:00@Copalia HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_0.pdf@EU-1-09-579_h_a_dec_0.pdf@2009-04-11 00:00:00@Repaglinide Krka@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_0.pdf@EU-1-09-553_h_a_dec_0.pdf@2009-09-28 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_0.pdf@EU-1-09-569_h_a_dec_0.pdf@2009-10-16 00:00:00@Exforge HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_0.pdf@EU-1-09-573_h_a_dec_0.pdf@2009-10-29 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_0.pdf@EU-1-09-580_h_a_dec_0.pdf@2009-10-14 00:00:00@Enyglid@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_0.pdf@EU-1-09-583_h_a_dec_0.pdf@2009-11-26 00:00:00@Irbesartan / Hydrochlorothiazide  Teva@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_0.pdf@EU-1-09-581_h_a_dec_0.pdf@2009-10-15 00:00:00@Resolor@prucalopride@NAS before 2012@False@OD Not Found@Movetis NV@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_0.pdf@EU-1-09-587_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_0.pdf@EU-1-09-565_h_a_dec_0.pdf@2009-10-23 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_0.pdf@EU-1-09-584_h_a_dec_0.pdf@2009-11-30 00:00:00@Sildenafil Teva@sildenafil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_0.pdf@EU-1-09-591_h_a_dec_0.pdf@2009-11-26 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_0.pdf@EU-1-09-574_h_a_dec_0.pdf@2009-04-11 00:00:00@Dafiro HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_0.pdf@EU-1-09-588_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark Europe@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_0.pdf@EU-1-09-576_h_a_dec_0.pdf@2009-10-30 00:00:00@Irbesartan Teva@Irbesartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_0.pdf@EU-1-09-595_h_a_dec_0.pdf@2009-10-12 00:00:00@Sildenafil Actavis@Sildenafil@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_0.pdf@EU-1-09-599_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine Sandoz@Rivastigmine@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_0.pdf@EU-1-09-585_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@NAS before 2012@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_0.pdf@EU-1-09-592_h_a_dec_0.pdf@2009-10-12 00:00:00@Olazax Disperzi@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_0.pdf@EU-1-09-596_h_a_dec_0.pdf@2009-10-12 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_0.pdf@EU-1-09-589_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine HEXAL@Rivastigmine@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_0.pdf@EU-1-09-577_h_a_dec_0.pdf@2009-10-19 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@exceptional@Parsed
EU-1-09-600_h_a_dec_0.pdf@EU-1-09-600_h_a_dec_0.pdf@2009-11-30 00:00:00@Zutectra@Human Hepatitis B  Immunoglobulin@NAS before 2012@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_0.pdf@EU-1-09-586_h_a_dec_0.pdf@2009-11-30 00:00:00@Oslif Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_0.pdf@EU-1-09-593_h_a_dec_0.pdf@2009-11-30 00:00:00@Onbrez Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_0.pdf@EU-1-09-597_h_a_dec_0.pdf@2009-11-12 00:00:00@Olazax@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_0.pdf@EU-1-09-578_h_a_dec_0.pdf@2009-10-19 00:00:00@Pandemic  influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline  Biologicals@Pandemic influenza vaccine (H5N1) (split virion, inactivated,  adjuvanted) A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@exceptional@Parsed
EU-1-09-603_h_a_dec_0.pdf@EU-1-09-603_h_a_dec_0.pdf@2009-12-23 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_0.pdf@EU-1-09-601_h_a_dec_0.pdf@2009-12-23 00:00:00@Zenas@amifampridine@NAS before 2012@False@adopted@EUSA Pharma SAS@exceptional@Parsed
EU-1-09-590_h_a_dec_0.pdf@EU-1-09-590_h_a_dec_0.pdf@2009-09-12 00:00:00@Prevenar 13@Pneumococcal  polysaccharide conjugate vaccine (13-valent, adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_0.pdf@EU-1-09-607_h_a_dec_0.pdf@2010-01-29 00:00:00@Silodyx@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_0.pdf@EU-1-09-604_h_a_dec_0.pdf@2010-08-01 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_0.pdf@EU-1-09-594_h_a_dec_0.pdf@2009-11-30 00:00:00@Hirobriz Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_0.pdf@EU-1-09-602_h_a_dec_0.pdf@2010-11-01 00:00:00@Scintimun@besilesomab@NAS before 2012@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_0.pdf@EU-1-10-612_h_a_dec_0.pdf@2010-11-03 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@adopted@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_0.pdf@EU-1-09-598_h_a_dec_0.pdf@2009-11-30 00:00:00@Nevirapine Teva@nevirapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_0.pdf@EU-1-10-615_h_a_dec_0.pdf@2010-03-15 00:00:00@Temozolomide Hospira@Temozolomide@NAS before 2012@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_0.pdf@EU-1-09-608_h_a_dec_0.pdf@2010-01-29 00:00:00@Urorec@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_0.pdf@EU-1-09-605_h_a_dec_0.pdf@2010-01-25 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@ALFRED E. TIEFENBACHER, (GmbH  & Co. KG)@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_0.pdf@EU-1-10-619_h_a_dec_0.pdf@2010-03-15 00:00:00@DuoPlavin@clopidogrel /  acetylsalicylic acid@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_0.pdf@EU-1-10-627_h_a_dec_0.pdf@2010-04-29 00:00:00@Raloxifene Teva@Raloxifene  hydrochloride@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_0.pdf@EU-1-09-609_h_a_dec_0.pdf@2010-01-25 00:00:00@Elonva@corifollitropin alfa@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_0.pdf@EU-1-10-631_h_a_dec_0.pdf@2010-08-06 00:00:00@Nivestim@Filgrastim@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_0.pdf@EU-1-10-628_h_a_dec_0.pdf@2010-06-14 00:00:00@Votrient@Pazopanib  hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-620_h_a_dec_0.pdf@EU-1-10-620_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristfor@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_0.pdf@EU-1-10-618_h_a_dec_0.pdf@2010-05-26 00:00:00@Prolia@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_0.pdf@EU-1-10-635_h_a_dec_0.pdf@2010-10-06 00:00:00@Olanzapine Apotex@Olanzapine@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_0.pdf@EU-1-10-632_h_a_dec_0.pdf@2010-04-06 00:00:00@Tolura@telmisartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_0.pdf@EU-1-09-606_h_a_dec_0.pdf@2010-01-28 00:00:00@Temozolomide Teva@Temozolomide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_0.pdf@EU-1-10-614_h_a_dec_0.pdf@2010-03-15 00:00:00@Menveo@Meningococcal Group A, C,  W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_0.pdf@EU-1-10-621_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_0.pdf@EU-1-10-639_h_a_dec_0.pdf@2010-09-30 00:00:00@Telmisartan Actavis@telmisartan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_0.pdf@EU-1-10-633_h_a_dec_0.pdf@2010-10-06 00:00:00@Topotecan Hospira@Topotecan@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_0.pdf@EU-1-10-636_h_a_dec_0.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_0.pdf@EU-1-10-643_h_a_dec_0.pdf@2010-06-09 00:00:00@Rapiscan@regadenoson@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_0.pdf@EU-1-10-640_h_a_dec_0.pdf@2010-01-09 00:00:00@Sycrest@asenapine@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_0.pdf@EU-1-10-647_h_a_dec_0.pdf@2010-07-10 00:00:00@Myclausen@mycophenolate mofetil@NAS before 2012@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_0.pdf@EU-1-10-652_h_a_dec_0.pdf@2011-07-20 00:00:00@TOBI Podhaler@Tobramycin@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_0.pdf@EU-1-10-658_h_a_dec_0.pdf@2010-11-29 00:00:00@Aflunov@Prepandemic influenza  vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_0.pdf@EU-1-10-637_h_a_dec_0.pdf@2010-07-27 00:00:00@Leflunomide medac@leflunomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_0.pdf@EU-1-10-622_h_a_dec_0.pdf@2010-03-15 00:00:00@TEPADINA@Thiotepa@NAS before 2012@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_0.pdf@EU-1-10-644_h_a_dec_0.pdf@2010-08-31 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_0.pdf@EU-1-10-648_h_a_dec_0.pdf@2010-07-10 00:00:00@Twynsta@telmisartan / amlodipine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_0.pdf@EU-1-10-654_h_a_dec_0.pdf@2010-11-29 00:00:00@Leflunomide ratiopharm@leflunomide@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_0.pdf@EU-1-10-659_h_a_dec_0.pdf@2011-01-21 00:00:00@Iasibon@Ibandronic acid@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_0.pdf@EU-1-10-641_h_a_dec_0.pdf@2010-10-28 00:00:00@Ruconest@conestat alfa@NAS before 2012@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_0.pdf@EU-1-10-638_h_a_dec_0.pdf@2010-07-27 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_0.pdf@EU-1-10-645_h_a_dec_0.pdf@2010-01-09 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_0.pdf@EU-1-10-660_h_a_dec_0.pdf@2011-06-01 00:00:00@Potactasol@topotecan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_0.pdf@EU-1-10-642_h_a_dec_0.pdf@2010-09-17 00:00:00@Ibandronic Acid Teva@Ibandronic  acid@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_0.pdf@EU-1-10-655_h_a_dec_0.pdf@2010-03-12 00:00:00@Brilique@ticagrelor@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_0.pdf@EU-1-10-665_h_a_dec_0.pdf@2011-02-18 00:00:00@Entacapone Teva@entacapone@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_0.pdf@EU-1-10-646_h_a_dec_0.pdf@2010-08-26 00:00:00@VPRIV@Velaglucerase alfa@NAS before 2012@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_0.pdf@EU-1-10-663_h_a_dec_0.pdf@2011-02-28 00:00:00@Lamivudine / Zidovudine Teva@lamivudine, zidovudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_0.pdf@EU-1-11-669_h_a_dec_0.pdf@2011-03-14 00:00:00@Teysuno@Tegafur/gimeracil/oteracil@NAS before 2012@False@OD Not Found@Taiho Pharma Europe, Limited@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_0.pdf@EU-1-11-673_h_a_dec_0.pdf@2011-04-03 00:00:00@Ifirmacombi@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_0.pdf@EU-1-11-667_h_a_dec_0.pdf@2011-02-28 00:00:00@Esbriet@Pirfenidone@NAS before 2012@False@adopted@InterMune Europe Ltd@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_0.pdf@EU-1-11-677_h_a_dec_0.pdf@2011-03-17 00:00:00@GILENYA@Fingolimod@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_0.pdf@EU-1-11-682_h_a_dec_0.pdf@2011-06-05 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@NAS before 2012@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_0.pdf@EU-1-11-687_h_a_dec_0.pdf@2011-04-14 00:00:00@Hizentra@human normal immunoglobulin@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_0.pdf@EU-1-11-676_h_a_dec_0.pdf@2011-03-17 00:00:00@JEVTANA@cabazitaxel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_0.pdf@EU-1-11-690_h_a_dec_0.pdf@2011-07-27 00:00:00@Zoely@nomegestrol/estradiol@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_0.pdf@EU-1-11-685_h_a_dec_0.pdf@2011-07-26 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_0.pdf@EU-1-11-688_h_a_dec_0.pdf@2011-06-15 00:00:00@Cinryze@C1 inhibitor, human@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_0.pdf@EU-1-11-694_h_a_dec_0.pdf@2011-06-17 00:00:00@NULOJIX@belatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_0.pdf@EU-1-11-698_h_a_dec_0.pdf@2011-07-13 00:00:00@Yervoy@ipilimumab@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_0.pdf@EU-1-11-672_h_a_dec_0.pdf@2011-04-03 00:00:00@Xeplion@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_0.pdf@EU-1-11-691_h_a_dec_0.pdf@2011-05-18 00:00:00@Eliquis@apixaban@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_0.pdf@EU-1-11-702_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam ratiopharm@Levetiracetam@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_0.pdf@EU-1-11-678_h_a_dec_0.pdf@2011-03-17 00:00:00@HALAVEN@eribulin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_0.pdf@EU-1-11-706_h_a_dec_0.pdf@2011-08-24 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_0.pdf@EU-1-11-696_h_a_dec_0.pdf@2011-06-17 00:00:00@BYDUREON@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_0.pdf@EU-1-11-699_h_a_dec_0.pdf@2011-07-20 00:00:00@Fampyra@fampridine@NAS before 2012@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-703_h_a_dec_0.pdf@EU-1-11-703_h_a_dec_0.pdf@2011-07-13 00:00:00@Xgeva@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_0.pdf@EU-1-11-710_h_a_dec_0.pdf@2011-02-09 00:00:00@Votubia@Everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-692_h_a_dec_0.pdf@EU-1-11-692_h_a_dec_0.pdf@2011-05-18 00:00:00@Yellox@bromfenac@NAS before 2012@False@OD Not Found@Croma-Pharma GmbH@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_0.pdf@EU-1-11-707_h_a_dec_0.pdf@2011-08-24 00:00:00@Trajenta@linagliptin@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_0.pdf@EU-1-11-679_h_a_dec_0.pdf@2011-04-14 00:00:00@Pravafenix@fenofibrate /  pravastatin@NAS before 2012@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_0.pdf@EU-1-11-708_h_a_dec_0.pdf@2011-08-18 00:00:00@Entacapone Orion@entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_0.pdf@EU-1-11-700_h_a_dec_0.pdf@2011-07-13 00:00:00@Benlysta@belimumab@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_0.pdf@EU-1-11-697_h_a_dec_0.pdf@2011-07-13 00:00:00@Temozolomide Sun@Temozolomide@NAS before 2012@False@OD Not Found@Sun Pharmaceuticals Industries Europe  B.V.@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_0.pdf@EU-1-11-693_h_a_dec_0.pdf@2011-06-16 00:00:00@Rivastigmine Actavis@Rivastigmine@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_0.pdf@EU-1-11-714_h_a_dec_0.pdf@2011-05-09 00:00:00@Zytiga@abiraterone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_0.pdf@EU-1-11-718_h_a_dec_0.pdf@2011-09-16 00:00:00@Dexdor@dexmedetomidine@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_0.pdf@EU-1-11-709_h_a_dec_0.pdf@2011-05-09 00:00:00@Buccolam@Midazolam@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_0.pdf@EU-1-11-715_h_a_dec_0.pdf@2011-03-11 00:00:00@Plenadren@Hydrocortisone@NAS before 2012@False@adopted@DuoCort Pharma AB@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_0.pdf@EU-1-11-719_h_a_dec_0.pdf@2011-03-10 00:00:00@Telmisartan Teva Pharma@telmisartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_0.pdf@EU-1-11-716_h_a_dec_0.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_0.pdf@EU-1-11-722_h_a_dec_0.pdf@2012-03-21 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_0.pdf@EU-1-11-731_h_a_dec_0.pdf@2011-11-24 00:00:00@Komboglyze@saxagliptin / metformin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_0.pdf@EU-1-11-701_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam Teva@Levetiracetam@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_0.pdf@EU-1-11-727_h_a_dec_0.pdf@2012-09-03 00:00:00@Mercaptopurine Nova Laboratories@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_0.pdf@EU-1-11-733_h_a_dec_0.pdf@2011-05-12 00:00:00@Dificlir@fidaxomicin@NAS before 2012@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_0.pdf@EU-1-11-737_h_a_dec_0.pdf@2011-11-28 00:00:00@Eviplera@emtricitabine / rilpivirine (as  hydrochloride) / tenofovir disoproxil (as fumarate)@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_0.pdf@EU-1-11-711_h_a_dec_0.pdf@2011-03-10 00:00:00@Matever@Levetiracetam@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_0.pdf@EU-1-11-734_h_a_dec_0.pdf@2011-07-12 00:00:00@Edarbi@azilsartan medoxomil@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_0.pdf@EU-1-11-717_h_a_dec_0.pdf@2011-11-16 00:00:00@Vyndaqel@tafamidis@NAS before 2012@False@adopted@Pfizer Specialty UK Limited@exceptional@Parsed
EU-1-11-741_h_a_dec_0.pdf@EU-1-11-741_h_a_dec_0.pdf@2011-12-14 00:00:00@Levetiracetam SUN@Levetiracetam@NAS before 2012@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_0.pdf@EU-1-11-732_h_a_dec_0.pdf@2011-11-24 00:00:00@Desloratadine Teva@desloratadine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_0.pdf@EU-1-11-745_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_0.pdf@EU-1-11-736_h_a_dec_0.pdf@2011-11-28 00:00:00@EDURANT@rilpivirine@NAS before 2012@False@OD Not Found@Janssen Cilag International NV@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_0.pdf@EU-1-11-749_h_a_dec_0.pdf@2012-02-17 00:00:00@Caprelsa@Vandetanib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-11-712_h_a_dec_0.pdf@EU-1-11-712_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Accord@Levetiracetam@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_0.pdf@EU-1-11-742_h_a_dec_0.pdf@2012-09-01 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma BV@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_0.pdf@EU-1-12-753_h_a_dec_0.pdf@2012-04-24 00:00:00@Signifor@Pasireotide@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_0.pdf@EU-1-11-746_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_0.pdf@EU-1-11-738_h_a_dec_0.pdf@2011-05-12 00:00:00@Levetiracetam Actavis Group@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_0.pdf@EU-1-11-743_h_a_dec_0.pdf@2011-12-22 00:00:00@Repaglinide Accord@Repaglinide@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_0.pdf@EU-1-11-713_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Actavis@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_0.pdf@EU-1-12-757_h_a_dec_0.pdf@2012-03-26 00:00:00@Pioglitazone Teva@Pioglitazone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_0.pdf@EU-1-11-747_h_a_dec_0.pdf@2012-02-13 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_0.pdf@EU-1-11-739_h_a_dec_0.pdf@2011-11-28 00:00:00@Dasselta@desloratadine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_0.pdf@EU-1-12-755_h_a_dec_0.pdf@2012-03-15 00:00:00@Pioglitazone Actavis@Pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_0.pdf@EU-1-12-759_h_a_dec_0.pdf@2012-04-20 00:00:00@Zoledronic acid Actavis@Zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_0.pdf@EU-1-12-750_h_a_dec_0.pdf@2012-02-23 00:00:00@Esmya@ulipristal@False@False@OD Not Found@PregLem France SAS.@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_0.pdf@EU-1-11-740_h_a_dec_0.pdf@2011-12-14 00:00:00@Ameluz@5-aminolevulinic acid@NAS before 2012@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_0.pdf@EU-1-12-766_h_a_dec_0.pdf@2012-04-20 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_0.pdf@EU-1-12-761_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Teva@Capecitabine@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_0.pdf@EU-1-12-769_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_0.pdf@EU-1-12-760_h_a_dec_0.pdf@2012-04-13 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_0.pdf@EU-1-12-777_h_a_dec_0.pdf@2012-03-09 00:00:00@Inlyta@Axitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_0.pdf@EU-1-12-773_h_a_dec_0.pdf@2012-08-23 00:00:00@Jakavi@ruxolitinib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_0.pdf@EU-1-12-762_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_0.pdf@EU-1-12-767_h_a_dec_0.pdf@2012-04-20 00:00:00@Nimenrix@Meningococcal Group A, C, W-135 and  Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_0.pdf@EU-1-12-751_h_a_dec_0.pdf@2012-02-17 00:00:00@Zelboraf@vemurafenib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_0.pdf@EU-1-12-781_h_a_dec_0.pdf@2012-07-20 00:00:00@Bretaris Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_0.pdf@EU-1-12-770_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_0.pdf@EU-1-12-763_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Krka@capecitabine@False@False@OD Not Found@KRKA, d.d@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_0.pdf@EU-1-12-775_h_a_dec_0.pdf@2012-03-09 00:00:00@NovoThirteen@catridecacog@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_0.pdf@EU-1-12-778_h_a_dec_0.pdf@2012-07-20 00:00:00@Eklira Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_0.pdf@EU-1-12-782_h_a_dec_0.pdf@2012-07-23 00:00:00@Kalydeco@ivacaftor@True@False@adopted@Vertex Pharmaceuticals (U.K.) Limited,@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_0.pdf@EU-1-12-768_h_a_dec_0.pdf@2012-07-05 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_0.pdf@EU-1-12-776_h_a_dec_0.pdf@2012-07-23 00:00:00@Fycompa@Perampanel@True@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_0.pdf@EU-1-12-785_h_a_dec_0.pdf@2012-08-23 00:00:00@Zinforo@ceftaroline fosamil@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_0.pdf@EU-1-12-764_h_a_dec_0.pdf@2012-10-05 00:00:00@Pixuvri@Pixantrone@True@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-789_h_a_dec_0.pdf@EU-1-12-789_h_a_dec_0.pdf@2012-09-28 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_0.pdf@EU-1-12-779_h_a_dec_0.pdf@2012-03-08 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_0.pdf@EU-1-12-786_h_a_dec_0.pdf@2012-08-23 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_0.pdf@EU-1-12-790_h_a_dec_0.pdf@2012-09-28 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_0.pdf@EU-1-12-793_h_a_dec_0.pdf@2012-10-23 00:00:00@XALKORI@crizotinib@True@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-787_h_a_dec_0.pdf@EU-1-12-787_h_a_dec_0.pdf@2012-08-30 00:00:00@Revestive@teduglutide@True@False@adopted@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_0.pdf@EU-1-12-780_h_a_dec_0.pdf@2012-07-20 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_0.pdf@EU-1-12-783_h_a_dec_0.pdf@2012-08-23 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_0.pdf@EU-1-12-792_h_a_dec_0.pdf@2012-09-20 00:00:00@Dacogen@Decitabine@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_0.pdf@EU-1-12-797_h_a_dec_0.pdf@2012-11-22 00:00:00@Eylea@aflibercept@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_0.pdf@EU-1-12-771_h_a_dec_0.pdf@2012-08-16 00:00:00@Zoledronic acid Teva@Zoledronic acid@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_0.pdf@EU-1-12-784_h_a_dec_0.pdf@2012-08-23 00:00:00@Cuprymina@Copper  64Cu chloride@True@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_0.pdf@EU-1-12-788_h_a_dec_0.pdf@2012-09-28 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_0.pdf@EU-1-12-801_h_a_dec_0.pdf@2012-11-26 00:00:00@Constella@linaclotide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_0.pdf@EU-1-12-794_h_a_dec_0.pdf@2012-10-25 00:00:00@Adcetris@Brentuximab vedotin@True@False@adopted@Takeda Global Research and Development  Centre (Europe) Ltd.@conditional@Parsed
EU-1-12-805_h_a_dec_0.pdf@EU-1-12-805_h_a_dec_0.pdf@2013-01-14 00:00:00@Amyvid@Florbetapir (18F)@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_0.pdf@EU-1-12-809_h_a_dec_0.pdf@2012-12-20 00:00:00@Betmiga@mirabegron@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_0.pdf@EU-1-12-814_h_a_dec_0.pdf@2013-01-02 00:00:00@ZALTRAP@aflibercept@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_0.pdf@EU-1-12-802_h_a_dec_0.pdf@2012-11-19 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_0.pdf@EU-1-12-798_h_a_dec_0.pdf@2012-11-19 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_0.pdf@EU-1-13-818_h_a_dec_0.pdf@2013-03-27 00:00:00@Bosulif@Bosutinib@True@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-12-815_h_a_dec_0.pdf@EU-1-12-815_h_a_dec_0.pdf@2013-02-25 00:00:00@Selincro@nalmefene@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_0.pdf@EU-1-12-811_h_a_dec_0.pdf@2013-01-02 00:00:00@Lyxumia@lixisenatide@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_0.pdf@EU-1-12-806_h_a_dec_0.pdf@2013-01-21 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_0.pdf@EU-1-12-799_h_a_dec_0.pdf@2012-11-22 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_0.pdf@EU-1-12-795_h_a_dec_0.pdf@2012-12-11 00:00:00@Forxiga@dapagliflozin@True@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_0.pdf@EU-1-12-803_h_a_dec_0.pdf@2012-12-18 00:00:00@NexoBrid@Concentrate  proteolytic enzymes  enriched in bromelain@False@False@adopted@TEVA Pharma GmbH@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_0.pdf@EU-1-13-813_h_a_dec_0.pdf@2013-04-03 00:00:00@Perjeta@pertuzumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_0.pdf@EU-1-12-800_h_a_dec_0.pdf@2012-11-19 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_0.pdf@EU-1-13-819_h_a_dec_0.pdf@2013-03-13 00:00:00@JETREA@OCRIPLASMIN@True@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_0.pdf@EU-1-12-812_h_a_dec_0.pdf@2013-01-14 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA,  component, adsorbed)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_0.pdf@EU-1-13-822_h_a_dec_0.pdf@2013-07-31 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_0.pdf@EU-1-12-807_h_a_dec_0.pdf@2013-01-21 00:00:00@Tresiba@Insulin degludec@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_0.pdf@EU-1-13-826_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-817_h_a_dec_0.pdf@EU-1-13-817_h_a_dec_0.pdf@2013-03-13 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-823_h_a_dec_0.pdf@EU-1-13-823_h_a_dec_0.pdf@2013-02-20 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd.@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_0.pdf@EU-1-13-827_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_0.pdf@EU-1-13-830_h_a_dec_0.pdf@2013-05-24 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine /  tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_0.pdf@EU-1-13-820_h_a_dec_0.pdf@2013-04-29 00:00:00@Maruxa@Memantine@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_0.pdf@EU-1-13-834_h_a_dec_0.pdf@2014-01-16 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_0.pdf@EU-1-13-838_h_a_dec_0.pdf@2013-08-26 00:00:00@AUBAGIO@Teriflunomide@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_0.pdf@EU-1-13-828_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexacima@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_0.pdf@EU-1-13-821_h_a_dec_0.pdf@2013-03-13 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_0.pdf@EU-1-13-824_h_a_dec_0.pdf@2013-04-22 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_0.pdf@EU-1-12-808_h_a_dec_0.pdf@2013-08-01 00:00:00@Imatinib Teva@imatinib@False@False@appointed@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_0.pdf@EU-1-13-835_h_a_dec_0.pdf@2013-05-16 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_0.pdf@EU-1-13-842_h_a_dec_0.pdf@2013-09-19 00:00:00@Incresync@alogliptin / pioglitazone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_0.pdf@EU-1-13-832_h_a_dec_0.pdf@2013-06-24 00:00:00@Stayveer@bosentan@False@False@adopted@Marklas Nederland BV@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_0.pdf@EU-1-13-829_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_0.pdf@EU-1-13-839_h_a_dec_0.pdf@2013-01-07 00:00:00@Iclusig@ponatinib@True@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_0.pdf@EU-1-13-846_h_a_dec_0.pdf@2013-06-21 00:00:00@Xtandi@enzalutamide@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_0.pdf@EU-1-13-836_h_a_dec_0.pdf@2013-06-13 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_0.pdf@EU-1-13-843_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipdomet@alogliptin / metformin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_0.pdf@EU-1-13-850_h_a_dec_0.pdf@2013-05-08 00:00:00@Pomalidomidea Celgene@Pomalidomide@True@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_0.pdf@EU-1-13-837_h_a_dec_0.pdf@2014-01-30 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_0.pdf@EU-1-13-848_h_a_dec_0.pdf@2013-12-07 00:00:00@Erivedge@vismodegib@True@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-844_h_a_dec_0.pdf@EU-1-13-844_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipidia@alogliptin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_0.pdf@EU-1-13-854_h_a_dec_0.pdf@2013-10-09 00:00:00@Inflectra@infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_0.pdf@EU-1-13-858_h_a_dec_0.pdf@2013-08-26 00:00:00@Stivarga@regorafenib@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_0.pdf@EU-1-13-840_h_a_dec_0.pdf@2013-05-16 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_0.pdf@EU-1-13-862_h_a_dec_0.pdf@2013-09-19 00:00:00@Ultibro Breezhaler@Indacaterol  maleate/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_0.pdf@EU-1-13-855_h_a_dec_0.pdf@2013-07-31 00:00:00@Imvanex@modified  vaccinia ankara virus@True@False@appointed@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-845_h_a_dec_0.pdf@EU-1-13-845_h_a_dec_0.pdf@2013-01-07 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_0.pdf@EU-1-13-841_h_a_dec_0.pdf@2013-06-13 00:00:00@Spedra@avanafil@True@False@OD Not Found@VIVUS BV@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_0.pdf@EU-1-13-859_h_a_dec_0.pdf@2013-11-11 00:00:00@Levodopa-Carbidopa-Entacapone Sandoz@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_0.pdf@EU-1-13-851_h_a_dec_0.pdf@2013-07-31 00:00:00@Lojuxta@Lomitapide@True@False@appointed@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-869_h_a_dec_0.pdf@EU-1-13-869_h_a_dec_0.pdf@2013-12-09 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_0.pdf@EU-1-13-856_h_a_dec_0.pdf@2013-07-25 00:00:00@Lonquex@lipegfilgrastim@True@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_0.pdf@EU-1-13-863_h_a_dec_0.pdf@2013-09-19 00:00:00@Xoterna Breezhaler@indacaterol / glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_0.pdf@EU-1-13-860_h_a_dec_0.pdf@2013-08-26 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_0.pdf@EU-1-13-871_h_a_dec_0.pdf@2013-09-27 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_0.pdf@EU-1-13-857_h_a_dec_0.pdf@2013-12-08 00:00:00@Voncento@human coagulation factor VIII / human  von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_0.pdf@EU-1-13-877_h_a_dec_0.pdf@2013-10-18 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_0.pdf@EU-1-13-870_h_a_dec_0.pdf@2012-05-25 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS (Cell Therapies Research &  Services)@exceptional@Parsed
EU-1-13-861_h_a_dec_0.pdf@EU-1-13-861_h_a_dec_0.pdf@2013-06-09 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Raptor Pharmaceuticals Europe BV@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_0.pdf@EU-1-13-865_h_a_dec_0.pdf@2013-08-26 00:00:00@Tafinlar@DABRAFENIB@True@False@OD Not Found@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-13-852_h_a_dec_0.pdf@EU-1-13-852_h_a_dec_0.pdf@2013-07-31 00:00:00@Atosiban SUN@atosiban@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_0.pdf@EU-1-13-872_h_a_dec_0.pdf@2013-09-19 00:00:00@Tybost@cobicistat@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-880_h_a_dec_0.pdf@EU-1-13-880_h_a_dec_0.pdf@2013-04-12 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_0.pdf@EU-1-13-878_h_a_dec_0.pdf@2013-10-18 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.p.A.@exceptional@Parsed
EU-1-13-884_h_a_dec_0.pdf@EU-1-13-884_h_a_dec_0.pdf@2013-11-15 00:00:00@Invokana@canagliflozin@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_0.pdf@EU-1-13-853_h_a_dec_0.pdf@2013-10-09 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_0.pdf@EU-1-13-888_h_a_dec_0.pdf@2013-11-13 00:00:00@NovoEight@turoctocog alfa@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_0.pdf@EU-1-13-881_h_a_dec_0.pdf@2013-11-15 00:00:00@Lidocaine/Prilocaine Plethora@lidocaine /  prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-879_h_a_dec_0.pdf@EU-1-13-879_h_a_dec_0.pdf@2013-09-25 00:00:00@Giotrif@afatinib@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_0.pdf@EU-1-13-885_h_a_dec_0.pdf@2013-11-15 00:00:00@Kadcyla@Trastuzumab emtansine@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_0.pdf@EU-1-13-889_h_a_dec_0.pdf@2014-08-01 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_0.pdf@EU-1-13-873_h_a_dec_0.pdf@2013-11-13 00:00:00@Xofigo@Radium Ra 223 dichloride@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_0.pdf@EU-1-13-866_h_a_dec_0.pdf@2013-08-26 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Abbott Healthcare Products Ltd@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_0.pdf@EU-1-13-882_h_a_dec_0.pdf@2013-11-15 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_0.pdf@EU-1-13-886_h_a_dec_0.pdf@2013-11-13 00:00:00@Relvar Elllipta@fluticasone furoate/vilanterol  trifenatate@True@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_0.pdf@EU-1-13-890_h_a_dec_0.pdf@2014-03-21 00:00:00@Cometriq@cabozantinib@True@False@adopted@TMC Pharma Services Ltd.@conditional@Parsed
EU-1-13-892_h_a_dec_0.pdf@EU-1-13-892_h_a_dec_0.pdf@2014-01-16 00:00:00@Tivicay@dolutegravir@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_0.pdf@EU-1-13-875_h_a_dec_0.pdf@2014-04-28 00:00:00@Deltyba@delamanid@True@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-896_h_a_dec_0.pdf@EU-1-13-896_h_a_dec_0.pdf@2014-07-04 00:00:00@Para-aminosalicylic acid Lucane@aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_0.pdf@EU-1-13-904_h_a_dec_0.pdf@2014-02-21 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International Tour Europlaza,  20 avenue André Prothin, La Défense 4, La Défense Cedex 92927, France@CMA Not Found@Parsed
EU-1-13-909_h_a_dec_0.pdf@EU-1-13-909_h_a_dec_0.pdf@2014-03-27 00:00:00@Bemfola@Follitropin alfa@False@False@OD Not Found@FINOX Biotech AG@CMA Not Found@Parsed
EU-1-13-905_h_a_dec_0.pdf@EU-1-13-905_h_a_dec_0.pdf@2014-02-20 00:00:00@Izba@travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_0.pdf@EU-1-13-900_h_a_dec_0.pdf@2014-01-16 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_0.pdf@EU-1-13-891_h_a_dec_0.pdf@2013-12-18 00:00:00@Brintellix@vortioxetine@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_0.pdf@EU-1-14-913_h_a_dec_0.pdf@2014-03-21 00:00:00@Latuda@lurasidone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_0.pdf@EU-1-13-887_h_a_dec_0.pdf@2013-04-12 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated,  nasal)@True@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_0.pdf@EU-1-13-893_h_a_dec_0.pdf@2013-12-20 00:00:00@Opsumit@macitentan@True@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_0.pdf@EU-1-14-898_h_a_dec_0.pdf@2014-08-05 00:00:00@Anoro@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_0.pdf@EU-1-13-906_h_a_dec_0.pdf@2014-02-20 00:00:00@Neuraceq@florbetaben (18F)@True@False@OD Not Found@Piramal Imaging GmbH@CMA Not Found@Parsed
EU-1-14-915_h_a_dec_0.pdf@EU-1-14-915_h_a_dec_0.pdf@2014-05-22 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_0.pdf@EU-1-13-894_h_a_dec_0.pdf@2014-01-16 00:00:00@Sovaldi@sofosbuvir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_0.pdf@EU-1-14-899_h_a_dec_0.pdf@2014-08-05 00:00:00@Laventair@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_0.pdf@EU-1-13-907_h_a_dec_0.pdf@2014-03-27 00:00:00@Adempas@riociguat@True@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_0.pdf@EU-1-13-901_h_a_dec_0.pdf@2014-05-03 00:00:00@Sirturo@bedaquiline@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-14-914_h_a_dec_0.pdf@EU-1-14-914_h_a_dec_0.pdf@2014-04-28 00:00:00@Vimizim@elosulfase alfa@True@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_0.pdf@EU-1-14-919_h_a_dec_0.pdf@2014-04-23 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@PIERRE FABRE DERMATOLOGIE@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_0.pdf@EU-1-14-916_h_a_dec_0.pdf@2014-10-04 00:00:00@Pregabalin Pfizer@Pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_0.pdf@EU-1-13-902_h_a_dec_0.pdf@2014-07-31 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics, Limited@conditional@Parsed
EU-1-14-923_h_a_dec_0.pdf@EU-1-14-923_h_a_dec_0.pdf@2014-05-22 00:00:00@Entyvio@vedolizumab@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_0.pdf@EU-1-14-930_h_a_dec_0.pdf@2014-05-22 00:00:00@Jardiance@empagliflozin@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_0.pdf@EU-1-14-934_h_a_dec_0.pdf@2014-07-18 00:00:00@Plegridy@peginterferon beta-1a@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_0.pdf@EU-1-14-920_h_a_dec_0.pdf@2014-04-28 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_0.pdf@EU-1-14-938_h_a_dec_0.pdf@2014-09-18 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_0.pdf@EU-1-14-917_h_a_dec_0.pdf@2014-04-23 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_0.pdf@EU-1-14-943_h_a_dec_0.pdf@2014-08-26 00:00:00@Velphoro@oxyhydroxide, sucrose and starches@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_0.pdf@EU-1-14-931_h_a_dec_0.pdf@2014-06-30 00:00:00@Mekinist@trametinib@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_0.pdf@EU-1-14-928_h_a_dec_0.pdf@2014-05-22 00:00:00@Sylvant@siltuximab@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_0.pdf@EU-1-14-921_h_a_dec_0.pdf@2014-04-28 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_0.pdf@EU-1-14-935_h_a_dec_0.pdf@2014-07-18 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_0.pdf@EU-1-14-944_h_a_dec_0.pdf@2014-09-09 00:00:00@ABASRIA@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_0.pdf@EU-1-14-918_h_a_dec_0.pdf@2014-04-23 00:00:00@Vokanamet@canagliflozin / metformin  hydrochloride@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_0.pdf@EU-1-14-929_h_a_dec_0.pdf@2014-02-05 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_0.pdf@EU-1-14-940_h_a_dec_0.pdf@2014-01-09 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_0.pdf@EU-1-14-922_h_a_dec_0.pdf@2014-04-28 00:00:00@Incruse@umeclidinium bromide@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_0.pdf@EU-1-14-936_h_a_dec_0.pdf@2014-07-22 00:00:00@Nuwiq@simoctocog alfa@True@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_0.pdf@EU-1-14-933_h_a_dec_0.pdf@2014-07-18 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_0.pdf@EU-1-14-946_h_a_dec_0.pdf@2014-09-18 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_0.pdf@EU-1-14-945_h_a_dec_0.pdf@2014-10-21 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_0.pdf@EU-1-14-954_h_a_dec_0.pdf@2014-11-21 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_0.pdf@EU-1-14-951_h_a_dec_0.pdf@2014-09-22 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_0.pdf@EU-1-14-941_h_a_dec_0.pdf@2014-08-22 00:00:00@Vizamyl@flutemetamol ( 18F)@True@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_0.pdf@EU-1-14-958_h_a_dec_0.pdf@2014-11-17 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_0.pdf@EU-1-14-937_h_a_dec_0.pdf@2014-07-23 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_0.pdf@EU-1-14-952_h_a_dec_0.pdf@2015-01-15 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_0.pdf@EU-1-14-955_h_a_dec_0.pdf@2014-11-19 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Navidea Biopharmaceuticals Limited@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_0.pdf@EU-1-14-962_h_a_dec_0.pdf@2014-08-12 00:00:00@Moventig@naloxegol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_0.pdf@EU-1-14-947_h_a_dec_0.pdf@2014-09-18 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_0.pdf@EU-1-14-967_h_a_dec_0.pdf@2014-11-19 00:00:00@REZOLSTA@DARUNAVIR / COBICISTAT@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_0.pdf@EU-1-14-972_h_a_dec_0.pdf@2014-08-12 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_0.pdf@EU-1-14-977_h_a_dec_0.pdf@2015-12-01 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_0.pdf@EU-1-14-956_h_a_dec_0.pdf@2014-11-21 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_0.pdf@EU-1-14-963_h_a_dec_0.pdf@2014-11-19 00:00:00@Brimica Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_0.pdf@EU-1-14-973_h_a_dec_0.pdf@2015-03-26 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Aptalis Pharma SAS@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_0.pdf@EU-1-14-978_h_a_dec_0.pdf@2015-01-15 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_0.pdf@EU-1-14-964_h_a_dec_0.pdf@2014-11-19 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_0.pdf@EU-1-14-969_h_a_dec_0.pdf@2014-12-22 00:00:00@Scenesse@afamelanotide@False@False@adopted@Clinuvel UK Limited@exceptional@Parsed
EU-1-14-959_h_a_dec_0.pdf@EU-1-14-959_h_a_dec_0.pdf@2014-12-16 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_0.pdf@EU-1-14-974_h_a_dec_0.pdf@2015-01-19 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_0.pdf@EU-1-14-980_h_a_dec_0.pdf@2015-01-15 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-970_h_a_dec_0.pdf@EU-1-14-970_h_a_dec_0.pdf@2014-12-19 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_0.pdf@EU-1-14-965_h_a_dec_0.pdf@2014-11-19 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_0.pdf@EU-1-14-979_h_a_dec_0.pdf@2015-01-15 00:00:00@Ofev@Nintedanib@True@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_0.pdf@EU-1-14-957_h_a_dec_0.pdf@2014-12-19 00:00:00@Cyramza@ramucirumab@False@False@adopted@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_0.pdf@EU-1-14-975_h_a_dec_0.pdf@2015-02-19 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_0.pdf@EU-1-14-971_h_a_dec_0.pdf@2014-05-12 00:00:00@Paliperidone Janssen@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_0.pdf@EU-1-14-960_h_a_dec_0.pdf@2014-12-16 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_0.pdf@EU-1-14-984_h_a_dec_0.pdf@2015-02-24 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_0.pdf@EU-1-15-1003_h_a_dec_0.pdf@2015-05-27 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_0.pdf@EU-1-14-988_h_a_dec_0.pdf@2015-03-26 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_0.pdf@EU-1-14-961_h_a_dec_0.pdf@2014-11-21 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-986_h_a_dec_0.pdf@EU-1-14-986_h_a_dec_0.pdf@2015-02-19 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Durata Therapeutics International B.V.@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_0.pdf@EU-1-15-1011_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_0.pdf@EU-1-15-1007_h_a_dec_0.pdf@2015-10-06 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine  (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_0.pdf@EU-1-14-981_h_a_dec_0.pdf@2015-01-15 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_0.pdf@EU-1-14-987_h_a_dec_0.pdf@2015-02-17 00:00:00@Holoclar@Ex vivo expanded autologous  human corneal epithelial cells containing stem cells@True@True@adopted@Chiesi Farmaceutici S.P.A.@conditional@Parsed
EU-1-15-1012_h_a_dec_0.pdf@EU-1-15-1012_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_0.pdf@EU-1-15-1004_h_a_dec_0.pdf@2015-05-27 00:00:00@Voriconazole Hospira@voriconazole@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_0.pdf@EU-1-15-1015_h_a_dec_0.pdf@2015-08-28 00:00:00@Strensiq@asfotase alfa@True@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1000_h_a_dec_0.pdf@EU-1-15-1000_h_a_dec_0.pdf@2015-05-27 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_0.pdf@EU-1-15-1008_h_a_dec_0.pdf@2015-03-07 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_0.pdf@EU-1-15-1013_h_a_dec_0.pdf@2015-06-19 00:00:00@Lumark@lutetium, isotope  mass 177@True@False@OD Not Found@IDB Radiopharmacy B.V.@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_0.pdf@EU-1-15-1019_h_a_dec_0.pdf@2015-07-20 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_0.pdf@EU-1-15-1005_h_a_dec_0.pdf@2015-06-30 00:00:00@Aripiprazole Pharmathen@aripiprazole@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-15-1016_h_a_dec_0.pdf@EU-1-15-1016_h_a_dec_0.pdf@2015-07-17 00:00:00@Repatha@Evolocumab@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_0.pdf@EU-1-15-1009_h_a_dec_0.pdf@2015-06-25 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_0.pdf@EU-1-15-1001_h_a_dec_0.pdf@2015-05-27 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_0.pdf@EU-1-15-1020_h_a_dec_0.pdf@2015-08-09 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland)  GmbH@exceptional@Parsed
EU-1-15-1014_h_a_dec_0.pdf@EU-1-15-1014_h_a_dec_0.pdf@2015-06-19 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1018_h_a_dec_0.pdf@EU-1-15-1018_h_a_dec_0.pdf@2015-07-28 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_0.pdf@EU-1-15-1021_h_a_dec_0.pdf@2015-07-17 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_0.pdf@EU-1-15-1010_h_a_dec_0.pdf@2015-06-19 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_0.pdf@EU-1-15-1002_h_a_dec_0.pdf@2015-05-28 00:00:00@Lenvima@Lenvatinib@False@False@adopted@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_0.pdf@EU-1-15-1023_h_a_dec_0.pdf@2015-08-28 00:00:00@Farydak@panobinostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_0.pdf@EU-1-15-1027_h_a_dec_0.pdf@2015-08-28 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_0.pdf@EU-1-15-1031_h_a_dec_0.pdf@2015-09-23 00:00:00@Praluent@alirocumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_0.pdf@EU-1-15-1035_h_a_dec_0.pdf@2015-11-11 00:00:00@Obizur@susoctocog alfa@True@False@adopted@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-14-983_h_a_dec_0.pdf@EU-1-14-983_h_a_dec_0.pdf@2015-01-15 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_0.pdf@EU-1-15-1036_h_a_dec_0.pdf@2015-10-15 00:00:00@Cresemba@isavuconazole@True@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_0.pdf@EU-1-15-1024_h_a_dec_0.pdf@2015-07-17 00:00:00@KEYTRUDA@pembrolizumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_0.pdf@EU-1-15-1028_h_a_dec_0.pdf@2015-08-20 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_0.pdf@EU-1-15-1032_h_a_dec_0.pdf@2015-09-18 00:00:00@Zerbaxa@ceftolozane / tazobactam@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_0.pdf@EU-1-15-1040_h_a_dec_0.pdf@2015-09-17 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_0.pdf@EU-1-15-1029_h_a_dec_0.pdf@2015-08-20 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_0.pdf@EU-1-15-1041_h_a_dec_0.pdf@2015-08-09 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne  S.A.@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_0.pdf@EU-1-15-1037_h_a_dec_0.pdf@2015-09-18 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_0.pdf@EU-1-15-1033_h_a_dec_0.pdf@2015-08-28 00:00:00@Kanuma@sebelipase alfa@True@False@adopted@Synageva BioPharma Ltd@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_0.pdf@EU-1-15-1043_h_a_dec_0.pdf@2015-02-12 00:00:00@Nucala@mepolizumab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_0.pdf@EU-1-15-1047_h_a_dec_0.pdf@2015-11-23 00:00:00@Blincyto@blinatumomab@True@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1030_h_a_dec_0.pdf@EU-1-15-1030_h_a_dec_0.pdf@2015-08-14 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_0.pdf@EU-1-15-1055_h_a_dec_0.pdf@2015-02-12 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_0.pdf@EU-1-15-1051_h_a_dec_0.pdf@2015-11-16 00:00:00@Ebymect@dapagliflozin / metfomin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1038_h_a_dec_0.pdf@EU-1-15-1038_h_a_dec_0.pdf@2015-11-27 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_0.pdf@EU-1-15-1056_h_a_dec_0.pdf@2015-11-20 00:00:00@Praxbind@Idarucizumab@True@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_0.pdf@EU-1-15-1059_h_a_dec_0.pdf@2015-11-19 00:00:00@Orkambi@Lumacaftor / Ivacaftor@True@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_0.pdf@EU-1-15-1052_h_a_dec_0.pdf@2015-09-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_0.pdf@EU-1-15-1063_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Actavis@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1048_h_a_dec_0.pdf@EU-1-15-1048_h_a_dec_0.pdf@2015-11-20 00:00:00@Cotellic@cobimetinib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_0.pdf@EU-1-15-1045_h_a_dec_0.pdf@2015-11-16 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_0.pdf@EU-1-15-1064_h_a_dec_0.pdf@2015-12-16 00:00:00@Imlygic@talimogene laherparepvec@True@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_0.pdf@EU-1-15-1057_h_a_dec_0.pdf@2015-11-20 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_0.pdf@EU-1-15-1053_h_a_dec_0.pdf@2016-03-16 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_0.pdf@EU-1-15-1060_h_a_dec_0.pdf@2015-11-19 00:00:00@Kyprolis@carfilzomib@True@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1049_h_a_dec_0.pdf@EU-1-15-1049_h_a_dec_0.pdf@2017-01-19 00:00:00@Cystadrops@mercaptamine@False@False@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_0.pdf@EU-1-15-1058_h_a_dec_0.pdf@2015-11-19 00:00:00@Entresto@sacubitril / valsartan@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_0.pdf@EU-1-15-1046_h_a_dec_0.pdf@2015-11-19 00:00:00@Elocta@efmoroctocog alfa@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_0.pdf@EU-1-15-1065_h_a_dec_0.pdf@2016-11-01 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_0.pdf@EU-1-15-1067_h_a_dec_0.pdf@2016-01-14 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_0.pdf@EU-1-15-1054_h_a_dec_0.pdf@2015-11-19 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_0.pdf@EU-1-15-1066_h_a_dec_0.pdf@2016-06-24 00:00:00@Ongentys@opicapone@True@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_0.pdf@EU-1-15-1071_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_0.pdf@EU-1-15-1025_h_a_dec_0.pdf@2015-07-13 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_0.pdf@EU-1-15-1068_h_a_dec_0.pdf@2016-03-31 00:00:00@Wakix@Pitolisant hydrochloride@True@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_0.pdf@EU-1-15-1075_h_a_dec_0.pdf@2016-02-18 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Iron Therapeutics (UK) Ltd@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_0.pdf@EU-1-15-1061_h_a_dec_0.pdf@2015-11-19 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine /  tenofovir alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_0.pdf@EU-1-15-1079_h_a_dec_0.pdf@2016-02-15 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b  conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_0.pdf@EU-1-15-1076_h_a_dec_0.pdf@2016-02-18 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_0.pdf@EU-1-15-1083_h_a_dec_0.pdf@2016-12-05 00:00:00@Uptravi@selexipag@True@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_0.pdf@EU-1-15-1072_h_a_dec_0.pdf@2016-01-14 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_0.pdf@EU-1-15-1070_h_a_dec_0.pdf@2016-01-14 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_0.pdf@EU-1-15-1082_h_a_dec_0.pdf@2016-05-26 00:00:00@Galafold@migalastat@True@False@adopted@Amicus Therapeutics UK Ltd@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_0.pdf@EU-1-15-990_h_a_dec_0.pdf@2015-03-19 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@SANTEN S.A.S.@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_0.pdf@EU-1-15-1073_h_a_dec_0.pdf@2016-01-14 00:00:00@Briviact@brivaracetam@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_0.pdf@EU-1-15-1085_h_a_dec_0.pdf@2016-04-25 00:00:00@Taltz@ixekizumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_0.pdf@EU-1-15-1078_h_a_dec_0.pdf@2017-04-24 00:00:00@Natpar@parathyroid hormone@False@False@adopted@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-994_h_a_dec_0.pdf@EU-1-15-994_h_a_dec_0.pdf@2015-03-23 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_0.pdf@EU-1-15-999_h_a_dec_0.pdf@2015-06-05 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-15-991_h_a_dec_0.pdf@EU-1-15-991_h_a_dec_0.pdf@2015-03-23 00:00:00@Sivextro@tedizolid phosphate@True@False@OD Not Found@Cubist (UK) Ltd@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_0.pdf@EU-1-15-1062_h_a_dec_0.pdf@2015-11-27 00:00:00@Ravicti@Glycerol phenylbutyrate@True@False@adopted@Horizon Therapeutics Limited@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_0.pdf@EU-1-16-1088_h_a_dec_0.pdf@2016-11-05 00:00:00@Empliciti@elotuzumab@True@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_0.pdf@EU-1-15-997_h_a_dec_0.pdf@2015-06-25 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_0.pdf@EU-1-15-1074_h_a_dec_0.pdf@2016-01-14 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_0.pdf@EU-1-16-1086_h_a_dec_0.pdf@2016-02-02 00:00:00@TAGRISSO@osimertinib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1089_h_a_dec_0.pdf@EU-1-16-1089_h_a_dec_0.pdf@2016-05-20 00:00:00@Pandemic influenza vaccine H5N1  MedImmune@Pandemic influenza vaccine (H5N1) (live attenuated, nasal)@True@False@OD Not Found@MedImmune, LLC@conditional@Parsed
EU-1-16-1092_h_a_dec_0.pdf@EU-1-16-1092_h_a_dec_0.pdf@2016-03-22 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_0.pdf@EU-1-15-989_h_a_dec_0.pdf@2015-03-19 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_0.pdf@EU-1-15-992_h_a_dec_0.pdf@2015-03-23 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1090_h_a_dec_0.pdf@EU-1-16-1090_h_a_dec_0.pdf@2016-04-04 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_0.pdf@EU-1-16-1096_h_a_dec_0.pdf@2016-04-25 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1093_h_a_dec_0.pdf@EU-1-16-1093_h_a_dec_0.pdf@2016-03-31 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1087_h_a_dec_0.pdf@EU-1-16-1087_h_a_dec_0.pdf@2016-03-16 00:00:00@Coagadex@human coagulation factor X@False@False@adopted@Bio Products Laboratory Ltd@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_0.pdf@EU-1-16-1091_h_a_dec_0.pdf@2016-08-22 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1097_h_a_dec_0.pdf@EU-1-16-1097_h_a_dec_0.pdf@2016-05-26 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction  that contains CD34+ cells transduced with retroviral vector that encodes for the human  ADA cDNA sequence@True@True@adopted@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_0.pdf@EU-1-16-1101_h_a_dec_0.pdf@2016-05-20 00:00:00@Darzalex@daratumumab@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1094_h_a_dec_0.pdf@EU-1-16-1094_h_a_dec_0.pdf@2016-11-21 00:00:00@Ninlaro@ixazomib@True@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-15-993_h_a_dec_0.pdf@EU-1-15-993_h_a_dec_0.pdf@2015-06-19 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_0.pdf@EU-1-16-1098_h_a_dec_0.pdf@2016-12-05 00:00:00@ALPROLIX@eftrenonacog alfa@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-16-1104_h_a_dec_0.pdf@EU-1-16-1104_h_a_dec_0.pdf@2016-05-26 00:00:00@Palonosetron Accord@palonosetron@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_0.pdf@EU-1-16-1108_h_a_dec_0.pdf@2016-07-15 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_0.pdf@EU-1-16-1114_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_0.pdf@EU-1-16-1105_h_a_dec_0.pdf@2016-06-07 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_0.pdf@EU-1-16-1102_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_0.pdf@EU-1-16-1095_h_a_dec_0.pdf@2016-11-05 00:00:00@IDELVION@albutrepenonacog alfa@True@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_0.pdf@EU-1-16-1106_h_a_dec_0.pdf@2016-05-26 00:00:00@Flixabi@Infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_0.pdf@EU-1-16-1103_h_a_dec_0.pdf@2016-05-26 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_0.pdf@EU-1-16-1115_h_a_dec_0.pdf@2016-07-22 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_0.pdf@EU-1-16-1109_h_a_dec_0.pdf@2016-06-24 00:00:00@Zavicefta@ceftazidime/avibactam@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_0.pdf@EU-1-16-1099_h_a_dec_0.pdf@2016-04-21 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_0.pdf@EU-1-16-1124_h_a_dec_0.pdf@2016-08-18 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_0.pdf@EU-1-16-1119_h_a_dec_0.pdf@2016-07-22 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_0.pdf@EU-1-16-1116_h_a_dec_0.pdf@2016-06-07 00:00:00@Epclusa@sofosbuvir/velpatasvir@True@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_0.pdf@EU-1-16-1110_h_a_dec_0.pdf@2017-10-04 00:00:00@Chenodeoxycholic acid  sigma-tau@chenodeoxycholic acid@False@False@adopted@sigma-tau Arzeimittel GmbH@exceptional@Parsed
EU-1-16-1128_h_a_dec_0.pdf@EU-1-16-1128_h_a_dec_0.pdf@2016-08-25 00:00:00@Kisplyx@Lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_0.pdf@EU-1-16-1132_h_a_dec_0.pdf@2016-09-15 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_0.pdf@EU-1-16-1136_h_a_dec_0.pdf@2016-09-09 00:00:00@CABOMETYX@cabozantinib@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_0.pdf@EU-1-16-1125_h_a_dec_0.pdf@2016-08-16 00:00:00@Cinqaero@reslizumab@True@False@OD Not Found@Teva Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_0.pdf@EU-1-16-1112_h_a_dec_0.pdf@2016-06-21 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir  alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_0.pdf@EU-1-16-1140_h_a_dec_0.pdf@2017-04-01 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1144_h_a_dec_0.pdf@EU-1-16-1144_h_a_dec_0.pdf@2016-11-11 00:00:00@Ivabradine Zentiva@Ivabradine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_0.pdf@EU-1-16-1129_h_a_dec_0.pdf@2016-08-12 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@MYLAN S.A.S@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_0.pdf@EU-1-16-1127_h_a_dec_0.pdf@2016-09-15 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_0.pdf@EU-1-16-1137_h_a_dec_0.pdf@2016-11-14 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_0.pdf@EU-1-16-1146_h_a_dec_0.pdf@2016-11-11 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_0.pdf@EU-1-16-1148_h_a_dec_0.pdf@2016-09-11 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_0.pdf@EU-1-16-1147_h_a_dec_0.pdf@2016-09-11 00:00:00@IBRANCE@palbociclib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_0.pdf@EU-1-16-1138_h_a_dec_0.pdf@2016-05-12 00:00:00@Venclyxto@venetoclax@True@False@adopted@AbbVie Ltd@conditional@Parsed
EU-1-16-1130_h_a_dec_0.pdf@EU-1-16-1130_h_a_dec_0.pdf@2016-10-14 00:00:00@Onivyde@irinotecan@False@False@adopted@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_0.pdf@EU-1-16-1153_h_a_dec_0.pdf@2017-09-01 00:00:00@Tadalafil Generics@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1150_h_a_dec_0.pdf@EU-1-16-1150_h_a_dec_0.pdf@2016-12-12 00:00:00@Rekovelle@follitropin delta@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_0.pdf@EU-1-16-1154_h_a_dec_0.pdf@2017-09-01 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1141_h_a_dec_0.pdf@EU-1-16-1141_h_a_dec_0.pdf@2016-08-12 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_0.pdf@EU-1-16-1133_h_a_dec_0.pdf@2016-12-16 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_0.pdf@EU-1-16-1157_h_a_dec_0.pdf@2017-11-01 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_0.pdf@EU-1-16-1161_h_a_dec_0.pdf@2017-11-01 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_0.pdf@EU-1-16-1151_h_a_dec_0.pdf@2016-08-12 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_0.pdf@EU-1-16-1155_h_a_dec_0.pdf@2017-07-17 00:00:00@Kyntheum@brodalumab@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_0.pdf@EU-1-16-1164_h_a_dec_0.pdf@2017-03-22 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_0.pdf@EU-1-16-1139_h_a_dec_0.pdf@2016-12-12 00:00:00@OCALIVA@obeticholic acid@True@False@adopted@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1142_h_a_dec_0.pdf@EU-1-16-1142_h_a_dec_0.pdf@2016-11-11 00:00:00@Parsabiv@etelcalcetide@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1152_h_a_dec_0.pdf@EU-1-16-1152_h_a_dec_0.pdf@2017-04-20 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_0.pdf@EU-1-16-1134_h_a_dec_0.pdf@2016-09-15 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_0.pdf@EU-1-16-1158_h_a_dec_0.pdf@2017-04-01 00:00:00@AFSTYLA@lonoctocog alfa@True@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1156_h_a_dec_0.pdf@EU-1-16-1156_h_a_dec_0.pdf@2017-01-18 00:00:00@ZINPLAVA@bezlotoxumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_0.pdf@EU-1-16-1166_h_a_dec_0.pdf@2017-02-27 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_0.pdf@EU-1-16-1169_h_a_dec_0.pdf@2017-02-16 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-17-1173_h_a_dec_0.pdf@EU-1-17-1173_h_a_dec_0.pdf@2018-03-22 00:00:00@Lokelma@sodium zirconium cyclosilicate@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_0.pdf@EU-1-17-1181_h_a_dec_0.pdf@2017-10-07 00:00:00@Spherox@associated chondrocytes@True@True@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1177_h_a_dec_0.pdf@EU-1-17-1177_h_a_dec_0.pdf@2017-03-22 00:00:00@Tadalafil Lilly@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_0.pdf@EU-1-16-1135_h_a_dec_0.pdf@2016-09-15 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_0.pdf@EU-1-16-1159_h_a_dec_0.pdf@2017-04-01 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_0.pdf@EU-1-16-1167_h_a_dec_0.pdf@2017-02-17 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_0.pdf@EU-1-17-1174_h_a_dec_0.pdf@2017-03-20 00:00:00@Rolufta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_0.pdf@EU-1-16-1170_h_a_dec_0.pdf@2017-02-13 00:00:00@Olumiant@baricitinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_0.pdf@EU-1-17-1178_h_a_dec_0.pdf@2017-03-22 00:00:00@Xeljanz@Tofacitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_0.pdf@EU-1-17-1182_h_a_dec_0.pdf@2017-04-28 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA, d.d.@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_0.pdf@EU-1-17-1185_h_a_dec_0.pdf@2017-06-15 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_0.pdf@EU-1-17-1175_h_a_dec_0.pdf@2017-03-22 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_0.pdf@EU-1-17-1184_h_a_dec_0.pdf@2017-06-15 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_0.pdf@EU-1-16-1160_h_a_dec_0.pdf@2017-09-01 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_0.pdf@EU-1-17-1176_h_a_dec_0.pdf@2017-03-22 00:00:00@Yargesa@miglustat@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_0.pdf@EU-1-16-1171_h_a_dec_0.pdf@2017-03-03 00:00:00@Ledaga@chlormethine@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_0.pdf@EU-1-16-1168_h_a_dec_0.pdf@2017-02-13 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_0.pdf@EU-1-17-1186_h_a_dec_0.pdf@2017-05-22 00:00:00@Axumin@fluciclovine (18F)@True@False@OD Not Found@Blue Earth Diagnostics Ltd@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_0.pdf@EU-1-17-1189_h_a_dec_0.pdf@2017-02-06 00:00:00@Elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1193_h_a_dec_0.pdf@EU-1-17-1193_h_a_dec_0.pdf@2017-02-06 00:00:00@Refixia@nonacog beta pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_0.pdf@EU-1-17-1172_h_a_dec_0.pdf@2017-03-29 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind Ltd@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_0.pdf@EU-1-17-1187_h_a_dec_0.pdf@2017-05-24 00:00:00@Trumenba@meningococcal group B vaccine  (recombinant, adsorbed)@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1197_h_a_dec_0.pdf@EU-1-17-1197_h_a_dec_0.pdf@2017-06-07 00:00:00@OXERVATE@cenegermin@True@False@adopted@Dompé farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_0.pdf@EU-1-17-1202_h_a_dec_0.pdf@2017-06-23 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-17-1194_h_a_dec_0.pdf@EU-1-17-1194_h_a_dec_0.pdf@2017-06-15 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1190_h_a_dec_0.pdf@EU-1-17-1190_h_a_dec_0.pdf@2017-05-22 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_0.pdf@EU-1-17-1179_h_a_dec_0.pdf@2017-07-19 00:00:00@Veltassa@patiromer@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-17-1199_h_a_dec_0.pdf@EU-1-17-1199_h_a_dec_0.pdf@2017-05-09 00:00:00@Cuprior@trientine@False@False@adopted@gmp-orphan SA@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_0.pdf@EU-1-17-1203_h_a_dec_0.pdf@2017-07-19 00:00:00@Insulin lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_0.pdf@EU-1-17-1208_h_a_dec_0.pdf@2017-07-17 00:00:00@Trimbow@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_0.pdf@EU-1-17-1195_h_a_dec_0.pdf@2017-06-23 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_0.pdf@EU-1-17-1191_h_a_dec_0.pdf@2017-08-05 00:00:00@Dinutuximab beta Apeiron@dinutuximab beta@False@False@adopted@APEIRON Biologics AG@exceptional@Parsed
EU-1-17-1200_h_a_dec_0.pdf@EU-1-17-1200_h_a_dec_0.pdf@2017-06-29 00:00:00@Besponsa@inotuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_0.pdf@EU-1-17-1211_h_a_dec_0.pdf@2017-09-26 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_0.pdf@EU-1-17-1205_h_a_dec_0.pdf@2017-07-17 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_0.pdf@EU-1-17-1188_h_a_dec_0.pdf@2017-05-30 00:00:00@Spinraza@nusinersen@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1209_h_a_dec_0.pdf@EU-1-17-1209_h_a_dec_0.pdf@2017-07-13 00:00:00@Reagila@cariprazine@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_0.pdf@EU-1-17-1196_h_a_dec_0.pdf@2017-06-23 00:00:00@Kevzara@sarilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_0.pdf@EU-1-17-1212_h_a_dec_0.pdf@2017-08-22 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_0.pdf@EU-1-17-1192_h_a_dec_0.pdf@2017-05-30 00:00:00@Brineura@cerliponase  alfa@True@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1201_h_a_dec_0.pdf@EU-1-17-1201_h_a_dec_0.pdf@2017-06-23 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_0.pdf@EU-1-17-1210_h_a_dec_0.pdf@2017-07-17 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-17-1215_h_a_dec_0.pdf@EU-1-17-1215_h_a_dec_0.pdf@2017-08-24 00:00:00@Fotivda@tivozanib@True@False@OD Not Found@EUSA Pharma (UK) Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_0.pdf@EU-1-17-1213_h_a_dec_0.pdf@2017-07-26 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_0.pdf@EU-1-17-1219_h_a_dec_0.pdf@2018-06-07 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_0.pdf@EU-1-17-1227_h_a_dec_0.pdf@2017-09-18 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_0.pdf@EU-1-17-1223_h_a_dec_0.pdf@2017-07-26 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_0.pdf@EU-1-17-1216_h_a_dec_0.pdf@2017-08-24 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_0.pdf@EU-1-17-1231_h_a_dec_0.pdf@2018-08-01 00:00:00@Ocrevus@ocrelizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_0.pdf@EU-1-17-1220_h_a_dec_0.pdf@2017-09-21 00:00:00@Tecentriq@atezolizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_0.pdf@EU-1-17-1228_h_a_dec_0.pdf@2017-10-11 00:00:00@TOOKAD@padeliporfin@True@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_0.pdf@EU-1-17-1235_h_a_dec_0.pdf@2017-11-16 00:00:00@Zejula@niraparib@True@False@adopted@TESARO UK LIMITED@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_0.pdf@EU-1-17-1224_h_a_dec_0.pdf@2017-09-18 00:00:00@Xermelo@telotristat@True@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_0.pdf@EU-1-17-1229_h_a_dec_0.pdf@2017-09-26 00:00:00@Dupixent@dupilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_0.pdf@EU-1-17-1214_h_a_dec_0.pdf@2017-09-18 00:00:00@Bavencio@avelumab@True@False@adopted@Merck Serono Europe Limited@conditional@Parsed
EU-1-17-1236_h_a_dec_0.pdf@EU-1-17-1236_h_a_dec_0.pdf@2017-11-15 00:00:00@Trelegy Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_0.pdf@EU-1-17-1225_h_a_dec_0.pdf@2017-09-21 00:00:00@Symtuza@Darunavir ethanolate/ cobistat/  emtricitabine/ tenofovir alafenamide fumarate@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_0.pdf@EU-1-17-1217_h_a_dec_0.pdf@2017-08-24 00:00:00@Nitisinone MendeliKABS@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_0.pdf@EU-1-17-1232_h_a_dec_0.pdf@2020-04-28 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1239_h_a_dec_0.pdf@EU-1-17-1239_h_a_dec_0.pdf@2017-10-11 00:00:00@VeraSeal@human fibrinogen / human thrombin@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_0.pdf@EU-1-17-1226_h_a_dec_0.pdf@2017-09-26 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@True@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_0.pdf@EU-1-17-1233_h_a_dec_0.pdf@2017-10-11 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_0.pdf@EU-1-17-1218_h_a_dec_0.pdf@2017-09-18 00:00:00@Rydapt@Midostaurin@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_0.pdf@EU-1-17-1237_h_a_dec_0.pdf@2017-11-15 00:00:00@Elebrato Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_0.pdf@EU-1-17-1241_h_a_dec_0.pdf@2017-11-15 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_0.pdf@EU-1-17-1221_h_a_dec_0.pdf@2017-08-22 00:00:00@Kisqali@ribociclib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_0.pdf@EU-1-17-1234_h_a_dec_0.pdf@2017-10-11 00:00:00@Tremfya@Guselkumab@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_0.pdf@EU-1-17-1230_h_a_dec_0.pdf@2017-09-18 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_0.pdf@EU-1-17-1242_h_a_dec_0.pdf@2017-10-11 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_0.pdf@EU-1-17-1238_h_a_dec_0.pdf@2017-10-11 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_0.pdf@EU-1-17-1222_h_a_dec_0.pdf@2017-05-09 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_0.pdf@EU-1-17-1244_h_a_dec_0.pdf@2017-08-12 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-17-1247_h_a_dec_0.pdf@EU-1-17-1247_h_a_dec_0.pdf@2018-08-01 00:00:00@ADYNOVI@rurioctocog alfa pegol@True@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_0.pdf@EU-1-17-1251_h_a_dec_0.pdf@2018-08-02 00:00:00@Ozempic@semaglutide@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_0.pdf@EU-1-17-1245_h_a_dec_0.pdf@2018-08-01 00:00:00@PREVYMIS@letermovir@True@False@adopted@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1255_h_a_dec_0.pdf@EU-1-17-1255_h_a_dec_0.pdf@2018-08-01 00:00:00@Intrarosa@Prasterone@False@False@OD Not Found@Endoceutics Ltd.@CMA Not Found@Parsed
EU-1-18-1264_h_a_dec_0.pdf@EU-1-18-1264_h_a_dec_0.pdf@2018-11-22 00:00:00@Alunbrig@brigatinib@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_0.pdf@EU-1-17-1260_h_a_dec_0.pdf@2018-09-02 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Ltd@CMA Not Found@Parsed
EU-1-18-1269_h_a_dec_0.pdf@EU-1-18-1269_h_a_dec_0.pdf@2018-04-13 00:00:00@Alpivab@peramivir@True@False@OD Not Found@BioCryst UK Ltd.@CMA Not Found@Parsed
EU-1-17-1249_h_a_dec_0.pdf@EU-1-17-1249_h_a_dec_0.pdf@2018-01-26 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-17-1256_h_a_dec_0.pdf@EU-1-17-1256_h_a_dec_0.pdf@2018-02-15 00:00:00@Anagrelide Mylan@anagrelide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_0.pdf@EU-1-17-1252_h_a_dec_0.pdf@2018-08-01 00:00:00@Fasenra@benralizumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1261_h_a_dec_0.pdf@EU-1-17-1261_h_a_dec_0.pdf@2018-03-23 00:00:00@Alofisel@Darvadstrocel@True@True@adopted@TiGenix S.A.U.@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_0.pdf@EU-1-17-1246_h_a_dec_0.pdf@2018-01-15 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_0.pdf@EU-1-18-1265_h_a_dec_0.pdf@2018-03-23 00:00:00@Segluromet@ertugliflozin / metformin  hydrochloride@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_0.pdf@EU-1-18-1270_h_a_dec_0.pdf@2018-03-23 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1257_h_a_dec_0.pdf@EU-1-17-1257_h_a_dec_0.pdf@2018-09-02 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_0.pdf@EU-1-17-1262_h_a_dec_0.pdf@2018-02-19 00:00:00@CRYSVITA@Burosumab@True@False@adopted@Kyowa Kirin Limited@conditional@Parsed
EU-1-17-1253_h_a_dec_0.pdf@EU-1-17-1253_h_a_dec_0.pdf@2018-08-01 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1273_h_a_dec_0.pdf@EU-1-18-1273_h_a_dec_0.pdf@2018-05-16 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_0.pdf@EU-1-17-1250_h_a_dec_0.pdf@2018-05-24 00:00:00@Rubraca@rucaparib@True@False@adopted@Clovis Oncology UK Limited@conditional@Parsed
EU-1-18-1271_h_a_dec_0.pdf@EU-1-18-1271_h_a_dec_0.pdf@2018-02-23 00:00:00@Hemlibra@emicizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1254_h_a_dec_0.pdf@EU-1-17-1254_h_a_dec_0.pdf@2018-08-01 00:00:00@Jorveza@budesonide@False@False@adopted@Dr. Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1258_h_a_dec_0.pdf@EU-1-17-1258_h_a_dec_0.pdf@2018-03-23 00:00:00@Lamzede@velmanase alfa@True@False@adopted@Chiesi Farmaceutici S.p.A.@exceptional@Parsed
EU-1-18-1266_h_a_dec_0.pdf@EU-1-18-1266_h_a_dec_0.pdf@2018-03-23 00:00:00@Steglujan@ertugliflozin / sitagliptin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_0.pdf@EU-1-17-1263_h_a_dec_0.pdf@2018-08-02 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-18-1277_h_a_dec_0.pdf@EU-1-18-1277_h_a_dec_0.pdf@2018-04-19 00:00:00@Mylotarg@gemtuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_0.pdf@EU-1-18-1274_h_a_dec_0.pdf@2018-04-26 00:00:00@Trydonis@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_0.pdf@EU-1-18-1281_h_a_dec_0.pdf@2018-05-16 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_0.pdf@EU-1-18-1286_h_a_dec_0.pdf@2018-07-26 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_0.pdf@EU-1-18-1272_h_a_dec_0.pdf@2018-03-21 00:00:00@Shingrix@herpes zoster vaccine (recombinant,  adjuvanted)@True@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_0.pdf@EU-1-18-1267_h_a_dec_0.pdf@2018-03-21 00:00:00@Steglatro@ertugliflozin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1275_h_a_dec_0.pdf@EU-1-18-1275_h_a_dec_0.pdf@2018-04-23 00:00:00@Riarify@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1290_h_a_dec_0.pdf@EU-1-18-1290_h_a_dec_0.pdf@2018-07-26 00:00:00@Nityr@nitisinone@False@False@OD Not Found@Cycle Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_0.pdf@EU-1-18-1282_h_a_dec_0.pdf@2018-05-16 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_0.pdf@EU-1-18-1278_h_a_dec_0.pdf@2018-07-19 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1291_h_a_dec_0.pdf@EU-1-18-1291_h_a_dec_0.pdf@2019-02-18 00:00:00@Rizmoic@naldemedine@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_0.pdf@EU-1-18-1276_h_a_dec_0.pdf@2018-07-30 00:00:00@Myalepta@metreleptin@True@False@adopted@Aegerion Pharmaceuticals B.V.@exceptional@Parsed
EU-1-18-1287_h_a_dec_0.pdf@EU-1-18-1287_h_a_dec_0.pdf@2018-07-26 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1298_h_a_dec_0.pdf@EU-1-18-1298_h_a_dec_0.pdf@2018-08-31 00:00:00@VEYVONDI@vonicog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-18-1279_h_a_dec_0.pdf@EU-1-18-1279_h_a_dec_0.pdf@2018-05-24 00:00:00@AMGLIDIA@glibenclamide@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1294_h_a_dec_0.pdf@EU-1-18-1294_h_a_dec_0.pdf@2018-07-26 00:00:00@RXULTI@brexpiprazole@True@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_0.pdf@EU-1-18-1292_h_a_dec_0.pdf@2018-11-20 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1283_h_a_dec_0.pdf@EU-1-18-1283_h_a_dec_0.pdf@2018-05-22 00:00:00@Pemetrexed Krka@pemetrexed@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_0.pdf@EU-1-18-1299_h_a_dec_0.pdf@2018-08-23 00:00:00@Yescarta@axicabtagene ciloleucel@True@True@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_0.pdf@EU-1-18-1293_h_a_dec_0.pdf@2018-07-26 00:00:00@Aimovig@erenumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1280_h_a_dec_0.pdf@EU-1-18-1280_h_a_dec_0.pdf@2018-05-18 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_0.pdf@EU-1-18-1289_h_a_dec_0.pdf@2018-06-21 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir  alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-18-1302_h_a_dec_0.pdf@EU-1-18-1302_h_a_dec_0.pdf@2018-09-20 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-18-1284_h_a_dec_0.pdf@EU-1-18-1284_h_a_dec_0.pdf@2018-06-25 00:00:00@Dzuveo@sufentanil@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-18-1305_h_a_dec_0.pdf@EU-1-18-1305_h_a_dec_0.pdf@2018-08-31 00:00:00@Cablivi@caplacizumab@True@False@adopted@Ablynx N.V.@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_0.pdf@EU-1-18-1307_h_a_dec_0.pdf@2018-09-27 00:00:00@Verzenios@abemaciclib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_0.pdf@EU-1-18-1295_h_a_dec_0.pdf@Date is blank@Trazimera@trastuzumab@NAS before 2012@NA before 2012@NA before 2000@Pfizer Europe MA EEIG@CMA not available before 2006@Parsed
EU-1-18-1301_h_a_dec_0.pdf@EU-1-18-1301_h_a_dec_0.pdf@2018-08-23 00:00:00@Mepsevii@vestronidase  alfa@True@False@adopted@Ultragenyx Germany GmbH@exceptional@Parsed
EU-1-18-1311_h_a_dec_0.pdf@EU-1-18-1311_h_a_dec_0.pdf@2018-08-31 00:00:00@Nerlynx@neratinib@True@False@OD Not Found@Puma Biotechnology, Ltd.@CMA Not Found@Parsed
EU-1-18-1315_h_a_dec_0.pdf@EU-1-18-1315_h_a_dec_0.pdf@2018-09-20 00:00:00@Mektovi@binimetinib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_0.pdf@EU-1-18-1306_h_a_dec_0.pdf@2018-10-31 00:00:00@Symkevi@tezacaftor/ivacaftor@True@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_0.pdf@EU-1-18-1319_h_a_dec_0.pdf@2018-09-17 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_0.pdf@EU-1-18-1323_h_a_dec_0.pdf@2018-09-17 00:00:00@Ilumetri@tildrakizumab@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-18-1308_h_a_dec_0.pdf@EU-1-18-1308_h_a_dec_0.pdf@2018-08-23 00:00:00@Vyxeos@daunorubicin / cytarabine@False@False@adopted@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_0.pdf@EU-1-18-1316_h_a_dec_0.pdf@2018-09-20 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1327_h_a_dec_0.pdf@EU-1-18-1327_h_a_dec_0.pdf@2018-11-22 00:00:00@Ziextenzo@pegfilgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_0.pdf@EU-1-18-1296_h_a_dec_0.pdf@2018-06-07 00:00:00@Tegsedi@inotersen@True@False@adopted@IONIS USA Limited@CMA Not Found@Parsed
EU-1-18-1324_h_a_dec_0.pdf@EU-1-18-1324_h_a_dec_0.pdf@2018-11-22 00:00:00@Jivi@damoctocog alfa pegol@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_0.pdf@EU-1-18-1312_h_a_dec_0.pdf@2018-09-20 00:00:00@Xerava@Eravacycline@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1310_h_a_dec_0.pdf@EU-1-18-1310_h_a_dec_0.pdf@2018-09-20 00:00:00@Deferiprone Lipomed@Deferiprone@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_0.pdf@EU-1-18-1328_h_a_dec_0.pdf@2018-11-20 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Cinfa Biotech S.L.@CMA Not Found@Parsed
EU-1-18-1325_h_a_dec_0.pdf@EU-1-18-1325_h_a_dec_0.pdf@2018-12-18 00:00:00@Namuscla@Mexiletine@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_0.pdf@EU-1-18-1320_h_a_dec_0.pdf@2018-08-27 00:00:00@Onpattro@patisiran@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_0.pdf@EU-1-18-1317_h_a_dec_0.pdf@2019-06-05 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_0.pdf@EU-1-18-1331_h_a_dec_0.pdf@2018-11-22 00:00:00@Luxturna@voretigene neparvovec@True@True@adopted@Spark Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_0.pdf@EU-1-18-1329_h_a_dec_0.pdf@2018-11-20 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_0.pdf@EU-1-18-1313_h_a_dec_0.pdf@2018-09-21 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1321_h_a_dec_0.pdf@EU-1-18-1321_h_a_dec_0.pdf@2018-09-27 00:00:00@Gefitinib Mylan@gefitinib@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_0.pdf@EU-1-18-1318_h_a_dec_0.pdf@2018-09-20 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited,@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_0.pdf@EU-1-18-1297_h_a_dec_0.pdf@2018-08-23 00:00:00@Kymriah@tisagenlecleucel@True@True@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_0.pdf@EU-1-18-1326_h_a_dec_0.pdf@2018-12-12 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen,  inactivated, prepared in cell cultures)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1332_h_a_dec_0.pdf@EU-1-18-1332_h_a_dec_0.pdf@2018-11-22 00:00:00@Pifeltro@doravirine@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_0.pdf@EU-1-18-1330_h_a_dec_0.pdf@2018-11-14 00:00:00@Emgality@galcanezumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_0.pdf@EU-1-18-1314_h_a_dec_0.pdf@2018-09-20 00:00:00@Braftovi@encorafenib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1335_h_a_dec_0.pdf@EU-1-18-1335_h_a_dec_0.pdf@2018-11-22 00:00:00@Poteligeo@Mogamulizumab@True@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_0.pdf@EU-1-18-1322_h_a_dec_0.pdf@2018-09-21 00:00:00@Imfinzi@durvalumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1339_h_a_dec_0.pdf@EU-1-18-1339_h_a_dec_0.pdf@2018-12-18 00:00:00@Bevespi Aerosphere@glycopyrronium bromide /  formoterol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_0.pdf@EU-1-18-1333_h_a_dec_0.pdf@2018-11-22 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir  disoproxil@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_0.pdf@EU-1-18-1336_h_a_dec_0.pdf@2018-11-20 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1344_h_a_dec_0.pdf@EU-1-18-1344_h_a_dec_0.pdf@2019-02-14 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1347_h_a_dec_0.pdf@EU-1-18-1347_h_a_dec_0.pdf@2019-03-28 00:00:00@Febuxostat Krka@febuxostat@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1351_h_a_dec_0.pdf@EU-1-18-1351_h_a_dec_0.pdf@2019-06-20 00:00:00@Trecondi@treosulfan@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_0.pdf@EU-1-18-1340_h_a_dec_0.pdf@2018-11-22 00:00:00@TAKHZYRO@lanadelumab@True@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1348_h_a_dec_0.pdf@EU-1-18-1348_h_a_dec_0.pdf@2019-02-18 00:00:00@Lusutrombopag Shionogi@lusutrombopag@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1337_h_a_dec_0.pdf@EU-1-18-1337_h_a_dec_0.pdf@2019-11-01 00:00:00@Macimorelin Aeterna Zentaris@macimorelin@True@False@OD Not Found@Æterna Zentaris GmbH@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_0.pdf@EU-1-19-1355_h_a_dec_0.pdf@2019-06-05 00:00:00@Lorviqua@lorlatinib@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-18-1345_h_a_dec_0.pdf@EU-1-18-1345_h_a_dec_0.pdf@2019-04-26 00:00:00@Ondexxya@andexanet alfa@True@False@OD Not Found@Portola Netherlands B.V.@conditional@Parsed
EU-1-18-1334_h_a_dec_0.pdf@EU-1-18-1334_h_a_dec_0.pdf@2018-11-20 00:00:00@Vabomere@meropenem/vaborbactam@True@False@OD Not Found@Rempex London Limited@CMA Not Found@Parsed
EU-1-19-1356_h_a_dec_0.pdf@EU-1-19-1356_h_a_dec_0.pdf@2019-02-04 00:00:00@Idacio@adalimumab@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-18-1352_h_a_dec_0.pdf@EU-1-18-1352_h_a_dec_0.pdf@2019-02-15 00:00:00@Besremi@ropeginterferon alfa-2b@True@False@OD Not Found@AOP Orphan Pharmaceuticals AG@CMA Not Found@Parsed
EU-1-18-1349_h_a_dec_0.pdf@EU-1-18-1349_h_a_dec_0.pdf@2019-04-26 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@exceptional@Parsed
EU-1-18-1338_h_a_dec_0.pdf@EU-1-18-1338_h_a_dec_0.pdf@2018-12-12 00:00:00@Dengvaxia@dengue tetravalent vaccine (live,  attenuated)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1346_h_a_dec_0.pdf@EU-1-18-1346_h_a_dec_0.pdf@2019-02-18 00:00:00@Miglustat Dipharma@miglustat@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-19-1353_h_a_dec_0.pdf@EU-1-19-1353_h_a_dec_0.pdf@2019-03-25 00:00:00@Atazanavir Krka@atazanavir@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_0.pdf@EU-1-18-1341_h_a_dec_0.pdf@2018-12-12 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1359_h_a_dec_0.pdf@EU-1-19-1359_h_a_dec_0.pdf@2019-09-26 00:00:00@Trogarzo@ibalizumab@True@False@OD Not Found@Theratechnologies International Limited@CMA Not Found@Parsed
EU-1-18-1350_h_a_dec_0.pdf@EU-1-18-1350_h_a_dec_0.pdf@2019-02-18 00:00:00@Tobramycin PARI@tobramycin@False@False@adopted@PARI Pharma GmbH@CMA Not Found@Parsed
EU-1-19-1364_h_a_dec_0.pdf@EU-1-19-1364_h_a_dec_0.pdf@2019-09-27 00:00:00@NUCEIVA@botulinum toxin type A@False@False@OD Not Found@Evolus Pharma Limited@CMA Not Found@Parsed
EU-1-19-1368_h_a_dec_0.pdf@EU-1-19-1368_h_a_dec_0.pdf@2019-06-20 00:00:00@Ambrisentan Mylan@ambrisentan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1354_h_a_dec_0.pdf@EU-1-19-1354_h_a_dec_0.pdf@2019-02-04 00:00:00@Vizimpro@dacomitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1342_h_a_dec_0.pdf@EU-1-18-1342_h_a_dec_0.pdf@2019-01-14 00:00:00@Erleada@apalutamide@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_0.pdf@EU-1-19-1360_h_a_dec_0.pdf@2019-03-05 00:00:00@Waylivra@volanesorsen@True@False@adopted@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1371_h_a_dec_0.pdf@EU-1-19-1371_h_a_dec_0.pdf@2019-02-07 00:00:00@Ultomiris@Ravulizumab@True@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_0.pdf@EU-1-19-1358_h_a_dec_0.pdf@2019-03-28 00:00:00@AJOVY@fremanezumab@True@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-19-1365_h_a_dec_0.pdf@EU-1-19-1365_h_a_dec_0.pdf@2019-07-25 00:00:00@Cufence@trientine dihydrochloride@False@False@OD Not Found@Univar BV@CMA Not Found@Parsed
EU-1-19-1369_h_a_dec_0.pdf@EU-1-19-1369_h_a_dec_0.pdf@2019-06-20 00:00:00@Sixmo@buprenorphine@False@False@OD Not Found@L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A,@CMA Not Found@Parsed
EU-1-19-1375_h_a_dec_0.pdf@EU-1-19-1375_h_a_dec_0.pdf@2019-06-20 00:00:00@Grasustek@pegfilgrastim@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1379_h_a_dec_0.pdf@EU-1-19-1379_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole Accord@posaconazole@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1383_h_a_dec_0.pdf@EU-1-19-1383_h_a_dec_0.pdf@2019-08-26 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1361_h_a_dec_0.pdf@EU-1-19-1361_h_a_dec_0.pdf@2019-04-26 00:00:00@Skyrizi@risankizumab@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1380_h_a_dec_0.pdf@EU-1-19-1380_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole AHCL@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1372_h_a_dec_0.pdf@EU-1-19-1372_h_a_dec_0.pdf@2019-06-25 00:00:00@Striascan@ioflupane ( 123I)@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-19-1381_h_a_dec_0.pdf@EU-1-19-1381_h_a_dec_0.pdf@2019-07-25 00:00:00@LysaKare@arginine / lysine@False@False@OD Not Found@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-19-1366_h_a_dec_0.pdf@EU-1-19-1366_h_a_dec_0.pdf@2019-01-07 00:00:00@Xromi@hydroxycarbamide@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-19-1370_h_a_dec_0.pdf@EU-1-19-1370_h_a_dec_0.pdf@2019-01-07 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_0.pdf@EU-1-19-1376_h_a_dec_0.pdf@2019-06-28 00:00:00@LIBTAYO@cemiplimab@True@False@OD Not Found@Regeneron Ireland U.C.@conditional@Parsed
EU-1-19-1373_h_a_dec_0.pdf@EU-1-19-1373_h_a_dec_0.pdf@2019-06-20 00:00:00@Doptelet@avatrombopag@True@False@OD Not Found@Dova Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-19-1384_h_a_dec_0.pdf@EU-1-19-1384_h_a_dec_0.pdf@2019-08-23 00:00:00@Giapreza@angiotensin II acetate@True@False@OD Not Found@La Jolla Pharmaceutical II B.V.@CMA Not Found@Parsed
EU-1-19-1387_h_a_dec_0.pdf@EU-1-19-1387_h_a_dec_0.pdf@2019-11-14 00:00:00@Senstend@lidocaine / prilocaine@False@False@OD Not Found@Plethora Pharma Solutions Ltd.@CMA Not Found@Parsed
EU-1-19-1374_h_a_dec_0.pdf@EU-1-19-1374_h_a_dec_0.pdf@2019-06-20 00:00:00@Esperoct@turoctocog alfa pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-19-1377_h_a_dec_0.pdf@EU-1-19-1377_h_a_dec_0.pdf@2019-06-20 00:00:00@Talzenna@talazoparib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1388_h_a_dec_0.pdf@EU-1-19-1388_h_a_dec_0.pdf@2020-01-16 00:00:00@Polivy@polatuzumab vedotin@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-19-1392_h_a_dec_0.pdf@EU-1-19-1392_h_a_dec_0.pdf@2019-11-11 00:00:00@Ervebo@ZEBOV-GP, live)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1362_h_a_dec_0.pdf@EU-1-19-1362_h_a_dec_0.pdf@2019-03-05 00:00:00@Palynziq@pegvaliase@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_0.pdf@EU-1-19-1396_h_a_dec_0.pdf@2019-11-14 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1385_h_a_dec_0.pdf@EU-1-19-1385_h_a_dec_0.pdf@2019-09-19 00:00:00@VITRAKVI@larotrectinib@True@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1397_h_a_dec_0.pdf@EU-1-19-1397_h_a_dec_0.pdf@2019-11-14 00:00:00@Bortezomib Fresenius Kabi@bortezomib@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1393_h_a_dec_0.pdf@EU-1-19-1393_h_a_dec_0.pdf@2019-12-16 00:00:00@Quofenix@delafloxacin@True@False@OD Not Found@A. Menarini - Industrie Farmaceutiche Riunite  - s.r.l.@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_0.pdf@EU-1-19-1405_h_a_dec_0.pdf@2020-09-01 00:00:00@TAVLESSE@fostamatinib@True@False@OD Not Found@Rigel Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-19-1389_h_a_dec_0.pdf@EU-1-19-1389_h_a_dec_0.pdf@2019-09-19 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1400_h_a_dec_0.pdf@EU-1-19-1400_h_a_dec_0.pdf@2019-11-19 00:00:00@Rhokiinsa@netarsudil@True@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1398_h_a_dec_0.pdf@EU-1-19-1398_h_a_dec_0.pdf@2019-11-14 00:00:00@Arsenic Trioxide Accord@arsenic trioxide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1406_h_a_dec_0.pdf@EU-1-19-1406_h_a_dec_0.pdf@2019-12-16 00:00:00@Baqsimi@Glucagon@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1409_h_a_dec_0.pdf@EU-1-19-1409_h_a_dec_0.pdf@2019-12-19 00:00:00@Pegfilgrastim Mundipharma@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-19-1386_h_a_dec_0.pdf@EU-1-19-1386_h_a_dec_0.pdf@2019-09-26 00:00:00@Deferasirox Mylan@deferasirox@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1394_h_a_dec_0.pdf@EU-1-19-1394_h_a_dec_0.pdf@2020-04-17 00:00:00@Tigecycline Accord@tigecycline@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1399_h_a_dec_0.pdf@EU-1-19-1399_h_a_dec_0.pdf@2019-10-24 00:00:00@Xospata@gilteritinib@True@False@adopted@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-19-1390_h_a_dec_0.pdf@EU-1-19-1390_h_a_dec_0.pdf@2019-09-19 00:00:00@Inbrija@levodopa@False@False@OD Not Found@Acorda Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_0.pdf@EU-1-19-1410_h_a_dec_0.pdf@2019-12-18 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1395_h_a_dec_0.pdf@EU-1-19-1395_h_a_dec_0.pdf@2020-09-01 00:00:00@Clopidogrel/Acetylsalicylic acid Mylan@clopidogrel /  acetylsalicylic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1407_h_a_dec_0.pdf@EU-1-19-1407_h_a_dec_0.pdf@2020-09-01 00:00:00@Isturisa@osilodrostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1413_h_a_dec_0.pdf@EU-1-19-1413_h_a_dec_0.pdf@2020-02-13 00:00:00@Azacitidine Accord@Azacitidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1403_h_a_dec_0.pdf@EU-1-19-1403_h_a_dec_0.pdf@2020-03-04 00:00:00@Budesonide/Formoterol Teva Pharma B.V.@budesonide / formoterol fumarate dihydrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_0.pdf@EU-1-19-1417_h_a_dec_0.pdf@2020-02-13 00:00:00@Beovu@brolucizumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1421_h_a_dec_0.pdf@EU-1-19-1421_h_a_dec_0.pdf@2020-03-27 00:00:00@Staquis@crisaborole@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1425_h_a_dec_0.pdf@EU-1-20-1425_h_a_dec_0.pdf@2020-01-04 00:00:00@Nilemdo@bempedoic acid@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-19-1408_h_a_dec_0.pdf@EU-1-19-1408_h_a_dec_0.pdf@2020-01-16 00:00:00@Sunosi@solriamfetol@True@False@OD Not Found@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1418_h_a_dec_0.pdf@EU-1-19-1418_h_a_dec_0.pdf@2020-02-13 00:00:00@Dexmedetomidine Accord@dexmedetomidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_0.pdf@EU-1-19-1414_h_a_dec_0.pdf@2020-01-13 00:00:00@Mayzent@siponimod@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1419_h_a_dec_0.pdf@EU-1-19-1419_h_a_dec_0.pdf@2020-03-04 00:00:00@Trepulmix@treprostinil sodium@False@False@adopted@SciPharm Sàrl@CMA Not Found@Parsed
EU-1-20-1422_h_a_dec_0.pdf@EU-1-20-1422_h_a_dec_0.pdf@2020-03-24 00:00:00@Liumjev@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1411_h_a_dec_0.pdf@EU-1-19-1411_h_a_dec_0.pdf@2019-09-12 00:00:00@Evenity@romosozumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_0.pdf@EU-1-19-1404_h_a_dec_0.pdf@2019-12-16 00:00:00@Rinvoq@upadacitinib@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_0.pdf@EU-1-19-1420_h_a_dec_0.pdf@2020-02-13 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-20-1426_h_a_dec_0.pdf@EU-1-20-1426_h_a_dec_0.pdf@2020-03-27 00:00:00@Azacitidine Mylan@Azacitidine@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-19-1415_h_a_dec_0.pdf@EU-1-19-1415_h_a_dec_0.pdf@2020-02-13 00:00:00@Amsparity@adalimumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1412_h_a_dec_0.pdf@EU-1-19-1412_h_a_dec_0.pdf@2020-09-01 00:00:00@Deferasirox Accord@deferasirox@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1429_h_a_dec_0.pdf@EU-1-20-1429_h_a_dec_0.pdf@2020-03-04 00:00:00@Cinacalcet Accordpharma@cinacalcet@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1433_h_a_dec_0.pdf@EU-1-20-1433_h_a_dec_0.pdf@2020-05-20 00:00:00@Fluad Tetra@influenza vaccine (surface antigen,  inactivated, adjuvanted)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_0.pdf@EU-1-20-1437_h_a_dec_0.pdf@2020-07-31 00:00:00@Pretomanid FGK@pretomanid@True@False@adopted@FGK Representative Service GmbH@conditional@Parsed
EU-1-20-1427_h_a_dec_0.pdf@EU-1-20-1427_h_a_dec_0.pdf@2020-01-04 00:00:00@Arsenic trioxide Mylan@arsenic trioxide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1423_h_a_dec_0.pdf@EU-1-20-1423_h_a_dec_0.pdf@2020-01-04 00:00:00@Vaxchora@Cholera vaccine (recombinant, live,  oral)@True@False@OD Not Found@Emergent Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1430_h_a_dec_0.pdf@EU-1-20-1430_h_a_dec_0.pdf@2020-03-04 00:00:00@Rybelsus@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1434_h_a_dec_0.pdf@EU-1-20-1434_h_a_dec_0.pdf@2020-04-23 00:00:00@Fetcroja@cefiderocol@True@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-20-1428_h_a_dec_0.pdf@EU-1-20-1428_h_a_dec_0.pdf@2020-02-03 00:00:00@Givlaari@givosiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-19-1416_h_a_dec_0.pdf@EU-1-19-1416_h_a_dec_0.pdf@2020-03-24 00:00:00@Azacitidine Betapharm@Azacitidine@False@False@OD Not Found@betapharm Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-20-1438_h_a_dec_0.pdf@EU-1-20-1438_h_a_dec_0.pdf@2020-03-07 00:00:00@Enerzair Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1441_h_a_dec_0.pdf@EU-1-20-1441_h_a_dec_0.pdf@2020-05-30 00:00:00@Bemrist Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1445_h_a_dec_0.pdf@EU-1-20-1445_h_a_dec_0.pdf@2020-01-07 00:00:00@Mvabea@Ebola vaccine  (MVA-BN-Filo [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1424_h_a_dec_0.pdf@EU-1-20-1424_h_a_dec_0.pdf@2020-03-27 00:00:00@Nustendi@bempedoic acid / ezetimibe@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1435_h_a_dec_0.pdf@EU-1-20-1435_h_a_dec_0.pdf@2020-05-30 00:00:00@Sarclisa@isatuximab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1442_h_a_dec_0.pdf@EU-1-20-1442_h_a_dec_0.pdf@2020-05-20 00:00:00@Zeposia@ozanimod@True@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1439_h_a_dec_0.pdf@EU-1-20-1439_h_a_dec_0.pdf@2020-05-30 00:00:00@Atectura Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1446_h_a_dec_0.pdf@EU-1-20-1446_h_a_dec_0.pdf@2020-07-31 00:00:00@Hepcludex@bulevirtide@True@False@adopted@Myr GmbH@conditional@Parsed
EU-1-20-1431_h_a_dec_0.pdf@EU-1-20-1431_h_a_dec_0.pdf@2020-01-04 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1450_h_a_dec_0.pdf@EU-1-20-1450_h_a_dec_0.pdf@2020-06-25 00:00:00@Fingolimod Accord@fingolimod@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1454_h_a_dec_0.pdf@EU-1-20-1454_h_a_dec_0.pdf@2020-08-19 00:00:00@Aybintio@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_0.pdf@EU-1-20-1443_h_a_dec_0.pdf@2020-05-18 00:00:00@Zolgensma@onasemnogene  abeparvovec@True@False@adopted@AveXis EU Limited@conditional@Parsed
EU-1-20-1440_h_a_dec_0.pdf@EU-1-20-1440_h_a_dec_0.pdf@2020-03-07 00:00:00@Zimbus Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1451_h_a_dec_0.pdf@EU-1-20-1451_h_a_dec_0.pdf@2020-06-26 00:00:00@Daurismo@glasdegib@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1447_h_a_dec_0.pdf@EU-1-20-1447_h_a_dec_0.pdf@2020-06-25 00:00:00@Insulin aspart Sanofi@insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1436_h_a_dec_0.pdf@EU-1-20-1436_h_a_dec_0.pdf@2020-05-20 00:00:00@Nepexto@etanercept@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1432_h_a_dec_0.pdf@EU-1-20-1432_h_a_dec_0.pdf@2020-03-27 00:00:00@NUBEQA@darolutamide@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-20-1458_h_a_dec_0.pdf@EU-1-20-1458_h_a_dec_0.pdf@2020-07-23 00:00:00@Apixaban Accord@apixaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1455_h_a_dec_0.pdf@EU-1-20-1455_h_a_dec_0.pdf@2020-07-27 00:00:00@Piqray@alpelisib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1448_h_a_dec_0.pdf@EU-1-20-1448_h_a_dec_0.pdf@2020-08-28 00:00:00@Cabazitaxel Accord@cabazitaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1452_h_a_dec_0.pdf@EU-1-20-1452_h_a_dec_0.pdf@2020-06-25 00:00:00@Reblozyl@luspatercept@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1465_h_a_dec_0.pdf@EU-1-20-1465_h_a_dec_0.pdf@2020-08-19 00:00:00@Gencebok@caffeine citrate@False@False@OD Not Found@Gennisium Pharma@CMA Not Found@Parsed
EU-1-20-1444_h_a_dec_0.pdf@EU-1-20-1444_h_a_dec_0.pdf@2020-01-07 00:00:00@Zabdeno@Ebola vaccine  (Ad26.ZEBOV-GP [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1459_h_a_dec_0.pdf@EU-1-20-1459_h_a_dec_0.pdf@2020-03-07 00:00:00@Veklury@remdesivir@True@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1456_h_a_dec_0.pdf@EU-1-20-1456_h_a_dec_0.pdf@2020-07-27 00:00:00@Zercepac@trastuzumab@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1470_h_a_dec_0.pdf@EU-1-20-1470_h_a_dec_0.pdf@2020-08-19 00:00:00@Methylthioninium chloride Cosmo@methylthioninium chloride@False@False@OD Not Found@Cosmo Technologies Ltd@CMA Not Found@Parsed
EU-1-20-1468_h_a_dec_0.pdf@EU-1-20-1468_h_a_dec_0.pdf@2020-08-21 00:00:00@Kaftrio@ivacaftor / tezacaftor / elexacaftor@True@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-20-1453_h_a_dec_0.pdf@EU-1-20-1453_h_a_dec_0.pdf@2020-06-18 00:00:00@Paliperidone Janssen-Cilag International@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1474_h_a_dec_0.pdf@EU-1-20-1474_h_a_dec_0.pdf@2020-08-25 00:00:00@BLENREP@belantamab mafodotin@True@False@adopted@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1471_h_a_dec_0.pdf@EU-1-20-1471_h_a_dec_0.pdf@2020-08-25 00:00:00@Idefirix@imlifidase@True@False@adopted@Hansa Biopharma AB@conditional@Parsed
EU-1-20-1478_h_a_dec_0.pdf@EU-1-20-1478_h_a_dec_0.pdf@2020-09-24 00:00:00@Zynrelef@bupivacaine/meloxicam@False@False@OD Not Found@Heron Therapeutics, B.V.@CMA Not Found@Parsed
EU-1-20-1457_h_a_dec_0.pdf@EU-1-20-1457_h_a_dec_0.pdf@2020-07-27 00:00:00@Xenleta@lefamulin@True@False@OD Not Found@Nabriva Therapeutics Ireland DAC@CMA Not Found@Parsed
EU-1-20-1469_h_a_dec_0.pdf@EU-1-20-1469_h_a_dec_0.pdf@2020-10-27 00:00:00@ARIKAYCE liposomal@amikacin@False@False@adopted@Insmed Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1482_h_a_dec_0.pdf@EU-1-20-1482_h_a_dec_0.pdf@2020-12-17 00:00:00@REKAMBYS@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1479_h_a_dec_0.pdf@EU-1-20-1479_h_a_dec_0.pdf@2020-05-11 00:00:00@Calquence@acalabrutinib@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1460_h_a_dec_0.pdf@EU-1-20-1460_h_a_dec_0.pdf@2020-07-31 00:00:00@Rozlytrek@entrectinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1473_h_a_dec_0.pdf@EU-1-20-1473_h_a_dec_0.pdf@2020-09-24 00:00:00@AYVAKYT@avapritinib@True@False@adopted@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1475_h_a_dec_0.pdf@EU-1-20-1475_h_a_dec_0.pdf@2020-09-17 00:00:00@Arsenic trioxide medac@arsenic trioxide@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-20-1480_h_a_dec_0.pdf@EU-1-20-1480_h_a_dec_0.pdf@2020-09-24 00:00:00@Jyseleca@filgotinib@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1486_h_a_dec_0.pdf@EU-1-20-1486_h_a_dec_0.pdf@2020-11-18 00:00:00@Nyvepria@pegfilgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1494_h_a_dec_0.pdf@EU-1-20-1494_h_a_dec_0.pdf@2020-09-12 00:00:00@Leqvio@inclisiran@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1490_h_a_dec_0.pdf@EU-1-20-1490_h_a_dec_0.pdf@2020-12-18 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1483_h_a_dec_0.pdf@EU-1-20-1483_h_a_dec_0.pdf@2020-11-18 00:00:00@MenQuadfi@Meningococcal group A, C, W and Y  conjugate vaccine@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1476_h_a_dec_0.pdf@EU-1-20-1476_h_a_dec_0.pdf@2020-10-28 00:00:00@Adakveo@crizanlizumab@True@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1487_h_a_dec_0.pdf@EU-1-20-1487_h_a_dec_0.pdf@2020-11-16 00:00:00@PHELINUN@melphalan@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_0.pdf@EU-1-20-1481_h_a_dec_0.pdf@2020-12-17 00:00:00@Vocabria@cabotegravir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1495_h_a_dec_0.pdf@EU-1-20-1495_h_a_dec_0.pdf@2020-12-17 00:00:00@Palforzia@defatted powder  Arachis hypogaea L.,  semen (peanuts)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-20-1484_h_a_dec_0.pdf@EU-1-20-1484_h_a_dec_0.pdf@2020-11-16 00:00:00@Supemtek@quadrivalent influenza vaccine  (recombinant, prepared in cell culture)@True@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1491_h_a_dec_0.pdf@EU-1-20-1491_h_a_dec_0.pdf@2020-12-18 00:00:00@Fintepla@fenfluramine@False@False@adopted@Zogenix ROI Limited@CMA Not Found@Parsed
EU-1-20-1462_h_a_dec_0.pdf@EU-1-20-1462_h_a_dec_0.pdf@2020-08-27 00:00:00@Livogiva@teriparatide@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-20-1477_h_a_dec_0.pdf@EU-1-20-1477_h_a_dec_0.pdf@2020-09-24 00:00:00@Fampridine Accord@fampridine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1485_h_a_dec_0.pdf@EU-1-20-1485_h_a_dec_0.pdf@2020-11-18 00:00:00@Obiltoxaximab SFL@obiltoxaximab@True@False@adopted@the applicant@exceptional@Parsed
EU-1-20-1488_h_a_dec_0.pdf@EU-1-20-1488_h_a_dec_0.pdf@2020-11-16 00:00:00@Rivaroxaban Accord@rivaroxaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1502_h_a_dec_0.pdf@EU-1-20-1502_h_a_dec_0.pdf@2021-07-01 00:00:00@Roclanda@Latanoprost / netarsudil@False@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1498_h_a_dec_0.pdf@EU-1-20-1498_h_a_dec_0.pdf@2020-09-12 00:00:00@TRIXEO AEROSPHERE@Formoterol /  glycopyrronium bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_0.pdf@EU-1-20-1492_h_a_dec_0.pdf@2020-12-14 00:00:00@Tecartus@autologous anti-CD19-transduced  CD3+ cells@True@True@adopted@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1496_h_a_dec_0.pdf@EU-1-20-1496_h_a_dec_0.pdf@2020-11-19 00:00:00@Oxlumo@lumasiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1506_h_a_dec_0.pdf@EU-1-20-1506_h_a_dec_0.pdf@2021-05-02 00:00:00@Kixelle@Insulin aspart@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1493_h_a_dec_0.pdf@EU-1-20-1493_h_a_dec_0.pdf@2020-12-17 00:00:00@Libmeldy@autologous CD34+ cell enriched population  that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral  vector encoding the human arylsulfatase A gene@True@True@adopted@Orchard Therapeutics (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-20-1503_h_a_dec_0.pdf@EU-1-20-1503_h_a_dec_0.pdf@2021-02-18 00:00:00@Heplisav B@hepatitis B surface antigen@False@False@OD Not Found@Dynavax GmbH@CMA Not Found@Parsed
EU-1-20-1510_h_a_dec_0.pdf@EU-1-20-1510_h_a_dec_0.pdf@2021-03-26 00:00:00@Oyavas@bevacizumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-20-1499_h_a_dec_0.pdf@EU-1-20-1499_h_a_dec_0.pdf@2021-11-01 00:00:00@Onbevzi@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1497_h_a_dec_0.pdf@EU-1-20-1497_h_a_dec_0.pdf@2020-12-21 00:00:00@Phesgo@pertuzumab / trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1514_h_a_dec_0.pdf@EU-1-20-1514_h_a_dec_0.pdf@2021-08-02 00:00:00@Inrebic@fedratinib@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1500_h_a_dec_0.pdf@EU-1-20-1500_h_a_dec_0.pdf@2021-07-01 00:00:00@Xofluza@baloxavir marboxil@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1504_h_a_dec_0.pdf@EU-1-20-1504_h_a_dec_0.pdf@2021-07-01 00:00:00@ELZONRIS@tagraxofusp@True@False@adopted@Stemline Therapeutics B.V.@exceptional@Parsed
EU-1-20-1507_h_a_dec_0.pdf@EU-1-20-1507_h_a_dec_0.pdf@2021-06-01 00:00:00@COVID-19 Vaccine Moderna@COVID-19 mRNA Vaccine (nucleoside modified)@True@False@OD Not Found@MODERNA BIOTECH SPAIN, S.L.@conditional@Parsed
EU-1-20-1511_h_a_dec_0.pdf@EU-1-20-1511_h_a_dec_0.pdf@2021-11-02 00:00:00@Sunitinib Accord@sunitinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1489_h_a_dec_0.pdf@EU-1-20-1489_h_a_dec_0.pdf@2020-11-16 00:00:00@EXPAREL liposomal@bupivacaine@False@False@OD Not Found@Pacira Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1501_h_a_dec_0.pdf@EU-1-20-1501_h_a_dec_0.pdf@2021-03-31 00:00:00@Sogroya@somapacitan@True@False@adopted@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1518_h_a_dec_0.pdf@EU-1-20-1518_h_a_dec_0.pdf@2021-04-02 00:00:00@Rukobia@fostemsavir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1512_h_a_dec_0.pdf@EU-1-20-1512_h_a_dec_0.pdf@2021-04-26 00:00:00@Abiraterone Accord@abiraterone acetate@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1519_h_a_dec_0.pdf@EU-1-20-1519_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka d.d. Novo mesto@lenalidomide@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1515_h_a_dec_0.pdf@EU-1-20-1515_h_a_dec_0.pdf@2021-04-21 00:00:00@Abevmy@bevacizumab@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1523_h_a_dec_0.pdf@EU-1-20-1523_h_a_dec_0.pdf@2021-11-02 00:00:00@Ogluo@glucagon@False@False@OD Not Found@Xeris Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1526_h_a_dec_0.pdf@EU-1-20-1526_h_a_dec_0.pdf@2021-11-02 00:00:00@TUKYSA@tucatinib@False@False@OD Not Found@Seagen B.V.@CMA Not Found@Parsed
EU-1-20-1505_h_a_dec_0.pdf@EU-1-20-1505_h_a_dec_0.pdf@2021-03-26 00:00:00@Byfavo@remimazolam@True@False@OD Not Found@PAION Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1520_h_a_dec_0.pdf@EU-1-20-1520_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1513_h_a_dec_0.pdf@EU-1-20-1513_h_a_dec_0.pdf@2021-11-02 00:00:00@Yuflyma@adalimumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-20-1517_h_a_dec_0.pdf@EU-1-20-1517_h_a_dec_0.pdf@2021-04-30 00:00:00@Sibnayal@potassium citrate/potassium hydrogen  carbonate@False@False@OD Not Found@ADVICENNE@CMA Not Found@Parsed
EU-1-20-1508_h_a_dec_0.pdf@EU-1-20-1508_h_a_dec_0.pdf@2021-01-18 00:00:00@Enhertu@trastuzumab deruxtecan@True@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1524_h_a_dec_0.pdf@EU-1-20-1524_h_a_dec_0.pdf@2021-03-26 00:00:00@Vazkepa@icosapent ethyl@True@False@OD Not Found@Amarin Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1527_h_a_dec_0.pdf@EU-1-20-1527_h_a_dec_0.pdf@2021-11-02 00:00:00@Retsevmo@selpercatinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@conditional@Parsed
EU-1-21-1530_h_a_dec_0.pdf@EU-1-21-1530_h_a_dec_0.pdf@2021-03-26 00:00:00@Ontozry@cenobamate@True@False@OD Not Found@Arvelle Therapeutics Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1531_h_a_dec_0.pdf@EU-1-21-1531_h_a_dec_0.pdf@2021-03-26 00:00:00@Evrysdi@risdiplam@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1534_h_a_dec_0.pdf@EU-1-21-1534_h_a_dec_0.pdf@2021-03-26 00:00:00@BroPair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1532_h_a_dec_0.pdf@EU-1-21-1532_h_a_dec_0.pdf@2021-03-26 00:00:00@Kesimpta@ofatumumab@False@False@OD Not Found@Novartis Ireland Limited@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_0.pdf@EU-1-20-1525_h_a_dec_0.pdf@2021-11-03 00:00:00@COVID-19 Vaccine Janssen@19 vaccine (Ad26.COV2-S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1521_h_a_dec_0.pdf@EU-1-20-1521_h_a_dec_0.pdf@2021-12-02 00:00:00@Lenalidomide Krka d.d.@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-21-1538_h_a_dec_0.pdf@EU-1-21-1538_h_a_dec_0.pdf@2021-04-21 00:00:00@JEMPERLI@dostarlimab@True@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-21-1535_h_a_dec_0.pdf@EU-1-21-1535_h_a_dec_0.pdf@2021-03-26 00:00:00@Pemazyre@pemigatinib@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-20-1528_h_a_dec_0.pdf@EU-1-20-1528_h_a_dec_0.pdf@2020-12-21 00:00:00@Comirnaty@COVID-19 mRNA  Vaccine (nucleoside modified)@True@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1542_h_a_dec_0.pdf@EU-1-21-1542_h_a_dec_0.pdf@2021-05-19 00:00:00@Copiktra@duvelisib@True@False@OD Not Found@Verastem Europe GmbH@CMA Not Found@Parsed
EU-1-20-1509_h_a_dec_0.pdf@EU-1-20-1509_h_a_dec_0.pdf@2021-03-26 00:00:00@Alymsys@bevacizumab@False@False@OD Not Found@Mabxience Research SL@CMA Not Found@Parsed
EU-1-21-1533_h_a_dec_0.pdf@EU-1-21-1533_h_a_dec_0.pdf@2021-03-26 00:00:00@Seffalair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1548_h_a_dec_0.pdf@EU-1-21-1548_h_a_dec_0.pdf@2021-05-19 00:00:00@Lydisilka@drospirenone / estetrol@False@False@OD Not Found@Estetra SRL@CMA Not Found@Parsed
EU-1-21-1539_h_a_dec_0.pdf@EU-1-21-1539_h_a_dec_0.pdf@2021-08-18 00:00:00@Abecma@idecabtagene vicleucel@True@True@adopted@Celgene Europe B.V.@conditional@Parsed
EU-1-21-1544_h_a_dec_0.pdf@EU-1-21-1544_h_a_dec_0.pdf@2021-04-30 00:00:00@Orladeyo@berotralstat@True@False@OD Not Found@Biocryst Ireland Limited@CMA Not Found@Parsed
EU-1-21-1536_h_a_dec_0.pdf@EU-1-21-1536_h_a_dec_0.pdf@2021-03-26 00:00:00@Thiotepa Riemser@thiotepa@False@False@OD Not Found@RIEMSER Pharma GmbH@CMA Not Found@Parsed
EU-1-21-1552_h_a_dec_0.pdf@EU-1-21-1552_h_a_dec_0.pdf@2021-06-17 00:00:00@Koselugo@selumetinib@True@False@adopted@AstraZeneca AB@conditional@Parsed
EU-1-21-1556_h_a_dec_0.pdf@EU-1-21-1556_h_a_dec_0.pdf@2021-06-17 00:00:00@Onureg@azacitidine@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-21-1537_h_a_dec_0.pdf@EU-1-21-1537_h_a_dec_0.pdf@2021-03-26 00:00:00@NEXPOVIO@selinexor@True@False@OD Not Found@Karyopharm Europe GmbH@conditional@Parsed
EU-1-21-1546_h_a_dec_0.pdf@EU-1-21-1546_h_a_dec_0.pdf@2021-07-22 00:00:00@Ozawave@pitolisant@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-21-1540_h_a_dec_0.pdf@EU-1-21-1540_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accord@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1549_h_a_dec_0.pdf@EU-1-21-1549_h_a_dec_0.pdf@2021-05-27 00:00:00@Efmody@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
EU-1-21-1541_h_a_dec_0.pdf@EU-1-21-1541_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accordpharma@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1547_h_a_dec_0.pdf@EU-1-21-1547_h_a_dec_0.pdf@2021-05-19 00:00:00@Drovelis@drospirenone / estetrol@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1550_h_a_dec_0.pdf@EU-1-21-1550_h_a_dec_0.pdf@2021-05-19 00:00:00@Ponvory@ponesimod@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-21-1553_h_a_dec_0.pdf@EU-1-21-1553_h_a_dec_0.pdf@2021-06-24 00:00:00@Abiraterone Krka@abiraterone acetate@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-21-1557_h_a_dec_0.pdf@EU-1-21-1557_h_a_dec_0.pdf@2021-06-21 00:00:00@Jayempi@azathioprine@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-21-1560_h_a_dec_0.pdf@EU-1-21-1560_h_a_dec_0.pdf@2021-06-17 00:00:00@Celsunax@ioflupane (123I)@False@False@OD Not Found@Pinax Pharma GmbH@CMA Not Found@Parsed
EU-1-21-1564_h_a_dec_0.pdf@EU-1-21-1564_h_a_dec_0.pdf@2021-07-16 00:00:00@Imcivree@setmelanotide@True@False@adopted@Rhythm Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-21-1554_h_a_dec_0.pdf@EU-1-21-1554_h_a_dec_0.pdf@2021-06-17 00:00:00@Adtralza@tralokinumab@True@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-21-1558_h_a_dec_0.pdf@EU-1-21-1558_h_a_dec_0.pdf@2021-07-16 00:00:00@Klisyri@tirbanibulin@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-21-1568_h_a_dec_0.pdf@EU-1-21-1568_h_a_dec_0.pdf@2021-09-22 00:00:00@Imatinib Koanaa@imatinib@False@False@OD Not Found@Koanaa Healthcare GmbH@CMA Not Found@Parsed
EU-1-21-1561_h_a_dec_0.pdf@EU-1-21-1561_h_a_dec_0.pdf@2021-07-16 00:00:00@Verquvo@vericiguat@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1555_h_a_dec_0.pdf@EU-1-21-1555_h_a_dec_0.pdf@2021-11-18 00:00:00@Gavreto@pralsetinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-21-1565_h_a_dec_0.pdf@EU-1-21-1565_h_a_dec_0.pdf@2021-07-16 00:00:00@Ryeqo@relugolix / estradiol / norethisterone  acetate@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1551_h_a_dec_0.pdf@EU-1-21-1551_h_a_dec_0.pdf@2021-06-17 00:00:00@Evkeeza@evinacumab@True@False@OD Not Found@Regeneron Ireland Designated Activity  Company (DAC)@exceptional@Parsed
EU-1-21-1559_h_a_dec_0.pdf@EU-1-21-1559_h_a_dec_0.pdf@2021-06-24 00:00:00@Enspryng@satralizumab@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1569_h_a_dec_0.pdf@EU-1-21-1569_h_a_dec_0.pdf@2021-11-18 00:00:00@QINLOCK@ripretinib@True@False@adopted@Deciphera Pharmaceuticals (Netherlands)  B.V.@CMA Not Found@Parsed
EU-1-21-1572_h_a_dec_0.pdf@EU-1-21-1572_h_a_dec_0.pdf@2021-08-18 00:00:00@Byooviz@ranibizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-21-1566_h_a_dec_0.pdf@EU-1-21-1566_h_a_dec_0.pdf@2021-07-16 00:00:00@Bylvay@odevixibat@True@False@adopted@Albireo AB@exceptional@Parsed
EU-1-21-1576_h_a_dec_0.pdf@EU-1-21-1576_h_a_dec_0.pdf@2021-11-22 00:00:00@Brukinsa@zanubrutinib@True@False@OD Not Found@BeiGene Ireland Limited@CMA Not Found@Parsed
EU-1-21-1570_h_a_dec_0.pdf@EU-1-21-1570_h_a_dec_0.pdf@2021-08-26 00:00:00@Minjuvi@tafasitamab@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1562_h_a_dec_0.pdf@EU-1-21-1562_h_a_dec_0.pdf@2021-12-17 00:00:00@Xevudy@sotrovimab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_0.pdf@EU-1-21-1529_h_a_dec_0.pdf@2021-01-29 00:00:00@COVID-19 Vaccine AstraZeneca@COVID-19 Vaccine (ChAdOx1-S [recombinant])@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-21-1582_h_a_dec_0.pdf@EU-1-21-1582_h_a_dec_0.pdf@2021-11-22 00:00:00@Artesunate Amivas@artesunate@True@False@adopted@Amivas Ireland Limited@CMA Not Found@Parsed
EU-1-21-1573_h_a_dec_0.pdf@EU-1-21-1573_h_a_dec_0.pdf@2021-08-18 00:00:00@Fingolimod Mylan@fingolimod@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1567_h_a_dec_0.pdf@EU-1-21-1567_h_a_dec_0.pdf@2021-07-16 00:00:00@Icatibant Accord@icatibant@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1577_h_a_dec_0.pdf@EU-1-21-1577_h_a_dec_0.pdf@2021-08-26 00:00:00@Voxzogo@vosoritide@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-21-1571_h_a_dec_0.pdf@EU-1-21-1571_h_a_dec_0.pdf@2021-08-20 00:00:00@Abiraterone Mylan@abiraterone acetate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1591_h_a_dec_0.pdf@EU-1-21-1591_h_a_dec_0.pdf@2021-12-13 00:00:00@Vaxneuvance@Pneumococcal polysaccharide  conjugate vaccine (15 ‑ valent, adsorbed)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-21-1574_h_a_dec_0.pdf@EU-1-21-1574_h_a_dec_0.pdf@2021-08-18 00:00:00@Evrenzo@roxadustat@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1587_h_a_dec_0.pdf@EU-1-21-1587_h_a_dec_0.pdf@2022-08-17 00:00:00@RAYVOW@lasmiditan@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-21-1599_h_a_dec_0.pdf@EU-1-21-1599_h_a_dec_0.pdf@2022-01-24 00:00:00@Vyepti@eptinezumab@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-21-1583_h_a_dec_0.pdf@EU-1-21-1583_h_a_dec_0.pdf@2021-11-15 00:00:00@Sugammadex Mylan@sugammadex@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1595_h_a_dec_0.pdf@EU-1-21-1595_h_a_dec_0.pdf@2021-12-13 00:00:00@ASPAVELI@pegcetacoplan@True@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-21-1592_h_a_dec_0.pdf@EU-1-21-1592_h_a_dec_0.pdf@2021-11-22 00:00:00@Trodelvy@sacituzumab govitecan@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-21-1588_h_a_dec_0.pdf@EU-1-21-1588_h_a_dec_0.pdf@2021-12-11 00:00:00@Rivaroxaban Mylan@rivaroxaban@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1600_h_a_dec_0.pdf@EU-1-21-1600_h_a_dec_0.pdf@2022-06-01 00:00:00@Tecovirimat SIGA@tecovirimat@True@False@OD Not Found@SIGA Technologies Netherlands B.V.@exceptional@Parsed
EU-1-21-1575_h_a_dec_0.pdf@EU-1-21-1575_h_a_dec_0.pdf@2021-08-20 00:00:00@Bimzelx@bimekizumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-21-1578_h_a_dec_0.pdf@EU-1-21-1578_h_a_dec_0.pdf@2022-02-21 00:00:00@Ontilyv@opicapone@False@False@OD Not Found@Bial - Portela & Cª, SA@CMA Not Found@Parsed
EU-1-21-1593_h_a_dec_0.pdf@EU-1-21-1593_h_a_dec_0.pdf@2021-09-12 00:00:00@Cibinqo@abrocitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1596_h_a_dec_0.pdf@EU-1-21-1596_h_a_dec_0.pdf@2022-02-16 00:00:00@Tepmetko@tepotinib@True@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-21-1585_h_a_dec_0.pdf@EU-1-21-1585_h_a_dec_0.pdf@2021-11-15 00:00:00@Vumerity@diroximel fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1601_h_a_dec_0.pdf@EU-1-21-1601_h_a_dec_0.pdf@2021-12-11 00:00:00@Ronapreve@casirivimab / imdevimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1589_h_a_dec_0.pdf@EU-1-21-1589_h_a_dec_0.pdf@2021-11-15 00:00:00@Hukyndra@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1579_h_a_dec_0.pdf@EU-1-21-1579_h_a_dec_0.pdf@2022-06-24 00:00:00@Nexviadyme@avalglucosidase alfa@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-21-1597_h_a_dec_0.pdf@EU-1-21-1597_h_a_dec_0.pdf@2021-12-11 00:00:00@Regkirona@regdanvimab@True@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-21-1586_h_a_dec_0.pdf@EU-1-21-1586_h_a_dec_0.pdf@2022-11-01 00:00:00@Voraxaze@glucarpidase@True@False@adopted@the applicant@exceptional@Parsed
EU-1-21-1594_h_a_dec_0.pdf@EU-1-21-1594_h_a_dec_0.pdf@2021-09-12 00:00:00@Rybrevant@amivantamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1602_h_a_dec_0.pdf@EU-1-21-1602_h_a_dec_0.pdf@2022-04-25 00:00:00@Uplizna@inebilizumab@True@False@adopted@Viela Bio B.V.@CMA Not Found@Parsed
EU-1-21-1607_h_a_dec_0.pdf@EU-1-21-1607_h_a_dec_0.pdf@2022-11-01 00:00:00@Lonapegsomatropin Ascendis Pharma@Lonapegsomatropin@True@False@adopted@Ascendis Pharma Endocrinology Division A/S,@CMA Not Found@Parsed
EU-1-21-1603_h_a_dec_0.pdf@EU-1-21-1603_h_a_dec_0.pdf@2022-06-01 00:00:00@Lumykras@sotorasib@True@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-21-1590_h_a_dec_0.pdf@EU-1-21-1590_h_a_dec_0.pdf@2021-12-11 00:00:00@Libmyris@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1615_h_a_dec_0.pdf@EU-1-21-1615_h_a_dec_0.pdf@2022-04-13 00:00:00@Padcev@enfortumab vedotin@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1623_h_a_dec_0.pdf@EU-1-21-1623_h_a_dec_0.pdf@2022-02-14 00:00:00@Saphnelo@anifrolumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-21-1619_h_a_dec_0.pdf@EU-1-21-1619_h_a_dec_0.pdf@2022-02-16 00:00:00@Sitagliptin/Metformin hydrochloride Mylan@sitagliptin/metformin hydrochloride@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1598_h_a_dec_0.pdf@EU-1-21-1598_h_a_dec_0.pdf@2021-09-12 00:00:00@Sitagliptin SUN@sitagliptin fumarate@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-21-1604_h_a_dec_0.pdf@EU-1-21-1604_h_a_dec_0.pdf@2022-06-01 00:00:00@Riltrava Aerosphere@formoterol / glycopyrronium  bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-21-1608_h_a_dec_0.pdf@EU-1-21-1608_h_a_dec_0.pdf@2022-06-01 00:00:00@Wegovy@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-21-1605_h_a_dec_0.pdf@EU-1-21-1605_h_a_dec_0.pdf@2022-11-01 00:00:00@Tavneos@avacopan@True@False@adopted@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-21-1620_h_a_dec_0.pdf@EU-1-21-1620_h_a_dec_0.pdf@2022-02-16 00:00:00@Sapropterin Dipharma@sapropterin@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-22-1633_h_a_dec_0.pdf@EU-1-22-1633_h_a_dec_0.pdf@2022-04-25 00:00:00@Sitagliptin Accord@Sitagliptin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1616_h_a_dec_0.pdf@EU-1-21-1616_h_a_dec_0.pdf@2022-02-16 00:00:00@Kerendia@finerenone@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-22-1629_h_a_dec_0.pdf@EU-1-22-1629_h_a_dec_0.pdf@2022-05-31 00:00:00@ZOLSKETIL pegylated liposomal@doxorubicin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1621_h_a_dec_0.pdf@EU-1-21-1621_h_a_dec_0.pdf@2022-02-14 00:00:00@OKEDI@risperidone@False@False@OD Not Found@Laboratorios Farmacéuticos Rovi, S.A.@CMA Not Found@Parsed
EU-1-21-1624_h_a_dec_0.pdf@EU-1-21-1624_h_a_dec_0.pdf@2022-06-24 00:00:00@COVID-19 Vaccine (inactivated, adjuvanted)  Valneva@COVID-19 vaccine (inactivated, adjuvanted, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-21-1606_h_a_dec_0.pdf@EU-1-21-1606_h_a_dec_0.pdf@2022-06-14 00:00:00@Yselty@linzagolix choline@True@False@OD Not Found@ObsEva Ireland Ltd.@CMA Not Found@Parsed
EU-1-22-1634_h_a_dec_0.pdf@EU-1-22-1634_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Mylan@dimethyl fumarate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1611_h_a_dec_0.pdf@EU-1-21-1611_h_a_dec_0.pdf@2022-03-24 00:00:00@Vildagliptin/Metformin hydrochloride Accord@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1617_h_a_dec_0.pdf@EU-1-21-1617_h_a_dec_0.pdf@2022-02-14 00:00:00@Ngenla@somatrogon@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-22-1630_h_a_dec_0.pdf@EU-1-22-1630_h_a_dec_0.pdf@2022-01-04 00:00:00@KIMMTRAK@tebentafusp@True@False@adopted@Immunocore Ireland Limited@CMA Not Found@Parsed
EU-1-21-1622_h_a_dec_0.pdf@EU-1-21-1622_h_a_dec_0.pdf@2022-02-14 00:00:00@Oxbryta@voxelotor@True@False@adopted@Global Blood Therapeutics Netherlands B.V.,@CMA Not Found@Parsed
EU-1-21-1612_h_a_dec_0.pdf@EU-1-21-1612_h_a_dec_0.pdf@2022-02-14 00:00:00@Apexxnar@pneumococcal polysaccharide conjugate  vaccine (20-valent, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-22-1625_h_a_dec_0.pdf@EU-1-22-1625_h_a_dec_0.pdf@2022-01-28 00:00:00@Paxlovid@trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide /  ritonavir@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-22-1638_h_a_dec_0.pdf@EU-1-22-1638_h_a_dec_0.pdf@2022-04-29 00:00:00@QUVIVIQ@daridorexant@True@False@OD Not Found@Idorsia Pharmaceuticals Deutschland GmbH,@CMA Not Found@Parsed
EU-1-22-1635_h_a_dec_0.pdf@EU-1-22-1635_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumerate Polpharma@dimethyl  fumarate@False@False@OD Not Found@Zakłady Farmaceutyczne POLPHARMA S.A.,@CMA Not Found@Parsed
EU-1-22-1631_h_a_dec_0.pdf@EU-1-22-1631_h_a_dec_0.pdf@2022-04-04 00:00:00@Breyanzi@lisocabtagene maraleucel@True@True@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-22-1642_h_a_dec_0.pdf@EU-1-22-1642_h_a_dec_0.pdf@2022-04-29 00:00:00@Orgovyx@relugolix@False@False@OD Not Found@Myovant Sciences Ireland Limited@CMA Not Found@Parsed
EU-1-22-1646_h_a_dec_0.pdf@EU-1-22-1646_h_a_dec_0.pdf@2022-05-19 00:00:00@Amifampridine SERB@amifampridine@False@False@OD Not Found@SERB S.A.@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_0.pdf@EU-1-21-1618_h_a_dec_0.pdf@2021-12-20 00:00:00@Nuvaxovid@COVID-19 Vaccine  (recombinant, adjuvanted)@True@False@OD Not Found@Novavax CZ, a.s.@conditional@Parsed
EU-1-22-1639_h_a_dec_0.pdf@EU-1-22-1639_h_a_dec_0.pdf@2022-04-25 00:00:00@Truvelog Mix 30@Insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-22-1632_h_a_dec_0.pdf@EU-1-22-1632_h_a_dec_0.pdf@2022-03-28 00:00:00@Stimufend@pegfilgrastim@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1637_h_a_dec_0.pdf@EU-1-22-1637_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Neuraxpharm@dimethyl  fumarate@False@False@OD Not Found@Laboratorios Lesvi, S.L.@CMA Not Found@Parsed
EU-1-22-1647_h_a_dec_0.pdf@EU-1-22-1647_h_a_dec_0.pdf@2022-05-24 00:00:00@Camcevi@leuprorelin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1655_h_a_dec_0.pdf@EU-1-22-1655_h_a_dec_0.pdf@2022-06-20 00:00:00@Pirfenidone AET@pirfenidone@False@False@OD Not Found@Alfred E. Tiefenbacher (GmbH & Co. KG)@CMA Not Found@Parsed
EU-1-22-1643_h_a_dec_0.pdf@EU-1-22-1643_h_a_dec_0.pdf@2022-04-25 00:00:00@Kapruvia@difelikefalin@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-22-1650_h_a_dec_0.pdf@EU-1-22-1650_h_a_dec_0.pdf@2022-06-20 00:00:00@Tabrecta@capmatinib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-22-1664_h_a_dec_0.pdf@EU-1-22-1664_h_a_dec_0.pdf@2022-07-15 00:00:00@Cevenfacta@eptacog beta (activated)@False@False@OD Not Found@Laboratoire français du Fractionnement et des  Biotechnologies@CMA Not Found@Parsed
EU-1-22-1640_h_a_dec_0.pdf@EU-1-22-1640_h_a_dec_0.pdf@2022-05-05 00:00:00@Amversio@betaine anhydrous@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-22-1659_h_a_dec_0.pdf@EU-1-22-1659_h_a_dec_0.pdf@2022-06-24 00:00:00@Xenpozyme@olipudase alfa@True@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-22-1648_h_a_dec_0.pdf@EU-1-22-1648_h_a_dec_0.pdf@2022-05-25 00:00:00@CARVYKTI@ciltacabtagene  autoleucel@True@True@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1651_h_a_dec_0.pdf@EU-1-22-1651_h_a_dec_0.pdf@2022-03-25 00:00:00@EVUSHELD@tixagevimab / cilgavimab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1644_h_a_dec_0.pdf@EU-1-22-1644_h_a_dec_0.pdf@2022-04-25 00:00:00@Inpremzia@insulin human (rDNA)@False@False@OD Not Found@Baxter Holding B.V.@CMA Not Found@Parsed
EU-1-22-1656_h_a_dec_0.pdf@EU-1-22-1656_h_a_dec_0.pdf@2022-07-15 00:00:00@Ertapenem SUN@ertapenem@False@False@OD Not Found@Sun Pharmaceutical Industries Europe B.V.@CMA Not Found@Parsed
EU-1-22-1666_h_a_dec_0.pdf@EU-1-22-1666_h_a_dec_0.pdf@2022-09-15 00:00:00@Celdoxome pegylated liposomal@doxorubicin  hydrochloride@False@False@OD Not Found@YES Pharmaceutical Development Services  GmbH@CMA Not Found@Parsed
EU-1-22-1641_h_a_dec_0.pdf@EU-1-22-1641_h_a_dec_0.pdf@2022-04-25 00:00:00@PreHevbri@Hepatitis B vaccine (recombinant,  adsorbed)@False@False@OD Not Found@VBI Vaccines B.V.@CMA Not Found@Parsed
EU-1-22-1645_h_a_dec_0.pdf@EU-1-22-1645_h_a_dec_0.pdf@2022-04-25 00:00:00@Vydura@rimegepant@True@False@OD Not Found@Biohaven Pharmaceutical Ireland DAC@CMA Not Found@Parsed
EU-1-22-1657_h_a_dec_0.pdf@EU-1-22-1657_h_a_dec_0.pdf@2022-07-15 00:00:00@Kinpeygo@budesonide@False@False@adopted@Calliditas Therapeutics AB@conditional@Parsed
EU-1-22-1669_h_a_dec_0.pdf@EU-1-22-1669_h_a_dec_0.pdf@2022-08-17 00:00:00@Pepaxti@melphalan flufenamide@False@False@OD Not Found@Oncopeptides AB (publ)@CMA Not Found@Parsed
EU-1-22-1667_h_a_dec_0.pdf@EU-1-22-1667_h_a_dec_0.pdf@2022-08-17 00:00:00@VEGZELMA@bevacizumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-22-1649_h_a_dec_0.pdf@EU-1-22-1649_h_a_dec_0.pdf@2022-03-06 00:00:00@Lunsumio@mosunetuzumab@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-22-1670_h_a_dec_0.pdf@EU-1-22-1670_h_a_dec_0.pdf@2022-08-25 00:00:00@Scemblix@asciminib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-22-1660_h_a_dec_0.pdf@EU-1-22-1660_h_a_dec_0.pdf@2022-07-18 00:00:00@Zokinvy@lonafarnib@True@False@adopted@EigerBio Europe Limited@exceptional@Parsed
EU-1-22-1652_h_a_dec_0.pdf@EU-1-22-1652_h_a_dec_0.pdf@2022-06-21 00:00:00@Filsuvez@birch bark extract@False@False@adopted@Amryt Pharmaceuticals DAC@CMA Not Found@Parsed
EU-1-22-1674_h_a_dec_0.pdf@EU-1-22-1674_h_a_dec_0.pdf@2022-10-08 00:00:00@Vyvgart@efgartigimod alfa@True@False@adopted@argenx BV@CMA Not Found@Parsed
EU-1-22-1671_h_a_dec_0.pdf@EU-1-22-1671_h_a_dec_0.pdf@2022-08-17 00:00:00@Sunlenca@lenacapavir@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-22-1678_h_a_dec_0.pdf@EU-1-22-1678_h_a_dec_0.pdf@2022-09-15 00:00:00@Lupkynis@voclosporin@True@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1661_h_a_dec_0.pdf@EU-1-22-1661_h_a_dec_0.pdf@2022-07-22 00:00:00@Sitagliptin/Metformin hydrochloride Accord@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1668_h_a_dec_0.pdf@EU-1-22-1668_h_a_dec_0.pdf@2022-08-24 00:00:00@Roctavian@valoctocogene  roxaparvovec@True@True@adopted@BioMarin International Limited@conditional@Parsed
EU-1-22-1658_h_a_dec_0.pdf@EU-1-22-1658_h_a_dec_0.pdf@2022-07-15 00:00:00@Ganirelix Gedeon Richter@ganirelix@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-22-1675_h_a_dec_0.pdf@EU-1-22-1675_h_a_dec_0.pdf@2022-08-23 00:00:00@TECVAYLI@teclistamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1679_h_a_dec_0.pdf@EU-1-22-1679_h_a_dec_0.pdf@2022-09-15 00:00:00@Opdualag@nivolumab/relatlimab@True@False@OD Not Found@Bristol Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-22-1673_h_a_dec_0.pdf@EU-1-22-1673_h_a_dec_0.pdf@2022-08-25 00:00:00@Ranivisio@ranibizumab@False@False@OD Not Found@Midas Pharma GmbH@CMA Not Found@Parsed
EU-1-22-1676_h_a_dec_0.pdf@EU-1-22-1676_h_a_dec_0.pdf@2022-09-19 00:00:00@Thalidomide Lipomed@Thalidomide@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-22-1680_h_a_dec_0.pdf@EU-1-22-1680_h_a_dec_0.pdf@2022-09-15 00:00:00@ilLuzyce@lutetium ( 177Lu) chloride@False@False@OD Not Found@Billev Pharma ApS@CMA Not Found@Parsed
EU-1-22-1683_h_a_dec_0.pdf@EU-1-22-1683_h_a_dec_0.pdf@2022-09-15 00:00:00@Vabysmo@Faricimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-22-1653_h_a_dec_0.pdf@EU-1-22-1653_h_a_dec_0.pdf@2022-07-18 00:00:00@Upstaza@eladocagene  exuparvovec@True@True@adopted@PTC Therapeutics International Limited@exceptional@Parsed
EU-1-22-1677_h_a_dec_0.pdf@EU-1-22-1677_h_a_dec_0.pdf@2022-09-19 00:00:00@Tezspire@tezepelumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1663_h_a_dec_0.pdf@EU-1-22-1663_h_a_dec_0.pdf@2022-07-15 00:00:00@Sugammadex Fresenius Kabi@sugammadex@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_0.pdf@EU-1-96-010_h_a_dec_0.pdf@Date is blank@Rilutek®@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-22-1681_h_a_dec_0.pdf@EU-1-22-1681_h_a_dec_0.pdf@2022-09-15 00:00:00@Amvuttra@vutrisiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1684_h_a_dec_0.pdf@EU-1-22-1684_h_a_dec_0.pdf@2022-09-15 00:00:00@NULIBRY@fosdenopterin@True@False@adopted@the applicant@exceptional@Parsed
EU-1-96-018_h_a_dec_0.pdf@EU-1-96-018_h_a_dec_0.pdf@1996-08-29 00:00:00@Rapilysin®@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-22-1685_h_a_dec_0.pdf@EU-1-22-1685_h_a_dec_0.pdf@2022-09-15 00:00:00@Mounjaro@tirzepatide@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_0.pdf@EU-1-96-015_h_a_dec_0.pdf@1996-08-08 00:00:00@1COMMISSION DECISION   8 August 1996   granting the marketing authorization for the medicinal    product for human use,    “EPIVIR ®”@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo  Group  Ltd.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_0.pdf@EU-1-96-011_h_a_dec_0.pdf@1996-06-21 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Sequus Pharmaceuticals, Incorporated@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_0.pdf@EU-1-96-022_h_a_dec_0.pdf@1996-09-27 00:00:00@ZYPREXA@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_0.pdf@EU-1-96-020_h_a_dec_0.pdf@1996-09-20 00:00:00@TWINRIX ADULT@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_0.pdf@EU-1-96-012_h_a_dec_0.pdf@Date is blank@Bondronat®@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_0.pdf@EU-1-96-007_h_a_dec_0.pdf@1996-04-30 00:00:00@HUMALOG®@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_0.pdf@EU-1-96-026_h_a_dec_0.pdf@Date is blank@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_0.pdf@EU-1-96-016_h_a_dec_0.pdf@Date is blank@Norvir®@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott laboratories Limited@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_0.pdf@EU-1-97-030_h_a_dec_0.pdf@1997-02-21 00:00:00@INSUMAN@Insulin human@NAS before 2012@NA before 2012@NA before 2000@HOECHST AG@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_0.pdf@EU-1-96-027_h_a_dec_0.pdf@1996-12-11 00:00:00@HYCAMTIN@Topotecan hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_0.pdf@EU-1-97-044_h_a_dec_0.pdf@1997-08-27 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_0.pdf@EU-1-97-039_h_a_dec_0.pdf@1997-06-23 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_0.pdf@EU-1-97-029_h_a_dec_0.pdf@1997-02-10 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_0.pdf@EU-1-97-045_h_a_dec_0.pdf@1997-08-14 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@NA before 2000@INFAI@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_0.pdf@EU-1-97-046_h_a_dec_0.pdf@1997-08-27 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_0.pdf@EU-1-97-050_h_a_dec_0.pdf@1997-10-14 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_0.pdf@EU-1-97-055_h_a_dec_0.pdf@1998-05-02 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_0.pdf@EU-1-95-003_h_a_dec_0.pdf@Date is blank@BETAFERON@Interferon beta-lb@NAS before 2012@NA before 2012@NA before 2000@Schering  Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_0.pdf@EU-1-98-058_h_a_dec_0.pdf@2022-03-18 00:00:00@COMBIVIR@lamivudine/zidovudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_0.pdf@EU-1-98-063_h_a_dec_0.pdf@1998-05-04 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_0.pdf@EU-1-96-008_h_a_dec_0.pdf@1996-05-03 00:00:00@Puregon®@Follitropin ß@NAS before 2012@NA before 2012@NA before 2000@Organon (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_0.pdf@EU-1-96-004_h_a_dec_0.pdf@1996-02-14 00:00:00@FARESTON@toremifene@NAS before 2012@NA before 2012@NA before 2000@Ercopharm A/S@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_0.pdf@EU-1-97-047_h_a_dec_0.pdf@1997-08-27 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe, B.V.@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_0.pdf@EU-1-97-051_h_a_dec_0.pdf@1998-02-23 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_0.pdf@EU-1-97-057_h_a_dec_0.pdf@1998-02-05 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@NA before 2000@CIS bio international@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_0.pdf@EU-1-98-066_h_a_dec_0.pdf@2022-05-12 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-064_h_a_dec_0.pdf@EU-1-98-064_h_a_dec_0.pdf@1998-07-05 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@NA before 2000@B.S.I.A. Limited@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_0.pdf@EU-1-98-065_h_a_dec_0.pdf@1980-01-01 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@NA before 2000@MAH Not Found@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_0.pdf@EU-1-98-070_h_a_dec_0.pdf@2022-10-15 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_0.pdf@EU-1-97-053_h_a_dec_0.pdf@1997-11-17 00:00:00@CEREZYME@imiglucerase@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_0.pdf@EU-1-98-074_h_a_dec_0.pdf@1998-05-08 00:00:00@CELVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_0.pdf@EU-1-98-080_h_a_dec_0.pdf@1998-09-18 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@NA before 2000@Laboratoires 3M Santé@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_0.pdf@EU-1-97-049_h_a_dec_0.pdf@1997-08-27 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_0.pdf@EU-1-98-082_h_a_dec_0.pdf@1998-09-16 00:00:00@COMTESS@entacapone@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_0.pdf@EU-1-98-067_h_a_dec_0.pdf@1998-02-06 00:00:00@MABTHERA@Rituximab@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_0.pdf@EU-1-98-081_h_a_dec_0.pdf@1998-09-22 00:00:00@COMTAN@entacapone@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_0.pdf@EU-1-98-076_h_a_dec_0.pdf@1998-08-17 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_0.pdf@EU-1-98-071_h_a_dec_0.pdf@1998-07-29 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_0.pdf@EU-1-98-084_h_a_dec_0.pdf@1998-09-10 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_0.pdf@EU-1-98-086_h_a_dec_0.pdf@1998-10-15 00:00:00@COAPROVEL@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_0.pdf@EU-1-98-073_h_a_dec_0.pdf@1998-05-08 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_0.pdf@EU-1-98-077_h_a_dec_0.pdf@1998-09-14 00:00:00@VIAGRA@sildenafil@NAS before 2012@NA before 2012@NA before 2000@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_0.pdf@EU-1-98-085_h_a_dec_0.pdf@1998-10-16 00:00:00@KARVEZIDE@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Bristol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_0.pdf@EU-1-98-090_h_a_dec_0.pdf@1998-12-16 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_0.pdf@EU-1-98-095_h_a_dec_0.pdf@1999-01-27 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@NA before 2000@Alcon Laboratories (UK) Ltd@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_0.pdf@EU-1-98-091_h_a_dec_0.pdf@1998-12-16 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_0.pdf@EU-1-99-100_h_a_dec_0.pdf@1999-04-13 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@NA before 2000@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_0.pdf@EU-1-98-096_h_a_dec_0.pdf@1999-01-26 00:00:00@TEMODAL@Temozolomide@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_0.pdf@EU-1-99-103_h_a_dec_0.pdf@1999-04-13 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_0.pdf@EU-1-97-031_h_a_dec_0.pdf@1998-02-04 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_0.pdf@EU-1-98-069_h_a_dec_0.pdf@1998-07-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_0.pdf@EU-1-98-089_h_a_dec_0.pdf@1998-11-12 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_0.pdf@EU-1-99-107_h_a_dec_0.pdf@1999-07-05 00:00:00@REBETOL@ribavirin@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_0.pdf@EU-1-98-092_h_a_dec_0.pdf@1998-04-12 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_0.pdf@EU-1-99-111_h_a_dec_0.pdf@1999-05-28 00:00:00@STOCRIN@efavirenz@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_0.pdf@EU-1-99-116_h_a_dec_0.pdf@1999-08-13 00:00:00@REMICADE@infliximab@NAS before 2012@NA before 2012@NA before 2000@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_0.pdf@EU-1-99-119_h_a_dec_0.pdf@1999-07-09 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_0.pdf@EU-1-99-097_h_a_dec_0.pdf@1999-04-13 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_0.pdf@EU-1-99-108_h_a_dec_0.pdf@1999-08-25 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@NA before 2000@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_0.pdf@EU-1-99-123_h_a_dec_0.pdf@2000-01-28 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_0.pdf@EU-1-99-124_h_a_dec_0.pdf@2000-01-20 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@NA before 2000@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_0.pdf@EU-1-99-109_h_a_dec_0.pdf@1999-01-07 00:00:00@INTEGRILIN@Eptifibatide@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_0.pdf@EU-1-97-033_h_a_dec_0.pdf@1997-03-13 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_0.pdf@EU-1-99-120_h_a_dec_0.pdf@1999-08-12 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_0.pdf@EU-1-99-125_h_a_dec_0.pdf@2000-03-02 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_0.pdf@EU-1-99-117_h_a_dec_0.pdf@1999-08-13 00:00:00@SYNAGIS@palivizumab@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_0.pdf@EU-1-99-110_h_a_dec_0.pdf@1999-05-28 00:00:00@SUSTIVA@efavirenz@NAS before 2012@NA before 2012@NA before 2000@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_0.pdf@EU-1-99-122_h_a_dec_0.pdf@2000-09-03 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_0.pdf@EU-1-99-118_h_a_dec_0.pdf@1999-02-09 00:00:00@ARAVA@leflunomide@NAS before 2012@NA before 2012@NA before 2000@Hoechst marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_0.pdf@EU-1-99-126_h_a_dec_0.pdf@2000-03-02 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@NA before 2000@Wyeth Research (UK) Limited@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_0.pdf@EU-1-99-112_h_a_dec_0.pdf@1999-08-07 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_0.pdf@EU-1-99-114_h_a_dec_0.pdf@1999-07-29 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_0.pdf@EU-1-00-130_h_a_dec_0.pdf@2000-05-17 00:00:00@Orgalutran@Ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_0.pdf@EU-1-00-129_h_a_dec_0.pdf@2000-09-03 00:00:00@Azopt@brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_1.pdf@EU-1-00-129_h_a_dec_1.pdf@2000-11-16 00:00:00@AZOPT@brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_1.pdf@EU-1-00-130_h_a_dec_1.pdf@2001-09-18 00:00:00@Orgalutran@Ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_10.pdf@EU-1-00-129_h_a_dec_10.pdf@2012-06-15 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_0.pdf@EU-1-00-133_h_a_dec_0.pdf@2000-06-27 00:00:00@OPTISULIN insulin glargine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_0.pdf@EU-1-00-135_h_a_dec_0.pdf@2000-07-27 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_0.pdf@EU-1-00-141_h_a_dec_0.pdf@2000-07-13 00:00:00@MYOCET@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@The Liposome Company Ltd@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_0.pdf@EU-1-00-134_h_a_dec_0.pdf@2000-09-06 00:00:00@Lantus@insulin glargin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_10.pdf@EU-1-00-130_h_a_dec_10.pdf@2011-01-27 00:00:00@Orgalutran@ganirelix@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_0.pdf@EU-1-00-140_h_a_dec_0.pdf@2000-07-27 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@CIBA Vision Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_1.pdf@EU-1-00-135_h_a_dec_1.pdf@2001-02-22 00:00:00@DaTSCAN@Ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_1.pdf@EU-1-00-141_h_a_dec_1.pdf@2001-03-20 00:00:00@MYOCET@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@The Liposome Company Ltd@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_11.pdf@EU-1-00-130_h_a_dec_11.pdf@2012-10-09 00:00:00@Orgalutran@ganirelix@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_1.pdf@EU-1-00-140_h_a_dec_1.pdf@2001-02-16 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Ophtalmics Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_11.pdf@EU-1-00-129_h_a_dec_11.pdf@2014-05-03 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_1.pdf@EU-1-00-133_h_a_dec_1.pdf@2002-09-08 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_1.pdf@EU-1-00-134_h_a_dec_1.pdf@2001-06-02 00:00:00@Lantus@insulin glargin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_10.pdf@EU-1-00-135_h_a_dec_10.pdf@2006-07-28 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_10.pdf@EU-1-00-141_h_a_dec_10.pdf@2008-11-24 00:00:00@Myocet@Doxorubicin@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_10.pdf@EU-1-00-140_h_a_dec_10.pdf@2005-03-29 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_10.pdf@EU-1-00-133_h_a_dec_10.pdf@2008-03-31 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_10.pdf@EU-1-00-134_h_a_dec_10.pdf@2004-09-20 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_11.pdf@EU-1-00-135_h_a_dec_11.pdf@2006-09-18 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_12.pdf@EU-1-00-129_h_a_dec_12.pdf@2015-04-13 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_11.pdf@EU-1-00-140_h_a_dec_11.pdf@2005-04-07 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_11.pdf@EU-1-00-133_h_a_dec_11.pdf@2008-06-25 00:00:00@Optisulin@insulin glargine@NAS before 2012@True@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
le before 2006@Parsed
EU-1-00-141_h_a_dec_11.pdf@EU-1-00-141_h_a_dec_11.pdf@2010-05-26 00:00:00@Myocet@Doxorubicin@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_12.pdf@EU-1-00-135_h_a_dec_12.pdf@2007-03-29 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_13.pdf@EU-1-00-130_h_a_dec_13.pdf@2017-11-04 00:00:00@Orgalutran@ganirelix@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_12.pdf@EU-1-00-140_h_a_dec_12.pdf@2007-05-06 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_13.pdf@EU-1-00-129_h_a_dec_13.pdf@2017-05-31 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_13.pdf@EU-1-00-135_h_a_dec_13.pdf@2007-04-24 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_12.pdf@EU-1-00-134_h_a_dec_12.pdf@2005-04-27 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_12.pdf@EU-1-00-133_h_a_dec_12.pdf@2008-09-17 00:00:00@Optisulin@insulin glargine@NAS before 2012@True@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_13.pdf@EU-1-00-140_h_a_dec_13.pdf@2008-03-17 00:00:00@Visudyne@verteporfin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
ot available before 2006@Parsed
EU-1-00-133_h_a_dec_13.pdf@EU-1-00-133_h_a_dec_13.pdf@2008-11-28 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_13.pdf@EU-1-00-141_h_a_dec_13.pdf@2011-03-24 00:00:00@Myocet@Doxorubicin@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_14.pdf@EU-1-00-130_h_a_dec_14.pdf@2018-06-29 00:00:00@Orgalutran@ganirelix@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_14.pdf@EU-1-00-135_h_a_dec_14.pdf@2010-07-28 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@False@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_14.pdf@EU-1-00-129_h_a_dec_14.pdf@2018-12-04 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_14.pdf@EU-1-00-140_h_a_dec_14.pdf@2008-04-23 00:00:00@Visudyne@verteporfin@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_14.pdf@EU-1-00-134_h_a_dec_14.pdf@2006-05-05 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_14.pdf@EU-1-00-141_h_a_dec_14.pdf@2012-02-17 00:00:00@Myocet@Doxorubicin@False@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_15.pdf@EU-1-00-135_h_a_dec_15.pdf@2011-04-18 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@False@OD Not Found@GE Healthcare  Limited@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_14.pdf@EU-1-00-133_h_a_dec_14.pdf@2009-09-03 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_15.pdf@EU-1-00-134_h_a_dec_15.pdf@2006-07-08 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_15.pdf@EU-1-00-140_h_a_dec_15.pdf@2008-04-12 00:00:00@Visudyne@verteporfin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_15.pdf@EU-1-00-141_h_a_dec_15.pdf@2012-10-29 00:00:00@Myocet@Doxorubicin@False@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_16.pdf@EU-1-00-135_h_a_dec_16.pdf@2013-03-22 00:00:00@DaTSCAN@Ioflupane (123I)@False@False@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_15.pdf@EU-1-00-130_h_a_dec_15.pdf@2019-04-10 00:00:00@Orgalutran@ganirelix@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_15.pdf@EU-1-00-133_h_a_dec_15.pdf@2009-09-17 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_15.pdf@EU-1-00-129_h_a_dec_15.pdf@2019-06-06 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_16.pdf@EU-1-00-134_h_a_dec_16.pdf@2006-01-09 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_16.pdf@EU-1-00-141_h_a_dec_16.pdf@2013-01-14 00:00:00@Myocet@Doxorubicin@False@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_16.pdf@EU-1-00-133_h_a_dec_16.pdf@2009-04-11 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_16.pdf@EU-1-00-140_h_a_dec_16.pdf@2010-03-23 00:00:00@Visudyne@verteporfin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_17.pdf@EU-1-00-135_h_a_dec_17.pdf@2017-09-01 00:00:00@DaTSCAN@Ioflupane (123I)@False@False@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_17.pdf@EU-1-00-134_h_a_dec_17.pdf@2006-10-31 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_16.pdf@EU-1-00-130_h_a_dec_16.pdf@2021-04-13 00:00:00@Orgalutran@ganirelix@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_17.pdf@EU-1-00-141_h_a_dec_17.pdf@2013-02-10 00:00:00@Myocet@Doxorubicin@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_17.pdf@EU-1-00-133_h_a_dec_17.pdf@2010-05-05 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_17.pdf@EU-1-00-140_h_a_dec_17.pdf@2010-05-05 00:00:00@Visudyne@verteporfin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_2.pdf@EU-1-00-130_h_a_dec_2.pdf@2002-04-18 00:00:00@Orgalutran@ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_18.pdf@EU-1-00-134_h_a_dec_18.pdf@2007-11-23 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_16.pdf@EU-1-00-129_h_a_dec_16.pdf@2022-06-24 00:00:00@Azopt@Brinzolamide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_3.pdf@EU-1-00-130_h_a_dec_3.pdf@2003-07-18 00:00:00@Orgalutran@ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_18.pdf@EU-1-00-135_h_a_dec_18.pdf@2019-05-03 00:00:00@DaTSCAN@Ioflupane (123I)@False@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_18.pdf@EU-1-00-141_h_a_dec_18.pdf@2015-01-27 00:00:00@Myocet@Doxorubicin@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_18.pdf@EU-1-00-140_h_a_dec_18.pdf@2011-03-14 00:00:00@Visudyne@verteporfin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_18.pdf@EU-1-00-133_h_a_dec_18.pdf@2011-01-24 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_19.pdf@EU-1-00-134_h_a_dec_19.pdf@2008-06-25 00:00:00@Lantus@insulin glargine@NAS before 2012@True@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_19.pdf@EU-1-00-135_h_a_dec_19.pdf@2022-03-02 00:00:00@DaTSCAN@Ioflupane (123I)@False@False@OD Not Found@GE Healthcare B.V.@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_4.pdf@EU-1-00-130_h_a_dec_4.pdf@2005-03-03 00:00:00@Orgalutran@ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_19.pdf@EU-1-00-141_h_a_dec_19.pdf@2019-07-18 00:00:00@Myocet@Doxorubicin@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_19.pdf@EU-1-00-133_h_a_dec_19.pdf@2011-10-08 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_2.pdf@EU-1-00-134_h_a_dec_2.pdf@2002-01-28 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_2.pdf@EU-1-00-140_h_a_dec_2.pdf@2001-03-20 00:00:00@VISUDYNE@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Ophtalmics Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_2.pdf@EU-1-00-129_h_a_dec_2.pdf@2002-12-11 00:00:00@Azopt@Brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-130_h_a_dec_5.pdf@EU-1-00-130_h_a_dec_5.pdf@2005-10-25 00:00:00@Orgalutran@ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_2.pdf@EU-1-00-141_h_a_dec_2.pdf@1980-01-01 00:00:00@MYOCET@Doxorubicin@NAS before 2012@NA before 2012@NA before 2000@The Liposome Company Ltd@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_2.pdf@EU-1-00-133_h_a_dec_2.pdf@2004-02-03 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-135_h_a_dec_2.pdf@EU-1-00-135_h_a_dec_2.pdf@2002-07-05 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_20.pdf@EU-1-00-134_h_a_dec_20.pdf@2008-09-17 00:00:00@Lantus@insulin glargine@NAS before 2012@True@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_20.pdf@EU-1-00-140_h_a_dec_20.pdf@2012-10-23 00:00:00@Visudyne@verteporfin@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_6.pdf@EU-1-00-130_h_a_dec_6.pdf@2007-04-06 00:00:00@Orgalutran@ganirelix@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_20.pdf@EU-1-00-133_h_a_dec_20.pdf@2011-08-24 00:00:00@Optisulin@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_3.pdf@EU-1-00-135_h_a_dec_3.pdf@2002-09-09 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_3.pdf@EU-1-00-129_h_a_dec_3.pdf@2005-02-06 00:00:00@Azopt@Brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_21.pdf@EU-1-00-134_h_a_dec_21.pdf@2008-11-28 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_20.pdf@EU-1-00-141_h_a_dec_20.pdf@2020-10-19 00:00:00@Myocet  liposomal@Doxorubicin@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_4.pdf@EU-1-00-135_h_a_dec_4.pdf@2002-10-17 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Amersham plc@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_21.pdf@EU-1-00-133_h_a_dec_21.pdf@2012-04-20 00:00:00@Optisulin@insulin glargine@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_7.pdf@EU-1-00-130_h_a_dec_7.pdf@2008-01-18 00:00:00@Orgalutran@ganirelix@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_4.pdf@EU-1-00-129_h_a_dec_4.pdf@2007-02-20 00:00:00@Azopt@Brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_21.pdf@EU-1-00-140_h_a_dec_21.pdf@2015-09-18 00:00:00@Visudyne@verteporfin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_5.pdf@EU-1-00-135_h_a_dec_5.pdf@2002-10-28 00:00:00@DaTSCAN@ioflupane (123I)@NAS before 2012@NA before 2012@OD Not Found@Nycomed Amersham plc@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_22.pdf@EU-1-00-134_h_a_dec_22.pdf@2009-09-17 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_22.pdf@EU-1-00-133_h_a_dec_22.pdf@2012-05-25 00:00:00@Optisulin@insulin glargine@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_8.pdf@EU-1-00-130_h_a_dec_8.pdf@2010-01-20 00:00:00@Orgalutran@ganirelix@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_23.pdf@EU-1-00-134_h_a_dec_23.pdf@2009-04-11 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_6.pdf@EU-1-00-135_h_a_dec_6.pdf@2004-01-20 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Amersham plc@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_3.pdf@EU-1-00-141_h_a_dec_3.pdf@2002-03-21 00:00:00@Myocet@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_22.pdf@EU-1-00-140_h_a_dec_22.pdf@2016-12-19 00:00:00@Visudyne@verteporfin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_6.pdf@EU-1-00-129_h_a_dec_6.pdf@2007-11-30 00:00:00@Azopt@Brinzolamide@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-130_h_a_dec_9.pdf@EU-1-00-130_h_a_dec_9.pdf@2010-10-05 00:00:00@Orgalutran@ganirelix@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_23.pdf@EU-1-00-133_h_a_dec_23.pdf@2013-12-20 00:00:00@Optisulin@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_7.pdf@EU-1-00-135_h_a_dec_7.pdf@2005-02-28 00:00:00@DaTSCAN@ioflupane ( 123i)@NAS before 2012@NA before 2012@OD Not Found@Amersham plc@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_24.pdf@EU-1-00-134_h_a_dec_24.pdf@2010-05-05 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-129_h_a_dec_7.pdf@EU-1-00-129_h_a_dec_7.pdf@2008-06-20 00:00:00@Azopt@Brinzolamide@NAS before 2012@True@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_4.pdf@EU-1-00-141_h_a_dec_4.pdf@2002-12-04 00:00:00@Myocet@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_23.pdf@EU-1-00-140_h_a_dec_23.pdf@2018-06-07 00:00:00@Visudyne@verteporfin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_8.pdf@EU-1-00-135_h_a_dec_8.pdf@2005-07-09 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@Amersham Plc@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_8.pdf@EU-1-00-129_h_a_dec_8.pdf@2010-01-29 00:00:00@Azopt@Brinzolamide@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_24.pdf@EU-1-00-133_h_a_dec_24.pdf@2014-12-15 00:00:00@Optisulin@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_25.pdf@EU-1-00-134_h_a_dec_25.pdf@2011-01-24 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-135_h_a_dec_9.pdf@EU-1-00-135_h_a_dec_9.pdf@2006-06-16 00:00:00@DaTSCAN@ioflupane ( 123I)@NAS before 2012@NA before 2012@OD Not Found@GE Healthcare Limited@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_5.pdf@EU-1-00-141_h_a_dec_5.pdf@2002-12-18 00:00:00@Myocet@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-129_h_a_dec_9.pdf@EU-1-00-129_h_a_dec_9.pdf@2011-09-16 00:00:00@Azopt@Brinzolamide@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_26.pdf@EU-1-00-134_h_a_dec_26.pdf@2011-10-08 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_25.pdf@EU-1-00-133_h_a_dec_25.pdf@2015-02-17 00:00:00@Optisulin@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_24.pdf@EU-1-00-140_h_a_dec_24.pdf@2019-07-25 00:00:00@Visudyne@verteporfin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_27.pdf@EU-1-00-134_h_a_dec_27.pdf@2011-08-24 00:00:00@Lantus@insulin glargine@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_6.pdf@EU-1-00-141_h_a_dec_6.pdf@2005-09-15 00:00:00@Myocet@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_26.pdf@EU-1-00-133_h_a_dec_26.pdf@2015-04-24 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_28.pdf@EU-1-00-134_h_a_dec_28.pdf@2012-04-20 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_25.pdf@EU-1-00-140_h_a_dec_25.pdf@2020-05-11 00:00:00@Visudyne@verteporfin@False@False@OD Not Found@CHEPLAPHARM Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-00-141_h_a_dec_7.pdf@EU-1-00-141_h_a_dec_7.pdf@2006-07-28 00:00:00@Myocet@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_0.pdf@EU-1-00-142_h_a_dec_0.pdf@2000-01-08 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_27.pdf@EU-1-00-133_h_a_dec_27.pdf@2016-06-30 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_3.pdf@EU-1-00-140_h_a_dec_3.pdf@2001-10-09 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Ophtalmics Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_29.pdf@EU-1-00-134_h_a_dec_29.pdf@2012-05-25 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_1.pdf@EU-1-00-142_h_a_dec_1.pdf@2000-11-29 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_8.pdf@EU-1-00-141_h_a_dec_8.pdf@2007-04-06 00:00:00@Myocet@Doxorubicin@NAS before 2012@NA before 2012@OD Not Found@Zeneus Pharma Limited@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_28.pdf@EU-1-00-133_h_a_dec_28.pdf@2017-03-10 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_10.pdf@EU-1-00-142_h_a_dec_10.pdf@2005-10-06 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-141_h_a_dec_9.pdf@EU-1-00-141_h_a_dec_9.pdf@2008-10-27 00:00:00@Myocet@Doxorubicin@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_29.pdf@EU-1-00-133_h_a_dec_29.pdf@2018-07-12 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_3.pdf@EU-1-00-134_h_a_dec_3.pdf@2002-05-12 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_4.pdf@EU-1-00-140_h_a_dec_4.pdf@2002-05-24 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Ophtalmics Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_11.pdf@EU-1-00-142_h_a_dec_11.pdf@2005-09-15 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_3.pdf@EU-1-00-133_h_a_dec_3.pdf@2004-07-13 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_0.pdf@EU-1-00-143_h_a_dec_0.pdf@2000-04-08 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@NA before 2000@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_0.pdf@EU-1-00-145_h_a_dec_0.pdf@2000-08-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_30.pdf@EU-1-00-134_h_a_dec_30.pdf@2013-12-20 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_5.pdf@EU-1-00-140_h_a_dec_5.pdf@2002-08-22 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Ophtalmics Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_1.pdf@EU-1-00-143_h_a_dec_1.pdf@2001-10-24 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_30.pdf@EU-1-00-133_h_a_dec_30.pdf@2019-11-28 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_12.pdf@EU-1-00-142_h_a_dec_12.pdf@2005-05-10 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_1.pdf@EU-1-00-145_h_a_dec_1.pdf@2002-05-22 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-140_h_a_dec_6.pdf@EU-1-00-140_h_a_dec_6.pdf@2003-01-14 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Ophtalmics Europe Ltd@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_10.pdf@EU-1-00-143_h_a_dec_10.pdf@2007-01-29 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_31.pdf@EU-1-00-133_h_a_dec_31.pdf@2020-01-16 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_31.pdf@EU-1-00-134_h_a_dec_31.pdf@2014-12-15 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_13.pdf@EU-1-00-142_h_a_dec_13.pdf@2005-05-10 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_10.pdf@EU-1-00-145_h_a_dec_10.pdf@2007-09-03 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_7.pdf@EU-1-00-140_h_a_dec_7.pdf@2003-09-22 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_32.pdf@EU-1-00-133_h_a_dec_32.pdf@2022-05-19 00:00:00@Toujeo@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_11.pdf@EU-1-00-143_h_a_dec_11.pdf@2007-07-24 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_32.pdf@EU-1-00-134_h_a_dec_32.pdf@2015-02-17 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_11.pdf@EU-1-00-145_h_a_dec_11.pdf@2007-04-24 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_14.pdf@EU-1-00-142_h_a_dec_14.pdf@2006-03-29 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_8.pdf@EU-1-00-140_h_a_dec_8.pdf@2004-01-14 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_4.pdf@EU-1-00-133_h_a_dec_4.pdf@2004-08-31 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_12.pdf@EU-1-00-143_h_a_dec_12.pdf@2007-10-30 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_12.pdf@EU-1-00-145_h_a_dec_12.pdf@2008-05-09 00:00:00@Herceptin@trastuzumab@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_33.pdf@EU-1-00-134_h_a_dec_33.pdf@2015-07-28 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
arsed
EU-1-00-142_h_a_dec_15.pdf@EU-1-00-142_h_a_dec_15.pdf@2007-04-24 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-140_h_a_dec_9.pdf@EU-1-00-140_h_a_dec_9.pdf@2005-01-26 00:00:00@Visudyne@verteporfin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_5.pdf@EU-1-00-133_h_a_dec_5.pdf@2005-10-01 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_13.pdf@EU-1-00-143_h_a_dec_13.pdf@2007-12-18 00:00:00@KOGENATE Bayer@Recombinant coagulation factor  VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_1.pdf@EU-1-00-146_h_a_dec_1.pdf@2002-07-18 00:00:00@Keppra@levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_13.pdf@EU-1-00-145_h_a_dec_13.pdf@2008-09-09 00:00:00@Herceptin@trastuzumab@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_34.pdf@EU-1-00-134_h_a_dec_34.pdf@2017-03-10 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_16.pdf@EU-1-00-142_h_a_dec_16.pdf@2007-08-27 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_6.pdf@EU-1-00-133_h_a_dec_6.pdf@2005-04-27 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_35.pdf@EU-1-00-134_h_a_dec_35.pdf@2019-08-04 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_14.pdf@EU-1-00-143_h_a_dec_14.pdf@2022-12-01 00:00:01@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@False@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_10.pdf@EU-1-00-146_h_a_dec_10.pdf@2005-02-14 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_14.pdf@EU-1-00-145_h_a_dec_14.pdf@2008-02-12 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_17.pdf@EU-1-00-142_h_a_dec_17.pdf@2007-12-18 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_7.pdf@EU-1-00-133_h_a_dec_7.pdf@2005-08-07 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_36.pdf@EU-1-00-134_h_a_dec_36.pdf@2020-01-16 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_11.pdf@EU-1-00-146_h_a_dec_11.pdf@2005-04-27 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_15.pdf@EU-1-00-145_h_a_dec_15.pdf@2010-01-19 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_15.pdf@EU-1-00-143_h_a_dec_15.pdf@2009-07-04 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_18.pdf@EU-1-00-142_h_a_dec_18.pdf@2008-04-18 00:00:00@NovoMix@Insulin aspart@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_37.pdf@EU-1-00-134_h_a_dec_37.pdf@2022-01-25 00:00:00@Lantus@insulin glargine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-133_h_a_dec_8.pdf@EU-1-00-133_h_a_dec_8.pdf@2006-07-08 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_12.pdf@EU-1-00-146_h_a_dec_12.pdf@2005-08-07 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_16.pdf@EU-1-00-145_h_a_dec_16.pdf@2010-07-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
r Schering Pharma AG@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_4.pdf@EU-1-00-134_h_a_dec_4.pdf@2003-04-03 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_19.pdf@EU-1-00-142_h_a_dec_19.pdf@2008-06-18 00:00:00@NovoMix@Insulin aspart@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_13.pdf@EU-1-00-146_h_a_dec_13.pdf@2005-09-13 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_0.pdf@EU-1-00-149_h_a_dec_0.pdf@2000-11-10 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-133_h_a_dec_9.pdf@EU-1-00-133_h_a_dec_9.pdf@2007-11-14 00:00:00@Optisulin@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_17.pdf@EU-1-00-143_h_a_dec_17.pdf@2009-07-27 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_17.pdf@EU-1-00-145_h_a_dec_17.pdf@2010-06-08 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_2.pdf@EU-1-00-142_h_a_dec_2.pdf@2001-01-22 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_5.pdf@EU-1-00-134_h_a_dec_5.pdf@2003-04-22 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_14.pdf@EU-1-00-146_h_a_dec_14.pdf@2005-09-13 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_18.pdf@EU-1-00-143_h_a_dec_18.pdf@2009-10-16 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_1.pdf@EU-1-00-149_h_a_dec_1.pdf@2002-10-07 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_18.pdf@EU-1-00-145_h_a_dec_18.pdf@2010-10-25 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_6.pdf@EU-1-00-134_h_a_dec_6.pdf@2003-10-17 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_20.pdf@EU-1-00-142_h_a_dec_20.pdf@2008-07-28 00:00:00@NovoMix@Insulin aspart@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_15.pdf@EU-1-00-146_h_a_dec_15.pdf@2006-03-29 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_10.pdf@EU-1-00-149_h_a_dec_10.pdf@2012-08-23 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_19.pdf@EU-1-00-143_h_a_dec_19.pdf@2010-03-26 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_7.pdf@EU-1-00-134_h_a_dec_7.pdf@2004-07-13 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_19.pdf@EU-1-00-145_h_a_dec_19.pdf@2011-01-27 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_21.pdf@EU-1-00-142_h_a_dec_21.pdf@2009-10-13 00:00:00@NovoMix@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_16.pdf@EU-1-00-146_h_a_dec_16.pdf@2006-04-27 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_2.pdf@EU-1-00-145_h_a_dec_2.pdf@2003-01-14 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-134_h_a_dec_8.pdf@EU-1-00-134_h_a_dec_8.pdf@2004-08-31 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_22.pdf@EU-1-00-142_h_a_dec_22.pdf@2010-02-07 00:00:00@NovoMix@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_11.pdf@EU-1-00-149_h_a_dec_11.pdf@2014-08-19 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_20.pdf@EU-1-00-145_h_a_dec_20.pdf@2011-04-20 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_17.pdf@EU-1-00-146_h_a_dec_17.pdf@2006-07-25 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-134_h_a_dec_9.pdf@EU-1-00-134_h_a_dec_9.pdf@2004-08-31 00:00:00@Lantus@insulin glargine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_2.pdf@EU-1-00-143_h_a_dec_2.pdf@2002-05-12 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_21.pdf@EU-1-00-145_h_a_dec_21.pdf@2011-06-23 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_23.pdf@EU-1-00-142_h_a_dec_23.pdf@2011-02-28 00:00:00@NovoMix@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_18.pdf@EU-1-00-146_h_a_dec_18.pdf@2006-07-08 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_12.pdf@EU-1-00-149_h_a_dec_12.pdf@2016-08-09 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_22.pdf@EU-1-00-145_h_a_dec_22.pdf@2011-12-19 00:00:00@Herceptin@trastuzumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_24.pdf@EU-1-00-142_h_a_dec_24.pdf@2011-03-17 00:00:00@NovoMix@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_20.pdf@EU-1-00-143_h_a_dec_20.pdf@2010-07-28 00:00:00@Kogenate Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_19.pdf@EU-1-00-146_h_a_dec_19.pdf@2006-10-30 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_23.pdf@EU-1-00-145_h_a_dec_23.pdf@2012-02-17 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_2.pdf@EU-1-00-146_h_a_dec_2.pdf@2002-03-26 00:00:00@Keppra@levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_21.pdf@EU-1-00-143_h_a_dec_21.pdf@2010-06-08 00:00:00@Kogenate Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_25.pdf@EU-1-00-142_h_a_dec_25.pdf@2014-11-13 00:00:00@NovoMix@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_20.pdf@EU-1-00-146_h_a_dec_20.pdf@2007-04-01 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_13.pdf@EU-1-00-149_h_a_dec_13.pdf@2018-06-21 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  21.6.2018  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2000)2808 for “Panretin@alitretinoin@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_24.pdf@EU-1-00-145_h_a_dec_24.pdf@2013-08-26 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_26.pdf@EU-1-00-142_h_a_dec_26.pdf@2016-12-12 00:00:00@NovoMix@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_22.pdf@EU-1-00-143_h_a_dec_22.pdf@2010-06-08 00:00:00@Kogenate Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_21.pdf@EU-1-00-146_h_a_dec_21.pdf@2007-01-08 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_27.pdf@EU-1-00-142_h_a_dec_27.pdf@2017-12-18 00:00:00@NovoMix@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_23.pdf@EU-1-00-143_h_a_dec_23.pdf@2010-12-20 00:00:00@Kogenate Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_25.pdf@EU-1-00-145_h_a_dec_25.pdf@2013-12-18 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_14.pdf@EU-1-00-149_h_a_dec_14.pdf@2018-12-20 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_22.pdf@EU-1-00-146_h_a_dec_22.pdf@2007-10-19 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_24.pdf@EU-1-00-143_h_a_dec_24.pdf@2011-10-11 00:00:00@Kogenate  Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_15.pdf@EU-1-00-149_h_a_dec_15.pdf@2020-01-31 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_23.pdf@EU-1-00-146_h_a_dec_23.pdf@2007-12-21 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_28.pdf@EU-1-00-142_h_a_dec_28.pdf@2019-03-13 00:00:00@NovoMix@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_26.pdf@EU-1-00-145_h_a_dec_26.pdf@2015-06-02 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_25.pdf@EU-1-00-143_h_a_dec_25.pdf@2012-03-19 00:00:00@Kogenate Bayer@Recombinant coagulation factor VIII (octocog alfa)@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_26.pdf@EU-1-00-143_h_a_dec_26.pdf@2012-04-20 00:00:00@Kogenate Bayer@Recombinant coagulation factor VIII (octocog alfa)@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_16.pdf@EU-1-00-149_h_a_dec_16.pdf@2020-06-08 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_29.pdf@EU-1-00-142_h_a_dec_29.pdf@2021-10-19 00:00:00@NovoMix@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_27.pdf@EU-1-00-145_h_a_dec_27.pdf@2016-02-22 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_27.pdf@EU-1-00-143_h_a_dec_27.pdf@2012-10-23 00:00:00@Kogenate Bayer@Recombinant coagulation factor VIII (octocog alfa)@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_25.pdf@EU-1-00-146_h_a_dec_25.pdf@2008-07-25 00:00:00@Keppra@Levetiracetam@NAS before 2012@True@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_3.pdf@EU-1-00-142_h_a_dec_3.pdf@2022-03-01 00:00:00@NovoMix 30@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_0.pdf@EU-1-00-150_h_a_dec_0.pdf@2000-10-13 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_17.pdf@EU-1-00-149_h_a_dec_17.pdf@2020-03-11 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Amdipharm Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_26.pdf@EU-1-00-146_h_a_dec_26.pdf@2009-01-26 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_28.pdf@EU-1-00-145_h_a_dec_28.pdf@2017-11-01 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_4.pdf@EU-1-00-142_h_a_dec_4.pdf@2002-11-08 00:00:00@NovoMix@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_28.pdf@EU-1-00-143_h_a_dec_28.pdf@2014-02-20 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_1.pdf@EU-1-00-150_h_a_dec_1.pdf@2001-02-16 00:00:00@ACTOS pioglitazone@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_27.pdf@EU-1-00-146_h_a_dec_27.pdf@2009-02-09 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_18.pdf@EU-1-00-149_h_a_dec_18.pdf@2020-10-11 00:00:00@Panretin@alitretinoin@False@False@OD Not Found@Amdipharm Limited@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_10.pdf@EU-1-00-150_h_a_dec_10.pdf@2006-03-29 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_29.pdf@EU-1-00-143_h_a_dec_29.pdf@2017-11-04 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_2.pdf@EU-1-00-149_h_a_dec_2.pdf@2003-10-04 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_29.pdf@EU-1-00-145_h_a_dec_29.pdf@2018-03-16 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_28.pdf@EU-1-00-146_h_a_dec_28.pdf@2009-02-09 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_11.pdf@EU-1-00-150_h_a_dec_11.pdf@2006-07-20 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_3.pdf@EU-1-00-143_h_a_dec_3.pdf@2003-01-31 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_3.pdf@EU-1-00-149_h_a_dec_3.pdf@2003-11-06 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-142_h_a_dec_5.pdf@EU-1-00-142_h_a_dec_5.pdf@2003-08-22 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_3.pdf@EU-1-00-145_h_a_dec_3.pdf@2004-10-06 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_29.pdf@EU-1-00-146_h_a_dec_29.pdf@2010-06-07 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_12.pdf@EU-1-00-150_h_a_dec_12.pdf@2006-10-26 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_6.pdf@EU-1-00-142_h_a_dec_6.pdf@2003-08-10 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_4.pdf@EU-1-00-149_h_a_dec_4.pdf@2004-06-12 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_30.pdf@EU-1-00-143_h_a_dec_30.pdf@2017-11-16 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 16.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2000)2375 for “KOGENATE Bayer@Recombinant coagulation factor VIII (octocog  alfa)@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_3.pdf@EU-1-00-146_h_a_dec_3.pdf@2002-07-18 00:00:00@Keppra@levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_13.pdf@EU-1-00-150_h_a_dec_13.pdf@2007-01-26 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_7.pdf@EU-1-00-142_h_a_dec_7.pdf@2004-04-15 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_30.pdf@EU-1-00-145_h_a_dec_30.pdf@2018-06-04 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_5.pdf@EU-1-00-149_h_a_dec_5.pdf@2005-11-17 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-00-143_h_a_dec_4.pdf@EU-1-00-143_h_a_dec_4.pdf@2004-06-23 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_30.pdf@EU-1-00-146_h_a_dec_30.pdf@2010-01-09 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_8.pdf@EU-1-00-142_h_a_dec_8.pdf@2004-07-07 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_14.pdf@EU-1-00-150_h_a_dec_14.pdf@2007-08-20 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_31.pdf@EU-1-00-145_h_a_dec_31.pdf@2019-11-03 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_5.pdf@EU-1-00-143_h_a_dec_5.pdf@2004-09-21 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_31.pdf@EU-1-00-146_h_a_dec_31.pdf@2011-02-18 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_6.pdf@EU-1-00-149_h_a_dec_6.pdf@2007-11-04 00:00:00@Panretin@alitretinoin@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA Not Found@Parsed
EU-1-00-142_h_a_dec_9.pdf@EU-1-00-142_h_a_dec_9.pdf@2004-08-24 00:00:00@NovoMix 30@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_32.pdf@EU-1-00-145_h_a_dec_32.pdf@2019-07-25 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_15.pdf@EU-1-00-150_h_a_dec_15.pdf@2009-09-17 00:00:00@Actos@pioglitazone@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_6.pdf@EU-1-00-143_h_a_dec_6.pdf@2005-07-22 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_7.pdf@EU-1-00-149_h_a_dec_7.pdf@2009-08-28 00:00:00@Panretin@alitretinoin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_33.pdf@EU-1-00-145_h_a_dec_33.pdf@2020-09-30 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_33.pdf@EU-1-00-146_h_a_dec_33.pdf@2011-10-24 00:00:00@Keppra@Levetiracetam@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_16.pdf@EU-1-00-150_h_a_dec_16.pdf@2010-03-30 00:00:00@Actos@pioglitazone@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_7.pdf@EU-1-00-143_h_a_dec_7.pdf@2005-07-09 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-00-149_h_a_dec_8.pdf@EU-1-00-149_h_a_dec_8.pdf@2010-03-26 00:00:00@Panretin@alitretinoin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_34.pdf@EU-1-00-146_h_a_dec_34.pdf@2012-05-25 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_34.pdf@EU-1-00-145_h_a_dec_34.pdf@2021-01-09 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_8.pdf@EU-1-00-143_h_a_dec_8.pdf@2006-03-04 00:00:00@KOGENATE Bayer@Recombinant coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_17.pdf@EU-1-00-150_h_a_dec_17.pdf@2010-08-31 00:00:00@Actos@pioglitazone@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-149_h_a_dec_9.pdf@EU-1-00-149_h_a_dec_9.pdf@2010-09-27 00:00:00@Panretin@alitretinoin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_35.pdf@EU-1-00-146_h_a_dec_35.pdf@2012-10-25 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_0.pdf@EU-1-00-152_h_a_dec_0.pdf@2000-10-23 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae   type b vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_18.pdf@EU-1-00-150_h_a_dec_18.pdf@2011-12-22 00:00:00@Actos@pioglitazone@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_35.pdf@EU-1-00-145_h_a_dec_35.pdf@2022-08-07 00:00:00@Herceptin@trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-143_h_a_dec_9.pdf@EU-1-00-143_h_a_dec_9.pdf@2006-07-08 00:00:00@KOGENATE Bayer@Recombinant  coagulation factor VIII (octocog alfa)@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_1.pdf@EU-1-00-152_h_a_dec_1.pdf@2001-07-16 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae   type b vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_36.pdf@EU-1-00-146_h_a_dec_36.pdf@2012-10-25 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_4.pdf@EU-1-00-145_h_a_dec_4.pdf@2004-10-22 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_19.pdf@EU-1-00-150_h_a_dec_19.pdf@2011-12-22 00:00:00@Actos@pioglitazone@NAS before 2012@False@OD Not Found@Takeda Global Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_37.pdf@EU-1-00-146_h_a_dec_37.pdf@2013-08-26 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_10.pdf@EU-1-00-152_h_a_dec_10.pdf@2005-11-17 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B  recombinant (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_2.pdf@EU-1-00-150_h_a_dec_2.pdf@2002-02-19 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-145_h_a_dec_5.pdf@EU-1-00-145_h_a_dec_5.pdf@2005-04-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_0.pdf@EU-1-00-155_h_a_dec_0.pdf@2000-11-29 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_20.pdf@EU-1-00-150_h_a_dec_20.pdf@2012-12-18 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Global  Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_11.pdf@EU-1-00-152_h_a_dec_11.pdf@2006-01-24 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed),  inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b  vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_6.pdf@EU-1-00-145_h_a_dec_6.pdf@2005-06-28 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_38.pdf@EU-1-00-146_h_a_dec_38.pdf@2014-10-10 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_1.pdf@EU-1-00-155_h_a_dec_1.pdf@2000-11-29 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_21.pdf@EU-1-00-150_h_a_dec_21.pdf@2013-04-29 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_12.pdf@EU-1-00-152_h_a_dec_12.pdf@2007-04-13 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_7.pdf@EU-1-00-145_h_a_dec_7.pdf@2005-08-09 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_39.pdf@EU-1-00-146_h_a_dec_39.pdf@2015-08-20 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_10.pdf@EU-1-00-155_h_a_dec_10.pdf@2010-03-15 00:00:00@Luveris@Lutropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_13.pdf@EU-1-00-152_h_a_dec_13.pdf@2007-03-05 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_8.pdf@EU-1-00-145_h_a_dec_8.pdf@2006-05-22 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_22.pdf@EU-1-00-150_h_a_dec_22.pdf@2013-11-13 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_11.pdf@EU-1-00-155_h_a_dec_11.pdf@2010-06-17 00:00:00@Luveris@Lutropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_14.pdf@EU-1-00-152_h_a_dec_14.pdf@2007-12-20 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_40.pdf@EU-1-00-146_h_a_dec_40.pdf@2016-11-11 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-145_h_a_dec_9.pdf@EU-1-00-145_h_a_dec_9.pdf@2006-10-20 00:00:00@Herceptin@trastuzumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_23.pdf@EU-1-00-150_h_a_dec_23.pdf@2015-06-19 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_12.pdf@EU-1-00-155_h_a_dec_12.pdf@2011-03-18 00:00:00@Luveris@Lutropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe  Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_41.pdf@EU-1-00-146_h_a_dec_41.pdf@2018-11-28 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_15.pdf@EU-1-00-152_h_a_dec_15.pdf@2008-08-08 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_24.pdf@EU-1-00-150_h_a_dec_24.pdf@2016-05-26 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_13.pdf@EU-1-00-155_h_a_dec_13.pdf@2011-05-23 00:00:00@Luveris@Lutropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe  Limited@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_0.pdf@EU-1-00-156_h_a_dec_0.pdf@2000-12-28 00:00:00@TRIZIVIR@abacavir / lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_42.pdf@EU-1-00-146_h_a_dec_42.pdf@2019-04-10 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_16.pdf@EU-1-00-152_h_a_dec_16.pdf@2008-10-31 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_25.pdf@EU-1-00-150_h_a_dec_25.pdf@2017-04-28 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
ound@Parsed
EU-1-00-156_h_a_dec_1.pdf@EU-1-00-156_h_a_dec_1.pdf@2001-09-11 00:00:00@TRIZIVIR@abacavir / lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_43.pdf@EU-1-00-146_h_a_dec_43.pdf@2020-12-17 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_26.pdf@EU-1-00-150_h_a_dec_26.pdf@2019-06-06 00:00:00@Actos@pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_17.pdf@EU-1-00-152_h_a_dec_17.pdf@2010-10-05 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis,  hepatitis B recombinant (adsorbed), inactivated poliomyelitis and adsorbed  conjugated Haemophilus influenzae type b vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_10.pdf@EU-1-00-156_h_a_dec_10.pdf@2006-10-04 00:00:00@TRIZIVIR@abacavir, lamivudine, zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_15.pdf@EU-1-00-155_h_a_dec_15.pdf@2013-12-18 00:00:00@Luveris@Lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_44.pdf@EU-1-00-146_h_a_dec_44.pdf@2022-08-07 00:00:00@Keppra@levetiracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_18.pdf@EU-1-00-152_h_a_dec_18.pdf@2010-08-31 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B  recombinant (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae type b vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_5.pdf@EU-1-00-146_h_a_dec_5.pdf@2003-02-14 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_11.pdf@EU-1-00-156_h_a_dec_11.pdf@2006-11-22 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_16.pdf@EU-1-00-155_h_a_dec_16.pdf@2015-04-24 00:00:00@Luveris@Lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_3.pdf@EU-1-00-150_h_a_dec_3.pdf@2002-12-04 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-146_h_a_dec_6.pdf@EU-1-00-146_h_a_dec_6.pdf@2003-03-03 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_12.pdf@EU-1-00-156_h_a_dec_12.pdf@2007-01-24 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_19.pdf@EU-1-00-152_h_a_dec_19.pdf@2011-06-15 00:00:00@Infanrix  hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed),  inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b  vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_7.pdf@EU-1-00-146_h_a_dec_7.pdf@2003-08-28 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_4.pdf@EU-1-00-150_h_a_dec_4.pdf@2002-11-26 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_13.pdf@EU-1-00-156_h_a_dec_13.pdf@2007-04-06 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_5.pdf@EU-1-00-150_h_a_dec_5.pdf@2003-03-17 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_17.pdf@EU-1-00-155_h_a_dec_17.pdf@2018-08-20 00:00:00@Luveris@Lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_8.pdf@EU-1-00-146_h_a_dec_8.pdf@2004-05-02 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_14.pdf@EU-1-00-156_h_a_dec_14.pdf@2007-03-09 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_6.pdf@EU-1-00-150_h_a_dec_6.pdf@2003-08-28 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_18.pdf@EU-1-00-155_h_a_dec_18.pdf@2022-01-31 00:00:00@Luveris@Lutropin alfa@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-00-146_h_a_dec_9.pdf@EU-1-00-146_h_a_dec_9.pdf@2004-07-13 00:00:00@Keppra@Levetiracetam@NAS before 2012@NA before 2012@OD Not Found@UCB S.A.@CMA not available before 2006@Parsed
EU-1-00-150_h_a_dec_7.pdf@EU-1-00-150_h_a_dec_7.pdf@2003-09-16 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_15.pdf@EU-1-00-156_h_a_dec_15.pdf@2007-11-21 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_2.pdf@EU-1-00-155_h_a_dec_2.pdf@2001-09-13 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_3.pdf@EU-1-00-155_h_a_dec_3.pdf@2002-01-28 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_16.pdf@EU-1-00-156_h_a_dec_16.pdf@2008-02-28 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_8.pdf@EU-1-00-150_h_a_dec_8.pdf@2005-10-01 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_0.pdf@EU-1-00-157_h_a_dec_0.pdf@2001-01-15 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_4.pdf@EU-1-00-155_h_a_dec_4.pdf@2002-05-15 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_17.pdf@EU-1-00-156_h_a_dec_17.pdf@2009-03-27 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-150_h_a_dec_9.pdf@EU-1-00-150_h_a_dec_9.pdf@2005-10-13 00:00:00@Actos@pioglitazone@NAS before 2012@NA before 2012@OD Not Found@Takeda Europe R&D Centre Ltd@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_1.pdf@EU-1-00-157_h_a_dec_1.pdf@2001-06-08 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_18.pdf@EU-1-00-156_h_a_dec_18.pdf@2009-05-27 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_5.pdf@EU-1-00-155_h_a_dec_5.pdf@2003-04-03 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_6.pdf@EU-1-00-155_h_a_dec_6.pdf@2003-09-22 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_10.pdf@EU-1-00-157_h_a_dec_10.pdf@2003-03-17 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_19.pdf@EU-1-00-156_h_a_dec_19.pdf@2009-11-23 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_11.pdf@EU-1-00-157_h_a_dec_11.pdf@2003-07-30 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_2.pdf@EU-1-00-156_h_a_dec_2.pdf@2002-10-17 00:00:00@TRIZIVIR@abacavir / Lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-155_h_a_dec_7.pdf@EU-1-00-155_h_a_dec_7.pdf@2004-08-31 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_12.pdf@EU-1-00-157_h_a_dec_12.pdf@2004-12-02 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_20.pdf@EU-1-00-156_h_a_dec_20.pdf@2010-12-05 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_8.pdf@EU-1-00-155_h_a_dec_8.pdf@2006-01-24 00:00:00@Luveris@Lutropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_13.pdf@EU-1-00-157_h_a_dec_13.pdf@1980-01-01 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_0.pdf@EU-1-00-160_h_a_dec_0.pdf@2001-01-15 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_21.pdf@EU-1-00-156_h_a_dec_21.pdf@2010-05-26 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-00-155_h_a_dec_9.pdf@EU-1-00-155_h_a_dec_9.pdf@2009-05-26 00:00:00@Luveris@Lutropin alfa@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_14.pdf@EU-1-00-157_h_a_dec_14.pdf@2005-10-01 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_1.pdf@EU-1-00-160_h_a_dec_1.pdf@2001-06-08 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_22.pdf@EU-1-00-156_h_a_dec_22.pdf@2010-11-29 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_10.pdf@EU-1-00-160_h_a_dec_10.pdf@2003-03-17 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_23.pdf@EU-1-00-156_h_a_dec_23.pdf@2011-07-06 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK  Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_15.pdf@EU-1-00-157_h_a_dec_15.pdf@2006-09-01 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_11.pdf@EU-1-00-160_h_a_dec_11.pdf@2003-07-30 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_24.pdf@EU-1-00-156_h_a_dec_24.pdf@2012-06-07 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare UK  Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_16.pdf@EU-1-00-157_h_a_dec_16.pdf@2006-01-20 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_0.pdf@EU-1-00-161_h_a_dec_0.pdf@2001-01-15 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_12.pdf@EU-1-00-160_h_a_dec_12.pdf@2004-12-02 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_25.pdf@EU-1-00-156_h_a_dec_25.pdf@2013-03-26 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_17.pdf@EU-1-00-157_h_a_dec_17.pdf@2006-09-02 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_1.pdf@EU-1-00-161_h_a_dec_1.pdf@2001-06-08 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_13.pdf@EU-1-00-160_h_a_dec_13.pdf@2004-09-20 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_26.pdf@EU-1-00-156_h_a_dec_26.pdf@2013-05-23 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_18.pdf@EU-1-00-157_h_a_dec_18.pdf@2006-01-09 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_10.pdf@EU-1-00-161_h_a_dec_10.pdf@2003-03-17 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_14.pdf@EU-1-00-160_h_a_dec_14.pdf@2005-10-01 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-162_h_a_dec_0.pdf@EU-1-00-162_h_a_dec_0.pdf@2001-01-29 00:00:00@Prandin@repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_11.pdf@EU-1-00-161_h_a_dec_11.pdf@2003-07-30 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_27.pdf@EU-1-00-156_h_a_dec_27.pdf@2015-05-13 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_19.pdf@EU-1-00-157_h_a_dec_19.pdf@2007-04-23 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_1.pdf@EU-1-00-162_h_a_dec_1.pdf@2001-06-08 00:00:00@Prandin@repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_15.pdf@EU-1-00-160_h_a_dec_15.pdf@2006-09-01 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_12.pdf@EU-1-00-161_h_a_dec_12.pdf@2004-12-02 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_2.pdf@EU-1-00-157_h_a_dec_2.pdf@2001-09-20 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-162_h_a_dec_10.pdf@EU-1-00-162_h_a_dec_10.pdf@2004-05-04 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_16.pdf@EU-1-00-160_h_a_dec_16.pdf@2006-01-20 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_28.pdf@EU-1-00-156_h_a_dec_28.pdf@2016-04-25 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_13.pdf@EU-1-00-161_h_a_dec_13.pdf@2004-09-20 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_20.pdf@EU-1-00-157_h_a_dec_20.pdf@2007-05-06 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_11.pdf@EU-1-00-162_h_a_dec_11.pdf@2005-04-02 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_17.pdf@EU-1-00-160_h_a_dec_17.pdf@2006-09-02 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_14.pdf@EU-1-00-161_h_a_dec_14.pdf@2005-10-01 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_21.pdf@EU-1-00-157_h_a_dec_21.pdf@2008-03-31 00:00:00@Azomyr@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_29.pdf@EU-1-00-156_h_a_dec_29.pdf@2017-06-16 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_12.pdf@EU-1-00-162_h_a_dec_12.pdf@2006-05-22 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_18.pdf@EU-1-00-160_h_a_dec_18.pdf@2006-01-09 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_15.pdf@EU-1-00-161_h_a_dec_15.pdf@2006-09-01 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_3.pdf@EU-1-00-156_h_a_dec_3.pdf@2003-06-30 00:00:00@TRIZIVIR@abacavir / Lamivudine/ zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_22.pdf@EU-1-00-157_h_a_dec_22.pdf@2010-03-23 00:00:00@Azomyr@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_13.pdf@EU-1-00-162_h_a_dec_13.pdf@2007-06-29 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_31.pdf@EU-1-00-156_h_a_dec_31.pdf@2019-10-24 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_16.pdf@EU-1-00-161_h_a_dec_16.pdf@2006-01-20 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_23.pdf@EU-1-00-157_h_a_dec_23.pdf@2011-09-16 00:00:00@Azomyr@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_19.pdf@EU-1-00-160_h_a_dec_19.pdf@2007-04-23 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_14.pdf@EU-1-00-162_h_a_dec_14.pdf@2008-07-23 00:00:00@Prandin@Repaglinide@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_32.pdf@EU-1-00-156_h_a_dec_32.pdf@2021-09-03 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_2.pdf@EU-1-00-160_h_a_dec_2.pdf@2001-09-20 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_17.pdf@EU-1-00-161_h_a_dec_17.pdf@2006-09-02 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_24.pdf@EU-1-00-157_h_a_dec_24.pdf@2012-09-02 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_15.pdf@EU-1-00-162_h_a_dec_15.pdf@2008-12-17 00:00:00@Prandin@Repaglinide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_33.pdf@EU-1-00-156_h_a_dec_33.pdf@2021-08-20 00:00:00@Trizivir@abacavir, lamivudine, zidovudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_20.pdf@EU-1-00-160_h_a_dec_20.pdf@2007-05-06 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_18.pdf@EU-1-00-161_h_a_dec_18.pdf@2006-01-09 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_16.pdf@EU-1-00-162_h_a_dec_16.pdf@2012-04-20 00:00:00@Prandin@Repaglinide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_25.pdf@EU-1-00-157_h_a_dec_25.pdf@2014-08-19 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_4.pdf@EU-1-00-156_h_a_dec_4.pdf@2004-01-14 00:00:00@TRIZIVIR@abacavir / Lamivudine/  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_0.pdf@EU-1-00-163_h_a_dec_0.pdf@2001-02-02 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_21.pdf@EU-1-00-160_h_a_dec_21.pdf@2008-03-31 00:00:00@Aerius@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_1.pdf@EU-1-00-163_h_a_dec_1.pdf@2002-03-21 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-162_h_a_dec_17.pdf@EU-1-00-162_h_a_dec_17.pdf@2015-11-19 00:00:00@Prandin@Repaglinide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_5.pdf@EU-1-00-156_h_a_dec_5.pdf@2004-01-30 00:00:00@TRIZIVIR@abacavir / Lamivudine/  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_19.pdf@EU-1-00-161_h_a_dec_19.pdf@2007-04-23 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_26.pdf@EU-1-00-157_h_a_dec_26.pdf@2015-06-08 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_2.pdf@EU-1-00-161_h_a_dec_2.pdf@2001-09-20 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_6.pdf@EU-1-00-156_h_a_dec_6.pdf@2004-05-02 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_22.pdf@EU-1-00-160_h_a_dec_22.pdf@2010-03-23 00:00:00@Aerius@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_18.pdf@EU-1-00-162_h_a_dec_18.pdf@2017-04-28 00:00:00@Prandin@Repaglinide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_20.pdf@EU-1-00-161_h_a_dec_20.pdf@2007-05-06 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_11.pdf@EU-1-00-163_h_a_dec_11.pdf@2011-06-17 00:00:00@Xeloda@capecitabine@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_2.pdf@EU-1-00-162_h_a_dec_2.pdf@2001-12-11 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-156_h_a_dec_7.pdf@EU-1-00-156_h_a_dec_7.pdf@2004-05-26 00:00:00@TRIZIVIR@abacavir/ Lamivudine/  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_23.pdf@EU-1-00-160_h_a_dec_23.pdf@2011-09-16 00:00:00@Aerius@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_27.pdf@EU-1-00-157_h_a_dec_27.pdf@2017-05-24 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_2.pdf@EU-1-00-152_h_a_dec_2.pdf@2001-12-19 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus influenzae   type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_12.pdf@EU-1-00-163_h_a_dec_12.pdf@2012-09-20 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_3.pdf@EU-1-00-162_h_a_dec_3.pdf@2002-01-28 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_21.pdf@EU-1-00-161_h_a_dec_21.pdf@2008-03-31 00:00:00@Neoclarityn@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_24.pdf@EU-1-00-160_h_a_dec_24.pdf@2012-09-02 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_8.pdf@EU-1-00-156_h_a_dec_8.pdf@2004-11-17 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_20.pdf@EU-1-00-152_h_a_dec_20.pdf@2011-07-26 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.  EN 3    EN (adsorbed), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_4.pdf@EU-1-00-162_h_a_dec_4.pdf@2002-06-17 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_13.pdf@EU-1-00-163_h_a_dec_13.pdf@2013-11-29 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_22.pdf@EU-1-00-161_h_a_dec_22.pdf@2010-03-23 00:00:00@Neoclarityn@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_28.pdf@EU-1-00-157_h_a_dec_28.pdf@2018-06-29 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-156_h_a_dec_9.pdf@EU-1-00-156_h_a_dec_9.pdf@2005-05-01 00:00:00@TRIZIVIR@abacavir, lamivudine,  zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_25.pdf@EU-1-00-160_h_a_dec_25.pdf@2014-08-19 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_5.pdf@EU-1-00-162_h_a_dec_5.pdf@2002-10-09 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_21.pdf@EU-1-00-152_h_a_dec_21.pdf@2014-09-30 00:00:00@Infanrix  hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed),  inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b  vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_29.pdf@EU-1-00-157_h_a_dec_29.pdf@2020-04-21 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_23.pdf@EU-1-00-161_h_a_dec_23.pdf@2011-09-16 00:00:00@Neoclarityn@desloratadine@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_14.pdf@EU-1-00-163_h_a_dec_14.pdf@2013-12-18 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_6.pdf@EU-1-00-162_h_a_dec_6.pdf@2003-01-15 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-157_h_a_dec_3.pdf@EU-1-00-157_h_a_dec_3.pdf@2002-12-04 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_22.pdf@EU-1-00-152_h_a_dec_22.pdf@2015-08-20 00:00:00@Infanrix hexa@diphtheria (d),  tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis  (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_26.pdf@EU-1-00-160_h_a_dec_26.pdf@2015-06-08 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_24.pdf@EU-1-00-161_h_a_dec_24.pdf@2012-02-17 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_7.pdf@EU-1-00-162_h_a_dec_7.pdf@2003-11-06 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_23.pdf@EU-1-00-152_h_a_dec_23.pdf@2015-10-28 00:00:00@Infanrix hexa@diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv),  poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine  (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_30.pdf@EU-1-00-157_h_a_dec_30.pdf@2021-10-05 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_15.pdf@EU-1-00-163_h_a_dec_15.pdf@2014-12-15 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_8.pdf@EU-1-00-162_h_a_dec_8.pdf@2003-01-08 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_27.pdf@EU-1-00-160_h_a_dec_27.pdf@2017-05-24 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_24.pdf@EU-1-00-152_h_a_dec_24.pdf@2017-11-09 00:00:00@Infanrix hexa@diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv),  poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine  (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_25.pdf@EU-1-00-161_h_a_dec_25.pdf@2014-08-19 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_31.pdf@EU-1-00-157_h_a_dec_31.pdf@2022-05-30 00:00:00@Azomyr@desloratadine@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-162_h_a_dec_9.pdf@EU-1-00-162_h_a_dec_9.pdf@2003-08-10 00:00:00@Prandin@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_16.pdf@EU-1-00-163_h_a_dec_16.pdf@2016-01-14 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_25.pdf@EU-1-00-152_h_a_dec_25.pdf@2019-01-23 00:00:00@Infanrix hexa@diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv),  poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine  (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_4.pdf@EU-1-00-157_h_a_dec_4.pdf@2002-04-16 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_28.pdf@EU-1-00-160_h_a_dec_28.pdf@2018-06-29 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_26.pdf@EU-1-00-161_h_a_dec_26.pdf@2015-07-28 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_26.pdf@EU-1-00-152_h_a_dec_26.pdf@2020-01-13 00:00:00@Infanrix hexa@diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv),  poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine  (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_5.pdf@EU-1-00-157_h_a_dec_5.pdf@2002-04-16 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_29.pdf@EU-1-00-160_h_a_dec_29.pdf@2021-04-26 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_17.pdf@EU-1-00-163_h_a_dec_17.pdf@2017-10-07 00:00:00@  myocardial  infarction@Active Substance Not Found@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_27.pdf@EU-1-00-152_h_a_dec_27.pdf@2021-09-16 00:00:00@Infanrix  hexa@diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna)  (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib)  conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_6.pdf@EU-1-00-157_h_a_dec_6.pdf@2002-05-17 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_3.pdf@EU-1-00-160_h_a_dec_3.pdf@2002-12-04 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_27.pdf@EU-1-00-161_h_a_dec_27.pdf@2017-05-24 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_7.pdf@EU-1-00-157_h_a_dec_7.pdf@2002-07-18 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_3.pdf@EU-1-00-152_h_a_dec_3.pdf@2002-06-02 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant  (adsorbed), inactivated poliomyelitis and adsorbed conjugated  Haemophilus  influenzae  type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_30.pdf@EU-1-00-160_h_a_dec_30.pdf@2021-10-05 00:00:00@Aerius@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_18.pdf@EU-1-00-163_h_a_dec_18.pdf@2018-03-16 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_8.pdf@EU-1-00-157_h_a_dec_8.pdf@2002-09-30 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_4.pdf@EU-1-00-152_h_a_dec_4.pdf@2002-10-24 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_0.pdf@EU-1-00-164_h_a_dec_0.pdf@2001-02-16 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_28.pdf@EU-1-00-161_h_a_dec_28.pdf@2018-06-15 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-00-157_h_a_dec_9.pdf@EU-1-00-157_h_a_dec_9.pdf@2002-09-30 00:00:00@Azomyr@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_31.pdf@EU-1-00-160_h_a_dec_31.pdf@2022-05-30 00:00:00@Aerius@desloratadine@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_19.pdf@EU-1-00-163_h_a_dec_19.pdf@2019-03-28 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_5.pdf@EU-1-00-152_h_a_dec_5.pdf@2003-01-08 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_1.pdf@EU-1-00-164_h_a_dec_1.pdf@2002-12-18 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA not available before 2006@Parsed
EU-1-00-160_h_a_dec_4.pdf@EU-1-00-160_h_a_dec_4.pdf@2002-04-16 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_6.pdf@EU-1-00-152_h_a_dec_6.pdf@2003-07-08 00:00:00@Infanrix hexa@Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_0.pdf@EU-1-00-165_h_a_dec_0.pdf@2001-02-02 00:00:00@OVIDRELLE@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_2.pdf@EU-1-00-163_h_a_dec_2.pdf@2004-03-25 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_10.pdf@EU-1-00-164_h_a_dec_10.pdf@2011-04-14 00:00:00@NutropinAq@Somatropin@NAS before 2012@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_29.pdf@EU-1-00-161_h_a_dec_29.pdf@2021-01-29 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_5.pdf@EU-1-00-160_h_a_dec_5.pdf@2002-04-16 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_7.pdf@EU-1-00-152_h_a_dec_7.pdf@2004-01-27 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_1.pdf@EU-1-00-165_h_a_dec_1.pdf@2001-10-09 00:00:00@OVITRELLE@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_20.pdf@EU-1-00-163_h_a_dec_20.pdf@2019-05-27 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_3.pdf@EU-1-00-161_h_a_dec_3.pdf@2002-12-04 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_11.pdf@EU-1-00-164_h_a_dec_11.pdf@2012-02-03 00:00:00@NutropinAq@Somatropin@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_6.pdf@EU-1-00-160_h_a_dec_6.pdf@2002-05-17 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-152_h_a_dec_8.pdf@EU-1-00-152_h_a_dec_8.pdf@2004-01-27 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_10.pdf@EU-1-00-165_h_a_dec_10.pdf@2012-07-05 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_21.pdf@EU-1-00-163_h_a_dec_21.pdf@2020-03-07 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 3.7.2020 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2001)209 for “Xeloda@capecitabine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_7.pdf@EU-1-00-160_h_a_dec_7.pdf@2002-07-18 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_12.pdf@EU-1-00-164_h_a_dec_12.pdf@2014-06-05 00:00:00@NutropinAq@Somatropin@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-152_h_a_dec_9.pdf@EU-1-00-152_h_a_dec_9.pdf@2005-09-13 00:00:00@Infanrix hexa@Diphtheria, tetanus,  acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis  and adsorbed conjugated Haemophilus influenzae type b vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_11.pdf@EU-1-00-165_h_a_dec_11.pdf@2013-12-17 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
 2006@Parsed
EU-1-00-163_h_a_dec_22.pdf@EU-1-00-163_h_a_dec_22.pdf@2021-05-27 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_30.pdf@EU-1-00-161_h_a_dec_30.pdf@2021-04-13 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-00-164_h_a_dec_13.pdf@EU-1-00-164_h_a_dec_13.pdf@2018-02-22 00:00:00@NutropinAq@Somatropin@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-160_h_a_dec_9.pdf@EU-1-00-160_h_a_dec_9.pdf@2002-09-30 00:00:00@Aerius@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_23.pdf@EU-1-00-163_h_a_dec_23.pdf@2022-08-07 00:00:00@Xeloda@capecitabine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_12.pdf@EU-1-00-165_h_a_dec_12.pdf@2015-05-13 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-164_h_a_dec_14.pdf@EU-1-00-164_h_a_dec_14.pdf@2019-08-23 00:00:00@NutropinAq@Somatropin@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_31.pdf@EU-1-00-161_h_a_dec_31.pdf@2022-05-30 00:00:00@Neoclarityn@desloratadine@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-00-163_h_a_dec_3.pdf@EU-1-00-163_h_a_dec_3.pdf@2005-03-30 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_15.pdf@EU-1-00-164_h_a_dec_15.pdf@2021-02-18 00:00:00@NutropinAq@Somatropin@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_4.pdf@EU-1-00-161_h_a_dec_4.pdf@2002-04-16 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_13.pdf@EU-1-00-165_h_a_dec_13.pdf@2017-10-11 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-164_h_a_dec_2.pdf@EU-1-00-164_h_a_dec_2.pdf@2003-02-24 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@IPSEN Limited@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_4.pdf@EU-1-00-163_h_a_dec_4.pdf@2006-09-02 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_0.pdf@EU-1-00-166_h_a_dec_0.pdf@2001-01-22 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_5.pdf@EU-1-00-161_h_a_dec_5.pdf@2002-04-16 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_3.pdf@EU-1-00-164_h_a_dec_3.pdf@2003-07-18 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@IPSEN Limited@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_5.pdf@EU-1-00-163_h_a_dec_5.pdf@2006-05-31 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_1.pdf@EU-1-00-166_h_a_dec_1.pdf@2001-02-07 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_14.pdf@EU-1-00-165_h_a_dec_14.pdf@2018-09-20 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-164_h_a_dec_4.pdf@EU-1-00-164_h_a_dec_4.pdf@2004-03-19 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@IPSEN Limited@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_6.pdf@EU-1-00-163_h_a_dec_6.pdf@2007-03-28 00:00:00@Xeloda@capecitabine@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_10.pdf@EU-1-00-166_h_a_dec_10.pdf@2005-03-29 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_15.pdf@EU-1-00-165_h_a_dec_15.pdf@2019-08-23 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_6.pdf@EU-1-00-161_h_a_dec_6.pdf@2002-05-17 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_5.pdf@EU-1-00-164_h_a_dec_5.pdf@2004-06-12 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@IPSEN Limited@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_7.pdf@EU-1-00-163_h_a_dec_7.pdf@2008-01-31 00:00:00@Xeloda@capecitabine@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_11.pdf@EU-1-00-166_h_a_dec_11.pdf@2005-08-07 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_7.pdf@EU-1-00-161_h_a_dec_7.pdf@2002-07-18 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_0.pdf@EU-1-00-169_h_a_dec_0.pdf@2001-02-23 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_12.pdf@EU-1-00-166_h_a_dec_12.pdf@2005-08-16 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-161_h_a_dec_8.pdf@EU-1-00-161_h_a_dec_8.pdf@2002-09-30 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_8.pdf@EU-1-00-163_h_a_dec_8.pdf@2008-03-27 00:00:00@Xeloda@capecitabine@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_16.pdf@EU-1-00-165_h_a_dec_16.pdf@2021-11-10 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-00-164_h_a_dec_6.pdf@EU-1-00-164_h_a_dec_6.pdf@2006-03-21 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@IPSEN Limited@CMA Not Found@Parsed
EU-1-00-161_h_a_dec_9.pdf@EU-1-00-161_h_a_dec_9.pdf@2002-09-30 00:00:00@Neoclarityn@desloratadine@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-00-163_h_a_dec_9.pdf@EU-1-00-163_h_a_dec_9.pdf@2008-10-31 00:00:00@Xeloda@capecitabine@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_13.pdf@EU-1-00-166_h_a_dec_13.pdf@2005-08-26 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_7.pdf@EU-1-00-164_h_a_dec_7.pdf@2006-10-30 00:00:00@NutropinAq@Somatropin@NAS before 2012@NA before 2012@OD Not Found@IPSEN Limited@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_17.pdf@EU-1-00-165_h_a_dec_17.pdf@2022-10-14 00:00:00@Ovitrelle@Choriogonadotrophin alfa@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_1.pdf@EU-1-00-169_h_a_dec_1.pdf@2002-02-04 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_14.pdf@EU-1-00-166_h_a_dec_14.pdf@2005-10-19 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_8.pdf@EU-1-00-164_h_a_dec_8.pdf@2009-07-29 00:00:00@NutropinAq@Somatropin@NAS before 2012@False@OD Not Found@IPSEN Limited@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_2.pdf@EU-1-00-165_h_a_dec_2.pdf@2003-03-17 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_0.pdf@EU-1-00-170_h_a_dec_0.pdf@2001-02-23 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_10.pdf@EU-1-00-169_h_a_dec_10.pdf@2009-10-21 00:00:00@Metalyse@tenecteplase@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_15.pdf@EU-1-00-166_h_a_dec_15.pdf@2005-11-15 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Solstice Neurosciences Ltd@CMA not available before 2006@Parsed
EU-1-00-165_h_a_dec_3.pdf@EU-1-00-165_h_a_dec_3.pdf@2003-10-24 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-00-164_h_a_dec_9.pdf@EU-1-00-164_h_a_dec_9.pdf@2011-01-24 00:00:00@NutropinAq@Somatropin@NAS before 2012@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_1.pdf@EU-1-00-170_h_a_dec_1.pdf@2002-04-18 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_11.pdf@EU-1-00-169_h_a_dec_11.pdf@2010-04-06 00:00:00@Metalyse@tenecteplase@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_16.pdf@EU-1-00-166_h_a_dec_16.pdf@2006-06-04 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Solstice Neurosciences Ltd@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_4.pdf@EU-1-00-165_h_a_dec_4.pdf@2004-09-20 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_10.pdf@EU-1-00-170_h_a_dec_10.pdf@2007-10-19 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_12.pdf@EU-1-00-169_h_a_dec_12.pdf@2014-02-20 00:00:00@Metalyse@tenecteplase@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_17.pdf@EU-1-00-166_h_a_dec_17.pdf@2007-03-28 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Solstice Neurosciences Ltd@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_5.pdf@EU-1-00-165_h_a_dec_5.pdf@2005-10-25 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_11.pdf@EU-1-00-170_h_a_dec_11.pdf@2008-02-28 00:00:00@Fasturtec@rasburicase@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_13.pdf@EU-1-00-169_h_a_dec_13.pdf@2015-09-18 00:00:00@Metalyse@tenecteplase@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_18.pdf@EU-1-00-166_h_a_dec_18.pdf@2007-08-21 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Solstice Neurosciences Ltd@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_6.pdf@EU-1-00-165_h_a_dec_6.pdf@2006-01-31 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_12.pdf@EU-1-00-170_h_a_dec_12.pdf@2009-01-26 00:00:00@Fasturtec@rasburicase@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_14.pdf@EU-1-00-169_h_a_dec_14.pdf@2016-10-21 00:00:00@Metalyse@tenecteplase@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_19.pdf@EU-1-00-166_h_a_dec_19.pdf@2007-09-25 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Solstice Neurosciences Ltd@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_7.pdf@EU-1-00-165_h_a_dec_7.pdf@2009-04-06 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_13.pdf@EU-1-00-170_h_a_dec_13.pdf@2009-02-26 00:00:00@Fasturtec@rasburicase@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_15.pdf@EU-1-00-169_h_a_dec_15.pdf@2018-09-28 00:00:00@Metalyse@tenecteplase@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_2.pdf@EU-1-00-166_h_a_dec_2.pdf@2001-04-07 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_14.pdf@EU-1-00-170_h_a_dec_14.pdf@2012-03-19 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_8.pdf@EU-1-00-165_h_a_dec_8.pdf@2010-03-15 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_0.pdf@EU-1-01-171_h_a_dec_0.pdf@2001-03-13 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_16.pdf@EU-1-00-169_h_a_dec_16.pdf@2022-06-01 00:00:00@Metalyse@tenecteplase@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_20.pdf@EU-1-00-166_h_a_dec_20.pdf@2008-02-26 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_15.pdf@EU-1-00-170_h_a_dec_15.pdf@2012-05-25 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@SANOFI@CMA Not Found@Parsed
EU-1-00-165_h_a_dec_9.pdf@EU-1-00-165_h_a_dec_9.pdf@2011-06-23 00:00:00@Ovitrelle@Choriogonadotrophin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_0.pdf@EU-1-01-172_h_a_dec_0.pdf@2001-03-20 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_1.pdf@EU-1-01-171_h_a_dec_1.pdf@2001-08-03 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_2.pdf@EU-1-00-169_h_a_dec_2.pdf@2002-09-18 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_16.pdf@EU-1-00-170_h_a_dec_16.pdf@2012-10-25 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_10.pdf@EU-1-01-171_h_a_dec_10.pdf@2003-01-09 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_1.pdf@EU-1-01-172_h_a_dec_1.pdf@2002-03-26 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_3.pdf@EU-1-00-169_h_a_dec_3.pdf@2002-11-27 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-01-173_h_a_dec_0.pdf@EU-1-01-173_h_a_dec_0.pdf@2001-03-20 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_11.pdf@EU-1-01-171_h_a_dec_11.pdf@2004-01-29 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_10.pdf@EU-1-01-172_h_a_dec_10.pdf@2004-09-09 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-173_h_a_dec_1.pdf@EU-1-01-173_h_a_dec_1.pdf@2002-02-28 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_17.pdf@EU-1-00-170_h_a_dec_17.pdf@2013-11-20 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_22.pdf@EU-1-00-166_h_a_dec_22.pdf@2009-03-25 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_4.pdf@EU-1-00-169_h_a_dec_4.pdf@2003-01-23 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_12.pdf@EU-1-01-171_h_a_dec_12.pdf@2004-02-09 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
before 2006@Parsed
EU-1-00-166_h_a_dec_23.pdf@EU-1-00-166_h_a_dec_23.pdf@2009-07-23 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_10.pdf@EU-1-01-173_h_a_dec_10.pdf@2011-04-03 00:00:00@Vaniqa@eflornithine@NAS before 2012@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_18.pdf@EU-1-00-170_h_a_dec_18.pdf@2014-10-27 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_6.pdf@EU-1-00-169_h_a_dec_6.pdf@2003-07-23 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_12.pdf@EU-1-01-172_h_a_dec_12.pdf@2004-12-17 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_13.pdf@EU-1-01-171_h_a_dec_13.pdf@2005-01-20 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_24.pdf@EU-1-00-166_h_a_dec_24.pdf@2010-11-29 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_11.pdf@EU-1-01-173_h_a_dec_11.pdf@2014-05-22 00:00:00@Vaniqa@eflornithine@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-00-169_h_a_dec_7.pdf@EU-1-00-169_h_a_dec_7.pdf@2004-01-27 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_0.pdf@EU-1-01-176_h_a_dec_0.pdf@2001-03-20 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_13.pdf@EU-1-01-172_h_a_dec_13.pdf@2005-12-01 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-00-170_h_a_dec_19.pdf@EU-1-00-170_h_a_dec_19.pdf@2014-12-16 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_14.pdf@EU-1-01-171_h_a_dec_14.pdf@2005-04-28 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-00-166_h_a_dec_25.pdf@EU-1-00-166_h_a_dec_25.pdf@2011-09-16 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_12.pdf@EU-1-01-173_h_a_dec_12.pdf@2015-08-07 00:00:00@Vaniqa@eflornithine@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_1.pdf@EU-1-01-176_h_a_dec_1.pdf@2002-07-19 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_8.pdf@EU-1-00-169_h_a_dec_8.pdf@2006-02-13 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_2.pdf@EU-1-00-170_h_a_dec_2.pdf@2003-04-06 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_14.pdf@EU-1-01-172_h_a_dec_14.pdf@2005-08-24 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_15.pdf@EU-1-01-171_h_a_dec_15.pdf@2005-07-11 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-00-169_h_a_dec_9.pdf@EU-1-00-169_h_a_dec_9.pdf@2007-05-03 00:00:00@Metalyse@tenecteplase@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_26.pdf@EU-1-00-166_h_a_dec_26.pdf@2014-02-21 00:00:00@NeuroBloc@Botulinum Toxin Type B@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_10.pdf@EU-1-01-176_h_a_dec_10.pdf@2007-04-06 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_20.pdf@EU-1-00-170_h_a_dec_20.pdf@2016-02-22 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_15.pdf@EU-1-01-172_h_a_dec_15.pdf@2006-06-04 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_16.pdf@EU-1-01-171_h_a_dec_16.pdf@2006-09-01 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_13.pdf@EU-1-01-173_h_a_dec_13.pdf@2018-03-16 00:00:00@Vaniqa@eflornithine@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_11.pdf@EU-1-01-176_h_a_dec_11.pdf@2007-10-19 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_21.pdf@EU-1-00-170_h_a_dec_21.pdf@2017-05-24 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_17.pdf@EU-1-01-171_h_a_dec_17.pdf@2006-02-28 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_16.pdf@EU-1-01-172_h_a_dec_16.pdf@2006-06-27 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_27.pdf@EU-1-00-166_h_a_dec_27.pdf@2015-02-19 00:00:00@NeuroBloc@Botulinum Toxin Type B@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_12.pdf@EU-1-01-176_h_a_dec_12.pdf@2009-07-14 00:00:00@Zometa@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_22.pdf@EU-1-00-170_h_a_dec_22.pdf@2021-11-15 00:00:00@Fasturtec@rasburicase@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_18.pdf@EU-1-01-171_h_a_dec_18.pdf@2006-06-04 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_14.pdf@EU-1-01-173_h_a_dec_14.pdf@2022-09-29 00:00:00@Vaniqa@eflornithine@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_17.pdf@EU-1-01-172_h_a_dec_17.pdf@2006-06-27 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@the Member States.                                                   4 OJ L 159@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_3.pdf@EU-1-00-170_h_a_dec_3.pdf@2003-06-30 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi Synthelabo@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_13.pdf@EU-1-01-176_h_a_dec_13.pdf@2010-01-25 00:00:00@Zometa@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_2.pdf@EU-1-01-173_h_a_dec_2.pdf@2003-05-08 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Women First HealthCare Limited@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_19.pdf@EU-1-01-171_h_a_dec_19.pdf@2006-05-31 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_28.pdf@EU-1-00-166_h_a_dec_28.pdf@2018-04-23 00:00:00@NeuroBloc@Botulinum Toxin  Type B@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_18.pdf@EU-1-01-172_h_a_dec_18.pdf@2006-04-12 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_4.pdf@EU-1-00-170_h_a_dec_4.pdf@2005-01-08 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_14.pdf@EU-1-01-176_h_a_dec_14.pdf@2011-06-29 00:00:00@Zometa@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_3.pdf@EU-1-01-173_h_a_dec_3.pdf@2004-04-03 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Women First HealthCare Limited@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_2.pdf@EU-1-01-171_h_a_dec_2.pdf@2001-10-16 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-177_h_a_dec_0.pdf@EU-1-01-177_h_a_dec_0.pdf@2001-03-26 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_19.pdf@EU-1-01-172_h_a_dec_19.pdf@2007-01-16 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_5.pdf@EU-1-00-170_h_a_dec_5.pdf@2006-09-02 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_29.pdf@EU-1-00-166_h_a_dec_29.pdf@2018-09-20 00:00:00@NeuroBloc@Botulinum Toxin Type B@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
V.@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_15.pdf@EU-1-01-176_h_a_dec_15.pdf@2011-08-24 00:00:00@Zometa@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_4.pdf@EU-1-01-173_h_a_dec_4.pdf@2004-10-13 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_2.pdf@EU-1-01-172_h_a_dec_2.pdf@2002-03-26 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_20.pdf@EU-1-01-171_h_a_dec_20.pdf@2006-07-28 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_6.pdf@EU-1-00-170_h_a_dec_6.pdf@2006-04-27 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_3.pdf@EU-1-00-166_h_a_dec_3.pdf@2001-10-29 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-177_h_a_dec_10.pdf@EU-1-01-177_h_a_dec_10.pdf@2012-10-24 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_16.pdf@EU-1-01-176_h_a_dec_16.pdf@2012-10-24 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_5.pdf@EU-1-01-173_h_a_dec_5.pdf@2005-07-27 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_20.pdf@EU-1-01-172_h_a_dec_20.pdf@2007-03-28 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_21.pdf@EU-1-01-171_h_a_dec_21.pdf@2006-07-09 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_7.pdf@EU-1-00-170_h_a_dec_7.pdf@2006-07-08 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_30.pdf@EU-1-00-166_h_a_dec_30.pdf@2020-04-28 00:00:00@NeuroBloc@Botulinum Toxin Type B@False@False@OD Not Found@Sloan Pharma S.a.r.l.@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_11.pdf@EU-1-01-177_h_a_dec_11.pdf@2015-04-13 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_17.pdf@EU-1-01-176_h_a_dec_17.pdf@2013-05-27 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_21.pdf@EU-1-01-172_h_a_dec_21.pdf@2007-07-25 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_6.pdf@EU-1-01-173_h_a_dec_6.pdf@2006-04-18 00:00:00@Vaniqa@eflornithine@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_22.pdf@EU-1-01-171_h_a_dec_22.pdf@2007-03-29 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_31.pdf@EU-1-00-166_h_a_dec_31.pdf@2022-04-13 00:00:00@NeuroBloc@Botulinum Toxin Type B@False@False@OD Not Found@Sloan Pharma S.a.r.l.@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_8.pdf@EU-1-00-170_h_a_dec_8.pdf@2006-01-09 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_12.pdf@EU-1-01-177_h_a_dec_12.pdf@2015-06-19 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_22.pdf@EU-1-01-172_h_a_dec_22.pdf@2007-10-24 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_4.pdf@EU-1-00-166_h_a_dec_4.pdf@2003-07-03 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_18.pdf@EU-1-01-176_h_a_dec_18.pdf@2014-11-17 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_23.pdf@EU-1-01-171_h_a_dec_23.pdf@2007-07-25 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-170_h_a_dec_9.pdf@EU-1-00-170_h_a_dec_9.pdf@2007-10-08 00:00:00@Fasturtec@rasburicase@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_13.pdf@EU-1-01-177_h_a_dec_13.pdf@2017-08-22 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_5.pdf@EU-1-00-166_h_a_dec_5.pdf@2003-07-15 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_23.pdf@EU-1-01-172_h_a_dec_23.pdf@2007-11-20 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_8.pdf@EU-1-01-173_h_a_dec_8.pdf@2008-06-06 00:00:00@Vaniqa@eflornithine@NAS before 2012@True@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_24.pdf@EU-1-01-171_h_a_dec_24.pdf@2007-08-27 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_6.pdf@EU-1-00-166_h_a_dec_6.pdf@2003-09-16 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_24.pdf@EU-1-01-172_h_a_dec_24.pdf@2008-03-18 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@False@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_19.pdf@EU-1-01-176_h_a_dec_19.pdf@2015-03-07 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-173_h_a_dec_9.pdf@EU-1-01-173_h_a_dec_9.pdf@2010-03-15 00:00:00@Vaniqa@eflornithine@NAS before 2012@False@OD Not Found@Laboratorios Almirall@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_14.pdf@EU-1-01-177_h_a_dec_14.pdf@2019-04-17 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_7.pdf@EU-1-00-166_h_a_dec_7.pdf@2004-01-29 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_25.pdf@EU-1-01-171_h_a_dec_25.pdf@2007-11-20 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_25.pdf@EU-1-01-172_h_a_dec_25.pdf@2008-06-20 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@True@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_2.pdf@EU-1-01-176_h_a_dec_2.pdf@2003-03-24 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_26.pdf@EU-1-01-171_h_a_dec_26.pdf@2008-04-21 00:00:00@Rapamune@sirolimus@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_8.pdf@EU-1-00-166_h_a_dec_8.pdf@2004-12-17 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_26.pdf@EU-1-01-172_h_a_dec_26.pdf@2008-08-22 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@True@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_15.pdf@EU-1-01-177_h_a_dec_15.pdf@2021-09-03 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_27.pdf@EU-1-01-171_h_a_dec_27.pdf@2008-10-30 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-00-166_h_a_dec_9.pdf@EU-1-00-166_h_a_dec_9.pdf@2005-02-28 00:00:00@NeuroBloc@Botulinum Toxin Type B@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_0.pdf@EU-1-01-178_h_a_dec_0.pdf@2001-03-29 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_20.pdf@EU-1-01-176_h_a_dec_20.pdf@2016-06-21 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_27.pdf@EU-1-01-172_h_a_dec_27.pdf@2008-10-30 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_1.pdf@EU-1-01-178_h_a_dec_1.pdf@2002-11-07 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_28.pdf@EU-1-01-171_h_a_dec_28.pdf@2009-04-29 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_28.pdf@EU-1-01-172_h_a_dec_28.pdf@2008-11-24 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_16.pdf@EU-1-01-177_h_a_dec_16.pdf@2021-08-26 00:00:00@SonoVue@sulphur hexafluoride@False@False@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_0.pdf@EU-1-01-183_h_a_dec_0.pdf@2001-04-27 00:00:00@HBVAXPRO@Hepatitis B (Recombinant) vaccine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_21.pdf@EU-1-01-176_h_a_dec_21.pdf@2017-06-15 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_29.pdf@EU-1-01-171_h_a_dec_29.pdf@2009-12-21 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_10.pdf@EU-1-01-178_h_a_dec_10.pdf@2009-08-21 00:00:00@TARGRETIN@bexarotene@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_29.pdf@EU-1-01-172_h_a_dec_29.pdf@2009-08-21 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
ble before 2006@Parsed
EU-1-01-183_h_a_dec_1.pdf@EU-1-01-183_h_a_dec_1.pdf@2001-11-15 00:00:00@HBVAXPRO@Hepatitis B (Recombinant) vaccine@NAS before 2012@NA before 2012@OD Not Found@AVENTIS PASTEUR MSD SNC@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_3.pdf@EU-1-01-171_h_a_dec_3.pdf@2002-12-04 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-177_h_a_dec_3.pdf@EU-1-01-177_h_a_dec_3.pdf@2002-04-12 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_3.pdf@EU-1-01-172_h_a_dec_3.pdf@2002-09-13 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_11.pdf@EU-1-01-178_h_a_dec_11.pdf@2015-04-13 00:00:00@Targretin@bexarotene@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_22.pdf@EU-1-01-176_h_a_dec_22.pdf@2018-04-26 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_10.pdf@EU-1-01-183_h_a_dec_10.pdf@2008-10-13 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_30.pdf@EU-1-01-171_h_a_dec_30.pdf@2010-01-28 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_4.pdf@EU-1-01-177_h_a_dec_4.pdf@2003-03-24 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_30.pdf@EU-1-01-172_h_a_dec_30.pdf@2009-11-23 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_31.pdf@EU-1-01-171_h_a_dec_31.pdf@2010-03-15 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_5.pdf@EU-1-01-177_h_a_dec_5.pdf@2004-09-27 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_11.pdf@EU-1-01-183_h_a_dec_11.pdf@2010-01-20 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_12.pdf@EU-1-01-178_h_a_dec_12.pdf@2015-05-27 00:00:00@Targretin@bexarotene@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_31.pdf@EU-1-01-172_h_a_dec_31.pdf@2010-08-01 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_23.pdf@EU-1-01-176_h_a_dec_23.pdf@2019-07-25 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-01-171_h_a_dec_32.pdf@EU-1-01-171_h_a_dec_32.pdf@2010-01-07 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_6.pdf@EU-1-01-177_h_a_dec_6.pdf@2006-04-24 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_12.pdf@EU-1-01-183_h_a_dec_12.pdf@2010-08-31 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_32.pdf@EU-1-01-172_h_a_dec_32.pdf@2010-09-02 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_33.pdf@EU-1-01-171_h_a_dec_33.pdf@2010-06-07 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_7.pdf@EU-1-01-177_h_a_dec_7.pdf@2006-12-19 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@NA before 2012@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_13.pdf@EU-1-01-183_h_a_dec_13.pdf@2011-03-17 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen  (HbsAg)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_24.pdf@EU-1-01-176_h_a_dec_24.pdf@2021-03-26 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_33.pdf@EU-1-01-172_h_a_dec_33.pdf@2010-03-30 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_13.pdf@EU-1-01-178_h_a_dec_13.pdf@2018-06-21 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  21.6.2018  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2001)818 for “Targretin@bexarotene@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_34.pdf@EU-1-01-171_h_a_dec_34.pdf@2011-06-01 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_8.pdf@EU-1-01-177_h_a_dec_8.pdf@2008-02-09 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@True@OD Not Found@Bracco International B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_14.pdf@EU-1-01-183_h_a_dec_14.pdf@2011-03-24 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@NAS before 2012@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_34.pdf@EU-1-01-172_h_a_dec_34.pdf@2010-07-28 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories  Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_35.pdf@EU-1-01-171_h_a_dec_35.pdf@2011-01-21 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa  Limited@CMA Not Found@Parsed
EU-1-01-177_h_a_dec_9.pdf@EU-1-01-177_h_a_dec_9.pdf@2011-01-24 00:00:00@SonoVue@sulphur hexafluoride@NAS before 2012@False@OD Not Found@Bracco International  B.V.@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_25.pdf@EU-1-01-176_h_a_dec_25.pdf@2022-06-24 00:00:00@Zometa@zoledronic acid@False@False@OD Not Found@Phoenix Labs Unlimited Company@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_35.pdf@EU-1-01-172_h_a_dec_35.pdf@2010-08-26 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories  Limited@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_15.pdf@EU-1-01-183_h_a_dec_15.pdf@2011-08-26 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_0.pdf@EU-1-01-185_h_a_dec_0.pdf@2001-08-06 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_14.pdf@EU-1-01-178_h_a_dec_14.pdf@2018-09-17 00:00:00@Targretin@bexarotene@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_36.pdf@EU-1-01-171_h_a_dec_36.pdf@2011-05-23 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa  Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_3.pdf@EU-1-01-176_h_a_dec_3.pdf@2003-04-06 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_1.pdf@EU-1-01-185_h_a_dec_1.pdf@2001-08-10 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_36.pdf@EU-1-01-172_h_a_dec_36.pdf@2010-12-13 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_16.pdf@EU-1-01-183_h_a_dec_16.pdf@2015-11-02 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_15.pdf@EU-1-01-178_h_a_dec_15.pdf@2019-07-11 00:00:00@Targretin@bexarotene@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_37.pdf@EU-1-01-171_h_a_dec_37.pdf@2011-07-27 00:00:00@Rapamune@sirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_4.pdf@EU-1-01-176_h_a_dec_4.pdf@2004-04-11 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_37.pdf@EU-1-01-172_h_a_dec_37.pdf@2011-02-28 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_10.pdf@EU-1-01-185_h_a_dec_10.pdf@2005-08-09 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_38.pdf@EU-1-01-171_h_a_dec_38.pdf@2012-06-02 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_17.pdf@EU-1-01-183_h_a_dec_17.pdf@2017-12-18 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_16.pdf@EU-1-01-178_h_a_dec_16.pdf@2021-06-21 00:00:00@Targretin@bexarotene@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_39.pdf@EU-1-01-171_h_a_dec_39.pdf@2012-10-10 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_5.pdf@EU-1-01-176_h_a_dec_5.pdf@2005-03-22 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_2.pdf@EU-1-01-178_h_a_dec_2.pdf@2002-10-17 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_38.pdf@EU-1-01-172_h_a_dec_38.pdf@2011-03-18 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott  Laboratories@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_11.pdf@EU-1-01-185_h_a_dec_11.pdf@2006-02-28 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_18.pdf@EU-1-01-183_h_a_dec_18.pdf@2019-12-18 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_4.pdf@EU-1-01-171_h_a_dec_4.pdf@2002-12-04 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-178_h_a_dec_3.pdf@EU-1-01-178_h_a_dec_3.pdf@2003-04-06 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_6.pdf@EU-1-01-176_h_a_dec_6.pdf@2005-12-23 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_39.pdf@EU-1-01-172_h_a_dec_39.pdf@2011-04-18 00:00:00@Kaletra@lopinavir / Ritonavir@NAS before 2012@False@OD Not Found@Abbott  Laboratories@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_12.pdf@EU-1-01-185_h_a_dec_12.pdf@2006-05-19 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_19.pdf@EU-1-01-183_h_a_dec_19.pdf@2021-11-01 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_13.pdf@EU-1-01-185_h_a_dec_13.pdf@2006-05-19 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
e before 2006@Parsed
EU-1-01-183_h_a_dec_2.pdf@EU-1-01-183_h_a_dec_2.pdf@2002-10-23 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_40.pdf@EU-1-01-171_h_a_dec_40.pdf@2013-11-11 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_7.pdf@EU-1-01-176_h_a_dec_7.pdf@2006-04-24 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_0.pdf@EU-1-01-188_h_a_dec_0.pdf@2001-03-08 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@adopted@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_4.pdf@EU-1-01-172_h_a_dec_4.pdf@2002-07-10 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_20.pdf@EU-1-01-183_h_a_dec_20.pdf@2022-04-04 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen (HbsAg)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_5.pdf@EU-1-01-178_h_a_dec_5.pdf@2006-04-24 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_1.pdf@EU-1-01-188_h_a_dec_1.pdf@2002-07-03 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe  B.V.@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_14.pdf@EU-1-01-185_h_a_dec_14.pdf@2006-10-30 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-176_h_a_dec_8.pdf@EU-1-01-176_h_a_dec_8.pdf@2006-01-06 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_40.pdf@EU-1-01-172_h_a_dec_40.pdf@2012-02-21 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@Abbott  Laboratories@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_41.pdf@EU-1-01-171_h_a_dec_41.pdf@2015-11-27 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_6.pdf@EU-1-01-178_h_a_dec_6.pdf@2007-01-26 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_3.pdf@EU-1-01-183_h_a_dec_3.pdf@2005-03-29 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD@CMA not available before 2006@Parsed
EU-1-01-176_h_a_dec_9.pdf@EU-1-01-176_h_a_dec_9.pdf@2006-10-19 00:00:00@Zometa@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_15.pdf@EU-1-01-185_h_a_dec_15.pdf@2006-11-29 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_10.pdf@EU-1-01-188_h_a_dec_10.pdf@2005-03-03 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_41.pdf@EU-1-01-172_h_a_dec_41.pdf@2012-08-30 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@Abbott Laboratories@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_7.pdf@EU-1-01-178_h_a_dec_7.pdf@2004-11-04 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Ligand Pharmaceuticals UK Ltd@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_4.pdf@EU-1-01-183_h_a_dec_4.pdf@2005-04-25 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_42.pdf@EU-1-01-171_h_a_dec_42.pdf@2017-06-23 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_16.pdf@EU-1-01-185_h_a_dec_16.pdf@2007-02-05 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_11.pdf@EU-1-01-188_h_a_dec_11.pdf@2005-01-08 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_42.pdf@EU-1-01-172_h_a_dec_42.pdf@2012-10-25 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@Abbott Laboratories@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_8.pdf@EU-1-01-178_h_a_dec_8.pdf@2007-11-12 00:00:00@TARGRETIN@bexarotene@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_5.pdf@EU-1-01-183_h_a_dec_5.pdf@2006-02-13 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_17.pdf@EU-1-01-185_h_a_dec_17.pdf@2007-08-30 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-178_h_a_dec_9.pdf@EU-1-01-178_h_a_dec_9.pdf@2008-08-25 00:00:00@TARGRETIN@bexarotene@NAS before 2012@True@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_43.pdf@EU-1-01-171_h_a_dec_43.pdf@2018-02-08 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_12.pdf@EU-1-01-188_h_a_dec_12.pdf@2006-02-13 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-01-172_h_a_dec_43.pdf@EU-1-01-172_h_a_dec_43.pdf@2012-10-31 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd.@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_18.pdf@EU-1-01-185_h_a_dec_18.pdf@2008-02-26 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_6.pdf@EU-1-01-183_h_a_dec_6.pdf@2006-04-08 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface antigen  (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_13.pdf@EU-1-01-188_h_a_dec_13.pdf@2006-07-28 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_19.pdf@EU-1-01-185_h_a_dec_19.pdf@2008-03-07 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-183_h_a_dec_7.pdf@EU-1-01-183_h_a_dec_7.pdf@2006-04-08 00:00:00@HBVAXPRO@Recombinant Hepatitis B virus small surface  antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_44.pdf@EU-1-01-171_h_a_dec_44.pdf@2018-10-16 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_44.pdf@EU-1-01-172_h_a_dec_44.pdf@2013-12-18 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_2.pdf@EU-1-01-185_h_a_dec_2.pdf@2002-07-30 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_8.pdf@EU-1-01-183_h_a_dec_8.pdf@2006-08-21 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_45.pdf@EU-1-01-171_h_a_dec_45.pdf@2019-09-13 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_14.pdf@EU-1-01-188_h_a_dec_14.pdf@2006-01-09 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_20.pdf@EU-1-01-185_h_a_dec_20.pdf@2008-01-09 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_0.pdf@EU-1-01-189_h_a_dec_0.pdf@2001-03-08 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@adopted@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-183_h_a_dec_9.pdf@EU-1-01-183_h_a_dec_9.pdf@2007-12-21 00:00:00@HBVAXPRO@Recombinant Hepatitis  B virus small surface antigen (HbsAg)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_46.pdf@EU-1-01-172_h_a_dec_46.pdf@2015-03-30 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_46.pdf@EU-1-01-171_h_a_dec_46.pdf@2021-07-16 00:00:00@Rapamune@sirolimus@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_15.pdf@EU-1-01-188_h_a_dec_15.pdf@2007-01-24 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_1.pdf@EU-1-01-189_h_a_dec_1.pdf@2002-02-28 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_5.pdf@EU-1-01-171_h_a_dec_5.pdf@2002-08-10 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_21.pdf@EU-1-01-185_h_a_dec_21.pdf@2008-10-28 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-171_h_a_dec_6.pdf@EU-1-01-171_h_a_dec_6.pdf@2003-10-01 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
ed
EU-1-01-188_h_a_dec_16.pdf@EU-1-01-188_h_a_dec_16.pdf@2007-02-15 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-01-171_h_a_dec_7.pdf@EU-1-01-171_h_a_dec_7.pdf@2003-01-28 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_47.pdf@EU-1-01-172_h_a_dec_47.pdf@2016-09-08 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_0.pdf@EU-1-01-190_h_a_dec_0.pdf@2001-07-16 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_11.pdf@EU-1-01-189_h_a_dec_11.pdf@2004-01-16 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_8.pdf@EU-1-01-171_h_a_dec_8.pdf@2003-06-30 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_22.pdf@EU-1-01-185_h_a_dec_22.pdf@2009-10-28 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_1.pdf@EU-1-01-190_h_a_dec_1.pdf@2002-04-18 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_17.pdf@EU-1-01-188_h_a_dec_17.pdf@2007-10-22 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_12.pdf@EU-1-01-189_h_a_dec_12.pdf@2004-07-20 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-171_h_a_dec_9.pdf@EU-1-01-171_h_a_dec_9.pdf@2003-05-08 00:00:00@Rapamune@sirolimus@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_48.pdf@EU-1-01-172_h_a_dec_48.pdf@2016-08-18 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_10.pdf@EU-1-01-190_h_a_dec_10.pdf@2011-10-27 00:00:00@Ceprotin@Protein C@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_13.pdf@EU-1-01-189_h_a_dec_13.pdf@2004-07-29 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_23.pdf@EU-1-01-185_h_a_dec_23.pdf@2010-03-23 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_18.pdf@EU-1-01-188_h_a_dec_18.pdf@2008-06-02 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-01-190_h_a_dec_11.pdf@EU-1-01-190_h_a_dec_11.pdf@2016-05-20 00:00:00@Ceprotin@Protein C@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_14.pdf@EU-1-01-189_h_a_dec_14.pdf@2005-03-03 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe AB@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_24.pdf@EU-1-01-185_h_a_dec_24.pdf@2010-07-28 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_49.pdf@EU-1-01-172_h_a_dec_49.pdf@2017-05-24 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_15.pdf@EU-1-01-189_h_a_dec_15.pdf@2005-07-27 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe AB@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_19.pdf@EU-1-01-188_h_a_dec_19.pdf@2010-01-25 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_12.pdf@EU-1-01-190_h_a_dec_12.pdf@2019-04-10 00:00:00@Ceprotin@Protein C@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_5.pdf@EU-1-01-172_h_a_dec_5.pdf@2002-12-11 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_25.pdf@EU-1-01-185_h_a_dec_25.pdf@2010-03-12 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_2.pdf@EU-1-01-188_h_a_dec_2.pdf@2002-02-12 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-190_h_a_dec_13.pdf@EU-1-01-190_h_a_dec_13.pdf@2020-04-02 00:00:00@Ceprotin@Protein C@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_26.pdf@EU-1-01-185_h_a_dec_26.pdf@2010-12-20 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_17.pdf@EU-1-01-189_h_a_dec_17.pdf@2006-07-28 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe AB@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_50.pdf@EU-1-01-172_h_a_dec_50.pdf@2017-07-26 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_20.pdf@EU-1-01-188_h_a_dec_20.pdf@2011-02-28 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_14.pdf@EU-1-01-190_h_a_dec_14.pdf@2021-10-19 00:00:00@Ceprotin@Protein C@False@False@OD Not Found@Takeda Manufacturing Austria AG@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_0.pdf@EU-1-01-194_h_a_dec_0.pdf@2001-01-08 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_27.pdf@EU-1-01-185_h_a_dec_27.pdf@2011-02-28 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_21.pdf@EU-1-01-188_h_a_dec_21.pdf@2011-07-06 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@False@adopted@Genzyme Europe  B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_18.pdf@EU-1-01-189_h_a_dec_18.pdf@2006-01-09 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe AB@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_15.pdf@EU-1-01-190_h_a_dec_15.pdf@2021-12-16 00:00:00@Ceprotin@Protein C@False@False@OD Not Found@Takeda Manufacturing Austria AG@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_1.pdf@EU-1-01-194_h_a_dec_1.pdf@2002-02-04 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_51.pdf@EU-1-01-172_h_a_dec_51.pdf@2017-08-24 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_28.pdf@EU-1-01-185_h_a_dec_28.pdf@2011-05-12 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_2.pdf@EU-1-01-190_h_a_dec_2.pdf@2003-06-30 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_22.pdf@EU-1-01-188_h_a_dec_22.pdf@2011-11-22 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_19.pdf@EU-1-01-189_h_a_dec_19.pdf@2006-11-24 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe AB@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_10.pdf@EU-1-01-194_h_a_dec_10.pdf@2011-03-17 00:00:00@INOmax@nitric oxide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_29.pdf@EU-1-01-185_h_a_dec_29.pdf@2012-10-29 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_2.pdf@EU-1-01-189_h_a_dec_2.pdf@2002-10-04 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_23.pdf@EU-1-01-188_h_a_dec_23.pdf@2011-11-22 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_3.pdf@EU-1-01-190_h_a_dec_3.pdf@2004-02-23 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_52.pdf@EU-1-01-172_h_a_dec_52.pdf@2018-05-23 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_3.pdf@EU-1-01-185_h_a_dec_3.pdf@2002-08-22 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_11.pdf@EU-1-01-194_h_a_dec_11.pdf@2011-03-17 00:00:00@INOmax@nitric oxide@NAS before 2012@False@OD Not Found@INO Therapeutics AB@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_20.pdf@EU-1-01-189_h_a_dec_20.pdf@2007-12-02 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-01-190_h_a_dec_4.pdf@EU-1-01-190_h_a_dec_4.pdf@2004-09-27 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_53.pdf@EU-1-01-172_h_a_dec_53.pdf@2019-04-29 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_24.pdf@EU-1-01-188_h_a_dec_24.pdf@2014-07-23 00:00:00@Fabrazyme@Agalsidase beta@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_30.pdf@EU-1-01-185_h_a_dec_30.pdf@2013-07-25 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_12.pdf@EU-1-01-194_h_a_dec_12.pdf@2011-03-18 00:00:00@INOmax@nitric oxide@NAS before 2012@False@OD Not Found@INO Therapeutics AB@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_21.pdf@EU-1-01-189_h_a_dec_21.pdf@2008-05-03 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-01-190_h_a_dec_5.pdf@EU-1-01-190_h_a_dec_5.pdf@2005-07-03 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-01-172_h_a_dec_54.pdf@EU-1-01-172_h_a_dec_54.pdf@2019-04-07 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_25.pdf@EU-1-01-188_h_a_dec_25.pdf@2015-06-19 00:00:00@Fabrazyme@Agalsidase beta@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_13.pdf@EU-1-01-194_h_a_dec_13.pdf@2011-03-18 00:00:00@INOmax@nitric oxide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_22.pdf@EU-1-01-189_h_a_dec_22.pdf@2009-05-29 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_31.pdf@EU-1-01-185_h_a_dec_31.pdf@2014-09-16 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_6.pdf@EU-1-01-190_h_a_dec_6.pdf@2006-01-19 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-01-172_h_a_dec_55.pdf@EU-1-01-172_h_a_dec_55.pdf@2020-10-27 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_26.pdf@EU-1-01-188_h_a_dec_26.pdf@2017-12-20 00:00:00@Fabrazyme@Agalsidase beta@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_14.pdf@EU-1-01-194_h_a_dec_14.pdf@2012-10-29 00:00:00@INOmax@Nitric oxide@False@False@OD Not Found@INO Therapeutics AB@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_23.pdf@EU-1-01-189_h_a_dec_23.pdf@2009-12-22 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-01-190_h_a_dec_7.pdf@EU-1-01-190_h_a_dec_7.pdf@2006-07-28 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_32.pdf@EU-1-01-185_h_a_dec_32.pdf@2015-11-11 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_56.pdf@EU-1-01-172_h_a_dec_56.pdf@2021-02-12 00:00:00@Kaletra@lopinavir / Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_27.pdf@EU-1-01-188_h_a_dec_27.pdf@2019-11-28 00:00:00@Fabrazyme@Agalsidase beta@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_24.pdf@EU-1-01-189_h_a_dec_24.pdf@2011-02-02 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB,@exceptional@Parsed
EU-1-01-190_h_a_dec_8.pdf@EU-1-01-190_h_a_dec_8.pdf@2007-03-01 00:00:00@Ceprotin@Protein C@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_15.pdf@EU-1-01-194_h_a_dec_15.pdf@2014-01-16 00:00:00@INOmax@Nitric oxide@False@False@OD Not Found@Linde Healthcare AB@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_33.pdf@EU-1-01-185_h_a_dec_33.pdf@2017-08-24 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_6.pdf@EU-1-01-172_h_a_dec_6.pdf@2002-11-13 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_28.pdf@EU-1-01-188_h_a_dec_28.pdf@2020-10-27 00:00:00@Fabrazyme@Agalsidase beta@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_25.pdf@EU-1-01-189_h_a_dec_25.pdf@2012-02-17 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB,@exceptional@Parsed
EU-1-01-172_h_a_dec_7.pdf@EU-1-01-172_h_a_dec_7.pdf@2003-09-07 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_16.pdf@EU-1-01-194_h_a_dec_16.pdf@2015-09-18 00:00:00@INOmax@Nitric oxide@False@False@OD Not Found@Linde Healthcare AB@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_34.pdf@EU-1-01-185_h_a_dec_34.pdf@2018-08-23 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_29.pdf@EU-1-01-188_h_a_dec_29.pdf@2021-06-17 00:00:00@Fabrazyme@Agalsidase beta@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_26.pdf@EU-1-01-189_h_a_dec_26.pdf@2012-09-17 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB,@CMA Not Found@Parsed
EU-1-01-172_h_a_dec_8.pdf@EU-1-01-172_h_a_dec_8.pdf@2004-01-30 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_35.pdf@EU-1-01-185_h_a_dec_35.pdf@2020-06-02 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_17.pdf@EU-1-01-194_h_a_dec_17.pdf@2017-02-16 00:00:00@INOmax@Nitric oxide@False@False@OD Not Found@Linde Healthcare AB@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_3.pdf@EU-1-01-188_h_a_dec_3.pdf@2003-01-24 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_27.pdf@EU-1-01-189_h_a_dec_27.pdf@2013-01-07 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-01-172_h_a_dec_9.pdf@EU-1-01-172_h_a_dec_9.pdf@2004-01-30 00:00:00@Kaletra@lopinavir/ ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_36.pdf@EU-1-01-185_h_a_dec_36.pdf@2022-05-19 00:00:00@Aranesp@darbepoetin alfa@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_4.pdf@EU-1-01-188_h_a_dec_4.pdf@2003-08-04 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_4.pdf@EU-1-01-185_h_a_dec_4.pdf@Date is blank@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@NA before 2000@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_18.pdf@EU-1-01-194_h_a_dec_18.pdf@2019-11-03 00:00:00@INOmax@Nitric oxide@False@False@OD Not Found@Linde Healthcare AB@CMA Not Found@Parsed
EU-1-01-188_h_a_dec_5.pdf@EU-1-01-188_h_a_dec_5.pdf@2003-05-19 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_28.pdf@EU-1-01-189_h_a_dec_28.pdf@2014-03-21 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-01-195_h_a_dec_0.pdf@EU-1-01-195_h_a_dec_0.pdf@2001-01-08 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_5.pdf@EU-1-01-185_h_a_dec_5.pdf@2003-11-08 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_6.pdf@EU-1-01-188_h_a_dec_6.pdf@2003-07-22 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_29.pdf@EU-1-01-189_h_a_dec_29.pdf@2015-10-02 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-01-195_h_a_dec_1.pdf@EU-1-01-195_h_a_dec_1.pdf@2003-03-24 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_6.pdf@EU-1-01-185_h_a_dec_6.pdf@2004-04-14 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_19.pdf@EU-1-01-194_h_a_dec_19.pdf@2021-02-19 00:00:00@INOmax@Nitric oxide@False@False@OD Not Found@Linde Healthcare AB@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_3.pdf@EU-1-01-189_h_a_dec_3.pdf@2002-10-09 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
ed
EU-1-01-195_h_a_dec_10.pdf@EU-1-01-195_h_a_dec_10.pdf@2007-02-05 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_2.pdf@EU-1-01-194_h_a_dec_2.pdf@2002-10-22 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-185_h_a_dec_7.pdf@EU-1-01-185_h_a_dec_7.pdf@2004-09-09 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_30.pdf@EU-1-01-189_h_a_dec_30.pdf@2015-07-20 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-01-188_h_a_dec_8.pdf@EU-1-01-188_h_a_dec_8.pdf@2004-01-16 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_11.pdf@EU-1-01-195_h_a_dec_11.pdf@2008-01-29 00:00:00@Liprolog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_3.pdf@EU-1-01-194_h_a_dec_3.pdf@2003-02-10 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-188_h_a_dec_9.pdf@EU-1-01-188_h_a_dec_9.pdf@2004-09-08 00:00:00@Fabrazyme@Agalsidase beta@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_31.pdf@EU-1-01-189_h_a_dec_31.pdf@2016-06-10 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_8.pdf@EU-1-01-185_h_a_dec_8.pdf@2005-02-28 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_32.pdf@EU-1-01-189_h_a_dec_32.pdf@2018-10-25 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_4.pdf@EU-1-01-194_h_a_dec_4.pdf@2003-01-12 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@AGA AB@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_12.pdf@EU-1-01-195_h_a_dec_12.pdf@2008-11-07 00:00:00@Liprolog@Insulin lispro@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-185_h_a_dec_9.pdf@EU-1-01-185_h_a_dec_9.pdf@2005-08-07 00:00:00@Aranesp@darbepoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_33.pdf@EU-1-01-189_h_a_dec_33.pdf@2021-11-26 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_5.pdf@EU-1-01-194_h_a_dec_5.pdf@2004-02-08 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@INO Therapeutics AB@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_13.pdf@EU-1-01-195_h_a_dec_13.pdf@2009-03-27 00:00:00@Liprolog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_14.pdf@EU-1-01-195_h_a_dec_14.pdf@2009-04-22 00:00:00@Liprolog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_0.pdf@EU-1-01-196_h_a_dec_0.pdf@2001-10-24 00:00:00@Caspofungin MSD@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_6.pdf@EU-1-01-194_h_a_dec_6.pdf@2006-07-28 00:00:00@INOmax@nitric oxide@NAS before 2012@NA before 2012@OD Not Found@INO Therapeutics AB@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_1.pdf@EU-1-01-196_h_a_dec_1.pdf@2003-02-17 00:00:00@Caspofungin MSD@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_34.pdf@EU-1-01-189_h_a_dec_34.pdf@2022-01-04 00:00:00@Replagal@Agalsidase alfa@False@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_7.pdf@EU-1-01-194_h_a_dec_7.pdf@2009-10-28 00:00:00@Beromun@Tasonermin (Tumor  Necrosis Factor alfa-1a)@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_15.pdf@EU-1-01-195_h_a_dec_15.pdf@2009-01-07 00:00:00@Liprolog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_4.pdf@EU-1-01-189_h_a_dec_4.pdf@2002-10-09 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_10.pdf@EU-1-01-196_h_a_dec_10.pdf@2006-09-29 00:00:00@Cancidas@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-194_h_a_dec_8.pdf@EU-1-01-194_h_a_dec_8.pdf@2011-01-13 00:00:00@INOmax@nitric oxide@NAS before 2012@False@OD Not Found@INO Therapeutics AB@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_5.pdf@EU-1-01-189_h_a_dec_5.pdf@2002-03-10 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_16.pdf@EU-1-01-195_h_a_dec_16.pdf@2011-03-17 00:00:00@Liprolog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_0.pdf@EU-1-01-197_h_a_dec_0.pdf@2001-10-24 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Scotia Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-01-194_h_a_dec_9.pdf@EU-1-01-194_h_a_dec_9.pdf@2011-01-21 00:00:00@INOmax@nitric oxide@NAS before 2012@False@OD Not Found@INO Therapeutics AB@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_11.pdf@EU-1-01-196_h_a_dec_11.pdf@2008-11-26 00:00:00@Cancidas@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_6.pdf@EU-1-01-189_h_a_dec_6.pdf@2003-01-28 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_17.pdf@EU-1-01-195_h_a_dec_17.pdf@2011-04-20 00:00:00@Liprolog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_1.pdf@EU-1-01-197_h_a_dec_1.pdf@2002-02-19 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@QuantaNova Limited@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_7.pdf@EU-1-01-189_h_a_dec_7.pdf@2003-02-17 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_12.pdf@EU-1-01-196_h_a_dec_12.pdf@2009-01-07 00:00:00@Cancidas@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_18.pdf@EU-1-01-195_h_a_dec_18.pdf@2012-10-25 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_10.pdf@EU-1-01-197_h_a_dec_10.pdf@2005-10-13 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Biolitec pharma Ltd United Drug@CMA not available before 2006@Parsed
EU-1-01-189_h_a_dec_8.pdf@EU-1-01-189_h_a_dec_8.pdf@2003-02-17 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_13.pdf@EU-1-01-196_h_a_dec_13.pdf@2009-07-23 00:00:00@Cancidas@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_11.pdf@EU-1-01-197_h_a_dec_11.pdf@2006-11-29 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Biolitec pharma Ltd@CMA Not Found@Parsed
EU-1-01-189_h_a_dec_9.pdf@EU-1-01-189_h_a_dec_9.pdf@2003-07-22 00:00:00@Replagal@Agalsidase alfa@NAS before 2012@NA before 2012@OD Not Found@TKT Europe-5S AB@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_19.pdf@EU-1-01-195_h_a_dec_19.pdf@2014-01-10 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_14.pdf@EU-1-01-196_h_a_dec_14.pdf@2010-11-03 00:00:00@Cancidas@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_12.pdf@EU-1-01-197_h_a_dec_12.pdf@2007-04-13 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Biolitec pharma Ltd@exceptional@Parsed
EU-1-01-195_h_a_dec_2.pdf@EU-1-01-195_h_a_dec_2.pdf@2003-07-11 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_15.pdf@EU-1-01-196_h_a_dec_15.pdf@2010-11-26 00:00:00@Cancidas@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_13.pdf@EU-1-01-197_h_a_dec_13.pdf@2007-10-15 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Biolitec pharma Ltd@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_0.pdf@EU-1-01-198_h_a_dec_0.pdf@2001-07-11 00:00:00@Glivec@imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_20.pdf@EU-1-01-195_h_a_dec_20.pdf@2016-05-26 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_1.pdf@EU-1-01-198_h_a_dec_1.pdf@2002-05-24 00:00:00@Glivec@imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_16.pdf@EU-1-01-196_h_a_dec_16.pdf@2011-01-17 00:00:00@Cancidas@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_14.pdf@EU-1-01-197_h_a_dec_14.pdf@2008-05-21 00:00:00@Foscan@temoporfin@NAS before 2012@True@OD Not Found@Biolitec pharma Ltd@exceptional@Parsed
EU-1-01-195_h_a_dec_21.pdf@EU-1-01-195_h_a_dec_21.pdf@2017-10-23 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_17.pdf@EU-1-01-196_h_a_dec_17.pdf@2011-07-09 00:00:00@CANCIDAS@caspofungin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_10.pdf@EU-1-01-198_h_a_dec_10.pdf@2005-08-07 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-197_h_a_dec_15.pdf@EU-1-01-197_h_a_dec_15.pdf@2009-05-11 00:00:00@Foscan@temoporfin@NAS before 2012@False@OD Not Found@Biolitec pharma Ltd@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_18.pdf@EU-1-01-196_h_a_dec_18.pdf@2012-10-29 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_0.pdf@EU-1-01-199_h_a_dec_0.pdf@2001-11-27 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_11.pdf@EU-1-01-198_h_a_dec_11.pdf@2006-02-28 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_16.pdf@EU-1-01-197_h_a_dec_16.pdf@2012-04-13 00:00:00@Foscan@temoporfin@False@False@OD Not Found@Biolitec pharma Ltd@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_22.pdf@EU-1-01-195_h_a_dec_22.pdf@2019-12-02 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_1.pdf@EU-1-01-199_h_a_dec_1.pdf@2002-03-14 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_12.pdf@EU-1-01-198_h_a_dec_12.pdf@2006-03-20 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-01-197_h_a_dec_17.pdf@EU-1-01-197_h_a_dec_17.pdf@2012-10-29 00:00:00@Foscan@temoporfin@False@False@OD Not Found@Biolitec pharma Ltd@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_19.pdf@EU-1-01-196_h_a_dec_19.pdf@2014-04-23 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_10.pdf@EU-1-01-199_h_a_dec_10.pdf@2010-11-29 00:00:00@Travatan@Travoprost@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK)  Ltd.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_13.pdf@EU-1-01-198_h_a_dec_13.pdf@2006-03-20 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-01-195_h_a_dec_23.pdf@EU-1-01-195_h_a_dec_23.pdf@2020-01-16 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_2.pdf@EU-1-01-196_h_a_dec_2.pdf@2003-09-04 00:00:00@CANCIDAS@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_11.pdf@EU-1-01-199_h_a_dec_11.pdf@2011-04-14 00:00:00@Travatan@Travoprost@NAS before 2012@False@OD Not Found@Alcon Laboratories  (UK) Ltd.@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_18.pdf@EU-1-01-197_h_a_dec_18.pdf@2013-11-10 00:00:00@Foscan@temoporfin@False@False@OD Not Found@Biolitec Pharma Ltd@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_14.pdf@EU-1-01-198_h_a_dec_14.pdf@2006-09-13 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_20.pdf@EU-1-01-196_h_a_dec_20.pdf@2015-10-06 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_24.pdf@EU-1-01-195_h_a_dec_24.pdf@2021-09-23 00:00:00@Liprolog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_15.pdf@EU-1-01-198_h_a_dec_15.pdf@2006-09-21 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_19.pdf@EU-1-01-197_h_a_dec_19.pdf@2015-08-07 00:00:00@Foscan@temoporfin@False@False@OD Not Found@biolitec pharma ltd.@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_12.pdf@EU-1-01-199_h_a_dec_12.pdf@2014-01-31 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_3.pdf@EU-1-01-195_h_a_dec_3.pdf@2003-07-11 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_16.pdf@EU-1-01-198_h_a_dec_16.pdf@2006-11-28 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_2.pdf@EU-1-01-197_h_a_dec_2.pdf@2002-12-04 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Scotia Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_21.pdf@EU-1-01-196_h_a_dec_21.pdf@2017-04-24 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-01-195_h_a_dec_4.pdf@EU-1-01-195_h_a_dec_4.pdf@2004-10-29 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_13.pdf@EU-1-01-199_h_a_dec_13.pdf@2014-12-19 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_20.pdf@EU-1-01-197_h_a_dec_20.pdf@2016-11-11 00:00:00@Foscan@temoporfin@False@False@OD Not Found@biolitec Pharma Ltd..@CMA Not Found@Parsed
CMA Not Found@Parsed
EU-1-01-195_h_a_dec_5.pdf@EU-1-01-195_h_a_dec_5.pdf@2006-02-13 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_3.pdf@EU-1-01-197_h_a_dec_3.pdf@2002-09-13 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@biolitec pharma limited@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_22.pdf@EU-1-01-196_h_a_dec_22.pdf@2018-08-08 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_18.pdf@EU-1-01-198_h_a_dec_18.pdf@2007-04-13 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-01-197_h_a_dec_4.pdf@EU-1-01-197_h_a_dec_4.pdf@2002-05-12 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@biolitec pharma limited@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_6.pdf@EU-1-01-195_h_a_dec_6.pdf@2006-01-09 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_14.pdf@EU-1-01-199_h_a_dec_14.pdf@2016-01-25 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_23.pdf@EU-1-01-196_h_a_dec_23.pdf@2019-05-12 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_19.pdf@EU-1-01-198_h_a_dec_19.pdf@2007-11-20 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_5.pdf@EU-1-01-197_h_a_dec_5.pdf@2003-09-07 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@biolitec pharma limited@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_7.pdf@EU-1-01-195_h_a_dec_7.pdf@2006-11-20 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_2.pdf@EU-1-01-198_h_a_dec_2.pdf@2002-12-19 00:00:00@Glivec@imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-197_h_a_dec_6.pdf@EU-1-01-197_h_a_dec_6.pdf@2003-10-20 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@biolitec pharma limited@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_15.pdf@EU-1-01-199_h_a_dec_15.pdf@2017-04-20 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_24.pdf@EU-1-01-196_h_a_dec_24.pdf@2021-02-08 00:00:00@CANCIDAS@caspofungin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
Not Found@Parsed
EU-1-01-198_h_a_dec_20.pdf@EU-1-01-198_h_a_dec_20.pdf@2009-04-29 00:00:00@Glivec@Imatinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_7.pdf@EU-1-01-197_h_a_dec_7.pdf@2004-02-20 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@biolitec pharma limited@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_3.pdf@EU-1-01-196_h_a_dec_3.pdf@2003-05-19 00:00:00@CANCIDAS@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-195_h_a_dec_9.pdf@EU-1-01-195_h_a_dec_9.pdf@2007-03-27 00:00:00@Liprolog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_21.pdf@EU-1-01-198_h_a_dec_21.pdf@2010-03-26 00:00:00@Glivec@Imatinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_8.pdf@EU-1-01-197_h_a_dec_8.pdf@2005-05-01 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@biolitec pharma limited@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_4.pdf@EU-1-01-196_h_a_dec_4.pdf@2004-05-02 00:00:00@CANCIDAS@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_16.pdf@EU-1-01-199_h_a_dec_16.pdf@2018-04-13 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_22.pdf@EU-1-01-198_h_a_dec_22.pdf@2010-03-26 00:00:00@Glivec@Imatinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-197_h_a_dec_9.pdf@EU-1-01-197_h_a_dec_9.pdf@2005-03-29 00:00:00@Foscan@temoporfin@NAS before 2012@NA before 2012@OD Not Found@Biolitec pharma (Ireland) Ltd.@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_5.pdf@EU-1-01-196_h_a_dec_5.pdf@2004-11-05 00:00:00@Cancidas@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_23.pdf@EU-1-01-198_h_a_dec_23.pdf@2010-12-20 00:00:00@Glivec@Imatinib@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_17.pdf@EU-1-01-199_h_a_dec_17.pdf@2018-08-05 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_6.pdf@EU-1-01-196_h_a_dec_6.pdf@2004-05-13 00:00:00@Cancidas@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_24.pdf@EU-1-01-198_h_a_dec_24.pdf@2011-02-21 00:00:00@Glivec@Imatinib@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-01-196_h_a_dec_7.pdf@EU-1-01-196_h_a_dec_7.pdf@2004-10-28 00:00:00@Cancidas@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_25.pdf@EU-1-01-198_h_a_dec_25.pdf@2011-05-23 00:00:00@Glivec@Imatinib@NAS before 2012@False@adopted@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_18.pdf@EU-1-01-199_h_a_dec_18.pdf@2019-09-08 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_0.pdf@EU-1-01-200_h_a_dec_0.pdf@2002-05-02 00:00:00@Viread@Tenofovir disoproxil (as fumarate)@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_8.pdf@EU-1-01-196_h_a_dec_8.pdf@2005-10-05 00:00:00@Cancidas@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_26.pdf@EU-1-01-198_h_a_dec_26.pdf@2011-12-14 00:00:00@Glivec@Imatinib@NAS before 2012@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_0.pdf@EU-1-02-201_h_a_dec_0.pdf@2002-02-28 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_1.pdf@EU-1-01-200_h_a_dec_1.pdf@2002-05-12 00:00:00@Viread@Tenofovir disoproxil (as fumarate)@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_1.pdf@EU-1-02-201_h_a_dec_1.pdf@2002-09-10 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-01-196_h_a_dec_9.pdf@EU-1-01-196_h_a_dec_9.pdf@2006-03-23 00:00:00@Cancidas@caspofungin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@exceptional@Parsed
EU-1-01-198_h_a_dec_27.pdf@EU-1-01-198_h_a_dec_27.pdf@2012-01-20 00:00:00@Glivec@Imatinib@False@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_10.pdf@EU-1-01-200_h_a_dec_10.pdf@2004-01-14 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_19.pdf@EU-1-01-199_h_a_dec_19.pdf@2022-09-21 00:00:00@Travatan@Travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_10.pdf@EU-1-02-201_h_a_dec_10.pdf@2006-03-29 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_28.pdf@EU-1-01-198_h_a_dec_28.pdf@2012-02-21 00:00:00@Glivec@Imatinib@False@False@adopted@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_2.pdf@EU-1-01-199_h_a_dec_2.pdf@2002-12-11 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_11.pdf@EU-1-01-200_h_a_dec_11.pdf@2004-01-30 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_3.pdf@EU-1-01-199_h_a_dec_3.pdf@2003-02-14 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_11.pdf@EU-1-02-201_h_a_dec_11.pdf@2006-12-06 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_29.pdf@EU-1-01-198_h_a_dec_29.pdf@2012-10-23 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_12.pdf@EU-1-01-200_h_a_dec_12.pdf@2004-01-30 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-199_h_a_dec_4.pdf@EU-1-01-199_h_a_dec_4.pdf@2003-07-28 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_3.pdf@EU-1-01-198_h_a_dec_3.pdf@2003-06-30 00:00:00@Glivec@Imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_12.pdf@EU-1-02-201_h_a_dec_12.pdf@2006-11-20 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_5.pdf@EU-1-01-199_h_a_dec_5.pdf@2003-10-24 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_13.pdf@EU-1-01-200_h_a_dec_13.pdf@2004-10-06 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_13.pdf@EU-1-02-201_h_a_dec_13.pdf@2007-03-05 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_6.pdf@EU-1-01-199_h_a_dec_6.pdf@2005-01-25 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_30.pdf@EU-1-01-198_h_a_dec_30.pdf@2013-06-27 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_14.pdf@EU-1-01-200_h_a_dec_14.pdf@2004-10-06 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_14.pdf@EU-1-02-201_h_a_dec_14.pdf@2009-02-26 00:00:00@Protopic@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_7.pdf@EU-1-01-199_h_a_dec_7.pdf@2006-06-10 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_15.pdf@EU-1-01-200_h_a_dec_15.pdf@2004-02-08 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_31.pdf@EU-1-01-198_h_a_dec_31.pdf@2014-07-18 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_15.pdf@EU-1-02-201_h_a_dec_15.pdf@2009-07-04 00:00:00@Protopic@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_8.pdf@EU-1-01-199_h_a_dec_8.pdf@2007-01-03 00:00:00@Travatan@Travoprost@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_16.pdf@EU-1-01-200_h_a_dec_16.pdf@2004-10-28 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_0.pdf@EU-1-02-203_h_a_dec_0.pdf@2002-08-03 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_16.pdf@EU-1-02-201_h_a_dec_16.pdf@2011-02-21 00:00:00@Protopic@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-01-199_h_a_dec_9.pdf@EU-1-01-199_h_a_dec_9.pdf@2010-10-28 00:00:00@Travatan@Travoprost@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK)  Ltd.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_32.pdf@EU-1-01-198_h_a_dec_32.pdf@2016-01-14 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_17.pdf@EU-1-01-200_h_a_dec_17.pdf@2004-06-12 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_1.pdf@EU-1-02-203_h_a_dec_1.pdf@2002-11-07 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_17.pdf@EU-1-02-201_h_a_dec_17.pdf@2011-06-23 00:00:00@Protopic@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_18.pdf@EU-1-01-200_h_a_dec_18.pdf@2005-10-01 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_18.pdf@EU-1-02-201_h_a_dec_18.pdf@2012-08-30 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_10.pdf@EU-1-02-203_h_a_dec_10.pdf@2008-11-20 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_33.pdf@EU-1-01-198_h_a_dec_33.pdf@2017-08-05 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_19.pdf@EU-1-01-200_h_a_dec_19.pdf@2005-07-03 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_11.pdf@EU-1-02-203_h_a_dec_11.pdf@2009-06-30 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_19.pdf@EU-1-02-201_h_a_dec_19.pdf@2013-12-18 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_2.pdf@EU-1-01-200_h_a_dec_2.pdf@2003-06-02 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_34.pdf@EU-1-01-198_h_a_dec_34.pdf@2018-06-25 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_12.pdf@EU-1-02-203_h_a_dec_12.pdf@2010-09-02 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_2.pdf@EU-1-02-201_h_a_dec_2.pdf@2002-08-11 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_20.pdf@EU-1-01-200_h_a_dec_20.pdf@2005-08-07 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_13.pdf@EU-1-02-203_h_a_dec_13.pdf@2010-03-19 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_20.pdf@EU-1-02-201_h_a_dec_20.pdf@2015-12-16 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_35.pdf@EU-1-01-198_h_a_dec_35.pdf@2019-03-28 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_21.pdf@EU-1-01-200_h_a_dec_21.pdf@2005-10-25 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_14.pdf@EU-1-02-203_h_a_dec_14.pdf@2011-02-21 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Swedish Orphan  Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_0.pdf@EU-1-02-204_h_a_dec_0.pdf@2002-05-03 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_21.pdf@EU-1-02-201_h_a_dec_21.pdf@2016-06-16 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_15.pdf@EU-1-02-203_h_a_dec_15.pdf@2011-12-04 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Swedish Orphan Biovitrum AB (publ),@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_22.pdf@EU-1-01-200_h_a_dec_22.pdf@2006-02-28 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_1.pdf@EU-1-02-204_h_a_dec_1.pdf@2002-05-17 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_22.pdf@EU-1-02-201_h_a_dec_22.pdf@2016-09-19 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_36.pdf@EU-1-01-198_h_a_dec_36.pdf@2020-03-04 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_16.pdf@EU-1-02-203_h_a_dec_16.pdf@2012-10-25 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ),@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_23.pdf@EU-1-01-200_h_a_dec_23.pdf@2006-01-09 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_10.pdf@EU-1-02-204_h_a_dec_10.pdf@2007-07-23 00:00:00@Trisenox@Arsenic trioxide@NAS before 2012@NA before 2012@OD Not Found@Cephalon Europe@exceptional@Parsed
EU-1-02-201_h_a_dec_23.pdf@EU-1-02-201_h_a_dec_23.pdf@2018-10-29 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_24.pdf@EU-1-01-200_h_a_dec_24.pdf@2007-08-01 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_11.pdf@EU-1-02-204_h_a_dec_11.pdf@2009-04-21 00:00:00@Trisenox@Arsenic trioxide@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_37.pdf@EU-1-01-198_h_a_dec_37.pdf@2021-05-21 00:00:00@Glivec@Imatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_17.pdf@EU-1-02-203_h_a_dec_17.pdf@2013-11-15 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_12.pdf@EU-1-02-204_h_a_dec_12.pdf@2009-09-21 00:00:00@Trisenox@Arsenic trioxide@NAS before 2012@False@OD Not Found@Cephalon Europe@exceptional@Parsed
EU-1-01-200_h_a_dec_25.pdf@EU-1-01-200_h_a_dec_25.pdf@2007-01-15 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_24.pdf@EU-1-02-201_h_a_dec_24.pdf@2021-06-24 00:00:00@Protopic@Tacrolimus@False@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_18.pdf@EU-1-02-203_h_a_dec_18.pdf@2014-06-27 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_3.pdf@EU-1-02-201_h_a_dec_3.pdf@2003-09-04 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_13.pdf@EU-1-02-204_h_a_dec_13.pdf@2010-10-08 00:00:00@Trisenox@Arsenic trioxide@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_26.pdf@EU-1-01-200_h_a_dec_26.pdf@2007-02-28 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_38.pdf@EU-1-01-198_h_a_dec_38.pdf@2022-03-22 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_19.pdf@EU-1-02-203_h_a_dec_19.pdf@2016-02-06 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_4.pdf@EU-1-02-201_h_a_dec_4.pdf@2003-09-22 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_4.pdf@EU-1-01-198_h_a_dec_4.pdf@2003-07-14 00:00:00@Glivec@Imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_14.pdf@EU-1-02-204_h_a_dec_14.pdf@2011-11-22 00:00:00@Trisenox@Arsenic trioxide@NAS before 2012@False@adopted@Cephalon Europe@exceptional@Parsed
EU-1-01-200_h_a_dec_27.pdf@EU-1-01-200_h_a_dec_27.pdf@2007-02-05 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_2.pdf@EU-1-02-203_h_a_dec_2.pdf@2002-10-23 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_5.pdf@EU-1-01-198_h_a_dec_5.pdf@2003-11-11 00:00:00@Glivec@Imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_5.pdf@EU-1-02-201_h_a_dec_5.pdf@2004-01-27 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-205_h_a_dec_0.pdf@EU-1-02-205_h_a_dec_0.pdf@2002-08-03 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_15.pdf@EU-1-02-204_h_a_dec_15.pdf@2012-06-27 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Cephalon Europe@exceptional@Parsed
EU-1-02-203_h_a_dec_20.pdf@EU-1-02-203_h_a_dec_20.pdf@2018-06-04 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_28.pdf@EU-1-01-200_h_a_dec_28.pdf@2008-04-23 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@True@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_6.pdf@EU-1-01-198_h_a_dec_6.pdf@2004-03-31 00:00:00@Glivec@Imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-205_h_a_dec_1.pdf@EU-1-02-205_h_a_dec_1.pdf@2002-09-07 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_6.pdf@EU-1-02-201_h_a_dec_6.pdf@2004-02-03 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_16.pdf@EU-1-02-204_h_a_dec_16.pdf@2013-01-28 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_21.pdf@EU-1-02-203_h_a_dec_21.pdf@2020-09-03 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_7.pdf@EU-1-01-198_h_a_dec_7.pdf@2005-05-01 00:00:00@Glivec@Imatinib mesilate@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_29.pdf@EU-1-01-200_h_a_dec_29.pdf@2008-12-09 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@True@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_10.pdf@EU-1-02-205_h_a_dec_10.pdf@2013-02-25 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland,  (901969)@CMA Not Found@Parsed
EU-1-02-201_h_a_dec_7.pdf@EU-1-02-201_h_a_dec_7.pdf@2004-04-03 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_22.pdf@EU-1-02-203_h_a_dec_22.pdf@2020-04-28 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_3.pdf@EU-1-01-200_h_a_dec_3.pdf@2003-03-27 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_17.pdf@EU-1-02-204_h_a_dec_17.pdf@2014-11-13 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-01-198_h_a_dec_8.pdf@EU-1-01-198_h_a_dec_8.pdf@2005-03-30 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_8.pdf@EU-1-02-201_h_a_dec_8.pdf@2004-05-19 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-203_h_a_dec_23.pdf@EU-1-02-203_h_a_dec_23.pdf@2021-12-17 00:00:00@Kineret@Anakinra@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_18.pdf@EU-1-02-204_h_a_dec_18.pdf@2015-01-30 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_30.pdf@EU-1-01-200_h_a_dec_30.pdf@2009-04-22 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_3.pdf@EU-1-02-203_h_a_dec_3.pdf@2003-04-23 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-01-198_h_a_dec_9.pdf@EU-1-01-198_h_a_dec_9.pdf@2005-02-06 00:00:00@Glivec@Imatinib@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-02-201_h_a_dec_9.pdf@EU-1-02-201_h_a_dec_9.pdf@2005-10-06 00:00:00@Protopic@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Fujisawa GmbH@CMA not available before 2006@Parsed
EU-1-02-205_h_a_dec_12.pdf@EU-1-02-205_h_a_dec_12.pdf@2013-12-20 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_19.pdf@EU-1-02-204_h_a_dec_19.pdf@2016-11-14 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_31.pdf@EU-1-01-200_h_a_dec_31.pdf@2010-03-15 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_4.pdf@EU-1-02-203_h_a_dec_4.pdf@2005-07-28 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_2.pdf@EU-1-02-204_h_a_dec_2.pdf@2003-08-10 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_32.pdf@EU-1-01-200_h_a_dec_32.pdf@2010-09-04 00:00:00@Viread@tenofovir disoproxil  fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_5.pdf@EU-1-02-203_h_a_dec_5.pdf@2006-05-31 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_13.pdf@EU-1-02-205_h_a_dec_13.pdf@2016-01-14 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_20.pdf@EU-1-02-204_h_a_dec_20.pdf@2018-04-30 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_33.pdf@EU-1-01-200_h_a_dec_33.pdf@2010-06-09 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_6.pdf@EU-1-02-203_h_a_dec_6.pdf@2006-07-28 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_21.pdf@EU-1-02-204_h_a_dec_21.pdf@2018-07-26 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_34.pdf@EU-1-01-200_h_a_dec_34.pdf@2011-03-18 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_14.pdf@EU-1-02-205_h_a_dec_14.pdf@2016-03-22 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_7.pdf@EU-1-02-203_h_a_dec_7.pdf@2007-03-20 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_22.pdf@EU-1-02-204_h_a_dec_22.pdf@2019-05-27 00:00:00@Trisenox@Arsenic trioxide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_35.pdf@EU-1-01-200_h_a_dec_35.pdf@2011-03-24 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_8.pdf@EU-1-02-203_h_a_dec_8.pdf@2007-04-24 00:00:00@Kineret@Anakinra@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_23.pdf@EU-1-02-204_h_a_dec_23.pdf@2020-10-27 00:00:00@TRISENOX@Arsenic trioxide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_36.pdf@EU-1-01-200_h_a_dec_36.pdf@2011-05-18 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited,@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_15.pdf@EU-1-02-205_h_a_dec_15.pdf@2018-12-04 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-203_h_a_dec_9.pdf@EU-1-02-203_h_a_dec_9.pdf@2008-01-04 00:00:00@Kineret@Anakinra@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_0.pdf@EU-1-02-206_h_a_dec_0.pdf@2002-03-21 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_3.pdf@EU-1-02-204_h_a_dec_3.pdf@2004-09-09 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_37.pdf@EU-1-01-200_h_a_dec_37.pdf@2011-07-13 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_1.pdf@EU-1-02-206_h_a_dec_1.pdf@2003-01-15 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_0.pdf@EU-1-02-209_h_a_dec_0.pdf@2002-03-22 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_38.pdf@EU-1-01-200_h_a_dec_38.pdf@2011-05-08 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_4.pdf@EU-1-02-204_h_a_dec_4.pdf@2005-04-07 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Ltd@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_1.pdf@EU-1-02-209_h_a_dec_1.pdf@2003-09-04 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_10.pdf@EU-1-02-206_h_a_dec_10.pdf@2007-04-20 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_16.pdf@EU-1-02-205_h_a_dec_16.pdf@2019-01-18 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_39.pdf@EU-1-01-200_h_a_dec_39.pdf@2011-12-14 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_5.pdf@EU-1-02-204_h_a_dec_5.pdf@2005-06-10 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_10.pdf@EU-1-02-209_h_a_dec_10.pdf@2006-04-07 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_11.pdf@EU-1-02-206_h_a_dec_11.pdf@2007-08-29 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_4.pdf@EU-1-01-200_h_a_dec_4.pdf@2003-05-19 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_6.pdf@EU-1-02-204_h_a_dec_6.pdf@2006-04-24 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cell Therapeutics (UK) Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_40.pdf@EU-1-01-200_h_a_dec_40.pdf@2012-01-31 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_12.pdf@EU-1-02-206_h_a_dec_12.pdf@2007-08-29 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_17.pdf@EU-1-02-205_h_a_dec_17.pdf@2021-04-21 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_11.pdf@EU-1-02-209_h_a_dec_11.pdf@2007-03-29 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_7.pdf@EU-1-02-204_h_a_dec_7.pdf@2006-11-07 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cephalon UK Ltd@exceptional@Parsed
EU-1-02-206_h_a_dec_13.pdf@EU-1-02-206_h_a_dec_13.pdf@2007-03-09 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_41.pdf@EU-1-01-200_h_a_dec_41.pdf@2012-11-22 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_12.pdf@EU-1-02-209_h_a_dec_12.pdf@2007-04-23 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-204_h_a_dec_8.pdf@EU-1-02-204_h_a_dec_8.pdf@2007-02-15 00:00:00@Trisenox@Arsenic Trioxide@NAS before 2012@NA before 2012@OD Not Found@Cephalon UK Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_14.pdf@EU-1-02-206_h_a_dec_14.pdf@2007-09-10 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_42.pdf@EU-1-01-200_h_a_dec_42.pdf@2013-04-29 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_18.pdf@EU-1-02-205_h_a_dec_18.pdf@2022-01-20 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_13.pdf@EU-1-02-209_h_a_dec_13.pdf@2008-01-31 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_0.pdf@EU-1-02-212_h_a_dec_0.pdf@2002-03-19 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-204_h_a_dec_9.pdf@EU-1-02-204_h_a_dec_9.pdf@2007-05-06 00:00:00@Trisenox@Arsenic trioxide@NAS before 2012@NA before 2012@OD Not Found@Cephalon UK Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_1.pdf@EU-1-02-212_h_a_dec_1.pdf@2002-03-10 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_15.pdf@EU-1-02-206_h_a_dec_15.pdf@2008-03-19 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_14.pdf@EU-1-02-209_h_a_dec_14.pdf@2009-02-25 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_43.pdf@EU-1-01-200_h_a_dec_43.pdf@2013-01-07 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_19.pdf@EU-1-02-205_h_a_dec_19.pdf@2022-05-13 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_10.pdf@EU-1-02-212_h_a_dec_10.pdf@2004-09-11 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_15.pdf@EU-1-02-209_h_a_dec_15.pdf@2009-07-14 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_16.pdf@EU-1-02-206_h_a_dec_16.pdf@2008-08-22 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@True@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_2.pdf@EU-1-02-205_h_a_dec_2.pdf@2002-10-23 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_11.pdf@EU-1-02-212_h_a_dec_11.pdf@2005-10-01 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_44.pdf@EU-1-01-200_h_a_dec_44.pdf@2013-10-18 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_16.pdf@EU-1-02-209_h_a_dec_16.pdf@2009-07-23 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_17.pdf@EU-1-02-206_h_a_dec_17.pdf@2008-12-22 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_3.pdf@EU-1-02-205_h_a_dec_3.pdf@2004-01-20 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_12.pdf@EU-1-02-212_h_a_dec_12.pdf@2005-03-29 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_17.pdf@EU-1-02-209_h_a_dec_17.pdf@2010-03-15 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_45.pdf@EU-1-01-200_h_a_dec_45.pdf@2015-03-19 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_18.pdf@EU-1-02-206_h_a_dec_18.pdf@2009-03-25 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_0.pdf@EU-1-02-213_h_a_dec_0.pdf@2002-04-19 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_18.pdf@EU-1-02-209_h_a_dec_18.pdf@2010-07-28 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_4.pdf@EU-1-02-205_h_a_dec_4.pdf@2006-04-27 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_13.pdf@EU-1-02-212_h_a_dec_13.pdf@2005-10-27 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_19.pdf@EU-1-02-206_h_a_dec_19.pdf@2010-01-20 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_1.pdf@EU-1-02-213_h_a_dec_1.pdf@2002-05-08 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-01-200_h_a_dec_46.pdf@EU-1-01-200_h_a_dec_46.pdf@2016-02-26 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_19.pdf@EU-1-02-209_h_a_dec_19.pdf@2010-06-09 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_2.pdf@EU-1-02-206_h_a_dec_2.pdf@2003-03-20 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_14.pdf@EU-1-02-212_h_a_dec_14.pdf@2006-01-31 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_5.pdf@EU-1-02-205_h_a_dec_5.pdf@2007-02-20 00:00:00@Lumigan@Bimatoprost@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_10.pdf@EU-1-02-213_h_a_dec_10.pdf@2009-01-27 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_2.pdf@EU-1-02-209_h_a_dec_2.pdf@2004-04-22 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_20.pdf@EU-1-02-206_h_a_dec_20.pdf@2010-08-31 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_15.pdf@EU-1-02-212_h_a_dec_15.pdf@2006-05-31 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_47.pdf@EU-1-01-200_h_a_dec_47.pdf@2017-02-16 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_6.pdf@EU-1-02-205_h_a_dec_6.pdf@2009-02-09 00:00:00@Lumigan@Bimatoprost@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_11.pdf@EU-1-02-213_h_a_dec_11.pdf@2009-03-18 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_20.pdf@EU-1-02-209_h_a_dec_20.pdf@2022-12-01 00:00:01@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_21.pdf@EU-1-02-206_h_a_dec_21.pdf@2011-02-28 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_16.pdf@EU-1-02-212_h_a_dec_16.pdf@2006-08-28 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_21.pdf@EU-1-02-209_h_a_dec_21.pdf@2011-06-23 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_12.pdf@EU-1-02-213_h_a_dec_12.pdf@2009-07-04 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_7.pdf@EU-1-02-205_h_a_dec_7.pdf@2010-07-01 00:00:00@Lumigan@Bimatoprost@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_22.pdf@EU-1-02-206_h_a_dec_22.pdf@2011-05-18 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_48.pdf@EU-1-01-200_h_a_dec_48.pdf@2018-04-23 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_17.pdf@EU-1-02-212_h_a_dec_17.pdf@2006-10-26 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_22.pdf@EU-1-02-209_h_a_dec_22.pdf@2011-11-22 00:00:00@Dynastat@Parecoxib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_8.pdf@EU-1-02-205_h_a_dec_8.pdf@2012-07-23 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan  Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_23.pdf@EU-1-02-206_h_a_dec_23.pdf@2011-10-20 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_13.pdf@EU-1-02-213_h_a_dec_13.pdf@2009-05-29 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_0.pdf@EU-1-02-214_h_a_dec_0.pdf@2002-04-19 00:00:00@BolusacPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_23.pdf@EU-1-02-209_h_a_dec_23.pdf@2012-01-24 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_18.pdf@EU-1-02-212_h_a_dec_18.pdf@2007-02-05 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-205_h_a_dec_9.pdf@EU-1-02-205_h_a_dec_9.pdf@2012-11-19 00:00:00@Lumigan@Bimatoprost@False@False@OD Not Found@Allergan  Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_24.pdf@EU-1-02-206_h_a_dec_24.pdf@2012-04-07 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_14.pdf@EU-1-02-213_h_a_dec_14.pdf@2009-08-28 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_49.pdf@EU-1-01-200_h_a_dec_49.pdf@2018-07-23 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_1.pdf@EU-1-02-214_h_a_dec_1.pdf@2002-04-12 00:00:00@BolusacPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_24.pdf@EU-1-02-209_h_a_dec_24.pdf@2012-10-10 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_19.pdf@EU-1-02-212_h_a_dec_19.pdf@2007-09-07 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_15.pdf@EU-1-02-213_h_a_dec_15.pdf@2010-04-27 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_5.pdf@EU-1-01-200_h_a_dec_5.pdf@2003-10-07 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_25.pdf@EU-1-02-206_h_a_dec_25.pdf@2013-11-29 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_10.pdf@EU-1-02-214_h_a_dec_10.pdf@2009-01-29 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_25.pdf@EU-1-02-209_h_a_dec_25.pdf@2012-10-24 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_2.pdf@EU-1-02-212_h_a_dec_2.pdf@2003-02-24 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_16.pdf@EU-1-02-213_h_a_dec_16.pdf@2010-07-27 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_20.pdf@EU-1-02-212_h_a_dec_20.pdf@2008-01-28 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_11.pdf@EU-1-02-214_h_a_dec_11.pdf@2009-03-18 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_17.pdf@EU-1-02-213_h_a_dec_17.pdf@2011-02-28 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_50.pdf@EU-1-01-200_h_a_dec_50.pdf@2019-08-04 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_26.pdf@EU-1-02-206_h_a_dec_26.pdf@2014-08-26 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_21.pdf@EU-1-02-212_h_a_dec_21.pdf@2008-06-20 00:00:00@Vfend@voriconazole@NAS before 2012@True@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_18.pdf@EU-1-02-213_h_a_dec_18.pdf@2011-02-05 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_12.pdf@EU-1-02-214_h_a_dec_12.pdf@2009-07-04 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_22.pdf@EU-1-02-212_h_a_dec_22.pdf@2009-02-02 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_19.pdf@EU-1-02-213_h_a_dec_19.pdf@2012-05-25 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_51.pdf@EU-1-01-200_h_a_dec_51.pdf@2020-01-16 00:00:00@Viread@tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_27.pdf@EU-1-02-206_h_a_dec_27.pdf@2015-09-30 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Aspen Pharma Trading Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_27.pdf@EU-1-02-209_h_a_dec_27.pdf@2015-10-15 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_13.pdf@EU-1-02-214_h_a_dec_13.pdf@2009-05-05 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_23.pdf@EU-1-02-212_h_a_dec_23.pdf@2009-08-27 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_0.pdf@EU-1-02-215_h_a_dec_0.pdf@2002-04-22 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_2.pdf@EU-1-02-213_h_a_dec_2.pdf@2003-06-25 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_1.pdf@EU-1-02-215_h_a_dec_1.pdf@2002-08-22 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_14.pdf@EU-1-02-214_h_a_dec_14.pdf@2009-05-29 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_24.pdf@EU-1-02-212_h_a_dec_24.pdf@2010-01-09 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_20.pdf@EU-1-02-213_h_a_dec_20.pdf@2012-03-07 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_28.pdf@EU-1-02-206_h_a_dec_28.pdf@2016-09-15 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Aspen Pharma Trading Limited@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_52.pdf@EU-1-01-200_h_a_dec_52.pdf@2021-01-14 00:00:00@Viread@tenofovir disoproxil  fumarate@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_15.pdf@EU-1-02-214_h_a_dec_15.pdf@2009-10-13 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_10.pdf@EU-1-02-215_h_a_dec_10.pdf@2008-02-07 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_25.pdf@EU-1-02-212_h_a_dec_25.pdf@2010-11-29 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_28.pdf@EU-1-02-209_h_a_dec_28.pdf@2018-02-22 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_21.pdf@EU-1-02-213_h_a_dec_21.pdf@2012-10-24 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_6.pdf@EU-1-01-200_h_a_dec_6.pdf@2003-09-07 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_16.pdf@EU-1-02-214_h_a_dec_16.pdf@2010-04-27 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_26.pdf@EU-1-02-212_h_a_dec_26.pdf@2010-12-20 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_22.pdf@EU-1-02-213_h_a_dec_22.pdf@2013-05-30 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_11.pdf@EU-1-02-215_h_a_dec_11.pdf@2009-01-27 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_7.pdf@EU-1-01-200_h_a_dec_7.pdf@2003-09-07 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_17.pdf@EU-1-02-214_h_a_dec_17.pdf@2011-02-28 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_27.pdf@EU-1-02-212_h_a_dec_27.pdf@2011-08-24 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_29.pdf@EU-1-02-206_h_a_dec_29.pdf@2018-08-23 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Aspen Pharma Trading Limited@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_12.pdf@EU-1-02-215_h_a_dec_12.pdf@2009-03-17 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_8.pdf@EU-1-01-200_h_a_dec_8.pdf@2003-01-08 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-209_h_a_dec_29.pdf@EU-1-02-209_h_a_dec_29.pdf@2018-09-28 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_18.pdf@EU-1-02-214_h_a_dec_18.pdf@2011-02-05 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_28.pdf@EU-1-02-212_h_a_dec_28.pdf@2011-10-11 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_23.pdf@EU-1-02-213_h_a_dec_23.pdf@2014-04-09 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2002)1564 for “MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-01-200_h_a_dec_9.pdf@EU-1-01-200_h_a_dec_9.pdf@2003-10-17 00:00:00@Viread@tenofovir disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_3.pdf@EU-1-02-206_h_a_dec_3.pdf@2003-10-24 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_13.pdf@EU-1-02-215_h_a_dec_13.pdf@2009-07-04 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_19.pdf@EU-1-02-214_h_a_dec_19.pdf@2012-03-04 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_24.pdf@EU-1-02-213_h_a_dec_24.pdf@2018-12-03 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_29.pdf@EU-1-02-212_h_a_dec_29.pdf@2011-12-14 00:00:00@Vfend@voriconazole@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_3.pdf@EU-1-02-209_h_a_dec_3.pdf@2004-06-12 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_2.pdf@EU-1-02-214_h_a_dec_2.pdf@2003-04-22 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_14.pdf@EU-1-02-215_h_a_dec_14.pdf@2022-12-01 00:00:01@PritorPlus@Telmisartan/hydrochlorothiazide@False@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_3.pdf@EU-1-02-212_h_a_dec_3.pdf@2003-09-07 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_25.pdf@EU-1-02-213_h_a_dec_25.pdf@2019-10-24 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_30.pdf@EU-1-02-206_h_a_dec_30.pdf@2021-03-17 00:00:00@Arixtra@Fondaparinux sodium@False@False@OD Not Found@Aspen Pharma Trading Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_30.pdf@EU-1-02-209_h_a_dec_30.pdf@2020-01-04 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_20.pdf@EU-1-02-214_h_a_dec_20.pdf@2012-05-25 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_15.pdf@EU-1-02-215_h_a_dec_15.pdf@2009-05-27 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_4.pdf@EU-1-02-206_h_a_dec_4.pdf@2003-07-11 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_30.pdf@EU-1-02-212_h_a_dec_30.pdf@2012-02-21 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_26.pdf@EU-1-02-213_h_a_dec_26.pdf@2021-03-22 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_31.pdf@EU-1-02-209_h_a_dec_31.pdf@2021-04-16 00:00:00@Dynastat@Parecoxib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_21.pdf@EU-1-02-214_h_a_dec_21.pdf@2012-03-07 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_5.pdf@EU-1-02-206_h_a_dec_5.pdf@2004-12-11 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_31.pdf@EU-1-02-212_h_a_dec_31.pdf@2012-04-20 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_16.pdf@EU-1-02-215_h_a_dec_16.pdf@2009-10-14 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_27.pdf@EU-1-02-213_h_a_dec_27.pdf@2022-08-07 00:00:00@MicardisPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_22.pdf@EU-1-02-214_h_a_dec_22.pdf@2012-10-24 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_6.pdf@EU-1-02-206_h_a_dec_6.pdf@2005-12-01 00:00:00@Arixtra@Fondaparinux  sodium@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Synthelabo@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_32.pdf@EU-1-02-212_h_a_dec_32.pdf@2012-06-28 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_4.pdf@EU-1-02-209_h_a_dec_4.pdf@2004-06-12 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_17.pdf@EU-1-02-215_h_a_dec_17.pdf@2010-04-29 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_3.pdf@EU-1-02-213_h_a_dec_3.pdf@2005-12-23 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_33.pdf@EU-1-02-212_h_a_dec_33.pdf@2012-08-23 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_23.pdf@EU-1-02-214_h_a_dec_23.pdf@2013-05-30 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_7.pdf@EU-1-02-206_h_a_dec_7.pdf@2005-01-25 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-02-213_h_a_dec_4.pdf@EU-1-02-213_h_a_dec_4.pdf@2006-06-26 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_5.pdf@EU-1-02-209_h_a_dec_5.pdf@2005-01-26 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_18.pdf@EU-1-02-215_h_a_dec_18.pdf@2011-02-21 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_34.pdf@EU-1-02-212_h_a_dec_34.pdf@2012-08-23 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-206_h_a_dec_8.pdf@EU-1-02-206_h_a_dec_8.pdf@2005-07-07 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_35.pdf@EU-1-02-212_h_a_dec_35.pdf@2012-10-29 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_19.pdf@EU-1-02-215_h_a_dec_19.pdf@2011-02-05 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_5.pdf@EU-1-02-213_h_a_dec_5.pdf@2007-03-01 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_6.pdf@EU-1-02-209_h_a_dec_6.pdf@2005-10-06 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_24.pdf@EU-1-02-214_h_a_dec_24.pdf@2014-04-09 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2002)1570 for “Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_2.pdf@EU-1-02-215_h_a_dec_2.pdf@2003-06-03 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-02-206_h_a_dec_9.pdf@EU-1-02-206_h_a_dec_9.pdf@2006-12-09 00:00:00@Arixtra@Fondaparinux sodium@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_25.pdf@EU-1-02-214_h_a_dec_25.pdf@2018-03-16 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_20.pdf@EU-1-02-215_h_a_dec_20.pdf@2012-08-03 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_6.pdf@EU-1-02-213_h_a_dec_6.pdf@2007-05-03 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_36.pdf@EU-1-02-212_h_a_dec_36.pdf@2014-04-23 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_7.pdf@EU-1-02-209_h_a_dec_7.pdf@2005-05-10 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_21.pdf@EU-1-02-215_h_a_dec_21.pdf@2012-05-25 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_26.pdf@EU-1-02-214_h_a_dec_26.pdf@2018-12-04 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_7.pdf@EU-1-02-213_h_a_dec_7.pdf@2007-04-23 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_22.pdf@EU-1-02-215_h_a_dec_22.pdf@2012-06-28 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_37.pdf@EU-1-02-212_h_a_dec_37.pdf@2014-06-23 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_8.pdf@EU-1-02-209_h_a_dec_8.pdf@2006-01-25 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_27.pdf@EU-1-02-214_h_a_dec_27.pdf@2019-10-24 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_8.pdf@EU-1-02-213_h_a_dec_8.pdf@2008-03-27 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_23.pdf@EU-1-02-215_h_a_dec_23.pdf@2012-10-24 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_28.pdf@EU-1-02-214_h_a_dec_28.pdf@2021-09-03 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_38.pdf@EU-1-02-212_h_a_dec_38.pdf@2015-11-19 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-213_h_a_dec_9.pdf@EU-1-02-213_h_a_dec_9.pdf@2008-04-07 00:00:00@MicardisPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-02-209_h_a_dec_9.pdf@EU-1-02-209_h_a_dec_9.pdf@2006-05-05 00:00:00@Dynastat@Parecoxib@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Europe EEIG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_24.pdf@EU-1-02-215_h_a_dec_24.pdf@2013-05-29 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_29.pdf@EU-1-02-214_h_a_dec_29.pdf@2022-01-07 00:00:00@Kinzalkomb@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_39.pdf@EU-1-02-212_h_a_dec_39.pdf@2015-12-16 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_3.pdf@EU-1-02-214_h_a_dec_3.pdf@2005-12-23 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_25.pdf@EU-1-02-215_h_a_dec_25.pdf@2014-04-09 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2002)1581 for “PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_4.pdf@EU-1-02-212_h_a_dec_4.pdf@2003-09-16 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-214_h_a_dec_4.pdf@EU-1-02-214_h_a_dec_4.pdf@2006-03-22 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_26.pdf@EU-1-02-215_h_a_dec_26.pdf@2018-07-03 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_5.pdf@EU-1-02-214_h_a_dec_5.pdf@2007-04-01 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_40.pdf@EU-1-02-212_h_a_dec_40.pdf@2018-02-19 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_27.pdf@EU-1-02-215_h_a_dec_27.pdf@2018-04-13 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_6.pdf@EU-1-02-214_h_a_dec_6.pdf@2007-05-03 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_28.pdf@EU-1-02-215_h_a_dec_28.pdf@2019-04-11 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_41.pdf@EU-1-02-212_h_a_dec_41.pdf@2018-09-28 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_7.pdf@EU-1-02-214_h_a_dec_7.pdf@2007-04-23 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_29.pdf@EU-1-02-215_h_a_dec_29.pdf@2021-09-03 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_8.pdf@EU-1-02-214_h_a_dec_8.pdf@2008-03-27 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_42.pdf@EU-1-02-212_h_a_dec_42.pdf@2018-12-12 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_3.pdf@EU-1-02-215_h_a_dec_3.pdf@2006-01-13 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_43.pdf@EU-1-02-212_h_a_dec_43.pdf@2021-03-26 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-214_h_a_dec_9.pdf@EU-1-02-214_h_a_dec_9.pdf@2008-03-07 00:00:00@Kinzalkomb@Telmisartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_30.pdf@EU-1-02-215_h_a_dec_30.pdf@2022-06-29 00:00:00@PritorPlus@Telmisartan / hydrochlorothiazide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_0.pdf@EU-1-02-216_h_a_dec_0.pdf@2002-04-18 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_44.pdf@EU-1-02-212_h_a_dec_44.pdf@2021-10-19 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_1.pdf@EU-1-02-216_h_a_dec_1.pdf@2002-12-11 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_4.pdf@EU-1-02-215_h_a_dec_4.pdf@2006-03-22 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-02-217_h_a_dec_1.pdf@EU-1-02-217_h_a_dec_1.pdf@2003-09-04 00:00:00@Opatanol@Olopatadine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-02-212_h_a_dec_45.pdf@EU-1-02-212_h_a_dec_45.pdf@2022-06-01 00:00:00@Vfend@voriconazole@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_10.pdf@EU-1-02-216_h_a_dec_10.pdf@2007-08-27 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_5.pdf@EU-1-02-215_h_a_dec_5.pdf@2006-10-20 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-217_h_a_dec_2.pdf@EU-1-02-217_h_a_dec_2.pdf@2007-05-22 00:00:00@Opatanol@Olopatadine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_5.pdf@EU-1-02-212_h_a_dec_5.pdf@2003-10-24 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-216_h_a_dec_11.pdf@EU-1-02-216_h_a_dec_11.pdf@2008-12-22 00:00:00@Invanz@Ertapenem@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-217_h_a_dec_3.pdf@EU-1-02-217_h_a_dec_3.pdf@2007-08-21 00:00:00@Opatanol@Olopatadine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_0.pdf@EU-1-02-218_h_a_dec_0.pdf@2002-05-17 00:00:00@Memantine Merz Pharmaceuticals GmbH@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_6.pdf@EU-1-02-215_h_a_dec_6.pdf@2007-08-01 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_12.pdf@EU-1-02-216_h_a_dec_12.pdf@2009-07-23 00:00:00@Invanz@Ertapenem@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_6.pdf@EU-1-02-212_h_a_dec_6.pdf@2004-02-23 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-217_h_a_dec_4.pdf@EU-1-02-217_h_a_dec_4.pdf@2007-08-21 00:00:00@Opatanol@Olopatadine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_1.pdf@EU-1-02-218_h_a_dec_1.pdf@2002-07-19 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-215_h_a_dec_7.pdf@EU-1-02-215_h_a_dec_7.pdf@2007-02-28 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_13.pdf@EU-1-02-216_h_a_dec_13.pdf@2009-08-28 00:00:00@Invanz@Ertapenem@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_7.pdf@EU-1-02-212_h_a_dec_7.pdf@2004-08-06 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_10.pdf@EU-1-02-218_h_a_dec_10.pdf@2008-08-05 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_8.pdf@EU-1-02-215_h_a_dec_8.pdf@2007-05-14 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_8.pdf@EU-1-02-212_h_a_dec_8.pdf@2004-09-06 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-217_h_a_dec_5.pdf@EU-1-02-217_h_a_dec_5.pdf@2014-03-03 00:00:00@Opatanol@Olopatadine@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_11.pdf@EU-1-02-218_h_a_dec_11.pdf@2008-08-05 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-212_h_a_dec_9.pdf@EU-1-02-212_h_a_dec_9.pdf@2004-11-08 00:00:00@Vfend@voriconazole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-216_h_a_dec_15.pdf@EU-1-02-216_h_a_dec_15.pdf@2010-07-28 00:00:00@Invanz@Ertapenem@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-02-215_h_a_dec_9.pdf@EU-1-02-215_h_a_dec_9.pdf@2008-01-04 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-02-217_h_a_dec_6.pdf@EU-1-02-217_h_a_dec_6.pdf@2017-04-24 00:00:00@Opatanol@Olopatadine@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_12.pdf@EU-1-02-218_h_a_dec_12.pdf@2008-02-12 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_16.pdf@EU-1-02-216_h_a_dec_16.pdf@2011-02-28 00:00:00@Invanz@Ertapenem@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_0.pdf@EU-1-02-219_h_a_dec_0.pdf@2002-05-15 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_13.pdf@EU-1-02-218_h_a_dec_13.pdf@2009-06-24 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_17.pdf@EU-1-02-216_h_a_dec_17.pdf@2011-12-22 00:00:00@Invanz@Ertapenem@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_1.pdf@EU-1-02-219_h_a_dec_1.pdf@2002-09-27 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-217_h_a_dec_7.pdf@EU-1-02-217_h_a_dec_7.pdf@2018-04-19 00:00:00@Opatanol@Olopatadine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
 available before 2006@Parsed
EU-1-02-218_h_a_dec_14.pdf@EU-1-02-218_h_a_dec_14.pdf@2009-07-31 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_18.pdf@EU-1-02-216_h_a_dec_18.pdf@2012-06-27 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_10.pdf@EU-1-02-219_h_a_dec_10.pdf@2007-08-27 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_1.pdf@EU-1-02-220_h_a_dec_1.pdf@2002-10-17 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_15.pdf@EU-1-02-218_h_a_dec_15.pdf@2010-03-23 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_11.pdf@EU-1-02-219_h_a_dec_11.pdf@2008-04-17 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_10.pdf@EU-1-02-220_h_a_dec_10.pdf@2005-11-15 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-217_h_a_dec_8.pdf@EU-1-02-217_h_a_dec_8.pdf@2019-09-13 00:00:00@Opatanol@Olopatadine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_19.pdf@EU-1-02-216_h_a_dec_19.pdf@2014-10-27 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_16.pdf@EU-1-02-218_h_a_dec_16.pdf@2010-10-25 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz  Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_2.pdf@EU-1-02-216_h_a_dec_2.pdf@2003-04-22 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_11.pdf@EU-1-02-220_h_a_dec_11.pdf@2006-06-26 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_12.pdf@EU-1-02-219_h_a_dec_12.pdf@2008-08-05 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_17.pdf@EU-1-02-218_h_a_dec_17.pdf@2011-10-27 00:00:00@Axura@Memantine@NAS before 2012@False@OD Not Found@Merz Pharmaceuticals  GmbH@CMA Not Found@Parsed
EU-1-02-217_h_a_dec_9.pdf@EU-1-02-217_h_a_dec_9.pdf@2021-11-18 00:00:00@Opatanol@Olopatadine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_12.pdf@EU-1-02-220_h_a_dec_12.pdf@2006-10-08 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_20.pdf@EU-1-02-216_h_a_dec_20.pdf@2015-08-10 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_18.pdf@EU-1-02-218_h_a_dec_18.pdf@2012-10-31 00:00:00@Axura@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_13.pdf@EU-1-02-219_h_a_dec_13.pdf@2008-08-05 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_13.pdf@EU-1-02-220_h_a_dec_13.pdf@2006-10-27 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_19.pdf@EU-1-02-218_h_a_dec_19.pdf@2015-04-13 00:00:00@Axura@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_14.pdf@EU-1-02-219_h_a_dec_14.pdf@2008-02-12 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_21.pdf@EU-1-02-216_h_a_dec_21.pdf@2017-11-01 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_2.pdf@EU-1-02-218_h_a_dec_2.pdf@2002-02-10 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_14.pdf@EU-1-02-220_h_a_dec_14.pdf@2007-07-06 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_0.pdf@EU-1-02-221_h_a_dec_0.pdf@2002-06-20 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_15.pdf@EU-1-02-219_h_a_dec_15.pdf@2009-05-29 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_20.pdf@EU-1-02-218_h_a_dec_20.pdf@2019-06-06 00:00:00@Axura@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_15.pdf@EU-1-02-220_h_a_dec_15.pdf@2007-07-06 00:00:00@Tracleer@bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_1.pdf@EU-1-02-221_h_a_dec_1.pdf@2003-01-14 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_16.pdf@EU-1-02-219_h_a_dec_16.pdf@2009-06-23 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_22.pdf@EU-1-02-216_h_a_dec_22.pdf@2018-08-05 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_21.pdf@EU-1-02-218_h_a_dec_21.pdf@2020-04-05 00:00:00@Axura@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_16.pdf@EU-1-02-220_h_a_dec_16.pdf@2007-06-13 00:00:00@Tracleer@bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_0.pdf@EU-1-02-222_h_a_dec_0.pdf@2002-06-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_10.pdf@EU-1-02-221_h_a_dec_10.pdf@2006-07-20 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_17.pdf@EU-1-02-219_h_a_dec_17.pdf@2009-07-29 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_1.pdf@EU-1-02-222_h_a_dec_1.pdf@2003-07-11 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_22.pdf@EU-1-02-218_h_a_dec_22.pdf@2022-04-04 00:00:00@Axura@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_17.pdf@EU-1-02-220_h_a_dec_17.pdf@2007-10-31 00:00:00@Tracleer@bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_23.pdf@EU-1-02-216_h_a_dec_23.pdf@2020-10-19 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_11.pdf@EU-1-02-221_h_a_dec_11.pdf@2006-11-22 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_18.pdf@EU-1-02-219_h_a_dec_18.pdf@2009-11-20 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_3.pdf@EU-1-02-218_h_a_dec_3.pdf@2003-01-09 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_18.pdf@EU-1-02-220_h_a_dec_18.pdf@2007-12-18 00:00:00@Tracleer@bosentan@NAS before 2012@NA before 2012@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_10.pdf@EU-1-02-222_h_a_dec_10.pdf@2007-09-13 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_12.pdf@EU-1-02-221_h_a_dec_12.pdf@2007-04-01 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_19.pdf@EU-1-02-220_h_a_dec_19.pdf@2007-12-18 00:00:00@Tracleer@bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_4.pdf@EU-1-02-218_h_a_dec_4.pdf@2004-07-13 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_19.pdf@EU-1-02-219_h_a_dec_19.pdf@2010-03-26 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_24.pdf@EU-1-02-216_h_a_dec_24.pdf@2021-12-13 00:00:00@Invanz@Ertapenem@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_11.pdf@EU-1-02-222_h_a_dec_11.pdf@2007-09-19 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_2.pdf@EU-1-02-220_h_a_dec_2.pdf@2003-06-26 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_13.pdf@EU-1-02-221_h_a_dec_13.pdf@2007-01-03 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_2.pdf@EU-1-02-219_h_a_dec_2.pdf@2002-11-20 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-218_h_a_dec_5.pdf@EU-1-02-218_h_a_dec_5.pdf@2005-11-15 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA not available before 2006@Parsed
EU-1-02-216_h_a_dec_3.pdf@EU-1-02-216_h_a_dec_3.pdf@2003-01-12 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_12.pdf@EU-1-02-222_h_a_dec_12.pdf@2007-10-24 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_14.pdf@EU-1-02-221_h_a_dec_14.pdf@2007-06-21 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_20.pdf@EU-1-02-220_h_a_dec_20.pdf@2008-07-29 00:00:00@Tracleer@bosentan@NAS before 2012@True@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_6.pdf@EU-1-02-218_h_a_dec_6.pdf@2006-04-27 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_20.pdf@EU-1-02-219_h_a_dec_20.pdf@2010-10-25 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_4.pdf@EU-1-02-216_h_a_dec_4.pdf@2004-10-03 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_13.pdf@EU-1-02-222_h_a_dec_13.pdf@2008-06-18 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_15.pdf@EU-1-02-221_h_a_dec_15.pdf@2007-06-21 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_21.pdf@EU-1-02-220_h_a_dec_21.pdf@2009-01-07 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_21.pdf@EU-1-02-219_h_a_dec_21.pdf@2011-10-24 00:00:00@Ebixa@Memantine@NAS before 2012@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_7.pdf@EU-1-02-218_h_a_dec_7.pdf@2006-11-28 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_5.pdf@EU-1-02-216_h_a_dec_5.pdf@2005-07-07 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed

EU-1-02-222_h_a_dec_14.pdf@EU-1-02-222_h_a_dec_14.pdf@2008-07-07 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_22.pdf@EU-1-02-219_h_a_dec_22.pdf@2012-10-31 00:00:00@Ebixa@Memantine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_22.pdf@EU-1-02-220_h_a_dec_22.pdf@2009-01-07 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_8.pdf@EU-1-02-218_h_a_dec_8.pdf@2007-06-20 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_17.pdf@EU-1-02-221_h_a_dec_17.pdf@2008-06-20 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_6.pdf@EU-1-02-216_h_a_dec_6.pdf@2006-01-25 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_23.pdf@EU-1-02-219_h_a_dec_23.pdf@2015-08-09 00:00:00@Ebixa@Memantine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_15.pdf@EU-1-02-222_h_a_dec_15.pdf@2008-03-09 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_23.pdf@EU-1-02-220_h_a_dec_23.pdf@2009-07-07 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-218_h_a_dec_9.pdf@EU-1-02-218_h_a_dec_9.pdf@2007-07-30 00:00:00@Axura@Memantine@NAS before 2012@NA before 2012@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_18.pdf@EU-1-02-221_h_a_dec_18.pdf@2008-10-30 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_24.pdf@EU-1-02-219_h_a_dec_24.pdf@2017-09-14 00:00:00@Ebixa@Memantine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_7.pdf@EU-1-02-216_h_a_dec_7.pdf@2006-01-09 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_16.pdf@EU-1-02-222_h_a_dec_16.pdf@2008-10-31 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_24.pdf@EU-1-02-220_h_a_dec_24.pdf@2010-01-20 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_19.pdf@EU-1-02-221_h_a_dec_19.pdf@2008-11-28 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_8.pdf@EU-1-02-216_h_a_dec_8.pdf@2006-10-24 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_17.pdf@EU-1-02-222_h_a_dec_17.pdf@2009-01-26 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_25.pdf@EU-1-02-220_h_a_dec_25.pdf@2010-04-22 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_2.pdf@EU-1-02-221_h_a_dec_2.pdf@2003-07-23 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_25.pdf@EU-1-02-219_h_a_dec_25.pdf@2020-02-13 00:00:00@Ebixa@Memantine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_18.pdf@EU-1-02-222_h_a_dec_18.pdf@2009-11-05 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-216_h_a_dec_9.pdf@EU-1-02-216_h_a_dec_9.pdf@2007-03-21 00:00:00@Invanz@Ertapenem@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_26.pdf@EU-1-02-220_h_a_dec_26.pdf@2010-09-16 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
ound@Parsed
EU-1-02-219_h_a_dec_26.pdf@EU-1-02-219_h_a_dec_26.pdf@2022-04-02 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_19.pdf@EU-1-02-222_h_a_dec_19.pdf@2009-09-09 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_21.pdf@EU-1-02-221_h_a_dec_21.pdf@2009-08-21 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_27.pdf@EU-1-02-220_h_a_dec_27.pdf@2011-02-28 00:00:00@Tracleer@bosentan@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_3.pdf@EU-1-02-219_h_a_dec_3.pdf@2003-08-28 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_2.pdf@EU-1-02-222_h_a_dec_2.pdf@2004-01-27 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_28.pdf@EU-1-02-220_h_a_dec_28.pdf@2011-12-19 00:00:00@Tracleer@bosentan@NAS before 2012@False@adopted@Actelion  Registration Ltd@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_22.pdf@EU-1-02-221_h_a_dec_22.pdf@2009-10-23 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_4.pdf@EU-1-02-219_h_a_dec_4.pdf@2003-01-09 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_29.pdf@EU-1-02-220_h_a_dec_29.pdf@2012-04-20 00:00:00@Tracleer@bosentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_20.pdf@EU-1-02-222_h_a_dec_20.pdf@2009-09-14 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_23.pdf@EU-1-02-221_h_a_dec_23.pdf@2010-02-07 00:00:00@Pegasys@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_3.pdf@EU-1-02-220_h_a_dec_3.pdf@2003-09-22 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-219_h_a_dec_5.pdf@EU-1-02-219_h_a_dec_5.pdf@2004-07-13 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_24.pdf@EU-1-02-221_h_a_dec_24.pdf@2011-04-18 00:00:00@Pegasys@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_21.pdf@EU-1-02-222_h_a_dec_21.pdf@2009-10-23 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_0.pdf@EU-1-02-223_h_a_dec_0.pdf@2002-08-22 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_30.pdf@EU-1-02-220_h_a_dec_30.pdf@2012-10-25 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_6.pdf@EU-1-02-219_h_a_dec_6.pdf@2005-11-15 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA not available before 2006@Parsed
EU-1-02-224_h_a_dec_0.pdf@EU-1-02-224_h_a_dec_0.pdf@2002-08-30 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_25.pdf@EU-1-02-221_h_a_dec_25.pdf@2011-06-29 00:00:00@Pegasys@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_1.pdf@EU-1-02-223_h_a_dec_1.pdf@2003-02-17 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_22.pdf@EU-1-02-222_h_a_dec_22.pdf@2010-01-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_31.pdf@EU-1-02-220_h_a_dec_31.pdf@2012-11-22 00:00:00@Tracleer@bosentan@False@False@adopted@Actelion Registration  Ltd@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_26.pdf@EU-1-02-221_h_a_dec_26.pdf@2011-12-14 00:00:00@Pegasys@peginterferon alfa-2a@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_7.pdf@EU-1-02-219_h_a_dec_7.pdf@2006-04-27 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_1.pdf@EU-1-02-224_h_a_dec_1.pdf@2004-03-31 00:00:00@Ambirix@Inactivated hepatitis A virus,  Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_23.pdf@EU-1-02-222_h_a_dec_23.pdf@2010-03-15 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_27.pdf@EU-1-02-221_h_a_dec_27.pdf@2012-09-28 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_8.pdf@EU-1-02-219_h_a_dec_8.pdf@2006-11-28 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_11.pdf@EU-1-02-223_h_a_dec_11.pdf@2012-02-21 00:00:00@Evra@Norelgestromin/Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_10.pdf@EU-1-02-224_h_a_dec_10.pdf@2017-09-10 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_32.pdf@EU-1-02-220_h_a_dec_32.pdf@2013-12-13 00:00:00@Tracleer@bosentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_28.pdf@EU-1-02-221_h_a_dec_28.pdf@2013-03-13 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_12.pdf@EU-1-02-223_h_a_dec_12.pdf@2012-06-15 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-219_h_a_dec_9.pdf@EU-1-02-219_h_a_dec_9.pdf@2007-06-13 00:00:00@Ebixa@Memantine@NAS before 2012@NA before 2012@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_11.pdf@EU-1-02-224_h_a_dec_11.pdf@2021-03-22 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_24.pdf@EU-1-02-222_h_a_dec_24.pdf@2010-04-27 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_33.pdf@EU-1-02-220_h_a_dec_33.pdf@2015-12-01 00:00:00@Tracleer@bosentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_2.pdf@EU-1-02-224_h_a_dec_2.pdf@2007-03-01 00:00:00@Ambirix@Inactivated hepatitis A virus,  Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_13.pdf@EU-1-02-223_h_a_dec_13.pdf@2014-01-16 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC)      COMMISSION IMPLEMENTING DECISION  16.1.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation  “Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_29.pdf@EU-1-02-221_h_a_dec_29.pdf@2014-04-23 00:00:00@Pegasys@2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_25.pdf@EU-1-02-222_h_a_dec_25.pdf@2010-02-07 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_0.pdf@EU-1-02-226_h_a_dec_0.pdf@2002-09-09 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-223_h_a_dec_14.pdf@EU-1-02-223_h_a_dec_14.pdf@2016-03-30 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_3.pdf@EU-1-02-224_h_a_dec_3.pdf@2007-07-09 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_3.pdf@EU-1-02-221_h_a_dec_3.pdf@2004-01-14 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_26.pdf@EU-1-02-222_h_a_dec_26.pdf@2010-11-26 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_34.pdf@EU-1-02-220_h_a_dec_34.pdf@2015-12-01 00:00:00@Tracleer@bosentan@False@False@appointed@MAH Not Found@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_1.pdf@EU-1-02-226_h_a_dec_1.pdf@2003-01-31 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-223_h_a_dec_15.pdf@EU-1-02-223_h_a_dec_15.pdf@2017-06-04 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_4.pdf@EU-1-02-224_h_a_dec_4.pdf@2010-10-28 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_27.pdf@EU-1-02-222_h_a_dec_27.pdf@2010-12-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_10.pdf@EU-1-02-226_h_a_dec_10.pdf@2006-04-08 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_30.pdf@EU-1-02-221_h_a_dec_30.pdf@2014-04-28 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_16.pdf@EU-1-02-223_h_a_dec_16.pdf@2017-06-23 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_5.pdf@EU-1-02-224_h_a_dec_5.pdf@2010-11-26 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_35.pdf@EU-1-02-220_h_a_dec_35.pdf@2015-08-20 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_29.pdf@EU-1-02-222_h_a_dec_29.pdf@2011-06-23 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_11.pdf@EU-1-02-226_h_a_dec_11.pdf@2006-08-28 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_17.pdf@EU-1-02-223_h_a_dec_17.pdf@2019-09-12 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_6.pdf@EU-1-02-224_h_a_dec_6.pdf@2011-12-22 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_31.pdf@EU-1-02-221_h_a_dec_31.pdf@2015-10-15 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_3.pdf@EU-1-02-222_h_a_dec_3.pdf@2004-11-16 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_36.pdf@EU-1-02-220_h_a_dec_36.pdf@2016-08-18 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_12.pdf@EU-1-02-226_h_a_dec_12.pdf@2007-03-29 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_7.pdf@EU-1-02-224_h_a_dec_7.pdf@2012-06-02 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@False@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_32.pdf@EU-1-02-221_h_a_dec_32.pdf@2016-01-08 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_13.pdf@EU-1-02-226_h_a_dec_13.pdf@2007-08-30 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_18.pdf@EU-1-02-223_h_a_dec_18.pdf@2021-05-21 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_30.pdf@EU-1-02-222_h_a_dec_30.pdf@2011-03-11 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-224_h_a_dec_8.pdf@EU-1-02-224_h_a_dec_8.pdf@2012-07-20 00:00:00@Ambirix@Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_37.pdf@EU-1-02-220_h_a_dec_37.pdf@2016-09-09 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_0.pdf@EU-1-02-227_h_a_dec_0.pdf@2002-08-22 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_14.pdf@EU-1-02-226_h_a_dec_14.pdf@2008-06-19 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@True@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_33.pdf@EU-1-02-221_h_a_dec_33.pdf@2016-10-14 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
ithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_31.pdf@EU-1-02-222_h_a_dec_31.pdf@2011-11-28 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_19.pdf@EU-1-02-223_h_a_dec_19.pdf@2021-08-20 00:00:00@Evra@Norelgestromin / Ethinyl estradiol@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_1.pdf@EU-1-02-227_h_a_dec_1.pdf@2004-01-29 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_15.pdf@EU-1-02-226_h_a_dec_15.pdf@2010-03-26 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_38.pdf@EU-1-02-220_h_a_dec_38.pdf@2017-07-19 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_2.pdf@EU-1-02-223_h_a_dec_2.pdf@2003-04-03 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_34.pdf@EU-1-02-221_h_a_dec_34.pdf@2017-10-11 00:00:00@Brand name Not Found@Active Substance Not Found@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_10.pdf@EU-1-02-227_h_a_dec_10.pdf@2007-11-20 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_16.pdf@EU-1-02-226_h_a_dec_16.pdf@2010-08-31 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_32.pdf@EU-1-02-222_h_a_dec_32.pdf@2012-05-22 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_3.pdf@EU-1-02-223_h_a_dec_3.pdf@2003-04-22 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-223_h_a_dec_4.pdf@EU-1-02-223_h_a_dec_4.pdf@2003-03-10 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_17.pdf@EU-1-02-226_h_a_dec_17.pdf@2011-06-15 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_39.pdf@EU-1-02-220_h_a_dec_39.pdf@2017-09-26 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_11.pdf@EU-1-02-227_h_a_dec_11.pdf@2008-01-17 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_33.pdf@EU-1-02-222_h_a_dec_33.pdf@2012-05-22 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_35.pdf@EU-1-02-221_h_a_dec_35.pdf@2018-03-15 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_5.pdf@EU-1-02-223_h_a_dec_5.pdf@2007-01-25 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_18.pdf@EU-1-02-226_h_a_dec_18.pdf@2011-05-08 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_4.pdf@EU-1-02-220_h_a_dec_4.pdf@2003-10-24 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_0.pdf@EU-1-02-229_h_a_dec_0.pdf@2002-07-10 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_34.pdf@EU-1-02-222_h_a_dec_34.pdf@2012-10-09 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_12.pdf@EU-1-02-227_h_a_dec_12.pdf@2008-04-21 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_36.pdf@EU-1-02-221_h_a_dec_36.pdf@2021-04-16 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_6.pdf@EU-1-02-223_h_a_dec_6.pdf@2007-07-09 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_19.pdf@EU-1-02-226_h_a_dec_19.pdf@2012-01-31 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic Biopharma BV@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_1.pdf@EU-1-02-229_h_a_dec_1.pdf@2003-08-13 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_35.pdf@EU-1-02-222_h_a_dec_35.pdf@2012-01-10 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_37.pdf@EU-1-02-221_h_a_dec_37.pdf@2021-12-08 00:00:00@Pegasys@peginterferon alfa-2a@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_2.pdf@EU-1-02-226_h_a_dec_2.pdf@2003-10-06 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_40.pdf@EU-1-02-220_h_a_dec_40.pdf@2018-08-11 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_13.pdf@EU-1-02-227_h_a_dec_13.pdf@2009-10-23 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_10.pdf@EU-1-02-229_h_a_dec_10.pdf@2011-10-11 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_7.pdf@EU-1-02-223_h_a_dec_7.pdf@2008-06-20 00:00:00@Evra@Norelgestromin/Ethinylestradiol@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_20.pdf@EU-1-02-226_h_a_dec_20.pdf@2012-07-20 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic Biopharma BV@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_36.pdf@EU-1-02-222_h_a_dec_36.pdf@2013-04-12 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_11.pdf@EU-1-02-229_h_a_dec_11.pdf@2012-06-27 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_4.pdf@EU-1-02-221_h_a_dec_4.pdf@2004-10-29 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_14.pdf@EU-1-02-227_h_a_dec_14.pdf@2011-08-04 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_41.pdf@EU-1-02-220_h_a_dec_41.pdf@2020-07-13 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_8.pdf@EU-1-02-223_h_a_dec_8.pdf@2008-08-09 00:00:00@Evra@Norelgestromin/Ethinyl  estradiol@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_21.pdf@EU-1-02-226_h_a_dec_21.pdf@2014-05-14 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_12.pdf@EU-1-02-229_h_a_dec_12.pdf@2012-11-19 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_5.pdf@EU-1-02-221_h_a_dec_5.pdf@2005-01-26 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_15.pdf@EU-1-02-227_h_a_dec_15.pdf@2011-05-27 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_22.pdf@EU-1-02-226_h_a_dec_22.pdf@2014-12-19 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma B.V.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_37.pdf@EU-1-02-222_h_a_dec_37.pdf@2015-05-05 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-223_h_a_dec_9.pdf@EU-1-02-223_h_a_dec_9.pdf@2008-12-22 00:00:00@Evra@Norelgestromin/Ethinyl  estradiol@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_13.pdf@EU-1-02-229_h_a_dec_13.pdf@2013-12-18 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_42.pdf@EU-1-02-220_h_a_dec_42.pdf@2022-08-07 00:00:00@Tracleer@bosentan@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_16.pdf@EU-1-02-227_h_a_dec_16.pdf@2012-05-25 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_6.pdf@EU-1-02-221_h_a_dec_6.pdf@2005-02-23 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_23.pdf@EU-1-02-226_h_a_dec_23.pdf@2015-10-11 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_14.pdf@EU-1-02-229_h_a_dec_14.pdf@2015-03-23 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_5.pdf@EU-1-02-220_h_a_dec_5.pdf@2004-08-23 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_17.pdf@EU-1-02-227_h_a_dec_17.pdf@2013-03-09 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_7.pdf@EU-1-02-221_h_a_dec_7.pdf@2005-10-25 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_24.pdf@EU-1-02-226_h_a_dec_24.pdf@2015-11-20 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_15.pdf@EU-1-02-229_h_a_dec_15.pdf@2016-08-12 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_6.pdf@EU-1-02-220_h_a_dec_6.pdf@2004-09-13 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-221_h_a_dec_8.pdf@EU-1-02-221_h_a_dec_8.pdf@2006-01-26 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_18.pdf@EU-1-02-227_h_a_dec_18.pdf@2013-11-15 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_25.pdf@EU-1-02-226_h_a_dec_25.pdf@2017-05-31 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma  B.V.@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_7.pdf@EU-1-02-220_h_a_dec_7.pdf@2004-11-30 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_39.pdf@EU-1-02-222_h_a_dec_39.pdf@2017-04-20 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-221_h_a_dec_9.pdf@EU-1-02-221_h_a_dec_9.pdf@2006-05-29 00:00:00@PEGASYS@peginterferon alfa-2a@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_16.pdf@EU-1-02-229_h_a_dec_16.pdf@2018-12-04 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-220_h_a_dec_8.pdf@EU-1-02-220_h_a_dec_8.pdf@2005-06-16 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_26.pdf@EU-1-02-226_h_a_dec_26.pdf@2019-08-08 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma B.V.@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_19.pdf@EU-1-02-227_h_a_dec_19.pdf@2013-11-15 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_4.pdf@EU-1-02-222_h_a_dec_4.pdf@2005-02-23 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-02-220_h_a_dec_9.pdf@EU-1-02-220_h_a_dec_9.pdf@2005-10-19 00:00:00@Tracleer@Bosentan@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_17.pdf@EU-1-02-229_h_a_dec_17.pdf@2019-08-04 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_27.pdf@EU-1-02-226_h_a_dec_27.pdf@2022-09-21 00:00:00@InductOs@Dibotermin alfa@False@False@OD Not Found@Medtronic BioPharma B.V.@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_2.pdf@EU-1-02-227_h_a_dec_2.pdf@2005-01-25 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_3.pdf@EU-1-02-226_h_a_dec_3.pdf@2003-07-22 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_18.pdf@EU-1-02-229_h_a_dec_18.pdf@2020-08-28 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_19.pdf@EU-1-02-229_h_a_dec_19.pdf@2022-01-25 00:00:00@Actraphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_40.pdf@EU-1-02-222_h_a_dec_40.pdf@2018-06-04 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_4.pdf@EU-1-02-226_h_a_dec_4.pdf@2004-01-20 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_20.pdf@EU-1-02-227_h_a_dec_20.pdf@2014-11-13 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_2.pdf@EU-1-02-229_h_a_dec_2.pdf@2003-08-22 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_0.pdf@EU-1-02-230_h_a_dec_0.pdf@2002-07-10 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-226_h_a_dec_5.pdf@EU-1-02-226_h_a_dec_5.pdf@2004-02-23 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_41.pdf@EU-1-02-222_h_a_dec_41.pdf@2019-11-01 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_21.pdf@EU-1-02-227_h_a_dec_21.pdf@2016-05-26 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_3.pdf@EU-1-02-229_h_a_dec_3.pdf@2004-02-08 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_1.pdf@EU-1-02-230_h_a_dec_1.pdf@2003-08-13 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_42.pdf@EU-1-02-222_h_a_dec_42.pdf@2020-02-13 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_6.pdf@EU-1-02-226_h_a_dec_6.pdf@2004-09-24 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-229_h_a_dec_4.pdf@EU-1-02-229_h_a_dec_4.pdf@2005-05-10 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_10.pdf@EU-1-02-230_h_a_dec_10.pdf@2011-10-11 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_7.pdf@EU-1-02-226_h_a_dec_7.pdf@2005-03-29 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-02-222_h_a_dec_43.pdf@EU-1-02-222_h_a_dec_43.pdf@2020-08-04 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_22.pdf@EU-1-02-227_h_a_dec_22.pdf@2018-02-19 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_11.pdf@EU-1-02-230_h_a_dec_11.pdf@2012-06-27 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_5.pdf@EU-1-02-229_h_a_dec_5.pdf@2007-09-18 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_44.pdf@EU-1-02-222_h_a_dec_44.pdf@2021-02-19 00:00:00@Tamiflu@Oseltamivir@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_8.pdf@EU-1-02-226_h_a_dec_8.pdf@2006-02-13 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_12.pdf@EU-1-02-230_h_a_dec_12.pdf@2012-11-19 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_6.pdf@EU-1-02-229_h_a_dec_6.pdf@2008-12-17 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-226_h_a_dec_9.pdf@EU-1-02-226_h_a_dec_9.pdf@2006-03-29 00:00:00@InductOs@Dibotermin alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_5.pdf@EU-1-02-222_h_a_dec_5.pdf@2006-01-20 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_23.pdf@EU-1-02-227_h_a_dec_23.pdf@2018-10-31 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_7.pdf@EU-1-02-229_h_a_dec_7.pdf@2009-01-10 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_13.pdf@EU-1-02-230_h_a_dec_13.pdf@2013-12-18 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_6.pdf@EU-1-02-222_h_a_dec_6.pdf@2006-01-25 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_14.pdf@EU-1-02-230_h_a_dec_14.pdf@2015-06-19 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_8.pdf@EU-1-02-229_h_a_dec_8.pdf@2010-03-11 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_7.pdf@EU-1-02-222_h_a_dec_7.pdf@2006-12-09 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_24.pdf@EU-1-02-227_h_a_dec_24.pdf@2019-11-22 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_15.pdf@EU-1-02-230_h_a_dec_15.pdf@2016-08-12 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-229_h_a_dec_9.pdf@EU-1-02-229_h_a_dec_9.pdf@2011-03-17 00:00:00@Actraphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_8.pdf@EU-1-02-222_h_a_dec_8.pdf@2007-03-28 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_16.pdf@EU-1-02-230_h_a_dec_16.pdf@2018-12-04 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_25.pdf@EU-1-02-227_h_a_dec_25.pdf@2021-12-13 00:00:00@Neulasta@Pegfilgrastim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-222_h_a_dec_9.pdf@EU-1-02-222_h_a_dec_9.pdf@2007-06-29 00:00:00@Tamiflu@Oseltamivir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_17.pdf@EU-1-02-230_h_a_dec_17.pdf@2019-11-03 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_3.pdf@EU-1-02-227_h_a_dec_3.pdf@2005-04-29 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_18.pdf@EU-1-02-230_h_a_dec_18.pdf@2020-08-28 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_0.pdf@EU-1-02-231_h_a_dec_0.pdf@2002-07-10 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_4.pdf@EU-1-02-227_h_a_dec_4.pdf@2005-01-08 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_19.pdf@EU-1-02-230_h_a_dec_19.pdf@2022-01-25 00:00:00@Actrapid@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_1.pdf@EU-1-02-231_h_a_dec_1.pdf@2003-08-13 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_5.pdf@EU-1-02-227_h_a_dec_5.pdf@2005-08-31 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_2.pdf@EU-1-02-230_h_a_dec_2.pdf@2003-08-22 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_10.pdf@EU-1-02-231_h_a_dec_10.pdf@2011-10-27 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_6.pdf@EU-1-02-227_h_a_dec_6.pdf@2005-10-28 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-02-230_h_a_dec_3.pdf@EU-1-02-230_h_a_dec_3.pdf@2004-02-08 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_11.pdf@EU-1-02-231_h_a_dec_11.pdf@2012-06-27 00:00:00@Mixtard@Insulin human  (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_0.pdf@EU-1-02-233_h_a_dec_0.pdf@2002-07-10 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_7.pdf@EU-1-02-227_h_a_dec_7.pdf@2007-03-01 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_12.pdf@EU-1-02-231_h_a_dec_12.pdf@2012-11-19 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_4.pdf@EU-1-02-230_h_a_dec_4.pdf@2005-05-10 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_1.pdf@EU-1-02-233_h_a_dec_1.pdf@2003-08-13 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-227_h_a_dec_8.pdf@EU-1-02-227_h_a_dec_8.pdf@2007-07-16 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_5.pdf@EU-1-02-230_h_a_dec_5.pdf@2007-09-18 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_10.pdf@EU-1-02-233_h_a_dec_10.pdf@2011-03-24 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_13.pdf@EU-1-02-231_h_a_dec_13.pdf@2013-12-20 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-227_h_a_dec_9.pdf@EU-1-02-227_h_a_dec_9.pdf@2007-07-16 00:00:00@Neulasta@Pegfilgrastim@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_6.pdf@EU-1-02-230_h_a_dec_6.pdf@2008-12-17 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_11.pdf@EU-1-02-233_h_a_dec_11.pdf@2011-12-14 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_14.pdf@EU-1-02-231_h_a_dec_14.pdf@2015-02-19 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_12.pdf@EU-1-02-233_h_a_dec_12.pdf@2012-06-27 00:00:00@Insulatard@Insulin human  (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_7.pdf@EU-1-02-230_h_a_dec_7.pdf@2009-01-10 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_15.pdf@EU-1-02-231_h_a_dec_15.pdf@2016-12-16 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_13.pdf@EU-1-02-233_h_a_dec_13.pdf@2012-11-19 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_8.pdf@EU-1-02-230_h_a_dec_8.pdf@2011-02-18 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_16.pdf@EU-1-02-231_h_a_dec_16.pdf@2018-01-03 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-230_h_a_dec_9.pdf@EU-1-02-230_h_a_dec_9.pdf@2011-03-14 00:00:00@Actrapid@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_17.pdf@EU-1-02-231_h_a_dec_17.pdf@2019-03-28 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_14.pdf@EU-1-02-233_h_a_dec_14.pdf@2014-01-22 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_18.pdf@EU-1-02-231_h_a_dec_18.pdf@2020-03-07 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_15.pdf@EU-1-02-233_h_a_dec_15.pdf@2015-11-06 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_19.pdf@EU-1-02-231_h_a_dec_19.pdf@2021-09-22 00:00:00@Mixtard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_16.pdf@EU-1-02-233_h_a_dec_16.pdf@2016-08-09 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_0.pdf@EU-1-02-234_h_a_dec_0.pdf@2002-07-10 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_2.pdf@EU-1-02-231_h_a_dec_2.pdf@2003-08-22 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_17.pdf@EU-1-02-233_h_a_dec_17.pdf@2018-01-03 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_1.pdf@EU-1-02-234_h_a_dec_1.pdf@2003-08-13 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_3.pdf@EU-1-02-231_h_a_dec_3.pdf@2004-02-08 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_18.pdf@EU-1-02-233_h_a_dec_18.pdf@2019-03-28 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_10.pdf@EU-1-02-234_h_a_dec_10.pdf@2011-03-17 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_4.pdf@EU-1-02-231_h_a_dec_4.pdf@2005-05-10 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_19.pdf@EU-1-02-233_h_a_dec_19.pdf@2020-03-07 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_11.pdf@EU-1-02-234_h_a_dec_11.pdf@2011-03-11 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_0.pdf@EU-1-02-237_h_a_dec_0.pdf@2002-12-11 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_2.pdf@EU-1-02-233_h_a_dec_2.pdf@2003-08-25 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_5.pdf@EU-1-02-231_h_a_dec_5.pdf@2007-09-18 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_1.pdf@EU-1-02-237_h_a_dec_1.pdf@2003-01-23 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-234_h_a_dec_12.pdf@EU-1-02-234_h_a_dec_12.pdf@2012-06-27 00:00:00@Protaphane@Insulin human  (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_20.pdf@EU-1-02-233_h_a_dec_20.pdf@2021-09-22 00:00:00@Insulatard@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_13.pdf@EU-1-02-234_h_a_dec_13.pdf@2012-11-19 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_10.pdf@EU-1-02-237_h_a_dec_10.pdf@2006-12-06 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_6.pdf@EU-1-02-231_h_a_dec_6.pdf@2008-12-12 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_11.pdf@EU-1-02-237_h_a_dec_11.pdf@2006-07-28 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_3.pdf@EU-1-02-233_h_a_dec_3.pdf@2004-02-08 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-231_h_a_dec_7.pdf@EU-1-02-231_h_a_dec_7.pdf@2009-01-10 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_14.pdf@EU-1-02-234_h_a_dec_14.pdf@2014-01-22 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_4.pdf@EU-1-02-233_h_a_dec_4.pdf@2005-05-10 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_0.pdf@EU-1-02-238_h_a_dec_0.pdf@2002-11-20 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@adopted@Oxford GlycoSciences (UK) Ltd@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_12.pdf@EU-1-02-237_h_a_dec_12.pdf@2007-06-20 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-231_h_a_dec_8.pdf@EU-1-02-231_h_a_dec_8.pdf@2011-01-21 00:00:00@Mixtard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_15.pdf@EU-1-02-234_h_a_dec_15.pdf@2015-11-06 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_1.pdf@EU-1-02-238_h_a_dec_1.pdf@2003-03-02 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Limited@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_0.pdf@EU-1-02-240_h_a_dec_0.pdf@2002-11-13 00:00:00@ Somavert Pegvisomant @Active Substance Not Found@NAS before 2012@NA before 2012@adopted@Pharmacia Enterprises S.A@CMA not available before 2006@Parsed
EU-1-02-233_h_a_dec_5.pdf@EU-1-02-233_h_a_dec_5.pdf@2007-09-18 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_13.pdf@EU-1-02-237_h_a_dec_13.pdf@2007-10-08 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_16.pdf@EU-1-02-234_h_a_dec_16.pdf@2016-08-09 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
sed
EU-1-02-238_h_a_dec_10.pdf@EU-1-02-238_h_a_dec_10.pdf@2008-03-18 00:00:00@Zavesca@Miglustat@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_1.pdf@EU-1-02-240_h_a_dec_1.pdf@2003-08-18 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Enterprises S.A.@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_14.pdf@EU-1-02-237_h_a_dec_14.pdf@2007-09-17 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_17.pdf@EU-1-02-234_h_a_dec_17.pdf@2018-01-03 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_6.pdf@EU-1-02-233_h_a_dec_6.pdf@2008-04-18 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_11.pdf@EU-1-02-238_h_a_dec_11.pdf@2008-05-20 00:00:00@Zavesca@Miglustat@NAS before 2012@True@OD Not Found@Actelion Registration Ltd@exceptional@Parsed
EU-1-02-240_h_a_dec_10.pdf@EU-1-02-240_h_a_dec_10.pdf@2009-11-20 00:00:00@Somavert@Pegvisomant@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_18.pdf@EU-1-02-234_h_a_dec_18.pdf@2019-06-06 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_15.pdf@EU-1-02-237_h_a_dec_15.pdf@2007-10-18 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_7.pdf@EU-1-02-233_h_a_dec_7.pdf@2009-01-10 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_0.pdf@EU-1-02-246_h_a_dec_0.pdf@2003-01-24 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_11.pdf@EU-1-02-240_h_a_dec_11.pdf@2010-01-25 00:00:00@Somavert@Pegvisomant@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_19.pdf@EU-1-02-234_h_a_dec_19.pdf@2020-03-07 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_12.pdf@EU-1-02-238_h_a_dec_12.pdf@2008-10-28 00:00:00@Zavesca@Miglustat@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_16.pdf@EU-1-02-237_h_a_dec_16.pdf@2007-10-18 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_8.pdf@EU-1-02-233_h_a_dec_8.pdf@2010-04-29 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_12.pdf@EU-1-02-240_h_a_dec_12.pdf@2011-04-18 00:00:00@Somavert@Pegvisomant@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_2.pdf@EU-1-02-234_h_a_dec_2.pdf@2003-08-22 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-246_h_a_dec_1.pdf@EU-1-02-246_h_a_dec_1.pdf@2004-09-21 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_13.pdf@EU-1-02-238_h_a_dec_13.pdf@2009-01-26 00:00:00@Zavesca@Miglustat@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_17.pdf@EU-1-02-237_h_a_dec_17.pdf@2008-02-29 00:00:00@Cialis@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-233_h_a_dec_9.pdf@EU-1-02-233_h_a_dec_9.pdf@2011-02-21 00:00:00@Insulatard@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_13.pdf@EU-1-02-240_h_a_dec_13.pdf@2011-12-19 00:00:00@Somavert@Pegvisomant@NAS before 2012@False@adopted@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_20.pdf@EU-1-02-234_h_a_dec_20.pdf@2021-09-22 00:00:00@Protaphane@Insulin human (rDNA)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_10.pdf@EU-1-02-246_h_a_dec_10.pdf@2018-11-01 00:00:00@Carbaglu@Carglumic acid@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_14.pdf@EU-1-02-238_h_a_dec_14.pdf@2009-05-26 00:00:00@Zavesca@Miglustat@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@exceptional@Parsed
EU-1-02-237_h_a_dec_18.pdf@EU-1-02-237_h_a_dec_18.pdf@2008-03-17 00:00:00@Cialis@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_14.pdf@EU-1-02-240_h_a_dec_14.pdf@2012-10-09 00:00:00@Somavert@Pegvisomant@False@False@adopted@Pfizer Ltd@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_11.pdf@EU-1-02-246_h_a_dec_11.pdf@2020-04-23 00:00:00@Carbaglu@Carglumic acid@False@False@adopted@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_3.pdf@EU-1-02-234_h_a_dec_3.pdf@2004-02-08 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_15.pdf@EU-1-02-238_h_a_dec_15.pdf@2010-02-06 00:00:00@Zavesca@Miglustat@NAS before 2012@False@OD Not Found@Actelion Registration Ltd@exceptional@Parsed
EU-1-02-237_h_a_dec_19.pdf@EU-1-02-237_h_a_dec_19.pdf@2008-03-09 00:00:00@Cialis@tadalafil@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_4.pdf@EU-1-02-234_h_a_dec_4.pdf@2005-05-10 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_2.pdf@EU-1-02-237_h_a_dec_2.pdf@2003-10-20 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_16.pdf@EU-1-02-238_h_a_dec_16.pdf@2011-05-16 00:00:00@Zavesca@Miglustat@NAS before 2012@False@adopted@Actelion Registration Ltd@exceptional@Parsed
EU-1-02-246_h_a_dec_2.pdf@EU-1-02-246_h_a_dec_2.pdf@2005-04-27 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_15.pdf@EU-1-02-240_h_a_dec_15.pdf@2015-11-02 00:00:00@Somavert@Pegvisomant@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_20.pdf@EU-1-02-237_h_a_dec_20.pdf@2010-09-02 00:00:00@Cialis@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_5.pdf@EU-1-02-234_h_a_dec_5.pdf@2007-09-18 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_17.pdf@EU-1-02-238_h_a_dec_17.pdf@2011-12-22 00:00:00@Zavesca@Miglustat@NAS before 2012@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_3.pdf@EU-1-02-246_h_a_dec_3.pdf@2006-06-26 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@exceptional@Parsed
EU-1-02-240_h_a_dec_16.pdf@EU-1-02-240_h_a_dec_16.pdf@2015-07-17 00:00:00@Somavert@Pegvisomant@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_18.pdf@EU-1-02-238_h_a_dec_18.pdf@2012-08-23 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@exceptional@Parsed
EU-1-02-234_h_a_dec_6.pdf@EU-1-02-234_h_a_dec_6.pdf@2008-04-25 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_4.pdf@EU-1-02-246_h_a_dec_4.pdf@2008-05-20 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@True@OD Not Found@Orphan Europe@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_19.pdf@EU-1-02-238_h_a_dec_19.pdf@2012-08-10 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_22.pdf@EU-1-02-237_h_a_dec_22.pdf@2011-02-21 00:00:00@Cialis@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_17.pdf@EU-1-02-240_h_a_dec_17.pdf@2017-02-06 00:00:00@Somavert@Pegvisomant@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_7.pdf@EU-1-02-234_h_a_dec_7.pdf@2009-01-10 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_2.pdf@EU-1-02-238_h_a_dec_2.pdf@2003-08-10 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-02-246_h_a_dec_5.pdf@EU-1-02-246_h_a_dec_5.pdf@2010-03-15 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@False@OD Not Found@Orphan Europe@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_23.pdf@EU-1-02-237_h_a_dec_23.pdf@2012-10-09 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_8.pdf@EU-1-02-234_h_a_dec_8.pdf@2010-04-29 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_6.pdf@EU-1-02-246_h_a_dec_6.pdf@2011-05-27 00:00:00@Carbaglu@Carglumic acid@NAS before 2012@False@OD Not Found@Orphan Europe  SARL@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_18.pdf@EU-1-02-240_h_a_dec_18.pdf@2018-08-23 00:00:00@Somavert@Pegvisomant@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-02-234_h_a_dec_9.pdf@EU-1-02-234_h_a_dec_9.pdf@2011-02-21 00:00:00@Protaphane@Insulin human (rDNA)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_24.pdf@EU-1-02-237_h_a_dec_24.pdf@2012-01-10 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_20.pdf@EU-1-02-238_h_a_dec_20.pdf@2013-12-08 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_19.pdf@EU-1-02-240_h_a_dec_19.pdf@2019-09-16 00:00:00@Somavert@Pegvisomant@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_25.pdf@EU-1-02-237_h_a_dec_25.pdf@2012-10-24 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_7.pdf@EU-1-02-246_h_a_dec_7.pdf@2012-03-15 00:00:00@Carbaglu@Carglumic acid@False@False@adopted@Orphan Europe@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_2.pdf@EU-1-02-240_h_a_dec_2.pdf@2003-09-16 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Enterprises S.A.@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_26.pdf@EU-1-02-237_h_a_dec_26.pdf@2012-10-24 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-02-246_h_a_dec_8.pdf@EU-1-02-246_h_a_dec_8.pdf@2014-07-05 00:00:00@Carbaglu@Carglumic acid@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_27.pdf@EU-1-02-237_h_a_dec_27.pdf@2013-01-21 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_0.pdf@EU-1-03-247_h_a_dec_0.pdf@2003-10-06 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-02-246_h_a_dec_9.pdf@EU-1-02-246_h_a_dec_9.pdf@2015-11-19 00:00:00@Carbaglu@Carglumic acid@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_28.pdf@EU-1-02-237_h_a_dec_28.pdf@2013-02-13 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_20.pdf@EU-1-02-240_h_a_dec_20.pdf@2021-06-21 00:00:00@Somavert@Pegvisomant@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_21.pdf@EU-1-02-238_h_a_dec_21.pdf@2014-10-27 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_3.pdf@EU-1-02-240_h_a_dec_3.pdf@2003-10-20 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_1.pdf@EU-1-03-247_h_a_dec_1.pdf@2004-01-20 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-02-237_h_a_dec_29.pdf@EU-1-02-237_h_a_dec_29.pdf@2014-03-14 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_4.pdf@EU-1-02-240_h_a_dec_4.pdf@2004-04-08 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_22.pdf@EU-1-02-238_h_a_dec_22.pdf@2016-08-08 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_10.pdf@EU-1-03-247_h_a_dec_10.pdf@2009-08-28 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_3.pdf@EU-1-02-237_h_a_dec_3.pdf@2004-01-27 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-02-240_h_a_dec_5.pdf@EU-1-02-240_h_a_dec_5.pdf@2005-09-13 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_11.pdf@EU-1-03-247_h_a_dec_11.pdf@2010-10-25 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_30.pdf@EU-1-02-237_h_a_dec_30.pdf@2015-08-14 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_6.pdf@EU-1-02-240_h_a_dec_6.pdf@2005-11-15 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_0.pdf@EU-1-03-248_h_a_dec_0.pdf@2003-06-03 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_23.pdf@EU-1-02-238_h_a_dec_23.pdf@2017-07-19 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_0.pdf@EU-1-03-249_h_a_dec_0.pdf@2003-04-03 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_12.pdf@EU-1-03-247_h_a_dec_12.pdf@2011-03-24 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_31.pdf@EU-1-02-237_h_a_dec_31.pdf@2016-07-22 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_7.pdf@EU-1-02-240_h_a_dec_7.pdf@2007-09-20 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_1.pdf@EU-1-03-248_h_a_dec_1.pdf@2004-01-27 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_1.pdf@EU-1-03-249_h_a_dec_1.pdf@2004-01-27 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-247_h_a_dec_13.pdf@EU-1-03-247_h_a_dec_13.pdf@2011-05-27 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_32.pdf@EU-1-02-237_h_a_dec_32.pdf@2018-01-30 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_8.pdf@EU-1-02-240_h_a_dec_8.pdf@2007-12-21 00:00:00@Somavert@Pegvisomant@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_10.pdf@EU-1-03-248_h_a_dec_10.pdf@2006-11-24 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_24.pdf@EU-1-02-238_h_a_dec_24.pdf@2018-09-07 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_14.pdf@EU-1-03-247_h_a_dec_14.pdf@2011-07-26 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_10.pdf@EU-1-03-249_h_a_dec_10.pdf@2006-11-24 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_11.pdf@EU-1-03-248_h_a_dec_11.pdf@2007-11-21 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-240_h_a_dec_9.pdf@EU-1-02-240_h_a_dec_9.pdf@2008-12-16 00:00:00@Somavert@Pegvisomant@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_15.pdf@EU-1-03-247_h_a_dec_15.pdf@2013-02-13 00:00:00@Forsteo@Teriparatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_11.pdf@EU-1-03-249_h_a_dec_11.pdf@2007-11-20 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_33.pdf@EU-1-02-237_h_a_dec_33.pdf@2022-04-02 00:00:00@Cialis@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_25.pdf@EU-1-02-238_h_a_dec_25.pdf@2018-09-28 00:00:00@Zavesca@Miglustat@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_12.pdf@EU-1-03-248_h_a_dec_12.pdf@2008-07-02 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_16.pdf@EU-1-03-247_h_a_dec_16.pdf@2015-09-04 00:00:00@Forsteo@Teriparatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_4.pdf@EU-1-02-237_h_a_dec_4.pdf@2004-01-27 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_12.pdf@EU-1-03-249_h_a_dec_12.pdf@2008-07-02 00:00:00@Vivanza@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_13.pdf@EU-1-03-248_h_a_dec_13.pdf@2008-03-17 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_17.pdf@EU-1-03-247_h_a_dec_17.pdf@2017-02-16 00:00:00@Forsteo@Teriparatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_26.pdf@EU-1-02-238_h_a_dec_26.pdf@2021-08-02 00:00:00@Zavesca@Miglustat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_5.pdf@EU-1-02-237_h_a_dec_5.pdf@2004-06-07 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_13.pdf@EU-1-03-249_h_a_dec_13.pdf@2008-03-17 00:00:00@Vivanza@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_14.pdf@EU-1-03-248_h_a_dec_14.pdf@2008-07-28 00:00:00@Levitra@Vardenafil@NAS before 2012@True@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_6.pdf@EU-1-02-237_h_a_dec_6.pdf@2004-11-30 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_0.pdf@EU-1-03-251_h_a_dec_0.pdf@2003-06-03 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_15.pdf@EU-1-03-248_h_a_dec_15.pdf@2009-02-25 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_27.pdf@EU-1-02-238_h_a_dec_27.pdf@2022-07-22 00:00:00@Zavesca@Miglustat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_18.pdf@EU-1-03-247_h_a_dec_18.pdf@2018-10-18 00:00:00@Forsteo@Teriparatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_7.pdf@EU-1-02-237_h_a_dec_7.pdf@2005-03-29 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_1.pdf@EU-1-03-251_h_a_dec_1.pdf@2004-01-29 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_15.pdf@EU-1-03-249_h_a_dec_15.pdf@2009-02-25 00:00:00@Vivanza@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_3.pdf@EU-1-02-238_h_a_dec_3.pdf@2004-08-18 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_16.pdf@EU-1-03-248_h_a_dec_16.pdf@2009-06-22 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_19.pdf@EU-1-03-247_h_a_dec_19.pdf@2021-10-19 00:00:00@Forsteo@Teriparatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_8.pdf@EU-1-02-237_h_a_dec_8.pdf@2005-10-25 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_10.pdf@EU-1-03-251_h_a_dec_10.pdf@2007-10-23 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_16.pdf@EU-1-03-249_h_a_dec_16.pdf@2009-06-18 00:00:00@Vivanza@Vardenafil@NAS before 2012@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_4.pdf@EU-1-02-238_h_a_dec_4.pdf@2005-03-06 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_17.pdf@EU-1-03-248_h_a_dec_17.pdf@2010-01-09 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_17.pdf@EU-1-03-249_h_a_dec_17.pdf@2011-04-20 00:00:00@Vivanza@Vardenafil@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-02-237_h_a_dec_9.pdf@EU-1-02-237_h_a_dec_9.pdf@2005-11-15 00:00:00@Cialis@tadalafil@NAS before 2012@NA before 2012@OD Not Found@Lilly ICOS Limited@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_11.pdf@EU-1-03-251_h_a_dec_11.pdf@2008-02-28 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_2.pdf@EU-1-03-247_h_a_dec_2.pdf@2005-04-27 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-02-238_h_a_dec_5.pdf@EU-1-02-238_h_a_dec_5.pdf@2006-04-24 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@exceptional@Parsed
EU-1-03-252_h_a_dec_0.pdf@EU-1-03-252_h_a_dec_0.pdf@2003-05-27 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_18.pdf@EU-1-03-248_h_a_dec_18.pdf@2011-03-24 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_12.pdf@EU-1-03-251_h_a_dec_12.pdf@2008-03-18 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_6.pdf@EU-1-02-238_h_a_dec_6.pdf@2007-02-20 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_3.pdf@EU-1-03-247_h_a_dec_3.pdf@2005-05-09 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_1.pdf@EU-1-03-252_h_a_dec_1.pdf@2004-08-06 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_18.pdf@EU-1-03-249_h_a_dec_18.pdf@2011-11-16 00:00:00@Vivanza@Vardenafil@NAS before 2012@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_19.pdf@EU-1-03-248_h_a_dec_19.pdf@2011-04-20 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_13.pdf@EU-1-03-251_h_a_dec_13.pdf@2008-01-04 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_4.pdf@EU-1-03-247_h_a_dec_4.pdf@2007-06-21 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_7.pdf@EU-1-02-238_h_a_dec_7.pdf@2007-02-28 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_19.pdf@EU-1-03-249_h_a_dec_19.pdf@2012-02-21 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_10.pdf@EU-1-03-252_h_a_dec_10.pdf@2007-08-30 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_8.pdf@EU-1-02-238_h_a_dec_8.pdf@2007-05-22 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@exceptional@Parsed
EU-1-03-248_h_a_dec_20.pdf@EU-1-03-248_h_a_dec_20.pdf@2011-10-11 00:00:00@Levitra@Vardenafil@NAS before 2012@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_5.pdf@EU-1-03-247_h_a_dec_5.pdf@2007-08-21 00:00:00@Forsteo@Teriparatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_14.pdf@EU-1-03-251_h_a_dec_14.pdf@2008-04-21 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@True@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_11.pdf@EU-1-03-252_h_a_dec_11.pdf@2007-02-10 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@exceptional@Parsed
EU-1-03-249_h_a_dec_2.pdf@EU-1-03-249_h_a_dec_2.pdf@2004-02-03 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_21.pdf@EU-1-03-248_h_a_dec_21.pdf@2012-02-21 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-02-238_h_a_dec_9.pdf@EU-1-02-238_h_a_dec_9.pdf@2007-07-09 00:00:00@Zavesca@Miglustat@NAS before 2012@NA before 2012@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_15.pdf@EU-1-03-251_h_a_dec_15.pdf@2008-08-13 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@True@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_6.pdf@EU-1-03-247_h_a_dec_6.pdf@2008-02-04 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_20.pdf@EU-1-03-249_h_a_dec_20.pdf@2013-01-21 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_12.pdf@EU-1-03-252_h_a_dec_12.pdf@2007-10-31 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_22.pdf@EU-1-03-248_h_a_dec_22.pdf@2012-03-19 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_21.pdf@EU-1-03-249_h_a_dec_21.pdf@2013-06-27 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_7.pdf@EU-1-03-247_h_a_dec_7.pdf@2008-04-21 00:00:00@Forsteo@Teriparatide@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_16.pdf@EU-1-03-251_h_a_dec_16.pdf@2008-12-17 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_13.pdf@EU-1-03-252_h_a_dec_13.pdf@2007-08-30 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_23.pdf@EU-1-03-248_h_a_dec_23.pdf@2013-01-21 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_22.pdf@EU-1-03-249_h_a_dec_22.pdf@2016-01-22 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_8.pdf@EU-1-03-247_h_a_dec_8.pdf@2008-05-20 00:00:00@Forsteo@Teriparatide@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_17.pdf@EU-1-03-251_h_a_dec_17.pdf@2009-01-27 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_14.pdf@EU-1-03-252_h_a_dec_14.pdf@2008-08-07 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_24.pdf@EU-1-03-248_h_a_dec_24.pdf@2015-09-04 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-247_h_a_dec_9.pdf@EU-1-03-247_h_a_dec_9.pdf@2009-02-25 00:00:00@Forsteo@Teriparatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_23.pdf@EU-1-03-249_h_a_dec_23.pdf@2017-06-04 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_18.pdf@EU-1-03-251_h_a_dec_18.pdf@2009-06-30 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_16.pdf@EU-1-03-252_h_a_dec_16.pdf@2010-03-22 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_25.pdf@EU-1-03-248_h_a_dec_25.pdf@2016-01-22 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_24.pdf@EU-1-03-249_h_a_dec_24.pdf@2019-08-26 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_19.pdf@EU-1-03-251_h_a_dec_19.pdf@2011-05-18 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited,@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_0.pdf@EU-1-03-253_h_a_dec_0.pdf@2003-10-06 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_17.pdf@EU-1-03-252_h_a_dec_17.pdf@2010-04-27 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_26.pdf@EU-1-03-248_h_a_dec_26.pdf@2017-03-29 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_25.pdf@EU-1-03-249_h_a_dec_25.pdf@2019-09-12 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_2.pdf@EU-1-03-251_h_a_dec_2.pdf@2004-02-03 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_1.pdf@EU-1-03-253_h_a_dec_1.pdf@2004-07-13 00:00:00@Aldurazyme@laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_27.pdf@EU-1-03-248_h_a_dec_27.pdf@2019-08-26 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_26.pdf@EU-1-03-249_h_a_dec_26.pdf@2021-03-22 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_20.pdf@EU-1-03-251_h_a_dec_20.pdf@2011-05-08 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited,@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_18.pdf@EU-1-03-252_h_a_dec_18.pdf@2014-04-07 00:00:00@Fuzeon@Enfuvirtide@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_10.pdf@EU-1-03-253_h_a_dec_10.pdf@2009-02-07 00:00:00@Aldurazyme@Laronidase@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_28.pdf@EU-1-03-248_h_a_dec_28.pdf@2019-09-12 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_27.pdf@EU-1-03-249_h_a_dec_27.pdf@2022-03-02 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_21.pdf@EU-1-03-251_h_a_dec_21.pdf@2011-12-19 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-03-254_h_a_dec_0.pdf@EU-1-03-254_h_a_dec_0.pdf@2003-09-07 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@adopted@Pierre Fabre Médicament@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_11.pdf@EU-1-03-253_h_a_dec_11.pdf@2010-04-27 00:00:00@Aldurazyme@Laronidase@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_28.pdf@EU-1-03-249_h_a_dec_28.pdf@2022-03-02 00:00:00@Vivanza@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_29.pdf@EU-1-03-248_h_a_dec_29.pdf@2021-03-22 00:00:00@Levitra@Vardenafil@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_19.pdf@EU-1-03-252_h_a_dec_19.pdf@2015-12-16 00:00:00@Fuzeon@Enfuvirtide@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_22.pdf@EU-1-03-251_h_a_dec_22.pdf@2012-08-23 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-03-254_h_a_dec_1.pdf@EU-1-03-254_h_a_dec_1.pdf@2005-10-27 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@OD Not Found@Pierre Fabre Médicament@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_3.pdf@EU-1-03-249_h_a_dec_3.pdf@2004-01-06 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_3.pdf@EU-1-03-248_h_a_dec_3.pdf@2004-01-06 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_2.pdf@EU-1-03-252_h_a_dec_2.pdf@2004-10-15 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_12.pdf@EU-1-03-253_h_a_dec_12.pdf@2011-11-21 00:00:00@Aldurazyme@Laronidase@NAS before 2012@False@adopted@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-255_h_a_dec_0.pdf@EU-1-03-255_h_a_dec_0.pdf@2003-09-16 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@adopted@Schering AG@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_23.pdf@EU-1-03-251_h_a_dec_23.pdf@2013-05-14 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_4.pdf@EU-1-03-248_h_a_dec_4.pdf@2005-03-29 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_4.pdf@EU-1-03-249_h_a_dec_4.pdf@2005-03-29 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_10.pdf@EU-1-03-254_h_a_dec_10.pdf@2014-05-22 00:00:00@Busilvex@busulfan@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_24.pdf@EU-1-03-251_h_a_dec_24.pdf@2015-11-02 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_20.pdf@EU-1-03-252_h_a_dec_20.pdf@2018-06-04 00:00:00@Fuzeon@Enfuvirtide@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_13.pdf@EU-1-03-253_h_a_dec_13.pdf@2013-02-18 00:00:00@Aldurazyme@Laronidase@False@False@adopted@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-255_h_a_dec_1.pdf@EU-1-03-255_h_a_dec_1.pdf@2004-04-13 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-248_h_a_dec_5.pdf@EU-1-03-248_h_a_dec_5.pdf@2005-08-16 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-249_h_a_dec_5.pdf@EU-1-03-249_h_a_dec_5.pdf@2005-08-16 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_11.pdf@EU-1-03-254_h_a_dec_11.pdf@2014-08-26 00:00:00@Busilvex@busulfan@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_25.pdf@EU-1-03-251_h_a_dec_25.pdf@2016-08-02 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_21.pdf@EU-1-03-252_h_a_dec_21.pdf@2019-04-10 00:00:00@Fuzeon@Enfuvirtide@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_14.pdf@EU-1-03-253_h_a_dec_14.pdf@2013-12-18 00:00:00@Aldurazyme@Laronidase@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-255_h_a_dec_10.pdf@EU-1-03-255_h_a_dec_10.pdf@2010-03-19 00:00:00@Ventavis@Iloprost@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@exceptional@Parsed
EU-1-03-249_h_a_dec_6.pdf@EU-1-03-249_h_a_dec_6.pdf@2005-11-15 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_12.pdf@EU-1-03-254_h_a_dec_12.pdf@2017-05-24 00:00:00@Busilvex@busulfan@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_6.pdf@EU-1-03-248_h_a_dec_6.pdf@2005-11-15 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-03-252_h_a_dec_3.pdf@EU-1-03-252_h_a_dec_3.pdf@2004-12-17 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_11.pdf@EU-1-03-255_h_a_dec_11.pdf@2010-12-20 00:00:00@Ventavis@Iloprost@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_7.pdf@EU-1-03-249_h_a_dec_7.pdf@2006-05-05 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_15.pdf@EU-1-03-253_h_a_dec_15.pdf@2014-11-19 00:00:00@Aldurazyme@Laronidase@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-254_h_a_dec_13.pdf@EU-1-03-254_h_a_dec_13.pdf@2021-10-19 00:00:00@Busilvex@busulfan@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_26.pdf@EU-1-03-251_h_a_dec_26.pdf@2018-05-28 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-248_h_a_dec_7.pdf@EU-1-03-248_h_a_dec_7.pdf@2006-05-05 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_12.pdf@EU-1-03-255_h_a_dec_12.pdf@2011-02-21 00:00:00@Ventavis@Iloprost@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_4.pdf@EU-1-03-252_h_a_dec_4.pdf@2005-11-04 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-253_h_a_dec_16.pdf@EU-1-03-253_h_a_dec_16.pdf@2015-12-16 00:00:00@Aldurazyme@Laronidase@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-249_h_a_dec_8.pdf@EU-1-03-249_h_a_dec_8.pdf@2006-12-06 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-254_h_a_dec_2.pdf@EU-1-03-254_h_a_dec_2.pdf@2007-11-22 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_13.pdf@EU-1-03-255_h_a_dec_13.pdf@2012-03-15 00:00:00@Ventavis@Iloprost@False@False@adopted@Bayer Pharma AG@exceptional@Parsed
EU-1-03-248_h_a_dec_8.pdf@EU-1-03-248_h_a_dec_8.pdf@2006-12-06 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_5.pdf@EU-1-03-252_h_a_dec_5.pdf@2005-05-10 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_27.pdf@EU-1-03-251_h_a_dec_27.pdf@2019-07-25 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-03-249_h_a_dec_9.pdf@EU-1-03-249_h_a_dec_9.pdf@2006-07-28 00:00:00@Vivanza@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_14.pdf@EU-1-03-255_h_a_dec_14.pdf@2012-04-20 00:00:00@Ventavis@Iloprost@False@False@adopted@Bayer Pharma AG@exceptional@Parsed
EU-1-03-248_h_a_dec_9.pdf@EU-1-03-248_h_a_dec_9.pdf@2006-07-28 00:00:00@Levitra@Vardenafil@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_17.pdf@EU-1-03-253_h_a_dec_17.pdf@2019-04-10 00:00:00@Aldurazyme@Laronidase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_6.pdf@EU-1-03-252_h_a_dec_6.pdf@2006-07-20 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-254_h_a_dec_3.pdf@EU-1-03-254_h_a_dec_3.pdf@2007-04-12 00:00:00@Busilvex@busulfan@NAS before 2012@NA before 2012@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_7.pdf@EU-1-03-252_h_a_dec_7.pdf@2006-09-21 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@exceptional@Parsed
EU-1-03-251_h_a_dec_28.pdf@EU-1-03-251_h_a_dec_28.pdf@2020-09-15 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_15.pdf@EU-1-03-255_h_a_dec_15.pdf@2013-08-26 00:00:00@Ventavis@Iloprost@False@False@adopted@Bayer Pharma AG@exceptional@Parsed
EU-1-03-252_h_a_dec_8.pdf@EU-1-03-252_h_a_dec_8.pdf@2006-10-24 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_18.pdf@EU-1-03-253_h_a_dec_18.pdf@2021-11-15 00:00:00@Aldurazyme@Laronidase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-254_h_a_dec_4.pdf@EU-1-03-254_h_a_dec_4.pdf@2008-08-07 00:00:00@Busilvex@busulfan@NAS before 2012@True@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_29.pdf@EU-1-03-251_h_a_dec_29.pdf@2022-05-05 00:00:00@Hepsera@adefovir dipivoxil@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_2.pdf@EU-1-03-253_h_a_dec_2.pdf@2005-12-01 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_5.pdf@EU-1-03-254_h_a_dec_5.pdf@2011-07-26 00:00:00@Busilvex@busulfan@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_3.pdf@EU-1-03-253_h_a_dec_3.pdf@2005-03-22 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_6.pdf@EU-1-03-254_h_a_dec_6.pdf@2011-11-24 00:00:00@Busilvex@busulfan@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_16.pdf@EU-1-03-255_h_a_dec_16.pdf@2014-07-18 00:00:00@Ventavis@Iloprost@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_4.pdf@EU-1-03-253_h_a_dec_4.pdf@2006-01-19 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-254_h_a_dec_7.pdf@EU-1-03-254_h_a_dec_7.pdf@2012-05-25 00:00:00@Busilvex@Busulfan@False@False@adopted@Pierre Fabre médicament@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_3.pdf@EU-1-03-251_h_a_dec_3.pdf@2004-05-25 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-254_h_a_dec_8.pdf@EU-1-03-254_h_a_dec_8.pdf@2012-07-20 00:00:00@Busilvex@busulfan@False@False@OD Not Found@Pierre Fabre  Médicament@CMA Not Found@Parsed
EU-1-03-252_h_a_dec_9.pdf@EU-1-03-252_h_a_dec_9.pdf@2007-01-24 00:00:00@Fuzeon@Enfuvirtide@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-254_h_a_dec_9.pdf@EU-1-03-254_h_a_dec_9.pdf@2013-11-29 00:00:00@Busilvex@busulfan@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_17.pdf@EU-1-03-255_h_a_dec_17.pdf@2015-03-11 00:00:00@Ventavis@Iloprost@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_4.pdf@EU-1-03-251_h_a_dec_4.pdf@2005-09-13 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_5.pdf@EU-1-03-251_h_a_dec_5.pdf@2005-09-15 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_18.pdf@EU-1-03-255_h_a_dec_18.pdf@2017-11-09 00:00:00@Ventavis@Iloprost@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_5.pdf@EU-1-03-253_h_a_dec_5.pdf@2006-05-31 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_6.pdf@EU-1-03-251_h_a_dec_6.pdf@2006-03-29 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_19.pdf@EU-1-03-255_h_a_dec_19.pdf@2018-09-02 00:00:00@Ventavis@Iloprost@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_6.pdf@EU-1-03-253_h_a_dec_6.pdf@2007-05-02 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-253_h_a_dec_7.pdf@EU-1-03-253_h_a_dec_7.pdf@2007-10-31 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_7.pdf@EU-1-03-251_h_a_dec_7.pdf@2006-04-08 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_8.pdf@EU-1-03-253_h_a_dec_8.pdf@2007-12-20 00:00:00@Aldurazyme@Laronidase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-03-255_h_a_dec_20.pdf@EU-1-03-255_h_a_dec_20.pdf@2020-02-13 00:00:00@Ventavis@Iloprost@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-03-251_h_a_dec_8.pdf@EU-1-03-251_h_a_dec_8.pdf@2006-08-28 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-253_h_a_dec_9.pdf@EU-1-03-253_h_a_dec_9.pdf@2008-05-20 00:00:00@Aldurazyme@Laronidase@NAS before 2012@True@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_3.pdf@EU-1-03-255_h_a_dec_3.pdf@2005-05-09 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-251_h_a_dec_9.pdf@EU-1-03-251_h_a_dec_9.pdf@2007-05-14 00:00:00@Hepsera@adefovir dipivoxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_0.pdf@EU-1-03-256_h_a_dec_0.pdf@2003-08-09 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_4.pdf@EU-1-03-255_h_a_dec_4.pdf@2006-02-05 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_5.pdf@EU-1-03-255_h_a_dec_5.pdf@2006-08-06 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_1.pdf@EU-1-03-256_h_a_dec_1.pdf@2004-10-06 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_0.pdf@EU-1-03-260_h_a_dec_0.pdf@2003-10-17 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_10.pdf@EU-1-03-256_h_a_dec_10.pdf@2007-05-14 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_6.pdf@EU-1-03-255_h_a_dec_6.pdf@2007-05-30 00:00:00@Ventavis@Iloprost@NAS before 2012@NA before 2012@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_1.pdf@EU-1-03-260_h_a_dec_1.pdf@2005-03-29 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_11.pdf@EU-1-03-256_h_a_dec_11.pdf@2007-04-06 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-255_h_a_dec_7.pdf@EU-1-03-255_h_a_dec_7.pdf@2008-07-28 00:00:00@Ventavis@Iloprost@NAS before 2012@True@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_10.pdf@EU-1-03-260_h_a_dec_10.pdf@2010-03-23 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_12.pdf@EU-1-03-256_h_a_dec_12.pdf@2007-06-29 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_11.pdf@EU-1-03-260_h_a_dec_11.pdf@2010-02-06 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_0.pdf@EU-1-03-261_h_a_dec_0.pdf@2003-10-24 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_8.pdf@EU-1-03-255_h_a_dec_8.pdf@2022-12-01 00:00:01@Ventavis@Iloprost@False@True@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_13.pdf@EU-1-03-256_h_a_dec_13.pdf@2003-08-09 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_12.pdf@EU-1-03-260_h_a_dec_12.pdf@2010-08-26 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_1.pdf@EU-1-03-261_h_a_dec_1.pdf@2004-06-23 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-255_h_a_dec_9.pdf@EU-1-03-255_h_a_dec_9.pdf@2009-05-27 00:00:00@Ventavis@Iloprost@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@exceptional@Parsed
EU-1-03-256_h_a_dec_14.pdf@EU-1-03-256_h_a_dec_14.pdf@2007-09-10 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_0.pdf@EU-1-03-262_h_a_dec_0.pdf@2003-11-11 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_13.pdf@EU-1-03-260_h_a_dec_13.pdf@2011-08-24 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_0.pdf@EU-1-03-263_h_a_dec_0.pdf@2004-04-28 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@NA before 2012@OD Not Found@SBL Vaccin AB@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_10.pdf@EU-1-03-261_h_a_dec_10.pdf@2007-04-25 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_15.pdf@EU-1-03-256_h_a_dec_15.pdf@2007-12-19 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_14.pdf@EU-1-03-260_h_a_dec_14.pdf@2013-01-14 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_1.pdf@EU-1-03-262_h_a_dec_1.pdf@2004-10-22 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-263_h_a_dec_1.pdf@EU-1-03-263_h_a_dec_1.pdf@2005-08-16 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@NA before 2012@OD Not Found@SBL Vaccin AB@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_11.pdf@EU-1-03-261_h_a_dec_11.pdf@2007-08-22 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_16.pdf@EU-1-03-256_h_a_dec_16.pdf@2008-01-17 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_0.pdf@EU-1-03-264_h_a_dec_0.pdf@2004-01-16 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_15.pdf@EU-1-03-260_h_a_dec_15.pdf@2016-01-25 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_10.pdf@EU-1-03-262_h_a_dec_10.pdf@2009-07-31 00:00:00@EMEND@aprepitant@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_12.pdf@EU-1-03-261_h_a_dec_12.pdf@2008-09-22 00:00:00@Emtriva@Emtricitabine@NAS before 2012@True@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_17.pdf@EU-1-03-256_h_a_dec_17.pdf@2008-06-23 00:00:00@Humira@Adalimumab@NAS before 2012@True@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_2.pdf@EU-1-03-263_h_a_dec_2.pdf@2005-08-16 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@NA before 2012@OD Not Found@SBL Vaccin AB@CMA not available before 2006@Parsed
EU-1-03-260_h_a_dec_16.pdf@EU-1-03-260_h_a_dec_16.pdf@2019-01-31 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_11.pdf@EU-1-03-262_h_a_dec_11.pdf@2010-12-01 00:00:00@EMEND@aprepitant@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_18.pdf@EU-1-03-256_h_a_dec_18.pdf@2008-07-17 00:00:00@Humira@Adalimumab@NAS before 2012@True@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_13.pdf@EU-1-03-261_h_a_dec_13.pdf@2009-06-18 00:00:00@Emtriva@Emtricitabine@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_17.pdf@EU-1-03-260_h_a_dec_17.pdf@2019-07-31 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_10.pdf@EU-1-03-264_h_a_dec_10.pdf@2009-07-01 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_12.pdf@EU-1-03-262_h_a_dec_12.pdf@2011-01-02 00:00:00@Emend@aprepitant@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_3.pdf@EU-1-03-263_h_a_dec_3.pdf@2009-03-25 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@False@OD Not Found@SBL Vaccin AB@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_19.pdf@EU-1-03-256_h_a_dec_19.pdf@2008-08-13 00:00:00@Humira@Adalimumab@NAS before 2012@True@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_14.pdf@EU-1-03-261_h_a_dec_14.pdf@2009-12-18 00:00:00@Emtriva@Emtricitabine@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_18.pdf@EU-1-03-260_h_a_dec_18.pdf@2021-09-12 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_11.pdf@EU-1-03-264_h_a_dec_11.pdf@2009-04-09 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_13.pdf@EU-1-03-262_h_a_dec_13.pdf@2011-10-24 00:00:00@Emend@aprepitant@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_4.pdf@EU-1-03-263_h_a_dec_4.pdf@2011-02-21 00:00:00@Dukoral@Oral cholera vaccine@NAS before 2012@False@OD Not Found@Crucell Sweden  AB@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_15.pdf@EU-1-03-261_h_a_dec_15.pdf@2010-08-26 00:00:00@Emtriva@Emtricitabine@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_2.pdf@EU-1-03-260_h_a_dec_2.pdf@2005-08-30 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_2.pdf@EU-1-03-256_h_a_dec_2.pdf@2004-07-19 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_12.pdf@EU-1-03-264_h_a_dec_12.pdf@2011-08-24 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_5.pdf@EU-1-03-263_h_a_dec_5.pdf@2015-08-04 00:00:00@Dukoral@Oral cholera vaccine@False@False@OD Not Found@Valneva Sweden AB@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_14.pdf@EU-1-03-262_h_a_dec_14.pdf@2011-11-28 00:00:00@Emend@aprepitant@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_0.pdf@EU-1-03-265_h_a_dec_0.pdf@2004-02-23 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@appointed@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_16.pdf@EU-1-03-261_h_a_dec_16.pdf@2011-12-04 00:00:00@Emtriva@Emtricitabine@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited,@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_3.pdf@EU-1-03-260_h_a_dec_3.pdf@2006-11-07 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_6.pdf@EU-1-03-263_h_a_dec_6.pdf@2019-04-07 00:00:00@Dukoral@Oral cholera vaccine@False@False@OD Not Found@Valneva Sweden AB@CMA Not Found@Parsed
rsed
EU-1-03-262_h_a_dec_15.pdf@EU-1-03-262_h_a_dec_15.pdf@2011-12-19 00:00:00@Emend@aprepitant@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_13.pdf@EU-1-03-264_h_a_dec_13.pdf@2011-10-11 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_7.pdf@EU-1-03-263_h_a_dec_7.pdf@2020-07-16 00:00:00@Dukoral@Oral cholera vaccine@False@False@OD Not Found@Valneva Sweden AB@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_16.pdf@EU-1-03-262_h_a_dec_16.pdf@2012-10-10 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_21.pdf@EU-1-03-256_h_a_dec_21.pdf@2008-08-29 00:00:00@Humira@Adalimumab@NAS before 2012@True@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_1.pdf@EU-1-03-265_h_a_dec_1.pdf@2005-05-18 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_17.pdf@EU-1-03-261_h_a_dec_17.pdf@2011-05-23 00:00:00@Emtriva@Emtricitabine@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_17.pdf@EU-1-03-262_h_a_dec_17.pdf@2013-03-22 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-03-263_h_a_dec_8.pdf@EU-1-03-263_h_a_dec_8.pdf@2021-07-01 00:00:00@Dukoral@Oral cholera vaccine@False@False@OD Not Found@Valneva Sweden AB@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_22.pdf@EU-1-03-256_h_a_dec_22.pdf@2009-02-25 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_4.pdf@EU-1-03-260_h_a_dec_4.pdf@2007-01-24 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_18.pdf@EU-1-03-261_h_a_dec_18.pdf@2011-07-27 00:00:00@Emtriva@Emtricitabine@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_14.pdf@EU-1-03-264_h_a_dec_14.pdf@2012-11-30 00:00:00@Zevalin@Ibritumomab tiuxetan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_10.pdf@EU-1-03-265_h_a_dec_10.pdf@2009-02-07 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_18.pdf@EU-1-03-262_h_a_dec_18.pdf@2013-12-18 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_23.pdf@EU-1-03-256_h_a_dec_23.pdf@2009-07-24 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_5.pdf@EU-1-03-260_h_a_dec_5.pdf@2007-08-29 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_11.pdf@EU-1-03-265_h_a_dec_11.pdf@2010-08-02 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_19.pdf@EU-1-03-261_h_a_dec_19.pdf@2013-01-07 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_24.pdf@EU-1-03-256_h_a_dec_24.pdf@2009-08-28 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_15.pdf@EU-1-03-264_h_a_dec_15.pdf@2014-03-14 00:00:00@Zevalin@Ibritumomab tiuxetan@False@False@OD Not Found@Spectrum Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_12.pdf@EU-1-03-265_h_a_dec_12.pdf@2010-05-05 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_19.pdf@EU-1-03-262_h_a_dec_19.pdf@2015-12-16 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_16.pdf@EU-1-03-264_h_a_dec_16.pdf@2015-04-15 00:00:00@Zevalin@Ibritumomab tiuxetan@False@False@OD Not Found@Spectrum Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_25.pdf@EU-1-03-256_h_a_dec_25.pdf@2010-03-15 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_6.pdf@EU-1-03-260_h_a_dec_6.pdf@2008-04-21 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_2.pdf@EU-1-03-261_h_a_dec_2.pdf@2004-02-08 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_17.pdf@EU-1-03-264_h_a_dec_17.pdf@2017-07-13 00:00:00@Zevalin@Ibritumomab tiuxetan@False@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_26.pdf@EU-1-03-256_h_a_dec_26.pdf@2010-03-23 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_2.pdf@EU-1-03-262_h_a_dec_2.pdf@2005-03-30 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-265_h_a_dec_13.pdf@EU-1-03-265_h_a_dec_13.pdf@2011-04-14 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_7.pdf@EU-1-03-260_h_a_dec_7.pdf@2008-09-15 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@True@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_14.pdf@EU-1-03-265_h_a_dec_14.pdf@2011-06-29 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_20.pdf@EU-1-03-261_h_a_dec_20.pdf@2015-03-30 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_0.pdf@EU-1-03-267_h_a_dec_0.pdf@2004-02-03 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_27.pdf@EU-1-03-256_h_a_dec_27.pdf@2010-04-29 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_20.pdf@EU-1-03-262_h_a_dec_20.pdf@2017-02-17 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_18.pdf@EU-1-03-264_h_a_dec_18.pdf@2017-08-12 00:00:00@Zevalin@Ibritumomab tiuxetan@False@False@OD Not Found@Spectrum Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_15.pdf@EU-1-03-265_h_a_dec_15.pdf@2011-07-27 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_8.pdf@EU-1-03-260_h_a_dec_8.pdf@2009-03-19 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_1.pdf@EU-1-03-267_h_a_dec_1.pdf@2004-07-19 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_21.pdf@EU-1-03-261_h_a_dec_21.pdf@2016-06-24 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_21.pdf@EU-1-03-262_h_a_dec_21.pdf@2017-10-19 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_16.pdf@EU-1-03-265_h_a_dec_16.pdf@2013-12-18 00:00:00@Bonviva@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_10.pdf@EU-1-03-267_h_a_dec_10.pdf@2007-01-17 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-260_h_a_dec_9.pdf@EU-1-03-260_h_a_dec_9.pdf@2009-03-27 00:00:00@Stalevo@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_19.pdf@EU-1-03-264_h_a_dec_19.pdf@2020-11-02 00:00:00@Zevalin@Ibritumomab tiuxetan@False@False@OD Not Found@Spectrum Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_29.pdf@EU-1-03-256_h_a_dec_29.pdf@2010-01-07 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_11.pdf@EU-1-03-267_h_a_dec_11.pdf@2007-03-27 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_22.pdf@EU-1-03-261_h_a_dec_22.pdf@2016-03-11 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_2.pdf@EU-1-03-264_h_a_dec_2.pdf@2005-07-27 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_22.pdf@EU-1-03-262_h_a_dec_22.pdf@2018-05-24 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_3.pdf@EU-1-03-256_h_a_dec_3.pdf@2005-01-25 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-265_h_a_dec_17.pdf@EU-1-03-265_h_a_dec_17.pdf@2016-04-21 00:00:00@Bonviva@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_12.pdf@EU-1-03-267_h_a_dec_12.pdf@2007-04-26 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_3.pdf@EU-1-03-264_h_a_dec_3.pdf@2005-11-15 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_23.pdf@EU-1-03-262_h_a_dec_23.pdf@2020-08-19 00:00:00@Emend@aprepitant@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_13.pdf@EU-1-03-267_h_a_dec_13.pdf@2007-07-20 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@exceptional@Parsed
EU-1-03-256_h_a_dec_30.pdf@EU-1-03-256_h_a_dec_30.pdf@2010-08-31 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories  Limited@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_23.pdf@EU-1-03-261_h_a_dec_23.pdf@2018-04-06 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_3.pdf@EU-1-03-262_h_a_dec_3.pdf@2005-04-28 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_4.pdf@EU-1-03-264_h_a_dec_4.pdf@2006-10-19 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_18.pdf@EU-1-03-265_h_a_dec_18.pdf@2018-04-04 00:00:00@Bonviva@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_14.pdf@EU-1-03-267_h_a_dec_14.pdf@2007-12-19 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_31.pdf@EU-1-03-256_h_a_dec_31.pdf@2011-01-21 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_4.pdf@EU-1-03-262_h_a_dec_4.pdf@2005-04-28 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-264_h_a_dec_5.pdf@EU-1-03-264_h_a_dec_5.pdf@2006-11-14 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_15.pdf@EU-1-03-267_h_a_dec_15.pdf@2008-04-17 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_24.pdf@EU-1-03-261_h_a_dec_24.pdf@2019-10-21 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_32.pdf@EU-1-03-256_h_a_dec_32.pdf@2011-02-21 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_6.pdf@EU-1-03-264_h_a_dec_6.pdf@2007-10-15 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_19.pdf@EU-1-03-265_h_a_dec_19.pdf@2019-05-22 00:00:00@Bonviva@Ibandronic acid@False@False@OD Not Found@Atnahs Pharma UK Limited@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_5.pdf@EU-1-03-262_h_a_dec_5.pdf@2005-07-09 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_16.pdf@EU-1-03-267_h_a_dec_16.pdf@2008-04-21 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_7.pdf@EU-1-03-264_h_a_dec_7.pdf@2007-10-22 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@NA before 2012@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_33.pdf@EU-1-03-256_h_a_dec_33.pdf@2011-03-18 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_2.pdf@EU-1-03-265_h_a_dec_2.pdf@2005-09-15 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_6.pdf@EU-1-03-262_h_a_dec_6.pdf@2006-05-29 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_17.pdf@EU-1-03-267_h_a_dec_17.pdf@2008-06-20 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_25.pdf@EU-1-03-261_h_a_dec_25.pdf@2021-06-17 00:00:00@Emtriva@Emtricitabine@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_34.pdf@EU-1-03-256_h_a_dec_34.pdf@2011-10-24 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_20.pdf@EU-1-03-265_h_a_dec_20.pdf@2021-06-17 00:00:00@Bonviva@Ibandronic acid@False@False@OD Not Found@Atnahs Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_8.pdf@EU-1-03-264_h_a_dec_8.pdf@2008-04-18 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@True@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_7.pdf@EU-1-03-262_h_a_dec_7.pdf@2006-05-29 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_18.pdf@EU-1-03-267_h_a_dec_18.pdf@2008-07-25 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@exceptional@Parsed
EU-1-03-256_h_a_dec_35.pdf@EU-1-03-256_h_a_dec_35.pdf@2011-12-19 00:00:00@Humira@Adalimumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_3.pdf@EU-1-03-261_h_a_dec_3.pdf@2004-12-17 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-262_h_a_dec_8.pdf@EU-1-03-262_h_a_dec_8.pdf@2007-02-28 00:00:00@EMEND@aprepitant@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-264_h_a_dec_9.pdf@EU-1-03-264_h_a_dec_9.pdf@2008-05-22 00:00:00@Zevalin@Ibritumomab tiuxetan@NAS before 2012@True@OD Not Found@Bayer Schering Pharma AG@exceptional@Parsed
EU-1-03-268_h_a_dec_0.pdf@EU-1-03-268_h_a_dec_0.pdf@2004-10-03 00:00:00@Cholestagel@colesevelam hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_19.pdf@EU-1-03-267_h_a_dec_19.pdf@2008-10-27 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_21.pdf@EU-1-03-265_h_a_dec_21.pdf@2022-07-25 00:00:00@Bonviva@Ibandronic acid@False@False@OD Not Found@Atnahs Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_36.pdf@EU-1-03-256_h_a_dec_36.pdf@2012-01-20 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_4.pdf@EU-1-03-261_h_a_dec_4.pdf@2005-03-03 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-268_h_a_dec_1.pdf@EU-1-03-268_h_a_dec_1.pdf@2008-05-03 00:00:00@Cholestagel@colesevelam  hydrochloride@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-262_h_a_dec_9.pdf@EU-1-03-262_h_a_dec_9.pdf@2008-09-22 00:00:00@EMEND@aprepitant@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_2.pdf@EU-1-03-267_h_a_dec_2.pdf@2004-12-17 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_37.pdf@EU-1-03-256_h_a_dec_37.pdf@2012-04-04 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_3.pdf@EU-1-03-265_h_a_dec_3.pdf@2005-09-15 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-03-261_h_a_dec_5.pdf@EU-1-03-261_h_a_dec_5.pdf@2005-07-09 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-268_h_a_dec_10.pdf@EU-1-03-268_h_a_dec_10.pdf@2017-04-28 00:00:00@Cholestagel@colesevelam hydrochloride@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_38.pdf@EU-1-03-256_h_a_dec_38.pdf@2012-04-20 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_20.pdf@EU-1-03-267_h_a_dec_20.pdf@2009-06-02 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_4.pdf@EU-1-03-265_h_a_dec_4.pdf@2006-03-29 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_6.pdf@EU-1-03-261_h_a_dec_6.pdf@2005-11-15 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-03-268_h_a_dec_11.pdf@EU-1-03-268_h_a_dec_11.pdf@2019-11-14 00:00:00@Cholestagel@colesevelam hydrochloride@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_21.pdf@EU-1-03-267_h_a_dec_21.pdf@2009-02-26 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_39.pdf@EU-1-03-256_h_a_dec_39.pdf@2012-06-27 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_12.pdf@EU-1-03-268_h_a_dec_12.pdf@2021-04-16 00:00:00@Cholestagel@colesevelam hydrochloride@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_7.pdf@EU-1-03-261_h_a_dec_7.pdf@2006-04-27 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_5.pdf@EU-1-03-265_h_a_dec_5.pdf@2006-07-28 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_2.pdf@EU-1-03-268_h_a_dec_2.pdf@2008-06-19 00:00:00@Cholestagel@colesevelam  hydrochloride@NAS before 2012@True@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_4.pdf@EU-1-03-256_h_a_dec_4.pdf@2005-04-25 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_22.pdf@EU-1-03-267_h_a_dec_22.pdf@2009-05-15 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_8.pdf@EU-1-03-261_h_a_dec_8.pdf@2007-12-01 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_6.pdf@EU-1-03-265_h_a_dec_6.pdf@2006-08-28 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_40.pdf@EU-1-03-256_h_a_dec_40.pdf@2012-07-23 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_3.pdf@EU-1-03-268_h_a_dec_3.pdf@2008-09-07 00:00:00@Cholestagel@colesevelam  hydrochloride@NAS before 2012@True@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_0.pdf@EU-1-03-269_h_a_dec_0.pdf@2004-10-03 00:00:00@Faslodex@Fulvestrant@NAS before 2012@NA before 2012@OD Not Found@AstraZeneca UK Limited@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_23.pdf@EU-1-03-267_h_a_dec_23.pdf@2009-08-06 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-261_h_a_dec_9.pdf@EU-1-03-261_h_a_dec_9.pdf@2007-03-27 00:00:00@Emtriva@Emtricitabine@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_4.pdf@EU-1-03-268_h_a_dec_4.pdf@2008-12-22 00:00:00@Cholestagel@colesevelam  hydrochloride@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_7.pdf@EU-1-03-265_h_a_dec_7.pdf@2007-04-25 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_41.pdf@EU-1-03-256_h_a_dec_41.pdf@2012-08-23 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_1.pdf@EU-1-03-269_h_a_dec_1.pdf@2005-05-07 00:00:00@Faslodex@Fulvestrant@NAS before 2012@NA before 2012@OD Not Found@AstraZeneca UK Limited@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_24.pdf@EU-1-03-267_h_a_dec_24.pdf@2009-07-07 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_5.pdf@EU-1-03-268_h_a_dec_5.pdf@2009-03-30 00:00:00@Cholestagel@colesevelam hydrochloride@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_8.pdf@EU-1-03-265_h_a_dec_8.pdf@2008-10-07 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_42.pdf@EU-1-03-256_h_a_dec_42.pdf@2012-10-23 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_10.pdf@EU-1-03-269_h_a_dec_10.pdf@2017-05-22 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-265_h_a_dec_9.pdf@EU-1-03-265_h_a_dec_9.pdf@2009-02-23 00:00:00@Bonviva@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_25.pdf@EU-1-03-267_h_a_dec_25.pdf@2009-11-20 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_6.pdf@EU-1-03-268_h_a_dec_6.pdf@2010-03-23 00:00:00@Cholestagel@colesevelam  hydrochloride@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_43.pdf@EU-1-03-256_h_a_dec_43.pdf@2012-10-24 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_26.pdf@EU-1-03-267_h_a_dec_26.pdf@2010-03-15 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_7.pdf@EU-1-03-268_h_a_dec_7.pdf@2011-10-08 00:00:00@Cholestagel@colesevelam hydrochloride@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_11.pdf@EU-1-03-269_h_a_dec_11.pdf@2017-07-25 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_44.pdf@EU-1-03-256_h_a_dec_44.pdf@2012-11-22 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd.@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_27.pdf@EU-1-03-267_h_a_dec_27.pdf@2010-05-07 00:00:00@Reyataz@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_8.pdf@EU-1-03-268_h_a_dec_8.pdf@2012-02-21 00:00:00@Cholestagel@colesevelam hydrochloride@False@False@OD Not Found@Genzyme Europe  B.V.@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_12.pdf@EU-1-03-269_h_a_dec_12.pdf@2017-10-11 00:00:00@Brand name Not Found@Active Substance Not Found@False@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_45.pdf@EU-1-03-256_h_a_dec_45.pdf@2013-02-25 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd.@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_28.pdf@EU-1-03-267_h_a_dec_28.pdf@2011-03-24 00:00:00@Reyataz@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-268_h_a_dec_9.pdf@EU-1-03-268_h_a_dec_9.pdf@2015-12-16 00:00:00@Cholestagel@colesevelam hydrochloride@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_0.pdf@EU-1-03-270_h_a_dec_0.pdf@2004-06-15 00:00:00@Oxybutynin Nicobrand@Oxybutynin@NAS before 2012@NA before 2012@OD Not Found@Nicobrand Limited@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_29.pdf@EU-1-03-267_h_a_dec_29.pdf@2011-08-24 00:00:00@Reyataz@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_1.pdf@EU-1-03-270_h_a_dec_1.pdf@2005-05-23 00:00:00@Kentera@Oxybutynin@NAS before 2012@NA before 2012@OD Not Found@Nicobrand Limited@CMA not available before 2006@Parsed
EU-1-03-269_h_a_dec_13.pdf@EU-1-03-269_h_a_dec_13.pdf@2018-03-21 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_46.pdf@EU-1-03-256_h_a_dec_46.pdf@2014-06-02 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_3.pdf@EU-1-03-267_h_a_dec_3.pdf@2005-02-21 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-03-270_h_a_dec_10.pdf@EU-1-03-270_h_a_dec_10.pdf@2019-11-14 00:00:00@Kentera@Oxybutynin@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_14.pdf@EU-1-03-269_h_a_dec_14.pdf@2019-01-08 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_47.pdf@EU-1-03-256_h_a_dec_47.pdf@2012-10-23 00:00:00@Humira@Adalimumab@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_30.pdf@EU-1-03-267_h_a_dec_30.pdf@2011-11-22 00:00:00@Reyataz@atazanavir sulphate@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_15.pdf@EU-1-03-269_h_a_dec_15.pdf@2020-10-27 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_11.pdf@EU-1-03-270_h_a_dec_11.pdf@2021-09-03 00:00:00@Kentera@Oxybutynin@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_0.pdf@EU-1-03-271_h_a_dec_0.pdf@2004-02-03 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_31.pdf@EU-1-03-267_h_a_dec_31.pdf@2012-06-28 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_2.pdf@EU-1-03-270_h_a_dec_2.pdf@2006-09-03 00:00:00@Kentera@Oxybutynin@NAS before 2012@NA before 2012@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_2.pdf@EU-1-03-269_h_a_dec_2.pdf@2006-10-20 00:00:00@Faslodex@Fulvestrant@NAS before 2012@NA before 2012@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_0.pdf@EU-1-04-273_h_a_dec_0.pdf@2004-04-28 00:00:00@Lysodren@Mitotane@NAS before 2012@NA before 2012@adopted@Laboratoire HRA Pharma@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_48.pdf@EU-1-03-256_h_a_dec_48.pdf@2014-01-09 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
 not available before 2006@Parsed
EU-1-03-267_h_a_dec_32.pdf@EU-1-03-267_h_a_dec_32.pdf@2012-08-23 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_0.pdf@EU-1-04-274_h_a_dec_0.pdf@2004-04-26 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@appointed@Millenium Pharmaceuticals, Ltd@CMA not available before 2006@Parsed
EU-1-03-270_h_a_dec_3.pdf@EU-1-03-270_h_a_dec_3.pdf@2009-04-30 00:00:00@Kentera@Oxybutynin@NAS before 2012@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_3.pdf@EU-1-03-269_h_a_dec_3.pdf@2008-12-16 00:00:00@Faslodex@Fulvestrant@NAS before 2012@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_1.pdf@EU-1-04-273_h_a_dec_1.pdf@2006-02-28 00:00:00@Lysodren@Mitotane@NAS before 2012@NA before 2012@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_10.pdf@EU-1-03-271_h_a_dec_10.pdf@2012-10-09 00:00:00@Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_4.pdf@EU-1-03-270_h_a_dec_4.pdf@2010-12-11 00:00:00@Kentera@Oxybutynin@NAS before 2012@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_1.pdf@EU-1-04-274_h_a_dec_1.pdf@2004-09-20 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Millennium Pharmaceuticals, Ltd@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_33.pdf@EU-1-03-267_h_a_dec_33.pdf@2013-06-21 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_10.pdf@EU-1-04-273_h_a_dec_10.pdf@2021-03-22 00:00:00@Lysodren@Mitotane@False@False@OD Not Found@HRA Pharma Rare Diseases@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_4.pdf@EU-1-03-269_h_a_dec_4.pdf@2010-03-15 00:00:00@Faslodex@Fulvestrant@NAS before 2012@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_49.pdf@EU-1-03-256_h_a_dec_49.pdf@2014-11-19 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_11.pdf@EU-1-03-271_h_a_dec_11.pdf@2013-12-20 00:00:00@Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_5.pdf@EU-1-03-270_h_a_dec_5.pdf@2011-08-24 00:00:00@Kentera@Oxybutynin@NAS before 2012@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_10.pdf@EU-1-04-274_h_a_dec_10.pdf@2008-10-01 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-04-273_h_a_dec_2.pdf@EU-1-04-273_h_a_dec_2.pdf@2007-04-26 00:00:00@Lysodren@Mitotane@NAS before 2012@NA before 2012@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_5.pdf@EU-1-03-269_h_a_dec_5.pdf@2010-10-25 00:00:00@Faslodex@Fulvestrant@NAS before 2012@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_5.pdf@EU-1-03-256_h_a_dec_5.pdf@2005-01-08 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_34.pdf@EU-1-03-267_h_a_dec_34.pdf@2013-11-25 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_6.pdf@EU-1-03-270_h_a_dec_6.pdf@2011-12-19 00:00:00@Kentera@Oxybutynin@NAS before 2012@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_12.pdf@EU-1-03-271_h_a_dec_12.pdf@2015-01-15 00:00:00@Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_11.pdf@EU-1-04-274_h_a_dec_11.pdf@2008-04-21 00:00:00@Velcade@bortezomib@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_3.pdf@EU-1-04-273_h_a_dec_3.pdf@2009-03-25 00:00:00@Lysodren@Mitotane@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_6.pdf@EU-1-03-269_h_a_dec_6.pdf@2011-07-27 00:00:00@Faslodex@Fulvestrant@NAS before 2012@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_50.pdf@EU-1-03-256_h_a_dec_50.pdf@2015-03-26 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_13.pdf@EU-1-03-271_h_a_dec_13.pdf@2016-06-24 00:00:00@Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_35.pdf@EU-1-03-267_h_a_dec_35.pdf@2015-02-19 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_7.pdf@EU-1-03-269_h_a_dec_7.pdf@2012-02-17 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca UK  Limited@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_7.pdf@EU-1-03-270_h_a_dec_7.pdf@2015-12-16 00:00:00@Kentera@Oxybutynin@False@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_4.pdf@EU-1-04-273_h_a_dec_4.pdf@2011-03-10 00:00:00@Lysodren@Mitotane@NAS before 2012@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_12.pdf@EU-1-04-274_h_a_dec_12.pdf@2008-07-29 00:00:00@Velcade@bortezomib@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_14.pdf@EU-1-03-271_h_a_dec_14.pdf@2017-11-24 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 24.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2004)718 for “Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_5.pdf@EU-1-04-273_h_a_dec_5.pdf@2012-08-23 00:00:00@Lysodren@Mitotane@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_13.pdf@EU-1-04-274_h_a_dec_13.pdf@2008-08-29 00:00:00@Velcade@bortezomib@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_51.pdf@EU-1-03-256_h_a_dec_51.pdf@2015-07-28 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_36.pdf@EU-1-03-267_h_a_dec_36.pdf@2015-10-28 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_8.pdf@EU-1-03-269_h_a_dec_8.pdf@2013-12-18 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_8.pdf@EU-1-03-270_h_a_dec_8.pdf@2016-12-16 00:00:00@Kentera@Oxybutynin@False@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_15.pdf@EU-1-03-271_h_a_dec_15.pdf@2019-06-06 00:00:00@Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_14.pdf@EU-1-04-274_h_a_dec_14.pdf@2008-04-11 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-04-273_h_a_dec_6.pdf@EU-1-04-273_h_a_dec_6.pdf@2014-03-06 00:00:00@Lysodren@Mitotane@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_16.pdf@EU-1-03-271_h_a_dec_16.pdf@2020-01-04 00:00:00@Advate@octocog alfa@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-03-269_h_a_dec_9.pdf@EU-1-03-269_h_a_dec_9.pdf@2016-02-03 00:00:00@Faslodex@Fulvestrant@False@False@OD Not Found@AstraZeneca UK Limited@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_15.pdf@EU-1-04-274_h_a_dec_15.pdf@2009-03-31 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_37.pdf@EU-1-03-267_h_a_dec_37.pdf@2016-06-21 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_52.pdf@EU-1-03-256_h_a_dec_52.pdf@2015-11-19 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-270_h_a_dec_9.pdf@EU-1-03-270_h_a_dec_9.pdf@2018-11-22 00:00:00@Kentera@Oxybutynin@False@False@OD Not Found@Nicobrand Limited@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_7.pdf@EU-1-04-273_h_a_dec_7.pdf@2015-02-26 00:00:00@Lysodren@Mitotane@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_17.pdf@EU-1-03-271_h_a_dec_17.pdf@2022-02-24 00:00:00@ADVATE@octocog alfa@False@False@OD Not Found@Takeda Manufacturing Austria AG@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_16.pdf@EU-1-04-274_h_a_dec_16.pdf@2009-05-29 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_8.pdf@EU-1-04-273_h_a_dec_8.pdf@2017-05-16 00:00:00@Lysodren@Mitotane@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_38.pdf@EU-1-03-267_h_a_dec_38.pdf@2017-11-12 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_2.pdf@EU-1-03-271_h_a_dec_2.pdf@2005-11-15 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_53.pdf@EU-1-03-256_h_a_dec_53.pdf@2016-04-04 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_17.pdf@EU-1-04-274_h_a_dec_17.pdf@2009-10-28 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-273_h_a_dec_9.pdf@EU-1-04-273_h_a_dec_9.pdf@2019-09-19 00:00:00@Lysodren@Mitotane@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_3.pdf@EU-1-03-271_h_a_dec_3.pdf@2007-01-17 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-275_h_a_dec_0.pdf@EU-1-04-275_h_a_dec_0.pdf@2004-04-14 00:00:00@Litak@Cladribine@NAS before 2012@NA before 2012@adopted@Lipomed GmbH@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_18.pdf@EU-1-04-274_h_a_dec_18.pdf@2009-11-30 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-03-267_h_a_dec_39.pdf@EU-1-03-267_h_a_dec_39.pdf@2019-01-31 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_54.pdf@EU-1-03-256_h_a_dec_54.pdf@2016-11-05 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_4.pdf@EU-1-03-271_h_a_dec_4.pdf@2007-07-24 00:00:00@Advate@octocog alpha@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-275_h_a_dec_1.pdf@EU-1-04-275_h_a_dec_1.pdf@2006-08-03 00:00:00@Litak@Cladribine@NAS before 2012@NA before 2012@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_19.pdf@EU-1-04-274_h_a_dec_19.pdf@2010-04-27 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_4.pdf@EU-1-03-267_h_a_dec_4.pdf@2005-08-24 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_0.pdf@EU-1-04-276_h_a_dec_0.pdf@2004-04-06 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-275_h_a_dec_2.pdf@EU-1-04-275_h_a_dec_2.pdf@2009-03-27 00:00:00@Litak@Cladribine@NAS before 2012@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_5.pdf@EU-1-03-271_h_a_dec_5.pdf@2008-05-22 00:00:00@Advate@octocog alpha@NAS before 2012@True@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_0.pdf@EU-1-04-277_h_a_dec_0.pdf@2004-08-06 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_55.pdf@EU-1-03-256_h_a_dec_55.pdf@2016-06-24 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_2.pdf@EU-1-04-274_h_a_dec_2.pdf@2005-04-20 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-04-275_h_a_dec_3.pdf@EU-1-04-275_h_a_dec_3.pdf@2009-12-18 00:00:00@Litak@Cladribine@NAS before 2012@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_40.pdf@EU-1-03-267_h_a_dec_40.pdf@2019-03-13 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_1.pdf@EU-1-04-276_h_a_dec_1.pdf@2005-03-30 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-277_h_a_dec_1.pdf@EU-1-04-277_h_a_dec_1.pdf@2005-10-06 00:00:00@TachoSil@Human Fibrinogen / Human  Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA not available before 2006@Parsed
EU-1-03-271_h_a_dec_6.pdf@EU-1-03-271_h_a_dec_6.pdf@2009-02-26 00:00:00@Advate@octocog alpha@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_20.pdf@EU-1-04-274_h_a_dec_20.pdf@2010-02-06 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-04-275_h_a_dec_4.pdf@EU-1-04-275_h_a_dec_4.pdf@2018-07-03 00:00:00@Litak@Cladribine@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_56.pdf@EU-1-03-256_h_a_dec_56.pdf@2016-12-12 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_10.pdf@EU-1-04-277_h_a_dec_10.pdf@2015-09-18 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_10.pdf@EU-1-04-276_h_a_dec_10.pdf@2006-11-28 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_7.pdf@EU-1-03-271_h_a_dec_7.pdf@2009-05-29 00:00:00@Advate@octocog alfa@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_21.pdf@EU-1-04-274_h_a_dec_21.pdf@2010-02-07 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_41.pdf@EU-1-03-267_h_a_dec_41.pdf@2020-08-28 00:00:00@Reyataz@atazanavir sulphate@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_11.pdf@EU-1-04-277_h_a_dec_11.pdf@2016-03-30 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_22.pdf@EU-1-04-274_h_a_dec_22.pdf@2010-12-13 00:00:00@VELCADE@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-04-276_h_a_dec_11.pdf@EU-1-04-276_h_a_dec_11.pdf@2007-05-06 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_5.pdf@EU-1-03-267_h_a_dec_5.pdf@2005-09-16 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-04-277_h_a_dec_12.pdf@EU-1-04-277_h_a_dec_12.pdf@2017-09-26 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-03-271_h_a_dec_9.pdf@EU-1-03-271_h_a_dec_9.pdf@2011-12-19 00:00:00@Advate@octocog alfa@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_57.pdf@EU-1-03-256_h_a_dec_57.pdf@2017-03-24 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_23.pdf@EU-1-04-274_h_a_dec_23.pdf@2011-06-29 00:00:00@Velcade@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@exceptional@Parsed
EU-1-04-277_h_a_dec_13.pdf@EU-1-04-277_h_a_dec_13.pdf@2019-05-20 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_12.pdf@EU-1-04-276_h_a_dec_12.pdf@2007-10-29 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_0.pdf@EU-1-04-278_h_a_dec_0.pdf@2004-01-06 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-03-267_h_a_dec_6.pdf@EU-1-03-267_h_a_dec_6.pdf@2005-11-17 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_24.pdf@EU-1-04-274_h_a_dec_24.pdf@2011-08-24 00:00:00@VELCADE@bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@exceptional@Parsed
EU-1-04-277_h_a_dec_14.pdf@EU-1-04-277_h_a_dec_14.pdf@2020-11-16 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_13.pdf@EU-1-04-276_h_a_dec_13.pdf@2008-02-29 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_7.pdf@EU-1-03-267_h_a_dec_7.pdf@2006-01-25 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_58.pdf@EU-1-03-256_h_a_dec_58.pdf@2017-05-09 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_1.pdf@EU-1-04-278_h_a_dec_1.pdf@2005-03-29 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_25.pdf@EU-1-04-274_h_a_dec_25.pdf@2011-11-24 00:00:00@VELCADE@Bortezomib@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_15.pdf@EU-1-04-277_h_a_dec_15.pdf@2021-09-15 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_14.pdf@EU-1-04-276_h_a_dec_14.pdf@2008-03-31 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_8.pdf@EU-1-03-267_h_a_dec_8.pdf@2006-06-07 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_10.pdf@EU-1-04-278_h_a_dec_10.pdf@2009-07-01 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_26.pdf@EU-1-04-274_h_a_dec_26.pdf@2012-03-19 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag  International NV@exceptional@Parsed
EU-1-04-277_h_a_dec_2.pdf@EU-1-04-277_h_a_dec_2.pdf@2006-02-28 00:00:00@TachoSil@Human Fibrinogen / Human  Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_15.pdf@EU-1-04-276_h_a_dec_15.pdf@2008-06-20 00:00:00@Abilify@aripiprazole@NAS before 2012@True@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_59.pdf@EU-1-03-256_h_a_dec_59.pdf@2017-10-11 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-03-267_h_a_dec_9.pdf@EU-1-03-267_h_a_dec_9.pdf@2006-07-28 00:00:00@REYATAZ@atazanavir sulphate@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@exceptional@Parsed
EU-1-04-278_h_a_dec_11.pdf@EU-1-04-278_h_a_dec_11.pdf@2009-04-16 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_27.pdf@EU-1-04-274_h_a_dec_27.pdf@2012-03-21 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_3.pdf@EU-1-04-277_h_a_dec_3.pdf@2007-03-08 00:00:00@TachoSil@Human Fibrinogen / Human  Thrombin@NAS before 2012@NA before 2012@OD Not Found@Nycomed Austria GMBH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_16.pdf@EU-1-04-276_h_a_dec_16.pdf@2008-08-25 00:00:00@Abilify@aripiprazole@NAS before 2012@True@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_6.pdf@EU-1-03-256_h_a_dec_6.pdf@2006-01-20 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_12.pdf@EU-1-04-278_h_a_dec_12.pdf@2010-03-30 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_28.pdf@EU-1-04-274_h_a_dec_28.pdf@2012-05-25 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_4.pdf@EU-1-04-277_h_a_dec_4.pdf@2008-04-04 00:00:00@TachoSil@Human Fibrinogen / Human  Thrombin@NAS before 2012@True@OD Not Found@Nycomed Austria GmbH@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_17.pdf@EU-1-04-276_h_a_dec_17.pdf@2009-02-24 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_13.pdf@EU-1-04-278_h_a_dec_13.pdf@2010-09-23 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_5.pdf@EU-1-04-277_h_a_dec_5.pdf@2009-10-02 00:00:00@TachoSil@Human Fibrinogen / Human  Thrombin@NAS before 2012@False@OD Not Found@Nycomed Austria GmbH@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_29.pdf@EU-1-04-274_h_a_dec_29.pdf@2012-09-20 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_18.pdf@EU-1-04-276_h_a_dec_18.pdf@2009-04-21 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_60.pdf@EU-1-03-256_h_a_dec_60.pdf@2017-08-12 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_3.pdf@EU-1-04-274_h_a_dec_3.pdf@2005-07-27 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-04-277_h_a_dec_6.pdf@EU-1-04-277_h_a_dec_6.pdf@2009-04-30 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@NAS before 2012@False@OD Not Found@Nycomed Austria GmbH@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_14.pdf@EU-1-04-278_h_a_dec_14.pdf@2011-02-21 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_19.pdf@EU-1-04-276_h_a_dec_19.pdf@2009-08-06 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_7.pdf@EU-1-04-277_h_a_dec_7.pdf@2010-01-07 00:00:00@TachoSil@Human Fibrinogen / Human  Thrombin@NAS before 2012@False@OD Not Found@Nycomed Austria GmbH@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_30.pdf@EU-1-04-274_h_a_dec_30.pdf@2012-09-20 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_15.pdf@EU-1-04-278_h_a_dec_15.pdf@2011-03-28 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_61.pdf@EU-1-03-256_h_a_dec_61.pdf@2018-03-15 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_8.pdf@EU-1-04-277_h_a_dec_8.pdf@2012-12-18 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Nycomed Austria GmbH@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_31.pdf@EU-1-04-274_h_a_dec_31.pdf@2013-07-31 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_2.pdf@EU-1-04-276_h_a_dec_2.pdf@2005-06-20 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-03-256_h_a_dec_62.pdf@EU-1-03-256_h_a_dec_62.pdf@2018-04-23 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_17.pdf@EU-1-04-278_h_a_dec_17.pdf@2011-10-24 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_63.pdf@EU-1-03-256_h_a_dec_63.pdf@2019-04-29 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_20.pdf@EU-1-04-276_h_a_dec_20.pdf@2009-07-07 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-277_h_a_dec_9.pdf@EU-1-04-277_h_a_dec_9.pdf@2014-03-21 00:00:00@TachoSil@Human Fibrinogen / Human Thrombin@False@False@OD Not Found@Takeda Austria GmbH@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_32.pdf@EU-1-04-274_h_a_dec_32.pdf@2013-12-18 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_18.pdf@EU-1-04-278_h_a_dec_18.pdf@2011-11-22 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_64.pdf@EU-1-03-256_h_a_dec_64.pdf@2020-04-28 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_21.pdf@EU-1-04-276_h_a_dec_21.pdf@2009-08-21 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_19.pdf@EU-1-04-278_h_a_dec_19.pdf@2011-12-19 00:00:00@Levemir@insulin detemir@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_33.pdf@EU-1-04-274_h_a_dec_33.pdf@2014-10-01 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_65.pdf@EU-1-03-256_h_a_dec_65.pdf@2020-11-20 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_22.pdf@EU-1-04-276_h_a_dec_22.pdf@2009-05-11 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_2.pdf@EU-1-04-278_h_a_dec_2.pdf@2005-04-07 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_34.pdf@EU-1-04-274_h_a_dec_34.pdf@2015-01-30 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_66.pdf@EU-1-03-256_h_a_dec_66.pdf@2021-12-16 00:00:00@Humira@Adalimumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_23.pdf@EU-1-04-276_h_a_dec_23.pdf@2010-03-23 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_0.pdf@EU-1-04-279_h_a_dec_0.pdf@2004-06-07 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_35.pdf@EU-1-04-274_h_a_dec_35.pdf@2016-01-14 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_7.pdf@EU-1-03-256_h_a_dec_7.pdf@2006-01-06 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_20.pdf@EU-1-04-278_h_a_dec_20.pdf@2014-01-29 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_24.pdf@EU-1-04-276_h_a_dec_24.pdf@2009-05-11 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_1.pdf@EU-1-04-279_h_a_dec_1.pdf@2005-10-05 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-274_h_a_dec_36.pdf@EU-1-04-274_h_a_dec_36.pdf@2016-01-25 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_21.pdf@EU-1-04-278_h_a_dec_21.pdf@2015-05-27 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_8.pdf@EU-1-03-256_h_a_dec_8.pdf@2006-07-11 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_0.pdf@EU-1-04-280_h_a_dec_0.pdf@2004-11-08 00:00:00@YENTREVE@Duloxetine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_25.pdf@EU-1-04-276_h_a_dec_25.pdf@2010-06-08 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_37.pdf@EU-1-04-274_h_a_dec_37.pdf@2018-08-02 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_10.pdf@EU-1-04-279_h_a_dec_10.pdf@2007-06-29 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_22.pdf@EU-1-04-278_h_a_dec_22.pdf@2015-07-28 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-03-256_h_a_dec_9.pdf@EU-1-03-256_h_a_dec_9.pdf@2007-05-03 00:00:00@Humira@Adalimumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd.@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_1.pdf@EU-1-04-280_h_a_dec_1.pdf@2004-11-08 00:00:00@YENTREVE@Duloxetine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_26.pdf@EU-1-04-276_h_a_dec_26.pdf@2010-05-11 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_38.pdf@EU-1-04-274_h_a_dec_38.pdf@2019-02-20 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_23.pdf@EU-1-04-278_h_a_dec_23.pdf@2016-12-16 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_11.pdf@EU-1-04-279_h_a_dec_11.pdf@2007-12-18 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_10.pdf@EU-1-04-280_h_a_dec_10.pdf@2009-06-24 00:00:00@YENTREVE@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_27.pdf@EU-1-04-276_h_a_dec_27.pdf@2011-01-21 00:00:00@Abilify@aripiprazole@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical  Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_24.pdf@EU-1-04-278_h_a_dec_24.pdf@2017-11-16 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_39.pdf@EU-1-04-274_h_a_dec_39.pdf@2021-02-18 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_12.pdf@EU-1-04-279_h_a_dec_12.pdf@2008-02-29 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_11.pdf@EU-1-04-280_h_a_dec_11.pdf@2009-07-07 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_28.pdf@EU-1-04-276_h_a_dec_28.pdf@2012-10-05 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_25.pdf@EU-1-04-278_h_a_dec_25.pdf@2019-03-25 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_4.pdf@EU-1-04-274_h_a_dec_4.pdf@2005-10-19 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_13.pdf@EU-1-04-279_h_a_dec_13.pdf@2008-03-27 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_12.pdf@EU-1-04-280_h_a_dec_12.pdf@2010-08-31 00:00:00@Yentreve@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_29.pdf@EU-1-04-276_h_a_dec_29.pdf@2012-11-19 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical  Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_26.pdf@EU-1-04-278_h_a_dec_26.pdf@2021-09-23 00:00:00@Levemir@insulin detemir@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_14.pdf@EU-1-04-279_h_a_dec_14.pdf@2008-12-22 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_13.pdf@EU-1-04-280_h_a_dec_13.pdf@2011-01-21 00:00:00@Yentreve@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_3.pdf@EU-1-04-276_h_a_dec_3.pdf@2005-10-28 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-278_h_a_dec_3.pdf@EU-1-04-278_h_a_dec_3.pdf@2006-06-07 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_14.pdf@EU-1-04-280_h_a_dec_14.pdf@2011-07-27 00:00:00@Yentreve@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_15.pdf@EU-1-04-279_h_a_dec_15.pdf@2009-02-13 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_41.pdf@EU-1-04-274_h_a_dec_41.pdf@2022-07-06 00:00:00@VELCADE@bortezomib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_30.pdf@EU-1-04-276_h_a_dec_30.pdf@2013-01-24 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_4.pdf@EU-1-04-278_h_a_dec_4.pdf@2007-02-27 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_15.pdf@EU-1-04-280_h_a_dec_15.pdf@2013-01-07 00:00:00@Yentreve@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_16.pdf@EU-1-04-279_h_a_dec_16.pdf@2009-05-29 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_5.pdf@EU-1-04-274_h_a_dec_5.pdf@2006-01-19 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-04-276_h_a_dec_31.pdf@EU-1-04-276_h_a_dec_31.pdf@2013-06-13 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_5.pdf@EU-1-04-278_h_a_dec_5.pdf@2007-08-06 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_6.pdf@EU-1-04-274_h_a_dec_6.pdf@2006-07-28 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_17.pdf@EU-1-04-279_h_a_dec_17.pdf@2009-07-08 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_16.pdf@EU-1-04-280_h_a_dec_16.pdf@2014-08-10 00:00:00@Yentreve@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_6.pdf@EU-1-04-278_h_a_dec_6.pdf@2007-06-21 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_7.pdf@EU-1-04-274_h_a_dec_7.pdf@2007-03-01 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-04-276_h_a_dec_32.pdf@EU-1-04-276_h_a_dec_32.pdf@2014-10-04 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_18.pdf@EU-1-04-279_h_a_dec_18.pdf@2009-08-20 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_17.pdf@EU-1-04-280_h_a_dec_17.pdf@2015-05-27 00:00:00@Yentreve@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_7.pdf@EU-1-04-278_h_a_dec_7.pdf@2007-10-15 00:00:00@Levemir@insulin detemir@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_8.pdf@EU-1-04-274_h_a_dec_8.pdf@2007-07-30 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_19.pdf@EU-1-04-279_h_a_dec_19.pdf@2009-09-14 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_18.pdf@EU-1-04-280_h_a_dec_18.pdf@2016-06-30 00:00:00@Yentreve@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_33.pdf@EU-1-04-276_h_a_dec_33.pdf@2015-02-19 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_8.pdf@EU-1-04-278_h_a_dec_8.pdf@2008-04-18 00:00:00@Levemir@insulin detemir@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-274_h_a_dec_9.pdf@EU-1-04-274_h_a_dec_9.pdf@2007-12-14 00:00:00@Velcade@bortezomib@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_2.pdf@EU-1-04-279_h_a_dec_2.pdf@2005-08-07 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_20.pdf@EU-1-04-279_h_a_dec_20.pdf@2009-12-21 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_19.pdf@EU-1-04-280_h_a_dec_19.pdf@2019-12-18 00:00:00@Yentreve@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-278_h_a_dec_9.pdf@EU-1-04-278_h_a_dec_9.pdf@2008-04-18 00:00:00@Levemir@insulin detemir@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_34.pdf@EU-1-04-276_h_a_dec_34.pdf@2015-04-24 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_22.pdf@EU-1-04-279_h_a_dec_22.pdf@2010-08-06 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_2.pdf@EU-1-04-280_h_a_dec_2.pdf@2005-09-19 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_35.pdf@EU-1-04-276_h_a_dec_35.pdf@2016-04-21 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_23.pdf@EU-1-04-279_h_a_dec_23.pdf@2010-06-14 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_20.pdf@EU-1-04-280_h_a_dec_20.pdf@2021-06-17 00:00:00@Yentreve@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_24.pdf@EU-1-04-279_h_a_dec_24.pdf@2010-08-26 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_3.pdf@EU-1-04-280_h_a_dec_3.pdf@2005-11-17 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_0.pdf@EU-1-04-281_h_a_dec_0.pdf@2004-06-29 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA not available before 2006@Parsed
EU-1-04-276_h_a_dec_36.pdf@EU-1-04-276_h_a_dec_36.pdf@2017-03-08 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_25.pdf@EU-1-04-279_h_a_dec_25.pdf@2011-06-17 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_1.pdf@EU-1-04-281_h_a_dec_1.pdf@2005-09-13 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA not available before 2006@Parsed
EU-1-04-280_h_a_dec_4.pdf@EU-1-04-280_h_a_dec_4.pdf@2006-03-29 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_26.pdf@EU-1-04-279_h_a_dec_26.pdf@2011-10-24 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_10.pdf@EU-1-04-281_h_a_dec_10.pdf@2010-02-06 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_5.pdf@EU-1-04-280_h_a_dec_5.pdf@2006-05-31 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_37.pdf@EU-1-04-276_h_a_dec_37.pdf@2018-08-23 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_27.pdf@EU-1-04-279_h_a_dec_27.pdf@2011-11-22 00:00:00@Lyrica@pregabalin@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_11.pdf@EU-1-04-281_h_a_dec_11.pdf@2010-07-28 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_6.pdf@EU-1-04-280_h_a_dec_6.pdf@2006-11-28 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_38.pdf@EU-1-04-276_h_a_dec_38.pdf@2019-04-29 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_12.pdf@EU-1-04-281_h_a_dec_12.pdf@2010-05-11 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_28.pdf@EU-1-04-279_h_a_dec_28.pdf@2014-02-13 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_7.pdf@EU-1-04-280_h_a_dec_7.pdf@2007-08-28 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_39.pdf@EU-1-04-276_h_a_dec_39.pdf@2020-04-28 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_13.pdf@EU-1-04-281_h_a_dec_13.pdf@2011-04-18 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_8.pdf@EU-1-04-280_h_a_dec_8.pdf@2008-04-23 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_4.pdf@EU-1-04-276_h_a_dec_4.pdf@2005-07-11 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_29.pdf@EU-1-04-279_h_a_dec_29.pdf@2015-01-22 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_14.pdf@EU-1-04-281_h_a_dec_14.pdf@2011-06-23 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-280_h_a_dec_9.pdf@EU-1-04-280_h_a_dec_9.pdf@2009-03-04 00:00:00@YENTREVE@duloxetine  hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_40.pdf@EU-1-04-276_h_a_dec_40.pdf@2021-09-29 00:00:00@Abilify@aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_0.pdf@EU-1-04-282_h_a_dec_0.pdf@2004-12-07 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-284_h_a_dec_0.pdf@EU-1-04-284_h_a_dec_0.pdf@2004-07-29 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@adopted@Orphan Europe@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_3.pdf@EU-1-04-279_h_a_dec_3.pdf@2005-11-17 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_15.pdf@EU-1-04-281_h_a_dec_15.pdf@2011-10-24 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_5.pdf@EU-1-04-276_h_a_dec_5.pdf@2006-04-27 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_1.pdf@EU-1-04-282_h_a_dec_1.pdf@2004-12-17 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-284_h_a_dec_1.pdf@EU-1-04-284_h_a_dec_1.pdf@2005-08-26 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_16.pdf@EU-1-04-281_h_a_dec_16.pdf@2012-01-13 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_30.pdf@EU-1-04-279_h_a_dec_30.pdf@2015-12-16 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_6.pdf@EU-1-04-276_h_a_dec_6.pdf@2006-05-31 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_10.pdf@EU-1-04-282_h_a_dec_10.pdf@2007-02-07 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_10.pdf@EU-1-04-284_h_a_dec_10.pdf@2020-04-23 00:00:00@Pedea@Ibuprofen@False@False@OD Not Found@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_17.pdf@EU-1-04-281_h_a_dec_17.pdf@2012-06-02 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_7.pdf@EU-1-04-276_h_a_dec_7.pdf@2006-07-09 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_18.pdf@EU-1-04-281_h_a_dec_18.pdf@2012-08-30 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_11.pdf@EU-1-04-282_h_a_dec_11.pdf@2007-07-24 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_2.pdf@EU-1-04-284_h_a_dec_2.pdf@2005-08-26 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_31.pdf@EU-1-04-279_h_a_dec_31.pdf@2016-09-11 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_8.pdf@EU-1-04-276_h_a_dec_8.pdf@2006-04-10 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_12.pdf@EU-1-04-282_h_a_dec_12.pdf@2007-09-13 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_3.pdf@EU-1-04-284_h_a_dec_3.pdf@2006-03-29 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_19.pdf@EU-1-04-281_h_a_dec_19.pdf@2013-12-18 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-276_h_a_dec_9.pdf@EU-1-04-276_h_a_dec_9.pdf@2006-04-10 00:00:00@Abilify@aripiprazole@NAS before 2012@NA before 2012@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_0.pdf@EU-1-04-285_h_a_dec_0.pdf@2004-09-27 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_32.pdf@EU-1-04-279_h_a_dec_32.pdf@2018-02-19 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_13.pdf@EU-1-04-282_h_a_dec_13.pdf@2007-10-23 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_4.pdf@EU-1-04-284_h_a_dec_4.pdf@2006-11-24 00:00:00@Pedea@Ibuprofen@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_2.pdf@EU-1-04-281_h_a_dec_2.pdf@2006-03-29 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_14.pdf@EU-1-04-282_h_a_dec_14.pdf@2007-11-21 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_5.pdf@EU-1-04-284_h_a_dec_5.pdf@2008-09-07 00:00:00@Pedea@Ibuprofen@NAS before 2012@True@OD Not Found@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_1.pdf@EU-1-04-285_h_a_dec_1.pdf@2005-05-13 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-04-281_h_a_dec_20.pdf@EU-1-04-281_h_a_dec_20.pdf@2014-05-12 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_33.pdf@EU-1-04-279_h_a_dec_33.pdf@2018-07-30 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_15.pdf@EU-1-04-282_h_a_dec_15.pdf@2008-01-18 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_6.pdf@EU-1-04-284_h_a_dec_6.pdf@2009-07-24 00:00:00@Pedea@Ibuprofen@NAS before 2012@False@OD Not Found@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_10.pdf@EU-1-04-285_h_a_dec_10.pdf@2010-06-09 00:00:00@Apidra@Insulin glulisine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_21.pdf@EU-1-04-281_h_a_dec_21.pdf@2019-05-22 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_34.pdf@EU-1-04-279_h_a_dec_34.pdf@2020-02-21 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_16.pdf@EU-1-04-282_h_a_dec_16.pdf@2008-02-28 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_11.pdf@EU-1-04-285_h_a_dec_11.pdf@2011-01-24 00:00:00@Apidra@Insulin glulisine@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_22.pdf@EU-1-04-281_h_a_dec_22.pdf@2020-06-25 00:00:00@Erbitux@cetuximab@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_7.pdf@EU-1-04-284_h_a_dec_7.pdf@2014-10-03 00:00:00@Pedea@Ibuprofen@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
 Found@Parsed
EU-1-04-279_h_a_dec_35.pdf@EU-1-04-279_h_a_dec_35.pdf@2020-02-06 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_12.pdf@EU-1-04-285_h_a_dec_12.pdf@2011-05-09 00:00:00@Apidra@Insulin glulisine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_3.pdf@EU-1-04-281_h_a_dec_3.pdf@2007-02-20 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_8.pdf@EU-1-04-284_h_a_dec_8.pdf@2018-05-02 00:00:00@Pedea@Ibuprofen@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_18.pdf@EU-1-04-282_h_a_dec_18.pdf@2008-07-07 00:00:00@Telzir@Fosamprenavir@NAS before 2012@True@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_36.pdf@EU-1-04-279_h_a_dec_36.pdf@2020-11-20 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_13.pdf@EU-1-04-285_h_a_dec_13.pdf@2012-04-20 00:00:00@Apidra@Insulin glulisine@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_4.pdf@EU-1-04-281_h_a_dec_4.pdf@2007-02-27 00:00:00@Erbitux@cetuximab@NAS before 2012@NA before 2012@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-284_h_a_dec_9.pdf@EU-1-04-284_h_a_dec_9.pdf@2018-05-22 00:00:00@Pedea@Ibuprofen@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_19.pdf@EU-1-04-282_h_a_dec_19.pdf@2008-07-29 00:00:00@Telzir@Fosamprenavir@NAS before 2012@True@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_14.pdf@EU-1-04-285_h_a_dec_14.pdf@2012-11-19 00:00:00@Apidra@Insulin glulisine@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_37.pdf@EU-1-04-279_h_a_dec_37.pdf@2021-12-11 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_5.pdf@EU-1-04-281_h_a_dec_5.pdf@2008-02-28 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_2.pdf@EU-1-04-282_h_a_dec_2.pdf@2005-08-24 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_38.pdf@EU-1-04-279_h_a_dec_38.pdf@2022-09-21 00:00:00@Lyrica@pregabalin@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_15.pdf@EU-1-04-285_h_a_dec_15.pdf@2014-01-10 00:00:00@Apidra@Insulin glulisine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_6.pdf@EU-1-04-281_h_a_dec_6.pdf@2008-07-17 00:00:00@Erbitux@cetuximab@NAS before 2012@True@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_20.pdf@EU-1-04-282_h_a_dec_20.pdf@2008-10-21 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-286_h_a_dec_0.pdf@EU-1-04-286_h_a_dec_0.pdf@2004-10-13 00:00:00@Wilzin@Zinc acetate dihydrate@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_4.pdf@EU-1-04-279_h_a_dec_4.pdf@2006-03-20 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_16.pdf@EU-1-04-285_h_a_dec_16.pdf@2017-03-08 00:00:00@Apidra@Insulin glulisine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_7.pdf@EU-1-04-281_h_a_dec_7.pdf@2008-11-24 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_21.pdf@EU-1-04-282_h_a_dec_21.pdf@2008-12-22 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-286_h_a_dec_1.pdf@EU-1-04-286_h_a_dec_1.pdf@2008-04-22 00:00:00@Wilzin@Zinc acetate dihydrate@NAS before 2012@True@OD Not Found@Orphan Europe S.a.r.l.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_5.pdf@EU-1-04-279_h_a_dec_5.pdf@2006-05-15 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_17.pdf@EU-1-04-285_h_a_dec_17.pdf@2019-11-04 00:00:00@Apidra@Insulin glulisine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_8.pdf@EU-1-04-281_h_a_dec_8.pdf@2009-06-17 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_22.pdf@EU-1-04-282_h_a_dec_22.pdf@2009-02-26 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_18.pdf@EU-1-04-285_h_a_dec_18.pdf@2021-08-20 00:00:00@Apidra@Insulin glulisine@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_6.pdf@EU-1-04-279_h_a_dec_6.pdf@2006-04-07 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-04-281_h_a_dec_9.pdf@EU-1-04-281_h_a_dec_9.pdf@2010-01-20 00:00:00@Erbitux@cetuximab@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-04-286_h_a_dec_3.pdf@EU-1-04-286_h_a_dec_3.pdf@2014-01-29 00:00:00@Wilzin@Zinc acetate dihydrate@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_23.pdf@EU-1-04-282_h_a_dec_23.pdf@2009-03-25 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_2.pdf@EU-1-04-285_h_a_dec_2.pdf@2005-04-07 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-04-279_h_a_dec_7.pdf@EU-1-04-279_h_a_dec_7.pdf@2006-07-09 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-04-286_h_a_dec_4.pdf@EU-1-04-286_h_a_dec_4.pdf@2016-05-17 00:00:00@Wilzin@Zinc  acetate dihydrate@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_24.pdf@EU-1-04-282_h_a_dec_24.pdf@2009-05-15 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_8.pdf@EU-1-04-279_h_a_dec_8.pdf@2006-10-30 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_3.pdf@EU-1-04-285_h_a_dec_3.pdf@2006-05-05 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-286_h_a_dec_5.pdf@EU-1-04-286_h_a_dec_5.pdf@2018-02-19 00:00:00@Wilzin@Zinc  acetate dihydrate@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_25.pdf@EU-1-04-282_h_a_dec_25.pdf@2009-11-23 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-279_h_a_dec_9.pdf@EU-1-04-279_h_a_dec_9.pdf@2007-01-17 00:00:00@Lyrica@pregabalin@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_4.pdf@EU-1-04-285_h_a_dec_4.pdf@2006-01-09 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-286_h_a_dec_6.pdf@EU-1-04-286_h_a_dec_6.pdf@2020-04-05 00:00:00@Wilzin@Zinc  acetate dihydrate@False@False@OD Not Found@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_26.pdf@EU-1-04-282_h_a_dec_26.pdf@2010-01-20 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_5.pdf@EU-1-04-285_h_a_dec_5.pdf@2006-10-24 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_27.pdf@EU-1-04-282_h_a_dec_27.pdf@2010-05-26 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_6.pdf@EU-1-04-285_h_a_dec_6.pdf@2007-02-07 00:00:00@Apidra@Insulin glulisine@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_28.pdf@EU-1-04-282_h_a_dec_28.pdf@2010-08-26 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_0.pdf@EU-1-04-290_h_a_dec_0.pdf@2004-09-20 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-04-285_h_a_dec_7.pdf@EU-1-04-285_h_a_dec_7.pdf@2008-06-20 00:00:00@Apidra@Insulin glulisine@NAS before 2012@True@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_0.pdf@EU-1-04-292_h_a_dec_0.pdf@2004-10-22 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-04-282_h_a_dec_29.pdf@EU-1-04-282_h_a_dec_29.pdf@2011-04-18 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@ViiV Healthcare UK  Ltd@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_1.pdf@EU-1-04-290_h_a_dec_1.pdf@2006-01-30 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_1.pdf@EU-1-04-292_h_a_dec_1.pdf@2005-09-13 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA not available before 2006@Parsed
EU-1-04-285_h_a_dec_8.pdf@EU-1-04-285_h_a_dec_8.pdf@2009-08-20 00:00:00@Apidra@Insulin glulisine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_3.pdf@EU-1-04-282_h_a_dec_3.pdf@2005-10-25 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-04-290_h_a_dec_10.pdf@EU-1-04-290_h_a_dec_10.pdf@2010-09-16 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-285_h_a_dec_9.pdf@EU-1-04-285_h_a_dec_9.pdf@2010-12-01 00:00:00@Apidra@Insulin glulisine@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_30.pdf@EU-1-04-282_h_a_dec_30.pdf@2011-05-23 00:00:00@Telzir@Fosamprenavir@NAS before 2012@False@OD Not Found@ViiV Healthcare  UK Ltd@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_11.pdf@EU-1-04-290_h_a_dec_11.pdf@2011-01-27 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_11.pdf@EU-1-04-292_h_a_dec_11.pdf@2009-02-07 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_31.pdf@EU-1-04-282_h_a_dec_31.pdf@2012-04-04 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_12.pdf@EU-1-04-290_h_a_dec_12.pdf@2011-10-24 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_12.pdf@EU-1-04-292_h_a_dec_12.pdf@2009-08-31 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_32.pdf@EU-1-04-282_h_a_dec_32.pdf@2012-10-23 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_13.pdf@EU-1-04-290_h_a_dec_13.pdf@2012-07-23 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_13.pdf@EU-1-04-292_h_a_dec_13.pdf@2009-09-23 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_33.pdf@EU-1-04-282_h_a_dec_33.pdf@2013-03-26 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_14.pdf@EU-1-04-290_h_a_dec_14.pdf@2012-10-23 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_14.pdf@EU-1-04-292_h_a_dec_14.pdf@2010-10-28 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_34.pdf@EU-1-04-282_h_a_dec_34.pdf@2013-11-20 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_15.pdf@EU-1-04-290_h_a_dec_15.pdf@2013-11-15 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_15.pdf@EU-1-04-292_h_a_dec_15.pdf@2011-02-18 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_35.pdf@EU-1-04-282_h_a_dec_35.pdf@2015-05-05 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_16.pdf@EU-1-04-290_h_a_dec_16.pdf@2015-11-19 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_16.pdf@EU-1-04-292_h_a_dec_16.pdf@2012-01-30 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_17.pdf@EU-1-04-292_h_a_dec_17.pdf@2012-02-21 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe  B.V.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_17.pdf@EU-1-04-290_h_a_dec_17.pdf@2017-06-02 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_36.pdf@EU-1-04-282_h_a_dec_36.pdf@2016-04-04 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_18.pdf@EU-1-04-292_h_a_dec_18.pdf@2013-12-13 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_18.pdf@EU-1-04-290_h_a_dec_18.pdf@2018-12-18 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_19.pdf@EU-1-04-292_h_a_dec_19.pdf@2015-08-07 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_37.pdf@EU-1-04-282_h_a_dec_37.pdf@2018-09-28 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_2.pdf@EU-1-04-292_h_a_dec_2.pdf@2006-02-28 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_38.pdf@EU-1-04-282_h_a_dec_38.pdf@2019-06-18 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_19.pdf@EU-1-04-290_h_a_dec_19.pdf@2020-11-02 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_20.pdf@EU-1-04-292_h_a_dec_20.pdf@2016-08-12 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_39.pdf@EU-1-04-282_h_a_dec_39.pdf@2021-09-03 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_2.pdf@EU-1-04-290_h_a_dec_2.pdf@2007-01-26 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_21.pdf@EU-1-04-292_h_a_dec_21.pdf@2017-08-28 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_4.pdf@EU-1-04-282_h_a_dec_4.pdf@2006-02-28 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_0.pdf@EU-1-04-294_h_a_dec_0.pdf@2004-10-22 00:00:00@EMSELEX@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-290_h_a_dec_20.pdf@EU-1-04-290_h_a_dec_20.pdf@2021-10-05 00:00:00@Alimta@pemetrexed@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_40.pdf@EU-1-04-282_h_a_dec_40.pdf@2022-03-18 00:00:00@Telzir@Fosamprenavir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_22.pdf@EU-1-04-292_h_a_dec_22.pdf@2018-12-12 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_1.pdf@EU-1-04-294_h_a_dec_1.pdf@2005-11-17 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-290_h_a_dec_3.pdf@EU-1-04-290_h_a_dec_3.pdf@2007-03-14 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_5.pdf@EU-1-04-282_h_a_dec_5.pdf@2006-04-18 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_10.pdf@EU-1-04-294_h_a_dec_10.pdf@2013-04-22 00:00:00@Emselex@darifenacin hydrobromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_4.pdf@EU-1-04-290_h_a_dec_4.pdf@2007-10-31 00:00:00@Alimta@pemetrexed@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_0.pdf@EU-1-04-295_h_a_dec_0.pdf@2004-11-16 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@adopted@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-04-282_h_a_dec_6.pdf@EU-1-04-282_h_a_dec_6.pdf@2006-03-11 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_23.pdf@EU-1-04-292_h_a_dec_23.pdf@2019-01-07 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_11.pdf@EU-1-04-294_h_a_dec_11.pdf@2015-12-01 00:00:00@Emselex@darifenacin hydrobromide@False@False@OD Not Found@Merus Labs Luxco S.à R.L.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_5.pdf@EU-1-04-290_h_a_dec_5.pdf@2008-01-22 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_1.pdf@EU-1-04-295_h_a_dec_1.pdf@2005-08-09 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-04-282_h_a_dec_7.pdf@EU-1-04-282_h_a_dec_7.pdf@2007-03-01 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_12.pdf@EU-1-04-294_h_a_dec_12.pdf@2017-06-23 00:00:00@Emselex@darifenacin hydrobromide@False@False@OD Not Found@Merus Labs Luxco S.à R.L.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_6.pdf@EU-1-04-290_h_a_dec_6.pdf@2008-08-04 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_24.pdf@EU-1-04-292_h_a_dec_24.pdf@2021-01-21 00:00:00@Mimpara@Cinacalcet@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_10.pdf@EU-1-04-295_h_a_dec_10.pdf@2008-11-25 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_8.pdf@EU-1-04-282_h_a_dec_8.pdf@2007-01-18 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_13.pdf@EU-1-04-294_h_a_dec_13.pdf@2018-02-15 00:00:00@Emselex@darifenacin hydrobromide@False@False@OD Not Found@Merus Labs Luxco S.à R.L.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_7.pdf@EU-1-04-290_h_a_dec_7.pdf@2009-06-01 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_3.pdf@EU-1-04-292_h_a_dec_3.pdf@2006-03-29 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-282_h_a_dec_9.pdf@EU-1-04-282_h_a_dec_9.pdf@2007-02-28 00:00:00@Telzir@Fosamprenavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_11.pdf@EU-1-04-295_h_a_dec_11.pdf@2009-02-26 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_0.pdf@EU-1-04-296_h_a_dec_0.pdf@2004-12-17 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-294_h_a_dec_14.pdf@EU-1-04-294_h_a_dec_14.pdf@2021-02-18 00:00:00@Emselex@darifenacin hydrobromide@False@False@OD Not Found@Merus Labs Luxco II S.à R.L.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_8.pdf@EU-1-04-290_h_a_dec_8.pdf@2009-02-07 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_12.pdf@EU-1-04-295_h_a_dec_12.pdf@2009-04-30 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-292_h_a_dec_4.pdf@EU-1-04-292_h_a_dec_4.pdf@2006-07-13 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-290_h_a_dec_9.pdf@EU-1-04-290_h_a_dec_9.pdf@2009-09-21 00:00:00@Alimta@pemetrexed@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_1.pdf@EU-1-04-296_h_a_dec_1.pdf@2005-04-07 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-294_h_a_dec_15.pdf@EU-1-04-294_h_a_dec_15.pdf@2021-01-14 00:00:00@Emselex@darifenacin hydrobromide@False@False@OD Not Found@Merus Labs Luxco II S.à R.L.@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_5.pdf@EU-1-04-292_h_a_dec_5.pdf@2007-08-31 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_13.pdf@EU-1-04-295_h_a_dec_13.pdf@2009-10-30 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_10.pdf@EU-1-04-296_h_a_dec_10.pdf@2008-08-12 00:00:00@Cymbalta@duloxetine  hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_2.pdf@EU-1-04-294_h_a_dec_2.pdf@2006-11-29 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_0.pdf@EU-1-04-298_h_a_dec_0.pdf@2004-12-17 00:00:00@Kivexa@abacavir / lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-04-295_h_a_dec_14.pdf@EU-1-04-295_h_a_dec_14.pdf@2010-03-26 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_6.pdf@EU-1-04-292_h_a_dec_6.pdf@2007-12-21 00:00:00@Mimpara@Cinacalcet@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_11.pdf@EU-1-04-296_h_a_dec_11.pdf@2009-02-03 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_3.pdf@EU-1-04-294_h_a_dec_3.pdf@2007-03-23 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_1.pdf@EU-1-04-298_h_a_dec_1.pdf@Date is blank@Kivexa@abacavir / Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-04-292_h_a_dec_7.pdf@EU-1-04-292_h_a_dec_7.pdf@2008-03-17 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_15.pdf@EU-1-04-295_h_a_dec_15.pdf@2010-05-26 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-296_h_a_dec_12.pdf@EU-1-04-296_h_a_dec_12.pdf@2009-03-25 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_4.pdf@EU-1-04-294_h_a_dec_4.pdf@2008-04-23 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_10.pdf@EU-1-04-298_h_a_dec_10.pdf@2009-11-25 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_16.pdf@EU-1-04-295_h_a_dec_16.pdf@2010-11-26 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical  Contracts Ltd@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_8.pdf@EU-1-04-292_h_a_dec_8.pdf@2008-06-19 00:00:00@Mimpara@Cinacalcet@NAS before 2012@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_13.pdf@EU-1-04-296_h_a_dec_13.pdf@2009-06-24 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_5.pdf@EU-1-04-294_h_a_dec_5.pdf@2008-08-25 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_17.pdf@EU-1-04-295_h_a_dec_17.pdf@2011-06-05 00:00:00@Xagrid@anagrelide@NAS before 2012@False@adopted@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-298_h_a_dec_11.pdf@EU-1-04-298_h_a_dec_11.pdf@2009-11-12 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-292_h_a_dec_9.pdf@EU-1-04-292_h_a_dec_9.pdf@2008-10-29 00:00:00@Mimpara@Cinacalcet@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_14.pdf@EU-1-04-296_h_a_dec_14.pdf@2009-01-07 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_6.pdf@EU-1-04-294_h_a_dec_6.pdf@2009-07-31 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_18.pdf@EU-1-04-295_h_a_dec_18.pdf@2011-03-10 00:00:00@Xagrid@anagrelide@NAS before 2012@False@adopted@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-299_h_a_dec_0.pdf@EU-1-04-299_h_a_dec_0.pdf@2005-02-02 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-04-298_h_a_dec_12.pdf@EU-1-04-298_h_a_dec_12.pdf@2010-05-26 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_19.pdf@EU-1-04-295_h_a_dec_19.pdf@2013-01-14 00:00:00@Xagrid@anagrelide@False@False@adopted@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-294_h_a_dec_7.pdf@EU-1-04-294_h_a_dec_7.pdf@2009-09-24 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_15.pdf@EU-1-04-296_h_a_dec_15.pdf@2009-11-20 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-299_h_a_dec_1.pdf@EU-1-04-299_h_a_dec_1.pdf@2009-02-03 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine  (adjuvanted, adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_13.pdf@EU-1-04-298_h_a_dec_13.pdf@2010-07-28 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_2.pdf@EU-1-04-295_h_a_dec_2.pdf@2005-07-11 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA not available before 2006@Parsed
EU-1-04-294_h_a_dec_8.pdf@EU-1-04-294_h_a_dec_8.pdf@2010-12-20 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_16.pdf@EU-1-04-296_h_a_dec_16.pdf@2010-06-09 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-299_h_a_dec_2.pdf@EU-1-04-299_h_a_dec_2.pdf@2009-10-12 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_20.pdf@EU-1-04-295_h_a_dec_20.pdf@2013-05-16 00:00:00@Xagrid@anagrelide@False@False@adopted@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-298_h_a_dec_14.pdf@EU-1-04-298_h_a_dec_14.pdf@2011-03-18 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK  Ltd@CMA Not Found@Parsed
EU-1-04-294_h_a_dec_9.pdf@EU-1-04-294_h_a_dec_9.pdf@2011-12-14 00:00:00@Emselex@darifenacin hydrobromide@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_17.pdf@EU-1-04-296_h_a_dec_17.pdf@2011-01-27 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-04-299_h_a_dec_3.pdf@EU-1-04-299_h_a_dec_3.pdf@2010-07-28 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_15.pdf@EU-1-04-298_h_a_dec_15.pdf@2011-06-05 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_18.pdf@EU-1-04-296_h_a_dec_18.pdf@2011-07-26 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_21.pdf@EU-1-04-295_h_a_dec_21.pdf@2014-07-18 00:00:00@Xagrid@anagrelide@False@False@adopted@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-299_h_a_dec_4.pdf@EU-1-04-299_h_a_dec_4.pdf@2011-12-19 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_16.pdf@EU-1-04-298_h_a_dec_16.pdf@2011-10-24 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_19.pdf@EU-1-04-296_h_a_dec_19.pdf@2013-04-07 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_17.pdf@EU-1-04-298_h_a_dec_17.pdf@2012-08-08 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK  Ltd@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_22.pdf@EU-1-04-295_h_a_dec_22.pdf@2014-07-11 00:00:00@Xagrid@anagrelide@False@False@adopted@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-296_h_a_dec_2.pdf@EU-1-04-296_h_a_dec_2.pdf@2005-04-07 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-299_h_a_dec_5.pdf@EU-1-04-299_h_a_dec_5.pdf@2014-11-17 00:00:00@Fendrix@Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_18.pdf@EU-1-04-298_h_a_dec_18.pdf@2013-03-26 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_19.pdf@EU-1-04-298_h_a_dec_19.pdf@2013-05-27 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_20.pdf@EU-1-04-296_h_a_dec_20.pdf@2014-10-20 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_23.pdf@EU-1-04-295_h_a_dec_23.pdf@2016-01-18 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-300_h_a_dec_0.pdf@EU-1-04-300_h_a_dec_0.pdf@2005-12-01 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-04-298_h_a_dec_2.pdf@EU-1-04-298_h_a_dec_2.pdf@2005-07-11 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-04-296_h_a_dec_21.pdf@EU-1-04-296_h_a_dec_21.pdf@2015-05-27 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_0.pdf@EU-1-04-302_h_a_dec_0.pdf@2005-02-21 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@adopted@Elan Pharma International Ltd@CMA not available before 2006@Parsed
EU-1-04-295_h_a_dec_24.pdf@EU-1-04-295_h_a_dec_24.pdf@2017-06-16 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-303_h_a_dec_0.pdf@EU-1-04-303_h_a_dec_0.pdf@2005-02-21 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@adopted@Swedish Orphan International AB@CMA not available before 2006@Parsed
EU-1-04-296_h_a_dec_22.pdf@EU-1-04-296_h_a_dec_22.pdf@2016-07-22 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_1.pdf@EU-1-04-300_h_a_dec_1.pdf@2005-12-23 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-04-302_h_a_dec_1.pdf@EU-1-04-302_h_a_dec_1.pdf@2006-03-20 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_20.pdf@EU-1-04-298_h_a_dec_20.pdf@2014-11-17 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_0.pdf@EU-1-04-304_h_a_dec_0.pdf@2005-02-21 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA not available before 2006@Parsed
EU-1-04-303_h_a_dec_1.pdf@EU-1-04-303_h_a_dec_1.pdf@2006-04-18 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_10.pdf@EU-1-04-300_h_a_dec_10.pdf@2008-08-29 00:00:00@Avastin@bevacizumab@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_10.pdf@EU-1-04-302_h_a_dec_10.pdf@2010-12-01 00:00:00@Prialt@ziconotide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_25.pdf@EU-1-04-295_h_a_dec_25.pdf@2018-11-07 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceutical Contracts Limited@exceptional@Parsed
EU-1-04-296_h_a_dec_23.pdf@EU-1-04-296_h_a_dec_23.pdf@2018-09-02 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_11.pdf@EU-1-04-300_h_a_dec_11.pdf@2009-03-25 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_10.pdf@EU-1-04-303_h_a_dec_10.pdf@2017-01-26 00:00:00@Orfadin@Nitisinone@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_1.pdf@EU-1-04-304_h_a_dec_1.pdf@2005-10-06 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA not available before 2006@Parsed
EU-1-04-302_h_a_dec_11.pdf@EU-1-04-302_h_a_dec_11.pdf@2012-06-02 00:00:00@Prialt@ziconotide@False@False@adopted@Eisai Limited@exceptional@Parsed
EU-1-04-298_h_a_dec_21.pdf@EU-1-04-298_h_a_dec_21.pdf@2015-06-22 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_12.pdf@EU-1-04-300_h_a_dec_12.pdf@2009-05-29 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_11.pdf@EU-1-04-303_h_a_dec_11.pdf@2018-11-20 00:00:00@Orfadin@Nitisinone@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_12.pdf@EU-1-04-302_h_a_dec_12.pdf@2012-09-20 00:00:00@Prialt@ziconotide@False@False@adopted@Eisai Limited@exceptional@Parsed
EU-1-04-304_h_a_dec_10.pdf@EU-1-04-304_h_a_dec_10.pdf@2016-02-22 00:00:00@Azilect@rasagiline@False@False@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_24.pdf@EU-1-04-296_h_a_dec_24.pdf@2020-09-01 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_13.pdf@EU-1-04-300_h_a_dec_13.pdf@2009-07-23 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_26.pdf@EU-1-04-295_h_a_dec_26.pdf@2018-08-23 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceutical Contracts Limited@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_12.pdf@EU-1-04-303_h_a_dec_12.pdf@2019-05-12 00:00:00@Orfadin@Nitisinone@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_22.pdf@EU-1-04-298_h_a_dec_22.pdf@2016-06-29 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_11.pdf@EU-1-04-304_h_a_dec_11.pdf@2017-12-20 00:00:00@Azilect@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_14.pdf@EU-1-04-300_h_a_dec_14.pdf@2009-12-21 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_13.pdf@EU-1-04-302_h_a_dec_13.pdf@2014-01-17 00:00:00@Prialt@ziconotide@False@False@adopted@Eisai Limited@exceptional@Parsed
EU-1-04-303_h_a_dec_13.pdf@EU-1-04-303_h_a_dec_13.pdf@2020-10-22 00:00:00@Orfadin@Nitisinone@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_25.pdf@EU-1-04-296_h_a_dec_25.pdf@2021-06-21 00:00:00@Cymbalta@duloxetine hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_27.pdf@EU-1-04-295_h_a_dec_27.pdf@2020-06-18 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_15.pdf@EU-1-04-300_h_a_dec_15.pdf@2010-01-20 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_2.pdf@EU-1-04-303_h_a_dec_2.pdf@2006-08-28 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@OD Not Found@Swedish Orphan International AB@exceptional@Parsed
EU-1-04-298_h_a_dec_23.pdf@EU-1-04-298_h_a_dec_23.pdf@2017-06-07 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_12.pdf@EU-1-04-304_h_a_dec_12.pdf@2019-06-06 00:00:00@Azilect@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_14.pdf@EU-1-04-302_h_a_dec_14.pdf@2014-09-18 00:00:00@Prialt@ziconotide@False@False@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_3.pdf@EU-1-04-296_h_a_dec_3.pdf@2005-09-15 00:00:00@Cymbalta@duloxetine  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_16.pdf@EU-1-04-300_h_a_dec_16.pdf@2010-02-06 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_3.pdf@EU-1-04-303_h_a_dec_3.pdf@2007-08-23 00:00:00@Orfadin@Nitisinone@NAS before 2012@NA before 2012@OD Not Found@Swedish Orphan International AB@exceptional@Parsed
EU-1-04-295_h_a_dec_28.pdf@EU-1-04-295_h_a_dec_28.pdf@2021-11-18 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_17.pdf@EU-1-04-300_h_a_dec_17.pdf@2010-06-07 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_4.pdf@EU-1-04-296_h_a_dec_4.pdf@2006-03-29 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_15.pdf@EU-1-04-302_h_a_dec_15.pdf@2018-01-15 00:00:00@Prialt@ziconotide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_13.pdf@EU-1-04-304_h_a_dec_13.pdf@2021-09-22 00:00:00@Azilect@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_4.pdf@EU-1-04-303_h_a_dec_4.pdf@2009-09-21 00:00:00@Orfadin@Nitisinone@NAS before 2012@False@OD Not Found@Swedish Orphan International AB@exceptional@Parsed
EU-1-04-298_h_a_dec_24.pdf@EU-1-04-298_h_a_dec_24.pdf@2018-10-16 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_18.pdf@EU-1-04-300_h_a_dec_18.pdf@2010-08-31 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_5.pdf@EU-1-04-296_h_a_dec_5.pdf@2006-05-31 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_2.pdf@EU-1-04-304_h_a_dec_2.pdf@2006-01-25 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_25.pdf@EU-1-04-298_h_a_dec_25.pdf@2019-10-21 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_5.pdf@EU-1-04-303_h_a_dec_5.pdf@2010-01-19 00:00:00@Orfadin@Nitisinone@NAS before 2012@False@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_29.pdf@EU-1-04-295_h_a_dec_29.pdf@2021-03-12 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_6.pdf@EU-1-04-296_h_a_dec_6.pdf@2006-11-24 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_16.pdf@EU-1-04-302_h_a_dec_16.pdf@2018-02-07 00:00:00@Prialt@ziconotide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_19.pdf@EU-1-04-300_h_a_dec_19.pdf@2010-11-26 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_3.pdf@EU-1-04-304_h_a_dec_3.pdf@2007-02-04 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_26.pdf@EU-1-04-298_h_a_dec_26.pdf@2021-09-03 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_6.pdf@EU-1-04-303_h_a_dec_6.pdf@2011-01-02 00:00:00@Orfadin@Nitisinone@NAS before 2012@False@adopted@Swedish Orphan Biovitrum International  AB@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_3.pdf@EU-1-04-295_h_a_dec_3.pdf@2006-02-28 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_17.pdf@EU-1-04-302_h_a_dec_17.pdf@2019-12-18 00:00:00@Prialt@ziconotide@False@False@OD Not Found@RIEMSER Pharma GmbH@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_7.pdf@EU-1-04-296_h_a_dec_7.pdf@2007-08-28 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_2.pdf@EU-1-04-300_h_a_dec_2.pdf@2006-04-07 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_27.pdf@EU-1-04-298_h_a_dec_27.pdf@2021-08-20 00:00:00@Kivexa@abacavir / Lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_4.pdf@EU-1-04-304_h_a_dec_4.pdf@2007-09-10 00:00:00@AZILECT@rasagiline@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_18.pdf@EU-1-04-302_h_a_dec_18.pdf@2022-04-07 00:00:00@Prialt@ziconotide@False@False@OD Not Found@Esteve Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_20.pdf@EU-1-04-300_h_a_dec_20.pdf@2010-12-20 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_8.pdf@EU-1-04-296_h_a_dec_8.pdf@2008-04-21 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_7.pdf@EU-1-04-303_h_a_dec_7.pdf@2014-06-27 00:00:00@Orfadin@Nitisinone@False@False@adopted@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_5.pdf@EU-1-04-304_h_a_dec_5.pdf@2009-09-21 00:00:00@AZILECT@rasagiline@NAS before 2012@False@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_3.pdf@EU-1-04-298_h_a_dec_3.pdf@2006-11-28 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_19.pdf@EU-1-04-302_h_a_dec_19.pdf@2022-02-08 00:00:00@Prialt@ziconotide@False@False@OD Not Found@Esteve Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_30.pdf@EU-1-04-295_h_a_dec_30.pdf@2022-02-28 00:00:00@Xagrid@anagrelide@False@False@OD Not Found@Takeda Pharmaceuticals International AG Ireland Branch@CMA Not Found@Parsed
EU-1-04-296_h_a_dec_9.pdf@EU-1-04-296_h_a_dec_9.pdf@2008-07-28 00:00:00@Cymbalta@duloxetine hydrochloride@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_21.pdf@EU-1-04-300_h_a_dec_21.pdf@2011-02-28 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_8.pdf@EU-1-04-303_h_a_dec_8.pdf@2015-05-05 00:00:00@Orfadin@Nitisinone@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_4.pdf@EU-1-04-298_h_a_dec_4.pdf@2007-01-17 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_6.pdf@EU-1-04-304_h_a_dec_6.pdf@2009-11-23 00:00:00@AZILECT@rasagiline@NAS before 2012@False@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_2.pdf@EU-1-04-302_h_a_dec_2.pdf@2006-03-29 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_4.pdf@EU-1-04-295_h_a_dec_4.pdf@2006-05-19 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-300_h_a_dec_22.pdf@EU-1-04-300_h_a_dec_22.pdf@2011-03-24 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_5.pdf@EU-1-04-298_h_a_dec_5.pdf@2007-05-30 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-04-303_h_a_dec_9.pdf@EU-1-04-303_h_a_dec_9.pdf@2015-06-19 00:00:00@Orfadin@Nitisinone@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_7.pdf@EU-1-04-304_h_a_dec_7.pdf@2010-10-25 00:00:00@Azilect@rasagiline@NAS before 2012@False@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_3.pdf@EU-1-04-302_h_a_dec_3.pdf@2006-05-31 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_5.pdf@EU-1-04-295_h_a_dec_5.pdf@2006-07-08 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_23.pdf@EU-1-04-300_h_a_dec_23.pdf@2011-06-29 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_6.pdf@EU-1-04-298_h_a_dec_6.pdf@2007-08-27 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_8.pdf@EU-1-04-304_h_a_dec_8.pdf@2012-03-26 00:00:00@Azilect@rasagiline@False@False@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_4.pdf@EU-1-04-302_h_a_dec_4.pdf@2006-07-28 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd@exceptional@Parsed
EU-1-04-295_h_a_dec_6.pdf@EU-1-04-295_h_a_dec_6.pdf@2007-03-28 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_24.pdf@EU-1-04-300_h_a_dec_24.pdf@2011-07-27 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_7.pdf@EU-1-04-298_h_a_dec_7.pdf@2008-02-29 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_5.pdf@EU-1-04-302_h_a_dec_5.pdf@2006-09-13 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_7.pdf@EU-1-04-295_h_a_dec_7.pdf@2007-05-15 00:00:00@Xagrid@anagrelide@NAS before 2012@NA before 2012@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-300_h_a_dec_25.pdf@EU-1-04-300_h_a_dec_25.pdf@2011-11-24 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-304_h_a_dec_9.pdf@EU-1-04-304_h_a_dec_9.pdf@2013-11-15 00:00:00@Azilect@rasagiline@False@False@OD Not Found@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-04-298_h_a_dec_8.pdf@EU-1-04-298_h_a_dec_8.pdf@2009-04-21 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_6.pdf@EU-1-04-302_h_a_dec_6.pdf@2007-11-05 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_26.pdf@EU-1-04-300_h_a_dec_26.pdf@2011-12-19 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_8.pdf@EU-1-04-295_h_a_dec_8.pdf@2008-01-25 00:00:00@Xagrid@anagrelide@NAS before 2012@False@OD Not Found@Shire Pharmaceutical Contracts Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_0.pdf@EU-1-04-305_h_a_dec_0.pdf@2005-02-21 00:00:00@Truvada@Emtricitabine / Tenofovir Disoproxil@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-04-302_h_a_dec_7.pdf@EU-1-04-302_h_a_dec_7.pdf@2007-07-20 00:00:00@Prialt@ziconotide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@exceptional@Parsed
EU-1-04-298_h_a_dec_9.pdf@EU-1-04-298_h_a_dec_9.pdf@2009-08-06 00:00:00@Kivexa@abacavir / Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_27.pdf@EU-1-04-300_h_a_dec_27.pdf@2012-06-02 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-295_h_a_dec_9.pdf@EU-1-04-295_h_a_dec_9.pdf@2008-05-21 00:00:00@Xagrid@anagrelide@NAS before 2012@True@OD Not Found@Shire Pharmaceutical Contracts Ltd@exceptional@Parsed
EU-1-04-306_h_a_dec_0.pdf@EU-1-04-306_h_a_dec_0.pdf@2005-03-22 00:00:00@Aloxi@Palonosetron@NAS before 2012@NA before 2012@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA not available before 2006@Parsed
EU-1-04-305_h_a_dec_1.pdf@EU-1-04-305_h_a_dec_1.pdf@2005-10-25 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_28.pdf@EU-1-04-300_h_a_dec_28.pdf@2012-03-19 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_8.pdf@EU-1-04-302_h_a_dec_8.pdf@2008-08-25 00:00:00@Prialt@ziconotide@NAS before 2012@True@OD Not Found@Eisai Limited@exceptional@Parsed
EU-1-04-306_h_a_dec_1.pdf@EU-1-04-306_h_a_dec_1.pdf@2009-01-29 00:00:00@Aloxi@Palonosetron@NAS before 2012@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_10.pdf@EU-1-04-305_h_a_dec_10.pdf@2007-01-03 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_0.pdf@EU-1-04-307_h_a_dec_0.pdf@2005-10-03 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_29.pdf@EU-1-04-300_h_a_dec_29.pdf@2012-06-27 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-302_h_a_dec_9.pdf@EU-1-04-302_h_a_dec_9.pdf@2009-04-09 00:00:00@Prialt@ziconotide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_11.pdf@EU-1-04-305_h_a_dec_11.pdf@2007-04-24 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_3.pdf@EU-1-04-300_h_a_dec_3.pdf@2007-03-27 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_1.pdf@EU-1-04-307_h_a_dec_1.pdf@2006-01-13 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_10.pdf@EU-1-04-306_h_a_dec_10.pdf@2018-04-26 00:00:00@Aloxi@Palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_30.pdf@EU-1-04-300_h_a_dec_30.pdf@2012-08-30 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_12.pdf@EU-1-04-305_h_a_dec_12.pdf@2007-11-30 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_10.pdf@EU-1-04-307_h_a_dec_10.pdf@2010-07-27 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_2.pdf@EU-1-04-306_h_a_dec_2.pdf@2009-12-18 00:00:00@Aloxi@Palonosetron@NAS before 2012@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_31.pdf@EU-1-04-300_h_a_dec_31.pdf@2012-10-24 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_11.pdf@EU-1-04-307_h_a_dec_11.pdf@2010-10-25 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
t Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_0.pdf@EU-1-05-308_h_a_dec_0.pdf@2005-04-15 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-04-307_h_a_dec_12.pdf@EU-1-04-307_h_a_dec_12.pdf@2011-09-19 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_14.pdf@EU-1-04-305_h_a_dec_14.pdf@2008-02-28 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_4.pdf@EU-1-04-306_h_a_dec_4.pdf@2010-05-05 00:00:00@Aloxi@Palonosetron@NAS before 2012@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_32.pdf@EU-1-04-300_h_a_dec_32.pdf@2013-05-27 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_1.pdf@EU-1-05-308_h_a_dec_1.pdf@2006-09-26 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_13.pdf@EU-1-04-307_h_a_dec_13.pdf@2012-03-30 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_5.pdf@EU-1-04-306_h_a_dec_5.pdf@2010-12-20 00:00:00@Aloxi@Palonosetron@NAS before 2012@False@OD Not Found@Helsinn Birex  Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_15.pdf@EU-1-04-305_h_a_dec_15.pdf@2008-08-29 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@True@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_10.pdf@EU-1-05-308_h_a_dec_10.pdf@2010-03-30 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_14.pdf@EU-1-04-307_h_a_dec_14.pdf@2012-06-27 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_6.pdf@EU-1-04-306_h_a_dec_6.pdf@2012-02-21 00:00:00@Aloxi@Palonosetron@False@False@OD Not Found@Helsinn Birex  Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_0.pdf@EU-1-05-310_h_a_dec_0.pdf@2005-08-24 00:00:00@FOSAVANCE@Alendronate Sodium / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-04-300_h_a_dec_33.pdf@EU-1-04-300_h_a_dec_33.pdf@2014-06-30 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_16.pdf@EU-1-04-305_h_a_dec_16.pdf@2008-12-22 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_11.pdf@EU-1-05-308_h_a_dec_11.pdf@2010-04-29 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_15.pdf@EU-1-04-307_h_a_dec_15.pdf@2012-07-20 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_7.pdf@EU-1-04-306_h_a_dec_7.pdf@2013-05-22 00:00:00@Aloxi@Palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_1.pdf@EU-1-05-310_h_a_dec_1.pdf@2006-10-30 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_17.pdf@EU-1-04-305_h_a_dec_17.pdf@2009-10-12 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_12.pdf@EU-1-05-308_h_a_dec_12.pdf@2010-12-05 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_34.pdf@EU-1-04-300_h_a_dec_34.pdf@2014-07-31 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_18.pdf@EU-1-04-305_h_a_dec_18.pdf@2010-01-20 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_10.pdf@EU-1-05-310_h_a_dec_10.pdf@2009-06-11 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_16.pdf@EU-1-04-307_h_a_dec_16.pdf@2013-02-10 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_13.pdf@EU-1-05-308_h_a_dec_13.pdf@2011-12-04 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_0.pdf@EU-1-05-311_h_a_dec_0.pdf@2005-09-19 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-04-305_h_a_dec_2.pdf@EU-1-04-305_h_a_dec_2.pdf@2005-11-16 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-05-308_h_a_dec_14.pdf@EU-1-05-308_h_a_dec_14.pdf@2011-06-29 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_11.pdf@EU-1-05-310_h_a_dec_11.pdf@2010-08-16 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-04-306_h_a_dec_9.pdf@EU-1-04-306_h_a_dec_9.pdf@2015-02-24 00:00:00@Aloxi@Palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_35.pdf@EU-1-04-300_h_a_dec_35.pdf@2014-11-17 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_1.pdf@EU-1-05-311_h_a_dec_1.pdf@2006-03-22 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_20.pdf@EU-1-04-305_h_a_dec_20.pdf@2010-11-26 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_12.pdf@EU-1-05-310_h_a_dec_12.pdf@2010-11-29 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_15.pdf@EU-1-05-308_h_a_dec_15.pdf@2012-06-02 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_21.pdf@EU-1-04-305_h_a_dec_21.pdf@2011-05-27 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited,@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_10.pdf@EU-1-05-311_h_a_dec_10.pdf@2010-01-07 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_18.pdf@EU-1-04-307_h_a_dec_18.pdf@2017-04-01 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_16.pdf@EU-1-05-308_h_a_dec_16.pdf@2012-09-03 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_36.pdf@EU-1-04-300_h_a_dec_36.pdf@2015-03-30 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
 Dohme Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_22.pdf@EU-1-04-305_h_a_dec_22.pdf@2011-07-27 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@NAS before 2012@False@OD Not Found@Gilead Sciences  International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_11.pdf@EU-1-05-311_h_a_dec_11.pdf@2010-02-07 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_17.pdf@EU-1-05-308_h_a_dec_17.pdf@2012-04-20 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_12.pdf@EU-1-05-311_h_a_dec_12.pdf@2011-08-03 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_19.pdf@EU-1-04-307_h_a_dec_19.pdf@2018-08-01 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_14.pdf@EU-1-05-310_h_a_dec_14.pdf@2011-03-18 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_23.pdf@EU-1-04-305_h_a_dec_23.pdf@2013-01-07 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_37.pdf@EU-1-04-300_h_a_dec_37.pdf@2016-02-06 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
fore 2006@Parsed
EU-1-05-311_h_a_dec_13.pdf@EU-1-05-311_h_a_dec_13.pdf@2011-05-18 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_15.pdf@EU-1-05-310_h_a_dec_15.pdf@2011-06-29 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_18.pdf@EU-1-05-308_h_a_dec_18.pdf@2014-11-07 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_2.pdf@EU-1-04-307_h_a_dec_2.pdf@2006-07-09 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_14.pdf@EU-1-05-311_h_a_dec_14.pdf@2011-08-24 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_16.pdf@EU-1-05-310_h_a_dec_16.pdf@2011-07-27 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_1.pdf@EU-1-05-312_h_a_dec_1.pdf@2007-01-02 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_24.pdf@EU-1-04-305_h_a_dec_24.pdf@2015-10-03 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_15.pdf@EU-1-05-311_h_a_dec_15.pdf@2012-06-21 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_17.pdf@EU-1-05-310_h_a_dec_17.pdf@2012-05-25 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_19.pdf@EU-1-05-308_h_a_dec_19.pdf@2015-01-19 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_10.pdf@EU-1-05-312_h_a_dec_10.pdf@2011-04-18 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@False@adopted@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_38.pdf@EU-1-04-300_h_a_dec_38.pdf@2017-02-06 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_16.pdf@EU-1-05-311_h_a_dec_16.pdf@2012-10-29 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_2.pdf@EU-1-05-308_h_a_dec_2.pdf@2006-10-24 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_25.pdf@EU-1-04-305_h_a_dec_25.pdf@2016-11-02 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_20.pdf@EU-1-04-307_h_a_dec_20.pdf@2018-09-21 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_39.pdf@EU-1-04-300_h_a_dec_39.pdf@2018-03-16 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_18.pdf@EU-1-05-310_h_a_dec_18.pdf@2015-04-24 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_17.pdf@EU-1-05-311_h_a_dec_17.pdf@2013-08-26 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_12.pdf@EU-1-05-312_h_a_dec_12.pdf@2014-06-27 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_26.pdf@EU-1-04-305_h_a_dec_26.pdf@2016-08-18 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_20.pdf@EU-1-05-308_h_a_dec_20.pdf@2015-05-28 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_22.pdf@EU-1-04-307_h_a_dec_22.pdf@2021-11-01 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_4.pdf@EU-1-04-300_h_a_dec_4.pdf@2007-04-23 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_18.pdf@EU-1-05-311_h_a_dec_18.pdf@2014-08-10 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_21.pdf@EU-1-05-308_h_a_dec_21.pdf@2016-02-12 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_13.pdf@EU-1-05-312_h_a_dec_13.pdf@2015-08-09 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma Ltd@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_27.pdf@EU-1-04-305_h_a_dec_27.pdf@2017-03-24 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_19.pdf@EU-1-05-310_h_a_dec_19.pdf@2016-09-15 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_40.pdf@EU-1-04-300_h_a_dec_40.pdf@2020-03-04 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_41.pdf@EU-1-04-300_h_a_dec_41.pdf@2022-01-31 00:00:00@Avastin@bevacizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_19.pdf@EU-1-05-311_h_a_dec_19.pdf@2016-01-25 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_23.pdf@EU-1-04-307_h_a_dec_23.pdf@2022-01-27 00:00:00@Zonegran@zonisamide@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_14.pdf@EU-1-05-312_h_a_dec_14.pdf@2017-06-29 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma Ltd@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_2.pdf@EU-1-05-310_h_a_dec_2.pdf@2007-04-10 00:00:00@FOSAVANCE@Alendronate Sodium / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_22.pdf@EU-1-05-308_h_a_dec_22.pdf@2018-07-03 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_28.pdf@EU-1-04-305_h_a_dec_28.pdf@2018-05-02 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_2.pdf@EU-1-05-311_h_a_dec_2.pdf@2006-11-22 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_15.pdf@EU-1-05-312_h_a_dec_15.pdf@2018-06-15 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma Ltd@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_5.pdf@EU-1-04-300_h_a_dec_5.pdf@2007-08-21 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_3.pdf@EU-1-04-307_h_a_dec_3.pdf@2007-03-28 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_23.pdf@EU-1-05-308_h_a_dec_23.pdf@2018-04-19 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_20.pdf@EU-1-05-310_h_a_dec_20.pdf@2018-02-15 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_16.pdf@EU-1-05-312_h_a_dec_16.pdf@2018-08-13 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_29.pdf@EU-1-04-305_h_a_dec_29.pdf@2018-04-06 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_20.pdf@EU-1-05-311_h_a_dec_20.pdf@2017-10-30 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_6.pdf@EU-1-04-300_h_a_dec_6.pdf@2007-10-24 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_4.pdf@EU-1-04-307_h_a_dec_4.pdf@2007-10-29 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_17.pdf@EU-1-05-312_h_a_dec_17.pdf@2019-07-18 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_3.pdf@EU-1-04-305_h_a_dec_3.pdf@2005-12-23 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA not available before 2006@Parsed
EU-1-05-308_h_a_dec_24.pdf@EU-1-05-308_h_a_dec_24.pdf@2019-07-31 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_21.pdf@EU-1-05-311_h_a_dec_21.pdf@2017-11-12 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_21.pdf@EU-1-05-310_h_a_dec_21.pdf@2018-09-07 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_18.pdf@EU-1-05-312_h_a_dec_18.pdf@2020-12-17 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_7.pdf@EU-1-04-300_h_a_dec_7.pdf@2007-12-14 00:00:00@Avastin@bevacizumab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_5.pdf@EU-1-04-307_h_a_dec_5.pdf@2007-12-18 00:00:00@Zonegran@zonisamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_30.pdf@EU-1-04-305_h_a_dec_30.pdf@2019-07-19 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_19.pdf@EU-1-05-312_h_a_dec_19.pdf@2022-06-21 00:00:00@Xyrem@Sodium oxybate@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_25.pdf@EU-1-05-308_h_a_dec_25.pdf@2021-09-03 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_22.pdf@EU-1-05-311_h_a_dec_22.pdf@2018-06-04 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-300_h_a_dec_8.pdf@EU-1-04-300_h_a_dec_8.pdf@2008-01-25 00:00:00@Avastin@bevacizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_22.pdf@EU-1-05-310_h_a_dec_22.pdf@2021-04-21 00:00:00@Fosavance@Alendronate Sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_6.pdf@EU-1-04-307_h_a_dec_6.pdf@2008-03-31 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_2.pdf@EU-1-05-312_h_a_dec_2.pdf@2007-01-03 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_23.pdf@EU-1-05-311_h_a_dec_23.pdf@2019-07-02 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_26.pdf@EU-1-05-308_h_a_dec_26.pdf@2022-01-04 00:00:00@Aclasta@zoledronic acid@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
ed
EU-1-05-310_h_a_dec_3.pdf@EU-1-05-310_h_a_dec_3.pdf@2007-10-24 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_3.pdf@EU-1-05-312_h_a_dec_3.pdf@2007-09-18 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_31.pdf@EU-1-04-305_h_a_dec_31.pdf@2021-07-01 00:00:00@Truvada@emtricitabine /  tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_7.pdf@EU-1-04-307_h_a_dec_7.pdf@2009-11-02 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_24.pdf@EU-1-05-311_h_a_dec_24.pdf@2022-02-18 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_3.pdf@EU-1-05-308_h_a_dec_3.pdf@2007-07-25 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_25.pdf@EU-1-05-311_h_a_dec_25.pdf@2022-09-19 00:00:00@Tarceva@Erlotinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_4.pdf@EU-1-05-312_h_a_dec_4.pdf@2007-10-31 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@NA before 2012@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_4.pdf@EU-1-05-310_h_a_dec_4.pdf@2007-10-24 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_8.pdf@EU-1-04-307_h_a_dec_8.pdf@2009-07-07 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_32.pdf@EU-1-04-305_h_a_dec_32.pdf@2022-07-06 00:00:00@Truvada@emtricitabine / tenofovir disoproxil fumarate@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_4.pdf@EU-1-05-308_h_a_dec_4.pdf@2007-03-10 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_3.pdf@EU-1-05-311_h_a_dec_3.pdf@2007-01-24 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_5.pdf@EU-1-05-312_h_a_dec_5.pdf@2008-03-06 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@True@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_5.pdf@EU-1-05-310_h_a_dec_5.pdf@2008-08-22 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-04-307_h_a_dec_9.pdf@EU-1-04-307_h_a_dec_9.pdf@2009-12-21 00:00:00@Zonegran@zonisamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_5.pdf@EU-1-05-308_h_a_dec_5.pdf@2007-03-10 00:00:00@Aclasta@zoledronic acid@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_4.pdf@EU-1-04-305_h_a_dec_4.pdf@2006-02-28 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_4.pdf@EU-1-05-311_h_a_dec_4.pdf@2007-02-27 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_6.pdf@EU-1-05-312_h_a_dec_6.pdf@2009-09-01 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@False@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_6.pdf@EU-1-05-310_h_a_dec_6.pdf@2008-08-22 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_6.pdf@EU-1-05-308_h_a_dec_6.pdf@2022-12-01 00:00:01@Aclasta@zoledronic acid@False@True@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_5.pdf@EU-1-04-305_h_a_dec_5.pdf@2006-03-29 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_5.pdf@EU-1-05-311_h_a_dec_5.pdf@2007-07-24 00:00:00@Tarceva@Erlotinib@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_7.pdf@EU-1-05-312_h_a_dec_7.pdf@2010-02-07 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@False@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_7.pdf@EU-1-05-310_h_a_dec_7.pdf@2009-07-04 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_7.pdf@EU-1-05-308_h_a_dec_7.pdf@2008-09-26 00:00:00@Aclasta@zoledronic acid@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_6.pdf@EU-1-04-305_h_a_dec_6.pdf@2006-02-28 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_6.pdf@EU-1-05-311_h_a_dec_6.pdf@2008-01-18 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_8.pdf@EU-1-05-312_h_a_dec_8.pdf@2010-09-17 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@False@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_8.pdf@EU-1-05-310_h_a_dec_8.pdf@2009-07-07 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_8.pdf@EU-1-05-308_h_a_dec_8.pdf@2009-06-22 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_7.pdf@EU-1-05-311_h_a_dec_7.pdf@2009-01-27 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_7.pdf@EU-1-04-305_h_a_dec_7.pdf@2006-03-29 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-312_h_a_dec_9.pdf@EU-1-05-312_h_a_dec_9.pdf@2011-03-18 00:00:00@Xyrem@Sodium oxybate@NAS before 2012@False@OD Not Found@UCB Pharma Ltd.@CMA Not Found@Parsed
EU-1-05-308_h_a_dec_9.pdf@EU-1-05-308_h_a_dec_9.pdf@2009-06-22 00:00:00@Aclasta@zoledronic acid@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-05-310_h_a_dec_9.pdf@EU-1-05-310_h_a_dec_9.pdf@2009-03-08 00:00:00@FOSAVANCE@Alendronate Sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_8.pdf@EU-1-05-311_h_a_dec_8.pdf@2009-05-28 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_8.pdf@EU-1-04-305_h_a_dec_8.pdf@2006-08-28 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-311_h_a_dec_9.pdf@EU-1-05-311_h_a_dec_9.pdf@2010-04-27 00:00:00@Tarceva@Erlotinib@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-04-305_h_a_dec_9.pdf@EU-1-04-305_h_a_dec_9.pdf@2007-12-01 00:00:00@Truvada@emtricitabine / tenofovir  disoproxil fumarate@NAS before 2012@NA before 2012@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_0.pdf@EU-1-05-315_h_a_dec_0.pdf@2005-10-25 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-05-317_h_a_dec_0.pdf@EU-1-05-317_h_a_dec_0.pdf@2005-10-25 00:00:00@Corlentor@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-05-316_h_a_dec_0.pdf@EU-1-05-316_h_a_dec_0.pdf@2005-10-25 00:00:00@Procoralan@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-05-315_h_a_dec_1.pdf@EU-1-05-315_h_a_dec_1.pdf@2005-12-23 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-05-317_h_a_dec_1.pdf@EU-1-05-317_h_a_dec_1.pdf@2005-10-25 00:00:00@Corlentor@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA not available before 2006@Parsed
EU-1-05-318_h_a_dec_0.pdf@EU-1-05-318_h_a_dec_0.pdf@2005-10-28 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@adopted@PFIZER Ltd@CMA not available before 2006@Parsed
EU-1-05-315_h_a_dec_10.pdf@EU-1-05-315_h_a_dec_10.pdf@2007-10-15 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_1.pdf@EU-1-05-316_h_a_dec_1.pdf@2007-06-03 00:00:00@Procoralan@Ivabradine@NAS before 2012@NA before 2012@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_0.pdf@EU-1-05-319_h_a_dec_0.pdf@2005-10-25 00:00:00@Xolair@omalizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-05-318_h_a_dec_1.pdf@EU-1-05-318_h_a_dec_1.pdf@2006-06-16 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_11.pdf@EU-1-05-315_h_a_dec_11.pdf@2007-10-22 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_10.pdf@EU-1-05-316_h_a_dec_10.pdf@2012-10-25 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_10.pdf@EU-1-05-317_h_a_dec_10.pdf@2014-08-22 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_1.pdf@EU-1-05-319_h_a_dec_1.pdf@2006-04-24 00:00:00@Xolair@omalizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_0.pdf@EU-1-05-320_h_a_dec_0.pdf@2005-10-25 00:00:00@Noxafil@Posaconazole@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-05-318_h_a_dec_10.pdf@EU-1-05-318_h_a_dec_10.pdf@2009-03-08 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_0.pdf@EU-1-05-322_h_a_dec_0.pdf@2006-01-19 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@NA before 2012@OD Not Found@AEA Technology QSA GmbH@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_12.pdf@EU-1-05-315_h_a_dec_12.pdf@2007-12-19 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_11.pdf@EU-1-05-317_h_a_dec_11.pdf@2014-08-22 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_11.pdf@EU-1-05-316_h_a_dec_11.pdf@2013-12-18 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_10.pdf@EU-1-05-319_h_a_dec_10.pdf@2011-06-17 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_1.pdf@EU-1-05-322_h_a_dec_1.pdf@2006-11-20 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@NA before 2012@OD Not Found@QSA Global GmbH@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_1.pdf@EU-1-05-320_h_a_dec_1.pdf@2006-10-30 00:00:00@Noxafil@Posaconazole@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_13.pdf@EU-1-05-315_h_a_dec_13.pdf@2008-03-27 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_11.pdf@EU-1-05-318_h_a_dec_11.pdf@2009-12-21 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_12.pdf@EU-1-05-317_h_a_dec_12.pdf@2015-01-15 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_2.pdf@EU-1-05-322_h_a_dec_2.pdf@2009-06-29 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@False@OD Not Found@Nuclitec GmbH@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_11.pdf@EU-1-05-319_h_a_dec_11.pdf@2012-05-25 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_10.pdf@EU-1-05-320_h_a_dec_10.pdf@2012-08-23 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_14.pdf@EU-1-05-315_h_a_dec_14.pdf@2008-04-22 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@exceptional@Parsed
EU-1-05-316_h_a_dec_12.pdf@EU-1-05-316_h_a_dec_12.pdf@2014-08-22 00:00:00@Procoralan@Ivabradine@False@False@adopted@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_13.pdf@EU-1-05-317_h_a_dec_13.pdf@2016-01-25 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_12.pdf@EU-1-05-318_h_a_dec_12.pdf@2009-10-12 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_3.pdf@EU-1-05-322_h_a_dec_3.pdf@2010-02-02 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@False@OD Not Found@Eckert & Ziegler Nuclitec GmbH@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_15.pdf@EU-1-05-315_h_a_dec_15.pdf@2008-07-07 00:00:00@Aptivus@Tipranavir@NAS before 2012@True@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_14.pdf@EU-1-05-317_h_a_dec_14.pdf@2017-03-04 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_12.pdf@EU-1-05-319_h_a_dec_12.pdf@2014-02-28 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
bH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_13.pdf@EU-1-05-318_h_a_dec_13.pdf@2010-08-26 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_11.pdf@EU-1-05-320_h_a_dec_11.pdf@2014-04-23 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_16.pdf@EU-1-05-315_h_a_dec_16.pdf@2008-10-21 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_13.pdf@EU-1-05-316_h_a_dec_13.pdf@2014-08-22 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_15.pdf@EU-1-05-317_h_a_dec_15.pdf@2019-11-01 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_5.pdf@EU-1-05-322_h_a_dec_5.pdf@2011-08-24 00:00:00@Yttriga@Yttrium (90Y) Chloride@NAS before 2012@False@OD Not Found@Eckert & Ziegler Nuclitec GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_14.pdf@EU-1-05-318_h_a_dec_14.pdf@2010-09-23 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_17.pdf@EU-1-05-315_h_a_dec_17.pdf@2008-12-22 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_14.pdf@EU-1-05-316_h_a_dec_14.pdf@2015-01-15 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_16.pdf@EU-1-05-317_h_a_dec_16.pdf@2022-09-15 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_13.pdf@EU-1-05-319_h_a_dec_13.pdf@2015-06-22 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_12.pdf@EU-1-05-320_h_a_dec_12.pdf@2014-09-18 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_6.pdf@EU-1-05-322_h_a_dec_6.pdf@2012-04-20 00:00:00@Yttriga@Yttrium (90Y) Chloride@False@False@OD Not Found@Eckert & Ziegler Radiopharma GmbH,@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_15.pdf@EU-1-05-318_h_a_dec_15.pdf@2011-01-21 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_15.pdf@EU-1-05-316_h_a_dec_15.pdf@2016-01-25 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_18.pdf@EU-1-05-315_h_a_dec_18.pdf@2009-02-03 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_2.pdf@EU-1-05-317_h_a_dec_2.pdf@2009-05-05 00:00:00@Corlentor@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-322_h_a_dec_7.pdf@EU-1-05-322_h_a_dec_7.pdf@2015-08-07 00:00:00@Yttriga@Yttrium ( 90Y) Chloride@False@False@OD Not Found@Eckert & Ziegler Radiopharma GmbH@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_16.pdf@EU-1-05-316_h_a_dec_16.pdf@2017-03-04 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_16.pdf@EU-1-05-318_h_a_dec_16.pdf@2011-01-21 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_19.pdf@EU-1-05-315_h_a_dec_19.pdf@2009-05-29 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_3.pdf@EU-1-05-317_h_a_dec_3.pdf@2009-10-23 00:00:00@Corlentor@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_14.pdf@EU-1-05-319_h_a_dec_14.pdf@2016-09-09 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_13.pdf@EU-1-05-320_h_a_dec_13.pdf@2016-07-15 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_17.pdf@EU-1-05-316_h_a_dec_17.pdf@2019-11-01 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_2.pdf@EU-1-05-315_h_a_dec_2.pdf@2006-03-29 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_17.pdf@EU-1-05-318_h_a_dec_17.pdf@2011-03-24 00:00:00@Revatio@sildenafil@NAS before 2012@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_4.pdf@EU-1-05-317_h_a_dec_4.pdf@2010-08-31 00:00:00@Corlentor@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_18.pdf@EU-1-05-316_h_a_dec_18.pdf@2022-09-15 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_20.pdf@EU-1-05-315_h_a_dec_20.pdf@2009-06-23 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_5.pdf@EU-1-05-317_h_a_dec_5.pdf@2010-11-29 00:00:00@Corlentor@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_18.pdf@EU-1-05-318_h_a_dec_18.pdf@2011-02-05 00:00:00@Revatio@sildenafil@NAS before 2012@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_14.pdf@EU-1-05-320_h_a_dec_14.pdf@2016-07-22 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_0.pdf@EU-1-05-323_h_a_dec_0.pdf@2006-06-04 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Aventis Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_15.pdf@EU-1-05-319_h_a_dec_15.pdf@2018-04-26 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_2.pdf@EU-1-05-316_h_a_dec_2.pdf@2009-03-27 00:00:00@Procoralan@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_21.pdf@EU-1-05-315_h_a_dec_21.pdf@2009-06-23 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_6.pdf@EU-1-05-317_h_a_dec_6.pdf@2011-08-26 00:00:00@Sebivo@telbivudine@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_19.pdf@EU-1-05-318_h_a_dec_19.pdf@2011-10-24 00:00:00@Revatio@sildenafil@NAS before 2012@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_1.pdf@EU-1-05-323_h_a_dec_1.pdf@2006-12-09 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_15.pdf@EU-1-05-320_h_a_dec_15.pdf@2017-06-26 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_7.pdf@EU-1-05-317_h_a_dec_7.pdf@2012-06-02 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_2.pdf@EU-1-05-318_h_a_dec_2.pdf@2006-08-28 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_10.pdf@EU-1-05-323_h_a_dec_10.pdf@2011-05-09 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_16.pdf@EU-1-05-319_h_a_dec_16.pdf@2018-10-12 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_22.pdf@EU-1-05-315_h_a_dec_22.pdf@2009-10-16 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_3.pdf@EU-1-05-316_h_a_dec_3.pdf@2009-05-05 00:00:00@Procoralan@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_8.pdf@EU-1-05-317_h_a_dec_8.pdf@2012-10-25 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_11.pdf@EU-1-05-323_h_a_dec_11.pdf@2012-02-21 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_20.pdf@EU-1-05-318_h_a_dec_20.pdf@2012-03-21 00:00:00@Revatio@sildenafil@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_16.pdf@EU-1-05-320_h_a_dec_16.pdf@2018-06-07 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_23.pdf@EU-1-05-315_h_a_dec_23.pdf@2009-11-23 00:00:00@Aptivus@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_21.pdf@EU-1-05-318_h_a_dec_21.pdf@2012-04-13 00:00:00@Revatio@sildenafil@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_12.pdf@EU-1-05-323_h_a_dec_12.pdf@2012-03-19 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-05-317_h_a_dec_9.pdf@EU-1-05-317_h_a_dec_9.pdf@2013-12-18 00:00:00@Corlentor@Ivabradine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_4.pdf@EU-1-05-316_h_a_dec_4.pdf@2009-10-23 00:00:00@Procoralan@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_17.pdf@EU-1-05-319_h_a_dec_17.pdf@2020-02-28 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_24.pdf@EU-1-05-315_h_a_dec_24.pdf@2010-05-10 00:00:00@APTIVUS@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_22.pdf@EU-1-05-318_h_a_dec_22.pdf@2012-06-27 00:00:00@Revatio@sildenafil@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_13.pdf@EU-1-05-323_h_a_dec_13.pdf@2012-04-20 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_17.pdf@EU-1-05-320_h_a_dec_17.pdf@2020-10-15 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_25.pdf@EU-1-05-315_h_a_dec_25.pdf@2011-06-29 00:00:00@APTIVUS@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_14.pdf@EU-1-05-323_h_a_dec_14.pdf@2013-02-18 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_5.pdf@EU-1-05-316_h_a_dec_5.pdf@2010-08-31 00:00:00@Procoralan@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_23.pdf@EU-1-05-318_h_a_dec_23.pdf@2013-12-13 00:00:00@Revatio@sildenafil@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_18.pdf@EU-1-05-319_h_a_dec_18.pdf@2020-07-31 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_26.pdf@EU-1-05-315_h_a_dec_26.pdf@2011-12-19 00:00:00@APTIVUS@Tipranavir@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_15.pdf@EU-1-05-323_h_a_dec_15.pdf@2013-07-31 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_6.pdf@EU-1-05-316_h_a_dec_6.pdf@2010-11-29 00:00:00@Procoralan@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_18.pdf@EU-1-05-320_h_a_dec_18.pdf@2021-08-18 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_27.pdf@EU-1-05-315_h_a_dec_27.pdf@2013-12-18 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_24.pdf@EU-1-05-318_h_a_dec_24.pdf@2014-11-17 00:00:00@Revatio@sildenafil@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_16.pdf@EU-1-05-323_h_a_dec_16.pdf@2013-12-18 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_19.pdf@EU-1-05-319_h_a_dec_19.pdf@2022-10-14 00:00:00@Xolair@omalizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_7.pdf@EU-1-05-316_h_a_dec_7.pdf@2011-08-26 00:00:00@Procoralan@Ivabradine@NAS before 2012@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_17.pdf@EU-1-05-323_h_a_dec_17.pdf@2015-12-01 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_28.pdf@EU-1-05-315_h_a_dec_28.pdf@2014-06-08 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_25.pdf@EU-1-05-318_h_a_dec_25.pdf@2015-08-25 00:00:00@1) The following notifications for minor variations are added to the marketing  authorisation:  Application number  Scope (EU numbers affected)   EMEA/H/C/638/IG/44/G  C.I.9.e), C.I.9.g), C.I.9.h) (EU/1/05/318/001-002)  2) Annex I is replaced by the text set out in Annex I to this Decision;  3) Annex II is replaced by the text set out in Annex II to this Decision;  4) Annex III is replaced by the text set out in Annex III to this Decision.@Active Substance Not Found@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_19.pdf@EU-1-05-320_h_a_dec_19.pdf@2021-10-19 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_2.pdf@EU-1-05-319_h_a_dec_2.pdf@2007-05-30 00:00:00@Xolair@omalizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_8.pdf@EU-1-05-316_h_a_dec_8.pdf@2012-09-02 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_18.pdf@EU-1-05-323_h_a_dec_18.pdf@2015-12-16 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_29.pdf@EU-1-05-315_h_a_dec_29.pdf@2015-06-19 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_26.pdf@EU-1-05-318_h_a_dec_26.pdf@2016-03-31 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_0.pdf@EU-1-05-324_h_a_dec_0.pdf@2006-01-24 00:00:00@Naglazyme@Recombinant human N-acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@NA before 2012@adopted@BioMarin Europe Limited@exceptional@Parsed
EU-1-05-320_h_a_dec_2.pdf@EU-1-05-320_h_a_dec_2.pdf@2007-10-30 00:00:00@Noxafil@Posaconazole@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-316_h_a_dec_9.pdf@EU-1-05-316_h_a_dec_9.pdf@2012-09-02 00:00:00@Procoralan@Ivabradine@False@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_19.pdf@EU-1-05-323_h_a_dec_19.pdf@2017-12-18 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_3.pdf@EU-1-05-315_h_a_dec_3.pdf@2006-08-28 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_3.pdf@EU-1-05-319_h_a_dec_3.pdf@2009-07-01 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_1.pdf@EU-1-05-324_h_a_dec_1.pdf@2006-04-12 00:00:00@Naglazyme@acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@NA before 2012@OD Not Found@MAH Not Found@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_30.pdf@EU-1-05-315_h_a_dec_30.pdf@2017-06-02 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_2.pdf@EU-1-05-323_h_a_dec_2.pdf@2008-06-20 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_27.pdf@EU-1-05-318_h_a_dec_27.pdf@2016-07-29 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_4.pdf@EU-1-05-319_h_a_dec_4.pdf@2009-10-02 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_10.pdf@EU-1-05-324_h_a_dec_10.pdf@2012-11-15 00:00:00@Naglazyme@galsulfase@False@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-05-315_h_a_dec_31.pdf@EU-1-05-315_h_a_dec_31.pdf@2017-10-11 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_20.pdf@EU-1-05-320_h_a_dec_20.pdf@2022-06-01 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_20.pdf@EU-1-05-323_h_a_dec_20.pdf@2019-10-21 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_5.pdf@EU-1-05-319_h_a_dec_5.pdf@2009-07-27 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_28.pdf@EU-1-05-318_h_a_dec_28.pdf@2017-10-11 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_11.pdf@EU-1-05-324_h_a_dec_11.pdf@2014-12-15 00:00:00@Naglazyme@galsulfase@False@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-05-323_h_a_dec_21.pdf@EU-1-05-323_h_a_dec_21.pdf@2021-09-07 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_32.pdf@EU-1-05-315_h_a_dec_32.pdf@2019-09-23 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_33.pdf@EU-1-05-315_h_a_dec_33.pdf@2020-07-27 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_12.pdf@EU-1-05-324_h_a_dec_12.pdf@2017-09-01 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin Europe Ltd.@exceptional@Parsed
EU-1-05-323_h_a_dec_22.pdf@EU-1-05-323_h_a_dec_22.pdf@2022-04-13 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_21.pdf@EU-1-05-320_h_a_dec_21.pdf@2022-04-02 00:00:00@Noxafil@Posaconazole@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_6.pdf@EU-1-05-319_h_a_dec_6.pdf@2010-01-25 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_29.pdf@EU-1-05-318_h_a_dec_29.pdf@2018-07-30 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_34.pdf@EU-1-05-315_h_a_dec_34.pdf@2021-06-21 00:00:00@APTIVUS@Tipranavir@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_3.pdf@EU-1-05-320_h_a_dec_3.pdf@2008-03-03 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_3.pdf@EU-1-05-323_h_a_dec_3.pdf@2009-03-25 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_7.pdf@EU-1-05-319_h_a_dec_7.pdf@2010-03-30 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_3.pdf@EU-1-05-318_h_a_dec_3.pdf@2007-01-17 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_0.pdf@EU-1-05-328_h_a_dec_0.pdf@2006-01-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_13.pdf@EU-1-05-324_h_a_dec_13.pdf@2018-07-13 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_4.pdf@EU-1-05-315_h_a_dec_4.pdf@2006-11-24 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_4.pdf@EU-1-05-323_h_a_dec_4.pdf@2009-01-07 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_4.pdf@EU-1-05-320_h_a_dec_4.pdf@2008-04-12 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_30.pdf@EU-1-05-318_h_a_dec_30.pdf@2020-02-06 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_5.pdf@EU-1-05-315_h_a_dec_5.pdf@2007-01-24 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_8.pdf@EU-1-05-319_h_a_dec_8.pdf@2010-06-09 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_1.pdf@EU-1-05-328_h_a_dec_1.pdf@2006-01-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_5.pdf@EU-1-05-323_h_a_dec_5.pdf@2010-01-19 00:00:00@ProQuad@Measles, Mumps, Rubella  and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_5.pdf@EU-1-05-320_h_a_dec_5.pdf@2009-10-28 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_14.pdf@EU-1-05-324_h_a_dec_14.pdf@2020-03-04 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin International Limited@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_31.pdf@EU-1-05-318_h_a_dec_31.pdf@2020-12-14 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_6.pdf@EU-1-05-315_h_a_dec_6.pdf@2007-02-27 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_6.pdf@EU-1-05-323_h_a_dec_6.pdf@2010-06-09 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-05-319_h_a_dec_9.pdf@EU-1-05-319_h_a_dec_9.pdf@2010-12-11 00:00:00@Xolair@omalizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_10.pdf@EU-1-05-328_h_a_dec_10.pdf@2010-03-26 00:00:00@CUBICIN@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_6.pdf@EU-1-05-320_h_a_dec_6.pdf@2009-11-23 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_32.pdf@EU-1-05-318_h_a_dec_32.pdf@2021-11-15 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_7.pdf@EU-1-05-315_h_a_dec_7.pdf@2007-03-21 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@exceptional@Parsed
EU-1-05-324_h_a_dec_15.pdf@EU-1-05-324_h_a_dec_15.pdf@2020-05-05 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin International Limited@exceptional@Parsed
EU-1-05-323_h_a_dec_7.pdf@EU-1-05-323_h_a_dec_7.pdf@2010-10-25 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_8.pdf@EU-1-05-315_h_a_dec_8.pdf@2007-04-06 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_33.pdf@EU-1-05-318_h_a_dec_33.pdf@2022-01-04 00:00:00@Revatio@sildenafil@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_11.pdf@EU-1-05-328_h_a_dec_11.pdf@2010-08-26 00:00:00@Cubicin@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-320_h_a_dec_7.pdf@EU-1-05-320_h_a_dec_7.pdf@2010-09-30 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_8.pdf@EU-1-05-323_h_a_dec_8.pdf@2011-02-28 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine  (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-05-315_h_a_dec_9.pdf@EU-1-05-315_h_a_dec_9.pdf@2007-02-07 00:00:00@Aptivus@Tipranavir@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_4.pdf@EU-1-05-318_h_a_dec_4.pdf@2007-03-27 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_16.pdf@EU-1-05-324_h_a_dec_16.pdf@2021-11-01 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin International Limited@exceptional@Parsed
EU-1-05-320_h_a_dec_8.pdf@EU-1-05-320_h_a_dec_8.pdf@2011-06-10 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_12.pdf@EU-1-05-328_h_a_dec_12.pdf@2010-11-29 00:00:00@Cubicin@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-323_h_a_dec_9.pdf@EU-1-05-323_h_a_dec_9.pdf@2011-03-17 00:00:00@ProQuad@Measles, Mumps, Rubella and Varicella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_5.pdf@EU-1-05-318_h_a_dec_5.pdf@2007-04-13 00:00:00@Revatio@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@exceptional@Parsed
EU-1-05-320_h_a_dec_9.pdf@EU-1-05-320_h_a_dec_9.pdf@2011-12-19 00:00:00@Noxafil@Posaconazole@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_17.pdf@EU-1-05-324_h_a_dec_17.pdf@2021-03-12 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin International Limited@exceptional@Parsed
EU-1-05-328_h_a_dec_13.pdf@EU-1-05-328_h_a_dec_13.pdf@2011-01-21 00:00:00@Cubicin@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_6.pdf@EU-1-05-318_h_a_dec_6.pdf@2008-03-17 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_14.pdf@EU-1-05-328_h_a_dec_14.pdf@2012-02-21 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-05-318_h_a_dec_7.pdf@EU-1-05-318_h_a_dec_7.pdf@2008-08-25 00:00:00@Revatio@sildenafil@NAS before 2012@True@OD Not Found@Pfizer Limited@exceptional@Parsed
EU-1-05-324_h_a_dec_18.pdf@EU-1-05-324_h_a_dec_18.pdf@2022-01-04 00:00:00@Naglazyme@galsulfase@False@False@OD Not Found@BioMarin International Limited@exceptional@Parsed
EU-1-05-318_h_a_dec_8.pdf@EU-1-05-318_h_a_dec_8.pdf@2008-10-28 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_15.pdf@EU-1-05-328_h_a_dec_15.pdf@2013-03-12 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_2.pdf@EU-1-05-324_h_a_dec_2.pdf@2007-02-07 00:00:00@Naglazyme@galsulfase@NAS before 2012@NA before 2012@OD Not Found@BioMarin Europe Limited@exceptional@Parsed
EU-1-05-318_h_a_dec_9.pdf@EU-1-05-318_h_a_dec_9.pdf@2009-07-07 00:00:00@Revatio@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_3.pdf@EU-1-05-324_h_a_dec_3.pdf@2008-01-31 00:00:00@Naglazyme@acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@False@OD Not Found@BioMarin Europe Limited@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_16.pdf@EU-1-05-328_h_a_dec_16.pdf@2015-09-04 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_4.pdf@EU-1-05-324_h_a_dec_4.pdf@2008-07-29 00:00:00@Naglazyme@sulphatase (galsulfase)@NAS before 2012@True@OD Not Found@BioMarin Europe Limited@exceptional@Parsed
EU-1-05-329_h_a_dec_0.pdf@EU-1-05-329_h_a_dec_0.pdf@2006-01-19 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_17.pdf@EU-1-05-328_h_a_dec_17.pdf@2015-11-19 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_5.pdf@EU-1-05-324_h_a_dec_5.pdf@2009-01-07 00:00:00@Naglazyme@sulphatase (galsulfase)@NAS before 2012@False@OD Not Found@BioMarin Europe Ltd@exceptional@Parsed
EU-1-05-329_h_a_dec_1.pdf@EU-1-05-329_h_a_dec_1.pdf@2007-08-21 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@NA before 2012@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_18.pdf@EU-1-05-328_h_a_dec_18.pdf@2016-04-25 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_10.pdf@EU-1-05-329_h_a_dec_10.pdf@2016-02-06 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_6.pdf@EU-1-05-324_h_a_dec_6.pdf@2010-06-08 00:00:00@Naglazyme@sulphatase (galsulfase)@NAS before 2012@False@OD Not Found@BioMarin Europe Ltd@exceptional@Parsed
EU-1-05-330_h_a_dec_0.pdf@EU-1-05-330_h_a_dec_0.pdf@2006-02-21 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_11.pdf@EU-1-05-329_h_a_dec_11.pdf@2019-05-03 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_19.pdf@EU-1-05-328_h_a_dec_19.pdf@2016-09-06 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_7.pdf@EU-1-05-324_h_a_dec_7.pdf@2010-12-20 00:00:00@Naglazyme@Recombinant  human  N-acetylgalactosamine  4-sulphatase  (galsulfase)@NAS before 2012@False@adopted@BioMarin Europe  Ltd@exceptional@Parsed
EU-1-05-331_h_a_dec_0.pdf@EU-1-05-331_h_a_dec_0.pdf@2006-02-15 00:00:00@Neupro@Rotigotine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_1.pdf@EU-1-05-330_h_a_dec_1.pdf@2006-11-12 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_12.pdf@EU-1-05-329_h_a_dec_12.pdf@2019-10-21 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_2.pdf@EU-1-05-328_h_a_dec_2.pdf@2006-01-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Limited@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_8.pdf@EU-1-05-324_h_a_dec_8.pdf@2011-01-26 00:00:00@Naglazyme@Recombinant human N-acetylgalactosamine 4-sulphatase (galsulfase)@NAS before 2012@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_13.pdf@EU-1-05-329_h_a_dec_13.pdf@2020-09-06 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Takeda Manufacturing Austria AG@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_10.pdf@EU-1-05-330_h_a_dec_10.pdf@2011-01-24 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_0.pdf@EU-1-06-332_h_a_dec_0.pdf@2006-12-04 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-324_h_a_dec_9.pdf@EU-1-05-324_h_a_dec_9.pdf@2011-10-20 00:00:00@Naglazyme@Recombinant  human  N-acetylgalactosamine  4-sulphatase  (galsulfase)@NAS before 2012@False@adopted@BioMarin Europe  Ltd@exceptional@Parsed
EU-1-05-331_h_a_dec_1.pdf@EU-1-05-331_h_a_dec_1.pdf@2007-09-01 00:00:00@Neupro@Rotigotine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_20.pdf@EU-1-05-328_h_a_dec_20.pdf@2016-06-24 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
a AG@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_11.pdf@EU-1-05-330_h_a_dec_11.pdf@2011-04-14 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_1.pdf@EU-1-06-332_h_a_dec_1.pdf@2007-04-20 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_2.pdf@EU-1-05-329_h_a_dec_2.pdf@2010-01-25 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_10.pdf@EU-1-05-331_h_a_dec_10.pdf@2010-03-15 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_12.pdf@EU-1-05-330_h_a_dec_12.pdf@2011-06-05 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_10.pdf@EU-1-06-332_h_a_dec_10.pdf@2015-03-16 00:00:00@Omnitrope@Somatropin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_21.pdf@EU-1-05-328_h_a_dec_21.pdf@2017-06-16 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_3.pdf@EU-1-05-329_h_a_dec_3.pdf@2010-05-05 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_13.pdf@EU-1-05-330_h_a_dec_13.pdf@2011-06-05 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_0.pdf@EU-1-06-333_h_a_dec_0.pdf@2006-03-29 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@NA before 2012@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_11.pdf@EU-1-05-331_h_a_dec_11.pdf@2010-08-18 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_11.pdf@EU-1-06-332_h_a_dec_11.pdf@2018-02-27 00:00:00@Omnitrope@Somatropin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_14.pdf@EU-1-05-330_h_a_dec_14.pdf@2011-05-18 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_4.pdf@EU-1-05-329_h_a_dec_4.pdf@2010-01-07 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_22.pdf@EU-1-05-328_h_a_dec_22.pdf@2017-11-16 00:00:00@Brand name Not Found@Active Substance Not Found@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_1.pdf@EU-1-06-333_h_a_dec_1.pdf@2006-07-28 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_12.pdf@EU-1-06-332_h_a_dec_12.pdf@2021-11-02 00:00:00@Omnitrope@Somatropin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_0.pdf@EU-1-06-334_h_a_dec_0.pdf@2006-05-29 00:00:00@Evoltra@clofarabine@NAS before 2012@NA before 2012@adopted@Bioenvision Limited@exceptional@Parsed
EU-1-05-330_h_a_dec_15.pdf@EU-1-05-330_h_a_dec_15.pdf@2011-10-24 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_12.pdf@EU-1-05-331_h_a_dec_12.pdf@2010-11-29 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_5.pdf@EU-1-05-329_h_a_dec_5.pdf@2010-01-07 00:00:00@Kiovig@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_10.pdf@EU-1-06-333_h_a_dec_10.pdf@2011-11-22 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_13.pdf@EU-1-06-332_h_a_dec_13.pdf@2022-10-14 00:00:00@Omnitrope@Somatropin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_1.pdf@EU-1-06-334_h_a_dec_1.pdf@2007-08-29 00:00:00@Evoltra@clofarabine@NAS before 2012@NA before 2012@OD Not Found@Bioenvision Limited@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_6.pdf@EU-1-05-329_h_a_dec_6.pdf@2010-06-12 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_16.pdf@EU-1-05-330_h_a_dec_16.pdf@2013-11-20 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_13.pdf@EU-1-05-331_h_a_dec_13.pdf@2011-02-21 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma  Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_23.pdf@EU-1-05-328_h_a_dec_23.pdf@2018-06-25 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_2.pdf@EU-1-06-332_h_a_dec_2.pdf@2007-05-15 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_10.pdf@EU-1-06-334_h_a_dec_10.pdf@2011-11-21 00:00:00@Evoltra@clofarabine@NAS before 2012@False@adopted@Genzyme Europe BV@exceptional@Parsed
EU-1-06-333_h_a_dec_11.pdf@EU-1-06-333_h_a_dec_11.pdf@2013-12-18 00:00:00@Myozyme@alglucosidase alfa@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_7.pdf@EU-1-05-329_h_a_dec_7.pdf@2011-07-27 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_17.pdf@EU-1-05-330_h_a_dec_17.pdf@2015-08-04 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_14.pdf@EU-1-05-331_h_a_dec_14.pdf@2011-08-24 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_3.pdf@EU-1-06-332_h_a_dec_3.pdf@2007-09-19 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_12.pdf@EU-1-06-333_h_a_dec_12.pdf@2017-10-07 00:00:00@Myozyme@alglucosidase alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_11.pdf@EU-1-06-334_h_a_dec_11.pdf@2011-03-24 00:00:00@Evoltra@clofarabine@NAS before 2012@False@adopted@Genzyme Europe BV@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_24.pdf@EU-1-05-328_h_a_dec_24.pdf@2018-08-08 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_8.pdf@EU-1-05-329_h_a_dec_8.pdf@2012-10-31 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_18.pdf@EU-1-05-330_h_a_dec_18.pdf@2016-01-14 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_12.pdf@EU-1-06-334_h_a_dec_12.pdf@2012-04-13 00:00:00@Evoltra@clofarabine@False@False@adopted@Genzyme Europe BV@exceptional@Parsed
EU-1-06-333_h_a_dec_13.pdf@EU-1-06-333_h_a_dec_13.pdf@2019-11-22 00:00:00@Myozyme@alglucosidase alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_4.pdf@EU-1-06-332_h_a_dec_4.pdf@2007-09-19 00:00:00@Omnitrope@Somatropin@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_15.pdf@EU-1-05-331_h_a_dec_15.pdf@2012-03-26 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_25.pdf@EU-1-05-328_h_a_dec_25.pdf@2019-11-14 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_19.pdf@EU-1-05-330_h_a_dec_19.pdf@2017-04-20 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-329_h_a_dec_9.pdf@EU-1-05-329_h_a_dec_9.pdf@2014-03-06 00:00:00@Kiovig@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Baxter AG@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_14.pdf@EU-1-06-333_h_a_dec_14.pdf@2020-10-11 00:00:00@Myozyme@alglucosidase alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_5.pdf@EU-1-06-332_h_a_dec_5.pdf@2008-03-18 00:00:00@Omnitrope@Somatropin@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_16.pdf@EU-1-05-331_h_a_dec_16.pdf@2012-03-26 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_26.pdf@EU-1-05-328_h_a_dec_26.pdf@2021-01-29 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_13.pdf@EU-1-06-334_h_a_dec_13.pdf@2014-10-10 00:00:00@Evoltra@clofarabine@False@False@adopted@Genzyme Europe B.V.@exceptional@Parsed
EU-1-05-330_h_a_dec_2.pdf@EU-1-05-330_h_a_dec_2.pdf@2007-06-12 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_15.pdf@EU-1-06-333_h_a_dec_15.pdf@2021-10-19 00:00:00@Myozyme@alglucosidase alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_6.pdf@EU-1-06-332_h_a_dec_6.pdf@2011-02-28 00:00:00@Omnitrope@Somatropin@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_17.pdf@EU-1-05-331_h_a_dec_17.pdf@2012-08-23 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing  Ireland Ltd.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_20.pdf@EU-1-05-330_h_a_dec_20.pdf@2018-01-30 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_27.pdf@EU-1-05-328_h_a_dec_27.pdf@2022-02-14 00:00:00@Cubicin@Daptomycin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_7.pdf@EU-1-06-332_h_a_dec_7.pdf@2011-06-16 00:00:00@Omnitrope@Somatropin@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_14.pdf@EU-1-06-334_h_a_dec_14.pdf@2014-11-19 00:00:00@Evoltra@clofarabine@False@False@adopted@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-333_h_a_dec_2.pdf@EU-1-06-333_h_a_dec_2.pdf@2007-09-10 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_18.pdf@EU-1-05-331_h_a_dec_18.pdf@2013-01-14 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_21.pdf@EU-1-05-330_h_a_dec_21.pdf@2019-03-25 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_3.pdf@EU-1-05-328_h_a_dec_3.pdf@2006-07-25 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Chiron Corporation Ltd@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_8.pdf@EU-1-06-332_h_a_dec_8.pdf@2012-02-03 00:00:00@Omnitrope@Somatropin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_15.pdf@EU-1-06-334_h_a_dec_15.pdf@2015-03-16 00:00:00@Evoltra@clofarabine@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-333_h_a_dec_3.pdf@EU-1-06-333_h_a_dec_3.pdf@2008-10-30 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_22.pdf@EU-1-05-330_h_a_dec_22.pdf@2021-01-02 00:00:00@Rotarix@Rotavirus vaccine, live@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_19.pdf@EU-1-05-331_h_a_dec_19.pdf@2013-05-27 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_4.pdf@EU-1-05-328_h_a_dec_4.pdf@2007-08-31 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_16.pdf@EU-1-06-334_h_a_dec_16.pdf@2015-09-18 00:00:00@Evoltra@clofarabine@False@False@adopted@Genzyme Europe B.V.@conditional@Parsed
EU-1-06-333_h_a_dec_4.pdf@EU-1-06-333_h_a_dec_4.pdf@2009-02-20 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-332_h_a_dec_9.pdf@EU-1-06-332_h_a_dec_9.pdf@2014-07-18 00:00:00@Omnitrope@Somatropin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_3.pdf@EU-1-05-330_h_a_dec_3.pdf@2008-06-19 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_5.pdf@EU-1-05-328_h_a_dec_5.pdf@2007-12-19 00:00:00@CUBICIN@Daptomycin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_2.pdf@EU-1-05-331_h_a_dec_2.pdf@2008-04-08 00:00:00@Neupro@Rotigotine@NAS before 2012@True@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_0.pdf@EU-1-06-336_h_a_dec_0.pdf@2006-04-24 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_5.pdf@EU-1-06-333_h_a_dec_5.pdf@2009-02-23 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_17.pdf@EU-1-06-334_h_a_dec_17.pdf@2016-01-14 00:00:00@Evoltra@clofarabine@False@False@adopted@Genzyme Europe B.V.@exceptional@Parsed
EU-1-05-328_h_a_dec_6.pdf@EU-1-05-328_h_a_dec_6.pdf@2008-07-22 00:00:00@CUBICIN@Daptomycin@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_4.pdf@EU-1-05-330_h_a_dec_4.pdf@2008-04-07 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_6.pdf@EU-1-06-333_h_a_dec_6.pdf@2009-08-21 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_1.pdf@EU-1-06-336_h_a_dec_1.pdf@2007-06-29 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_18.pdf@EU-1-06-334_h_a_dec_18.pdf@2016-09-15 00:00:00@Evoltra@clofarabine@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-05-331_h_a_dec_20.pdf@EU-1-05-331_h_a_dec_20.pdf@2013-07-31 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_7.pdf@EU-1-05-328_h_a_dec_7.pdf@2009-04-17 00:00:00@CUBICIN@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_5.pdf@EU-1-05-330_h_a_dec_5.pdf@2008-01-09 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_7.pdf@EU-1-06-333_h_a_dec_7.pdf@2009-10-28 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_2.pdf@EU-1-06-334_h_a_dec_2.pdf@2008-01-17 00:00:00@Evoltra@clofarabine@NAS before 2012@False@OD Not Found@Bioenvision Limited@exceptional@Parsed
EU-1-06-336_h_a_dec_10.pdf@EU-1-06-336_h_a_dec_10.pdf@2010-01-07 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_8.pdf@EU-1-05-328_h_a_dec_8.pdf@2009-07-16 00:00:00@CUBICIN@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_21.pdf@EU-1-05-331_h_a_dec_21.pdf@2014-11-19 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_20.pdf@EU-1-06-334_h_a_dec_20.pdf@2018-12-12 00:00:00@Evoltra@clofarabine@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-336_h_a_dec_11.pdf@EU-1-06-336_h_a_dec_11.pdf@2011-06-05 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_8.pdf@EU-1-06-333_h_a_dec_8.pdf@2010-08-26 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_6.pdf@EU-1-05-330_h_a_dec_6.pdf@2009-08-21 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-05-328_h_a_dec_9.pdf@EU-1-05-328_h_a_dec_9.pdf@2010-03-15 00:00:00@CUBICIN@Daptomycin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_21.pdf@EU-1-06-334_h_a_dec_21.pdf@2019-11-14 00:00:00@Evoltra@clofarabine@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-336_h_a_dec_12.pdf@EU-1-06-336_h_a_dec_12.pdf@2011-06-05 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-333_h_a_dec_9.pdf@EU-1-06-333_h_a_dec_9.pdf@2011-02-21 00:00:00@Myozyme@alglucosidase alpha@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_7.pdf@EU-1-05-330_h_a_dec_7.pdf@2010-03-30 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_22.pdf@EU-1-05-331_h_a_dec_22.pdf@2016-01-22 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_22.pdf@EU-1-06-334_h_a_dec_22.pdf@2020-09-24 00:00:00@Evoltra@clofarabine@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-336_h_a_dec_13.pdf@EU-1-06-336_h_a_dec_13.pdf@2011-05-23 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_8.pdf@EU-1-05-330_h_a_dec_8.pdf@2010-09-30 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_23.pdf@EU-1-06-334_h_a_dec_23.pdf@2021-12-11 00:00:00@Evoltra@clofarabine@False@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-336_h_a_dec_14.pdf@EU-1-06-336_h_a_dec_14.pdf@2011-06-17 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_23.pdf@EU-1-05-331_h_a_dec_23.pdf@2017-02-16 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_0.pdf@EU-1-06-337_h_a_dec_0.pdf@2006-05-05 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_15.pdf@EU-1-06-336_h_a_dec_15.pdf@2011-08-24 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-05-330_h_a_dec_9.pdf@EU-1-05-330_h_a_dec_9.pdf@2010-03-11 00:00:00@Rotarix@Rotavirus vaccine, live@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_1.pdf@EU-1-06-337_h_a_dec_1.pdf@2007-04-23 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_3.pdf@EU-1-06-334_h_a_dec_3.pdf@2008-04-06 00:00:00@Evoltra@clofarabine@NAS before 2012@True@OD Not Found@Bioenvision Limited@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_24.pdf@EU-1-05-331_h_a_dec_24.pdf@2017-09-28 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Manufacturing Ireland Ltd@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_16.pdf@EU-1-06-336_h_a_dec_16.pdf@2011-10-27 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_0.pdf@EU-1-06-338_h_a_dec_0.pdf@2006-04-24 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_25.pdf@EU-1-05-331_h_a_dec_25.pdf@2017-11-12 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_4.pdf@EU-1-06-334_h_a_dec_4.pdf@2009-02-20 00:00:00@Evoltra@clofarabine@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-06-337_h_a_dec_10.pdf@EU-1-06-337_h_a_dec_10.pdf@2013-02-20 00:00:00@M-M-RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_17.pdf@EU-1-06-336_h_a_dec_17.pdf@2011-11-21 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_26.pdf@EU-1-05-331_h_a_dec_26.pdf@2018-08-11 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_11.pdf@EU-1-06-337_h_a_dec_11.pdf@2015-09-04 00:00:00@M-M- RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_5.pdf@EU-1-06-334_h_a_dec_5.pdf@2009-04-29 00:00:00@Evoltra@clofarabine@NAS before 2012@False@OD Not Found@Genzyme Europe BV@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_1.pdf@EU-1-06-338_h_a_dec_1.pdf@2008-03-31 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_18.pdf@EU-1-06-336_h_a_dec_18.pdf@2012-08-30 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_27.pdf@EU-1-05-331_h_a_dec_27.pdf@2021-11-01 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_12.pdf@EU-1-06-337_h_a_dec_12.pdf@2017-12-15 00:00:00@M-M- RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_6.pdf@EU-1-06-334_h_a_dec_6.pdf@2009-10-12 00:00:00@Evoltra@clofarabine@NAS before 2012@False@OD Not Found@Genzyme Europe BV@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_19.pdf@EU-1-06-336_h_a_dec_19.pdf@2012-11-30 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_10.pdf@EU-1-06-338_h_a_dec_10.pdf@2018-05-31 00:00:00@DuoTrav@Travoprost / Timolol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
nd@Parsed
EU-1-05-331_h_a_dec_28.pdf@EU-1-05-331_h_a_dec_28.pdf@2022-04-02 00:00:00@Neupro@Rotigotine@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_2.pdf@EU-1-06-336_h_a_dec_2.pdf@2007-10-24 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_7.pdf@EU-1-06-334_h_a_dec_7.pdf@2010-03-15 00:00:00@Evoltra@clofarabine@NAS before 2012@False@OD Not Found@Genzyme Europe BV@exceptional@Parsed
EU-1-06-337_h_a_dec_14.pdf@EU-1-06-337_h_a_dec_14.pdf@2021-03-22 00:00:00@M-M- RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_20.pdf@EU-1-06-336_h_a_dec_20.pdf@2013-11-15 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_8.pdf@EU-1-06-334_h_a_dec_8.pdf@2010-03-19 00:00:00@Evoltra@clofarabine@NAS before 2012@False@OD Not Found@Genzyme Europe BV@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_3.pdf@EU-1-05-331_h_a_dec_3.pdf@2008-08-29 00:00:00@Neupro@Rotigotine@NAS before 2012@True@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_0.pdf@EU-1-06-340_h_a_dec_0.pdf@2006-05-19 00:00:00@Ganfort@bimatoprost/timolol@NAS before 2012@NA before 2012@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_11.pdf@EU-1-06-338_h_a_dec_11.pdf@2022-05-19 00:00:00@DuoTrav@Travoprost / Timolol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_15.pdf@EU-1-06-337_h_a_dec_15.pdf@2022-04-13 00:00:00@M-M-RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_4.pdf@EU-1-05-331_h_a_dec_4.pdf@2008-08-29 00:00:00@Neupro@Rotigotine@NAS before 2012@True@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-334_h_a_dec_9.pdf@EU-1-06-334_h_a_dec_9.pdf@2011-03-24 00:00:00@Evoltra@clofarabine@NAS before 2012@False@adopted@Genzyme Europe BV@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_2.pdf@EU-1-06-337_h_a_dec_2.pdf@2007-06-25 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_2.pdf@EU-1-06-338_h_a_dec_2.pdf@2008-07-31 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@True@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_1.pdf@EU-1-06-340_h_a_dec_1.pdf@2009-02-03 00:00:00@Ganfort@bimatoprost/timolol@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_21.pdf@EU-1-06-336_h_a_dec_21.pdf@2014-11-17 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_5.pdf@EU-1-05-331_h_a_dec_5.pdf@2008-06-11 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_3.pdf@EU-1-06-338_h_a_dec_3.pdf@2009-02-02 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_3.pdf@EU-1-06-337_h_a_dec_3.pdf@2008-04-18 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_0.pdf@EU-1-06-341_h_a_dec_0.pdf@2006-05-19 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_22.pdf@EU-1-06-336_h_a_dec_22.pdf@2015-05-28 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_10.pdf@EU-1-06-340_h_a_dec_10.pdf@2021-01-29 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_6.pdf@EU-1-05-331_h_a_dec_6.pdf@2009-02-04 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_1.pdf@EU-1-06-341_h_a_dec_1.pdf@2007-03-01 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_4.pdf@EU-1-06-338_h_a_dec_4.pdf@2010-07-10 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_4.pdf@EU-1-06-337_h_a_dec_4.pdf@2008-06-20 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_5.pdf@EU-1-06-338_h_a_dec_5.pdf@2011-03-24 00:00:00@DuoTrav@Travoprost/Timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories  (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_5.pdf@EU-1-06-337_h_a_dec_5.pdf@2010-01-19 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_10.pdf@EU-1-06-341_h_a_dec_10.pdf@2010-10-25 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_23.pdf@EU-1-06-336_h_a_dec_23.pdf@2016-02-22 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_11.pdf@EU-1-06-340_h_a_dec_11.pdf@2022-06-14 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_6.pdf@EU-1-06-338_h_a_dec_6.pdf@2012-08-10 00:00:00@DuoTrav@Travoprost / Timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_8.pdf@EU-1-05-331_h_a_dec_8.pdf@2009-07-16 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_6.pdf@EU-1-06-337_h_a_dec_6.pdf@2010-03-15 00:00:00@M-M-RVAXPRO@Measles, Mumps  and Rubella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_11.pdf@EU-1-06-341_h_a_dec_11.pdf@2010-12-20 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_2.pdf@EU-1-06-340_h_a_dec_2.pdf@2011-06-23 00:00:00@Ganfort@bimatoprost/timolol@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_7.pdf@EU-1-06-337_h_a_dec_7.pdf@2010-06-09 00:00:00@M-M-RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-05-331_h_a_dec_9.pdf@EU-1-05-331_h_a_dec_9.pdf@2009-08-31 00:00:00@Neupro@Rotigotine@NAS before 2012@False@OD Not Found@Schwarz Pharma Ltd@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_24.pdf@EU-1-06-336_h_a_dec_24.pdf@2017-05-16 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_7.pdf@EU-1-06-338_h_a_dec_7.pdf@2014-03-21 00:00:00@DuoTrav@Travoprost / Timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_3.pdf@EU-1-06-340_h_a_dec_3.pdf@2012-06-07 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_0.pdf@EU-1-06-342_h_a_dec_0.pdf@2006-07-19 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@adopted@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_12.pdf@EU-1-06-341_h_a_dec_12.pdf@2011-03-24 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_8.pdf@EU-1-06-337_h_a_dec_8.pdf@2010-10-25 00:00:00@M-M-RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_4.pdf@EU-1-06-340_h_a_dec_4.pdf@2012-10-24 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan  Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_13.pdf@EU-1-06-341_h_a_dec_13.pdf@2012-01-20 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_1.pdf@EU-1-06-342_h_a_dec_1.pdf@2007-03-01 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-337_h_a_dec_9.pdf@EU-1-06-337_h_a_dec_9.pdf@2011-05-05 00:00:00@M-M-RVAXPRO@Measles, Mumps and Rubella Vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_25.pdf@EU-1-06-336_h_a_dec_25.pdf@2018-07-30 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_8.pdf@EU-1-06-338_h_a_dec_8.pdf@2015-06-19 00:00:00@DuoTrav@Travoprost / Timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_5.pdf@EU-1-06-340_h_a_dec_5.pdf@2013-03-13 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland,  (901969)@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_14.pdf@EU-1-06-341_h_a_dec_14.pdf@2012-02-21 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_26.pdf@EU-1-06-336_h_a_dec_26.pdf@2021-10-05 00:00:00@Tygacil@Tigecycline@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_10.pdf@EU-1-06-342_h_a_dec_10.pdf@2009-07-24 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_15.pdf@EU-1-06-341_h_a_dec_15.pdf@2012-03-21 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_3.pdf@EU-1-06-336_h_a_dec_3.pdf@2007-12-19 00:00:00@Tygacil@tigecycline@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_6.pdf@EU-1-06-340_h_a_dec_6.pdf@2013-04-10 00:00:00@Ganfort@bimatoprost /  timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-338_h_a_dec_9.pdf@EU-1-06-338_h_a_dec_9.pdf@2017-05-16 00:00:00@DuoTrav@Travoprost / Timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_11.pdf@EU-1-06-342_h_a_dec_11.pdf@2009-10-15 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_16.pdf@EU-1-06-341_h_a_dec_16.pdf@2012-08-23 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_4.pdf@EU-1-06-336_h_a_dec_4.pdf@2008-03-27 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_12.pdf@EU-1-06-342_h_a_dec_12.pdf@2009-11-23 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_17.pdf@EU-1-06-341_h_a_dec_17.pdf@2013-02-13 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_7.pdf@EU-1-06-340_h_a_dec_7.pdf@2016-09-15 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_5.pdf@EU-1-06-336_h_a_dec_5.pdf@2008-06-25 00:00:00@Tygacil@tigecycline@NAS before 2012@True@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_13.pdf@EU-1-06-342_h_a_dec_13.pdf@2010-08-26 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_18.pdf@EU-1-06-341_h_a_dec_18.pdf@2015-12-01 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_0.pdf@EU-1-06-343_h_a_dec_0.pdf@2006-06-26 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_8.pdf@EU-1-06-340_h_a_dec_8.pdf@2018-03-27 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_19.pdf@EU-1-06-341_h_a_dec_19.pdf@2015-12-18 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_14.pdf@EU-1-06-342_h_a_dec_14.pdf@2010-11-26 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_0.pdf@EU-1-06-346_h_a_dec_0.pdf@2006-06-27 00:00:00@Tysabri@Natalizumab@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_1.pdf@EU-1-06-343_h_a_dec_1.pdf@2007-04-26 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_7.pdf@EU-1-06-336_h_a_dec_7.pdf@2009-07-07 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_2.pdf@EU-1-06-341_h_a_dec_2.pdf@2007-07-24 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_10.pdf@EU-1-06-343_h_a_dec_10.pdf@2009-03-08 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_8.pdf@EU-1-06-336_h_a_dec_8.pdf@2010-03-26 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_15.pdf@EU-1-06-342_h_a_dec_15.pdf@2011-12-04 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_1.pdf@EU-1-06-346_h_a_dec_1.pdf@2006-06-27 00:00:00@Tysabri@Natalizumab@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-340_h_a_dec_9.pdf@EU-1-06-340_h_a_dec_9.pdf@2019-09-19 00:00:00@Ganfort@bimatoprost / timolol@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_20.pdf@EU-1-06-341_h_a_dec_20.pdf@2016-11-02 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-336_h_a_dec_9.pdf@EU-1-06-336_h_a_dec_9.pdf@2010-04-29 00:00:00@Tygacil@tigecycline@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_16.pdf@EU-1-06-342_h_a_dec_16.pdf@2011-02-05 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_12.pdf@EU-1-06-343_h_a_dec_12.pdf@2010-08-26 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_10.pdf@EU-1-06-346_h_a_dec_10.pdf@2010-10-05 00:00:00@Tysabri@natalizumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_17.pdf@EU-1-06-342_h_a_dec_17.pdf@2011-06-29 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@adopted@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_21.pdf@EU-1-06-341_h_a_dec_21.pdf@2018-01-15 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_13.pdf@EU-1-06-343_h_a_dec_13.pdf@2010-10-25 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_18.pdf@EU-1-06-342_h_a_dec_18.pdf@2011-01-08 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@adopted@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_11.pdf@EU-1-06-346_h_a_dec_11.pdf@2010-10-05 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_22.pdf@EU-1-06-341_h_a_dec_22.pdf@2019-10-24 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_14.pdf@EU-1-06-343_h_a_dec_14.pdf@2011-02-21 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_23.pdf@EU-1-06-341_h_a_dec_23.pdf@2021-08-18 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_12.pdf@EU-1-06-346_h_a_dec_12.pdf@2010-11-29 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma  International Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_19.pdf@EU-1-06-342_h_a_dec_19.pdf@2011-10-24 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_15.pdf@EU-1-06-343_h_a_dec_15.pdf@2011-02-28 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_0.pdf@EU-1-06-347_h_a_dec_0.pdf@2006-07-19 00:00:00@SUTENT@sunitinib@NAS before 2012@NA before 2012@adopted@Pfizer Ltd@conditional@Parsed
EU-1-06-346_h_a_dec_13.pdf@EU-1-06-346_h_a_dec_13.pdf@2011-02-21 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma  International Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_2.pdf@EU-1-06-342_h_a_dec_2.pdf@2007-01-24 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_16.pdf@EU-1-06-343_h_a_dec_16.pdf@2011-12-05 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_0.pdf@EU-1-06-348_h_a_dec_0.pdf@2006-06-27 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_14.pdf@EU-1-06-346_h_a_dec_14.pdf@2011-04-20 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma  International Ltd.@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_3.pdf@EU-1-06-341_h_a_dec_3.pdf@2008-07-28 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_1.pdf@EU-1-06-347_h_a_dec_1.pdf@2007-11-01 00:00:00@SUTENT@sunitinib malate@NAS before 2012@NA before 2012@adopted@Pfizer Ltd@conditional@Parsed
EU-1-06-342_h_a_dec_20.pdf@EU-1-06-342_h_a_dec_20.pdf@2012-06-27 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_17.pdf@EU-1-06-343_h_a_dec_17.pdf@2012-10-24 00:00:00@Baraclude@entecavir@False@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_15.pdf@EU-1-06-346_h_a_dec_15.pdf@2011-06-16 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_1.pdf@EU-1-06-348_h_a_dec_1.pdf@2007-07-24 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_10.pdf@EU-1-06-347_h_a_dec_10.pdf@2009-03-08 00:00:00@SUTENT@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_4.pdf@EU-1-06-341_h_a_dec_4.pdf@2008-01-09 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_16.pdf@EU-1-06-346_h_a_dec_16.pdf@2011-06-16 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma  International Ltd.@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_10.pdf@EU-1-06-348_h_a_dec_10.pdf@2010-03-30 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_18.pdf@EU-1-06-343_h_a_dec_18.pdf@2014-08-22 00:00:00@Baraclude@entecavir@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_11.pdf@EU-1-06-347_h_a_dec_11.pdf@2009-08-20 00:00:00@SUTENT@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_5.pdf@EU-1-06-341_h_a_dec_5.pdf@2009-01-26 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_21.pdf@EU-1-06-342_h_a_dec_21.pdf@2014-01-31 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_17.pdf@EU-1-06-346_h_a_dec_17.pdf@2011-06-17 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_11.pdf@EU-1-06-348_h_a_dec_11.pdf@2010-06-08 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_12.pdf@EU-1-06-347_h_a_dec_12.pdf@2009-10-28 00:00:00@SUTENT@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_6.pdf@EU-1-06-341_h_a_dec_6.pdf@2009-05-29 00:00:00@Zostavax@Zoster vaccine (Live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_19.pdf@EU-1-06-343_h_a_dec_19.pdf@2017-03-03 00:00:00@Baraclude@entecavir@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_18.pdf@EU-1-06-346_h_a_dec_18.pdf@2012-05-25 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Elan Pharma  International Ltd.@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_22.pdf@EU-1-06-342_h_a_dec_22.pdf@2014-05-23 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_13.pdf@EU-1-06-347_h_a_dec_13.pdf@2010-03-15 00:00:00@SUTENT@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_12.pdf@EU-1-06-348_h_a_dec_12.pdf@2011-01-21 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_19.pdf@EU-1-06-346_h_a_dec_19.pdf@2012-11-19 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Elan Pharma  International Ltd.@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_7.pdf@EU-1-06-341_h_a_dec_7.pdf@2009-10-28 00:00:00@Zostavax@shingles (herpes zoster)  vaccine (live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_2.pdf@EU-1-06-343_h_a_dec_2.pdf@2007-08-22 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_14.pdf@EU-1-06-347_h_a_dec_14.pdf@2010-03-23 00:00:00@SUTENT@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_2.pdf@EU-1-06-346_h_a_dec_2.pdf@2006-06-28 00:00:00@Tysabri@Natalizumab@NAS before 2012@NA before 2012@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_13.pdf@EU-1-06-348_h_a_dec_13.pdf@2011-01-27 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_8.pdf@EU-1-06-341_h_a_dec_8.pdf@2010-01-20 00:00:00@Zostavax@shingles (herpes zoster)  vaccine (live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_23.pdf@EU-1-06-342_h_a_dec_23.pdf@2014-11-21 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_15.pdf@EU-1-06-347_h_a_dec_15.pdf@2010-01-07 00:00:00@Sutent@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_20.pdf@EU-1-06-343_h_a_dec_20.pdf@2019-03-25 00:00:00@Baraclude@entecavir@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_14.pdf@EU-1-06-348_h_a_dec_14.pdf@2011-02-28 00:00:00@RotaTeq@Rotavirus vaccine  (live, oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur  MSD, SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_20.pdf@EU-1-06-346_h_a_dec_20.pdf@2013-06-13 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-341_h_a_dec_9.pdf@EU-1-06-341_h_a_dec_9.pdf@2010-08-26 00:00:00@Zostavax@shingles (herpes zoster) vaccine (live)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_24.pdf@EU-1-06-342_h_a_dec_24.pdf@2017-06-07 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_16.pdf@EU-1-06-347_h_a_dec_16.pdf@2010-11-29 00:00:00@Sutent@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_15.pdf@EU-1-06-348_h_a_dec_15.pdf@2011-08-04 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_25.pdf@EU-1-06-342_h_a_dec_25.pdf@2019-06-06 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_16.pdf@EU-1-06-348_h_a_dec_16.pdf@2011-05-18 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_17.pdf@EU-1-06-347_h_a_dec_17.pdf@2010-12-20 00:00:00@Sutent@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_21.pdf@EU-1-06-343_h_a_dec_21.pdf@2021-01-22 00:00:00@Baraclude@entecavir@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_21.pdf@EU-1-06-346_h_a_dec_21.pdf@2013-09-07 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_26.pdf@EU-1-06-342_h_a_dec_26.pdf@2020-09-10 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_18.pdf@EU-1-06-347_h_a_dec_18.pdf@2011-08-18 00:00:00@Sutent@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_17.pdf@EU-1-06-348_h_a_dec_17.pdf@2012-02-21 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_3.pdf@EU-1-06-343_h_a_dec_3.pdf@2007-11-20 00:00:00@Baraclude@entecavir@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_27.pdf@EU-1-06-342_h_a_dec_27.pdf@2022-03-28 00:00:00@Nexavar@Sorafenib@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_19.pdf@EU-1-06-347_h_a_dec_19.pdf@2012-09-01 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_18.pdf@EU-1-06-348_h_a_dec_18.pdf@2012-10-24 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_22.pdf@EU-1-06-346_h_a_dec_22.pdf@2013-08-26 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_4.pdf@EU-1-06-343_h_a_dec_4.pdf@2008-06-25 00:00:00@Baraclude@entecavir@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_3.pdf@EU-1-06-342_h_a_dec_3.pdf@2007-08-21 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_2.pdf@EU-1-06-347_h_a_dec_2.pdf@2007-01-17 00:00:00@SUTENT@sunitinib malate@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_0.pdf@EU-1-06-350_h_a_dec_0.pdf@2006-07-28 00:00:00@Savene@Dexrazoxane@NAS before 2012@NA before 2012@adopted@TopoTarget A/S@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_5.pdf@EU-1-06-343_h_a_dec_5.pdf@2008-08-22 00:00:00@Baraclude@entecavir@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_19.pdf@EU-1-06-348_h_a_dec_19.pdf@2014-01-29 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_23.pdf@EU-1-06-346_h_a_dec_23.pdf@2014-11-13 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_20.pdf@EU-1-06-347_h_a_dec_20.pdf@2012-09-20 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_4.pdf@EU-1-06-342_h_a_dec_4.pdf@2007-10-29 00:00:00@Nexavar@Sorafenib@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_1.pdf@EU-1-06-350_h_a_dec_1.pdf@2007-09-03 00:00:00@Savene@Dexrazoxane@NAS before 2012@NA before 2012@OD Not Found@TopoTarget A/S@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_6.pdf@EU-1-06-343_h_a_dec_6.pdf@2009-10-02 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_2.pdf@EU-1-06-348_h_a_dec_2.pdf@2007-07-09 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_21.pdf@EU-1-06-347_h_a_dec_21.pdf@2012-11-15 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_7.pdf@EU-1-06-343_h_a_dec_7.pdf@2009-02-26 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_5.pdf@EU-1-06-342_h_a_dec_5.pdf@2008-04-18 00:00:00@Nexavar@Sorafenib@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_24.pdf@EU-1-06-346_h_a_dec_24.pdf@2016-04-18 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_20.pdf@EU-1-06-348_h_a_dec_20.pdf@2015-02-19 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_0.pdf@EU-1-06-354_h_a_dec_0.pdf@2006-07-28 00:00:00@Competact@Pioglitazone /  metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_6.pdf@EU-1-06-342_h_a_dec_6.pdf@2008-11-25 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_8.pdf@EU-1-06-343_h_a_dec_8.pdf@2009-08-06 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_10.pdf@EU-1-06-350_h_a_dec_10.pdf@2019-11-01 00:00:00@Savene@Dexrazoxane@False@False@OD Not Found@Clinigen Healthcare Limited@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_22.pdf@EU-1-06-347_h_a_dec_22.pdf@2013-11-15 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_21.pdf@EU-1-06-348_h_a_dec_21.pdf@2016-12-16 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_1.pdf@EU-1-06-354_h_a_dec_1.pdf@2007-04-01 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_25.pdf@EU-1-06-346_h_a_dec_25.pdf@2016-04-25 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-343_h_a_dec_9.pdf@EU-1-06-343_h_a_dec_9.pdf@2009-07-07 00:00:00@Baraclude@entecavir@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_7.pdf@EU-1-06-342_h_a_dec_7.pdf@2009-02-03 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_22.pdf@EU-1-06-348_h_a_dec_22.pdf@2017-09-18 00:00:00@RotaTeq@Rotavirus vaccine  (live, oral)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_2.pdf@EU-1-06-350_h_a_dec_2.pdf@2010-06-07 00:00:00@Savene@Dexrazoxane@NAS before 2012@False@OD Not Found@TopoTarget A/S@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_10.pdf@EU-1-06-354_h_a_dec_10.pdf@2012-12-20 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Global  Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_26.pdf@EU-1-06-346_h_a_dec_26.pdf@2016-06-24 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_3.pdf@EU-1-06-350_h_a_dec_3.pdf@2011-07-18 00:00:00@Savene@Dexrazoxane@NAS before 2012@False@adopted@SpePharm Holding BV@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_23.pdf@EU-1-06-348_h_a_dec_23.pdf@2019-04-26 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_8.pdf@EU-1-06-342_h_a_dec_8.pdf@2009-07-04 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_23.pdf@EU-1-06-347_h_a_dec_23.pdf@2015-02-17 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_11.pdf@EU-1-06-354_h_a_dec_11.pdf@2013-04-17 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_4.pdf@EU-1-06-350_h_a_dec_4.pdf@2012-07-20 00:00:00@Savene@Dexrazoxane@False@False@adopted@SpePharm Holding BV@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_24.pdf@EU-1-06-348_h_a_dec_24.pdf@2020-08-25 00:00:00@RotaTeq@Rotavirus vaccine  (live, oral)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-342_h_a_dec_9.pdf@EU-1-06-342_h_a_dec_9.pdf@2009-07-04 00:00:00@Nexavar@Sorafenib@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_27.pdf@EU-1-06-346_h_a_dec_27.pdf@2017-11-09 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_12.pdf@EU-1-06-354_h_a_dec_12.pdf@2013-11-13 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_25.pdf@EU-1-06-348_h_a_dec_25.pdf@2022-01-04 00:00:00@RotaTeq@Rotavirus vaccine (live, oral)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_24.pdf@EU-1-06-347_h_a_dec_24.pdf@2016-11-02 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_5.pdf@EU-1-06-350_h_a_dec_5.pdf@2013-09-19 00:00:00@Savene@Dexrazoxane@False@False@adopted@SpePharm Holding B.V.@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_13.pdf@EU-1-06-354_h_a_dec_13.pdf@2015-03-07 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_3.pdf@EU-1-06-348_h_a_dec_3.pdf@2007-11-12 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_28.pdf@EU-1-06-346_h_a_dec_28.pdf@2018-02-08 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_14.pdf@EU-1-06-354_h_a_dec_14.pdf@2016-04-25 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_4.pdf@EU-1-06-348_h_a_dec_4.pdf@2007-12-14 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_25.pdf@EU-1-06-347_h_a_dec_25.pdf@2016-09-11 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_6.pdf@EU-1-06-350_h_a_dec_6.pdf@2014-07-18 00:00:00@Savene@Dexrazoxane@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_15.pdf@EU-1-06-354_h_a_dec_15.pdf@2016-05-26 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_5.pdf@EU-1-06-348_h_a_dec_5.pdf@2008-04-23 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_29.pdf@EU-1-06-346_h_a_dec_29.pdf@2020-04-23 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_7.pdf@EU-1-06-350_h_a_dec_7.pdf@2015-12-01 00:00:00@Savene@Dexrazoxane@False@False@adopted@Clinigen Healthcare Limited@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_16.pdf@EU-1-06-354_h_a_dec_16.pdf@2016-12-12 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DANISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2006)3495 for “Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_6.pdf@EU-1-06-348_h_a_dec_6.pdf@2008-10-28 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_26.pdf@EU-1-06-347_h_a_dec_26.pdf@2018-04-19 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_3.pdf@EU-1-06-346_h_a_dec_3.pdf@2008-04-25 00:00:00@Tysabri@Natalizumab@NAS before 2012@True@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_17.pdf@EU-1-06-354_h_a_dec_17.pdf@2017-10-30 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_0.pdf@EU-1-06-356_h_a_dec_0.pdf@2006-08-28 00:00:00@Exjade@deferasirox@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_7.pdf@EU-1-06-348_h_a_dec_7.pdf@2009-06-29 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_8.pdf@EU-1-06-350_h_a_dec_8.pdf@2016-11-03 00:00:00@Savene@Dexrazoxane@False@False@adopted@Clinigen Healthcare Limited@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_30.pdf@EU-1-06-346_h_a_dec_30.pdf@2021-03-26 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_18.pdf@EU-1-06-354_h_a_dec_18.pdf@2019-05-22 00:00:00@Competact@Pioglitazone /  metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_8.pdf@EU-1-06-348_h_a_dec_8.pdf@2009-10-23 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_1.pdf@EU-1-06-356_h_a_dec_1.pdf@2006-08-28 00:00:00@Exjade@deferasirox@NAS before 2012@NA before 2012@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_27.pdf@EU-1-06-347_h_a_dec_27.pdf@2018-10-16 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-348_h_a_dec_9.pdf@EU-1-06-348_h_a_dec_9.pdf@2010-01-20 00:00:00@RotaTeq@Rotavirus vaccine (live,  oral)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_10.pdf@EU-1-06-356_h_a_dec_10.pdf@2011-07-27 00:00:00@Exjade@deferasirox@NAS before 2012@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_19.pdf@EU-1-06-354_h_a_dec_19.pdf@2021-06-21 00:00:00@Competact@Pioglitazone / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-350_h_a_dec_9.pdf@EU-1-06-350_h_a_dec_9.pdf@2017-11-15 00:00:00@Savene@Dexrazoxane@False@False@OD Not Found@Clinigen Healthcare Limited@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_28.pdf@EU-1-06-347_h_a_dec_28.pdf@2019-02-14 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_0.pdf@EU-1-06-357_h_a_dec_0.pdf@2006-09-20 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_31.pdf@EU-1-06-346_h_a_dec_31.pdf@2021-05-19 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_11.pdf@EU-1-06-356_h_a_dec_11.pdf@2011-12-19 00:00:00@Exjade@deferasirox@NAS before 2012@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_2.pdf@EU-1-06-354_h_a_dec_2.pdf@2007-08-20 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_29.pdf@EU-1-06-347_h_a_dec_29.pdf@2020-10-22 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_1.pdf@EU-1-06-357_h_a_dec_1.pdf@2007-06-13 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_12.pdf@EU-1-06-356_h_a_dec_12.pdf@2012-10-24 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_32.pdf@EU-1-06-346_h_a_dec_32.pdf@2021-08-26 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_3.pdf@EU-1-06-354_h_a_dec_3.pdf@2007-10-24 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_3.pdf@EU-1-06-347_h_a_dec_3.pdf@2007-10-24 00:00:00@SUTENT@sunitinib malate@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_13.pdf@EU-1-06-356_h_a_dec_13.pdf@2012-12-20 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_10.pdf@EU-1-06-357_h_a_dec_10.pdf@2009-07-24 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_30.pdf@EU-1-06-347_h_a_dec_30.pdf@2021-09-11 00:00:00@Sutent@sunitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_4.pdf@EU-1-06-354_h_a_dec_4.pdf@2009-08-21 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@False@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_33.pdf@EU-1-06-346_h_a_dec_33.pdf@2022-05-30 00:00:00@Tysabri@Natalizumab@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_11.pdf@EU-1-06-357_h_a_dec_11.pdf@2009-08-31 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_14.pdf@EU-1-06-356_h_a_dec_14.pdf@2014-04-28 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_4.pdf@EU-1-06-347_h_a_dec_4.pdf@2007-11-22 00:00:00@SUTENT@sunitinib malate@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_0.pdf@EU-1-06-359_h_a_dec_0.pdf@2006-09-26 00:00:00@Suboxone@buprenorphine /  naloxone@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_0.pdf@EU-1-06-360_h_a_dec_0.pdf@2006-09-26 00:00:00@Champix@varenicline tartrate@NAS before 2012@NA before 2012@OD Not Found@PFIZER Ltd@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_5.pdf@EU-1-06-354_h_a_dec_5.pdf@2010-03-26 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_4.pdf@EU-1-06-346_h_a_dec_4.pdf@2008-06-20 00:00:00@Tysabri@Natalizumab@NAS before 2012@True@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_5.pdf@EU-1-06-347_h_a_dec_5.pdf@2008-01-25 00:00:00@SUTENT@sunitinib malate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_12.pdf@EU-1-06-357_h_a_dec_12.pdf@2010-01-19 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_15.pdf@EU-1-06-356_h_a_dec_15.pdf@2014-04-09 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_1.pdf@EU-1-06-359_h_a_dec_1.pdf@2007-07-30 00:00:00@Suboxone@buprenorphine / naloxone@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_6.pdf@EU-1-06-354_h_a_dec_6.pdf@2011-02-21 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@False@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_1.pdf@EU-1-06-360_h_a_dec_1.pdf@2007-04-26 00:00:00@Champix@varenicline tartrate@NAS before 2012@NA before 2012@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_5.pdf@EU-1-06-346_h_a_dec_5.pdf@2008-03-09 00:00:00@Tysabri@Natalizumab@NAS before 2012@True@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_6.pdf@EU-1-06-347_h_a_dec_6.pdf@2008-08-22 00:00:00@SUTENT@sunitinib malate@NAS before 2012@True@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_13.pdf@EU-1-06-357_h_a_dec_13.pdf@2010-12-05 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_16.pdf@EU-1-06-356_h_a_dec_16.pdf@2015-07-17 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_10.pdf@EU-1-06-360_h_a_dec_10.pdf@2010-10-25 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_7.pdf@EU-1-06-354_h_a_dec_7.pdf@2011-05-27 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_6.pdf@EU-1-06-346_h_a_dec_6.pdf@2008-10-30 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_10.pdf@EU-1-06-359_h_a_dec_10.pdf@2020-04-02 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@Indivior Europe Limited@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_7.pdf@EU-1-06-347_h_a_dec_7.pdf@2008-10-30 00:00:00@SUTENT@sunitinib malate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_14.pdf@EU-1-06-357_h_a_dec_14.pdf@2010-08-18 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_8.pdf@EU-1-06-354_h_a_dec_8.pdf@2011-12-22 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_11.pdf@EU-1-06-360_h_a_dec_11.pdf@2010-12-20 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_17.pdf@EU-1-06-356_h_a_dec_17.pdf@2016-03-22 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Limited@exceptional@Parsed
EU-1-06-346_h_a_dec_7.pdf@EU-1-06-346_h_a_dec_7.pdf@2008-12-19 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_8.pdf@EU-1-06-347_h_a_dec_8.pdf@2009-10-02 00:00:00@SUTENT@sunitinib malate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_15.pdf@EU-1-06-357_h_a_dec_15.pdf@2011-07-27 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant,  adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_12.pdf@EU-1-06-360_h_a_dec_12.pdf@2011-07-06 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-354_h_a_dec_9.pdf@EU-1-06-354_h_a_dec_9.pdf@2011-12-22 00:00:00@Competact@Pioglitazone / metformin@NAS before 2012@False@OD Not Found@Takeda Global Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_11.pdf@EU-1-06-359_h_a_dec_11.pdf@2020-03-07 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@Indivior Europe Limited@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_8.pdf@EU-1-06-346_h_a_dec_8.pdf@2009-01-23 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_16.pdf@EU-1-06-357_h_a_dec_16.pdf@2011-01-08 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant,  adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-347_h_a_dec_9.pdf@EU-1-06-347_h_a_dec_9.pdf@2009-05-29 00:00:00@SUTENT@sunitinib@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_18.pdf@EU-1-06-356_h_a_dec_18.pdf@2016-04-18 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_13.pdf@EU-1-06-360_h_a_dec_13.pdf@2011-06-17 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-346_h_a_dec_9.pdf@EU-1-06-346_h_a_dec_9.pdf@2009-05-26 00:00:00@Tysabri@Natalizumab@NAS before 2012@False@OD Not Found@Elan Pharma International Ltd.@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_14.pdf@EU-1-06-360_h_a_dec_14.pdf@2011-11-21 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_17.pdf@EU-1-06-357_h_a_dec_17.pdf@2011-11-16 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant,  adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_12.pdf@EU-1-06-359_h_a_dec_12.pdf@2021-08-18 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@Indivior Europe Limited@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_19.pdf@EU-1-06-356_h_a_dec_19.pdf@2016-07-15 00:00:00@Exjade@deferasirox@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_15.pdf@EU-1-06-360_h_a_dec_15.pdf@2012-01-20 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_18.pdf@EU-1-06-357_h_a_dec_18.pdf@2011-12-19 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant,  adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_16.pdf@EU-1-06-360_h_a_dec_16.pdf@2012-03-21 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_2.pdf@EU-1-06-356_h_a_dec_2.pdf@2007-02-07 00:00:00@Exjade@deferasirox@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_19.pdf@EU-1-06-357_h_a_dec_19.pdf@2012-05-22 00:00:00@Gardasil@Human Papillomavirus Vaccine  [Types 6, 11, 16, 18]  (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_13.pdf@EU-1-06-359_h_a_dec_13.pdf@2022-07-18 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@Indivior Europe Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_17.pdf@EU-1-06-360_h_a_dec_17.pdf@2012-04-13 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_2.pdf@EU-1-06-357_h_a_dec_2.pdf@2007-07-24 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_2.pdf@EU-1-06-359_h_a_dec_2.pdf@2010-06-08 00:00:00@Suboxone@buprenorphine / naloxone@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_18.pdf@EU-1-06-360_h_a_dec_18.pdf@2012-11-19 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_20.pdf@EU-1-06-356_h_a_dec_20.pdf@2017-08-14 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_20.pdf@EU-1-06-357_h_a_dec_20.pdf@2012-11-30 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD,  SNC@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_19.pdf@EU-1-06-360_h_a_dec_19.pdf@2013-11-03 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_3.pdf@EU-1-06-359_h_a_dec_3.pdf@2011-09-16 00:00:00@Suboxone@buprenorphine / naloxone@NAS before 2012@False@OD Not Found@RB Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_0.pdf@EU-1-06-361_h_a_dec_0.pdf@2006-09-20 00:00:00@Luminity@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_4.pdf@EU-1-06-359_h_a_dec_4.pdf@2011-09-16 00:00:00@Suboxone@buprenorphine / naloxone@NAS before 2012@False@OD Not Found@RB Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_2.pdf@EU-1-06-360_h_a_dec_2.pdf@2008-02-28 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_21.pdf@EU-1-06-356_h_a_dec_21.pdf@2017-10-11 00:00:00@Brand name Not Found@Active Substance Not Found@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_21.pdf@EU-1-06-357_h_a_dec_21.pdf@2014-03-27 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_1.pdf@EU-1-06-361_h_a_dec_1.pdf@2007-08-22 00:00:00@Luminity@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma Belgium Sprl@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_22.pdf@EU-1-06-356_h_a_dec_22.pdf@2018-04-19 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_20.pdf@EU-1-06-360_h_a_dec_20.pdf@2014-06-06 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_5.pdf@EU-1-06-359_h_a_dec_5.pdf@2014-05-23 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@RB Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_22.pdf@EU-1-06-357_h_a_dec_22.pdf@2014-06-06 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_10.pdf@EU-1-06-361_h_a_dec_10.pdf@2014-02-21 00:00:00@Luminity@Perflutren@False@False@OD Not Found@Lantheus MI UK  Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_21.pdf@EU-1-06-360_h_a_dec_21.pdf@2015-11-02 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_23.pdf@EU-1-06-357_h_a_dec_23.pdf@2015-05-27 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_0.pdf@EU-1-06-362_h_a_dec_0.pdf@2006-11-20 00:00:00@BYETTA@exenatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_6.pdf@EU-1-06-359_h_a_dec_6.pdf@2014-05-23 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@RB Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_23.pdf@EU-1-06-356_h_a_dec_23.pdf@2018-07-23 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_24.pdf@EU-1-06-357_h_a_dec_24.pdf@2015-10-12 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_1.pdf@EU-1-06-362_h_a_dec_1.pdf@2007-08-30 00:00:00@BYETTA@exenatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_11.pdf@EU-1-06-361_h_a_dec_11.pdf@2015-05-13 00:00:00@Luminity@perflutren@False@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_22.pdf@EU-1-06-360_h_a_dec_22.pdf@2016-05-17 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_10.pdf@EU-1-06-362_h_a_dec_10.pdf@2012-03-19 00:00:00@Byetta@exenatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_7.pdf@EU-1-06-359_h_a_dec_7.pdf@2015-03-30 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@RB Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_25.pdf@EU-1-06-357_h_a_dec_25.pdf@2016-12-01 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant,  adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_24.pdf@EU-1-06-356_h_a_dec_24.pdf@2019-07-19 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_11.pdf@EU-1-06-362_h_a_dec_11.pdf@2012-10-29 00:00:00@Byetta@exenatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_23.pdf@EU-1-06-360_h_a_dec_23.pdf@2016-06-29 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_26.pdf@EU-1-06-357_h_a_dec_26.pdf@2017-06-02 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SAS@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_12.pdf@EU-1-06-361_h_a_dec_12.pdf@2016-07-15 00:00:00@Luminity@perflutren@False@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_8.pdf@EU-1-06-359_h_a_dec_8.pdf@2015-11-16 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@Indivior UK Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_12.pdf@EU-1-06-362_h_a_dec_12.pdf@2013-06-03 00:00:00@Byetta@exenatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_25.pdf@EU-1-06-356_h_a_dec_25.pdf@2020-07-31 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_27.pdf@EU-1-06-357_h_a_dec_27.pdf@2017-12-20 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_24.pdf@EU-1-06-360_h_a_dec_24.pdf@2018-05-31 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-359_h_a_dec_9.pdf@EU-1-06-359_h_a_dec_9.pdf@2018-05-31 00:00:00@Suboxone@buprenorphine / naloxone@False@False@OD Not Found@Indivior UK Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_28.pdf@EU-1-06-357_h_a_dec_28.pdf@2019-12-06 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_13.pdf@EU-1-06-361_h_a_dec_13.pdf@2019-11-03 00:00:00@Luminity@perflutren@False@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_13.pdf@EU-1-06-362_h_a_dec_13.pdf@2014-07-28 00:00:00@Byetta@exenatide@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_26.pdf@EU-1-06-356_h_a_dec_26.pdf@2021-09-15 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_29.pdf@EU-1-06-357_h_a_dec_29.pdf@2021-11-15 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_14.pdf@EU-1-06-362_h_a_dec_14.pdf@2015-01-15 00:00:00@Byetta@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_25.pdf@EU-1-06-360_h_a_dec_25.pdf@2018-07-30 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_0.pdf@EU-1-06-363_h_a_dec_0.pdf@2006-11-20 00:00:00@Sprycel@Dasatinib@NAS before 2012@NA before 2012@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_14.pdf@EU-1-06-361_h_a_dec_14.pdf@2020-09-24 00:00:00@Luminity@perflutren@False@False@OD Not Found@Lantheus EU Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_3.pdf@EU-1-06-357_h_a_dec_3.pdf@2008-10-04 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_15.pdf@EU-1-06-362_h_a_dec_15.pdf@2015-12-16 00:00:00@Byetta@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_26.pdf@EU-1-06-360_h_a_dec_26.pdf@2019-09-16 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_27.pdf@EU-1-06-356_h_a_dec_27.pdf@2022-01-24 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_1.pdf@EU-1-06-363_h_a_dec_1.pdf@2007-08-22 00:00:00@Sprycel@Dasatinib@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_30.pdf@EU-1-06-357_h_a_dec_30.pdf@2022-04-29 00:00:00@Gardasil@Human Papillomavirus Vaccine [Types 6, 11, 16, 18]  (Recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_27.pdf@EU-1-06-360_h_a_dec_27.pdf@2021-11-18 00:00:00@Champix@varenicline tartrate@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_16.pdf@EU-1-06-362_h_a_dec_16.pdf@2016-07-22 00:00:00@Byetta@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_15.pdf@EU-1-06-361_h_a_dec_15.pdf@2021-09-16 00:00:00@Luminity@perflutren@False@False@OD Not Found@Lantheus EU Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_10.pdf@EU-1-06-363_h_a_dec_10.pdf@2010-05-05 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_4.pdf@EU-1-06-357_h_a_dec_4.pdf@2008-10-07 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_3.pdf@EU-1-06-360_h_a_dec_3.pdf@2008-08-08 00:00:00@Champix@varenicline tartrate@NAS before 2012@True@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_28.pdf@EU-1-06-356_h_a_dec_28.pdf@2022-08-25 00:00:00@Exjade@deferasirox@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_2.pdf@EU-1-06-361_h_a_dec_2.pdf@2007-10-29 00:00:00@Luminity@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_4.pdf@EU-1-06-360_h_a_dec_4.pdf@2008-11-25 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_11.pdf@EU-1-06-363_h_a_dec_11.pdf@2010-07-28 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_17.pdf@EU-1-06-362_h_a_dec_17.pdf@2018-11-07 00:00:00@Byetta@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_5.pdf@EU-1-06-357_h_a_dec_5.pdf@2008-02-09 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@True@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_3.pdf@EU-1-06-356_h_a_dec_3.pdf@2008-07-23 00:00:00@Exjade@deferasirox@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_3.pdf@EU-1-06-361_h_a_dec_3.pdf@2008-11-25 00:00:00@Luminity@Perflutren@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_5.pdf@EU-1-06-360_h_a_dec_5.pdf@2009-07-04 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_0.pdf@EU-1-06-364_h_a_dec_0.pdf@2007-04-01 00:00:00@ADROVANCE@Alendronate sodium  / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_12.pdf@EU-1-06-363_h_a_dec_12.pdf@2010-09-30 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_6.pdf@EU-1-06-357_h_a_dec_6.pdf@2008-10-31 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_4.pdf@EU-1-06-356_h_a_dec_4.pdf@2008-12-17 00:00:00@Exjade@deferasirox@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_4.pdf@EU-1-06-361_h_a_dec_4.pdf@2009-02-20 00:00:00@Luminity@Perflutren@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_6.pdf@EU-1-06-360_h_a_dec_6.pdf@2009-03-08 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_18.pdf@EU-1-06-362_h_a_dec_18.pdf@2019-06-06 00:00:00@Byetta@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_1.pdf@EU-1-06-364_h_a_dec_1.pdf@2007-02-10 00:00:00@ADROVANCE@Alendronate sodium / Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_13.pdf@EU-1-06-363_h_a_dec_13.pdf@2010-10-25 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_7.pdf@EU-1-06-357_h_a_dec_7.pdf@2009-02-02 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_5.pdf@EU-1-06-356_h_a_dec_5.pdf@2009-03-25 00:00:00@Exjade@deferasirox@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_5.pdf@EU-1-06-361_h_a_dec_5.pdf@2009-07-27 00:00:00@Luminity@Perflutren@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma Belgium  Sprl@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_7.pdf@EU-1-06-360_h_a_dec_7.pdf@2009-08-27 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_10.pdf@EU-1-06-364_h_a_dec_10.pdf@2011-03-18 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_6.pdf@EU-1-06-356_h_a_dec_6.pdf@2009-07-14 00:00:00@Exjade@deferasirox@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_14.pdf@EU-1-06-363_h_a_dec_14.pdf@2010-06-12 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@adopted@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_8.pdf@EU-1-06-357_h_a_dec_8.pdf@2009-04-03 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_19.pdf@EU-1-06-362_h_a_dec_19.pdf@2021-11-01 00:00:00@Byetta@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_6.pdf@EU-1-06-361_h_a_dec_6.pdf@2009-08-21 00:00:00@Luminity@Perflutren@NAS before 2012@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_8.pdf@EU-1-06-360_h_a_dec_8.pdf@2009-11-30 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_11.pdf@EU-1-06-364_h_a_dec_11.pdf@2011-06-29 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_7.pdf@EU-1-06-356_h_a_dec_7.pdf@2009-11-23 00:00:00@Exjade@deferasirox@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_15.pdf@EU-1-06-363_h_a_dec_15.pdf@2011-05-23 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_2.pdf@EU-1-06-362_h_a_dec_2.pdf@2007-10-31 00:00:00@BYETTA@exenatide@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-360_h_a_dec_9.pdf@EU-1-06-360_h_a_dec_9.pdf@2009-03-12 00:00:00@Champix@varenicline tartrate@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_7.pdf@EU-1-06-361_h_a_dec_7.pdf@2011-09-13 00:00:00@Luminity@Perflutren@NAS before 2012@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-357_h_a_dec_9.pdf@EU-1-06-357_h_a_dec_9.pdf@2009-05-28 00:00:00@Gardasil@Human Papillomavirus  Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)@NAS before 2012@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_12.pdf@EU-1-06-364_h_a_dec_12.pdf@2011-07-07 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_16.pdf@EU-1-06-363_h_a_dec_16.pdf@2011-03-10 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_8.pdf@EU-1-06-356_h_a_dec_8.pdf@2010-03-15 00:00:00@Exjade@deferasirox@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_3.pdf@EU-1-06-362_h_a_dec_3.pdf@2008-01-28 00:00:00@BYETTA@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_8.pdf@EU-1-06-361_h_a_dec_8.pdf@2011-07-12 00:00:00@Luminity@Perflutren@NAS before 2012@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_17.pdf@EU-1-06-363_h_a_dec_17.pdf@2012-01-20 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-06-356_h_a_dec_9.pdf@EU-1-06-356_h_a_dec_9.pdf@2010-12-20 00:00:00@Exjade@deferasirox@NAS before 2012@False@adopted@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_13.pdf@EU-1-06-364_h_a_dec_13.pdf@2011-11-21 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-361_h_a_dec_9.pdf@EU-1-06-361_h_a_dec_9.pdf@2012-05-25 00:00:00@Luminity@Perflutren@False@False@OD Not Found@Lantheus MI UK Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_4.pdf@EU-1-06-362_h_a_dec_4.pdf@2009-07-01 00:00:00@BYETTA@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_18.pdf@EU-1-06-363_h_a_dec_18.pdf@2012-02-21 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_19.pdf@EU-1-06-363_h_a_dec_19.pdf@2011-03-10 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_14.pdf@EU-1-06-364_h_a_dec_14.pdf@2016-02-06 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_5.pdf@EU-1-06-362_h_a_dec_5.pdf@2009-06-03 00:00:00@BYETTA@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_6.pdf@EU-1-06-362_h_a_dec_6.pdf@2010-03-15 00:00:00@BYETTA@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_2.pdf@EU-1-06-363_h_a_dec_2.pdf@2008-06-30 00:00:00@Sprycel@Dasatinib@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_0.pdf@EU-1-06-365_h_a_dec_0.pdf@2007-08-01 00:00:00@Elaprase@Idursulfase@NAS before 2012@NA before 2012@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-364_h_a_dec_15.pdf@EU-1-06-364_h_a_dec_15.pdf@2016-09-19 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_7.pdf@EU-1-06-362_h_a_dec_7.pdf@2010-06-08 00:00:00@Byetta@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_20.pdf@EU-1-06-363_h_a_dec_20.pdf@2012-08-30 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_1.pdf@EU-1-06-365_h_a_dec_1.pdf@2007-10-15 00:00:00@Elaprase@Idursulfase@NAS before 2012@NA before 2012@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_8.pdf@EU-1-06-362_h_a_dec_8.pdf@2011-06-29 00:00:00@Byetta@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_21.pdf@EU-1-06-363_h_a_dec_21.pdf@2012-11-19 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_10.pdf@EU-1-06-365_h_a_dec_10.pdf@2012-09-24 00:00:00@Elaprase@Idursulfase@False@False@OD Not Found@Shire Human Genetic Therapies AB,@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_16.pdf@EU-1-06-364_h_a_dec_16.pdf@2018-06-07 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-362_h_a_dec_9.pdf@EU-1-06-362_h_a_dec_9.pdf@2011-09-19 00:00:00@Byetta@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_11.pdf@EU-1-06-365_h_a_dec_11.pdf@2013-09-19 00:00:00@Elaprase@Idursulfase@False@False@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-363_h_a_dec_22.pdf@EU-1-06-363_h_a_dec_22.pdf@2014-07-08 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_17.pdf@EU-1-06-364_h_a_dec_17.pdf@2021-04-21 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_0.pdf@EU-1-06-366_h_a_dec_0.pdf@2007-08-01 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_0.pdf@EU-1-06-367_h_a_dec_0.pdf@2007-04-01 00:00:00@Diacomit@Stiripentol@NAS before 2012@NA before 2012@adopted@Biocodex@conditional@Parsed
EU-1-06-365_h_a_dec_12.pdf@EU-1-06-365_h_a_dec_12.pdf@2013-11-25 00:00:00@Elaprase@Idursulfase@False@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_2.pdf@EU-1-06-364_h_a_dec_2.pdf@2007-10-31 00:00:00@ADROVANCE@Alendronate sodium /  Colecalciferol@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_1.pdf@EU-1-06-367_h_a_dec_1.pdf@2007-12-14 00:00:00@Diacomit@stiripentol@NAS before 2012@NA before 2012@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-366_h_a_dec_1.pdf@EU-1-06-366_h_a_dec_1.pdf@2007-08-27 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_23.pdf@EU-1-06-363_h_a_dec_23.pdf@2015-03-19 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_3.pdf@EU-1-06-364_h_a_dec_3.pdf@2008-07-31 00:00:00@ADROVANCE@Alendronate sodium /  Colecalciferol@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_10.pdf@EU-1-06-366_h_a_dec_10.pdf@2012-02-03 00:00:00@Tandemact@Pioglitazone/Glimepiride@False@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd.@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_10.pdf@EU-1-06-367_h_a_dec_10.pdf@2012-11-22 00:00:00@Diacomit@Stiripentol@False@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-365_h_a_dec_13.pdf@EU-1-06-365_h_a_dec_13.pdf@2014-04-23 00:00:00@Elaprase@Idursulfase@False@False@adopted@Shire Human Genetic Therapies AB@conditional@Parsed
EU-1-06-366_h_a_dec_11.pdf@EU-1-06-366_h_a_dec_11.pdf@2013-01-14 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Global  Research and Development Centre (Europe) Ltd.@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_4.pdf@EU-1-06-364_h_a_dec_4.pdf@2009-07-04 00:00:00@ADROVANCE@Alendronate sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_14.pdf@EU-1-06-365_h_a_dec_14.pdf@2015-09-14 00:00:00@Elaprase@Idursulfase@False@False@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-367_h_a_dec_11.pdf@EU-1-06-367_h_a_dec_11.pdf@2014-08-01 00:00:00@Diacomit@Stiripentol@False@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-363_h_a_dec_24.pdf@EU-1-06-363_h_a_dec_24.pdf@2016-07-15 00:00:00@Sprycel@Dasatinib@False@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_5.pdf@EU-1-06-364_h_a_dec_5.pdf@2009-02-07 00:00:00@ADROVANCE@Alendronate sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_12.pdf@EU-1-06-366_h_a_dec_12.pdf@2013-04-22 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_15.pdf@EU-1-06-365_h_a_dec_15.pdf@2016-09-09 00:00:00@Elaprase@Idursulfase@False@False@adopted@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_6.pdf@EU-1-06-364_h_a_dec_6.pdf@2009-07-16 00:00:00@ADROVANCE@Alendronate sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_12.pdf@EU-1-06-367_h_a_dec_12.pdf@2014-06-23 00:00:00@Diacomit@Stiripentol@False@False@adopted@Biocodex@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_0.pdf@EU-1-06-370_h_a_dec_0.pdf@2007-01-17 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_13.pdf@EU-1-06-366_h_a_dec_13.pdf@2013-11-13 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_25.pdf@EU-1-06-363_h_a_dec_25.pdf@2018-05-31 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_7.pdf@EU-1-06-364_h_a_dec_7.pdf@2009-10-29 00:00:00@ADROVANCE@Alendronate sodium /  Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_10.pdf@EU-1-06-370_h_a_dec_10.pdf@2012-06-28 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_13.pdf@EU-1-06-367_h_a_dec_13.pdf@2018-09-20 00:00:00@Diacomit@Stiripentol@False@False@OD Not Found@Biocodex@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_16.pdf@EU-1-06-365_h_a_dec_16.pdf@2018-12-17 00:00:00@Elaprase@Idursulfase@False@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-366_h_a_dec_14.pdf@EU-1-06-366_h_a_dec_14.pdf@2015-08-07 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_0.pdf@EU-1-06-371_h_a_dec_0.pdf@2007-01-16 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_11.pdf@EU-1-06-370_h_a_dec_11.pdf@2012-08-30 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-364_h_a_dec_8.pdf@EU-1-06-364_h_a_dec_8.pdf@2010-11-29 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_14.pdf@EU-1-06-367_h_a_dec_14.pdf@2021-09-03 00:00:00@Diacomit@Stiripentol@False@False@OD Not Found@Biocodex@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_15.pdf@EU-1-06-366_h_a_dec_15.pdf@2016-05-26 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_12.pdf@EU-1-06-370_h_a_dec_12.pdf@2012-10-29 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_1.pdf@EU-1-06-371_h_a_dec_1.pdf@2008-02-06 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_17.pdf@EU-1-06-365_h_a_dec_17.pdf@2020-05-11 00:00:00@Elaprase@Idursulfase@False@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-364_h_a_dec_9.pdf@EU-1-06-364_h_a_dec_9.pdf@2011-01-27 00:00:00@Adrovance@Alendronate sodium / Colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_15.pdf@EU-1-06-367_h_a_dec_15.pdf@2021-05-19 00:00:00@Diacomit@Stiripentol@False@False@OD Not Found@Biocodex@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_26.pdf@EU-1-06-363_h_a_dec_26.pdf@2018-02-07 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_16.pdf@EU-1-06-366_h_a_dec_16.pdf@2016-09-09 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_10.pdf@EU-1-06-371_h_a_dec_10.pdf@2011-11-21 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_2.pdf@EU-1-06-367_h_a_dec_2.pdf@2008-11-20 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-370_h_a_dec_13.pdf@EU-1-06-370_h_a_dec_13.pdf@2013-07-31 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_17.pdf@EU-1-06-366_h_a_dec_17.pdf@2017-10-11 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_11.pdf@EU-1-06-371_h_a_dec_11.pdf@2012-06-28 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_3.pdf@EU-1-06-367_h_a_dec_3.pdf@2009-01-28 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_18.pdf@EU-1-06-365_h_a_dec_18.pdf@2022-04-04 00:00:00@Elaprase@Idursulfase@False@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_27.pdf@EU-1-06-363_h_a_dec_27.pdf@2019-06-02 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_12.pdf@EU-1-06-371_h_a_dec_12.pdf@2012-08-23 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_14.pdf@EU-1-06-370_h_a_dec_14.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)184 for “Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_4.pdf@EU-1-06-367_h_a_dec_4.pdf@2009-11-26 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-371_h_a_dec_13.pdf@EU-1-06-371_h_a_dec_13.pdf@2012-10-25 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
arsed
EU-1-06-366_h_a_dec_18.pdf@EU-1-06-366_h_a_dec_18.pdf@2019-05-27 00:00:00@Tandemact@Pioglitazone /  Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_5.pdf@EU-1-06-367_h_a_dec_5.pdf@2010-11-03 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_15.pdf@EU-1-06-370_h_a_dec_15.pdf@2015-05-05 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_28.pdf@EU-1-06-363_h_a_dec_28.pdf@2019-03-28 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_3.pdf@EU-1-06-365_h_a_dec_3.pdf@2008-02-09 00:00:00@Elaprase@Idursulfase@NAS before 2012@True@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-371_h_a_dec_14.pdf@EU-1-06-371_h_a_dec_14.pdf@2013-07-31 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_6.pdf@EU-1-06-367_h_a_dec_6.pdf@2010-05-11 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-365_h_a_dec_4.pdf@EU-1-06-365_h_a_dec_4.pdf@2009-04-02 00:00:00@Elaprase@Idursulfase@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_0.pdf@EU-1-06-372_h_a_dec_0.pdf@2007-01-16 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_16.pdf@EU-1-06-370_h_a_dec_16.pdf@2016-03-22 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_7.pdf@EU-1-06-367_h_a_dec_7.pdf@2010-12-13 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-366_h_a_dec_19.pdf@EU-1-06-366_h_a_dec_19.pdf@2020-10-19 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_5.pdf@EU-1-06-365_h_a_dec_5.pdf@2009-09-21 00:00:00@Elaprase@Idursulfase@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-371_h_a_dec_15.pdf@EU-1-06-371_h_a_dec_15.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)172 for “Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_29.pdf@EU-1-06-363_h_a_dec_29.pdf@2020-02-13 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_8.pdf@EU-1-06-367_h_a_dec_8.pdf@2010-12-13 00:00:00@Diacomit@Stiripentol@NAS before 2012@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-372_h_a_dec_1.pdf@EU-1-06-372_h_a_dec_1.pdf@2008-02-06 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_2.pdf@EU-1-06-366_h_a_dec_2.pdf@2007-12-11 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_17.pdf@EU-1-06-370_h_a_dec_17.pdf@2018-08-02 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_3.pdf@EU-1-06-363_h_a_dec_3.pdf@2008-07-22 00:00:00@Sprycel@Dasatinib@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_6.pdf@EU-1-06-365_h_a_dec_6.pdf@2010-01-20 00:00:00@Elaprase@Idursulfase@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_16.pdf@EU-1-06-371_h_a_dec_16.pdf@2015-05-05 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-367_h_a_dec_9.pdf@EU-1-06-367_h_a_dec_9.pdf@2012-01-13 00:00:00@Diacomit@Stiripentol@False@False@OD Not Found@Biocodex@conditional@Parsed
EU-1-06-372_h_a_dec_10.pdf@EU-1-06-372_h_a_dec_10.pdf@2011-11-21 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_20.pdf@EU-1-06-366_h_a_dec_20.pdf@2021-06-24 00:00:00@Tandemact@Pioglitazone / Glimepiride@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_7.pdf@EU-1-06-365_h_a_dec_7.pdf@2010-03-15 00:00:00@Elaprase@Idursulfase@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_11.pdf@EU-1-06-372_h_a_dec_11.pdf@2012-06-28 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_18.pdf@EU-1-06-370_h_a_dec_18.pdf@2018-06-25 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_17.pdf@EU-1-06-371_h_a_dec_17.pdf@2016-02-03 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_3.pdf@EU-1-06-366_h_a_dec_3.pdf@2007-11-30 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_30.pdf@EU-1-06-363_h_a_dec_30.pdf@2021-04-30 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_8.pdf@EU-1-06-365_h_a_dec_8.pdf@2011-02-18 00:00:00@Elaprase@Idursulfase@NAS before 2012@False@OD Not Found@Shire Human Genetic Therapies AB,@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_12.pdf@EU-1-06-372_h_a_dec_12.pdf@2012-08-23 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_4.pdf@EU-1-06-366_h_a_dec_4.pdf@2007-11-12 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@NA before 2012@OD Not Found@Takeda Global Research and  Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-365_h_a_dec_9.pdf@EU-1-06-365_h_a_dec_9.pdf@2011-03-10 00:00:00@Elaprase@Idursulfase@NAS before 2012@False@adopted@Shire Human Genetic Therapies AB@exceptional@Parsed
EU-1-06-372_h_a_dec_13.pdf@EU-1-06-372_h_a_dec_13.pdf@2012-10-25 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_18.pdf@EU-1-06-371_h_a_dec_18.pdf@2018-01-30 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_31.pdf@EU-1-06-363_h_a_dec_31.pdf@2022-03-22 00:00:00@Sprycel@Dasatinib@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_19.pdf@EU-1-06-370_h_a_dec_19.pdf@2019-11-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  11.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)184 for “Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_5.pdf@EU-1-06-366_h_a_dec_5.pdf@2008-03-31 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@False@OD Not Found@Takeda Global Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_4.pdf@EU-1-06-363_h_a_dec_4.pdf@2009-09-01 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_14.pdf@EU-1-06-372_h_a_dec_14.pdf@2013-07-31 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_2.pdf@EU-1-06-370_h_a_dec_2.pdf@2008-10-06 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_6.pdf@EU-1-06-366_h_a_dec_6.pdf@2009-08-31 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd.@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_19.pdf@EU-1-06-371_h_a_dec_19.pdf@2018-07-06 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_5.pdf@EU-1-06-363_h_a_dec_5.pdf@2009-01-15 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_15.pdf@EU-1-06-372_h_a_dec_15.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)175 for “Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_7.pdf@EU-1-06-366_h_a_dec_7.pdf@2010-03-23 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd.@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_2.pdf@EU-1-06-371_h_a_dec_2.pdf@2008-10-06 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_20.pdf@EU-1-06-370_h_a_dec_20.pdf@2020-03-07 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_6.pdf@EU-1-06-363_h_a_dec_6.pdf@2009-01-29 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_0.pdf@EU-1-06-374_h_a_dec_0.pdf@2007-01-22 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_0.pdf@EU-1-06-376_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_16.pdf@EU-1-06-372_h_a_dec_16.pdf@2015-05-05 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_7.pdf@EU-1-06-363_h_a_dec_7.pdf@2009-10-02 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_1.pdf@EU-1-06-374_h_a_dec_1.pdf@2007-01-22 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_8.pdf@EU-1-06-366_h_a_dec_8.pdf@2011-12-22 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_20.pdf@EU-1-06-371_h_a_dec_20.pdf@2019-02-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  2.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)172 for “Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_1.pdf@EU-1-06-376_h_a_dec_1.pdf@2008-11-06 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@True@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_21.pdf@EU-1-06-370_h_a_dec_21.pdf@2021-02-19 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 1   EN COMMISSION IMPLEMENTING DECISION  19.2.2021  amending Commission Decision C(2019) 2978  11 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(2007) 184 for “Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_17.pdf@EU-1-06-372_h_a_dec_17.pdf@2016-02-03 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_8.pdf@EU-1-06-363_h_a_dec_8.pdf@2009-02-26 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_10.pdf@EU-1-06-374_h_a_dec_10.pdf@2011-06-01 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-366_h_a_dec_9.pdf@EU-1-06-366_h_a_dec_9.pdf@2011-12-22 00:00:00@Tandemact@Pioglitazone/Glimepiride@NAS before 2012@False@OD Not Found@Takeda Global Research and Development Centre (Europe) Ltd.@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_22.pdf@EU-1-06-370_h_a_dec_22.pdf@2021-11-10 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_10.pdf@EU-1-06-376_h_a_dec_10.pdf@2012-01-20 00:00:00@Irbesartan Winthrop@Irbesartan@False@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_18.pdf@EU-1-06-372_h_a_dec_18.pdf@2018-01-30 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-363_h_a_dec_9.pdf@EU-1-06-363_h_a_dec_9.pdf@2009-07-28 00:00:00@Sprycel@Dasatinib@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_11.pdf@EU-1-06-374_h_a_dec_11.pdf@2011-06-01 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_11.pdf@EU-1-06-376_h_a_dec_11.pdf@2012-08-30 00:00:00@Irbesartan  Zentiva@Irbesartan@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_12.pdf@EU-1-06-374_h_a_dec_12.pdf@2011-05-27 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_23.pdf@EU-1-06-370_h_a_dec_23.pdf@2022-09-29 00:00:00@Exforge@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_22.pdf@EU-1-06-371_h_a_dec_22.pdf@2021-12-02 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_12.pdf@EU-1-06-376_h_a_dec_12.pdf@2012-09-28 00:00:00@Irbesartan Zentiva@Irbesartan@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_19.pdf@EU-1-06-372_h_a_dec_19.pdf@2018-04-06 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_13.pdf@EU-1-06-374_h_a_dec_13.pdf@2011-05-27 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_3.pdf@EU-1-06-370_h_a_dec_3.pdf@2009-02-13 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_13.pdf@EU-1-06-376_h_a_dec_13.pdf@2012-08-30 00:00:00@Irbesartan  Zentiva@Irbesartan@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_2.pdf@EU-1-06-372_h_a_dec_2.pdf@2008-10-06 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_14.pdf@EU-1-06-374_h_a_dec_14.pdf@2011-02-09 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_23.pdf@EU-1-06-371_h_a_dec_23.pdf@2021-11-10 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_4.pdf@EU-1-06-370_h_a_dec_4.pdf@2009-03-27 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_14.pdf@EU-1-06-376_h_a_dec_14.pdf@2013-07-31 00:00:00@Irbesartan  Zentiva@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_15.pdf@EU-1-06-374_h_a_dec_15.pdf@2011-12-14 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_5.pdf@EU-1-06-370_h_a_dec_5.pdf@2010-09-02 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_16.pdf@EU-1-06-374_h_a_dec_16.pdf@2012-06-27 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_20.pdf@EU-1-06-372_h_a_dec_20.pdf@2019-02-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  2.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)175 for “Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_15.pdf@EU-1-06-376_h_a_dec_15.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)199 for “Irbesartan Zentiva@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_24.pdf@EU-1-06-371_h_a_dec_24.pdf@2022-09-21 00:00:00@Dafiro@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_6.pdf@EU-1-06-370_h_a_dec_6.pdf@2010-03-23 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_17.pdf@EU-1-06-374_h_a_dec_17.pdf@2012-10-29 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_16.pdf@EU-1-06-376_h_a_dec_16.pdf@2016-06-21 00:00:00@Irbesartan Zentiva@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_3.pdf@EU-1-06-371_h_a_dec_3.pdf@2009-02-13 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_7.pdf@EU-1-06-370_h_a_dec_7.pdf@2011-01-02 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_0.pdf@EU-1-06-377_h_a_dec_0.pdf@2007-01-19 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_21.pdf@EU-1-06-372_h_a_dec_21.pdf@2020-06-26 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_17.pdf@EU-1-06-376_h_a_dec_17.pdf@2018-07-19 00:00:00@Irbesartan  Zentiva@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_4.pdf@EU-1-06-371_h_a_dec_4.pdf@2009-03-27 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_18.pdf@EU-1-06-374_h_a_dec_18.pdf@2013-04-07 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_8.pdf@EU-1-06-370_h_a_dec_8.pdf@2011-07-27 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_1.pdf@EU-1-06-377_h_a_dec_1.pdf@2008-01-28 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_5.pdf@EU-1-06-371_h_a_dec_5.pdf@2010-11-03 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_18.pdf@EU-1-06-376_h_a_dec_18.pdf@2018-10-10 00:00:00@Irbesartan Zentiva@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-370_h_a_dec_9.pdf@EU-1-06-370_h_a_dec_9.pdf@2011-11-22 00:00:00@Exforge@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_22.pdf@EU-1-06-372_h_a_dec_22.pdf@2021-12-02 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_6.pdf@EU-1-06-371_h_a_dec_6.pdf@2010-03-19 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_10.pdf@EU-1-06-377_h_a_dec_10.pdf@2011-06-01 00:00:00@Irbesartan HCT Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_19.pdf@EU-1-06-374_h_a_dec_19.pdf@2014-04-09 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_19.pdf@EU-1-06-376_h_a_dec_19.pdf@2019-02-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE CZECH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 2.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)199 for “Irbesartan Zentiva@Irbesartan@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_11.pdf@EU-1-06-377_h_a_dec_11.pdf@2011-06-16 00:00:00@Irbesartan  HCT Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_2.pdf@EU-1-06-374_h_a_dec_2.pdf@2007-11-20 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_2.pdf@EU-1-06-376_h_a_dec_2.pdf@2009-02-25 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_7.pdf@EU-1-06-371_h_a_dec_7.pdf@2011-01-24 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_23.pdf@EU-1-06-372_h_a_dec_23.pdf@2021-11-10 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_12.pdf@EU-1-06-377_h_a_dec_12.pdf@2011-07-09 00:00:00@Irbesartan HCT Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_8.pdf@EU-1-06-371_h_a_dec_8.pdf@2011-08-04 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_20.pdf@EU-1-06-376_h_a_dec_20.pdf@2021-02-19 00:00:00@Irbesartan Zentiva@Irbesartan@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_20.pdf@EU-1-06-374_h_a_dec_20.pdf@2015-07-20 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-371_h_a_dec_9.pdf@EU-1-06-371_h_a_dec_9.pdf@2011-07-27 00:00:00@Dafiro@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_13.pdf@EU-1-06-377_h_a_dec_13.pdf@2011-10-24 00:00:00@Irbesartan  HCT Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_24.pdf@EU-1-06-372_h_a_dec_24.pdf@2022-09-29 00:00:00@Copalia@amlodipine / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_21.pdf@EU-1-06-376_h_a_dec_21.pdf@2021-07-16 00:00:00@Irbesartan  Zentiva@Irbesartan@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_14.pdf@EU-1-06-377_h_a_dec_14.pdf@2012-02-27 00:00:00@Irbesartan HCT Winthrop@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_21.pdf@EU-1-06-374_h_a_dec_21.pdf@2016-08-09 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_3.pdf@EU-1-06-372_h_a_dec_3.pdf@2009-02-13 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_22.pdf@EU-1-06-376_h_a_dec_22.pdf@2022-07-18 00:00:00@Irbesartan  Zentiva@Irbesartan@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_15.pdf@EU-1-06-377_h_a_dec_15.pdf@2012-06-27 00:00:00@Irbesartan HCT Zentiva (Ex-Winthrop)@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_4.pdf@EU-1-06-372_h_a_dec_4.pdf@2009-03-27 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_3.pdf@EU-1-06-376_h_a_dec_3.pdf@2009-03-17 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_16.pdf@EU-1-06-377_h_a_dec_16.pdf@2012-12-11 00:00:00@Irbesartan HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_5.pdf@EU-1-06-372_h_a_dec_5.pdf@2010-03-15 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_22.pdf@EU-1-06-374_h_a_dec_22.pdf@2016-11-11 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_0.pdf@EU-1-06-378_h_a_dec_0.pdf@2007-01-16 00:00:00@Inovelon@Rufinamide@NAS before 2012@NA before 2012@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_17.pdf@EU-1-06-377_h_a_dec_17.pdf@2013-07-31 00:00:00@Irbesartan  HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_4.pdf@EU-1-06-376_h_a_dec_4.pdf@2009-08-04 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_6.pdf@EU-1-06-372_h_a_dec_6.pdf@2010-03-19 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_1.pdf@EU-1-06-378_h_a_dec_1.pdf@2007-08-23 00:00:00@Inovelon@Rufinamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_23.pdf@EU-1-06-374_h_a_dec_23.pdf@2016-11-14 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_5.pdf@EU-1-06-376_h_a_dec_5.pdf@2010-12-05 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_7.pdf@EU-1-06-372_h_a_dec_7.pdf@2011-01-13 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_18.pdf@EU-1-06-377_h_a_dec_18.pdf@2014-04-09 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)200 for “Irbesartan HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_8.pdf@EU-1-06-372_h_a_dec_8.pdf@2011-08-04 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_6.pdf@EU-1-06-376_h_a_dec_6.pdf@2010-05-11 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@SANOFI PHARMA  BRISTOL MYERS SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_10.pdf@EU-1-06-378_h_a_dec_10.pdf@2018-03-08 00:00:00@Inovelon@Rufinamide@False@False@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_24.pdf@EU-1-06-374_h_a_dec_24.pdf@2018-04-26 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_19.pdf@EU-1-06-377_h_a_dec_19.pdf@2017-08-28 00:00:00@Irbesartan  HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-372_h_a_dec_9.pdf@EU-1-06-372_h_a_dec_9.pdf@2011-07-27 00:00:00@Copalia@amlodipine / valsartan@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_7.pdf@EU-1-06-376_h_a_dec_7.pdf@2011-06-01 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_0.pdf@EU-1-06-379_h_a_dec_0.pdf@2007-02-15 00:00:00@Cystadane@Betaine anhydrous@NAS before 2012@NA before 2012@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_2.pdf@EU-1-06-377_h_a_dec_2.pdf@2008-10-06 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@True@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_11.pdf@EU-1-06-378_h_a_dec_11.pdf@2018-09-21 00:00:00@Inovelon@Rufinamide@False@False@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-06-376_h_a_dec_9.pdf@EU-1-06-376_h_a_dec_9.pdf@2011-05-07 00:00:00@Irbesartan Winthrop@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_0.pdf@EU-1-06-380_h_a_dec_0.pdf@2007-12-02 00:00:00@Prezista@darunavir”, a  medicinal product for human use  (Text with EEA relevance)   THE COMMISSION OF THE EUROPEAN COMMUNITIES,  Having regard to the Treaty establishing the European Community,     Having regard to Regulation (EC) No 726/2004  the European Parliament and  the  Council  31 March 2004 laying down Community procedures for the authorisation and  supervision  medicinal products for human and veterinary use and establishing a  European Medicines Agency 1, and in particular Article 10(2) and 14(7) thereof, Having regard to Commission Regulation (EC) No 507/2006 on the conditional  marketing authorisation for medicinal products for human use falling within the scope   Regulation (EC) No 726/2004  the European Parliament and  the Council 2, Having regard to the application submitted by Janssen-Cilag International NV on 1  February 2006 under Article 4(1)  Regulation (EC) No 726/2004,   Having regard to the opinion  the European Medicines Agency, formulated by the  Committee for Medicinal Products for Human Use on 14 December 2006,   Whereas:   (1)@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-06-379_h_a_dec_1.pdf@EU-1-06-379_h_a_dec_1.pdf@2008-05-20 00:00:00@Cystadane@Betaine anhydrous@NAS before 2012@True@OD Not Found@Orphan Europe S.a.r.l.@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_25.pdf@EU-1-06-374_h_a_dec_25.pdf@2019-12-06 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_12.pdf@EU-1-06-378_h_a_dec_12.pdf@2019-07-31 00:00:00@Inovelon@Rufinamide@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_20.pdf@EU-1-06-377_h_a_dec_20.pdf@2018-08-11 00:00:00@Irbesartan HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_1.pdf@EU-1-06-380_h_a_dec_1.pdf@2007-07-24 00:00:00@Prezista@darunavir@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_2.pdf@EU-1-06-379_h_a_dec_2.pdf@2009-04-03 00:00:00@Cystadane@Betaine anhydrous@NAS before 2012@False@OD Not Found@Orphan Europe S.a.r.l.@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_13.pdf@EU-1-06-378_h_a_dec_13.pdf@2021-06-17 00:00:00@Inovelon@Rufinamide@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_10.pdf@EU-1-06-380_h_a_dec_10.pdf@2008-11-25 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_26.pdf@EU-1-06-374_h_a_dec_26.pdf@2019-03-09 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_3.pdf@EU-1-06-379_h_a_dec_3.pdf@2012-02-13 00:00:00@Cystadane@Betaine anhydrous@False@False@adopted@Orphan Europe S.a.r.l.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_11.pdf@EU-1-06-380_h_a_dec_11.pdf@2008-12-16 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-06-378_h_a_dec_2.pdf@EU-1-06-378_h_a_dec_2.pdf@2007-08-23 00:00:00@Inovelon@Rufinamide@NAS before 2012@NA before 2012@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_21.pdf@EU-1-06-377_h_a_dec_21.pdf@2019-04-15 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE CZECH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  15.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)200 for “Irbesartan HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_4.pdf@EU-1-06-379_h_a_dec_4.pdf@2014-06-02 00:00:00@Cystadane@Betaine anhydrous@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_3.pdf@EU-1-06-378_h_a_dec_3.pdf@2008-08-04 00:00:00@Inovelon@Rufinamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_27.pdf@EU-1-06-374_h_a_dec_27.pdf@2019-10-21 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_12.pdf@EU-1-06-380_h_a_dec_12.pdf@2008-12-22 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_5.pdf@EU-1-06-379_h_a_dec_5.pdf@2015-11-19 00:00:00@Cystadane@Betaine anhydrous@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_4.pdf@EU-1-06-378_h_a_dec_4.pdf@2009-02-09 00:00:00@Inovelon@Rufinamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_13.pdf@EU-1-06-380_h_a_dec_13.pdf@2009-01-29 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_22.pdf@EU-1-06-377_h_a_dec_22.pdf@2021-02-19 00:00:00@, medicinal product for human use use  (Text with EEA relevance) (ONLY THE CZECH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  19.2.2021  amending Commission Decision C(2019)3064  15 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(2007)200 for “Irbesartan  HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_6.pdf@EU-1-06-379_h_a_dec_6.pdf@2016-11-21 00:00:00@Cystadane@Betaine anhydrous@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_28.pdf@EU-1-06-374_h_a_dec_28.pdf@2020-09-12 00:00:00@Lucentis@ranibizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_5.pdf@EU-1-06-378_h_a_dec_5.pdf@2010-11-03 00:00:00@Inovelon@Rufinamide@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_14.pdf@EU-1-06-380_h_a_dec_14.pdf@2009-06-23 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_7.pdf@EU-1-06-379_h_a_dec_7.pdf@2016-08-12 00:00:00@Cystadane@Betaine anhydrous@False@False@adopted@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_6.pdf@EU-1-06-378_h_a_dec_6.pdf@2011-11-21 00:00:00@Inovelon@Rufinamide@NAS before 2012@False@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_3.pdf@EU-1-06-374_h_a_dec_3.pdf@2007-12-19 00:00:00@Lucentis@ranibizumab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_15.pdf@EU-1-06-380_h_a_dec_15.pdf@2009-06-23 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_8.pdf@EU-1-06-379_h_a_dec_8.pdf@2018-09-02 00:00:00@Cystadane@Betaine anhydrous@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_4.pdf@EU-1-06-374_h_a_dec_4.pdf@2008-02-09 00:00:00@Lucentis@ranibizumab@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_23.pdf@EU-1-06-377_h_a_dec_23.pdf@2021-04-06 00:00:00@Irbesartan  HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_16.pdf@EU-1-06-380_h_a_dec_16.pdf@2009-10-23 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_0.pdf@EU-1-07-382_h_a_dec_0.pdf@2007-03-21 00:00:00@Xelevia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_8.pdf@EU-1-06-378_h_a_dec_8.pdf@2013-12-13 00:00:00@Inovelon@Rufinamide@False@False@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-06-379_h_a_dec_9.pdf@EU-1-06-379_h_a_dec_9.pdf@2020-04-23 00:00:00@Cystadane@Betaine anhydrous@False@False@OD Not Found@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_17.pdf@EU-1-06-380_h_a_dec_17.pdf@2010-03-15 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_24.pdf@EU-1-06-377_h_a_dec_24.pdf@2022-07-06 00:00:00@Irbesartan  HCT Zentiva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_5.pdf@EU-1-06-374_h_a_dec_5.pdf@2008-10-27 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_1.pdf@EU-1-07-382_h_a_dec_1.pdf@2007-08-29 00:00:00@Xelevia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_3.pdf@EU-1-06-377_h_a_dec_3.pdf@2009-07-01 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_6.pdf@EU-1-06-374_h_a_dec_6.pdf@2008-11-24 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-378_h_a_dec_9.pdf@EU-1-06-378_h_a_dec_9.pdf@2017-11-01 00:00:00@Inovelon@Rufinamide@False@False@adopted@Eisai Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_10.pdf@EU-1-07-382_h_a_dec_10.pdf@2010-11-26 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_18.pdf@EU-1-06-380_h_a_dec_18.pdf@2010-02-06 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_7.pdf@EU-1-06-374_h_a_dec_7.pdf@2009-06-17 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_0.pdf@EU-1-07-383_h_a_dec_0.pdf@2007-03-21 00:00:00@Januvia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_4.pdf@EU-1-06-377_h_a_dec_4.pdf@2009-06-03 00:00:00@Irbesartan Hydrochlorothiazide  Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_11.pdf@EU-1-07-382_h_a_dec_11.pdf@2011-09-02 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_8.pdf@EU-1-06-374_h_a_dec_8.pdf@2009-06-08 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_5.pdf@EU-1-06-377_h_a_dec_5.pdf@2009-03-27 00:00:00@Irbesartan HCT Winthrop@irbesartan  / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-06-374_h_a_dec_9.pdf@EU-1-06-374_h_a_dec_9.pdf@2010-03-30 00:00:00@Lucentis@ranibizumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_12.pdf@EU-1-07-382_h_a_dec_12.pdf@2011-09-13 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_19.pdf@EU-1-06-380_h_a_dec_19.pdf@2010-11-29 00:00:00@PREZISTA@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_0.pdf@EU-1-07-386_h_a_dec_0.pdf@2007-04-20 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_1.pdf@EU-1-07-383_h_a_dec_1.pdf@2007-08-29 00:00:00@Januvia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_6.pdf@EU-1-06-377_h_a_dec_6.pdf@2009-04-17 00:00:00@Irbesartan HCT Winthrop@irbesartan  / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_13.pdf@EU-1-07-382_h_a_dec_13.pdf@2011-12-22 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_10.pdf@EU-1-07-383_h_a_dec_10.pdf@2010-11-26 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_7.pdf@EU-1-06-377_h_a_dec_7.pdf@2009-12-21 00:00:00@Irbesartan HCT Winthrop@irbesartan  / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_14.pdf@EU-1-07-382_h_a_dec_14.pdf@2012-01-20 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_11.pdf@EU-1-07-383_h_a_dec_11.pdf@2011-11-02 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_15.pdf@EU-1-07-382_h_a_dec_15.pdf@2012-10-09 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_2.pdf@EU-1-06-380_h_a_dec_2.pdf@2007-08-27 00:00:00@Prezista@darunavir@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_12.pdf@EU-1-07-383_h_a_dec_12.pdf@2011-08-24 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_16.pdf@EU-1-07-382_h_a_dec_16.pdf@2012-12-18 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_20.pdf@EU-1-06-380_h_a_dec_20.pdf@2011-02-28 00:00:00@PREZISTA@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_13.pdf@EU-1-07-383_h_a_dec_13.pdf@2011-12-22 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_8.pdf@EU-1-06-377_h_a_dec_8.pdf@2010-04-02 00:00:00@Irbesartan HCT Winthrop@irbesartan  / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_17.pdf@EU-1-07-382_h_a_dec_17.pdf@2014-07-28 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_21.pdf@EU-1-06-380_h_a_dec_21.pdf@2011-05-18 00:00:00@PREZISTA@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_1.pdf@EU-1-07-386_h_a_dec_1.pdf@2007-09-18 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@NA before 2012@OD Not Found@Schwarz Pharma AG@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_14.pdf@EU-1-07-383_h_a_dec_14.pdf@2012-02-23 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-377_h_a_dec_9.pdf@EU-1-06-377_h_a_dec_9.pdf@2010-05-26 00:00:00@Irbesartan HCT Winthrop@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@SANOFI PHARMA BRISTOL MYERS  SQUIBB SNC@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_10.pdf@EU-1-07-386_h_a_dec_10.pdf@2012-03-15 00:00:00@Toviaz@fesoterodine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_22.pdf@EU-1-06-380_h_a_dec_22.pdf@2011-07-27 00:00:00@PREZISTA@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_18.pdf@EU-1-07-382_h_a_dec_18.pdf@2015-05-06 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_15.pdf@EU-1-07-383_h_a_dec_15.pdf@2012-08-30 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_23.pdf@EU-1-06-380_h_a_dec_23.pdf@2012-02-21 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_11.pdf@EU-1-07-386_h_a_dec_11.pdf@2012-10-25 00:00:00@Toviaz@fesoterodine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_0.pdf@EU-1-07-387_h_a_dec_0.pdf@2007-04-23 00:00:00@Advagraf@Tacrolimus@NAS before 2012@NA before 2012@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_16.pdf@EU-1-07-383_h_a_dec_16.pdf@2012-12-17 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_19.pdf@EU-1-07-382_h_a_dec_19.pdf@2016-06-16 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_24.pdf@EU-1-06-380_h_a_dec_24.pdf@2012-06-27 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_2.pdf@EU-1-07-382_h_a_dec_2.pdf@2007-12-18 00:00:00@Xelevia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_1.pdf@EU-1-07-387_h_a_dec_1.pdf@2008-01-25 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_12.pdf@EU-1-07-386_h_a_dec_12.pdf@2015-09-23 00:00:00@Toviaz@fesoterodine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_17.pdf@EU-1-07-383_h_a_dec_17.pdf@2014-09-30 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_25.pdf@EU-1-06-380_h_a_dec_25.pdf@2012-10-24 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_10.pdf@EU-1-07-387_h_a_dec_10.pdf@2011-11-22 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma  Europe B.V.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_26.pdf@EU-1-06-380_h_a_dec_26.pdf@2013-01-14 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_13.pdf@EU-1-07-386_h_a_dec_13.pdf@2017-06-07 00:00:00@Toviaz@fesoterodine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_20.pdf@EU-1-07-382_h_a_dec_20.pdf@2017-11-09 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_18.pdf@EU-1-07-383_h_a_dec_18.pdf@2015-05-28 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_27.pdf@EU-1-06-380_h_a_dec_27.pdf@2013-01-07 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_12.pdf@EU-1-07-387_h_a_dec_12.pdf@2012-10-29 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_19.pdf@EU-1-07-383_h_a_dec_19.pdf@2016-06-24 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_14.pdf@EU-1-07-386_h_a_dec_14.pdf@2018-07-30 00:00:00@Toviaz@fesoterodine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_21.pdf@EU-1-07-382_h_a_dec_21.pdf@2017-12-18 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_13.pdf@EU-1-07-387_h_a_dec_13.pdf@2013-02-18 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_28.pdf@EU-1-06-380_h_a_dec_28.pdf@2013-09-19 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_2.pdf@EU-1-07-383_h_a_dec_2.pdf@2007-12-19 00:00:00@Januvia@sitagliptin@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_15.pdf@EU-1-07-386_h_a_dec_15.pdf@2020-07-16 00:00:00@Toviaz@fesoterodine@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_22.pdf@EU-1-07-382_h_a_dec_22.pdf@2018-05-22 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_14.pdf@EU-1-07-387_h_a_dec_14.pdf@2014-10-15 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_0.pdf@EU-1-07-389_h_a_dec_0.pdf@2007-05-21 00:00:00@ORENCIA@abatacept@NAS before 2012@NA before 2012@OD Not Found@BRISTOL MYERS SQUIBB PHARMA  EEIG@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_29.pdf@EU-1-06-380_h_a_dec_29.pdf@2013-09-19 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_20.pdf@EU-1-07-383_h_a_dec_20.pdf@2017-11-09 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_15.pdf@EU-1-07-387_h_a_dec_15.pdf@2016-06-16 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_2.pdf@EU-1-07-386_h_a_dec_2.pdf@2008-07-07 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@True@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_1.pdf@EU-1-07-389_h_a_dec_1.pdf@2009-02-25 00:00:00@ORENCIA@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_23.pdf@EU-1-07-382_h_a_dec_23.pdf@2018-08-20 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_3.pdf@EU-1-06-380_h_a_dec_3.pdf@2007-12-18 00:00:00@Prezista@darunavir@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_10.pdf@EU-1-07-389_h_a_dec_10.pdf@2012-04-10 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_21.pdf@EU-1-07-383_h_a_dec_21.pdf@2017-08-12 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_3.pdf@EU-1-07-386_h_a_dec_3.pdf@2008-11-28 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_24.pdf@EU-1-07-382_h_a_dec_24.pdf@2020-09-03 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_16.pdf@EU-1-07-387_h_a_dec_16.pdf@2019-02-18 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_30.pdf@EU-1-06-380_h_a_dec_30.pdf@2013-11-15 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_11.pdf@EU-1-07-389_h_a_dec_11.pdf@2013-03-12 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_4.pdf@EU-1-07-386_h_a_dec_4.pdf@2009-07-29 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_31.pdf@EU-1-06-380_h_a_dec_31.pdf@2014-10-30 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_22.pdf@EU-1-07-383_h_a_dec_22.pdf@2018-05-16 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_17.pdf@EU-1-07-387_h_a_dec_17.pdf@2020-02-28 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_25.pdf@EU-1-07-382_h_a_dec_25.pdf@2021-05-21 00:00:00@Xelevia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_5.pdf@EU-1-07-386_h_a_dec_5.pdf@2010-08-02 00:00:00@TOVIAZ@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_32.pdf@EU-1-06-380_h_a_dec_32.pdf@2016-02-26 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_12.pdf@EU-1-07-389_h_a_dec_12.pdf@2014-04-28 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_23.pdf@EU-1-07-383_h_a_dec_23.pdf@2018-08-08 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_3.pdf@EU-1-07-382_h_a_dec_3.pdf@2008-02-26 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_33.pdf@EU-1-06-380_h_a_dec_33.pdf@2018-05-02 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_18.pdf@EU-1-07-387_h_a_dec_18.pdf@2021-03-22 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_6.pdf@EU-1-07-386_h_a_dec_6.pdf@2010-04-06 00:00:00@Toviaz@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_24.pdf@EU-1-07-383_h_a_dec_24.pdf@2020-02-28 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_4.pdf@EU-1-07-382_h_a_dec_4.pdf@2009-05-29 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_34.pdf@EU-1-06-380_h_a_dec_34.pdf@2018-06-07 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_7.pdf@EU-1-07-386_h_a_dec_7.pdf@2010-10-25 00:00:00@Toviaz@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_13.pdf@EU-1-07-389_h_a_dec_13.pdf@2015-08-10 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_25.pdf@EU-1-07-383_h_a_dec_25.pdf@2021-05-25 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_5.pdf@EU-1-07-382_h_a_dec_5.pdf@2009-07-23 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_19.pdf@EU-1-07-387_h_a_dec_19.pdf@2022-02-17 00:00:00@Advagraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed

EU-1-07-386_h_a_dec_8.pdf@EU-1-07-386_h_a_dec_8.pdf@2011-03-24 00:00:00@Toviaz@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_26.pdf@EU-1-07-383_h_a_dec_26.pdf@2022-02-09 00:00:00@Januvia@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_6.pdf@EU-1-07-382_h_a_dec_6.pdf@2009-08-28 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_36.pdf@EU-1-06-380_h_a_dec_36.pdf@2019-03-05 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_2.pdf@EU-1-07-387_h_a_dec_2.pdf@2008-10-28 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_14.pdf@EU-1-07-389_h_a_dec_14.pdf@2016-08-25 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-386_h_a_dec_9.pdf@EU-1-07-386_h_a_dec_9.pdf@2011-10-24 00:00:00@Toviaz@fesoterodine@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_3.pdf@EU-1-07-383_h_a_dec_3.pdf@2008-02-26 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_8.pdf@EU-1-07-382_h_a_dec_8.pdf@2010-06-08 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_37.pdf@EU-1-06-380_h_a_dec_37.pdf@2020-08-28 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_3.pdf@EU-1-07-387_h_a_dec_3.pdf@2009-02-25 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_15.pdf@EU-1-07-389_h_a_dec_15.pdf@2017-07-25 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_4.pdf@EU-1-07-383_h_a_dec_4.pdf@2009-02-06 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-382_h_a_dec_9.pdf@EU-1-07-382_h_a_dec_9.pdf@2010-03-11 00:00:00@Xelevia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_38.pdf@EU-1-06-380_h_a_dec_38.pdf@2021-09-29 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_4.pdf@EU-1-07-387_h_a_dec_4.pdf@2009-03-25 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_0.pdf@EU-1-07-391_h_a_dec_0.pdf@2007-06-14 00:00:00@Revlimid@lenalidomide@NAS before 2012@NA before 2012@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_39.pdf@EU-1-06-380_h_a_dec_39.pdf@2022-09-15 00:00:00@PREZISTA@darunavir@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_5.pdf@EU-1-07-383_h_a_dec_5.pdf@2009-07-29 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_5.pdf@EU-1-07-387_h_a_dec_5.pdf@2009-04-27 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_1.pdf@EU-1-07-391_h_a_dec_1.pdf@2007-06-14 00:00:00@Revlimid@lenalidomide@NAS before 2012@NA before 2012@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_16.pdf@EU-1-07-389_h_a_dec_16.pdf@2019-08-04 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_0.pdf@EU-1-07-392_h_a_dec_0.pdf@2007-06-29 00:00:00@Circadin@melatonin@NAS before 2012@NA before 2012@OD Not Found@Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_6.pdf@EU-1-07-383_h_a_dec_6.pdf@2009-08-21 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_6.pdf@EU-1-07-387_h_a_dec_6.pdf@2011-04-20 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_10.pdf@EU-1-07-391_h_a_dec_10.pdf@2009-02-24 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_5.pdf@EU-1-06-380_h_a_dec_5.pdf@2008-06-20 00:00:00@Prezista@darunavir@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_7.pdf@EU-1-07-383_h_a_dec_7.pdf@2009-09-11 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_1.pdf@EU-1-07-392_h_a_dec_1.pdf@2008-09-07 00:00:00@Circadin@melatonin@NAS before 2012@True@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_17.pdf@EU-1-07-389_h_a_dec_17.pdf@2020-09-12 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_7.pdf@EU-1-07-387_h_a_dec_7.pdf@2011-06-29 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_6.pdf@EU-1-06-380_h_a_dec_6.pdf@2008-04-07 00:00:00@Prezista@darunavir@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_11.pdf@EU-1-07-391_h_a_dec_11.pdf@2009-07-08 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_8.pdf@EU-1-07-383_h_a_dec_8.pdf@2010-06-08 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_2.pdf@EU-1-07-389_h_a_dec_2.pdf@2009-05-29 00:00:00@ORENCIA@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_8.pdf@EU-1-07-387_h_a_dec_8.pdf@2011-05-09 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_7.pdf@EU-1-06-380_h_a_dec_7.pdf@2008-07-28 00:00:00@Prezista@darunavir@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_12.pdf@EU-1-07-391_h_a_dec_12.pdf@2009-07-08 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_10.pdf@EU-1-07-392_h_a_dec_10.pdf@2013-12-08 00:00:00@Circadin@Melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-387_h_a_dec_9.pdf@EU-1-07-387_h_a_dec_9.pdf@2011-10-27 00:00:00@Advagraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-07-383_h_a_dec_9.pdf@EU-1-07-383_h_a_dec_9.pdf@2010-03-11 00:00:00@Januvia@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_3.pdf@EU-1-07-389_h_a_dec_3.pdf@2010-01-20 00:00:00@Orencia@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_8.pdf@EU-1-06-380_h_a_dec_8.pdf@2008-08-29 00:00:00@Prezista@darunavir@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_13.pdf@EU-1-07-391_h_a_dec_13.pdf@2009-10-19 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_11.pdf@EU-1-07-392_h_a_dec_11.pdf@2014-06-27 00:00:00@Circadin@Melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-06-380_h_a_dec_9.pdf@EU-1-06-380_h_a_dec_9.pdf@2008-10-24 00:00:00@Prezista@darunavir@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_4.pdf@EU-1-07-389_h_a_dec_4.pdf@2010-01-07 00:00:00@Orencia@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_14.pdf@EU-1-07-391_h_a_dec_14.pdf@2009-12-16 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_5.pdf@EU-1-07-389_h_a_dec_5.pdf@2010-03-12 00:00:00@Orencia@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_12.pdf@EU-1-07-392_h_a_dec_12.pdf@2015-07-17 00:00:00@Circadin@Melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_15.pdf@EU-1-07-391_h_a_dec_15.pdf@2009-12-16 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_6.pdf@EU-1-07-389_h_a_dec_6.pdf@2011-06-23 00:00:00@Orencia@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_16.pdf@EU-1-07-391_h_a_dec_16.pdf@2010-08-01 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_7.pdf@EU-1-07-389_h_a_dec_7.pdf@2010-01-20 00:00:00@Orencia@abatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_13.pdf@EU-1-07-392_h_a_dec_13.pdf@2019-07-02 00:00:00@Circadin@Melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_17.pdf@EU-1-07-391_h_a_dec_17.pdf@2010-08-01 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_8.pdf@EU-1-07-389_h_a_dec_8.pdf@2012-06-02 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_14.pdf@EU-1-07-392_h_a_dec_14.pdf@2020-08-17 00:00:00@Circadin@Melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC SARL@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_0.pdf@EU-1-07-393_h_a_dec_0.pdf@2007-06-20 00:00:00@Soliris@Eculizumab@NAS before 2012@NA before 2012@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-389_h_a_dec_9.pdf@EU-1-07-389_h_a_dec_9.pdf@2012-03-15 00:00:00@Orencia@abatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_15.pdf@EU-1-07-392_h_a_dec_15.pdf@2022-01-24 00:00:00@Circadin@Melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC SARL@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_18.pdf@EU-1-07-391_h_a_dec_18.pdf@2010-12-01 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_1.pdf@EU-1-07-393_h_a_dec_1.pdf@2007-06-20 00:00:00@Soliris@Eculizumab@NAS before 2012@NA before 2012@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_2.pdf@EU-1-07-392_h_a_dec_2.pdf@2008-07-29 00:00:00@Circadin@melatonin@NAS before 2012@True@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_19.pdf@EU-1-07-391_h_a_dec_19.pdf@2010-03-15 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_0.pdf@EU-1-07-395_h_a_dec_0.pdf@2007-06-25 00:00:00@Invega@paliperidone@NAS before 2012@NA before 2012@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_10.pdf@EU-1-07-393_h_a_dec_10.pdf@2012-04-13 00:00:00@Soliris@Eculizumab@False@False@OD Not Found@Alexion Europe  S.A.S.@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_3.pdf@EU-1-07-392_h_a_dec_3.pdf@2009-08-10 00:00:00@Circadin@melatonin@NAS before 2012@False@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_2.pdf@EU-1-07-391_h_a_dec_2.pdf@2008-03-18 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_1.pdf@EU-1-07-395_h_a_dec_1.pdf@2008-04-22 00:00:00@Invega@paliperidone@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_0.pdf@EU-1-07-396_h_a_dec_0.pdf@2007-06-25 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_11.pdf@EU-1-07-393_h_a_dec_11.pdf@2012-05-25 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_1.pdf@EU-1-07-396_h_a_dec_1.pdf@2008-04-04 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_4.pdf@EU-1-07-392_h_a_dec_4.pdf@2009-11-20 00:00:00@Circadin@melatonin@NAS before 2012@False@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_12.pdf@EU-1-07-393_h_a_dec_12.pdf@2012-06-18 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_20.pdf@EU-1-07-391_h_a_dec_20.pdf@2010-03-23 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_10.pdf@EU-1-07-395_h_a_dec_10.pdf@2011-08-04 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_5.pdf@EU-1-07-392_h_a_dec_5.pdf@2010-02-06 00:00:00@Circadin@melatonin@NAS before 2012@False@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_13.pdf@EU-1-07-393_h_a_dec_13.pdf@2012-06-18 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_10.pdf@EU-1-07-396_h_a_dec_10.pdf@2022-10-14 00:00:00@Pergoveris@follitropin alfa / lutropin alfa@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_21.pdf@EU-1-07-391_h_a_dec_21.pdf@2010-05-10 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_11.pdf@EU-1-07-395_h_a_dec_11.pdf@2011-12-10 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_14.pdf@EU-1-07-393_h_a_dec_14.pdf@2012-04-10 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_2.pdf@EU-1-07-396_h_a_dec_2.pdf@2009-08-06 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_12.pdf@EU-1-07-395_h_a_dec_12.pdf@2012-05-14 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_6.pdf@EU-1-07-392_h_a_dec_6.pdf@2010-11-26 00:00:00@Circadin@melatonin@NAS before 2012@False@OD Not Found@RAD Neurim  Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_22.pdf@EU-1-07-391_h_a_dec_22.pdf@2010-10-25 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_15.pdf@EU-1-07-393_h_a_dec_15.pdf@2012-06-18 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_3.pdf@EU-1-07-396_h_a_dec_3.pdf@2010-03-15 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_13.pdf@EU-1-07-395_h_a_dec_13.pdf@2012-06-27 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_7.pdf@EU-1-07-392_h_a_dec_7.pdf@2011-07-09 00:00:00@Circadin@melatonin@NAS before 2012@False@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_23.pdf@EU-1-07-391_h_a_dec_23.pdf@2010-12-13 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_16.pdf@EU-1-07-393_h_a_dec_16.pdf@2013-04-29 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_0.pdf@EU-1-07-397_h_a_dec_0.pdf@2007-06-29 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@NA before 2012@adopted@OTL Pharma/Addmedica@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_4.pdf@EU-1-07-396_h_a_dec_4.pdf@2010-10-06 00:00:00@Pergoveris@follitropin alfa/lutropin  alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_14.pdf@EU-1-07-395_h_a_dec_14.pdf@2013-08-26 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_5.pdf@EU-1-07-396_h_a_dec_5.pdf@2011-09-22 00:00:00@Pergoveris@follitropin alfa/lutropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_1.pdf@EU-1-07-397_h_a_dec_1.pdf@2007-06-29 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@NA before 2012@adopted@OTL Pharma/Addmedica@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_24.pdf@EU-1-07-391_h_a_dec_24.pdf@2010-12-13 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_8.pdf@EU-1-07-392_h_a_dec_8.pdf@2012-02-13 00:00:00@Circadin@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_6.pdf@EU-1-07-396_h_a_dec_6.pdf@2012-05-22 00:00:00@Pergoveris@follitropin alfa/lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_15.pdf@EU-1-07-395_h_a_dec_15.pdf@2014-05-23 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_17.pdf@EU-1-07-393_h_a_dec_17.pdf@2013-12-18 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_10.pdf@EU-1-07-397_h_a_dec_10.pdf@2012-10-31 00:00:00@Siklos@hydroxycarbamide@False@False@adopted@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-392_h_a_dec_9.pdf@EU-1-07-392_h_a_dec_9.pdf@2012-04-20 00:00:00@Circadin@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC  Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_25.pdf@EU-1-07-391_h_a_dec_25.pdf@2010-12-17 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_7.pdf@EU-1-07-396_h_a_dec_7.pdf@2015-03-02 00:00:00@Pergoveris@follitropin alfa / lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_16.pdf@EU-1-07-395_h_a_dec_16.pdf@2015-05-28 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_18.pdf@EU-1-07-393_h_a_dec_18.pdf@2014-03-21 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_11.pdf@EU-1-07-397_h_a_dec_11.pdf@2014-04-23 00:00:00@Siklos@hydroxycarbamide@False@False@adopted@Addmedica@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_26.pdf@EU-1-07-391_h_a_dec_26.pdf@2011-01-21 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_17.pdf@EU-1-07-395_h_a_dec_17.pdf@2017-08-24 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_19.pdf@EU-1-07-393_h_a_dec_19.pdf@2015-03-30 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_8.pdf@EU-1-07-396_h_a_dec_8.pdf@2017-08-05 00:00:00@Pergoveris@follitropin alfa / lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_12.pdf@EU-1-07-397_h_a_dec_12.pdf@2017-04-24 00:00:00@Siklos@hydroxycarbamide@False@False@OD Not Found@Addmedica@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_27.pdf@EU-1-07-391_h_a_dec_27.pdf@2012-09-01 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_18.pdf@EU-1-07-395_h_a_dec_18.pdf@2019-06-06 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_13.pdf@EU-1-07-397_h_a_dec_13.pdf@2018-02-08 00:00:00@Siklos@hydroxycarbamide@False@False@OD Not Found@Addmedica@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_2.pdf@EU-1-07-393_h_a_dec_2.pdf@2009-05-28 00:00:00@Soliris@Eculizumab@NAS before 2012@False@OD Not Found@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-396_h_a_dec_9.pdf@EU-1-07-396_h_a_dec_9.pdf@2018-08-20 00:00:00@Pergoveris@follitropin alfa / lutropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_19.pdf@EU-1-07-395_h_a_dec_19.pdf@2022-05-05 00:00:00@Invega@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_28.pdf@EU-1-07-391_h_a_dec_28.pdf@2012-01-13 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_14.pdf@EU-1-07-397_h_a_dec_14.pdf@2021-05-27 00:00:00@Siklos@hydroxycarbamide@False@False@OD Not Found@Addmedica@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_20.pdf@EU-1-07-393_h_a_dec_20.pdf@2015-07-20 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_29.pdf@EU-1-07-391_h_a_dec_29.pdf@2012-04-13 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_0.pdf@EU-1-07-399_h_a_dec_0.pdf@2007-07-30 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_2.pdf@EU-1-07-395_h_a_dec_2.pdf@2009-12-01 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_15.pdf@EU-1-07-397_h_a_dec_15.pdf@2021-12-16 00:00:00@Siklos@hydroxycarbamide@False@False@OD Not Found@Addmedica@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_21.pdf@EU-1-07-393_h_a_dec_21.pdf@2016-09-19 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_3.pdf@EU-1-07-391_h_a_dec_3.pdf@2008-03-18 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_1.pdf@EU-1-07-399_h_a_dec_1.pdf@2009-03-27 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_2.pdf@EU-1-07-397_h_a_dec_2.pdf@2008-07-07 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@True@OD Not Found@Addmedica@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_22.pdf@EU-1-07-393_h_a_dec_22.pdf@2017-08-14 00:00:00@Eculizumab@Active Substance Not Found@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_3.pdf@EU-1-07-395_h_a_dec_3.pdf@2009-12-01 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_30.pdf@EU-1-07-391_h_a_dec_30.pdf@2012-10-09 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_3.pdf@EU-1-07-397_h_a_dec_3.pdf@2010-10-09 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@False@OD Not Found@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_31.pdf@EU-1-07-391_h_a_dec_31.pdf@2012-11-19 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_0.pdf@EU-1-07-400_h_a_dec_0.pdf@2007-07-20 00:00:00@MIRCERA@methoxy polyethylene glycol-epoetin  beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_23.pdf@EU-1-07-393_h_a_dec_23.pdf@2018-11-22 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_10.pdf@EU-1-07-399_h_a_dec_10.pdf@2021-04-13 00:00:00@Aerinaze@desloratadine; pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_4.pdf@EU-1-07-395_h_a_dec_4.pdf@2009-07-07 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_32.pdf@EU-1-07-391_h_a_dec_32.pdf@2013-01-17 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_4.pdf@EU-1-07-397_h_a_dec_4.pdf@2011-02-28 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@False@OD Not Found@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_24.pdf@EU-1-07-393_h_a_dec_24.pdf@2019-08-26 00:00:00@Eculizumab@Active Substance Not Found@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_5.pdf@EU-1-07-395_h_a_dec_5.pdf@2009-05-11 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_1.pdf@EU-1-07-400_h_a_dec_1.pdf@2007-07-20 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_5.pdf@EU-1-07-397_h_a_dec_5.pdf@2011-02-28 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_11.pdf@EU-1-07-399_h_a_dec_11.pdf@2022-05-30 00:00:00@Aerinaze@desloratadine;  pseudoephedrine sulphate@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_25.pdf@EU-1-07-393_h_a_dec_25.pdf@2021-02-19 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_6.pdf@EU-1-07-395_h_a_dec_6.pdf@2009-11-23 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_6.pdf@EU-1-07-397_h_a_dec_6.pdf@2011-06-29 00:00:00@Siklos@hydroxycarbamide@NAS before 2012@False@OD Not Found@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_33.pdf@EU-1-07-391_h_a_dec_33.pdf@2013-06-13 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_10.pdf@EU-1-07-400_h_a_dec_10.pdf@2010-08-26 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_26.pdf@EU-1-07-393_h_a_dec_26.pdf@2022-03-18 00:00:00@Soliris@Eculizumab@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_2.pdf@EU-1-07-399_h_a_dec_2.pdf@2010-03-15 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@NAS before 2012@False@OD Not Found@SP Europe@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_7.pdf@EU-1-07-395_h_a_dec_7.pdf@2010-03-26 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_7.pdf@EU-1-07-397_h_a_dec_7.pdf@2012-10-05 00:00:00@Siklos@hydroxycarbamide@False@False@OD Not Found@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_11.pdf@EU-1-07-400_h_a_dec_11.pdf@2010-05-10 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_3.pdf@EU-1-07-393_h_a_dec_3.pdf@2009-05-28 00:00:00@Soliris@Eculizumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_8.pdf@EU-1-07-395_h_a_dec_8.pdf@2010-01-07 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_34.pdf@EU-1-07-391_h_a_dec_34.pdf@2013-11-13 00:00:00@Revlimid@Lenalidomide@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
MA Not Found@Parsed
EU-1-07-397_h_a_dec_8.pdf@EU-1-07-397_h_a_dec_8.pdf@2012-06-28 00:00:00@Siklos@hydroxycarbamide@False@False@adopted@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_12.pdf@EU-1-07-400_h_a_dec_12.pdf@2011-06-17 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_4.pdf@EU-1-07-393_h_a_dec_4.pdf@2009-11-11 00:00:00@Soliris@Eculizumab@NAS before 2012@False@OD Not Found@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_4.pdf@EU-1-07-399_h_a_dec_4.pdf@2012-02-17 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-395_h_a_dec_9.pdf@EU-1-07-395_h_a_dec_9.pdf@2010-12-13 00:00:00@Invega@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-07-397_h_a_dec_9.pdf@EU-1-07-397_h_a_dec_9.pdf@2012-06-28 00:00:00@Siklos@hydroxycarbamide@False@False@OD Not Found@ADDMEDICA@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_13.pdf@EU-1-07-400_h_a_dec_13.pdf@2011-10-20 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_0.pdf@EU-1-07-401_h_a_dec_0.pdf@2007-07-23 00:00:00@Orlistat GSK@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_5.pdf@EU-1-07-399_h_a_dec_5.pdf@2012-05-22 00:00:00@Aerinaze@desloratadine/pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_5.pdf@EU-1-07-393_h_a_dec_5.pdf@2009-12-21 00:00:00@Soliris@Eculizumab@NAS before 2012@False@OD Not Found@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_14.pdf@EU-1-07-400_h_a_dec_14.pdf@2012-05-15 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_1.pdf@EU-1-07-401_h_a_dec_1.pdf@2009-01-20 00:00:00@alli@Orlistat@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_6.pdf@EU-1-07-393_h_a_dec_6.pdf@2010-07-10 00:00:00@Soliris@Eculizumab@NAS before 2012@False@OD Not Found@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_36.pdf@EU-1-07-391_h_a_dec_36.pdf@2015-02-19 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_6.pdf@EU-1-07-399_h_a_dec_6.pdf@2014-08-26 00:00:00@Aerinaze@desloratadine; pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_15.pdf@EU-1-07-400_h_a_dec_15.pdf@2012-09-20 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_10.pdf@EU-1-07-401_h_a_dec_10.pdf@2012-09-24 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_7.pdf@EU-1-07-393_h_a_dec_7.pdf@2011-03-24 00:00:00@Soliris@Eculizumab@NAS before 2012@False@adopted@Alexion Europe  S.A.S.@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_0.pdf@EU-1-07-402_h_a_dec_0.pdf@2007-03-08 00:00:00@INCRELEX@Mecasermin@NAS before 2012@NA before 2012@adopted@Tercica Europe Limited@exceptional@Parsed
EU-1-07-391_h_a_dec_37.pdf@EU-1-07-391_h_a_dec_37.pdf@2016-01-06 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_7.pdf@EU-1-07-399_h_a_dec_7.pdf@2017-05-22 00:00:00@Aerinaze@desloratadine;  pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_16.pdf@EU-1-07-400_h_a_dec_16.pdf@2014-12-15 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_11.pdf@EU-1-07-401_h_a_dec_11.pdf@2014-04-28 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_8.pdf@EU-1-07-393_h_a_dec_8.pdf@2011-11-24 00:00:00@Soliris@Eculizumab@NAS before 2012@False@adopted@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_1.pdf@EU-1-07-402_h_a_dec_1.pdf@2007-03-08 00:00:00@INCRELEX@Mecasermin@NAS before 2012@NA before 2012@adopted@Tercica Europe Limited@exceptional@Parsed
EU-1-07-391_h_a_dec_38.pdf@EU-1-07-391_h_a_dec_38.pdf@2016-08-07 00:00:00@Lenalidomide@Active Substance Not Found@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-393_h_a_dec_9.pdf@EU-1-07-393_h_a_dec_9.pdf@2011-11-24 00:00:00@Soliris@Eculizumab@NAS before 2012@False@OD Not Found@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_17.pdf@EU-1-07-400_h_a_dec_17.pdf@2016-06-07 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_8.pdf@EU-1-07-399_h_a_dec_8.pdf@2018-04-23 00:00:00@Aerinaze@desloratadine; pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_10.pdf@EU-1-07-402_h_a_dec_10.pdf@2011-06-17 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-401_h_a_dec_12.pdf@EU-1-07-401_h_a_dec_12.pdf@2015-05-28 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_11.pdf@EU-1-07-402_h_a_dec_11.pdf@2012-03-08 00:00:00@INCRELEX@Mecasermin@False@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-391_h_a_dec_39.pdf@EU-1-07-391_h_a_dec_39.pdf@2016-09-09 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-399_h_a_dec_9.pdf@EU-1-07-399_h_a_dec_9.pdf@2018-06-15 00:00:00@Aerinaze@desloratadine; pseudoephedrine sulphate@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_18.pdf@EU-1-07-400_h_a_dec_18.pdf@2018-03-16 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_12.pdf@EU-1-07-402_h_a_dec_12.pdf@2012-08-30 00:00:00@INCRELEX@Mecasermin@False@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-401_h_a_dec_13.pdf@EU-1-07-401_h_a_dec_13.pdf@2015-11-23 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_4.pdf@EU-1-07-391_h_a_dec_4.pdf@2008-07-31 00:00:00@Revlimid@Lenalidomide@NAS before 2012@True@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_13.pdf@EU-1-07-402_h_a_dec_13.pdf@2013-04-22 00:00:00@INCRELEX@Mecasermin@False@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-400_h_a_dec_19.pdf@EU-1-07-400_h_a_dec_19.pdf@2020-10-22 00:00:00@Mircera@methoxy polyethylene glycol-epoetin beta@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_14.pdf@EU-1-07-402_h_a_dec_14.pdf@2015-05-05 00:00:00@INCRELEX@Mecasermin@False@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-401_h_a_dec_14.pdf@EU-1-07-401_h_a_dec_14.pdf@2017-06-29 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_40.pdf@EU-1-07-391_h_a_dec_40.pdf@2017-02-16 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_15.pdf@EU-1-07-402_h_a_dec_15.pdf@2015-05-27 00:00:00@INCRELEX@Mecasermin@False@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-400_h_a_dec_2.pdf@EU-1-07-400_h_a_dec_2.pdf@2007-07-20 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_0.pdf@EU-1-07-403_h_a_dec_0.pdf@2007-08-22 00:00:00@Atriance@nelarabine@NAS before 2012@NA before 2012@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-404_h_a_dec_0.pdf@EU-1-07-404_h_a_dec_0.pdf@2007-08-23 00:00:00@Flebogammadif@human normal  immunoglobulin@NAS before 2012@NA before 2012@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_15.pdf@EU-1-07-401_h_a_dec_15.pdf@2018-11-26 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_16.pdf@EU-1-07-402_h_a_dec_16.pdf@2016-08-04 00:00:00@INCRELEX@Mecasermin@False@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-400_h_a_dec_3.pdf@EU-1-07-400_h_a_dec_3.pdf@2008-05-03 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_41.pdf@EU-1-07-391_h_a_dec_41.pdf@2017-02-23 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_1.pdf@EU-1-07-403_h_a_dec_1.pdf@2008-11-19 00:00:00@Atriance@nelarabine@NAS before 2012@False@OD Not Found@Glaxo Group Limited@exceptional@Parsed
EU-1-07-405_h_a_dec_0.pdf@EU-1-07-405_h_a_dec_0.pdf@2007-08-22 00:00:00@Rasilez@aliskiren@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_1.pdf@EU-1-07-404_h_a_dec_1.pdf@2009-07-24 00:00:00@Flebogammadif@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_17.pdf@EU-1-07-402_h_a_dec_17.pdf@2017-02-06 00:00:00@INCRELEX@Mecasermin@False@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-400_h_a_dec_4.pdf@EU-1-07-400_h_a_dec_4.pdf@2008-04-23 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_16.pdf@EU-1-07-401_h_a_dec_16.pdf@2021-01-07 00:00:00@alli@Orlistat@False@False@OD Not Found@GlaxoSmithKline Dungarvan Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_1.pdf@EU-1-07-405_h_a_dec_1.pdf@2008-09-07 00:00:00@Rasilez@aliskiren@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_18.pdf@EU-1-07-402_h_a_dec_18.pdf@2017-06-16 00:00:00@INCRELEX@Mecasermin@False@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-403_h_a_dec_10.pdf@EU-1-07-403_h_a_dec_10.pdf@2015-04-24 00:00:00@Atriance@nelarabine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_42.pdf@EU-1-07-391_h_a_dec_42.pdf@2017-09-18 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_2.pdf@EU-1-07-404_h_a_dec_2.pdf@2010-12-13 00:00:00@Flebogamma DIF@Human normal immunoglobulin  (IVIg)@NAS before 2012@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_5.pdf@EU-1-07-400_h_a_dec_5.pdf@2008-05-09 00:00:00@MIRCERA@methoxy polyethylene glycol-epoetin beta@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_10.pdf@EU-1-07-405_h_a_dec_10.pdf@2011-02-21 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_19.pdf@EU-1-07-402_h_a_dec_19.pdf@2018-09-20 00:00:00@INCRELEX@Mecasermin@False@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-403_h_a_dec_11.pdf@EU-1-07-403_h_a_dec_11.pdf@2016-12-01 00:00:00@Atriance@nelarabine@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-07-401_h_a_dec_2.pdf@EU-1-07-401_h_a_dec_2.pdf@2009-10-14 00:00:00@alli@Orlistat@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_3.pdf@EU-1-07-404_h_a_dec_3.pdf@2012-08-30 00:00:00@Flebogamma DIF@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_11.pdf@EU-1-07-405_h_a_dec_11.pdf@2011-03-18 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_6.pdf@EU-1-07-400_h_a_dec_6.pdf@2009-07-04 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_43.pdf@EU-1-07-391_h_a_dec_43.pdf@2018-06-29 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_2.pdf@EU-1-07-402_h_a_dec_2.pdf@2008-02-07 00:00:00@INCRELEX@Mecasermin@NAS before 2012@True@OD Not Found@Tercica Europe Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_3.pdf@EU-1-07-401_h_a_dec_3.pdf@2009-11-24 00:00:00@alli@Orlistat@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_12.pdf@EU-1-07-405_h_a_dec_12.pdf@2011-04-18 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_12.pdf@EU-1-07-403_h_a_dec_12.pdf@2017-06-16 00:00:00@Atriance@nelarabine@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_7.pdf@EU-1-07-400_h_a_dec_7.pdf@2010-03-15 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_44.pdf@EU-1-07-391_h_a_dec_44.pdf@2019-05-13 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_20.pdf@EU-1-07-402_h_a_dec_20.pdf@2019-12-16 00:00:00@INCRELEX@Mecasermin@False@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-404_h_a_dec_4.pdf@EU-1-07-404_h_a_dec_4.pdf@2014-04-07 00:00:00@Flebogamma DIF@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_4.pdf@EU-1-07-401_h_a_dec_4.pdf@2010-08-18 00:00:00@alli@Orlistat@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_13.pdf@EU-1-07-405_h_a_dec_13.pdf@2011-05-23 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_21.pdf@EU-1-07-402_h_a_dec_21.pdf@2021-04-21 00:00:00@INCRELEX@Mecasermin@False@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-391_h_a_dec_45.pdf@EU-1-07-391_h_a_dec_45.pdf@2019-12-18 00:00:00@Revlimid@Lenalidomide@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-400_h_a_dec_8.pdf@EU-1-07-400_h_a_dec_8.pdf@2010-04-29 00:00:00@MIRCERA@methoxy polyethylene  glycol-epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_14.pdf@EU-1-07-405_h_a_dec_14.pdf@2011-11-22 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_5.pdf@EU-1-07-401_h_a_dec_5.pdf@2010-11-29 00:00:00@alli@Orlistat@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_5.pdf@EU-1-07-404_h_a_dec_5.pdf@2015-08-07 00:00:00@Flebogamma  DIF@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_46.pdf@EU-1-07-391_h_a_dec_46.pdf@2020-02-06 00:00:00@Revlimid@Lenalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_13.pdf@EU-1-07-403_h_a_dec_13.pdf@2018-04-30 00:00:00@Atriance@nelarabine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_22.pdf@EU-1-07-402_h_a_dec_22.pdf@2022-08-07 00:00:00@INCRELEX@Mecasermin@False@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-400_h_a_dec_9.pdf@EU-1-07-400_h_a_dec_9.pdf@2010-04-06 00:00:00@Mircera@epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_15.pdf@EU-1-07-405_h_a_dec_15.pdf@2012-04-20 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_6.pdf@EU-1-07-401_h_a_dec_6.pdf@2011-01-08 00:00:00@alli@Orlistat@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_6.pdf@EU-1-07-404_h_a_dec_6.pdf@2016-12-12 00:00:00@Flebogamma  DIF@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_47.pdf@EU-1-07-391_h_a_dec_47.pdf@2020-09-24 00:00:00@Revlimid@Lenalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_3.pdf@EU-1-07-402_h_a_dec_3.pdf@2008-07-29 00:00:00@INCRELEX@Mecasermin@NAS before 2012@True@OD Not Found@Tercica Europe Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_16.pdf@EU-1-07-405_h_a_dec_16.pdf@2012-05-25 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_7.pdf@EU-1-07-401_h_a_dec_7.pdf@2012-01-30 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_14.pdf@EU-1-07-403_h_a_dec_14.pdf@2020-08-27 00:00:00@Atriance@nelarabine@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-07-404_h_a_dec_7.pdf@EU-1-07-404_h_a_dec_7.pdf@2017-04-24 00:00:00@Flebogamma DIF@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_4.pdf@EU-1-07-402_h_a_dec_4.pdf@2008-11-20 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@OD Not Found@Tercica Europe Limited@exceptional@Parsed
EU-1-07-405_h_a_dec_17.pdf@EU-1-07-405_h_a_dec_17.pdf@2012-08-23 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_8.pdf@EU-1-07-401_h_a_dec_8.pdf@2012-04-13 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_48.pdf@EU-1-07-391_h_a_dec_48.pdf@2020-11-16 00:00:00@Revlimid@Lenalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_18.pdf@EU-1-07-405_h_a_dec_18.pdf@2012-11-22 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-07-404_h_a_dec_8.pdf@EU-1-07-404_h_a_dec_8.pdf@2019-07-31 00:00:00@Flebogamma  DIF@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_5.pdf@EU-1-07-402_h_a_dec_5.pdf@2009-07-14 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@OD Not Found@Tercica Europe Limited@CMA Not Found@Parsed
EU-1-07-401_h_a_dec_9.pdf@EU-1-07-401_h_a_dec_9.pdf@2012-06-21 00:00:00@alli@Orlistat@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_15.pdf@EU-1-07-403_h_a_dec_15.pdf@2021-12-11 00:00:00@Atriance@nelarabine@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-07-405_h_a_dec_19.pdf@EU-1-07-405_h_a_dec_19.pdf@2013-01-24 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_49.pdf@EU-1-07-391_h_a_dec_49.pdf@2021-09-16 00:00:00@Revlimid@Lenalidomide@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_6.pdf@EU-1-07-402_h_a_dec_6.pdf@2010-03-30 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-403_h_a_dec_2.pdf@EU-1-07-403_h_a_dec_2.pdf@2009-03-18 00:00:00@Atriance@nelarabine@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_2.pdf@EU-1-07-405_h_a_dec_2.pdf@2008-08-28 00:00:00@Rasilez@aliskiren@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_5.pdf@EU-1-07-391_h_a_dec_5.pdf@2008-07-31 00:00:00@Revlimid@Lenalidomide@NAS before 2012@True@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_7.pdf@EU-1-07-402_h_a_dec_7.pdf@2010-07-28 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_20.pdf@EU-1-07-405_h_a_dec_20.pdf@2013-02-18 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_3.pdf@EU-1-07-403_h_a_dec_3.pdf@2010-01-20 00:00:00@Atriance@nelarabine@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_8.pdf@EU-1-07-402_h_a_dec_8.pdf@2011-01-02 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@OD Not Found@Ipsen Pharma@exceptional@Parsed
EU-1-07-403_h_a_dec_4.pdf@EU-1-07-403_h_a_dec_4.pdf@2010-11-29 00:00:00@Atriance@nelarabine@NAS before 2012@False@OD Not Found@Glaxo Group Limited@exceptional@Parsed
EU-1-07-405_h_a_dec_21.pdf@EU-1-07-405_h_a_dec_21.pdf@2013-04-17 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_50.pdf@EU-1-07-391_h_a_dec_50.pdf@2022-10-14 00:00:00@Revlimid@Lenalidomide@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-402_h_a_dec_9.pdf@EU-1-07-402_h_a_dec_9.pdf@2011-06-16 00:00:00@INCRELEX@Mecasermin@NAS before 2012@False@adopted@Ipsen Pharma@exceptional@Parsed
EU-1-07-403_h_a_dec_5.pdf@EU-1-07-403_h_a_dec_5.pdf@2011-07-20 00:00:00@Atriance@nelarabine@NAS before 2012@False@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-391_h_a_dec_6.pdf@EU-1-07-391_h_a_dec_6.pdf@2008-08-22 00:00:00@Revlimid@Lenalidomide@NAS before 2012@True@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_0.pdf@EU-1-07-410_h_a_dec_0.pdf@2007-08-28 00:00:00@Binocrit@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_22.pdf@EU-1-07-405_h_a_dec_22.pdf@2013-06-27 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_6.pdf@EU-1-07-403_h_a_dec_6.pdf@2011-11-24 00:00:00@Atriance@nelarabine@NAS before 2012@False@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-391_h_a_dec_7.pdf@EU-1-07-391_h_a_dec_7.pdf@2008-10-27 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_7.pdf@EU-1-07-403_h_a_dec_7.pdf@2012-03-21 00:00:00@Atriance@nelarabine@False@False@adopted@Glaxo Group  Limited@exceptional@Parsed
EU-1-07-410_h_a_dec_1.pdf@EU-1-07-410_h_a_dec_1.pdf@2007-08-28 00:00:00@Binocrit@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_0.pdf@EU-1-07-411_h_a_dec_0.pdf@2007-08-28 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@HEXAL Biotech ForschungsGmbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_23.pdf@EU-1-07-405_h_a_dec_23.pdf@2013-07-26 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_8.pdf@EU-1-07-391_h_a_dec_8.pdf@2008-11-20 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_8.pdf@EU-1-07-403_h_a_dec_8.pdf@2012-06-18 00:00:00@Atriance@nelarabine@False@False@adopted@Glaxo Group Limited@exceptional@Parsed
EU-1-07-410_h_a_dec_10.pdf@EU-1-07-410_h_a_dec_10.pdf@2010-01-20 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_1.pdf@EU-1-07-411_h_a_dec_1.pdf@2007-08-28 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@HEXAL Biotech ForschungsGmbH@CMA Not Found@Parsed
EU-1-07-391_h_a_dec_9.pdf@EU-1-07-391_h_a_dec_9.pdf@2008-12-22 00:00:00@Revlimid@Lenalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_24.pdf@EU-1-07-405_h_a_dec_24.pdf@2013-03-12 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-403_h_a_dec_9.pdf@EU-1-07-403_h_a_dec_9.pdf@2013-12-20 00:00:00@Atriance@nelarabine@False@False@adopted@Glaxo Group Ltd@exceptional@Parsed
EU-1-07-410_h_a_dec_11.pdf@EU-1-07-410_h_a_dec_11.pdf@2010-08-18 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_10.pdf@EU-1-07-411_h_a_dec_10.pdf@2010-01-20 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_12.pdf@EU-1-07-410_h_a_dec_12.pdf@2011-03-14 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_11.pdf@EU-1-07-411_h_a_dec_11.pdf@2010-08-18 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_25.pdf@EU-1-07-405_h_a_dec_25.pdf@2014-06-27 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_0.pdf@EU-1-07-412_h_a_dec_0.pdf@2007-08-28 00:00:00@Abseamed@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_12.pdf@EU-1-07-411_h_a_dec_12.pdf@2011-03-14 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_1.pdf@EU-1-07-412_h_a_dec_1.pdf@2007-08-28 00:00:00@Abseamed@epoetin alfa@NAS before 2012@NA before 2012@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_13.pdf@EU-1-07-410_h_a_dec_13.pdf@2011-03-14 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_26.pdf@EU-1-07-405_h_a_dec_26.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)4035 for “Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_0.pdf@EU-1-07-413_h_a_dec_0.pdf@2007-07-09 00:00:00@Gliolan@5-aminolevulinic acid hydrochloride@NAS before 2012@NA before 2012@adopted@Medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_14.pdf@EU-1-07-410_h_a_dec_14.pdf@2012-06-18 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_10.pdf@EU-1-07-412_h_a_dec_10.pdf@2010-01-20 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_13.pdf@EU-1-07-411_h_a_dec_13.pdf@2011-03-14 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_1.pdf@EU-1-07-413_h_a_dec_1.pdf@2007-07-09 00:00:00@Gliolan@5-aminolevulinic acid  hydrochloride@NAS before 2012@NA before 2012@adopted@Medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_14.pdf@EU-1-07-411_h_a_dec_14.pdf@2012-06-18 00:00:00@Epoetin alfa Hexal@epoetin alfa@False@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_11.pdf@EU-1-07-412_h_a_dec_11.pdf@2010-08-31 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel  Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_27.pdf@EU-1-07-405_h_a_dec_27.pdf@2015-06-19 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_15.pdf@EU-1-07-410_h_a_dec_15.pdf@2014-03-21 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_2.pdf@EU-1-07-413_h_a_dec_2.pdf@2012-02-17 00:00:00@Gliolan@5-aminolevulinic acid  hydrochloride@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_12.pdf@EU-1-07-412_h_a_dec_12.pdf@2011-10-03 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice  Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_16.pdf@EU-1-07-410_h_a_dec_16.pdf@2015-07-31 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_0.pdf@EU-1-07-414_h_a_dec_0.pdf@2007-09-26 00:00:00@Galvus@vildagliptin@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_15.pdf@EU-1-07-411_h_a_dec_15.pdf@2014-03-21 00:00:00@Epoetin  alfa Hexal@epoetin alfa@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_3.pdf@EU-1-07-413_h_a_dec_3.pdf@2012-08-30 00:00:00@Gliolan@5-aminolevulinic acid hydrochloride@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_28.pdf@EU-1-07-405_h_a_dec_28.pdf@2016-06-24 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_17.pdf@EU-1-07-410_h_a_dec_17.pdf@2016-03-31 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_16.pdf@EU-1-07-411_h_a_dec_16.pdf@2015-07-31 00:00:00@Epoetin alfa  Hexal@epoetin alfa@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_1.pdf@EU-1-07-414_h_a_dec_1.pdf@2008-01-25 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_4.pdf@EU-1-07-413_h_a_dec_4.pdf@2015-01-19 00:00:00@Gliolan@aminolevulinic acid hydrochloride@False@False@adopted@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_13.pdf@EU-1-07-412_h_a_dec_13.pdf@2011-10-03 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice  Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_18.pdf@EU-1-07-410_h_a_dec_18.pdf@2017-07-09 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_10.pdf@EU-1-07-414_h_a_dec_10.pdf@2011-11-24 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_17.pdf@EU-1-07-411_h_a_dec_17.pdf@2016-03-31 00:00:00@Epoetin alfa  Hexal@epoetin alfa@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_29.pdf@EU-1-07-405_h_a_dec_29.pdf@2017-05-22 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_5.pdf@EU-1-07-413_h_a_dec_5.pdf@2019-11-07 00:00:00@Gliolan@aminolevulinic acid hydrochloride@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_14.pdf@EU-1-07-412_h_a_dec_14.pdf@2012-06-15 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_11.pdf@EU-1-07-414_h_a_dec_11.pdf@2012-01-30 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_19.pdf@EU-1-07-410_h_a_dec_19.pdf@2018-08-31 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_18.pdf@EU-1-07-411_h_a_dec_18.pdf@2017-07-09 00:00:00@Epoetin alfa  Hexal@epoetin alfa@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_3.pdf@EU-1-07-405_h_a_dec_3.pdf@2009-03-04 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_6.pdf@EU-1-07-413_h_a_dec_6.pdf@2020-10-27 00:00:00@Gliolan@aminolevulinic acid hydrochloride@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_19.pdf@EU-1-07-411_h_a_dec_19.pdf@2018-08-31 00:00:00@Epoetin alfa  Hexal@epoetin alfa@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_12.pdf@EU-1-07-414_h_a_dec_12.pdf@2012-07-23 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_2.pdf@EU-1-07-410_h_a_dec_2.pdf@2008-02-29 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_15.pdf@EU-1-07-412_h_a_dec_15.pdf@2014-03-21 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-413_h_a_dec_7.pdf@EU-1-07-413_h_a_dec_7.pdf@2022-03-24 00:00:00@Gliolan@5-aminolevulinic acid hydrochloride@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_13.pdf@EU-1-07-414_h_a_dec_13.pdf@2012-10-29 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_30.pdf@EU-1-07-405_h_a_dec_30.pdf@2017-08-22 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_20.pdf@EU-1-07-410_h_a_dec_20.pdf@2019-11-14 00:00:00@Binocrit@epoetin alfa@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_2.pdf@EU-1-07-411_h_a_dec_2.pdf@2008-02-29 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@HEXAL Biotech ForschungsGmbH@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_16.pdf@EU-1-07-412_h_a_dec_16.pdf@2015-07-31 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_14.pdf@EU-1-07-414_h_a_dec_14.pdf@2013-07-31 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_17.pdf@EU-1-07-412_h_a_dec_17.pdf@2016-03-30 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_3.pdf@EU-1-07-410_h_a_dec_3.pdf@2008-08-07 00:00:00@Binocrit@epoetin alfa@NAS before 2012@True@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_31.pdf@EU-1-07-405_h_a_dec_31.pdf@2018-09-20 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Noden Pharma DAC@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_0.pdf@EU-1-07-415_h_a_dec_0.pdf@2007-09-27 00:00:00@Zalasta@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_18.pdf@EU-1-07-412_h_a_dec_18.pdf@2017-09-18 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_3.pdf@EU-1-07-411_h_a_dec_3.pdf@2008-08-07 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@True@OD Not Found@HEXAL Biotech Forschungs GmbH@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_4.pdf@EU-1-07-410_h_a_dec_4.pdf@2008-10-29 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_15.pdf@EU-1-07-414_h_a_dec_15.pdf@2015-04-24 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_19.pdf@EU-1-07-412_h_a_dec_19.pdf@2018-08-31 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_1.pdf@EU-1-07-415_h_a_dec_1.pdf@2008-02-04 00:00:00@Zalasta@Olanzapine@NAS before 2012@True@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
MA Not Found@Parsed
EU-1-07-410_h_a_dec_5.pdf@EU-1-07-410_h_a_dec_5.pdf@2008-11-21 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_32.pdf@EU-1-07-405_h_a_dec_32.pdf@2019-09-10 00:00:00@Rasilez@aliskiren@False@False@OD Not Found@Noden Pharma DAC@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_5.pdf@EU-1-07-411_h_a_dec_5.pdf@2008-11-21 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@HEXAL Biotech Forschungs GmbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_16.pdf@EU-1-07-414_h_a_dec_16.pdf@2015-12-16 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_2.pdf@EU-1-07-412_h_a_dec_2.pdf@2008-02-26 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_6.pdf@EU-1-07-410_h_a_dec_6.pdf@2009-10-07 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_4.pdf@EU-1-07-405_h_a_dec_4.pdf@2009-04-22 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_10.pdf@EU-1-07-415_h_a_dec_10.pdf@2014-08-26 00:00:00@Zalasta@Olanzapine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_6.pdf@EU-1-07-411_h_a_dec_6.pdf@2009-10-07 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_20.pdf@EU-1-07-412_h_a_dec_20.pdf@2019-07-11 00:00:00@Abseamed@epoetin alfa@False@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_7.pdf@EU-1-07-410_h_a_dec_7.pdf@2009-08-25 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_17.pdf@EU-1-07-414_h_a_dec_17.pdf@2018-01-03 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_11.pdf@EU-1-07-415_h_a_dec_11.pdf@2015-10-22 00:00:00@Zalasta@Olanzapine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_5.pdf@EU-1-07-405_h_a_dec_5.pdf@2009-03-12 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_7.pdf@EU-1-07-411_h_a_dec_7.pdf@2009-08-25 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_3.pdf@EU-1-07-412_h_a_dec_3.pdf@2008-06-27 00:00:00@Abseamed@epoetin alfa@NAS before 2012@True@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_6.pdf@EU-1-07-405_h_a_dec_6.pdf@2010-03-30 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_12.pdf@EU-1-07-415_h_a_dec_12.pdf@2017-05-18 00:00:00@Zalasta@Olanzapine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_8.pdf@EU-1-07-410_h_a_dec_8.pdf@2009-01-10 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_8.pdf@EU-1-07-411_h_a_dec_8.pdf@2009-01-10 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_4.pdf@EU-1-07-412_h_a_dec_4.pdf@2008-10-22 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_7.pdf@EU-1-07-405_h_a_dec_7.pdf@2010-02-06 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-410_h_a_dec_9.pdf@EU-1-07-410_h_a_dec_9.pdf@2009-12-16 00:00:00@Binocrit@epoetin alfa@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_13.pdf@EU-1-07-415_h_a_dec_13.pdf@2020-02-21 00:00:00@Zalasta@Olanzapine@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-07-411_h_a_dec_9.pdf@EU-1-07-411_h_a_dec_9.pdf@2009-12-16 00:00:00@Epoetin alfa Hexal@epoetin alfa@NAS before 2012@False@OD Not Found@Hexal AG.@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_5.pdf@EU-1-07-412_h_a_dec_5.pdf@2008-11-21 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_8.pdf@EU-1-07-405_h_a_dec_8.pdf@2010-03-11 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_2.pdf@EU-1-07-415_h_a_dec_2.pdf@2008-08-07 00:00:00@Zalasta@Olanzapine@NAS before 2012@True@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_19.pdf@EU-1-07-414_h_a_dec_19.pdf@2020-12-18 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_6.pdf@EU-1-07-412_h_a_dec_6.pdf@2009-07-14 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-405_h_a_dec_9.pdf@EU-1-07-405_h_a_dec_9.pdf@2011-01-21 00:00:00@Rasilez@aliskiren@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_3.pdf@EU-1-07-415_h_a_dec_3.pdf@2008-08-22 00:00:00@Zalasta@Olanzapine@NAS before 2012@True@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_2.pdf@EU-1-07-414_h_a_dec_2.pdf@2008-10-13 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_7.pdf@EU-1-07-412_h_a_dec_7.pdf@2009-08-28 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_4.pdf@EU-1-07-415_h_a_dec_4.pdf@2008-11-26 00:00:00@Zalasta@Olanzapine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_0.pdf@EU-1-07-416_h_a_dec_0.pdf@2007-09-20 00:00:00@ECALTA@anidulafungin@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_8.pdf@EU-1-07-412_h_a_dec_8.pdf@2009-11-26 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co KG@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_20.pdf@EU-1-07-414_h_a_dec_20.pdf@2021-06-21 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_5.pdf@EU-1-07-415_h_a_dec_5.pdf@2009-07-17 00:00:00@Zalasta@Olanzapine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_1.pdf@EU-1-07-416_h_a_dec_1.pdf@2009-06-01 00:00:00@ECALTA@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-412_h_a_dec_9.pdf@EU-1-07-412_h_a_dec_9.pdf@2009-11-12 00:00:00@Abseamed@epoetin alfa@NAS before 2012@False@OD Not Found@Medice Arzneimittel Pütter GmbH & Co  KG@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_6.pdf@EU-1-07-415_h_a_dec_6.pdf@2009-10-30 00:00:00@Zalasta@Olanzapine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_10.pdf@EU-1-07-416_h_a_dec_10.pdf@2012-08-23 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_21.pdf@EU-1-07-414_h_a_dec_21.pdf@2022-07-15 00:00:00@Galvus@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_7.pdf@EU-1-07-415_h_a_dec_7.pdf@2011-07-20 00:00:00@Zalasta@Olanzapine@NAS before 2012@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_11.pdf@EU-1-07-416_h_a_dec_11.pdf@2014-08-26 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_3.pdf@EU-1-07-414_h_a_dec_3.pdf@2008-10-31 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-415_h_a_dec_8.pdf@EU-1-07-415_h_a_dec_8.pdf@2012-07-26 00:00:00@Zalasta@Olanzapine@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_4.pdf@EU-1-07-414_h_a_dec_4.pdf@2009-08-21 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_12.pdf@EU-1-07-416_h_a_dec_12.pdf@2017-05-24 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
ed
EU-1-07-414_h_a_dec_5.pdf@EU-1-07-414_h_a_dec_5.pdf@2010-03-26 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_6.pdf@EU-1-07-414_h_a_dec_6.pdf@2010-02-07 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_13.pdf@EU-1-07-416_h_a_dec_13.pdf@2017-08-28 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_7.pdf@EU-1-07-414_h_a_dec_7.pdf@2011-01-24 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_14.pdf@EU-1-07-416_h_a_dec_14.pdf@2018-09-27 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_0.pdf@EU-1-07-417_h_a_dec_0.pdf@2007-09-17 00:00:00@Yondelis@Trabectedin@NAS before 2012@NA before 2012@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-414_h_a_dec_8.pdf@EU-1-07-414_h_a_dec_8.pdf@2011-12-10 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_15.pdf@EU-1-07-416_h_a_dec_15.pdf@2020-03-06 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_1.pdf@EU-1-07-417_h_a_dec_1.pdf@2008-10-13 00:00:00@Yondelis@Trabectedin@NAS before 2012@False@OD Not Found@Pharma Mar, S.A.@CMA Not Found@Parsed
EU-1-07-414_h_a_dec_9.pdf@EU-1-07-414_h_a_dec_9.pdf@2011-10-27 00:00:00@Galvus@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_16.pdf@EU-1-07-416_h_a_dec_16.pdf@2021-10-19 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_10.pdf@EU-1-07-417_h_a_dec_10.pdf@2014-03-06 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@exceptional@Parsed
EU-1-07-416_h_a_dec_2.pdf@EU-1-07-416_h_a_dec_2.pdf@2009-07-16 00:00:00@ECALTA@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_0.pdf@EU-1-07-418_h_a_dec_0.pdf@2007-09-17 00:00:00@CELSENTRI@maraviroc@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_0.pdf@EU-1-07-419_h_a_dec_0.pdf@2007-09-20 00:00:00@Cervarix@16 and Human Papilloma Virus 18 L1 proteins@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_3.pdf@EU-1-07-416_h_a_dec_3.pdf@2009-07-23 00:00:00@ECALTA@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_11.pdf@EU-1-07-417_h_a_dec_11.pdf@2014-06-23 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@conditional@Parsed
EU-1-07-418_h_a_dec_1.pdf@EU-1-07-418_h_a_dec_1.pdf@2007-09-18 00:00:00@CELSENTRI@maraviroc@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_1.pdf@EU-1-07-419_h_a_dec_1.pdf@2008-08-13 00:00:00@Cervarix@Human Papilloma Virus-16  and Human Papilloma Virus 18 L1 proteins@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_4.pdf@EU-1-07-416_h_a_dec_4.pdf@2010-01-09 00:00:00@Ecalta@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_0.pdf@EU-1-07-420_h_a_dec_0.pdf@2007-11-23 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@NA before 2012@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_10.pdf@EU-1-07-418_h_a_dec_10.pdf@2010-02-06 00:00:00@Celsentri@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_10.pdf@EU-1-07-419_h_a_dec_10.pdf@2011-08-26 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.  EN 3    EN proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_5.pdf@EU-1-07-416_h_a_dec_5.pdf@2011-06-29 00:00:00@Ecalta@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_13.pdf@EU-1-07-417_h_a_dec_13.pdf@2015-06-19 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_1.pdf@EU-1-07-420_h_a_dec_1.pdf@2009-01-16 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_0.pdf@EU-1-07-422_h_a_dec_0.pdf@2007-11-19 00:00:00@Tasigna@Nilotinib@NAS before 2012@NA before 2012@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_11.pdf@EU-1-07-418_h_a_dec_11.pdf@2010-12-20 00:00:00@Celsentri@maraviroc@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_11.pdf@EU-1-07-419_h_a_dec_11.pdf@2011-05-12 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.  EN 3    EN L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_6.pdf@EU-1-07-416_h_a_dec_6.pdf@2011-07-27 00:00:00@Ecalta@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_14.pdf@EU-1-07-417_h_a_dec_14.pdf@2016-06-29 00:00:00@Yondelis@Trabectedin@False@False@OD Not Found@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_12.pdf@EU-1-07-418_h_a_dec_12.pdf@2011-12-10 00:00:00@Celsentri@maraviroc@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_2.pdf@EU-1-07-420_h_a_dec_2.pdf@2010-05-26 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_7.pdf@EU-1-07-416_h_a_dec_7.pdf@2011-07-12 00:00:00@Ecalta@anidulafungin@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_1.pdf@EU-1-07-422_h_a_dec_1.pdf@2007-11-19 00:00:00@Tasigna@Nilotinib@NAS before 2012@NA before 2012@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_12.pdf@EU-1-07-419_h_a_dec_12.pdf@2012-09-17 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1  proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_15.pdf@EU-1-07-417_h_a_dec_15.pdf@2017-06-16 00:00:00@Yondelis@Trabectedin@False@False@OD Not Found@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_13.pdf@EU-1-07-418_h_a_dec_13.pdf@2011-11-21 00:00:00@Celsentri@maraviroc@NAS before 2012@False@OD Not Found@ViiV Healthcare UK  Ltd@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_3.pdf@EU-1-07-420_h_a_dec_3.pdf@2010-07-10 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-416_h_a_dec_8.pdf@EU-1-07-416_h_a_dec_8.pdf@2012-05-25 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_10.pdf@EU-1-07-422_h_a_dec_10.pdf@2009-12-22 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_13.pdf@EU-1-07-419_h_a_dec_13.pdf@2013-03-27 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_4.pdf@EU-1-07-420_h_a_dec_4.pdf@2011-10-11 00:00:00@Cyanokit@hydroxocobalamin@NAS before 2012@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_16.pdf@EU-1-07-417_h_a_dec_16.pdf@2017-10-19 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_14.pdf@EU-1-07-418_h_a_dec_14.pdf@2012-07-20 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_0.pdf@EU-1-07-423_h_a_dec_0.pdf@2007-03-12 00:00:00@Vectibix@panitumumab@NAS before 2012@NA before 2012@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-416_h_a_dec_9.pdf@EU-1-07-416_h_a_dec_9.pdf@2012-06-28 00:00:00@Ecalta@anidulafungin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_11.pdf@EU-1-07-422_h_a_dec_11.pdf@2010-03-23 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_5.pdf@EU-1-07-420_h_a_dec_5.pdf@2012-07-20 00:00:00@Cyanokit@hydroxocobalamin@False@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_14.pdf@EU-1-07-419_h_a_dec_14.pdf@2013-12-18 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_17.pdf@EU-1-07-417_h_a_dec_17.pdf@2018-06-25 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_1.pdf@EU-1-07-423_h_a_dec_1.pdf@2008-08-08 00:00:00@Vectibix@panitumumab@NAS before 2012@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_15.pdf@EU-1-07-418_h_a_dec_15.pdf@2014-02-21 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_12.pdf@EU-1-07-422_h_a_dec_12.pdf@2010-08-26 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_6.pdf@EU-1-07-420_h_a_dec_6.pdf@2015-06-22 00:00:00@Cyanokit@hydroxocobalamin@False@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_18.pdf@EU-1-07-417_h_a_dec_18.pdf@2019-03-05 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_13.pdf@EU-1-07-422_h_a_dec_13.pdf@2010-12-20 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_10.pdf@EU-1-07-423_h_a_dec_10.pdf@2011-10-11 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@conditional@Parsed
EU-1-07-419_h_a_dec_15.pdf@EU-1-07-419_h_a_dec_15.pdf@2014-11-21 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_16.pdf@EU-1-07-418_h_a_dec_16.pdf@2015-06-05 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_7.pdf@EU-1-07-420_h_a_dec_7.pdf@2015-12-08 00:00:00@Cyanokit@hydroxocobalamin@False@False@OD Not Found@Merck Santé s.a.s.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_19.pdf@EU-1-07-417_h_a_dec_19.pdf@2020-09-24 00:00:00@Yondelis@Trabectedin@False@False@OD Not Found@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_14.pdf@EU-1-07-422_h_a_dec_14.pdf@2010-12-20 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_11.pdf@EU-1-07-423_h_a_dec_11.pdf@2011-10-11 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-419_h_a_dec_16.pdf@EU-1-07-419_h_a_dec_16.pdf@2015-10-12 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_8.pdf@EU-1-07-420_h_a_dec_8.pdf@2018-07-30 00:00:00@Cyanokit@hydroxocobalamin@False@False@OD Not Found@SERB S.A.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_15.pdf@EU-1-07-422_h_a_dec_15.pdf@2011-05-23 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@adopted@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_2.pdf@EU-1-07-417_h_a_dec_2.pdf@2009-03-25 00:00:00@Yondelis@Trabectedin@NAS before 2012@False@OD Not Found@Pharma Mar, S.A.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_12.pdf@EU-1-07-423_h_a_dec_12.pdf@2012-01-20 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-424_h_a_dec_0.pdf@EU-1-07-424_h_a_dec_0.pdf@2007-11-19 00:00:00@TORISEL@Temsirolimus@NAS before 2012@NA before 2012@adopted@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_17.pdf@EU-1-07-419_h_a_dec_17.pdf@2016-12-01 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_17.pdf@EU-1-07-418_h_a_dec_17.pdf@2016-10-03 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-07-420_h_a_dec_9.pdf@EU-1-07-420_h_a_dec_9.pdf@2020-04-23 00:00:00@Cyanokit@hydroxocobalamin@False@False@OD Not Found@SERB S.A.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_16.pdf@EU-1-07-422_h_a_dec_16.pdf@2011-06-17 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@adopted@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_13.pdf@EU-1-07-423_h_a_dec_13.pdf@2012-02-17 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-419_h_a_dec_18.pdf@EU-1-07-419_h_a_dec_18.pdf@2016-07-29 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_1.pdf@EU-1-07-424_h_a_dec_1.pdf@2009-07-01 00:00:00@TORISEL@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_20.pdf@EU-1-07-417_h_a_dec_20.pdf@2022-08-07 00:00:00@Yondelis@Trabectedin@False@False@OD Not Found@Pharma Mar S.A.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_14.pdf@EU-1-07-423_h_a_dec_14.pdf@2012-06-27 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-422_h_a_dec_17.pdf@EU-1-07-422_h_a_dec_17.pdf@2011-11-22 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_19.pdf@EU-1-07-419_h_a_dec_19.pdf@2018-01-24 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_10.pdf@EU-1-07-424_h_a_dec_10.pdf@2011-06-23 00:00:00@Torisel@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_18.pdf@EU-1-07-418_h_a_dec_18.pdf@2017-06-07 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_15.pdf@EU-1-07-423_h_a_dec_15.pdf@2012-08-23 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-422_h_a_dec_18.pdf@EU-1-07-422_h_a_dec_18.pdf@2011-12-19 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_3.pdf@EU-1-07-417_h_a_dec_3.pdf@2009-06-22 00:00:00@Yondelis@Trabectedin@NAS before 2012@False@OD Not Found@Pharma Mar@exceptional@Parsed
EU-1-07-419_h_a_dec_2.pdf@EU-1-07-419_h_a_dec_2.pdf@2008-11-26 00:00:00@Cervarix@Human Papilloma Virus-16  and Human Papilloma Virus 18 L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_11.pdf@EU-1-07-424_h_a_dec_11.pdf@2011-02-09 00:00:00@Torisel@Temsirolimus@NAS before 2012@False@adopted@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_16.pdf@EU-1-07-423_h_a_dec_16.pdf@2012-10-25 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-418_h_a_dec_19.pdf@EU-1-07-418_h_a_dec_19.pdf@2018-09-28 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_19.pdf@EU-1-07-422_h_a_dec_19.pdf@2012-06-27 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_4.pdf@EU-1-07-417_h_a_dec_4.pdf@2009-06-23 00:00:00@Yondelis@Trabectedin@NAS before 2012@False@OD Not Found@Pharma Mar, S.A.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_12.pdf@EU-1-07-424_h_a_dec_12.pdf@2011-07-12 00:00:00@Torisel@Temsirolimus@NAS before 2012@False@adopted@Pfizer Limited@CMA Not Found@Parsed
D Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_0.pdf@EU-1-07-425_h_a_dec_0.pdf@2007-11-14 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_17.pdf@EU-1-07-423_h_a_dec_17.pdf@2013-01-14 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-418_h_a_dec_2.pdf@EU-1-07-418_h_a_dec_2.pdf@2008-10-28 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_5.pdf@EU-1-07-417_h_a_dec_5.pdf@2009-10-28 00:00:00@Yondelis@Trabectedin@NAS before 2012@False@OD Not Found@Pharma Mar, S.A.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_13.pdf@EU-1-07-424_h_a_dec_13.pdf@2012-05-25 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_2.pdf@EU-1-07-422_h_a_dec_2.pdf@2009-05-01 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_21.pdf@EU-1-07-419_h_a_dec_21.pdf@2020-09-03 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_1.pdf@EU-1-07-425_h_a_dec_1.pdf@2008-02-13 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_18.pdf@EU-1-07-423_h_a_dec_18.pdf@2013-07-25 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-424_h_a_dec_14.pdf@EU-1-07-424_h_a_dec_14.pdf@2012-09-20 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_20.pdf@EU-1-07-418_h_a_dec_20.pdf@2019-01-10 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_20.pdf@EU-1-07-422_h_a_dec_20.pdf@2012-09-20 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_6.pdf@EU-1-07-417_h_a_dec_6.pdf@2011-05-16 00:00:00@Yondelis@Trabectedin@NAS before 2012@False@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-419_h_a_dec_22.pdf@EU-1-07-419_h_a_dec_22.pdf@2021-04-30 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_10.pdf@EU-1-07-425_h_a_dec_10.pdf@2012-10-25 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_15.pdf@EU-1-07-424_h_a_dec_15.pdf@2012-09-24 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_21.pdf@EU-1-07-418_h_a_dec_21.pdf@2020-09-10 00:00:00@Celsentri@maraviroc@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_19.pdf@EU-1-07-423_h_a_dec_19.pdf@2014-02-21 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-417_h_a_dec_7.pdf@EU-1-07-417_h_a_dec_7.pdf@2012-01-31 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-419_h_a_dec_23.pdf@EU-1-07-419_h_a_dec_23.pdf@2022-09-21 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_21.pdf@EU-1-07-422_h_a_dec_21.pdf@2013-12-20 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_3.pdf@EU-1-07-418_h_a_dec_3.pdf@2008-10-31 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_11.pdf@EU-1-07-425_h_a_dec_11.pdf@2013-07-26 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_2.pdf@EU-1-07-423_h_a_dec_2.pdf@2008-10-24 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-417_h_a_dec_8.pdf@EU-1-07-417_h_a_dec_8.pdf@2012-03-08 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar, S.A.@exceptional@Parsed
EU-1-07-419_h_a_dec_3.pdf@EU-1-07-419_h_a_dec_3.pdf@2008-11-26 00:00:00@Cervarix@Human Papilloma Virus-16  and Human Papilloma Virus 18 L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_16.pdf@EU-1-07-424_h_a_dec_16.pdf@2013-11-20 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_4.pdf@EU-1-07-418_h_a_dec_4.pdf@2009-07-07 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_22.pdf@EU-1-07-422_h_a_dec_22.pdf@2014-12-15 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_4.pdf@EU-1-07-419_h_a_dec_4.pdf@2009-04-22 00:00:00@Cervarix@Human Papilloma Virus-16  and Human Papilloma Virus 18 L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_12.pdf@EU-1-07-425_h_a_dec_12.pdf@2015-09-04 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_20.pdf@EU-1-07-423_h_a_dec_20.pdf@2014-05-12 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-417_h_a_dec_9.pdf@EU-1-07-417_h_a_dec_9.pdf@2013-12-18 00:00:00@Yondelis@Trabectedin@False@False@adopted@Pharma Mar S.A.@exceptional@Parsed
EU-1-07-424_h_a_dec_17.pdf@EU-1-07-424_h_a_dec_17.pdf@2015-10-15 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_5.pdf@EU-1-07-418_h_a_dec_5.pdf@2009-07-08 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_5.pdf@EU-1-07-419_h_a_dec_5.pdf@2009-07-24 00:00:00@Cervarix@Human Papilloma Virus-16  and Human Papilloma Virus 18 L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_21.pdf@EU-1-07-423_h_a_dec_21.pdf@2015-01-15 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-422_h_a_dec_23.pdf@EU-1-07-422_h_a_dec_23.pdf@2016-02-06 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_6.pdf@EU-1-07-418_h_a_dec_6.pdf@2009-05-11 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_6.pdf@EU-1-07-419_h_a_dec_6.pdf@2009-11-23 00:00:00@Cervarix@Human Papilloma Virus-16  and Human Papilloma Virus 18 L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_22.pdf@EU-1-07-423_h_a_dec_22.pdf@2015-03-30 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_13.pdf@EU-1-07-425_h_a_dec_13.pdf@2015-12-16 00:00:00@Eucreas@vildagliptin /  metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_18.pdf@EU-1-07-424_h_a_dec_18.pdf@2016-01-14 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_7.pdf@EU-1-07-418_h_a_dec_7.pdf@2010-03-26 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_24.pdf@EU-1-07-422_h_a_dec_24.pdf@2017-05-22 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_23.pdf@EU-1-07-423_h_a_dec_23.pdf@2016-04-13 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_8.pdf@EU-1-07-418_h_a_dec_8.pdf@2010-03-26 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_14.pdf@EU-1-07-425_h_a_dec_14.pdf@2016-12-12 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  12.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2007)5575 for “Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_19.pdf@EU-1-07-424_h_a_dec_19.pdf@2016-12-12 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_24.pdf@EU-1-07-423_h_a_dec_24.pdf@2017-02-27 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_8.pdf@EU-1-07-419_h_a_dec_8.pdf@2010-06-08 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 159, 27.6.2003, p. 24. 3 OJ L 334, 12.12.2008, p. 7.  EN 3    EN L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_25.pdf@EU-1-07-422_h_a_dec_25.pdf@2017-05-24 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_25.pdf@EU-1-07-423_h_a_dec_25.pdf@2018-01-30 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-418_h_a_dec_9.pdf@EU-1-07-418_h_a_dec_9.pdf@2010-05-05 00:00:00@CELSENTRI@maraviroc@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_2.pdf@EU-1-07-424_h_a_dec_2.pdf@2009-05-26 00:00:00@TORISEL@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-419_h_a_dec_9.pdf@EU-1-07-419_h_a_dec_9.pdf@2011-02-21 00:00:00@Cervarix@Human Papilloma Virus-16 and Human Papilloma Virus 18  L1 proteins@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_15.pdf@EU-1-07-425_h_a_dec_15.pdf@2018-02-22 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_26.pdf@EU-1-07-423_h_a_dec_26.pdf@2018-12-18 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_26.pdf@EU-1-07-422_h_a_dec_26.pdf@2017-11-15 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_0.pdf@EU-1-07-427_h_a_dec_0.pdf@2007-12-12 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_20.pdf@EU-1-07-424_h_a_dec_20.pdf@2017-07-13 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_27.pdf@EU-1-07-423_h_a_dec_27.pdf@2019-09-23 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_16.pdf@EU-1-07-425_h_a_dec_16.pdf@2018-04-23 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_27.pdf@EU-1-07-422_h_a_dec_27.pdf@2018-04-26 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_1.pdf@EU-1-07-427_h_a_dec_1.pdf@2008-10-06 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@True@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_28.pdf@EU-1-07-423_h_a_dec_28.pdf@2021-07-16 00:00:00@Vectibix@panitumumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_21.pdf@EU-1-07-424_h_a_dec_21.pdf@2018-03-23 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_10.pdf@EU-1-07-427_h_a_dec_10.pdf@2012-12-11 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_17.pdf@EU-1-07-425_h_a_dec_17.pdf@2020-10-19 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_3.pdf@EU-1-07-423_h_a_dec_3.pdf@2008-12-22 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_28.pdf@EU-1-07-422_h_a_dec_28.pdf@2019-11-07 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_11.pdf@EU-1-07-427_h_a_dec_11.pdf@2014-02-28 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_4.pdf@EU-1-07-423_h_a_dec_4.pdf@2009-03-19 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-424_h_a_dec_22.pdf@EU-1-07-424_h_a_dec_22.pdf@2018-08-08 00:00:00@Torisel@Temsirolimus@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_18.pdf@EU-1-07-425_h_a_dec_18.pdf@2021-06-21 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_29.pdf@EU-1-07-422_h_a_dec_29.pdf@2019-11-14 00:00:00@Tasigna@Nilotinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_5.pdf@EU-1-07-423_h_a_dec_5.pdf@2009-07-04 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_12.pdf@EU-1-07-427_h_a_dec_12.pdf@2015-09-04 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_23.pdf@EU-1-07-424_h_a_dec_23.pdf@2019-09-12 00:00:00@Torisel@Temsirolimus@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_3.pdf@EU-1-07-422_h_a_dec_3.pdf@2009-02-26 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_2.pdf@EU-1-07-425_h_a_dec_2.pdf@2008-10-30 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_0.pdf@EU-1-07-428_h_a_dec_0.pdf@2008-01-14 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_6.pdf@EU-1-07-423_h_a_dec_6.pdf@2010-03-15 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-424_h_a_dec_24.pdf@EU-1-07-424_h_a_dec_24.pdf@2021-10-19 00:00:00@Torisel@Temsirolimus@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_13.pdf@EU-1-07-427_h_a_dec_13.pdf@2016-10-21 00:00:00@Olanzapine  Teva@Olanzapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_1.pdf@EU-1-07-428_h_a_dec_1.pdf@2009-10-02 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioSciences Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_3.pdf@EU-1-07-425_h_a_dec_3.pdf@2009-08-28 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_3.pdf@EU-1-07-424_h_a_dec_3.pdf@2009-08-21 00:00:00@TORISEL@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_7.pdf@EU-1-07-423_h_a_dec_7.pdf@2010-04-29 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_10.pdf@EU-1-07-428_h_a_dec_10.pdf@2012-06-27 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_30.pdf@EU-1-07-422_h_a_dec_30.pdf@2020-11-16 00:00:00@Tasigna@Nilotinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_4.pdf@EU-1-07-425_h_a_dec_4.pdf@2010-03-15 00:00:00@Eucreas@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_0.pdf@EU-1-07-431_h_a_dec_0.pdf@2007-12-18 00:00:00@Retacrit@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_14.pdf@EU-1-07-427_h_a_dec_14.pdf@2018-02-19 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_4.pdf@EU-1-07-424_h_a_dec_4.pdf@2009-10-14 00:00:00@TORISEL@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_8.pdf@EU-1-07-423_h_a_dec_8.pdf@2010-12-13 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-07-428_h_a_dec_11.pdf@EU-1-07-428_h_a_dec_11.pdf@2013-01-14 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_5.pdf@EU-1-07-425_h_a_dec_5.pdf@2010-02-07 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_5.pdf@EU-1-07-424_h_a_dec_5.pdf@2009-12-23 00:00:00@TORISEL@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_1.pdf@EU-1-07-431_h_a_dec_1.pdf@2007-12-18 00:00:00@Retacrit@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_15.pdf@EU-1-07-427_h_a_dec_15.pdf@2020-07-31 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-423_h_a_dec_9.pdf@EU-1-07-423_h_a_dec_9.pdf@2011-05-23 00:00:00@Vectibix@panitumumab@NAS before 2012@False@OD Not Found@Amgen Europe  B.V.@conditional@Parsed
EU-1-07-422_h_a_dec_31.pdf@EU-1-07-422_h_a_dec_31.pdf@2022-03-28 00:00:00@Tasigna@Nilotinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_6.pdf@EU-1-07-425_h_a_dec_6.pdf@2011-01-24 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_10.pdf@EU-1-07-431_h_a_dec_10.pdf@2012-11-15 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_6.pdf@EU-1-07-424_h_a_dec_6.pdf@2010-01-25 00:00:00@TORISEL@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_12.pdf@EU-1-07-428_h_a_dec_12.pdf@2013-03-12 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_4.pdf@EU-1-07-422_h_a_dec_4.pdf@2009-07-04 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_7.pdf@EU-1-07-425_h_a_dec_7.pdf@2011-10-27 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_16.pdf@EU-1-07-427_h_a_dec_16.pdf@2022-03-24 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_7.pdf@EU-1-07-424_h_a_dec_7.pdf@2010-02-07 00:00:00@Torisel@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_11.pdf@EU-1-07-431_h_a_dec_11.pdf@2014-08-19 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_13.pdf@EU-1-07-428_h_a_dec_13.pdf@2013-12-20 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_8.pdf@EU-1-07-425_h_a_dec_8.pdf@2011-11-24 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_5.pdf@EU-1-07-422_h_a_dec_5.pdf@2009-04-21 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_2.pdf@EU-1-07-427_h_a_dec_2.pdf@2008-02-09 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@True@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_8.pdf@EU-1-07-424_h_a_dec_8.pdf@2010-05-11 00:00:00@Torisel@Temsirolimus@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_12.pdf@EU-1-07-431_h_a_dec_12.pdf@2015-12-08 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-425_h_a_dec_9.pdf@EU-1-07-425_h_a_dec_9.pdf@2012-07-23 00:00:00@Eucreas@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_6.pdf@EU-1-07-422_h_a_dec_6.pdf@2009-08-06 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_14.pdf@EU-1-07-428_h_a_dec_14.pdf@2014-10-27 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_3.pdf@EU-1-07-427_h_a_dec_3.pdf@2008-11-21 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-424_h_a_dec_9.pdf@EU-1-07-424_h_a_dec_9.pdf@2011-01-24 00:00:00@Torisel@Temsirolimus@NAS before 2012@False@adopted@Wyeth Europa Ltd@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_7.pdf@EU-1-07-422_h_a_dec_7.pdf@2009-07-27 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_4.pdf@EU-1-07-427_h_a_dec_4.pdf@2009-07-20 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_13.pdf@EU-1-07-431_h_a_dec_13.pdf@2017-09-18 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_15.pdf@EU-1-07-428_h_a_dec_15.pdf@2015-02-26 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_8.pdf@EU-1-07-422_h_a_dec_8.pdf@2009-06-08 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_5.pdf@EU-1-07-427_h_a_dec_5.pdf@2009-10-19 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-422_h_a_dec_9.pdf@EU-1-07-422_h_a_dec_9.pdf@2009-08-25 00:00:00@Tasigna@Nilotinib@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_14.pdf@EU-1-07-431_h_a_dec_14.pdf@2018-06-09 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_6.pdf@EU-1-07-427_h_a_dec_6.pdf@2010-10-28 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_16.pdf@EU-1-07-428_h_a_dec_16.pdf@2015-07-28 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_0.pdf@EU-1-07-432_h_a_dec_0.pdf@2007-12-18 00:00:00@Silapo@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_7.pdf@EU-1-07-427_h_a_dec_7.pdf@2011-06-14 00:00:00@Olanzapine Teva@Olanzapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_17.pdf@EU-1-07-428_h_a_dec_17.pdf@2016-11-11 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_15.pdf@EU-1-07-431_h_a_dec_15.pdf@2018-09-28 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_8.pdf@EU-1-07-427_h_a_dec_8.pdf@2012-02-17 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_1.pdf@EU-1-07-432_h_a_dec_1.pdf@2007-12-18 00:00:00@Silapo@epoetin zeta@NAS before 2012@NA before 2012@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_0.pdf@EU-1-07-433_h_a_dec_0.pdf@2007-11-12 00:00:00@NEVANAC@nepafenac@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-427_h_a_dec_9.pdf@EU-1-07-427_h_a_dec_9.pdf@2012-08-08 00:00:00@Olanzapine Teva@Olanzapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_16.pdf@EU-1-07-431_h_a_dec_16.pdf@2020-07-31 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_0.pdf@EU-1-07-434_h_a_dec_0.pdf@2008-11-01 00:00:00@Avamys@Flucticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_10.pdf@EU-1-07-432_h_a_dec_10.pdf@2012-07-26 00:00:00@Silapo@epoetin zeta@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_1.pdf@EU-1-07-433_h_a_dec_1.pdf@2011-01-17 00:00:00@Nevanac@nepafenac@NAS before 2012@False@OD Not Found@Alcon Laboratories  (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_17.pdf@EU-1-07-431_h_a_dec_17.pdf@2021-10-22 00:00:00@Retacrit@epoetin zeta@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_1.pdf@EU-1-07-434_h_a_dec_1.pdf@2008-11-01 00:00:00@Avamys@Fluticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_18.pdf@EU-1-07-428_h_a_dec_18.pdf@2018-07-30 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_11.pdf@EU-1-07-432_h_a_dec_11.pdf@2015-10-16 00:00:00@Silapo@epoetin zeta@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_2.pdf@EU-1-07-431_h_a_dec_2.pdf@2008-08-13 00:00:00@Retacrit@epoetin zeta@NAS before 2012@True@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_10.pdf@EU-1-07-434_h_a_dec_10.pdf@2012-07-20 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_19.pdf@EU-1-07-428_h_a_dec_19.pdf@2019-07-25 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_12.pdf@EU-1-07-432_h_a_dec_12.pdf@2018-06-09 00:00:00@Silapo@epoetin zeta@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_10.pdf@EU-1-07-433_h_a_dec_10.pdf@2018-04-23 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_11.pdf@EU-1-07-434_h_a_dec_11.pdf@2012-12-17 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_3.pdf@EU-1-07-431_h_a_dec_3.pdf@2008-11-21 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_2.pdf@EU-1-07-428_h_a_dec_2.pdf@2009-02-04 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_13.pdf@EU-1-07-432_h_a_dec_13.pdf@2019-01-18 00:00:00@Silapo@epoetin zeta@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_4.pdf@EU-1-07-431_h_a_dec_4.pdf@2009-07-01 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_11.pdf@EU-1-07-433_h_a_dec_11.pdf@2019-08-26 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_20.pdf@EU-1-07-428_h_a_dec_20.pdf@2019-11-11 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_14.pdf@EU-1-07-432_h_a_dec_14.pdf@2021-11-01 00:00:00@Silapo@epoetin zeta@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_12.pdf@EU-1-07-434_h_a_dec_12.pdf@2014-04-28 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_21.pdf@EU-1-07-428_h_a_dec_21.pdf@2021-04-03 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_5.pdf@EU-1-07-431_h_a_dec_5.pdf@2009-12-23 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_2.pdf@EU-1-07-432_h_a_dec_2.pdf@2008-07-22 00:00:00@Silapo@epoetin zeta@NAS before 2012@True@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_13.pdf@EU-1-07-434_h_a_dec_13.pdf@2016-07-03 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_12.pdf@EU-1-07-433_h_a_dec_12.pdf@2022-10-14 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_6.pdf@EU-1-07-431_h_a_dec_6.pdf@2010-06-04 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_3.pdf@EU-1-07-432_h_a_dec_3.pdf@2008-08-13 00:00:00@Silapo@epoetin zeta@NAS before 2012@True@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_22.pdf@EU-1-07-428_h_a_dec_22.pdf@2021-05-03 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_7.pdf@EU-1-07-431_h_a_dec_7.pdf@2010-01-07 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_2.pdf@EU-1-07-433_h_a_dec_2.pdf@2011-07-27 00:00:00@Nevanac@nepafenac@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_14.pdf@EU-1-07-434_h_a_dec_14.pdf@2018-04-30 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_4.pdf@EU-1-07-432_h_a_dec_4.pdf@2008-11-24 00:00:00@Silapo@epoetin zeta@NAS before 2012@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_3.pdf@EU-1-07-433_h_a_dec_3.pdf@2011-12-22 00:00:00@Nevanac@nepafenac@NAS before 2012@False@OD Not Found@Alcon Laboratories  (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_8.pdf@EU-1-07-431_h_a_dec_8.pdf@2010-11-10 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@HOSPIRA Enterprises B.V.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_5.pdf@EU-1-07-432_h_a_dec_5.pdf@2009-12-16 00:00:00@Silapo@epoetin zeta@NAS before 2012@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_4.pdf@EU-1-07-433_h_a_dec_4.pdf@2012-09-24 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-431_h_a_dec_9.pdf@EU-1-07-431_h_a_dec_9.pdf@2011-07-26 00:00:00@Retacrit@epoetin zeta@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_23.pdf@EU-1-07-428_h_a_dec_23.pdf@2022-02-06 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_15.pdf@EU-1-07-434_h_a_dec_15.pdf@2018-06-12 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_5.pdf@EU-1-07-433_h_a_dec_5.pdf@2013-03-05 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_6.pdf@EU-1-07-432_h_a_dec_6.pdf@2010-06-04 00:00:00@Silapo@epoetin zeta@NAS before 2012@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_0.pdf@EU-1-07-435_h_a_dec_0.pdf@2008-10-01 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_3.pdf@EU-1-07-428_h_a_dec_3.pdf@2009-07-29 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_6.pdf@EU-1-07-433_h_a_dec_6.pdf@2014-03-06 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_7.pdf@EU-1-07-432_h_a_dec_7.pdf@2010-01-07 00:00:00@Silapo@epoetin zeta@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_1.pdf@EU-1-07-435_h_a_dec_1.pdf@2008-04-25 00:00:00@TESAVEL@sitagliptin@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_4.pdf@EU-1-07-428_h_a_dec_4.pdf@2010-03-15 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_16.pdf@EU-1-07-434_h_a_dec_16.pdf@2021-04-21 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_8.pdf@EU-1-07-432_h_a_dec_8.pdf@2010-10-15 00:00:00@Silapo@epoetin zeta@NAS before 2012@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_10.pdf@EU-1-07-435_h_a_dec_10.pdf@2011-08-24 00:00:00@Tesavel@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_5.pdf@EU-1-07-428_h_a_dec_5.pdf@2010-02-06 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience  Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_2.pdf@EU-1-07-434_h_a_dec_2.pdf@2009-07-04 00:00:00@Avamys@Flucticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_7.pdf@EU-1-07-433_h_a_dec_7.pdf@2015-03-30 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_11.pdf@EU-1-07-435_h_a_dec_11.pdf@2011-12-19 00:00:00@Tesavel@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-07-432_h_a_dec_9.pdf@EU-1-07-432_h_a_dec_9.pdf@2011-05-08 00:00:00@Silapo@epoetin zeta@NAS before 2012@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_6.pdf@EU-1-07-428_h_a_dec_6.pdf@2010-06-09 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience  Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_3.pdf@EU-1-07-434_h_a_dec_3.pdf@2009-02-06 00:00:00@Avamys@Flucticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_12.pdf@EU-1-07-435_h_a_dec_12.pdf@2012-09-20 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_0.pdf@EU-1-07-436_h_a_dec_0.pdf@2007-12-20 00:00:00@ISENTRESS@raltegravir@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Limited@conditional@Parsed
EU-1-07-434_h_a_dec_4.pdf@EU-1-07-434_h_a_dec_4.pdf@2009-11-12 00:00:00@Avamys@Fluticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_8.pdf@EU-1-07-433_h_a_dec_8.pdf@2016-07-29 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_7.pdf@EU-1-07-428_h_a_dec_7.pdf@2011-10-03 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Abraxis BioScience Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_13.pdf@EU-1-07-435_h_a_dec_13.pdf@2012-12-20 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_1.pdf@EU-1-07-436_h_a_dec_1.pdf@2008-08-28 00:00:00@ISENTRESS@raltegravir@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_5.pdf@EU-1-07-434_h_a_dec_5.pdf@2010-01-25 00:00:00@Avamys@Fluticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_8.pdf@EU-1-07-428_h_a_dec_8.pdf@2011-06-29 00:00:00@Abraxane@paclitaxel@NAS before 2012@False@OD Not Found@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_14.pdf@EU-1-07-435_h_a_dec_14.pdf@2014-07-18 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-433_h_a_dec_9.pdf@EU-1-07-433_h_a_dec_9.pdf@2017-05-16 00:00:00@Nevanac@nepafenac@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-07-428_h_a_dec_9.pdf@EU-1-07-428_h_a_dec_9.pdf@2012-04-20 00:00:00@Abraxane@paclitaxel@False@False@OD Not Found@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_10.pdf@EU-1-07-436_h_a_dec_10.pdf@2010-08-31 00:00:00@Isentress@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_6.pdf@EU-1-07-434_h_a_dec_6.pdf@2010-10-14 00:00:00@Avamys@Fluticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_7.pdf@EU-1-07-434_h_a_dec_7.pdf@2011-08-26 00:00:00@Avamys@Fluticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_11.pdf@EU-1-07-436_h_a_dec_11.pdf@2011-01-24 00:00:00@Isentress@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_15.pdf@EU-1-07-435_h_a_dec_15.pdf@2015-10-06 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_8.pdf@EU-1-07-434_h_a_dec_8.pdf@2011-10-11 00:00:00@Avamys@Fluticasone furoate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_12.pdf@EU-1-07-436_h_a_dec_12.pdf@2011-11-21 00:00:00@Isentress@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Limited@CMA Not Found@Parsed
EU-1-07-434_h_a_dec_9.pdf@EU-1-07-434_h_a_dec_9.pdf@2012-03-15 00:00:00@Avamys@Fluticasone furoate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_0.pdf@EU-1-07-437_h_a_dec_0.pdf@2008-11-01 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_13.pdf@EU-1-07-436_h_a_dec_13.pdf@2012-02-17 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_16.pdf@EU-1-07-435_h_a_dec_16.pdf@2016-06-16 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_14.pdf@EU-1-07-436_h_a_dec_14.pdf@2012-03-19 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_1.pdf@EU-1-07-437_h_a_dec_1.pdf@2009-10-02 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_15.pdf@EU-1-07-436_h_a_dec_15.pdf@2012-07-31 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme  Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_17.pdf@EU-1-07-435_h_a_dec_17.pdf@2017-11-09 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_10.pdf@EU-1-07-437_h_a_dec_10.pdf@2012-12-11 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_0.pdf@EU-1-07-438_h_a_dec_0.pdf@2008-02-21 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_0.pdf@EU-1-07-439_h_a_dec_0.pdf@2008-02-21 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_11.pdf@EU-1-07-437_h_a_dec_11.pdf@2013-03-22 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_16.pdf@EU-1-07-436_h_a_dec_16.pdf@2012-10-25 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme  Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_0.pdf@EU-1-07-440_h_a_dec_0.pdf@2008-10-06 00:00:00@Tyverb@lapatinib@NAS before 2012@True@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-438_h_a_dec_1.pdf@EU-1-07-438_h_a_dec_1.pdf@2008-07-25 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@True@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_18.pdf@EU-1-07-435_h_a_dec_18.pdf@2017-08-12 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_1.pdf@EU-1-07-439_h_a_dec_1.pdf@2008-07-25 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@True@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_0.pdf@EU-1-08-441_h_a_dec_0.pdf@2008-04-04 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_1.pdf@EU-1-07-440_h_a_dec_1.pdf@2009-02-26 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_17.pdf@EU-1-07-436_h_a_dec_17.pdf@2013-02-25 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_10.pdf@EU-1-07-438_h_a_dec_10.pdf@2016-02-18 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_10.pdf@EU-1-07-439_h_a_dec_10.pdf@2016-02-18 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_12.pdf@EU-1-07-437_h_a_dec_12.pdf@2013-12-20 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_1.pdf@EU-1-08-441_h_a_dec_1.pdf@2009-06-29 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_10.pdf@EU-1-07-440_h_a_dec_10.pdf@2010-06-09 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-435_h_a_dec_19.pdf@EU-1-07-435_h_a_dec_19.pdf@2018-05-22 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_11.pdf@EU-1-07-438_h_a_dec_11.pdf@2017-12-04 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_18.pdf@EU-1-07-436_h_a_dec_18.pdf@2013-12-17 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_11.pdf@EU-1-07-439_h_a_dec_11.pdf@2017-04-20 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_11.pdf@EU-1-07-440_h_a_dec_11.pdf@2011-08-04 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-08-441_h_a_dec_10.pdf@EU-1-08-441_h_a_dec_10.pdf@2014-02-28 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_2.pdf@EU-1-07-435_h_a_dec_2.pdf@2009-05-28 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_12.pdf@EU-1-07-440_h_a_dec_12.pdf@2011-05-23 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group  Limited@conditional@Parsed
EU-1-07-437_h_a_dec_13.pdf@EU-1-07-437_h_a_dec_13.pdf@2017-11-01 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_12.pdf@EU-1-07-438_h_a_dec_12.pdf@2018-05-03 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_19.pdf@EU-1-07-436_h_a_dec_19.pdf@2014-05-14 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_12.pdf@EU-1-07-439_h_a_dec_12.pdf@2018-05-03 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_11.pdf@EU-1-08-441_h_a_dec_11.pdf@2015-05-03 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_13.pdf@EU-1-07-440_h_a_dec_13.pdf@2012-01-31 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-435_h_a_dec_20.pdf@EU-1-07-435_h_a_dec_20.pdf@2018-08-08 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_14.pdf@EU-1-07-437_h_a_dec_14.pdf@2018-01-30 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_12.pdf@EU-1-08-441_h_a_dec_12.pdf@2015-03-19 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_2.pdf@EU-1-07-436_h_a_dec_2.pdf@2008-11-19 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@conditional@Parsed
EU-1-07-438_h_a_dec_13.pdf@EU-1-07-438_h_a_dec_13.pdf@2019-04-10 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_14.pdf@EU-1-07-440_h_a_dec_14.pdf@2012-04-13 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-435_h_a_dec_21.pdf@EU-1-07-435_h_a_dec_21.pdf@2020-09-03 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_13.pdf@EU-1-07-439_h_a_dec_13.pdf@2019-08-26 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_13.pdf@EU-1-08-441_h_a_dec_13.pdf@2015-07-28 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@MAH Not Found@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_15.pdf@EU-1-07-440_h_a_dec_15.pdf@2012-07-31 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-435_h_a_dec_22.pdf@EU-1-07-435_h_a_dec_22.pdf@2021-05-27 00:00:00@TESAVEL@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_14.pdf@EU-1-07-438_h_a_dec_14.pdf@2020-11-18 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_20.pdf@EU-1-07-436_h_a_dec_20.pdf@2014-08-22 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_15.pdf@EU-1-07-437_h_a_dec_15.pdf@2018-04-30 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_14.pdf@EU-1-08-441_h_a_dec_14.pdf@2018-01-30 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_16.pdf@EU-1-07-440_h_a_dec_16.pdf@2013-04-17 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-435_h_a_dec_23.pdf@EU-1-07-435_h_a_dec_23.pdf@2022-09-21 00:00:00@Tesavel@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_14.pdf@EU-1-07-439_h_a_dec_14.pdf@2021-02-19 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_15.pdf@EU-1-08-441_h_a_dec_15.pdf@2018-08-05 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_15.pdf@EU-1-07-438_h_a_dec_15.pdf@2021-02-19 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_3.pdf@EU-1-07-435_h_a_dec_3.pdf@2009-06-08 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_21.pdf@EU-1-07-436_h_a_dec_21.pdf@2015-11-19 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_16.pdf@EU-1-07-437_h_a_dec_16.pdf@2018-07-23 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_17.pdf@EU-1-07-440_h_a_dec_17.pdf@2013-07-25 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-08-441_h_a_dec_16.pdf@EU-1-08-441_h_a_dec_16.pdf@2019-06-06 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_4.pdf@EU-1-07-435_h_a_dec_4.pdf@2009-08-20 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_17.pdf@EU-1-07-437_h_a_dec_17.pdf@2019-12-16 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_15.pdf@EU-1-07-439_h_a_dec_15.pdf@2021-12-13 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_16.pdf@EU-1-07-438_h_a_dec_16.pdf@2022-02-17 00:00:00@Myfenax@Mycophenolate  mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_22.pdf@EU-1-07-436_h_a_dec_22.pdf@2016-11-14 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_17.pdf@EU-1-08-441_h_a_dec_17.pdf@2020-08-28 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_18.pdf@EU-1-07-437_h_a_dec_18.pdf@2021-07-23 00:00:00@Ivemend@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_5.pdf@EU-1-07-435_h_a_dec_5.pdf@2009-10-28 00:00:00@TESAVEL@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_18.pdf@EU-1-07-440_h_a_dec_18.pdf@2014-12-03 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Ltd@conditional@Parsed
EU-1-07-438_h_a_dec_2.pdf@EU-1-07-438_h_a_dec_2.pdf@2009-02-26 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_23.pdf@EU-1-07-436_h_a_dec_23.pdf@2017-07-13 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_19.pdf@EU-1-07-437_h_a_dec_19.pdf@2022-09-29 00:00:00@IVEMEND@fosaprepitant@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_18.pdf@EU-1-08-441_h_a_dec_18.pdf@2021-07-04 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_6.pdf@EU-1-07-435_h_a_dec_6.pdf@2010-08-18 00:00:00@Tesavel@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_16.pdf@EU-1-07-439_h_a_dec_16.pdf@2022-02-17 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_19.pdf@EU-1-07-440_h_a_dec_19.pdf@2015-11-02 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Ltd@conditional@Parsed
EU-1-07-438_h_a_dec_3.pdf@EU-1-07-438_h_a_dec_3.pdf@2009-08-21 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_2.pdf@EU-1-07-437_h_a_dec_2.pdf@2009-07-29 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_7.pdf@EU-1-07-435_h_a_dec_7.pdf@2010-03-11 00:00:00@Tesavel@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_2.pdf@EU-1-07-439_h_a_dec_2.pdf@2009-02-26 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_2.pdf@EU-1-07-440_h_a_dec_2.pdf@2009-03-25 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-07-438_h_a_dec_4.pdf@EU-1-07-438_h_a_dec_4.pdf@2010-03-23 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_24.pdf@EU-1-07-436_h_a_dec_24.pdf@2018-03-23 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_19.pdf@EU-1-08-441_h_a_dec_19.pdf@2022-12-08 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_3.pdf@EU-1-07-437_h_a_dec_3.pdf@2009-12-23 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_8.pdf@EU-1-07-435_h_a_dec_8.pdf@2010-03-12 00:00:00@Tesavel@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_3.pdf@EU-1-07-439_h_a_dec_3.pdf@2009-08-21 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_5.pdf@EU-1-07-438_h_a_dec_5.pdf@2011-05-27 00:00:00@Myfenax@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_2.pdf@EU-1-08-441_h_a_dec_2.pdf@2009-10-12 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_4.pdf@EU-1-07-437_h_a_dec_4.pdf@2010-03-26 00:00:00@IVEMEND@fosaprepitant  dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_20.pdf@EU-1-07-440_h_a_dec_20.pdf@2015-02-17 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Ltd@conditional@Parsed
EU-1-07-439_h_a_dec_4.pdf@EU-1-07-439_h_a_dec_4.pdf@2010-03-23 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_25.pdf@EU-1-07-436_h_a_dec_25.pdf@2018-07-06 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-435_h_a_dec_9.pdf@EU-1-07-435_h_a_dec_9.pdf@2011-09-02 00:00:00@Tesavel@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_6.pdf@EU-1-07-438_h_a_dec_6.pdf@2012-11-06 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_3.pdf@EU-1-08-441_h_a_dec_3.pdf@2009-10-12 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_5.pdf@EU-1-07-437_h_a_dec_5.pdf@2010-08-31 00:00:00@Ivemend@fosaprepitant dimeglumine@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_5.pdf@EU-1-07-439_h_a_dec_5.pdf@2011-05-27 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_26.pdf@EU-1-07-436_h_a_dec_26.pdf@2019-10-21 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_7.pdf@EU-1-07-438_h_a_dec_7.pdf@2012-11-19 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_21.pdf@EU-1-07-440_h_a_dec_21.pdf@2015-05-05 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_4.pdf@EU-1-08-441_h_a_dec_4.pdf@2009-10-12 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_6.pdf@EU-1-07-437_h_a_dec_6.pdf@2011-02-21 00:00:00@Ivemend@fosaprepitant@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_27.pdf@EU-1-07-436_h_a_dec_27.pdf@2021-06-28 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_6.pdf@EU-1-07-439_h_a_dec_6.pdf@2012-11-06 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_8.pdf@EU-1-07-438_h_a_dec_8.pdf@2014-10-30 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_5.pdf@EU-1-08-441_h_a_dec_5.pdf@2010-03-15 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_7.pdf@EU-1-07-437_h_a_dec_7.pdf@2011-03-18 00:00:00@Ivemend@fosaprepitant@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_22.pdf@EU-1-07-440_h_a_dec_22.pdf@2015-06-19 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_28.pdf@EU-1-07-436_h_a_dec_28.pdf@2022-06-29 00:00:00@Isentress@raltegravir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_7.pdf@EU-1-07-439_h_a_dec_7.pdf@2012-11-19 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-438_h_a_dec_9.pdf@EU-1-07-438_h_a_dec_9.pdf@2015-01-27 00:00:00@Myfenax@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_6.pdf@EU-1-08-441_h_a_dec_6.pdf@2010-03-11 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_8.pdf@EU-1-07-437_h_a_dec_8.pdf@2011-06-14 00:00:00@Ivemend@fosaprepitant@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_23.pdf@EU-1-07-440_h_a_dec_23.pdf@2016-06-29 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_3.pdf@EU-1-07-436_h_a_dec_3.pdf@2009-07-01 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_7.pdf@EU-1-08-441_h_a_dec_7.pdf@2011-11-22 00:00:00@Effentora@fentanyl citrate@NAS before 2012@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_8.pdf@EU-1-07-439_h_a_dec_8.pdf@2014-10-30 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-437_h_a_dec_9.pdf@EU-1-07-437_h_a_dec_9.pdf@2011-12-22 00:00:00@Ivemend@fosaprepitant@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_4.pdf@EU-1-07-436_h_a_dec_4.pdf@2009-04-21 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_8.pdf@EU-1-08-441_h_a_dec_8.pdf@2012-12-20 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Cephalon Europe@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_24.pdf@EU-1-07-440_h_a_dec_24.pdf@2018-05-22 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-439_h_a_dec_9.pdf@EU-1-07-439_h_a_dec_9.pdf@2015-03-19 00:00:00@Mycophenolate mofetil Teva@Mycophenolate mofetil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-441_h_a_dec_9.pdf@EU-1-08-441_h_a_dec_9.pdf@2013-02-20 00:00:00@Effentora@fentanyl citrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_5.pdf@EU-1-07-436_h_a_dec_5.pdf@2009-05-28 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_6.pdf@EU-1-07-436_h_a_dec_6.pdf@2009-07-14 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@conditional@Parsed
EU-1-07-440_h_a_dec_25.pdf@EU-1-07-440_h_a_dec_25.pdf@2018-07-30 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_7.pdf@EU-1-07-436_h_a_dec_7.pdf@2009-07-16 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_8.pdf@EU-1-07-436_h_a_dec_8.pdf@2009-09-09 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_26.pdf@EU-1-07-440_h_a_dec_26.pdf@2019-05-22 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_0.pdf@EU-1-08-442_h_a_dec_0.pdf@2008-03-18 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-07-436_h_a_dec_9.pdf@EU-1-07-436_h_a_dec_9.pdf@2010-03-26 00:00:00@ISENTRESS@raltegravir@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_0.pdf@EU-1-08-444_h_a_dec_0.pdf@2008-09-15 00:00:00@Ratiograstim@filgrastim@NAS before 2012@True@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_0.pdf@EU-1-08-443_h_a_dec_0.pdf@2008-04-16 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@adopted@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_1.pdf@EU-1-08-442_h_a_dec_1.pdf@2008-03-18 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_1.pdf@EU-1-08-443_h_a_dec_1.pdf@2008-04-16 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@adopted@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_1.pdf@EU-1-08-444_h_a_dec_1.pdf@2010-08-01 00:00:00@Ratiograstim@filgrastim@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_27.pdf@EU-1-07-440_h_a_dec_27.pdf@2019-09-19 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_10.pdf@EU-1-08-442_h_a_dec_10.pdf@2010-12-20 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_10.pdf@EU-1-08-443_h_a_dec_10.pdf@2010-03-23 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_10.pdf@EU-1-08-444_h_a_dec_10.pdf@2022-04-04 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_11.pdf@EU-1-08-443_h_a_dec_11.pdf@2010-09-30 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_28.pdf@EU-1-07-440_h_a_dec_28.pdf@2020-09-17 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_11.pdf@EU-1-08-442_h_a_dec_11.pdf@2011-01-21 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_2.pdf@EU-1-08-444_h_a_dec_2.pdf@2010-10-14 00:00:00@Ratiograstim@filgrastim@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_12.pdf@EU-1-08-443_h_a_dec_12.pdf@2010-11-26 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_12.pdf@EU-1-08-442_h_a_dec_12.pdf@2011-01-08 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_3.pdf@EU-1-08-444_h_a_dec_3.pdf@2011-07-20 00:00:00@Ratiograstim@filgrastim@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_13.pdf@EU-1-08-443_h_a_dec_13.pdf@2010-12-20 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@adopted@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_0.pdf@EU-1-08-445_h_a_dec_0.pdf@2008-09-15 00:00:00@Tevagrastim@filgrastim@NAS before 2012@True@OD Not Found@Teva Generics GmbH@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_4.pdf@EU-1-08-444_h_a_dec_4.pdf@2012-10-31 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_29.pdf@EU-1-07-440_h_a_dec_29.pdf@2021-10-28 00:00:00@Tyverb@lapatinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_13.pdf@EU-1-08-442_h_a_dec_13.pdf@2011-01-08 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_0.pdf@EU-1-08-446_h_a_dec_0.pdf@2008-04-25 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_14.pdf@EU-1-08-443_h_a_dec_14.pdf@2011-04-18 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@adopted@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_5.pdf@EU-1-08-444_h_a_dec_5.pdf@2013-07-19 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_3.pdf@EU-1-07-440_h_a_dec_3.pdf@2009-05-11 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_14.pdf@EU-1-08-442_h_a_dec_14.pdf@2011-11-28 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_1.pdf@EU-1-08-445_h_a_dec_1.pdf@2009-12-21 00:00:00@Tevagrastim@filgrastim@NAS before 2012@False@OD Not Found@Teva Generics GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_1.pdf@EU-1-08-446_h_a_dec_1.pdf@2009-07-05 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_15.pdf@EU-1-08-443_h_a_dec_15.pdf@2011-04-18 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_15.pdf@EU-1-08-442_h_a_dec_15.pdf@2011-12-22 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_4.pdf@EU-1-07-440_h_a_dec_4.pdf@2010-01-20 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_2.pdf@EU-1-08-445_h_a_dec_2.pdf@2011-06-23 00:00:00@Tevagrastim@filgrastim@NAS before 2012@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_6.pdf@EU-1-08-444_h_a_dec_6.pdf@2014-04-12 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_10.pdf@EU-1-08-446_h_a_dec_10.pdf@2017-11-28 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_16.pdf@EU-1-08-443_h_a_dec_16.pdf@2011-08-26 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_5.pdf@EU-1-07-440_h_a_dec_5.pdf@2010-04-27 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_16.pdf@EU-1-08-442_h_a_dec_16.pdf@2012-09-02 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_3.pdf@EU-1-08-445_h_a_dec_3.pdf@2012-06-02 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_7.pdf@EU-1-08-444_h_a_dec_7.pdf@2017-05-18 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_11.pdf@EU-1-08-446_h_a_dec_11.pdf@2019-01-31 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_17.pdf@EU-1-08-443_h_a_dec_17.pdf@2011-11-22 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@adopted@Celgene Europe  Limited@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_4.pdf@EU-1-08-445_h_a_dec_4.pdf@2012-10-31 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_17.pdf@EU-1-08-442_h_a_dec_17.pdf@2012-04-13 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_6.pdf@EU-1-07-440_h_a_dec_6.pdf@2010-04-29 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-08-444_h_a_dec_8.pdf@EU-1-08-444_h_a_dec_8.pdf@2019-05-13 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_12.pdf@EU-1-08-446_h_a_dec_12.pdf@2020-04-28 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_18.pdf@EU-1-08-443_h_a_dec_18.pdf@2012-08-23 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_5.pdf@EU-1-08-445_h_a_dec_5.pdf@2013-07-19 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_18.pdf@EU-1-08-442_h_a_dec_18.pdf@2012-05-25 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_7.pdf@EU-1-07-440_h_a_dec_7.pdf@2010-05-05 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-08-444_h_a_dec_9.pdf@EU-1-08-444_h_a_dec_9.pdf@2020-06-17 00:00:00@Ratiograstim@filgrastim@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_13.pdf@EU-1-08-446_h_a_dec_13.pdf@2020-11-20 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_19.pdf@EU-1-08-443_h_a_dec_19.pdf@2012-12-18 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_19.pdf@EU-1-08-442_h_a_dec_19.pdf@2012-06-28 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_8.pdf@EU-1-07-440_h_a_dec_8.pdf@2010-06-17 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_6.pdf@EU-1-08-445_h_a_dec_6.pdf@2014-04-12 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_2.pdf@EU-1-08-443_h_a_dec_2.pdf@2008-04-16 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@adopted@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_2.pdf@EU-1-08-446_h_a_dec_2.pdf@2009-08-21 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_2.pdf@EU-1-08-442_h_a_dec_2.pdf@2009-10-02 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_0.pdf@EU-1-08-447_h_a_dec_0.pdf@2008-04-21 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Ipsen Manufacturing Ireland Ltd (IMIL),@CMA Not Found@Parsed
EU-1-07-440_h_a_dec_9.pdf@EU-1-07-440_h_a_dec_9.pdf@2010-07-28 00:00:00@Tyverb@lapatinib@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_7.pdf@EU-1-08-445_h_a_dec_7.pdf@2019-05-13 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_20.pdf@EU-1-08-443_h_a_dec_20.pdf@2013-09-04 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_3.pdf@EU-1-08-446_h_a_dec_3.pdf@2010-01-27 00:00:00@Privigen@Human normal  immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_20.pdf@EU-1-08-442_h_a_dec_20.pdf@2012-07-26 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_1.pdf@EU-1-08-447_h_a_dec_1.pdf@2008-01-09 00:00:00@Adenuric@febuxostat@NAS before 2012@True@OD Not Found@Ipsen Manufacturing Ireland Ltd (IMIL)@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_8.pdf@EU-1-08-445_h_a_dec_8.pdf@2020-06-18 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_10.pdf@EU-1-08-447_h_a_dec_10.pdf@2012-10-24 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International  Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_21.pdf@EU-1-08-442_h_a_dec_21.pdf@2012-08-30 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_21.pdf@EU-1-08-443_h_a_dec_21.pdf@2013-07-19 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_4.pdf@EU-1-08-446_h_a_dec_4.pdf@2010-08-26 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-445_h_a_dec_9.pdf@EU-1-08-445_h_a_dec_9.pdf@2022-04-04 00:00:00@Tevagrastim@filgrastim@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_11.pdf@EU-1-08-447_h_a_dec_11.pdf@2012-12-20 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_22.pdf@EU-1-08-442_h_a_dec_22.pdf@2012-08-30 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_5.pdf@EU-1-08-446_h_a_dec_5.pdf@2012-03-19 00:00:00@Privigen@Human normal immunoglobulin  (IVIg)@False@False@OD Not Found@CSL Behring  GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_22.pdf@EU-1-08-443_h_a_dec_22.pdf@2015-05-27 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_23.pdf@EU-1-08-442_h_a_dec_23.pdf@2013-01-17 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_6.pdf@EU-1-08-446_h_a_dec_6.pdf@2013-03-13 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_12.pdf@EU-1-08-447_h_a_dec_12.pdf@2014-01-16 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_24.pdf@EU-1-08-442_h_a_dec_24.pdf@2013-01-21 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_7.pdf@EU-1-08-446_h_a_dec_7.pdf@2013-03-26 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_23.pdf@EU-1-08-443_h_a_dec_23.pdf@2015-11-19 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_13.pdf@EU-1-08-447_h_a_dec_13.pdf@2015-06-02 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_25.pdf@EU-1-08-442_h_a_dec_25.pdf@2013-07-15 00:00:00@Pradaxa@dabigatran  etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_0.pdf@EU-1-08-448_h_a_dec_0.pdf@2008-04-25 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_14.pdf@EU-1-08-447_h_a_dec_14.pdf@2015-08-04 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_8.pdf@EU-1-08-446_h_a_dec_8.pdf@2014-10-22 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_24.pdf@EU-1-08-443_h_a_dec_24.pdf@2016-07-15 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_1.pdf@EU-1-08-448_h_a_dec_1.pdf@2008-04-25 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_26.pdf@EU-1-08-442_h_a_dec_26.pdf@2013-12-18 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_15.pdf@EU-1-08-447_h_a_dec_15.pdf@2016-08-12 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-446_h_a_dec_9.pdf@EU-1-08-446_h_a_dec_9.pdf@2016-10-27 00:00:00@Privigen@Human normal immunoglobulin (IVIg)@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_10.pdf@EU-1-08-448_h_a_dec_10.pdf@2012-12-20 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_25.pdf@EU-1-08-443_h_a_dec_25.pdf@2018-08-02 00:00:00@Thalidomide Celgene@Thalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_16.pdf@EU-1-08-447_h_a_dec_16.pdf@2017-11-01 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_0.pdf@EU-1-08-451_h_a_dec_0.pdf@2008-04-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_27.pdf@EU-1-08-442_h_a_dec_27.pdf@2014-03-06 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_0.pdf@EU-1-08-454_h_a_dec_0.pdf@2008-05-20 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_11.pdf@EU-1-08-448_h_a_dec_11.pdf@2014-02-20 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_17.pdf@EU-1-08-447_h_a_dec_17.pdf@2018-05-03 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_1.pdf@EU-1-08-451_h_a_dec_1.pdf@2008-04-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_28.pdf@EU-1-08-442_h_a_dec_28.pdf@2015-03-07 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_1.pdf@EU-1-08-454_h_a_dec_1.pdf@2009-06-02 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_18.pdf@EU-1-08-447_h_a_dec_18.pdf@2019-05-22 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_12.pdf@EU-1-08-448_h_a_dec_12.pdf@2015-07-28 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_29.pdf@EU-1-08-442_h_a_dec_29.pdf@2016-01-08 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_10.pdf@EU-1-08-451_h_a_dec_10.pdf@2009-12-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_19.pdf@EU-1-08-447_h_a_dec_19.pdf@2019-07-31 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_13.pdf@EU-1-08-448_h_a_dec_13.pdf@2016-06-29 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_10.pdf@EU-1-08-454_h_a_dec_10.pdf@2016-02-09 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_3.pdf@EU-1-08-442_h_a_dec_3.pdf@2009-02-26 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_11.pdf@EU-1-08-451_h_a_dec_11.pdf@2011-02-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_27.pdf@EU-1-08-443_h_a_dec_27.pdf@2018-08-08 00:00:00@Thalidomide Celgene@Thalidomide@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_0.pdf@EU-1-08-455_h_a_dec_0.pdf@2008-07-16 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_2.pdf@EU-1-08-447_h_a_dec_2.pdf@2009-07-05 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Beaufour Ipsen Pharma@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_30.pdf@EU-1-08-442_h_a_dec_30.pdf@2017-10-19 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_12.pdf@EU-1-08-451_h_a_dec_12.pdf@2011-08-18 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_28.pdf@EU-1-08-443_h_a_dec_28.pdf@2019-07-31 00:00:00@Thalidomide Celgene@Thalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_14.pdf@EU-1-08-448_h_a_dec_14.pdf@2018-02-19 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_11.pdf@EU-1-08-454_h_a_dec_11.pdf@2018-12-04 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_3.pdf@EU-1-08-447_h_a_dec_3.pdf@2009-05-19 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Beaufour Ipsen Pharma@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_1.pdf@EU-1-08-455_h_a_dec_1.pdf@2008-07-16 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_29.pdf@EU-1-08-443_h_a_dec_29.pdf@2020-02-06 00:00:00@Thalidomide  Celgene@Thalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_31.pdf@EU-1-08-442_h_a_dec_31.pdf@2018-08-01 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_14.pdf@EU-1-08-451_h_a_dec_14.pdf@2012-03-21 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_10.pdf@EU-1-08-455_h_a_dec_10.pdf@2011-08-24 00:00:00@Janumet@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_15.pdf@EU-1-08-448_h_a_dec_15.pdf@2018-07-26 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_4.pdf@EU-1-08-447_h_a_dec_4.pdf@2009-12-18 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_32.pdf@EU-1-08-442_h_a_dec_32.pdf@2018-07-06 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_3.pdf@EU-1-08-443_h_a_dec_3.pdf@2008-10-20 00:00:00@Thalidomide Pharmion@Thalidomide@NAS before 2012@False@OD Not Found@Pharmion Ltd@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_12.pdf@EU-1-08-454_h_a_dec_12.pdf@2019-06-06 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_15.pdf@EU-1-08-451_h_a_dec_15.pdf@2012-04-13 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_11.pdf@EU-1-08-455_h_a_dec_11.pdf@2012-08-23 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_33.pdf@EU-1-08-442_h_a_dec_33.pdf@2019-05-13 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_5.pdf@EU-1-08-447_h_a_dec_5.pdf@2010-08-31 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Menarini International  Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_16.pdf@EU-1-08-448_h_a_dec_16.pdf@2019-12-18 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_16.pdf@EU-1-08-451_h_a_dec_16.pdf@2012-05-25 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_12.pdf@EU-1-08-455_h_a_dec_12.pdf@2012-12-18 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_30.pdf@EU-1-08-443_h_a_dec_30.pdf@2020-09-15 00:00:00@Thalidomide Celgene@Thalidomide@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_34.pdf@EU-1-08-442_h_a_dec_34.pdf@2019-12-16 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_17.pdf@EU-1-08-451_h_a_dec_17.pdf@2012-03-08 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_6.pdf@EU-1-08-447_h_a_dec_6.pdf@2011-01-21 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Menarini International  Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_13.pdf@EU-1-08-454_h_a_dec_13.pdf@2020-09-30 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_13.pdf@EU-1-08-455_h_a_dec_13.pdf@2013-03-13 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_31.pdf@EU-1-08-443_h_a_dec_31.pdf@2021-07-16 00:00:00@Thalidomide Celgene@Thalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_17.pdf@EU-1-08-448_h_a_dec_17.pdf@2021-04-02 00:00:00@Mycamine@micafungin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_35.pdf@EU-1-08-442_h_a_dec_35.pdf@2021-11-01 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_7.pdf@EU-1-08-447_h_a_dec_7.pdf@2011-03-28 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Menarini  International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_18.pdf@EU-1-08-451_h_a_dec_18.pdf@2013-01-14 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_2.pdf@EU-1-08-448_h_a_dec_2.pdf@2008-09-29 00:00:00@Mycamine@micafungin@NAS before 2012@True@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_32.pdf@EU-1-08-443_h_a_dec_32.pdf@2021-09-12 00:00:00@Thalidomide BMS@Thalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_36.pdf@EU-1-08-442_h_a_dec_36.pdf@2021-09-12 00:00:00@Pradaxa@dabigatran etexilate  mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_14.pdf@EU-1-08-454_h_a_dec_14.pdf@2021-03-11 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_14.pdf@EU-1-08-455_h_a_dec_14.pdf@2014-03-06 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_8.pdf@EU-1-08-447_h_a_dec_8.pdf@2011-11-24 00:00:00@Adenuric@febuxostat@NAS before 2012@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_19.pdf@EU-1-08-451_h_a_dec_19.pdf@2014-04-23 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_37.pdf@EU-1-08-442_h_a_dec_37.pdf@2022-01-20 00:00:00@Pradaxa@dabigatran etexilate mesilate@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-447_h_a_dec_9.pdf@EU-1-08-447_h_a_dec_9.pdf@2012-01-24 00:00:00@Adenuric@febuxostat@False@False@OD Not Found@Menarini International  Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_3.pdf@EU-1-08-448_h_a_dec_3.pdf@2008-09-29 00:00:00@Mycamine@micafungin@NAS before 2012@True@OD Not Found@Astellas Pharma GmbH@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_15.pdf@EU-1-08-455_h_a_dec_15.pdf@2015-05-13 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_33.pdf@EU-1-08-443_h_a_dec_33.pdf@2021-12-13 00:00:00@Thalidomide BMS@Thalidomide@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_2.pdf@EU-1-08-451_h_a_dec_2.pdf@2009-01-26 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_2.pdf@EU-1-08-454_h_a_dec_2.pdf@2009-03-25 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_4.pdf@EU-1-08-442_h_a_dec_4.pdf@2009-03-25 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_4.pdf@EU-1-08-448_h_a_dec_4.pdf@2009-11-20 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_4.pdf@EU-1-08-443_h_a_dec_4.pdf@2009-01-30 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_3.pdf@EU-1-08-454_h_a_dec_3.pdf@2010-03-30 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_16.pdf@EU-1-08-455_h_a_dec_16.pdf@2016-06-30 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_5.pdf@EU-1-08-442_h_a_dec_5.pdf@2009-08-20 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_5.pdf@EU-1-08-448_h_a_dec_5.pdf@2010-06-08 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_20.pdf@EU-1-08-451_h_a_dec_20.pdf@2015-05-27 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_5.pdf@EU-1-08-443_h_a_dec_5.pdf@2009-01-30 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_6.pdf@EU-1-08-442_h_a_dec_6.pdf@2009-10-28 00:00:00@Pradaxa@dabigatran etexilate  mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_6.pdf@EU-1-08-448_h_a_dec_6.pdf@2010-10-29 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_4.pdf@EU-1-08-454_h_a_dec_4.pdf@2011-12-05 00:00:00@Extavia@Interferon beta-1b@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_17.pdf@EU-1-08-455_h_a_dec_17.pdf@2016-12-12 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  12.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)3868 for “Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_21.pdf@EU-1-08-451_h_a_dec_21.pdf@2015-11-20 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_6.pdf@EU-1-08-443_h_a_dec_6.pdf@2009-02-24 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_5.pdf@EU-1-08-454_h_a_dec_5.pdf@2012-05-25 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_7.pdf@EU-1-08-448_h_a_dec_7.pdf@2010-12-20 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma  Europe B.V.@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_7.pdf@EU-1-08-442_h_a_dec_7.pdf@2010-01-07 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_7.pdf@EU-1-08-443_h_a_dec_7.pdf@2009-08-27 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_8.pdf@EU-1-08-448_h_a_dec_8.pdf@2011-08-24 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@Astellas Pharma  Europe B.V.@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_18.pdf@EU-1-08-455_h_a_dec_18.pdf@2017-12-15 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_6.pdf@EU-1-08-454_h_a_dec_6.pdf@2012-12-20 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_22.pdf@EU-1-08-451_h_a_dec_22.pdf@2016-10-27 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-448_h_a_dec_9.pdf@EU-1-08-448_h_a_dec_9.pdf@2011-08-24 00:00:00@Mycamine@micafungin@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_8.pdf@EU-1-08-442_h_a_dec_8.pdf@2010-08-26 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_8.pdf@EU-1-08-443_h_a_dec_8.pdf@2009-10-19 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_19.pdf@EU-1-08-455_h_a_dec_19.pdf@2018-05-22 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-442_h_a_dec_9.pdf@EU-1-08-442_h_a_dec_9.pdf@2010-10-25 00:00:00@Pradaxa@dabigatran etexilate mesilate@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-08-443_h_a_dec_9.pdf@EU-1-08-443_h_a_dec_9.pdf@2010-03-15 00:00:00@Thalidomide Celgene@Thalidomide@NAS before 2012@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_8.pdf@EU-1-08-454_h_a_dec_8.pdf@2014-04-09 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_0.pdf@EU-1-08-456_h_a_dec_0.pdf@2008-07-16 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_23.pdf@EU-1-08-451_h_a_dec_23.pdf@2018-04-19 00:00:00@Volibris@Ambrisentan@False@False@adopted@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_2.pdf@EU-1-08-455_h_a_dec_2.pdf@2009-02-06 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-454_h_a_dec_9.pdf@EU-1-08-454_h_a_dec_9.pdf@2015-08-09 00:00:00@Extavia@Interferon beta-1b@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_1.pdf@EU-1-08-456_h_a_dec_1.pdf@2008-07-16 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_24.pdf@EU-1-08-451_h_a_dec_24.pdf@2018-10-29 00:00:00@Volibris@Ambrisentan@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_20.pdf@EU-1-08-455_h_a_dec_20.pdf@2018-06-29 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_10.pdf@EU-1-08-456_h_a_dec_10.pdf@2011-08-24 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_11.pdf@EU-1-08-456_h_a_dec_11.pdf@2012-08-23 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_21.pdf@EU-1-08-455_h_a_dec_21.pdf@2021-09-15 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_25.pdf@EU-1-08-451_h_a_dec_25.pdf@2019-10-21 00:00:00@Volibris@Ambrisentan@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_12.pdf@EU-1-08-456_h_a_dec_12.pdf@2012-12-18 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_22.pdf@EU-1-08-455_h_a_dec_22.pdf@2022-09-29 00:00:00@Janumet@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_13.pdf@EU-1-08-456_h_a_dec_13.pdf@2013-03-13 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_3.pdf@EU-1-08-455_h_a_dec_3.pdf@2009-07-29 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_0.pdf@EU-1-08-457_h_a_dec_0.pdf@2008-07-16 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_26.pdf@EU-1-08-451_h_a_dec_26.pdf@2021-09-22 00:00:00@Volibris@Ambrisentan@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_0.pdf@EU-1-08-461_h_a_dec_0.pdf@2008-11-07 00:00:00@Firazyr@icatibant@NAS before 2012@True@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_4.pdf@EU-1-08-455_h_a_dec_4.pdf@2009-09-16 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_1.pdf@EU-1-08-457_h_a_dec_1.pdf@2008-07-16 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_0.pdf@EU-1-08-462_h_a_dec_0.pdf@2008-09-07 00:00:00@Latixa@ranolazine@NAS before 2012@True@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_3.pdf@EU-1-08-451_h_a_dec_3.pdf@2009-02-26 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_5.pdf@EU-1-08-455_h_a_dec_5.pdf@2009-10-28 00:00:00@Janumet@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_1.pdf@EU-1-08-461_h_a_dec_1.pdf@2009-07-29 00:00:00@Firazyr@icatibant@NAS before 2012@False@OD Not Found@Jerini AG@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_10.pdf@EU-1-08-457_h_a_dec_10.pdf@2011-08-24 00:00:00@Efficib@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_1.pdf@EU-1-08-462_h_a_dec_1.pdf@2008-09-07 00:00:00@Latixa@ranolazine@NAS before 2012@True@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_4.pdf@EU-1-08-451_h_a_dec_4.pdf@2009-07-04 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_15.pdf@EU-1-08-456_h_a_dec_15.pdf@2015-05-13 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_6.pdf@EU-1-08-455_h_a_dec_6.pdf@2010-06-08 00:00:00@Janumet@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_10.pdf@EU-1-08-461_h_a_dec_10.pdf@2015-06-02 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_11.pdf@EU-1-08-457_h_a_dec_11.pdf@2012-08-23 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_10.pdf@EU-1-08-462_h_a_dec_10.pdf@2012-03-19 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International  Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_5.pdf@EU-1-08-451_h_a_dec_5.pdf@2009-08-28 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_7.pdf@EU-1-08-455_h_a_dec_7.pdf@2010-03-11 00:00:00@Janumet@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_11.pdf@EU-1-08-462_h_a_dec_11.pdf@2012-10-25 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_11.pdf@EU-1-08-461_h_a_dec_11.pdf@2016-05-26 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_12.pdf@EU-1-08-457_h_a_dec_12.pdf@2012-12-18 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_6.pdf@EU-1-08-451_h_a_dec_6.pdf@2009-12-21 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_16.pdf@EU-1-08-456_h_a_dec_16.pdf@2016-06-30 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_12.pdf@EU-1-08-462_h_a_dec_12.pdf@2012-10-29 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
nd@Parsed
EU-1-08-457_h_a_dec_13.pdf@EU-1-08-457_h_a_dec_13.pdf@2013-03-13 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_12.pdf@EU-1-08-461_h_a_dec_12.pdf@2017-10-19 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_7.pdf@EU-1-08-451_h_a_dec_7.pdf@2010-01-20 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_13.pdf@EU-1-08-462_h_a_dec_13.pdf@2013-06-03 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-455_h_a_dec_9.pdf@EU-1-08-455_h_a_dec_9.pdf@2011-02-21 00:00:00@Janumet@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_13.pdf@EU-1-08-461_h_a_dec_13.pdf@2018-04-26 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_17.pdf@EU-1-08-456_h_a_dec_17.pdf@2016-12-12 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  12.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)3871 for “Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_8.pdf@EU-1-08-451_h_a_dec_8.pdf@2010-03-23 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_14.pdf@EU-1-08-457_h_a_dec_14.pdf@2014-03-06 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_14.pdf@EU-1-08-462_h_a_dec_14.pdf@2013-11-13 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-451_h_a_dec_9.pdf@EU-1-08-451_h_a_dec_9.pdf@2010-01-20 00:00:00@Volibris@Ambrisentan@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_14.pdf@EU-1-08-461_h_a_dec_14.pdf@2018-08-23 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_18.pdf@EU-1-08-456_h_a_dec_18.pdf@2017-12-15 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_15.pdf@EU-1-08-462_h_a_dec_15.pdf@2015-08-07 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_15.pdf@EU-1-08-457_h_a_dec_15.pdf@2015-05-13 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_16.pdf@EU-1-08-462_h_a_dec_16.pdf@2015-11-19 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_19.pdf@EU-1-08-456_h_a_dec_19.pdf@2018-05-22 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_15.pdf@EU-1-08-461_h_a_dec_15.pdf@2019-12-18 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_16.pdf@EU-1-08-457_h_a_dec_16.pdf@2016-06-30 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_17.pdf@EU-1-08-462_h_a_dec_17.pdf@2017-12-20 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_2.pdf@EU-1-08-456_h_a_dec_2.pdf@2009-02-06 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_18.pdf@EU-1-08-462_h_a_dec_18.pdf@2018-11-22 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_17.pdf@EU-1-08-457_h_a_dec_17.pdf@2016-12-12 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  12.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)3867 for “Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_19.pdf@EU-1-08-462_h_a_dec_19.pdf@2020-10-03 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_16.pdf@EU-1-08-461_h_a_dec_16.pdf@2021-10-25 00:00:00@Firazyr@icatibant@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_20.pdf@EU-1-08-456_h_a_dec_20.pdf@2018-06-29 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_2.pdf@EU-1-08-461_h_a_dec_2.pdf@2010-03-15 00:00:00@Firazyr@icatibant@NAS before 2012@False@OD Not Found@Jerini AG@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_0.pdf@EU-1-08-463_h_a_dec_0.pdf@2008-02-07 00:00:00@RELISTOR@methylnaltrexone  bromide@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_2.pdf@EU-1-08-462_h_a_dec_2.pdf@2009-02-25 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_18.pdf@EU-1-08-457_h_a_dec_18.pdf@2017-12-15 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_21.pdf@EU-1-08-456_h_a_dec_21.pdf@2021-09-15 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_3.pdf@EU-1-08-461_h_a_dec_3.pdf@2011-02-21 00:00:00@Firazyr@icatibant@NAS before 2012@False@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_0.pdf@EU-1-08-465_h_a_dec_0.pdf@2008-07-16 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_1.pdf@EU-1-08-463_h_a_dec_1.pdf@2009-03-07 00:00:00@RELISTOR@methylnaltrexone  bromide@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_20.pdf@EU-1-08-462_h_a_dec_20.pdf@2021-03-26 00:00:00@Ranexa@ranolazine@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_0.pdf@EU-1-08-466_h_a_dec_0.pdf@2008-07-25 00:00:00@Bridion@sugammadex@NAS before 2012@True@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_22.pdf@EU-1-08-456_h_a_dec_22.pdf@2022-09-29 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_19.pdf@EU-1-08-457_h_a_dec_19.pdf@2018-05-22 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_4.pdf@EU-1-08-461_h_a_dec_4.pdf@2011-02-28 00:00:00@Firazyr@icatibant@NAS before 2012@False@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_1.pdf@EU-1-08-465_h_a_dec_1.pdf@2009-02-13 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_3.pdf@EU-1-08-462_h_a_dec_3.pdf@2009-02-25 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@CV Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_1.pdf@EU-1-08-466_h_a_dec_1.pdf@2010-09-02 00:00:00@Bridion@sugammadex@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_10.pdf@EU-1-08-463_h_a_dec_10.pdf@2014-11-09 00:00:00@Relistor@methylnaltrexone bromide@False@False@OD Not Found@TMC Pharma Services Ltd.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_3.pdf@EU-1-08-456_h_a_dec_3.pdf@2009-07-29 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_5.pdf@EU-1-08-461_h_a_dec_5.pdf@2011-04-18 00:00:00@Firazyr@icatibant@NAS before 2012@False@adopted@Jerini AG@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_2.pdf@EU-1-08-457_h_a_dec_2.pdf@2009-02-06 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_10.pdf@EU-1-08-465_h_a_dec_10.pdf@2012-12-17 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_4.pdf@EU-1-08-462_h_a_dec_4.pdf@2009-08-25 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_4.pdf@EU-1-08-456_h_a_dec_4.pdf@2009-09-16 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_6.pdf@EU-1-08-461_h_a_dec_6.pdf@2012-08-03 00:00:00@Firazyr@icatibant@False@False@OD Not Found@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_10.pdf@EU-1-08-466_h_a_dec_10.pdf@2015-06-02 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_11.pdf@EU-1-08-465_h_a_dec_11.pdf@2013-05-30 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_11.pdf@EU-1-08-463_h_a_dec_11.pdf@2015-05-27 00:00:00@Relistor@methylnaltrexone bromide@False@False@OD Not Found@TMC Pharma Services Ltd@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_5.pdf@EU-1-08-462_h_a_dec_5.pdf@2010-10-05 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_7.pdf@EU-1-08-461_h_a_dec_7.pdf@2012-08-23 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies  GmbH@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_5.pdf@EU-1-08-456_h_a_dec_5.pdf@2009-10-28 00:00:00@Velmetia@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_20.pdf@EU-1-08-457_h_a_dec_20.pdf@2018-06-29 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_12.pdf@EU-1-08-465_h_a_dec_12.pdf@2013-07-19 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_6.pdf@EU-1-08-462_h_a_dec_6.pdf@2010-10-05 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_11.pdf@EU-1-08-466_h_a_dec_11.pdf@2016-02-26 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_8.pdf@EU-1-08-461_h_a_dec_8.pdf@2012-10-25 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies  GmbH@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_6.pdf@EU-1-08-456_h_a_dec_6.pdf@2010-06-08 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_12.pdf@EU-1-08-463_h_a_dec_12.pdf@2016-01-28 00:00:00@Relistor@methylnaltrexone bromide@False@False@OD Not Found@TMC Pharma Services Ltd@CMA Not Found@Parsed
EU-1-08-461_h_a_dec_9.pdf@EU-1-08-461_h_a_dec_9.pdf@2013-03-13 00:00:00@Firazyr@icatibant@False@False@adopted@Shire Orphan Therapies GmbH@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_7.pdf@EU-1-08-462_h_a_dec_7.pdf@2011-01-27 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_13.pdf@EU-1-08-465_h_a_dec_13.pdf@2014-09-18 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_21.pdf@EU-1-08-457_h_a_dec_21.pdf@2021-08-26 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_7.pdf@EU-1-08-456_h_a_dec_7.pdf@2010-03-11 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_8.pdf@EU-1-08-462_h_a_dec_8.pdf@2011-02-21 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@Menarini  International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_14.pdf@EU-1-08-465_h_a_dec_14.pdf@2015-02-26 00:00:00@Clopidogrel  Zentiva@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_13.pdf@EU-1-08-463_h_a_dec_13.pdf@2017-09-01 00:00:00@Relistor@methylnaltrexone  bromide@False@False@OD Not Found@PharmaSwiss Česká republika s.r.o.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_12.pdf@EU-1-08-466_h_a_dec_12.pdf@2017-07-26 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_22.pdf@EU-1-08-457_h_a_dec_22.pdf@2022-09-21 00:00:00@Efficib@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_8.pdf@EU-1-08-456_h_a_dec_8.pdf@2010-11-26 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-462_h_a_dec_9.pdf@EU-1-08-462_h_a_dec_9.pdf@2011-06-17 00:00:00@Ranexa@ranolazine@NAS before 2012@False@OD Not Found@Menarini  International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_15.pdf@EU-1-08-465_h_a_dec_15.pdf@2017-03-04 00:00:00@Clopidogrel  Zentiva@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_3.pdf@EU-1-08-457_h_a_dec_3.pdf@2009-07-29 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_13.pdf@EU-1-08-466_h_a_dec_13.pdf@2018-07-30 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-08-456_h_a_dec_9.pdf@EU-1-08-456_h_a_dec_9.pdf@2011-02-21 00:00:00@Velmetia@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_14.pdf@EU-1-08-463_h_a_dec_14.pdf@2019-12-16 00:00:00@Relistor@methylnaltrexone bromide@False@False@OD Not Found@PharmaSwiss Česká republika s.r.o.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_4.pdf@EU-1-08-457_h_a_dec_4.pdf@2009-09-16 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_16.pdf@EU-1-08-465_h_a_dec_16.pdf@2018-04-30 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_14.pdf@EU-1-08-466_h_a_dec_14.pdf@2020-04-23 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_5.pdf@EU-1-08-457_h_a_dec_5.pdf@2009-10-28 00:00:00@Efficib@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_17.pdf@EU-1-08-465_h_a_dec_17.pdf@2018-10-25 00:00:00@Clopidogrel  Zentiva@Clopidogrel@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_15.pdf@EU-1-08-466_h_a_dec_15.pdf@2021-07-16 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_15.pdf@EU-1-08-463_h_a_dec_15.pdf@2021-09-12 00:00:00@Relistor@methylnaltrexone bromide@False@False@OD Not Found@Bausch Health Ireland Limited@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_16.pdf@EU-1-08-466_h_a_dec_16.pdf@2022-01-24 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_6.pdf@EU-1-08-457_h_a_dec_6.pdf@2010-06-08 00:00:00@Efficib@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_18.pdf@EU-1-08-465_h_a_dec_18.pdf@2019-03-09 00:00:00@Clopidogrel  Zentiva@Clopidogrel@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_2.pdf@EU-1-08-463_h_a_dec_2.pdf@2009-12-22 00:00:00@RELISTOR@methylnaltrexone  bromide@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_0.pdf@EU-1-08-468_h_a_dec_0.pdf@2008-08-28 00:00:00@INTELENCE@etravirine@NAS before 2012@True@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-466_h_a_dec_2.pdf@EU-1-08-466_h_a_dec_2.pdf@2010-04-27 00:00:00@Bridion@sugammadex@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_7.pdf@EU-1-08-457_h_a_dec_7.pdf@2010-03-11 00:00:00@Efficib@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_19.pdf@EU-1-08-465_h_a_dec_19.pdf@2020-11-16 00:00:00@Clopidogrel  Zentiva@Clopidogrel@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_3.pdf@EU-1-08-463_h_a_dec_3.pdf@2010-05-07 00:00:00@Relistor@methylnaltrexone bromide@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_1.pdf@EU-1-08-468_h_a_dec_1.pdf@2009-04-23 00:00:00@INTELENCE@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_2.pdf@EU-1-08-465_h_a_dec_2.pdf@2009-08-13 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_3.pdf@EU-1-08-466_h_a_dec_3.pdf@2010-02-06 00:00:00@Bridion@sugammadex@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_8.pdf@EU-1-08-457_h_a_dec_8.pdf@2010-11-26 00:00:00@Efficib@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_4.pdf@EU-1-08-463_h_a_dec_4.pdf@2010-01-09 00:00:00@Relistor@methylnaltrexone bromide@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_0.pdf@EU-1-08-469_h_a_dec_0.pdf@2008-12-09 00:00:00@Oprymea@Pramipexole@NAS before 2012@True@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_10.pdf@EU-1-08-468_h_a_dec_10.pdf@2010-11-29 00:00:00@Intelence@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_4.pdf@EU-1-08-466_h_a_dec_4.pdf@2010-03-11 00:00:00@Bridion@sugammadex@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_20.pdf@EU-1-08-465_h_a_dec_20.pdf@2021-09-07 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-08-457_h_a_dec_9.pdf@EU-1-08-457_h_a_dec_9.pdf@2011-02-21 00:00:00@Efficib@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_5.pdf@EU-1-08-463_h_a_dec_5.pdf@2010-06-09 00:00:00@Relistor@methylnaltrexone bromide@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_11.pdf@EU-1-08-468_h_a_dec_11.pdf@2011-07-20 00:00:00@Intelence@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-469_h_a_dec_1.pdf@EU-1-08-469_h_a_dec_1.pdf@2009-02-26 00:00:00@Oprymea@Pramipexole@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_21.pdf@EU-1-08-465_h_a_dec_21.pdf@2021-12-16 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_6.pdf@EU-1-08-463_h_a_dec_6.pdf@2011-06-17 00:00:00@Relistor@methylnaltrexone bromide@NAS before 2012@False@OD Not Found@Wyeth Europa  Limited@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_12.pdf@EU-1-08-468_h_a_dec_12.pdf@2011-08-24 00:00:00@Intelence@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@conditional@Parsed
EU-1-08-466_h_a_dec_6.pdf@EU-1-08-466_h_a_dec_6.pdf@2012-07-23 00:00:00@Bridion@sugammadex@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_10.pdf@EU-1-08-469_h_a_dec_10.pdf@2018-12-03 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_3.pdf@EU-1-08-465_h_a_dec_3.pdf@2010-01-29 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_13.pdf@EU-1-08-468_h_a_dec_13.pdf@2011-11-24 00:00:00@Intelence@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-463_h_a_dec_7.pdf@EU-1-08-463_h_a_dec_7.pdf@2011-05-07 00:00:00@Relistor@methylnaltrexone bromide@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_11.pdf@EU-1-08-469_h_a_dec_11.pdf@2020-07-31 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_7.pdf@EU-1-08-466_h_a_dec_7.pdf@2012-10-25 00:00:00@Bridion@sugammadex@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_0.pdf@EU-1-08-470_h_a_dec_0.pdf@2008-08-29 00:00:00@Vimpat@lacosamide@NAS before 2012@True@OD Not Found@UCB S.A.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_4.pdf@EU-1-08-465_h_a_dec_4.pdf@2010-04-29 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_14.pdf@EU-1-08-468_h_a_dec_14.pdf@2012-03-19 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_8.pdf@EU-1-08-463_h_a_dec_8.pdf@2011-07-27 00:00:00@Relistor@methylnaltrexone bromide@NAS before 2012@False@OD Not Found@Wyeth Europa  Limited@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_8.pdf@EU-1-08-466_h_a_dec_8.pdf@2013-06-21 00:00:00@Bridion@sugammadex@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_2.pdf@EU-1-08-469_h_a_dec_2.pdf@2009-05-15 00:00:00@Oprymea@Pramipexole@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_1.pdf@EU-1-08-470_h_a_dec_1.pdf@2009-02-02 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_5.pdf@EU-1-08-465_h_a_dec_5.pdf@2010-06-09 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_15.pdf@EU-1-08-468_h_a_dec_15.pdf@2012-07-20 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-469_h_a_dec_3.pdf@EU-1-08-469_h_a_dec_3.pdf@2009-08-13 00:00:00@Oprymea@Pramipexole@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_10.pdf@EU-1-08-470_h_a_dec_10.pdf@2012-02-21 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-466_h_a_dec_9.pdf@EU-1-08-466_h_a_dec_9.pdf@2013-09-10 00:00:00@Revestive@teduglutide@False@False@adopted@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-08-463_h_a_dec_9.pdf@EU-1-08-463_h_a_dec_9.pdf@2013-05-27 00:00:00@Relistor@methylnaltrexone bromide@False@False@OD Not Found@TMC Pharma Services Ltd.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_16.pdf@EU-1-08-468_h_a_dec_16.pdf@2013-06-03 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-465_h_a_dec_6.pdf@EU-1-08-465_h_a_dec_6.pdf@2011-01-13 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_11.pdf@EU-1-08-470_h_a_dec_11.pdf@2012-03-19 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_4.pdf@EU-1-08-469_h_a_dec_4.pdf@2011-03-28 00:00:00@Oprymea@Pramipexole@NAS before 2012@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_17.pdf@EU-1-08-468_h_a_dec_17.pdf@2013-06-21 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-465_h_a_dec_7.pdf@EU-1-08-465_h_a_dec_7.pdf@2011-07-06 00:00:00@Clopidogrel Winthrop@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_12.pdf@EU-1-08-470_h_a_dec_12.pdf@2012-10-24 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_5.pdf@EU-1-08-469_h_a_dec_5.pdf@2013-09-04 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_18.pdf@EU-1-08-468_h_a_dec_18.pdf@2013-01-07 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-465_h_a_dec_8.pdf@EU-1-08-465_h_a_dec_8.pdf@2011-10-11 00:00:00@Clopidogrel Zentiva@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_13.pdf@EU-1-08-470_h_a_dec_13.pdf@2012-11-22 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_6.pdf@EU-1-08-469_h_a_dec_6.pdf@2013-11-11 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_14.pdf@EU-1-08-470_h_a_dec_14.pdf@2013-07-31 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-465_h_a_dec_9.pdf@EU-1-08-465_h_a_dec_9.pdf@2012-05-25 00:00:00@Clopidogrel Zentiva@Clopidogrel@False@False@OD Not Found@SANOFI@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_0.pdf@EU-1-08-472_h_a_dec_0.pdf@2008-09-30 00:00:00@Xarelto@rivaroxaban@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_19.pdf@EU-1-08-468_h_a_dec_19.pdf@2013-11-20 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-469_h_a_dec_7.pdf@EU-1-08-469_h_a_dec_7.pdf@2015-02-17 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@Krka@CMA Not Found@Parsed
AG@CMA Not Found@Parsed
als S.A.@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_16.pdf@EU-1-08-470_h_a_dec_16.pdf@2016-02-06 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_10.pdf@EU-1-08-472_h_a_dec_10.pdf@2013-05-22 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_8.pdf@EU-1-08-469_h_a_dec_8.pdf@2016-07-07 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_1.pdf@EU-1-08-473_h_a_dec_1.pdf@2008-06-10 00:00:00@EVICEL@human fibrinogen / human  thrombin@NAS before 2012@True@OD Not Found@OMRIX biopharmaceuticals S.A.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_20.pdf@EU-1-08-468_h_a_dec_20.pdf@2014-08-01 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_11.pdf@EU-1-08-472_h_a_dec_11.pdf@2013-05-08 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_0.pdf@EU-1-08-475_h_a_dec_0.pdf@2008-07-10 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@True@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-469_h_a_dec_9.pdf@EU-1-08-469_h_a_dec_9.pdf@2017-07-26 00:00:00@Oprymea@pramipexole@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_17.pdf@EU-1-08-470_h_a_dec_17.pdf@2016-12-12 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_10.pdf@EU-1-08-473_h_a_dec_10.pdf@2013-02-13 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_21.pdf@EU-1-08-468_h_a_dec_21.pdf@2015-03-26 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_18.pdf@EU-1-08-470_h_a_dec_18.pdf@2017-03-24 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_1.pdf@EU-1-08-475_h_a_dec_1.pdf@2009-07-17 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_11.pdf@EU-1-08-473_h_a_dec_11.pdf@2013-07-26 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_12.pdf@EU-1-08-472_h_a_dec_12.pdf@2014-07-31 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_22.pdf@EU-1-08-468_h_a_dec_22.pdf@2016-09-15 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_19.pdf@EU-1-08-470_h_a_dec_19.pdf@2017-09-14 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_0.pdf@EU-1-08-476_h_a_dec_0.pdf@2008-01-10 00:00:00@Tadalafil Lilly@tadalafil@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_13.pdf@EU-1-08-472_h_a_dec_13.pdf@2015-07-28 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_23.pdf@EU-1-08-468_h_a_dec_23.pdf@2018-07-30 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_12.pdf@EU-1-08-473_h_a_dec_12.pdf@2013-11-20 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_10.pdf@EU-1-08-475_h_a_dec_10.pdf@2014-08-19 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_2.pdf@EU-1-08-470_h_a_dec_2.pdf@2009-07-24 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_14.pdf@EU-1-08-472_h_a_dec_14.pdf@2016-07-07 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_1.pdf@EU-1-08-476_h_a_dec_1.pdf@2009-11-30 00:00:00@Adcirca@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_24.pdf@EU-1-08-468_h_a_dec_24.pdf@2018-08-23 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_13.pdf@EU-1-08-473_h_a_dec_13.pdf@2015-01-27 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_11.pdf@EU-1-08-475_h_a_dec_11.pdf@2016-06-07 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_20.pdf@EU-1-08-470_h_a_dec_20.pdf@2019-07-31 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_10.pdf@EU-1-08-476_h_a_dec_10.pdf@2017-02-27 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_25.pdf@EU-1-08-468_h_a_dec_25.pdf@2019-07-11 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_15.pdf@EU-1-08-472_h_a_dec_15.pdf@2017-08-05 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_14.pdf@EU-1-08-473_h_a_dec_14.pdf@2016-10-24 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_11.pdf@EU-1-08-476_h_a_dec_11.pdf@2018-02-19 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_16.pdf@EU-1-08-472_h_a_dec_16.pdf@2017-06-23 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_26.pdf@EU-1-08-468_h_a_dec_26.pdf@2020-04-28 00:00:00@Intelence@etravirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_12.pdf@EU-1-08-475_h_a_dec_12.pdf@2017-07-25 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_15.pdf@EU-1-08-473_h_a_dec_15.pdf@2018-08-23 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_21.pdf@EU-1-08-470_h_a_dec_21.pdf@2020-03-09 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
@Parsed
EU-1-08-472_h_a_dec_17.pdf@EU-1-08-472_h_a_dec_17.pdf@2017-08-22 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_0.pdf@EU-1-08-477_h_a_dec_0.pdf@2008-07-10 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@True@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-473_h_a_dec_16.pdf@EU-1-08-473_h_a_dec_16.pdf@2021-07-16 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_2.pdf@EU-1-08-476_h_a_dec_2.pdf@2010-03-26 00:00:00@Adcirca@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_22.pdf@EU-1-08-470_h_a_dec_22.pdf@2020-01-12 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_3.pdf@EU-1-08-468_h_a_dec_3.pdf@2009-04-11 00:00:00@INTELENCE@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_13.pdf@EU-1-08-475_h_a_dec_13.pdf@2018-12-11 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_1.pdf@EU-1-08-477_h_a_dec_1.pdf@2010-04-29 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@False@OD Not Found@EpiCept GmbH@exceptional@Parsed
EU-1-08-472_h_a_dec_18.pdf@EU-1-08-472_h_a_dec_18.pdf@2017-10-19 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_23.pdf@EU-1-08-470_h_a_dec_23.pdf@2022-04-03 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_3.pdf@EU-1-08-476_h_a_dec_3.pdf@2010-03-11 00:00:00@Adcirca@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_2.pdf@EU-1-08-473_h_a_dec_2.pdf@2009-04-23 00:00:00@EVICEL@human fibrinogen / human  thrombin@NAS before 2012@False@OD Not Found@OMRIX biopharmaceuticals S.A. / N.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_4.pdf@EU-1-08-468_h_a_dec_4.pdf@2009-12-11 00:00:00@INTELENCE@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_14.pdf@EU-1-08-475_h_a_dec_14.pdf@2020-08-28 00:00:00@Olanzapine  Mylan@Olanzapine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_10.pdf@EU-1-08-477_h_a_dec_10.pdf@2015-06-02 00:00:00@Ceplene@Histamine dihydrochloride@False@False@OD Not Found@Meda AB@exceptional@Parsed
EU-1-08-470_h_a_dec_24.pdf@EU-1-08-470_h_a_dec_24.pdf@2022-08-07 00:00:00@Vimpat@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_4.pdf@EU-1-08-476_h_a_dec_4.pdf@2011-04-20 00:00:00@Adcirca@tadalafil@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_19.pdf@EU-1-08-472_h_a_dec_19.pdf@2018-05-22 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_3.pdf@EU-1-08-473_h_a_dec_3.pdf@2022-12-01 00:00:01@EVICEL@human fibrinogen / human  thrombin@False@False@OD Not Found@OMRIX biopharmaceuticals S.A. / N.V.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_11.pdf@EU-1-08-477_h_a_dec_11.pdf@2016-06-30 00:00:00@Ceplene@Histamine dihydrochloride@False@False@OD Not Found@Meda AB@exceptional@Parsed
EU-1-08-470_h_a_dec_3.pdf@EU-1-08-470_h_a_dec_3.pdf@2009-12-21 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_2.pdf@EU-1-08-472_h_a_dec_2.pdf@2009-10-21 00:00:00@Xarelto@rivaroxaban@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_5.pdf@EU-1-08-468_h_a_dec_5.pdf@2009-11-26 00:00:00@INTELENCE@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_5.pdf@EU-1-08-476_h_a_dec_5.pdf@2012-08-23 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_4.pdf@EU-1-08-473_h_a_dec_4.pdf@2010-09-02 00:00:00@EVICEL@human  fibrinogen / human thrombin@NAS before 2012@False@OD Not Found@OMRIX biopharmaceuticals S.A. / N.V.@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_15.pdf@EU-1-08-475_h_a_dec_15.pdf@2021-12-11 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_20.pdf@EU-1-08-472_h_a_dec_20.pdf@2018-02-07 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_4.pdf@EU-1-08-470_h_a_dec_4.pdf@2010-04-27 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_6.pdf@EU-1-08-468_h_a_dec_6.pdf@2010-03-30 00:00:00@INTELENCE@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_6.pdf@EU-1-08-476_h_a_dec_6.pdf@2013-01-24 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_12.pdf@EU-1-08-477_h_a_dec_12.pdf@2017-08-12 00:00:00@Ceplene@Histamine dihydrochloride@False@False@adopted@Meda AB@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_2.pdf@EU-1-08-475_h_a_dec_2.pdf@2009-10-23 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_5.pdf@EU-1-08-473_h_a_dec_5.pdf@2010-03-30 00:00:00@EVICEL@human fibrinogen / human  thrombin@NAS before 2012@False@OD Not Found@OMRIX biopharmaceuticals S.A. / N.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_21.pdf@EU-1-08-472_h_a_dec_21.pdf@2018-08-23 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_7.pdf@EU-1-08-476_h_a_dec_7.pdf@2013-12-02 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_7.pdf@EU-1-08-468_h_a_dec_7.pdf@2010-04-29 00:00:00@INTELENCE@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-470_h_a_dec_5.pdf@EU-1-08-470_h_a_dec_5.pdf@2010-02-06 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_13.pdf@EU-1-08-477_h_a_dec_13.pdf@2018-07-26 00:00:00@Ceplene@Histamine dihydrochloride@False@False@adopted@Noventia Pharma Srl@exceptional@Parsed
EU-1-08-473_h_a_dec_6.pdf@EU-1-08-473_h_a_dec_6.pdf@2010-06-08 00:00:00@Evicel@human fibrinogen / human  thrombin@NAS before 2012@False@OD Not Found@OMRIX  biopharmaceuticals S.A. / N.V.@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_3.pdf@EU-1-08-475_h_a_dec_3.pdf@2010-06-08 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_22.pdf@EU-1-08-472_h_a_dec_22.pdf@2018-08-27 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_8.pdf@EU-1-08-476_h_a_dec_8.pdf@2013-05-22 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_8.pdf@EU-1-08-468_h_a_dec_8.pdf@2010-02-07 00:00:00@Intelence@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-470_h_a_dec_6.pdf@EU-1-08-470_h_a_dec_6.pdf@2010-06-09 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_14.pdf@EU-1-08-477_h_a_dec_14.pdf@2022-09-09 00:00:00@Ceplene@Histamine dihydrochloride@False@False@OD Not Found@Noventia Pharma Srl@exceptional@Parsed
EU-1-08-475_h_a_dec_4.pdf@EU-1-08-475_h_a_dec_4.pdf@2010-03-11 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_7.pdf@EU-1-08-473_h_a_dec_7.pdf@2011-03-28 00:00:00@Evicel@human fibrinogen / human thrombin@NAS before 2012@False@OD Not Found@OMRIX biopharmaceuticals S.A. / N.V.,@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_23.pdf@EU-1-08-472_h_a_dec_23.pdf@2019-01-07 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-476_h_a_dec_9.pdf@EU-1-08-476_h_a_dec_9.pdf@2015-08-20 00:00:00@Adcirca@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-468_h_a_dec_9.pdf@EU-1-08-468_h_a_dec_9.pdf@2010-02-07 00:00:00@Intelence@etravirine@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-08-470_h_a_dec_7.pdf@EU-1-08-470_h_a_dec_7.pdf@2010-10-25 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_2.pdf@EU-1-08-477_h_a_dec_2.pdf@2011-01-24 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@False@OD Not Found@EpiCept GmbH@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_5.pdf@EU-1-08-475_h_a_dec_5.pdf@2011-06-16 00:00:00@Olanzapine Mylan@Olanzapine@NAS before 2012@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_8.pdf@EU-1-08-473_h_a_dec_8.pdf@2012-02-27 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_24.pdf@EU-1-08-472_h_a_dec_24.pdf@2020-08-28 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_3.pdf@EU-1-08-477_h_a_dec_3.pdf@2011-04-14 00:00:00@Ceplene@Histamine  dihydrochloride@NAS before 2012@False@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-470_h_a_dec_8.pdf@EU-1-08-470_h_a_dec_8.pdf@2011-06-05 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-473_h_a_dec_9.pdf@EU-1-08-473_h_a_dec_9.pdf@2012-07-26 00:00:00@Evicel@human fibrinogen / human thrombin@False@False@OD Not Found@Omrix Biopharmaceuticals N.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_25.pdf@EU-1-08-472_h_a_dec_25.pdf@2021-01-21 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_6.pdf@EU-1-08-475_h_a_dec_6.pdf@2012-01-13 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_4.pdf@EU-1-08-477_h_a_dec_4.pdf@2011-08-12 00:00:00@Ceplene@Histamine dihydrochloride@NAS before 2012@False@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-470_h_a_dec_9.pdf@EU-1-08-470_h_a_dec_9.pdf@2011-11-24 00:00:00@Vimpat@lacosamide@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_26.pdf@EU-1-08-472_h_a_dec_26.pdf@2021-06-21 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_7.pdf@EU-1-08-475_h_a_dec_7.pdf@2012-03-08 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_5.pdf@EU-1-08-477_h_a_dec_5.pdf@2012-04-20 00:00:00@Ceplene@Histamine dihydrochloride@False@False@adopted@EpiCept GmbH@exceptional@Parsed
EU-1-08-472_h_a_dec_27.pdf@EU-1-08-472_h_a_dec_27.pdf@2021-08-26 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-08-475_h_a_dec_8.pdf@EU-1-08-475_h_a_dec_8.pdf@2012-10-25 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_6.pdf@EU-1-08-477_h_a_dec_6.pdf@2012-05-31 00:00:00@Ceplene@Histamine dihydrochloride@False@False@OD Not Found@EpiCept GmbH@exceptional@Parsed
EU-1-08-475_h_a_dec_9.pdf@EU-1-08-475_h_a_dec_9.pdf@2013-05-22 00:00:00@Olanzapine Mylan@Olanzapine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_3.pdf@EU-1-08-472_h_a_dec_3.pdf@2010-10-14 00:00:00@Xarelto@rivaroxaban@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_0.pdf@EU-1-08-479_h_a_dec_0.pdf@2008-11-19 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_7.pdf@EU-1-08-477_h_a_dec_7.pdf@2012-10-15 00:00:00@Ceplene@Histamine dihydrochloride@False@False@OD Not Found@EpiCept GmbH@exceptional@Parsed
EU-1-08-472_h_a_dec_4.pdf@EU-1-08-472_h_a_dec_4.pdf@2011-01-24 00:00:00@Xarelto@rivaroxaban@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_8.pdf@EU-1-08-477_h_a_dec_8.pdf@2013-08-26 00:00:00@Ceplene@Histamine  dihydrochloride@False@False@adopted@Meda AB@exceptional@Parsed
EU-1-08-479_h_a_dec_1.pdf@EU-1-08-479_h_a_dec_1.pdf@2008-11-19 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_5.pdf@EU-1-08-472_h_a_dec_5.pdf@2011-12-14 00:00:00@Xarelto@rivaroxaban@NAS before 2012@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_10.pdf@EU-1-08-479_h_a_dec_10.pdf@2013-08-26 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_0.pdf@EU-1-08-480_h_a_dec_0.pdf@2008-01-12 00:00:00@Irbesartan Krka@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-477_h_a_dec_9.pdf@EU-1-08-477_h_a_dec_9.pdf@2014-03-21 00:00:00@Ceplene@Histamine dihydrochloride@False@False@adopted@Meda AB@exceptional@Parsed
EU-1-08-472_h_a_dec_6.pdf@EU-1-08-472_h_a_dec_6.pdf@2011-09-12 00:00:00@Xarelto@rivaroxaban@NAS before 2012@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_11.pdf@EU-1-08-479_h_a_dec_11.pdf@2015-05-05 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_1.pdf@EU-1-08-480_h_a_dec_1.pdf@2009-08-28 00:00:00@Irbesartan Krka@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_0.pdf@EU-1-08-481_h_a_dec_0.pdf@2008-02-12 00:00:00@Kuvan@sapropterin  dihydrochloride@NAS before 2012@False@adopted@Merck KGaA@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_7.pdf@EU-1-08-472_h_a_dec_7.pdf@2012-05-25 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_12.pdf@EU-1-08-479_h_a_dec_12.pdf@2016-04-13 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_13.pdf@EU-1-08-479_h_a_dec_13.pdf@2017-09-18 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_10.pdf@EU-1-08-480_h_a_dec_10.pdf@2020-10-19 00:00:00@Ifirmasta@Irbesartan@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_1.pdf@EU-1-08-481_h_a_dec_1.pdf@2009-07-24 00:00:00@Kuvan@sapropterin dihydrochloride@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_8.pdf@EU-1-08-472_h_a_dec_8.pdf@2012-10-29 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_14.pdf@EU-1-08-479_h_a_dec_14.pdf@2019-02-25 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-472_h_a_dec_9.pdf@EU-1-08-472_h_a_dec_9.pdf@2012-11-15 00:00:00@Xarelto@rivaroxaban@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_15.pdf@EU-1-08-479_h_a_dec_15.pdf@2020-02-18 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_10.pdf@EU-1-08-481_h_a_dec_10.pdf@2017-11-01 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_11.pdf@EU-1-08-480_h_a_dec_11.pdf@2021-02-19 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC)    EN 1   EN COMMISSION IMPLEMENTING DECISION  19.2.2021  amending Commission Decision C(2019)3067  15 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(2008)7923 for “Ifirmasta@Irbesartan@False@False@OD Not Found@to Krka@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_16.pdf@EU-1-08-479_h_a_dec_16.pdf@2021-11-22 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_0.pdf@EU-1-08-482_h_a_dec_0.pdf@2008-11-25 00:00:00@AZARGA@brinzolamide / timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_11.pdf@EU-1-08-481_h_a_dec_11.pdf@2017-07-13 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_0.pdf@EU-1-08-483_h_a_dec_0.pdf@2008-01-12 00:00:00@Zomarist@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_2.pdf@EU-1-08-479_h_a_dec_2.pdf@2009-07-27 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_12.pdf@EU-1-08-480_h_a_dec_12.pdf@2022-04-03 00:00:00@Ifirmasta@Irbesartan@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_1.pdf@EU-1-08-482_h_a_dec_1.pdf@2009-12-21 00:00:00@AZARGA@brinzolamide / timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_3.pdf@EU-1-08-479_h_a_dec_3.pdf@2009-12-21 00:00:00@ZYPADHERA@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_2.pdf@EU-1-08-480_h_a_dec_2.pdf@2010-04-19 00:00:00@Ifirmasta@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_1.pdf@EU-1-08-483_h_a_dec_1.pdf@2009-02-09 00:00:00@Zomarist@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_2.pdf@EU-1-08-482_h_a_dec_2.pdf@2011-11-02 00:00:00@Azarga@brinzolamide / timolol@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_12.pdf@EU-1-08-481_h_a_dec_12.pdf@2018-12-06 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_3.pdf@EU-1-08-480_h_a_dec_3.pdf@2011-09-19 00:00:00@Ifirmasta@Irbesartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_4.pdf@EU-1-08-479_h_a_dec_4.pdf@2010-01-09 00:00:00@Zypadhera@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_3.pdf@EU-1-08-482_h_a_dec_3.pdf@2012-09-20 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_10.pdf@EU-1-08-483_h_a_dec_10.pdf@2013-05-08 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_4.pdf@EU-1-08-480_h_a_dec_4.pdf@2012-10-31 00:00:00@Ifirmasta@Irbesartan@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_5.pdf@EU-1-08-479_h_a_dec_5.pdf@2011-09-13 00:00:00@Zypadhera@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_13.pdf@EU-1-08-481_h_a_dec_13.pdf@2019-05-20 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_5.pdf@EU-1-08-480_h_a_dec_5.pdf@2013-08-26 00:00:00@Ifirmasta@Irbesartan@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_6.pdf@EU-1-08-479_h_a_dec_6.pdf@2011-10-20 00:00:00@Zypadhera@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_4.pdf@EU-1-08-482_h_a_dec_4.pdf@2013-08-26 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_11.pdf@EU-1-08-483_h_a_dec_11.pdf@2015-04-13 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_7.pdf@EU-1-08-479_h_a_dec_7.pdf@2011-11-24 00:00:00@Zypadhera@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_14.pdf@EU-1-08-481_h_a_dec_14.pdf@2021-04-02 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@OD Not Found@BioMarin International Limited@CMA Not Found@Parsed
 COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)7923 for “Ifirmasta@Irbesartan@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_5.pdf@EU-1-08-482_h_a_dec_5.pdf@2015-03-19 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_8.pdf@EU-1-08-479_h_a_dec_8.pdf@2012-06-27 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_12.pdf@EU-1-08-483_h_a_dec_12.pdf@2015-12-16 00:00:00@Zomarist@vildagliptin /  metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_7.pdf@EU-1-08-480_h_a_dec_7.pdf@2015-10-12 00:00:00@Ifirmasta@Irbesartan@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_2.pdf@EU-1-08-481_h_a_dec_2.pdf@2010-12-05 00:00:00@Kuvan@sapropterin dihydrochloride@NAS before 2012@False@OD Not Found@Merck KGaA@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_0.pdf@EU-1-08-484_h_a_dec_0.pdf@2008-01-12 00:00:00@Vildagliptin/metformin  hydrochloride Novartis@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-479_h_a_dec_9.pdf@EU-1-08-479_h_a_dec_9.pdf@2013-05-27 00:00:00@Zypadhera@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_8.pdf@EU-1-08-480_h_a_dec_8.pdf@2017-09-14 00:00:00@Ifirmasta@Irbesartan@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_6.pdf@EU-1-08-482_h_a_dec_6.pdf@2017-05-16 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_3.pdf@EU-1-08-481_h_a_dec_3.pdf@2011-01-17 00:00:00@Kuvan@sapropterin dihydrochloride@NAS before 2012@False@adopted@Merck KGaA@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_1.pdf@EU-1-08-484_h_a_dec_1.pdf@2009-08-31 00:00:00@Icandra@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_13.pdf@EU-1-08-483_h_a_dec_13.pdf@2016-12-12 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  12.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)7921 for “Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_4.pdf@EU-1-08-481_h_a_dec_4.pdf@2011-01-21 00:00:00@Kuvan@sapropterin dihydrochloride@NAS before 2012@False@adopted@Merck KGaA@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_7.pdf@EU-1-08-482_h_a_dec_7.pdf@2018-04-19 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_10.pdf@EU-1-08-484_h_a_dec_10.pdf@2013-05-08 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_5.pdf@EU-1-08-481_h_a_dec_5.pdf@2011-07-26 00:00:00@Kuvan@sapropterin dihydrochloride@NAS before 2012@False@adopted@Merck Serono Europe  Limited@CMA Not Found@Parsed
EU-1-08-480_h_a_dec_9.pdf@EU-1-08-480_h_a_dec_9.pdf@2019-04-15 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  15.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)7923 for “Ifirmasta@Irbesartan@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_14.pdf@EU-1-08-483_h_a_dec_14.pdf@2018-03-16 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_6.pdf@EU-1-08-481_h_a_dec_6.pdf@2012-05-25 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@Merck Serono  Europe Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_11.pdf@EU-1-08-484_h_a_dec_11.pdf@2015-04-13 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_8.pdf@EU-1-08-482_h_a_dec_8.pdf@2019-06-20 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_15.pdf@EU-1-08-483_h_a_dec_15.pdf@2018-12-04 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_7.pdf@EU-1-08-481_h_a_dec_7.pdf@2013-11-13 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_12.pdf@EU-1-08-484_h_a_dec_12.pdf@2015-12-16 00:00:00@Icandra@vildagliptin / metformin  hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-482_h_a_dec_9.pdf@EU-1-08-482_h_a_dec_9.pdf@2022-05-19 00:00:00@Azarga@brinzolamide / timolol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_16.pdf@EU-1-08-483_h_a_dec_16.pdf@2020-09-30 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_0.pdf@EU-1-08-485_h_a_dec_0.pdf@2008-11-19 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_8.pdf@EU-1-08-481_h_a_dec_8.pdf@2015-06-22 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@Merck Serono Europe Limited@exceptional@Parsed
EU-1-08-484_h_a_dec_13.pdf@EU-1-08-484_h_a_dec_13.pdf@2016-08-12 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  8.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2008)7922 for “Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_0.pdf@EU-1-08-486_h_a_dec_0.pdf@2008-11-19 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_1.pdf@EU-1-08-485_h_a_dec_1.pdf@2009-08-21 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_17.pdf@EU-1-08-483_h_a_dec_17.pdf@2021-05-07 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_1.pdf@EU-1-08-486_h_a_dec_1.pdf@2009-08-25 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_0.pdf@EU-1-08-488_h_a_dec_0.pdf@2008-12-17 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-481_h_a_dec_9.pdf@EU-1-08-481_h_a_dec_9.pdf@2016-07-01 00:00:00@Kuvan@sapropterin dihydrochloride@False@False@adopted@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_10.pdf@EU-1-08-485_h_a_dec_10.pdf@2012-10-29 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_14.pdf@EU-1-08-484_h_a_dec_14.pdf@2018-02-19 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_10.pdf@EU-1-08-486_h_a_dec_10.pdf@2012-01-30 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_2.pdf@EU-1-08-483_h_a_dec_2.pdf@2010-03-15 00:00:00@Zomarist@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_1.pdf@EU-1-08-488_h_a_dec_1.pdf@2009-10-20 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@OD Not Found@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_11.pdf@EU-1-08-486_h_a_dec_11.pdf@2012-06-28 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_0.pdf@EU-1-08-490_h_a_dec_0.pdf@2008-12-18 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_3.pdf@EU-1-08-483_h_a_dec_3.pdf@2010-05-07 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_10.pdf@EU-1-08-488_h_a_dec_10.pdf@2013-03-13 00:00:00@Vidaza@Azacitidine@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_11.pdf@EU-1-08-485_h_a_dec_11.pdf@2013-07-31 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_15.pdf@EU-1-08-484_h_a_dec_15.pdf@2018-12-04 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_12.pdf@EU-1-08-486_h_a_dec_12.pdf@2012-10-29 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_4.pdf@EU-1-08-483_h_a_dec_4.pdf@2011-01-27 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_1.pdf@EU-1-08-490_h_a_dec_1.pdf@2008-12-18 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_11.pdf@EU-1-08-488_h_a_dec_11.pdf@2013-11-13 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_12.pdf@EU-1-08-485_h_a_dec_12.pdf@2013-11-28 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_5.pdf@EU-1-08-483_h_a_dec_5.pdf@2011-10-11 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_10.pdf@EU-1-08-490_h_a_dec_10.pdf@2020-06-26 00:00:00@Pramipexole  Teva@pramipexole@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_13.pdf@EU-1-08-486_h_a_dec_13.pdf@2013-07-31 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_16.pdf@EU-1-08-484_h_a_dec_16.pdf@2020-09-30 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_0.pdf@EU-1-08-492_h_a_dec_0.pdf@2009-01-16 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_6.pdf@EU-1-08-483_h_a_dec_6.pdf@2011-11-24 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_11.pdf@EU-1-08-490_h_a_dec_11.pdf@2021-12-13 00:00:00@Pramipexole Teva@pramipexole@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_12.pdf@EU-1-08-488_h_a_dec_12.pdf@2014-10-27 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_13.pdf@EU-1-08-485_h_a_dec_13.pdf@2015-04-24 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_7.pdf@EU-1-08-483_h_a_dec_7.pdf@2012-06-28 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_1.pdf@EU-1-08-492_h_a_dec_1.pdf@2009-01-16 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_14.pdf@EU-1-08-486_h_a_dec_14.pdf@2013-11-28 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_2.pdf@EU-1-08-490_h_a_dec_2.pdf@2009-05-20 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_17.pdf@EU-1-08-484_h_a_dec_17.pdf@2021-05-07 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_8.pdf@EU-1-08-483_h_a_dec_8.pdf@2012-10-29 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_10.pdf@EU-1-08-492_h_a_dec_10.pdf@2011-01-08 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_13.pdf@EU-1-08-488_h_a_dec_13.pdf@2015-02-17 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_14.pdf@EU-1-08-485_h_a_dec_14.pdf@2015-12-16 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_3.pdf@EU-1-08-490_h_a_dec_3.pdf@2009-08-20 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_2.pdf@EU-1-08-484_h_a_dec_2.pdf@2010-03-15 00:00:00@Icandra@vildagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-483_h_a_dec_9.pdf@EU-1-08-483_h_a_dec_9.pdf@2013-07-31 00:00:00@Zomarist@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_14.pdf@EU-1-08-488_h_a_dec_14.pdf@2015-10-28 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_4.pdf@EU-1-08-490_h_a_dec_4.pdf@2011-05-16 00:00:00@Pramipexole Teva@Pramipexole@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_15.pdf@EU-1-08-486_h_a_dec_15.pdf@2015-04-24 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_11.pdf@EU-1-08-492_h_a_dec_11.pdf@2011-09-22 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_3.pdf@EU-1-08-484_h_a_dec_3.pdf@2010-05-07 00:00:00@Icandra@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_15.pdf@EU-1-08-485_h_a_dec_15.pdf@2018-01-03 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_5.pdf@EU-1-08-490_h_a_dec_5.pdf@2013-08-26 00:00:00@Pramipexole Teva@pramipexole@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_12.pdf@EU-1-08-492_h_a_dec_12.pdf@2012-05-25 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_15.pdf@EU-1-08-488_h_a_dec_15.pdf@2016-03-30 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_4.pdf@EU-1-08-484_h_a_dec_4.pdf@2011-01-27 00:00:00@Icandra@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_16.pdf@EU-1-08-486_h_a_dec_16.pdf@2015-12-16 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_6.pdf@EU-1-08-490_h_a_dec_6.pdf@2015-01-27 00:00:00@Pramipexole Teva@pramipexole@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_13.pdf@EU-1-08-492_h_a_dec_13.pdf@2012-11-22 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_16.pdf@EU-1-08-485_h_a_dec_16.pdf@2018-04-26 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_5.pdf@EU-1-08-484_h_a_dec_5.pdf@2011-10-24 00:00:00@Icandra@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_7.pdf@EU-1-08-490_h_a_dec_7.pdf@2016-12-16 00:00:00@Pramipexole  Teva@pramipexole@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_16.pdf@EU-1-08-488_h_a_dec_16.pdf@2016-06-29 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_6.pdf@EU-1-08-484_h_a_dec_6.pdf@2011-11-24 00:00:00@Icandra@vildagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_17.pdf@EU-1-08-486_h_a_dec_17.pdf@2018-01-03 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_8.pdf@EU-1-08-490_h_a_dec_8.pdf@2018-04-30 00:00:00@Pramipexole  Teva@pramipexole@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_14.pdf@EU-1-08-492_h_a_dec_14.pdf@2013-05-30 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_7.pdf@EU-1-08-484_h_a_dec_7.pdf@2012-06-28 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_17.pdf@EU-1-08-485_h_a_dec_17.pdf@2020-12-18 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-490_h_a_dec_9.pdf@EU-1-08-490_h_a_dec_9.pdf@2019-03-09 00:00:00@Pramipexole  Teva@pramipexole@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_8.pdf@EU-1-08-484_h_a_dec_8.pdf@2012-10-29 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_17.pdf@EU-1-08-488_h_a_dec_17.pdf@2018-12-04 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_18.pdf@EU-1-08-486_h_a_dec_18.pdf@2018-04-26 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_0.pdf@EU-1-08-494_h_a_dec_0.pdf@2009-01-16 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_15.pdf@EU-1-08-492_h_a_dec_15.pdf@2013-09-25 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_18.pdf@EU-1-08-485_h_a_dec_18.pdf@2021-06-21 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_1.pdf@EU-1-08-494_h_a_dec_1.pdf@2009-01-16 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-484_h_a_dec_9.pdf@EU-1-08-484_h_a_dec_9.pdf@2013-07-31 00:00:00@Icandra@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_18.pdf@EU-1-08-488_h_a_dec_18.pdf@2018-07-30 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_19.pdf@EU-1-08-486_h_a_dec_19.pdf@2020-12-18 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_10.pdf@EU-1-08-494_h_a_dec_10.pdf@2011-12-10 00:00:00@Stelara@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_16.pdf@EU-1-08-492_h_a_dec_16.pdf@2014-04-23 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_19.pdf@EU-1-08-488_h_a_dec_19.pdf@2019-02-04 00:00:00@Vidaza@Azacitidine@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_2.pdf@EU-1-08-486_h_a_dec_2.pdf@2010-03-26 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_11.pdf@EU-1-08-494_h_a_dec_11.pdf@2012-01-13 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_19.pdf@EU-1-08-485_h_a_dec_19.pdf@2022-07-15 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_2.pdf@EU-1-08-488_h_a_dec_2.pdf@2010-10-14 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@OD Not Found@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_12.pdf@EU-1-08-494_h_a_dec_12.pdf@2012-02-21 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_2.pdf@EU-1-08-485_h_a_dec_2.pdf@2010-03-26 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_17.pdf@EU-1-08-492_h_a_dec_17.pdf@2014-01-09 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_20.pdf@EU-1-08-488_h_a_dec_20.pdf@2020-08-04 00:00:00@Vidaza@Azacitidine@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_20.pdf@EU-1-08-486_h_a_dec_20.pdf@2021-06-21 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_13.pdf@EU-1-08-494_h_a_dec_13.pdf@2012-10-29 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_3.pdf@EU-1-08-485_h_a_dec_3.pdf@2010-02-07 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_21.pdf@EU-1-08-486_h_a_dec_21.pdf@2022-07-15 00:00:00@Xiliarx@vildagliptin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_18.pdf@EU-1-08-492_h_a_dec_18.pdf@2015-07-17 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_14.pdf@EU-1-08-494_h_a_dec_14.pdf@2013-09-19 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_4.pdf@EU-1-08-485_h_a_dec_4.pdf@2011-01-24 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_21.pdf@EU-1-08-488_h_a_dec_21.pdf@2021-06-28 00:00:00@Vidaza@Azacitidine@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_0.pdf@EU-1-08-495_h_a_dec_0.pdf@2009-06-02 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_3.pdf@EU-1-08-486_h_a_dec_3.pdf@2010-02-07 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_5.pdf@EU-1-08-485_h_a_dec_5.pdf@2011-12-10 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_0.pdf@EU-1-08-496_h_a_dec_0.pdf@2009-06-02 00:00:00@Filgrastim Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_15.pdf@EU-1-08-494_h_a_dec_15.pdf@2014-02-21 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_1.pdf@EU-1-08-495_h_a_dec_1.pdf@2009-10-21 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_4.pdf@EU-1-08-486_h_a_dec_4.pdf@2011-01-24 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_6.pdf@EU-1-08-485_h_a_dec_6.pdf@2011-10-27 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_1.pdf@EU-1-08-496_h_a_dec_1.pdf@2009-10-21 00:00:00@Filgrastim Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_19.pdf@EU-1-08-492_h_a_dec_19.pdf@2016-07-29 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_22.pdf@EU-1-08-488_h_a_dec_22.pdf@2022-03-28 00:00:00@Vidaza@Azacitidine@False@False@OD Not Found@Bristol Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_7.pdf@EU-1-08-485_h_a_dec_7.pdf@2011-11-24 00:00:00@Jalra@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_2.pdf@EU-1-08-495_h_a_dec_2.pdf@2010-03-11 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_5.pdf@EU-1-08-486_h_a_dec_5.pdf@2011-12-10 00:00:00@Xiliarx@Carglumic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_2.pdf@EU-1-08-496_h_a_dec_2.pdf@2010-03-11 00:00:00@Filgrastim Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_3.pdf@EU-1-08-488_h_a_dec_3.pdf@2011-06-14 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@OD Not Found@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_16.pdf@EU-1-08-494_h_a_dec_16.pdf@2014-11-21 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_2.pdf@EU-1-08-492_h_a_dec_2.pdf@2009-10-28 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_8.pdf@EU-1-08-485_h_a_dec_8.pdf@2012-01-30 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_3.pdf@EU-1-08-495_h_a_dec_3.pdf@2011-10-08 00:00:00@Zarzio@Filgrastim@NAS before 2012@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_6.pdf@EU-1-08-486_h_a_dec_6.pdf@2011-10-27 00:00:00@Xiliarx@Carglumic acid@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_3.pdf@EU-1-08-496_h_a_dec_3.pdf@2011-10-08 00:00:00@Filgrastim  Hexal@Filgrastim@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_4.pdf@EU-1-08-488_h_a_dec_4.pdf@2011-10-08 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_17.pdf@EU-1-08-494_h_a_dec_17.pdf@2015-06-22 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-485_h_a_dec_9.pdf@EU-1-08-485_h_a_dec_9.pdf@2012-06-28 00:00:00@Jalra@vildagliptin@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_7.pdf@EU-1-08-486_h_a_dec_7.pdf@2011-11-24 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_4.pdf@EU-1-08-495_h_a_dec_4.pdf@2013-11-13 00:00:00@Zarzio@Filgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_20.pdf@EU-1-08-492_h_a_dec_20.pdf@2017-09-18 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_5.pdf@EU-1-08-488_h_a_dec_5.pdf@2011-11-24 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@OD Not Found@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_18.pdf@EU-1-08-494_h_a_dec_18.pdf@2016-07-15 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_4.pdf@EU-1-08-496_h_a_dec_4.pdf@2013-11-13 00:00:00@Filgrastim Hexal@Filgrastim@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_8.pdf@EU-1-08-486_h_a_dec_8.pdf@2011-12-10 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_19.pdf@EU-1-08-494_h_a_dec_19.pdf@2016-11-11 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_5.pdf@EU-1-08-496_h_a_dec_5.pdf@2015-06-02 00:00:00@Filgrastim  Hexal@Filgrastim@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_6.pdf@EU-1-08-488_h_a_dec_6.pdf@2011-12-22 00:00:00@Vidaza@Azacitidine@NAS before 2012@False@OD Not Found@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_5.pdf@EU-1-08-495_h_a_dec_5.pdf@2013-11-13 00:00:00@Zarzio@Filgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-486_h_a_dec_9.pdf@EU-1-08-486_h_a_dec_9.pdf@2011-10-27 00:00:00@Xiliarx@vildagliptin@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_6.pdf@EU-1-08-496_h_a_dec_6.pdf@2016-06-30 00:00:00@Filgrastim  Hexal@Filgrastim@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_7.pdf@EU-1-08-488_h_a_dec_7.pdf@2012-04-20 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_21.pdf@EU-1-08-492_h_a_dec_21.pdf@2018-06-04 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_2.pdf@EU-1-08-494_h_a_dec_2.pdf@2009-12-22 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_8.pdf@EU-1-08-488_h_a_dec_8.pdf@2012-05-25 00:00:00@Vidaza@Azacitidine@False@False@adopted@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_20.pdf@EU-1-08-494_h_a_dec_20.pdf@2018-01-30 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_22.pdf@EU-1-08-492_h_a_dec_22.pdf@2018-12-04 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-496_h_a_dec_8.pdf@EU-1-08-496_h_a_dec_8.pdf@2020-07-17 00:00:00@Filgrastim  Hexal@Filgrastim@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_8.pdf@EU-1-08-495_h_a_dec_8.pdf@2018-08-27 00:00:00@Zarzio@Filgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_21.pdf@EU-1-08-494_h_a_dec_21.pdf@2018-09-17 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_23.pdf@EU-1-08-492_h_a_dec_23.pdf@2018-08-23 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-488_h_a_dec_9.pdf@EU-1-08-488_h_a_dec_9.pdf@2012-08-10 00:00:00@Vidaza@Azacitidine@False@False@OD Not Found@Celgene Europe Ltd@CMA Not Found@Parsed
EU-1-08-495_h_a_dec_9.pdf@EU-1-08-495_h_a_dec_9.pdf@2020-07-17 00:00:00@Zarzio@Filgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_24.pdf@EU-1-08-492_h_a_dec_24.pdf@2018-10-29 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_22.pdf@EU-1-08-494_h_a_dec_22.pdf@2019-03-09 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_0.pdf@EU-1-08-497_h_a_dec_0.pdf@2009-04-02 00:00:00@Nplate@romiplostim@NAS before 2012@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_23.pdf@EU-1-08-494_h_a_dec_23.pdf@2019-09-16 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_25.pdf@EU-1-08-492_h_a_dec_25.pdf@2019-01-15 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_1.pdf@EU-1-08-497_h_a_dec_1.pdf@2009-04-02 00:00:00@Nplate@romiplostim@NAS before 2012@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_26.pdf@EU-1-08-492_h_a_dec_26.pdf@2020-01-04 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_24.pdf@EU-1-08-494_h_a_dec_24.pdf@2020-01-20 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_10.pdf@EU-1-08-497_h_a_dec_10.pdf@2016-01-22 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_27.pdf@EU-1-08-492_h_a_dec_27.pdf@2021-04-21 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_25.pdf@EU-1-08-494_h_a_dec_25.pdf@2021-11-01 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_0.pdf@EU-1-08-499_h_a_dec_0.pdf@2009-02-19 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_0.pdf@EU-1-08-498_h_a_dec_0.pdf@2009-02-19 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_11.pdf@EU-1-08-497_h_a_dec_11.pdf@2016-04-21 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_1.pdf@EU-1-08-499_h_a_dec_1.pdf@2009-02-19 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_26.pdf@EU-1-08-494_h_a_dec_26.pdf@2021-09-03 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_1.pdf@EU-1-08-498_h_a_dec_1.pdf@2009-02-19 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_12.pdf@EU-1-08-497_h_a_dec_12.pdf@2017-02-06 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_0.pdf@EU-1-08-501_h_a_dec_0.pdf@2009-03-31 00:00:00@IXIARO@Japanese Encephalitis  vaccine (inactivated, adsorbed)@NAS before 2012@False@adopted@Intercell AG@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_10.pdf@EU-1-08-499_h_a_dec_10.pdf@2014-06-19 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_28.pdf@EU-1-08-492_h_a_dec_28.pdf@2021-06-12 00:00:00@RoActemra@tocilizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_13.pdf@EU-1-08-497_h_a_dec_13.pdf@2018-01-30 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_27.pdf@EU-1-08-494_h_a_dec_27.pdf@2021-12-11 00:00:00@Stelara@ustekinumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_1.pdf@EU-1-08-501_h_a_dec_1.pdf@2009-10-28 00:00:00@IXIARO@Japanese Encephalitis  vaccine (inactivated, adsorbed)@NAS before 2012@False@OD Not Found@Intercell AG@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_10.pdf@EU-1-08-498_h_a_dec_10.pdf@2014-06-23 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_14.pdf@EU-1-08-497_h_a_dec_14.pdf@2019-01-31 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_3.pdf@EU-1-08-492_h_a_dec_3.pdf@2009-11-20 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_11.pdf@EU-1-08-499_h_a_dec_11.pdf@2014-11-19 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_0.pdf@EU-1-08-502_h_a_dec_0.pdf@2009-06-03 00:00:00@MEPACT@mifamurtide@NAS before 2012@False@adopted@IDM Pharma S.A.@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_3.pdf@EU-1-08-494_h_a_dec_3.pdf@2010-11-03 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_10.pdf@EU-1-08-501_h_a_dec_10.pdf@2017-04-28 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_11.pdf@EU-1-08-498_h_a_dec_11.pdf@2014-11-19 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_15.pdf@EU-1-08-497_h_a_dec_15.pdf@2020-05-20 00:00:00@Nplate@romiplostim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_1.pdf@EU-1-08-502_h_a_dec_1.pdf@2010-06-08 00:00:00@Mepact@mifamurtide@NAS before 2012@False@OD Not Found@IDM PHARMA SAS@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_12.pdf@EU-1-08-499_h_a_dec_12.pdf@2015-11-19 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_4.pdf@EU-1-08-492_h_a_dec_4.pdf@2010-03-30 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_11.pdf@EU-1-08-501_h_a_dec_11.pdf@2018-08-01 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_4.pdf@EU-1-08-494_h_a_dec_4.pdf@2010-11-03 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_16.pdf@EU-1-08-497_h_a_dec_16.pdf@2021-01-22 00:00:00@Nplate@romiplostim@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_10.pdf@EU-1-08-502_h_a_dec_10.pdf@2017-10-11 00:00:00@Mepact@mifamurtide@False@False@adopted@Takeda France SAS@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_13.pdf@EU-1-08-499_h_a_dec_13.pdf@2016-11-18 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_12.pdf@EU-1-08-498_h_a_dec_12.pdf@2015-11-19 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_2.pdf@EU-1-08-497_h_a_dec_2.pdf@2009-08-10 00:00:00@Nplate@romiplostim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_5.pdf@EU-1-08-492_h_a_dec_5.pdf@2010-04-27 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_12.pdf@EU-1-08-501_h_a_dec_12.pdf@2018-11-22 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_5.pdf@EU-1-08-494_h_a_dec_5.pdf@2010-03-15 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_11.pdf@EU-1-08-502_h_a_dec_11.pdf@2019-02-20 00:00:00@Mepact@mifamurtide@False@False@adopted@Takeda France SAS@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_14.pdf@EU-1-08-499_h_a_dec_14.pdf@2017-10-11 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_13.pdf@EU-1-08-498_h_a_dec_13.pdf@2016-11-18 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_3.pdf@EU-1-08-497_h_a_dec_3.pdf@2010-11-01 00:00:00@Nplate@romiplostim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_13.pdf@EU-1-08-501_h_a_dec_13.pdf@2020-10-03 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_12.pdf@EU-1-08-502_h_a_dec_12.pdf@2019-12-16 00:00:00@Mepact@mifamurtide@False@False@OD Not Found@Takeda France SAS@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_6.pdf@EU-1-08-494_h_a_dec_6.pdf@2009-12-22 00:00:00@STELARA@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_15.pdf@EU-1-08-499_h_a_dec_15.pdf@2018-12-12 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_6.pdf@EU-1-08-492_h_a_dec_6.pdf@2010-04-06 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_14.pdf@EU-1-08-501_h_a_dec_14.pdf@2022-04-29 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_13.pdf@EU-1-08-502_h_a_dec_13.pdf@2021-04-21 00:00:00@Mepact@mifamurtide@False@False@OD Not Found@Takeda France SAS@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_16.pdf@EU-1-08-499_h_a_dec_16.pdf@2021-04-21 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_4.pdf@EU-1-08-497_h_a_dec_4.pdf@2010-11-26 00:00:00@Nplate@romiplostim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_7.pdf@EU-1-08-494_h_a_dec_7.pdf@2010-08-26 00:00:00@Stelara@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_7.pdf@EU-1-08-492_h_a_dec_7.pdf@2010-12-20 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_14.pdf@EU-1-08-498_h_a_dec_14.pdf@2017-01-12 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_2.pdf@EU-1-08-501_h_a_dec_2.pdf@2010-03-23 00:00:00@IXIARO@Japanese Encephalitis  vaccine (inactivated, adsorbed)@NAS before 2012@False@OD Not Found@Intercell AG@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_2.pdf@EU-1-08-499_h_a_dec_2.pdf@2010-08-26 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_2.pdf@EU-1-08-502_h_a_dec_2.pdf@2010-09-30 00:00:00@Mepact@mifamurtide@NAS before 2012@False@OD Not Found@IDM PHARMA SAS@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_5.pdf@EU-1-08-497_h_a_dec_5.pdf@2011-02-02 00:00:00@Nplate@romiplostim@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_8.pdf@EU-1-08-494_h_a_dec_8.pdf@2010-12-20 00:00:00@Stelara@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_3.pdf@EU-1-08-501_h_a_dec_3.pdf@2011-09-22 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@NAS before 2012@False@OD Not Found@Intercell AG@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_6.pdf@EU-1-08-497_h_a_dec_6.pdf@2011-08-24 00:00:00@Nplate@romiplostim@NAS before 2012@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_8.pdf@EU-1-08-492_h_a_dec_8.pdf@2011-03-18 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_3.pdf@EU-1-08-502_h_a_dec_3.pdf@2011-08-24 00:00:00@Mepact@mifamurtide@NAS before 2012@False@OD Not Found@IDM PHARMA SAS@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_3.pdf@EU-1-08-499_h_a_dec_3.pdf@2011-01-21 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_15.pdf@EU-1-08-498_h_a_dec_15.pdf@2019-07-01 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_4.pdf@EU-1-08-502_h_a_dec_4.pdf@2012-05-25 00:00:00@Mepact@mifamurtide@False@False@adopted@IDM PHARMA SAS@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_4.pdf@EU-1-08-501_h_a_dec_4.pdf@2012-05-25 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Intercell AG@CMA Not Found@Parsed
EU-1-08-494_h_a_dec_9.pdf@EU-1-08-494_h_a_dec_9.pdf@2011-07-26 00:00:00@Stelara@ustekinumab@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_4.pdf@EU-1-08-499_h_a_dec_4.pdf@2011-07-27 00:00:00@Valdoxan@agomelatine@NAS before 2012@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_7.pdf@EU-1-08-497_h_a_dec_7.pdf@2012-10-23 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-492_h_a_dec_9.pdf@EU-1-08-492_h_a_dec_9.pdf@2011-01-08 00:00:00@RoActemra@tocilizumab@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_5.pdf@EU-1-08-502_h_a_dec_5.pdf@2012-08-23 00:00:00@Mepact@mifamurtide@False@False@OD Not Found@IDM PHARMA SAS@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_5.pdf@EU-1-08-501_h_a_dec_5.pdf@2013-01-02 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Intercell AG@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_5.pdf@EU-1-08-499_h_a_dec_5.pdf@2012-03-26 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_16.pdf@EU-1-08-498_h_a_dec_16.pdf@2021-04-30 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_8.pdf@EU-1-08-497_h_a_dec_8.pdf@2013-12-20 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_6.pdf@EU-1-08-501_h_a_dec_6.pdf@2013-05-27 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Intercell AG@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_6.pdf@EU-1-08-499_h_a_dec_6.pdf@2012-04-20 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-497_h_a_dec_9.pdf@EU-1-08-497_h_a_dec_9.pdf@2015-11-11 00:00:00@Nplate@romiplostim@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_7.pdf@EU-1-08-499_h_a_dec_7.pdf@2012-10-24 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires  Servier@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_7.pdf@EU-1-08-502_h_a_dec_7.pdf@2013-05-09 00:00:00@Mepact@mifamurtide@False@False@OD Not Found@IDM PHARMA SAS@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_17.pdf@EU-1-08-498_h_a_dec_17.pdf@2022-01-07 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_7.pdf@EU-1-08-501_h_a_dec_7.pdf@2014-02-28 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_8.pdf@EU-1-08-499_h_a_dec_8.pdf@2013-11-13 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_2.pdf@EU-1-08-498_h_a_dec_2.pdf@2010-08-26 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland)  Industries Limited@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_8.pdf@EU-1-08-502_h_a_dec_8.pdf@2013-12-18 00:00:00@Mepact@mifamurtide@False@False@adopted@Takeda France SAS@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_8.pdf@EU-1-08-501_h_a_dec_8.pdf@2016-04-13 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_3.pdf@EU-1-08-498_h_a_dec_3.pdf@2011-01-21 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland)  Industries Limited@CMA Not Found@Parsed
EU-1-08-502_h_a_dec_9.pdf@EU-1-08-502_h_a_dec_9.pdf@2016-12-23 00:00:00@Mepact@mifamurtide@False@False@adopted@Takeda France SAS@CMA Not Found@Parsed
EU-1-08-501_h_a_dec_9.pdf@EU-1-08-501_h_a_dec_9.pdf@2016-02-05 00:00:00@Ixiaro@Japanese Encephalitis vaccine (inactivated, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-08-499_h_a_dec_9.pdf@EU-1-08-499_h_a_dec_9.pdf@2013-11-13 00:00:00@Valdoxan@agomelatine@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_4.pdf@EU-1-08-498_h_a_dec_4.pdf@2011-07-27 00:00:00@Thymanax@agomelatine@NAS before 2012@False@OD Not Found@Servier (Ireland)  Industries Limited@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_5.pdf@EU-1-08-498_h_a_dec_5.pdf@2012-03-21 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland)  Industries Limited@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_6.pdf@EU-1-08-498_h_a_dec_6.pdf@2012-04-20 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_7.pdf@EU-1-08-498_h_a_dec_7.pdf@2012-10-24 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland)  Industries Limited@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_0.pdf@EU-1-08-503_h_a_dec_0.pdf@2009-02-25 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_0.pdf@EU-1-08-504_h_a_dec_0.pdf@2009-02-17 00:00:00@FIRMAGON@degarelix (as acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_8.pdf@EU-1-08-498_h_a_dec_8.pdf@2013-11-13 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_1.pdf@EU-1-08-503_h_a_dec_1.pdf@2009-02-25 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_0.pdf@EU-1-09-508_h_a_dec_0.pdf@2009-03-30 00:00:00@Synflorix@Pneumococcal  polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_1.pdf@EU-1-08-504_h_a_dec_1.pdf@2009-02-17 00:00:00@FIRMAGON@degarelix (as  acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_10.pdf@EU-1-08-503_h_a_dec_10.pdf@2019-11-19 00:00:00@Efient@prasugrel@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_0.pdf@EU-1-09-511_h_a_dec_0.pdf@2009-04-17 00:00:00@CONBRIZA@bazedoxifene@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_1.pdf@EU-1-09-508_h_a_dec_1.pdf@2009-10-12 00:00:00@Synflorix@Pneumococcal  polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-498_h_a_dec_9.pdf@EU-1-08-498_h_a_dec_9.pdf@2013-11-13 00:00:00@Thymanax@agomelatine@False@False@OD Not Found@Servier (Ireland) Industries Limited@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_11.pdf@EU-1-08-503_h_a_dec_11.pdf@2020-12-14 00:00:00@Efient@prasugrel@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_10.pdf@EU-1-09-508_h_a_dec_10.pdf@2016-02-05 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_1.pdf@EU-1-09-511_h_a_dec_1.pdf@2010-07-27 00:00:00@Conbriza@bazedoxifene@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_10.pdf@EU-1-08-504_h_a_dec_10.pdf@2021-10-19 00:00:00@Firmagon@degarelix (as acetate)@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_0.pdf@EU-1-09-514_h_a_dec_0.pdf@2009-04-21 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_12.pdf@EU-1-08-503_h_a_dec_12.pdf@2022-09-29 00:00:00@Efient@prasugrel@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_11.pdf@EU-1-09-508_h_a_dec_11.pdf@2017-03-10 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_2.pdf@EU-1-08-504_h_a_dec_2.pdf@2009-07-24 00:00:00@FIRMAGON@degarelix (as acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_1.pdf@EU-1-09-514_h_a_dec_1.pdf@2009-12-14 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_12.pdf@EU-1-09-508_h_a_dec_12.pdf@2018-10-25 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_2.pdf@EU-1-08-503_h_a_dec_2.pdf@2009-12-14 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_10.pdf@EU-1-09-511_h_a_dec_10.pdf@2016-07-22 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_10.pdf@EU-1-09-514_h_a_dec_10.pdf@2015-07-28 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@BIAL - Portela & Ca@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_3.pdf@EU-1-08-504_h_a_dec_3.pdf@2010-10-14 00:00:00@Firmagon@degarelix (as acetate)@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_13.pdf@EU-1-09-508_h_a_dec_13.pdf@2018-11-22 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_3.pdf@EU-1-08-503_h_a_dec_3.pdf@2011-04-20 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed

EU-1-09-514_h_a_dec_11.pdf@EU-1-09-514_h_a_dec_11.pdf@2016-08-12 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_4.pdf@EU-1-08-504_h_a_dec_4.pdf@2012-06-28 00:00:00@Firmagon@degarelix (as acetate)@False@False@OD Not Found@Ferring  Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_4.pdf@EU-1-08-503_h_a_dec_4.pdf@2011-10-24 00:00:00@Efient@prasugrel@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_14.pdf@EU-1-09-508_h_a_dec_14.pdf@2022-12-08 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_1.pdf@EU-1-09-515_h_a_dec_1.pdf@2011-05-12 00:00:00@Controloc Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_12.pdf@EU-1-09-514_h_a_dec_12.pdf@2017-04-28 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_11.pdf@EU-1-09-511_h_a_dec_11.pdf@2018-02-08 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_5.pdf@EU-1-08-504_h_a_dec_5.pdf@2013-11-13 00:00:00@Firmagon@degarelix (as acetate)@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_2.pdf@EU-1-09-508_h_a_dec_2.pdf@2011-01-24 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_5.pdf@EU-1-08-503_h_a_dec_5.pdf@2013-11-13 00:00:00@Efient@prasugrel@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_13.pdf@EU-1-09-514_h_a_dec_13.pdf@2017-09-18 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_2.pdf@EU-1-09-515_h_a_dec_2.pdf@2013-05-30 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_12.pdf@EU-1-09-511_h_a_dec_12.pdf@2021-12-13 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_0.pdf@EU-1-09-516_h_a_dec_0.pdf@2009-12-06 00:00:00@SOMAC Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_3.pdf@EU-1-09-508_h_a_dec_3.pdf@2011-06-29 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.   (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_6.pdf@EU-1-08-504_h_a_dec_6.pdf@2013-11-13 00:00:00@Firmagon@degarelix (as acetate)@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_6.pdf@EU-1-08-503_h_a_dec_6.pdf@2013-12-18 00:00:00@Efient@prasugrel@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_1.pdf@EU-1-09-516_h_a_dec_1.pdf@2011-05-12 00:00:00@Somac Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_2.pdf@EU-1-09-511_h_a_dec_2.pdf@2010-12-20 00:00:00@Conbriza@bazedoxifene@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_14.pdf@EU-1-09-514_h_a_dec_14.pdf@2019-06-06 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_4.pdf@EU-1-09-508_h_a_dec_4.pdf@2011-05-08 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_3.pdf@EU-1-09-515_h_a_dec_3.pdf@2014-02-21 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_2.pdf@EU-1-09-516_h_a_dec_2.pdf@2013-05-30 00:00:00@SOMAC  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_7.pdf@EU-1-08-503_h_a_dec_7.pdf@2015-10-12 00:00:00@Efient@prasugrel@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_5.pdf@EU-1-09-508_h_a_dec_5.pdf@2012-01-31 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_7.pdf@EU-1-08-504_h_a_dec_7.pdf@2014-11-21 00:00:00@Firmagon@degarelix (as acetate)@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_3.pdf@EU-1-09-511_h_a_dec_3.pdf@2011-02-21 00:00:00@Conbriza@bazedoxifene@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_4.pdf@EU-1-09-515_h_a_dec_4.pdf@2015-08-07 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH, (HRB 701257)@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_15.pdf@EU-1-09-514_h_a_dec_15.pdf@2019-09-23 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_8.pdf@EU-1-08-503_h_a_dec_8.pdf@2017-12-20 00:00:00@Efient@prasugrel@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_6.pdf@EU-1-09-508_h_a_dec_6.pdf@2012-10-25 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_3.pdf@EU-1-09-516_h_a_dec_3.pdf@2014-02-21 00:00:00@SOMAC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_8.pdf@EU-1-08-504_h_a_dec_8.pdf@2019-12-16 00:00:00@Firmagon@degarelix (as  acetate)@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_5.pdf@EU-1-09-515_h_a_dec_5.pdf@2016-08-12 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_4.pdf@EU-1-09-511_h_a_dec_4.pdf@2011-10-11 00:00:00@Conbriza@bazedoxifene@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-08-503_h_a_dec_9.pdf@EU-1-08-503_h_a_dec_9.pdf@2018-11-22 00:00:00@Efient@prasugrel@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_5.pdf@EU-1-09-511_h_a_dec_5.pdf@2012-05-25 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_4.pdf@EU-1-09-516_h_a_dec_4.pdf@2015-08-07 00:00:00@SOMAC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH, (HRB 701257)@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_6.pdf@EU-1-09-515_h_a_dec_6.pdf@2017-04-28 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_16.pdf@EU-1-09-514_h_a_dec_16.pdf@2021-10-05 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_7.pdf@EU-1-09-508_h_a_dec_7.pdf@2013-11-25 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-08-504_h_a_dec_9.pdf@EU-1-08-504_h_a_dec_9.pdf@2021-06-21 00:00:00@Firmagon@degarelix (as acetate)@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_6.pdf@EU-1-09-511_h_a_dec_6.pdf@2012-01-10 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_5.pdf@EU-1-09-516_h_a_dec_5.pdf@2016-08-12 00:00:00@SOMAC  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_7.pdf@EU-1-09-515_h_a_dec_7.pdf@2018-02-07 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_6.pdf@EU-1-09-516_h_a_dec_6.pdf@2017-04-28 00:00:00@SOMAC  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_17.pdf@EU-1-09-514_h_a_dec_17.pdf@2022-04-03 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_8.pdf@EU-1-09-508_h_a_dec_8.pdf@2014-02-21 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_8.pdf@EU-1-09-515_h_a_dec_8.pdf@2020-04-02 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_7.pdf@EU-1-09-511_h_a_dec_7.pdf@2013-08-14 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_7.pdf@EU-1-09-516_h_a_dec_7.pdf@2018-02-07 00:00:00@SOMAC  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_2.pdf@EU-1-09-514_h_a_dec_2.pdf@2010-11-29 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-09-515_h_a_dec_9.pdf@EU-1-09-515_h_a_dec_9.pdf@2022-07-06 00:00:00@CONTROLOC Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_8.pdf@EU-1-09-511_h_a_dec_8.pdf@2014-02-17 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-508_h_a_dec_9.pdf@EU-1-09-508_h_a_dec_9.pdf@2014-10-27 00:00:00@Synflorix@Pneumococcal polysaccharide conjugate vaccine (adsorbed)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_3.pdf@EU-1-09-514_h_a_dec_3.pdf@2011-06-16 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_0.pdf@EU-1-09-517_h_a_dec_0.pdf@2009-12-06 00:00:00@PANTOZOL Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-516_h_a_dec_9.pdf@EU-1-09-516_h_a_dec_9.pdf@2022-07-06 00:00:00@SOMAC  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_4.pdf@EU-1-09-514_h_a_dec_4.pdf@2011-10-11 00:00:00@Zebinix@eslicarbazepine acetate@NAS before 2012@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-09-511_h_a_dec_9.pdf@EU-1-09-511_h_a_dec_9.pdf@2016-05-26 00:00:00@Conbriza@bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_1.pdf@EU-1-09-517_h_a_dec_1.pdf@2011-05-12 00:00:00@Pantozol Control@pantoprazole@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_5.pdf@EU-1-09-514_h_a_dec_5.pdf@2012-08-23 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@BIAL - Portela & Ca@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_2.pdf@EU-1-09-517_h_a_dec_2.pdf@2013-05-30 00:00:00@PANTOZOL Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_6.pdf@EU-1-09-514_h_a_dec_6.pdf@2012-08-23 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@BIAL - Portela & Ca,  SA@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_3.pdf@EU-1-09-517_h_a_dec_3.pdf@2014-02-21 00:00:00@PANTOZOL Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_0.pdf@EU-1-09-521_h_a_dec_0.pdf@2009-10-06 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_0.pdf@EU-1-09-522_h_a_dec_0.pdf@2009-05-15 00:00:00@Ellaone@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_7.pdf@EU-1-09-514_h_a_dec_7.pdf@2013-01-14 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@BIAL - Portela & Ca@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_0.pdf@EU-1-09-523_h_a_dec_0.pdf@2009-05-15 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_1.pdf@EU-1-09-522_h_a_dec_1.pdf@2009-10-23 00:00:00@Ellaone@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_4.pdf@EU-1-09-517_h_a_dec_4.pdf@2015-08-07 00:00:00@PANTOZOL Control@pantoprazole@False@False@OD Not Found@Takeda GmbH, (HRB 701257)@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_1.pdf@EU-1-09-521_h_a_dec_1.pdf@2009-10-06 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_1.pdf@EU-1-09-523_h_a_dec_1.pdf@2011-04-18 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_5.pdf@EU-1-09-517_h_a_dec_5.pdf@2016-08-12 00:00:00@PANTOZOL  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_10.pdf@EU-1-09-522_h_a_dec_10.pdf@2016-02-05 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_0.pdf@EU-1-09-524_h_a_dec_0.pdf@2009-05-15 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@NeurogesX UK Limited@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_8.pdf@EU-1-09-514_h_a_dec_8.pdf@2014-01-22 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_10.pdf@EU-1-09-523_h_a_dec_10.pdf@2022-02-16 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_10.pdf@EU-1-09-521_h_a_dec_10.pdf@2019-08-26 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_6.pdf@EU-1-09-517_h_a_dec_6.pdf@2017-04-28 00:00:00@PANTOZOL  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_11.pdf@EU-1-09-522_h_a_dec_11.pdf@2017-08-06 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_1.pdf@EU-1-09-524_h_a_dec_1.pdf@2009-05-15 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@NeurogesX UK Limited@CMA Not Found@Parsed
EU-1-09-514_h_a_dec_9.pdf@EU-1-09-514_h_a_dec_9.pdf@2015-03-16 00:00:00@Zebinix@eslicarbazepine acetate@False@False@OD Not Found@BIAL - Portela & Ca@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_2.pdf@EU-1-09-523_h_a_dec_2.pdf@2011-07-07 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_11.pdf@EU-1-09-521_h_a_dec_11.pdf@2021-02-18 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_7.pdf@EU-1-09-517_h_a_dec_7.pdf@2018-02-07 00:00:00@PANTOZOL  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_12.pdf@EU-1-09-522_h_a_dec_12.pdf@2017-10-11 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_0.pdf@EU-1-09-525_h_a_dec_0.pdf@2009-11-05 00:00:00@Nimvastid@Rivastigmine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_10.pdf@EU-1-09-524_h_a_dec_10.pdf@2017-04-05 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_3.pdf@EU-1-09-523_h_a_dec_3.pdf@2011-08-24 00:00:00@Modigraf@Tacrolimus@NAS before 2012@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_8.pdf@EU-1-09-517_h_a_dec_8.pdf@2020-04-02 00:00:00@PANTOZOL  Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_2.pdf@EU-1-09-521_h_a_dec_2.pdf@2010-03-19 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_13.pdf@EU-1-09-522_h_a_dec_13.pdf@2020-04-02 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_1.pdf@EU-1-09-525_h_a_dec_1.pdf@2010-03-15 00:00:00@Nimvastid@Rivastigmine@NAS before 2012@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_11.pdf@EU-1-09-524_h_a_dec_11.pdf@2018-09-07 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Grünenthal GmbH@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_4.pdf@EU-1-09-523_h_a_dec_4.pdf@2012-08-30 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe  B.V.@CMA Not Found@Parsed
EU-1-09-517_h_a_dec_9.pdf@EU-1-09-517_h_a_dec_9.pdf@2022-07-06 00:00:00@PANTOZOL Control@pantoprazole@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_14.pdf@EU-1-09-522_h_a_dec_14.pdf@2022-02-16 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_2.pdf@EU-1-09-525_h_a_dec_2.pdf@2011-01-13 00:00:00@Nimvastid@Rivastigmine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_12.pdf@EU-1-09-524_h_a_dec_12.pdf@2019-03-28 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Grünenthal GmbH@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_5.pdf@EU-1-09-523_h_a_dec_5.pdf@2013-02-18 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma  Europe B.V.@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_3.pdf@EU-1-09-521_h_a_dec_3.pdf@2010-06-09 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_3.pdf@EU-1-09-525_h_a_dec_3.pdf@2012-03-26 00:00:00@Nimvastid@Rivastigmine@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_2.pdf@EU-1-09-522_h_a_dec_2.pdf@2010-10-06 00:00:00@Ellaone@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA  Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_13.pdf@EU-1-09-524_h_a_dec_13.pdf@2020-07-31 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Grünenthal GmbH@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_6.pdf@EU-1-09-523_h_a_dec_6.pdf@2014-02-17 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_4.pdf@EU-1-09-521_h_a_dec_4.pdf@2011-12-22 00:00:00@Renvela@sevelamer (carbonate)@NAS before 2012@False@OD Not Found@Genzyme Europe  B.V.@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_4.pdf@EU-1-09-525_h_a_dec_4.pdf@2012-10-29 00:00:00@Nimvastid@Rivastigmine@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_3.pdf@EU-1-09-522_h_a_dec_3.pdf@2010-02-07 00:00:00@ellaOne@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_14.pdf@EU-1-09-524_h_a_dec_14.pdf@2021-09-07 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Grünenthal GmbH@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_0.pdf@EU-1-09-526_h_a_dec_0.pdf@2009-06-24 00:00:00@IRESSA@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_7.pdf@EU-1-09-523_h_a_dec_7.pdf@2016-06-21 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_4.pdf@EU-1-09-522_h_a_dec_4.pdf@2011-10-11 00:00:00@ellaOne@ulipristal acetate@NAS before 2012@False@OD Not Found@Laboratoire HRA  Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_2.pdf@EU-1-09-524_h_a_dec_2.pdf@2009-09-25 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@NeurogesX UK Limited@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_5.pdf@EU-1-09-525_h_a_dec_5.pdf@2014-01-16 00:00:00@Nimvastid@Rivastigmine@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_5.pdf@EU-1-09-521_h_a_dec_5.pdf@2014-03-21 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_1.pdf@EU-1-09-526_h_a_dec_1.pdf@2010-01-19 00:00:00@IRESSA@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_8.pdf@EU-1-09-523_h_a_dec_8.pdf@2019-02-14 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_5.pdf@EU-1-09-522_h_a_dec_5.pdf@2012-06-28 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_3.pdf@EU-1-09-524_h_a_dec_3.pdf@2010-01-25 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-525_h_a_dec_6.pdf@EU-1-09-525_h_a_dec_6.pdf@2016-05-09 00:00:00@Nimvastid@Rivastigmine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_6.pdf@EU-1-09-521_h_a_dec_6.pdf@2016-08-25 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-523_h_a_dec_9.pdf@EU-1-09-523_h_a_dec_9.pdf@2020-02-28 00:00:00@Modigraf@Tacrolimus@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_4.pdf@EU-1-09-524_h_a_dec_4.pdf@2010-11-19 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_10.pdf@EU-1-09-526_h_a_dec_10.pdf@2022-04-02 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_7.pdf@EU-1-09-521_h_a_dec_7.pdf@2017-06-26 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_6.pdf@EU-1-09-522_h_a_dec_6.pdf@2013-12-20 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_2.pdf@EU-1-09-526_h_a_dec_2.pdf@2010-11-26 00:00:00@Iressa@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_5.pdf@EU-1-09-524_h_a_dec_5.pdf@2011-02-21 00:00:00@Qutenza@Capsaicin@NAS before 2012@False@OD Not Found@Astellas Pharma  Europe B.V.@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_8.pdf@EU-1-09-521_h_a_dec_8.pdf@2018-09-20 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_3.pdf@EU-1-09-526_h_a_dec_3.pdf@2011-01-08 00:00:00@Iressa@gefitinib@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_6.pdf@EU-1-09-524_h_a_dec_6.pdf@2013-11-03 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_7.pdf@EU-1-09-522_h_a_dec_7.pdf@2014-03-21 00:00:00@ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_0.pdf@EU-1-09-528_h_a_dec_0.pdf@2009-02-07 00:00:00@Nymusa@Caffeine citrate@NAS before 2012@False@adopted@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-521_h_a_dec_9.pdf@EU-1-09-521_h_a_dec_9.pdf@2019-02-20 00:00:00@Renvela@sevelamer (carbonate)@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_4.pdf@EU-1-09-526_h_a_dec_4.pdf@2012-04-20 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_7.pdf@EU-1-09-524_h_a_dec_7.pdf@2014-12-03 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_1.pdf@EU-1-09-528_h_a_dec_1.pdf@2009-02-07 00:00:00@Nymusa@Caffeine citrate@NAS before 2012@False@adopted@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_8.pdf@EU-1-09-522_h_a_dec_8.pdf@2014-01-10 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  1.10.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)4049 for “ellaOne@ulipristal acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_0.pdf@EU-1-09-529_h_a_dec_0.pdf@2009-06-30 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_5.pdf@EU-1-09-526_h_a_dec_5.pdf@2014-04-23 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_2.pdf@EU-1-09-528_h_a_dec_2.pdf@2010-04-06 00:00:00@Nymusa@Caffeine citrate@NAS before 2012@False@OD Not Found@CHIESI  FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_1.pdf@EU-1-09-529_h_a_dec_1.pdf@2010-12-20 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-522_h_a_dec_9.pdf@EU-1-09-522_h_a_dec_9.pdf@2015-07-01 00:00:00@ellaOne@ulipristal  acetate@False@False@OD Not Found@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_8.pdf@EU-1-09-524_h_a_dec_8.pdf@2014-04-23 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_6.pdf@EU-1-09-526_h_a_dec_6.pdf@2015-10-15 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_3.pdf@EU-1-09-528_h_a_dec_3.pdf@2011-09-02 00:00:00@Peyona@Caffeine citrate@NAS before 2012@False@OD Not Found@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_0.pdf@EU-1-09-530_h_a_dec_0.pdf@2009-06-29 00:00:00@Repaglinide Teva@Repaglinide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-524_h_a_dec_9.pdf@EU-1-09-524_h_a_dec_9.pdf@2015-08-20 00:00:00@Qutenza@Capsaicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_10.pdf@EU-1-09-529_h_a_dec_10.pdf@2014-04-28 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_4.pdf@EU-1-09-528_h_a_dec_4.pdf@2012-05-31 00:00:00@Peyona@Caffeine citrate@False@False@adopted@CHIESI FARMACEUTICI SpA@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_7.pdf@EU-1-09-526_h_a_dec_7.pdf@2017-03-29 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_1.pdf@EU-1-09-530_h_a_dec_1.pdf@2011-10-11 00:00:00@Repaglinide Teva@Repaglinide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_11.pdf@EU-1-09-529_h_a_dec_11.pdf@2014-12-19 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_2.pdf@EU-1-09-530_h_a_dec_2.pdf@2012-10-29 00:00:00@Repaglinide Teva@Repaglinide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_5.pdf@EU-1-09-528_h_a_dec_5.pdf@2014-03-03 00:00:00@Peyona@Caffeine citrate@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_8.pdf@EU-1-09-526_h_a_dec_8.pdf@2019-08-04 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_12.pdf@EU-1-09-529_h_a_dec_12.pdf@2015-03-19 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_0.pdf@EU-1-09-531_h_a_dec_0.pdf@2009-07-20 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-528_h_a_dec_6.pdf@EU-1-09-528_h_a_dec_6.pdf@2016-02-24 00:00:00@Peyona@Caffeine citrate@False@False@adopted@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_3.pdf@EU-1-09-530_h_a_dec_3.pdf@2013-12-18 00:00:00@Repaglinide Teva@Repaglinide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_13.pdf@EU-1-09-529_h_a_dec_13.pdf@2016-05-26 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_0.pdf@EU-1-09-533_h_a_dec_0.pdf@2009-07-24 00:00:00@Vedrop@tocofersolan@NAS before 2012@False@OD Not Found@Orphan Europe SARL@exceptional@Parsed
EU-1-09-528_h_a_dec_7.pdf@EU-1-09-528_h_a_dec_7.pdf@2018-04-19 00:00:00@Peyona@Caffeine citrate@False@False@adopted@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-09-526_h_a_dec_9.pdf@EU-1-09-526_h_a_dec_9.pdf@2020-09-03 00:00:00@Iressa@gefitinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_1.pdf@EU-1-09-531_h_a_dec_1.pdf@2009-07-20 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_0.pdf@EU-1-09-535_h_a_dec_0.pdf@2009-07-28 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_14.pdf@EU-1-09-529_h_a_dec_14.pdf@2016-09-22 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_4.pdf@EU-1-09-530_h_a_dec_4.pdf@2014-06-19 00:00:00@Repaglinide Teva@Repaglinide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_1.pdf@EU-1-09-533_h_a_dec_1.pdf@2011-02-28 00:00:00@Vedrop@tocofersolan@NAS before 2012@False@adopted@Orphan Europe SARL@exceptional@Parsed
EU-1-09-528_h_a_dec_8.pdf@EU-1-09-528_h_a_dec_8.pdf@2022-05-19 00:00:00@Peyona@Caffeine citrate@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_10.pdf@EU-1-09-531_h_a_dec_10.pdf@2016-09-22 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_2.pdf@EU-1-09-533_h_a_dec_2.pdf@2012-10-04 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe SARL@exceptional@Parsed

EU-1-09-535_h_a_dec_1.pdf@EU-1-09-535_h_a_dec_1.pdf@2010-06-08 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_11.pdf@EU-1-09-531_h_a_dec_11.pdf@2017-10-23 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_5.pdf@EU-1-09-530_h_a_dec_5.pdf@2014-11-21 00:00:00@Repaglinide Teva@Repaglinide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_3.pdf@EU-1-09-533_h_a_dec_3.pdf@2012-08-30 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe SARL@exceptional@Parsed
EU-1-09-529_h_a_dec_16.pdf@EU-1-09-529_h_a_dec_16.pdf@2018-08-27 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_6.pdf@EU-1-09-530_h_a_dec_6.pdf@2017-04-28 00:00:00@Repaglinide  Teva@Repaglinide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_10.pdf@EU-1-09-535_h_a_dec_10.pdf@2021-05-19 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_12.pdf@EU-1-09-531_h_a_dec_12.pdf@2018-08-05 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_17.pdf@EU-1-09-529_h_a_dec_17.pdf@2019-09-08 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_4.pdf@EU-1-09-533_h_a_dec_4.pdf@2013-04-22 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe S.A.R.L.@exceptional@Parsed
EU-1-09-531_h_a_dec_13.pdf@EU-1-09-531_h_a_dec_13.pdf@2019-05-03 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_18.pdf@EU-1-09-529_h_a_dec_18.pdf@2019-09-10 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_0.pdf@EU-1-09-537_h_a_dec_0.pdf@2009-07-31 00:00:00@Mozobil@plerixafor@NAS before 2012@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_11.pdf@EU-1-09-535_h_a_dec_11.pdf@2021-12-16 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_5.pdf@EU-1-09-533_h_a_dec_5.pdf@2014-03-21 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe S.A.R.L.@exceptional@Parsed
EU-1-09-535_h_a_dec_2.pdf@EU-1-09-535_h_a_dec_2.pdf@2011-03-24 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-530_h_a_dec_7.pdf@EU-1-09-530_h_a_dec_7.pdf@2022-03-22 00:00:00@Repaglinide Teva@Repaglinide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_0.pdf@EU-1-09-538_h_a_dec_0.pdf@2009-03-08 00:00:00@Afinitor@everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_14.pdf@EU-1-09-531_h_a_dec_14.pdf@2019-01-07 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_19.pdf@EU-1-09-529_h_a_dec_19.pdf@2020-09-24 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_1.pdf@EU-1-09-537_h_a_dec_1.pdf@2010-03-15 00:00:00@Mozobil@plerixafor@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_3.pdf@EU-1-09-535_h_a_dec_3.pdf@2011-11-22 00:00:00@Grepid@Clopidogrel@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_1.pdf@EU-1-09-538_h_a_dec_1.pdf@2010-03-15 00:00:00@Afinitor@everolimus@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_15.pdf@EU-1-09-531_h_a_dec_15.pdf@2020-11-16 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_2.pdf@EU-1-09-529_h_a_dec_2.pdf@2011-10-11 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_10.pdf@EU-1-09-538_h_a_dec_10.pdf@2012-12-18 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_4.pdf@EU-1-09-535_h_a_dec_4.pdf@2012-07-26 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_16.pdf@EU-1-09-531_h_a_dec_16.pdf@2021-07-04 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_6.pdf@EU-1-09-533_h_a_dec_6.pdf@2014-04-23 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe S.A.R.L.@exceptional@Parsed
EU-1-09-537_h_a_dec_10.pdf@EU-1-09-537_h_a_dec_10.pdf@2022-07-06 00:00:00@Mozobil@Plerixafor@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_11.pdf@EU-1-09-538_h_a_dec_11.pdf@2013-05-27 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_3.pdf@EU-1-09-529_h_a_dec_3.pdf@2011-10-11 00:00:00@Victoza@liraglutide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_17.pdf@EU-1-09-531_h_a_dec_17.pdf@2022-02-06 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_7.pdf@EU-1-09-533_h_a_dec_7.pdf@2015-06-11 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe S.A.R.L.@exceptional@Parsed
EU-1-09-537_h_a_dec_2.pdf@EU-1-09-537_h_a_dec_2.pdf@2012-05-25 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_5.pdf@EU-1-09-535_h_a_dec_5.pdf@2014-11-04 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_4.pdf@EU-1-09-529_h_a_dec_4.pdf@2012-02-21 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_12.pdf@EU-1-09-538_h_a_dec_12.pdf@2014-05-16 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_2.pdf@EU-1-09-531_h_a_dec_2.pdf@2011-06-29 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_6.pdf@EU-1-09-535_h_a_dec_6.pdf@2016-06-24 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_8.pdf@EU-1-09-533_h_a_dec_8.pdf@2018-05-02 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Orphan Europe S.A.R.L.@exceptional@Parsed
EU-1-09-529_h_a_dec_5.pdf@EU-1-09-529_h_a_dec_5.pdf@2012-04-20 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_3.pdf@EU-1-09-537_h_a_dec_3.pdf@2014-11-02 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_0.pdf@EU-1-09-539_h_a_dec_0.pdf@2009-03-08 00:00:00@Samsca@tolvaptan@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_6.pdf@EU-1-09-529_h_a_dec_6.pdf@2012-05-25 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_7.pdf@EU-1-09-535_h_a_dec_7.pdf@2017-07-19 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_13.pdf@EU-1-09-538_h_a_dec_13.pdf@2014-12-16 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_1.pdf@EU-1-09-539_h_a_dec_1.pdf@2011-06-16 00:00:00@Samsca@tolvaptan@NAS before 2012@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-533_h_a_dec_9.pdf@EU-1-09-533_h_a_dec_9.pdf@2020-12-05 00:00:00@Vedrop@tocofersolan@False@False@OD Not Found@Recordati Rare Diseases@exceptional@Parsed
EU-1-09-531_h_a_dec_3.pdf@EU-1-09-531_h_a_dec_3.pdf@2011-06-29 00:00:00@Instanyl@Fentanyl@NAS before 2012@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_4.pdf@EU-1-09-537_h_a_dec_4.pdf@2014-11-04 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_7.pdf@EU-1-09-529_h_a_dec_7.pdf@2012-10-23 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_8.pdf@EU-1-09-535_h_a_dec_8.pdf@2019-06-06 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_14.pdf@EU-1-09-538_h_a_dec_14.pdf@2016-02-24 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_8.pdf@EU-1-09-529_h_a_dec_8.pdf@2013-11-03 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_4.pdf@EU-1-09-531_h_a_dec_4.pdf@2012-02-27 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_5.pdf@EU-1-09-537_h_a_dec_5.pdf@2014-09-22 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_10.pdf@EU-1-09-539_h_a_dec_10.pdf@2018-10-31 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-535_h_a_dec_9.pdf@EU-1-09-535_h_a_dec_9.pdf@2020-04-05 00:00:00@Grepid@Clopidogrel@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_6.pdf@EU-1-09-537_h_a_dec_6.pdf@2016-02-03 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_11.pdf@EU-1-09-539_h_a_dec_11.pdf@2021-04-21 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_5.pdf@EU-1-09-531_h_a_dec_5.pdf@2012-10-25 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-09-529_h_a_dec_9.pdf@EU-1-09-529_h_a_dec_9.pdf@2014-11-04 00:00:00@Victoza@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_15.pdf@EU-1-09-538_h_a_dec_15.pdf@2016-05-26 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_12.pdf@EU-1-09-539_h_a_dec_12.pdf@2022-01-25 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_7.pdf@EU-1-09-537_h_a_dec_7.pdf@2017-09-18 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_0.pdf@EU-1-09-540_h_a_dec_0.pdf@2009-07-28 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_2.pdf@EU-1-09-539_h_a_dec_2.pdf@2012-09-03 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_6.pdf@EU-1-09-531_h_a_dec_6.pdf@2014-02-28 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_8.pdf@EU-1-09-537_h_a_dec_8.pdf@2017-10-19 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_16.pdf@EU-1-09-538_h_a_dec_16.pdf@2018-08-05 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_1.pdf@EU-1-09-540_h_a_dec_1.pdf@2010-03-23 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_3.pdf@EU-1-09-539_h_a_dec_3.pdf@2012-04-20 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-537_h_a_dec_9.pdf@EU-1-09-537_h_a_dec_9.pdf@2019-05-13 00:00:00@Mozobil@Plerixafor@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_10.pdf@EU-1-09-540_h_a_dec_10.pdf@2021-05-19 00:00:00@Clopidogrel  Teva@Clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_0.pdf@EU-1-09-543_h_a_dec_0.pdf@2009-09-21 00:00:00@Cayston@aztreonam@NAS before 2012@False@adopted@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-531_h_a_dec_7.pdf@EU-1-09-531_h_a_dec_7.pdf@2014-04-23 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_4.pdf@EU-1-09-539_h_a_dec_4.pdf@2012-10-29 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_17.pdf@EU-1-09-538_h_a_dec_17.pdf@2019-02-04 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_11.pdf@EU-1-09-540_h_a_dec_11.pdf@2021-11-26 00:00:00@Clopidogrel Teva@Clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_1.pdf@EU-1-09-543_h_a_dec_1.pdf@2010-03-15 00:00:00@Cayston@aztreonam@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_8.pdf@EU-1-09-531_h_a_dec_8.pdf@2015-05-03 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_5.pdf@EU-1-09-539_h_a_dec_5.pdf@2013-05-27 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_2.pdf@EU-1-09-540_h_a_dec_2.pdf@2011-02-21 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-531_h_a_dec_9.pdf@EU-1-09-531_h_a_dec_9.pdf@2015-07-28 00:00:00@Instanyl@Fentanyl@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_18.pdf@EU-1-09-538_h_a_dec_18.pdf@2021-07-23 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_0.pdf@EU-1-09-544_h_a_dec_0.pdf@2009-01-10 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_10.pdf@EU-1-09-543_h_a_dec_10.pdf@2018-05-24 00:00:00@Cayston@aztreonam@False@False@adopted@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_3.pdf@EU-1-09-540_h_a_dec_3.pdf@2011-10-11 00:00:00@Clopidogrel Teva@Clopidogrel@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_6.pdf@EU-1-09-539_h_a_dec_6.pdf@2014-02-28 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_1.pdf@EU-1-09-544_h_a_dec_1.pdf@2009-01-10 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_19.pdf@EU-1-09-538_h_a_dec_19.pdf@2022-06-13 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_0.pdf@EU-1-09-545_h_a_dec_0.pdf@2009-01-10 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_4.pdf@EU-1-09-540_h_a_dec_4.pdf@2014-05-16 00:00:00@Clopidogrel Teva@Clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_11.pdf@EU-1-09-543_h_a_dec_11.pdf@2020-04-28 00:00:00@Cayston@aztreonam@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_7.pdf@EU-1-09-539_h_a_dec_7.pdf@2014-06-19 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_10.pdf@EU-1-09-544_h_a_dec_10.pdf@2014-05-16 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_2.pdf@EU-1-09-538_h_a_dec_2.pdf@2010-03-30 00:00:00@Afinitor@everolimus@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_1.pdf@EU-1-09-545_h_a_dec_1.pdf@2010-02-07 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers  Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_5.pdf@EU-1-09-540_h_a_dec_5.pdf@2015-01-30 00:00:00@Clopidogrel Teva@Clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_2.pdf@EU-1-09-543_h_a_dec_2.pdf@2010-08-26 00:00:00@Cayston@aztreonam@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-538_h_a_dec_3.pdf@EU-1-09-538_h_a_dec_3.pdf@2010-04-27 00:00:00@Afinitor@everolimus@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_11.pdf@EU-1-09-544_h_a_dec_11.pdf@2014-12-16 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_8.pdf@EU-1-09-539_h_a_dec_8.pdf@2017-09-18 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_6.pdf@EU-1-09-540_h_a_dec_6.pdf@2016-05-26 00:00:00@Clopidogrel  Teva@Clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_3.pdf@EU-1-09-543_h_a_dec_3.pdf@2011-03-24 00:00:00@Cayston@aztreonam@NAS before 2012@False@adopted@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-545_h_a_dec_10.pdf@EU-1-09-545_h_a_dec_10.pdf@2013-07-26 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_4.pdf@EU-1-09-538_h_a_dec_4.pdf@2011-03-28 00:00:00@Afinitor@everolimus@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_12.pdf@EU-1-09-544_h_a_dec_12.pdf@2015-08-10 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_7.pdf@EU-1-09-540_h_a_dec_7.pdf@2017-06-23 00:00:00@Clopidogrel  Teva@Clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_4.pdf@EU-1-09-543_h_a_dec_4.pdf@2011-05-09 00:00:00@Cayston@aztreonam@NAS before 2012@False@adopted@Gilead Sciences International Limited@conditional@Parsed
EU-1-09-538_h_a_dec_5.pdf@EU-1-09-538_h_a_dec_5.pdf@2011-06-14 00:00:00@Afinitor@everolimus@NAS before 2012@False@adopted@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-09-539_h_a_dec_9.pdf@EU-1-09-539_h_a_dec_9.pdf@2018-06-29 00:00:00@Samsca@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_13.pdf@EU-1-09-544_h_a_dec_13.pdf@2015-12-16 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_8.pdf@EU-1-09-540_h_a_dec_8.pdf@2019-01-31 00:00:00@Clopidogrel  Teva@Clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_11.pdf@EU-1-09-545_h_a_dec_11.pdf@2014-04-23 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_5.pdf@EU-1-09-543_h_a_dec_5.pdf@2012-05-25 00:00:00@Cayston@aztreonam@False@False@adopted@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_6.pdf@EU-1-09-538_h_a_dec_6.pdf@2011-08-24 00:00:00@Afinitor@everolimus@NAS before 2012@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_14.pdf@EU-1-09-544_h_a_dec_14.pdf@2017-04-28 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-540_h_a_dec_9.pdf@EU-1-09-540_h_a_dec_9.pdf@2020-04-05 00:00:00@Clopidogrel  Teva@Clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_6.pdf@EU-1-09-543_h_a_dec_6.pdf@2012-07-23 00:00:00@Cayston@aztreonam@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_7.pdf@EU-1-09-538_h_a_dec_7.pdf@2011-11-22 00:00:00@Afinitor@everolimus@NAS before 2012@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_12.pdf@EU-1-09-545_h_a_dec_12.pdf@2014-07-18 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_0.pdf@EU-1-09-546_h_a_dec_0.pdf@2009-01-10 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_15.pdf@EU-1-09-544_h_a_dec_15.pdf@2018-08-01 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-538_h_a_dec_8.pdf@EU-1-09-538_h_a_dec_8.pdf@2012-03-19 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_16.pdf@EU-1-09-544_h_a_dec_16.pdf@2018-07-06 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_7.pdf@EU-1-09-543_h_a_dec_7.pdf@2014-06-27 00:00:00@Cayston@aztreonam@False@False@adopted@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_13.pdf@EU-1-09-545_h_a_dec_13.pdf@2014-10-15 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_1.pdf@EU-1-09-546_h_a_dec_1.pdf@2009-01-10 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_14.pdf@EU-1-09-545_h_a_dec_14.pdf@2015-04-24 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_17.pdf@EU-1-09-544_h_a_dec_17.pdf@2019-04-17 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_10.pdf@EU-1-09-546_h_a_dec_10.pdf@2012-06-02 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_15.pdf@EU-1-09-545_h_a_dec_15.pdf@2016-10-03 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_8.pdf@EU-1-09-543_h_a_dec_8.pdf@2015-05-13 00:00:00@Cayston@aztreonam@False@False@adopted@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_0.pdf@EU-1-09-550_h_a_dec_0.pdf@2009-09-21 00:00:00@Javlor@vinflunine ditartrate@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_18.pdf@EU-1-09-544_h_a_dec_18.pdf@2020-06-26 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_16.pdf@EU-1-09-545_h_a_dec_16.pdf@2017-11-04 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_11.pdf@EU-1-09-546_h_a_dec_11.pdf@2012-10-09 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_1.pdf@EU-1-09-550_h_a_dec_1.pdf@2010-12-20 00:00:00@Javlor@vinflunine ditartrate@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_17.pdf@EU-1-09-545_h_a_dec_17.pdf@2017-06-26 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_12.pdf@EU-1-09-546_h_a_dec_12.pdf@2012-11-19 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_19.pdf@EU-1-09-544_h_a_dec_19.pdf@2020-07-27 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_0.pdf@EU-1-09-551_h_a_dec_0.pdf@2009-09-21 00:00:00@Vizarsin@sildenafil@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-543_h_a_dec_9.pdf@EU-1-09-543_h_a_dec_9.pdf@2016-05-26 00:00:00@Cayston@aztreonam@False@False@adopted@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_2.pdf@EU-1-09-550_h_a_dec_2.pdf@2011-10-11 00:00:00@Javlor@vinflunine ditartrate@NAS before 2012@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_1.pdf@EU-1-09-551_h_a_dec_1.pdf@2011-03-28 00:00:00@Vizarsin@sildenafil@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_18.pdf@EU-1-09-545_h_a_dec_18.pdf@2018-02-08 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_10.pdf@EU-1-09-551_h_a_dec_10.pdf@2022-01-24 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_3.pdf@EU-1-09-550_h_a_dec_3.pdf@2012-06-27 00:00:00@Javlor@vinflunine ditartrate@False@False@OD Not Found@Pierre Fabre  Médicament@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_13.pdf@EU-1-09-546_h_a_dec_13.pdf@2013-07-25 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_2.pdf@EU-1-09-544_h_a_dec_2.pdf@2010-08-26 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_2.pdf@EU-1-09-551_h_a_dec_2.pdf@2012-03-15 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_19.pdf@EU-1-09-545_h_a_dec_19.pdf@2021-09-03 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_4.pdf@EU-1-09-550_h_a_dec_4.pdf@2012-10-29 00:00:00@Javlor@vinflunine ditartrate@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_14.pdf@EU-1-09-546_h_a_dec_14.pdf@2013-03-09 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_20.pdf@EU-1-09-544_h_a_dec_20.pdf@2021-02-12 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_5.pdf@EU-1-09-550_h_a_dec_5.pdf@2013-06-21 00:00:00@Javlor@vinflunine ditartrate@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_3.pdf@EU-1-09-551_h_a_dec_3.pdf@2012-05-15 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_2.pdf@EU-1-09-545_h_a_dec_2.pdf@2010-06-09 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers  Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_3.pdf@EU-1-09-544_h_a_dec_3.pdf@2010-11-29 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_15.pdf@EU-1-09-546_h_a_dec_15.pdf@2013-09-19 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_4.pdf@EU-1-09-544_h_a_dec_4.pdf@2011-09-02 00:00:00@Cimzia@certolizumab pegol@NAS before 2012@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_6.pdf@EU-1-09-550_h_a_dec_6.pdf@2014-05-16 00:00:00@Javlor@vinflunine ditartrate@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_4.pdf@EU-1-09-551_h_a_dec_4.pdf@2013-12-20 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_20.pdf@EU-1-09-545_h_a_dec_20.pdf@2022-04-13 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_0.pdf@EU-1-09-553_h_a_dec_0.pdf@2009-09-28 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_16.pdf@EU-1-09-546_h_a_dec_16.pdf@2014-06-19 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_5.pdf@EU-1-09-544_h_a_dec_5.pdf@2012-06-21 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_0.pdf@EU-1-09-555_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_7.pdf@EU-1-09-550_h_a_dec_7.pdf@2014-06-19 00:00:00@Javlor@vinflunine ditartrate@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_1.pdf@EU-1-09-555_h_a_dec_1.pdf@2010-03-23 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_5.pdf@EU-1-09-551_h_a_dec_5.pdf@2014-05-16 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_3.pdf@EU-1-09-545_h_a_dec_3.pdf@2011-02-28 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers  Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_1.pdf@EU-1-09-553_h_a_dec_1.pdf@2010-02-07 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_10.pdf@EU-1-09-555_h_a_dec_10.pdf@2020-02-06 00:00:00@Clopidogrel  TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_17.pdf@EU-1-09-546_h_a_dec_17.pdf@2015-01-15 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_6.pdf@EU-1-09-544_h_a_dec_6.pdf@2012-06-27 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_4.pdf@EU-1-09-545_h_a_dec_4.pdf@2011-02-28 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_6.pdf@EU-1-09-551_h_a_dec_6.pdf@2015-07-28 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_10.pdf@EU-1-09-553_h_a_dec_10.pdf@2021-05-19 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-550_h_a_dec_8.pdf@EU-1-09-550_h_a_dec_8.pdf@2022-01-24 00:00:00@Javlor@vinflunine ditartrate@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_19.pdf@EU-1-09-546_h_a_dec_19.pdf@2016-06-24 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_5.pdf@EU-1-09-545_h_a_dec_5.pdf@2011-10-24 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers  Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_11.pdf@EU-1-09-555_h_a_dec_11.pdf@2021-10-05 00:00:00@Clopidogrel  TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_6.pdf@EU-1-09-545_h_a_dec_6.pdf@2011-11-22 00:00:00@Onglyza@saxagliptin@NAS before 2012@False@OD Not Found@Bristol Myers  Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_7.pdf@EU-1-09-551_h_a_dec_7.pdf@2016-02-22 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_7.pdf@EU-1-09-544_h_a_dec_7.pdf@2012-04-10 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma SA.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_8.pdf@EU-1-09-545_h_a_dec_8.pdf@2013-02-18 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_11.pdf@EU-1-09-553_h_a_dec_11.pdf@2021-10-25 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_2.pdf@EU-1-09-546_h_a_dec_2.pdf@2010-03-23 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_8.pdf@EU-1-09-551_h_a_dec_8.pdf@2017-04-28 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_12.pdf@EU-1-09-555_h_a_dec_12.pdf@2021-10-28 00:00:00@Clopidogrel TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_20.pdf@EU-1-09-546_h_a_dec_20.pdf@2017-11-09 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-545_h_a_dec_9.pdf@EU-1-09-545_h_a_dec_9.pdf@2013-05-23 00:00:00@Onglyza@saxagliptin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-09-551_h_a_dec_9.pdf@EU-1-09-551_h_a_dec_9.pdf@2019-01-31 00:00:00@Vizarsin@sildenafil@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_8.pdf@EU-1-09-544_h_a_dec_8.pdf@2013-10-18 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_2.pdf@EU-1-09-553_h_a_dec_2.pdf@2011-11-02 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_2.pdf@EU-1-09-555_h_a_dec_2.pdf@2011-02-28 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_3.pdf@EU-1-09-553_h_a_dec_3.pdf@2011-11-28 00:00:00@Zyllt@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_21.pdf@EU-1-09-546_h_a_dec_21.pdf@2018-02-07 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-544_h_a_dec_9.pdf@EU-1-09-544_h_a_dec_9.pdf@2013-11-25 00:00:00@Cimzia@certolizumab pegol@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_3.pdf@EU-1-09-555_h_a_dec_3.pdf@2011-03-11 00:00:00@Clopidogrel TAD@Clopidogrel@NAS before 2012@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_4.pdf@EU-1-09-555_h_a_dec_4.pdf@2012-12-09 00:00:00@Clopidogrel TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_4.pdf@EU-1-09-553_h_a_dec_4.pdf@2014-05-14 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_22.pdf@EU-1-09-546_h_a_dec_22.pdf@2019-02-18 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_5.pdf@EU-1-09-555_h_a_dec_5.pdf@2014-05-22 00:00:00@Clopidogrel TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_0.pdf@EU-1-09-556_h_a_dec_0.pdf@2009-09-23 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_5.pdf@EU-1-09-553_h_a_dec_5.pdf@2015-04-13 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_6.pdf@EU-1-09-555_h_a_dec_6.pdf@2015-05-27 00:00:00@Clopidogrel  TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_1.pdf@EU-1-09-556_h_a_dec_1.pdf@2010-03-23 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_23.pdf@EU-1-09-546_h_a_dec_23.pdf@2020-02-28 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_7.pdf@EU-1-09-555_h_a_dec_7.pdf@2016-05-27 00:00:00@Clopidogrel  TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_6.pdf@EU-1-09-553_h_a_dec_6.pdf@2016-09-06 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_10.pdf@EU-1-09-556_h_a_dec_10.pdf@2020-12-05 00:00:00@Clopidogrel  Krka@Clopidogrel@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_24.pdf@EU-1-09-546_h_a_dec_24.pdf@2021-03-22 00:00:00@Simponi@golimumab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_7.pdf@EU-1-09-553_h_a_dec_7.pdf@2017-02-08 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_8.pdf@EU-1-09-555_h_a_dec_8.pdf@2017-07-19 00:00:00@Clopidogrel  TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_11.pdf@EU-1-09-556_h_a_dec_11.pdf@2021-05-19 00:00:00@Clopidogrel  Krka@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_8.pdf@EU-1-09-553_h_a_dec_8.pdf@2019-03-25 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-09-555_h_a_dec_9.pdf@EU-1-09-555_h_a_dec_9.pdf@2019-06-06 00:00:00@Clopidogrel  TAD@Clopidogrel@False@False@OD Not Found@TAD Pharma GmbH@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_3.pdf@EU-1-09-546_h_a_dec_3.pdf@2010-07-28 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_12.pdf@EU-1-09-556_h_a_dec_12.pdf@2021-10-28 00:00:00@Clopidogrel Krka@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-553_h_a_dec_9.pdf@EU-1-09-553_h_a_dec_9.pdf@2020-03-06 00:00:00@Zyllt@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_4.pdf@EU-1-09-546_h_a_dec_4.pdf@2010-10-25 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_2.pdf@EU-1-09-556_h_a_dec_2.pdf@2011-11-02 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_3.pdf@EU-1-09-556_h_a_dec_3.pdf@2011-03-11 00:00:00@Clopidogrel Krka@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_5.pdf@EU-1-09-546_h_a_dec_5.pdf@2011-01-27 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_0.pdf@EU-1-09-558_h_a_dec_0.pdf@2009-09-21 00:00:00@Zylagren@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_4.pdf@EU-1-09-556_h_a_dec_4.pdf@2012-12-09 00:00:00@Clopidogrel Krka@Clopidogrel@False@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_6.pdf@EU-1-09-546_h_a_dec_6.pdf@2011-02-21 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_1.pdf@EU-1-09-558_h_a_dec_1.pdf@2010-03-15 00:00:00@Zylagren@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_7.pdf@EU-1-09-546_h_a_dec_7.pdf@2011-04-20 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_5.pdf@EU-1-09-556_h_a_dec_5.pdf@2014-05-14 00:00:00@Clopidogrel Krka@Clopidogrel@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_0.pdf@EU-1-09-559_h_a_dec_0.pdf@2009-09-21 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_8.pdf@EU-1-09-546_h_a_dec_8.pdf@2011-05-27 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_10.pdf@EU-1-09-558_h_a_dec_10.pdf@2019-10-24 00:00:00@Clopidogrel  BGR@Clopidogrel@False@False@OD Not Found@Laboratoires BIOGARAN@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_6.pdf@EU-1-09-556_h_a_dec_6.pdf@2015-06-05 00:00:00@Clopidogrel  Krka@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_0.pdf@EU-1-09-562_h_a_dec_0.pdf@2009-09-21 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_11.pdf@EU-1-09-558_h_a_dec_11.pdf@2021-08-02 00:00:00@Clopidogrel  BGR@Clopidogrel@False@False@OD Not Found@Laboratoires BIOGARAN@CMA Not Found@Parsed
EU-1-09-546_h_a_dec_9.pdf@EU-1-09-546_h_a_dec_9.pdf@2011-05-09 00:00:00@Simponi@golimumab@NAS before 2012@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_1.pdf@EU-1-09-559_h_a_dec_1.pdf@2010-03-30 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_7.pdf@EU-1-09-556_h_a_dec_7.pdf@2016-02-06 00:00:00@Clopidogrel  Krka@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_0.pdf@EU-1-09-564_h_a_dec_0.pdf@2009-10-23 00:00:00@ILARIS@canakinumab@NAS before 2012@False@adopted@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-562_h_a_dec_1.pdf@EU-1-09-562_h_a_dec_1.pdf@2010-11-03 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_2.pdf@EU-1-09-558_h_a_dec_2.pdf@2011-02-21 00:00:00@Zylagren@Clopidogrel@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_10.pdf@EU-1-09-559_h_a_dec_10.pdf@2020-04-05 00:00:00@Clopidogrel  Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_8.pdf@EU-1-09-556_h_a_dec_8.pdf@2017-07-19 00:00:00@Clopidogrel  Krka@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_1.pdf@EU-1-09-564_h_a_dec_1.pdf@2009-10-23 00:00:00@ILARIS@canakinumab@NAS before 2012@False@adopted@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-559_h_a_dec_11.pdf@EU-1-09-559_h_a_dec_11.pdf@2021-10-05 00:00:00@Clopidogrel  Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_0.pdf@EU-1-09-565_h_a_dec_0.pdf@2009-10-23 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_4.pdf@EU-1-09-558_h_a_dec_4.pdf@2014-08-05 00:00:00@Zylagren@Clopidogrel@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-556_h_a_dec_9.pdf@EU-1-09-556_h_a_dec_9.pdf@2019-03-28 00:00:00@Clopidogrel  Krka@Clopidogrel@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_11.pdf@EU-1-09-562_h_a_dec_11.pdf@2020-05-14 00:00:00@Clopidogrel  Krka d.d.@Clopidogrel@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_10.pdf@EU-1-09-564_h_a_dec_10.pdf@2013-02-18 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-559_h_a_dec_12.pdf@EU-1-09-559_h_a_dec_12.pdf@2021-10-25 00:00:00@Clopidogrel Taw Pharma@Clopidogrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_1.pdf@EU-1-09-565_h_a_dec_1.pdf@2010-03-15 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_12.pdf@EU-1-09-562_h_a_dec_12.pdf@2021-05-19 00:00:00@Clopidogrel Krka d.d.@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_5.pdf@EU-1-09-558_h_a_dec_5.pdf@2014-08-27 00:00:00@Clopidogrel BGR@Clopidogrel@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_10.pdf@EU-1-09-565_h_a_dec_10.pdf@2019-01-23 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_11.pdf@EU-1-09-564_h_a_dec_11.pdf@2013-08-26 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-562_h_a_dec_13.pdf@EU-1-09-562_h_a_dec_13.pdf@2021-12-16 00:00:00@Clopidogrel Krka d.d.@Clopidogrel@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_13.pdf@EU-1-09-559_h_a_dec_13.pdf@2021-11-15 00:00:00@Clopidogrel Taw Pharma@Clopidogrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_6.pdf@EU-1-09-558_h_a_dec_6.pdf@2016-02-06 00:00:00@Clopidogrel  BGR@Clopidogrel@False@False@OD Not Found@Laboratoires BIOGARAN@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_2.pdf@EU-1-09-565_h_a_dec_2.pdf@2011-08-02 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_2.pdf@EU-1-09-562_h_a_dec_2.pdf@2011-03-24 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_12.pdf@EU-1-09-564_h_a_dec_12.pdf@2014-06-19 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-558_h_a_dec_7.pdf@EU-1-09-558_h_a_dec_7.pdf@2017-05-22 00:00:00@Clopidogrel  BGR@Clopidogrel@False@False@OD Not Found@Laboratoires BIOGARAN@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_3.pdf@EU-1-09-565_h_a_dec_3.pdf@2011-05-08 00:00:00@Biopoin@epoetin theta@NAS before 2012@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_14.pdf@EU-1-09-559_h_a_dec_14.pdf@2022-02-21 00:00:00@Clopidogrel Taw Pharma@Clopidogrel@False@False@OD Not Found@Taw Pharma (Ireland) Limited@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_3.pdf@EU-1-09-562_h_a_dec_3.pdf@2011-04-14 00:00:00@Zopya@Clopidogrel@NAS before 2012@False@OD Not Found@Norpharm Regulatory Services Ltd@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_8.pdf@EU-1-09-558_h_a_dec_8.pdf@2017-07-19 00:00:00@Clopidogrel  BGR@Clopidogrel@False@False@OD Not Found@Laboratoires BIOGARAN@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_4.pdf@EU-1-09-565_h_a_dec_4.pdf@2012-10-10 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_0.pdf@EU-1-09-566_h_a_dec_0.pdf@2009-10-23 00:00:00@Lamivudine Teva@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_13.pdf@EU-1-09-564_h_a_dec_13.pdf@2014-09-18 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-562_h_a_dec_4.pdf@EU-1-09-562_h_a_dec_4.pdf@2012-03-21 00:00:00@Clopidogrel Krka d.d.@Clopidogrel@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_2.pdf@EU-1-09-559_h_a_dec_2.pdf@2011-08-03 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-558_h_a_dec_9.pdf@EU-1-09-558_h_a_dec_9.pdf@2019-02-04 00:00:00@Clopidogrel  BGR@Clopidogrel@False@False@OD Not Found@Laboratoires BIOGARAN@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_1.pdf@EU-1-09-566_h_a_dec_1.pdf@2012-05-31 00:00:00@Lamivudine Teva@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_5.pdf@EU-1-09-565_h_a_dec_5.pdf@2013-09-10 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@CT Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_3.pdf@EU-1-09-559_h_a_dec_3.pdf@2011-10-11 00:00:00@Clopidogrel Mylan@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_5.pdf@EU-1-09-562_h_a_dec_5.pdf@2012-12-09 00:00:00@Clopidogrel Krka d.d.@Clopidogrel@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_14.pdf@EU-1-09-564_h_a_dec_14.pdf@2015-09-23 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-566_h_a_dec_2.pdf@EU-1-09-566_h_a_dec_2.pdf@2014-09-09 00:00:00@Lamivudine Teva@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_4.pdf@EU-1-09-559_h_a_dec_4.pdf@2014-10-04 00:00:00@Clopidogrel Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_6.pdf@EU-1-09-562_h_a_dec_6.pdf@2014-03-06 00:00:00@Clopidogrel Krka d.d.@Clopidogrel@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_6.pdf@EU-1-09-565_h_a_dec_6.pdf@2014-08-26 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_15.pdf@EU-1-09-564_h_a_dec_15.pdf@2016-01-08 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-566_h_a_dec_3.pdf@EU-1-09-566_h_a_dec_3.pdf@2014-12-16 00:00:00@Lamivudine Teva@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_0.pdf@EU-1-09-568_h_a_dec_0.pdf@2009-10-16 00:00:00@Clopidogrel MYLAN Pharma@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_7.pdf@EU-1-09-562_h_a_dec_7.pdf@2015-10-06 00:00:00@Clopidogrel  Krka d.d.@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_7.pdf@EU-1-09-565_h_a_dec_7.pdf@2015-08-25 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_5.pdf@EU-1-09-559_h_a_dec_5.pdf@2014-05-22 00:00:00@Clopidogrel Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_4.pdf@EU-1-09-566_h_a_dec_4.pdf@2017-02-23 00:00:00@Lamivudine  Teva@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_1.pdf@EU-1-09-568_h_a_dec_1.pdf@2009-11-12 00:00:00@Clopidogrel MYLAN Pharma@Clopidogrel@NAS before 2012@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_6.pdf@EU-1-09-559_h_a_dec_6.pdf@2015-09-04 00:00:00@Clopidogrel  Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_8.pdf@EU-1-09-562_h_a_dec_8.pdf@2016-05-20 00:00:00@Clopidogrel  Krka d.d.@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_16.pdf@EU-1-09-564_h_a_dec_16.pdf@2017-02-23 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-565_h_a_dec_8.pdf@EU-1-09-565_h_a_dec_8.pdf@2016-02-18 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_5.pdf@EU-1-09-566_h_a_dec_5.pdf@2019-11-04 00:00:00@Lamivudine  Teva@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-562_h_a_dec_9.pdf@EU-1-09-562_h_a_dec_9.pdf@2017-06-07 00:00:00@Clopidogrel  Krka d.d.@Clopidogrel@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_10.pdf@EU-1-09-568_h_a_dec_10.pdf@2021-11-02 00:00:00@Clopidogrel  Taw Pharma@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_7.pdf@EU-1-09-559_h_a_dec_7.pdf@2016-12-05 00:00:00@Clopidogrel  Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-565_h_a_dec_9.pdf@EU-1-09-565_h_a_dec_9.pdf@2017-12-06 00:00:00@Biopoin@epoetin theta@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-09-566_h_a_dec_6.pdf@EU-1-09-566_h_a_dec_6.pdf@2021-04-06 00:00:00@Lamivudine Teva@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_17.pdf@EU-1-09-564_h_a_dec_17.pdf@2017-03-22 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-559_h_a_dec_8.pdf@EU-1-09-559_h_a_dec_8.pdf@2017-06-15 00:00:00@Clopidogrel  Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_11.pdf@EU-1-09-568_h_a_dec_11.pdf@2021-01-06 00:00:00@Clopidogrel Taw Pharma@Clopidogrel@False@False@OD Not Found@Taw Pharma (Ireland) Limited@CMA Not Found@Parsed
EU-1-09-559_h_a_dec_9.pdf@EU-1-09-559_h_a_dec_9.pdf@2019-03-25 00:00:00@Clopidogrel  Mylan@Clopidogrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_18.pdf@EU-1-09-564_h_a_dec_18.pdf@2018-07-30 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_0.pdf@EU-1-09-569_h_a_dec_0.pdf@2009-10-16 00:00:00@Exforge HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_0.pdf@EU-1-09-571_h_a_dec_0.pdf@2009-10-16 00:00:00@PANDEMIC  INFLUENZA VACCINE H5N1 BAXTER@Pandemic influenza vaccine (H5N1  whole virion, Vero cell derived, inactivated)@NAS before 2012@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-569_h_a_dec_1.pdf@EU-1-09-569_h_a_dec_1.pdf@2010-03-26 00:00:00@Exforge HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_0.pdf@EU-1-09-572_h_a_dec_0.pdf@2009-10-16 00:00:00@ALENDRONATE SODIUM AND  COLECALCIFEROL, MSD@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_12.pdf@EU-1-09-568_h_a_dec_12.pdf@2021-10-25 00:00:00@Clopidogrel Viatris@Clopidogrel@False@False@OD Not Found@Taw Pharma (Ireland) Limited@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_1.pdf@EU-1-09-571_h_a_dec_1.pdf@2011-12-19 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic  influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)@NAS before 2012@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-564_h_a_dec_19.pdf@EU-1-09-564_h_a_dec_19.pdf@2019-06-06 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_1.pdf@EU-1-09-572_h_a_dec_1.pdf@2010-03-15 00:00:00@ALENDRONATE SODIUM AND  COLECALCIFEROL, MSD@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_10.pdf@EU-1-09-569_h_a_dec_10.pdf@2016-02-03 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_2.pdf@EU-1-09-571_h_a_dec_2.pdf@2012-03-26 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic influenza vaccine                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.   (H5N1 whole virion, Vero cell derived, inactivated)@False@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-568_h_a_dec_13.pdf@EU-1-09-568_h_a_dec_13.pdf@2021-09-11 00:00:00@Clopidogrel Viatris@Clopidogrel@False@False@OD Not Found@Taw Pharma (Ireland) Limited@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_0.pdf@EU-1-09-573_h_a_dec_0.pdf@2009-10-29 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_2.pdf@EU-1-09-564_h_a_dec_2.pdf@2010-03-26 00:00:00@ILARIS@canakinumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_10.pdf@EU-1-09-572_h_a_dec_10.pdf@2016-09-19 00:00:00@Vantavo@alendronic acid / colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_3.pdf@EU-1-09-571_h_a_dec_3.pdf@2013-11-25 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic influenza  vaccine (H5N1 whole virion, Vero cell derived, inactivated)@False@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-573_h_a_dec_1.pdf@EU-1-09-573_h_a_dec_1.pdf@2010-11-03 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_14.pdf@EU-1-09-568_h_a_dec_14.pdf@2022-03-02 00:00:00@Clopidogrel Viatris@Clopidogrel@False@False@OD Not Found@Viatris Limited@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_20.pdf@EU-1-09-564_h_a_dec_20.pdf@2021-07-23 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_11.pdf@EU-1-09-569_h_a_dec_11.pdf@2018-01-30 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_11.pdf@EU-1-09-572_h_a_dec_11.pdf@2018-02-15 00:00:00@Vantavo@alendronic acid / colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_2.pdf@EU-1-09-573_h_a_dec_2.pdf@2011-11-02 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_4.pdf@EU-1-09-571_h_a_dec_4.pdf@2014-05-14 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)@False@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-568_h_a_dec_2.pdf@EU-1-09-568_h_a_dec_2.pdf@2010-09-30 00:00:00@Clopidogrel Apotex@Clopidogrel@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_3.pdf@EU-1-09-573_h_a_dec_3.pdf@2011-07-27 00:00:00@Eporatio@epoetin theta@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_5.pdf@EU-1-09-571_h_a_dec_5.pdf@2015-11-27 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic  influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)@False@False@OD Not Found@Baxter AG@exceptional@Parsed
EU-1-09-568_h_a_dec_3.pdf@EU-1-09-568_h_a_dec_3.pdf@2012-10-15 00:00:00@Clopidogrel Apotex@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_12.pdf@EU-1-09-572_h_a_dec_12.pdf@2018-09-07 00:00:00@Vantavo@alendronic acid / colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_21.pdf@EU-1-09-564_h_a_dec_21.pdf@2022-07-06 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_12.pdf@EU-1-09-569_h_a_dec_12.pdf@2018-07-06 00:00:00@Exforge HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_0.pdf@EU-1-09-574_h_a_dec_0.pdf@2009-04-11 00:00:00@Dafiro HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_4.pdf@EU-1-09-573_h_a_dec_4.pdf@2013-12-18 00:00:00@Eporatio@epoetin theta@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_3.pdf@EU-1-09-564_h_a_dec_3.pdf@2010-06-12 00:00:00@Ilaris@canakinumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_13.pdf@EU-1-09-572_h_a_dec_13.pdf@2021-04-13 00:00:00@Vantavo@alendronic acid / colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_1.pdf@EU-1-09-574_h_a_dec_1.pdf@2010-03-23 00:00:00@Dafiro HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_4.pdf@EU-1-09-568_h_a_dec_4.pdf@2014-09-18 00:00:00@Clopidogrel Apotex@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_6.pdf@EU-1-09-571_h_a_dec_6.pdf@2017-03-24 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic  influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)@False@False@OD Not Found@Nanotherapeutics Bohumil, s.r.o.@exceptional@Parsed
EU-1-09-564_h_a_dec_4.pdf@EU-1-09-564_h_a_dec_4.pdf@2011-02-28 00:00:00@Ilaris@canakinumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-573_h_a_dec_5.pdf@EU-1-09-573_h_a_dec_5.pdf@2014-11-09 00:00:00@Eporatio@epoetin theta@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_5.pdf@EU-1-09-568_h_a_dec_5.pdf@2016-04-07 00:00:00@Clopidogrel  Apotex@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_2.pdf@EU-1-09-572_h_a_dec_2.pdf@2010-10-25 00:00:00@Vantavo@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_13.pdf@EU-1-09-569_h_a_dec_13.pdf@2019-02-04 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  2.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8136 for “Exforge HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_10.pdf@EU-1-09-574_h_a_dec_10.pdf@2016-07-04 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_5.pdf@EU-1-09-564_h_a_dec_5.pdf@2011-03-31 00:00:00@Ilaris@canakinumab@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_6.pdf@EU-1-09-568_h_a_dec_6.pdf@2017-05-31 00:00:00@Clopidogrel  Apotex@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_6.pdf@EU-1-09-573_h_a_dec_6.pdf@2015-08-20 00:00:00@Eporatio@epoetin theta@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_3.pdf@EU-1-09-572_h_a_dec_3.pdf@2010-11-29 00:00:00@Vantavo@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-09-571_h_a_dec_7.pdf@EU-1-09-571_h_a_dec_7.pdf@2018-12-12 00:00:00@Pandemic influenza vaccine H5N1 BAXTER@Pandemic  influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)@False@False@OD Not Found@Nanotherapeutics UK Limited@exceptional@Parsed
EU-1-09-574_h_a_dec_11.pdf@EU-1-09-574_h_a_dec_11.pdf@2018-01-30 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_7.pdf@EU-1-09-568_h_a_dec_7.pdf@2019-04-17 00:00:00@Clopidogrel  Apotex@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
rtis Europharm Limited@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_6.pdf@EU-1-09-564_h_a_dec_6.pdf@2011-09-16 00:00:00@Ilaris@canakinumab@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@exceptional@Parsed
EU-1-09-572_h_a_dec_4.pdf@EU-1-09-572_h_a_dec_4.pdf@2011-02-02 00:00:00@Vantavo@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_7.pdf@EU-1-09-573_h_a_dec_7.pdf@2016-02-22 00:00:00@Eporatio@epoetin theta@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_8.pdf@EU-1-09-568_h_a_dec_8.pdf@2020-04-05 00:00:00@Clopidogrel  Apotex@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_7.pdf@EU-1-09-564_h_a_dec_7.pdf@2012-01-13 00:00:00@Ilaris@canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-572_h_a_dec_5.pdf@EU-1-09-572_h_a_dec_5.pdf@2011-03-24 00:00:00@Vantavo@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-564_h_a_dec_9.pdf@EU-1-09-564_h_a_dec_9.pdf@2013-01-24 00:00:00@Ilaris@Canakinumab@False@False@OD Not Found@Novartis Europharm Limited@exceptional@Parsed
EU-1-09-574_h_a_dec_12.pdf@EU-1-09-574_h_a_dec_12.pdf@2018-06-25 00:00:00@Dafiro HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_15.pdf@EU-1-09-569_h_a_dec_15.pdf@2021-12-02 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_6.pdf@EU-1-09-572_h_a_dec_6.pdf@2011-06-29 00:00:00@Vantavo@alendronic acid / colecalciferol@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-568_h_a_dec_9.pdf@EU-1-09-568_h_a_dec_9.pdf@2021-12-02 00:00:00@Clopidogrel Taw Pharma@Clopidogrel@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-09-573_h_a_dec_9.pdf@EU-1-09-573_h_a_dec_9.pdf@2018-10-29 00:00:00@Eporatio@epoetin theta@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_8.pdf@EU-1-09-572_h_a_dec_8.pdf@2012-05-25 00:00:00@Vantavo@alendronic acid / colecalciferol@False@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_16.pdf@EU-1-09-569_h_a_dec_16.pdf@2021-06-17 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_0.pdf@EU-1-09-575_h_a_dec_0.pdf@2009-04-11 00:00:00@Copalia HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_13.pdf@EU-1-09-574_h_a_dec_13.pdf@2019-11-04 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  11.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8663 for “Dafiro HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_1.pdf@EU-1-09-575_h_a_dec_1.pdf@2010-03-23 00:00:00@Copalia HCT@amlodipine besylate /  valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-572_h_a_dec_9.pdf@EU-1-09-572_h_a_dec_9.pdf@2014-09-18 00:00:00@Vantavo@alendronic acid / colecalciferol@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_17.pdf@EU-1-09-569_h_a_dec_17.pdf@2022-09-13 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_14.pdf@EU-1-09-574_h_a_dec_14.pdf@2020-06-18 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_10.pdf@EU-1-09-575_h_a_dec_10.pdf@2016-03-22 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_2.pdf@EU-1-09-569_h_a_dec_2.pdf@2011-03-24 00:00:00@Exforge HCT@amlodipine besylate / valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_15.pdf@EU-1-09-574_h_a_dec_15.pdf@2021-02-19 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 1   EN COMMISSION IMPLEMENTING DECISION  19.2.2021  amending Commission Decision C(2019) 2981  11 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(2009) 8663 for “Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_11.pdf@EU-1-09-575_h_a_dec_11.pdf@2018-01-30 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_0.pdf@EU-1-09-576_h_a_dec_0.pdf@2009-10-30 00:00:00@Irbesartan Teva@Irbesartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_3.pdf@EU-1-09-569_h_a_dec_3.pdf@2012-06-28 00:00:00@Exforge HCT@amlodipine  besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_16.pdf@EU-1-09-574_h_a_dec_16.pdf@2021-06-17 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_12.pdf@EU-1-09-575_h_a_dec_12.pdf@2018-06-25 00:00:00@Copalia HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_0.pdf@EU-1-09-577_h_a_dec_0.pdf@2009-10-19 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@exceptional@Parsed
EU-1-09-576_h_a_dec_1.pdf@EU-1-09-576_h_a_dec_1.pdf@2011-01-02 00:00:00@Irbesartan Teva@Irbesartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_4.pdf@EU-1-09-569_h_a_dec_4.pdf@2012-08-23 00:00:00@Exforge HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_1.pdf@EU-1-09-577_h_a_dec_1.pdf@2011-06-05 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated  antigen@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@exceptional@Parsed
EU-1-09-578_h_a_dec_0.pdf@EU-1-09-578_h_a_dec_0.pdf@2009-10-19 00:00:00@Pandemic  influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline  Biologicals@Pandemic influenza vaccine (H5N1) (split virion, inactivated,  adjuvanted) A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@exceptional@Parsed
EU-1-09-576_h_a_dec_10.pdf@EU-1-09-576_h_a_dec_10.pdf@2020-11-24 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_5.pdf@EU-1-09-569_h_a_dec_5.pdf@2012-10-25 00:00:00@Exforge HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_17.pdf@EU-1-09-574_h_a_dec_17.pdf@2022-02-09 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_2.pdf@EU-1-09-577_h_a_dec_2.pdf@2012-03-21 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated  antigen@False@False@OD Not Found@Novartis Vaccines  and Diagnostics S.r.l.@exceptional@Parsed
EU-1-09-578_h_a_dec_1.pdf@EU-1-09-578_h_a_dec_1.pdf@2011-04-18 00:00:00@Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.   GlaxoSmithKline Biologicals@Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@exceptional@Parsed
EU-1-09-575_h_a_dec_13.pdf@EU-1-09-575_h_a_dec_13.pdf@2019-11-04 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  11.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8664 for “Copalia HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_11.pdf@EU-1-09-576_h_a_dec_11.pdf@2021-02-19 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_2.pdf@EU-1-09-574_h_a_dec_2.pdf@2011-03-17 00:00:00@Dafiro HCT@amlodipine besylate / valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_6.pdf@EU-1-09-569_h_a_dec_6.pdf@2013-07-31 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_0.pdf@EU-1-09-579_h_a_dec_0.pdf@2009-04-11 00:00:00@Repaglinide Krka@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_3.pdf@EU-1-09-577_h_a_dec_3.pdf@2014-06-27 00:00:00@Foclivia@A/Viet  Nam/1194/2004 (H5N1) virus surface inactivated antigen@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_12.pdf@EU-1-09-576_h_a_dec_12.pdf@2022-02-24 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_10.pdf@EU-1-09-578_h_a_dec_10.pdf@2022-05-24 00:00:00@Adjupanrix@Purified antigen fractions  inactivated split virions  A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-574_h_a_dec_3.pdf@EU-1-09-574_h_a_dec_3.pdf@2012-06-28 00:00:00@Dafiro HCT@amlodipine  besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_1.pdf@EU-1-09-579_h_a_dec_1.pdf@2012-10-29 00:00:00@Repaglinide Krka@Repaglinide@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_14.pdf@EU-1-09-575_h_a_dec_14.pdf@2020-06-18 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_2.pdf@EU-1-09-576_h_a_dec_2.pdf@2012-05-25 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_2.pdf@EU-1-09-578_h_a_dec_2.pdf@2011-11-22 00:00:00@Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)  GlaxoSmithKline Biologicals@Pandemic influenza vaccine (H5N1) (split virion,  inactivated, adjuvanted) A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@exceptional@Parsed
EU-1-09-569_h_a_dec_7.pdf@EU-1-09-569_h_a_dec_7.pdf@2014-06-30 00:00:00@Exforge HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_4.pdf@EU-1-09-574_h_a_dec_4.pdf@2012-08-30 00:00:00@Dafiro HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_4.pdf@EU-1-09-577_h_a_dec_4.pdf@2015-05-27 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_3.pdf@EU-1-09-578_h_a_dec_3.pdf@2011-12-22 00:00:00@Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals@Pandemic  influenza  vaccine  (H5N1)  (split  virion,  inactivated,  adjuvanted)  A/VietNam/1194/2004 NIBRG-14@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-576_h_a_dec_3.pdf@EU-1-09-576_h_a_dec_3.pdf@2012-10-25 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_2.pdf@EU-1-09-579_h_a_dec_2.pdf@2014-08-22 00:00:00@Repaglinide Krka@Repaglinide@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_5.pdf@EU-1-09-574_h_a_dec_5.pdf@2012-10-31 00:00:00@Dafiro HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_5.pdf@EU-1-09-577_h_a_dec_5.pdf@2017-09-01 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated  antigen@False@False@OD Not Found@Seqirus S.r.l.@exceptional@Parsed
EU-1-09-578_h_a_dec_4.pdf@EU-1-09-578_h_a_dec_4.pdf@2012-10-31 00:00:00@Adjupanrix@Purified antigen fractions  inactivated split virions  A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-569_h_a_dec_8.pdf@EU-1-09-569_h_a_dec_8.pdf@2014-04-09 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8136 for “Exforge HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_15.pdf@EU-1-09-575_h_a_dec_15.pdf@2021-02-19 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  19.2.2021  amending Commission Decision C(2019) 2980  11 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(2009) 8664 for “Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_3.pdf@EU-1-09-579_h_a_dec_3.pdf@2017-02-16 00:00:00@Repaglinide  Krka@Repaglinide@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-577_h_a_dec_6.pdf@EU-1-09-577_h_a_dec_6.pdf@2019-11-28 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated  antigen@False@False@OD Not Found@Seqirus S.r.l.,@exceptional@Parsed
EU-1-09-576_h_a_dec_4.pdf@EU-1-09-576_h_a_dec_4.pdf@2014-07-18 00:00:00@Irbesartan Teva@Irbesartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_6.pdf@EU-1-09-574_h_a_dec_6.pdf@2013-07-31 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_5.pdf@EU-1-09-578_h_a_dec_5.pdf@2014-02-28 00:00:00@Adjupanrix@Purified antigen fractions  inactivated split virions  A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-577_h_a_dec_7.pdf@EU-1-09-577_h_a_dec_7.pdf@2021-11-22 00:00:00@Foclivia@A/Viet Nam/1194/2004 (H5N1) virus surface inactivated  antigen@False@False@OD Not Found@Seqirus S.r.l.,@exceptional@Parsed
EU-1-09-575_h_a_dec_16.pdf@EU-1-09-575_h_a_dec_16.pdf@2021-06-17 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-569_h_a_dec_9.pdf@EU-1-09-569_h_a_dec_9.pdf@2015-05-05 00:00:00@Exforge  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_7.pdf@EU-1-09-574_h_a_dec_7.pdf@2014-04-07 00:00:00@Dafiro HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_5.pdf@EU-1-09-576_h_a_dec_5.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8603 for “Irbesartan Teva@Irbesartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-579_h_a_dec_4.pdf@EU-1-09-579_h_a_dec_4.pdf@2021-10-19 00:00:00@Repaglinide Krka@Repaglinide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_6.pdf@EU-1-09-578_h_a_dec_6.pdf@2014-05-22 00:00:00@Adjupanrix@Purified antigen fractions  inactivated split virions  A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-09-574_h_a_dec_8.pdf@EU-1-09-574_h_a_dec_8.pdf@2014-04-09 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8663 for “Dafiro HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_6.pdf@EU-1-09-576_h_a_dec_6.pdf@2014-01-12 00:00:00@Irbesartan Teva@Irbesartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_17.pdf@EU-1-09-575_h_a_dec_17.pdf@2022-02-09 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_7.pdf@EU-1-09-576_h_a_dec_7.pdf@2016-08-02 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_7.pdf@EU-1-09-578_h_a_dec_7.pdf@2014-07-18 00:00:00@Adjupanrix@Purified antigen fractions   inactivated split virions A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-574_h_a_dec_9.pdf@EU-1-09-574_h_a_dec_9.pdf@2015-05-05 00:00:00@Dafiro  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_2.pdf@EU-1-09-575_h_a_dec_2.pdf@2011-03-17 00:00:00@Copalia HCT@amlodipine besylate / valsartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_8.pdf@EU-1-09-576_h_a_dec_8.pdf@2017-12-06 00:00:00@Irbesartan  Teva@Irbesartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_8.pdf@EU-1-09-578_h_a_dec_8.pdf@2015-11-06 00:00:00@Adjupanrix@Purified antigen fractions  inactivated split virions  A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-580_h_a_dec_0.pdf@EU-1-09-580_h_a_dec_0.pdf@2009-10-14 00:00:00@Enyglid@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_3.pdf@EU-1-09-575_h_a_dec_3.pdf@2012-06-28 00:00:00@Copalia HCT@amlodipine  besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_0.pdf@EU-1-09-581_h_a_dec_0.pdf@2009-10-15 00:00:00@Resolor@prucalopride@NAS before 2012@False@OD Not Found@Movetis NV@CMA Not Found@Parsed
EU-1-09-576_h_a_dec_9.pdf@EU-1-09-576_h_a_dec_9.pdf@2019-11-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 11.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8603 for “Irbesartan Teva@Irbesartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-578_h_a_dec_9.pdf@EU-1-09-578_h_a_dec_9.pdf@2019-07-31 00:00:00@Adjupanrix@Purified  antigen fractions  inactivated split virions A/VietNam/1194/2004 NIBRG-14 (H5N1)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@exceptional@Parsed
EU-1-09-580_h_a_dec_1.pdf@EU-1-09-580_h_a_dec_1.pdf@2010-03-11 00:00:00@Enyglid@Repaglinide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_4.pdf@EU-1-09-575_h_a_dec_4.pdf@2012-08-30 00:00:00@Copalia HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_1.pdf@EU-1-09-581_h_a_dec_1.pdf@2011-06-01 00:00:00@Resolor@prucalopride@NAS before 2012@False@OD Not Found@Movetis NV@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_5.pdf@EU-1-09-575_h_a_dec_5.pdf@2012-10-31 00:00:00@Copalia HCT@amlodipine besylate / valsartan /  hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_2.pdf@EU-1-09-580_h_a_dec_2.pdf@2012-08-11 00:00:00@Enyglid@Repaglinide@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_10.pdf@EU-1-09-581_h_a_dec_10.pdf@2020-02-21 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_6.pdf@EU-1-09-575_h_a_dec_6.pdf@2013-07-31 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_3.pdf@EU-1-09-580_h_a_dec_3.pdf@2014-08-22 00:00:00@Enyglid@Repaglinide@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_4.pdf@EU-1-09-580_h_a_dec_4.pdf@2017-02-16 00:00:00@Enyglid@Repaglinide@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_11.pdf@EU-1-09-581_h_a_dec_11.pdf@2021-06-17 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_7.pdf@EU-1-09-575_h_a_dec_7.pdf@2014-04-07 00:00:00@Copalia HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_0.pdf@EU-1-09-583_h_a_dec_0.pdf@2009-11-26 00:00:00@Irbesartan / Hydrochlorothiazide  Teva@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-580_h_a_dec_5.pdf@EU-1-09-580_h_a_dec_5.pdf@2021-09-11 00:00:00@Enyglid@Repaglinide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_0.pdf@EU-1-09-584_h_a_dec_0.pdf@2009-11-30 00:00:00@Sildenafil Teva@sildenafil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_1.pdf@EU-1-09-583_h_a_dec_1.pdf@2010-10-25 00:00:00@Irbesartan / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_8.pdf@EU-1-09-575_h_a_dec_8.pdf@2014-04-09 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)8664 for “Copalia HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_1.pdf@EU-1-09-584_h_a_dec_1.pdf@2010-04-22 00:00:00@Sildenafil Teva@sildenafil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-575_h_a_dec_9.pdf@EU-1-09-575_h_a_dec_9.pdf@2015-05-05 00:00:00@Copalia  HCT@amlodipine besylate / valsartan / hydrochlorothiazide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_12.pdf@EU-1-09-581_h_a_dec_12.pdf@2021-09-15 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_0.pdf@EU-1-09-585_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@NAS before 2012@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_10.pdf@EU-1-09-583_h_a_dec_10.pdf@2019-11-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  11.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)9600 for “Irbesartan / Hydrochlorothiazide Teva@irbesartan /  hydrochlorothiazide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_1.pdf@EU-1-09-585_h_a_dec_1.pdf@2011-07-20 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@NAS before 2012@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_2.pdf@EU-1-09-581_h_a_dec_2.pdf@2011-09-16 00:00:00@Resolor@prucalopride@NAS before 2012@False@OD Not Found@Shire-Movetis NV@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_0.pdf@EU-1-09-586_h_a_dec_0.pdf@2009-11-30 00:00:00@Oslif Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_2.pdf@EU-1-09-584_h_a_dec_2.pdf@2010-11-29 00:00:00@Sildenafil Teva@sildenafil@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_3.pdf@EU-1-09-581_h_a_dec_3.pdf@2012-01-30 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire-Movetis NV@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_2.pdf@EU-1-09-585_h_a_dec_2.pdf@2012-02-17 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma  GmbH@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_3.pdf@EU-1-09-584_h_a_dec_3.pdf@2012-10-09 00:00:00@Sildenafil  Teva@sildenafil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_1.pdf@EU-1-09-586_h_a_dec_1.pdf@2010-03-23 00:00:00@Oslif Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_11.pdf@EU-1-09-583_h_a_dec_11.pdf@2021-02-19 00:00:00@Irbesartan /  Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_4.pdf@EU-1-09-581_h_a_dec_4.pdf@2012-02-23 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire-Movetis NV@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_3.pdf@EU-1-09-585_h_a_dec_3.pdf@2012-08-11 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_4.pdf@EU-1-09-584_h_a_dec_4.pdf@2014-01-31 00:00:00@Sildenafil  Teva@sildenafil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_5.pdf@EU-1-09-581_h_a_dec_5.pdf@2012-03-19 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire-Movetis NV@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_10.pdf@EU-1-09-586_h_a_dec_10.pdf@2019-08-14 00:00:00@Oslif  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_12.pdf@EU-1-09-583_h_a_dec_12.pdf@2022-01-07 00:00:00@Irbesartan  / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_4.pdf@EU-1-09-585_h_a_dec_4.pdf@2014-06-05 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_5.pdf@EU-1-09-584_h_a_dec_5.pdf@2014-09-09 00:00:00@Sildenafil Teva@sildenafil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_2.pdf@EU-1-09-583_h_a_dec_2.pdf@2012-10-05 00:00:00@Irbesartan  / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_6.pdf@EU-1-09-581_h_a_dec_6.pdf@2013-09-25 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire-Movetis NV@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_11.pdf@EU-1-09-586_h_a_dec_11.pdf@2021-04-21 00:00:00@Oslif  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_3.pdf@EU-1-09-583_h_a_dec_3.pdf@2012-10-29 00:00:00@Irbesartan  / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_0.pdf@EU-1-09-587_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_5.pdf@EU-1-09-585_h_a_dec_5.pdf@2014-08-19 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_6.pdf@EU-1-09-584_h_a_dec_6.pdf@2015-10-03 00:00:00@Sildenafil Teva@sildenafil@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_1.pdf@EU-1-09-587_h_a_dec_1.pdf@2010-05-26 00:00:00@Olanzapine Glenmark@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_4.pdf@EU-1-09-583_h_a_dec_4.pdf@2013-12-13 00:00:00@Irbesartan  / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_6.pdf@EU-1-09-585_h_a_dec_6.pdf@2015-11-30 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_12.pdf@EU-1-09-586_h_a_dec_12.pdf@2022-01-24 00:00:00@Oslif  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_7.pdf@EU-1-09-581_h_a_dec_7.pdf@2014-06-06 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_10.pdf@EU-1-09-587_h_a_dec_10.pdf@2020-08-28 00:00:00@Olanzapine  Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_8.pdf@EU-1-09-581_h_a_dec_8.pdf@2015-05-27 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_5.pdf@EU-1-09-583_h_a_dec_5.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2009)9600 for “Irbesartan / Hydrochlorothiazide Teva@irbesartan /  hydrochlorothiazide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_7.pdf@EU-1-09-584_h_a_dec_7.pdf@2016-07-01 00:00:00@Sildenafil  Teva@sildenafil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_7.pdf@EU-1-09-585_h_a_dec_7.pdf@2017-07-25 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_2.pdf@EU-1-09-586_h_a_dec_2.pdf@2010-06-09 00:00:00@Oslif  Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_2.pdf@EU-1-09-587_h_a_dec_2.pdf@2011-01-24 00:00:00@Olanzapine Glenmark@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_8.pdf@EU-1-09-584_h_a_dec_8.pdf@2017-06-04 00:00:00@Sildenafil  Teva@sildenafil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-585_h_a_dec_8.pdf@EU-1-09-585_h_a_dec_8.pdf@2021-09-23 00:00:00@Rivastigmine 1 A Pharma@Rivastigmine@False@False@OD Not Found@1 A Pharma GmbH@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_6.pdf@EU-1-09-583_h_a_dec_6.pdf@2014-07-11 00:00:00@Irbesartan / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-581_h_a_dec_9.pdf@EU-1-09-581_h_a_dec_9.pdf@2019-01-31 00:00:00@Resolor@prucalopride@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_3.pdf@EU-1-09-586_h_a_dec_3.pdf@2011-10-08 00:00:00@Oslif  Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_3.pdf@EU-1-09-587_h_a_dec_3.pdf@2012-02-27 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-584_h_a_dec_9.pdf@EU-1-09-584_h_a_dec_9.pdf@2021-09-29 00:00:00@Sildenafil  Teva@sildenafil@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_7.pdf@EU-1-09-583_h_a_dec_7.pdf@2015-05-05 00:00:00@Irbesartan / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_4.pdf@EU-1-09-587_h_a_dec_4.pdf@2012-07-16 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_4.pdf@EU-1-09-586_h_a_dec_4.pdf@2012-07-23 00:00:00@Oslif Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_8.pdf@EU-1-09-583_h_a_dec_8.pdf@2017-02-16 00:00:00@Irbesartan /  Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_0.pdf@EU-1-09-588_h_a_dec_0.pdf@2009-03-12 00:00:00@Olanzapine Glenmark Europe@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics (Europe) Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_5.pdf@EU-1-09-587_h_a_dec_5.pdf@2012-10-25 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_5.pdf@EU-1-09-586_h_a_dec_5.pdf@2013-08-26 00:00:00@Oslif Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_6.pdf@EU-1-09-587_h_a_dec_6.pdf@2012-10-12 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_1.pdf@EU-1-09-588_h_a_dec_1.pdf@2010-05-26 00:00:00@Olanzapine Glenmark Europe@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-583_h_a_dec_9.pdf@EU-1-09-583_h_a_dec_9.pdf@2018-10-18 00:00:00@Irbesartan  / Hydrochlorothiazide Teva@irbesartan / hydrochlorothiazide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_10.pdf@EU-1-09-588_h_a_dec_10.pdf@2020-08-28 00:00:00@Olanzapine  Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_6.pdf@EU-1-09-586_h_a_dec_6.pdf@2014-09-18 00:00:00@Oslif Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_7.pdf@EU-1-09-587_h_a_dec_7.pdf@2014-08-19 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals Europe Limited@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_2.pdf@EU-1-09-588_h_a_dec_2.pdf@2011-01-24 00:00:00@Olanzapine Glenmark Europe@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_7.pdf@EU-1-09-586_h_a_dec_7.pdf@2015-09-30 00:00:00@Oslif  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_8.pdf@EU-1-09-587_h_a_dec_8.pdf@2017-10-23 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals Europe Limited@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_3.pdf@EU-1-09-588_h_a_dec_3.pdf@2012-02-27 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_4.pdf@EU-1-09-588_h_a_dec_4.pdf@2012-08-30 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_0.pdf@EU-1-09-589_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine HEXAL@Rivastigmine@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_8.pdf@EU-1-09-586_h_a_dec_8.pdf@2017-09-18 00:00:00@Oslif Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-587_h_a_dec_9.pdf@EU-1-09-587_h_a_dec_9.pdf@2019-01-31 00:00:00@Olanzapine Glenmark@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals Europe Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_0.pdf@EU-1-09-590_h_a_dec_0.pdf@2009-09-12 00:00:00@Prevenar 13@Pneumococcal  polysaccharide conjugate vaccine (13-valent, adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_5.pdf@EU-1-09-588_h_a_dec_5.pdf@2012-10-25 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_0.pdf@EU-1-09-591_h_a_dec_0.pdf@2009-11-26 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_1.pdf@EU-1-09-589_h_a_dec_1.pdf@2011-03-14 00:00:00@Rivastigmine HEXAL@Rivastigmine@NAS before 2012@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_6.pdf@EU-1-09-588_h_a_dec_6.pdf@2012-10-12 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Generics  (Europe) Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_1.pdf@EU-1-09-590_h_a_dec_1.pdf@2010-07-28 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent,  adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_1.pdf@EU-1-09-591_h_a_dec_1.pdf@2009-11-26 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-586_h_a_dec_9.pdf@EU-1-09-586_h_a_dec_9.pdf@2018-08-05 00:00:00@Oslif Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_3.pdf@EU-1-09-589_h_a_dec_3.pdf@2012-11-22 00:00:00@Rivastigmine HEXAL@Rivastigmine@False@False@OD Not Found@HEXAL AG@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_7.pdf@EU-1-09-588_h_a_dec_7.pdf@2014-08-19 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals Europe Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_10.pdf@EU-1-09-590_h_a_dec_10.pdf@2012-12-20 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_4.pdf@EU-1-09-589_h_a_dec_4.pdf@2014-04-23 00:00:00@Rivastigmine HEXAL@Rivastigmine@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_10.pdf@EU-1-09-591_h_a_dec_10.pdf@2011-12-22 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_8.pdf@EU-1-09-588_h_a_dec_8.pdf@2017-10-23 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals Europe Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_11.pdf@EU-1-09-591_h_a_dec_11.pdf@2012-08-30 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_5.pdf@EU-1-09-589_h_a_dec_5.pdf@2014-11-07 00:00:00@Rivastigmine HEXAL@Rivastigmine@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_11.pdf@EU-1-09-590_h_a_dec_11.pdf@2013-09-07 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_0.pdf@EU-1-09-592_h_a_dec_0.pdf@2009-10-12 00:00:00@Olazax Disperzi@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_12.pdf@EU-1-09-591_h_a_dec_12.pdf@2012-10-24 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_6.pdf@EU-1-09-589_h_a_dec_6.pdf@2015-11-27 00:00:00@Rivastigmine HEXAL@Rivastigmine@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-09-588_h_a_dec_9.pdf@EU-1-09-588_h_a_dec_9.pdf@2019-01-31 00:00:00@Olanzapine Glenmark Europe@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals Europe Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_1.pdf@EU-1-09-592_h_a_dec_1.pdf@2010-05-26 00:00:00@Olazax Disperzi@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-589_h_a_dec_7.pdf@EU-1-09-589_h_a_dec_7.pdf@2021-10-19 00:00:00@Rivastigmine HEXAL@Rivastigmine@False@False@OD Not Found@Hexal AG@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_12.pdf@EU-1-09-590_h_a_dec_12.pdf@2013-11-20 00:00:00@Prevenar 13@Pneumococcal  polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_13.pdf@EU-1-09-591_h_a_dec_13.pdf@2013-09-25 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_13.pdf@EU-1-09-590_h_a_dec_13.pdf@2014-06-23 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_0.pdf@EU-1-09-593_h_a_dec_0.pdf@2009-11-30 00:00:00@Onbrez Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_14.pdf@EU-1-09-591_h_a_dec_14.pdf@2013-11-15 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_10.pdf@EU-1-09-592_h_a_dec_10.pdf@2020-09-12 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_1.pdf@EU-1-09-593_h_a_dec_1.pdf@2010-03-26 00:00:00@Onbrez Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_14.pdf@EU-1-09-590_h_a_dec_14.pdf@2014-09-18 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_2.pdf@EU-1-09-592_h_a_dec_2.pdf@2011-01-21 00:00:00@Olazax Disperzi@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_0.pdf@EU-1-09-594_h_a_dec_0.pdf@2009-11-30 00:00:00@Hirobriz Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_10.pdf@EU-1-09-593_h_a_dec_10.pdf@2018-04-23 00:00:00@Onbrez Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_3.pdf@EU-1-09-592_h_a_dec_3.pdf@2012-09-02 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_15.pdf@EU-1-09-590_h_a_dec_15.pdf@2015-02-26 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_16.pdf@EU-1-09-591_h_a_dec_16.pdf@2017-10-30 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_1.pdf@EU-1-09-594_h_a_dec_1.pdf@2010-03-26 00:00:00@Hirobriz Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_4.pdf@EU-1-09-592_h_a_dec_4.pdf@2012-08-23 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_11.pdf@EU-1-09-593_h_a_dec_11.pdf@2019-08-26 00:00:00@Onbrez  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_17.pdf@EU-1-09-591_h_a_dec_17.pdf@2019-09-19 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_0.pdf@EU-1-09-595_h_a_dec_0.pdf@2009-10-12 00:00:00@Sildenafil Actavis@Sildenafil@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_5.pdf@EU-1-09-592_h_a_dec_5.pdf@2012-10-25 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_16.pdf@EU-1-09-590_h_a_dec_16.pdf@2016-10-21 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_10.pdf@EU-1-09-594_h_a_dec_10.pdf@2019-01-08 00:00:00@Hirobriz  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_18.pdf@EU-1-09-591_h_a_dec_18.pdf@2020-02-06 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_1.pdf@EU-1-09-595_h_a_dec_1.pdf@2011-06-10 00:00:00@Sildenafil  Actavis@Sildenafil@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_6.pdf@EU-1-09-592_h_a_dec_6.pdf@2013-01-28 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_0.pdf@EU-1-09-596_h_a_dec_0.pdf@2009-10-12 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_12.pdf@EU-1-09-593_h_a_dec_12.pdf@2020-09-12 00:00:00@Onbrez  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_19.pdf@EU-1-09-591_h_a_dec_19.pdf@2022-12-01 00:00:00@Multaq@dronedarone@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_17.pdf@EU-1-09-590_h_a_dec_17.pdf@2017-10-23 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_1.pdf@EU-1-09-596_h_a_dec_1.pdf@2012-06-28 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_11.pdf@EU-1-09-594_h_a_dec_11.pdf@2020-12-14 00:00:00@Hirobriz  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_2.pdf@EU-1-09-591_h_a_dec_2.pdf@2010-10-14 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_2.pdf@EU-1-09-595_h_a_dec_2.pdf@2014-03-03 00:00:00@Sildenafil  Actavis@Sildenafil@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_7.pdf@EU-1-09-592_h_a_dec_7.pdf@2014-06-08 00:00:00@Olazax Disperzi@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_10.pdf@EU-1-09-596_h_a_dec_10.pdf@2021-07-23 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_13.pdf@EU-1-09-593_h_a_dec_13.pdf@2021-12-13 00:00:00@Onbrez  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_3.pdf@EU-1-09-591_h_a_dec_3.pdf@2011-01-21 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_18.pdf@EU-1-09-590_h_a_dec_18.pdf@2018-09-27 00:00:00@Prevenar 13@valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_8.pdf@EU-1-09-592_h_a_dec_8.pdf@2017-09-14 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_12.pdf@EU-1-09-594_h_a_dec_12.pdf@2021-11-29 00:00:00@Hirobriz  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_11.pdf@EU-1-09-596_h_a_dec_11.pdf@2022-09-30 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_2.pdf@EU-1-09-593_h_a_dec_2.pdf@2010-08-26 00:00:00@Onbrez Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_3.pdf@EU-1-09-595_h_a_dec_3.pdf@2014-04-09 00:00:00@Sildenafil Actavis@Sildenafil@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_4.pdf@EU-1-09-591_h_a_dec_4.pdf@2011-07-06 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_2.pdf@EU-1-09-594_h_a_dec_2.pdf@2010-08-26 00:00:00@Hirobriz Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_19.pdf@EU-1-09-590_h_a_dec_19.pdf@2019-11-19 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_2.pdf@EU-1-09-596_h_a_dec_2.pdf@2012-06-28 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_3.pdf@EU-1-09-593_h_a_dec_3.pdf@2011-11-07 00:00:00@Onbrez  Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_5.pdf@EU-1-09-591_h_a_dec_5.pdf@2011-07-18 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_3.pdf@EU-1-09-594_h_a_dec_3.pdf@2011-07-07 00:00:00@Hirobriz  Breezhaler@indacaterol@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_2.pdf@EU-1-09-590_h_a_dec_2.pdf@2010-01-09 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent,  adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines  S.A.@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_4.pdf@EU-1-09-595_h_a_dec_4.pdf@2016-01-25 00:00:00@Sildenafil  Actavis@Sildenafil@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_3.pdf@EU-1-09-596_h_a_dec_3.pdf@2014-11-09 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_4.pdf@EU-1-09-593_h_a_dec_4.pdf@2012-07-26 00:00:00@Onbrez Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-09-592_h_a_dec_9.pdf@EU-1-09-592_h_a_dec_9.pdf@2020-03-16 00:00:00@Olazax Disperzi@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_6.pdf@EU-1-09-591_h_a_dec_6.pdf@2011-07-18 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_4.pdf@EU-1-09-594_h_a_dec_4.pdf@2012-03-08 00:00:00@Hirobriz Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_7.pdf@EU-1-09-591_h_a_dec_7.pdf@2011-08-24 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_20.pdf@EU-1-09-590_h_a_dec_20.pdf@2020-11-25 00:00:00@Prevenar 13@Pneumococcal  polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_4.pdf@EU-1-09-596_h_a_dec_4.pdf@2014-11-17 00:00:00@Lamivudine Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_5.pdf@EU-1-09-595_h_a_dec_5.pdf@2017-05-22 00:00:00@Sildenafil  Actavis@Sildenafil@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_5.pdf@EU-1-09-593_h_a_dec_5.pdf@2013-08-26 00:00:00@Onbrez Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_8.pdf@EU-1-09-591_h_a_dec_8.pdf@2011-08-24 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_3.pdf@EU-1-09-590_h_a_dec_3.pdf@2010-11-26 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent,  adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle  Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_5.pdf@EU-1-09-594_h_a_dec_5.pdf@2013-08-26 00:00:00@Hirobriz Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_5.pdf@EU-1-09-596_h_a_dec_5.pdf@2016-02-18 00:00:00@Lamivudine  Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-591_h_a_dec_9.pdf@EU-1-09-591_h_a_dec_9.pdf@2011-12-22 00:00:00@Multaq@dronedarone@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_4.pdf@EU-1-09-590_h_a_dec_4.pdf@2011-06-29 00:00:00@Prevenar 13@Pneumococcal polysaccharide  conjugate vaccine (13-valent, adsorbed)@NAS before 2012@False@adopted@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_6.pdf@EU-1-09-596_h_a_dec_6.pdf@2016-09-16 00:00:00@Lamivudine  Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_6.pdf@EU-1-09-593_h_a_dec_6.pdf@2014-09-18 00:00:00@Onbrez Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-595_h_a_dec_6.pdf@EU-1-09-595_h_a_dec_6.pdf@2021-07-23 00:00:00@Sildenafil  Actavis@Sildenafil@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_5.pdf@EU-1-09-590_h_a_dec_5.pdf@2011-06-29 00:00:00@Prevenar  13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@NAS before 2012@False@OD Not Found@Wyeth Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_6.pdf@EU-1-09-594_h_a_dec_6.pdf@2014-09-18 00:00:00@Hirobriz Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_7.pdf@EU-1-09-596_h_a_dec_7.pdf@2018-09-28 00:00:00@Lamivudine  Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_6.pdf@EU-1-09-590_h_a_dec_6.pdf@2011-10-24 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent,  adsorbed)@NAS before 2012@False@OD Not Found@Wyeth-Lederle  Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_7.pdf@EU-1-09-593_h_a_dec_7.pdf@2015-10-15 00:00:00@Onbrez  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_8.pdf@EU-1-09-596_h_a_dec_8.pdf@2019-11-22 00:00:00@Lamivudine  Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_7.pdf@EU-1-09-594_h_a_dec_7.pdf@2015-08-09 00:00:00@Hirobriz  Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_7.pdf@EU-1-09-590_h_a_dec_7.pdf@2012-03-19 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent,  adsorbed)@False@False@OD Not Found@Wyeth-Lederle Vaccines  S.A.@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_0.pdf@EU-1-09-597_h_a_dec_0.pdf@2009-11-12 00:00:00@Olazax@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-596_h_a_dec_9.pdf@EU-1-09-596_h_a_dec_9.pdf@2019-12-16 00:00:00@Lamivudine  Teva Pharma B.V.@Lamivudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_8.pdf@EU-1-09-590_h_a_dec_8.pdf@2012-03-07 00:00:00@Prevenar 13@Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)@False@False@OD Not Found@Wyeth-Lederle Vaccines S.A.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_8.pdf@EU-1-09-593_h_a_dec_8.pdf@2017-09-26 00:00:00@Onbrez Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_0.pdf@EU-1-09-598_h_a_dec_0.pdf@2009-11-30 00:00:00@Nevirapine Teva@nevirapine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_1.pdf@EU-1-09-597_h_a_dec_1.pdf@2010-12-05 00:00:00@Olazax@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_0.pdf@EU-1-09-599_h_a_dec_0.pdf@2009-11-12 00:00:00@Rivastigmine Sandoz@Rivastigmine@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_8.pdf@EU-1-09-594_h_a_dec_8.pdf@2017-09-26 00:00:00@Hirobriz Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-590_h_a_dec_9.pdf@EU-1-09-590_h_a_dec_9.pdf@2012-11-22 00:00:00@Prevenar 13@1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.   valent, adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_1.pdf@EU-1-09-598_h_a_dec_1.pdf@2012-05-25 00:00:00@Nevirapine Teva@nevirapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_1.pdf@EU-1-09-599_h_a_dec_1.pdf@2011-07-20 00:00:00@Rivastigmine Sandoz@Rivastigmine@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_2.pdf@EU-1-09-597_h_a_dec_2.pdf@2011-09-02 00:00:00@Olazax@Olanzapine@NAS before 2012@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-593_h_a_dec_9.pdf@EU-1-09-593_h_a_dec_9.pdf@2018-04-23 00:00:00@Onbrez Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_2.pdf@EU-1-09-599_h_a_dec_2.pdf@2012-02-17 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz  Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-594_h_a_dec_9.pdf@EU-1-09-594_h_a_dec_9.pdf@2018-06-07 00:00:00@Hirobriz Breezhaler@indacaterol@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_2.pdf@EU-1-09-598_h_a_dec_2.pdf@2014-02-20 00:00:00@Nevirapine Teva@nevirapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_3.pdf@EU-1-09-597_h_a_dec_3.pdf@2012-09-02 00:00:00@Olazax  Disperzi@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_3.pdf@EU-1-09-599_h_a_dec_3.pdf@2012-10-31 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz Pharmaceuticals  GmbH@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_0.pdf@EU-1-09-600_h_a_dec_0.pdf@2009-11-30 00:00:00@Zutectra@Human Hepatitis B  Immunoglobulin@NAS before 2012@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_4.pdf@EU-1-09-597_h_a_dec_4.pdf@2012-06-07 00:00:00@Olazax@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_3.pdf@EU-1-09-598_h_a_dec_3.pdf@2014-08-26 00:00:00@Nevirapine Teva@nevirapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_1.pdf@EU-1-09-600_h_a_dec_1.pdf@2011-11-02 00:00:00@Zutectra@Human Hepatitis B Immunoglobulin@NAS before 2012@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_5.pdf@EU-1-09-597_h_a_dec_5.pdf@2012-10-15 00:00:00@Olazax@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_4.pdf@EU-1-09-599_h_a_dec_4.pdf@2014-04-28 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_2.pdf@EU-1-09-600_h_a_dec_2.pdf@2011-11-28 00:00:00@Zutectra@Human Hepatitis B Immunoglobulin@NAS before 2012@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_6.pdf@EU-1-09-597_h_a_dec_6.pdf@2012-11-30 00:00:00@Olazax@Olanzapine@False@False@OD Not Found@Glenmark  Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_4.pdf@EU-1-09-598_h_a_dec_4.pdf@2014-10-22 00:00:00@Nevirapine Teva@nevirapine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_5.pdf@EU-1-09-599_h_a_dec_5.pdf@2014-11-07 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_3.pdf@EU-1-09-600_h_a_dec_3.pdf@2014-06-06 00:00:00@Zutectra@Human Hepatitis B Immunoglobulin@False@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_5.pdf@EU-1-09-598_h_a_dec_5.pdf@2017-03-24 00:00:00@Nevirapine  Teva@nevirapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_0.pdf@EU-1-09-602_h_a_dec_0.pdf@2010-11-01 00:00:00@Scintimun@besilesomab@NAS before 2012@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_0.pdf@EU-1-09-601_h_a_dec_0.pdf@2009-12-23 00:00:00@Zenas@amifampridine@NAS before 2012@False@adopted@EUSA Pharma SAS@exceptional@Parsed
EU-1-09-599_h_a_dec_6.pdf@EU-1-09-599_h_a_dec_6.pdf@2015-08-04 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_6.pdf@EU-1-09-598_h_a_dec_6.pdf@2019-10-17 00:00:00@Nevirapine  Teva@nevirapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_1.pdf@EU-1-09-602_h_a_dec_1.pdf@2011-03-24 00:00:00@Scintimun@besilesomab@NAS before 2012@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_4.pdf@EU-1-09-600_h_a_dec_4.pdf@2014-09-16 00:00:00@Zutectra@Human Hepatitis B Immunoglobulin@False@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_1.pdf@EU-1-09-601_h_a_dec_1.pdf@2010-04-15 00:00:00@Firdapse@amifampridine@NAS before 2012@False@OD Not Found@EUSA Pharma SAS@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_7.pdf@EU-1-09-599_h_a_dec_7.pdf@2015-11-27 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_8.pdf@EU-1-09-597_h_a_dec_8.pdf@2017-05-09 00:00:00@Olazax@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_0.pdf@EU-1-09-603_h_a_dec_0.pdf@2009-12-23 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_5.pdf@EU-1-09-600_h_a_dec_5.pdf@2015-12-16 00:00:00@Zutectra@Human Hepatitis B Immunoglobulin@False@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-598_h_a_dec_7.pdf@EU-1-09-598_h_a_dec_7.pdf@2021-09-29 00:00:00@Nevirapine Teva@nevirapine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_2.pdf@EU-1-09-602_h_a_dec_2.pdf@2014-08-26 00:00:00@Scintimun@besilesomab@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_8.pdf@EU-1-09-599_h_a_dec_8.pdf@2017-07-17 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-09-597_h_a_dec_9.pdf@EU-1-09-597_h_a_dec_9.pdf@2020-09-24 00:00:00@Olazax@Olanzapine@False@False@OD Not Found@Glenmark Pharmaceuticals s.r.o.@CMA Not Found@Parsed
EU-1-09-600_h_a_dec_6.pdf@EU-1-09-600_h_a_dec_6.pdf@2019-11-04 00:00:00@Zutectra@Human Hepatitis B Immunoglobulin@False@False@OD Not Found@Biotest Pharma GmbH@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_3.pdf@EU-1-09-602_h_a_dec_3.pdf@2016-02-22 00:00:00@Scintimun@besilesomab@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_10.pdf@EU-1-09-601_h_a_dec_10.pdf@2017-10-30 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin Europe Ltd.@exceptional@Parsed
EU-1-09-603_h_a_dec_1.pdf@EU-1-09-603_h_a_dec_1.pdf@2010-06-08 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-599_h_a_dec_9.pdf@EU-1-09-599_h_a_dec_9.pdf@2021-12-13 00:00:00@Rivastigmine Sandoz@Rivastigmine@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-09-602_h_a_dec_4.pdf@EU-1-09-602_h_a_dec_4.pdf@2017-06-02 00:00:00@Scintimun@besilesomab@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_2.pdf@EU-1-09-603_h_a_dec_2.pdf@2011-12-04 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_11.pdf@EU-1-09-601_h_a_dec_11.pdf@2018-07-13 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-09-604_h_a_dec_0.pdf@EU-1-09-604_h_a_dec_0.pdf@2010-08-01 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_3.pdf@EU-1-09-603_h_a_dec_3.pdf@2011-07-13 00:00:00@Sildenafil ratiopharm@Sildenafil@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_0.pdf@EU-1-09-605_h_a_dec_0.pdf@2010-01-25 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@ALFRED E. TIEFENBACHER, (GmbH  & Co. KG)@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_1.pdf@EU-1-09-604_h_a_dec_1.pdf@2010-08-18 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_0.pdf@EU-1-09-606_h_a_dec_0.pdf@2010-01-28 00:00:00@Temozolomide Teva@Temozolomide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_12.pdf@EU-1-09-601_h_a_dec_12.pdf@2019-08-23 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_4.pdf@EU-1-09-603_h_a_dec_4.pdf@2013-09-12 00:00:00@Sildenafil  ratiopharm@Sildenafil@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_1.pdf@EU-1-09-605_h_a_dec_1.pdf@2010-03-26 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@ALFRED E. TIEFENBACHER, (GmbH  & Co. KG)@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_1.pdf@EU-1-09-606_h_a_dec_1.pdf@2010-11-26 00:00:00@Temozolomide Teva@Temozolomide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_10.pdf@EU-1-09-604_h_a_dec_10.pdf@2018-10-16 00:00:00@Leflunomide Zentiva@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_0.pdf@EU-1-09-607_h_a_dec_0.pdf@2010-01-29 00:00:00@Silodyx@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_10.pdf@EU-1-09-605_h_a_dec_10.pdf@2018-02-08 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_10.pdf@EU-1-09-606_h_a_dec_10.pdf@2020-11-16 00:00:00@Temozolomide  Teva@temozolomide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_5.pdf@EU-1-09-603_h_a_dec_5.pdf@2014-09-09 00:00:00@Sildenafil ratiopharm@Sildenafil@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_13.pdf@EU-1-09-601_h_a_dec_13.pdf@2020-05-14 00:00:00@Firdapse@amifampridine@False@False@OD Not Found@BioMarin International Limited@exceptional@Parsed
EU-1-09-604_h_a_dec_11.pdf@EU-1-09-604_h_a_dec_11.pdf@2022-03-18 00:00:00@Leflunomide  Zentiva@leflunomide@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_1.pdf@EU-1-09-607_h_a_dec_1.pdf@2010-01-29 00:00:00@Silodyx@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_11.pdf@EU-1-09-605_h_a_dec_11.pdf@2019-12-06 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-603_h_a_dec_6.pdf@EU-1-09-603_h_a_dec_6.pdf@2016-01-25 00:00:00@Sildenafil  ratiopharm@Sildenafil@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_0.pdf@EU-1-09-608_h_a_dec_0.pdf@2010-01-29 00:00:00@Urorec@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_14.pdf@EU-1-09-601_h_a_dec_14.pdf@2020-11-18 00:00:00@Firdapse@amifampridine@False@False@OD Not Found@SERB S.A.@exceptional@Parsed
EU-1-09-606_h_a_dec_2.pdf@EU-1-09-606_h_a_dec_2.pdf@2011-03-31 00:00:00@Temozolomide Teva@Temozolomide@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_2.pdf@EU-1-09-604_h_a_dec_2.pdf@2011-04-18 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_3.pdf@EU-1-09-604_h_a_dec_3.pdf@2011-07-27 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_2.pdf@EU-1-09-607_h_a_dec_2.pdf@2011-03-24 00:00:00@Silodyx@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_12.pdf@EU-1-09-605_h_a_dec_12.pdf@2020-10-19 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_2.pdf@EU-1-09-601_h_a_dec_2.pdf@2011-12-04 00:00:00@Firdapse@amifampridine@NAS before 2012@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-09-603_h_a_dec_7.pdf@EU-1-09-603_h_a_dec_7.pdf@2021-09-29 00:00:00@Sildenafil  ratiopharm@Sildenafil@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_3.pdf@EU-1-09-606_h_a_dec_3.pdf@2012-05-31 00:00:00@Temozolomide Teva@temozolomide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_1.pdf@EU-1-09-608_h_a_dec_1.pdf@2010-01-29 00:00:00@Urorec@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_4.pdf@EU-1-09-604_h_a_dec_4.pdf@2011-10-27 00:00:00@Leflunomide Winthrop@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_3.pdf@EU-1-09-601_h_a_dec_3.pdf@2011-11-21 00:00:00@Firdapse@amifampridine@NAS before 2012@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-09-607_h_a_dec_3.pdf@EU-1-09-607_h_a_dec_3.pdf@2012-04-20 00:00:00@Silodyx@silodosin@False@False@OD Not Found@Recordati Ireland  Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_2.pdf@EU-1-09-605_h_a_dec_2.pdf@2011-01-21 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_4.pdf@EU-1-09-606_h_a_dec_4.pdf@2012-10-25 00:00:00@Temozolomide Teva@temozolomide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_2.pdf@EU-1-09-608_h_a_dec_2.pdf@2011-03-24 00:00:00@Urorec@silodosin@NAS before 2012@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_5.pdf@EU-1-09-604_h_a_dec_5.pdf@2012-03-19 00:00:00@Leflunomide Winthrop@leflunomide@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_4.pdf@EU-1-09-601_h_a_dec_4.pdf@2012-10-29 00:00:00@Firdapse@amifampridine@False@False@OD Not Found@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_3.pdf@EU-1-09-605_h_a_dec_3.pdf@2011-09-19 00:00:00@Temomedac@Temozolomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_3.pdf@EU-1-09-608_h_a_dec_3.pdf@2012-04-20 00:00:00@Urorec@silodosin@False@False@OD Not Found@Recordati Ireland  Ltd.@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_5.pdf@EU-1-09-606_h_a_dec_5.pdf@2014-11-02 00:00:00@Temozolomide Teva@temozolomide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_5.pdf@EU-1-09-601_h_a_dec_5.pdf@2013-03-13 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-09-604_h_a_dec_6.pdf@EU-1-09-604_h_a_dec_6.pdf@2012-12-20 00:00:00@Leflunomide Winthrop@leflunomide@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_4.pdf@EU-1-09-607_h_a_dec_4.pdf@2013-11-13 00:00:00@Silodyx@silodosin@False@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_4.pdf@EU-1-09-605_h_a_dec_4.pdf@2012-04-24 00:00:00@Temomedac@Temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_0.pdf@EU-1-09-609_h_a_dec_0.pdf@2010-01-25 00:00:00@Elonva@corifollitropin alfa@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_6.pdf@EU-1-09-601_h_a_dec_6.pdf@2014-01-16 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin Europe Ltd@exceptional@Parsed
EU-1-09-605_h_a_dec_5.pdf@EU-1-09-605_h_a_dec_5.pdf@2012-10-25 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_6.pdf@EU-1-09-606_h_a_dec_6.pdf@2014-08-26 00:00:00@Temozolomide Teva@temozolomide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_7.pdf@EU-1-09-604_h_a_dec_7.pdf@2014-11-19 00:00:00@Leflunomide Winthrop@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_4.pdf@EU-1-09-608_h_a_dec_4.pdf@2013-11-13 00:00:00@Urorec@silodosin@False@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_1.pdf@EU-1-09-609_h_a_dec_1.pdf@2010-08-26 00:00:00@Elonva@corifollitropin alfa@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_5.pdf@EU-1-09-607_h_a_dec_5.pdf@2014-09-18 00:00:00@Silodyx@silodosin@False@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_7.pdf@EU-1-09-606_h_a_dec_7.pdf@2015-08-25 00:00:00@Temozolomide Teva@temozolomide@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_6.pdf@EU-1-09-605_h_a_dec_6.pdf@2014-03-31 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_8.pdf@EU-1-09-604_h_a_dec_8.pdf@2016-10-14 00:00:00@Leflunomide  Winthrop@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_7.pdf@EU-1-09-601_h_a_dec_7.pdf@2014-11-28 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_10.pdf@EU-1-09-609_h_a_dec_10.pdf@2018-08-05 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_5.pdf@EU-1-09-608_h_a_dec_5.pdf@2014-09-18 00:00:00@Urorec@silodosin@False@False@OD Not Found@Recordati Ireland Ltd.@CMA Not Found@Parsed
EU-1-09-604_h_a_dec_9.pdf@EU-1-09-604_h_a_dec_9.pdf@2018-06-25 00:00:00@Leflunomide  Winthrop@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_8.pdf@EU-1-09-606_h_a_dec_8.pdf@2017-04-28 00:00:00@Temozolomide  Teva@temozolomide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_11.pdf@EU-1-09-609_h_a_dec_11.pdf@2019-09-16 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_6.pdf@EU-1-09-607_h_a_dec_6.pdf@2016-02-24 00:00:00@Silodyx@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_7.pdf@EU-1-09-605_h_a_dec_7.pdf@2014-07-18 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate  mbH@CMA Not Found@Parsed
EU-1-09-606_h_a_dec_9.pdf@EU-1-09-606_h_a_dec_9.pdf@2018-07-30 00:00:00@Temozolomide  Teva@temozolomide@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_12.pdf@EU-1-09-609_h_a_dec_12.pdf@2020-09-10 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_6.pdf@EU-1-09-608_h_a_dec_6.pdf@2016-02-26 00:00:00@Urorec@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_8.pdf@EU-1-09-605_h_a_dec_8.pdf@2015-07-28 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-601_h_a_dec_9.pdf@EU-1-09-601_h_a_dec_9.pdf@2016-07-29 00:00:00@Firdapse@amifampridine@False@False@adopted@BioMarin Europe Ltd.@CMA Not Found@Parsed
EU-1-09-605_h_a_dec_9.pdf@EU-1-09-605_h_a_dec_9.pdf@2016-07-22 00:00:00@Temomedac@temozolomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_13.pdf@EU-1-09-609_h_a_dec_13.pdf@2021-06-14 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-09-607_h_a_dec_7.pdf@EU-1-09-607_h_a_dec_7.pdf@2020-07-17 00:00:00@Silodyx@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-09-608_h_a_dec_7.pdf@EU-1-09-608_h_a_dec_7.pdf@2020-03-08 00:00:00@Urorec@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_14.pdf@EU-1-09-609_h_a_dec_14.pdf@2022-06-21 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_2.pdf@EU-1-09-609_h_a_dec_2.pdf@2011-05-16 00:00:00@Elonva@corifollitropin alfa@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_3.pdf@EU-1-09-609_h_a_dec_3.pdf@2012-02-17 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_0.pdf@EU-1-10-614_h_a_dec_0.pdf@2010-03-15 00:00:00@Menveo@Meningococcal Group A, C,  W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_0.pdf@EU-1-10-612_h_a_dec_0.pdf@2010-11-03 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@adopted@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_0.pdf@EU-1-10-615_h_a_dec_0.pdf@2010-03-15 00:00:00@Temozolomide Hospira@Temozolomide@NAS before 2012@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_1.pdf@EU-1-10-614_h_a_dec_1.pdf@2010-06-09 00:00:00@Menveo@Meningococcal Group A, C, W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_4.pdf@EU-1-09-609_h_a_dec_4.pdf@2013-09-19 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_1.pdf@EU-1-10-615_h_a_dec_1.pdf@2011-05-27 00:00:00@Temozolomide Hospira@Temozolomide@NAS before 2012@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_1.pdf@EU-1-10-612_h_a_dec_1.pdf@2010-11-03 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@adopted@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_10.pdf@EU-1-10-614_h_a_dec_10.pdf@2016-02-03 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@GSK Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_0.pdf@EU-1-10-619_h_a_dec_0.pdf@2010-03-15 00:00:00@DuoPlavin@clopidogrel /  acetylsalicylic acid@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_1.pdf@EU-1-10-618_h_a_dec_1.pdf@2011-02-02 00:00:00@Prolia@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
nd@Parsed
EU-1-10-614_h_a_dec_11.pdf@EU-1-10-614_h_a_dec_11.pdf@2017-10-30 00:00:00@Menveo@Meningococcal  Group A, C, W-135 and Y Coniugate  Vaccine@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_10.pdf@EU-1-10-615_h_a_dec_10.pdf@2019-02-25 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_1.pdf@EU-1-10-619_h_a_dec_1.pdf@2010-06-08 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol- Myers Squibb SNC@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_10.pdf@EU-1-10-612_h_a_dec_10.pdf@2016-01-28 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_10.pdf@EU-1-10-618_h_a_dec_10.pdf@2014-08-26 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_6.pdf@EU-1-09-609_h_a_dec_6.pdf@2014-08-22 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_0.pdf@EU-1-10-620_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristfor@sitagliptin / metformin  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_10.pdf@EU-1-10-619_h_a_dec_10.pdf@2017-03-04 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_12.pdf@EU-1-10-614_h_a_dec_12.pdf@2020-01-23 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@GSK Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_11.pdf@EU-1-10-618_h_a_dec_11.pdf@2015-01-15 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_11.pdf@EU-1-10-615_h_a_dec_11.pdf@2020-10-19 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_11.pdf@EU-1-10-619_h_a_dec_11.pdf@2018-10-25 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_7.pdf@EU-1-09-609_h_a_dec_7.pdf@2014-10-30 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_1.pdf@EU-1-10-620_h_a_dec_1.pdf@2010-06-08 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_11.pdf@EU-1-10-612_h_a_dec_11.pdf@2016-04-04 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_12.pdf@EU-1-10-618_h_a_dec_12.pdf@2015-06-30 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_13.pdf@EU-1-10-614_h_a_dec_13.pdf@2021-01-29 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@GSK Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_12.pdf@EU-1-10-619_h_a_dec_12.pdf@2019-03-09 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_13.pdf@EU-1-10-618_h_a_dec_13.pdf@2017-02-05 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_12.pdf@EU-1-10-615_h_a_dec_12.pdf@2022-04-02 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_8.pdf@EU-1-09-609_h_a_dec_8.pdf@2016-11-21 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_13.pdf@EU-1-10-619_h_a_dec_13.pdf@2019-11-14 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_10.pdf@EU-1-10-620_h_a_dec_10.pdf@2015-11-11 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_12.pdf@EU-1-10-612_h_a_dec_12.pdf@2017-02-16 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_2.pdf@EU-1-10-615_h_a_dec_2.pdf@2012-05-25 00:00:00@Temozolomide Hospira@temozolomide@False@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_14.pdf@EU-1-10-614_h_a_dec_14.pdf@2022-09-29 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@GSK Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_14.pdf@EU-1-10-618_h_a_dec_14.pdf@2017-06-23 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_14.pdf@EU-1-10-619_h_a_dec_14.pdf@2020-11-16 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-09-609_h_a_dec_9.pdf@EU-1-09-609_h_a_dec_9.pdf@2018-04-26 00:00:00@Elonva@corifollitropin alfa@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_3.pdf@EU-1-10-615_h_a_dec_3.pdf@2012-10-25 00:00:00@Temozolomide Hospira@temozolomide@False@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_15.pdf@EU-1-10-618_h_a_dec_15.pdf@2017-09-18 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_2.pdf@EU-1-10-614_h_a_dec_2.pdf@2011-01-27 00:00:00@Menveo@Meningococcal Group A, C, W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_13.pdf@EU-1-10-612_h_a_dec_13.pdf@2017-07-19 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_11.pdf@EU-1-10-620_h_a_dec_11.pdf@2016-12-12 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  12.12.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2010)1783 for “Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_2.pdf@EU-1-10-619_h_a_dec_2.pdf@2010-12-20 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol- Myers Squibb SNC@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_16.pdf@EU-1-10-618_h_a_dec_16.pdf@2018-04-06 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_3.pdf@EU-1-10-614_h_a_dec_3.pdf@2011-03-18 00:00:00@Menveo@Meningococcal  Group A, C, W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines  and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_4.pdf@EU-1-10-615_h_a_dec_4.pdf@2014-02-28 00:00:00@Temozolomide Hospira@temozolomide@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_3.pdf@EU-1-10-619_h_a_dec_3.pdf@2012-05-25 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_14.pdf@EU-1-10-612_h_a_dec_14.pdf@2017-09-28 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_12.pdf@EU-1-10-620_h_a_dec_12.pdf@2017-12-15 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_17.pdf@EU-1-10-618_h_a_dec_17.pdf@2019-04-07 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_4.pdf@EU-1-10-614_h_a_dec_4.pdf@2011-07-26 00:00:00@Menveo@Meningococcal Group A, C, W-135 and Y Coniugate  Vaccine@NAS before 2012@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_4.pdf@EU-1-10-619_h_a_dec_4.pdf@2013-05-30 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_15.pdf@EU-1-10-612_h_a_dec_15.pdf@2018-06-04 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_18.pdf@EU-1-10-618_h_a_dec_18.pdf@2020-01-16 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_5.pdf@EU-1-10-615_h_a_dec_5.pdf@2015-12-01 00:00:00@Temozolomide Hospira@temozolomide@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_5.pdf@EU-1-10-614_h_a_dec_5.pdf@2012-04-24 00:00:00@Menveo@Meningococcal Group A, C, W-135 and Y Coniugate  Vaccine@False@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_5.pdf@EU-1-10-619_h_a_dec_5.pdf@2013-07-19 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_13.pdf@EU-1-10-620_h_a_dec_13.pdf@2018-05-22 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_19.pdf@EU-1-10-618_h_a_dec_19.pdf@2022-01-25 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_6.pdf@EU-1-10-614_h_a_dec_6.pdf@2012-06-27 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_6.pdf@EU-1-10-615_h_a_dec_6.pdf@2015-05-27 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_2.pdf@EU-1-10-618_h_a_dec_2.pdf@2011-08-26 00:00:00@Prolia@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_16.pdf@EU-1-10-612_h_a_dec_16.pdf@2018-06-07 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_6.pdf@EU-1-10-619_h_a_dec_6.pdf@2014-09-18 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_0.pdf@EU-1-10-621_h_a_dec_0.pdf@2010-03-15 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_14.pdf@EU-1-10-620_h_a_dec_14.pdf@2018-06-29 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_7.pdf@EU-1-10-614_h_a_dec_7.pdf@2014-02-28 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_20.pdf@EU-1-10-618_h_a_dec_20.pdf@2022-05-05 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_1.pdf@EU-1-10-621_h_a_dec_1.pdf@2010-06-08 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_7.pdf@EU-1-10-619_h_a_dec_7.pdf@2014-11-19 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_15.pdf@EU-1-10-620_h_a_dec_15.pdf@2021-06-09 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_7.pdf@EU-1-10-615_h_a_dec_7.pdf@2016-02-06 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_3.pdf@EU-1-10-618_h_a_dec_3.pdf@2012-02-27 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe  B.V.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_8.pdf@EU-1-10-614_h_a_dec_8.pdf@2014-07-28 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_4.pdf@EU-1-10-618_h_a_dec_4.pdf@2012-03-15 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe  B.V.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_17.pdf@EU-1-10-612_h_a_dec_17.pdf@2019-06-02 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_8.pdf@EU-1-10-619_h_a_dec_8.pdf@2016-02-03 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_16.pdf@EU-1-10-620_h_a_dec_16.pdf@2022-09-29 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_10.pdf@EU-1-10-621_h_a_dec_10.pdf@2014-12-16 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_8.pdf@EU-1-10-615_h_a_dec_8.pdf@2017-05-22 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_5.pdf@EU-1-10-618_h_a_dec_5.pdf@2012-04-20 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe  B.V.@CMA Not Found@Parsed
EU-1-10-619_h_a_dec_9.pdf@EU-1-10-619_h_a_dec_9.pdf@2016-08-12 00:00:00@DuoPlavin@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_2.pdf@EU-1-10-620_h_a_dec_2.pdf@2010-03-11 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-614_h_a_dec_9.pdf@EU-1-10-614_h_a_dec_9.pdf@2014-04-12 00:00:00@Menveo@Meningococcal Group A, C, W135 and Y Conjugate Vaccine@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_6.pdf@EU-1-10-618_h_a_dec_6.pdf@2012-10-23 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_18.pdf@EU-1-10-612_h_a_dec_18.pdf@2019-12-18 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_11.pdf@EU-1-10-621_h_a_dec_11.pdf@2015-05-28 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_3.pdf@EU-1-10-620_h_a_dec_3.pdf@2010-11-26 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-615_h_a_dec_9.pdf@EU-1-10-615_h_a_dec_9.pdf@2018-06-29 00:00:00@Temozolomide Accord@temozolomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_7.pdf@EU-1-10-618_h_a_dec_7.pdf@2012-11-15 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_4.pdf@EU-1-10-620_h_a_dec_4.pdf@2011-02-21 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_12.pdf@EU-1-10-621_h_a_dec_12.pdf@2016-06-30 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_8.pdf@EU-1-10-618_h_a_dec_8.pdf@2013-12-20 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_19.pdf@EU-1-10-612_h_a_dec_19.pdf@2020-12-14 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_5.pdf@EU-1-10-620_h_a_dec_5.pdf@2011-08-24 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_2.pdf@EU-1-10-612_h_a_dec_2.pdf@2011-02-05 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_13.pdf@EU-1-10-621_h_a_dec_13.pdf@2017-03-10 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_6.pdf@EU-1-10-620_h_a_dec_6.pdf@2012-08-30 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_0.pdf@EU-1-10-622_h_a_dec_0.pdf@2010-03-15 00:00:00@TEPADINA@Thiotepa@NAS before 2012@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-618_h_a_dec_9.pdf@EU-1-10-618_h_a_dec_9.pdf@2014-03-06 00:00:00@Prolia@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_0.pdf@EU-1-10-627_h_a_dec_0.pdf@2010-04-29 00:00:00@Raloxifene Teva@Raloxifene  hydrochloride@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_7.pdf@EU-1-10-620_h_a_dec_7.pdf@2012-12-18 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_1.pdf@EU-1-10-622_h_a_dec_1.pdf@2011-06-01 00:00:00@Tepadina@Thiotepa@NAS before 2012@False@OD Not Found@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_14.pdf@EU-1-10-621_h_a_dec_14.pdf@2017-12-15 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_1.pdf@EU-1-10-627_h_a_dec_1.pdf@2011-09-13 00:00:00@Raloxifene  Teva@Raloxifene hydrochloride@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_20.pdf@EU-1-10-612_h_a_dec_20.pdf@2022-04-02 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_8.pdf@EU-1-10-620_h_a_dec_8.pdf@2014-03-06 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_2.pdf@EU-1-10-627_h_a_dec_2.pdf@2012-10-29 00:00:00@Raloxifene  Teva@Raloxifene hydrochloride@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_10.pdf@EU-1-10-622_h_a_dec_10.pdf@2022-08-07 00:00:00@Tepadina@Thiotepa@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_15.pdf@EU-1-10-621_h_a_dec_15.pdf@2018-05-22 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_3.pdf@EU-1-10-612_h_a_dec_3.pdf@2011-02-05 00:00:00@Revolade@Eltrombopag@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Trading Services Limited@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_2.pdf@EU-1-10-622_h_a_dec_2.pdf@2011-08-26 00:00:00@Tepadina@Thiotepa@NAS before 2012@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_3.pdf@EU-1-10-627_h_a_dec_3.pdf@2015-06-02 00:00:00@Raloxifene Teva@Raloxifene hydrochloride@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-620_h_a_dec_9.pdf@EU-1-10-620_h_a_dec_9.pdf@2014-12-16 00:00:00@Ristfor@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_4.pdf@EU-1-10-612_h_a_dec_4.pdf@2012-04-26 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_3.pdf@EU-1-10-622_h_a_dec_3.pdf@2011-06-01 00:00:00@Tepadina@Thiotepa@NAS before 2012@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_4.pdf@EU-1-10-627_h_a_dec_4.pdf@2015-05-27 00:00:00@Raloxifene Teva@Raloxifene hydrochloride@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_16.pdf@EU-1-10-621_h_a_dec_16.pdf@2018-08-23 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_5.pdf@EU-1-10-612_h_a_dec_5.pdf@2012-06-27 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@GlaxoSmithKline  Trading Services Limited@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_5.pdf@EU-1-10-627_h_a_dec_5.pdf@2017-06-07 00:00:00@Raloxifene  Teva@Raloxifene hydrochloride@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_17.pdf@EU-1-10-621_h_a_dec_17.pdf@2020-09-03 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_4.pdf@EU-1-10-622_h_a_dec_4.pdf@2014-04-28 00:00:00@Tepadina@Thiotepa@False@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_0.pdf@EU-1-10-628_h_a_dec_0.pdf@2010-06-14 00:00:00@Votrient@Pazopanib  hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-612_h_a_dec_6.pdf@EU-1-10-612_h_a_dec_6.pdf@2013-09-19 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-10-627_h_a_dec_6.pdf@EU-1-10-627_h_a_dec_6.pdf@2021-12-20 00:00:00@Raloxifene  Teva@Raloxifene hydrochloride@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_18.pdf@EU-1-10-621_h_a_dec_18.pdf@2021-08-27 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_0.pdf@EU-1-10-631_h_a_dec_0.pdf@2010-08-06 00:00:00@Nivestim@Filgrastim@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_1.pdf@EU-1-10-628_h_a_dec_1.pdf@2011-01-02 00:00:00@Votrient@Pazopanib hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_5.pdf@EU-1-10-622_h_a_dec_5.pdf@2014-11-17 00:00:00@Tepadina@Thiotepa@False@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_19.pdf@EU-1-10-621_h_a_dec_19.pdf@2022-09-29 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_1.pdf@EU-1-10-631_h_a_dec_1.pdf@2011-01-02 00:00:00@Nivestim@Filgrastim@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_7.pdf@EU-1-10-612_h_a_dec_7.pdf@2015-01-15 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_10.pdf@EU-1-10-628_h_a_dec_10.pdf@2012-10-24 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-622_h_a_dec_6.pdf@EU-1-10-622_h_a_dec_6.pdf@2016-12-05 00:00:00@Tepadina@Thiotepa@False@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_2.pdf@EU-1-10-621_h_a_dec_2.pdf@2010-03-11 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_10.pdf@EU-1-10-631_h_a_dec_10.pdf@2020-11-18 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_0.pdf@EU-1-10-632_h_a_dec_0.pdf@2010-04-06 00:00:00@Tolura@telmisartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_11.pdf@EU-1-10-628_h_a_dec_11.pdf@2011-06-05 00:00:00@Votrient@Pazopanib hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-633_h_a_dec_0.pdf@EU-1-10-633_h_a_dec_0.pdf@2010-10-06 00:00:00@Topotecan Hospira@Topotecan@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_7.pdf@EU-1-10-622_h_a_dec_7.pdf@2018-02-08 00:00:00@Tepadina@Thiotepa@False@False@adopted@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_1.pdf@EU-1-10-632_h_a_dec_1.pdf@2011-04-20 00:00:00@Tolura@telmisartan@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_3.pdf@EU-1-10-621_h_a_dec_3.pdf@2010-11-26 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_2.pdf@EU-1-10-631_h_a_dec_2.pdf@2012-06-14 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_8.pdf@EU-1-10-612_h_a_dec_8.pdf@2015-06-05 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_1.pdf@EU-1-10-633_h_a_dec_1.pdf@2011-06-10 00:00:00@Topotecan  Hospira@topotecan@NAS before 2012@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_8.pdf@EU-1-10-622_h_a_dec_8.pdf@2020-03-11 00:00:00@Tepadina@Thiotepa@False@False@OD Not Found@ADIENNE S.r.l.@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_2.pdf@EU-1-10-632_h_a_dec_2.pdf@2012-10-31 00:00:00@Tolura@telmisartan@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_13.pdf@EU-1-10-628_h_a_dec_13.pdf@2013-06-14 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-621_h_a_dec_4.pdf@EU-1-10-621_h_a_dec_4.pdf@2011-02-21 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_2.pdf@EU-1-10-633_h_a_dec_2.pdf@2012-05-15 00:00:00@Topotecan  Hospira@topotecan@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-622_h_a_dec_9.pdf@EU-1-10-622_h_a_dec_9.pdf@2021-03-26 00:00:00@Tepadina@Thiotepa@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_4.pdf@EU-1-10-631_h_a_dec_4.pdf@2015-01-15 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-612_h_a_dec_9.pdf@EU-1-10-612_h_a_dec_9.pdf@2015-08-25 00:00:00@Revolade@Eltrombopag@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_5.pdf@EU-1-10-621_h_a_dec_5.pdf@2011-08-24 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_3.pdf@EU-1-10-633_h_a_dec_3.pdf@2012-10-29 00:00:00@Topotecan  Hospira@topotecan@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_3.pdf@EU-1-10-632_h_a_dec_3.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2010)3711 for “Tolura@telmisartan@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_14.pdf@EU-1-10-628_h_a_dec_14.pdf@2013-01-07 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_6.pdf@EU-1-10-621_h_a_dec_6.pdf@2011-12-22 00:00:00@Ristaben@sitagliptin@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_5.pdf@EU-1-10-631_h_a_dec_5.pdf@2015-05-27 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_4.pdf@EU-1-10-632_h_a_dec_4.pdf@2015-03-19 00:00:00@Tolura@telmisartan@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_4.pdf@EU-1-10-633_h_a_dec_4.pdf@2014-06-27 00:00:00@Topotecan  Hospira@topotecan@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_7.pdf@EU-1-10-621_h_a_dec_7.pdf@2012-08-30 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme  Ltd.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_8.pdf@EU-1-10-621_h_a_dec_8.pdf@2012-12-18 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp &  Dohme Ltd.@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_5.pdf@EU-1-10-632_h_a_dec_5.pdf@2016-06-24 00:00:00@Tolura@telmisartan@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_15.pdf@EU-1-10-628_h_a_dec_15.pdf@2015-01-15 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_6.pdf@EU-1-10-631_h_a_dec_6.pdf@2016-06-07 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_5.pdf@EU-1-10-633_h_a_dec_5.pdf@2015-05-28 00:00:00@Topotecan Hospira@topotecan@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_6.pdf@EU-1-10-632_h_a_dec_6.pdf@2019-09-23 00:00:00@Tolura@telmisartan@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-10-621_h_a_dec_9.pdf@EU-1-10-621_h_a_dec_9.pdf@2014-08-19 00:00:00@Ristaben@sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_7.pdf@EU-1-10-631_h_a_dec_7.pdf@2017-09-18 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_6.pdf@EU-1-10-633_h_a_dec_6.pdf@2016-11-14 00:00:00@Topotecan  Hospira@topotecan@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_16.pdf@EU-1-10-628_h_a_dec_16.pdf@2015-05-05 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-10-632_h_a_dec_7.pdf@EU-1-10-632_h_a_dec_7.pdf@2021-02-08 00:00:00@Tolura@telmisartan@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_8.pdf@EU-1-10-631_h_a_dec_8.pdf@2018-08-23 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_7.pdf@EU-1-10-633_h_a_dec_7.pdf@2018-09-20 00:00:00@Topotecan Hospira@topotecan@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_17.pdf@EU-1-10-628_h_a_dec_17.pdf@2015-07-17 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_0.pdf@EU-1-10-635_h_a_dec_0.pdf@2010-10-06 00:00:00@Olanzapine Apotex@Olanzapine@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-631_h_a_dec_9.pdf@EU-1-10-631_h_a_dec_9.pdf@2019-09-16 00:00:00@Nivestim@Filgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_1.pdf@EU-1-10-635_h_a_dec_1.pdf@2011-12-05 00:00:00@Olanzapine Apotex@Olanzapine@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_8.pdf@EU-1-10-633_h_a_dec_8.pdf@2019-05-12 00:00:00@Topotecan  Hospira@topotecan@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-10-633_h_a_dec_9.pdf@EU-1-10-633_h_a_dec_9.pdf@2021-10-22 00:00:00@Topotecan  Hospira@topotecan@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_18.pdf@EU-1-10-628_h_a_dec_18.pdf@2016-07-14 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_10.pdf@EU-1-10-635_h_a_dec_10.pdf@2021-06-24 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_2.pdf@EU-1-10-635_h_a_dec_2.pdf@2012-06-02 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_0.pdf@EU-1-10-636_h_a_dec_0.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_19.pdf@EU-1-10-628_h_a_dec_19.pdf@2017-11-09 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_3.pdf@EU-1-10-635_h_a_dec_3.pdf@2012-09-20 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_0.pdf@EU-1-10-637_h_a_dec_0.pdf@2010-07-27 00:00:00@Leflunomide medac@leflunomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_1.pdf@EU-1-10-636_h_a_dec_1.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_2.pdf@EU-1-10-628_h_a_dec_2.pdf@2011-02-05 00:00:00@Votrient@Pazopanib hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-635_h_a_dec_4.pdf@EU-1-10-635_h_a_dec_4.pdf@2012-11-22 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_0.pdf@EU-1-10-638_h_a_dec_0.pdf@2010-07-27 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_0.pdf@EU-1-10-639_h_a_dec_0.pdf@2010-09-30 00:00:00@Telmisartan Actavis@telmisartan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_10.pdf@EU-1-10-636_h_a_dec_10.pdf@2015-08-04 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_1.pdf@EU-1-10-637_h_a_dec_1.pdf@2010-07-27 00:00:00@Leflunomide medac@leflunomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_5.pdf@EU-1-10-635_h_a_dec_5.pdf@2014-07-28 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_1.pdf@EU-1-10-638_h_a_dec_1.pdf@2010-07-27 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd,,@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_1.pdf@EU-1-10-639_h_a_dec_1.pdf@2012-10-05 00:00:00@Telmisartan Actavis@telmisartan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_0.pdf@EU-1-10-640_h_a_dec_0.pdf@2010-01-09 00:00:00@Sycrest@asenapine@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_20.pdf@EU-1-10-628_h_a_dec_20.pdf@2018-08-01 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_11.pdf@EU-1-10-636_h_a_dec_11.pdf@2015-04-24 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_6.pdf@EU-1-10-635_h_a_dec_6.pdf@2015-11-02 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_2.pdf@EU-1-10-637_h_a_dec_2.pdf@2010-07-27 00:00:00@Leflunomide medac@leflunomide@NAS before 2012@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_2.pdf@EU-1-10-639_h_a_dec_2.pdf@2012-10-29 00:00:00@Telmisartan Actavis@telmisartan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_1.pdf@EU-1-10-640_h_a_dec_1.pdf@2011-07-27 00:00:00@Sycrest@asenapine@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_12.pdf@EU-1-10-636_h_a_dec_12.pdf@2015-10-28 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Takeda GmbH, (HRB 701257)@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_10.pdf@EU-1-10-638_h_a_dec_10.pdf@2014-08-26 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_7.pdf@EU-1-10-635_h_a_dec_7.pdf@2017-09-14 00:00:00@Olanzapine  Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_3.pdf@EU-1-10-637_h_a_dec_3.pdf@2012-01-30 00:00:00@Leflunomide medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_10.pdf@EU-1-10-640_h_a_dec_10.pdf@2021-04-02 00:00:00@Sycrest@asenapine@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_21.pdf@EU-1-10-628_h_a_dec_21.pdf@2018-08-05 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_13.pdf@EU-1-10-636_h_a_dec_13.pdf@2016-11-18 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Takeda GmbH, (HRB 701016)@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_3.pdf@EU-1-10-639_h_a_dec_3.pdf@2014-04-09 00:00:00@, medicinal product for human use (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2010)6912 for “Telmisartan Actavis@telmisartan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_4.pdf@EU-1-10-637_h_a_dec_4.pdf@2012-10-29 00:00:00@Leflunomide medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_2.pdf@EU-1-10-640_h_a_dec_2.pdf@2011-10-24 00:00:00@Sycrest@asenapine@NAS before 2012@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_14.pdf@EU-1-10-636_h_a_dec_14.pdf@2018-04-23 00:00:00@Daxas@roflumilast@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_11.pdf@EU-1-10-638_h_a_dec_11.pdf@2015-03-23 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_8.pdf@EU-1-10-635_h_a_dec_8.pdf@2019-12-06 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_5.pdf@EU-1-10-637_h_a_dec_5.pdf@2013-07-25 00:00:00@Leflunomide medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_3.pdf@EU-1-10-640_h_a_dec_3.pdf@2012-06-27 00:00:00@Sycrest@asenapine@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_4.pdf@EU-1-10-639_h_a_dec_4.pdf@2015-06-19 00:00:00@Telmisartan Actavis@telmisartan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_15.pdf@EU-1-10-636_h_a_dec_15.pdf@2020-05-20 00:00:00@Daxas@roflumilast@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_22.pdf@EU-1-10-628_h_a_dec_22.pdf@2020-07-27 00:00:00@Votrient@Pazopanib  hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_4.pdf@EU-1-10-640_h_a_dec_4.pdf@2012-10-29 00:00:00@Sycrest@asenapine@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_6.pdf@EU-1-10-637_h_a_dec_6.pdf@2015-03-23 00:00:00@Leflunomide medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate  mbH@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_12.pdf@EU-1-10-638_h_a_dec_12.pdf@2017-11-15 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_16.pdf@EU-1-10-636_h_a_dec_16.pdf@2021-06-05 00:00:00@Daxas@roflumilast@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-635_h_a_dec_9.pdf@EU-1-10-635_h_a_dec_9.pdf@2020-06-25 00:00:00@Olanzapine Apotex@Olanzapine@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_7.pdf@EU-1-10-637_h_a_dec_7.pdf@2016-07-15 00:00:00@Leflunomide  medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-639_h_a_dec_5.pdf@EU-1-10-639_h_a_dec_5.pdf@2021-09-22 00:00:00@Telmisartan Actavis@telmisartan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_5.pdf@EU-1-10-640_h_a_dec_5.pdf@2014-11-02 00:00:00@Sycrest@asenapine@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_17.pdf@EU-1-10-636_h_a_dec_17.pdf@2022-09-21 00:00:00@Daxas@roflumilast@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_8.pdf@EU-1-10-637_h_a_dec_8.pdf@2018-06-21 00:00:00@Leflunomide  medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_23.pdf@EU-1-10-628_h_a_dec_23.pdf@2020-12-17 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_6.pdf@EU-1-10-640_h_a_dec_6.pdf@2015-05-05 00:00:00@Sycrest@asenapine@False@False@OD Not Found@N.V. Organon@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_13.pdf@EU-1-10-638_h_a_dec_13.pdf@2018-11-20 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_2.pdf@EU-1-10-636_h_a_dec_2.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-637_h_a_dec_9.pdf@EU-1-10-637_h_a_dec_9.pdf@2021-06-24 00:00:00@Leflunomide medac@leflunomide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_7.pdf@EU-1-10-640_h_a_dec_7.pdf@2015-10-28 00:00:00@Sycrest@asenapine@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_3.pdf@EU-1-10-636_h_a_dec_3.pdf@2010-05-07 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_24.pdf@EU-1-10-628_h_a_dec_24.pdf@2022-08-07 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-640_h_a_dec_8.pdf@EU-1-10-640_h_a_dec_8.pdf@2017-05-31 00:00:00@Sycrest@asenapine@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_14.pdf@EU-1-10-638_h_a_dec_14.pdf@2020-09-03 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_4.pdf@EU-1-10-636_h_a_dec_4.pdf@2011-10-24 00:00:00@Daxas@roflumilast@NAS before 2012@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_0.pdf@EU-1-10-641_h_a_dec_0.pdf@2010-10-28 00:00:00@Ruconest@conestat alfa@NAS before 2012@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_3.pdf@EU-1-10-628_h_a_dec_3.pdf@2011-06-05 00:00:00@Votrient@Pazopanib hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-640_h_a_dec_9.pdf@EU-1-10-640_h_a_dec_9.pdf@2019-07-02 00:00:00@Sycrest@asenapine@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_5.pdf@EU-1-10-636_h_a_dec_5.pdf@2012-04-10 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_1.pdf@EU-1-10-641_h_a_dec_1.pdf@2010-10-28 00:00:00@Ruconest@conestat alfa@NAS before 2012@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_4.pdf@EU-1-10-628_h_a_dec_4.pdf@2011-10-24 00:00:00@Votrient@Pazopanib hydrochloride@NAS before 2012@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-638_h_a_dec_15.pdf@EU-1-10-638_h_a_dec_15.pdf@2022-06-13 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_6.pdf@EU-1-10-636_h_a_dec_6.pdf@2012-10-24 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_2.pdf@EU-1-10-641_h_a_dec_2.pdf@2012-02-03 00:00:00@Ruconest@conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_5.pdf@EU-1-10-628_h_a_dec_5.pdf@2012-03-19 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-638_h_a_dec_2.pdf@EU-1-10-638_h_a_dec_2.pdf@2010-07-27 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_7.pdf@EU-1-10-636_h_a_dec_7.pdf@2013-03-22 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Nycomed GmbH@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_6.pdf@EU-1-10-628_h_a_dec_6.pdf@2012-05-22 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-641_h_a_dec_3.pdf@EU-1-10-641_h_a_dec_3.pdf@2014-10-03 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_8.pdf@EU-1-10-636_h_a_dec_8.pdf@2013-03-26 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_3.pdf@EU-1-10-638_h_a_dec_3.pdf@2011-06-16 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan  Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_7.pdf@EU-1-10-628_h_a_dec_7.pdf@2012-05-25 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-642_h_a_dec_0.pdf@EU-1-10-642_h_a_dec_0.pdf@2010-09-17 00:00:00@Ibandronic Acid Teva@Ibandronic  acid@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_4.pdf@EU-1-10-641_h_a_dec_4.pdf@2015-09-18 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_4.pdf@EU-1-10-638_h_a_dec_4.pdf@2011-03-11 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan  Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-636_h_a_dec_9.pdf@EU-1-10-636_h_a_dec_9.pdf@2014-01-09 00:00:00@Daxas@roflumilast@False@False@OD Not Found@Takeda GmbH@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_8.pdf@EU-1-10-628_h_a_dec_8.pdf@2012-03-08 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-643_h_a_dec_0.pdf@EU-1-10-643_h_a_dec_0.pdf@2010-06-09 00:00:00@Rapiscan@regadenoson@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_1.pdf@EU-1-10-642_h_a_dec_1.pdf@2010-09-17 00:00:00@Ibandronic Acid Teva@Ibandronic  acid@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_5.pdf@EU-1-10-641_h_a_dec_5.pdf@2016-03-31 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_0.pdf@EU-1-10-644_h_a_dec_0.pdf@2010-08-31 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_5.pdf@EU-1-10-638_h_a_dec_5.pdf@2011-12-22 00:00:00@Ozurdex@Dexamethasone@NAS before 2012@False@OD Not Found@Allergan  Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-628_h_a_dec_9.pdf@EU-1-10-628_h_a_dec_9.pdf@2012-08-30 00:00:00@Votrient@Pazopanib hydrochloride@False@False@OD Not Found@Glaxo Group Limited@conditional@Parsed
EU-1-10-642_h_a_dec_10.pdf@EU-1-10-642_h_a_dec_10.pdf@2021-07-23 00:00:00@Ibandronic Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_1.pdf@EU-1-10-643_h_a_dec_1.pdf@2011-11-01 00:00:00@Rapiscan@regadenoson@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_6.pdf@EU-1-10-641_h_a_dec_6.pdf@2017-11-01 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_6.pdf@EU-1-10-638_h_a_dec_6.pdf@2012-10-09 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan  Pharmaceuticals (Ireland) Ltd@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_1.pdf@EU-1-10-644_h_a_dec_1.pdf@2010-08-31 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_2.pdf@EU-1-10-642_h_a_dec_2.pdf@2011-06-29 00:00:00@Ibandronic Acid Teva@Ibandronic acid@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_7.pdf@EU-1-10-641_h_a_dec_7.pdf@2017-08-24 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_7.pdf@EU-1-10-638_h_a_dec_7.pdf@2013-06-03 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland,  (901969)@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_3.pdf@EU-1-10-642_h_a_dec_3.pdf@2012-10-05 00:00:00@Ibandronic Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_10.pdf@EU-1-10-643_h_a_dec_10.pdf@2017-11-12 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_8.pdf@EU-1-10-641_h_a_dec_8.pdf@2018-08-11 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_10.pdf@EU-1-10-644_h_a_dec_10.pdf@2017-02-06 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_8.pdf@EU-1-10-638_h_a_dec_8.pdf@2013-05-16 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_4.pdf@EU-1-10-642_h_a_dec_4.pdf@2012-10-29 00:00:00@Ibandronic Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_0.pdf@EU-1-10-645_h_a_dec_0.pdf@2010-01-09 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-641_h_a_dec_9.pdf@EU-1-10-641_h_a_dec_9.pdf@2020-04-28 00:00:00@Ruconest@Conestat alfa@False@False@OD Not Found@Pharming Group N.V.@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_11.pdf@EU-1-10-643_h_a_dec_11.pdf@2018-11-20 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_1.pdf@EU-1-10-645_h_a_dec_1.pdf@2010-01-09 00:00:00@Brinavess@vernakalant  hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-638_h_a_dec_9.pdf@EU-1-10-638_h_a_dec_9.pdf@2014-06-19 00:00:00@Ozurdex@dexamethasone@False@False@OD Not Found@Allergan Pharmaceuticals Ireland@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_5.pdf@EU-1-10-642_h_a_dec_5.pdf@2014-06-27 00:00:00@Ibandronic Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_11.pdf@EU-1-10-644_h_a_dec_11.pdf@2018-08-05 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Kyowa Kirin Services Ltd@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_6.pdf@EU-1-10-642_h_a_dec_6.pdf@2014-01-12 00:00:00@Ibandronic Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_10.pdf@EU-1-10-645_h_a_dec_10.pdf@2015-05-27 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Cardiome UK Limited@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_12.pdf@EU-1-10-643_h_a_dec_12.pdf@2019-01-23 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_12.pdf@EU-1-10-644_h_a_dec_12.pdf@2018-07-19 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Kyowa Kirin Services Ltd@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_7.pdf@EU-1-10-642_h_a_dec_7.pdf@2015-06-25 00:00:00@Ibandronic Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_0.pdf@EU-1-10-646_h_a_dec_0.pdf@2010-08-26 00:00:00@VPRIV@Velaglucerase alfa@NAS before 2012@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_11.pdf@EU-1-10-645_h_a_dec_11.pdf@2015-07-28 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Cardiome UK Limited@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_13.pdf@EU-1-10-644_h_a_dec_13.pdf@2020-06-18 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_8.pdf@EU-1-10-642_h_a_dec_8.pdf@2016-09-15 00:00:00@Ibandronic  Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_13.pdf@EU-1-10-643_h_a_dec_13.pdf@2020-03-24 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_1.pdf@EU-1-10-646_h_a_dec_1.pdf@2011-06-29 00:00:00@VPRIV@Velaglucerase alfa@NAS before 2012@False@adopted@Shire Pharmaceuticals Ireland Limited,@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_14.pdf@EU-1-10-644_h_a_dec_14.pdf@2021-03-31 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-10-642_h_a_dec_9.pdf@EU-1-10-642_h_a_dec_9.pdf@2017-10-30 00:00:00@Ibandronic  Acid Teva@Ibandronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_0.pdf@EU-1-10-647_h_a_dec_0.pdf@2010-07-10 00:00:00@Myclausen@mycophenolate mofetil@NAS before 2012@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_12.pdf@EU-1-10-645_h_a_dec_12.pdf@2018-08-08 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Cardiome UK Limited@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_15.pdf@EU-1-10-644_h_a_dec_15.pdf@2022-07-15 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_1.pdf@EU-1-10-647_h_a_dec_1.pdf@2011-09-16 00:00:00@Myclausen@mycophenolate mofetil@NAS before 2012@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_14.pdf@EU-1-10-643_h_a_dec_14.pdf@2021-12-13 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_10.pdf@EU-1-10-646_h_a_dec_10.pdf@2019-03-28 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_13.pdf@EU-1-10-645_h_a_dec_13.pdf@2020-02-06 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Correvio@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_2.pdf@EU-1-10-644_h_a_dec_2.pdf@2011-06-14 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_2.pdf@EU-1-10-647_h_a_dec_2.pdf@2012-06-28 00:00:00@Myclausen@mycophenolate mofetil@False@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG,@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_2.pdf@EU-1-10-643_h_a_dec_2.pdf@2011-10-27 00:00:00@Rapiscan@regadenoson@NAS before 2012@False@OD Not Found@Rapidscan Pharma  Solutions EU Ltd.@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_3.pdf@EU-1-10-644_h_a_dec_3.pdf@2011-11-22 00:00:00@PecFent@Fentanyl@NAS before 2012@False@OD Not Found@Archimedes Development  Ltd@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_2.pdf@EU-1-10-645_h_a_dec_2.pdf@2011-11-02 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_0.pdf@EU-1-10-648_h_a_dec_0.pdf@2010-07-10 00:00:00@Twynsta@telmisartan / amlodipine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_3.pdf@EU-1-10-647_h_a_dec_3.pdf@2012-10-29 00:00:00@Myclausen@mycophenolate mofetil@False@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG,@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_3.pdf@EU-1-10-643_h_a_dec_3.pdf@2012-03-21 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma  Solutions EU Ltd.@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_4.pdf@EU-1-10-644_h_a_dec_4.pdf@2012-09-24 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_1.pdf@EU-1-10-648_h_a_dec_1.pdf@2011-06-14 00:00:00@Twynsta@telmisartan / amlodipine@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_3.pdf@EU-1-10-645_h_a_dec_3.pdf@2011-04-14 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_0.pdf@EU-1-10-652_h_a_dec_0.pdf@2011-07-20 00:00:00@TOBI Podhaler@Tobramycin@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_11.pdf@EU-1-10-646_h_a_dec_11.pdf@2020-06-18 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_4.pdf@EU-1-10-643_h_a_dec_4.pdf@2012-10-29 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd.,@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_5.pdf@EU-1-10-644_h_a_dec_5.pdf@2012-10-31 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_10.pdf@EU-1-10-648_h_a_dec_10.pdf@2018-05-31 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_4.pdf@EU-1-10-647_h_a_dec_4.pdf@2014-10-27 00:00:00@Myclausen@mycophenolate mofetil@False@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_4.pdf@EU-1-10-645_h_a_dec_4.pdf@2011-04-14 00:00:00@Brinavess@vernakalant hydrochloride@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_1.pdf@EU-1-10-652_h_a_dec_1.pdf@2011-07-20 00:00:00@TOBI Podhaler@Tobramycin@NAS before 2012@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_5.pdf@EU-1-10-647_h_a_dec_5.pdf@2015-05-27 00:00:00@Myclausen@mycophenolate mofetil@False@False@OD Not Found@Herbert J. Passauer GmbH & Co. KG@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_11.pdf@EU-1-10-648_h_a_dec_11.pdf@2019-06-05 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_5.pdf@EU-1-10-645_h_a_dec_5.pdf@2012-03-26 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Merck Sharp &  Dohme Limited@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_6.pdf@EU-1-10-644_h_a_dec_6.pdf@2014-02-28 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_5.pdf@EU-1-10-643_h_a_dec_5.pdf@2013-11-15 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd.@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_12.pdf@EU-1-10-646_h_a_dec_12.pdf@2020-07-23 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_6.pdf@EU-1-10-647_h_a_dec_6.pdf@2016-12-08 00:00:00@Myclausen@mycophenolate mofetil@False@False@OD Not Found@Passauer Pharma GmbH@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_12.pdf@EU-1-10-648_h_a_dec_12.pdf@2020-08-13 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_6.pdf@EU-1-10-645_h_a_dec_6.pdf@2012-04-20 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_10.pdf@EU-1-10-652_h_a_dec_10.pdf@2021-11-22 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Mylan IRE Healthcare Ltd@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_7.pdf@EU-1-10-645_h_a_dec_7.pdf@2012-08-23 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme  Limited@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_7.pdf@EU-1-10-647_h_a_dec_7.pdf@2018-05-03 00:00:00@Myclausen@mycophenolate  mofetil@False@False@OD Not Found@Passauer Pharma GmbH@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_6.pdf@EU-1-10-643_h_a_dec_6.pdf@2014-01-16 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd.@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_2.pdf@EU-1-10-648_h_a_dec_2.pdf@2012-02-27 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_7.pdf@EU-1-10-644_h_a_dec_7.pdf@2015-03-30 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_2.pdf@EU-1-10-652_h_a_dec_2.pdf@2012-05-14 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_13.pdf@EU-1-10-646_h_a_dec_13.pdf@2021-09-29 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_3.pdf@EU-1-10-648_h_a_dec_3.pdf@2012-05-25 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_8.pdf@EU-1-10-647_h_a_dec_8.pdf@2021-02-18 00:00:00@Myclausen@mycophenolate mofetil@False@False@OD Not Found@Passauer Pharma GmbH@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_8.pdf@EU-1-10-645_h_a_dec_8.pdf@2013-06-21 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_2.pdf@EU-1-10-646_h_a_dec_2.pdf@2012-03-26 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire  Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_8.pdf@EU-1-10-644_h_a_dec_8.pdf@2015-07-17 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_4.pdf@EU-1-10-648_h_a_dec_4.pdf@2012-10-25 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_3.pdf@EU-1-10-652_h_a_dec_3.pdf@2013-09-24 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-647_h_a_dec_9.pdf@EU-1-10-647_h_a_dec_9.pdf@2022-02-16 00:00:00@Myclausen@mycophenolate  mofetil@False@False@OD Not Found@Passauer Pharma GmbH@CMA Not Found@Parsed
EU-1-10-645_h_a_dec_9.pdf@EU-1-10-645_h_a_dec_9.pdf@2014-11-28 00:00:00@Brinavess@vernakalant hydrochloride@False@False@OD Not Found@Cardiome UK Limited@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_7.pdf@EU-1-10-643_h_a_dec_7.pdf@2014-07-22 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd.@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_3.pdf@EU-1-10-646_h_a_dec_3.pdf@2012-06-27 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire  Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_5.pdf@EU-1-10-648_h_a_dec_5.pdf@2013-12-08 00:00:00@Twynsta@telmisartan /  amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-644_h_a_dec_9.pdf@EU-1-10-644_h_a_dec_9.pdf@2015-07-28 00:00:00@PecFent@Fentanyl@False@False@OD Not Found@Archimedes Development Ltd@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_4.pdf@EU-1-10-652_h_a_dec_4.pdf@2015-01-15 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_8.pdf@EU-1-10-643_h_a_dec_8.pdf@2015-04-24 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_4.pdf@EU-1-10-646_h_a_dec_4.pdf@2013-12-20 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_6.pdf@EU-1-10-648_h_a_dec_6.pdf@2014-02-13 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_5.pdf@EU-1-10-652_h_a_dec_5.pdf@2015-11-02 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-643_h_a_dec_9.pdf@EU-1-10-643_h_a_dec_9.pdf@2015-07-17 00:00:00@Rapiscan@regadenoson@False@False@OD Not Found@Rapidscan Pharma Solutions EU Ltd@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_5.pdf@EU-1-10-646_h_a_dec_5.pdf@2015-01-27 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_0.pdf@EU-1-10-654_h_a_dec_0.pdf@2010-11-29 00:00:00@Leflunomide ratiopharm@leflunomide@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_6.pdf@EU-1-10-652_h_a_dec_6.pdf@2016-02-18 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_7.pdf@EU-1-10-648_h_a_dec_7.pdf@2014-04-09 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2010)7080 for “Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_0.pdf@EU-1-10-655_h_a_dec_0.pdf@2010-03-12 00:00:00@Brilique@ticagrelor@NAS before 2012@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_6.pdf@EU-1-10-646_h_a_dec_6.pdf@2015-06-19 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_1.pdf@EU-1-10-654_h_a_dec_1.pdf@2010-11-29 00:00:00@Leflunomide ratiopharm@leflunomide@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_8.pdf@EU-1-10-648_h_a_dec_8.pdf@2015-08-20 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_1.pdf@EU-1-10-655_h_a_dec_1.pdf@2012-05-14 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_7.pdf@EU-1-10-652_h_a_dec_7.pdf@2018-04-23 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_10.pdf@EU-1-10-654_h_a_dec_10.pdf@2021-07-28 00:00:00@Leflunomide ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_7.pdf@EU-1-10-646_h_a_dec_7.pdf@2016-09-06 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_0.pdf@EU-1-10-658_h_a_dec_0.pdf@2010-11-29 00:00:00@Aflunov@Prepandemic influenza  vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-648_h_a_dec_9.pdf@EU-1-10-648_h_a_dec_9.pdf@2017-02-16 00:00:00@Twynsta@telmisartan / amlodipine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_10.pdf@EU-1-10-655_h_a_dec_10.pdf@2021-11-15 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_2.pdf@EU-1-10-654_h_a_dec_2.pdf@2011-09-22 00:00:00@Leflunomide ratiopharm@leflunomide@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_0.pdf@EU-1-10-659_h_a_dec_0.pdf@2011-01-21 00:00:00@Iasibon@Ibandronic acid@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_1.pdf@EU-1-10-658_h_a_dec_1.pdf@2011-05-09 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@NAS before 2012@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_8.pdf@EU-1-10-646_h_a_dec_8.pdf@2016-08-25 00:00:00@VPRIV@Velaglucerase alfa@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_2.pdf@EU-1-10-655_h_a_dec_2.pdf@2012-10-24 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_8.pdf@EU-1-10-652_h_a_dec_8.pdf@2019-06-28 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_3.pdf@EU-1-10-654_h_a_dec_3.pdf@2012-09-20 00:00:00@Leflunomide ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_1.pdf@EU-1-10-659_h_a_dec_1.pdf@2012-04-07 00:00:00@Iasibon@Ibandronic acid@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-646_h_a_dec_9.pdf@EU-1-10-646_h_a_dec_9.pdf@2016-10-14 00:00:00@(1) The development  this orphan medicinal product has complied with all measures  in the agreed paediatric investigation plan P/0157/2012. Therefore, the market  exclusivity period referred to in Article 8(1)  Regulation (EC) No 141/2000 should be  extended to twelve years in accordance with Article 37  Regulation (EC) No  1901/2006.@Active Substance Not Found@False@False@adopted@MAH Not Found@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_3.pdf@EU-1-10-655_h_a_dec_3.pdf@2014-06-23 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_10.pdf@EU-1-10-658_h_a_dec_10.pdf@2020-06-25 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Seqirus S.r.l.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_4.pdf@EU-1-10-654_h_a_dec_4.pdf@2014-01-22 00:00:00@Leflunomide ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-652_h_a_dec_9.pdf@EU-1-10-652_h_a_dec_9.pdf@2020-07-27 00:00:00@TOBI Podhaler@Tobramycin@False@False@adopted@Mylan IRE Healthcare Ltd@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_2.pdf@EU-1-10-659_h_a_dec_2.pdf@2014-05-22 00:00:00@Iasibon@Ibandronic acid@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_5.pdf@EU-1-10-654_h_a_dec_5.pdf@2015-06-02 00:00:00@Leflunomide  ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_4.pdf@EU-1-10-655_h_a_dec_4.pdf@2015-07-17 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_11.pdf@EU-1-10-658_h_a_dec_11.pdf@2022-03-24 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Seqirus S.r.l.@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_3.pdf@EU-1-10-659_h_a_dec_3.pdf@2015-08-07 00:00:00@Iasibon@Ibandronic acid@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_6.pdf@EU-1-10-654_h_a_dec_6.pdf@2015-05-13 00:00:00@Leflunomide  ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_5.pdf@EU-1-10-655_h_a_dec_5.pdf@2016-02-18 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_2.pdf@EU-1-10-658_h_a_dec_2.pdf@2012-06-02 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated,                                                    1 OJ L 136, 30.4.2004, p. 1. 2 OJ L 334, 12.12.2008, p. 7.  EN 3    EN adjuvanted)@False@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_7.pdf@EU-1-10-654_h_a_dec_7.pdf@2015-06-19 00:00:00@Leflunomide ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_4.pdf@EU-1-10-659_h_a_dec_4.pdf@2015-09-30 00:00:00@Iasibon@Ibandronic acid@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_6.pdf@EU-1-10-655_h_a_dec_6.pdf@2017-05-18 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_3.pdf@EU-1-10-658_h_a_dec_3.pdf@2012-04-20 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated,  adjuvanted)@False@False@OD Not Found@Novartis Vaccines and  Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_8.pdf@EU-1-10-654_h_a_dec_8.pdf@2016-09-22 00:00:00@Leflunomide  ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_5.pdf@EU-1-10-659_h_a_dec_5.pdf@2016-11-14 00:00:00@Iasibon@Ibandronic acid@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_7.pdf@EU-1-10-655_h_a_dec_7.pdf@2018-09-21 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_0.pdf@EU-1-10-660_h_a_dec_0.pdf@2011-06-01 00:00:00@Potactasol@topotecan@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_4.pdf@EU-1-10-658_h_a_dec_4.pdf@2013-08-02 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_0.pdf@EU-1-10-663_h_a_dec_0.pdf@2011-02-28 00:00:00@Lamivudine / Zidovudine Teva@lamivudine, zidovudine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-654_h_a_dec_9.pdf@EU-1-10-654_h_a_dec_9.pdf@2018-11-26 00:00:00@Leflunomide  ratiopharm@leflunomide@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_8.pdf@EU-1-10-655_h_a_dec_8.pdf@2019-10-24 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_1.pdf@EU-1-10-660_h_a_dec_1.pdf@2012-04-07 00:00:00@Potactasol@topotecan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-659_h_a_dec_6.pdf@EU-1-10-659_h_a_dec_6.pdf@2021-12-11 00:00:00@Iasibon@Ibandronic acid@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_1.pdf@EU-1-10-663_h_a_dec_1.pdf@2012-05-25 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-655_h_a_dec_9.pdf@EU-1-10-655_h_a_dec_9.pdf@2021-09-29 00:00:00@Brilique@ticagrelor@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_5.pdf@EU-1-10-658_h_a_dec_5.pdf@2013-12-18 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_0.pdf@EU-1-10-665_h_a_dec_0.pdf@2011-02-18 00:00:00@Entacapone Teva@entacapone@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_2.pdf@EU-1-10-663_h_a_dec_2.pdf@2012-10-31 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_1.pdf@EU-1-10-665_h_a_dec_1.pdf@2012-10-09 00:00:00@Entacapone Teva@entacapone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_6.pdf@EU-1-10-658_h_a_dec_6.pdf@2015-05-27 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated,  adjuvanted)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_2.pdf@EU-1-10-660_h_a_dec_2.pdf@2015-05-10 00:00:00@Potactasol@topotecan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_3.pdf@EU-1-10-663_h_a_dec_3.pdf@2014-11-11 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_7.pdf@EU-1-10-658_h_a_dec_7.pdf@2015-07-17 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated,  adjuvanted)@False@False@OD Not Found@Novartis Vaccines Influenza S.r.l.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_2.pdf@EU-1-10-665_h_a_dec_2.pdf@2014-03-21 00:00:00@Entacapone Teva@entacapone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_4.pdf@EU-1-10-663_h_a_dec_4.pdf@2015-11-19 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-660_h_a_dec_3.pdf@EU-1-10-660_h_a_dec_3.pdf@2019-06-20 00:00:00@Potactasol@topotecan@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_8.pdf@EU-1-10-658_h_a_dec_8.pdf@2016-08-16 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Seqirus S.r.l.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_5.pdf@EU-1-10-663_h_a_dec_5.pdf@2016-08-12 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_3.pdf@EU-1-10-665_h_a_dec_3.pdf@2014-10-27 00:00:00@Entacapone Teva@entacapone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_0.pdf@EU-1-11-667_h_a_dec_0.pdf@2011-02-28 00:00:00@Esbriet@Pirfenidone@NAS before 2012@False@adopted@InterMune Europe Ltd@CMA Not Found@Parsed
EU-1-10-658_h_a_dec_9.pdf@EU-1-10-658_h_a_dec_9.pdf@2018-08-05 00:00:00@Aflunov@Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Seqirus S.r.l.@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_6.pdf@EU-1-10-663_h_a_dec_6.pdf@2019-03-28 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_4.pdf@EU-1-10-665_h_a_dec_4.pdf@2015-11-19 00:00:00@Entacapone Teva@entacapone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_1.pdf@EU-1-11-667_h_a_dec_1.pdf@2011-02-28 00:00:00@Esbriet@Pirfenidone@NAS before 2012@False@adopted@InterMune Europe Ltd@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_0.pdf@EU-1-11-669_h_a_dec_0.pdf@2011-03-14 00:00:00@Teysuno@Tegafur/gimeracil/oteracil@NAS before 2012@False@OD Not Found@Taiho Pharma Europe, Limited@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_7.pdf@EU-1-10-663_h_a_dec_7.pdf@2021-09-29 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_0.pdf@EU-1-11-672_h_a_dec_0.pdf@2011-04-03 00:00:00@Xeplion@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_0.pdf@EU-1-11-673_h_a_dec_0.pdf@2011-04-03 00:00:00@Ifirmacombi@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@KRKA, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_5.pdf@EU-1-10-665_h_a_dec_5.pdf@2017-03-20 00:00:00@Entacapone Teva@entacapone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_1.pdf@EU-1-11-669_h_a_dec_1.pdf@2011-12-10 00:00:00@Teysuno@Tegafur/gimeracil/oteracil@NAS before 2012@False@OD Not Found@Taiho Pharma Europe, Limited@CMA Not Found@Parsed
EU-1-10-663_h_a_dec_8.pdf@EU-1-10-663_h_a_dec_8.pdf@2022-09-26 00:00:00@Lamivudine / Zidovudine Teva@Lamivudine / Zidovudine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_1.pdf@EU-1-11-673_h_a_dec_1.pdf@2012-10-29 00:00:00@Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_10.pdf@EU-1-11-667_h_a_dec_10.pdf@2017-08-12 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_1.pdf@EU-1-11-672_h_a_dec_1.pdf@2011-12-10 00:00:00@Xeplion@paliperidone@NAS before 2012@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-10-665_h_a_dec_6.pdf@EU-1-10-665_h_a_dec_6.pdf@2022-04-02 00:00:00@Entacapone Teva@entacapone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_10.pdf@EU-1-11-669_h_a_dec_10.pdf@2019-08-08 00:00:00@Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_10.pdf@EU-1-11-672_h_a_dec_10.pdf@2022-07-06 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_2.pdf@EU-1-11-673_h_a_dec_2.pdf@2014-04-09 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2011)1603(final) for “Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_11.pdf@EU-1-11-667_h_a_dec_11.pdf@2018-08-02 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_11.pdf@EU-1-11-669_h_a_dec_11.pdf@2020-03-07 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 3.7.2020 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2011)1789(final) for “Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_2.pdf@EU-1-11-672_h_a_dec_2.pdf@2012-06-27 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_3.pdf@EU-1-11-673_h_a_dec_3.pdf@2015-11-19 00:00:00@Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_12.pdf@EU-1-11-669_h_a_dec_12.pdf@2022-01-24 00:00:00@Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_3.pdf@EU-1-11-672_h_a_dec_3.pdf@2013-03-09 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_4.pdf@EU-1-11-673_h_a_dec_4.pdf@2018-02-07 00:00:00@Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_12.pdf@EU-1-11-667_h_a_dec_12.pdf@2018-04-04 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_4.pdf@EU-1-11-672_h_a_dec_4.pdf@2013-03-12 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_2.pdf@EU-1-11-669_h_a_dec_2.pdf@2012-01-31 00:00:00@Teysuno@Tegafur/gimeracil/oteracil@False@False@OD Not Found@Nordic Group BV@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_5.pdf@EU-1-11-673_h_a_dec_5.pdf@2019-09-04 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 9.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2011)1603(final) for “Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_13.pdf@EU-1-11-667_h_a_dec_13.pdf@2019-09-04 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_0.pdf@EU-1-11-676_h_a_dec_0.pdf@2011-03-17 00:00:00@JEVTANA@cabazitaxel@NAS before 2012@False@OD Not Found@Sanofi-Aventis@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_5.pdf@EU-1-11-672_h_a_dec_5.pdf@2015-03-23 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
d
EU-1-11-678_h_a_dec_0.pdf@EU-1-11-678_h_a_dec_0.pdf@2011-03-17 00:00:00@HALAVEN@eribulin@NAS before 2012@False@OD Not Found@Eisai Limited@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_4.pdf@EU-1-11-669_h_a_dec_4.pdf@2013-07-26 00:00:00@Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_6.pdf@EU-1-11-672_h_a_dec_6.pdf@2015-12-16 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_6.pdf@EU-1-11-673_h_a_dec_6.pdf@2020-10-28 00:00:00@Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_1.pdf@EU-1-11-677_h_a_dec_1.pdf@2011-03-17 00:00:00@GILENYA@Fingolimod@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_5.pdf@EU-1-11-669_h_a_dec_5.pdf@2014-08-22 00:00:00@Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_7.pdf@EU-1-11-672_h_a_dec_7.pdf@2017-04-28 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_14.pdf@EU-1-11-667_h_a_dec_14.pdf@2019-11-11 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_10.pdf@EU-1-11-677_h_a_dec_10.pdf@2014-06-19 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_7.pdf@EU-1-11-673_h_a_dec_7.pdf@2021-02-18 00:00:00@Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_1.pdf@EU-1-11-676_h_a_dec_1.pdf@2012-05-14 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@SANOFI@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_6.pdf@EU-1-11-669_h_a_dec_6.pdf@2015-11-19 00:00:00@Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_15.pdf@EU-1-11-667_h_a_dec_15.pdf@2020-11-16 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_8.pdf@EU-1-11-672_h_a_dec_8.pdf@2018-01-03 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_1.pdf@EU-1-11-678_h_a_dec_1.pdf@2011-03-17 00:00:00@HALAVEN@eribulin@NAS before 2012@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_16.pdf@EU-1-11-667_h_a_dec_16.pdf@2021-09-12 00:00:00@Esbriet@Pirfenidone@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_11.pdf@EU-1-11-677_h_a_dec_11.pdf@2015-03-07 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_10.pdf@EU-1-11-676_h_a_dec_10.pdf@2017-03-24 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_10.pdf@EU-1-11-678_h_a_dec_10.pdf@2018-07-30 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_7.pdf@EU-1-11-669_h_a_dec_7.pdf@2016-11-11 00:00:00@Teysuno@Tegafur / gimeracil /  oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_2.pdf@EU-1-11-667_h_a_dec_2.pdf@2011-07-20 00:00:00@Esbriet@Pirfenidone@NAS before 2012@False@OD Not Found@InterMune UK Ltd@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_3.pdf@EU-1-11-667_h_a_dec_3.pdf@2012-02-03 00:00:00@Esbriet@Pirfenidone@False@False@OD Not Found@InterMune UK Ltd@CMA Not Found@Parsed
EU-1-11-672_h_a_dec_9.pdf@EU-1-11-672_h_a_dec_9.pdf@2019-05-16 00:00:00@Xeplion@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_11.pdf@EU-1-11-678_h_a_dec_11.pdf@2018-09-28 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_12.pdf@EU-1-11-677_h_a_dec_12.pdf@2015-10-28 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_4.pdf@EU-1-11-667_h_a_dec_4.pdf@2012-10-29 00:00:00@Esbriet@Pirfenidone@False@False@OD Not Found@InterMune UK Ltd@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_12.pdf@EU-1-11-678_h_a_dec_12.pdf@2019-10-24 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-11-673_h_a_dec_8.pdf@EU-1-11-673_h_a_dec_8.pdf@2022-07-06 00:00:00@Ifirmacombi@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_8.pdf@EU-1-11-669_h_a_dec_8.pdf@2017-10-11 00:00:00@Teysuno@Tegafur / gimeracil /  oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_11.pdf@EU-1-11-676_h_a_dec_11.pdf@2017-03-04 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_13.pdf@EU-1-11-678_h_a_dec_13.pdf@2021-04-02 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_13.pdf@EU-1-11-677_h_a_dec_13.pdf@2015-11-19 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_14.pdf@EU-1-11-678_h_a_dec_14.pdf@2022-03-18 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_12.pdf@EU-1-11-676_h_a_dec_12.pdf@2020-12-14 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-669_h_a_dec_9.pdf@EU-1-11-669_h_a_dec_9.pdf@2019-07-02 00:00:00@Teysuno@Tegafur / gimeracil / oteracil@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_5.pdf@EU-1-11-667_h_a_dec_5.pdf@2013-12-17 00:00:00@Esbriet@Pirfenidone@False@False@adopted@InterMune UK Limited@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_15.pdf@EU-1-11-678_h_a_dec_15.pdf@2022-02-06 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_13.pdf@EU-1-11-676_h_a_dec_13.pdf@2022-02-24 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_14.pdf@EU-1-11-676_h_a_dec_14.pdf@2022-05-30 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_2.pdf@EU-1-11-676_h_a_dec_2.pdf@2012-06-15 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@SANOFI@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_6.pdf@EU-1-11-667_h_a_dec_6.pdf@2014-06-27 00:00:00@Esbriet@Pirfenidone@False@False@adopted@InterMune UK Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_14.pdf@EU-1-11-677_h_a_dec_14.pdf@2015-11-23 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_3.pdf@EU-1-11-676_h_a_dec_3.pdf@2012-10-09 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-aventis  groupe@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_2.pdf@EU-1-11-678_h_a_dec_2.pdf@2012-04-20 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_7.pdf@EU-1-11-667_h_a_dec_7.pdf@2015-12-02 00:00:00@Esbriet@Pirfenidone@False@False@adopted@InterMune UK Limited@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_4.pdf@EU-1-11-676_h_a_dec_4.pdf@2012-10-29 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_15.pdf@EU-1-11-677_h_a_dec_15.pdf@2016-01-25 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_8.pdf@EU-1-11-667_h_a_dec_8.pdf@2015-08-09 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_3.pdf@EU-1-11-678_h_a_dec_3.pdf@2012-05-22 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_16.pdf@EU-1-11-677_h_a_dec_16.pdf@2016-08-12 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_5.pdf@EU-1-11-676_h_a_dec_5.pdf@2013-12-13 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-667_h_a_dec_9.pdf@EU-1-11-667_h_a_dec_9.pdf@2017-04-24 00:00:00@Esbriet@Pirfenidone@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_17.pdf@EU-1-11-677_h_a_dec_17.pdf@2017-08-12 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_4.pdf@EU-1-11-678_h_a_dec_4.pdf@2013-11-20 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_18.pdf@EU-1-11-677_h_a_dec_18.pdf@2018-04-23 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_0.pdf@EU-1-11-679_h_a_dec_0.pdf@2011-04-14 00:00:00@Pravafenix@fenofibrate /  pravastatin@NAS before 2012@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_6.pdf@EU-1-11-676_h_a_dec_6.pdf@2014-09-18 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_5.pdf@EU-1-11-678_h_a_dec_5.pdf@2014-06-27 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_1.pdf@EU-1-11-679_h_a_dec_1.pdf@2012-08-30 00:00:00@Pravafenix@fenofibrate / pravastatin@False@False@OD Not Found@LABORATOIRES  SMB SA@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_19.pdf@EU-1-11-677_h_a_dec_19.pdf@2018-11-22 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_7.pdf@EU-1-11-676_h_a_dec_7.pdf@2015-06-22 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_6.pdf@EU-1-11-678_h_a_dec_6.pdf@2015-07-17 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_2.pdf@EU-1-11-677_h_a_dec_2.pdf@2011-12-14 00:00:00@GILENYA@Fingolimod@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_2.pdf@EU-1-11-679_h_a_dec_2.pdf@2012-10-29 00:00:00@Pravafenix@fenofibrate / pravastatin@False@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_0.pdf@EU-1-11-682_h_a_dec_0.pdf@2011-06-05 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@NAS before 2012@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_8.pdf@EU-1-11-676_h_a_dec_8.pdf@2015-11-19 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_7.pdf@EU-1-11-678_h_a_dec_7.pdf@2015-11-19 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_20.pdf@EU-1-11-677_h_a_dec_20.pdf@2019-03-09 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_3.pdf@EU-1-11-679_h_a_dec_3.pdf@2014-11-02 00:00:00@Pravafenix@fenofibrate / pravastatin@False@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_1.pdf@EU-1-11-682_h_a_dec_1.pdf@2012-08-30 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@False@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-676_h_a_dec_9.pdf@EU-1-11-676_h_a_dec_9.pdf@2016-04-04 00:00:00@JEVTANA@cabazitaxel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_4.pdf@EU-1-11-679_h_a_dec_4.pdf@2016-01-14 00:00:00@Pravafenix@fenofibrate / pravastatin@False@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_8.pdf@EU-1-11-678_h_a_dec_8.pdf@2016-02-05 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_2.pdf@EU-1-11-682_h_a_dec_2.pdf@2014-12-16 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@False@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_21.pdf@EU-1-11-677_h_a_dec_21.pdf@2019-12-16 00:00:00@Gilenya@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_0.pdf@EU-1-11-685_h_a_dec_0.pdf@2011-07-26 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@NAS before 2012@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-679_h_a_dec_5.pdf@EU-1-11-679_h_a_dec_5.pdf@2021-10-03 00:00:00@Pravafenix@fenofibrate / pravastatin@False@False@OD Not Found@LABORATOIRES SMB SA@CMA Not Found@Parsed
EU-1-11-678_h_a_dec_9.pdf@EU-1-11-678_h_a_dec_9.pdf@2016-08-16 00:00:00@HALAVEN@eribulin@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_3.pdf@EU-1-11-682_h_a_dec_3.pdf@2016-08-02 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@False@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_1.pdf@EU-1-11-685_h_a_dec_1.pdf@2012-10-31 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@False@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_22.pdf@EU-1-11-677_h_a_dec_22.pdf@2020-11-16 00:00:00@Gilenya@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_4.pdf@EU-1-11-682_h_a_dec_4.pdf@2016-02-18 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@False@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_5.pdf@EU-1-11-682_h_a_dec_5.pdf@2017-11-09 00:00:00@Methylthioninium chloride Proveblue@methylthioninium chloride@False@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_2.pdf@EU-1-11-685_h_a_dec_2.pdf@2014-03-06 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@False@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_23.pdf@EU-1-11-677_h_a_dec_23.pdf@2020-12-14 00:00:00@Gilenya@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-682_h_a_dec_6.pdf@EU-1-11-682_h_a_dec_6.pdf@2018-08-02 00:00:00@Methylthioninium chloride  Proveblue@methylthioninium chloride@False@False@OD Not Found@Provepharm S.A.S.@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_3.pdf@EU-1-11-685_h_a_dec_3.pdf@2015-03-19 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@False@False@OD Not Found@Sandoz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_0.pdf@EU-1-11-687_h_a_dec_0.pdf@2011-04-14 00:00:00@Hizentra@human normal immunoglobulin@NAS before 2012@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_0.pdf@EU-1-11-688_h_a_dec_0.pdf@2011-06-15 00:00:00@Cinryze@C1 inhibitor, human@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_4.pdf@EU-1-11-685_h_a_dec_4.pdf@2016-04-13 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_1.pdf@EU-1-11-688_h_a_dec_1.pdf@2011-06-15 00:00:00@Cinryze@C1 inhibitor, human@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_1.pdf@EU-1-11-687_h_a_dec_1.pdf@2012-05-22 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_24.pdf@EU-1-11-677_h_a_dec_24.pdf@2022-01-27 00:00:00@Gilenya@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_5.pdf@EU-1-11-685_h_a_dec_5.pdf@2017-06-29 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_10.pdf@EU-1-11-688_h_a_dec_10.pdf@2022-05-17 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_2.pdf@EU-1-11-687_h_a_dec_2.pdf@2013-12-18 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_3.pdf@EU-1-11-677_h_a_dec_3.pdf@2011-12-14 00:00:00@GILENYA@Fingolimod@NAS before 2012@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-11-685_h_a_dec_6.pdf@EU-1-11-685_h_a_dec_6.pdf@2021-11-10 00:00:00@Ibandronic acid Sandoz@Ibandronic acid@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_2.pdf@EU-1-11-688_h_a_dec_2.pdf@2012-05-22 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@ViroPharma SPRL- BVBA@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_0.pdf@EU-1-11-690_h_a_dec_0.pdf@2011-07-27 00:00:00@Zoely@nomegestrol/estradiol@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_4.pdf@EU-1-11-677_h_a_dec_4.pdf@2012-06-18 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_3.pdf@EU-1-11-687_h_a_dec_3.pdf@2014-12-16 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_3.pdf@EU-1-11-688_h_a_dec_3.pdf@2012-10-25 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@ViroPharma SPRL- BVBA@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_1.pdf@EU-1-11-690_h_a_dec_1.pdf@2011-10-11 00:00:00@Zoely@nomegestrol/estradiol@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_0.pdf@EU-1-11-692_h_a_dec_0.pdf@2011-05-18 00:00:00@Yellox@bromfenac@NAS before 2012@False@OD Not Found@Croma-Pharma GmbH@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_0.pdf@EU-1-11-691_h_a_dec_0.pdf@2011-05-18 00:00:00@Eliquis@apixaban@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_5.pdf@EU-1-11-677_h_a_dec_5.pdf@2012-06-18 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_4.pdf@EU-1-11-687_h_a_dec_4.pdf@2016-02-18 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_1.pdf@EU-1-11-692_h_a_dec_1.pdf@2012-06-02 00:00:00@Yellox@bromfenac@False@False@OD Not Found@Croma-Pharma GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_4.pdf@EU-1-11-688_h_a_dec_4.pdf@2014-09-30 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_10.pdf@EU-1-11-690_h_a_dec_10.pdf@2019-01-31 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_6.pdf@EU-1-11-677_h_a_dec_6.pdf@2012-11-22 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_1.pdf@EU-1-11-691_h_a_dec_1.pdf@2012-11-19 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_5.pdf@EU-1-11-687_h_a_dec_5.pdf@2018-01-30 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_0.pdf@EU-1-11-693_h_a_dec_0.pdf@2011-06-16 00:00:00@Rivastigmine Actavis@Rivastigmine@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_2.pdf@EU-1-11-692_h_a_dec_2.pdf@2015-01-27 00:00:00@Yellox@bromfenac@False@False@OD Not Found@Croma-Pharma GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_5.pdf@EU-1-11-688_h_a_dec_5.pdf@2016-05-26 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_6.pdf@EU-1-11-687_h_a_dec_6.pdf@2018-05-03 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_11.pdf@EU-1-11-690_h_a_dec_11.pdf@2020-04-02 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_1.pdf@EU-1-11-693_h_a_dec_1.pdf@2012-05-25 00:00:00@Rivastigmine Actavis@Rivastigmine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_7.pdf@EU-1-11-677_h_a_dec_7.pdf@2013-11-25 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_10.pdf@EU-1-11-691_h_a_dec_10.pdf@2019-01-07 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_6.pdf@EU-1-11-688_h_a_dec_6.pdf@2017-01-26 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_7.pdf@EU-1-11-687_h_a_dec_7.pdf@2019-11-01 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_3.pdf@EU-1-11-692_h_a_dec_3.pdf@2015-02-26 00:00:00@Yellox@bromfenac@False@False@OD Not Found@PharmaSwiss Česká republika s.r.o.@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_2.pdf@EU-1-11-693_h_a_dec_2.pdf@2012-10-31 00:00:00@Rivastigmine Actavis@Rivastigmine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_12.pdf@EU-1-11-690_h_a_dec_12.pdf@2020-09-06 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_8.pdf@EU-1-11-687_h_a_dec_8.pdf@2020-01-13 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_8.pdf@EU-1-11-677_h_a_dec_8.pdf@2013-12-18 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed

EU-1-11-692_h_a_dec_4.pdf@EU-1-11-692_h_a_dec_4.pdf@2016-11-01 00:00:00@Yellox@bromfenac@False@False@OD Not Found@PharmaSwiss Česká republika s.r.o.@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_3.pdf@EU-1-11-693_h_a_dec_3.pdf@2013-04-17 00:00:00@Rivastigmine Actavis@Rivastigmine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_11.pdf@EU-1-11-691_h_a_dec_11.pdf@2020-02-17 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-687_h_a_dec_9.pdf@EU-1-11-687_h_a_dec_9.pdf@2021-11-15 00:00:00@Hizentra@human normal immunoglobulin@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_8.pdf@EU-1-11-688_h_a_dec_8.pdf@2020-07-31 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_13.pdf@EU-1-11-690_h_a_dec_13.pdf@2021-10-05 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_5.pdf@EU-1-11-692_h_a_dec_5.pdf@2017-07-26 00:00:00@Yellox@bromfenac@False@False@OD Not Found@PharmaSwiss Česká republika s.r.o.@CMA Not Found@Parsed
EU-1-11-677_h_a_dec_9.pdf@EU-1-11-677_h_a_dec_9.pdf@2014-05-23 00:00:00@GILENYA@Fingolimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-688_h_a_dec_9.pdf@EU-1-11-688_h_a_dec_9.pdf@2022-01-24 00:00:00@Cinryze@C1 inhibitor, human@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_4.pdf@EU-1-11-693_h_a_dec_4.pdf@2016-02-15 00:00:00@Rivastigmine Actavis@Rivastigmine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_12.pdf@EU-1-11-691_h_a_dec_12.pdf@2021-11-01 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_6.pdf@EU-1-11-692_h_a_dec_6.pdf@2020-05-14 00:00:00@Yellox@bromfenac@False@False@OD Not Found@PharmaSwiss Česká republika s.r.o.@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_14.pdf@EU-1-11-690_h_a_dec_14.pdf@2021-12-16 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_5.pdf@EU-1-11-693_h_a_dec_5.pdf@2017-02-16 00:00:00@Rivastigmine Actavis@Rivastigmine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_13.pdf@EU-1-11-691_h_a_dec_13.pdf@2021-03-31 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_7.pdf@EU-1-11-692_h_a_dec_7.pdf@2021-11-15 00:00:00@Yellox@bromfenac@False@False@OD Not Found@Bausch Health Ireland Limited@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_0.pdf@EU-1-11-694_h_a_dec_0.pdf@2011-06-17 00:00:00@NULOJIX@belatacept@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_15.pdf@EU-1-11-690_h_a_dec_15.pdf@2021-12-16 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-11-693_h_a_dec_6.pdf@EU-1-11-693_h_a_dec_6.pdf@2022-07-06 00:00:00@Rivastigmine Actavis@Rivastigmine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_1.pdf@EU-1-11-694_h_a_dec_1.pdf@2012-02-14 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_2.pdf@EU-1-11-690_h_a_dec_2.pdf@2012-04-20 00:00:00@Zoely@nomegestrol/estradiol@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_0.pdf@EU-1-11-696_h_a_dec_0.pdf@2011-06-17 00:00:00@BYDUREON@exenatide@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-11-692_h_a_dec_8.pdf@EU-1-11-692_h_a_dec_8.pdf@2022-04-02 00:00:00@Yellox@bromfenac@False@False@OD Not Found@Bausch Health Ireland Limited@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_14.pdf@EU-1-11-691_h_a_dec_14.pdf@2022-02-16 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_1.pdf@EU-1-11-696_h_a_dec_1.pdf@2013-03-13 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_3.pdf@EU-1-11-690_h_a_dec_3.pdf@2012-10-29 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex S.r.l.@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_10.pdf@EU-1-11-694_h_a_dec_10.pdf@2021-04-30 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_10.pdf@EU-1-11-696_h_a_dec_10.pdf@2017-10-11 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_2.pdf@EU-1-11-691_h_a_dec_2.pdf@2013-08-26 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_4.pdf@EU-1-11-690_h_a_dec_4.pdf@2013-11-06 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex S.r.l.@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_11.pdf@EU-1-11-696_h_a_dec_11.pdf@2018-08-27 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_0.pdf@EU-1-11-697_h_a_dec_0.pdf@2011-07-13 00:00:00@Temozolomide Sun@Temozolomide@NAS before 2012@False@OD Not Found@Sun Pharmaceuticals Industries Europe  B.V.@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_3.pdf@EU-1-11-691_h_a_dec_3.pdf@2013-11-15 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_11.pdf@EU-1-11-694_h_a_dec_11.pdf@2021-01-06 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_5.pdf@EU-1-11-690_h_a_dec_5.pdf@2014-01-16 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ITALIAN TEXT IS AUTHENTIC)      COMMISSION IMPLEMENTING DECISION  16.1.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation  “Zoely@nomegestrol  / estradiol@False@False@OD Not Found@Theramex S.r.l.@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_12.pdf@EU-1-11-696_h_a_dec_12.pdf@2019-09-23 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_1.pdf@EU-1-11-697_h_a_dec_1.pdf@2012-10-25 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceuticals Industries Europe B.V.@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_0.pdf@EU-1-11-699_h_a_dec_0.pdf@2011-07-20 00:00:00@Fampyra@fampridine@NAS before 2012@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-698_h_a_dec_0.pdf@EU-1-11-698_h_a_dec_0.pdf@2011-07-13 00:00:00@Yervoy@ipilimumab@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_5.pdf@EU-1-11-691_h_a_dec_5.pdf@2015-08-20 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_13.pdf@EU-1-11-696_h_a_dec_13.pdf@2020-01-23 00:00:00@Bydureon@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_6.pdf@EU-1-11-690_h_a_dec_6.pdf@2014-01-09 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Theramex S.r.l.@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_12.pdf@EU-1-11-694_h_a_dec_12.pdf@2021-12-13 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_1.pdf@EU-1-11-699_h_a_dec_1.pdf@2012-01-03 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-697_h_a_dec_2.pdf@EU-1-11-697_h_a_dec_2.pdf@2014-03-21 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_1.pdf@EU-1-11-698_h_a_dec_1.pdf@2011-07-13 00:00:00@Yervoy@ipilimumab@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_14.pdf@EU-1-11-696_h_a_dec_14.pdf@2021-11-01 00:00:00@Bydureon@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_2.pdf@EU-1-11-694_h_a_dec_2.pdf@2012-10-23 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_7.pdf@EU-1-11-690_h_a_dec_7.pdf@2016-04-21 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_10.pdf@EU-1-11-699_h_a_dec_10.pdf@2020-11-20 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_3.pdf@EU-1-11-697_h_a_dec_3.pdf@2015-07-28 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_6.pdf@EU-1-11-691_h_a_dec_6.pdf@2016-01-14 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_15.pdf@EU-1-11-696_h_a_dec_15.pdf@2022-05-30 00:00:00@Bydureon@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_3.pdf@EU-1-11-694_h_a_dec_3.pdf@2013-09-04 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_8.pdf@EU-1-11-690_h_a_dec_8.pdf@2017-03-10 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_11.pdf@EU-1-11-699_h_a_dec_11.pdf@2022-04-25 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_4.pdf@EU-1-11-697_h_a_dec_4.pdf@2016-04-21 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-691_h_a_dec_7.pdf@EU-1-11-691_h_a_dec_7.pdf@2017-02-16 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-690_h_a_dec_9.pdf@EU-1-11-690_h_a_dec_9.pdf@2019-01-23 00:00:00@Zoely@nomegestrol / estradiol@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_2.pdf@EU-1-11-699_h_a_dec_2.pdf@2012-05-22 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-698_h_a_dec_10.pdf@EU-1-11-698_h_a_dec_10.pdf@2018-08-01 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_4.pdf@EU-1-11-694_h_a_dec_4.pdf@2014-12-16 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_5.pdf@EU-1-11-697_h_a_dec_5.pdf@2018-07-30 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_2.pdf@EU-1-11-696_h_a_dec_2.pdf@2013-07-26 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_6.pdf@EU-1-11-697_h_a_dec_6.pdf@2019-07-25 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_3.pdf@EU-1-11-699_h_a_dec_3.pdf@2013-01-07 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-691_h_a_dec_8.pdf@EU-1-11-691_h_a_dec_8.pdf@2018-05-31 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_11.pdf@EU-1-11-698_h_a_dec_11.pdf@2018-01-18 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_5.pdf@EU-1-11-694_h_a_dec_5.pdf@2016-02-18 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-697_h_a_dec_7.pdf@EU-1-11-697_h_a_dec_7.pdf@2020-11-16 00:00:00@Temozolomide SUN@temozolomide@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_3.pdf@EU-1-11-696_h_a_dec_3.pdf@2014-08-01 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_4.pdf@EU-1-11-699_h_a_dec_4.pdf@2014-05-22 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-691_h_a_dec_9.pdf@EU-1-11-691_h_a_dec_9.pdf@2019-02-04 00:00:00@Eliquis@apixaban@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_6.pdf@EU-1-11-694_h_a_dec_6.pdf@2017-03-24 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_12.pdf@EU-1-11-698_h_a_dec_12.pdf@2018-05-31 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_4.pdf@EU-1-11-696_h_a_dec_4.pdf@2014-07-31 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_0.pdf@EU-1-11-700_h_a_dec_0.pdf@2011-07-13 00:00:00@Benlysta@belimumab@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_5.pdf@EU-1-11-699_h_a_dec_5.pdf@2015-03-07 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-694_h_a_dec_7.pdf@EU-1-11-694_h_a_dec_7.pdf@2018-05-02 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_1.pdf@EU-1-11-700_h_a_dec_1.pdf@2012-03-19 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group  Limited@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_13.pdf@EU-1-11-698_h_a_dec_13.pdf@2019-11-01 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@conditional@Parsed
EU-1-11-696_h_a_dec_5.pdf@EU-1-11-696_h_a_dec_5.pdf@2014-01-10 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_6.pdf@EU-1-11-699_h_a_dec_6.pdf@2016-05-26 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-696_h_a_dec_6.pdf@EU-1-11-696_h_a_dec_6.pdf@2015-01-19 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_10.pdf@EU-1-11-700_h_a_dec_10.pdf@2018-11-14 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_8.pdf@EU-1-11-694_h_a_dec_8.pdf@2019-02-04 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_14.pdf@EU-1-11-698_h_a_dec_14.pdf@2019-02-04 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_7.pdf@EU-1-11-696_h_a_dec_7.pdf@2015-12-16 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_7.pdf@EU-1-11-699_h_a_dec_7.pdf@2017-05-18 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-698_h_a_dec_15.pdf@EU-1-11-698_h_a_dec_15.pdf@2019-02-04 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_8.pdf@EU-1-11-696_h_a_dec_8.pdf@2016-02-18 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_11.pdf@EU-1-11-700_h_a_dec_11.pdf@2019-01-07 00:00:00@Benlysta@belimumab@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-11-694_h_a_dec_9.pdf@EU-1-11-694_h_a_dec_9.pdf@2020-03-04 00:00:00@NULOJIX@belatacept@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-696_h_a_dec_9.pdf@EU-1-11-696_h_a_dec_9.pdf@2017-08-24 00:00:00@BYDUREON@exenatide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_8.pdf@EU-1-11-699_h_a_dec_8.pdf@2017-05-22 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@conditional@Parsed
EU-1-11-701_h_a_dec_0.pdf@EU-1-11-701_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam Teva@Levetiracetam@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_0.pdf@EU-1-11-702_h_a_dec_0.pdf@2011-08-26 00:00:00@Levetiracetam ratiopharm@Levetiracetam@NAS before 2012@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_16.pdf@EU-1-11-698_h_a_dec_16.pdf@2019-12-17 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_1.pdf@EU-1-11-701_h_a_dec_1.pdf@2012-11-06 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_12.pdf@EU-1-11-700_h_a_dec_12.pdf@2019-10-21 00:00:00@Benlysta@belimumab@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_1.pdf@EU-1-11-702_h_a_dec_1.pdf@2012-10-09 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-699_h_a_dec_9.pdf@EU-1-11-699_h_a_dec_9.pdf@2018-02-08 00:00:00@Fampyra@fampridine@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_2.pdf@EU-1-11-701_h_a_dec_2.pdf@2012-10-31 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_17.pdf@EU-1-11-698_h_a_dec_17.pdf@2020-01-20 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_2.pdf@EU-1-11-702_h_a_dec_2.pdf@2014-11-12 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_3.pdf@EU-1-11-701_h_a_dec_3.pdf@2015-01-27 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_13.pdf@EU-1-11-700_h_a_dec_13.pdf@2020-06-26 00:00:00@Benlysta@belimumab@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_3.pdf@EU-1-11-702_h_a_dec_3.pdf@2016-04-28 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_0.pdf@EU-1-11-703_h_a_dec_0.pdf@2011-07-13 00:00:00@Xgeva@denosumab@NAS before 2012@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_4.pdf@EU-1-11-701_h_a_dec_4.pdf@2015-03-02 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_18.pdf@EU-1-11-698_h_a_dec_18.pdf@2020-05-11 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_4.pdf@EU-1-11-702_h_a_dec_4.pdf@2017-12-20 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_1.pdf@EU-1-11-703_h_a_dec_1.pdf@2012-01-31 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_5.pdf@EU-1-11-701_h_a_dec_5.pdf@2016-07-15 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
und@Parsed
EU-1-11-702_h_a_dec_5.pdf@EU-1-11-702_h_a_dec_5.pdf@2019-10-24 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_10.pdf@EU-1-11-703_h_a_dec_10.pdf@2017-09-18 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_6.pdf@EU-1-11-701_h_a_dec_6.pdf@2018-11-01 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_19.pdf@EU-1-11-698_h_a_dec_19.pdf@2021-07-01 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_0.pdf@EU-1-11-706_h_a_dec_0.pdf@2011-08-24 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_6.pdf@EU-1-11-702_h_a_dec_6.pdf@2021-01-29 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_11.pdf@EU-1-11-703_h_a_dec_11.pdf@2018-03-27 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_7.pdf@EU-1-11-701_h_a_dec_7.pdf@2019-10-29 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_0.pdf@EU-1-11-707_h_a_dec_0.pdf@2011-08-24 00:00:00@Trajenta@linagliptin@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_1.pdf@EU-1-11-706_h_a_dec_1.pdf@Date is blank@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-11-700_h_a_dec_15.pdf@EU-1-11-700_h_a_dec_15.pdf@2022-07-06 00:00:00@Benlysta@belimumab@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-11-702_h_a_dec_7.pdf@EU-1-11-702_h_a_dec_7.pdf@2021-06-14 00:00:00@Levetiracetam ratiopharm@levetiracetam@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_12.pdf@EU-1-11-703_h_a_dec_12.pdf@2018-06-25 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_2.pdf@EU-1-11-700_h_a_dec_2.pdf@2012-05-25 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group  Limited@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_1.pdf@EU-1-11-707_h_a_dec_1.pdf@2011-08-24 00:00:00@Trajenta@linagliptin@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_8.pdf@EU-1-11-701_h_a_dec_8.pdf@2020-10-08 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_2.pdf@EU-1-11-706_h_a_dec_2.pdf@2013-06-27 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_13.pdf@EU-1-11-703_h_a_dec_13.pdf@2019-06-28 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_20.pdf@EU-1-11-698_h_a_dec_20.pdf@2021-01-06 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_10.pdf@EU-1-11-707_h_a_dec_10.pdf@2018-12-03 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_3.pdf@EU-1-11-700_h_a_dec_3.pdf@2012-10-24 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group  Limited@CMA Not Found@Parsed
EU-1-11-701_h_a_dec_9.pdf@EU-1-11-701_h_a_dec_9.pdf@2021-06-17 00:00:00@Levetiracetam Teva@levetiracetam@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_3.pdf@EU-1-11-706_h_a_dec_3.pdf@2016-01-22 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_14.pdf@EU-1-11-703_h_a_dec_14.pdf@2019-11-19 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_11.pdf@EU-1-11-707_h_a_dec_11.pdf@2020-09-03 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_21.pdf@EU-1-11-698_h_a_dec_21.pdf@2021-06-24 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_4.pdf@EU-1-11-706_h_a_dec_4.pdf@2016-05-26 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_15.pdf@EU-1-11-703_h_a_dec_15.pdf@2021-06-17 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_12.pdf@EU-1-11-707_h_a_dec_12.pdf@2021-05-27 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_4.pdf@EU-1-11-700_h_a_dec_4.pdf@2013-07-15 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_2.pdf@EU-1-11-703_h_a_dec_2.pdf@2012-03-21 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe  B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_2.pdf@EU-1-11-707_h_a_dec_2.pdf@2012-10-24 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_5.pdf@EU-1-11-706_h_a_dec_5.pdf@2019-08-08 00:00:00@Levodopa/Carbidopa/Entacapone  Orion@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_5.pdf@EU-1-11-700_h_a_dec_5.pdf@2013-12-17 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_3.pdf@EU-1-11-703_h_a_dec_3.pdf@2012-08-23 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_3.pdf@EU-1-11-707_h_a_dec_3.pdf@2013-04-22 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_0.pdf@EU-1-11-708_h_a_dec_0.pdf@2011-08-18 00:00:00@Entacapone Orion@entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-706_h_a_dec_6.pdf@EU-1-11-706_h_a_dec_6.pdf@2022-01-07 00:00:00@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_23.pdf@EU-1-11-698_h_a_dec_23.pdf@2022-01-04 00:00:00@YERVOY@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_4.pdf@EU-1-11-703_h_a_dec_4.pdf@2012-10-29 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_6.pdf@EU-1-11-700_h_a_dec_6.pdf@2015-04-24 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_1.pdf@EU-1-11-708_h_a_dec_1.pdf@Date is blank@Levodopa/Carbidopa/Entacapone Orion@Levodopa,carbidopa,entacapone@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-11-698_h_a_dec_3.pdf@EU-1-11-698_h_a_dec_3.pdf@2012-06-21 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_4.pdf@EU-1-11-707_h_a_dec_4.pdf@2014-09-18 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_0.pdf@EU-1-11-709_h_a_dec_0.pdf@2011-05-09 00:00:00@Buccolam@Midazolam@NAS before 2012@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_2.pdf@EU-1-11-708_h_a_dec_2.pdf@2016-01-25 00:00:00@Entacapone Orion@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_5.pdf@EU-1-11-703_h_a_dec_5.pdf@2013-12-18 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_5.pdf@EU-1-11-707_h_a_dec_5.pdf@2015-09-23 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_7.pdf@EU-1-11-700_h_a_dec_7.pdf@2016-02-18 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_4.pdf@EU-1-11-698_h_a_dec_4.pdf@2013-10-31 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_1.pdf@EU-1-11-709_h_a_dec_1.pdf@2013-12-18 00:00:00@Buccolam@midazolam@False@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_3.pdf@EU-1-11-708_h_a_dec_3.pdf@2016-08-04 00:00:00@Entacapone Orion@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_6.pdf@EU-1-11-703_h_a_dec_6.pdf@2014-01-09 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_6.pdf@EU-1-11-707_h_a_dec_6.pdf@2016-02-18 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_2.pdf@EU-1-11-709_h_a_dec_2.pdf@2015-05-03 00:00:00@Buccolam@midazolam@False@False@OD Not Found@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_5.pdf@EU-1-11-698_h_a_dec_5.pdf@2013-12-18 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_8.pdf@EU-1-11-700_h_a_dec_8.pdf@2017-03-20 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_7.pdf@EU-1-11-703_h_a_dec_7.pdf@2015-07-13 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_4.pdf@EU-1-11-708_h_a_dec_4.pdf@2017-11-28 00:00:00@Entacapone Orion@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_7.pdf@EU-1-11-707_h_a_dec_7.pdf@2016-03-22 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_3.pdf@EU-1-11-709_h_a_dec_3.pdf@2016-05-26 00:00:00@Buccolam@midazolam@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-708_h_a_dec_5.pdf@EU-1-11-708_h_a_dec_5.pdf@2021-09-29 00:00:00@Entacapone Orion@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_8.pdf@EU-1-11-703_h_a_dec_8.pdf@2016-04-04 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_8.pdf@EU-1-11-707_h_a_dec_8.pdf@2016-09-30 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-700_h_a_dec_9.pdf@EU-1-11-700_h_a_dec_9.pdf@2017-10-11 00:00:00@Benlysta@belimumab@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_6.pdf@EU-1-11-698_h_a_dec_6.pdf@2015-06-19 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_4.pdf@EU-1-11-709_h_a_dec_4.pdf@2019-12-02 00:00:00@Buccolam@midazolam@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-703_h_a_dec_9.pdf@EU-1-11-703_h_a_dec_9.pdf@2017-06-16 00:00:00@Xgeva@denosumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-11-707_h_a_dec_9.pdf@EU-1-11-707_h_a_dec_9.pdf@2017-01-27 00:00:00@Trajenta@linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_0.pdf@EU-1-11-710_h_a_dec_0.pdf@2011-02-09 00:00:00@Votubia@Everolimus@NAS before 2012@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-709_h_a_dec_5.pdf@EU-1-11-709_h_a_dec_5.pdf@2020-07-27 00:00:00@Buccolam@midazolam@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_7.pdf@EU-1-11-698_h_a_dec_7.pdf@2015-12-14 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_1.pdf@EU-1-11-710_h_a_dec_1.pdf@2012-06-02 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm  Limited@conditional@Parsed
EU-1-11-709_h_a_dec_6.pdf@EU-1-11-709_h_a_dec_6.pdf@2021-02-25 00:00:00@Buccolam@midazolam@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_0.pdf@EU-1-11-711_h_a_dec_0.pdf@2011-03-10 00:00:00@Matever@Levetiracetam@NAS before 2012@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_8.pdf@EU-1-11-698_h_a_dec_8.pdf@2016-04-21 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_10.pdf@EU-1-11-710_h_a_dec_10.pdf@2014-12-16 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-711_h_a_dec_1.pdf@EU-1-11-711_h_a_dec_1.pdf@2012-09-28 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-709_h_a_dec_7.pdf@EU-1-11-709_h_a_dec_7.pdf@2022-05-13 00:00:00@Buccolam@midazolam@False@False@OD Not Found@Laboratorios Lesvi@CMA Not Found@Parsed
EU-1-11-698_h_a_dec_9.pdf@EU-1-11-698_h_a_dec_9.pdf@2017-05-31 00:00:00@Yervoy@ipilimumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_11.pdf@EU-1-11-710_h_a_dec_11.pdf@2015-07-28 00:00:00@Votubia@Everolimus@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-11-711_h_a_dec_2.pdf@EU-1-11-711_h_a_dec_2.pdf@2015-01-15 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_0.pdf@EU-1-11-712_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Accord@Levetiracetam@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_3.pdf@EU-1-11-711_h_a_dec_3.pdf@2016-06-29 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_12.pdf@EU-1-11-710_h_a_dec_12.pdf@2015-11-16 00:00:00@Votubia@Everolimus@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-11-711_h_a_dec_4.pdf@EU-1-11-711_h_a_dec_4.pdf@2018-01-25 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_0.pdf@EU-1-11-713_h_a_dec_0.pdf@2011-03-10 00:00:00@Levetiracetam Actavis@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_1.pdf@EU-1-11-712_h_a_dec_1.pdf@2012-09-17 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_5.pdf@EU-1-11-711_h_a_dec_5.pdf@2019-10-21 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_13.pdf@EU-1-11-710_h_a_dec_13.pdf@2015-10-12 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_1.pdf@EU-1-11-713_h_a_dec_1.pdf@2012-10-31 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_2.pdf@EU-1-11-712_h_a_dec_2.pdf@2012-10-31 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_0.pdf@EU-1-11-715_h_a_dec_0.pdf@2011-03-11 00:00:00@Plenadren@Hydrocortisone@NAS before 2012@False@adopted@DuoCort Pharma AB@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_0.pdf@EU-1-11-714_h_a_dec_0.pdf@2011-05-09 00:00:00@Zytiga@abiraterone@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_6.pdf@EU-1-11-711_h_a_dec_6.pdf@2020-09-24 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_2.pdf@EU-1-11-713_h_a_dec_2.pdf@2014-12-16 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_14.pdf@EU-1-11-710_h_a_dec_14.pdf@2017-01-27 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
Parsed
EU-1-11-715_h_a_dec_1.pdf@EU-1-11-715_h_a_dec_1.pdf@2012-03-26 00:00:00@Plenadren@Hydrocortisone@False@False@adopted@DuoCort Pharma AB@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_3.pdf@EU-1-11-712_h_a_dec_3.pdf@2014-01-29 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-711_h_a_dec_7.pdf@EU-1-11-711_h_a_dec_7.pdf@2021-06-17 00:00:00@Matever@levetiracetam@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_10.pdf@EU-1-11-714_h_a_dec_10.pdf@2017-11-15 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_2.pdf@EU-1-11-715_h_a_dec_2.pdf@2012-10-29 00:00:00@Plenadren@hydrocortisone@False@False@adopted@ViroPharma SPRL@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_4.pdf@EU-1-11-712_h_a_dec_4.pdf@2015-05-27 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_15.pdf@EU-1-11-710_h_a_dec_15.pdf@2017-07-26 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_3.pdf@EU-1-11-713_h_a_dec_3.pdf@2016-08-09 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_11.pdf@EU-1-11-714_h_a_dec_11.pdf@2019-02-20 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_3.pdf@EU-1-11-715_h_a_dec_3.pdf@2013-11-20 00:00:00@Plenadren@hydrocortisone@False@False@adopted@ViroPharma SPRL-BVBA@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_12.pdf@EU-1-11-714_h_a_dec_12.pdf@2020-04-23 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_5.pdf@EU-1-11-712_h_a_dec_5.pdf@2016-07-22 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_4.pdf@EU-1-11-713_h_a_dec_4.pdf@2018-07-03 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_4.pdf@EU-1-11-715_h_a_dec_4.pdf@2016-11-05 00:00:00@Plenadren@hydrocortisone@False@False@adopted@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_16.pdf@EU-1-11-710_h_a_dec_16.pdf@2018-05-31 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_13.pdf@EU-1-11-714_h_a_dec_13.pdf@2022-06-01 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_5.pdf@EU-1-11-715_h_a_dec_5.pdf@2016-08-08 00:00:00@Plenadren@hydrocortisone@False@False@adopted@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_2.pdf@EU-1-11-714_h_a_dec_2.pdf@2012-08-30 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag  International NV@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_5.pdf@EU-1-11-713_h_a_dec_5.pdf@2019-05-03 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_6.pdf@EU-1-11-715_h_a_dec_6.pdf@2017-09-21 00:00:00@Plenadren@hydrocortisone@False@False@adopted@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_6.pdf@EU-1-11-712_h_a_dec_6.pdf@2017-11-16 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_17.pdf@EU-1-11-710_h_a_dec_17.pdf@2018-07-06 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_0.pdf@EU-1-11-716_h_a_dec_0.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_3.pdf@EU-1-11-714_h_a_dec_3.pdf@2012-12-18 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_7.pdf@EU-1-11-715_h_a_dec_7.pdf@2019-01-31 00:00:00@Plenadren@hydrocortisone@False@False@adopted@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_6.pdf@EU-1-11-713_h_a_dec_6.pdf@2020-09-15 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_1.pdf@EU-1-11-716_h_a_dec_1.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_4.pdf@EU-1-11-714_h_a_dec_4.pdf@2013-07-25 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_0.pdf@EU-1-11-717_h_a_dec_0.pdf@2011-11-16 00:00:00@Vyndaqel@tafamidis@NAS before 2012@False@adopted@Pfizer Specialty UK Limited@exceptional@Parsed
EU-1-11-712_h_a_dec_7.pdf@EU-1-11-712_h_a_dec_7.pdf@2019-01-03 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_18.pdf@EU-1-11-710_h_a_dec_18.pdf@2019-12-06 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_10.pdf@EU-1-11-716_h_a_dec_10.pdf@2019-02-20 00:00:00@Eurartesim@piperaquine  tetraphosphate/artenimol@False@False@OD Not Found@Alfasigma S.p.A.@CMA Not Found@Parsed
EU-1-11-713_h_a_dec_7.pdf@EU-1-11-713_h_a_dec_7.pdf@2021-06-14 00:00:00@Levetiracetam Actavis@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-715_h_a_dec_8.pdf@EU-1-11-715_h_a_dec_8.pdf@2022-01-20 00:00:00@Plenadren@hydrocortisone@False@False@OD Not Found@Shire Services BVBA@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_1.pdf@EU-1-11-717_h_a_dec_1.pdf@2011-11-16 00:00:00@Vyndaqel@tafamidis@NAS before 2012@False@adopted@Pfizer Specialty UK Limited@exceptional@Parsed
EU-1-11-714_h_a_dec_5.pdf@EU-1-11-714_h_a_dec_5.pdf@2014-01-16 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_8.pdf@EU-1-11-712_h_a_dec_8.pdf@2020-09-15 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_11.pdf@EU-1-11-716_h_a_dec_11.pdf@2019-06-20 00:00:00@Eurartesim@piperaquine tetraphosphate/artenimol@False@False@OD Not Found@Alfasigma S.p.A.@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_2.pdf@EU-1-11-717_h_a_dec_2.pdf@2012-06-28 00:00:00@Vyndaqel@tafamidis@False@False@adopted@Pfizer Specialty UK Limited@exceptional@Parsed
EU-1-11-710_h_a_dec_19.pdf@EU-1-11-710_h_a_dec_19.pdf@2020-07-23 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-712_h_a_dec_9.pdf@EU-1-11-712_h_a_dec_9.pdf@2021-06-21 00:00:00@Levetiracetam Accord@levetiracetam@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_12.pdf@EU-1-11-716_h_a_dec_12.pdf@2020-01-20 00:00:00@Eurartesim@piperaquine tetraphosphate/artenimol@False@False@OD Not Found@Alfasigma S.p.A.@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_6.pdf@EU-1-11-714_h_a_dec_6.pdf@2014-07-18 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_2.pdf@EU-1-11-710_h_a_dec_2.pdf@2012-06-28 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis  Europharm Limited@conditional@Parsed
EU-1-11-717_h_a_dec_3.pdf@EU-1-11-717_h_a_dec_3.pdf@2014-06-05 00:00:00@Vyndaqel@tafamidis@False@False@adopted@Pfizer Limited@exceptional@Parsed
EU-1-11-716_h_a_dec_13.pdf@EU-1-11-716_h_a_dec_13.pdf@2020-08-28 00:00:00@Eurartesim@piperaquine tetraphosphate/artenimol@False@False@OD Not Found@Alfasigma S.p.A.@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_7.pdf@EU-1-11-714_h_a_dec_7.pdf@2015-07-28 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_14.pdf@EU-1-11-716_h_a_dec_14.pdf@2022-08-07 00:00:00@Eurartesim@piperaquine tetraphosphate/artenimol@False@False@OD Not Found@Alfasigma S.p.A.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_20.pdf@EU-1-11-710_h_a_dec_20.pdf@2020-08-25 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_0.pdf@EU-1-11-718_h_a_dec_0.pdf@2011-09-16 00:00:00@Dexdor@dexmedetomidine@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_8.pdf@EU-1-11-714_h_a_dec_8.pdf@2016-05-26 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_4.pdf@EU-1-11-717_h_a_dec_4.pdf@2015-05-13 00:00:00@Vyndaqel@tafamidis@False@False@adopted@Pfizer Limited@exceptional@Parsed
EU-1-11-716_h_a_dec_2.pdf@EU-1-11-716_h_a_dec_2.pdf@2012-03-26 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@False@False@OD Not Found@Sigma-Tau  Industrie Farmaceutiche Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-714_h_a_dec_9.pdf@EU-1-11-714_h_a_dec_9.pdf@2016-09-11 00:00:00@Zytiga@abiraterone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_0.pdf@EU-1-11-722_h_a_dec_0.pdf@2012-03-21 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_1.pdf@EU-1-11-718_h_a_dec_1.pdf@2013-12-18 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_3.pdf@EU-1-11-716_h_a_dec_3.pdf@2012-03-26 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@False@False@OD Not Found@Sigma-Tau  Industrie Farmaceutiche Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_21.pdf@EU-1-11-710_h_a_dec_21.pdf@2022-06-21 00:00:00@Votubia@Everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_5.pdf@EU-1-11-717_h_a_dec_5.pdf@2016-07-22 00:00:00@Vyndaqel@tafamidis@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_0.pdf@EU-1-11-719_h_a_dec_0.pdf@2011-03-10 00:00:00@Telmisartan Teva Pharma@telmisartan@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_1.pdf@EU-1-11-722_h_a_dec_1.pdf@2012-03-21 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_2.pdf@EU-1-11-718_h_a_dec_2.pdf@2015-03-11 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_4.pdf@EU-1-11-716_h_a_dec_4.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_3.pdf@EU-1-11-710_h_a_dec_3.pdf@2012-07-26 00:00:00@Votubia@Everolimus@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-11-719_h_a_dec_1.pdf@EU-1-11-719_h_a_dec_1.pdf@2012-10-29 00:00:00@Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_3.pdf@EU-1-11-718_h_a_dec_3.pdf@2016-05-26 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_4.pdf@EU-1-11-710_h_a_dec_4.pdf@2012-10-31 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm  Limited@conditional@Parsed
EU-1-11-717_h_a_dec_6.pdf@EU-1-11-717_h_a_dec_6.pdf@2018-03-08 00:00:00@Vyndaqel@tafamidis@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_5.pdf@EU-1-11-716_h_a_dec_5.pdf@2011-10-27 00:00:00@Eurartesim@piperaquine tetraphosphate /  dihydroartemisinin@NAS before 2012@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche  Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_2.pdf@EU-1-11-722_h_a_dec_2.pdf@2013-12-20 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_4.pdf@EU-1-11-718_h_a_dec_4.pdf@2017-08-12 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_2.pdf@EU-1-11-719_h_a_dec_2.pdf@2014-06-06 00:00:00@Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_7.pdf@EU-1-11-717_h_a_dec_7.pdf@2019-11-22 00:00:00@Vyndaqel@tafamidis@False@False@adopted@Pfizer Europe MA EEIG@exceptional@Parsed
EU-1-11-716_h_a_dec_6.pdf@EU-1-11-716_h_a_dec_6.pdf@2015-10-03 00:00:00@Eurartesim@piperaquine tetraphosphate / dihydroartemisinin@False@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_5.pdf@EU-1-11-710_h_a_dec_5.pdf@2013-07-15 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-718_h_a_dec_5.pdf@EU-1-11-718_h_a_dec_5.pdf@2018-02-08 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_3.pdf@EU-1-11-722_h_a_dec_3.pdf@2014-07-11 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_8.pdf@EU-1-11-717_h_a_dec_8.pdf@2020-02-17 00:00:00@tafamidis@Active Substance Not Found@False@False@adopted@Pfizer Europe MA EEIG@exceptional@Parsed
EU-1-11-716_h_a_dec_7.pdf@EU-1-11-716_h_a_dec_7.pdf@2016-06-21 00:00:00@Eurartesim@piperaquine tetraphosphate / dihydroartemisinin@False@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche Riunite S.p.A@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_0.pdf@EU-1-11-727_h_a_dec_0.pdf@2012-09-03 00:00:00@Mercaptopurine Nova Laboratories@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_3.pdf@EU-1-11-719_h_a_dec_3.pdf@2014-04-09 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2011)7179(final) for “Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-717_h_a_dec_9.pdf@EU-1-11-717_h_a_dec_9.pdf@2021-11-10 00:00:00@Vyndaqel@tafamidis@False@False@adopted@Pfizer Europe MA EEIG@exceptional@Parsed
EU-1-11-716_h_a_dec_8.pdf@EU-1-11-716_h_a_dec_8.pdf@2016-09-09 00:00:00@Eurartesim@piperaquine tetraphosphate/artenimol@False@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche Riunite  S.p.A@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_6.pdf@EU-1-11-718_h_a_dec_6.pdf@2019-01-18 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_1.pdf@EU-1-11-727_h_a_dec_1.pdf@2012-11-15 00:00:00@Xaluprine@Mercaptopurine@False@False@adopted@Nova Laboratories  Limited@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_4.pdf@EU-1-11-722_h_a_dec_4.pdf@2016-05-12 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_6.pdf@EU-1-11-710_h_a_dec_6.pdf@2013-07-17 00:00:00@Votubia@Everolimus@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-11-719_h_a_dec_4.pdf@EU-1-11-719_h_a_dec_4.pdf@2015-10-02 00:00:00@Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_7.pdf@EU-1-11-718_h_a_dec_7.pdf@2020-01-13 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-716_h_a_dec_9.pdf@EU-1-11-716_h_a_dec_9.pdf@2017-09-14 00:00:00@Eurartesim@piperaquine tetraphosphate/artenimol@False@False@OD Not Found@Sigma-Tau Industrie Farmaceutiche Riunite  S.p.A@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_2.pdf@EU-1-11-727_h_a_dec_2.pdf@2013-12-20 00:00:00@Xaluprine@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_8.pdf@EU-1-11-718_h_a_dec_8.pdf@2021-12-16 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_5.pdf@EU-1-11-719_h_a_dec_5.pdf@2016-09-06 00:00:00@Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_7.pdf@EU-1-11-710_h_a_dec_7.pdf@2013-11-15 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-722_h_a_dec_5.pdf@EU-1-11-722_h_a_dec_5.pdf@2019-02-14 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-718_h_a_dec_9.pdf@EU-1-11-718_h_a_dec_9.pdf@2022-08-07 00:00:00@Dexdor@dexmedetomidine@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_6.pdf@EU-1-11-719_h_a_dec_6.pdf@2019-07-25 00:00:00@Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_3.pdf@EU-1-11-727_h_a_dec_3.pdf@2014-11-19 00:00:00@Xaluprine@Mercaptopurine@False@False@OD Not Found@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-722_h_a_dec_6.pdf@EU-1-11-722_h_a_dec_6.pdf@2021-09-12 00:00:00@Pioglitazone Accord@pioglitazone@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-11-719_h_a_dec_7.pdf@EU-1-11-719_h_a_dec_7.pdf@2022-01-27 00:00:00@Telmisartan Teva Pharma@telmisartan@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_8.pdf@EU-1-11-710_h_a_dec_8.pdf@2014-06-19 00:00:00@Votubia@Everolimus@False@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-11-731_h_a_dec_0.pdf@EU-1-11-731_h_a_dec_0.pdf@2011-11-24 00:00:00@Komboglyze@saxagliptin / metformin@NAS before 2012@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_4.pdf@EU-1-11-727_h_a_dec_4.pdf@2016-11-18 00:00:00@Xaluprine@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_1.pdf@EU-1-11-731_h_a_dec_1.pdf@2012-09-24 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-11-710_h_a_dec_9.pdf@EU-1-11-710_h_a_dec_9.pdf@2014-07-18 00:00:00@Votubia@Everolimus@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-11-732_h_a_dec_0.pdf@EU-1-11-732_h_a_dec_0.pdf@2011-11-24 00:00:00@Desloratadine Teva@desloratadine@NAS before 2012@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_5.pdf@EU-1-11-727_h_a_dec_5.pdf@2017-07-13 00:00:00@Xaluprine@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_10.pdf@EU-1-11-731_h_a_dec_10.pdf@2018-08-13 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_1.pdf@EU-1-11-732_h_a_dec_1.pdf@2012-10-29 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_0.pdf@EU-1-11-733_h_a_dec_0.pdf@2011-05-12 00:00:00@Dificlir@fidaxomicin@NAS before 2012@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_0.pdf@EU-1-11-734_h_a_dec_0.pdf@2011-07-12 00:00:00@Edarbi@azilsartan medoxomil@NAS before 2012@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_6.pdf@EU-1-11-727_h_a_dec_6.pdf@2019-01-31 00:00:00@Xaluprine@Mercaptopurine@False@False@adopted@Nova Laboratories Limited@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_0.pdf@EU-1-11-736_h_a_dec_0.pdf@2011-11-28 00:00:00@EDURANT@rilpivirine@NAS before 2012@False@OD Not Found@Janssen Cilag International NV@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_1.pdf@EU-1-11-733_h_a_dec_1.pdf@2012-06-02 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_1.pdf@EU-1-11-734_h_a_dec_1.pdf@2012-12-07 00:00:00@Edarbi@azilsartan medoxomil@False@False@OD Not Found@Takeda Global Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_2.pdf@EU-1-11-732_h_a_dec_2.pdf@2014-01-12 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_1.pdf@EU-1-11-736_h_a_dec_1.pdf@2012-10-24 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_12.pdf@EU-1-11-731_h_a_dec_12.pdf@2022-04-13 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_2.pdf@EU-1-11-736_h_a_dec_2.pdf@2013-06-21 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
d
EU-1-11-733_h_a_dec_10.pdf@EU-1-11-733_h_a_dec_10.pdf@2020-02-13 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_3.pdf@EU-1-11-732_h_a_dec_3.pdf@2016-12-05 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_2.pdf@EU-1-11-731_h_a_dec_2.pdf@2012-10-24 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@Bristol Myers  Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_3.pdf@EU-1-11-731_h_a_dec_3.pdf@2013-02-18 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_2.pdf@EU-1-11-734_h_a_dec_2.pdf@2013-11-11 00:00:00@Edarbi@azilsartan  medoxomil@False@False@OD Not Found@Takeda Global Research and Development Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_11.pdf@EU-1-11-733_h_a_dec_11.pdf@2021-09-03 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_4.pdf@EU-1-11-732_h_a_dec_4.pdf@2016-08-08 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_3.pdf@EU-1-11-736_h_a_dec_3.pdf@2014-01-09 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_8.pdf@EU-1-11-727_h_a_dec_8.pdf@2021-04-16 00:00:00@Xaluprine@Mercaptopurine@False@False@adopted@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_12.pdf@EU-1-11-733_h_a_dec_12.pdf@2022-06-24 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Tillotts Pharma GmbH@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_5.pdf@EU-1-11-732_h_a_dec_5.pdf@2017-05-24 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_4.pdf@EU-1-11-736_h_a_dec_4.pdf@2015-11-20 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_3.pdf@EU-1-11-734_h_a_dec_3.pdf@2014-06-06 00:00:00@Edarbi@azilsartan medoxomil@False@False@OD Not Found@Takeda Global Research and Development Centre  (Europe) Ltd@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_4.pdf@EU-1-11-731_h_a_dec_4.pdf@2014-10-15 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_2.pdf@EU-1-11-733_h_a_dec_2.pdf@2012-06-27 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_6.pdf@EU-1-11-732_h_a_dec_6.pdf@2018-12-12 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_5.pdf@EU-1-11-736_h_a_dec_5.pdf@2016-07-22 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_5.pdf@EU-1-11-731_h_a_dec_5.pdf@2015-08-14 00:00:00@Komboglyze@saxagliptin /  metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-727_h_a_dec_9.pdf@EU-1-11-727_h_a_dec_9.pdf@2022-06-21 00:00:00@Xaluprine@Mercaptopurine@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_7.pdf@EU-1-11-732_h_a_dec_7.pdf@2021-04-30 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_4.pdf@EU-1-11-734_h_a_dec_4.pdf@2014-09-09 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE DANISH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  9.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2011)9280(final) for “Edarbi@azilsartan medoxomil@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_6.pdf@EU-1-11-736_h_a_dec_6.pdf@2017-08-24 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_6.pdf@EU-1-11-731_h_a_dec_6.pdf@2016-07-15 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_4.pdf@EU-1-11-733_h_a_dec_4.pdf@2013-12-13 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-732_h_a_dec_8.pdf@EU-1-11-732_h_a_dec_8.pdf@2022-05-30 00:00:00@Desloratadine Teva@desloratadine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_5.pdf@EU-1-11-734_h_a_dec_5.pdf@2016-11-14 00:00:00@Edarbi@azilsartan medoxomil@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_7.pdf@EU-1-11-731_h_a_dec_7.pdf@2016-12-12 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2011)8840(final) for “Komboglyze@saxagliptin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_7.pdf@EU-1-11-736_h_a_dec_7.pdf@2019-10-17 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_6.pdf@EU-1-11-734_h_a_dec_6.pdf@2019-03-25 00:00:00@Edarbi@azilsartan medoxomil@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_5.pdf@EU-1-11-733_h_a_dec_5.pdf@2014-03-21 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_8.pdf@EU-1-11-731_h_a_dec_8.pdf@2017-10-03 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 10.3.2017 correcting Decision C(2016)8647 final concerning, in the framework  Article 31   Directive 2001/83/EC  the European Parliament and  the Council, the marketing  authorisation granted by Decision C(2011)8840 final  for “Komboglyze@saxagliptin /  metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_8.pdf@EU-1-11-736_h_a_dec_8.pdf@2020-11-16 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_6.pdf@EU-1-11-733_h_a_dec_6.pdf@2015-05-28 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-734_h_a_dec_7.pdf@EU-1-11-734_h_a_dec_7.pdf@2022-03-02 00:00:00@Edarbi@azilsartan medoxomil@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-11-731_h_a_dec_9.pdf@EU-1-11-731_h_a_dec_9.pdf@2017-06-26 00:00:00@Komboglyze@saxagliptin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_0.pdf@EU-1-11-737_h_a_dec_0.pdf@2011-11-28 00:00:00@Eviplera@emtricitabine / rilpivirine (as  hydrochloride) / tenofovir disoproxil (as fumarate)@NAS before 2012@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_7.pdf@EU-1-11-733_h_a_dec_7.pdf@2016-08-22 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_0.pdf@EU-1-11-738_h_a_dec_0.pdf@2011-05-12 00:00:00@Levetiracetam Actavis Group@Levetiracetam@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-736_h_a_dec_9.pdf@EU-1-11-736_h_a_dec_9.pdf@2022-08-07 00:00:00@EDURANT@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_1.pdf@EU-1-11-737_h_a_dec_1.pdf@2012-10-24 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir  disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_1.pdf@EU-1-11-738_h_a_dec_1.pdf@2012-10-29 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_8.pdf@EU-1-11-733_h_a_dec_8.pdf@2018-07-19 00:00:00@Dificlir@fidaxomicin@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_10.pdf@EU-1-11-737_h_a_dec_10.pdf@2020-12-06 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-11-733_h_a_dec_9.pdf@EU-1-11-733_h_a_dec_9.pdf@2020-02-13 00:00:00@Dificlir@fidaxomicin@False@False@adopted@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_2.pdf@EU-1-11-738_h_a_dec_2.pdf@2014-12-15 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_0.pdf@EU-1-11-740_h_a_dec_0.pdf@2011-12-14 00:00:00@Ameluz@5-aminolevulinic acid@NAS before 2012@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_0.pdf@EU-1-11-739_h_a_dec_0.pdf@2011-11-28 00:00:00@Dasselta@desloratadine@NAS before 2012@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_11.pdf@EU-1-11-737_h_a_dec_11.pdf@2021-06-17 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_0.pdf@EU-1-11-741_h_a_dec_0.pdf@2011-12-14 00:00:00@Levetiracetam SUN@Levetiracetam@NAS before 2012@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_3.pdf@EU-1-11-738_h_a_dec_3.pdf@2016-08-08 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_2.pdf@EU-1-11-737_h_a_dec_2.pdf@2013-06-21 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_1.pdf@EU-1-11-739_h_a_dec_1.pdf@2014-08-22 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_1.pdf@EU-1-11-740_h_a_dec_1.pdf@2014-01-17 00:00:00@Ameluz@5-Aminolaevulinic acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_1.pdf@EU-1-11-741_h_a_dec_1.pdf@2012-10-31 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe  BV@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_0.pdf@EU-1-11-742_h_a_dec_0.pdf@2012-09-01 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma BV@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_2.pdf@EU-1-11-739_h_a_dec_2.pdf@2016-04-21 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_0.pdf@EU-1-11-743_h_a_dec_0.pdf@2011-12-22 00:00:00@Repaglinide Accord@Repaglinide@NAS before 2012@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_3.pdf@EU-1-11-737_h_a_dec_3.pdf@2013-11-29 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_4.pdf@EU-1-11-738_h_a_dec_4.pdf@2017-10-23 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_2.pdf@EU-1-11-741_h_a_dec_2.pdf@2013-12-18 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_1.pdf@EU-1-11-742_h_a_dec_1.pdf@2012-10-25 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma BV@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_1.pdf@EU-1-11-743_h_a_dec_1.pdf@2012-10-31 00:00:00@Repaglinide Accord@Repaglinide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_3.pdf@EU-1-11-739_h_a_dec_3.pdf@2016-08-16 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_3.pdf@EU-1-11-740_h_a_dec_3.pdf@2016-11-21 00:00:00@Ameluz@5-Aminolaevulinic acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_3.pdf@EU-1-11-741_h_a_dec_3.pdf@2015-06-02 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_4.pdf@EU-1-11-737_h_a_dec_4.pdf@2014-11-12 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_4.pdf@EU-1-11-739_h_a_dec_4.pdf@2017-05-18 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_4.pdf@EU-1-11-740_h_a_dec_4.pdf@2017-01-27 00:00:00@Ameluz@5-Aminolaevulinic acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_2.pdf@EU-1-11-742_h_a_dec_2.pdf@2014-04-07 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_5.pdf@EU-1-11-738_h_a_dec_5.pdf@2019-09-13 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_2.pdf@EU-1-11-743_h_a_dec_2.pdf@2016-09-19 00:00:00@Repaglinide Accord@Repaglinide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_4.pdf@EU-1-11-741_h_a_dec_4.pdf@2016-11-14 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_5.pdf@EU-1-11-739_h_a_dec_5.pdf@2019-07-02 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_5.pdf@EU-1-11-740_h_a_dec_5.pdf@2018-01-03 00:00:00@Ameluz@5-Aminolaevulinic acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_5.pdf@EU-1-11-737_h_a_dec_5.pdf@2016-03-31 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_3.pdf@EU-1-11-742_h_a_dec_3.pdf@2014-11-12 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_5.pdf@EU-1-11-741_h_a_dec_5.pdf@2017-12-20 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_6.pdf@EU-1-11-739_h_a_dec_6.pdf@2021-04-30 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_3.pdf@EU-1-11-743_h_a_dec_3.pdf@2019-02-25 00:00:00@Repaglinide Accord@Repaglinide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_6.pdf@EU-1-11-738_h_a_dec_6.pdf@2020-09-24 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_6.pdf@EU-1-11-740_h_a_dec_6.pdf@2019-04-26 00:00:00@Ameluz@5-Aminolaevulinic  acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_4.pdf@EU-1-11-742_h_a_dec_4.pdf@2016-02-03 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-739_h_a_dec_7.pdf@EU-1-11-739_h_a_dec_7.pdf@2022-05-30 00:00:00@Dasselta@desloratadine@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_6.pdf@EU-1-11-737_h_a_dec_6.pdf@2016-07-22 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir  disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_6.pdf@EU-1-11-741_h_a_dec_6.pdf@2019-10-24 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_7.pdf@EU-1-11-740_h_a_dec_7.pdf@2020-09-03 00:00:00@Ameluz@5-Aminolaevulinic acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_5.pdf@EU-1-11-742_h_a_dec_5.pdf@2016-09-09 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-743_h_a_dec_4.pdf@EU-1-11-743_h_a_dec_4.pdf@2021-01-09 00:00:00@Repaglinide Accord@Repaglinide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-11-738_h_a_dec_7.pdf@EU-1-11-738_h_a_dec_7.pdf@2021-06-21 00:00:00@Levetiracetam Actavis Group@levetiracetam@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_7.pdf@EU-1-11-741_h_a_dec_7.pdf@2021-03-18 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-740_h_a_dec_8.pdf@EU-1-11-740_h_a_dec_8.pdf@2022-10-02 00:00:00@Ameluz@5-Aminolaevulinic acid@False@False@OD Not Found@Biofrontera Bioscience GmbH@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_7.pdf@EU-1-11-737_h_a_dec_7.pdf@2017-12-15 00:00:00@Brand name Not Found@Active Substance Not Found@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-741_h_a_dec_8.pdf@EU-1-11-741_h_a_dec_8.pdf@2021-04-06 00:00:00@Levetiracetam SUN@levetiracetam@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_0.pdf@EU-1-11-745_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-742_h_a_dec_6.pdf@EU-1-11-742_h_a_dec_6.pdf@2019-04-11 00:00:00@Efavirenz Teva@efavirenz@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_8.pdf@EU-1-11-737_h_a_dec_8.pdf@2018-05-28 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_0.pdf@EU-1-11-746_h_a_dec_0.pdf@2012-01-13 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_1.pdf@EU-1-11-745_h_a_dec_1.pdf@2015-03-16 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_0.pdf@EU-1-11-747_h_a_dec_0.pdf@2012-02-13 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_1.pdf@EU-1-11-747_h_a_dec_1.pdf@2012-02-17 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_0.pdf@EU-1-12-750_h_a_dec_0.pdf@2012-02-23 00:00:00@Esmya@ulipristal@False@False@OD Not Found@PregLem France SAS.@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_2.pdf@EU-1-11-745_h_a_dec_2.pdf@2016-11-05 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_1.pdf@EU-1-11-746_h_a_dec_1.pdf@2014-01-09 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-737_h_a_dec_9.pdf@EU-1-11-737_h_a_dec_9.pdf@2019-01-07 00:00:00@Eviplera@emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_0.pdf@EU-1-11-749_h_a_dec_0.pdf@2012-02-17 00:00:00@Caprelsa@Vandetanib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-751_h_a_dec_0.pdf@EU-1-12-751_h_a_dec_0.pdf@2012-02-17 00:00:00@Zelboraf@vemurafenib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_10.pdf@EU-1-11-747_h_a_dec_10.pdf@2020-10-08 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_1.pdf@EU-1-12-750_h_a_dec_1.pdf@2012-02-23 00:00:00@Esmya@ulipristal@False@False@OD Not Found@PregLem France SAS.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_1.pdf@EU-1-11-749_h_a_dec_1.pdf@2012-02-17 00:00:00@Caprelsa@Vandetanib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_2.pdf@EU-1-11-746_h_a_dec_2.pdf@2016-04-21 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_11.pdf@EU-1-11-747_h_a_dec_11.pdf@2021-09-29 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_1.pdf@EU-1-12-751_h_a_dec_1.pdf@2012-12-20 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_3.pdf@EU-1-11-745_h_a_dec_3.pdf@2016-11-11 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_10.pdf@EU-1-11-749_h_a_dec_10.pdf@2017-02-17 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-11-746_h_a_dec_3.pdf@EU-1-11-746_h_a_dec_3.pdf@2016-08-08 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_10.pdf@EU-1-12-750_h_a_dec_10.pdf@2018-02-16 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_10.pdf@EU-1-12-751_h_a_dec_10.pdf@2022-02-18 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_2.pdf@EU-1-11-747_h_a_dec_2.pdf@2014-07-31 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_4.pdf@EU-1-11-746_h_a_dec_4.pdf@2017-05-18 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_11.pdf@EU-1-11-749_h_a_dec_11.pdf@2018-09-02 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-11-745_h_a_dec_4.pdf@EU-1-11-745_h_a_dec_4.pdf@2017-05-18 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_11.pdf@EU-1-12-750_h_a_dec_11.pdf@2018-07-26 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_2.pdf@EU-1-12-751_h_a_dec_2.pdf@2013-12-18 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_5.pdf@EU-1-11-746_h_a_dec_5.pdf@2018-12-11 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_12.pdf@EU-1-11-749_h_a_dec_12.pdf@2019-01-15 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-11-747_h_a_dec_3.pdf@EU-1-11-747_h_a_dec_3.pdf@2015-11-03 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  11.3.2015  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2012)1042(final) for “Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_12.pdf@EU-1-12-750_h_a_dec_12.pdf@2020-03-25 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_6.pdf@EU-1-11-746_h_a_dec_6.pdf@2020-11-24 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_5.pdf@EU-1-11-745_h_a_dec_5.pdf@2018-04-23 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_13.pdf@EU-1-11-749_h_a_dec_13.pdf@2020-01-13 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-12-751_h_a_dec_3.pdf@EU-1-12-751_h_a_dec_3.pdf@2014-12-16 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_7.pdf@EU-1-11-746_h_a_dec_7.pdf@2022-01-27 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_4.pdf@EU-1-11-747_h_a_dec_4.pdf@2015-11-19 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_14.pdf@EU-1-11-749_h_a_dec_14.pdf@2020-09-12 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-12-750_h_a_dec_13.pdf@EU-1-12-750_h_a_dec_13.pdf@2021-11-01 00:00:00@Esmya@Ulipristal Acetate 5mg@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_0.pdf@EU-1-12-753_h_a_dec_0.pdf@2012-04-24 00:00:00@Signifor@Pasireotide@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_4.pdf@EU-1-12-751_h_a_dec_4.pdf@2015-10-28 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_6.pdf@EU-1-11-745_h_a_dec_6.pdf@2021-01-29 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-746_h_a_dec_8.pdf@EU-1-11-746_h_a_dec_8.pdf@2022-05-30 00:00:00@Desloratadine ratiopharm@desloratadine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_2.pdf@EU-1-12-750_h_a_dec_2.pdf@2012-07-26 00:00:00@Esmya@ulipristal@False@False@OD Not Found@PregLem France SAS.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_15.pdf@EU-1-11-749_h_a_dec_15.pdf@2022-11-01 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-11-747_h_a_dec_5.pdf@EU-1-11-747_h_a_dec_5.pdf@2016-09-26 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_1.pdf@EU-1-12-753_h_a_dec_1.pdf@2013-12-08 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_16.pdf@EU-1-11-749_h_a_dec_16.pdf@2022-05-30 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-12-750_h_a_dec_3.pdf@EU-1-12-750_h_a_dec_3.pdf@2012-10-29 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_5.pdf@EU-1-12-751_h_a_dec_5.pdf@2016-09-22 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-745_h_a_dec_7.pdf@EU-1-11-745_h_a_dec_7.pdf@2022-05-30 00:00:00@Desloratadine Actavis@desloratadine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_6.pdf@EU-1-11-747_h_a_dec_6.pdf@2016-12-12 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_2.pdf@EU-1-11-749_h_a_dec_2.pdf@2013-02-18 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-755_h_a_dec_0.pdf@EU-1-12-755_h_a_dec_0.pdf@2012-03-15 00:00:00@Pioglitazone Actavis@Pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_2.pdf@EU-1-12-753_h_a_dec_2.pdf@2014-11-19 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_4.pdf@EU-1-12-750_h_a_dec_4.pdf@2013-12-18 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_6.pdf@EU-1-12-751_h_a_dec_6.pdf@2017-05-18 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_3.pdf@EU-1-11-749_h_a_dec_3.pdf@2013-12-20 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-755_h_a_dec_1.pdf@EU-1-12-755_h_a_dec_1.pdf@2012-03-15 00:00:00@Pioglitazone Actavis@Pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_6.pdf@EU-1-12-750_h_a_dec_6.pdf@2015-03-16 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_7.pdf@EU-1-11-747_h_a_dec_7.pdf@2017-07-08 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Forest Laboratories UK Ltd.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_3.pdf@EU-1-12-753_h_a_dec_3.pdf@2016-07-03 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_0.pdf@EU-1-12-757_h_a_dec_0.pdf@2012-03-26 00:00:00@Pioglitazone Teva@Pioglitazone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_4.pdf@EU-1-11-749_h_a_dec_4.pdf@2015-01-15 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-750_h_a_dec_7.pdf@EU-1-12-750_h_a_dec_7.pdf@2015-05-27 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_7.pdf@EU-1-12-751_h_a_dec_7.pdf@2018-06-04 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_8.pdf@EU-1-11-747_h_a_dec_8.pdf@2018-01-30 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_2.pdf@EU-1-12-755_h_a_dec_2.pdf@2014-11-11 00:00:00@Pioglitazone Actavis@pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_5.pdf@EU-1-11-749_h_a_dec_5.pdf@2015-12-16 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-757_h_a_dec_1.pdf@EU-1-12-757_h_a_dec_1.pdf@2012-03-26 00:00:00@Pioglitazone Teva@Pioglitazone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_4.pdf@EU-1-12-753_h_a_dec_4.pdf@2016-11-18 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_8.pdf@EU-1-12-751_h_a_dec_8.pdf@2019-02-18 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-11-747_h_a_dec_9.pdf@EU-1-11-747_h_a_dec_9.pdf@2019-07-19 00:00:00@Colobreathe@Colistimethate sodium@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_8.pdf@EU-1-12-750_h_a_dec_8.pdf@2016-11-14 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_6.pdf@EU-1-11-749_h_a_dec_6.pdf@2016-01-14 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-757_h_a_dec_3.pdf@EU-1-12-757_h_a_dec_3.pdf@2015-01-30 00:00:00@Pioglitazone Teva@pioglitazone@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-751_h_a_dec_9.pdf@EU-1-12-751_h_a_dec_9.pdf@2020-10-22 00:00:00@Zelboraf@vemurafenib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_3.pdf@EU-1-12-755_h_a_dec_3.pdf@2016-11-11 00:00:00@Pioglitazone Actavis@pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-750_h_a_dec_9.pdf@EU-1-12-750_h_a_dec_9.pdf@2017-08-12 00:00:00@Esmya@ulipristal@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_5.pdf@EU-1-12-753_h_a_dec_5.pdf@2017-09-18 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_4.pdf@EU-1-12-757_h_a_dec_4.pdf@2016-11-14 00:00:00@Pioglitazone Teva@pioglitazone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_7.pdf@EU-1-11-749_h_a_dec_7.pdf@2016-08-09 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_4.pdf@EU-1-12-755_h_a_dec_4.pdf@2016-11-14 00:00:00@Pioglitazone Actavis@pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_5.pdf@EU-1-12-757_h_a_dec_5.pdf@2017-02-17 00:00:00@Pioglitazone Teva@pioglitazone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_8.pdf@EU-1-11-749_h_a_dec_8.pdf@2016-10-21 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_6.pdf@EU-1-12-753_h_a_dec_6.pdf@2018-12-04 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-755_h_a_dec_5.pdf@EU-1-12-755_h_a_dec_5.pdf@2021-06-24 00:00:00@Pioglitazone Actavis@pioglitazone@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_0.pdf@EU-1-12-759_h_a_dec_0.pdf@2012-04-20 00:00:00@Zoledronic acid Actavis@Zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-757_h_a_dec_6.pdf@EU-1-12-757_h_a_dec_6.pdf@2018-11-28 00:00:00@Pioglitazone Teva@pioglitazone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-11-749_h_a_dec_9.pdf@EU-1-11-749_h_a_dec_9.pdf@2016-12-16 00:00:00@Caprelsa@vandetanib@False@False@OD Not Found@Genzyme Europe B.V.@conditional@Parsed
EU-1-12-757_h_a_dec_7.pdf@EU-1-12-757_h_a_dec_7.pdf@2021-06-21 00:00:00@Pioglitazone Teva@pioglitazone@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_1.pdf@EU-1-12-759_h_a_dec_1.pdf@2014-02-20 00:00:00@Zoledronic acid Actavis@zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_7.pdf@EU-1-12-753_h_a_dec_7.pdf@2020-05-18 00:00:00@Signifor@pasireotide@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_0.pdf@EU-1-12-760_h_a_dec_0.pdf@2012-04-13 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-753_h_a_dec_8.pdf@EU-1-12-753_h_a_dec_8.pdf@2021-12-05 00:00:00@Signifor@pasireotide@False@False@adopted@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_0.pdf@EU-1-12-761_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Teva@Capecitabine@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_0.pdf@EU-1-12-762_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_1.pdf@EU-1-12-760_h_a_dec_1.pdf@2012-04-13 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_2.pdf@EU-1-12-759_h_a_dec_2.pdf@2015-10-12 00:00:00@Zoledronic acid Actavis@zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_1.pdf@EU-1-12-761_h_a_dec_1.pdf@2014-02-20 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_0.pdf@EU-1-12-763_h_a_dec_0.pdf@2012-04-20 00:00:00@Capecitabine Krka@capecitabine@False@False@OD Not Found@KRKA, d.d@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_10.pdf@EU-1-12-762_h_a_dec_10.pdf@2022-04-04 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_3.pdf@EU-1-12-759_h_a_dec_3.pdf@2016-08-12 00:00:00@Zoledronic acid Actavis@zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_1.pdf@EU-1-12-763_h_a_dec_1.pdf@2012-10-25 00:00:00@Capecitabine Krka@capecitabine@False@False@OD Not Found@KRKA, d.d@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_10.pdf@EU-1-12-760_h_a_dec_10.pdf@2020-04-05 00:00:00@Bronchitol@Mannitol@False@False@OD Not Found@Pharmaxis Europe Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_2.pdf@EU-1-12-761_h_a_dec_2.pdf@2014-11-21 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_2.pdf@EU-1-12-762_h_a_dec_2.pdf@2014-02-20 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_3.pdf@EU-1-12-761_h_a_dec_3.pdf@2016-03-31 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_0.pdf@EU-1-12-764_h_a_dec_0.pdf@2012-10-05 00:00:00@Pixuvri@Pixantrone@True@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-763_h_a_dec_2.pdf@EU-1-12-763_h_a_dec_2.pdf@2013-11-15 00:00:00@Ecansya@capecitabine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_4.pdf@EU-1-12-759_h_a_dec_4.pdf@2018-09-28 00:00:00@Zoledronic acid Actavis@zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_11.pdf@EU-1-12-760_h_a_dec_11.pdf@2022-05-19 00:00:00@Bronchitol@Mannitol@False@False@OD Not Found@Pharmaxis Europe Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_4.pdf@EU-1-12-761_h_a_dec_4.pdf@2017-09-01 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_1.pdf@EU-1-12-764_h_a_dec_1.pdf@2012-10-29 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-763_h_a_dec_3.pdf@EU-1-12-763_h_a_dec_3.pdf@2015-04-13 00:00:00@Ecansya@capecitabine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_2.pdf@EU-1-12-760_h_a_dec_2.pdf@2012-10-29 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited,@exceptional@Parsed
EU-1-12-762_h_a_dec_3.pdf@EU-1-12-762_h_a_dec_3.pdf@2015-04-13 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_5.pdf@EU-1-12-761_h_a_dec_5.pdf@2019-10-17 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_4.pdf@EU-1-12-763_h_a_dec_4.pdf@2016-03-31 00:00:00@Ecansya@capecitabine@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-12-759_h_a_dec_5.pdf@EU-1-12-759_h_a_dec_5.pdf@2021-09-22 00:00:00@Zoledronic acid Actavis@zoledronic acid@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_4.pdf@EU-1-12-760_h_a_dec_4.pdf@2014-11-12 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_10.pdf@EU-1-12-764_h_a_dec_10.pdf@2018-03-23 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-766_h_a_dec_0.pdf@EU-1-12-766_h_a_dec_0.pdf@2012-04-20 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_4.pdf@EU-1-12-762_h_a_dec_4.pdf@2016-02-06 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_5.pdf@EU-1-12-763_h_a_dec_5.pdf@2016-09-12 00:00:00@Ecansya@capecitabine@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_6.pdf@EU-1-12-761_h_a_dec_6.pdf@2020-03-07 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC)    EN 1   EN COMMISSION IMPLEMENTING DECISION  3.7.2020  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2012)2850(final) for “Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_11.pdf@EU-1-12-764_h_a_dec_11.pdf@2018-08-23 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-760_h_a_dec_5.pdf@EU-1-12-760_h_a_dec_5.pdf@2016-01-14 00:00:00@Bronchitol@Mannitol@False@False@OD Not Found@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_5.pdf@EU-1-12-762_h_a_dec_5.pdf@2017-09-01 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_1.pdf@EU-1-12-766_h_a_dec_1.pdf@2014-07-18 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_12.pdf@EU-1-12-764_h_a_dec_12.pdf@2019-02-18 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-767_h_a_dec_0.pdf@EU-1-12-767_h_a_dec_0.pdf@2012-04-20 00:00:00@Nimenrix@Meningococcal Group A, C, W-135 and  Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_6.pdf@EU-1-12-763_h_a_dec_6.pdf@2019-04-15 00:00:00@Ecansya@capecitabine@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_6.pdf@EU-1-12-760_h_a_dec_6.pdf@2017-11-01 00:00:00@Bronchitol@Mannitol@False@False@OD Not Found@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_7.pdf@EU-1-12-761_h_a_dec_7.pdf@2020-07-17 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_2.pdf@EU-1-12-766_h_a_dec_2.pdf@2015-01-15 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_13.pdf@EU-1-12-764_h_a_dec_13.pdf@2019-06-06 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Deutschland GmbH@conditional@Parsed
EU-1-12-762_h_a_dec_6.pdf@EU-1-12-762_h_a_dec_6.pdf@2019-02-25 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_1.pdf@EU-1-12-767_h_a_dec_1.pdf@2014-04-23 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_7.pdf@EU-1-12-760_h_a_dec_7.pdf@2018-08-01 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_3.pdf@EU-1-12-766_h_a_dec_3.pdf@2016-01-25 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@ProStrakan Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_14.pdf@EU-1-12-764_h_a_dec_14.pdf@2019-08-10 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Deutschland GmbH@CMA Not Found@Parsed
EU-1-12-761_h_a_dec_8.pdf@EU-1-12-761_h_a_dec_8.pdf@2022-03-22 00:00:00@Capecitabine Teva@capecitabine@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_10.pdf@EU-1-12-767_h_a_dec_10.pdf@2019-04-10 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_7.pdf@EU-1-12-763_h_a_dec_7.pdf@2020-03-07 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  3.7.2020  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2012)2846(final) for “Ecansya@capecitabine@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_7.pdf@EU-1-12-762_h_a_dec_7.pdf@2019-02-04 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_15.pdf@EU-1-12-764_h_a_dec_15.pdf@2020-12-18 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_11.pdf@EU-1-12-767_h_a_dec_11.pdf@2021-02-18 00:00:00@Nimenrix@Meningococcal group  A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_8.pdf@EU-1-12-760_h_a_dec_8.pdf@2019-01-23 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_4.pdf@EU-1-12-766_h_a_dec_4.pdf@2017-09-01 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@Kyowa Kirin Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_2.pdf@EU-1-12-764_h_a_dec_2.pdf@2013-03-22 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-767_h_a_dec_12.pdf@EU-1-12-767_h_a_dec_12.pdf@2022-02-28 00:00:00@Nimenrix@Meningococcal group  A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-763_h_a_dec_8.pdf@EU-1-12-763_h_a_dec_8.pdf@2022-04-29 00:00:00@Ecansya@capecitabine@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_8.pdf@EU-1-12-762_h_a_dec_8.pdf@2020-03-07 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE SPANISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  3.7.2020  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2012)2845(final) for “Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-760_h_a_dec_9.pdf@EU-1-12-760_h_a_dec_9.pdf@2020-06-02 00:00:00@Bronchitol@Mannitol@False@False@adopted@Pharmaxis Europe Limited@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_5.pdf@EU-1-12-766_h_a_dec_5.pdf@2018-07-19 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@Kyowa Kirin Limited@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_2.pdf@EU-1-12-767_h_a_dec_2.pdf@2014-07-18 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_3.pdf@EU-1-12-764_h_a_dec_3.pdf@2013-12-08 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-768_h_a_dec_0.pdf@EU-1-12-768_h_a_dec_0.pdf@2012-07-05 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-766_h_a_dec_6.pdf@EU-1-12-766_h_a_dec_6.pdf@2021-04-16 00:00:00@SANCUSO@granisetron@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_3.pdf@EU-1-12-767_h_a_dec_3.pdf@2015-07-28 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-762_h_a_dec_9.pdf@EU-1-12-762_h_a_dec_9.pdf@2020-07-17 00:00:00@Capecitabine Accord@capecitabine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_1.pdf@EU-1-12-768_h_a_dec_1.pdf@2014-11-07 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_4.pdf@EU-1-12-767_h_a_dec_4.pdf@2015-12-16 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_2.pdf@EU-1-12-768_h_a_dec_2.pdf@2017-09-01 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_0.pdf@EU-1-12-769_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_5.pdf@EU-1-12-767_h_a_dec_5.pdf@2016-07-29 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_3.pdf@EU-1-12-768_h_a_dec_3.pdf@2018-08-05 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_5.pdf@EU-1-12-764_h_a_dec_5.pdf@2014-01-09 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@CMA Not Found@Parsed
EU-1-12-768_h_a_dec_4.pdf@EU-1-12-768_h_a_dec_4.pdf@2021-06-09 00:00:00@Riluzole Zentiva@Riluzole@False@False@OD Not Found@Zentiva k.s.@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_1.pdf@EU-1-12-769_h_a_dec_1.pdf@2012-10-29 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_6.pdf@EU-1-12-767_h_a_dec_6.pdf@2016-08-22 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_6.pdf@EU-1-12-764_h_a_dec_6.pdf@2015-03-23 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-770_h_a_dec_0.pdf@EU-1-12-770_h_a_dec_0.pdf@2012-05-22 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_0.pdf@EU-1-12-775_h_a_dec_0.pdf@2012-03-09 00:00:00@NovoThirteen@catridecacog@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_0.pdf@EU-1-12-771_h_a_dec_0.pdf@2012-08-16 00:00:00@Zoledronic acid Teva@Zoledronic acid@False@False@OD Not Found@TEVA Pharma B.V.@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_2.pdf@EU-1-12-769_h_a_dec_2.pdf@2014-05-16 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_0.pdf@EU-1-12-773_h_a_dec_0.pdf@2012-08-23 00:00:00@Jakavi@ruxolitinib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_1.pdf@EU-1-12-770_h_a_dec_1.pdf@2012-10-29 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology  Plc.@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_1.pdf@EU-1-12-775_h_a_dec_1.pdf@2012-03-09 00:00:00@NovoThirteen@catridecacog@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_1.pdf@EU-1-12-771_h_a_dec_1.pdf@2014-06-27 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_8.pdf@EU-1-12-767_h_a_dec_8.pdf@2017-02-16 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate vaccine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_7.pdf@EU-1-12-764_h_a_dec_7.pdf@2016-03-22 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-773_h_a_dec_1.pdf@EU-1-12-773_h_a_dec_1.pdf@2013-11-13 00:00:00@Jakavi@ruxolitinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_3.pdf@EU-1-12-769_h_a_dec_3.pdf@2015-03-07 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_2.pdf@EU-1-12-770_h_a_dec_2.pdf@2014-05-22 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_2.pdf@EU-1-12-775_h_a_dec_2.pdf@2014-02-21 00:00:00@NovoThirteen@catridecacog@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_2.pdf@EU-1-12-771_h_a_dec_2.pdf@2014-01-10 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-767_h_a_dec_9.pdf@EU-1-12-767_h_a_dec_9.pdf@2018-07-30 00:00:00@Nimenrix@Meningococcal group A, C, W-135 and Y conjugate  vaccine@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_8.pdf@EU-1-12-764_h_a_dec_8.pdf@2017-03-22 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-769_h_a_dec_4.pdf@EU-1-12-769_h_a_dec_4.pdf@2017-01-27 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_3.pdf@EU-1-12-775_h_a_dec_3.pdf@2017-05-24 00:00:00@NovoThirteen@catridecacog@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_10.pdf@EU-1-12-773_h_a_dec_10.pdf@2020-09-06 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_3.pdf@EU-1-12-771_h_a_dec_3.pdf@2014-12-19 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_3.pdf@EU-1-12-770_h_a_dec_3.pdf@2015-03-07 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_4.pdf@EU-1-12-771_h_a_dec_4.pdf@2016-11-02 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-775_h_a_dec_4.pdf@EU-1-12-775_h_a_dec_4.pdf@2020-08-27 00:00:00@NovoThirteen@catridecacog@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_5.pdf@EU-1-12-769_h_a_dec_5.pdf@2017-02-23 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_4.pdf@EU-1-12-770_h_a_dec_4.pdf@2016-12-12 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_11.pdf@EU-1-12-773_h_a_dec_11.pdf@2020-12-14 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-764_h_a_dec_9.pdf@EU-1-12-764_h_a_dec_9.pdf@2018-03-21 00:00:00@Pixuvri@pixantrone@False@False@OD Not Found@CTI Life Sciences Ltd@conditional@Parsed
EU-1-12-771_h_a_dec_5.pdf@EU-1-12-771_h_a_dec_5.pdf@2017-05-22 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_6.pdf@EU-1-12-771_h_a_dec_6.pdf@2018-09-28 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_5.pdf@EU-1-12-770_h_a_dec_5.pdf@2017-02-23 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_6.pdf@EU-1-12-769_h_a_dec_6.pdf@2018-02-07 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_12.pdf@EU-1-12-773_h_a_dec_12.pdf@2021-07-28 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_7.pdf@EU-1-12-771_h_a_dec_7.pdf@2019-09-12 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_6.pdf@EU-1-12-770_h_a_dec_6.pdf@2018-08-05 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-12-771_h_a_dec_8.pdf@EU-1-12-771_h_a_dec_8.pdf@2021-01-22 00:00:00@Zoledronic acid Teva@zoledronic acid@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_13.pdf@EU-1-12-773_h_a_dec_13.pdf@2022-04-29 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_7.pdf@EU-1-12-770_h_a_dec_7.pdf@2019-06-28 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_7.pdf@EU-1-12-769_h_a_dec_7.pdf@2019-01-03 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_0.pdf@EU-1-12-777_h_a_dec_0.pdf@2012-03-09 00:00:00@Inlyta@Axitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_0.pdf@EU-1-12-776_h_a_dec_0.pdf@2012-07-23 00:00:00@Fycompa@Perampanel@True@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_8.pdf@EU-1-12-770_h_a_dec_8.pdf@2020-02-24 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_8.pdf@EU-1-12-769_h_a_dec_8.pdf@2020-02-21 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_2.pdf@EU-1-12-773_h_a_dec_2.pdf@2014-03-10 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_1.pdf@EU-1-12-776_h_a_dec_1.pdf@2012-10-29 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-770_h_a_dec_9.pdf@EU-1-12-770_h_a_dec_9.pdf@2021-04-10 00:00:00@Docetaxel Kabi@Docetaxel@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_1.pdf@EU-1-12-777_h_a_dec_1.pdf@2013-08-26 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-769_h_a_dec_9.pdf@EU-1-12-769_h_a_dec_9.pdf@2021-04-10 00:00:00@Docetaxel Accord@Docetaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_10.pdf@EU-1-12-776_h_a_dec_10.pdf@2020-04-28 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_0.pdf@EU-1-12-779_h_a_dec_0.pdf@2012-03-08 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_3.pdf@EU-1-12-773_h_a_dec_3.pdf@2015-11-03 00:00:00@Jakavi@ruxolitinib@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_0.pdf@EU-1-12-778_h_a_dec_0.pdf@2012-07-20 00:00:00@Eklira Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_11.pdf@EU-1-12-776_h_a_dec_11.pdf@2020-10-11 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_2.pdf@EU-1-12-777_h_a_dec_2.pdf@2014-07-11 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_1.pdf@EU-1-12-779_h_a_dec_1.pdf@2013-03-12 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_12.pdf@EU-1-12-776_h_a_dec_12.pdf@2021-04-21 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_4.pdf@EU-1-12-773_h_a_dec_4.pdf@2016-04-13 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_1.pdf@EU-1-12-778_h_a_dec_1.pdf@2013-11-15 00:00:00@Eklira Genuair@aclidinium  bromide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_2.pdf@EU-1-12-779_h_a_dec_2.pdf@2015-01-15 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_13.pdf@EU-1-12-776_h_a_dec_13.pdf@2022-04-25 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_3.pdf@EU-1-12-777_h_a_dec_3.pdf@2016-11-05 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_10.pdf@EU-1-12-778_h_a_dec_10.pdf@2022-06-24 00:00:00@Eklira Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_5.pdf@EU-1-12-773_h_a_dec_5.pdf@2016-07-29 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_3.pdf@EU-1-12-779_h_a_dec_3.pdf@2015-03-07 00:00:00@Zoledronic acid medac@zoledronic  acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_2.pdf@EU-1-12-776_h_a_dec_2.pdf@2013-11-13 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_2.pdf@EU-1-12-778_h_a_dec_2.pdf@2014-04-23 00:00:00@Eklira Genuair@aclidinium  bromide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_4.pdf@EU-1-12-779_h_a_dec_4.pdf@2016-06-29 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_4.pdf@EU-1-12-777_h_a_dec_4.pdf@2017-05-22 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_6.pdf@EU-1-12-773_h_a_dec_6.pdf@2016-11-18 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_0.pdf@EU-1-12-780_h_a_dec_0.pdf@2012-07-20 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_5.pdf@EU-1-12-779_h_a_dec_5.pdf@2017-04-28 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_3.pdf@EU-1-12-776_h_a_dec_3.pdf@2015-06-22 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_3.pdf@EU-1-12-778_h_a_dec_3.pdf@2014-11-19 00:00:00@Eklira Genuair@aclidinium bromide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_6.pdf@EU-1-12-779_h_a_dec_6.pdf@2017-06-16 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_1.pdf@EU-1-12-780_h_a_dec_1.pdf@2012-10-25 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_5.pdf@EU-1-12-777_h_a_dec_5.pdf@2018-03-08 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_7.pdf@EU-1-12-773_h_a_dec_7.pdf@2017-04-24 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_4.pdf@EU-1-12-778_h_a_dec_4.pdf@2015-05-03 00:00:00@Eklira Genuair@aclidinium bromide@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_4.pdf@EU-1-12-776_h_a_dec_4.pdf@2016-09-19 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-779_h_a_dec_7.pdf@EU-1-12-779_h_a_dec_7.pdf@2020-09-17 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_10.pdf@EU-1-12-780_h_a_dec_10.pdf@2018-03-16 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_6.pdf@EU-1-12-777_h_a_dec_6.pdf@2018-11-22 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_8.pdf@EU-1-12-773_h_a_dec_8.pdf@2017-01-12 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_5.pdf@EU-1-12-778_h_a_dec_5.pdf@Date is blank@Eklira Genuair@aclidinium bromide@NAS before 2012@NA before 2012@NA before 2000@AstraZeneca AB@CMA not available before 2006@Parsed
EU-1-12-779_h_a_dec_8.pdf@EU-1-12-779_h_a_dec_8.pdf@2021-09-29 00:00:00@Zoledronic acid medac@zoledronic acid@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_11.pdf@EU-1-12-780_h_a_dec_11.pdf@2019-07-18 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_7.pdf@EU-1-12-777_h_a_dec_7.pdf@2019-11-11 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_5.pdf@EU-1-12-776_h_a_dec_5.pdf@2017-06-04 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_6.pdf@EU-1-12-778_h_a_dec_6.pdf@2016-11-14 00:00:00@Eklira Genuair@aclidinium  bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_12.pdf@EU-1-12-780_h_a_dec_12.pdf@2020-07-17 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_8.pdf@EU-1-12-777_h_a_dec_8.pdf@2020-09-12 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-773_h_a_dec_9.pdf@EU-1-12-773_h_a_dec_9.pdf@2018-05-22 00:00:00@Jakavi@ruxolitinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_7.pdf@EU-1-12-778_h_a_dec_7.pdf@2017-04-20 00:00:00@Eklira Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_6.pdf@EU-1-12-776_h_a_dec_6.pdf@2018-01-30 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_2.pdf@EU-1-12-780_h_a_dec_2.pdf@2013-04-22 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-777_h_a_dec_9.pdf@EU-1-12-777_h_a_dec_9.pdf@2022-09-21 00:00:00@Inlyta@Axitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_8.pdf@EU-1-12-778_h_a_dec_8.pdf@2018-04-13 00:00:00@Eklira  Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_7.pdf@EU-1-12-776_h_a_dec_7.pdf@2018-04-23 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-778_h_a_dec_9.pdf@EU-1-12-778_h_a_dec_9.pdf@2020-11-20 00:00:00@Eklira  Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_3.pdf@EU-1-12-780_h_a_dec_3.pdf@2014-01-24 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_0.pdf@EU-1-12-781_h_a_dec_0.pdf@2012-07-20 00:00:00@Bretaris Genuair@aclidinium bromide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_4.pdf@EU-1-12-780_h_a_dec_4.pdf@2015-05-27 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_8.pdf@EU-1-12-776_h_a_dec_8.pdf@2018-09-21 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_1.pdf@EU-1-12-781_h_a_dec_1.pdf@2013-11-15 00:00:00@Bretaris Genuair@aclidinium  bromide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_5.pdf@EU-1-12-780_h_a_dec_5.pdf@2016-02-26 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-776_h_a_dec_9.pdf@EU-1-12-776_h_a_dec_9.pdf@2019-10-29 00:00:00@Fycompa@Perampanel@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_0.pdf@EU-1-12-782_h_a_dec_0.pdf@2012-07-23 00:00:00@Kalydeco@ivacaftor@True@False@adopted@Vertex Pharmaceuticals (U.K.) Limited,@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_10.pdf@EU-1-12-781_h_a_dec_10.pdf@2022-06-24 00:00:00@Bretaris Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_6.pdf@EU-1-12-780_h_a_dec_6.pdf@2016-02-03 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_0.pdf@EU-1-12-783_h_a_dec_0.pdf@2012-08-23 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_0.pdf@EU-1-12-784_h_a_dec_0.pdf@2012-08-23 00:00:00@Cuprymina@Copper  64Cu chloride@True@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_1.pdf@EU-1-12-783_h_a_dec_1.pdf@2015-02-12 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_7.pdf@EU-1-12-780_h_a_dec_7.pdf@2016-12-12 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2012)5291(final) for “Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_1.pdf@EU-1-12-782_h_a_dec_1.pdf@2013-11-20 00:00:00@Kalydeco@ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (U.K.) Limited@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_1.pdf@EU-1-12-784_h_a_dec_1.pdf@2016-03-16 00:00:00@Cuprymina@Copper  64Cu chloride@False@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_8.pdf@EU-1-12-780_h_a_dec_8.pdf@2017-01-27 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_3.pdf@EU-1-12-781_h_a_dec_3.pdf@2014-11-19 00:00:00@Bretaris Genuair@aclidinium  bromide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_0.pdf@EU-1-12-785_h_a_dec_0.pdf@2012-08-23 00:00:00@Zinforo@ceftaroline fosamil@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_2.pdf@EU-1-12-784_h_a_dec_2.pdf@2017-07-19 00:00:00@Cuprymina@Copper  64Cu chloride@False@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_3.pdf@EU-1-12-783_h_a_dec_3.pdf@2017-11-12 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_10.pdf@EU-1-12-782_h_a_dec_10.pdf@2018-11-22 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-780_h_a_dec_9.pdf@EU-1-12-780_h_a_dec_9.pdf@2017-03-22 00:00:00@Jentadueto@linagliptin/metformin hydrochloride@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_4.pdf@EU-1-12-781_h_a_dec_4.pdf@2015-05-03 00:00:00@Bretaris Genuair@aclidinium bromide@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_1.pdf@EU-1-12-785_h_a_dec_1.pdf@2014-10-30 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_4.pdf@EU-1-12-783_h_a_dec_4.pdf@2019-02-25 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_5.pdf@EU-1-12-781_h_a_dec_5.pdf@2015-04-24 00:00:00@Bretaris Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_3.pdf@EU-1-12-784_h_a_dec_3.pdf@2019-04-17 00:00:00@Cuprymina@Copper 64Cu chloride@False@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_5.pdf@EU-1-12-783_h_a_dec_5.pdf@2020-12-14 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_11.pdf@EU-1-12-782_h_a_dec_11.pdf@2018-11-26 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_6.pdf@EU-1-12-781_h_a_dec_6.pdf@2016-11-14 00:00:00@Bretaris Genuair@aclidinium  bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-783_h_a_dec_6.pdf@EU-1-12-783_h_a_dec_6.pdf@2022-03-28 00:00:00@Zyclara@imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_10.pdf@EU-1-12-785_h_a_dec_10.pdf@2021-01-22 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_4.pdf@EU-1-12-784_h_a_dec_4.pdf@2020-02-28 00:00:00@Cuprymina@Copper 64Cu chloride@False@False@OD Not Found@SPARKLE S.r.l.@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_0.pdf@EU-1-12-786_h_a_dec_0.pdf@2012-08-23 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_7.pdf@EU-1-12-781_h_a_dec_7.pdf@2017-04-20 00:00:00@Bretaris Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_12.pdf@EU-1-12-782_h_a_dec_12.pdf@2019-09-12 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_8.pdf@EU-1-12-781_h_a_dec_8.pdf@2018-04-13 00:00:00@Eklira  Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-784_h_a_dec_5.pdf@EU-1-12-784_h_a_dec_5.pdf@2022-06-21 00:00:00@Cuprymina@Copper 64Cu chloride@False@False@OD Not Found@A.C.O.M. -ADVANCED CENTER  ONCOLOGY MACERATA -S.R.L.@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_11.pdf@EU-1-12-785_h_a_dec_11.pdf@2022-01-27 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_1.pdf@EU-1-12-786_h_a_dec_1.pdf@2014-02-20 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_0.pdf@EU-1-12-787_h_a_dec_0.pdf@2012-08-30 00:00:00@Revestive@teduglutide@True@False@adopted@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-12-781_h_a_dec_9.pdf@EU-1-12-781_h_a_dec_9.pdf@2020-11-20 00:00:00@Bretaris Genuair@aclidinium bromide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_13.pdf@EU-1-12-782_h_a_dec_13.pdf@2020-09-06 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_2.pdf@EU-1-12-786_h_a_dec_2.pdf@2016-02-22 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_2.pdf@EU-1-12-785_h_a_dec_2.pdf@2016-11-01 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_1.pdf@EU-1-12-787_h_a_dec_1.pdf@2013-09-10 00:00:00@Revestive@teduglutide@False@False@adopted@Nycomed Danmark ApS@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_3.pdf@EU-1-12-786_h_a_dec_3.pdf@2017-05-24 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_3.pdf@EU-1-12-785_h_a_dec_3.pdf@2016-01-06 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_0.pdf@EU-1-12-788_h_a_dec_0.pdf@2012-09-28 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_14.pdf@EU-1-12-782_h_a_dec_14.pdf@2020-08-21 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_4.pdf@EU-1-12-786_h_a_dec_4.pdf@2018-09-28 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_4.pdf@EU-1-12-785_h_a_dec_4.pdf@2017-02-23 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_0.pdf@EU-1-12-789_h_a_dec_0.pdf@2012-09-28 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_5.pdf@EU-1-12-786_h_a_dec_5.pdf@2020-01-04 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_10.pdf@EU-1-12-787_h_a_dec_10.pdf@2020-05-20 00:00:00@Revestive@teduglutide@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_5.pdf@EU-1-12-785_h_a_dec_5.pdf@2017-04-24 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_1.pdf@EU-1-12-788_h_a_dec_1.pdf@2014-06-19 00:00:00@Seebri Breezhaler@glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_15.pdf@EU-1-12-782_h_a_dec_15.pdf@2020-03-11 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_6.pdf@EU-1-12-786_h_a_dec_6.pdf@2021-09-22 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_0.pdf@EU-1-12-790_h_a_dec_0.pdf@2012-09-28 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_6.pdf@EU-1-12-785_h_a_dec_6.pdf@2017-07-17 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-12-789_h_a_dec_1.pdf@EU-1-12-789_h_a_dec_1.pdf@2014-06-19 00:00:00@Enurev Breezhaler@glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_2.pdf@EU-1-12-788_h_a_dec_2.pdf@2016-12-05 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_11.pdf@EU-1-12-787_h_a_dec_11.pdf@2021-12-16 00:00:00@Revestive@teduglutide@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_16.pdf@EU-1-12-782_h_a_dec_16.pdf@2020-11-25 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_1.pdf@EU-1-12-790_h_a_dec_1.pdf@2014-06-19 00:00:00@Tovanor Breezhaler@glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-786_h_a_dec_7.pdf@EU-1-12-786_h_a_dec_7.pdf@2021-11-15 00:00:00@Zoledronic acid Mylan@zoledronic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_7.pdf@EU-1-12-785_h_a_dec_7.pdf@2018-11-22 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_3.pdf@EU-1-12-788_h_a_dec_3.pdf@2017-07-19 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_2.pdf@EU-1-12-789_h_a_dec_2.pdf@2016-12-05 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_12.pdf@EU-1-12-787_h_a_dec_12.pdf@2022-05-17 00:00:00@Revestive@teduglutide@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_2.pdf@EU-1-12-790_h_a_dec_2.pdf@2016-12-05 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_17.pdf@EU-1-12-782_h_a_dec_17.pdf@2021-04-26 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_3.pdf@EU-1-12-789_h_a_dec_3.pdf@2017-07-13 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_8.pdf@EU-1-12-785_h_a_dec_8.pdf@2019-04-07 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_4.pdf@EU-1-12-788_h_a_dec_4.pdf@2018-09-07 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_2.pdf@EU-1-12-787_h_a_dec_2.pdf@2014-12-15 00:00:00@Revestive@teduglutide@False@False@adopted@NPS Pharma Holdings Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_3.pdf@EU-1-12-790_h_a_dec_3.pdf@2017-07-26 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_18.pdf@EU-1-12-782_h_a_dec_18.pdf@2022-07-01 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_4.pdf@EU-1-12-789_h_a_dec_4.pdf@2018-02-07 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_3.pdf@EU-1-12-787_h_a_dec_3.pdf@2015-11-11 00:00:00@Revestive@teduglutide@False@False@adopted@NPS Pharma Holdings Limited@CMA Not Found@Parsed
EU-1-12-785_h_a_dec_9.pdf@EU-1-12-785_h_a_dec_9.pdf@2019-07-25 00:00:00@Zinforo@ceftaroline fosamil@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_5.pdf@EU-1-12-788_h_a_dec_5.pdf@2020-09-12 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_19.pdf@EU-1-12-782_h_a_dec_19.pdf@2022-04-29 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_4.pdf@EU-1-12-790_h_a_dec_4.pdf@2018-09-07 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_4.pdf@EU-1-12-787_h_a_dec_4.pdf@2016-06-29 00:00:00@Revestive@teduglutide@False@False@adopted@NPS Pharma Holdings Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_0.pdf@EU-1-12-792_h_a_dec_0.pdf@2012-09-20 00:00:00@Dacogen@Decitabine@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_5.pdf@EU-1-12-789_h_a_dec_5.pdf@2020-11-20 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_2.pdf@EU-1-12-782_h_a_dec_2.pdf@2014-07-28 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (U.K.) Limited@CMA Not Found@Parsed
EU-1-12-788_h_a_dec_6.pdf@EU-1-12-788_h_a_dec_6.pdf@2022-04-29 00:00:00@Seebri Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_5.pdf@EU-1-12-790_h_a_dec_5.pdf@2020-09-12 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_1.pdf@EU-1-12-792_h_a_dec_1.pdf@2014-01-16 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_5.pdf@EU-1-12-787_h_a_dec_5.pdf@2016-08-25 00:00:00@Revestive@teduglutide@False@False@adopted@NPS Pharma Holdings Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_10.pdf@EU-1-12-792_h_a_dec_10.pdf@2020-03-24 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_3.pdf@EU-1-12-782_h_a_dec_3.pdf@2014-11-19 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (U.K.) Limited@CMA Not Found@Parsed
EU-1-12-789_h_a_dec_6.pdf@EU-1-12-789_h_a_dec_6.pdf@2022-06-13 00:00:00@Enurev Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-790_h_a_dec_6.pdf@EU-1-12-790_h_a_dec_6.pdf@2022-04-29 00:00:00@Tovanor Breezhaler@glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_6.pdf@EU-1-12-787_h_a_dec_6.pdf@2017-06-23 00:00:00@Revestive@teduglutide@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_11.pdf@EU-1-12-792_h_a_dec_11.pdf@2021-03-22 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_0.pdf@EU-1-12-793_h_a_dec_0.pdf@2012-10-23 00:00:00@XALKORI@crizotinib@True@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-782_h_a_dec_4.pdf@EU-1-12-782_h_a_dec_4.pdf@2015-08-20 00:00:00@Kalydeco@ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (U.K.) Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_0.pdf@EU-1-12-794_h_a_dec_0.pdf@2012-10-25 00:00:00@Adcetris@Brentuximab vedotin@True@False@adopted@Takeda Global Research and Development  Centre (Europe) Ltd.@conditional@Parsed
EU-1-12-792_h_a_dec_12.pdf@EU-1-12-792_h_a_dec_12.pdf@2022-06-29 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_1.pdf@EU-1-12-793_h_a_dec_1.pdf@2013-08-26 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-787_h_a_dec_8.pdf@EU-1-12-787_h_a_dec_8.pdf@2019-01-23 00:00:00@Revestive@teduglutide@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_5.pdf@EU-1-12-782_h_a_dec_5.pdf@2015-11-16 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_1.pdf@EU-1-12-794_h_a_dec_1.pdf@2013-08-26 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Global Research and Development  Centre (Europe) Ltd@conditional@Parsed
EU-1-12-792_h_a_dec_2.pdf@EU-1-12-792_h_a_dec_2.pdf@2014-07-18 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_10.pdf@EU-1-12-793_h_a_dec_10.pdf@2016-01-08 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-782_h_a_dec_6.pdf@EU-1-12-782_h_a_dec_6.pdf@2017-02-16 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_0.pdf@EU-1-12-797_h_a_dec_0.pdf@2012-11-22 00:00:00@Eylea@aflibercept@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_10.pdf@EU-1-12-794_h_a_dec_10.pdf@2017-12-15 00:00:00@Brentuximab vedotin@Active Substance Not Found@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-795_h_a_dec_0.pdf@EU-1-12-795_h_a_dec_0.pdf@2012-12-11 00:00:00@Forxiga@dapagliflozin@True@False@OD Not Found@Bristol Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-12-787_h_a_dec_9.pdf@EU-1-12-787_h_a_dec_9.pdf@2019-01-23 00:00:00@Revestive@teduglutide@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_3.pdf@EU-1-12-792_h_a_dec_3.pdf@2016-07-03 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_1.pdf@EU-1-12-797_h_a_dec_1.pdf@2013-08-26 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_11.pdf@EU-1-12-794_h_a_dec_11.pdf@2018-10-09 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-793_h_a_dec_11.pdf@EU-1-12-793_h_a_dec_11.pdf@2016-07-29 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-792_h_a_dec_4.pdf@EU-1-12-792_h_a_dec_4.pdf@2016-06-30 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_1.pdf@EU-1-12-795_h_a_dec_1.pdf@2014-05-03 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_7.pdf@EU-1-12-782_h_a_dec_7.pdf@2017-04-28 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_10.pdf@EU-1-12-797_h_a_dec_10.pdf@2018-07-30 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_12.pdf@EU-1-12-794_h_a_dec_12.pdf@2019-06-02 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-792_h_a_dec_5.pdf@EU-1-12-792_h_a_dec_5.pdf@2017-02-23 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_11.pdf@EU-1-12-797_h_a_dec_11.pdf@2019-10-21 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_12.pdf@EU-1-12-793_h_a_dec_12.pdf@2016-08-25 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-795_h_a_dec_10.pdf@EU-1-12-795_h_a_dec_10.pdf@2019-07-25 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_13.pdf@EU-1-12-794_h_a_dec_13.pdf@2019-09-19 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-782_h_a_dec_8.pdf@EU-1-12-782_h_a_dec_8.pdf@2018-08-23 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_6.pdf@EU-1-12-792_h_a_dec_6.pdf@2017-05-22 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_11.pdf@EU-1-12-795_h_a_dec_11.pdf@2019-07-31 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_12.pdf@EU-1-12-797_h_a_dec_12.pdf@2020-09-24 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_14.pdf@EU-1-12-794_h_a_dec_14.pdf@2020-12-05 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-793_h_a_dec_13.pdf@EU-1-12-793_h_a_dec_13.pdf@2016-11-11 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-792_h_a_dec_7.pdf@EU-1-12-792_h_a_dec_7.pdf@2017-08-24 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_13.pdf@EU-1-12-797_h_a_dec_13.pdf@2021-06-21 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_15.pdf@EU-1-12-794_h_a_dec_15.pdf@2020-07-23 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-12-782_h_a_dec_9.pdf@EU-1-12-782_h_a_dec_9.pdf@2018-10-10 00:00:00@Kalydeco@ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-12-792_h_a_dec_8.pdf@EU-1-12-792_h_a_dec_8.pdf@2019-01-23 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_12.pdf@EU-1-12-795_h_a_dec_12.pdf@2020-10-15 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_14.pdf@EU-1-12-793_h_a_dec_14.pdf@2018-01-18 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_14.pdf@EU-1-12-797_h_a_dec_14.pdf@2021-07-23 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_0.pdf@EU-1-12-798_h_a_dec_0.pdf@2012-11-19 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_16.pdf@EU-1-12-794_h_a_dec_16.pdf@2020-09-15 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-792_h_a_dec_9.pdf@EU-1-12-792_h_a_dec_9.pdf@2019-07-02 00:00:00@Dacogen@Decitabine@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_17.pdf@EU-1-12-794_h_a_dec_17.pdf@2020-12-14 00:00:00@ADCETRIS@Brentuximab  vedotin@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-797_h_a_dec_2.pdf@EU-1-12-797_h_a_dec_2.pdf@2014-06-08 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_1.pdf@EU-1-12-798_h_a_dec_1.pdf@2014-08-01 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_13.pdf@EU-1-12-795_h_a_dec_13.pdf@2020-03-11 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_15.pdf@EU-1-12-793_h_a_dec_15.pdf@2018-08-31 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_18.pdf@EU-1-12-794_h_a_dec_18.pdf@2021-09-16 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-797_h_a_dec_3.pdf@EU-1-12-797_h_a_dec_3.pdf@2014-08-26 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_16.pdf@EU-1-12-793_h_a_dec_16.pdf@2018-10-23 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_2.pdf@EU-1-12-798_h_a_dec_2.pdf@2015-03-23 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_14.pdf@EU-1-12-795_h_a_dec_14.pdf@2021-05-08 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_4.pdf@EU-1-12-797_h_a_dec_4.pdf@2015-02-24 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_19.pdf@EU-1-12-794_h_a_dec_19.pdf@2021-09-12 00:00:00@ADCETRIS@Brentuximab  vedotin@False@False@adopted@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_17.pdf@EU-1-12-793_h_a_dec_17.pdf@2020-09-03 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_5.pdf@EU-1-12-797_h_a_dec_5.pdf@2015-10-28 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_3.pdf@EU-1-12-798_h_a_dec_3.pdf@2016-12-08 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_18.pdf@EU-1-12-793_h_a_dec_18.pdf@2021-07-16 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_2.pdf@EU-1-12-794_h_a_dec_2.pdf@2013-10-24 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Global Research and Development  Centre (Europe) Ltd@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_15.pdf@EU-1-12-795_h_a_dec_15.pdf@2021-10-25 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_6.pdf@EU-1-12-797_h_a_dec_6.pdf@2016-06-30 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_0.pdf@EU-1-12-799_h_a_dec_0.pdf@2012-11-22 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_19.pdf@EU-1-12-793_h_a_dec_19.pdf@2022-06-21 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-798_h_a_dec_4.pdf@EU-1-12-798_h_a_dec_4.pdf@2017-09-18 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_20.pdf@EU-1-12-794_h_a_dec_20.pdf@2021-12-13 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-797_h_a_dec_7.pdf@EU-1-12-797_h_a_dec_7.pdf@2016-08-16 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_1.pdf@EU-1-12-799_h_a_dec_1.pdf@2015-05-13 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_0.pdf@EU-1-12-800_h_a_dec_0.pdf@2012-11-19 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Ltd.@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_16.pdf@EU-1-12-795_h_a_dec_16.pdf@2021-11-15 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_2.pdf@EU-1-12-793_h_a_dec_2.pdf@2014-01-29 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_8.pdf@EU-1-12-797_h_a_dec_8.pdf@2017-12-04 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_21.pdf@EU-1-12-794_h_a_dec_21.pdf@2022-04-13 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-798_h_a_dec_5.pdf@EU-1-12-798_h_a_dec_5.pdf@2019-02-20 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_2.pdf@EU-1-12-799_h_a_dec_2.pdf@2017-07-13 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-797_h_a_dec_9.pdf@EU-1-12-797_h_a_dec_9.pdf@2017-07-13 00:00:00@Eylea@aflibercept@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_1.pdf@EU-1-12-800_h_a_dec_1.pdf@2014-01-31 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_22.pdf@EU-1-12-794_h_a_dec_22.pdf@2022-05-24 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-798_h_a_dec_6.pdf@EU-1-12-798_h_a_dec_6.pdf@2021-06-24 00:00:00@Ibandronic acid Accord@Ibandronic acid@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_3.pdf@EU-1-12-793_h_a_dec_3.pdf@2014-03-21 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_3.pdf@EU-1-12-799_h_a_dec_3.pdf@2020-12-06 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_17.pdf@EU-1-12-795_h_a_dec_17.pdf@2022-07-15 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-799_h_a_dec_4.pdf@EU-1-12-799_h_a_dec_4.pdf@2022-04-04 00:00:00@Memantine Merz@Memantine@False@False@OD Not Found@Merz Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_3.pdf@EU-1-12-794_h_a_dec_3.pdf@2014-08-22 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-800_h_a_dec_2.pdf@EU-1-12-800_h_a_dec_2.pdf@2015-11-02 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_4.pdf@EU-1-12-793_h_a_dec_4.pdf@2014-05-14 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_5.pdf@EU-1-12-794_h_a_dec_5.pdf@2015-10-09 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-795_h_a_dec_2.pdf@EU-1-12-795_h_a_dec_2.pdf@2014-03-10 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_3.pdf@EU-1-12-800_h_a_dec_3.pdf@2016-06-24 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_5.pdf@EU-1-12-793_h_a_dec_5.pdf@2014-08-22 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-794_h_a_dec_6.pdf@EU-1-12-794_h_a_dec_6.pdf@2015-11-19 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-795_h_a_dec_3.pdf@EU-1-12-795_h_a_dec_3.pdf@2016-04-28 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_0.pdf@EU-1-12-801_h_a_dec_0.pdf@2012-11-26 00:00:00@Constella@linaclotide@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_7.pdf@EU-1-12-794_h_a_dec_7.pdf@2016-06-24 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-12-800_h_a_dec_4.pdf@EU-1-12-800_h_a_dec_4.pdf@2017-06-16 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_6.pdf@EU-1-12-793_h_a_dec_6.pdf@2015-07-17 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-795_h_a_dec_4.pdf@EU-1-12-795_h_a_dec_4.pdf@2017-04-20 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_0.pdf@EU-1-12-802_h_a_dec_0.pdf@2012-11-19 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_8.pdf@EU-1-12-794_h_a_dec_8.pdf@2016-10-21 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-801_h_a_dec_1.pdf@EU-1-12-801_h_a_dec_1.pdf@2014-02-20 00:00:00@Constella@linaclotide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_5.pdf@EU-1-12-795_h_a_dec_5.pdf@2017-07-19 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_5.pdf@EU-1-12-800_h_a_dec_5.pdf@2017-08-24 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_7.pdf@EU-1-12-793_h_a_dec_7.pdf@2015-11-19 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_1.pdf@EU-1-12-802_h_a_dec_1.pdf@2014-02-28 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-794_h_a_dec_9.pdf@EU-1-12-794_h_a_dec_9.pdf@2017-10-11 00:00:00@ADCETRIS@Brentuximab vedotin@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-12-795_h_a_dec_6.pdf@EU-1-12-795_h_a_dec_6.pdf@2017-08-28 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_2.pdf@EU-1-12-802_h_a_dec_2.pdf@2015-09-04 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_10.pdf@EU-1-12-801_h_a_dec_10.pdf@2022-07-06 00:00:00@Constella@linaclotide@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_8.pdf@EU-1-12-793_h_a_dec_8.pdf@2015-11-23 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-800_h_a_dec_6.pdf@EU-1-12-800_h_a_dec_6.pdf@2018-09-20 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_3.pdf@EU-1-12-802_h_a_dec_3.pdf@2016-05-26 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_2.pdf@EU-1-12-801_h_a_dec_2.pdf@2015-03-16 00:00:00@Constella@linaclotide@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_7.pdf@EU-1-12-795_h_a_dec_7.pdf@2018-12-04 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_7.pdf@EU-1-12-800_h_a_dec_7.pdf@2020-12-02 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_0.pdf@EU-1-12-803_h_a_dec_0.pdf@2012-12-18 00:00:00@NexoBrid@Concentrate  proteolytic enzymes  enriched in bromelain@False@False@adopted@TEVA Pharma GmbH@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_4.pdf@EU-1-12-802_h_a_dec_4.pdf@2017-06-16 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-793_h_a_dec_9.pdf@EU-1-12-793_h_a_dec_9.pdf@2016-05-26 00:00:00@XALKORI@crizotinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-12-800_h_a_dec_8.pdf@EU-1-12-800_h_a_dec_8.pdf@2020-10-22 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_5.pdf@EU-1-12-802_h_a_dec_5.pdf@2019-08-04 00:00:00@ Having regard to the opinion  the European Medicines Agency, formulated on 31 January  2019 by the Committee for Medicinal Products for Human Use on the periodic safety update  report for this medicinal product, Whereas: (1) The placing on the market  the medicinal product @Active Substance Not Found@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_1.pdf@EU-1-12-803_h_a_dec_1.pdf@2013-09-19 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@adopted@Teva Pharma GmbH@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_3.pdf@EU-1-12-801_h_a_dec_3.pdf@2016-02-22 00:00:00@Constella@linaclotide@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_8.pdf@EU-1-12-795_h_a_dec_8.pdf@2018-12-11 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-800_h_a_dec_9.pdf@EU-1-12-800_h_a_dec_9.pdf@2022-04-02 00:00:00@Zoledronic acid Hospira@zoledronic acid@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_6.pdf@EU-1-12-802_h_a_dec_6.pdf@2020-06-07 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 6.7.2020 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2012)8599(final) for “Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_2.pdf@EU-1-12-803_h_a_dec_2.pdf@2014-10-30 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@OD Not Found@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_4.pdf@EU-1-12-801_h_a_dec_4.pdf@2016-05-26 00:00:00@Constella@linaclotide@False@False@OD Not Found@Allergan Pharmaceuticals International Ltd.@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_7.pdf@EU-1-12-802_h_a_dec_7.pdf@2020-07-16 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-795_h_a_dec_9.pdf@EU-1-12-795_h_a_dec_9.pdf@2019-03-20 00:00:00@Forxiga@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_3.pdf@EU-1-12-803_h_a_dec_3.pdf@2017-09-18 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@OD Not Found@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_8.pdf@EU-1-12-802_h_a_dec_8.pdf@2020-11-18 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 18.11.2020 correcting Decision C(2020)4695(final)  6.07.2020 concerning, in the framework   Article 31  Directive 2001/83/EC  the European Parliament and  the Council, the  marketing authorisation granted by Decision C(2012)8599(final) for “Capecitabine  medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH, Theaterstraße 6, 22880 Wedel, Deutschland@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_5.pdf@EU-1-12-801_h_a_dec_5.pdf@2017-11-04 00:00:00@Constella@linaclotide@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_0.pdf@EU-1-12-805_h_a_dec_0.pdf@2013-01-14 00:00:00@Amyvid@Florbetapir (18F)@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_4.pdf@EU-1-12-803_h_a_dec_4.pdf@2017-10-11 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@adopted@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-802_h_a_dec_9.pdf@EU-1-12-802_h_a_dec_9.pdf@2022-03-24 00:00:00@Capecitabine medac@capecitabine@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_5.pdf@EU-1-12-803_h_a_dec_5.pdf@2018-09-28 00:00:00@NexoBrid@Concentrate   proteolytic enzymes enriched in bromelain@False@False@OD Not Found@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_1.pdf@EU-1-12-805_h_a_dec_1.pdf@2014-06-27 00:00:00@Amyvid@Florbetapir  (18F)@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
 Not Found@Parsed
EU-1-12-803_h_a_dec_6.pdf@EU-1-12-803_h_a_dec_6.pdf@2019-07-25 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@OD Not Found@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_0.pdf@EU-1-12-806_h_a_dec_0.pdf@2013-01-21 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_2.pdf@EU-1-12-805_h_a_dec_2.pdf@2015-10-12 00:00:00@Amyvid@Florbetapir ( 18F)@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_0.pdf@EU-1-12-807_h_a_dec_0.pdf@2013-01-21 00:00:00@Tresiba@Insulin degludec@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_7.pdf@EU-1-12-803_h_a_dec_7.pdf@2022-06-21 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@OD Not Found@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_7.pdf@EU-1-12-801_h_a_dec_7.pdf@2018-07-06 00:00:00@Constella@linaclotide@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_3.pdf@EU-1-12-805_h_a_dec_3.pdf@2017-06-02 00:00:00@Amyvid@Florbetapir ( 18F)@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_1.pdf@EU-1-12-806_h_a_dec_1.pdf@2013-01-21 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-803_h_a_dec_8.pdf@EU-1-12-803_h_a_dec_8.pdf@2022-12-08 00:00:00@NexoBrid@Concentrate  proteolytic enzymes enriched in bromelain@False@False@adopted@MediWound Germany GmbH@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_1.pdf@EU-1-12-807_h_a_dec_1.pdf@2013-01-21 00:00:00@Tresiba@Insulin degludec@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_4.pdf@EU-1-12-805_h_a_dec_4.pdf@2017-09-21 00:00:00@Amyvid@Florbetapir ( 18F)@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_5.pdf@EU-1-12-805_h_a_dec_5.pdf@2018-12-18 00:00:00@Amyvid@Florbetapir ( 18F)@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_2.pdf@EU-1-12-806_h_a_dec_2.pdf@2014-04-23 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_8.pdf@EU-1-12-801_h_a_dec_8.pdf@2020-02-06 00:00:00@Constella@linaclotide@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_2.pdf@EU-1-12-807_h_a_dec_2.pdf@2014-07-05 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_3.pdf@EU-1-12-806_h_a_dec_3.pdf@2016-04-13 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_0.pdf@EU-1-12-808_h_a_dec_0.pdf@2013-08-01 00:00:00@Imatinib Teva@imatinib@False@False@appointed@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_3.pdf@EU-1-12-807_h_a_dec_3.pdf@2015-01-30 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-805_h_a_dec_6.pdf@EU-1-12-805_h_a_dec_6.pdf@2021-09-12 00:00:00@Amyvid@Florbetapir  (18F)@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_4.pdf@EU-1-12-806_h_a_dec_4.pdf@2016-07-22 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-801_h_a_dec_9.pdf@EU-1-12-801_h_a_dec_9.pdf@2021-09-22 00:00:00@Constella@linaclotide@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_0.pdf@EU-1-12-809_h_a_dec_0.pdf@2012-12-20 00:00:00@Betmiga@mirabegron@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_4.pdf@EU-1-12-807_h_a_dec_4.pdf@2016-04-13 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_1.pdf@EU-1-12-808_h_a_dec_1.pdf@2013-08-01 00:00:00@Imatinib Teva@imatinib@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_5.pdf@EU-1-12-806_h_a_dec_5.pdf@2017-09-21 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_0.pdf@EU-1-12-811_h_a_dec_0.pdf@2013-01-02 00:00:00@Lyxumia@lixisenatide@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_10.pdf@EU-1-12-808_h_a_dec_10.pdf@2021-10-05 00:00:00@Imatinib  Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_5.pdf@EU-1-12-807_h_a_dec_5.pdf@2017-04-28 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_6.pdf@EU-1-12-806_h_a_dec_6.pdf@2018-09-20 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_1.pdf@EU-1-12-809_h_a_dec_1.pdf@2014-02-20 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_2.pdf@EU-1-12-808_h_a_dec_2.pdf@2013-05-31 00:00:00@Imatinib Teva@imatinib@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_1.pdf@EU-1-12-811_h_a_dec_1.pdf@2014-10-22 00:00:00@Lyxumia@lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_7.pdf@EU-1-12-806_h_a_dec_7.pdf@2019-03-05 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_6.pdf@EU-1-12-807_h_a_dec_6.pdf@2017-09-21 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_2.pdf@EU-1-12-811_h_a_dec_2.pdf@2015-10-15 00:00:00@Lyxumia@lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_2.pdf@EU-1-12-809_h_a_dec_2.pdf@2014-04-23 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-806_h_a_dec_8.pdf@EU-1-12-806_h_a_dec_8.pdf@2021-09-29 00:00:00@Ryzodeg@Insulin degludec/insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_7.pdf@EU-1-12-807_h_a_dec_7.pdf@2018-09-20 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_3.pdf@EU-1-12-808_h_a_dec_3.pdf@2014-11-11 00:00:00@Imatinib Teva@imatinib@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_3.pdf@EU-1-12-811_h_a_dec_3.pdf@2016-02-05 00:00:00@Lyxumia@lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_0.pdf@EU-1-12-812_h_a_dec_0.pdf@2013-01-14 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA,  component, adsorbed)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_0.pdf@EU-1-12-814_h_a_dec_0.pdf@2013-01-02 00:00:00@ZALTRAP@aflibercept@True@False@OD Not Found@Sanofi-aventis groupe@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_4.pdf@EU-1-12-808_h_a_dec_4.pdf@2015-06-05 00:00:00@Imatinib  Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_8.pdf@EU-1-12-807_h_a_dec_8.pdf@2019-04-11 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_1.pdf@EU-1-12-812_h_a_dec_1.pdf@2013-03-22 00:00:00@Article 1 The marketing authorisation provided for in Article 3  Regulation (EC) No 726/2004 is granted for the medicinal product @Active Substance Not Found@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_3.pdf@EU-1-12-809_h_a_dec_3.pdf@2014-11-19 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_4.pdf@EU-1-12-811_h_a_dec_4.pdf@2017-09-18 00:00:00@Lyxumia@lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_5.pdf@EU-1-12-808_h_a_dec_5.pdf@2016-05-17 00:00:00@Imatinib  Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-807_h_a_dec_9.pdf@EU-1-12-807_h_a_dec_9.pdf@2021-09-29 00:00:00@Tresiba@Insulin degludec@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_1.pdf@EU-1-12-814_h_a_dec_1.pdf@2014-06-27 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_10.pdf@EU-1-12-812_h_a_dec_10.pdf@2020-04-28 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-12-811_h_a_dec_5.pdf@EU-1-12-811_h_a_dec_5.pdf@2021-11-26 00:00:00@Lyxumia@lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_4.pdf@EU-1-12-809_h_a_dec_4.pdf@2015-03-16 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_6.pdf@EU-1-12-808_h_a_dec_6.pdf@2016-06-10 00:00:00@Imatinib  Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_11.pdf@EU-1-12-812_h_a_dec_11.pdf@2021-01-07 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_2.pdf@EU-1-12-814_h_a_dec_2.pdf@2014-11-19 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
sed
EU-1-12-808_h_a_dec_7.pdf@EU-1-12-808_h_a_dec_7.pdf@2017-09-18 00:00:00@Imatinib Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_2.pdf@EU-1-12-812_h_a_dec_2.pdf@2013-03-22 00:00:00@Article 1 The marketing authorisation provided for in Article 3  Regulation (EC) No 726/2004 is granted for the medicinal product @Active Substance Not Found@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.,@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_3.pdf@EU-1-12-814_h_a_dec_3.pdf@2016-04-28 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_6.pdf@EU-1-12-809_h_a_dec_6.pdf@2016-03-31 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_8.pdf@EU-1-12-808_h_a_dec_8.pdf@2019-03-28 00:00:00@Imatinib  Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-808_h_a_dec_9.pdf@EU-1-12-808_h_a_dec_9.pdf@2020-03-07 00:00:00@Imatinib  Teva@imatinib@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_4.pdf@EU-1-12-814_h_a_dec_4.pdf@2016-10-24 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_7.pdf@EU-1-12-809_h_a_dec_7.pdf@2017-09-18 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_3.pdf@EU-1-12-812_h_a_dec_3.pdf@2014-01-10 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@Novartis Vaccines and Diagnostics S.r.l.@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_5.pdf@EU-1-12-814_h_a_dec_5.pdf@2017-09-21 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_8.pdf@EU-1-12-809_h_a_dec_8.pdf@2019-02-04 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_4.pdf@EU-1-12-812_h_a_dec_4.pdf@2016-01-28 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_0.pdf@EU-1-12-815_h_a_dec_0.pdf@2013-02-25 00:00:00@Selincro@nalmefene@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_0.pdf@EU-1-13-813_h_a_dec_0.pdf@2013-04-03 00:00:00@Perjeta@pertuzumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_6.pdf@EU-1-12-814_h_a_dec_6.pdf@2020-10-15 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_5.pdf@EU-1-12-812_h_a_dec_5.pdf@2017-09-18 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-12-814_h_a_dec_7.pdf@EU-1-12-814_h_a_dec_7.pdf@2021-09-12 00:00:00@ZALTRAP@aflibercept@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_1.pdf@EU-1-12-815_h_a_dec_1.pdf@2014-05-22 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-12-809_h_a_dec_9.pdf@EU-1-12-809_h_a_dec_9.pdf@2022-09-21 00:00:00@Betmiga@mirabegron@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_1.pdf@EU-1-13-813_h_a_dec_1.pdf@2014-06-30 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_6.pdf@EU-1-12-812_h_a_dec_6.pdf@2018-07-06 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_2.pdf@EU-1-12-815_h_a_dec_2.pdf@2015-05-27 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_7.pdf@EU-1-12-812_h_a_dec_7.pdf@2018-11-22 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_10.pdf@EU-1-13-813_h_a_dec_10.pdf@2018-05-31 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-817_h_a_dec_0.pdf@EU-1-13-817_h_a_dec_0.pdf@2013-03-13 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_3.pdf@EU-1-12-815_h_a_dec_3.pdf@2016-11-18 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_8.pdf@EU-1-12-812_h_a_dec_8.pdf@2019-03-28 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_11.pdf@EU-1-13-813_h_a_dec_11.pdf@2019-03-28 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_4.pdf@EU-1-12-815_h_a_dec_4.pdf@2017-10-11 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-12-812_h_a_dec_9.pdf@EU-1-12-812_h_a_dec_9.pdf@2020-02-28 00:00:00@Bexsero@Meningococcal group B Vaccine (rDNA, component, adsorbed)@False@False@OD Not Found@GlaxoSmithKline Vaccines S.r.l.@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_12.pdf@EU-1-13-813_h_a_dec_12.pdf@2021-03-17 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-817_h_a_dec_1.pdf@EU-1-13-817_h_a_dec_1.pdf@2014-04-09 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2013)1643(final) for “Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_0.pdf@EU-1-13-818_h_a_dec_0.pdf@2013-03-27 00:00:00@Bosulif@Bosutinib@True@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-12-815_h_a_dec_5.pdf@EU-1-12-815_h_a_dec_5.pdf@2017-08-12 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_0.pdf@EU-1-13-819_h_a_dec_0.pdf@2013-03-13 00:00:00@JETREA@OCRIPLASMIN@True@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_13.pdf@EU-1-13-813_h_a_dec_13.pdf@2022-07-06 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_6.pdf@EU-1-12-815_h_a_dec_6.pdf@2018-11-20 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_1.pdf@EU-1-13-818_h_a_dec_1.pdf@2014-02-20 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-13-817_h_a_dec_2.pdf@EU-1-13-817_h_a_dec_2.pdf@2017-12-15 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_1.pdf@EU-1-13-819_h_a_dec_1.pdf@2014-10-30 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_2.pdf@EU-1-13-813_h_a_dec_2.pdf@2015-08-07 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_0.pdf@EU-1-13-820_h_a_dec_0.pdf@2013-04-29 00:00:00@Maruxa@Memantine@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_7.pdf@EU-1-12-815_h_a_dec_7.pdf@2020-09-03 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_2.pdf@EU-1-13-819_h_a_dec_2.pdf@2015-04-24 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-12-815_h_a_dec_8.pdf@EU-1-12-815_h_a_dec_8.pdf@2021-12-20 00:00:00@Selincro@nalmefene@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_10.pdf@EU-1-13-818_h_a_dec_10.pdf@2018-05-22 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-13-817_h_a_dec_3.pdf@EU-1-13-817_h_a_dec_3.pdf@2019-11-14 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_4.pdf@EU-1-13-813_h_a_dec_4.pdf@2015-09-18 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_3.pdf@EU-1-13-819_h_a_dec_3.pdf@2015-07-17 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_1.pdf@EU-1-13-820_h_a_dec_1.pdf@2013-05-08 00:00:00@Maruxa@Memantine@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_0.pdf@EU-1-13-821_h_a_dec_0.pdf@2013-03-13 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka, d. d., Novo mesto@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_4.pdf@EU-1-13-819_h_a_dec_4.pdf@2017-10-13 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_11.pdf@EU-1-13-818_h_a_dec_11.pdf@2018-02-08 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_5.pdf@EU-1-13-813_h_a_dec_5.pdf@2016-08-08 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-817_h_a_dec_4.pdf@EU-1-13-817_h_a_dec_4.pdf@2021-05-27 00:00:00@Actelsar HCT@telmisartan / hydrochlorothiazide@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_2.pdf@EU-1-13-820_h_a_dec_2.pdf@2014-08-26 00:00:00@Marixino@Memantine@False@False@OD Not Found@Consilient Health Ltd.@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_0.pdf@EU-1-13-822_h_a_dec_0.pdf@2013-07-31 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_5.pdf@EU-1-13-819_h_a_dec_5.pdf@2017-08-12 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@ThromboGenics NV@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_12.pdf@EU-1-13-818_h_a_dec_12.pdf@2019-02-18 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-13-821_h_a_dec_1.pdf@EU-1-13-821_h_a_dec_1.pdf@2014-04-09 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE SLOVENIAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2013)1644(final) for “Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_6.pdf@EU-1-13-813_h_a_dec_6.pdf@2016-10-27 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_6.pdf@EU-1-13-819_h_a_dec_6.pdf@2019-02-08 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@Oxurion NV@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_3.pdf@EU-1-13-820_h_a_dec_3.pdf@2017-05-16 00:00:00@Marixino@Memantine@False@False@OD Not Found@Consilient Health Ltd@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_1.pdf@EU-1-13-822_h_a_dec_1.pdf@2014-01-09 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_2.pdf@EU-1-13-821_h_a_dec_2.pdf@2015-05-27 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_14.pdf@EU-1-13-818_h_a_dec_14.pdf@2020-12-14 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_2.pdf@EU-1-13-822_h_a_dec_2.pdf@2017-05-22 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_3.pdf@EU-1-13-821_h_a_dec_3.pdf@2017-06-02 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_7.pdf@EU-1-13-819_h_a_dec_7.pdf@2020-09-15 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@Oxurion NV@CMA Not Found@Parsed
EU-1-13-823_h_a_dec_0.pdf@EU-1-13-823_h_a_dec_0.pdf@2013-02-20 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd.@CMA Not Found@Parsed
EU-1-13-813_h_a_dec_7.pdf@EU-1-13-813_h_a_dec_7.pdf@2017-08-12 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_4.pdf@EU-1-13-820_h_a_dec_4.pdf@2018-01-18 00:00:00@Marixino@Memantine@False@False@OD Not Found@Consilient Health Ltd@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_15.pdf@EU-1-13-818_h_a_dec_15.pdf@2021-11-02 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-13-823_h_a_dec_1.pdf@EU-1-13-823_h_a_dec_1.pdf@2013-02-20 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd.@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_4.pdf@EU-1-13-821_h_a_dec_4.pdf@2018-08-01 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_4.pdf@EU-1-13-822_h_a_dec_4.pdf@2018-11-26 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-819_h_a_dec_8.pdf@EU-1-13-819_h_a_dec_8.pdf@2021-09-12 00:00:00@JETREA@ocriplasmin@False@False@OD Not Found@Inceptua AB@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_16.pdf@EU-1-13-818_h_a_dec_16.pdf@2022-03-31 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-13-813_h_a_dec_8.pdf@EU-1-13-813_h_a_dec_8.pdf@2018-03-23 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_5.pdf@EU-1-13-822_h_a_dec_5.pdf@2020-12-06 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Eurocept International BV@CMA Not Found@Parsed
EU-1-13-823_h_a_dec_2.pdf@EU-1-13-823_h_a_dec_2.pdf@2014-03-06 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd.@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_5.pdf@EU-1-13-820_h_a_dec_5.pdf@2018-04-04 00:00:00@Marixino@Memantine@False@False@OD Not Found@Consilient Health Ltd@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_17.pdf@EU-1-13-818_h_a_dec_17.pdf@2022-07-04 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-13-813_h_a_dec_9.pdf@EU-1-13-813_h_a_dec_9.pdf@2018-04-30 00:00:00@Perjeta@pertuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-821_h_a_dec_5.pdf@EU-1-13-821_h_a_dec_5.pdf@2019-06-02 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-13-822_h_a_dec_6.pdf@EU-1-13-822_h_a_dec_6.pdf@2022-03-28 00:00:00@PHEBURANE@Sodium Phenylbutyrate@False@False@OD Not Found@Eurocept International BV@CMA Not Found@Parsed
EU-1-13-820_h_a_dec_6.pdf@EU-1-13-820_h_a_dec_6.pdf@2021-11-18 00:00:00@Marixino@Memantine@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-13-823_h_a_dec_3.pdf@EU-1-13-823_h_a_dec_3.pdf@2015-08-25 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Alexza UK Ltd@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_2.pdf@EU-1-13-818_h_a_dec_2.pdf@2014-06-23 00:00:00@Bosulif@Bosutinib@False@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-821_h_a_dec_6.pdf@EU-1-13-821_h_a_dec_6.pdf@2020-12-14 00:00:00@Tolucombi@telmisartan/hydrochlorothiazide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-13-823_h_a_dec_4.pdf@EU-1-13-823_h_a_dec_4.pdf@2018-01-15 00:00:00@Adasuve@loxapine@False@False@OD Not Found@Ferrer Internacional S.A.@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_0.pdf@EU-1-13-824_h_a_dec_0.pdf@2013-04-22 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_3.pdf@EU-1-13-818_h_a_dec_3.pdf@2015-02-26 00:00:00@Bosulif@Bosutinib@False@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-826_h_a_dec_0.pdf@EU-1-13-826_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_1.pdf@EU-1-13-824_h_a_dec_1.pdf@2014-11-11 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_0.pdf@EU-1-13-827_h_a_dec_0.pdf@2013-04-22 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_1.pdf@EU-1-13-826_h_a_dec_1.pdf@2014-03-06 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_4.pdf@EU-1-13-818_h_a_dec_4.pdf@2015-11-23 00:00:00@Bosulif@Bosutinib@False@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-824_h_a_dec_2.pdf@EU-1-13-824_h_a_dec_2.pdf@2016-04-13 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
myelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_0.pdf@EU-1-13-829_h_a_dec_0.pdf@2013-04-17 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae  type b conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD, SNC@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_0.pdf@EU-1-13-830_h_a_dec_0.pdf@2013-05-24 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine /  tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_2.pdf@EU-1-13-826_h_a_dec_2.pdf@2017-05-24 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_1.pdf@EU-1-13-827_h_a_dec_1.pdf@2016-06-29 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_5.pdf@EU-1-13-818_h_a_dec_5.pdf@2016-07-01 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-13-828_h_a_dec_1.pdf@EU-1-13-828_h_a_dec_1.pdf@2014-10-30 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_3.pdf@EU-1-13-824_h_a_dec_3.pdf@2017-03-24 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_3.pdf@EU-1-13-826_h_a_dec_3.pdf@2018-08-01 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_1.pdf@EU-1-13-829_h_a_dec_1.pdf@2014-10-27 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_1.pdf@EU-1-13-830_h_a_dec_1.pdf@2014-09-09 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_2.pdf@EU-1-13-827_h_a_dec_2.pdf@2018-08-01 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
tis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_2.pdf@EU-1-13-829_h_a_dec_2.pdf@2015-02-24 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_4.pdf@EU-1-13-824_h_a_dec_4.pdf@2018-08-01 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_6.pdf@EU-1-13-818_h_a_dec_6.pdf@2016-08-12 00:00:00@Bosulif@Bosutinib@False@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-828_h_a_dec_3.pdf@EU-1-13-828_h_a_dec_3.pdf@2016-05-13 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_10.pdf@EU-1-13-830_h_a_dec_10.pdf@2021-05-19 00:00:00@Stribild@elvitegravir / cobicistat  / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_3.pdf@EU-1-13-829_h_a_dec_3.pdf@2016-05-20 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-13-826_h_a_dec_4.pdf@EU-1-13-826_h_a_dec_4.pdf@2021-10-19 00:00:00@Memantine LEK@Memantine@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_3.pdf@EU-1-13-827_h_a_dec_3.pdf@2018-10-09 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_4.pdf@EU-1-13-828_h_a_dec_4.pdf@2017-11-04 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_7.pdf@EU-1-13-818_h_a_dec_7.pdf@2017-03-24 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-13-827_h_a_dec_4.pdf@EU-1-13-827_h_a_dec_4.pdf@2021-03-26 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-13-824_h_a_dec_5.pdf@EU-1-13-824_h_a_dec_5.pdf@2022-03-22 00:00:00@Nemdatine@Memantine@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_4.pdf@EU-1-13-829_h_a_dec_4.pdf@2016-11-11 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component),  hepatitis B (rDNA), poliomyelitis (inactivated) and  Haemophilus influenzae  type b  conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_5.pdf@EU-1-13-828_h_a_dec_5.pdf@2018-08-01 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur SA@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_11.pdf@EU-1-13-830_h_a_dec_11.pdf@2022-09-15 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_5.pdf@EU-1-13-829_h_a_dec_5.pdf@2018-08-01 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur Europe@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_8.pdf@EU-1-13-818_h_a_dec_8.pdf@2018-08-02 00:00:00@Bosulif@Bosutinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-13-832_h_a_dec_0.pdf@EU-1-13-832_h_a_dec_0.pdf@2013-06-24 00:00:00@Stayveer@bosentan@False@False@adopted@Marklas Nederland BV@CMA Not Found@Parsed
EU-1-13-827_h_a_dec_5.pdf@EU-1-13-827_h_a_dec_5.pdf@2021-10-19 00:00:00@Memantine Mylan@Memantine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_6.pdf@EU-1-13-828_h_a_dec_6.pdf@2018-12-17 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_2.pdf@EU-1-13-830_h_a_dec_2.pdf@2015-10-12 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine /  tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_6.pdf@EU-1-13-829_h_a_dec_6.pdf@2018-12-17 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_1.pdf@EU-1-13-832_h_a_dec_1.pdf@2014-12-19 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_7.pdf@EU-1-13-828_h_a_dec_7.pdf@2020-06-18 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-13-818_h_a_dec_9.pdf@EU-1-13-818_h_a_dec_9.pdf@2018-04-23 00:00:00@Bosulif@Bosutinib@False@False@adopted@Pfizer Limited@conditional@Parsed
EU-1-13-829_h_a_dec_7.pdf@EU-1-13-829_h_a_dec_7.pdf@2020-06-18 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_10.pdf@EU-1-13-832_h_a_dec_10.pdf@2022-07-06 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_3.pdf@EU-1-13-830_h_a_dec_3.pdf@2016-02-24 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-828_h_a_dec_8.pdf@EU-1-13-828_h_a_dec_8.pdf@2021-06-24 00:00:00@Hexacima@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_0.pdf@EU-1-13-835_h_a_dec_0.pdf@2013-05-16 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-829_h_a_dec_8.pdf@EU-1-13-829_h_a_dec_8.pdf@2021-06-28 00:00:00@Hexyon@diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and  Haemophilus influenzae  type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_2.pdf@EU-1-13-832_h_a_dec_2.pdf@2015-07-28 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_0.pdf@EU-1-13-834_h_a_dec_0.pdf@2014-01-16 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_3.pdf@EU-1-13-832_h_a_dec_3.pdf@2015-08-20 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_4.pdf@EU-1-13-830_h_a_dec_4.pdf@2017-06-02 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_1.pdf@EU-1-13-835_h_a_dec_1.pdf@2014-01-10 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_1.pdf@EU-1-13-834_h_a_dec_1.pdf@2016-08-02 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_4.pdf@EU-1-13-832_h_a_dec_4.pdf@2016-09-22 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_10.pdf@EU-1-13-835_h_a_dec_10.pdf@2022-03-02 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_5.pdf@EU-1-13-830_h_a_dec_5.pdf@2017-10-19 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_5.pdf@EU-1-13-832_h_a_dec_5.pdf@2017-09-26 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_2.pdf@EU-1-13-834_h_a_dec_2.pdf@2017-07-13 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_2.pdf@EU-1-13-835_h_a_dec_2.pdf@2015-09-12 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_6.pdf@EU-1-13-832_h_a_dec_6.pdf@2018-08-01 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_0.pdf@EU-1-13-836_h_a_dec_0.pdf@2013-06-13 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_6.pdf@EU-1-13-830_h_a_dec_6.pdf@2018-04-19 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_3.pdf@EU-1-13-834_h_a_dec_3.pdf@2018-02-08 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_0.pdf@EU-1-13-838_h_a_dec_0.pdf@2013-08-26 00:00:00@AUBAGIO@Teriflunomide@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_3.pdf@EU-1-13-835_h_a_dec_3.pdf@2016-08-12 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_1.pdf@EU-1-13-836_h_a_dec_1.pdf@2015-01-15 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_0.pdf@EU-1-13-837_h_a_dec_0.pdf@2014-01-30 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_7.pdf@EU-1-13-832_h_a_dec_7.pdf@2019-11-03 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_7.pdf@EU-1-13-830_h_a_dec_7.pdf@2018-05-22 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_2.pdf@EU-1-13-836_h_a_dec_2.pdf@2016-09-08 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_4.pdf@EU-1-13-834_h_a_dec_4.pdf@2018-11-20 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_1.pdf@EU-1-13-838_h_a_dec_1.pdf@2014-11-19 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_1.pdf@EU-1-13-837_h_a_dec_1.pdf@2015-04-13 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_4.pdf@EU-1-13-835_h_a_dec_4.pdf@2017-06-26 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_8.pdf@EU-1-13-832_h_a_dec_8.pdf@2019-11-03 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Marklas Nederland B.V.@CMA Not Found@Parsed
EU-1-13-836_h_a_dec_3.pdf@EU-1-13-836_h_a_dec_3.pdf@2018-04-13 00:00:00@Memantine ratiopharm@memantine@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_10.pdf@EU-1-13-838_h_a_dec_10.pdf@2022-08-07 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-832_h_a_dec_9.pdf@EU-1-13-832_h_a_dec_9.pdf@2020-09-15 00:00:00@Stayveer@bosentan@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_8.pdf@EU-1-13-830_h_a_dec_8.pdf@2018-04-06 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as  fumarate)@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_5.pdf@EU-1-13-834_h_a_dec_5.pdf@2019-11-03 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_5.pdf@EU-1-13-835_h_a_dec_5.pdf@2018-08-02 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_2.pdf@EU-1-13-838_h_a_dec_2.pdf@2015-06-19 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_10.pdf@EU-1-13-837_h_a_dec_10.pdf@2022-06-01 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_3.pdf@EU-1-13-838_h_a_dec_3.pdf@2015-12-16 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-830_h_a_dec_9.pdf@EU-1-13-830_h_a_dec_9.pdf@2019-08-04 00:00:00@Stribild@elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_6.pdf@EU-1-13-834_h_a_dec_6.pdf@2020-02-28 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_6.pdf@EU-1-13-835_h_a_dec_6.pdf@2019-02-20 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_4.pdf@EU-1-13-838_h_a_dec_4.pdf@2017-06-15 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_11.pdf@EU-1-13-837_h_a_dec_11.pdf@2022-05-13 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_0.pdf@EU-1-13-839_h_a_dec_0.pdf@2013-01-07 00:00:00@Iclusig@ponatinib@True@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_7.pdf@EU-1-13-835_h_a_dec_7.pdf@2020-02-21 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_5.pdf@EU-1-13-838_h_a_dec_5.pdf@2018-05-28 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_0.pdf@EU-1-13-840_h_a_dec_0.pdf@2013-05-16 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-13-834_h_a_dec_7.pdf@EU-1-13-834_h_a_dec_7.pdf@2021-09-23 00:00:00@Zoledronic acid Accord@zoledronic acid@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_8.pdf@EU-1-13-835_h_a_dec_8.pdf@2021-05-07 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_2.pdf@EU-1-13-837_h_a_dec_2.pdf@2015-12-16 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_6.pdf@EU-1-13-838_h_a_dec_6.pdf@2019-05-12 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_1.pdf@EU-1-13-839_h_a_dec_1.pdf@2013-12-20 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_1.pdf@EU-1-13-840_h_a_dec_1.pdf@2014-12-16 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-13-835_h_a_dec_9.pdf@EU-1-13-835_h_a_dec_9.pdf@2021-10-28 00:00:00@Voriconazole Accord@voriconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_7.pdf@EU-1-13-838_h_a_dec_7.pdf@2020-11-18 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_2.pdf@EU-1-13-840_h_a_dec_2.pdf@2016-05-26 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_3.pdf@EU-1-13-837_h_a_dec_3.pdf@2017-12-04 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_0.pdf@EU-1-13-841_h_a_dec_0.pdf@2013-06-13 00:00:00@Spedra@avanafil@True@False@OD Not Found@VIVUS BV@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_10.pdf@EU-1-13-839_h_a_dec_10.pdf@2017-09-21 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences UK Ltd@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_8.pdf@EU-1-13-838_h_a_dec_8.pdf@2021-06-17 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_3.pdf@EU-1-13-840_h_a_dec_3.pdf@2016-01-06 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-13-838_h_a_dec_9.pdf@EU-1-13-838_h_a_dec_9.pdf@2021-07-23 00:00:00@AUBAGIO@Teriflunomide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_0.pdf@EU-1-13-842_h_a_dec_0.pdf@2013-09-19 00:00:00@Incresync@alogliptin / pioglitazone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_1.pdf@EU-1-13-841_h_a_dec_1.pdf@2013-02-10 00:00:00@Spedra@avanafil@False@False@OD Not Found@VIVUS B.V.@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_4.pdf@EU-1-13-837_h_a_dec_4.pdf@2018-05-28 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
und@Parsed
EU-1-13-839_h_a_dec_11.pdf@EU-1-13-839_h_a_dec_11.pdf@2018-08-02 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences UK Ltd@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_1.pdf@EU-1-13-842_h_a_dec_1.pdf@2015-01-15 00:00:00@Incresync@alogliptin / pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_2.pdf@EU-1-13-841_h_a_dec_2.pdf@2015-01-22 00:00:00@Spedra@avanafil@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_5.pdf@EU-1-13-840_h_a_dec_5.pdf@2019-07-19 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_3.pdf@EU-1-13-841_h_a_dec_3.pdf@2015-09-18 00:00:00@Spedra@avanafil@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_2.pdf@EU-1-13-842_h_a_dec_2.pdf@2017-12-20 00:00:00@Incresync@alogliptin / pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_0.pdf@EU-1-13-843_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipdomet@alogliptin / metformin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_5.pdf@EU-1-13-837_h_a_dec_5.pdf@2018-09-20 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_6.pdf@EU-1-13-840_h_a_dec_6.pdf@2020-03-09 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_4.pdf@EU-1-13-841_h_a_dec_4.pdf@2016-05-12 00:00:00@Spedra@avanafil@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_12.pdf@EU-1-13-839_h_a_dec_12.pdf@2018-04-06 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences UK Ltd@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_1.pdf@EU-1-13-843_h_a_dec_1.pdf@2015-01-15 00:00:00@Vipdomet@alogliptin / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_7.pdf@EU-1-13-840_h_a_dec_7.pdf@2022-04-02 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_3.pdf@EU-1-13-842_h_a_dec_3.pdf@2018-05-24 00:00:00@Incresync@alogliptin / pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_5.pdf@EU-1-13-841_h_a_dec_5.pdf@2018-04-23 00:00:00@Spedra@avanafil@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_6.pdf@EU-1-13-837_h_a_dec_6.pdf@2018-11-14 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_13.pdf@EU-1-13-839_h_a_dec_13.pdf@2018-09-20 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences Distribution B.V.@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_0.pdf@EU-1-13-844_h_a_dec_0.pdf@2013-09-19 00:00:00@Vipidia@alogliptin@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_2.pdf@EU-1-13-843_h_a_dec_2.pdf@2016-12-12 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE DANISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2013)6214(final) for “Vipdomet@alogliptin / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-840_h_a_dec_8.pdf@EU-1-13-840_h_a_dec_8.pdf@2022-04-29 00:00:00@HyQvia@human normal immunoglobulin@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-13-841_h_a_dec_6.pdf@EU-1-13-841_h_a_dec_6.pdf@2021-10-19 00:00:00@Spedra@avanafil@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_14.pdf@EU-1-13-839_h_a_dec_14.pdf@2020-07-27 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences Distribution B.V.@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_7.pdf@EU-1-13-837_h_a_dec_7.pdf@2019-11-14 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_1.pdf@EU-1-13-844_h_a_dec_1.pdf@2015-08-01 00:00:00@Vipidia@alogliptin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_4.pdf@EU-1-13-842_h_a_dec_4.pdf@2021-07-01 00:00:00@Incresync@alogliptin /  pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_15.pdf@EU-1-13-839_h_a_dec_15.pdf@2022-08-07 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences Distribution B.V.@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_8.pdf@EU-1-13-837_h_a_dec_8.pdf@2020-09-01 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_3.pdf@EU-1-13-843_h_a_dec_3.pdf@2018-05-24 00:00:00@Vipdomet@alogliptin / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_2.pdf@EU-1-13-844_h_a_dec_2.pdf@2015-10-12 00:00:00@Vipidia@alogliptin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-837_h_a_dec_9.pdf@EU-1-13-837_h_a_dec_9.pdf@2020-11-24 00:00:00@Tecfidera@Dimethyl fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-842_h_a_dec_5.pdf@EU-1-13-842_h_a_dec_5.pdf@2022-04-04 00:00:00@Incresync@alogliptin / pioglitazone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_4.pdf@EU-1-13-843_h_a_dec_4.pdf@2021-07-01 00:00:00@Vipdomet@alogliptin / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_2.pdf@EU-1-13-839_h_a_dec_2.pdf@2014-09-18 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_3.pdf@EU-1-13-844_h_a_dec_3.pdf@2018-05-24 00:00:00@Vipidia@alogliptin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_0.pdf@EU-1-13-845_h_a_dec_0.pdf@2013-01-07 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_0.pdf@EU-1-13-846_h_a_dec_0.pdf@2013-06-21 00:00:00@Xtandi@enzalutamide@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-843_h_a_dec_5.pdf@EU-1-13-843_h_a_dec_5.pdf@2022-04-04 00:00:00@Vipdomet@alogliptin / metformin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_4.pdf@EU-1-13-844_h_a_dec_4.pdf@2021-07-01 00:00:00@Vipidia@alogliptin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_3.pdf@EU-1-13-839_h_a_dec_3.pdf@2015-01-15 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_1.pdf@EU-1-13-845_h_a_dec_1.pdf@2014-01-09 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_1.pdf@EU-1-13-846_h_a_dec_1.pdf@2014-11-28 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_10.pdf@EU-1-13-845_h_a_dec_10.pdf@2021-09-29 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-844_h_a_dec_5.pdf@EU-1-13-844_h_a_dec_5.pdf@2022-04-04 00:00:00@Vipidia@alogliptin@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_10.pdf@EU-1-13-846_h_a_dec_10.pdf@2021-04-02 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_4.pdf@EU-1-13-839_h_a_dec_4.pdf@2015-09-18 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_0.pdf@EU-1-13-848_h_a_dec_0.pdf@2013-12-07 00:00:00@Erivedge@vismodegib@True@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-845_h_a_dec_2.pdf@EU-1-13-845_h_a_dec_2.pdf@2015-11-16 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_11.pdf@EU-1-13-846_h_a_dec_11.pdf@2021-04-30 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_0.pdf@EU-1-13-851_h_a_dec_0.pdf@2013-07-31 00:00:00@Lojuxta@Lomitapide@True@False@appointed@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-846_h_a_dec_12.pdf@EU-1-13-846_h_a_dec_12.pdf@2021-06-17 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_0.pdf@EU-1-13-850_h_a_dec_0.pdf@2013-05-08 00:00:00@Pomalidomidea Celgene@Pomalidomide@True@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_5.pdf@EU-1-13-839_h_a_dec_5.pdf@2015-11-27 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_1.pdf@EU-1-13-848_h_a_dec_1.pdf@2014-06-19 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-845_h_a_dec_3.pdf@EU-1-13-845_h_a_dec_3.pdf@2017-04-01 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_1.pdf@EU-1-13-851_h_a_dec_1.pdf@2013-04-12 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-846_h_a_dec_2.pdf@EU-1-13-846_h_a_dec_2.pdf@2015-05-27 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_10.pdf@EU-1-13-848_h_a_dec_10.pdf@2019-11-11 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_1.pdf@EU-1-13-850_h_a_dec_1.pdf@2013-05-08 00:00:00@Pomalidomide Celgene@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_4.pdf@EU-1-13-845_h_a_dec_4.pdf@2017-11-01 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_6.pdf@EU-1-13-839_h_a_dec_6.pdf@2016-03-22 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_3.pdf@EU-1-13-846_h_a_dec_3.pdf@2015-06-22 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_11.pdf@EU-1-13-848_h_a_dec_11.pdf@2021-01-07 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_10.pdf@EU-1-13-851_h_a_dec_10.pdf@2020-09-03 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Amryt Pharmaceuticals DAC@exceptional@Parsed
EU-1-13-852_h_a_dec_0.pdf@EU-1-13-852_h_a_dec_0.pdf@2013-07-31 00:00:00@Atosiban SUN@atosiban@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV,@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_4.pdf@EU-1-13-846_h_a_dec_4.pdf@2015-08-28 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_10.pdf@EU-1-13-850_h_a_dec_10.pdf@2017-05-24 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_5.pdf@EU-1-13-845_h_a_dec_5.pdf@2017-04-05 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_2.pdf@EU-1-13-848_h_a_dec_2.pdf@2015-05-05 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-839_h_a_dec_7.pdf@EU-1-13-839_h_a_dec_7.pdf@2016-08-25 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-852_h_a_dec_1.pdf@EU-1-13-852_h_a_dec_1.pdf@2014-10-15 00:00:00@Atosiban SUN@atosiban@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_5.pdf@EU-1-13-846_h_a_dec_5.pdf@2015-11-27 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_11.pdf@EU-1-13-851_h_a_dec_11.pdf@2021-03-12 00:00:00@Lojuxta@Lomitapide@False@False@adopted@Amryt Pharmaceuticals DAC@exceptional@Parsed
EU-1-13-846_h_a_dec_6.pdf@EU-1-13-846_h_a_dec_6.pdf@2016-12-12 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_11.pdf@EU-1-13-850_h_a_dec_11.pdf@2018-04-23 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_3.pdf@EU-1-13-848_h_a_dec_3.pdf@2015-05-27 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-845_h_a_dec_6.pdf@EU-1-13-845_h_a_dec_6.pdf@2018-04-19 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_2.pdf@EU-1-13-851_h_a_dec_2.pdf@2013-04-12 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-852_h_a_dec_2.pdf@EU-1-13-852_h_a_dec_2.pdf@2018-05-28 00:00:00@Atosiban SUN@atosiban@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_8.pdf@EU-1-13-839_h_a_dec_8.pdf@2016-09-11 00:00:00@Iclusig@ponatinib@False@False@adopted@ARIAD Pharma Ltd@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_7.pdf@EU-1-13-846_h_a_dec_7.pdf@2017-09-21 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_12.pdf@EU-1-13-850_h_a_dec_12.pdf@2018-11-07 00:00:00@Imnovid@Pomalidomide@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_4.pdf@EU-1-13-848_h_a_dec_4.pdf@2016-05-26 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-851_h_a_dec_3.pdf@EU-1-13-851_h_a_dec_3.pdf@2013-12-18 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals@exceptional@Parsed
EU-1-13-845_h_a_dec_7.pdf@EU-1-13-845_h_a_dec_7.pdf@2019-02-14 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_8.pdf@EU-1-13-846_h_a_dec_8.pdf@2018-08-02 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-839_h_a_dec_9.pdf@EU-1-13-839_h_a_dec_9.pdf@2017-01-26 00:00:00@Iclusig@ponatinib@False@False@adopted@Incyte Biosciences UK Ltd@CMA Not Found@Parsed
EU-1-13-846_h_a_dec_9.pdf@EU-1-13-846_h_a_dec_9.pdf@2018-10-23 00:00:00@Xtandi@enzalutamide@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_13.pdf@EU-1-13-850_h_a_dec_13.pdf@2018-10-09 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_5.pdf@EU-1-13-848_h_a_dec_5.pdf@2016-11-11 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-853_h_a_dec_0.pdf@EU-1-13-853_h_a_dec_0.pdf@2013-10-09 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_4.pdf@EU-1-13-851_h_a_dec_4.pdf@2014-11-19 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals Limited@exceptional@Parsed
EU-1-13-845_h_a_dec_8.pdf@EU-1-13-845_h_a_dec_8.pdf@2020-08-13 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_6.pdf@EU-1-13-848_h_a_dec_6.pdf@2016-11-14 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-13-853_h_a_dec_1.pdf@EU-1-13-853_h_a_dec_1.pdf@2014-12-16 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-845_h_a_dec_9.pdf@EU-1-13-845_h_a_dec_9.pdf@2021-12-08 00:00:00@Imatinib Accord@Imatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_14.pdf@EU-1-13-850_h_a_dec_14.pdf@2018-09-28 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_5.pdf@EU-1-13-851_h_a_dec_5.pdf@2015-03-30 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals Limited@exceptional@Parsed
EU-1-13-853_h_a_dec_10.pdf@EU-1-13-853_h_a_dec_10.pdf@2021-09-11 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_7.pdf@EU-1-13-848_h_a_dec_7.pdf@2017-09-10 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_11.pdf@EU-1-13-853_h_a_dec_11.pdf@2022-07-15 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_6.pdf@EU-1-13-851_h_a_dec_6.pdf@2016-02-18 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals Limited@exceptional@Parsed
EU-1-13-850_h_a_dec_15.pdf@EU-1-13-850_h_a_dec_15.pdf@2019-05-13 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_2.pdf@EU-1-13-853_h_a_dec_2.pdf@2015-10-12 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_8.pdf@EU-1-13-848_h_a_dec_8.pdf@2018-03-15 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_0.pdf@EU-1-13-855_h_a_dec_0.pdf@2013-07-31 00:00:00@Imvanex@modified  vaccinia ankara virus@True@False@appointed@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-851_h_a_dec_7.pdf@EU-1-13-851_h_a_dec_7.pdf@2016-11-11 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_0.pdf@EU-1-13-854_h_a_dec_0.pdf@2013-10-09 00:00:00@Inflectra@infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_3.pdf@EU-1-13-853_h_a_dec_3.pdf@2017-01-23 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_16.pdf@EU-1-13-850_h_a_dec_16.pdf@2020-03-06 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-13-848_h_a_dec_9.pdf@EU-1-13-848_h_a_dec_9.pdf@2018-11-22 00:00:00@Erivedge@vismodegib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_1.pdf@EU-1-13-855_h_a_dec_1.pdf@2013-07-31 00:00:00@Imvanex@modified  vaccinia ankara virus@True@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-853_h_a_dec_4.pdf@EU-1-13-853_h_a_dec_4.pdf@2018-04-30 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_8.pdf@EU-1-13-851_h_a_dec_8.pdf@2018-04-23 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_17.pdf@EU-1-13-850_h_a_dec_17.pdf@2021-06-24 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_1.pdf@EU-1-13-854_h_a_dec_1.pdf@2014-09-30 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_10.pdf@EU-1-13-855_h_a_dec_10.pdf@2022-07-22 00:00:00@Imvanex@Smallpox and monkeypox vaccine (Live Modified  Vaccinia Virus Ankara)@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-853_h_a_dec_5.pdf@EU-1-13-853_h_a_dec_5.pdf@2018-06-21 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-851_h_a_dec_9.pdf@EU-1-13-851_h_a_dec_9.pdf@2018-08-27 00:00:00@Lojuxta@Lomitapide@False@False@OD Not Found@Aegerion Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_2.pdf@EU-1-13-854_h_a_dec_2.pdf@2015-09-23 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_18.pdf@EU-1-13-850_h_a_dec_18.pdf@2021-09-12 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Bristol Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_2.pdf@EU-1-13-855_h_a_dec_2.pdf@2014-08-22 00:00:00@Imvanex@modified vaccinia ankara  virus@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-853_h_a_dec_6.pdf@EU-1-13-853_h_a_dec_6.pdf@2019-09-16 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_0.pdf@EU-1-13-856_h_a_dec_0.pdf@2013-07-25 00:00:00@Lonquex@lipegfilgrastim@True@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_2.pdf@EU-1-13-850_h_a_dec_2.pdf@2013-05-08 00:00:00@Pomalidomide Celgene@Pomalidomide@True@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_0.pdf@EU-1-13-857_h_a_dec_0.pdf@2013-12-08 00:00:00@Voncento@human coagulation factor VIII / human  von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_3.pdf@EU-1-13-854_h_a_dec_3.pdf@2016-12-12 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_3.pdf@EU-1-13-855_h_a_dec_3.pdf@2015-09-18 00:00:00@Imvanex@modified vaccinia ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_1.pdf@EU-1-13-857_h_a_dec_1.pdf@2015-05-05 00:00:00@Voncento@human coagulation factor VIII / human von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_3.pdf@EU-1-13-850_h_a_dec_3.pdf@2014-08-26 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_7.pdf@EU-1-13-853_h_a_dec_7.pdf@2019-11-22 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_1.pdf@EU-1-13-856_h_a_dec_1.pdf@2014-10-04 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_4.pdf@EU-1-13-855_h_a_dec_4.pdf@2016-12-08 00:00:00@Imvanex@modified vaccinia ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-854_h_a_dec_4.pdf@EU-1-13-854_h_a_dec_4.pdf@2018-08-05 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_2.pdf@EU-1-13-857_h_a_dec_2.pdf@2015-07-31 00:00:00@Voncento@human coagulation factor VIII / human von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_8.pdf@EU-1-13-853_h_a_dec_8.pdf@2020-07-24 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_5.pdf@EU-1-13-855_h_a_dec_5.pdf@2017-06-02 00:00:00@Imvanex@modified vaccinia  ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-856_h_a_dec_10.pdf@EU-1-13-856_h_a_dec_10.pdf@2022-07-22 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_5.pdf@EU-1-13-854_h_a_dec_5.pdf@2018-06-21 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_3.pdf@EU-1-13-857_h_a_dec_3.pdf@2017-07-25 00:00:00@Voncento@human coagulation factor VIII / human von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_4.pdf@EU-1-13-850_h_a_dec_4.pdf@2014-11-19 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-853_h_a_dec_9.pdf@EU-1-13-853_h_a_dec_9.pdf@2021-04-30 00:00:00@Remsima@Infliximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_6.pdf@EU-1-13-855_h_a_dec_6.pdf@2017-11-15 00:00:00@Imvanex@modified vaccinia ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_2.pdf@EU-1-13-856_h_a_dec_2.pdf@2015-05-28 00:00:00@Sicor Biotech@Active Substance Not Found@False@False@OD Not Found@UAB "Sicor Biotech"@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_4.pdf@EU-1-13-857_h_a_dec_4.pdf@2017-11-15 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 15.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2013)5450(final) for “Voncento@human coagulation factor VIII / human von  Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_6.pdf@EU-1-13-854_h_a_dec_6.pdf@2018-07-30 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_0.pdf@EU-1-13-858_h_a_dec_0.pdf@2013-08-26 00:00:00@Stivarga@regorafenib@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_7.pdf@EU-1-13-855_h_a_dec_7.pdf@2018-04-23 00:00:00@Imvanex@modified vaccinia ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-850_h_a_dec_5.pdf@EU-1-13-850_h_a_dec_5.pdf@2015-05-27 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_3.pdf@EU-1-13-856_h_a_dec_3.pdf@2016-02-06 00:00:00@Sicor Biotech@Active Substance Not Found@False@False@OD Not Found@UAB "Sicor Biotech"@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_5.pdf@EU-1-13-857_h_a_dec_5.pdf@2018-04-26 00:00:00@Voncento@human coagulation factor VIII / human von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_1.pdf@EU-1-13-858_h_a_dec_1.pdf@2013-08-26 00:00:00@Stivarga@regorafenib@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_7.pdf@EU-1-13-854_h_a_dec_7.pdf@2019-09-16 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_8.pdf@EU-1-13-855_h_a_dec_8.pdf@2020-09-03 00:00:00@Imvanex@modified vaccinia ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-856_h_a_dec_4.pdf@EU-1-13-856_h_a_dec_4.pdf@2017-04-20 00:00:00@Sicor Biotech@Active Substance Not Found@False@False@OD Not Found@UAB "Sicor Biotech"@CMA Not Found@Parsed
EU-1-13-857_h_a_dec_6.pdf@EU-1-13-857_h_a_dec_6.pdf@2020-02-28 00:00:00@Voncento@human coagulation factor VIII / human von Willebrand factor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_8.pdf@EU-1-13-854_h_a_dec_8.pdf@2020-10-08 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_10.pdf@EU-1-13-858_h_a_dec_10.pdf@2018-05-22 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_6.pdf@EU-1-13-850_h_a_dec_6.pdf@2015-11-19 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-855_h_a_dec_9.pdf@EU-1-13-855_h_a_dec_9.pdf@2021-04-16 00:00:00@Imvanex@modified vaccinia ankara virus@False@False@OD Not Found@Bavarian Nordic A/S@exceptional@Parsed
EU-1-13-856_h_a_dec_5.pdf@EU-1-13-856_h_a_dec_5.pdf@2018-08-05 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@UAB "Sicor Biotech"@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_11.pdf@EU-1-13-858_h_a_dec_11.pdf@2018-06-25 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-854_h_a_dec_9.pdf@EU-1-13-854_h_a_dec_9.pdf@2021-10-22 00:00:00@Inflectra@Infliximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_12.pdf@EU-1-13-858_h_a_dec_12.pdf@2019-08-08 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_6.pdf@EU-1-13-856_h_a_dec_6.pdf@2019-01-21 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@UAB "Sicor Biotech"@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_7.pdf@EU-1-13-850_h_a_dec_7.pdf@2016-05-26 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_13.pdf@EU-1-13-858_h_a_dec_13.pdf@2020-10-22 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_7.pdf@EU-1-13-856_h_a_dec_7.pdf@2019-04-26 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_8.pdf@EU-1-13-850_h_a_dec_8.pdf@2016-06-24 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_14.pdf@EU-1-13-858_h_a_dec_14.pdf@2021-08-26 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_8.pdf@EU-1-13-856_h_a_dec_8.pdf@2020-07-13 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_0.pdf@EU-1-13-859_h_a_dec_0.pdf@2013-11-11 00:00:00@Levodopa-Carbidopa-Entacapone Sandoz@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-856_h_a_dec_9.pdf@EU-1-13-856_h_a_dec_9.pdf@2022-01-14 00:00:00@Lonquex@lipegfilgrastim@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-850_h_a_dec_9.pdf@EU-1-13-850_h_a_dec_9.pdf@2016-07-29 00:00:00@Imnovid@Pomalidomide@False@False@adopted@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_0.pdf@EU-1-13-860_h_a_dec_0.pdf@2013-08-26 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_1.pdf@EU-1-13-859_h_a_dec_1.pdf@2015-10-16 00:00:00@Corbilta@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_2.pdf@EU-1-13-858_h_a_dec_2.pdf@2014-07-28 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_2.pdf@EU-1-13-859_h_a_dec_2.pdf@2018-06-07 00:00:00@Corbilta@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_3.pdf@EU-1-13-858_h_a_dec_3.pdf@2014-12-16 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_4.pdf@EU-1-13-858_h_a_dec_4.pdf@2015-12-16 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_0.pdf@EU-1-13-861_h_a_dec_0.pdf@2013-06-09 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Raptor Pharmaceuticals Europe BV@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_0.pdf@EU-1-13-862_h_a_dec_0.pdf@2013-09-19 00:00:00@Ultibro Breezhaler@Indacaterol  maleate/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_3.pdf@EU-1-13-859_h_a_dec_3.pdf@2019-07-25 00:00:00@Corbilta@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_1.pdf@EU-1-13-860_h_a_dec_1.pdf@2014-03-21 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_5.pdf@EU-1-13-858_h_a_dec_5.pdf@2016-10-14 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_1.pdf@EU-1-13-862_h_a_dec_1.pdf@2014-12-16 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_1.pdf@EU-1-13-861_h_a_dec_1.pdf@2015-10-22 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Raptor Pharmaceuticals Europe BV@CMA Not Found@Parsed
EU-1-13-859_h_a_dec_4.pdf@EU-1-13-859_h_a_dec_4.pdf@2021-11-26 00:00:00@Corbilta@levodopa / carbidopa / entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_6.pdf@EU-1-13-858_h_a_dec_6.pdf@2017-01-27 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_10.pdf@EU-1-13-860_h_a_dec_10.pdf@2022-02-17 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@GlaxoSmithKline Dungarvan Limited@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_7.pdf@EU-1-13-858_h_a_dec_7.pdf@2017-12-06 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_2.pdf@EU-1-13-861_h_a_dec_2.pdf@2016-11-18 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Raptor Pharmaceuticals Europe BV@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_8.pdf@EU-1-13-858_h_a_dec_8.pdf@2017-02-08 00:00:00@similar medicinal product@Active Substance Not Found@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_2.pdf@EU-1-13-862_h_a_dec_2.pdf@2016-01-28 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_0.pdf@EU-1-13-863_h_a_dec_0.pdf@2013-09-19 00:00:00@Xoterna Breezhaler@indacaterol / glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_2.pdf@EU-1-13-860_h_a_dec_2.pdf@2015-05-27 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Consumer Healthcare Limited@CMA Not Found@Parsed
EU-1-13-858_h_a_dec_9.pdf@EU-1-13-858_h_a_dec_9.pdf@2017-07-08 00:00:00@Stivarga@regorafenib@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_3.pdf@EU-1-13-860_h_a_dec_3.pdf@2016-05-26 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Consumer Healthcare Limited@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_3.pdf@EU-1-13-861_h_a_dec_3.pdf@2017-12-15 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Chiesi Orphan B.V.@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_3.pdf@EU-1-13-862_h_a_dec_3.pdf@2017-10-30 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_4.pdf@EU-1-13-860_h_a_dec_4.pdf@2017-06-15 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Consumer Healthcare Limited@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_1.pdf@EU-1-13-863_h_a_dec_1.pdf@2014-12-16 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_4.pdf@EU-1-13-861_h_a_dec_4.pdf@2018-05-24 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@OD Not Found@Chiesi Orphan B.V.@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_5.pdf@EU-1-13-860_h_a_dec_5.pdf@2018-06-25 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Consumer Healthcare Limited@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_2.pdf@EU-1-13-863_h_a_dec_2.pdf@2016-01-28 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_5.pdf@EU-1-13-861_h_a_dec_5.pdf@2018-07-26 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_4.pdf@EU-1-13-862_h_a_dec_4.pdf@2018-05-22 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_0.pdf@EU-1-13-866_h_a_dec_0.pdf@2013-08-26 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Abbott Healthcare Products Ltd@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_6.pdf@EU-1-13-860_h_a_dec_6.pdf@2018-09-28 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Consumer Healthcare Limited@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_3.pdf@EU-1-13-863_h_a_dec_3.pdf@2017-09-26 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_7.pdf@EU-1-13-860_h_a_dec_7.pdf@2019-05-12 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Healthcare Ireland@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_5.pdf@EU-1-13-862_h_a_dec_5.pdf@2018-07-23 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_6.pdf@EU-1-13-861_h_a_dec_6.pdf@2019-10-29 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@adopted@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_2.pdf@EU-1-13-866_h_a_dec_2.pdf@2015-10-03 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Abbott Healthcare Products Ltd@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_0.pdf@EU-1-13-865_h_a_dec_0.pdf@2013-08-26 00:00:00@Tafinlar@DABRAFENIB@True@False@OD Not Found@GlaxoSmithKline Trading Services  Limited@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_6.pdf@EU-1-13-862_h_a_dec_6.pdf@2020-04-23 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-861_h_a_dec_7.pdf@EU-1-13-861_h_a_dec_7.pdf@2022-08-17 00:00:00@Procysbi@mercaptamine (cysteamine bitartrate)@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_4.pdf@EU-1-13-863_h_a_dec_4.pdf@2018-05-22 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_8.pdf@EU-1-13-860_h_a_dec_8.pdf@2020-10-11 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Healthcare Ireland@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_3.pdf@EU-1-13-866_h_a_dec_3.pdf@2016-04-13 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@BGP Products Ltd@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_4.pdf@EU-1-13-866_h_a_dec_4.pdf@2016-10-21 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@BGP Products Ltd@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_0.pdf@EU-1-13-869_h_a_dec_0.pdf@2013-12-09 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_5.pdf@EU-1-13-866_h_a_dec_5.pdf@2018-05-16 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Mylan Products Limited@CMA Not Found@Parsed
EU-1-13-862_h_a_dec_7.pdf@EU-1-13-862_h_a_dec_7.pdf@2022-01-24 00:00:00@Ultibro Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-860_h_a_dec_9.pdf@EU-1-13-860_h_a_dec_9.pdf@2021-10-03 00:00:00@Nexium Control@esomeprazole@False@False@OD Not Found@Pfizer Healthcare Ireland@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_1.pdf@EU-1-13-869_h_a_dec_1.pdf@2014-12-15 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_1.pdf@EU-1-13-865_h_a_dec_1.pdf@2014-11-21 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_5.pdf@EU-1-13-863_h_a_dec_5.pdf@2018-07-23 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_6.pdf@EU-1-13-866_h_a_dec_6.pdf@2018-08-20 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Mylan Products Limited@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_0.pdf@EU-1-13-870_h_a_dec_0.pdf@2012-05-25 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS (Cell Therapies Research &  Services)@exceptional@Parsed
EU-1-13-869_h_a_dec_10.pdf@EU-1-13-869_h_a_dec_10.pdf@2021-06-21 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Sanofi Belgium@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_10.pdf@EU-1-13-865_h_a_dec_10.pdf@2019-05-27 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_1.pdf@EU-1-13-870_h_a_dec_1.pdf@2012-05-25 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS (Cell Therapies Research &  Services)@exceptional@Parsed
EU-1-13-869_h_a_dec_11.pdf@EU-1-13-869_h_a_dec_11.pdf@2022-06-21 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Sanofi Belgium@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_6.pdf@EU-1-13-863_h_a_dec_6.pdf@2020-09-03 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_7.pdf@EU-1-13-866_h_a_dec_7.pdf@2020-02-21 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Mylan IRE Healthcare Ltd@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_2.pdf@EU-1-13-870_h_a_dec_2.pdf@2013-12-09 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS (Cell Therapies  Research & Services)@exceptional@Parsed
EU-1-13-869_h_a_dec_2.pdf@EU-1-13-869_h_a_dec_2.pdf@2016-06-21 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_11.pdf@EU-1-13-865_h_a_dec_11.pdf@2020-04-05 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-866_h_a_dec_8.pdf@EU-1-13-866_h_a_dec_8.pdf@2021-01-22 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Mylan IRE Healthcare Ltd@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_0.pdf@EU-1-13-871_h_a_dec_0.pdf@2013-09-27 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-863_h_a_dec_7.pdf@EU-1-13-863_h_a_dec_7.pdf@2021-11-18 00:00:00@Xoterna Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_3.pdf@EU-1-13-870_h_a_dec_3.pdf@2013-12-09 00:00:00@Orphacol@Cholic  acid@False@False@adopted@Laboratoires CTRS (Cell Therapies  Research & Services)@exceptional@Parsed
EU-1-13-872_h_a_dec_0.pdf@EU-1-13-872_h_a_dec_0.pdf@2013-09-19 00:00:00@Tybost@cobicistat@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_3.pdf@EU-1-13-869_h_a_dec_3.pdf@2017-11-15 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_4.pdf@EU-1-13-870_h_a_dec_4.pdf@2014-12-16 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS@exceptional@Parsed
EU-1-13-865_h_a_dec_12.pdf@EU-1-13-865_h_a_dec_12.pdf@2021-08-26 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_1.pdf@EU-1-13-871_h_a_dec_1.pdf@2014-09-16 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_1.pdf@EU-1-13-872_h_a_dec_1.pdf@2015-10-02 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_5.pdf@EU-1-13-870_h_a_dec_5.pdf@2015-03-19 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS@exceptional@Parsed
EU-1-13-866_h_a_dec_9.pdf@EU-1-13-866_h_a_dec_9.pdf@2022-06-14 00:00:00@Cholib@fenofibrate / simvastatin@False@False@OD Not Found@Mylan IRE Healthcare Ltd@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_2.pdf@EU-1-13-871_h_a_dec_2.pdf@2017-12-04 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_4.pdf@EU-1-13-869_h_a_dec_4.pdf@2017-08-12 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_10.pdf@EU-1-13-872_h_a_dec_10.pdf@Date is blank@Tybost@cobicistat@NAS before 2012@NA before 2012@NA before 2000@Gilead Sciences Ireland UC@CMA not available before 2006@Parsed
EU-1-13-865_h_a_dec_2.pdf@EU-1-13-865_h_a_dec_2.pdf@2015-06-05 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_3.pdf@EU-1-13-871_h_a_dec_3.pdf@2018-05-16 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_6.pdf@EU-1-13-870_h_a_dec_6.pdf@2018-08-05 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS@exceptional@Parsed
EU-1-13-869_h_a_dec_5.pdf@EU-1-13-869_h_a_dec_5.pdf@2018-02-07 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_7.pdf@EU-1-13-870_h_a_dec_7.pdf@2019-04-24 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS@exceptional@Parsed
EU-1-13-872_h_a_dec_11.pdf@EU-1-13-872_h_a_dec_11.pdf@2022-09-21 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_4.pdf@EU-1-13-871_h_a_dec_4.pdf@2019-11-01 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_3.pdf@EU-1-13-865_h_a_dec_3.pdf@2015-08-25 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_0.pdf@EU-1-13-873_h_a_dec_0.pdf@2013-11-13 00:00:00@Xofigo@Radium Ra 223 dichloride@True@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_8.pdf@EU-1-13-870_h_a_dec_8.pdf@2019-04-07 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS@exceptional@Parsed
EU-1-13-869_h_a_dec_6.pdf@EU-1-13-869_h_a_dec_6.pdf@2018-08-23 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Genzyme Therapeutics Ltd@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_2.pdf@EU-1-13-872_h_a_dec_2.pdf@2016-11-02 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_4.pdf@EU-1-13-865_h_a_dec_4.pdf@2016-02-05 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-871_h_a_dec_5.pdf@EU-1-13-871_h_a_dec_5.pdf@2020-06-18 00:00:00@Ovaleap@Follitropin alfa@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_2.pdf@EU-1-13-873_h_a_dec_2.pdf@2015-08-09 00:00:00@Xofigo@Radium Ra 223 dichloride@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-870_h_a_dec_9.pdf@EU-1-13-870_h_a_dec_9.pdf@2020-07-27 00:00:00@Orphacol@Cholic acid@False@False@adopted@Laboratoires CTRS@exceptional@Parsed
EU-1-13-869_h_a_dec_7.pdf@EU-1-13-869_h_a_dec_7.pdf@2019-04-29 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Sanofi Belgium@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_3.pdf@EU-1-13-872_h_a_dec_3.pdf@2017-03-17 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_3.pdf@EU-1-13-873_h_a_dec_3.pdf@2017-03-04 00:00:00@Xofigo@Radium Ra 223 dichloride@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_5.pdf@EU-1-13-865_h_a_dec_5.pdf@2017-03-29 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-869_h_a_dec_8.pdf@EU-1-13-869_h_a_dec_8.pdf@2020-01-16 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Sanofi Belgium@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_4.pdf@EU-1-13-873_h_a_dec_4.pdf@2017-08-14 00:00:00@Xofigo@Radium Ra 223  dichloride@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_0.pdf@EU-1-13-875_h_a_dec_0.pdf@2014-04-28 00:00:00@Deltyba@delamanid@True@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-869_h_a_dec_9.pdf@EU-1-13-869_h_a_dec_9.pdf@2020-03-07 00:00:00@Lemtrada@Alemtuzumab@False@False@OD Not Found@Sanofi Belgium@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_4.pdf@EU-1-13-872_h_a_dec_4.pdf@2018-05-22 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_5.pdf@EU-1-13-873_h_a_dec_5.pdf@2018-03-19 00:00:00@Xofigo@Radium Ra 223 dichloride@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_0.pdf@EU-1-13-877_h_a_dec_0.pdf@2013-10-18 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_1.pdf@EU-1-13-875_h_a_dec_1.pdf@2015-04-24 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-878_h_a_dec_0.pdf@EU-1-13-878_h_a_dec_0.pdf@2013-10-18 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.p.A.@exceptional@Parsed
EU-1-13-865_h_a_dec_6.pdf@EU-1-13-865_h_a_dec_6.pdf@2017-05-24 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-873_h_a_dec_6.pdf@EU-1-13-873_h_a_dec_6.pdf@2018-06-21 00:00:00@Xofigo@Radium Ra 223 dichloride@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_5.pdf@EU-1-13-872_h_a_dec_5.pdf@2018-04-06 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_1.pdf@EU-1-13-877_h_a_dec_1.pdf@2014-05-22 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_1.pdf@EU-1-13-878_h_a_dec_1.pdf@2015-12-01 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.p.A.@exceptional@Parsed
EU-1-13-875_h_a_dec_10.pdf@EU-1-13-875_h_a_dec_10.pdf@2021-09-16 00:00:00@Deltyba@delamanid@False@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-873_h_a_dec_7.pdf@EU-1-13-873_h_a_dec_7.pdf@2018-09-28 00:00:00@Xofigo@Radium Ra 223 dichloride@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_2.pdf@EU-1-13-877_h_a_dec_2.pdf@2015-08-09 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_6.pdf@EU-1-13-872_h_a_dec_6.pdf@2018-07-26 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_11.pdf@EU-1-13-875_h_a_dec_11.pdf@2022-02-16 00:00:00@Deltyba@delamanid@False@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-873_h_a_dec_8.pdf@EU-1-13-873_h_a_dec_8.pdf@2020-10-27 00:00:00@Xofigo@Radium Ra 223 dichloride@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_3.pdf@EU-1-13-877_h_a_dec_3.pdf@2017-06-26 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_7.pdf@EU-1-13-865_h_a_dec_7.pdf@2018-08-05 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_2.pdf@EU-1-13-878_h_a_dec_2.pdf@2016-01-28 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.p.A.@exceptional@Parsed
EU-1-13-875_h_a_dec_12.pdf@EU-1-13-875_h_a_dec_12.pdf@2022-03-22 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-877_h_a_dec_4.pdf@EU-1-13-877_h_a_dec_4.pdf@2018-07-30 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_3.pdf@EU-1-13-878_h_a_dec_3.pdf@2017-11-01 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.l@exceptional@Parsed
EU-1-13-872_h_a_dec_7.pdf@EU-1-13-872_h_a_dec_7.pdf@2019-08-04 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_2.pdf@EU-1-13-875_h_a_dec_2.pdf@2016-11-03 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-877_h_a_dec_5.pdf@EU-1-13-877_h_a_dec_5.pdf@2018-04-10 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_8.pdf@EU-1-13-865_h_a_dec_8.pdf@2018-06-07 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_3.pdf@EU-1-13-875_h_a_dec_3.pdf@2017-03-03 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-879_h_a_dec_0.pdf@EU-1-13-879_h_a_dec_0.pdf@2013-09-25 00:00:00@Giotrif@afatinib@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_4.pdf@EU-1-13-878_h_a_dec_4.pdf@2018-07-26 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.I.@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_6.pdf@EU-1-13-877_h_a_dec_6.pdf@2019-09-12 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_8.pdf@EU-1-13-872_h_a_dec_8.pdf@2020-09-03 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_4.pdf@EU-1-13-875_h_a_dec_4.pdf@2018-04-19 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-879_h_a_dec_1.pdf@EU-1-13-879_h_a_dec_1.pdf@2016-03-31 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-865_h_a_dec_9.pdf@EU-1-13-865_h_a_dec_9.pdf@2018-08-27 00:00:00@Tafinlar@DABRAFENIB@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-877_h_a_dec_7.pdf@EU-1-13-877_h_a_dec_7.pdf@2021-09-23 00:00:00@Grastofil@filgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_5.pdf@EU-1-13-878_h_a_dec_5.pdf@2019-11-07 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.I.@exceptional@Parsed
EU-1-13-875_h_a_dec_5.pdf@EU-1-13-875_h_a_dec_5.pdf@2019-02-04 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-879_h_a_dec_2.pdf@EU-1-13-879_h_a_dec_2.pdf@2016-11-14 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-872_h_a_dec_9.pdf@EU-1-13-872_h_a_dec_9.pdf@2020-05-20 00:00:00@Tybost@cobicistat@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-880_h_a_dec_0.pdf@EU-1-13-880_h_a_dec_0.pdf@2013-04-12 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_6.pdf@EU-1-13-875_h_a_dec_6.pdf@2019-07-25 00:00:00@Deltyba@delamanid@False@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-879_h_a_dec_3.pdf@EU-1-13-879_h_a_dec_3.pdf@2017-10-23 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_6.pdf@EU-1-13-878_h_a_dec_6.pdf@2020-01-04 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.I.@exceptional@Parsed
EU-1-13-875_h_a_dec_7.pdf@EU-1-13-875_h_a_dec_7.pdf@2020-04-23 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-879_h_a_dec_4.pdf@EU-1-13-879_h_a_dec_4.pdf@2018-05-16 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-880_h_a_dec_1.pdf@EU-1-13-880_h_a_dec_1.pdf@2015-02-19 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_8.pdf@EU-1-13-875_h_a_dec_8.pdf@2020-10-27 00:00:00@Deltyba@delamanid@False@False@adopted@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-879_h_a_dec_5.pdf@EU-1-13-879_h_a_dec_5.pdf@2019-06-06 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_7.pdf@EU-1-13-878_h_a_dec_7.pdf@2021-09-22 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.I.@exceptional@Parsed
EU-1-13-880_h_a_dec_2.pdf@EU-1-13-880_h_a_dec_2.pdf@2017-10-07 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-879_h_a_dec_6.pdf@EU-1-13-879_h_a_dec_6.pdf@2020-05-11 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-875_h_a_dec_9.pdf@EU-1-13-875_h_a_dec_9.pdf@2021-04-13 00:00:00@Deltyba@delamanid@False@False@OD Not Found@Otsuka Novel Products GmbH@conditional@Parsed
EU-1-13-881_h_a_dec_0.pdf@EU-1-13-881_h_a_dec_0.pdf@2013-11-15 00:00:00@Lidocaine/Prilocaine Plethora@lidocaine /  prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_8.pdf@EU-1-13-878_h_a_dec_8.pdf@2022-06-24 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.I.@exceptional@Parsed
EU-1-13-880_h_a_dec_3.pdf@EU-1-13-880_h_a_dec_3.pdf@2018-03-08 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-879_h_a_dec_7.pdf@EU-1-13-879_h_a_dec_7.pdf@2021-12-13 00:00:00@Giotrif@afatinib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_0.pdf@EU-1-13-882_h_a_dec_0.pdf@2013-11-15 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_1.pdf@EU-1-13-881_h_a_dec_1.pdf@2015-10-15 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-878_h_a_dec_9.pdf@EU-1-13-878_h_a_dec_9.pdf@2022-06-24 00:00:00@Defitelio@defibrotide@False@False@adopted@Gentium S.r.I.@exceptional@Parsed
EU-1-13-882_h_a_dec_1.pdf@EU-1-13-882_h_a_dec_1.pdf@2015-04-24 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-13-880_h_a_dec_4.pdf@EU-1-13-880_h_a_dec_4.pdf@2019-01-31 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_0.pdf@EU-1-13-884_h_a_dec_0.pdf@2013-11-15 00:00:00@Invokana@canagliflozin@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_2.pdf@EU-1-13-881_h_a_dec_2.pdf@2017-03-17 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-880_h_a_dec_5.pdf@EU-1-13-880_h_a_dec_5.pdf@2020-02-06 00:00:00@Memantine Accord@memantine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_1.pdf@EU-1-13-884_h_a_dec_1.pdf@2015-08-04 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_2.pdf@EU-1-13-882_h_a_dec_2.pdf@2016-04-28 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_3.pdf@EU-1-13-881_h_a_dec_3.pdf@2017-10-30 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Plethora Solutions Limited@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_0.pdf@EU-1-13-885_h_a_dec_0.pdf@2013-11-15 00:00:00@Kadcyla@Trastuzumab emtansine@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_10.pdf@EU-1-13-884_h_a_dec_10.pdf@2020-01-13 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_3.pdf@EU-1-13-882_h_a_dec_3.pdf@2018-08-27 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_1.pdf@EU-1-13-885_h_a_dec_1.pdf@2015-10-15 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_0.pdf@EU-1-13-886_h_a_dec_0.pdf@2013-11-13 00:00:00@Relvar Elllipta@fluticasone furoate/vilanterol  trifenatate@True@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_4.pdf@EU-1-13-881_h_a_dec_4.pdf@2018-09-17 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_11.pdf@EU-1-13-884_h_a_dec_11.pdf@2020-06-26 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_0.pdf@EU-1-13-887_h_a_dec_0.pdf@2013-04-12 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated,  nasal)@True@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_0.pdf@EU-1-13-888_h_a_dec_0.pdf@2013-11-13 00:00:00@NovoEight@turoctocog alfa@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_2.pdf@EU-1-13-885_h_a_dec_2.pdf@2016-01-22 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_12.pdf@EU-1-13-884_h_a_dec_12.pdf@2021-11-01 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_4.pdf@EU-1-13-882_h_a_dec_4.pdf@2018-10-16 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_1.pdf@EU-1-13-886_h_a_dec_1.pdf@2013-11-13 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol  trifenatate@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_5.pdf@EU-1-13-881_h_a_dec_5.pdf@2020-09-03 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_5.pdf@EU-1-13-882_h_a_dec_5.pdf@2019-04-29 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_1.pdf@EU-1-13-888_h_a_dec_1.pdf@2016-12-05 00:00:00@NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_1.pdf@EU-1-13-887_h_a_dec_1.pdf@2013-04-12 00:00:00@Fluenz Tetra@Influenza Virus Type A, H1N1 /  Influenza Virus Type A, H3N2 / Influenza Virus Type B (Victoria lineage) / Influenza  Virus, Type B (Yamagata lineage)@True@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_3.pdf@EU-1-13-885_h_a_dec_3.pdf@2017-02-16 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_13.pdf@EU-1-13-884_h_a_dec_13.pdf@2021-11-15 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_6.pdf@EU-1-13-882_h_a_dec_6.pdf@2020-04-28 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_10.pdf@EU-1-13-887_h_a_dec_10.pdf@2020-07-27 00:00:00@Fluenz  Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_10.pdf@EU-1-13-886_h_a_dec_10.pdf@2021-11-26 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_2.pdf@EU-1-13-888_h_a_dec_2.pdf@2017-11-15 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DANISH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 15.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2013)8066(final) for “NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_2.pdf@EU-1-13-884_h_a_dec_2.pdf@2015-08-20 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_11.pdf@EU-1-13-887_h_a_dec_11.pdf@2021-07-23 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_6.pdf@EU-1-13-881_h_a_dec_6.pdf@2020-08-27 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_7.pdf@EU-1-13-882_h_a_dec_7.pdf@2020-10-27 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_4.pdf@EU-1-13-885_h_a_dec_4.pdf@2018-03-16 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_3.pdf@EU-1-13-888_h_a_dec_3.pdf@2018-07-26 00:00:00@NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_3.pdf@EU-1-13-884_h_a_dec_3.pdf@2015-12-16 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_12.pdf@EU-1-13-887_h_a_dec_12.pdf@2022-07-27 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_2.pdf@EU-1-13-886_h_a_dec_2.pdf@2015-06-11 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-882_h_a_dec_8.pdf@EU-1-13-882_h_a_dec_8.pdf@2022-09-29 00:00:00@ABILIFY MAINTENA@Aripiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_5.pdf@EU-1-13-885_h_a_dec_5.pdf@2018-09-17 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_4.pdf@EU-1-13-888_h_a_dec_4.pdf@2018-07-30 00:00:00@NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-881_h_a_dec_7.pdf@EU-1-13-881_h_a_dec_7.pdf@2022-08-07 00:00:00@Fortacin@lidocaine / prilocaine@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_4.pdf@EU-1-13-884_h_a_dec_4.pdf@2016-04-25 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_2.pdf@EU-1-13-887_h_a_dec_2.pdf@2014-06-08 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_6.pdf@EU-1-13-885_h_a_dec_6.pdf@2019-12-16 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_5.pdf@EU-1-13-888_h_a_dec_5.pdf@2019-10-24 00:00:00@NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_5.pdf@EU-1-13-884_h_a_dec_5.pdf@2017-04-20 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_3.pdf@EU-1-13-887_h_a_dec_3.pdf@2015-08-28 00:00:00@Fluenz  Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_7.pdf@EU-1-13-885_h_a_dec_7.pdf@2020-09-12 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_3.pdf@EU-1-13-886_h_a_dec_3.pdf@2016-06-24 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 2    EN COMMISSION IMPLEMENTING DECISION  24.6.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2013)8089(final) for “Relvar Ellipta@fluticasone furoate/vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_6.pdf@EU-1-13-884_h_a_dec_6.pdf@2017-04-28 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_4.pdf@EU-1-13-887_h_a_dec_4.pdf@2016-07-29 00:00:00@Fluenz  Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-885_h_a_dec_8.pdf@EU-1-13-885_h_a_dec_8.pdf@2022-08-07 00:00:00@Kadcyla@Trastuzumab emtansine@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_6.pdf@EU-1-13-888_h_a_dec_6.pdf@2020-10-15 00:00:00@NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_4.pdf@EU-1-13-886_h_a_dec_4.pdf@2017-09-21 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_7.pdf@EU-1-13-884_h_a_dec_7.pdf@2018-07-26 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_5.pdf@EU-1-13-887_h_a_dec_5.pdf@2017-03-22 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@MedImmune, LLC@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_8.pdf@EU-1-13-884_h_a_dec_8.pdf@2018-04-09 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_6.pdf@EU-1-13-887_h_a_dec_6.pdf@2017-08-24 00:00:00@Fluenz  Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-888_h_a_dec_7.pdf@EU-1-13-888_h_a_dec_7.pdf@2021-10-19 00:00:00@NovoEight@turoctocog alfa@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_5.pdf@EU-1-13-886_h_a_dec_5.pdf@2018-05-03 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-884_h_a_dec_9.pdf@EU-1-13-884_h_a_dec_9.pdf@2019-10-21 00:00:00@Invokana@canagliflozin@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_7.pdf@EU-1-13-887_h_a_dec_7.pdf@2018-08-28 00:00:00@Fluenz  Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_0.pdf@EU-1-13-889_h_a_dec_0.pdf@2014-08-01 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_6.pdf@EU-1-13-886_h_a_dec_6.pdf@2013-11-13 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_8.pdf@EU-1-13-887_h_a_dec_8.pdf@2018-11-20 00:00:00@Fluenz Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_0.pdf@EU-1-13-890_h_a_dec_0.pdf@2014-03-21 00:00:00@Cometriq@cabozantinib@True@False@adopted@TMC Pharma Services Ltd.@conditional@Parsed
EU-1-13-889_h_a_dec_1.pdf@EU-1-13-889_h_a_dec_1.pdf@2015-11-03 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-887_h_a_dec_9.pdf@EU-1-13-887_h_a_dec_9.pdf@2019-08-23 00:00:00@Fluenz  Tetra@influenza vaccine (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-886_h_a_dec_7.pdf@EU-1-13-886_h_a_dec_7.pdf@2018-07-26 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_1.pdf@EU-1-13-890_h_a_dec_1.pdf@2015-01-19 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@TMC Pharma Services Ltd@conditional@Parsed
EU-1-13-891_h_a_dec_0.pdf@EU-1-13-891_h_a_dec_0.pdf@2013-12-18 00:00:00@Brintellix@vortioxetine@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_2.pdf@EU-1-13-889_h_a_dec_2.pdf@2017-06-04 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_10.pdf@EU-1-13-890_h_a_dec_10.pdf@2019-08-23 00:00:00@Cometriq@cabozantinib@False@False@adopted@Ipsen Pharma@conditional@Parsed
EU-1-13-886_h_a_dec_8.pdf@EU-1-13-886_h_a_dec_8.pdf@2018-12-12 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_0.pdf@EU-1-13-892_h_a_dec_0.pdf@2014-01-16 00:00:00@Tivicay@dolutegravir@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_1.pdf@EU-1-13-891_h_a_dec_1.pdf@2014-12-16 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_11.pdf@EU-1-13-890_h_a_dec_11.pdf@2020-02-21 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@Ipsen Pharma@conditional@Parsed
EU-1-13-893_h_a_dec_0.pdf@EU-1-13-893_h_a_dec_0.pdf@2013-12-20 00:00:00@Opsumit@macitentan@True@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_3.pdf@EU-1-13-889_h_a_dec_3.pdf@2018-11-20 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_2.pdf@EU-1-13-891_h_a_dec_2.pdf@2016-02-24 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_12.pdf@EU-1-13-890_h_a_dec_12.pdf@2021-11-02 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@Ipsen Pharma@conditional@Parsed
EU-1-13-886_h_a_dec_9.pdf@EU-1-13-886_h_a_dec_9.pdf@2019-12-16 00:00:00@Relvar Ellipta@fluticasone furoate/vilanterol@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_1.pdf@EU-1-13-892_h_a_dec_1.pdf@2015-04-24 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_13.pdf@EU-1-13-890_h_a_dec_13.pdf@2021-12-08 00:00:00@Cometriq@cabozantinib@False@False@adopted@Ipsen Pharma@conditional@Parsed
EU-1-13-891_h_a_dec_3.pdf@EU-1-13-891_h_a_dec_3.pdf@2017-11-01 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_0.pdf@EU-1-13-894_h_a_dec_0.pdf@2014-01-16 00:00:00@Sovaldi@sofosbuvir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_1.pdf@EU-1-13-893_h_a_dec_1.pdf@2013-12-20 00:00:00@Opsumit@macitentan@True@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_10.pdf@EU-1-13-892_h_a_dec_10.pdf@2020-11-16 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_4.pdf@EU-1-13-889_h_a_dec_4.pdf@2018-11-22 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_14.pdf@EU-1-13-890_h_a_dec_14.pdf@2021-09-16 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@Ipsen Pharma@conditional@Parsed
EU-1-13-891_h_a_dec_4.pdf@EU-1-13-891_h_a_dec_4.pdf@2018-11-20 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_11.pdf@EU-1-13-892_h_a_dec_11.pdf@2021-11-01 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_1.pdf@EU-1-13-894_h_a_dec_1.pdf@2015-05-27 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_5.pdf@EU-1-13-889_h_a_dec_5.pdf@2019-12-18 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_15.pdf@EU-1-13-890_h_a_dec_15.pdf@2022-09-26 00:00:00@Cometriq@cabozantinib@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_2.pdf@EU-1-13-893_h_a_dec_2.pdf@2015-01-15 00:00:00@Opsumit@macitentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_5.pdf@EU-1-13-891_h_a_dec_5.pdf@2019-06-28 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_12.pdf@EU-1-13-892_h_a_dec_12.pdf@2021-12-11 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_6.pdf@EU-1-13-889_h_a_dec_6.pdf@2021-04-26 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_6.pdf@EU-1-13-891_h_a_dec_6.pdf@2020-03-07 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_13.pdf@EU-1-13-892_h_a_dec_13.pdf@2022-01-31 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_2.pdf@EU-1-13-890_h_a_dec_2.pdf@2015-05-27 00:00:00@Cometriq@cabozantinib@False@False@adopted@TMC Pharma Services Ltd@conditional@Parsed
EU-1-13-894_h_a_dec_10.pdf@EU-1-13-894_h_a_dec_10.pdf@2019-10-21 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-889_h_a_dec_7.pdf@EU-1-13-889_h_a_dec_7.pdf@2021-09-07 00:00:00@Levetiracetam Hospira@levetiracetam@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_3.pdf@EU-1-13-893_h_a_dec_3.pdf@2015-07-28 00:00:00@Opsumit@macitentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_7.pdf@EU-1-13-891_h_a_dec_7.pdf@2020-11-18 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_2.pdf@EU-1-13-892_h_a_dec_2.pdf@2015-07-28 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_8.pdf@EU-1-13-891_h_a_dec_8.pdf@2021-07-16 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_3.pdf@EU-1-13-890_h_a_dec_3.pdf@2016-11-01 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@TMC Pharma Services Ltd@conditional@Parsed
EU-1-13-893_h_a_dec_4.pdf@EU-1-13-893_h_a_dec_4.pdf@2016-07-15 00:00:00@Opsumit@macitentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_11.pdf@EU-1-13-894_h_a_dec_11.pdf@2020-06-25 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-891_h_a_dec_9.pdf@EU-1-13-891_h_a_dec_9.pdf@2022-12-08 00:00:00@Brintellix@vortioxetine@False@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_3.pdf@EU-1-13-892_h_a_dec_3.pdf@2016-09-26 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_5.pdf@EU-1-13-893_h_a_dec_5.pdf@2017-07-17 00:00:00@Opsumit@macitentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_4.pdf@EU-1-13-890_h_a_dec_4.pdf@2016-09-30 00:00:00@Cometriq@cabozantinib@False@False@adopted@TMC Pharma Services Ltd@conditional@Parsed
EU-1-13-896_h_a_dec_0.pdf@EU-1-13-896_h_a_dec_0.pdf@2014-07-04 00:00:00@Para-aminosalicylic acid Lucane@aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_0.pdf@EU-1-13-900_h_a_dec_0.pdf@2014-01-16 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG,@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_12.pdf@EU-1-13-894_h_a_dec_12.pdf@2022-05-30 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_1.pdf@EU-1-13-896_h_a_dec_1.pdf@2015-05-13 00:00:00@Granupas@Para-aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_5.pdf@EU-1-13-890_h_a_dec_5.pdf@2016-12-12 00:00:00@Cometriq@cabozantinib@False@False@adopted@Ipsen Pharma@conditional@Parsed
EU-1-13-892_h_a_dec_4.pdf@EU-1-13-892_h_a_dec_4.pdf@2017-02-23 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_6.pdf@EU-1-13-893_h_a_dec_6.pdf@2018-08-23 00:00:00@Opsumit@macitentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_6.pdf@EU-1-13-890_h_a_dec_6.pdf@2017-11-01 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@Ipsen Pharma@conditional@Parsed
EU-1-13-894_h_a_dec_2.pdf@EU-1-13-894_h_a_dec_2.pdf@2016-01-28 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_2.pdf@EU-1-13-896_h_a_dec_2.pdf@2016-07-22 00:00:00@Granupas@Para-aminosalicylic  acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_1.pdf@EU-1-13-900_h_a_dec_1.pdf@2014-03-10 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@Bristol-Myers Squibb/AstraZeneca EEIG@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_7.pdf@EU-1-13-890_h_a_dec_7.pdf@2018-08-01 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@Ipsen Pharma@conditional@Parsed
EU-1-13-900_h_a_dec_10.pdf@EU-1-13-900_h_a_dec_10.pdf@2020-09-30 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_5.pdf@EU-1-13-892_h_a_dec_5.pdf@2017-12-20 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_3.pdf@EU-1-13-896_h_a_dec_3.pdf@2017-07-25 00:00:00@Granupas@Para-aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_7.pdf@EU-1-13-893_h_a_dec_7.pdf@2018-09-21 00:00:00@Opsumit@macitentan@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_3.pdf@EU-1-13-894_h_a_dec_3.pdf@2016-09-19 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_11.pdf@EU-1-13-900_h_a_dec_11.pdf@2022-03-02 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_8.pdf@EU-1-13-890_h_a_dec_8.pdf@2018-08-27 00:00:00@Cometriq@cabozantinib@False@False@adopted@Ipsen Pharma@conditional@Parsed
EU-1-13-896_h_a_dec_4.pdf@EU-1-13-896_h_a_dec_4.pdf@2018-06-29 00:00:00@Granupas@Para-aminosalicylic acid@False@False@adopted@Lucane Pharma@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_6.pdf@EU-1-13-892_h_a_dec_6.pdf@2018-08-05 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_8.pdf@EU-1-13-893_h_a_dec_8.pdf@2021-02-17 00:00:00@Opsumit@macitentan@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_2.pdf@EU-1-13-900_h_a_dec_2.pdf@2016-11-02 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_4.pdf@EU-1-13-894_h_a_dec_4.pdf@2017-02-23 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-890_h_a_dec_9.pdf@EU-1-13-890_h_a_dec_9.pdf@2019-03-28 00:00:00@Cometriq@cabozantinib@False@False@OD Not Found@Ipsen Pharma@conditional@Parsed
EU-1-13-892_h_a_dec_7.pdf@EU-1-13-892_h_a_dec_7.pdf@2018-09-21 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_5.pdf@EU-1-13-896_h_a_dec_5.pdf@2018-12-18 00:00:00@Granupas@Para-aminosalicylic acid@False@False@adopted@Eurocept International B.V.@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_3.pdf@EU-1-13-900_h_a_dec_3.pdf@2016-04-28 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-893_h_a_dec_9.pdf@EU-1-13-893_h_a_dec_9.pdf@2022-05-05 00:00:00@Opsumit@macitentan@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_5.pdf@EU-1-13-894_h_a_dec_5.pdf@2017-09-14 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-896_h_a_dec_6.pdf@EU-1-13-896_h_a_dec_6.pdf@2020-09-06 00:00:00@Granupas@Para-aminosalicylic acid@False@False@adopted@Eurocept International B.V.@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_0.pdf@EU-1-13-901_h_a_dec_0.pdf@2014-05-03 00:00:00@Sirturo@bedaquiline@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-900_h_a_dec_4.pdf@EU-1-13-900_h_a_dec_4.pdf@2016-12-12 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)308(final) for “Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_8.pdf@EU-1-13-892_h_a_dec_8.pdf@2019-04-11 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_1.pdf@EU-1-13-901_h_a_dec_1.pdf@2015-01-19 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-900_h_a_dec_5.pdf@EU-1-13-900_h_a_dec_5.pdf@2017-04-20 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-892_h_a_dec_9.pdf@EU-1-13-892_h_a_dec_9.pdf@2020-08-04 00:00:00@Tivicay@dolutegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_6.pdf@EU-1-13-894_h_a_dec_6.pdf@2018-06-07 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_10.pdf@EU-1-13-901_h_a_dec_10.pdf@2021-03-26 00:00:00@Sirturo@bedaquiline@False@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-896_h_a_dec_7.pdf@EU-1-13-896_h_a_dec_7.pdf@2022-08-22 00:00:00@Granupas@Para-aminosalicylic  acid@False@False@OD Not Found@Eurocept International B.V.@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_6.pdf@EU-1-13-900_h_a_dec_6.pdf@2017-12-20 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_11.pdf@EU-1-13-901_h_a_dec_11.pdf@2021-11-15 00:00:00@Sirturo@bedaquiline@False@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-900_h_a_dec_7.pdf@EU-1-13-900_h_a_dec_7.pdf@2018-09-28 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_7.pdf@EU-1-13-894_h_a_dec_7.pdf@2018-08-23 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_0.pdf@EU-1-13-902_h_a_dec_0.pdf@2014-07-31 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics, Limited@conditional@Parsed
EU-1-13-901_h_a_dec_12.pdf@EU-1-13-901_h_a_dec_12.pdf@2022-06-01 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-900_h_a_dec_8.pdf@EU-1-13-900_h_a_dec_8.pdf@2018-12-11 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_0.pdf@EU-1-13-904_h_a_dec_0.pdf@2014-02-21 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International Tour Europlaza,  20 avenue André Prothin, La Défense 4, La Défense Cedex 92927, France@CMA Not Found@Parsed
EU-1-13-900_h_a_dec_9.pdf@EU-1-13-900_h_a_dec_9.pdf@2019-07-25 00:00:00@Xigduo@dapagliflozin/metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_2.pdf@EU-1-13-901_h_a_dec_2.pdf@2016-07-01 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-894_h_a_dec_8.pdf@EU-1-13-894_h_a_dec_8.pdf@2018-09-17 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_1.pdf@EU-1-13-902_h_a_dec_1.pdf@2014-07-31 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics, Limited@conditional@Parsed
EU-1-13-905_h_a_dec_0.pdf@EU-1-13-905_h_a_dec_0.pdf@2014-02-20 00:00:00@Izba@travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_1.pdf@EU-1-13-904_h_a_dec_1.pdf@2015-02-06 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_3.pdf@EU-1-13-901_h_a_dec_3.pdf@2016-12-23 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-904_h_a_dec_2.pdf@EU-1-13-904_h_a_dec_2.pdf@2015-11-19 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International@CMA Not Found@Parsed
EU-1-13-894_h_a_dec_9.pdf@EU-1-13-894_h_a_dec_9.pdf@2019-08-23 00:00:00@Sovaldi@sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_4.pdf@EU-1-13-901_h_a_dec_4.pdf@2017-06-16 00:00:00@Sirturo@bedaquiline@False@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-905_h_a_dec_1.pdf@EU-1-13-905_h_a_dec_1.pdf@2017-04-20 00:00:00@Izba@travoprost@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_10.pdf@EU-1-13-902_h_a_dec_10.pdf@2019-06-06 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-904_h_a_dec_3.pdf@EU-1-13-904_h_a_dec_3.pdf@2016-11-11 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_0.pdf@EU-1-13-906_h_a_dec_0.pdf@2014-02-20 00:00:00@Neuraceq@florbetaben (18F)@True@False@OD Not Found@Piramal Imaging GmbH@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_5.pdf@EU-1-13-901_h_a_dec_5.pdf@2018-05-03 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-905_h_a_dec_2.pdf@EU-1-13-905_h_a_dec_2.pdf@2017-06-23 00:00:00@Izba@travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_4.pdf@EU-1-13-904_h_a_dec_4.pdf@2017-05-24 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_11.pdf@EU-1-13-902_h_a_dec_11.pdf@2019-07-25 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-901_h_a_dec_6.pdf@EU-1-13-901_h_a_dec_6.pdf@2019-11-01 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-906_h_a_dec_1.pdf@EU-1-13-906_h_a_dec_1.pdf@2014-03-04 00:00:00@Neuraceq@florbetaben (18F)@False@False@OD Not Found@Piramal Imaging GmbH@CMA Not Found@Parsed
EU-1-13-904_h_a_dec_5.pdf@EU-1-13-904_h_a_dec_5.pdf@2018-11-22 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_0.pdf@EU-1-13-907_h_a_dec_0.pdf@2014-03-27 00:00:00@Adempas@riociguat@True@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
@conditional@Parsed
EU-1-13-902_h_a_dec_12.pdf@EU-1-13-902_h_a_dec_12.pdf@2020-07-23 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-904_h_a_dec_6.pdf@EU-1-13-904_h_a_dec_6.pdf@2020-01-04 00:00:00@Mirvaso@brimonidine@False@False@OD Not Found@Galderma International@CMA Not Found@Parsed
EU-1-13-905_h_a_dec_3.pdf@EU-1-13-905_h_a_dec_3.pdf@2018-08-05 00:00:00@Izba@travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_2.pdf@EU-1-13-906_h_a_dec_2.pdf@2015-03-07 00:00:00@Neuraceq@florbetaben (18F)@False@False@OD Not Found@Piramal Imaging Limited@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_1.pdf@EU-1-13-907_h_a_dec_1.pdf@2015-10-15 00:00:00@Adempas@riociguat@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_8.pdf@EU-1-13-901_h_a_dec_8.pdf@2020-01-23 00:00:00@Sirturo@bedaquiline@False@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-902_h_a_dec_13.pdf@EU-1-13-902_h_a_dec_13.pdf@2021-06-17 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-907_h_a_dec_2.pdf@EU-1-13-907_h_a_dec_2.pdf@2016-08-22 00:00:00@Adempas@riociguat@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-901_h_a_dec_9.pdf@EU-1-13-901_h_a_dec_9.pdf@2021-11-01 00:00:00@Sirturo@bedaquiline@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-13-905_h_a_dec_4.pdf@EU-1-13-905_h_a_dec_4.pdf@2018-11-14 00:00:00@Izba@travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_3.pdf@EU-1-13-906_h_a_dec_3.pdf@2016-02-06 00:00:00@Neuraceq@florbetaben (18F)@False@False@OD Not Found@Piramal Imaging Limited@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_3.pdf@EU-1-13-907_h_a_dec_3.pdf@2017-02-05 00:00:00@Adempas@riociguat@False@False@adopted@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-13-909_h_a_dec_0.pdf@EU-1-13-909_h_a_dec_0.pdf@2014-03-27 00:00:00@Bemfola@Follitropin alfa@False@False@OD Not Found@FINOX Biotech AG@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_14.pdf@EU-1-13-902_h_a_dec_14.pdf@2022-06-20 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-907_h_a_dec_4.pdf@EU-1-13-907_h_a_dec_4.pdf@2018-07-03 00:00:00@Adempas@riociguat@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-13-905_h_a_dec_5.pdf@EU-1-13-905_h_a_dec_5.pdf@2022-09-13 00:00:00@Izba@travoprost@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_0.pdf@EU-1-14-898_h_a_dec_0.pdf@2014-08-05 00:00:00@Anoro@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_4.pdf@EU-1-13-906_h_a_dec_4.pdf@2016-11-11 00:00:00@Neuraceq@florbetaben (18F)@False@False@OD Not Found@Piramal Imaging Limited@CMA Not Found@Parsed
EU-1-13-909_h_a_dec_1.pdf@EU-1-13-909_h_a_dec_1.pdf@2015-03-07 00:00:00@Bemfola@follitropin alfa@False@False@OD Not Found@FINOX Biotech AG@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_5.pdf@EU-1-13-907_h_a_dec_5.pdf@2019-01-18 00:00:00@Adempas@riociguat@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_2.pdf@EU-1-13-902_h_a_dec_2.pdf@2014-10-10 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics, Limited@conditional@Parsed
EU-1-13-909_h_a_dec_2.pdf@EU-1-13-909_h_a_dec_2.pdf@2016-11-21 00:00:00@Bemfola@follitropin alfa@False@False@OD Not Found@FINOX Biotech AG@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_6.pdf@EU-1-13-907_h_a_dec_6.pdf@2020-02-17 00:00:00@Adempas@riociguat@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_5.pdf@EU-1-13-906_h_a_dec_5.pdf@2018-09-02 00:00:00@Neuraceq@florbetaben (18F)@False@False@OD Not Found@Piramal Imaging Limited@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_1.pdf@EU-1-14-898_h_a_dec_1.pdf@2016-03-30 00:00:00@Anoro@umeclidinium bromide /  vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-907_h_a_dec_7.pdf@EU-1-13-907_h_a_dec_7.pdf@2021-10-22 00:00:00@Adempas@riociguat@False@False@adopted@Bayer AG@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_3.pdf@EU-1-13-902_h_a_dec_3.pdf@2015-07-28 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-909_h_a_dec_3.pdf@EU-1-13-909_h_a_dec_3.pdf@2018-07-23 00:00:00@Bemfola@follitropin alfa@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_0.pdf@EU-1-14-913_h_a_dec_0.pdf@2014-03-21 00:00:00@Latuda@lurasidone@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_6.pdf@EU-1-13-906_h_a_dec_6.pdf@2018-12-03 00:00:00@Neuraceq@florbetaben (18F)@False@False@OD Not Found@Piramal Imaging Limited@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_10.pdf@EU-1-14-898_h_a_dec_10.pdf@2022-02-06 00:00:00@Anoro Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_0.pdf@EU-1-14-899_h_a_dec_0.pdf@2014-08-05 00:00:00@Laventair@umeclidinium bromide / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-909_h_a_dec_4.pdf@EU-1-13-909_h_a_dec_4.pdf@2018-12-11 00:00:00@Bemfola@follitropin alfa@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_4.pdf@EU-1-13-902_h_a_dec_4.pdf@2016-11-11 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-906_h_a_dec_7.pdf@EU-1-13-906_h_a_dec_7.pdf@2018-11-20 00:00:00@Neuraceq@florbetaben ( 18F)@False@False@OD Not Found@Life Radiopharma Berlin GmbH@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_1.pdf@EU-1-14-913_h_a_dec_1.pdf@2015-01-15 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_2.pdf@EU-1-14-898_h_a_dec_2.pdf@2016-09-22 00:00:00@Anoro@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-906_h_a_dec_8.pdf@EU-1-13-906_h_a_dec_8.pdf@2020-06-02 00:00:00@Neuraceq@florbetaben ( 18F)@False@False@OD Not Found@Life Radiopharma Berlin GmbH@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_10.pdf@EU-1-14-913_h_a_dec_10.pdf@2018-12-03 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Sunovion Pharmaceuticals Europe Ltd@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_1.pdf@EU-1-14-899_h_a_dec_1.pdf@2016-03-22 00:00:00@Laventair@umeclidinium  bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_5.pdf@EU-1-13-902_h_a_dec_5.pdf@2017-09-01 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-13-906_h_a_dec_9.pdf@EU-1-13-906_h_a_dec_9.pdf@2021-12-13 00:00:00@Neuraceq@florbetaben ( 18F)@False@False@OD Not Found@Life Radiopharma Berlin GmbH@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_11.pdf@EU-1-14-913_h_a_dec_11.pdf@2018-11-14 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Aziende Chimiche Riunite Angelini Francesco  - A.C.R.A.F. S.p.A.@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_3.pdf@EU-1-14-898_h_a_dec_3.pdf@2018-02-19 00:00:00@Anoro@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_12.pdf@EU-1-14-913_h_a_dec_12.pdf@2019-10-17 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_0.pdf@EU-1-14-914_h_a_dec_0.pdf@2014-04-28 00:00:00@Vimizim@elosulfase alfa@True@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_6.pdf@EU-1-13-902_h_a_dec_6.pdf@2017-06-16 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-14-899_h_a_dec_10.pdf@EU-1-14-899_h_a_dec_10.pdf@2022-02-16 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-915_h_a_dec_0.pdf@EU-1-14-915_h_a_dec_0.pdf@2014-05-22 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_13.pdf@EU-1-14-913_h_a_dec_13.pdf@2020-08-25 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_4.pdf@EU-1-14-898_h_a_dec_4.pdf@2018-11-26 00:00:00@Anoro Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_1.pdf@EU-1-14-914_h_a_dec_1.pdf@2015-08-07 00:00:00@Vimizim@elosulfase alfa@False@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_2.pdf@EU-1-14-899_h_a_dec_2.pdf@2016-09-09 00:00:00@Laventair@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_7.pdf@EU-1-13-902_h_a_dec_7.pdf@2018-03-23 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics International Limited@conditional@Parsed
EU-1-14-915_h_a_dec_1.pdf@EU-1-14-915_h_a_dec_1.pdf@2016-02-05 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_14.pdf@EU-1-14-913_h_a_dec_14.pdf@2021-10-25 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_5.pdf@EU-1-14-898_h_a_dec_5.pdf@2018-06-12 00:00:00@Anoro Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_2.pdf@EU-1-14-914_h_a_dec_2.pdf@2017-11-01 00:00:00@Vimizim@elosulfase alfa@False@False@adopted@BioMarin Europe Ltd.@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_3.pdf@EU-1-14-899_h_a_dec_3.pdf@2018-11-01 00:00:00@Laventair@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_0.pdf@EU-1-14-916_h_a_dec_0.pdf@2014-10-04 00:00:00@Pregabalin Pfizer@Pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_2.pdf@EU-1-14-913_h_a_dec_2.pdf@2015-07-17 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_8.pdf@EU-1-13-902_h_a_dec_8.pdf@2018-07-19 00:00:00@Translarna@ataluren@False@False@OD Not Found@PTC Therapeutics International Limited@conditional@Parsed
EU-1-14-915_h_a_dec_2.pdf@EU-1-14-915_h_a_dec_2.pdf@2018-05-02 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_6.pdf@EU-1-14-898_h_a_dec_6.pdf@2019-01-15 00:00:00@Anoro Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_3.pdf@EU-1-14-913_h_a_dec_3.pdf@2016-11-01 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_1.pdf@EU-1-14-916_h_a_dec_1.pdf@2015-08-07 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_3.pdf@EU-1-14-914_h_a_dec_3.pdf@2018-09-27 00:00:00@Vimizim@elosulfase alfa@False@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_4.pdf@EU-1-14-899_h_a_dec_4.pdf@2018-12-11 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-13-902_h_a_dec_9.pdf@EU-1-13-902_h_a_dec_9.pdf@2018-07-23 00:00:00@Translarna@ataluren@False@False@adopted@PTC Therapeutics International Limited@conditional@Parsed
EU-1-14-915_h_a_dec_3.pdf@EU-1-14-915_h_a_dec_3.pdf@2019-12-02 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_4.pdf@EU-1-14-913_h_a_dec_4.pdf@2016-11-01 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_10.pdf@EU-1-14-916_h_a_dec_10.pdf@2022-09-26 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_7.pdf@EU-1-14-898_h_a_dec_7.pdf@2019-07-25 00:00:00@Anoro Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_4.pdf@EU-1-14-914_h_a_dec_4.pdf@2018-09-27 00:00:00@Vimizim@elosulfase alfa@False@False@adopted@BioMarin Europe Ltd@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_5.pdf@EU-1-14-899_h_a_dec_5.pdf@2018-11-14 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_5.pdf@EU-1-14-913_h_a_dec_5.pdf@2016-02-15 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-915_h_a_dec_4.pdf@EU-1-14-915_h_a_dec_4.pdf@2019-11-04 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_2.pdf@EU-1-14-916_h_a_dec_2.pdf@2016-11-11 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_8.pdf@EU-1-14-898_h_a_dec_8.pdf@2019-09-19 00:00:00@Anoro Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_6.pdf@EU-1-14-899_h_a_dec_6.pdf@2019-11-01 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-914_h_a_dec_5.pdf@EU-1-14-914_h_a_dec_5.pdf@2018-12-20 00:00:00@Vimizim@elosulfase alfa@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-14-898_h_a_dec_9.pdf@EU-1-14-898_h_a_dec_9.pdf@2020-11-16 00:00:00@Anoro  Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_6.pdf@EU-1-14-913_h_a_dec_6.pdf@2017-03-22 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Sunovion Pharmaceuticals Europe Ltd@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_3.pdf@EU-1-14-916_h_a_dec_3.pdf@2018-07-03 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-915_h_a_dec_5.pdf@EU-1-14-915_h_a_dec_5.pdf@2021-02-12 00:00:00@Ebilfumin@oseltamivir@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_7.pdf@EU-1-14-899_h_a_dec_7.pdf@2019-01-08 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_7.pdf@EU-1-14-913_h_a_dec_7.pdf@2017-07-13 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Sunovion Pharmaceuticals Europe Ltd@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_4.pdf@EU-1-14-916_h_a_dec_4.pdf@2018-07-30 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_0.pdf@EU-1-14-917_h_a_dec_0.pdf@2014-04-23 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium  bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_8.pdf@EU-1-14-899_h_a_dec_8.pdf@2019-09-16 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_5.pdf@EU-1-14-916_h_a_dec_5.pdf@2018-12-12 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_0.pdf@EU-1-14-918_h_a_dec_0.pdf@2014-04-23 00:00:00@Vokanamet@canagliflozin / metformin  hydrochloride@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_8.pdf@EU-1-14-913_h_a_dec_8.pdf@2018-12-03 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Sunovion Pharmaceuticals Europe Ltd@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_6.pdf@EU-1-14-916_h_a_dec_6.pdf@2020-09-03 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_1.pdf@EU-1-14-917_h_a_dec_1.pdf@2014-12-16 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-913_h_a_dec_9.pdf@EU-1-14-913_h_a_dec_9.pdf@2018-12-03 00:00:00@Latuda@lurasidone@False@False@OD Not Found@Sunovion Pharmaceuticals Europe Ltd@CMA Not Found@Parsed
EU-1-14-899_h_a_dec_9.pdf@EU-1-14-899_h_a_dec_9.pdf@2020-09-10 00:00:00@Laventair Ellipta@umeclidinium bromide / vilanterol trifenatate@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_1.pdf@EU-1-14-918_h_a_dec_1.pdf@2015-08-20 00:00:00@Vokanamet@canagliflozin /  metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_0.pdf@EU-1-14-919_h_a_dec_0.pdf@2014-04-23 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@PIERRE FABRE DERMATOLOGIE@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_7.pdf@EU-1-14-916_h_a_dec_7.pdf@2020-02-06 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_1.pdf@EU-1-14-919_h_a_dec_1.pdf@2015-03-07 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@Pierre Fabre Dermatologie@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_2.pdf@EU-1-14-917_h_a_dec_2.pdf@2016-01-22 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_10.pdf@EU-1-14-918_h_a_dec_10.pdf@2020-06-02 00:00:00@Vokanamet@canagliflozin /  metformin  hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_8.pdf@EU-1-14-916_h_a_dec_8.pdf@2020-11-18 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_0.pdf@EU-1-14-920_h_a_dec_0.pdf@2014-04-28 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_2.pdf@EU-1-14-919_h_a_dec_2.pdf@2019-11-01 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@Pierre Fabre Dermatologie@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_2.pdf@EU-1-14-920_h_a_dec_2.pdf@2015-08-07 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_11.pdf@EU-1-14-918_h_a_dec_11.pdf@2020-11-16 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-916_h_a_dec_9.pdf@EU-1-14-916_h_a_dec_9.pdf@2021-11-15 00:00:00@Pregabalin Pfizer@pregabalin@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_12.pdf@EU-1-14-918_h_a_dec_12.pdf@2021-01-14 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_3.pdf@EU-1-14-920_h_a_dec_3.pdf@2016-04-07 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 4.7.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)2931(final) for “DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_3.pdf@EU-1-14-919_h_a_dec_3.pdf@2019-01-15 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@Pierre Fabre Dermatologie@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_2.pdf@EU-1-14-918_h_a_dec_2.pdf@2015-12-16 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-919_h_a_dec_4.pdf@EU-1-14-919_h_a_dec_4.pdf@2020-11-18 00:00:00@Hemangiol@propranolol@False@False@OD Not Found@Pierre Fabre Dermatologie@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_4.pdf@EU-1-14-917_h_a_dec_4.pdf@2018-08-05 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_4.pdf@EU-1-14-920_h_a_dec_4.pdf@2018-12-03 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_0.pdf@EU-1-14-921_h_a_dec_0.pdf@2014-04-28 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_3.pdf@EU-1-14-918_h_a_dec_3.pdf@2016-04-28 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_1.pdf@EU-1-14-921_h_a_dec_1.pdf@2016-04-07 00:00:00@, medicinal product  for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 4.7.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)2930(final) for “BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_4.pdf@EU-1-14-918_h_a_dec_4.pdf@2016-12-12 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)2814(final) for “Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_5.pdf@EU-1-14-917_h_a_dec_5.pdf@2019-01-15 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_5.pdf@EU-1-14-920_h_a_dec_5.pdf@2019-08-04 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_5.pdf@EU-1-14-918_h_a_dec_5.pdf@2017-04-20 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_2.pdf@EU-1-14-921_h_a_dec_2.pdf@2018-01-03 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_0.pdf@EU-1-14-922_h_a_dec_0.pdf@2014-04-28 00:00:00@Incruse@umeclidinium bromide@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_6.pdf@EU-1-14-917_h_a_dec_6.pdf@2020-09-03 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_6.pdf@EU-1-14-920_h_a_dec_6.pdf@2020-09-03 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_0.pdf@EU-1-14-923_h_a_dec_0.pdf@2014-05-22 00:00:00@Entyvio@vedolizumab@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_6.pdf@EU-1-14-918_h_a_dec_6.pdf@2017-04-28 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_0.pdf@EU-1-14-928_h_a_dec_0.pdf@2014-05-22 00:00:00@Sylvant@siltuximab@True@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_1.pdf@EU-1-14-923_h_a_dec_1.pdf@2015-08-20 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_7.pdf@EU-1-14-918_h_a_dec_7.pdf@2018-05-28 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_3.pdf@EU-1-14-921_h_a_dec_3.pdf@2019-08-04 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_1.pdf@EU-1-14-922_h_a_dec_1.pdf@2015-12-14 00:00:00@Incruse@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_7.pdf@EU-1-14-920_h_a_dec_7.pdf@2020-07-13 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-917_h_a_dec_7.pdf@EU-1-14-917_h_a_dec_7.pdf@2021-11-15 00:00:00@Ulunar Breezhaler@indacaterol/glycopyrronium bromide@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_2.pdf@EU-1-14-923_h_a_dec_2.pdf@2016-12-19 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_1.pdf@EU-1-14-928_h_a_dec_1.pdf@2015-07-17 00:00:00@Sylvant@siltuximab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_8.pdf@EU-1-14-918_h_a_dec_8.pdf@2018-08-27 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_2.pdf@EU-1-14-928_h_a_dec_2.pdf@2017-11-04 00:00:00@Sylvant@siltuximab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_10.pdf@EU-1-14-922_h_a_dec_10.pdf@2019-09-23 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_3.pdf@EU-1-14-923_h_a_dec_3.pdf@2018-09-02 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-920_h_a_dec_8.pdf@EU-1-14-920_h_a_dec_8.pdf@2021-05-21 00:00:00@DuoResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_4.pdf@EU-1-14-921_h_a_dec_4.pdf@2020-09-03 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_4.pdf@EU-1-14-923_h_a_dec_4.pdf@2018-08-23 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-918_h_a_dec_9.pdf@EU-1-14-918_h_a_dec_9.pdf@2018-12-18 00:00:00@Vokanamet@canagliflozin / metformin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_3.pdf@EU-1-14-928_h_a_dec_3.pdf@2018-12-04 00:00:00@Sylvant@siltuximab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_11.pdf@EU-1-14-922_h_a_dec_11.pdf@2020-09-24 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_5.pdf@EU-1-14-921_h_a_dec_5.pdf@2020-07-13 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_5.pdf@EU-1-14-923_h_a_dec_5.pdf@2018-12-12 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_0.pdf@EU-1-14-929_h_a_dec_0.pdf@2014-02-05 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol  trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_6.pdf@EU-1-14-923_h_a_dec_6.pdf@2019-02-20 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-921_h_a_dec_6.pdf@EU-1-14-921_h_a_dec_6.pdf@2021-05-21 00:00:00@BiResp Spiromax@budesonide / formoterol@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_12.pdf@EU-1-14-922_h_a_dec_12.pdf@2022-02-14 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_4.pdf@EU-1-14-928_h_a_dec_4.pdf@2019-02-04 00:00:00@Sylvant@siltuximab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_7.pdf@EU-1-14-923_h_a_dec_7.pdf@2020-04-28 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_1.pdf@EU-1-14-929_h_a_dec_1.pdf@2015-11-27 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_5.pdf@EU-1-14-928_h_a_dec_5.pdf@2019-03-09 00:00:00@Sylvant@siltuximab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_2.pdf@EU-1-14-922_h_a_dec_2.pdf@2016-11-11 00:00:00@Incruse@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_8.pdf@EU-1-14-923_h_a_dec_8.pdf@2021-03-22 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_0.pdf@EU-1-14-930_h_a_dec_0.pdf@2014-05-22 00:00:00@Jardiance@empagliflozin@True@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-14-923_h_a_dec_9.pdf@EU-1-14-923_h_a_dec_9.pdf@2022-01-31 00:00:00@Entyvio@vedolizumab@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_2.pdf@EU-1-14-929_h_a_dec_2.pdf@2016-06-24 00:00:00@,  medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 2    EN COMMISSION IMPLEMENTING DECISION  24.6.2016  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)3040(final) for “Revinty Ellipta@fluticasone furoate / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_3.pdf@EU-1-14-922_h_a_dec_3.pdf@2017-04-01 00:00:00@Incruse@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-928_h_a_dec_6.pdf@EU-1-14-928_h_a_dec_6.pdf@2022-04-29 00:00:00@Sylvant@siltuximab@False@False@adopted@EUSA Pharma (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_1.pdf@EU-1-14-930_h_a_dec_1.pdf@2015-12-14 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_10.pdf@EU-1-14-930_h_a_dec_10.pdf@2021-04-30 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_3.pdf@EU-1-14-929_h_a_dec_3.pdf@2017-09-21 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_4.pdf@EU-1-14-922_h_a_dec_4.pdf@2017-07-13 00:00:00@Incruse@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_0.pdf@EU-1-14-931_h_a_dec_0.pdf@2014-06-30 00:00:00@Mekinist@trametinib@True@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_11.pdf@EU-1-14-930_h_a_dec_11.pdf@2021-06-17 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_4.pdf@EU-1-14-929_h_a_dec_4.pdf@2018-07-03 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol trifenatate@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_0.pdf@EU-1-14-933_h_a_dec_0.pdf@2014-07-18 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_12.pdf@EU-1-14-930_h_a_dec_12.pdf@2021-10-22 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_1.pdf@EU-1-14-931_h_a_dec_1.pdf@2015-04-20 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_5.pdf@EU-1-14-922_h_a_dec_5.pdf@2018-12-06 00:00:00@Incruse@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_0.pdf@EU-1-14-934_h_a_dec_0.pdf@2014-07-18 00:00:00@Plegridy@peginterferon beta-1a@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_5.pdf@EU-1-14-929_h_a_dec_5.pdf@2014-02-05 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_13.pdf@EU-1-14-930_h_a_dec_13.pdf@2022-02-21 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_1.pdf@EU-1-14-933_h_a_dec_1.pdf@2016-11-02 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_0.pdf@EU-1-14-935_h_a_dec_0.pdf@2014-07-18 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_14.pdf@EU-1-14-930_h_a_dec_14.pdf@2022-03-03 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_10.pdf@EU-1-14-931_h_a_dec_10.pdf@2020-04-02 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_1.pdf@EU-1-14-934_h_a_dec_1.pdf@2015-08-09 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_6.pdf@EU-1-14-929_h_a_dec_6.pdf@2018-07-26 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_1.pdf@EU-1-14-935_h_a_dec_1.pdf@2015-12-14 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_6.pdf@EU-1-14-922_h_a_dec_6.pdf@2018-11-14 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_2.pdf@EU-1-14-933_h_a_dec_2.pdf@2017-08-05 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_2.pdf@EU-1-14-930_h_a_dec_2.pdf@2016-04-25 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_2.pdf@EU-1-14-935_h_a_dec_2.pdf@2017-11-04 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_3.pdf@EU-1-14-930_h_a_dec_3.pdf@2016-07-15 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_2.pdf@EU-1-14-934_h_a_dec_2.pdf@2016-08-09 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_11.pdf@EU-1-14-931_h_a_dec_11.pdf@2021-07-23 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_7.pdf@EU-1-14-922_h_a_dec_7.pdf@2018-11-20 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_3.pdf@EU-1-14-933_h_a_dec_3.pdf@2018-04-19 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_7.pdf@EU-1-14-929_h_a_dec_7.pdf@2018-12-12 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_3.pdf@EU-1-14-935_h_a_dec_3.pdf@2019-12-02 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_4.pdf@EU-1-14-930_h_a_dec_4.pdf@2017-01-19 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_4.pdf@EU-1-14-935_h_a_dec_4.pdf@2019-06-06 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_5.pdf@EU-1-14-930_h_a_dec_5.pdf@2017-04-20 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_3.pdf@EU-1-14-934_h_a_dec_3.pdf@2017-10-11 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_12.pdf@EU-1-14-931_h_a_dec_12.pdf@2021-08-26 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_8.pdf@EU-1-14-922_h_a_dec_8.pdf@2019-11-01 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_4.pdf@EU-1-14-933_h_a_dec_4.pdf@2019-02-20 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-929_h_a_dec_8.pdf@EU-1-14-929_h_a_dec_8.pdf@2019-12-16 00:00:00@Revinty Ellipta@fluticasone furoate / vilanterol@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_5.pdf@EU-1-14-935_h_a_dec_5.pdf@2021-02-19 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_6.pdf@EU-1-14-930_h_a_dec_6.pdf@2017-07-19 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-935_h_a_dec_6.pdf@EU-1-14-935_h_a_dec_6.pdf@2022-02-16 00:00:00@Envarsus@tacrolimus@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_4.pdf@EU-1-14-934_h_a_dec_4.pdf@2018-07-19 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_13.pdf@EU-1-14-931_h_a_dec_13.pdf@2022-04-29 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_7.pdf@EU-1-14-930_h_a_dec_7.pdf@2018-08-01 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-922_h_a_dec_9.pdf@EU-1-14-922_h_a_dec_9.pdf@2019-07-19 00:00:00@Incruse Ellipta@umeclidinium bromide@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_5.pdf@EU-1-14-933_h_a_dec_5.pdf@2020-09-15 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
d@Parsed
EU-1-14-934_h_a_dec_5.pdf@EU-1-14-934_h_a_dec_5.pdf@2019-03-25 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_8.pdf@EU-1-14-930_h_a_dec_8.pdf@2019-02-14 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_2.pdf@EU-1-14-931_h_a_dec_2.pdf@2015-08-25 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_6.pdf@EU-1-14-934_h_a_dec_6.pdf@2020-09-24 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-14-930_h_a_dec_9.pdf@EU-1-14-930_h_a_dec_9.pdf@2020-06-02 00:00:00@Jardiance@Empagliflozin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-933_h_a_dec_6.pdf@EU-1-14-933_h_a_dec_6.pdf@2022-09-29 00:00:00@Simbrinza@Brinzolamide / Brimonidine tartrate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_7.pdf@EU-1-14-934_h_a_dec_7.pdf@2020-12-14 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_3.pdf@EU-1-14-931_h_a_dec_3.pdf@2016-03-22 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-934_h_a_dec_8.pdf@EU-1-14-934_h_a_dec_8.pdf@2022-04-02 00:00:00@Plegridy@peginterferon beta-1a@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_0.pdf@EU-1-14-936_h_a_dec_0.pdf@2014-07-22 00:00:00@Nuwiq@simoctocog alfa@True@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_4.pdf@EU-1-14-931_h_a_dec_4.pdf@2016-08-16 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_0.pdf@EU-1-14-937_h_a_dec_0.pdf@2014-07-23 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_0.pdf@EU-1-14-938_h_a_dec_0.pdf@2014-09-18 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_1.pdf@EU-1-14-936_h_a_dec_1.pdf@2014-07-22 00:00:00@Nuwiq@simoctocog alfa@True@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_5.pdf@EU-1-14-931_h_a_dec_5.pdf@2017-03-27 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_0.pdf@EU-1-14-940_h_a_dec_0.pdf@2014-01-09 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@True@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_1.pdf@EU-1-14-937_h_a_dec_1.pdf@2016-05-20 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_3.pdf@EU-1-14-936_h_a_dec_3.pdf@2016-09-26 00:00:00@Nuwiq@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_1.pdf@EU-1-14-938_h_a_dec_1.pdf@2016-11-02 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_6.pdf@EU-1-14-931_h_a_dec_6.pdf@2017-08-14 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_2.pdf@EU-1-14-937_h_a_dec_2.pdf@2016-06-13 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_1.pdf@EU-1-14-940_h_a_dec_1.pdf@2016-07-03 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_4.pdf@EU-1-14-936_h_a_dec_4.pdf@2017-11-24 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 24.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)5318(final) for “Nuwiq@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_0.pdf@EU-1-14-941_h_a_dec_0.pdf@2014-08-22 00:00:00@Vizamyl@flutemetamol ( 18F)@True@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_10.pdf@EU-1-14-938_h_a_dec_10.pdf@2020-02-28 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_5.pdf@EU-1-14-936_h_a_dec_5.pdf@2018-03-23 00:00:00@Nuwiq@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_10.pdf@EU-1-14-940_h_a_dec_10.pdf@2021-11-15 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_3.pdf@EU-1-14-937_h_a_dec_3.pdf@2017-09-18 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_7.pdf@EU-1-14-931_h_a_dec_7.pdf@2018-12-04 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_0.pdf@EU-1-14-943_h_a_dec_0.pdf@2014-08-26 00:00:00@Velphoro@oxyhydroxide, sucrose and starches@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_1.pdf@EU-1-14-941_h_a_dec_1.pdf@2016-07-22 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_6.pdf@EU-1-14-936_h_a_dec_6.pdf@2019-04-26 00:00:00@Nuwiq@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_1.pdf@EU-1-14-943_h_a_dec_1.pdf@2016-09-09 00:00:00@Velphoro@mixture  polynuclear iron(iii)-oxyhydroxide, sucrose and starches@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma France@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_11.pdf@EU-1-14-938_h_a_dec_11.pdf@2021-09-29 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_2.pdf@EU-1-14-940_h_a_dec_2.pdf@2016-11-14 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_4.pdf@EU-1-14-937_h_a_dec_4.pdf@2018-06-04 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration Limited@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_2.pdf@EU-1-14-943_h_a_dec_2.pdf@2017-07-26 00:00:00@Velphoro@mixture  polynuclear iron(iii)-oxyhydroxide, sucrose and starches@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma France@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_7.pdf@EU-1-14-936_h_a_dec_7.pdf@2020-07-27 00:00:00@Nuwiq@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_2.pdf@EU-1-14-941_h_a_dec_2.pdf@2017-06-29 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_8.pdf@EU-1-14-931_h_a_dec_8.pdf@2018-08-27 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_2.pdf@EU-1-14-938_h_a_dec_2.pdf@2016-03-23 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_5.pdf@EU-1-14-937_h_a_dec_5.pdf@2019-02-04 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_3.pdf@EU-1-14-943_h_a_dec_3.pdf@2018-10-18 00:00:00@Velphoro@mixture  polynuclear iron(iii)-oxyhydroxide, sucrose and starches@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma France@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_3.pdf@EU-1-14-940_h_a_dec_3.pdf@2017-06-26 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-931_h_a_dec_9.pdf@EU-1-14-931_h_a_dec_9.pdf@2019-02-14 00:00:00@Mekinist@trametinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_6.pdf@EU-1-14-937_h_a_dec_6.pdf@2021-04-02 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_3.pdf@EU-1-14-941_h_a_dec_3.pdf@2018-11-07 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_4.pdf@EU-1-14-943_h_a_dec_4.pdf@2019-03-25 00:00:00@Velphoro@mixture  polynuclear iron(iii)-oxyhydroxide, sucrose and starches@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_3.pdf@EU-1-14-938_h_a_dec_3.pdf@2016-09-15 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-937_h_a_dec_7.pdf@EU-1-14-937_h_a_dec_7.pdf@2021-10-19 00:00:00@Gazyvaro@obinutuzumab@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-14-936_h_a_dec_9.pdf@EU-1-14-936_h_a_dec_9.pdf@2022-06-01 00:00:00@Nuwiq@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_4.pdf@EU-1-14-940_h_a_dec_4.pdf@2018-12-12 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-14-943_h_a_dec_5.pdf@EU-1-14-943_h_a_dec_5.pdf@2020-11-16 00:00:00@Velphoro@mixture  polynuclear iron(iii)-oxyhydroxide,  1OJ L 136, 30.4.2004, p. 1.2OJ L 334, 12.12.2008, p. 7.3OJ L 334, 12.12.2008, p. 7.EN2ENsucrose and starches@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma France@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_4.pdf@EU-1-14-941_h_a_dec_4.pdf@2019-11-01 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare Ltd@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_4.pdf@EU-1-14-938_h_a_dec_4.pdf@2016-09-19 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_5.pdf@EU-1-14-940_h_a_dec_5.pdf@2019-06-20 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_5.pdf@EU-1-14-941_h_a_dec_5.pdf@2019-07-25 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_5.pdf@EU-1-14-938_h_a_dec_5.pdf@2017-11-16 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_6.pdf@EU-1-14-940_h_a_dec_6.pdf@2020-01-04 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_6.pdf@EU-1-14-941_h_a_dec_6.pdf@2021-01-22 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_0.pdf@EU-1-14-944_h_a_dec_0.pdf@2014-09-09 00:00:00@ABASRIA@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_6.pdf@EU-1-14-938_h_a_dec_6.pdf@2018-05-03 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@conditional@Parsed
EU-1-14-945_h_a_dec_0.pdf@EU-1-14-945_h_a_dec_0.pdf@2014-10-21 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_1.pdf@EU-1-14-944_h_a_dec_1.pdf@2015-09-12 00:00:00@Abasaglar@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_7.pdf@EU-1-14-940_h_a_dec_7.pdf@2020-11-25 00:00:00@Triumeq@dolutegravir / abacavir  / lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_0.pdf@EU-1-14-946_h_a_dec_0.pdf@2014-09-18 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_1.pdf@EU-1-14-945_h_a_dec_1.pdf@2015-03-07 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-941_h_a_dec_7.pdf@EU-1-14-941_h_a_dec_7.pdf@2022-06-29 00:00:00@Vizamyl@flutemetamol (18F)@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_2.pdf@EU-1-14-944_h_a_dec_2.pdf@2017-11-04 00:00:00@Abasaglar@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_0.pdf@EU-1-14-947_h_a_dec_0.pdf@2014-09-18 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_7.pdf@EU-1-14-938_h_a_dec_7.pdf@2018-04-23 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_8.pdf@EU-1-14-940_h_a_dec_8.pdf@2021-06-25 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_10.pdf@EU-1-14-945_h_a_dec_10.pdf@2019-02-08 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_3.pdf@EU-1-14-944_h_a_dec_3.pdf@2018-02-27 00:00:00@Abasaglar@Insulin glargine@False@False@OD Not Found@Eli Lilly Regional Operations GmbH.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_1.pdf@EU-1-14-947_h_a_dec_1.pdf@2015-06-25 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_1.pdf@EU-1-14-946_h_a_dec_1.pdf@2015-10-12 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_11.pdf@EU-1-14-945_h_a_dec_11.pdf@2019-06-09 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_8.pdf@EU-1-14-938_h_a_dec_8.pdf@2018-07-06 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_4.pdf@EU-1-14-944_h_a_dec_4.pdf@2019-07-25 00:00:00@Abasaglar@Insulin glargine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_2.pdf@EU-1-14-947_h_a_dec_2.pdf@2016-02-24 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-940_h_a_dec_9.pdf@EU-1-14-940_h_a_dec_9.pdf@2021-09-22 00:00:00@Triumeq@dolutegravir / abacavir / lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_12.pdf@EU-1-14-945_h_a_dec_12.pdf@2020-07-17 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_5.pdf@EU-1-14-944_h_a_dec_5.pdf@2020-01-13 00:00:00@Abasaglar@Insulin glargine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_2.pdf@EU-1-14-946_h_a_dec_2.pdf@2016-12-12 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_3.pdf@EU-1-14-947_h_a_dec_3.pdf@2017-09-01 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-938_h_a_dec_9.pdf@EU-1-14-938_h_a_dec_9.pdf@2019-04-30 00:00:00@Zydelig@idelalisib@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_13.pdf@EU-1-14-945_h_a_dec_13.pdf@2020-08-19 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-944_h_a_dec_6.pdf@EU-1-14-944_h_a_dec_6.pdf@2021-06-24 00:00:00@Abasaglar@Insulin glargine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_4.pdf@EU-1-14-947_h_a_dec_4.pdf@2017-07-13 00:00:00@Xultophy@insulin degludec /  liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_0.pdf@EU-1-14-951_h_a_dec_0.pdf@2014-09-22 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_14.pdf@EU-1-14-945_h_a_dec_14.pdf@2020-08-28 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_3.pdf@EU-1-14-946_h_a_dec_3.pdf@2018-03-08 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_15.pdf@EU-1-14-945_h_a_dec_15.pdf@2021-08-20 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_1.pdf@EU-1-14-951_h_a_dec_1.pdf@2015-11-03 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_5.pdf@EU-1-14-947_h_a_dec_5.pdf@2018-07-06 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_4.pdf@EU-1-14-946_h_a_dec_4.pdf@2019-06-02 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_16.pdf@EU-1-14-945_h_a_dec_16.pdf@2022-02-08 00:00:00@IMBRUVICA@Ibrutinib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_6.pdf@EU-1-14-947_h_a_dec_6.pdf@2019-08-07 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_0.pdf@EU-1-14-952_h_a_dec_0.pdf@2015-01-15 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_2.pdf@EU-1-14-951_h_a_dec_2.pdf@2018-08-05 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_5.pdf@EU-1-14-946_h_a_dec_5.pdf@2019-12-06 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_17.pdf@EU-1-14-945_h_a_dec_17.pdf@2022-08-24 00:00:00@IMBRUVICA@Ibrutinib@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_1.pdf@EU-1-14-952_h_a_dec_1.pdf@2016-11-02 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_0.pdf@EU-1-14-954_h_a_dec_0.pdf@2014-11-21 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_3.pdf@EU-1-14-951_h_a_dec_3.pdf@2019-06-20 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_6.pdf@EU-1-14-946_h_a_dec_6.pdf@2021-06-28 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_7.pdf@EU-1-14-947_h_a_dec_7.pdf@2020-04-05 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_2.pdf@EU-1-14-945_h_a_dec_2.pdf@2016-05-26 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_2.pdf@EU-1-14-952_h_a_dec_2.pdf@2016-08-18 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-951_h_a_dec_4.pdf@EU-1-14-951_h_a_dec_4.pdf@2021-05-07 00:00:00@Busulfan Fresenius Kabi@busulfan@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_1.pdf@EU-1-14-954_h_a_dec_1.pdf@2016-03-31 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-946_h_a_dec_7.pdf@EU-1-14-946_h_a_dec_7.pdf@2022-07-18 00:00:00@Accofil@Filgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_3.pdf@EU-1-14-945_h_a_dec_3.pdf@2016-08-25 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_3.pdf@EU-1-14-952_h_a_dec_3.pdf@2017-06-23 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_2.pdf@EU-1-14-954_h_a_dec_2.pdf@2016-08-18 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-947_h_a_dec_8.pdf@EU-1-14-947_h_a_dec_8.pdf@2021-09-22 00:00:00@Xultophy@insulin degludec / liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_0.pdf@EU-1-14-955_h_a_dec_0.pdf@2014-11-19 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Navidea Biopharmaceuticals Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_4.pdf@EU-1-14-945_h_a_dec_4.pdf@2017-02-17 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_4.pdf@EU-1-14-952_h_a_dec_4.pdf@2018-09-20 00:00:00@Sevelamer carbonate Zentiva@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_3.pdf@EU-1-14-954_h_a_dec_3.pdf@2017-02-23 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_5.pdf@EU-1-14-945_h_a_dec_5.pdf@2017-08-24 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_0.pdf@EU-1-14-956_h_a_dec_0.pdf@2014-11-21 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_5.pdf@EU-1-14-952_h_a_dec_5.pdf@2019-08-23 00:00:00@Sevelamer carbonate Winthrop@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_4.pdf@EU-1-14-954_h_a_dec_4.pdf@2017-08-14 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_1.pdf@EU-1-14-955_h_a_dec_1.pdf@2017-01-23 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Navidea Biopharmaceuticals Limited@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_6.pdf@EU-1-14-945_h_a_dec_6.pdf@2018-09-02 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_1.pdf@EU-1-14-956_h_a_dec_1.pdf@2016-09-15 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_6.pdf@EU-1-14-952_h_a_dec_6.pdf@2019-11-11 00:00:00@Sevelamer carbonate Winthrop@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_2.pdf@EU-1-14-955_h_a_dec_2.pdf@2018-08-08 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
H@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_7.pdf@EU-1-14-945_h_a_dec_7.pdf@2018-06-29 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_10.pdf@EU-1-14-956_h_a_dec_10.pdf@2022-02-06 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_0.pdf@EU-1-14-957_h_a_dec_0.pdf@2014-12-19 00:00:00@Cyramza@ramucirumab@False@False@adopted@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_3.pdf@EU-1-14-955_h_a_dec_3.pdf@2019-09-16 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_6.pdf@EU-1-14-954_h_a_dec_6.pdf@2019-07-31 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-952_h_a_dec_7.pdf@EU-1-14-952_h_a_dec_7.pdf@2021-12-11 00:00:00@Sevelamer carbonate Winthrop@Sevelamer carbonate@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_8.pdf@EU-1-14-945_h_a_dec_8.pdf@2018-08-23 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_2.pdf@EU-1-14-956_h_a_dec_2.pdf@2016-12-12 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_0.pdf@EU-1-14-958_h_a_dec_0.pdf@2014-11-17 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_1.pdf@EU-1-14-957_h_a_dec_1.pdf@2016-01-25 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_7.pdf@EU-1-14-954_h_a_dec_7.pdf@2019-08-26 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_3.pdf@EU-1-14-956_h_a_dec_3.pdf@2017-06-16 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-945_h_a_dec_9.pdf@EU-1-14-945_h_a_dec_9.pdf@2019-06-25 00:00:00@IMBRUVICA@Ibrutinib@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-955_h_a_dec_4.pdf@EU-1-14-955_h_a_dec_4.pdf@2020-09-24 00:00:00@Lymphoseek@tilmanocept@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_2.pdf@EU-1-14-957_h_a_dec_2.pdf@2017-02-17 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_8.pdf@EU-1-14-954_h_a_dec_8.pdf@2020-07-23 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_1.pdf@EU-1-14-958_h_a_dec_1.pdf@2015-10-28 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_4.pdf@EU-1-14-956_h_a_dec_4.pdf@2018-02-22 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_3.pdf@EU-1-14-957_h_a_dec_3.pdf@2018-09-20 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-954_h_a_dec_9.pdf@EU-1-14-954_h_a_dec_9.pdf@2021-11-10 00:00:00@Vargatef@nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_5.pdf@EU-1-14-956_h_a_dec_5.pdf@2018-02-07 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_0.pdf@EU-1-14-959_h_a_dec_0.pdf@2014-12-16 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_4.pdf@EU-1-14-957_h_a_dec_4.pdf@2019-01-08 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_10.pdf@EU-1-14-958_h_a_dec_10.pdf@2019-01-08 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_6.pdf@EU-1-14-956_h_a_dec_6.pdf@2019-08-23 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_5.pdf@EU-1-14-957_h_a_dec_5.pdf@2019-09-26 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_1.pdf@EU-1-14-959_h_a_dec_1.pdf@2016-03-31 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_0.pdf@EU-1-14-960_h_a_dec_0.pdf@2014-12-16 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_6.pdf@EU-1-14-957_h_a_dec_6.pdf@2020-01-23 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_11.pdf@EU-1-14-958_h_a_dec_11.pdf@2019-10-29 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_10.pdf@EU-1-14-959_h_a_dec_10.pdf@2020-09-24 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_8.pdf@EU-1-14-956_h_a_dec_8.pdf@2020-11-18 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_7.pdf@EU-1-14-957_h_a_dec_7.pdf@2022-07-18 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_1.pdf@EU-1-14-960_h_a_dec_1.pdf@2016-08-09 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_0.pdf@EU-1-14-961_h_a_dec_0.pdf@2014-11-21 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-957_h_a_dec_8.pdf@EU-1-14-957_h_a_dec_8.pdf@2022-07-25 00:00:00@Cyramza@ramucirumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-956_h_a_dec_9.pdf@EU-1-14-956_h_a_dec_9.pdf@2021-06-17 00:00:00@Trulicity@dulaglutide@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_12.pdf@EU-1-14-958_h_a_dec_12.pdf@2020-03-07 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_11.pdf@EU-1-14-959_h_a_dec_11.pdf@2020-03-11 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_0.pdf@EU-1-14-962_h_a_dec_0.pdf@2014-08-12 00:00:00@Moventig@naloxegol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_1.pdf@EU-1-14-961_h_a_dec_1.pdf@2015-02-12 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_2.pdf@EU-1-14-960_h_a_dec_2.pdf@2018-01-24 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_12.pdf@EU-1-14-959_h_a_dec_12.pdf@2022-03-24 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_1.pdf@EU-1-14-962_h_a_dec_1.pdf@2016-09-30 00:00:00@Moventig@naloxegol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_13.pdf@EU-1-14-958_h_a_dec_13.pdf@2022-05-30 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_2.pdf@EU-1-14-961_h_a_dec_2.pdf@2017-06-23 00:00:00@, medicinal product for human use (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 2    EN COMMISSION IMPLEMENTING DECISION  23.6.2017  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2014)9036(final) for “Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_3.pdf@EU-1-14-960_h_a_dec_3.pdf@2018-02-08 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_2.pdf@EU-1-14-962_h_a_dec_2.pdf@2017-08-12 00:00:00@Moventig@naloxegol@False@False@OD Not Found@Kyowa Kirin Limited@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_13.pdf@EU-1-14-959_h_a_dec_13.pdf@2022-02-08 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_2.pdf@EU-1-14-958_h_a_dec_2.pdf@2015-12-18 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_4.pdf@EU-1-14-960_h_a_dec_4.pdf@2019-11-11 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_0.pdf@EU-1-14-963_h_a_dec_0.pdf@2014-11-19 00:00:00@Brimica Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_3.pdf@EU-1-14-961_h_a_dec_3.pdf@2018-12-04 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_2.pdf@EU-1-14-959_h_a_dec_2.pdf@2016-10-21 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-960_h_a_dec_5.pdf@EU-1-14-960_h_a_dec_5.pdf@2021-10-05 00:00:00@DUAVIVE@oestrogens conjugated / bazedoxifene@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_3.pdf@EU-1-14-958_h_a_dec_3.pdf@2016-02-05 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_3.pdf@EU-1-14-962_h_a_dec_3.pdf@2018-07-23 00:00:00@Moventig@naloxegol@False@False@OD Not Found@Kyowa Kirin Limited@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_3.pdf@EU-1-14-959_h_a_dec_3.pdf@2016-12-12 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_1.pdf@EU-1-14-963_h_a_dec_1.pdf@2015-02-26 00:00:00@Brimica Genuair@aclidinium bromide / formoterol fumarate  dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_4.pdf@EU-1-14-961_h_a_dec_4.pdf@2018-03-08 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_2.pdf@EU-1-14-963_h_a_dec_2.pdf@2016-12-05 00:00:00@Brimica Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_4.pdf@EU-1-14-962_h_a_dec_4.pdf@2018-12-12 00:00:00@Moventig@naloxegol@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_4.pdf@EU-1-14-958_h_a_dec_4.pdf@2016-07-22 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_4.pdf@EU-1-14-959_h_a_dec_4.pdf@2017-09-18 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_0.pdf@EU-1-14-964_h_a_dec_0.pdf@2014-11-19 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol  fumarate dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_5.pdf@EU-1-14-961_h_a_dec_5.pdf@2019-07-31 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_3.pdf@EU-1-14-963_h_a_dec_3.pdf@2016-08-22 00:00:00@Brimica Genuair@aclidinium  bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_5.pdf@EU-1-14-962_h_a_dec_5.pdf@2019-06-20 00:00:00@Moventig@naloxegol@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_5.pdf@EU-1-14-959_h_a_dec_5.pdf@2018-08-05 00:00:00@Lynparza@Olaparib@False@False@adopted@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_6.pdf@EU-1-14-961_h_a_dec_6.pdf@2020-09-17 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_4.pdf@EU-1-14-963_h_a_dec_4.pdf@2017-02-16 00:00:00@Brimica Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_5.pdf@EU-1-14-958_h_a_dec_5.pdf@2017-02-23 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_1.pdf@EU-1-14-964_h_a_dec_1.pdf@2015-02-26 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol fumarate  dihydrate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_6.pdf@EU-1-14-962_h_a_dec_6.pdf@2019-09-23 00:00:00@Moventig@naloxegol@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_0.pdf@EU-1-14-965_h_a_dec_0.pdf@2014-11-19 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_2.pdf@EU-1-14-964_h_a_dec_2.pdf@2016-05-26 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-962_h_a_dec_7.pdf@EU-1-14-962_h_a_dec_7.pdf@2020-09-10 00:00:00@Moventig@naloxegol@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_1.pdf@EU-1-14-965_h_a_dec_1.pdf@2015-05-03 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_6.pdf@EU-1-14-959_h_a_dec_6.pdf@2019-08-04 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_6.pdf@EU-1-14-958_h_a_dec_6.pdf@2017-05-24 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_5.pdf@EU-1-14-963_h_a_dec_5.pdf@2018-03-08 00:00:00@Brimica Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-961_h_a_dec_7.pdf@EU-1-14-961_h_a_dec_7.pdf@2021-09-15 00:00:00@Tadalafil Mylan@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_3.pdf@EU-1-14-964_h_a_dec_3.pdf@2016-08-22 00:00:00@Duaklir Genuair@aclidinium  bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_2.pdf@EU-1-14-965_h_a_dec_2.pdf@2016-02-22 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_6.pdf@EU-1-14-963_h_a_dec_6.pdf@2019-08-23 00:00:00@Brimica Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_3.pdf@EU-1-14-965_h_a_dec_3.pdf@2016-08-31 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_4.pdf@EU-1-14-964_h_a_dec_4.pdf@2017-02-16 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_7.pdf@EU-1-14-958_h_a_dec_7.pdf@2017-07-19 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_7.pdf@EU-1-14-959_h_a_dec_7.pdf@2019-12-06 00:00:00@Having regard to Commission Delegated Regulation (EU) No 357/2014  3 February 2014  supplementing Directive 2001/83/EC  the European Parliament and  the Council and  Regulation (EC) No 726/2004  the European Parliament and  the Council as regards  situations in which post-authorisation efficacy studies may be required, and in particular  Article 1(2) there 2, Having regard to Commission Regulation (EC) No 1234/2008  24 November 2008  concerning the examination  variations to the terms  marketing authorisations for  medicinal products for human use and veterinary medicinal products 3, and in particular Article 17(2) thereof,  Having regard to the changes to the terms  the decision granting the marketing  authorisation requested by AstraZeneca AB in accordance with Regulation (EC) No  1234/2008,  Having regard to the opinion  the European Medicines Agency, formulated on 26 April  2019 by the Committee for Medicinal Products for Human Use,  Whereas:  (1)  The European Medicines Agency's opinion is favourable to the variation  the terms   the decision granting the marketing authorisation as submitted by the marketing  authorisation holder.  (2)  The review  the data submitted by AstraZeneca AB on 15 September 2018 has  shown that the new therapeutic indication proposed for the medicinal product  @Active Substance Not Found@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-963_h_a_dec_7.pdf@EU-1-14-963_h_a_dec_7.pdf@2022-06-24 00:00:00@Brimica Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_4.pdf@EU-1-14-965_h_a_dec_4.pdf@2017-02-23 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_0.pdf@EU-1-14-967_h_a_dec_0.pdf@2014-11-19 00:00:00@REZOLSTA@DARUNAVIR / COBICISTAT@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_8.pdf@EU-1-14-959_h_a_dec_8.pdf@2019-01-10 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_5.pdf@EU-1-14-964_h_a_dec_5.pdf@2018-03-08 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_8.pdf@EU-1-14-958_h_a_dec_8.pdf@2018-07-06 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_5.pdf@EU-1-14-965_h_a_dec_5.pdf@2017-08-22 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_1.pdf@EU-1-14-967_h_a_dec_1.pdf@2017-01-26 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-964_h_a_dec_6.pdf@EU-1-14-964_h_a_dec_6.pdf@2019-08-23 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_6.pdf@EU-1-14-965_h_a_dec_6.pdf@2019-07-31 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-959_h_a_dec_9.pdf@EU-1-14-959_h_a_dec_9.pdf@2020-03-07 00:00:00@Lynparza@Olaparib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_0.pdf@EU-1-14-969_h_a_dec_0.pdf@2014-12-22 00:00:00@Scenesse@afamelanotide@False@False@adopted@Clinuvel UK Limited@exceptional@Parsed
EU-1-14-964_h_a_dec_7.pdf@EU-1-14-964_h_a_dec_7.pdf@2022-06-24 00:00:00@Duaklir Genuair@aclidinium bromide / formoterol fumarate dihydrate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-14-970_h_a_dec_0.pdf@EU-1-14-970_h_a_dec_0.pdf@2014-12-19 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxter Innovations GmbH@CMA Not Found@Parsed
EU-1-14-958_h_a_dec_9.pdf@EU-1-14-958_h_a_dec_9.pdf@2019-06-06 00:00:00@Harvoni@ledipasvir/sofosbuvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_7.pdf@EU-1-14-965_h_a_dec_7.pdf@2019-07-11 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_2.pdf@EU-1-14-967_h_a_dec_2.pdf@2018-08-02 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-970_h_a_dec_1.pdf@EU-1-14-970_h_a_dec_1.pdf@2016-05-26 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_8.pdf@EU-1-14-965_h_a_dec_8.pdf@2020-01-23 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@Laboratoire HRA Pharma@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_1.pdf@EU-1-14-969_h_a_dec_1.pdf@2016-12-08 00:00:00@Scenesse@afamelanotide@False@False@OD Not Found@Clinuvel UK Limited@exceptional@Parsed
EU-1-14-970_h_a_dec_2.pdf@EU-1-14-970_h_a_dec_2.pdf@2019-11-14 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-14-965_h_a_dec_9.pdf@EU-1-14-965_h_a_dec_9.pdf@2022-02-06 00:00:00@Ketoconazole HRA@ketoconazole@False@False@adopted@HRA Pharma Rare Diseases@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_3.pdf@EU-1-14-967_h_a_dec_3.pdf@2018-06-29 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-970_h_a_dec_3.pdf@EU-1-14-970_h_a_dec_3.pdf@2020-12-18 00:00:00@Rixubis@nonacog gamma@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_2.pdf@EU-1-14-969_h_a_dec_2.pdf@2019-03-20 00:00:00@SCENESSE@afamelanotide@False@False@adopted@Clinuvel UK Limited@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_0.pdf@EU-1-14-971_h_a_dec_0.pdf@2014-05-12 00:00:00@Paliperidone Janssen@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_4.pdf@EU-1-14-967_h_a_dec_4.pdf@2018-11-20 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_1.pdf@EU-1-14-971_h_a_dec_1.pdf@2016-04-13 00:00:00@Paliperidone Janssen@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_3.pdf@EU-1-14-969_h_a_dec_3.pdf@2019-11-19 00:00:00@SCENESSE@afamelanotide@False@False@adopted@Clinuvel Europe Limited@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_2.pdf@EU-1-14-971_h_a_dec_2.pdf@2016-05-26 00:00:00@Trevicta@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_0.pdf@EU-1-14-972_h_a_dec_0.pdf@2014-08-12 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_0.pdf@EU-1-14-973_h_a_dec_0.pdf@2015-03-26 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Aptalis Pharma SAS@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_5.pdf@EU-1-14-967_h_a_dec_5.pdf@2019-06-05 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_0.pdf@EU-1-14-974_h_a_dec_0.pdf@2015-01-19 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_0.pdf@EU-1-14-975_h_a_dec_0.pdf@2015-02-19 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_6.pdf@EU-1-14-971_h_a_dec_6.pdf@2017-09-14 00:00:00@Trevicta@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_1.pdf@EU-1-14-972_h_a_dec_1.pdf@2016-04-07 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_1.pdf@EU-1-14-973_h_a_dec_1.pdf@2015-08-07 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Aptalis Pharma SAS@CMA Not Found@Parsed
EU-1-14-969_h_a_dec_4.pdf@EU-1-14-969_h_a_dec_4.pdf@2020-09-12 00:00:00@SCENESSE@afamelanotide@False@False@adopted@Clinuvel Europe Limited@exceptional@Parsed
EU-1-14-974_h_a_dec_1.pdf@EU-1-14-974_h_a_dec_1.pdf@2016-02-25 00:00:00@Cerdelga@eliglustat@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_6.pdf@EU-1-14-967_h_a_dec_6.pdf@2019-07-31 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_1.pdf@EU-1-14-975_h_a_dec_1.pdf@2015-07-31 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_2.pdf@EU-1-14-972_h_a_dec_2.pdf@2017-12-20 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_2.pdf@EU-1-14-974_h_a_dec_2.pdf@2018-01-26 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_2.pdf@EU-1-14-975_h_a_dec_2.pdf@2016-11-14 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_7.pdf@EU-1-14-971_h_a_dec_7.pdf@2018-12-12 00:00:00@Trevicta@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_2.pdf@EU-1-14-973_h_a_dec_2.pdf@2015-09-14 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Aptalis Pharma SAS@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_7.pdf@EU-1-14-967_h_a_dec_7.pdf@2020-09-03 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_3.pdf@EU-1-14-972_h_a_dec_3.pdf@2019-07-31 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_3.pdf@EU-1-14-974_h_a_dec_3.pdf@2018-07-06 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_3.pdf@EU-1-14-975_h_a_dec_3.pdf@2017-06-29 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_4.pdf@EU-1-14-972_h_a_dec_4.pdf@2020-12-06 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_8.pdf@EU-1-14-971_h_a_dec_8.pdf@2019-11-14 00:00:00@Trevicta@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-974_h_a_dec_4.pdf@EU-1-14-974_h_a_dec_4.pdf@2019-12-16 00:00:00@Cerdelga@eliglustat@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_4.pdf@EU-1-14-975_h_a_dec_4.pdf@2018-12-11 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-972_h_a_dec_5.pdf@EU-1-14-972_h_a_dec_5.pdf@2021-06-17 00:00:00@Duloxetine Lilly@duloxetine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_3.pdf@EU-1-14-973_h_a_dec_3.pdf@2015-11-27 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Regintel Limited@CMA Not Found@Parsed
EU-1-14-967_h_a_dec_8.pdf@EU-1-14-967_h_a_dec_8.pdf@2021-09-23 00:00:00@Rezolsta@Darunavir/Cobicistat@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_4.pdf@EU-1-14-973_h_a_dec_4.pdf@2017-02-16 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Horizon Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_5.pdf@EU-1-14-975_h_a_dec_5.pdf@2019-11-11 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-971_h_a_dec_9.pdf@EU-1-14-971_h_a_dec_9.pdf@2022-04-29 00:00:00@Trevicta@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_6.pdf@EU-1-14-975_h_a_dec_6.pdf@2021-04-02 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_5.pdf@EU-1-14-973_h_a_dec_5.pdf@2018-07-06 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Chiesi Orphan B.V.@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_0.pdf@EU-1-14-977_h_a_dec_0.pdf@2015-12-01 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_7.pdf@EU-1-14-975_h_a_dec_7.pdf@2021-04-06 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_0.pdf@EU-1-14-979_h_a_dec_0.pdf@2015-01-15 00:00:00@Ofev@Nintedanib@True@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_6.pdf@EU-1-14-973_h_a_dec_6.pdf@2019-02-14 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ITALIAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 14.2.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2015)2244(final) for “Quinsair@levofloxacin@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_0.pdf@EU-1-14-978_h_a_dec_0.pdf@2015-01-15 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_1.pdf@EU-1-14-977_h_a_dec_1.pdf@2016-01-08 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-975_h_a_dec_8.pdf@EU-1-14-975_h_a_dec_8.pdf@2021-10-22 00:00:00@Clopidogrel ratiopharm@clopidogrel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_1.pdf@EU-1-14-979_h_a_dec_1.pdf@2015-12-08 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_7.pdf@EU-1-14-973_h_a_dec_7.pdf@2020-02-13 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_2.pdf@EU-1-14-977_h_a_dec_2.pdf@2018-07-26 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_1.pdf@EU-1-14-978_h_a_dec_1.pdf@2017-02-13 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_10.pdf@EU-1-14-979_h_a_dec_10.pdf@2020-04-17 00:00:00@Nintedanib@Active Substance Not Found@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_8.pdf@EU-1-14-973_h_a_dec_8.pdf@2021-05-21 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_3.pdf@EU-1-14-977_h_a_dec_3.pdf@2019-06-09 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_0.pdf@EU-1-14-980_h_a_dec_0.pdf@2015-01-15 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-973_h_a_dec_9.pdf@EU-1-14-973_h_a_dec_9.pdf@2022-08-07 00:00:00@Quinsair@levofloxacin@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_11.pdf@EU-1-14-979_h_a_dec_11.pdf@2020-07-13 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-977_h_a_dec_4.pdf@EU-1-14-977_h_a_dec_4.pdf@2021-09-23 00:00:00@Rasagiline ratiopharm@rasagiline@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_2.pdf@EU-1-14-978_h_a_dec_2.pdf@2018-02-19 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_0.pdf@EU-1-14-981_h_a_dec_0.pdf@2015-01-15 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_12.pdf@EU-1-14-979_h_a_dec_12.pdf@2021-07-01 00:00:00@Ofev@Nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_1.pdf@EU-1-14-980_h_a_dec_1.pdf@2015-11-19 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_1.pdf@EU-1-14-982_h_a_dec_1.pdf@2016-01-25 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_1.pdf@EU-1-14-981_h_a_dec_1.pdf@2016-08-07 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_13.pdf@EU-1-14-979_h_a_dec_13.pdf@2021-08-18 00:00:00@Ofev@Nintedanib@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_3.pdf@EU-1-14-978_h_a_dec_3.pdf@2018-05-28 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_10.pdf@EU-1-14-982_h_a_dec_10.pdf@2018-11-22 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_0.pdf@EU-1-14-983_h_a_dec_0.pdf@2015-01-15 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_10.pdf@EU-1-14-980_h_a_dec_10.pdf@2020-07-31 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_2.pdf@EU-1-14-979_h_a_dec_2.pdf@2016-01-22 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_11.pdf@EU-1-14-982_h_a_dec_11.pdf@2019-08-07 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_2.pdf@EU-1-14-981_h_a_dec_2.pdf@2016-08-12 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_4.pdf@EU-1-14-978_h_a_dec_4.pdf@2019-11-03 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi Limited@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_3.pdf@EU-1-14-979_h_a_dec_3.pdf@2016-07-22 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_0.pdf@EU-1-14-984_h_a_dec_0.pdf@2015-02-24 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_12.pdf@EU-1-14-982_h_a_dec_12.pdf@2019-09-19 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_1.pdf@EU-1-14-983_h_a_dec_1.pdf@2016-01-25 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_4.pdf@EU-1-14-979_h_a_dec_4.pdf@2016-02-09 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_11.pdf@EU-1-14-980_h_a_dec_11.pdf@2020-09-17 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_5.pdf@EU-1-14-978_h_a_dec_5.pdf@2019-10-21 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_1.pdf@EU-1-14-984_h_a_dec_1.pdf@2017-11-01 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_13.pdf@EU-1-14-982_h_a_dec_13.pdf@2020-09-10 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_10.pdf@EU-1-14-983_h_a_dec_10.pdf@2020-09-30 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_3.pdf@EU-1-14-981_h_a_dec_3.pdf@2018-02-08 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe Limited@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_6.pdf@EU-1-14-978_h_a_dec_6.pdf@2019-11-22 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_5.pdf@EU-1-14-979_h_a_dec_5.pdf@2017-09-01 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_2.pdf@EU-1-14-984_h_a_dec_2.pdf@2018-04-19 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_14.pdf@EU-1-14-982_h_a_dec_14.pdf@2021-09-22 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_11.pdf@EU-1-14-983_h_a_dec_11.pdf@2021-09-16 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_6.pdf@EU-1-14-979_h_a_dec_6.pdf@2017-07-19 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_12.pdf@EU-1-14-980_h_a_dec_12.pdf@2020-11-20 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_7.pdf@EU-1-14-978_h_a_dec_7.pdf@2021-07-23 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_3.pdf@EU-1-14-984_h_a_dec_3.pdf@2019-07-18 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_15.pdf@EU-1-14-982_h_a_dec_15.pdf@2022-02-06 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_12.pdf@EU-1-14-983_h_a_dec_12.pdf@2022-02-06 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_4.pdf@EU-1-14-981_h_a_dec_4.pdf@2018-12-18 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-14-978_h_a_dec_8.pdf@EU-1-14-978_h_a_dec_8.pdf@2022-02-24 00:00:00@Senshio@ospemifene@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_7.pdf@EU-1-14-979_h_a_dec_7.pdf@2018-07-26 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-984_h_a_dec_4.pdf@EU-1-14-984_h_a_dec_4.pdf@2019-09-19 00:00:00@Xadago@safinamide@False@False@OD Not Found@Zambon S.p.A.@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_2.pdf@EU-1-14-983_h_a_dec_2.pdf@2016-04-21 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_13.pdf@EU-1-14-980_h_a_dec_13.pdf@2021-07-16 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_5.pdf@EU-1-14-981_h_a_dec_5.pdf@2019-08-23 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_8.pdf@EU-1-14-979_h_a_dec_8.pdf@2019-07-25 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_2.pdf@EU-1-14-982_h_a_dec_2.pdf@2016-04-28 00:00:00@Viekirax@ombitasvir /  paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-979_h_a_dec_9.pdf@EU-1-14-979_h_a_dec_9.pdf@2019-09-23 00:00:00@Ofev@Nintedanib@False@False@adopted@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_14.pdf@EU-1-14-980_h_a_dec_14.pdf@2022-01-20 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_3.pdf@EU-1-14-983_h_a_dec_3.pdf@2017-02-23 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_6.pdf@EU-1-14-981_h_a_dec_6.pdf@2020-01-31 00:00:00@Otezla@apremilast@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_3.pdf@EU-1-14-982_h_a_dec_3.pdf@2016-08-18 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-986_h_a_dec_0.pdf@EU-1-14-986_h_a_dec_0.pdf@2015-02-19 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Durata Therapeutics International B.V.@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_0.pdf@EU-1-14-987_h_a_dec_0.pdf@2015-02-17 00:00:00@Holoclar@Ex vivo expanded autologous  human corneal epithelial cells containing stem cells@True@True@adopted@Chiesi Farmaceutici S.P.A.@conditional@Parsed
EU-1-14-983_h_a_dec_4.pdf@EU-1-14-983_h_a_dec_4.pdf@2017-10-11 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_4.pdf@EU-1-14-982_h_a_dec_4.pdf@2017-01-26 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_15.pdf@EU-1-14-980_h_a_dec_15.pdf@2022-06-20 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_7.pdf@EU-1-14-981_h_a_dec_7.pdf@2020-08-04 00:00:00@Otezla@apremilast@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-14-986_h_a_dec_1.pdf@EU-1-14-986_h_a_dec_1.pdf@2016-02-03 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Durata Therapeutics International B.V.@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_1.pdf@EU-1-14-987_h_a_dec_1.pdf@2015-10-12 00:00:00@Holoclar@Ex vivo expanded autologous human corneal epithelial  cells containing stem cells@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@conditional@Parsed
EU-1-14-982_h_a_dec_5.pdf@EU-1-14-982_h_a_dec_5.pdf@2017-02-23 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-981_h_a_dec_8.pdf@EU-1-14-981_h_a_dec_8.pdf@2021-06-21 00:00:00@Otezla@apremilast@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_5.pdf@EU-1-14-983_h_a_dec_5.pdf@2018-05-31 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_2.pdf@EU-1-14-980_h_a_dec_2.pdf@2017-03-22 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_2.pdf@EU-1-14-987_h_a_dec_2.pdf@2016-08-12 00:00:00@Holoclar@Ex vivo expanded autologous human corneal epithelial  cells containing stem cells@False@False@OD Not Found@Chiesi Farmaceutici S.P.A.@conditional@Parsed
EU-1-14-986_h_a_dec_2.pdf@EU-1-14-986_h_a_dec_2.pdf@2017-01-27 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Durata Therapeutics International B.V.@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_6.pdf@EU-1-14-983_h_a_dec_6.pdf@2018-04-10 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_3.pdf@EU-1-14-987_h_a_dec_3.pdf@2017-11-12 00:00:00@Holoclar@Ex vivo expanded autologous human corneal epithelial  cells containing stem cells@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@conditional@Parsed
EU-1-14-986_h_a_dec_3.pdf@EU-1-14-986_h_a_dec_3.pdf@2019-07-31 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_6.pdf@EU-1-14-982_h_a_dec_6.pdf@2017-11-15 00:00:00@Viekirax@ombitasvir /  paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_7.pdf@EU-1-14-983_h_a_dec_7.pdf@2018-12-11 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_3.pdf@EU-1-14-980_h_a_dec_3.pdf@2018-04-26 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_0.pdf@EU-1-14-988_h_a_dec_0.pdf@2015-03-26 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_8.pdf@EU-1-14-983_h_a_dec_8.pdf@2019-01-07 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_4.pdf@EU-1-14-987_h_a_dec_4.pdf@2019-01-15 00:00:00@Holoclar@Ex vivo expanded autologous human  corneal epithelial cells containing stem cells@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@conditional@Parsed
EU-1-14-986_h_a_dec_4.pdf@EU-1-14-986_h_a_dec_4.pdf@2019-05-12 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Allergan Pharmaceuticals International  Limited@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_7.pdf@EU-1-14-982_h_a_dec_7.pdf@2018-05-03 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-983_h_a_dec_9.pdf@EU-1-14-983_h_a_dec_9.pdf@2019-09-26 00:00:00@Exviera@dasabuvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_1.pdf@EU-1-14-988_h_a_dec_1.pdf@2016-12-12 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_4.pdf@EU-1-14-980_h_a_dec_4.pdf@2018-09-20 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_5.pdf@EU-1-14-987_h_a_dec_5.pdf@2020-02-21 00:00:00@Holoclar@Ex vivo expanded autologous human  corneal epithelial cells containing stem cells@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@conditional@Parsed
EU-1-15-1000_h_a_dec_0.pdf@EU-1-15-1000_h_a_dec_0.pdf@2015-05-27 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-14-986_h_a_dec_5.pdf@EU-1-14-986_h_a_dec_5.pdf@2021-10-19 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_8.pdf@EU-1-14-982_h_a_dec_8.pdf@2018-08-06 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_10.pdf@EU-1-14-988_h_a_dec_10.pdf@2021-06-17 00:00:00@Mysimba@naltrexone /  bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_5.pdf@EU-1-14-980_h_a_dec_5.pdf@2018-10-23 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-982_h_a_dec_9.pdf@EU-1-14-982_h_a_dec_9.pdf@2018-08-31 00:00:00@Viekirax@ombitasvir / paritaprevir / ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_1.pdf@EU-1-15-1000_h_a_dec_1.pdf@2017-11-09 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd.@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_6.pdf@EU-1-14-987_h_a_dec_6.pdf@2020-12-06 00:00:00@Holoclar@Ex vivo expanded autologous human corneal epithelial cells containing  stem cells@False@False@adopted@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-14-986_h_a_dec_6.pdf@EU-1-14-986_h_a_dec_6.pdf@2022-06-13 00:00:00@Xydalba@Dalbavancin@False@False@OD Not Found@Allergan Pharmaceuticals International Limited@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_6.pdf@EU-1-14-980_h_a_dec_6.pdf@2019-03-09 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_7.pdf@EU-1-14-987_h_a_dec_7.pdf@2021-07-01 00:00:00@Holoclar@Ex vivo expanded autologous human  corneal epithelial cells containing stem cells@False@False@OD Not Found@Holostem Terapie Avanzate S.r.l.@conditional@Parsed
EU-1-14-988_h_a_dec_11.pdf@EU-1-14-988_h_a_dec_11.pdf@2022-06-21 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_2.pdf@EU-1-15-1000_h_a_dec_2.pdf@2018-06-29 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-14-987_h_a_dec_8.pdf@EU-1-14-987_h_a_dec_8.pdf@2021-09-12 00:00:00@Holoclar@Ex vivo expanded autologous human  corneal epithelial cells containing stem cells@False@False@OD Not Found@Holostem Terapie Avanzate S.r.l.@conditional@Parsed
EU-1-14-980_h_a_dec_7.pdf@EU-1-14-980_h_a_dec_7.pdf@2019-09-16 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_2.pdf@EU-1-14-988_h_a_dec_2.pdf@2017-06-23 00:00:00@Mysimba@naltrexone /  bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_3.pdf@EU-1-15-1000_h_a_dec_3.pdf@2018-07-26 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_0.pdf@EU-1-15-1001_h_a_dec_0.pdf@2015-05-27 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_0.pdf@EU-1-15-1002_h_a_dec_0.pdf@2015-05-28 00:00:00@Lenvima@Lenvatinib@False@False@adopted@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_8.pdf@EU-1-14-980_h_a_dec_8.pdf@2019-10-21 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_3.pdf@EU-1-14-988_h_a_dec_3.pdf@2017-08-12 00:00:00@Mysimba@naltrexone /  bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_0.pdf@EU-1-15-1003_h_a_dec_0.pdf@2015-05-27 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_1.pdf@EU-1-15-1001_h_a_dec_1.pdf@2017-08-05 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_1.pdf@EU-1-15-1002_h_a_dec_1.pdf@2017-09-21 00:00:00@Lenvima@lenvatinib@False@False@adopted@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_4.pdf@EU-1-15-1000_h_a_dec_4.pdf@2018-12-11 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-14-980_h_a_dec_9.pdf@EU-1-14-980_h_a_dec_9.pdf@2020-04-28 00:00:00@Cosentyx@secukinumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_1.pdf@EU-1-15-1003_h_a_dec_1.pdf@2016-04-28 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_5.pdf@EU-1-15-1000_h_a_dec_5.pdf@2019-12-02 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_4.pdf@EU-1-14-988_h_a_dec_4.pdf@2018-01-26 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_2.pdf@EU-1-15-1002_h_a_dec_2.pdf@2018-08-20 00:00:00@Lenvima@lenvatinib@False@False@adopted@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_2.pdf@EU-1-15-1001_h_a_dec_2.pdf@2018-06-09 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_10.pdf@EU-1-15-1003_h_a_dec_10.pdf@2021-04-06 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_6.pdf@EU-1-15-1000_h_a_dec_6.pdf@2019-09-12 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_0.pdf@EU-1-15-1004_h_a_dec_0.pdf@2015-05-27 00:00:00@Voriconazole Hospira@voriconazole@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_7.pdf@EU-1-15-1000_h_a_dec_7.pdf@2020-03-04 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_11.pdf@EU-1-15-1003_h_a_dec_11.pdf@2022-04-03 00:00:00@Synjardy@empagliflozin /  metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_5.pdf@EU-1-14-988_h_a_dec_5.pdf@2018-02-07 00:00:00@Mysimba@naltrexone /  bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_1.pdf@EU-1-15-1004_h_a_dec_1.pdf@2016-01-28 00:00:00@Voriconazole Hospira@voriconazole@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_3.pdf@EU-1-15-1001_h_a_dec_3.pdf@2020-09-01 00:00:00@Akynzeo@netupitant / palonosetron@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_3.pdf@EU-1-15-1002_h_a_dec_3.pdf@2019-07-02 00:00:00@Lenvima@lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_8.pdf@EU-1-15-1000_h_a_dec_8.pdf@2021-03-31 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_2.pdf@EU-1-15-1003_h_a_dec_2.pdf@2016-07-15 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_4.pdf@EU-1-15-1002_h_a_dec_4.pdf@2020-05-20 00:00:00@Lenvima@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-15-1000_h_a_dec_9.pdf@EU-1-15-1000_h_a_dec_9.pdf@2022-03-22 00:00:00@Jinarc@tolvaptan@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_6.pdf@EU-1-14-988_h_a_dec_6.pdf@2019-06-28 00:00:00@Mysimba@naltrexone /  bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_3.pdf@EU-1-15-1003_h_a_dec_3.pdf@2016-12-12 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2015)3656(final) for “Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_2.pdf@EU-1-15-1004_h_a_dec_2.pdf@2017-01-26 00:00:00@Voriconazole Hikma@voriconazole@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_4.pdf@EU-1-15-1001_h_a_dec_4.pdf@2020-03-16 00:00:00@Akynzeo@‘netupitant/palonosetron’ or ‘fosnetupitant/palonosetron’@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_5.pdf@EU-1-15-1002_h_a_dec_5.pdf@2020-11-18 00:00:00@Lenvima@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_4.pdf@EU-1-15-1003_h_a_dec_4.pdf@2017-03-03 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_3.pdf@EU-1-15-1004_h_a_dec_3.pdf@2018-09-21 00:00:00@Voriconazole Hikma@voriconazole@False@False@OD Not Found@Hikma Farmacêutica (Portugal)@CMA Not Found@Parsed
EU-1-15-1002_h_a_dec_6.pdf@EU-1-15-1002_h_a_dec_6.pdf@2021-11-26 00:00:00@Lenvima@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_7.pdf@EU-1-14-988_h_a_dec_7.pdf@2019-10-24 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_5.pdf@EU-1-15-1003_h_a_dec_5.pdf@2017-04-20 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_5.pdf@EU-1-15-1001_h_a_dec_5.pdf@2021-05-27 00:00:00@Akynzeo@‘netupitant/palonosetron’ or ‘fosnetupitant/palonosetron’@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_4.pdf@EU-1-15-1004_h_a_dec_4.pdf@2020-03-24 00:00:00@Voriconazole Hikma@voriconazole@False@False@OD Not Found@Hikma Farmacêutica (Portugal), S.A.@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_6.pdf@EU-1-15-1003_h_a_dec_6.pdf@2017-07-19 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_8.pdf@EU-1-14-988_h_a_dec_8.pdf@2020-01-16 00:00:00@Mysimba@naltrexone / bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1004_h_a_dec_5.pdf@EU-1-15-1004_h_a_dec_5.pdf@2021-08-18 00:00:00@Voriconazole Hikma@voriconazole@False@False@OD Not Found@Hikma Farmacêutica (Portugal)@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_0.pdf@EU-1-15-1005_h_a_dec_0.pdf@2015-06-30 00:00:00@Aripiprazole Pharmathen@aripiprazole@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_7.pdf@EU-1-15-1003_h_a_dec_7.pdf@2018-08-01 00:00:00@Synjardy@empagliflozin /  metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1001_h_a_dec_6.pdf@EU-1-15-1001_h_a_dec_6.pdf@2021-12-11 00:00:00@Akynzeo@‘netupitant/palonosetron’ or  ‘fosnetupitant/palonosetron’@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd@exceptional@Parsed
EU-1-15-1004_h_a_dec_6.pdf@EU-1-15-1004_h_a_dec_6.pdf@2021-12-20 00:00:00@Voriconazole Hikma@voriconazole@False@False@OD Not Found@Hikma Farmacêutica (Portugal)@CMA Not Found@Parsed
EU-1-15-1003_h_a_dec_8.pdf@EU-1-15-1003_h_a_dec_8.pdf@2019-06-06 00:00:00@Synjardy@empagliflozin / metformin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-14-988_h_a_dec_9.pdf@EU-1-14-988_h_a_dec_9.pdf@2020-03-07 00:00:00@Mysimba@naltrexone /  bupropion@False@False@OD Not Found@Orexigen Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_1.pdf@EU-1-15-1005_h_a_dec_1.pdf@2016-01-08 00:00:00@Aripiprazole Mylan Pharma@aripiprazole@False@False@OD Not Found@Pharmathen S.A.@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_2.pdf@EU-1-15-1005_h_a_dec_2.pdf@2017-07-26 00:00:00@Aripiprazole Mylan Pharma@aripiprazole@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
H@CMA Not Found@Parsed
EU-1-15-1006_h_a_dec_1.pdf@EU-1-15-1006_h_a_dec_1.pdf@2017-05-22 00:00:00@Respreeza@human alpha1-proteinase inhibitor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_3.pdf@EU-1-15-1005_h_a_dec_3.pdf@2019-02-14 00:00:00@Aripiprazole Mylan Pharma@aripiprazole@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1006_h_a_dec_2.pdf@EU-1-15-1006_h_a_dec_2.pdf@2019-01-31 00:00:00@Respreeza@human alpha1-proteinase inhibitor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_4.pdf@EU-1-15-1005_h_a_dec_4.pdf@2020-02-25 00:00:00@Aripiprazole Mylan Pharma@aripiprazole@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_5.pdf@EU-1-15-1005_h_a_dec_5.pdf@2021-11-18 00:00:00@Aripiprazole Mylan Pharma@aripiprazole@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1006_h_a_dec_3.pdf@EU-1-15-1006_h_a_dec_3.pdf@2020-04-23 00:00:00@Respreeza@human alpha1-proteinase inhibitor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_0.pdf@EU-1-15-1007_h_a_dec_0.pdf@2015-10-06 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine  (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1006_h_a_dec_4.pdf@EU-1-15-1006_h_a_dec_4.pdf@2021-03-22 00:00:00@Respreeza@human alpha1-proteinase inhibitor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_0.pdf@EU-1-15-1008_h_a_dec_0.pdf@2015-03-07 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_0.pdf@EU-1-15-1009_h_a_dec_0.pdf@2015-06-25 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_1.pdf@EU-1-15-1007_h_a_dec_1.pdf@2016-12-01 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_0.pdf@EU-1-15-1010_h_a_dec_0.pdf@2015-06-19 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1006_h_a_dec_5.pdf@EU-1-15-1006_h_a_dec_5.pdf@2022-06-29 00:00:00@Respreeza@human alpha1-proteinase inhibitor@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-15-1005_h_a_dec_6.pdf@EU-1-15-1005_h_a_dec_6.pdf@2021-11-19 00:00:00@Aripiprazole Mylan Pharma@aripiprazole@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_1.pdf@EU-1-15-1009_h_a_dec_1.pdf@2017-02-13 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_0.pdf@EU-1-15-1011_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_2.pdf@EU-1-15-1007_h_a_dec_2.pdf@2016-04-04 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_1.pdf@EU-1-15-1008_h_a_dec_1.pdf@2017-01-12 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_1.pdf@EU-1-15-1010_h_a_dec_1.pdf@2016-12-23 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_1.pdf@EU-1-15-1011_h_a_dec_1.pdf@2016-06-10 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_2.pdf@EU-1-15-1009_h_a_dec_2.pdf@2018-03-21 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_3.pdf@EU-1-15-1007_h_a_dec_3.pdf@2017-03-03 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SAS@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_2.pdf@EU-1-15-1011_h_a_dec_2.pdf@2018-05-02 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_2.pdf@EU-1-15-1008_h_a_dec_2.pdf@2019-02-25 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_0.pdf@EU-1-15-1012_h_a_dec_0.pdf@2015-06-19 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_3.pdf@EU-1-15-1009_h_a_dec_3.pdf@2020-02-06 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_2.pdf@EU-1-15-1010_h_a_dec_2.pdf@2018-03-08 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_4.pdf@EU-1-15-1007_h_a_dec_4.pdf@2018-02-19 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_3.pdf@EU-1-15-1011_h_a_dec_3.pdf@2019-07-01 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_1.pdf@EU-1-15-1012_h_a_dec_1.pdf@2016-09-22 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_0.pdf@EU-1-15-1013_h_a_dec_0.pdf@2015-06-19 00:00:00@Lumark@lutetium, isotope  mass 177@True@False@OD Not Found@IDB Radiopharmacy B.V.@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_3.pdf@EU-1-15-1008_h_a_dec_3.pdf@2020-02-28 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Germany GmbH@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_3.pdf@EU-1-15-1010_h_a_dec_3.pdf@2019-10-21 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1009_h_a_dec_4.pdf@EU-1-15-1009_h_a_dec_4.pdf@2021-04-06 00:00:00@Aripiprazole Zentiva@aripiprazole@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_5.pdf@EU-1-15-1007_h_a_dec_5.pdf@2019-07-25 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_4.pdf@EU-1-15-1011_h_a_dec_4.pdf@2020-06-19 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_2.pdf@EU-1-15-1012_h_a_dec_2.pdf@2018-05-02 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_1.pdf@EU-1-15-1013_h_a_dec_1.pdf@2016-08-22 00:00:00@Lumark@lutetium, isotope  mass 177@False@False@OD Not Found@IDB Radiopharmacy B.V.@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_4.pdf@EU-1-15-1008_h_a_dec_4.pdf@2020-03-07 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Germany GmbH@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_4.pdf@EU-1-15-1010_h_a_dec_4.pdf@2020-02-13 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1011_h_a_dec_5.pdf@EU-1-15-1011_h_a_dec_5.pdf@2022-02-16 00:00:00@Pregabalin Sandoz@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_6.pdf@EU-1-15-1007_h_a_dec_6.pdf@2020-01-16 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_3.pdf@EU-1-15-1012_h_a_dec_3.pdf@2019-07-01 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_2.pdf@EU-1-15-1013_h_a_dec_2.pdf@2017-09-18 00:00:00@Lumark@lutetium, isotope   mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_5.pdf@EU-1-15-1008_h_a_dec_5.pdf@2020-09-17 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Germany GmbH@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_5.pdf@EU-1-15-1010_h_a_dec_5.pdf@2021-09-29 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_7.pdf@EU-1-15-1007_h_a_dec_7.pdf@2020-11-24 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-15-1008_h_a_dec_6.pdf@EU-1-15-1008_h_a_dec_6.pdf@2022-01-07 00:00:00@Hetlioz@tasimelteon@False@False@adopted@Vanda Pharmaceuticals Netherlands B.V.@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_4.pdf@EU-1-15-1012_h_a_dec_4.pdf@2020-06-19 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_3.pdf@EU-1-15-1013_h_a_dec_3.pdf@2018-04-04 00:00:00@Lumark@lutetium, isotope  mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_8.pdf@EU-1-15-1007_h_a_dec_8.pdf@2022-04-28 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-15-1012_h_a_dec_5.pdf@EU-1-15-1012_h_a_dec_5.pdf@2022-01-24 00:00:00@Pregabalin Sandoz GmbH@pregabalin@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1010_h_a_dec_6.pdf@EU-1-15-1010_h_a_dec_6.pdf@2021-10-19 00:00:00@Duloxetine Mylan@Duloxetine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_4.pdf@EU-1-15-1013_h_a_dec_4.pdf@2018-09-20 00:00:00@Lumark@lutetium, isotope  mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1007_h_a_dec_9.pdf@EU-1-15-1007_h_a_dec_9.pdf@2022-04-29 00:00:00@Gardasil 9@human papillomavirus 9-valent vaccine (recombinant, adsorbed)@False@False@OD Not Found@MSD VACCINS@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_0.pdf@EU-1-15-1014_h_a_dec_0.pdf@2015-06-19 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_0.pdf@EU-1-15-1015_h_a_dec_0.pdf@2015-08-28 00:00:00@Strensiq@asfotase alfa@True@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1013_h_a_dec_5.pdf@EU-1-15-1013_h_a_dec_5.pdf@2019-02-04 00:00:00@Lumark@lutetium, isotope   mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_1.pdf@EU-1-15-1015_h_a_dec_1.pdf@2016-11-11 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_0.pdf@EU-1-15-1016_h_a_dec_0.pdf@2015-07-17 00:00:00@Repatha@Evolocumab@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_6.pdf@EU-1-15-1013_h_a_dec_6.pdf@2019-09-19 00:00:00@Lumark@lutetium, isotope  mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_1.pdf@EU-1-15-1014_h_a_dec_1.pdf@2015-10-28 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_2.pdf@EU-1-15-1015_h_a_dec_2.pdf@2017-11-12 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_1.pdf@EU-1-15-1016_h_a_dec_1.pdf@2017-02-17 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1018_h_a_dec_0.pdf@EU-1-15-1018_h_a_dec_0.pdf@2015-07-28 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_7.pdf@EU-1-15-1013_h_a_dec_7.pdf@2020-04-23 00:00:00@Lumark@lutetium, isotope  mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_10.pdf@EU-1-15-1014_h_a_dec_10.pdf@2017-10-19 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_0.pdf@EU-1-15-1019_h_a_dec_0.pdf@2015-07-20 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_3.pdf@EU-1-15-1015_h_a_dec_3.pdf@2019-07-01 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_2.pdf@EU-1-15-1016_h_a_dec_2.pdf@2018-04-19 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1013_h_a_dec_8.pdf@EU-1-15-1013_h_a_dec_8.pdf@2020-09-17 00:00:00@Lumark@lutetium, isotope  mass 177@False@False@OD Not Found@IDB Holland B.V.@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_0.pdf@EU-1-15-1020_h_a_dec_0.pdf@2015-08-09 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland)  GmbH@exceptional@Parsed
EU-1-15-1018_h_a_dec_1.pdf@EU-1-15-1018_h_a_dec_1.pdf@2018-01-18 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_4.pdf@EU-1-15-1015_h_a_dec_4.pdf@2019-03-28 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_3.pdf@EU-1-15-1016_h_a_dec_3.pdf@2018-08-05 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_1.pdf@EU-1-15-1020_h_a_dec_1.pdf@2017-07-19 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland) GmbH@exceptional@Parsed
EU-1-15-1014_h_a_dec_11.pdf@EU-1-15-1014_h_a_dec_11.pdf@2018-03-23 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_1.pdf@EU-1-15-1019_h_a_dec_1.pdf@2016-02-05 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_5.pdf@EU-1-15-1015_h_a_dec_5.pdf@2020-04-28 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_4.pdf@EU-1-15-1016_h_a_dec_4.pdf@2019-04-29 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_2.pdf@EU-1-15-1020_h_a_dec_2.pdf@2019-07-02 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland) GmbH@exceptional@Parsed
EU-1-15-1018_h_a_dec_2.pdf@EU-1-15-1018_h_a_dec_2.pdf@2019-07-01 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_6.pdf@EU-1-15-1015_h_a_dec_6.pdf@2020-11-24 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_5.pdf@EU-1-15-1016_h_a_dec_5.pdf@2019-11-19 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_0.pdf@EU-1-15-1021_h_a_dec_0.pdf@2015-07-17 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_3.pdf@EU-1-15-1020_h_a_dec_3.pdf@2020-04-05 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland) GmbH@exceptional@Parsed
EU-1-15-1014_h_a_dec_12.pdf@EU-1-15-1014_h_a_dec_12.pdf@2018-04-23 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_2.pdf@EU-1-15-1019_h_a_dec_2.pdf@2018-05-28 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1015_h_a_dec_7.pdf@EU-1-15-1015_h_a_dec_7.pdf@2022-01-07 00:00:00@Strensiq@asfotase alfa@False@False@adopted@Alexion Europe SAS@exceptional@Parsed
EU-1-15-1016_h_a_dec_6.pdf@EU-1-15-1016_h_a_dec_6.pdf@2020-04-14 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_4.pdf@EU-1-15-1020_h_a_dec_4.pdf@2020-06-08 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland)  GmbH@exceptional@Parsed
EU-1-15-1021_h_a_dec_1.pdf@EU-1-15-1021_h_a_dec_1.pdf@2018-04-23 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1018_h_a_dec_3.pdf@EU-1-15-1018_h_a_dec_3.pdf@2019-03-25 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros London Limited@CMA Not Found@Parsed
EU-1-15-1016_h_a_dec_7.pdf@EU-1-15-1016_h_a_dec_7.pdf@2021-04-21 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_13.pdf@EU-1-15-1014_h_a_dec_13.pdf@2018-07-30 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1020_h_a_dec_5.pdf@EU-1-15-1020_h_a_dec_5.pdf@2022-07-15 00:00:00@Raxone@idebenone@False@False@adopted@Santhera Pharmaceuticals (Deutschland) GmbH@exceptional@Parsed
EU-1-15-1021_h_a_dec_2.pdf@EU-1-15-1021_h_a_dec_2.pdf@2019-11-04 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_3.pdf@EU-1-15-1019_h_a_dec_3.pdf@2019-02-20 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1016_h_a_dec_8.pdf@EU-1-15-1016_h_a_dec_8.pdf@2021-11-26 00:00:00@Repatha@evolocumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1018_h_a_dec_4.pdf@EU-1-15-1018_h_a_dec_4.pdf@2020-07-23 00:00:00@Omidria@phenylephrine / ketorolac@False@False@OD Not Found@Omeros Ireland Limited@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_3.pdf@EU-1-15-1021_h_a_dec_3.pdf@2019-09-16 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_14.pdf@EU-1-15-1014_h_a_dec_14.pdf@2018-09-20 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_4.pdf@EU-1-15-1019_h_a_dec_4.pdf@2019-02-25 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_4.pdf@EU-1-15-1021_h_a_dec_4.pdf@2020-05-20 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_0.pdf@EU-1-15-1023_h_a_dec_0.pdf@2015-08-28 00:00:00@Farydak@panobinostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_5.pdf@EU-1-15-1019_h_a_dec_5.pdf@2020-03-04 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1021_h_a_dec_5.pdf@EU-1-15-1021_h_a_dec_5.pdf@2022-03-02 00:00:00@Pregabalin Zentiva@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_15.pdf@EU-1-15-1014_h_a_dec_15.pdf@2019-11-01 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_0.pdf@EU-1-15-1024_h_a_dec_0.pdf@2015-07-17 00:00:00@KEYTRUDA@pembrolizumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_0.pdf@EU-1-15-1025_h_a_dec_0.pdf@2015-07-13 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_6.pdf@EU-1-15-1019_h_a_dec_6.pdf@2020-04-05 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_1.pdf@EU-1-15-1023_h_a_dec_1.pdf@2017-02-16 00:00:00@Farydak@panobinostat@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_1.pdf@EU-1-15-1024_h_a_dec_1.pdf@2016-07-29 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_7.pdf@EU-1-15-1019_h_a_dec_7.pdf@2021-02-18 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_16.pdf@EU-1-15-1014_h_a_dec_16.pdf@2019-03-28 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_2.pdf@EU-1-15-1023_h_a_dec_2.pdf@2017-06-23 00:00:00@Farydak@panobinostat@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_1.pdf@EU-1-15-1025_h_a_dec_1.pdf@2017-02-16 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1019_h_a_dec_8.pdf@EU-1-15-1019_h_a_dec_8.pdf@2021-07-23 00:00:00@Bortezomib Accord@bortezomib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_10.pdf@EU-1-15-1025_h_a_dec_10.pdf@2021-04-16 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_0.pdf@EU-1-15-1027_h_a_dec_0.pdf@2015-08-28 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_10.pdf@EU-1-15-1024_h_a_dec_10.pdf@2018-08-05 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_0.pdf@EU-1-15-1028_h_a_dec_0.pdf@2015-08-20 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_17.pdf@EU-1-15-1014_h_a_dec_17.pdf@2019-02-04 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_3.pdf@EU-1-15-1023_h_a_dec_3.pdf@2018-12-04 00:00:00@Farydak@panobinostat@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_11.pdf@EU-1-15-1025_h_a_dec_11.pdf@2021-06-21 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_11.pdf@EU-1-15-1024_h_a_dec_11.pdf@2018-06-21 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_1.pdf@EU-1-15-1028_h_a_dec_1.pdf@2016-11-14 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_1.pdf@EU-1-15-1027_h_a_dec_1.pdf@2016-12-12 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_4.pdf@EU-1-15-1023_h_a_dec_4.pdf@2019-06-06 00:00:00@Farydak@panobinostat@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_12.pdf@EU-1-15-1024_h_a_dec_12.pdf@2018-06-07 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_18.pdf@EU-1-15-1014_h_a_dec_18.pdf@2019-05-27 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_2.pdf@EU-1-15-1028_h_a_dec_2.pdf@2018-04-23 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_2.pdf@EU-1-15-1025_h_a_dec_2.pdf@2017-04-20 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_2.pdf@EU-1-15-1027_h_a_dec_2.pdf@2017-06-26 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_13.pdf@EU-1-15-1024_h_a_dec_13.pdf@2018-02-08 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_19.pdf@EU-1-15-1014_h_a_dec_19.pdf@2019-02-04 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_5.pdf@EU-1-15-1023_h_a_dec_5.pdf@2019-04-11 00:00:00@Farydak@panobinostat@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_3.pdf@EU-1-15-1028_h_a_dec_3.pdf@2020-09-03 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_0.pdf@EU-1-15-1029_h_a_dec_0.pdf@2015-08-20 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_3.pdf@EU-1-15-1025_h_a_dec_3.pdf@2017-11-12 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_14.pdf@EU-1-15-1024_h_a_dec_14.pdf@2018-04-09 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_3.pdf@EU-1-15-1027_h_a_dec_3.pdf@2019-01-23 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_1.pdf@EU-1-15-1029_h_a_dec_1.pdf@2017-02-16 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_2.pdf@EU-1-15-1014_h_a_dec_2.pdf@2016-04-04 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_6.pdf@EU-1-15-1023_h_a_dec_6.pdf@2020-04-28 00:00:00@Farydak@panobinostat@False@False@adopted@Secura Bio Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_4.pdf@EU-1-15-1028_h_a_dec_4.pdf@2020-08-13 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_15.pdf@EU-1-15-1024_h_a_dec_15.pdf@2018-12-12 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_4.pdf@EU-1-15-1025_h_a_dec_4.pdf@2018-07-12 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_2.pdf@EU-1-15-1029_h_a_dec_2.pdf@2018-03-16 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_4.pdf@EU-1-15-1027_h_a_dec_4.pdf@2019-05-03 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_16.pdf@EU-1-15-1024_h_a_dec_16.pdf@2019-11-01 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_7.pdf@EU-1-15-1023_h_a_dec_7.pdf@2020-02-06 00:00:00@Farydak@panobinostat@False@False@adopted@Secura Bio Limited@CMA Not Found@Parsed
EU-1-15-1028_h_a_dec_5.pdf@EU-1-15-1028_h_a_dec_5.pdf@2021-09-29 00:00:00@Duloxetine Zentiva@duloxetine@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_20.pdf@EU-1-15-1014_h_a_dec_20.pdf@2019-09-26 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_3.pdf@EU-1-15-1029_h_a_dec_3.pdf@2019-04-29 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_5.pdf@EU-1-15-1027_h_a_dec_5.pdf@2020-08-04 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_17.pdf@EU-1-15-1024_h_a_dec_17.pdf@2019-11-03 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_5.pdf@EU-1-15-1025_h_a_dec_5.pdf@2019-03-28 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_4.pdf@EU-1-15-1029_h_a_dec_4.pdf@2020-04-28 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_6.pdf@EU-1-15-1027_h_a_dec_6.pdf@2020-03-07 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_18.pdf@EU-1-15-1024_h_a_dec_18.pdf@2019-03-28 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1023_h_a_dec_8.pdf@EU-1-15-1023_h_a_dec_8.pdf@2022-08-07 00:00:00@Farydak@panobinostat@False@False@adopted@Secura Bio Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_21.pdf@EU-1-15-1014_h_a_dec_21.pdf@2019-10-21 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1027_h_a_dec_7.pdf@EU-1-15-1027_h_a_dec_7.pdf@2022-06-13 00:00:00@Pregabalin Accord@pregabalin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_5.pdf@EU-1-15-1029_h_a_dec_5.pdf@2020-06-26 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_6.pdf@EU-1-15-1025_h_a_dec_6.pdf@2019-11-14 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1029_h_a_dec_6.pdf@EU-1-15-1029_h_a_dec_6.pdf@2022-12-10 00:00:00@Aripiprazole Sandoz@Aripiprazole@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_0.pdf@EU-1-15-1030_h_a_dec_0.pdf@2015-08-14 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_22.pdf@EU-1-15-1014_h_a_dec_22.pdf@2020-01-20 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_2.pdf@EU-1-15-1024_h_a_dec_2.pdf@2016-08-18 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_7.pdf@EU-1-15-1025_h_a_dec_7.pdf@2020-03-27 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_20.pdf@EU-1-15-1024_h_a_dec_20.pdf@2019-08-26 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_1.pdf@EU-1-15-1030_h_a_dec_1.pdf@2016-02-24 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_23.pdf@EU-1-15-1014_h_a_dec_23.pdf@2020-04-23 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_0.pdf@EU-1-15-1031_h_a_dec_0.pdf@2015-09-23 00:00:00@Praluent@alirocumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_8.pdf@EU-1-15-1025_h_a_dec_8.pdf@2021-04-16 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_21.pdf@EU-1-15-1024_h_a_dec_21.pdf@2019-11-14 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_22.pdf@EU-1-15-1024_h_a_dec_22.pdf@2020-03-24 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_1.pdf@EU-1-15-1031_h_a_dec_1.pdf@2016-11-14 00:00:00@Praluent@alirocumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_24.pdf@EU-1-15-1014_h_a_dec_24.pdf@2020-05-11 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_23.pdf@EU-1-15-1024_h_a_dec_23.pdf@2020-02-06 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1025_h_a_dec_9.pdf@EU-1-15-1025_h_a_dec_9.pdf@2021-06-21 00:00:00@EVOTAZ@atazanavir / cobicistat@False@False@OD Not Found@Bristol-Myers Squibb/Pfizer EEIG@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_0.pdf@EU-1-15-1032_h_a_dec_0.pdf@2015-09-18 00:00:00@Zerbaxa@ceftolozane / tazobactam@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_2.pdf@EU-1-15-1030_h_a_dec_2.pdf@2017-05-31 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_2.pdf@EU-1-15-1031_h_a_dec_2.pdf@2018-12-12 00:00:00@Praluent@alirocumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_24.pdf@EU-1-15-1024_h_a_dec_24.pdf@2021-01-21 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_3.pdf@EU-1-15-1031_h_a_dec_3.pdf@2019-11-03 00:00:00@Praluent@alirocumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_25.pdf@EU-1-15-1014_h_a_dec_25.pdf@2020-11-20 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_1.pdf@EU-1-15-1032_h_a_dec_1.pdf@2016-10-14 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_25.pdf@EU-1-15-1024_h_a_dec_25.pdf@2021-09-03 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_3.pdf@EU-1-15-1030_h_a_dec_3.pdf@2018-08-05 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_4.pdf@EU-1-15-1031_h_a_dec_4.pdf@2020-02-06 00:00:00@Praluent@alirocumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_0.pdf@EU-1-15-1033_h_a_dec_0.pdf@2015-08-28 00:00:00@Kanuma@sebelipase alfa@True@False@adopted@Synageva BioPharma Ltd@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_26.pdf@EU-1-15-1014_h_a_dec_26.pdf@2021-04-13 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_2.pdf@EU-1-15-1032_h_a_dec_2.pdf@2018-08-05 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1031_h_a_dec_5.pdf@EU-1-15-1031_h_a_dec_5.pdf@2020-08-19 00:00:00@Praluent@alirocumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_4.pdf@EU-1-15-1030_h_a_dec_4.pdf@2019-04-10 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_1.pdf@EU-1-15-1033_h_a_dec_1.pdf@2015-05-10 00:00:00@Kanuma@sebelipase alfa@False@False@adopted@Synageva BioPharma Ltd@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_0.pdf@EU-1-15-1035_h_a_dec_0.pdf@2015-11-11 00:00:00@Obizur@susoctocog alfa@True@False@adopted@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1031_h_a_dec_6.pdf@EU-1-15-1031_h_a_dec_6.pdf@2021-11-15 00:00:00@Praluent@alirocumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_27.pdf@EU-1-15-1024_h_a_dec_27.pdf@2021-06-17 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_27.pdf@EU-1-15-1014_h_a_dec_27.pdf@2021-04-21 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_5.pdf@EU-1-15-1030_h_a_dec_5.pdf@2020-05-20 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_2.pdf@EU-1-15-1033_h_a_dec_2.pdf@2018-09-20 00:00:00@Kanuma@sebelipase alfa@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_3.pdf@EU-1-15-1032_h_a_dec_3.pdf@2018-06-15 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_1.pdf@EU-1-15-1035_h_a_dec_1.pdf@2017-05-16 00:00:00@Obizur@susoctocog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1033_h_a_dec_3.pdf@EU-1-15-1033_h_a_dec_3.pdf@2019-05-12 00:00:00@Kanuma@sebelipase alfa@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_4.pdf@EU-1-15-1032_h_a_dec_4.pdf@2019-08-23 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_28.pdf@EU-1-15-1024_h_a_dec_28.pdf@2021-06-24 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_28.pdf@EU-1-15-1014_h_a_dec_28.pdf@2021-01-06 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1030_h_a_dec_6.pdf@EU-1-15-1030_h_a_dec_6.pdf@2022-05-13 00:00:00@Odomzo@sonidegib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_2.pdf@EU-1-15-1035_h_a_dec_2.pdf@2020-11-16 00:00:00@Obizur@susoctocog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1033_h_a_dec_4.pdf@EU-1-15-1033_h_a_dec_4.pdf@2020-04-23 00:00:00@Kanuma@sebelipase alfa@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_5.pdf@EU-1-15-1032_h_a_dec_5.pdf@2020-04-17 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_29.pdf@EU-1-15-1014_h_a_dec_29.pdf@2021-04-13 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_3.pdf@EU-1-15-1035_h_a_dec_3.pdf@2021-08-20 00:00:00@OBIZUR@susoctocog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1033_h_a_dec_5.pdf@EU-1-15-1033_h_a_dec_5.pdf@2020-11-20 00:00:00@Kanuma@sebelipase alfa@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_6.pdf@EU-1-15-1032_h_a_dec_6.pdf@2021-06-17 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_29.pdf@EU-1-15-1024_h_a_dec_29.pdf@2021-10-19 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1033_h_a_dec_6.pdf@EU-1-15-1033_h_a_dec_6.pdf@2021-12-13 00:00:00@Kanuma@sebelipase alfa@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_4.pdf@EU-1-15-1035_h_a_dec_4.pdf@2022-03-28 00:00:00@OBIZUR@susoctocog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1014_h_a_dec_3.pdf@EU-1-15-1014_h_a_dec_3.pdf@2016-11-05 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_0.pdf@EU-1-15-1036_h_a_dec_0.pdf@2015-10-15 00:00:00@Cresemba@isavuconazole@True@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1032_h_a_dec_7.pdf@EU-1-15-1032_h_a_dec_7.pdf@2022-07-25 00:00:00@Zerbaxa@ceftolozane / tazobactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_3.pdf@EU-1-15-1024_h_a_dec_3.pdf@2017-01-27 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1035_h_a_dec_5.pdf@EU-1-15-1035_h_a_dec_5.pdf@2022-06-20 00:00:00@OBIZUR@susoctocog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@exceptional@Parsed
EU-1-15-1014_h_a_dec_30.pdf@EU-1-15-1014_h_a_dec_30.pdf@2021-06-24 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_1.pdf@EU-1-15-1036_h_a_dec_1.pdf@2016-11-02 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_0.pdf@EU-1-15-1037_h_a_dec_0.pdf@2015-09-18 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_30.pdf@EU-1-15-1024_h_a_dec_30.pdf@2021-11-15 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_31.pdf@EU-1-15-1014_h_a_dec_31.pdf@2021-07-28 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1038_h_a_dec_0.pdf@EU-1-15-1038_h_a_dec_0.pdf@2015-11-27 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_2.pdf@EU-1-15-1036_h_a_dec_2.pdf@2018-01-30 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_2.pdf@EU-1-15-1037_h_a_dec_2.pdf@2018-06-07 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1038_h_a_dec_1.pdf@EU-1-15-1038_h_a_dec_1.pdf@2019-05-16 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_0.pdf@EU-1-15-1041_h_a_dec_0.pdf@2015-08-09 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne  S.A.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_31.pdf@EU-1-15-1024_h_a_dec_31.pdf@2022-01-24 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_0.pdf@EU-1-15-1040_h_a_dec_0.pdf@2015-09-17 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_32.pdf@EU-1-15-1014_h_a_dec_32.pdf@2021-10-19 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1038_h_a_dec_2.pdf@EU-1-15-1038_h_a_dec_2.pdf@2020-04-05 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_1.pdf@EU-1-15-1041_h_a_dec_1.pdf@2017-08-05 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne S.A.@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_3.pdf@EU-1-15-1036_h_a_dec_3.pdf@2019-11-03 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Medical Ltd@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_4.pdf@EU-1-15-1037_h_a_dec_4.pdf@2020-08-19 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_32.pdf@EU-1-15-1024_h_a_dec_32.pdf@2022-04-25 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1038_h_a_dec_3.pdf@EU-1-15-1038_h_a_dec_3.pdf@2020-08-19 00:00:00@Pemetrexed medac@Pemetrexed@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_1.pdf@EU-1-15-1040_h_a_dec_1.pdf@2017-06-16 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_4.pdf@EU-1-15-1036_h_a_dec_4.pdf@2020-04-23 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Pharmaceutica Deutschland GmbH@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_2.pdf@EU-1-15-1041_h_a_dec_2.pdf@2019-07-01 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne S.A.@CMA Not Found@Parsed
EU-1-15-1037_h_a_dec_5.pdf@EU-1-15-1037_h_a_dec_5.pdf@2022-08-07 00:00:00@Pemetrexed Sandoz@pemetrexed@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_33.pdf@EU-1-15-1014_h_a_dec_33.pdf@2022-01-04 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_5.pdf@EU-1-15-1036_h_a_dec_5.pdf@2020-08-13 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Pharmaceutica Deutschland GmbH@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_33.pdf@EU-1-15-1024_h_a_dec_33.pdf@2022-05-19 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1041_h_a_dec_3.pdf@EU-1-15-1041_h_a_dec_3.pdf@2020-05-20 00:00:00@Ivabradine Anpharm@ivabradine@False@False@OD Not Found@ANPHARM Przedsiębiorstwo Farmaceutyczne  S.A.@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_2.pdf@EU-1-15-1040_h_a_dec_2.pdf@2018-09-28 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_6.pdf@EU-1-15-1036_h_a_dec_6.pdf@2022-05-19 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Pharmaceutica Deutschland GmbH@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_34.pdf@EU-1-15-1014_h_a_dec_34.pdf@2022-04-25 00:00:00@OPDIVO@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1036_h_a_dec_7.pdf@EU-1-15-1036_h_a_dec_7.pdf@2022-06-21 00:00:00@Cresemba@isavuconazole@False@False@adopted@Basilea Pharmaceutica Deutschland GmbH@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_34.pdf@EU-1-15-1024_h_a_dec_34.pdf@2022-06-22 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_0.pdf@EU-1-15-1043_h_a_dec_0.pdf@2015-02-12 00:00:00@Nucala@mepolizumab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_3.pdf@EU-1-15-1040_h_a_dec_3.pdf@2020-06-25 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_4.pdf@EU-1-15-1014_h_a_dec_4.pdf@2016-11-21 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_0.pdf@EU-1-15-1045_h_a_dec_0.pdf@2015-11-16 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_0.pdf@EU-1-15-1046_h_a_dec_0.pdf@2015-11-19 00:00:00@Elocta@efmoroctocog alfa@True@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_1.pdf@EU-1-15-1043_h_a_dec_1.pdf@2017-02-16 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_35.pdf@EU-1-15-1024_h_a_dec_35.pdf@2022-06-21 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_5.pdf@EU-1-15-1014_h_a_dec_5.pdf@2017-01-27 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1040_h_a_dec_4.pdf@EU-1-15-1040_h_a_dec_4.pdf@2021-09-22 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_1.pdf@EU-1-15-1045_h_a_dec_1.pdf@2016-12-12 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_1.pdf@EU-1-15-1046_h_a_dec_1.pdf@2016-03-23 00:00:00@Elocta@efmoroctocog alfa@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_4.pdf@EU-1-15-1024_h_a_dec_4.pdf@2017-02-05 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_2.pdf@EU-1-15-1043_h_a_dec_2.pdf@2018-02-19 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_2.pdf@EU-1-15-1046_h_a_dec_2.pdf@2017-05-31 00:00:00@Elocta@efmoroctocog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_6.pdf@EU-1-15-1014_h_a_dec_6.pdf@2017-03-24 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_2.pdf@EU-1-15-1045_h_a_dec_2.pdf@2017-11-15 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_0.pdf@EU-1-15-1047_h_a_dec_0.pdf@2015-11-23 00:00:00@Blincyto@blinatumomab@True@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1040_h_a_dec_5.pdf@EU-1-15-1040_h_a_dec_5.pdf@2021-12-20 00:00:00@Intuniv@guanfacine@False@False@OD Not Found@Takeda Pharmaceuticals International AG Ireland Branch@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_5.pdf@EU-1-15-1024_h_a_dec_5.pdf@2017-06-16 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_3.pdf@EU-1-15-1046_h_a_dec_3.pdf@2017-11-16 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 16.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2015)8287(final) for “Elocta@efmoroctocog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_3.pdf@EU-1-15-1043_h_a_dec_3.pdf@2018-08-27 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_1.pdf@EU-1-15-1047_h_a_dec_1.pdf@2016-09-22 00:00:00@Blincyto@blinatumomab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1014_h_a_dec_7.pdf@EU-1-15-1014_h_a_dec_7.pdf@2017-04-28 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_3.pdf@EU-1-15-1045_h_a_dec_3.pdf@2019-01-31 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_6.pdf@EU-1-15-1024_h_a_dec_6.pdf@2017-06-23 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_4.pdf@EU-1-15-1046_h_a_dec_4.pdf@2018-07-12 00:00:00@Elocta@efmoroctocog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_10.pdf@EU-1-15-1047_h_a_dec_10.pdf@2020-12-22 00:00:00@BLINCYTO@blinatumomab@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_4.pdf@EU-1-15-1043_h_a_dec_4.pdf@2019-07-31 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_8.pdf@EU-1-15-1014_h_a_dec_8.pdf@2017-02-06 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_11.pdf@EU-1-15-1047_h_a_dec_11.pdf@2021-03-26 00:00:00@BLINCYTO@blinatumomab@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1048_h_a_dec_0.pdf@EU-1-15-1048_h_a_dec_0.pdf@2015-11-20 00:00:00@Cotellic@cobimetinib@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_4.pdf@EU-1-15-1045_h_a_dec_4.pdf@2019-05-03 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_7.pdf@EU-1-15-1024_h_a_dec_7.pdf@2017-08-24 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_5.pdf@EU-1-15-1046_h_a_dec_5.pdf@2019-09-07 00:00:00@Elocta@efmoroctocog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@conditional@Parsed
EU-1-15-1043_h_a_dec_5.pdf@EU-1-15-1043_h_a_dec_5.pdf@2020-10-08 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_12.pdf@EU-1-15-1047_h_a_dec_12.pdf@2021-06-24 00:00:00@BLINCYTO@blinatumomab@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1045_h_a_dec_5.pdf@EU-1-15-1045_h_a_dec_5.pdf@2020-07-13 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1048_h_a_dec_1.pdf@EU-1-15-1048_h_a_dec_1.pdf@2016-01-06 00:00:00@Cotellic@cobimetinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1014_h_a_dec_9.pdf@EU-1-15-1014_h_a_dec_9.pdf@2017-09-18 00:00:00@Opdivo@nivolumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_6.pdf@EU-1-15-1046_h_a_dec_6.pdf@2020-08-19 00:00:00@Elocta@efmoroctocog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_2.pdf@EU-1-15-1047_h_a_dec_2.pdf@2016-10-21 00:00:00@Blincyto@blinatumomab@False@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1045_h_a_dec_6.pdf@EU-1-15-1045_h_a_dec_6.pdf@2020-09-30 00:00:00@Aripiprazole Accord@aripiprazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_8.pdf@EU-1-15-1024_h_a_dec_8.pdf@2017-08-12 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1043_h_a_dec_6.pdf@EU-1-15-1043_h_a_dec_6.pdf@2021-12-11 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_3.pdf@EU-1-15-1047_h_a_dec_3.pdf@2017-09-18 00:00:00@Blincyto@blinatumomab@False@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1048_h_a_dec_2.pdf@EU-1-15-1048_h_a_dec_2.pdf@2017-05-24 00:00:00@Cotellic@cobimetinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1046_h_a_dec_7.pdf@EU-1-15-1046_h_a_dec_7.pdf@2022-06-01 00:00:00@Elocta@efmoroctocog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-15-1024_h_a_dec_9.pdf@EU-1-15-1024_h_a_dec_9.pdf@2018-03-23 00:00:00@KEYTRUDA@pembrolizumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_4.pdf@EU-1-15-1047_h_a_dec_4.pdf@2018-03-23 00:00:00@Blincyto@blinatumomab@False@False@adopted@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1043_h_a_dec_7.pdf@EU-1-15-1043_h_a_dec_7.pdf@2022-04-29 00:00:00@Nucala@mepolizumab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_5.pdf@EU-1-15-1047_h_a_dec_5.pdf@2018-04-19 00:00:00@Blincyto@blinatumomab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-15-1048_h_a_dec_3.pdf@EU-1-15-1048_h_a_dec_3.pdf@2018-03-16 00:00:00@Cotellic@cobimetinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-15-1049_h_a_dec_0.pdf@EU-1-15-1049_h_a_dec_0.pdf@2017-01-19 00:00:00@Cystadrops@mercaptamine@False@False@adopted@Orphan Europe SARL@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_6.pdf@EU-1-15-1047_h_a_dec_6.pdf@2018-06-18 00:00:00@Blincyto@blinatumomab@False@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
ed
EU-1-15-1048_h_a_dec_4.pdf@EU-1-15-1048_h_a_dec_4.pdf@2020-06-25 00:00:00@Cotellic@cobimetinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_0.pdf@EU-1-15-1051_h_a_dec_0.pdf@2015-11-16 00:00:00@Ebymect@dapagliflozin / metfomin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1049_h_a_dec_2.pdf@EU-1-15-1049_h_a_dec_2.pdf@2020-04-05 00:00:00@Cystadrops@mercaptamine@False@False@adopted@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_7.pdf@EU-1-15-1047_h_a_dec_7.pdf@2018-08-23 00:00:00@Blincyto@blinatumomab@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1048_h_a_dec_5.pdf@EU-1-15-1048_h_a_dec_5.pdf@2022-10-02 00:00:00@Cotellic@cobimetinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_8.pdf@EU-1-15-1047_h_a_dec_8.pdf@2019-01-18 00:00:00@Blincyto@blinatumomab@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1049_h_a_dec_3.pdf@EU-1-15-1049_h_a_dec_3.pdf@2021-09-15 00:00:00@Cystadrops@mercaptamine@False@False@adopted@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_1.pdf@EU-1-15-1051_h_a_dec_1.pdf@2016-12-12 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 12.12.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2015)8132(final) for “Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1047_h_a_dec_9.pdf@EU-1-15-1047_h_a_dec_9.pdf@2019-10-21 00:00:00@BLINCYTO@blinatumomab@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_2.pdf@EU-1-15-1051_h_a_dec_2.pdf@2017-04-05 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_3.pdf@EU-1-15-1051_h_a_dec_3.pdf@2017-12-20 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_0.pdf@EU-1-15-1052_h_a_dec_0.pdf@2015-09-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_0.pdf@EU-1-15-1053_h_a_dec_0.pdf@2016-03-16 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_4.pdf@EU-1-15-1051_h_a_dec_4.pdf@2018-12-11 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_1.pdf@EU-1-15-1052_h_a_dec_1.pdf@2017-04-20 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_0.pdf@EU-1-15-1054_h_a_dec_0.pdf@2015-11-19 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_1.pdf@EU-1-15-1053_h_a_dec_1.pdf@2018-09-20 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_5.pdf@EU-1-15-1051_h_a_dec_5.pdf@2019-11-01 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_10.pdf@EU-1-15-1052_h_a_dec_10.pdf@2021-07-23 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_1.pdf@EU-1-15-1054_h_a_dec_1.pdf@2018-11-01 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_2.pdf@EU-1-15-1053_h_a_dec_2.pdf@2019-06-25 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_11.pdf@EU-1-15-1052_h_a_dec_11.pdf@2021-12-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_6.pdf@EU-1-15-1051_h_a_dec_6.pdf@2019-01-08 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_0.pdf@EU-1-15-1055_h_a_dec_0.pdf@2015-02-12 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_3.pdf@EU-1-15-1053_h_a_dec_3.pdf@2020-06-25 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_12.pdf@EU-1-15-1052_h_a_dec_12.pdf@2022-07-15 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_7.pdf@EU-1-15-1051_h_a_dec_7.pdf@2020-08-25 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_2.pdf@EU-1-15-1054_h_a_dec_2.pdf@2019-08-23 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_1.pdf@EU-1-15-1055_h_a_dec_1.pdf@2018-01-15 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_2.pdf@EU-1-15-1052_h_a_dec_2.pdf@2017-07-13 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_4.pdf@EU-1-15-1053_h_a_dec_4.pdf@2020-09-12 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1051_h_a_dec_8.pdf@EU-1-15-1051_h_a_dec_8.pdf@2022-04-02 00:00:00@Ebymect@dapagliflozin / metformin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_2.pdf@EU-1-15-1055_h_a_dec_2.pdf@2019-09-23 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1053_h_a_dec_5.pdf@EU-1-15-1053_h_a_dec_5.pdf@2022-02-08 00:00:00@Neofordex@dexamethasone@False@False@OD Not Found@Laboratoires CTRS@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_4.pdf@EU-1-15-1054_h_a_dec_4.pdf@2020-09-24 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_3.pdf@EU-1-15-1052_h_a_dec_3.pdf@2018-06-29 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1055_h_a_dec_3.pdf@EU-1-15-1055_h_a_dec_3.pdf@2020-07-23 00:00:00@Ciambra@pemetrexed@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_0.pdf@EU-1-15-1056_h_a_dec_0.pdf@2015-11-20 00:00:00@Praxbind@Idarucizumab@True@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_5.pdf@EU-1-15-1054_h_a_dec_5.pdf@2021-06-17 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_4.pdf@EU-1-15-1052_h_a_dec_4.pdf@2018-12-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_1.pdf@EU-1-15-1056_h_a_dec_1.pdf@2017-07-13 00:00:00@Praxbind@idarucizumab@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_5.pdf@EU-1-15-1052_h_a_dec_5.pdf@2019-03-20 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_2.pdf@EU-1-15-1056_h_a_dec_2.pdf@2018-06-07 00:00:00@Praxbind@idarucizumab@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1054_h_a_dec_6.pdf@EU-1-15-1054_h_a_dec_6.pdf@2021-09-29 00:00:00@Cinacalcet Mylan@cinacalcet@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_0.pdf@EU-1-15-1057_h_a_dec_0.pdf@2015-11-20 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_6.pdf@EU-1-15-1052_h_a_dec_6.pdf@2019-07-19 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_3.pdf@EU-1-15-1056_h_a_dec_3.pdf@2019-02-08 00:00:00@Praxbind@idarucizumab@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_7.pdf@EU-1-15-1052_h_a_dec_7.pdf@2019-07-25 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_4.pdf@EU-1-15-1056_h_a_dec_4.pdf@2020-07-27 00:00:00@Praxbind@idarucizumab@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_1.pdf@EU-1-15-1057_h_a_dec_1.pdf@2018-08-05 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_8.pdf@EU-1-15-1052_h_a_dec_8.pdf@2020-09-24 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_0.pdf@EU-1-15-1058_h_a_dec_0.pdf@2015-11-19 00:00:00@Entresto@sacubitril / valsartan@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1056_h_a_dec_5.pdf@EU-1-15-1056_h_a_dec_5.pdf@2021-09-29 00:00:00@Praxbind@idarucizumab@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-15-1052_h_a_dec_9.pdf@EU-1-15-1052_h_a_dec_9.pdf@2020-03-11 00:00:00@Edistride@dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_0.pdf@EU-1-15-1059_h_a_dec_0.pdf@2015-11-19 00:00:00@Orkambi@Lumacaftor / Ivacaftor@True@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_0.pdf@EU-1-15-1060_h_a_dec_0.pdf@2015-11-19 00:00:00@Kyprolis@carfilzomib@True@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_2.pdf@EU-1-15-1057_h_a_dec_2.pdf@2018-10-18 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_1.pdf@EU-1-15-1058_h_a_dec_1.pdf@2017-11-01 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_1.pdf@EU-1-15-1060_h_a_dec_1.pdf@2016-06-29 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_3.pdf@EU-1-15-1057_h_a_dec_3.pdf@2020-12-05 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_1.pdf@EU-1-15-1059_h_a_dec_1.pdf@2016-12-23 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_10.pdf@EU-1-15-1060_h_a_dec_10.pdf@2021-04-16 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_4.pdf@EU-1-15-1057_h_a_dec_4.pdf@2020-10-08 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_2.pdf@EU-1-15-1058_h_a_dec_2.pdf@2018-04-23 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_0.pdf@EU-1-15-1061_h_a_dec_0.pdf@2015-11-19 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine /  tenofovir alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_5.pdf@EU-1-15-1057_h_a_dec_5.pdf@2020-09-30 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_2.pdf@EU-1-15-1059_h_a_dec_2.pdf@2017-08-24 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_11.pdf@EU-1-15-1060_h_a_dec_11.pdf@2022-01-04 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_3.pdf@EU-1-15-1058_h_a_dec_3.pdf@2018-04-30 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1057_h_a_dec_6.pdf@EU-1-15-1057_h_a_dec_6.pdf@2022-01-31 00:00:00@Pemetrexed Hospira@pemetrexed@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_1.pdf@EU-1-15-1061_h_a_dec_1.pdf@2017-02-16 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_0.pdf@EU-1-15-1062_h_a_dec_0.pdf@2015-11-27 00:00:00@Ravicti@Glycerol phenylbutyrate@True@False@adopted@Horizon Therapeutics Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_2.pdf@EU-1-15-1060_h_a_dec_2.pdf@2016-12-12 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_0.pdf@EU-1-15-1063_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Actavis@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_3.pdf@EU-1-15-1059_h_a_dec_3.pdf@2018-08-01 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_3.pdf@EU-1-15-1060_h_a_dec_3.pdf@2017-11-15 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_10.pdf@EU-1-15-1061_h_a_dec_10.pdf@2022-05-13 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_1.pdf@EU-1-15-1062_h_a_dec_1.pdf@2016-02-24 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@adopted@Horizon Therapeutics Limited@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_4.pdf@EU-1-15-1058_h_a_dec_4.pdf@2019-04-15 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  15.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2015)8288(final) for “Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_1.pdf@EU-1-15-1063_h_a_dec_1.pdf@2017-02-16 00:00:00@Armisarte@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_4.pdf@EU-1-15-1060_h_a_dec_4.pdf@2018-04-19 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_4.pdf@EU-1-15-1059_h_a_dec_4.pdf@2018-02-19 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_0.pdf@EU-1-15-1064_h_a_dec_0.pdf@2015-12-16 00:00:00@Imlygic@talimogene laherparepvec@True@True@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_5.pdf@EU-1-15-1060_h_a_dec_5.pdf@2018-11-22 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_11.pdf@EU-1-15-1061_h_a_dec_11.pdf@2022-12-08 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_2.pdf@EU-1-15-1062_h_a_dec_2.pdf@2017-02-16 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@adopted@Horizon Pharma Ireland Limited@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_5.pdf@EU-1-15-1058_h_a_dec_5.pdf@2020-06-25 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_1.pdf@EU-1-15-1064_h_a_dec_1.pdf@2017-06-07 00:00:00@Imlygic@talimogene laherparepvec@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_2.pdf@EU-1-15-1063_h_a_dec_2.pdf@2018-05-24 00:00:00@Armisarte@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_6.pdf@EU-1-15-1060_h_a_dec_6.pdf@2019-04-26 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_5.pdf@EU-1-15-1059_h_a_dec_5.pdf@2018-08-23 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_2.pdf@EU-1-15-1064_h_a_dec_2.pdf@2018-07-30 00:00:00@Imlygic@talimogene  laherparepvec@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_12.pdf@EU-1-15-1061_h_a_dec_12.pdf@2022-03-10 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_6.pdf@EU-1-15-1058_h_a_dec_6.pdf@2020-06-25 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_3.pdf@EU-1-15-1062_h_a_dec_3.pdf@2018-12-04 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@adopted@Horizon Pharma Ireland Limited@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_7.pdf@EU-1-15-1060_h_a_dec_7.pdf@2019-11-14 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_3.pdf@EU-1-15-1063_h_a_dec_3.pdf@2019-01-15 00:00:00@Armisarte@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_3.pdf@EU-1-15-1064_h_a_dec_3.pdf@2019-06-06 00:00:00@Imlygic@talimogene laherparepvec@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_8.pdf@EU-1-15-1060_h_a_dec_8.pdf@2020-06-25 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_4.pdf@EU-1-15-1064_h_a_dec_4.pdf@2020-07-17 00:00:00@Imlygic@talimogene laherparepvec@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_7.pdf@EU-1-15-1058_h_a_dec_7.pdf@2021-05-19 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_4.pdf@EU-1-15-1062_h_a_dec_4.pdf@2018-12-18 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@adopted@Horizon Pharma Ireland Limited@CMA Not Found@Parsed
EU-1-15-1064_h_a_dec_5.pdf@EU-1-15-1064_h_a_dec_5.pdf@2020-11-18 00:00:00@Imlygic@talimogene laherparepvec@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1060_h_a_dec_9.pdf@EU-1-15-1060_h_a_dec_9.pdf@2020-12-17 00:00:00@Kyprolis@carfilzomib@False@False@adopted@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_4.pdf@EU-1-15-1063_h_a_dec_4.pdf@2020-08-13 00:00:00@Armisarte@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_3.pdf@EU-1-15-1061_h_a_dec_3.pdf@2017-08-12 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_7.pdf@EU-1-15-1059_h_a_dec_7.pdf@2019-01-15 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_5.pdf@EU-1-15-1062_h_a_dec_5.pdf@2019-06-06 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@OD Not Found@Horizon Pharma Ireland Limited@CMA Not Found@Parsed
EU-1-15-1058_h_a_dec_8.pdf@EU-1-15-1058_h_a_dec_8.pdf@2022-09-29 00:00:00@Entresto@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-1063_h_a_dec_5.pdf@EU-1-15-1063_h_a_dec_5.pdf@2022-01-07 00:00:00@Armisarte@pemetrexed@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_4.pdf@EU-1-15-1061_h_a_dec_4.pdf@2018-07-06 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir  alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_8.pdf@EU-1-15-1059_h_a_dec_8.pdf@2020-11-02 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_5.pdf@EU-1-15-1061_h_a_dec_5.pdf@2018-07-26 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_6.pdf@EU-1-15-1062_h_a_dec_6.pdf@2019-01-07 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@OD Not Found@Horizon Pharma Ireland Limited@CMA Not Found@Parsed
EU-1-15-1059_h_a_dec_9.pdf@EU-1-15-1059_h_a_dec_9.pdf@2020-11-18 00:00:00@Orkambi@Lumacaftor/Ivacaftor@False@False@OD Not Found@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_7.pdf@EU-1-15-1062_h_a_dec_7.pdf@2020-08-25 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@adopted@Immedica Pharma AB@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_0.pdf@EU-1-15-1065_h_a_dec_0.pdf@2016-11-01 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_0.pdf@EU-1-15-1066_h_a_dec_0.pdf@2016-06-24 00:00:00@Ongentys@opicapone@True@False@OD Not Found@BIAL - Portela & Ca, SA@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_6.pdf@EU-1-15-1061_h_a_dec_6.pdf@2019-03-28 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_0.pdf@EU-1-15-1067_h_a_dec_0.pdf@2016-01-14 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_1.pdf@EU-1-15-1066_h_a_dec_1.pdf@2018-02-19 00:00:00@Ongentys@opicapone@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-15-1062_h_a_dec_8.pdf@EU-1-15-1062_h_a_dec_8.pdf@2022-05-05 00:00:00@Ravicti@Glycerol phenylbutyrate@False@False@adopted@Immedica Pharma AB@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_1.pdf@EU-1-15-1065_h_a_dec_1.pdf@2019-06-02 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_1.pdf@EU-1-15-1067_h_a_dec_1.pdf@2017-05-31 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_2.pdf@EU-1-15-1066_h_a_dec_2.pdf@2019-03-13 00:00:00@Ongentys@opicapone@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_0.pdf@EU-1-15-1068_h_a_dec_0.pdf@2016-03-31 00:00:00@Wakix@Pitolisant hydrochloride@True@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_7.pdf@EU-1-15-1061_h_a_dec_7.pdf@2019-06-06 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_2.pdf@EU-1-15-1065_h_a_dec_2.pdf@2020-02-21 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_2.pdf@EU-1-15-1067_h_a_dec_2.pdf@2018-07-19 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_3.pdf@EU-1-15-1066_h_a_dec_3.pdf@2020-11-24 00:00:00@Ongentys@opicapone@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_1.pdf@EU-1-15-1068_h_a_dec_1.pdf@2017-09-14 00:00:00@Wakix@Pitolisant hydrochloride@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1065_h_a_dec_3.pdf@EU-1-15-1065_h_a_dec_3.pdf@2020-09-30 00:00:00@Eptifibatide Accord@eptifibatide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_3.pdf@EU-1-15-1067_h_a_dec_3.pdf@2019-10-29 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_4.pdf@EU-1-15-1066_h_a_dec_4.pdf@2021-02-18 00:00:00@Ongentys@opicapone@False@False@OD Not Found@Bial - Portela & Cª, SA@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_8.pdf@EU-1-15-1061_h_a_dec_8.pdf@2019-07-25 00:00:00@Genvoya@elvitegravir /  cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_2.pdf@EU-1-15-1068_h_a_dec_2.pdf@2017-10-13 00:00:00@Wakix@Pitolisant hydrochloride@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_0.pdf@EU-1-15-1070_h_a_dec_0.pdf@2016-01-14 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_4.pdf@EU-1-15-1067_h_a_dec_4.pdf@2020-11-16 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1066_h_a_dec_5.pdf@EU-1-15-1066_h_a_dec_5.pdf@2022-03-28 00:00:00@Ongentys@opicapone@False@False@OD Not Found@Bial - Portela & Cª@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_0.pdf@EU-1-15-1071_h_a_dec_0.pdf@2016-01-18 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_1.pdf@EU-1-15-1070_h_a_dec_1.pdf@2017-08-12 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_0.pdf@EU-1-15-1072_h_a_dec_0.pdf@2016-01-14 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_3.pdf@EU-1-15-1068_h_a_dec_3.pdf@2018-11-22 00:00:00@Wakix@Pitolisant hydrochloride@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1061_h_a_dec_9.pdf@EU-1-15-1061_h_a_dec_9.pdf@2020-09-17 00:00:00@Genvoya@elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_1.pdf@EU-1-15-1072_h_a_dec_1.pdf@2018-06-29 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_4.pdf@EU-1-15-1068_h_a_dec_4.pdf@2020-06-25 00:00:00@Wakix@Pitolisant  hydrochloride@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_2.pdf@EU-1-15-1070_h_a_dec_2.pdf@2018-10-12 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_1.pdf@EU-1-15-1071_h_a_dec_1.pdf@2018-07-06 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1067_h_a_dec_5.pdf@EU-1-15-1067_h_a_dec_5.pdf@2021-10-19 00:00:00@Lopinavir/Ritonavir Mylan@lopinavir / ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_5.pdf@EU-1-15-1068_h_a_dec_5.pdf@2020-12-17 00:00:00@Wakix@Pitolisant hydrochloride@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_2.pdf@EU-1-15-1072_h_a_dec_2.pdf@2019-04-26 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_3.pdf@EU-1-15-1070_h_a_dec_3.pdf@2019-04-26 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-1068_h_a_dec_6.pdf@EU-1-15-1068_h_a_dec_6.pdf@2022-10-02 00:00:00@Wakix@Pitolisant hydrochloride@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_2.pdf@EU-1-15-1071_h_a_dec_2.pdf@2019-02-25 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_0.pdf@EU-1-15-1073_h_a_dec_0.pdf@2016-01-14 00:00:00@Briviact@brivaracetam@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_4.pdf@EU-1-15-1070_h_a_dec_4.pdf@2020-09-03 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-1072_h_a_dec_3.pdf@EU-1-15-1072_h_a_dec_3.pdf@2020-09-24 00:00:00@Spectrila@asparaginase@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_3.pdf@EU-1-15-1071_h_a_dec_3.pdf@2020-02-28 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_1.pdf@EU-1-15-1073_h_a_dec_1.pdf@2017-03-22 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_5.pdf@EU-1-15-1070_h_a_dec_5.pdf@2020-04-23 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_2.pdf@EU-1-15-1073_h_a_dec_2.pdf@2017-04-20 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_4.pdf@EU-1-15-1071_h_a_dec_4.pdf@2020-09-10 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_6.pdf@EU-1-15-1070_h_a_dec_6.pdf@2020-11-20 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_0.pdf@EU-1-15-1074_h_a_dec_0.pdf@2016-01-14 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_3.pdf@EU-1-15-1073_h_a_dec_3.pdf@2018-11-07 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1071_h_a_dec_5.pdf@EU-1-15-1071_h_a_dec_5.pdf@2020-11-16 00:00:00@Pemetrexed Accord@pemetrexed@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_7.pdf@EU-1-15-1070_h_a_dec_7.pdf@2022-06-24 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_0.pdf@EU-1-15-1076_h_a_dec_0.pdf@2016-02-18 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_0.pdf@EU-1-15-1075_h_a_dec_0.pdf@2016-02-18 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Iron Therapeutics (UK) Ltd@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_4.pdf@EU-1-15-1073_h_a_dec_4.pdf@2020-09-10 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_8.pdf@EU-1-15-1070_h_a_dec_8.pdf@2022-07-15 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
arsed
EU-1-15-1074_h_a_dec_1.pdf@EU-1-15-1074_h_a_dec_1.pdf@2017-01-27 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_1.pdf@EU-1-15-1076_h_a_dec_1.pdf@2017-11-04 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_0.pdf@EU-1-15-1078_h_a_dec_0.pdf@2017-04-24 00:00:00@Natpar@parathyroid hormone@False@False@adopted@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1073_h_a_dec_5.pdf@EU-1-15-1073_h_a_dec_5.pdf@2020-11-25 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1070_h_a_dec_9.pdf@EU-1-15-1070_h_a_dec_9.pdf@2022-09-13 00:00:00@Oncaspar@pegaspargase@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_1.pdf@EU-1-15-1075_h_a_dec_1.pdf@2017-05-16 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Shield TX (UK) Limited@CMA Not Found@Parsed
EU-1-15-1073_h_a_dec_6.pdf@EU-1-15-1073_h_a_dec_6.pdf@2021-11-22 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_2.pdf@EU-1-15-1076_h_a_dec_2.pdf@2017-10-11 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 10.11.2017 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2016)1133(final) for “Kovaltry@octocog alfa@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_1.pdf@EU-1-15-1078_h_a_dec_1.pdf@2018-04-19 00:00:00@Natpar@parathyroid hormone@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1073_h_a_dec_7.pdf@EU-1-15-1073_h_a_dec_7.pdf@2022-02-24 00:00:00@Briviact@brivaracetam@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_2.pdf@EU-1-15-1074_h_a_dec_2.pdf@2017-05-31 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_3.pdf@EU-1-15-1076_h_a_dec_3.pdf@2019-09-09 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_2.pdf@EU-1-15-1075_h_a_dec_2.pdf@2018-03-23 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Shield TX (UK) Limited@CMA Not Found@Parsed
EU-1-15-1076_h_a_dec_4.pdf@EU-1-15-1076_h_a_dec_4.pdf@2020-09-17 00:00:00@Kovaltry@octocog alfa@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_3.pdf@EU-1-15-1074_h_a_dec_3.pdf@2018-08-11 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_0.pdf@EU-1-15-1079_h_a_dec_0.pdf@2016-02-15 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular,  component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b  conjugate vaccine (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_2.pdf@EU-1-15-1078_h_a_dec_2.pdf@2019-01-15 00:00:00@Natpar@parathyroid hormone@False@False@adopted@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1075_h_a_dec_3.pdf@EU-1-15-1075_h_a_dec_3.pdf@2019-01-31 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Shield TX (UK) Limited@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_0.pdf@EU-1-15-1082_h_a_dec_0.pdf@2016-05-26 00:00:00@Galafold@migalastat@True@False@adopted@Amicus Therapeutics UK Ltd@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_1.pdf@EU-1-15-1079_h_a_dec_1.pdf@2017-01-27 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular, component),  hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine  (adsorbed)@False@False@OD Not Found@Sanofi Pasteur MSD SNC@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_4.pdf@EU-1-15-1075_h_a_dec_4.pdf@2019-11-22 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_4.pdf@EU-1-15-1074_h_a_dec_4.pdf@2018-08-11 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_3.pdf@EU-1-15-1078_h_a_dec_3.pdf@2019-04-29 00:00:00@Natpar@parathyroid hormone@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1075_h_a_dec_5.pdf@EU-1-15-1075_h_a_dec_5.pdf@2019-12-16 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_1.pdf@EU-1-15-1082_h_a_dec_1.pdf@2018-12-04 00:00:00@Galafold@migalastat@False@False@adopted@Amicus Therapeutics UK Ltd@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_2.pdf@EU-1-15-1079_h_a_dec_2.pdf@2018-03-15 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)@False@False@OD Not Found@MCM Vaccine B.V.@CMA Not Found@Parsed
EU-1-15-1075_h_a_dec_6.pdf@EU-1-15-1075_h_a_dec_6.pdf@2020-11-25 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_5.pdf@EU-1-15-1074_h_a_dec_5.pdf@2019-11-14 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_3.pdf@EU-1-15-1079_h_a_dec_3.pdf@2020-01-13 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis  (inactivated) and haemophilus type b conjugate vaccine (adsorbed)@False@False@OD Not Found@MCM Vaccine B.V.@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_0.pdf@EU-1-15-1083_h_a_dec_0.pdf@2016-12-05 00:00:00@Uptravi@selexipag@True@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_4.pdf@EU-1-15-1078_h_a_dec_4.pdf@2020-04-17 00:00:00@Natpar@parathyroid hormone@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1075_h_a_dec_7.pdf@EU-1-15-1075_h_a_dec_7.pdf@2022-06-13 00:00:00@Feraccru@ferric maltol@False@False@OD Not Found@Norgine B.V.@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_0.pdf@EU-1-15-1085_h_a_dec_0.pdf@2016-04-25 00:00:00@Taltz@ixekizumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_2.pdf@EU-1-15-1082_h_a_dec_2.pdf@2019-03-28 00:00:00@Galafold@migalastat@False@False@adopted@Amicus Therapeutics UK Ltd@CMA Not Found@Parsed
EU-1-15-1079_h_a_dec_4.pdf@EU-1-15-1079_h_a_dec_4.pdf@2020-09-24 00:00:00@Vaxelis@Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA),  poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)@False@False@OD Not Found@MCM Vaccine B.V.@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_1.pdf@EU-1-15-1085_h_a_dec_1.pdf@2017-07-09 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_6.pdf@EU-1-15-1074_h_a_dec_6.pdf@2020-11-18 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_1.pdf@EU-1-15-1083_h_a_dec_1.pdf@2017-06-29 00:00:00@Uptravi@selexipag@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_5.pdf@EU-1-15-1078_h_a_dec_5.pdf@2021-04-15 00:00:00@Natpar@parathyroid hormone@False@False@OD Not Found@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1085_h_a_dec_2.pdf@EU-1-15-1085_h_a_dec_2.pdf@2017-08-12 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_3.pdf@EU-1-15-1082_h_a_dec_3.pdf@2021-11-02 00:00:00@Galafold@migalastat@False@False@adopted@Amicus Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-15-1074_h_a_dec_7.pdf@EU-1-15-1074_h_a_dec_7.pdf@2022-01-31 00:00:00@Benepali@etanercept@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_3.pdf@EU-1-15-1085_h_a_dec_3.pdf@2018-01-18 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_6.pdf@EU-1-15-1078_h_a_dec_6.pdf@2021-10-19 00:00:00@Natpar@parathyroid hormone@False@False@adopted@Shire Pharmaceuticals Ireland Limited@conditional@Parsed
EU-1-15-1083_h_a_dec_2.pdf@EU-1-15-1083_h_a_dec_2.pdf@2018-07-06 00:00:00@Uptravi@selexipag@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-1082_h_a_dec_4.pdf@EU-1-15-1082_h_a_dec_4.pdf@2021-07-23 00:00:00@Galafold@migalastat@False@False@adopted@Amicus Therapeutics Europe Limited@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_0.pdf@EU-1-15-990_h_a_dec_0.pdf@2015-03-19 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@SANTEN S.A.S.@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_4.pdf@EU-1-15-1085_h_a_dec_4.pdf@2019-06-02 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_0.pdf@EU-1-15-989_h_a_dec_0.pdf@2015-03-19 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_3.pdf@EU-1-15-1083_h_a_dec_3.pdf@2018-09-28 00:00:00@Uptravi@selexipag@False@False@OD Not Found@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_1.pdf@EU-1-15-990_h_a_dec_1.pdf@2015-11-06 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@SANTEN S.A.S.@CMA Not Found@Parsed
EU-1-15-1078_h_a_dec_7.pdf@EU-1-15-1078_h_a_dec_7.pdf@2022-03-22 00:00:00@Natpar@parathyroid hormone@False@False@OD Not Found@the applicant@conditional@Parsed
EU-1-15-1085_h_a_dec_5.pdf@EU-1-15-1085_h_a_dec_5.pdf@2020-02-06 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_1.pdf@EU-1-15-989_h_a_dec_1.pdf@2016-12-12 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_4.pdf@EU-1-15-1083_h_a_dec_4.pdf@2019-07-25 00:00:00@Uptravi@selexipag@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_2.pdf@EU-1-15-990_h_a_dec_2.pdf@2017-06-29 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@Santen Oy@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_6.pdf@EU-1-15-1085_h_a_dec_6.pdf@2020-06-26 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_3.pdf@EU-1-15-990_h_a_dec_3.pdf@2019-04-07 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@Santen Oy@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_5.pdf@EU-1-15-1083_h_a_dec_5.pdf@2020-12-14 00:00:00@Uptravi@selexipag@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_7.pdf@EU-1-15-1085_h_a_dec_7.pdf@2020-12-17 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_2.pdf@EU-1-15-989_h_a_dec_2.pdf@2018-06-25 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_0.pdf@EU-1-15-991_h_a_dec_0.pdf@2015-03-23 00:00:00@Sivextro@tedizolid phosphate@True@False@OD Not Found@Cubist (UK) Ltd@CMA Not Found@Parsed
EU-1-15-1083_h_a_dec_6.pdf@EU-1-15-1083_h_a_dec_6.pdf@2021-11-26 00:00:00@Uptravi@selexipag@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_4.pdf@EU-1-15-990_h_a_dec_4.pdf@2020-09-03 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@Santen Oy@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_0.pdf@EU-1-15-992_h_a_dec_0.pdf@2015-03-23 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-990_h_a_dec_5.pdf@EU-1-15-990_h_a_dec_5.pdf@2021-03-26 00:00:00@IKERVIS@Ciclosporin@False@False@OD Not Found@Santen Oy@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_3.pdf@EU-1-15-989_h_a_dec_3.pdf@2018-08-13 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-1085_h_a_dec_8.pdf@EU-1-15-1085_h_a_dec_8.pdf@2021-12-08 00:00:00@Taltz@ixekizumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_1.pdf@EU-1-15-991_h_a_dec_1.pdf@2016-11-01 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Cubist (UK) Ltd@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_0.pdf@EU-1-15-993_h_a_dec_0.pdf@2015-06-19 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_1.pdf@EU-1-15-992_h_a_dec_1.pdf@2016-09-22 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_1.pdf@EU-1-15-993_h_a_dec_1.pdf@2016-10-14 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_4.pdf@EU-1-15-989_h_a_dec_4.pdf@2019-11-01 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@Rempex London Ltd@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_2.pdf@EU-1-15-992_h_a_dec_2.pdf@2017-11-15 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_2.pdf@EU-1-15-991_h_a_dec_2.pdf@2017-06-16 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-994_h_a_dec_0.pdf@EU-1-15-994_h_a_dec_0.pdf@2015-03-23 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_3.pdf@EU-1-15-992_h_a_dec_3.pdf@2019-06-20 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_2.pdf@EU-1-15-993_h_a_dec_2.pdf@2017-07-13 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_5.pdf@EU-1-15-989_h_a_dec_5.pdf@2019-12-18 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_0.pdf@EU-1-15-997_h_a_dec_0.pdf@2015-06-25 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_3.pdf@EU-1-15-993_h_a_dec_3.pdf@2018-05-28 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_3.pdf@EU-1-15-991_h_a_dec_3.pdf@2018-08-08 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-15-994_h_a_dec_1.pdf@EU-1-15-994_h_a_dec_1.pdf@2016-02-09 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@The Medicines Company UK Ltd@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_6.pdf@EU-1-15-989_h_a_dec_6.pdf@2020-01-13 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@Menarini International Operations  Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_4.pdf@EU-1-15-992_h_a_dec_4.pdf@2019-09-23 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_4.pdf@EU-1-15-993_h_a_dec_4.pdf@2018-07-26 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_1.pdf@EU-1-15-997_h_a_dec_1.pdf@2017-11-01 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_4.pdf@EU-1-15-991_h_a_dec_4.pdf@2019-09-13 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-989_h_a_dec_7.pdf@EU-1-15-989_h_a_dec_7.pdf@2020-09-12 00:00:00@Orbactiv@oritavancin@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_5.pdf@EU-1-15-992_h_a_dec_5.pdf@2019-09-12 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_5.pdf@EU-1-15-993_h_a_dec_5.pdf@2019-07-25 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-994_h_a_dec_2.pdf@EU-1-15-994_h_a_dec_2.pdf@2018-12-12 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_5.pdf@EU-1-15-991_h_a_dec_5.pdf@2020-09-01 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_0.pdf@EU-1-15-999_h_a_dec_0.pdf@2015-06-05 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-15-992_h_a_dec_6.pdf@EU-1-15-992_h_a_dec_6.pdf@2020-09-24 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_6.pdf@EU-1-15-993_h_a_dec_6.pdf@2020-02-24 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_2.pdf@EU-1-15-997_h_a_dec_2.pdf@2017-02-06 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_6.pdf@EU-1-15-991_h_a_dec_6.pdf@2020-06-26 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-992_h_a_dec_7.pdf@EU-1-15-992_h_a_dec_7.pdf@2021-04-26 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-993_h_a_dec_7.pdf@EU-1-15-993_h_a_dec_7.pdf@2021-11-26 00:00:00@Lixiana@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-15-994_h_a_dec_3.pdf@EU-1-15-994_h_a_dec_3.pdf@2019-12-16 00:00:00@Kengrexal@cangrelor@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_1.pdf@EU-1-15-999_h_a_dec_1.pdf@2015-08-25 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-15-992_h_a_dec_8.pdf@EU-1-15-992_h_a_dec_8.pdf@2021-11-22 00:00:00@Saxenda@liraglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_7.pdf@EU-1-15-991_h_a_dec_7.pdf@2021-03-22 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_3.pdf@EU-1-15-997_h_a_dec_3.pdf@2018-10-09 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Generics [UK] Limited@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_0.pdf@EU-1-16-1086_h_a_dec_0.pdf@2016-02-02 00:00:00@TAGRISSO@osimertinib@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-15-997_h_a_dec_4.pdf@EU-1-15-997_h_a_dec_4.pdf@2020-03-04 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_10.pdf@EU-1-15-999_h_a_dec_10.pdf@2019-02-04 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-15-991_h_a_dec_8.pdf@EU-1-15-991_h_a_dec_8.pdf@2022-04-02 00:00:00@Sivextro@tedizolid phosphate@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_1.pdf@EU-1-16-1086_h_a_dec_1.pdf@2016-12-12 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1087_h_a_dec_0.pdf@EU-1-16-1087_h_a_dec_0.pdf@2016-03-16 00:00:00@Coagadex@human coagulation factor X@False@False@adopted@Bio Products Laboratory Ltd@CMA Not Found@Parsed
EU-1-15-997_h_a_dec_5.pdf@EU-1-15-997_h_a_dec_5.pdf@2021-03-11 00:00:00@Pregabalin Mylan@pregabalin@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_11.pdf@EU-1-15-999_h_a_dec_11.pdf@2021-01-14 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_10.pdf@EU-1-16-1086_h_a_dec_10.pdf@2022-03-24 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1087_h_a_dec_1.pdf@EU-1-16-1087_h_a_dec_1.pdf@2018-08-27 00:00:00@Coagadex@human coagulation factor X@False@False@adopted@Bio Products Laboratory Ltd@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_0.pdf@EU-1-16-1089_h_a_dec_0.pdf@2016-05-20 00:00:00@Pandemic influenza vaccine H5N1  MedImmune@Pandemic influenza vaccine (H5N1) (live attenuated, nasal)@True@False@OD Not Found@MedImmune, LLC@conditional@Parsed
EU-1-16-1086_h_a_dec_11.pdf@EU-1-16-1086_h_a_dec_11.pdf@2022-09-19 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_0.pdf@EU-1-16-1088_h_a_dec_0.pdf@2016-11-05 00:00:00@Empliciti@elotuzumab@True@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_12.pdf@EU-1-15-999_h_a_dec_12.pdf@2022-02-16 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_1.pdf@EU-1-16-1089_h_a_dec_1.pdf@2017-04-20 00:00:00@Pandemic influenza vaccine H5N1 MedImmune@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@MedImmune, LLC@conditional@Parsed
EU-1-16-1086_h_a_dec_2.pdf@EU-1-16-1086_h_a_dec_2.pdf@2017-03-22 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1087_h_a_dec_2.pdf@EU-1-16-1087_h_a_dec_2.pdf@2019-03-28 00:00:00@Coagadex@human coagulation factor X@False@False@OD Not Found@Bio Products Laboratory Ltd@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_1.pdf@EU-1-16-1088_h_a_dec_1.pdf@2017-04-10 00:00:00@Empliciti@elotuzumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_2.pdf@EU-1-15-999_h_a_dec_2.pdf@2016-03-22 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-16-1090_h_a_dec_0.pdf@EU-1-16-1090_h_a_dec_0.pdf@2016-04-04 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_3.pdf@EU-1-16-1086_h_a_dec_3.pdf@2017-04-24 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1089_h_a_dec_2.pdf@EU-1-16-1089_h_a_dec_2.pdf@2017-06-23 00:00:00@Pandemic influenza vaccine H5N1 AstraZeneca@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@MedImmune, LLC@conditional@Parsed
EU-1-16-1091_h_a_dec_0.pdf@EU-1-16-1091_h_a_dec_0.pdf@2016-08-22 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1087_h_a_dec_3.pdf@EU-1-16-1087_h_a_dec_3.pdf@2021-03-17 00:00:00@Coagadex@human coagulation factor X@False@False@adopted@BPL Bioproducts Laboratory GmbH@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_1.pdf@EU-1-16-1091_h_a_dec_1.pdf@2017-01-19 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1090_h_a_dec_1.pdf@EU-1-16-1090_h_a_dec_1.pdf@2017-08-05 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_3.pdf@EU-1-16-1089_h_a_dec_3.pdf@2018-04-04 00:00:00@Pandemic influenza vaccine H5N1 AstraZeneca@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1086_h_a_dec_4.pdf@EU-1-16-1086_h_a_dec_4.pdf@2018-07-06 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_3.pdf@EU-1-15-999_h_a_dec_3.pdf@2017-03-22 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-16-1088_h_a_dec_2.pdf@EU-1-16-1088_h_a_dec_2.pdf@2019-02-04 00:00:00@Empliciti@elotuzumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_2.pdf@EU-1-16-1091_h_a_dec_2.pdf@2018-05-24 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_4.pdf@EU-1-16-1089_h_a_dec_4.pdf@2019-04-17 00:00:00@Pandemic influenza vaccine H5N1 AstraZeneca@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1086_h_a_dec_5.pdf@EU-1-16-1086_h_a_dec_5.pdf@2018-08-31 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1090_h_a_dec_2.pdf@EU-1-16-1090_h_a_dec_2.pdf@2020-11-20 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_3.pdf@EU-1-16-1091_h_a_dec_3.pdf@2018-09-20 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_6.pdf@EU-1-16-1086_h_a_dec_6.pdf@2019-08-26 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_3.pdf@EU-1-16-1088_h_a_dec_3.pdf@2019-08-23 00:00:00@Empliciti@elotuzumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-16-1092_h_a_dec_0.pdf@EU-1-16-1092_h_a_dec_0.pdf@2016-03-22 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_4.pdf@EU-1-16-1091_h_a_dec_4.pdf@2019-10-21 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_5.pdf@EU-1-16-1089_h_a_dec_5.pdf@2020-03-16 00:00:00@Pandemic influenza vaccine H5N1 AstraZeneca@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1092_h_a_dec_1.pdf@EU-1-16-1092_h_a_dec_1.pdf@2017-10-13 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1086_h_a_dec_7.pdf@EU-1-16-1086_h_a_dec_7.pdf@2019-10-24 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1090_h_a_dec_3.pdf@EU-1-16-1090_h_a_dec_3.pdf@2021-10-19 00:00:00@Rasagiline Mylan@rasagiline@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_4.pdf@EU-1-15-999_h_a_dec_4.pdf@2017-06-23 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-16-1091_h_a_dec_5.pdf@EU-1-16-1091_h_a_dec_5.pdf@2021-01-29 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_6.pdf@EU-1-16-1091_h_a_dec_6.pdf@2021-04-26 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1092_h_a_dec_2.pdf@EU-1-16-1092_h_a_dec_2.pdf@2019-02-25 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_6.pdf@EU-1-16-1089_h_a_dec_6.pdf@2021-10-03 00:00:00@Pandemic influenza vaccine H5N1 AstraZeneca@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1086_h_a_dec_8.pdf@EU-1-16-1086_h_a_dec_8.pdf@2021-09-03 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_5.pdf@EU-1-15-999_h_a_dec_5.pdf@2017-07-26 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-16-1086_h_a_dec_9.pdf@EU-1-16-1086_h_a_dec_9.pdf@2021-05-21 00:00:00@TAGRISSO@osimertinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_7.pdf@EU-1-16-1091_h_a_dec_7.pdf@2021-07-16 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1092_h_a_dec_3.pdf@EU-1-16-1092_h_a_dec_3.pdf@2019-04-17 00:00:00@, medicinal  product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 17.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2016)1906(final) for “Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_4.pdf@EU-1-16-1088_h_a_dec_4.pdf@2020-10-19 00:00:00@Empliciti@elotuzumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-16-1089_h_a_dec_7.pdf@EU-1-16-1089_h_a_dec_7.pdf@2022-04-03 00:00:00@Pandemic influenza vaccine H5N1 AstraZeneca@Pandemic  influenza vaccine (H5N1) (live attenuated, nasal)@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-16-1092_h_a_dec_4.pdf@EU-1-16-1092_h_a_dec_4.pdf@2021-01-14 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1093_h_a_dec_0.pdf@EU-1-16-1093_h_a_dec_0.pdf@2016-03-31 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1088_h_a_dec_5.pdf@EU-1-16-1088_h_a_dec_5.pdf@2020-12-17 00:00:00@Empliciti@elotuzumab@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_6.pdf@EU-1-15-999_h_a_dec_6.pdf@2018-04-23 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1091_h_a_dec_8.pdf@EU-1-16-1091_h_a_dec_8.pdf@2021-09-29 00:00:00@Atazanavir Mylan@atazanavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1092_h_a_dec_5.pdf@EU-1-16-1092_h_a_dec_5.pdf@2021-12-02 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1093_h_a_dec_1.pdf@EU-1-16-1093_h_a_dec_1.pdf@2019-02-04 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_7.pdf@EU-1-15-999_h_a_dec_7.pdf@2018-07-06 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1093_h_a_dec_2.pdf@EU-1-16-1093_h_a_dec_2.pdf@2020-01-12 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1092_h_a_dec_6.pdf@EU-1-16-1092_h_a_dec_6.pdf@2021-09-15 00:00:00@Amlodipine/Valsartan Mylan@amlodipine/valsartan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1093_h_a_dec_3.pdf@EU-1-16-1093_h_a_dec_3.pdf@2021-11-15 00:00:00@Zonisamide Mylan@zonisamide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_8.pdf@EU-1-15-999_h_a_dec_8.pdf@2018-06-07 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_0.pdf@EU-1-16-1094_h_a_dec_0.pdf@2016-11-21 00:00:00@Ninlaro@ixazomib@True@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1096_h_a_dec_0.pdf@EU-1-16-1096_h_a_dec_0.pdf@2016-04-25 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_0.pdf@EU-1-16-1095_h_a_dec_0.pdf@2016-11-05 00:00:00@IDELVION@albutrepenonacog alfa@True@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-15-999_h_a_dec_9.pdf@EU-1-15-999_h_a_dec_9.pdf@2019-11-03 00:00:00@Zykadia@ceritinib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_1.pdf@EU-1-16-1094_h_a_dec_1.pdf@2017-09-18 00:00:00@Ninlaro@ixazomib@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1097_h_a_dec_0.pdf@EU-1-16-1097_h_a_dec_0.pdf@2016-05-26 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction  that contains CD34+ cells transduced with retroviral vector that encodes for the human  ADA cDNA sequence@True@True@adopted@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_1.pdf@EU-1-16-1095_h_a_dec_1.pdf@2018-01-03 00:00:00@IDELVION@albutrepenonacog alfa@False@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_1.pdf@EU-1-16-1096_h_a_dec_1.pdf@2018-07-03 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_2.pdf@EU-1-16-1095_h_a_dec_2.pdf@2020-06-18 00:00:00@IDELVION@albutrepenonacog alfa@False@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_2.pdf@EU-1-16-1096_h_a_dec_2.pdf@2019-03-09 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_2.pdf@EU-1-16-1094_h_a_dec_2.pdf@2018-06-07 00:00:00@Ninlaro@ixazomib@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1097_h_a_dec_1.pdf@EU-1-16-1097_h_a_dec_1.pdf@2018-07-30 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction that contains CD34+ cells  transduced with retroviral vector that encodes for the human ADA cDNA sequence@False@False@adopted@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_0.pdf@EU-1-16-1098_h_a_dec_0.pdf@2016-12-05 00:00:00@ALPROLIX@eftrenonacog alfa@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_3.pdf@EU-1-16-1096_h_a_dec_3.pdf@2020-01-04 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_3.pdf@EU-1-16-1094_h_a_dec_3.pdf@2018-09-17 00:00:00@Ninlaro@ixazomib@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1099_h_a_dec_0.pdf@EU-1-16-1099_h_a_dec_0.pdf@2016-04-21 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1095_h_a_dec_3.pdf@EU-1-16-1095_h_a_dec_3.pdf@2020-08-19 00:00:00@IDELVION@albutrepenonacog alfa@False@False@adopted@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1096_h_a_dec_4.pdf@EU-1-16-1096_h_a_dec_4.pdf@2020-12-14 00:00:00@Lonsurf@trifluridine / tipiracil@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1097_h_a_dec_2.pdf@EU-1-16-1097_h_a_dec_2.pdf@2018-08-23 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction that contains CD34+ cells  transduced with retroviral vector that encodes for the human ADA cDNA sequence@False@False@adopted@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_4.pdf@EU-1-16-1094_h_a_dec_4.pdf@2018-06-07 00:00:00@Ninlaro@ixazomib@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1098_h_a_dec_1.pdf@EU-1-16-1098_h_a_dec_1.pdf@2016-09-30 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_1.pdf@EU-1-16-1099_h_a_dec_1.pdf@2017-03-29 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_5.pdf@EU-1-16-1094_h_a_dec_5.pdf@2019-09-16 00:00:00@Ninlaro@ixazomib@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1095_h_a_dec_4.pdf@EU-1-16-1095_h_a_dec_4.pdf@2021-04-02 00:00:00@IDELVION@albutrepenonacog alfa@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_0.pdf@EU-1-16-1101_h_a_dec_0.pdf@2016-05-20 00:00:00@Darzalex@daratumumab@True@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1094_h_a_dec_6.pdf@EU-1-16-1094_h_a_dec_6.pdf@2020-08-25 00:00:00@Ninlaro@ixazomib@False@False@adopted@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1097_h_a_dec_3.pdf@EU-1-16-1097_h_a_dec_3.pdf@2021-04-30 00:00:00@Strimvelis@autologous CD34+ enriched cell fraction that contains CD34+ cells  transduced with retroviral vector that encodes for the human ADA cDNA sequence@False@False@adopted@Orchard Therapeutics (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_2.pdf@EU-1-16-1098_h_a_dec_2.pdf@2017-06-23 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_2.pdf@EU-1-16-1099_h_a_dec_2.pdf@2018-04-19 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_1.pdf@EU-1-16-1101_h_a_dec_1.pdf@2016-07-14 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1094_h_a_dec_7.pdf@EU-1-16-1094_h_a_dec_7.pdf@2020-11-20 00:00:00@Ninlaro@ixazomib@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1102_h_a_dec_0.pdf@EU-1-16-1102_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_3.pdf@EU-1-16-1098_h_a_dec_3.pdf@2018-07-06 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_3.pdf@EU-1-16-1099_h_a_dec_3.pdf@2018-05-28 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_10.pdf@EU-1-16-1101_h_a_dec_10.pdf@2020-03-06 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_1.pdf@EU-1-16-1102_h_a_dec_1.pdf@2017-11-15 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_8.pdf@EU-1-16-1094_h_a_dec_8.pdf@2021-12-11 00:00:00@Ninlaro@ixazomib@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1099_h_a_dec_4.pdf@EU-1-16-1099_h_a_dec_4.pdf@2019-06-06 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_11.pdf@EU-1-16-1101_h_a_dec_11.pdf@2021-06-21 00:00:00@Daratumumab@Active Substance Not Found@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_4.pdf@EU-1-16-1098_h_a_dec_4.pdf@2018-06-07 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_2.pdf@EU-1-16-1102_h_a_dec_2.pdf@2019-02-20 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1094_h_a_dec_9.pdf@EU-1-16-1094_h_a_dec_9.pdf@2022-09-13 00:00:00@Ninlaro@ixazomib@False@False@OD Not Found@Takeda Pharma A/S@conditional@Parsed
EU-1-16-1103_h_a_dec_0.pdf@EU-1-16-1103_h_a_dec_0.pdf@2016-05-26 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1104_h_a_dec_0.pdf@EU-1-16-1104_h_a_dec_0.pdf@2016-05-26 00:00:00@Palonosetron Accord@palonosetron@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_5.pdf@EU-1-16-1099_h_a_dec_5.pdf@2020-04-23 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_12.pdf@EU-1-16-1101_h_a_dec_12.pdf@2022-06-01 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_3.pdf@EU-1-16-1102_h_a_dec_3.pdf@2021-02-18 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_5.pdf@EU-1-16-1098_h_a_dec_5.pdf@2020-11-02 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_2.pdf@EU-1-16-1101_h_a_dec_2.pdf@2017-04-24 00:00:00@Darzalex@daratumumab@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1101_h_a_dec_3.pdf@EU-1-16-1101_h_a_dec_3.pdf@2017-04-28 00:00:00@Darzalex@daratumumab@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-16-1104_h_a_dec_1.pdf@EU-1-16-1104_h_a_dec_1.pdf@2019-01-03 00:00:00@Palonosetron Accord@palonosetron@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_6.pdf@EU-1-16-1099_h_a_dec_6.pdf@2021-11-02 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_4.pdf@EU-1-16-1102_h_a_dec_4.pdf@2021-06-21 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_6.pdf@EU-1-16-1098_h_a_dec_6.pdf@2020-10-19 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_1.pdf@EU-1-16-1103_h_a_dec_1.pdf@2017-11-09 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_4.pdf@EU-1-16-1101_h_a_dec_4.pdf@2018-06-25 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1102_h_a_dec_5.pdf@EU-1-16-1102_h_a_dec_5.pdf@2022-12-08 00:00:00@Bortezomib SUN@bortezomib@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-16-1104_h_a_dec_2.pdf@EU-1-16-1104_h_a_dec_2.pdf@2021-12-02 00:00:00@Palonosetron Accord@palonosetron@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-16-1099_h_a_dec_7.pdf@EU-1-16-1099_h_a_dec_7.pdf@2022-06-13 00:00:00@Descovy@emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_5.pdf@EU-1-16-1101_h_a_dec_5.pdf@2018-08-31 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_0.pdf@EU-1-16-1105_h_a_dec_0.pdf@2016-06-07 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1098_h_a_dec_7.pdf@EU-1-16-1098_h_a_dec_7.pdf@2021-11-02 00:00:00@ALPROLIX@eftrenonacog alfa@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_6.pdf@EU-1-16-1101_h_a_dec_6.pdf@2018-12-18 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_1.pdf@EU-1-16-1105_h_a_dec_1.pdf@2017-09-21 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_2.pdf@EU-1-16-1103_h_a_dec_2.pdf@2018-01-03 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_7.pdf@EU-1-16-1101_h_a_dec_7.pdf@2019-06-28 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_2.pdf@EU-1-16-1105_h_a_dec_2.pdf@2018-03-27 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_0.pdf@EU-1-16-1106_h_a_dec_0.pdf@2016-05-26 00:00:00@Flixabi@Infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_3.pdf@EU-1-16-1103_h_a_dec_3.pdf@2018-12-04 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_8.pdf@EU-1-16-1101_h_a_dec_8.pdf@2019-11-19 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_3.pdf@EU-1-16-1105_h_a_dec_3.pdf@2018-09-20 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1101_h_a_dec_9.pdf@EU-1-16-1101_h_a_dec_9.pdf@2020-01-20 00:00:00@Darzalex@daratumumab@False@False@adopted@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_4.pdf@EU-1-16-1105_h_a_dec_4.pdf@2019-03-28 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_0.pdf@EU-1-16-1108_h_a_dec_0.pdf@2016-07-15 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_5.pdf@EU-1-16-1105_h_a_dec_5.pdf@2019-09-23 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITG Isotope Technologies Garching GmbH@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_4.pdf@EU-1-16-1103_h_a_dec_4.pdf@2019-11-04 00:00:00@, medicinal product for human  use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  11.4.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2016)3275(final) for “Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_0.pdf@EU-1-16-1109_h_a_dec_0.pdf@2016-06-24 00:00:00@Zavicefta@ceftazidime/avibactam@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_1.pdf@EU-1-16-1106_h_a_dec_1.pdf@2017-06-23 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_0.pdf@EU-1-16-1110_h_a_dec_0.pdf@2017-10-04 00:00:00@Chenodeoxycholic acid  sigma-tau@chenodeoxycholic acid@False@False@adopted@sigma-tau Arzeimittel GmbH@exceptional@Parsed
EU-1-16-1108_h_a_dec_1.pdf@EU-1-16-1108_h_a_dec_1.pdf@2017-07-19 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_6.pdf@EU-1-16-1105_h_a_dec_6.pdf@2020-09-24 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITM Medical Isotopes GmbH@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_2.pdf@EU-1-16-1108_h_a_dec_2.pdf@2017-12-20 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_5.pdf@EU-1-16-1103_h_a_dec_5.pdf@2020-09-30 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_1.pdf@EU-1-16-1110_h_a_dec_1.pdf@2017-05-31 00:00:00@Chenodeoxycholic acid Leadiant@chenodeoxycholic acid@False@False@adopted@sigma-tau Arzeimittel GmbH@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_2.pdf@EU-1-16-1106_h_a_dec_2.pdf@2018-08-05 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_1.pdf@EU-1-16-1109_h_a_dec_1.pdf@2017-07-19 00:00:00@Zavicefta@ceftazidime/avibactam@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1105_h_a_dec_7.pdf@EU-1-16-1105_h_a_dec_7.pdf@2021-08-02 00:00:00@EndolucinBeta@Lutetium ( 177 Lu) chloride@False@False@OD Not Found@ITM Medical Isotopes GmbH@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_3.pdf@EU-1-16-1108_h_a_dec_3.pdf@2020-09-03 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_6.pdf@EU-1-16-1103_h_a_dec_6.pdf@2021-11-02 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_2.pdf@EU-1-16-1110_h_a_dec_2.pdf@2018-05-30 00:00:00@Chenodeoxycholic acid Leadiant@chenodeoxycholic acid@False@False@adopted@Leadiant GmbH@exceptional@Parsed
EU-1-16-1108_h_a_dec_4.pdf@EU-1-16-1108_h_a_dec_4.pdf@2021-09-03 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_3.pdf@EU-1-16-1106_h_a_dec_3.pdf@2018-08-11 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_3.pdf@EU-1-16-1110_h_a_dec_3.pdf@2020-12-17 00:00:00@Chenodeoxycholic acid Leadiant@chenodeoxycholic acid@False@False@adopted@Leadiant GmbH@exceptional@Parsed
EU-1-16-1109_h_a_dec_2.pdf@EU-1-16-1109_h_a_dec_2.pdf@2019-02-25 00:00:00@Zavicefta@ceftazidime/avibactam@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-16-1110_h_a_dec_4.pdf@EU-1-16-1110_h_a_dec_4.pdf@2021-09-12 00:00:00@Chenodeoxycholic acid Leadiant@chenodeoxycholic acid@False@False@adopted@Leadiant GmbH@exceptional@Parsed
EU-1-16-1108_h_a_dec_5.pdf@EU-1-16-1108_h_a_dec_5.pdf@2021-04-21 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_4.pdf@EU-1-16-1106_h_a_dec_4.pdf@2019-11-22 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_7.pdf@EU-1-16-1103_h_a_dec_7.pdf@2021-02-19 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)    EN 1   EN COMMISSION IMPLEMENTING DECISION  19.2.2021  amending Commission Decision C(2019) 2979  11 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(2016) 3275 for “Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1108_h_a_dec_6.pdf@EU-1-16-1108_h_a_dec_6.pdf@2021-05-19 00:00:00@Qtern@saxagliptin / dapagliflozin@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_0.pdf@EU-1-16-1112_h_a_dec_0.pdf@2016-06-21 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir  alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_0.pdf@EU-1-16-1114_h_a_dec_0.pdf@2016-07-22 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_3.pdf@EU-1-16-1109_h_a_dec_3.pdf@2020-06-08 00:00:00@Zavicefta@ceftazidime/avibactam@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_5.pdf@EU-1-16-1106_h_a_dec_5.pdf@2020-11-20 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_0.pdf@EU-1-16-1115_h_a_dec_0.pdf@2016-07-22 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_8.pdf@EU-1-16-1103_h_a_dec_8.pdf@2021-05-19 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_1.pdf@EU-1-16-1112_h_a_dec_1.pdf@2017-03-24 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_6.pdf@EU-1-16-1106_h_a_dec_6.pdf@2021-11-02 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_1.pdf@EU-1-16-1114_h_a_dec_1.pdf@2018-01-18 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1106_h_a_dec_7.pdf@EU-1-16-1106_h_a_dec_7.pdf@2022-04-29 00:00:00@Flixabi@infliximab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_4.pdf@EU-1-16-1109_h_a_dec_4.pdf@2020-10-22 00:00:00@Zavicefta@ceftazidime/avibactam@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_1.pdf@EU-1-16-1115_h_a_dec_1.pdf@2018-08-05 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-16-1103_h_a_dec_9.pdf@EU-1-16-1103_h_a_dec_9.pdf@2022-01-07 00:00:00@Neparvis@sacubitril / valsartan@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_2.pdf@EU-1-16-1114_h_a_dec_2.pdf@2018-08-08 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-16-1109_h_a_dec_5.pdf@EU-1-16-1109_h_a_dec_5.pdf@2021-11-02 00:00:00@Zavicefta@ceftazidime/avibactam@False@False@OD Not Found@Pfizer Ireland Pharmaceuticals@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_2.pdf@EU-1-16-1112_h_a_dec_2.pdf@2017-11-12 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_2.pdf@EU-1-16-1115_h_a_dec_2.pdf@2018-06-07 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Oncology Plc.@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_3.pdf@EU-1-16-1114_h_a_dec_3.pdf@2019-02-14 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_3.pdf@EU-1-16-1115_h_a_dec_3.pdf@2020-11-02 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_4.pdf@EU-1-16-1114_h_a_dec_4.pdf@2021-11-02 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_4.pdf@EU-1-16-1115_h_a_dec_4.pdf@2021-04-21 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_1.pdf@EU-1-16-1116_h_a_dec_1.pdf@2017-10-30 00:00:00@Brand name Not Found@Active Substance Not Found@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_3.pdf@EU-1-16-1112_h_a_dec_3.pdf@2018-05-16 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_5.pdf@EU-1-16-1114_h_a_dec_5.pdf@2021-04-28 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_0.pdf@EU-1-16-1119_h_a_dec_0.pdf@2016-07-22 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1115_h_a_dec_5.pdf@EU-1-16-1115_h_a_dec_5.pdf@2022-06-21 00:00:00@Pemetrexed Fresenius Kabi@pemetrexed@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_10.pdf@EU-1-16-1116_h_a_dec_10.pdf@2022-05-19 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1114_h_a_dec_6.pdf@EU-1-16-1114_h_a_dec_6.pdf@2022-02-24 00:00:00@Bortezomib Hospira@bortezomib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_4.pdf@EU-1-16-1112_h_a_dec_4.pdf@2019-06-06 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_0.pdf@EU-1-16-1124_h_a_dec_0.pdf@2016-08-18 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_0.pdf@EU-1-16-1125_h_a_dec_0.pdf@2016-08-16 00:00:00@Cinqaero@reslizumab@True@False@OD Not Found@Teva Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_2.pdf@EU-1-16-1116_h_a_dec_2.pdf@2018-05-28 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_1.pdf@EU-1-16-1119_h_a_dec_1.pdf@2017-11-30 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_1.pdf@EU-1-16-1124_h_a_dec_1.pdf@2017-07-08 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_5.pdf@EU-1-16-1112_h_a_dec_5.pdf@2020-01-04 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_2.pdf@EU-1-16-1124_h_a_dec_2.pdf@2018-05-16 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_3.pdf@EU-1-16-1116_h_a_dec_3.pdf@2019-05-20 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_2.pdf@EU-1-16-1119_h_a_dec_2.pdf@2018-06-15 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_1.pdf@EU-1-16-1125_h_a_dec_1.pdf@2017-04-28 00:00:00@Cinqaero@reslizumab@False@False@OD Not Found@Teva Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_3.pdf@EU-1-16-1124_h_a_dec_3.pdf@2019-03-25 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_0.pdf@EU-1-16-1127_h_a_dec_0.pdf@2016-09-15 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_6.pdf@EU-1-16-1112_h_a_dec_6.pdf@2021-01-14 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_3.pdf@EU-1-16-1119_h_a_dec_3.pdf@2020-01-13 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_4.pdf@EU-1-16-1124_h_a_dec_4.pdf@2019-08-23 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_4.pdf@EU-1-16-1119_h_a_dec_4.pdf@2021-01-29 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_0.pdf@EU-1-16-1128_h_a_dec_0.pdf@2016-08-25 00:00:00@Kisplyx@Lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_1.pdf@EU-1-16-1127_h_a_dec_1.pdf@2018-01-18 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_4.pdf@EU-1-16-1116_h_a_dec_4.pdf@2019-09-23 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_2.pdf@EU-1-16-1125_h_a_dec_2.pdf@2018-09-20 00:00:00@Cinqaero@reslizumab@False@False@OD Not Found@Teva Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-16-1112_h_a_dec_7.pdf@EU-1-16-1112_h_a_dec_7.pdf@2022-06-14 00:00:00@Odefsey@emtricitabine / rilpivirine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_5.pdf@EU-1-16-1119_h_a_dec_5.pdf@2021-06-05 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_5.pdf@EU-1-16-1124_h_a_dec_5.pdf@2019-10-17 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE DUTCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 17.10.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2016)5447(final) for “Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_2.pdf@EU-1-16-1127_h_a_dec_2.pdf@2018-07-12 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_3.pdf@EU-1-16-1125_h_a_dec_3.pdf@2019-10-12 00:00:00@Cinqaero@reslizumab@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_1.pdf@EU-1-16-1128_h_a_dec_1.pdf@2017-02-27 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_6.pdf@EU-1-16-1119_h_a_dec_6.pdf@2021-10-22 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_6.pdf@EU-1-16-1124_h_a_dec_6.pdf@2020-07-23 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_3.pdf@EU-1-16-1127_h_a_dec_3.pdf@2019-09-16 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_5.pdf@EU-1-16-1116_h_a_dec_5.pdf@2019-10-21 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_4.pdf@EU-1-16-1125_h_a_dec_4.pdf@2020-05-11 00:00:00@Cinqaero@reslizumab@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-16-1119_h_a_dec_7.pdf@EU-1-16-1119_h_a_dec_7.pdf@2022-02-06 00:00:00@Zepatier@elbasvir / grazoprevir@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_7.pdf@EU-1-16-1124_h_a_dec_7.pdf@2021-01-21 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_4.pdf@EU-1-16-1127_h_a_dec_4.pdf@2020-01-13 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_2.pdf@EU-1-16-1128_h_a_dec_2.pdf@2018-07-03 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1125_h_a_dec_5.pdf@EU-1-16-1125_h_a_dec_5.pdf@2021-01-06 00:00:00@Cinqaero@reslizumab@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-16-1124_h_a_dec_8.pdf@EU-1-16-1124_h_a_dec_8.pdf@2021-06-21 00:00:00@Nordimet@methotrexate@False@False@OD Not Found@Nordic Group B.V.@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_6.pdf@EU-1-16-1116_h_a_dec_6.pdf@2020-03-24 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_5.pdf@EU-1-16-1127_h_a_dec_5.pdf@2021-01-14 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_0.pdf@EU-1-16-1129_h_a_dec_0.pdf@2016-08-12 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@MYLAN S.A.S@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_3.pdf@EU-1-16-1128_h_a_dec_3.pdf@2019-07-02 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai Europe Limited@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_7.pdf@EU-1-16-1116_h_a_dec_7.pdf@2020-08-25 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_1.pdf@EU-1-16-1129_h_a_dec_1.pdf@2018-02-19 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_4.pdf@EU-1-16-1128_h_a_dec_4.pdf@2020-06-25 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-16-1127_h_a_dec_6.pdf@EU-1-16-1127_h_a_dec_6.pdf@2021-07-16 00:00:00@Tenofovir disoproxil Zentiva@tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_0.pdf@EU-1-16-1130_h_a_dec_0.pdf@2016-10-14 00:00:00@Onivyde@irinotecan@False@False@adopted@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_0.pdf@EU-1-16-1132_h_a_dec_0.pdf@2016-09-15 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_2.pdf@EU-1-16-1129_h_a_dec_2.pdf@2019-10-24 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_5.pdf@EU-1-16-1128_h_a_dec_5.pdf@2020-11-18 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_8.pdf@EU-1-16-1116_h_a_dec_8.pdf@2021-03-22 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_1.pdf@EU-1-16-1130_h_a_dec_1.pdf@2018-07-12 00:00:00@Onivyde@irinotecan@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_3.pdf@EU-1-16-1129_h_a_dec_3.pdf@2020-01-13 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_1.pdf@EU-1-16-1132_h_a_dec_1.pdf@2017-07-17 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_6.pdf@EU-1-16-1128_h_a_dec_6.pdf@2021-06-17 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_2.pdf@EU-1-16-1130_h_a_dec_2.pdf@2018-07-12 00:00:00@Onivyde@irinotecan@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_2.pdf@EU-1-16-1132_h_a_dec_2.pdf@2018-09-17 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1116_h_a_dec_9.pdf@EU-1-16-1116_h_a_dec_9.pdf@2022-07-01 00:00:00@Epclusa@sofosbuvir/velpatasvir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_4.pdf@EU-1-16-1129_h_a_dec_4.pdf@2021-11-01 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1128_h_a_dec_7.pdf@EU-1-16-1128_h_a_dec_7.pdf@2021-11-26 00:00:00@Kisplyx@lenvatinib@False@False@OD Not Found@Eisai GmbH@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_3.pdf@EU-1-16-1130_h_a_dec_3.pdf@2019-01-31 00:00:00@Onivyde@irinotecan@False@False@adopted@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_3.pdf@EU-1-16-1132_h_a_dec_3.pdf@2019-10-29 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_5.pdf@EU-1-16-1129_h_a_dec_5.pdf@2021-08-26 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_0.pdf@EU-1-16-1133_h_a_dec_0.pdf@2016-12-16 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_4.pdf@EU-1-16-1130_h_a_dec_4.pdf@2020-04-23 00:00:00@Onivyde pegylated liposomal@irinotecan@False@False@adopted@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_4.pdf@EU-1-16-1132_h_a_dec_4.pdf@2020-10-02 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Europe AB@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_1.pdf@EU-1-16-1133_h_a_dec_1.pdf@2017-02-06 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_0.pdf@EU-1-16-1134_h_a_dec_0.pdf@2016-09-15 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_5.pdf@EU-1-16-1130_h_a_dec_5.pdf@2020-10-08 00:00:00@Onivyde pegylated liposomal@irinotecan@False@False@adopted@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1129_h_a_dec_6.pdf@EU-1-16-1129_h_a_dec_6.pdf@2021-10-19 00:00:00@Tenofovir disoproxil Mylan@Tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_2.pdf@EU-1-16-1133_h_a_dec_2.pdf@2018-01-30 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_1.pdf@EU-1-16-1134_h_a_dec_1.pdf@2020-06-25 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_5.pdf@EU-1-16-1132_h_a_dec_5.pdf@2021-05-27 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_6.pdf@EU-1-16-1130_h_a_dec_6.pdf@2021-07-16 00:00:00@Onivyde pegylated liposomal@irinotecan@False@False@adopted@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_3.pdf@EU-1-16-1133_h_a_dec_3.pdf@2018-12-06 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_2.pdf@EU-1-16-1134_h_a_dec_2.pdf@2021-07-16 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_6.pdf@EU-1-16-1132_h_a_dec_6.pdf@2021-08-26 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-16-1130_h_a_dec_7.pdf@EU-1-16-1130_h_a_dec_7.pdf@2022-08-22 00:00:00@Onivyde pegylated liposomal@irinotecan@False@False@OD Not Found@Les Laboratoires Servier@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_4.pdf@EU-1-16-1133_h_a_dec_4.pdf@2018-12-17 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1134_h_a_dec_3.pdf@EU-1-16-1134_h_a_dec_3.pdf@2021-10-28 00:00:00@Mysildecard@sildenafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_0.pdf@EU-1-16-1135_h_a_dec_0.pdf@2016-09-15 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_7.pdf@EU-1-16-1132_h_a_dec_7.pdf@2022-06-01 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_5.pdf@EU-1-16-1133_h_a_dec_5.pdf@2021-05-19 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_0.pdf@EU-1-16-1136_h_a_dec_0.pdf@2016-09-09 00:00:00@CABOMETYX@cabozantinib@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_6.pdf@EU-1-16-1133_h_a_dec_6.pdf@2021-09-22 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_1.pdf@EU-1-16-1135_h_a_dec_1.pdf@2018-04-13 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1132_h_a_dec_8.pdf@EU-1-16-1132_h_a_dec_8.pdf@2022-01-20 00:00:00@Inhixa@enoxaparin sodium@False@False@OD Not Found@Techdow Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_1.pdf@EU-1-16-1136_h_a_dec_1.pdf@2018-08-05 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_0.pdf@EU-1-16-1137_h_a_dec_0.pdf@2016-11-14 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1133_h_a_dec_7.pdf@EU-1-16-1133_h_a_dec_7.pdf@2021-11-15 00:00:00@Emtricitabine/Tenofovir disoproxil Mylan@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_2.pdf@EU-1-16-1136_h_a_dec_2.pdf@2018-08-23 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_2.pdf@EU-1-16-1135_h_a_dec_2.pdf@2018-12-04 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_0.pdf@EU-1-16-1138_h_a_dec_0.pdf@2016-05-12 00:00:00@Venclyxto@venetoclax@True@False@adopted@AbbVie Ltd@conditional@Parsed
EU-1-16-1137_h_a_dec_1.pdf@EU-1-16-1137_h_a_dec_1.pdf@2018-01-30 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_3.pdf@EU-1-16-1136_h_a_dec_3.pdf@2018-12-11 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_3.pdf@EU-1-16-1135_h_a_dec_3.pdf@2019-03-28 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_0.pdf@EU-1-16-1139_h_a_dec_0.pdf@2016-12-12 00:00:00@OCALIVA@obeticholic acid@True@False@adopted@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1136_h_a_dec_4.pdf@EU-1-16-1136_h_a_dec_4.pdf@2020-07-31 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_2.pdf@EU-1-16-1137_h_a_dec_2.pdf@2019-05-03 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_0.pdf@EU-1-16-1140_h_a_dec_0.pdf@2017-04-01 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_1.pdf@EU-1-16-1139_h_a_dec_1.pdf@2017-01-12 00:00:00@OCALIVA@obeticholic acid@False@False@OD Not Found@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1136_h_a_dec_5.pdf@EU-1-16-1136_h_a_dec_5.pdf@2021-03-26 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_4.pdf@EU-1-16-1135_h_a_dec_4.pdf@2019-06-18 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Limited@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_3.pdf@EU-1-16-1137_h_a_dec_3.pdf@2020-06-02 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_1.pdf@EU-1-16-1140_h_a_dec_1.pdf@2018-05-24 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_1.pdf@EU-1-16-1138_h_a_dec_1.pdf@2017-10-30 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Ltd@conditional@Parsed
EU-1-16-1136_h_a_dec_6.pdf@EU-1-16-1136_h_a_dec_6.pdf@2021-04-21 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1137_h_a_dec_4.pdf@EU-1-16-1137_h_a_dec_4.pdf@2021-08-27 00:00:00@Granpidam@sildenafil@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_2.pdf@EU-1-16-1140_h_a_dec_2.pdf@2018-06-12 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_10.pdf@EU-1-16-1138_h_a_dec_10.pdf@2021-05-19 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_7.pdf@EU-1-16-1136_h_a_dec_7.pdf@2022-04-29 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
 Not Found@Parsed
EU-1-16-1139_h_a_dec_10.pdf@EU-1-16-1139_h_a_dec_10.pdf@2022-06-24 00:00:00@Ocaliva@obeticholic acid@False@False@adopted@Intercept Pharma International Limited@conditional@Parsed
EU-1-16-1140_h_a_dec_3.pdf@EU-1-16-1140_h_a_dec_3.pdf@2019-12-16 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_11.pdf@EU-1-16-1138_h_a_dec_11.pdf@2021-06-21 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-16-1136_h_a_dec_8.pdf@EU-1-16-1136_h_a_dec_8.pdf@2022-09-29 00:00:00@CABOMETYX@cabozantinib@False@False@OD Not Found@Ipsen Pharma@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_4.pdf@EU-1-16-1140_h_a_dec_4.pdf@2021-01-22 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1135_h_a_dec_6.pdf@EU-1-16-1135_h_a_dec_6.pdf@2021-06-17 00:00:00@Sialanar@glycopyrronium bromide@False@False@OD Not Found@Proveca Pharma Limited@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_2.pdf@EU-1-16-1139_h_a_dec_2.pdf@2018-03-21 00:00:00@OCALIVA@obeticholic acid@False@False@adopted@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1141_h_a_dec_0.pdf@EU-1-16-1141_h_a_dec_0.pdf@2016-08-12 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_5.pdf@EU-1-16-1140_h_a_dec_5.pdf@2021-09-16 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_2.pdf@EU-1-16-1138_h_a_dec_2.pdf@2018-05-31 00:00:00@Venclyxto@venetoclax@False@False@adopted@AbbVie Ltd@conditional@Parsed
EU-1-16-1141_h_a_dec_1.pdf@EU-1-16-1141_h_a_dec_1.pdf@2018-07-06 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_3.pdf@EU-1-16-1139_h_a_dec_3.pdf@2018-12-12 00:00:00@OCALIVA@obeticholic acid@False@False@OD Not Found@Intercept Pharma Ltd@conditional@Parsed
EU-1-16-1138_h_a_dec_3.pdf@EU-1-16-1138_h_a_dec_3.pdf@2018-08-23 00:00:00@Venclyxto@venetoclax@False@False@adopted@AbbVie Deutschland GmbH & Co. KG@conditional@Parsed
EU-1-16-1141_h_a_dec_2.pdf@EU-1-16-1141_h_a_dec_2.pdf@2019-01-10 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1140_h_a_dec_6.pdf@EU-1-16-1140_h_a_dec_6.pdf@2021-10-28 00:00:00@Darunavir Mylan@darunavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_4.pdf@EU-1-16-1138_h_a_dec_4.pdf@2018-06-09 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@conditional@Parsed
EU-1-16-1142_h_a_dec_0.pdf@EU-1-16-1142_h_a_dec_0.pdf@2016-11-11 00:00:00@Parsabiv@etelcalcetide@True@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1141_h_a_dec_3.pdf@EU-1-16-1141_h_a_dec_3.pdf@2020-03-27 00:00:00@SomaKit TOC@edotreotide@False@False@OD Not Found@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_4.pdf@EU-1-16-1139_h_a_dec_4.pdf@2019-01-23 00:00:00@OCALIVA@obeticholic acid@False@False@OD Not Found@Intercept Pharma Ltd@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_5.pdf@EU-1-16-1138_h_a_dec_5.pdf@2018-10-29 00:00:00@Venclyxto@venetoclax@False@False@adopted@AbbVie Deutschland GmbH & Co. KG@conditional@Parsed
EU-1-16-1144_h_a_dec_0.pdf@EU-1-16-1144_h_a_dec_0.pdf@2016-11-11 00:00:00@Ivabradine Zentiva@Ivabradine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1141_h_a_dec_4.pdf@EU-1-16-1141_h_a_dec_4.pdf@2021-09-16 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1142_h_a_dec_1.pdf@EU-1-16-1142_h_a_dec_1.pdf@2018-07-23 00:00:00@Parsabiv@etelcalcetide@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_6.pdf@EU-1-16-1138_h_a_dec_6.pdf@2018-11-20 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@conditional@Parsed
EU-1-16-1141_h_a_dec_5.pdf@EU-1-16-1141_h_a_dec_5.pdf@2021-12-11 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_7.pdf@EU-1-16-1138_h_a_dec_7.pdf@2019-06-28 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-16-1142_h_a_dec_2.pdf@EU-1-16-1142_h_a_dec_2.pdf@2018-08-23 00:00:00@Parsabiv@etelcalcetide@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_0.pdf@EU-1-16-1146_h_a_dec_0.pdf@2016-11-11 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1144_h_a_dec_1.pdf@EU-1-16-1144_h_a_dec_1.pdf@2018-08-13 00:00:00@Ivabradine Zentiva@ivabradine@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_5.pdf@EU-1-16-1139_h_a_dec_5.pdf@2020-11-02 00:00:00@OCALIVA@obeticholic acid@False@False@adopted@Intercept Pharma International Limited@conditional@Parsed
EU-1-16-1138_h_a_dec_8.pdf@EU-1-16-1138_h_a_dec_8.pdf@2020-09-03 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-16-1141_h_a_dec_6.pdf@EU-1-16-1141_h_a_dec_6.pdf@2022-09-19 00:00:00@SomaKit TOC@edotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_1.pdf@EU-1-16-1146_h_a_dec_1.pdf@2018-03-16 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_2.pdf@EU-1-16-1146_h_a_dec_2.pdf@2019-06-06 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_6.pdf@EU-1-16-1139_h_a_dec_6.pdf@2020-04-28 00:00:00@OCALIVA@obeticholic acid@False@False@OD Not Found@Intercept Pharma International Limited@conditional@Parsed
EU-1-16-1142_h_a_dec_3.pdf@EU-1-16-1142_h_a_dec_3.pdf@2019-09-23 00:00:00@Parsabiv@etelcalcetide@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1144_h_a_dec_2.pdf@EU-1-16-1144_h_a_dec_2.pdf@2021-01-29 00:00:00@Ivabradine Zentiva@ivabradine@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_3.pdf@EU-1-16-1146_h_a_dec_3.pdf@2020-10-15 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1138_h_a_dec_9.pdf@EU-1-16-1138_h_a_dec_9.pdf@2020-08-04 00:00:00@Venclyxto@venetoclax@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-16-1142_h_a_dec_4.pdf@EU-1-16-1142_h_a_dec_4.pdf@2021-09-16 00:00:00@Parsabiv@etelcalcetide@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1146_h_a_dec_4.pdf@EU-1-16-1146_h_a_dec_4.pdf@2021-07-16 00:00:00@Glyxambi@empagliflozin/linagliptin@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-16-1144_h_a_dec_3.pdf@EU-1-16-1144_h_a_dec_3.pdf@2021-09-29 00:00:00@Ivabradine Zentiva@ivabradine@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_7.pdf@EU-1-16-1139_h_a_dec_7.pdf@2021-11-01 00:00:00@Ocaliva@obeticholic acid@False@False@OD Not Found@Intercept Pharma International Limited@conditional@Parsed
EU-1-16-1139_h_a_dec_8.pdf@EU-1-16-1139_h_a_dec_8.pdf@2021-11-18 00:00:00@Ocaliva@obeticholic acid@False@False@adopted@Intercept Pharma International Limited@conditional@Parsed
EU-1-16-1148_h_a_dec_0.pdf@EU-1-16-1148_h_a_dec_0.pdf@2016-09-11 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_0.pdf@EU-1-16-1147_h_a_dec_0.pdf@2016-09-11 00:00:00@IBRANCE@palbociclib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_0.pdf@EU-1-16-1151_h_a_dec_0.pdf@2016-08-12 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka, d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-16-1150_h_a_dec_0.pdf@EU-1-16-1150_h_a_dec_0.pdf@2016-12-12 00:00:00@Rekovelle@follitropin delta@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-16-1150_h_a_dec_1.pdf@EU-1-16-1150_h_a_dec_1.pdf@2018-08-05 00:00:00@Rekovelle@follitropin delta@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_1.pdf@EU-1-16-1148_h_a_dec_1.pdf@2017-10-13 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_1.pdf@EU-1-16-1151_h_a_dec_1.pdf@2017-02-05 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_1.pdf@EU-1-16-1147_h_a_dec_1.pdf@2018-01-24 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-16-1150_h_a_dec_2.pdf@EU-1-16-1150_h_a_dec_2.pdf@2021-07-16 00:00:00@Rekovelle@follitropin delta@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-16-1139_h_a_dec_9.pdf@EU-1-16-1139_h_a_dec_9.pdf@2022-12-01 00:00:00@Ocaliva@obeticholic acid@False@False@OD Not Found@Intercept Pharma International Limited@conditional@Parsed
EU-1-16-1152_h_a_dec_1.pdf@EU-1-16-1152_h_a_dec_1.pdf@2018-07-26 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_2.pdf@EU-1-16-1148_h_a_dec_2.pdf@2019-01-23 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_0.pdf@EU-1-16-1153_h_a_dec_0.pdf@2017-09-01 00:00:00@Tadalafil Generics@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_2.pdf@EU-1-16-1151_h_a_dec_2.pdf@2017-11-15 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-16-1152_h_a_dec_2.pdf@EU-1-16-1152_h_a_dec_2.pdf@2019-07-25 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_3.pdf@EU-1-16-1148_h_a_dec_3.pdf@2019-03-09 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_1.pdf@EU-1-16-1153_h_a_dec_1.pdf@2018-02-19 00:00:00@Talmanco@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_2.pdf@EU-1-16-1147_h_a_dec_2.pdf@2018-07-30 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_3.pdf@EU-1-16-1151_h_a_dec_3.pdf@2018-11-20 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_2.pdf@EU-1-16-1153_h_a_dec_2.pdf@2020-11-16 00:00:00@Talmanco@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_4.pdf@EU-1-16-1148_h_a_dec_4.pdf@2021-09-03 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_3.pdf@EU-1-16-1147_h_a_dec_3.pdf@2019-10-24 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_4.pdf@EU-1-16-1151_h_a_dec_4.pdf@2020-07-23 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-16-1152_h_a_dec_4.pdf@EU-1-16-1152_h_a_dec_4.pdf@2021-06-24 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Berlin-Chemie AG@CMA Not Found@Parsed
EU-1-16-1148_h_a_dec_5.pdf@EU-1-16-1148_h_a_dec_5.pdf@2021-07-16 00:00:00@Emtricitabine/Tenofovir disoproxil Zentiva@emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_4.pdf@EU-1-16-1147_h_a_dec_4.pdf@2019-11-19 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_3.pdf@EU-1-16-1153_h_a_dec_3.pdf@2021-11-22 00:00:00@Talmanco@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_0.pdf@EU-1-16-1154_h_a_dec_0.pdf@2017-09-01 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Ltd.@CMA Not Found@Parsed
EU-1-16-1152_h_a_dec_5.pdf@EU-1-16-1152_h_a_dec_5.pdf@2021-09-12 00:00:00@Roteas@edoxaban@False@False@OD Not Found@Berlin-Chemie AG@CMA Not Found@Parsed
EU-1-16-1153_h_a_dec_4.pdf@EU-1-16-1153_h_a_dec_4.pdf@2021-09-11 00:00:00@Talmanco@tadalafil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_0.pdf@EU-1-16-1155_h_a_dec_0.pdf@2017-07-17 00:00:00@Kyntheum@brodalumab@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_5.pdf@EU-1-16-1147_h_a_dec_5.pdf@2020-02-13 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1151_h_a_dec_5.pdf@EU-1-16-1151_h_a_dec_5.pdf@2021-09-15 00:00:00@Emtricitabine/Tenofovir disoproxil Krka@emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_1.pdf@EU-1-16-1154_h_a_dec_1.pdf@2018-05-28 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_6.pdf@EU-1-16-1147_h_a_dec_6.pdf@2021-05-19 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_1.pdf@EU-1-16-1155_h_a_dec_1.pdf@2018-02-08 00:00:00@Kyntheum@brodalumab@False@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_2.pdf@EU-1-16-1155_h_a_dec_2.pdf@2019-09-13 00:00:00@Kyntheum@brodalumab@False@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-16-1147_h_a_dec_7.pdf@EU-1-16-1147_h_a_dec_7.pdf@2021-07-16 00:00:00@IBRANCE@palbociclib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_0.pdf@EU-1-16-1157_h_a_dec_0.pdf@2017-11-01 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_2.pdf@EU-1-16-1154_h_a_dec_2.pdf@2020-01-04 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1156_h_a_dec_0.pdf@EU-1-16-1156_h_a_dec_0.pdf@2017-01-18 00:00:00@ZINPLAVA@bezlotoxumab@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_3.pdf@EU-1-16-1155_h_a_dec_3.pdf@2020-09-30 00:00:00@Kyntheum@brodalumab@False@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_0.pdf@EU-1-16-1158_h_a_dec_0.pdf@2017-04-01 00:00:00@AFSTYLA@lonoctocog alfa@True@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_1.pdf@EU-1-16-1157_h_a_dec_1.pdf@2018-04-19 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1155_h_a_dec_4.pdf@EU-1-16-1155_h_a_dec_4.pdf@2022-04-25 00:00:00@Kyntheum@brodalumab@False@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_1.pdf@EU-1-16-1158_h_a_dec_1.pdf@2019-02-25 00:00:00@AFSTYLA@lonoctocog alfa@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_2.pdf@EU-1-16-1157_h_a_dec_2.pdf@2019-03-09 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_3.pdf@EU-1-16-1154_h_a_dec_3.pdf@2020-08-25 00:00:00@Vemlidy@tenofovir  alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1156_h_a_dec_1.pdf@EU-1-16-1156_h_a_dec_1.pdf@2018-06-15 00:00:00@ZINPLAVA@bezlotoxumab@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_0.pdf@EU-1-16-1159_h_a_dec_0.pdf@2017-04-01 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_2.pdf@EU-1-16-1158_h_a_dec_2.pdf@2020-03-04 00:00:00@AFSTYLA@lonoctocog alfa@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_3.pdf@EU-1-16-1157_h_a_dec_3.pdf@2020-02-17 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1156_h_a_dec_2.pdf@EU-1-16-1156_h_a_dec_2.pdf@2021-01-09 00:00:00@ZINPLAVA@bezlotoxumab@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_1.pdf@EU-1-16-1159_h_a_dec_1.pdf@2018-05-03 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1158_h_a_dec_3.pdf@EU-1-16-1158_h_a_dec_3.pdf@2021-08-20 00:00:00@AFSTYLA@lonoctocog alfa@False@False@OD Not Found@CSL Behring GmbH@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_4.pdf@EU-1-16-1154_h_a_dec_4.pdf@2021-09-29 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_4.pdf@EU-1-16-1157_h_a_dec_4.pdf@2020-09-03 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_0.pdf@EU-1-16-1160_h_a_dec_0.pdf@2017-09-01 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_0.pdf@EU-1-16-1161_h_a_dec_0.pdf@2017-11-01 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_5.pdf@EU-1-16-1154_h_a_dec_5.pdf@2021-12-16 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_2.pdf@EU-1-16-1159_h_a_dec_2.pdf@2019-06-02 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_1.pdf@EU-1-16-1160_h_a_dec_1.pdf@2018-12-04 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_5.pdf@EU-1-16-1157_h_a_dec_5.pdf@2021-12-11 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_3.pdf@EU-1-16-1159_h_a_dec_3.pdf@2020-09-03 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1154_h_a_dec_6.pdf@EU-1-16-1154_h_a_dec_6.pdf@2022-08-17 00:00:00@Vemlidy@tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_1.pdf@EU-1-16-1161_h_a_dec_1.pdf@2018-04-19 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_6.pdf@EU-1-16-1157_h_a_dec_6.pdf@2021-11-22 00:00:00@Suliqua@insulin glargine / lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_0.pdf@EU-1-16-1164_h_a_dec_0.pdf@2017-03-22 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_0.pdf@EU-1-16-1166_h_a_dec_0.pdf@2017-02-27 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1159_h_a_dec_4.pdf@EU-1-16-1159_h_a_dec_4.pdf@2021-09-16 00:00:00@Terrosa@teriparatide@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-16-1157_h_a_dec_7.pdf@EU-1-16-1157_h_a_dec_7.pdf@2022-08-22 00:00:00@Suliqua@insulin glargine /  lixisenatide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_1.pdf@EU-1-16-1164_h_a_dec_1.pdf@2018-10-29 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_2.pdf@EU-1-16-1160_h_a_dec_2.pdf@2019-02-25 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_2.pdf@EU-1-16-1161_h_a_dec_2.pdf@2020-12-05 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_1.pdf@EU-1-16-1166_h_a_dec_1.pdf@2018-11-28 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_2.pdf@EU-1-16-1164_h_a_dec_2.pdf@2018-11-28 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_2.pdf@EU-1-16-1166_h_a_dec_2.pdf@2019-12-16 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1161_h_a_dec_3.pdf@EU-1-16-1161_h_a_dec_3.pdf@2021-09-16 00:00:00@Movymia@teriparatide@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_3.pdf@EU-1-16-1160_h_a_dec_3.pdf@2019-01-07 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_3.pdf@EU-1-16-1164_h_a_dec_3.pdf@2019-03-28 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_0.pdf@EU-1-16-1167_h_a_dec_0.pdf@2017-02-17 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_3.pdf@EU-1-16-1166_h_a_dec_3.pdf@2021-10-03 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_4.pdf@EU-1-16-1160_h_a_dec_4.pdf@2019-07-31 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_4.pdf@EU-1-16-1164_h_a_dec_4.pdf@2020-02-06 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_0.pdf@EU-1-16-1168_h_a_dec_0.pdf@2017-02-13 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_1.pdf@EU-1-16-1167_h_a_dec_1.pdf@2018-04-26 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1166_h_a_dec_4.pdf@EU-1-16-1166_h_a_dec_4.pdf@2021-11-22 00:00:00@Pregabalin Zentiva k.s@pregabalin@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_5.pdf@EU-1-16-1160_h_a_dec_5.pdf@2020-09-30 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_1.pdf@EU-1-16-1168_h_a_dec_1.pdf@2018-12-20 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_2.pdf@EU-1-16-1167_h_a_dec_2.pdf@2019-11-04 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_5.pdf@EU-1-16-1164_h_a_dec_5.pdf@2021-12-08 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1160_h_a_dec_6.pdf@EU-1-16-1160_h_a_dec_6.pdf@2021-08-18 00:00:00@Fiasp@insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_2.pdf@EU-1-16-1168_h_a_dec_2.pdf@2020-07-17 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_0.pdf@EU-1-16-1169_h_a_dec_0.pdf@2017-02-16 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-16-1170_h_a_dec_0.pdf@EU-1-16-1170_h_a_dec_0.pdf@2017-02-13 00:00:00@Olumiant@baricitinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_3.pdf@EU-1-16-1167_h_a_dec_3.pdf@2019-07-19 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_3.pdf@EU-1-16-1168_h_a_dec_3.pdf@2021-09-07 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_4.pdf@EU-1-16-1167_h_a_dec_4.pdf@2020-10-15 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_1.pdf@EU-1-16-1170_h_a_dec_1.pdf@2018-06-29 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1164_h_a_dec_6.pdf@EU-1-16-1164_h_a_dec_6.pdf@2021-09-12 00:00:00@AMGEVITA@adalimumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-16-1168_h_a_dec_4.pdf@EU-1-16-1168_h_a_dec_4.pdf@2021-09-22 00:00:00@Vihuma@simoctocog alfa@False@False@OD Not Found@Octapharma AB@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_2.pdf@EU-1-16-1170_h_a_dec_2.pdf@2018-04-09 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_5.pdf@EU-1-16-1167_h_a_dec_5.pdf@2021-08-18 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_0.pdf@EU-1-16-1171_h_a_dec_0.pdf@2017-03-03 00:00:00@Ledaga@chlormethine@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_3.pdf@EU-1-16-1170_h_a_dec_3.pdf@2018-04-09 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_6.pdf@EU-1-16-1167_h_a_dec_6.pdf@2021-11-15 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_4.pdf@EU-1-16-1170_h_a_dec_4.pdf@2019-09-16 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_2.pdf@EU-1-16-1169_h_a_dec_2.pdf@2017-12-18 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration Limited@conditional@Parsed
EU-1-16-1171_h_a_dec_1.pdf@EU-1-16-1171_h_a_dec_1.pdf@2018-05-28 00:00:00@Ledaga@chlormethine@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-17-1173_h_a_dec_0.pdf@EU-1-17-1173_h_a_dec_0.pdf@2018-03-22 00:00:00@Lokelma@sodium zirconium cyclosilicate@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_5.pdf@EU-1-16-1170_h_a_dec_5.pdf@2019-11-22 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_0.pdf@EU-1-17-1172_h_a_dec_0.pdf@2017-03-29 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind Ltd@CMA Not Found@Parsed
EU-1-16-1167_h_a_dec_7.pdf@EU-1-16-1167_h_a_dec_7.pdf@2022-08-17 00:00:00@Truxima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1173_h_a_dec_1.pdf@EU-1-17-1173_h_a_dec_1.pdf@2019-11-04 00:00:00@Lokelma@sodium zirconium cyclosilicate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_3.pdf@EU-1-16-1169_h_a_dec_3.pdf@2018-03-15 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_6.pdf@EU-1-16-1170_h_a_dec_6.pdf@2020-10-19 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_2.pdf@EU-1-16-1171_h_a_dec_2.pdf@2018-12-18 00:00:00@Ledaga@chlormethine@False@False@adopted@Actelion Registration Ltd@CMA Not Found@Parsed
EU-1-17-1173_h_a_dec_2.pdf@EU-1-17-1173_h_a_dec_2.pdf@2020-04-28 00:00:00@Lokelma@sodium zirconium cyclosilicate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_1.pdf@EU-1-17-1172_h_a_dec_1.pdf@2018-05-22 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind Ltd@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_7.pdf@EU-1-16-1170_h_a_dec_7.pdf@2020-11-20 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_4.pdf@EU-1-16-1169_h_a_dec_4.pdf@2018-05-31 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1173_h_a_dec_3.pdf@EU-1-17-1173_h_a_dec_3.pdf@2022-01-24 00:00:00@Lokelma@sodium zirconium cyclosilicate@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_0.pdf@EU-1-17-1174_h_a_dec_0.pdf@2017-03-20 00:00:00@Rolufta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_8.pdf@EU-1-16-1170_h_a_dec_8.pdf@2021-12-11 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_5.pdf@EU-1-16-1169_h_a_dec_5.pdf@2020-03-04 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_3.pdf@EU-1-16-1171_h_a_dec_3.pdf@2020-02-28 00:00:00@Ledaga@chlormethine@False@False@adopted@Helsinn Birex Pharmaceuticals Ltd.@CMA Not Found@Parsed
EU-1-16-1170_h_a_dec_9.pdf@EU-1-16-1170_h_a_dec_9.pdf@2022-06-20 00:00:00@Olumiant@baricitinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_2.pdf@EU-1-17-1172_h_a_dec_2.pdf@2019-03-28 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind Ltd@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_6.pdf@EU-1-16-1169_h_a_dec_6.pdf@2022-07-15 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_1.pdf@EU-1-17-1174_h_a_dec_1.pdf@2018-06-21 00:00:00@Rolufta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-16-1171_h_a_dec_4.pdf@EU-1-16-1171_h_a_dec_4.pdf@2022-07-01 00:00:00@Ledaga@chlormethine@False@False@OD Not Found@Helsinn Birex Pharmaceuticals Ltd.@CMA Not Found@Parsed
EU-1-16-1169_h_a_dec_7.pdf@EU-1-16-1169_h_a_dec_7.pdf@2022-02-08 00:00:00@Alecensa@alectinib@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_0.pdf@EU-1-17-1176_h_a_dec_0.pdf@2017-03-22 00:00:00@Yargesa@miglustat@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_0.pdf@EU-1-17-1175_h_a_dec_0.pdf@2017-03-22 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_2.pdf@EU-1-17-1174_h_a_dec_2.pdf@2019-07-25 00:00:00@Rolufta Ellipta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_1.pdf@EU-1-17-1175_h_a_dec_1.pdf@2018-08-02 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_1.pdf@EU-1-17-1176_h_a_dec_1.pdf@2018-04-19 00:00:00@Yargesa@miglustat@False@False@OD Not Found@JensonR+ Limited@CMA Not Found@Parsed
EU-1-17-1177_h_a_dec_0.pdf@EU-1-17-1177_h_a_dec_0.pdf@2017-03-22 00:00:00@Tadalafil Lilly@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_4.pdf@EU-1-17-1172_h_a_dec_4.pdf@2019-08-26 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind (Europe) Limited@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_3.pdf@EU-1-17-1174_h_a_dec_3.pdf@2019-09-26 00:00:00@Rolufta Ellipta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1177_h_a_dec_1.pdf@EU-1-17-1177_h_a_dec_1.pdf@2018-05-30 00:00:00@Tadalafil Lilly@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_2.pdf@EU-1-17-1176_h_a_dec_2.pdf@2019-12-02 00:00:00@Yargesa@miglustat@False@False@OD Not Found@JensonR+ Limited@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_0.pdf@EU-1-17-1178_h_a_dec_0.pdf@2017-03-22 00:00:00@Xeljanz@Tofacitinib@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_0.pdf@EU-1-17-1179_h_a_dec_0.pdf@2017-07-19 00:00:00@Veltassa@patiromer@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_2.pdf@EU-1-17-1175_h_a_dec_2.pdf@2018-11-14 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Hospira UK Limited@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_3.pdf@EU-1-17-1176_h_a_dec_3.pdf@2019-04-15 00:00:00@Yargesa@miglustat@False@False@OD Not Found@Piramal Critical Care B.V.@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_4.pdf@EU-1-17-1174_h_a_dec_4.pdf@2020-09-30 00:00:00@Rolufta Ellipta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_1.pdf@EU-1-17-1179_h_a_dec_1.pdf@2019-06-06 00:00:00@Veltassa@patiromer@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma France@CMA Not Found@Parsed
EU-1-17-1177_h_a_dec_2.pdf@EU-1-17-1177_h_a_dec_2.pdf@2021-12-11 00:00:00@Tadalafil Lilly@tadalafil@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_3.pdf@EU-1-17-1175_h_a_dec_3.pdf@2019-01-10 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_5.pdf@EU-1-17-1172_h_a_dec_5.pdf@2019-10-21 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  21.10.2019  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2017) 2220(final) for “Jylamvo@methotrexate@False@False@OD Not Found@Therakind (Europe) Limited@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_4.pdf@EU-1-17-1176_h_a_dec_4.pdf@2021-01-29 00:00:00@Yargesa@miglustat@False@False@OD Not Found@Piramal Critical Care B.V.@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_2.pdf@EU-1-17-1179_h_a_dec_2.pdf@2021-10-22 00:00:00@Veltassa@patiromer@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma France@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_1.pdf@EU-1-17-1178_h_a_dec_1.pdf@2018-06-21 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1175_h_a_dec_4.pdf@EU-1-17-1175_h_a_dec_4.pdf@2021-12-11 00:00:00@Daptomycin Hospira@daptomycin@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1176_h_a_dec_5.pdf@EU-1-17-1176_h_a_dec_5.pdf@2022-11-01 00:00:00@Yargesa@miglustat@False@False@OD Not Found@Piramal Critical Care B.V.@CMA Not Found@Parsed
EU-1-17-1174_h_a_dec_5.pdf@EU-1-17-1174_h_a_dec_5.pdf@2022-07-01 00:00:00@Rolufta Ellipta@umeclidinium@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_10.pdf@EU-1-17-1178_h_a_dec_10.pdf@2021-11-15 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1179_h_a_dec_3.pdf@EU-1-17-1179_h_a_dec_3.pdf@2022-03-24 00:00:00@Veltassa@patiromer@False@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_6.pdf@EU-1-17-1172_h_a_dec_6.pdf@2020-10-08 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind (Europe) Limited@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_0.pdf@EU-1-17-1181_h_a_dec_0.pdf@2017-10-07 00:00:00@Spherox@associated chondrocytes@True@True@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_11.pdf@EU-1-17-1178_h_a_dec_11.pdf@2022-04-03 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_0.pdf@EU-1-17-1182_h_a_dec_0.pdf@2017-04-28 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA, d.d.@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_12.pdf@EU-1-17-1178_h_a_dec_12.pdf@2022-06-24 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_0.pdf@EU-1-17-1184_h_a_dec_0.pdf@2017-06-15 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_1.pdf@EU-1-17-1181_h_a_dec_1.pdf@2019-11-04 00:00:00@Spherox@spheroids  human autologous matrix-associated chondrocytes@False@False@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1172_h_a_dec_7.pdf@EU-1-17-1172_h_a_dec_7.pdf@2021-11-22 00:00:00@Jylamvo@methotrexate@False@False@OD Not Found@Therakind (Europe) Limited@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_0.pdf@EU-1-17-1185_h_a_dec_0.pdf@2017-06-15 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_1.pdf@EU-1-17-1182_h_a_dec_1.pdf@2017-10-11 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_1.pdf@EU-1-17-1184_h_a_dec_1.pdf@2018-11-10 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_13.pdf@EU-1-17-1178_h_a_dec_13.pdf@2022-09-13 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_2.pdf@EU-1-17-1181_h_a_dec_2.pdf@2020-09-10 00:00:00@Spherox@spheroids  human autologous matrix-associated chondrocytes@False@False@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_1.pdf@EU-1-17-1185_h_a_dec_1.pdf@2018-09-20 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_2.pdf@EU-1-17-1182_h_a_dec_2.pdf@2019-08-07 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_2.pdf@EU-1-17-1184_h_a_dec_2.pdf@2019-09-16 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_0.pdf@EU-1-17-1186_h_a_dec_0.pdf@2017-05-22 00:00:00@Axumin@fluciclovine (18F)@True@False@OD Not Found@Blue Earth Diagnostics Ltd@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_3.pdf@EU-1-17-1181_h_a_dec_3.pdf@2020-11-20 00:00:00@Spherox@spheroids  human autologous matrix-associated chondrocytes@False@False@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_2.pdf@EU-1-17-1185_h_a_dec_2.pdf@2019-09-23 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_3.pdf@EU-1-17-1182_h_a_dec_3.pdf@2020-06-25 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir disoproxil@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_3.pdf@EU-1-17-1184_h_a_dec_3.pdf@2020-09-10 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_2.pdf@EU-1-17-1178_h_a_dec_2.pdf@2018-06-25 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Limited@conditional@Parsed
EU-1-17-1181_h_a_dec_4.pdf@EU-1-17-1181_h_a_dec_4.pdf@2021-06-28 00:00:00@Spherox@spheroids  human autologous matrix-associated chondrocytes@False@False@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_3.pdf@EU-1-17-1185_h_a_dec_3.pdf@2020-09-10 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_1.pdf@EU-1-17-1186_h_a_dec_1.pdf@2019-01-23 00:00:00@Axumin@fluciclovine (18F)@False@False@OD Not Found@Blue Earth Diagnostics Ltd@CMA Not Found@Parsed
EU-1-17-1182_h_a_dec_4.pdf@EU-1-17-1182_h_a_dec_4.pdf@2022-06-01 00:00:00@Emtricitabine /Tenofovir disoproxil Krka d.d.@emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_4.pdf@EU-1-17-1184_h_a_dec_4.pdf@2021-05-27 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1181_h_a_dec_5.pdf@EU-1-17-1181_h_a_dec_5.pdf@2022-04-29 00:00:00@Spherox@spheroids  human autologous matrix-associated chondrocytes@False@False@OD Not Found@CO.DON AG@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_4.pdf@EU-1-17-1185_h_a_dec_4.pdf@2021-08-20 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_3.pdf@EU-1-17-1178_h_a_dec_3.pdf@2018-07-26 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_5.pdf@EU-1-17-1184_h_a_dec_5.pdf@2021-08-26 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_5.pdf@EU-1-17-1185_h_a_dec_5.pdf@2022-02-24 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_0.pdf@EU-1-17-1187_h_a_dec_0.pdf@2017-05-24 00:00:00@Trumenba@meningococcal group B vaccine  (recombinant, adsorbed)@True@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_2.pdf@EU-1-17-1186_h_a_dec_2.pdf@2019-06-02 00:00:00@Axumin@fluciclovine (18F)@False@False@OD Not Found@Blue Earth Diagnostics Ltd@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_6.pdf@EU-1-17-1184_h_a_dec_6.pdf@2022-02-16 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_4.pdf@EU-1-17-1178_h_a_dec_4.pdf@2018-08-11 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1185_h_a_dec_6.pdf@EU-1-17-1185_h_a_dec_6.pdf@2022-08-17 00:00:00@Rixathon@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_0.pdf@EU-1-17-1189_h_a_dec_0.pdf@2017-02-06 00:00:00@Elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1184_h_a_dec_7.pdf@EU-1-17-1184_h_a_dec_7.pdf@2022-08-17 00:00:00@Riximyo@rituximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_0.pdf@EU-1-17-1188_h_a_dec_0.pdf@2017-05-30 00:00:00@Spinraza@nusinersen@True@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_5.pdf@EU-1-17-1178_h_a_dec_5.pdf@2019-06-27 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_1.pdf@EU-1-17-1187_h_a_dec_1.pdf@2018-09-27 00:00:00@Trumenba@meningococcal group B vaccine (recombinant,  adsorbed)@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_1.pdf@EU-1-17-1189_h_a_dec_1.pdf@2019-01-31 00:00:00@Elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_3.pdf@EU-1-17-1186_h_a_dec_3.pdf@2020-08-25 00:00:00@Axumin@fluciclovine ( 18F)@False@False@OD Not Found@Blue Earth Diagnostics Ireland Ltd@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_2.pdf@EU-1-17-1187_h_a_dec_2.pdf@2020-06-18 00:00:00@Trumenba@meningococcal group B vaccine (recombinant, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_6.pdf@EU-1-17-1178_h_a_dec_6.pdf@2019-12-16 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_2.pdf@EU-1-17-1189_h_a_dec_2.pdf@2019-08-23 00:00:00@Elmiron@pentosan polysulfate  sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_1.pdf@EU-1-17-1188_h_a_dec_1.pdf@2018-08-31 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_3.pdf@EU-1-17-1187_h_a_dec_3.pdf@2020-05-11 00:00:00@Trumenba@meningococcal group B vaccine (recombinant, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_7.pdf@EU-1-17-1178_h_a_dec_7.pdf@2020-01-31 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_3.pdf@EU-1-17-1189_h_a_dec_3.pdf@2020-03-04 00:00:00@Elmiron@pentosan polysulfate  sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_4.pdf@EU-1-17-1186_h_a_dec_4.pdf@2021-11-18 00:00:00@Axumin@fluciclovine (18F)@False@False@OD Not Found@Blue Earth Diagnostics Ireland Ltd@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_8.pdf@EU-1-17-1178_h_a_dec_8.pdf@2021-07-23 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_4.pdf@EU-1-17-1189_h_a_dec_4.pdf@2021-09-29 00:00:00@elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1187_h_a_dec_4.pdf@EU-1-17-1187_h_a_dec_4.pdf@2022-04-25 00:00:00@Trumenba@meningococcal group B vaccine (recombinant, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_2.pdf@EU-1-17-1188_h_a_dec_2.pdf@2018-08-11 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1190_h_a_dec_0.pdf@EU-1-17-1190_h_a_dec_0.pdf@2017-05-22 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1178_h_a_dec_9.pdf@EU-1-17-1178_h_a_dec_9.pdf@2021-08-18 00:00:00@Xeljanz@Tofacitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1189_h_a_dec_5.pdf@EU-1-17-1189_h_a_dec_5.pdf@2022-11-01 00:00:00@elmiron@pentosan polysulfate sodium@False@False@OD Not Found@bene-Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-17-1186_h_a_dec_5.pdf@EU-1-17-1186_h_a_dec_5.pdf@2022-10-02 00:00:00@Axumin@fluciclovine (18F)@False@False@OD Not Found@Blue Earth Diagnostics Ireland Ltd@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_3.pdf@EU-1-17-1188_h_a_dec_3.pdf@2018-11-28 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-17-1190_h_a_dec_1.pdf@EU-1-17-1190_h_a_dec_1.pdf@2019-06-02 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_0.pdf@EU-1-17-1191_h_a_dec_0.pdf@2017-08-05 00:00:00@Dinutuximab beta Apeiron@dinutuximab beta@False@False@adopted@APEIRON Biologics AG@exceptional@Parsed
EU-1-17-1188_h_a_dec_4.pdf@EU-1-17-1188_h_a_dec_4.pdf@2019-03-25 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-17-1190_h_a_dec_2.pdf@EU-1-17-1190_h_a_dec_2.pdf@2020-04-02 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1193_h_a_dec_0.pdf@EU-1-17-1193_h_a_dec_0.pdf@2017-02-06 00:00:00@Refixia@nonacog beta pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_1.pdf@EU-1-17-1191_h_a_dec_1.pdf@2017-07-17 00:00:00@Dinutuximab beta Apeiron@dinutuximab beta@False@False@adopted@APEIRON Biologics AG@exceptional@Parsed
EU-1-17-1190_h_a_dec_3.pdf@EU-1-17-1190_h_a_dec_3.pdf@2022-02-14 00:00:00@Ivabradine Accord@ivabradine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_5.pdf@EU-1-17-1188_h_a_dec_5.pdf@2019-08-23 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-17-1194_h_a_dec_0.pdf@EU-1-17-1194_h_a_dec_0.pdf@2017-06-15 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_0.pdf@EU-1-17-1192_h_a_dec_0.pdf@2017-05-30 00:00:00@Brineura@cerliponase  alfa@True@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1193_h_a_dec_1.pdf@EU-1-17-1193_h_a_dec_1.pdf@2022-02-21 00:00:00@Refixia@nonacog beta pegol@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1188_h_a_dec_6.pdf@EU-1-17-1188_h_a_dec_6.pdf@2021-01-14 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-17-1194_h_a_dec_1.pdf@EU-1-17-1194_h_a_dec_1.pdf@2019-06-06 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_2.pdf@EU-1-17-1191_h_a_dec_2.pdf@2018-07-19 00:00:00@Qarziba@dinutuximab beta@False@False@adopted@EUSA Pharma (UK) Limited@exceptional@Parsed
EU-1-17-1188_h_a_dec_7.pdf@EU-1-17-1188_h_a_dec_7.pdf@2022-01-31 00:00:00@Spinraza@nusinersen@False@False@adopted@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-17-1194_h_a_dec_2.pdf@EU-1-17-1194_h_a_dec_2.pdf@2020-11-25 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_0.pdf@EU-1-17-1195_h_a_dec_0.pdf@2017-06-23 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_1.pdf@EU-1-17-1192_h_a_dec_1.pdf@2018-11-20 00:00:00@Brineura@cerliponase alfa@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_1.pdf@EU-1-17-1195_h_a_dec_1.pdf@2018-11-07 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_0.pdf@EU-1-17-1196_h_a_dec_0.pdf@2017-06-23 00:00:00@Kevzara@sarilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_3.pdf@EU-1-17-1191_h_a_dec_3.pdf@2019-11-03 00:00:00@Qarziba@dinutuximab beta@False@False@OD Not Found@EUSA Pharma (UK) Limited@exceptional@Parsed
EU-1-17-1194_h_a_dec_3.pdf@EU-1-17-1194_h_a_dec_3.pdf@2021-09-22 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_2.pdf@EU-1-17-1195_h_a_dec_2.pdf@2019-11-14 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1197_h_a_dec_0.pdf@EU-1-17-1197_h_a_dec_0.pdf@2017-06-07 00:00:00@OXERVATE@cenegermin@True@False@adopted@Dompé farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_1.pdf@EU-1-17-1196_h_a_dec_1.pdf@2018-12-12 00:00:00@Kevzara@sarilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_2.pdf@EU-1-17-1192_h_a_dec_2.pdf@2019-11-19 00:00:00@Brineura@cerliponase alfa@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_4.pdf@EU-1-17-1191_h_a_dec_4.pdf@2020-09-06 00:00:00@Qarziba@dinutuximab beta@False@False@adopted@EUSA Pharma (Netherlands) B.V.@exceptional@Parsed
EU-1-17-1195_h_a_dec_3.pdf@EU-1-17-1195_h_a_dec_3.pdf@2020-09-30 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1197_h_a_dec_1.pdf@EU-1-17-1197_h_a_dec_1.pdf@2022-03-28 00:00:00@OXERVATE@cenegermin@False@False@adopted@Dompé farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1199_h_a_dec_0.pdf@EU-1-17-1199_h_a_dec_0.pdf@2017-05-09 00:00:00@Cuprior@trientine@False@False@adopted@gmp-orphan SA@CMA Not Found@Parsed
EU-1-17-1191_h_a_dec_5.pdf@EU-1-17-1191_h_a_dec_5.pdf@2022-06-01 00:00:00@Qarziba@dinutuximab beta@False@False@adopted@EUSA Pharma (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_2.pdf@EU-1-17-1196_h_a_dec_2.pdf@2020-04-28 00:00:00@Kevzara@sarilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1194_h_a_dec_4.pdf@EU-1-17-1194_h_a_dec_4.pdf@2022-02-16 00:00:00@Febuxostat Mylan@febuxostat@False@False@OD Not Found@Mylan Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_4.pdf@EU-1-17-1195_h_a_dec_4.pdf@2021-10-19 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_3.pdf@EU-1-17-1192_h_a_dec_3.pdf@2020-02-13 00:00:00@Brineura@cerliponase alfa@False@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1199_h_a_dec_1.pdf@EU-1-17-1199_h_a_dec_1.pdf@2019-06-25 00:00:00@Cuprior@trientine@False@False@OD Not Found@gmp-orphan SA@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_3.pdf@EU-1-17-1196_h_a_dec_3.pdf@2020-11-19 00:00:00@Kevzara@sarilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1195_h_a_dec_5.pdf@EU-1-17-1195_h_a_dec_5.pdf@2022-04-04 00:00:00@Erelzi@etanercept@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-17-1199_h_a_dec_2.pdf@EU-1-17-1199_h_a_dec_2.pdf@2020-09-10 00:00:00@Cuprior@trientine@False@False@OD Not Found@Orphalan@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_4.pdf@EU-1-17-1196_h_a_dec_4.pdf@2021-11-15 00:00:00@Kevzara@sarilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1199_h_a_dec_3.pdf@EU-1-17-1199_h_a_dec_3.pdf@2022-08-17 00:00:00@Cuprior@trientine@False@False@OD Not Found@Orphalan@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_4.pdf@EU-1-17-1192_h_a_dec_4.pdf@2021-12-05 00:00:00@Brineura@cerliponase alfa@False@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1200_h_a_dec_0.pdf@EU-1-17-1200_h_a_dec_0.pdf@2017-06-29 00:00:00@Besponsa@inotuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1196_h_a_dec_5.pdf@EU-1-17-1196_h_a_dec_5.pdf@2022-04-25 00:00:00@Kevzara@sarilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1201_h_a_dec_0.pdf@EU-1-17-1201_h_a_dec_0.pdf@2017-06-23 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_0.pdf@EU-1-17-1202_h_a_dec_0.pdf@2017-06-23 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_5.pdf@EU-1-17-1192_h_a_dec_5.pdf@2022-03-28 00:00:00@Brineura@cerliponase alfa@False@False@adopted@BioMarin International Limited@exceptional@Parsed
EU-1-17-1201_h_a_dec_1.pdf@EU-1-17-1201_h_a_dec_1.pdf@2017-08-24 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_0.pdf@EU-1-17-1203_h_a_dec_0.pdf@2017-07-19 00:00:00@Insulin lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_1.pdf@EU-1-17-1200_h_a_dec_1.pdf@2018-07-26 00:00:00@Besponsa@inotuzumab ozogamicin@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_1.pdf@EU-1-17-1202_h_a_dec_1.pdf@2018-07-30 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-17-1201_h_a_dec_2.pdf@EU-1-17-1201_h_a_dec_2.pdf@2019-06-20 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_1.pdf@EU-1-17-1203_h_a_dec_1.pdf@2018-02-08 00:00:00@Insulin  lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_2.pdf@EU-1-17-1200_h_a_dec_2.pdf@2019-07-19 00:00:00@Besponsa@inotuzumab ozogamicin@False@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_0.pdf@EU-1-17-1205_h_a_dec_0.pdf@2017-07-17 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_2.pdf@EU-1-17-1202_h_a_dec_2.pdf@2018-07-12 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Lucane Pharma@CMA Not Found@Parsed
EU-1-17-1201_h_a_dec_3.pdf@EU-1-17-1201_h_a_dec_3.pdf@2020-08-19 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-17-1192_h_a_dec_6.pdf@EU-1-17-1192_h_a_dec_6.pdf@2022-06-29 00:00:00@Brineura@cerliponase alfa@False@False@OD Not Found@BioMarin International Limited@exceptional@Parsed
EU-1-17-1203_h_a_dec_2.pdf@EU-1-17-1203_h_a_dec_2.pdf@2019-10-29 00:00:00@Insulin  lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_3.pdf@EU-1-17-1200_h_a_dec_3.pdf@2020-07-23 00:00:00@Besponsa@inotuzumab ozogamicin@False@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_1.pdf@EU-1-17-1205_h_a_dec_1.pdf@2018-09-20 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_3.pdf@EU-1-17-1202_h_a_dec_3.pdf@2020-04-02 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Eurocept International B.V.@CMA Not Found@Parsed
EU-1-17-1201_h_a_dec_4.pdf@EU-1-17-1201_h_a_dec_4.pdf@2020-09-10 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_3.pdf@EU-1-17-1203_h_a_dec_3.pdf@2021-07-28 00:00:00@Insulin lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_4.pdf@EU-1-17-1200_h_a_dec_4.pdf@2021-03-11 00:00:00@Besponsa@inotuzumab ozogamicin@False@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_2.pdf@EU-1-17-1205_h_a_dec_2.pdf@2019-05-22 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1202_h_a_dec_4.pdf@EU-1-17-1202_h_a_dec_4.pdf@2022-03-28 00:00:00@Ucedane@carglumic acid@False@False@OD Not Found@Eurocept International B.V.@CMA Not Found@Parsed
EU-1-17-1201_h_a_dec_5.pdf@EU-1-17-1201_h_a_dec_5.pdf@2022-02-21 00:00:00@Skilarence@dimethyl fumarate@False@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-17-1203_h_a_dec_4.pdf@EU-1-17-1203_h_a_dec_4.pdf@2022-03-28 00:00:00@Insulin lispro Sanofi@insulin lispro@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1200_h_a_dec_5.pdf@EU-1-17-1200_h_a_dec_5.pdf@2022-02-16 00:00:00@Besponsa@inotuzumab ozogamicin@False@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_3.pdf@EU-1-17-1205_h_a_dec_3.pdf@2019-07-25 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_0.pdf@EU-1-17-1208_h_a_dec_0.pdf@2017-07-17 00:00:00@Trimbow@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1209_h_a_dec_0.pdf@EU-1-17-1209_h_a_dec_0.pdf@2017-07-13 00:00:00@Reagila@cariprazine@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_4.pdf@EU-1-17-1205_h_a_dec_4.pdf@2020-09-30 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_1.pdf@EU-1-17-1208_h_a_dec_1.pdf@2019-01-23 00:00:00@Trimbow@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_0.pdf@EU-1-17-1210_h_a_dec_0.pdf@2017-07-17 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_5.pdf@EU-1-17-1205_h_a_dec_5.pdf@2021-08-20 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_2.pdf@EU-1-17-1208_h_a_dec_2.pdf@2021-01-14 00:00:00@Trimbow@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_1.pdf@EU-1-17-1210_h_a_dec_1.pdf@2018-08-11 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-17-1209_h_a_dec_1.pdf@EU-1-17-1209_h_a_dec_1.pdf@2018-12-12 00:00:00@Reagila@cariprazine@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_0.pdf@EU-1-17-1211_h_a_dec_0.pdf@2017-09-26 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_3.pdf@EU-1-17-1208_h_a_dec_3.pdf@2021-07-04 00:00:00@Trimbow@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1205_h_a_dec_6.pdf@EU-1-17-1205_h_a_dec_6.pdf@2022-04-25 00:00:00@Blitzima@rituximab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_0.pdf@EU-1-17-1212_h_a_dec_0.pdf@2017-08-22 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_2.pdf@EU-1-17-1210_h_a_dec_2.pdf@2019-03-28 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-17-1208_h_a_dec_4.pdf@EU-1-17-1208_h_a_dec_4.pdf@2022-03-24 00:00:00@Trimbow@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_0.pdf@EU-1-17-1213_h_a_dec_0.pdf@2017-07-26 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-17-1209_h_a_dec_2.pdf@EU-1-17-1209_h_a_dec_2.pdf@2022-04-04 00:00:00@Reagila@cariprazine@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_1.pdf@EU-1-17-1211_h_a_dec_1.pdf@2019-02-25 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_3.pdf@EU-1-17-1210_h_a_dec_3.pdf@2020-04-23 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_1.pdf@EU-1-17-1212_h_a_dec_1.pdf@2018-09-07 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_1.pdf@EU-1-17-1213_h_a_dec_1.pdf@2018-04-26 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_4.pdf@EU-1-17-1210_h_a_dec_4.pdf@2021-06-05 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Zentiva@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_2.pdf@EU-1-17-1212_h_a_dec_2.pdf@2020-09-12 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_2.pdf@EU-1-17-1211_h_a_dec_2.pdf@2020-11-02 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_10.pdf@EU-1-17-1213_h_a_dec_10.pdf@2022-05-19 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_3.pdf@EU-1-17-1212_h_a_dec_3.pdf@2022-04-03 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-17-1210_h_a_dec_5.pdf@EU-1-17-1210_h_a_dec_5.pdf@2022-05-17 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva@efavirenz /  emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Zentiva, k.s.@CMA Not Found@Parsed
EU-1-17-1212_h_a_dec_4.pdf@EU-1-17-1212_h_a_dec_4.pdf@2022-04-25 00:00:00@MAVENCLAD@cladribine@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_3.pdf@EU-1-17-1211_h_a_dec_3.pdf@2022-04-03 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_0.pdf@EU-1-17-1214_h_a_dec_0.pdf@2017-09-18 00:00:00@Bavencio@avelumab@True@False@adopted@Merck Serono Europe Limited@conditional@Parsed
EU-1-17-1215_h_a_dec_0.pdf@EU-1-17-1215_h_a_dec_0.pdf@2017-08-24 00:00:00@Fotivda@tivozanib@True@False@OD Not Found@EUSA Pharma (UK) Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_2.pdf@EU-1-17-1213_h_a_dec_2.pdf@2018-06-15 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_3.pdf@EU-1-17-1213_h_a_dec_3.pdf@2019-11-03 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1211_h_a_dec_4.pdf@EU-1-17-1211_h_a_dec_4.pdf@2022-01-07 00:00:00@Entecavir Accord@entecavir@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_1.pdf@EU-1-17-1214_h_a_dec_1.pdf@2018-02-07 00:00:00@Bavencio@avelumab@False@False@adopted@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_0.pdf@EU-1-17-1216_h_a_dec_0.pdf@2017-08-24 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1215_h_a_dec_1.pdf@EU-1-17-1215_h_a_dec_1.pdf@2019-02-14 00:00:00@Fotivda@tivozanib@False@False@OD Not Found@EUSA Pharma (UK) Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_4.pdf@EU-1-17-1213_h_a_dec_4.pdf@2019-04-29 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_2.pdf@EU-1-17-1214_h_a_dec_2.pdf@2018-08-31 00:00:00@Bavencio@avelumab@False@False@OD Not Found@the applicant@conditional@Parsed
EU-1-17-1213_h_a_dec_5.pdf@EU-1-17-1213_h_a_dec_5.pdf@2019-07-25 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_0.pdf@EU-1-17-1217_h_a_dec_0.pdf@2017-08-24 00:00:00@Nitisinone MendeliKABS@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_0.pdf@EU-1-17-1219_h_a_dec_0.pdf@2018-06-07 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1215_h_a_dec_2.pdf@EU-1-17-1215_h_a_dec_2.pdf@2020-10-08 00:00:00@Fotivda@tivozanib@False@False@OD Not Found@EUSA Pharma (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_1.pdf@EU-1-17-1216_h_a_dec_1.pdf@2018-09-28 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_6.pdf@EU-1-17-1213_h_a_dec_6.pdf@2020-03-03 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_3.pdf@EU-1-17-1214_h_a_dec_3.pdf@2019-06-20 00:00:00@Bavencio@avelumab@False@False@OD Not Found@Merck Europe B.V.@conditional@Parsed
EU-1-17-1215_h_a_dec_3.pdf@EU-1-17-1215_h_a_dec_3.pdf@2022-01-24 00:00:00@Fotivda@tivozanib@False@False@OD Not Found@EUSA Pharma (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_1.pdf@EU-1-17-1219_h_a_dec_1.pdf@2019-04-07 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_0.pdf@EU-1-17-1221_h_a_dec_0.pdf@2017-08-22 00:00:00@Kisqali@ribociclib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_7.pdf@EU-1-17-1213_h_a_dec_7.pdf@2021-04-16 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_4.pdf@EU-1-17-1214_h_a_dec_4.pdf@2019-10-24 00:00:00@Bavencio@avelumab@False@False@adopted@Merck Europe B.V.@conditional@Parsed
EU-1-17-1217_h_a_dec_1.pdf@EU-1-17-1217_h_a_dec_1.pdf@2018-09-20 00:00:00@Nitisinone MDK@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_2.pdf@EU-1-17-1219_h_a_dec_2.pdf@2021-03-31 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1215_h_a_dec_4.pdf@EU-1-17-1215_h_a_dec_4.pdf@2022-07-15 00:00:00@Fotivda@tivozanib@False@False@OD Not Found@EUSA Pharma (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_2.pdf@EU-1-17-1216_h_a_dec_2.pdf@2018-10-29 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_8.pdf@EU-1-17-1213_h_a_dec_8.pdf@2021-06-21 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1219_h_a_dec_3.pdf@EU-1-17-1219_h_a_dec_3.pdf@2022-09-21 00:00:00@Verkazia@ciclosporin@False@False@adopted@Santen Oy@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_5.pdf@EU-1-17-1214_h_a_dec_5.pdf@2020-07-23 00:00:00@Bavencio@avelumab@False@False@OD Not Found@Merck Europe B.V.@conditional@Parsed
EU-1-17-1216_h_a_dec_3.pdf@EU-1-17-1216_h_a_dec_3.pdf@2019-12-02 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_1.pdf@EU-1-17-1221_h_a_dec_1.pdf@2018-12-04 00:00:00@Kisqali@ribociclib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1213_h_a_dec_9.pdf@EU-1-17-1213_h_a_dec_9.pdf@2022-03-22 00:00:00@Maviret@glecaprevir / pibrentasvir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_2.pdf@EU-1-17-1217_h_a_dec_2.pdf@2020-04-28 00:00:00@Nitisinone MDK@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_6.pdf@EU-1-17-1214_h_a_dec_6.pdf@2020-08-19 00:00:00@Bavencio@avelumab@False@False@OD Not Found@Merck Europe B.V.@conditional@Parsed
EU-1-17-1216_h_a_dec_4.pdf@EU-1-17-1216_h_a_dec_4.pdf@2019-08-26 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_7.pdf@EU-1-17-1214_h_a_dec_7.pdf@2020-09-24 00:00:00@Bavencio@avelumab@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_5.pdf@EU-1-17-1216_h_a_dec_5.pdf@2021-01-22 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_2.pdf@EU-1-17-1221_h_a_dec_2.pdf@2018-12-17 00:00:00@Kisqali@ribociclib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_0.pdf@EU-1-17-1220_h_a_dec_0.pdf@2017-09-21 00:00:00@Tecentriq@atezolizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_3.pdf@EU-1-17-1217_h_a_dec_3.pdf@2021-06-17 00:00:00@Nitisinone MDK@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_6.pdf@EU-1-17-1216_h_a_dec_6.pdf@2021-09-07 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_8.pdf@EU-1-17-1214_h_a_dec_8.pdf@2021-01-21 00:00:00@Bavencio@avelumab@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_0.pdf@EU-1-17-1223_h_a_dec_0.pdf@2017-07-26 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-17-1216_h_a_dec_7.pdf@EU-1-17-1216_h_a_dec_7.pdf@2022-04-29 00:00:00@Imraldi@adalimumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1214_h_a_dec_9.pdf@EU-1-17-1214_h_a_dec_9.pdf@2022-06-01 00:00:00@Bavencio@avelumab@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_3.pdf@EU-1-17-1221_h_a_dec_3.pdf@2019-07-31 00:00:00@Kisqali@ribociclib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_1.pdf@EU-1-17-1220_h_a_dec_1.pdf@2018-07-03 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_4.pdf@EU-1-17-1217_h_a_dec_4.pdf@2021-12-20 00:00:00@Nitisinone MDK@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_1.pdf@EU-1-17-1223_h_a_dec_1.pdf@2018-07-06 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_10.pdf@EU-1-17-1220_h_a_dec_10.pdf@2020-10-27 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_4.pdf@EU-1-17-1221_h_a_dec_4.pdf@2020-07-13 00:00:00@Kisqali@ribociclib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_11.pdf@EU-1-17-1220_h_a_dec_11.pdf@2021-03-26 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1217_h_a_dec_5.pdf@EU-1-17-1217_h_a_dec_5.pdf@2022-07-15 00:00:00@Nitisinone MDK@nitisinone@False@False@OD Not Found@MendeliKABS Europe Limited@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_2.pdf@EU-1-17-1223_h_a_dec_2.pdf@2019-06-06 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_12.pdf@EU-1-17-1220_h_a_dec_12.pdf@2021-03-31 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_0.pdf@EU-1-17-1225_h_a_dec_0.pdf@2017-09-21 00:00:00@Symtuza@Darunavir ethanolate/ cobistat/  emtricitabine/ tenofovir alafenamide fumarate@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_0.pdf@EU-1-17-1227_h_a_dec_0.pdf@2017-09-18 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_5.pdf@EU-1-17-1221_h_a_dec_5.pdf@2020-10-19 00:00:00@Kisqali@ribociclib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_1.pdf@EU-1-17-1225_h_a_dec_1.pdf@2018-06-07 00:00:00@Symtuza@darunavir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_13.pdf@EU-1-17-1220_h_a_dec_13.pdf@2021-04-30 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_1.pdf@EU-1-17-1227_h_a_dec_1.pdf@2021-04-16 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_14.pdf@EU-1-17-1220_h_a_dec_14.pdf@2021-08-20 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_2.pdf@EU-1-17-1225_h_a_dec_2.pdf@2018-11-20 00:00:00@Symtuza@darunavir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_3.pdf@EU-1-17-1223_h_a_dec_3.pdf@2019-09-26 00:00:00@Vosevi@sofosbuvir / velpatasvir  / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1221_h_a_dec_6.pdf@EU-1-17-1221_h_a_dec_6.pdf@2022-04-04 00:00:00@Kisqali@ribociclib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_0.pdf@EU-1-17-1218_h_a_dec_0.pdf@2017-09-18 00:00:00@Rydapt@Midostaurin@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_15.pdf@EU-1-17-1220_h_a_dec_15.pdf@2022-02-23 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_3.pdf@EU-1-17-1225_h_a_dec_3.pdf@2019-03-05 00:00:00@Symtuza@darunavir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_0.pdf@EU-1-17-1229_h_a_dec_0.pdf@2017-09-26 00:00:00@Dupixent@dupilumab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_2.pdf@EU-1-17-1227_h_a_dec_2.pdf@2021-11-10 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_16.pdf@EU-1-17-1220_h_a_dec_16.pdf@2022-04-25 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_4.pdf@EU-1-17-1223_h_a_dec_4.pdf@2019-04-11 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_4.pdf@EU-1-17-1225_h_a_dec_4.pdf@2019-01-07 00:00:00@Symtuza@darunavir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_1.pdf@EU-1-17-1229_h_a_dec_1.pdf@2018-12-17 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_1.pdf@EU-1-17-1218_h_a_dec_1.pdf@2018-04-30 00:00:00@Rydapt@Midostaurin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_17.pdf@EU-1-17-1220_h_a_dec_17.pdf@2022-07-06 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_5.pdf@EU-1-17-1225_h_a_dec_5.pdf@2021-09-29 00:00:00@Symtuza@darunavir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_10.pdf@EU-1-17-1229_h_a_dec_10.pdf@2022-02-09 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1227_h_a_dec_3.pdf@EU-1-17-1227_h_a_dec_3.pdf@2022-06-21 00:00:00@Entecavir Mylan@entecavir@False@False@OD Not Found@Mylan Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_5.pdf@EU-1-17-1223_h_a_dec_5.pdf@2021-04-21 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_2.pdf@EU-1-17-1220_h_a_dec_2.pdf@2018-04-04 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1225_h_a_dec_6.pdf@EU-1-17-1225_h_a_dec_6.pdf@2022-05-24 00:00:00@Symtuza@darunavir / cobicistat / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_0.pdf@EU-1-17-1222_h_a_dec_0.pdf@2017-05-09 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_2.pdf@EU-1-17-1218_h_a_dec_2.pdf@2019-04-17 00:00:00@Rydapt@Midostaurin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_11.pdf@EU-1-17-1229_h_a_dec_11.pdf@2022-09-29 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_3.pdf@EU-1-17-1220_h_a_dec_3.pdf@2018-02-07 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_1.pdf@EU-1-17-1222_h_a_dec_1.pdf@2018-06-25 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_2.pdf@EU-1-17-1229_h_a_dec_2.pdf@2019-06-05 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_6.pdf@EU-1-17-1223_h_a_dec_6.pdf@2021-09-16 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_4.pdf@EU-1-17-1220_h_a_dec_4.pdf@2019-02-25 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_2.pdf@EU-1-17-1222_h_a_dec_2.pdf@2019-02-08 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_0.pdf@EU-1-17-1228_h_a_dec_0.pdf@2017-10-11 00:00:00@TOOKAD@padeliporfin@True@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_3.pdf@EU-1-17-1218_h_a_dec_3.pdf@2021-01-22 00:00:00@Rydapt@Midostaurin@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_3.pdf@EU-1-17-1229_h_a_dec_3.pdf@2019-01-08 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_5.pdf@EU-1-17-1220_h_a_dec_5.pdf@2019-05-03 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_3.pdf@EU-1-17-1222_h_a_dec_3.pdf@2020-11-18 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_1.pdf@EU-1-17-1228_h_a_dec_1.pdf@2021-04-02 00:00:00@TOOKAD@padeliporfin@False@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_0.pdf@EU-1-17-1226_h_a_dec_0.pdf@2017-09-26 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@True@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_4.pdf@EU-1-17-1229_h_a_dec_4.pdf@2019-10-24 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_6.pdf@EU-1-17-1220_h_a_dec_6.pdf@2019-08-07 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_7.pdf@EU-1-17-1223_h_a_dec_7.pdf@2022-04-29 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_4.pdf@EU-1-17-1218_h_a_dec_4.pdf@2021-08-18 00:00:00@Rydapt@Midostaurin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_2.pdf@EU-1-17-1228_h_a_dec_2.pdf@2022-06-21 00:00:00@TOOKAD@padeliporfin@False@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_2.pdf@EU-1-17-1226_h_a_dec_2.pdf@2019-03-25 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_5.pdf@EU-1-17-1229_h_a_dec_5.pdf@2020-06-25 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_4.pdf@EU-1-17-1222_h_a_dec_4.pdf@2021-09-29 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz  / emtricitabine / tenofovir disoproxil@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1228_h_a_dec_3.pdf@EU-1-17-1228_h_a_dec_3.pdf@2022-09-26 00:00:00@TOOKAD@padeliporfin@False@False@OD Not Found@Steba Biotech S.A@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_7.pdf@EU-1-17-1220_h_a_dec_7.pdf@2019-08-26 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_3.pdf@EU-1-17-1226_h_a_dec_3.pdf@2020-01-04 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1223_h_a_dec_8.pdf@EU-1-17-1223_h_a_dec_8.pdf@2022-05-30 00:00:00@Vosevi@sofosbuvir / velpatasvir / voxilaprevir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_6.pdf@EU-1-17-1229_h_a_dec_6.pdf@2020-11-25 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_5.pdf@EU-1-17-1218_h_a_dec_5.pdf@2022-04-03 00:00:00@Rydapt@Midostaurin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_8.pdf@EU-1-17-1220_h_a_dec_8.pdf@2019-03-09 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_4.pdf@EU-1-17-1226_h_a_dec_4.pdf@2021-01-21 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_7.pdf@EU-1-17-1229_h_a_dec_7.pdf@2021-11-01 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1222_h_a_dec_5.pdf@EU-1-17-1222_h_a_dec_5.pdf@2022-05-24 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan@Efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@Mylan Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-17-1220_h_a_dec_9.pdf@EU-1-17-1220_h_a_dec_9.pdf@2020-08-19 00:00:00@Tecentriq@atezolizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_5.pdf@EU-1-17-1226_h_a_dec_5.pdf@2022-08-07 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1218_h_a_dec_6.pdf@EU-1-17-1218_h_a_dec_6.pdf@2022-05-30 00:00:00@Rydapt@Midostaurin@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_8.pdf@EU-1-17-1229_h_a_dec_8.pdf@2022-06-01 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1226_h_a_dec_6.pdf@EU-1-17-1226_h_a_dec_6.pdf@2022-09-26 00:00:00@Lutathera@lutetium ( 177Lu) oxodotreotide@False@False@adopted@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_0.pdf@EU-1-17-1231_h_a_dec_0.pdf@2018-08-01 00:00:00@Ocrevus@ocrelizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1229_h_a_dec_9.pdf@EU-1-17-1229_h_a_dec_9.pdf@2022-04-04 00:00:00@Dupixent@dupilumab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_0.pdf@EU-1-17-1224_h_a_dec_0.pdf@2017-09-18 00:00:00@Xermelo@telotristat@True@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_1.pdf@EU-1-17-1231_h_a_dec_1.pdf@2018-03-23 00:00:00@Ocrevus@ocrelizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_0.pdf@EU-1-17-1233_h_a_dec_0.pdf@2017-10-11 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_1.pdf@EU-1-17-1224_h_a_dec_1.pdf@2018-07-12 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_2.pdf@EU-1-17-1231_h_a_dec_2.pdf@2019-06-20 00:00:00@Ocrevus@ocrelizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_0.pdf@EU-1-17-1235_h_a_dec_0.pdf@2017-11-16 00:00:00@Zejula@niraparib@True@False@adopted@TESARO UK LIMITED@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_2.pdf@EU-1-17-1224_h_a_dec_2.pdf@2019-05-27 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_3.pdf@EU-1-17-1231_h_a_dec_3.pdf@2019-12-16 00:00:00@Ocrevus@ocrelizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_0.pdf@EU-1-17-1237_h_a_dec_0.pdf@2017-11-15 00:00:00@Elebrato Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_1.pdf@EU-1-17-1233_h_a_dec_1.pdf@2018-12-17 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_3.pdf@EU-1-17-1224_h_a_dec_3.pdf@2019-11-19 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_4.pdf@EU-1-17-1231_h_a_dec_4.pdf@2021-11-01 00:00:00@Ocrevus@ocrelizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_1.pdf@EU-1-17-1235_h_a_dec_1.pdf@2018-12-17 00:00:00@Zejula@niraparib@False@False@adopted@TESARO U.K. Limited@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_5.pdf@EU-1-17-1231_h_a_dec_5.pdf@2021-03-12 00:00:00@Ocrevus@ocrelizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_4.pdf@EU-1-17-1224_h_a_dec_4.pdf@2020-09-24 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_1.pdf@EU-1-17-1237_h_a_dec_1.pdf@2018-10-31 00:00:00@Elebrato Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_2.pdf@EU-1-17-1235_h_a_dec_2.pdf@2019-06-20 00:00:00@Zejula@niraparib@False@False@adopted@TESARO Bio Netherlands B.V.@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_2.pdf@EU-1-17-1233_h_a_dec_2.pdf@2019-04-17 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Mundipharma Corporation (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_5.pdf@EU-1-17-1224_h_a_dec_5.pdf@2021-12-11 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1231_h_a_dec_6.pdf@EU-1-17-1231_h_a_dec_6.pdf@2022-09-21 00:00:00@Ocrevus@ocrelizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_3.pdf@EU-1-17-1233_h_a_dec_3.pdf@2021-03-22 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Orexo AB@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_6.pdf@EU-1-17-1224_h_a_dec_6.pdf@2022-06-14 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_2.pdf@EU-1-17-1237_h_a_dec_2.pdf@2020-09-01 00:00:00@Elebrato Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_3.pdf@EU-1-17-1235_h_a_dec_3.pdf@2020-01-31 00:00:00@Zejula@niraparib@False@False@adopted@TESARO Bio Netherlands B.V.@CMA Not Found@Parsed
EU-1-17-1239_h_a_dec_0.pdf@EU-1-17-1239_h_a_dec_0.pdf@2017-10-11 00:00:00@VeraSeal@human fibrinogen / human thrombin@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-17-1233_h_a_dec_4.pdf@EU-1-17-1233_h_a_dec_4.pdf@2022-07-27 00:00:00@Zubsolv@buprenorphine / naloxone@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1224_h_a_dec_7.pdf@EU-1-17-1224_h_a_dec_7.pdf@2022-05-08 00:00:00@Xermelo@telotristat@False@False@adopted@Ipsen Pharma@CMA Not Found@Parsed
EU-1-17-1239_h_a_dec_1.pdf@EU-1-17-1239_h_a_dec_1.pdf@2020-11-18 00:00:00@VeraSeal@human fibrinogen / human thrombin@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_3.pdf@EU-1-17-1237_h_a_dec_3.pdf@2021-03-05 00:00:00@Elebrato Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_4.pdf@EU-1-17-1235_h_a_dec_4.pdf@2020-06-25 00:00:00@Zejula@niraparib@False@False@adopted@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1239_h_a_dec_2.pdf@EU-1-17-1239_h_a_dec_2.pdf@2022-09-19 00:00:00@VeraSeal@human fibrinogen / human thrombin@False@False@OD Not Found@Instituto Grifols, S.A.@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_0.pdf@EU-1-17-1230_h_a_dec_0.pdf@2017-09-18 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_4.pdf@EU-1-17-1237_h_a_dec_4.pdf@2021-09-16 00:00:00@Elebrato Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_0.pdf@EU-1-17-1232_h_a_dec_0.pdf@2020-04-28 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_5.pdf@EU-1-17-1235_h_a_dec_5.pdf@2020-10-27 00:00:00@Zejula@niraparib@False@False@adopted@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_0.pdf@EU-1-17-1234_h_a_dec_0.pdf@2017-10-11 00:00:00@Tremfya@Guselkumab@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_1.pdf@EU-1-17-1232_h_a_dec_1.pdf@2017-10-11 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_1.pdf@EU-1-17-1234_h_a_dec_1.pdf@2019-08-07 00:00:00@Tremfya@Guselkumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_0.pdf@EU-1-17-1241_h_a_dec_0.pdf@2017-11-15 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_1.pdf@EU-1-17-1230_h_a_dec_1.pdf@2018-04-04 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1237_h_a_dec_5.pdf@EU-1-17-1237_h_a_dec_5.pdf@2022-07-15 00:00:00@Elebrato Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_0.pdf@EU-1-17-1244_h_a_dec_0.pdf@2017-08-12 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_6.pdf@EU-1-17-1235_h_a_dec_6.pdf@2021-01-06 00:00:00@Zejula@niraparib@False@False@adopted@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_2.pdf@EU-1-17-1232_h_a_dec_2.pdf@2019-02-25 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_1.pdf@EU-1-17-1244_h_a_dec_1.pdf@2020-02-17 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_2.pdf@EU-1-17-1234_h_a_dec_2.pdf@2020-09-15 00:00:00@Tremfya@Guselkumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1232_h_a_dec_3.pdf@EU-1-17-1232_h_a_dec_3.pdf@2019-04-29 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_2.pdf@EU-1-17-1230_h_a_dec_2.pdf@2019-01-03 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_1.pdf@EU-1-17-1241_h_a_dec_1.pdf@2018-08-11 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis UK Limited@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_2.pdf@EU-1-17-1244_h_a_dec_2.pdf@2021-03-26 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
 Found@Parsed
EU-1-17-1232_h_a_dec_4.pdf@EU-1-17-1232_h_a_dec_4.pdf@2022-09-19 00:00:00@Miglustat Gen.Orph@Miglustat@False@False@OD Not Found@Gen.Orph@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_3.pdf@EU-1-17-1230_h_a_dec_3.pdf@2020-04-02 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1244_h_a_dec_3.pdf@EU-1-17-1244_h_a_dec_3.pdf@2022-05-08 00:00:00@Tacforius@tacrolimus@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_3.pdf@EU-1-17-1234_h_a_dec_3.pdf@2020-11-20 00:00:00@Tremfya@Guselkumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_0.pdf@EU-1-17-1238_h_a_dec_0.pdf@2017-10-11 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_4.pdf@EU-1-17-1230_h_a_dec_4.pdf@2021-12-11 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_8.pdf@EU-1-17-1235_h_a_dec_8.pdf@2022-05-30 00:00:00@Zejula@niraparib@False@False@adopted@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_5.pdf@EU-1-17-1230_h_a_dec_5.pdf@2021-11-22 00:00:00@Lacosamide Accord@lacosamide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_4.pdf@EU-1-17-1234_h_a_dec_4.pdf@2022-04-13 00:00:00@Tremfya@Guselkumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_0.pdf@EU-1-17-1245_h_a_dec_0.pdf@2018-08-01 00:00:00@PREVYMIS@letermovir@True@False@adopted@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_1.pdf@EU-1-17-1238_h_a_dec_1.pdf@2018-11-22 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation Limited@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_3.pdf@EU-1-17-1241_h_a_dec_3.pdf@2021-04-21 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1230_h_a_dec_6.pdf@EU-1-17-1230_h_a_dec_6.pdf@2022-08-24 00:00:00@Lacosamide Accord@lacosamide@False@False@adopted@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-17-1247_h_a_dec_0.pdf@EU-1-17-1247_h_a_dec_0.pdf@2018-08-01 00:00:00@ADYNOVI@rurioctocog alfa pegol@True@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-17-1235_h_a_dec_9.pdf@EU-1-17-1235_h_a_dec_9.pdf@2022-07-18 00:00:00@Zejula@niraparib@False@False@adopted@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1247_h_a_dec_1.pdf@EU-1-17-1247_h_a_dec_1.pdf@2019-03-25 00:00:00@ADYNOVI@rurioctocog alfa pegol@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-17-1234_h_a_dec_5.pdf@EU-1-17-1234_h_a_dec_5.pdf@2022-07-15 00:00:00@Tremfya@Guselkumab@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_1.pdf@EU-1-17-1245_h_a_dec_1.pdf@2018-07-23 00:00:00@PREVYMIS@letermovir@False@False@adopted@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1241_h_a_dec_4.pdf@EU-1-17-1241_h_a_dec_4.pdf@2022-07-15 00:00:00@Ontruzant@trastuzumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_2.pdf@EU-1-17-1238_h_a_dec_2.pdf@2020-09-03 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1247_h_a_dec_2.pdf@EU-1-17-1247_h_a_dec_2.pdf@2022-06-01 00:00:00@ADYNOVI@rurioctocog alfa pegol@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_2.pdf@EU-1-17-1245_h_a_dec_2.pdf@2019-08-26 00:00:00@PREVYMIS@letermovir@False@False@adopted@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_3.pdf@EU-1-17-1245_h_a_dec_3.pdf@2020-03-07 00:00:00@PREVYMIS@letermovir@False@False@adopted@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1238_h_a_dec_3.pdf@EU-1-17-1238_h_a_dec_3.pdf@2022-03-02 00:00:00@Nyxoid@naloxone@False@False@OD Not Found@Mundipharma Corporation (Ireland) Limited@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_4.pdf@EU-1-17-1245_h_a_dec_4.pdf@2021-12-16 00:00:00@PREVYMIS@letermovir@False@False@adopted@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1249_h_a_dec_0.pdf@EU-1-17-1249_h_a_dec_0.pdf@2018-01-26 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@Krka d. d., Novo Mesto@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_0.pdf@EU-1-17-1236_h_a_dec_0.pdf@2017-11-15 00:00:00@Trelegy Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_0.pdf@EU-1-17-1242_h_a_dec_0.pdf@2017-10-11 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_0.pdf@EU-1-17-1251_h_a_dec_0.pdf@2018-08-02 00:00:00@Ozempic@semaglutide@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1253_h_a_dec_0.pdf@EU-1-17-1253_h_a_dec_0.pdf@2018-08-01 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
 Found@Parsed
EU-1-17-1249_h_a_dec_1.pdf@EU-1-17-1249_h_a_dec_1.pdf@2018-10-12 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-17-1245_h_a_dec_5.pdf@EU-1-17-1245_h_a_dec_5.pdf@2022-08-24 00:00:00@PREVYMIS@letermovir@False@False@adopted@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_1.pdf@EU-1-17-1242_h_a_dec_1.pdf@2019-06-05 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_1.pdf@EU-1-17-1251_h_a_dec_1.pdf@2019-05-13 00:00:00@Ozempic@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1253_h_a_dec_1.pdf@EU-1-17-1253_h_a_dec_1.pdf@2018-08-27 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_1.pdf@EU-1-17-1236_h_a_dec_1.pdf@2018-10-31 00:00:00@Trelegy Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_2.pdf@EU-1-17-1242_h_a_dec_2.pdf@2019-11-14 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_2.pdf@EU-1-17-1251_h_a_dec_2.pdf@2020-03-27 00:00:00@Ozempic@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1253_h_a_dec_2.pdf@EU-1-17-1253_h_a_dec_2.pdf@2021-03-22 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_3.pdf@EU-1-17-1242_h_a_dec_3.pdf@2021-04-21 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1249_h_a_dec_2.pdf@EU-1-17-1249_h_a_dec_2.pdf@2019-12-18 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_3.pdf@EU-1-17-1251_h_a_dec_3.pdf@2020-09-30 00:00:00@Ozempic@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_2.pdf@EU-1-17-1236_h_a_dec_2.pdf@2020-02-21 00:00:00@Trelegy Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1255_h_a_dec_0.pdf@EU-1-17-1255_h_a_dec_0.pdf@2018-08-01 00:00:00@Intrarosa@Prasterone@False@False@OD Not Found@Endoceutics Ltd.@CMA Not Found@Parsed
EU-1-17-1249_h_a_dec_3.pdf@EU-1-17-1249_h_a_dec_3.pdf@2020-12-17 00:00:00@Darunavir Krka@darunavir@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_4.pdf@EU-1-17-1251_h_a_dec_4.pdf@2021-03-22 00:00:00@Ozempic@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1253_h_a_dec_3.pdf@EU-1-17-1253_h_a_dec_3.pdf@2021-03-11 00:00:00@Fulvestrant Mylan@fulvestrant@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_4.pdf@EU-1-17-1242_h_a_dec_4.pdf@2021-11-18 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_5.pdf@EU-1-17-1251_h_a_dec_5.pdf@2022-11-01 00:00:00@Ozempic@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_3.pdf@EU-1-17-1236_h_a_dec_3.pdf@2021-03-05 00:00:00@Trelegy Ellipta@fluticasone  furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_0.pdf@EU-1-17-1246_h_a_dec_0.pdf@2018-01-15 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1255_h_a_dec_1.pdf@EU-1-17-1255_h_a_dec_1.pdf@2019-11-03 00:00:00@Intrarosa@prasterone@False@False@OD Not Found@Endoceutics Ltd@CMA Not Found@Parsed
EU-1-17-1251_h_a_dec_6.pdf@EU-1-17-1251_h_a_dec_6.pdf@2022-09-21 00:00:00@Ozempic@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-17-1242_h_a_dec_5.pdf@EU-1-17-1242_h_a_dec_5.pdf@2022-08-22 00:00:00@Ritonavir Mylan@ritonavir@False@False@OD Not Found@Mylan Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-17-1254_h_a_dec_0.pdf@EU-1-17-1254_h_a_dec_0.pdf@2018-08-01 00:00:00@Jorveza@budesonide@False@False@adopted@Dr. Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1255_h_a_dec_2.pdf@EU-1-17-1255_h_a_dec_2.pdf@2020-01-04 00:00:00@Intrarosa@prasterone@False@False@OD Not Found@Endoceutics S.A.@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_4.pdf@EU-1-17-1236_h_a_dec_4.pdf@2021-09-16 00:00:00@Trelegy Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1254_h_a_dec_1.pdf@EU-1-17-1254_h_a_dec_1.pdf@2020-05-20 00:00:00@Jorveza@budesonide@False@False@adopted@Dr Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_1.pdf@EU-1-17-1246_h_a_dec_1.pdf@2019-06-02 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1255_h_a_dec_3.pdf@EU-1-17-1255_h_a_dec_3.pdf@2022-09-15 00:00:00@Intrarosa@prasterone@False@False@OD Not Found@Endoceutics S.A.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_0.pdf@EU-1-17-1250_h_a_dec_0.pdf@2018-05-24 00:00:00@Rubraca@rucaparib@True@False@adopted@Clovis Oncology UK Limited@conditional@Parsed
EU-1-17-1254_h_a_dec_2.pdf@EU-1-17-1254_h_a_dec_2.pdf@2021-11-15 00:00:00@Jorveza@budesonide@False@False@adopted@Dr Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1236_h_a_dec_5.pdf@EU-1-17-1236_h_a_dec_5.pdf@2022-07-15 00:00:00@Trelegy Ellipta@fluticasone furoate/umeclidinium/vilanterol@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-17-1254_h_a_dec_3.pdf@EU-1-17-1254_h_a_dec_3.pdf@2022-09-27 00:00:00@Jorveza@budesonide@False@False@OD Not Found@Dr Falk Pharma GmbH@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_2.pdf@EU-1-17-1246_h_a_dec_2.pdf@2020-02-13 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_1.pdf@EU-1-17-1250_h_a_dec_1.pdf@2018-07-12 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology UK Limited@conditional@Parsed
EU-1-17-1256_h_a_dec_0.pdf@EU-1-17-1256_h_a_dec_0.pdf@2018-02-15 00:00:00@Anagrelide Mylan@anagrelide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_3.pdf@EU-1-17-1246_h_a_dec_3.pdf@2020-01-04 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_0.pdf@EU-1-17-1252_h_a_dec_0.pdf@2018-08-01 00:00:00@Fasenra@benralizumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1257_h_a_dec_0.pdf@EU-1-17-1257_h_a_dec_0.pdf@2018-09-02 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1256_h_a_dec_1.pdf@EU-1-17-1256_h_a_dec_1.pdf@2021-09-07 00:00:00@Anagrelide Mylan@anagrelide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_1.pdf@EU-1-17-1252_h_a_dec_1.pdf@2019-02-25 00:00:00@Fasenra@benralizumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_10.pdf@EU-1-17-1250_h_a_dec_10.pdf@2022-04-05 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-17-1257_h_a_dec_1.pdf@EU-1-17-1257_h_a_dec_1.pdf@2019-01-03 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_4.pdf@EU-1-17-1246_h_a_dec_4.pdf@2020-09-15 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Technology (Ireland) UC@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_0.pdf@EU-1-17-1260_h_a_dec_0.pdf@2018-09-02 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Ltd@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_2.pdf@EU-1-17-1252_h_a_dec_2.pdf@2020-06-02 00:00:00@Fasenra@benralizumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1257_h_a_dec_2.pdf@EU-1-17-1257_h_a_dec_2.pdf@2019-01-08 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1256_h_a_dec_2.pdf@EU-1-17-1256_h_a_dec_2.pdf@2021-09-22 00:00:00@Anagrelide Mylan@anagrelide@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_3.pdf@EU-1-17-1252_h_a_dec_3.pdf@2022-01-25 00:00:00@Fasenra@benralizumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1257_h_a_dec_3.pdf@EU-1-17-1257_h_a_dec_3.pdf@2020-09-15 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_11.pdf@EU-1-17-1250_h_a_dec_11.pdf@2022-09-21 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-17-1246_h_a_dec_5.pdf@EU-1-17-1246_h_a_dec_5.pdf@2021-04-21 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Technology (Ireland) UC@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_1.pdf@EU-1-17-1260_h_a_dec_1.pdf@2018-06-09 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Limited@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_4.pdf@EU-1-17-1252_h_a_dec_4.pdf@2022-08-08 00:00:00@Fasenra@benralizumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_0.pdf@EU-1-17-1262_h_a_dec_0.pdf@2018-02-19 00:00:00@CRYSVITA@Burosumab@True@False@adopted@Kyowa Kirin Limited@conditional@Parsed
EU-1-17-1257_h_a_dec_4.pdf@EU-1-17-1257_h_a_dec_4.pdf@2021-12-16 00:00:00@Herzuma@trastuzumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_2.pdf@EU-1-17-1260_h_a_dec_2.pdf@2020-09-03 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
EU-1-17-1252_h_a_dec_5.pdf@EU-1-17-1252_h_a_dec_5.pdf@2022-09-15 00:00:00@Fasenra@benralizumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_2.pdf@EU-1-17-1250_h_a_dec_2.pdf@2019-01-23 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-18-1264_h_a_dec_0.pdf@EU-1-18-1264_h_a_dec_0.pdf@2018-11-22 00:00:00@Alunbrig@brigatinib@True@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-17-1246_h_a_dec_6.pdf@EU-1-17-1246_h_a_dec_6.pdf@2022-08-07 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Technology (Ireland) UC@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_1.pdf@EU-1-17-1262_h_a_dec_1.pdf@2018-09-17 00:00:00@CRYSVITA@Burosumab@False@False@adopted@Kyowa Kirin Limited@CMA Not Found@Parsed
EU-1-17-1260_h_a_dec_3.pdf@EU-1-17-1260_h_a_dec_3.pdf@2021-05-19 00:00:00@Alkindi@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_3.pdf@EU-1-17-1250_h_a_dec_3.pdf@2019-03-13 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@the applicant@conditional@Parsed
EU-1-17-1258_h_a_dec_0.pdf@EU-1-17-1258_h_a_dec_0.pdf@2018-03-23 00:00:00@Lamzede@velmanase alfa@True@False@adopted@Chiesi Farmaceutici S.p.A.@exceptional@Parsed
EU-1-17-1246_h_a_dec_7.pdf@EU-1-17-1246_h_a_dec_7.pdf@2022-09-21 00:00:00@Mvasi@bevacizumab@False@False@OD Not Found@Amgen Technology (Ireland) UC@CMA Not Found@Parsed
EU-1-18-1264_h_a_dec_1.pdf@EU-1-18-1264_h_a_dec_1.pdf@2019-11-19 00:00:00@Alunbrig@brigatinib@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_10.pdf@EU-1-17-1262_h_a_dec_10.pdf@2022-09-21 00:00:00@CRYSVITA@Burosumab@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@conditional@Parsed
EU-1-18-1266_h_a_dec_0.pdf@EU-1-18-1266_h_a_dec_0.pdf@2018-03-23 00:00:00@Steglujan@ertugliflozin / sitagliptin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_4.pdf@EU-1-17-1250_h_a_dec_4.pdf@2020-01-27 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-18-1264_h_a_dec_2.pdf@EU-1-18-1264_h_a_dec_2.pdf@2020-01-04 00:00:00@Alunbrig@brigatinib@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-17-1258_h_a_dec_1.pdf@EU-1-17-1258_h_a_dec_1.pdf@2019-04-10 00:00:00@Lamzede@velmanase alfa@False@False@adopted@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1261_h_a_dec_0.pdf@EU-1-17-1261_h_a_dec_0.pdf@2018-03-23 00:00:00@Alofisel@Darvadstrocel@True@True@adopted@TiGenix S.A.U.@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_2.pdf@EU-1-17-1262_h_a_dec_2.pdf@2019-01-17 00:00:00@CRYSVITA@Burosumab@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@conditional@Parsed
EU-1-18-1264_h_a_dec_3.pdf@EU-1-18-1264_h_a_dec_3.pdf@2021-05-07 00:00:00@Alunbrig@brigatinib@False@False@OD Not Found@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-17-1261_h_a_dec_1.pdf@EU-1-17-1261_h_a_dec_1.pdf@2018-08-05 00:00:00@Alofisel@Darvadstrocel@False@False@adopted@TiGenix S.A.U.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_5.pdf@EU-1-17-1250_h_a_dec_5.pdf@2020-04-17 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-18-1266_h_a_dec_1.pdf@EU-1-18-1266_h_a_dec_1.pdf@2018-08-23 00:00:00@Steglujan@ertugliflozin / sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-17-1258_h_a_dec_2.pdf@EU-1-17-1258_h_a_dec_2.pdf@2021-05-07 00:00:00@Lamzede@velmanase alfa@False@False@adopted@Chiesi Farmaceutici S.p.A.@exceptional@Parsed
EU-1-17-1262_h_a_dec_3.pdf@EU-1-17-1262_h_a_dec_3.pdf@2019-12-16 00:00:00@CRYSVITA@Burosumab@False@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-17-1261_h_a_dec_2.pdf@EU-1-17-1261_h_a_dec_2.pdf@2020-03-27 00:00:00@Alofisel@Darvadstrocel@False@False@adopted@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-18-1266_h_a_dec_2.pdf@EU-1-18-1266_h_a_dec_2.pdf@2019-02-04 00:00:00@Steglujan@ertugliflozin / sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_6.pdf@EU-1-17-1250_h_a_dec_6.pdf@2020-12-17 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-17-1261_h_a_dec_3.pdf@EU-1-17-1261_h_a_dec_3.pdf@2021-10-22 00:00:00@Alofisel@Darvadstrocel@False@False@adopted@Takeda Pharma A/S@CMA Not Found@Parsed
EU-1-18-1269_h_a_dec_0.pdf@EU-1-18-1269_h_a_dec_0.pdf@2018-04-13 00:00:00@Alpivab@peramivir@True@False@OD Not Found@BioCryst UK Ltd.@CMA Not Found@Parsed
EU-1-18-1266_h_a_dec_3.pdf@EU-1-18-1266_h_a_dec_3.pdf@2020-12-05 00:00:00@Steglujan@ertugliflozin / sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_4.pdf@EU-1-17-1262_h_a_dec_4.pdf@2019-12-16 00:00:00@CRYSVITA@Burosumab@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@conditional@Parsed
EU-1-17-1258_h_a_dec_3.pdf@EU-1-17-1258_h_a_dec_3.pdf@2021-03-11 00:00:00@Lamzede@velmanase alfa@False@False@adopted@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1266_h_a_dec_4.pdf@EU-1-18-1266_h_a_dec_4.pdf@2021-11-16 00:00:00@Steglujan@ertugliflozin / sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_7.pdf@EU-1-17-1250_h_a_dec_7.pdf@2021-04-03 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-18-1269_h_a_dec_1.pdf@EU-1-18-1269_h_a_dec_1.pdf@2019-06-06 00:00:00@Alpivab@peramivir@False@False@OD Not Found@BioCryst UK Ltd@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_5.pdf@EU-1-17-1262_h_a_dec_5.pdf@2020-09-30 00:00:00@CRYSVITA@Burosumab@False@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1266_h_a_dec_5.pdf@EU-1-18-1266_h_a_dec_5.pdf@2021-11-18 00:00:00@Steglujan@ertugliflozin / sitagliptin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_0.pdf@EU-1-18-1265_h_a_dec_0.pdf@2018-03-23 00:00:00@Segluromet@ertugliflozin / metformin  hydrochloride@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_0.pdf@EU-1-18-1271_h_a_dec_0.pdf@2018-02-23 00:00:00@Hemlibra@emicizumab@True@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-18-1269_h_a_dec_2.pdf@EU-1-18-1269_h_a_dec_2.pdf@2020-11-20 00:00:00@Alpivab@peramivir@False@False@OD Not Found@BioCryst Ireland Limited@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_6.pdf@EU-1-17-1262_h_a_dec_6.pdf@2021-11-01 00:00:00@CRYSVITA@Burosumab@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@conditional@Parsed
EU-1-17-1250_h_a_dec_8.pdf@EU-1-17-1250_h_a_dec_8.pdf@2021-09-16 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-18-1273_h_a_dec_0.pdf@EU-1-18-1273_h_a_dec_0.pdf@2018-05-16 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_1.pdf@EU-1-18-1265_h_a_dec_1.pdf@Date is blank@Segluromet@ertugliflozin / metformin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dohme Limited@CMA not available before 2006@Parsed
EU-1-17-1262_h_a_dec_7.pdf@EU-1-17-1262_h_a_dec_7.pdf@2021-11-01 00:00:00@CRYSVITA@Burosumab@False@False@appointed@MAH Not Found@conditional@Parsed
EU-1-18-1273_h_a_dec_1.pdf@EU-1-18-1273_h_a_dec_1.pdf@2019-08-26 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_1.pdf@EU-1-18-1271_h_a_dec_1.pdf@2018-04-30 00:00:00@Hemlibra@emicizumab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_2.pdf@EU-1-18-1265_h_a_dec_2.pdf@2019-03-28 00:00:00@Segluromet@ertugliflozin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1250_h_a_dec_9.pdf@EU-1-17-1250_h_a_dec_9.pdf@2022-04-03 00:00:00@Rubraca@rucaparib@False@False@OD Not Found@Clovis Oncology Ireland Limited@conditional@Parsed
EU-1-18-1273_h_a_dec_2.pdf@EU-1-18-1273_h_a_dec_2.pdf@2020-09-15 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_8.pdf@EU-1-17-1262_h_a_dec_8.pdf@2022-06-01 00:00:00@CRYSVITA@Burosumab@False@False@OD Not Found@Kyowa Kirin Holdings B.V.@conditional@Parsed
EU-1-18-1271_h_a_dec_2.pdf@EU-1-18-1271_h_a_dec_2.pdf@2019-02-14 00:00:00@Hemlibra@emicizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_0.pdf@EU-1-18-1270_h_a_dec_0.pdf@2018-03-23 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_3.pdf@EU-1-18-1265_h_a_dec_3.pdf@2020-12-05 00:00:00@Segluromet@ertugliflozin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_0.pdf@EU-1-18-1267_h_a_dec_0.pdf@2018-03-21 00:00:00@Steglatro@ertugliflozin@True@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_3.pdf@EU-1-18-1271_h_a_dec_3.pdf@2019-11-03 00:00:00@Hemlibra@emicizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_4.pdf@EU-1-18-1265_h_a_dec_4.pdf@2021-06-24 00:00:00@Segluromet@ertugliflozin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_1.pdf@EU-1-18-1270_h_a_dec_1.pdf@2019-04-17 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-17-1262_h_a_dec_9.pdf@EU-1-17-1262_h_a_dec_9.pdf@2022-07-25 00:00:00@Burosumab@Active Substance Not Found@False@False@adopted@Kyowa Kirin Holdings B.V.@conditional@Parsed
EU-1-18-1273_h_a_dec_3.pdf@EU-1-18-1273_h_a_dec_3.pdf@2021-10-19 00:00:00@Prasugrel Mylan@prasugrel@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_4.pdf@EU-1-18-1271_h_a_dec_4.pdf@2020-01-23 00:00:00@Hemlibra@emicizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-18-1265_h_a_dec_5.pdf@EU-1-18-1265_h_a_dec_5.pdf@2021-10-25 00:00:00@Segluromet@ertugliflozin / metformin hydrochloride@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_1.pdf@EU-1-18-1267_h_a_dec_1.pdf@2018-08-28 00:00:00@Steglatro@ertugliflozin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_2.pdf@EU-1-18-1270_h_a_dec_2.pdf@2020-01-16 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_5.pdf@EU-1-18-1271_h_a_dec_5.pdf@2021-08-18 00:00:00@Hemlibra@emicizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_3.pdf@EU-1-18-1270_h_a_dec_3.pdf@2021-03-22 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_2.pdf@EU-1-18-1267_h_a_dec_2.pdf@2019-02-04 00:00:00@Steglatro@ertugliflozin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1271_h_a_dec_6.pdf@EU-1-18-1271_h_a_dec_6.pdf@2022-09-15 00:00:00@Hemlibra@emicizumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_3.pdf@EU-1-18-1267_h_a_dec_3.pdf@2020-12-05 00:00:00@Steglatro@ertugliflozin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_0.pdf@EU-1-18-1274_h_a_dec_0.pdf@2018-04-26 00:00:00@Trydonis@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1270_h_a_dec_4.pdf@EU-1-18-1270_h_a_dec_4.pdf@2021-10-19 00:00:00@Semglee@Insulin glargine@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_4.pdf@EU-1-18-1267_h_a_dec_4.pdf@2021-09-07 00:00:00@Steglatro@ertugliflozin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1275_h_a_dec_0.pdf@EU-1-18-1275_h_a_dec_0.pdf@2018-04-23 00:00:00@Riarify@beclometasone / formoterol /  glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
 Novo Mesto@CMA Not Found@Parsed
EU-1-18-1267_h_a_dec_5.pdf@EU-1-18-1267_h_a_dec_5.pdf@2021-10-22 00:00:00@Steglatro@ertugliflozin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_1.pdf@EU-1-17-1263_h_a_dec_1.pdf@2018-08-31 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-18-1277_h_a_dec_0.pdf@EU-1-18-1277_h_a_dec_0.pdf@2018-04-19 00:00:00@Mylotarg@gemtuzumab ozogamicin@True@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_1.pdf@EU-1-18-1274_h_a_dec_1.pdf@2019-09-04 00:00:00@Trydonis@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1275_h_a_dec_1.pdf@EU-1-18-1275_h_a_dec_1.pdf@2019-08-04 00:00:00@Riarify@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_2.pdf@EU-1-17-1263_h_a_dec_2.pdf@2019-11-03 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@Krka d. d.@CMA Not Found@Parsed
EU-1-18-1277_h_a_dec_1.pdf@EU-1-18-1277_h_a_dec_1.pdf@2018-07-30 00:00:00@Mylotarg@gemtuzumab ozogamicin@False@False@adopted@Pfizer Limited@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_3.pdf@EU-1-17-1263_h_a_dec_3.pdf@2020-02-06 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine / tenofovir  disoproxil@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_2.pdf@EU-1-18-1274_h_a_dec_2.pdf@2021-05-07 00:00:00@Trydonis@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1275_h_a_dec_2.pdf@EU-1-18-1275_h_a_dec_2.pdf@2021-06-21 00:00:00@Riarify@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_0.pdf@EU-1-18-1272_h_a_dec_0.pdf@2018-03-21 00:00:00@Shingrix@herpes zoster vaccine (recombinant,  adjuvanted)@True@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-17-1263_h_a_dec_4.pdf@EU-1-17-1263_h_a_dec_4.pdf@2022-03-02 00:00:00@Efavirenz/Emtricitabine/Tenofovir disoproxil Krka@efavirenz / emtricitabine /  tenofovir disoproxil@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-18-1279_h_a_dec_0.pdf@EU-1-18-1279_h_a_dec_0.pdf@2018-05-24 00:00:00@AMGLIDIA@glibenclamide@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_0.pdf@EU-1-18-1281_h_a_dec_0.pdf@2018-05-16 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_1.pdf@EU-1-18-1272_h_a_dec_1.pdf@2020-03-24 00:00:00@Shingrix@herpes zoster vaccine (recombinant, adjuvanted)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-18-1277_h_a_dec_3.pdf@EU-1-18-1277_h_a_dec_3.pdf@2021-04-30 00:00:00@Mylotarg@gemtuzumab ozogamicin@False@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1274_h_a_dec_3.pdf@EU-1-18-1274_h_a_dec_3.pdf@2022-06-01 00:00:00@Trydonis@beclometasone / formoterol / glycopyrronium bromide@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-18-1279_h_a_dec_1.pdf@EU-1-18-1279_h_a_dec_1.pdf@2019-03-09 00:00:00@AMGLIDIA@glibenclamide@False@False@adopted@AMMTeK@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_1.pdf@EU-1-18-1281_h_a_dec_1.pdf@2019-07-25 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_2.pdf@EU-1-18-1272_h_a_dec_2.pdf@2020-08-25 00:00:00@Shingrix@herpes zoster vaccine (recombinant, adjuvanted)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_0.pdf@EU-1-18-1276_h_a_dec_0.pdf@2018-07-30 00:00:00@Myalepta@metreleptin@True@False@adopted@Aegerion Pharmaceuticals B.V.@exceptional@Parsed
EU-1-18-1279_h_a_dec_2.pdf@EU-1-18-1279_h_a_dec_2.pdf@2022-02-16 00:00:00@AMGLIDIA@glibenclamide@False@False@adopted@AMMTeK@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_2.pdf@EU-1-18-1281_h_a_dec_2.pdf@2020-10-27 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1272_h_a_dec_3.pdf@EU-1-18-1272_h_a_dec_3.pdf@2022-04-04 00:00:00@Shingrix@herpes zoster vaccine (recombinant, adjuvanted)@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_1.pdf@EU-1-18-1276_h_a_dec_1.pdf@2019-09-23 00:00:00@Myalepta@metreleptin@False@False@adopted@Aegerion Pharmaceuticals B.V.@exceptional@Parsed
EU-1-18-1283_h_a_dec_0.pdf@EU-1-18-1283_h_a_dec_0.pdf@2018-05-22 00:00:00@Pemetrexed Krka@pemetrexed@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1281_h_a_dec_3.pdf@EU-1-18-1281_h_a_dec_3.pdf@2021-12-16 00:00:00@KANJINTI@trastuzumab@False@False@OD Not Found@Amgen Europe B.V.@CMA Not Found@Parsed
EU-1-18-1283_h_a_dec_1.pdf@EU-1-18-1283_h_a_dec_1.pdf@2020-04-05 00:00:00@Pemetrexed Krka@pemetrexed@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_0.pdf@EU-1-18-1278_h_a_dec_0.pdf@2018-07-19 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_1.pdf@EU-1-18-1286_h_a_dec_1.pdf@2019-09-23 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_2.pdf@EU-1-18-1276_h_a_dec_2.pdf@2020-04-28 00:00:00@Myalepta@metreleptin@False@False@adopted@Aegerion Pharmaceuticals B.V.@exceptional@Parsed
EU-1-18-1283_h_a_dec_2.pdf@EU-1-18-1283_h_a_dec_2.pdf@2021-11-18 00:00:00@Pemetrexed Krka@pemetrexed@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-18-1280_h_a_dec_0.pdf@EU-1-18-1280_h_a_dec_0.pdf@2018-05-18 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_2.pdf@EU-1-18-1286_h_a_dec_2.pdf@2020-03-27 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_1.pdf@EU-1-18-1278_h_a_dec_1.pdf@2019-10-24 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1280_h_a_dec_1.pdf@EU-1-18-1280_h_a_dec_1.pdf@2019-04-10 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_3.pdf@EU-1-18-1286_h_a_dec_3.pdf@2021-09-03 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1276_h_a_dec_3.pdf@EU-1-18-1276_h_a_dec_3.pdf@2021-11-15 00:00:00@Myalepta@metreleptin@False@False@adopted@Amryt Pharmaceuticals DAC@exceptional@Parsed
EU-1-18-1280_h_a_dec_2.pdf@EU-1-18-1280_h_a_dec_2.pdf@2020-10-15 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1286_h_a_dec_4.pdf@EU-1-18-1286_h_a_dec_4.pdf@2021-10-22 00:00:00@Hyrimoz@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1284_h_a_dec_0.pdf@EU-1-18-1284_h_a_dec_0.pdf@2018-06-25 00:00:00@Dzuveo@sufentanil@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_0.pdf@EU-1-18-1282_h_a_dec_0.pdf@2018-05-16 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_2.pdf@EU-1-18-1278_h_a_dec_2.pdf@2020-03-06 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_0.pdf@EU-1-18-1289_h_a_dec_0.pdf@2018-06-21 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir  alafenamide@True@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-18-1280_h_a_dec_3.pdf@EU-1-18-1280_h_a_dec_3.pdf@2021-10-19 00:00:00@Zessly@infliximab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1284_h_a_dec_1.pdf@EU-1-18-1284_h_a_dec_1.pdf@2019-01-10 00:00:00@Dzuveo@sufentanil@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_1.pdf@EU-1-18-1282_h_a_dec_1.pdf@2019-01-23 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-18-1284_h_a_dec_2.pdf@EU-1-18-1284_h_a_dec_2.pdf@2021-12-11 00:00:00@Dzuveo@sufentanil@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-18-1278_h_a_dec_3.pdf@EU-1-18-1278_h_a_dec_3.pdf@2021-11-29 00:00:00@Carmustine Obvius@carmustine@False@False@OD Not Found@Obvius Investment B.V.@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_2.pdf@EU-1-18-1282_h_a_dec_2.pdf@2019-11-19 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_1.pdf@EU-1-18-1289_h_a_dec_1.pdf@2018-08-23 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences International Limited@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_3.pdf@EU-1-18-1282_h_a_dec_3.pdf@2020-01-04 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_0.pdf@EU-1-18-1292_h_a_dec_0.pdf@2018-11-20 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_2.pdf@EU-1-18-1289_h_a_dec_2.pdf@2019-10-21 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_4.pdf@EU-1-18-1282_h_a_dec_4.pdf@2021-04-02 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare B.V.@CMA Not Found@Parsed
EU-1-18-1290_h_a_dec_0.pdf@EU-1-18-1290_h_a_dec_0.pdf@2018-07-26 00:00:00@Nityr@nitisinone@False@False@OD Not Found@Cycle Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_1.pdf@EU-1-18-1292_h_a_dec_1.pdf@2019-01-10 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1294_h_a_dec_0.pdf@EU-1-18-1294_h_a_dec_0.pdf@2018-07-26 00:00:00@RXULTI@brexpiprazole@True@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_0.pdf@EU-1-18-1287_h_a_dec_0.pdf@2018-07-26 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1282_h_a_dec_5.pdf@EU-1-18-1282_h_a_dec_5.pdf@2022-01-31 00:00:00@Juluca@dolutegravir / rilpivirine@False@False@OD Not Found@ViiV Healthcare B.V.@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_1.pdf@EU-1-18-1287_h_a_dec_1.pdf@2019-08-07 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_3.pdf@EU-1-18-1289_h_a_dec_3.pdf@2020-10-28 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-18-1290_h_a_dec_1.pdf@EU-1-18-1290_h_a_dec_1.pdf@2019-12-18 00:00:00@Nityr@nitisinone@False@False@OD Not Found@Cycle Pharmaceuticals Ltd@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_2.pdf@EU-1-18-1292_h_a_dec_2.pdf@2020-08-13 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1294_h_a_dec_1.pdf@EU-1-18-1294_h_a_dec_1.pdf@2018-12-12 00:00:00@RXULTI@brexpiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Europe Ltd@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_0.pdf@EU-1-18-1296_h_a_dec_0.pdf@2018-06-07 00:00:00@Tegsedi@inotersen@True@False@adopted@IONIS USA Limited@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_2.pdf@EU-1-18-1287_h_a_dec_2.pdf@2020-03-27 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_3.pdf@EU-1-18-1287_h_a_dec_3.pdf@2021-02-19 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1292_h_a_dec_3.pdf@EU-1-18-1292_h_a_dec_3.pdf@2021-09-12 00:00:00@Apealea@paclitaxel@False@False@OD Not Found@Oasmia Pharmaceutical AB@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_4.pdf@EU-1-18-1289_h_a_dec_4.pdf@2020-11-18 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-18-1294_h_a_dec_2.pdf@EU-1-18-1294_h_a_dec_2.pdf@2020-05-11 00:00:00@RXULTI@brexpiprazole@False@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1290_h_a_dec_2.pdf@EU-1-18-1290_h_a_dec_2.pdf@2022-10-02 00:00:00@Nityr@nitisinone@False@False@OD Not Found@Cycle Pharmaceuticals (Europe) Ltd@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_1.pdf@EU-1-18-1296_h_a_dec_1.pdf@2018-12-09 00:00:00@Tegsedi@inotersen@False@False@adopted@IONIS USA Limited@CMA Not Found@Parsed
EU-1-18-1298_h_a_dec_0.pdf@EU-1-18-1298_h_a_dec_0.pdf@2018-08-31 00:00:00@VEYVONDI@vonicog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-18-1287_h_a_dec_4.pdf@EU-1-18-1287_h_a_dec_4.pdf@2021-10-19 00:00:00@Hefiya@adalimumab@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1298_h_a_dec_1.pdf@EU-1-18-1298_h_a_dec_1.pdf@2021-04-02 00:00:00@VEYVONDI@vonicog alfa@False@False@OD Not Found@Baxalta Innovations GmbH@CMA Not Found@Parsed
EU-1-18-1289_h_a_dec_5.pdf@EU-1-18-1289_h_a_dec_5.pdf@2021-10-22 00:00:00@Biktarvy@bictegravir / emtricitabine / tenofovir alafenamide@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-18-1291_h_a_dec_0.pdf@EU-1-18-1291_h_a_dec_0.pdf@2019-02-18 00:00:00@Rizmoic@naldemedine@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_2.pdf@EU-1-18-1296_h_a_dec_2.pdf@2019-01-03 00:00:00@Tegsedi@inotersen@False@False@adopted@Akcea Therapeutics UK Ltd.@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_0.pdf@EU-1-18-1293_h_a_dec_0.pdf@2018-07-26 00:00:00@Aimovig@erenumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1291_h_a_dec_1.pdf@EU-1-18-1291_h_a_dec_1.pdf@2019-12-16 00:00:00@Rizmoic@naldemedine@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_0.pdf@EU-1-18-1299_h_a_dec_0.pdf@2018-08-23 00:00:00@Yescarta@axicabtagene ciloleucel@True@True@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_3.pdf@EU-1-18-1296_h_a_dec_3.pdf@2019-09-19 00:00:00@Tegsedi@inotersen@False@False@adopted@Akcea Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_1.pdf@EU-1-18-1293_h_a_dec_1.pdf@2019-04-26 00:00:00@Aimovig@erenumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1291_h_a_dec_2.pdf@EU-1-18-1291_h_a_dec_2.pdf@2021-01-02 00:00:00@Rizmoic@naldemedine@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_1.pdf@EU-1-18-1299_h_a_dec_1.pdf@2019-10-21 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1301_h_a_dec_0.pdf@EU-1-18-1301_h_a_dec_0.pdf@2018-08-23 00:00:00@Mepsevii@vestronidase  alfa@True@False@adopted@Ultragenyx Germany GmbH@exceptional@Parsed
EU-1-18-1302_h_a_dec_0.pdf@EU-1-18-1302_h_a_dec_0.pdf@2018-09-20 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_2.pdf@EU-1-18-1299_h_a_dec_2.pdf@2020-01-13 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_0.pdf@EU-1-18-1295_h_a_dec_0.pdf@Date is blank@Trazimera@trastuzumab@NAS before 2012@NA before 2012@NA before 2000@Pfizer Europe MA EEIG@CMA not available before 2006@Parsed
EU-1-18-1296_h_a_dec_4.pdf@EU-1-18-1296_h_a_dec_4.pdf@2020-03-11 00:00:00@Tegsedi@inotersen@False@False@adopted@Akcea Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1301_h_a_dec_1.pdf@EU-1-18-1301_h_a_dec_1.pdf@2019-09-16 00:00:00@Mepsevii@vestronidase alfa@False@False@adopted@Ultragenyx Germany GmbH@exceptional@Parsed
EU-1-18-1299_h_a_dec_3.pdf@EU-1-18-1299_h_a_dec_3.pdf@2020-11-25 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_2.pdf@EU-1-18-1293_h_a_dec_2.pdf@2019-08-23 00:00:00@Aimovig@erenumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1302_h_a_dec_1.pdf@EU-1-18-1302_h_a_dec_1.pdf@2020-09-01 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_1.pdf@EU-1-18-1295_h_a_dec_1.pdf@2019-07-31 00:00:00@Trazimera@trastuzumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1305_h_a_dec_0.pdf@EU-1-18-1305_h_a_dec_0.pdf@2018-08-31 00:00:00@Cablivi@caplacizumab@True@False@adopted@Ablynx N.V.@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_4.pdf@EU-1-18-1299_h_a_dec_4.pdf@2021-10-03 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@OD Not Found@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1302_h_a_dec_2.pdf@EU-1-18-1302_h_a_dec_2.pdf@2021-04-30 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
sed
EU-1-18-1296_h_a_dec_5.pdf@EU-1-18-1296_h_a_dec_5.pdf@2021-04-21 00:00:00@Tegsedi@inotersen@False@False@adopted@Akcea Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_2.pdf@EU-1-18-1295_h_a_dec_2.pdf@2021-01-22 00:00:00@Trazimera@trastuzumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_3.pdf@EU-1-18-1293_h_a_dec_3.pdf@2020-02-13 00:00:00@Aimovig@erenumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1302_h_a_dec_3.pdf@EU-1-18-1302_h_a_dec_3.pdf@2022-02-06 00:00:00@Kigabeq@vigabatrin@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
sed
EU-1-18-1305_h_a_dec_1.pdf@EU-1-18-1305_h_a_dec_1.pdf@2019-08-10 00:00:00@Cablivi@caplacizumab@False@False@adopted@Ablynx N.V.@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_5.pdf@EU-1-18-1299_h_a_dec_5.pdf@2022-01-20 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1295_h_a_dec_3.pdf@EU-1-18-1295_h_a_dec_3.pdf@2021-12-20 00:00:00@Trazimera@trastuzumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1305_h_a_dec_2.pdf@EU-1-18-1305_h_a_dec_2.pdf@2020-09-06 00:00:00@Cablivi@caplacizumab@False@False@adopted@Ablynx N.V.@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_6.pdf@EU-1-18-1299_h_a_dec_6.pdf@2022-06-21 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_4.pdf@EU-1-18-1293_h_a_dec_4.pdf@2020-08-25 00:00:00@Aimovig@erenumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_0.pdf@EU-1-18-1307_h_a_dec_0.pdf@2018-09-27 00:00:00@Verzenios@abemaciclib@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1310_h_a_dec_0.pdf@EU-1-18-1310_h_a_dec_0.pdf@2018-09-20 00:00:00@Deferiprone Lipomed@Deferiprone@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-18-1299_h_a_dec_7.pdf@EU-1-18-1299_h_a_dec_7.pdf@2022-08-17 00:00:00@Yescarta@axicabtagene ciloleucel@False@False@adopted@Kite Pharma EU B.V.@CMA Not Found@Parsed
EU-1-18-1310_h_a_dec_1.pdf@EU-1-18-1310_h_a_dec_1.pdf@2020-12-06 00:00:00@Deferiprone Lipomed@Deferiprone@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_1.pdf@EU-1-18-1307_h_a_dec_1.pdf@2019-10-21 00:00:00@Verzenios@abemaciclib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1296_h_a_dec_7.pdf@EU-1-18-1296_h_a_dec_7.pdf@2022-09-21 00:00:00@Tegsedi@inotersen@False@False@adopted@Akcea Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1293_h_a_dec_5.pdf@EU-1-18-1293_h_a_dec_5.pdf@2022-06-13 00:00:00@Aimovig@erenumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1310_h_a_dec_2.pdf@EU-1-18-1310_h_a_dec_2.pdf@2021-07-28 00:00:00@Deferiprone Lipomed@Deferiprone@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_2.pdf@EU-1-18-1307_h_a_dec_2.pdf@2020-01-17 00:00:00@Verzenios@abemaciclib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_0.pdf@EU-1-18-1306_h_a_dec_0.pdf@2018-10-31 00:00:00@Symkevi@tezacaftor/ivacaftor@True@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_0.pdf@EU-1-18-1311_h_a_dec_0.pdf@2018-08-31 00:00:00@Nerlynx@neratinib@True@False@OD Not Found@Puma Biotechnology, Ltd.@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_3.pdf@EU-1-18-1307_h_a_dec_3.pdf@2020-12-17 00:00:00@Verzenios@abemaciclib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_1.pdf@EU-1-18-1306_h_a_dec_1.pdf@2019-11-01 00:00:00@Symkevi@tezacaftor/ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Europe) Limited@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_1.pdf@EU-1-18-1311_h_a_dec_1.pdf@2019-03-28 00:00:00@Nerlynx@neratinib@False@False@OD Not Found@Puma Biotechnology, Ltd.@CMA Not Found@Parsed
EU-1-18-1315_h_a_dec_0.pdf@EU-1-18-1315_h_a_dec_0.pdf@2018-09-20 00:00:00@Mektovi@binimetinib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_0.pdf@EU-1-18-1313_h_a_dec_0.pdf@2018-09-21 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1307_h_a_dec_4.pdf@EU-1-18-1307_h_a_dec_4.pdf@2022-01-04 00:00:00@Verzenios@abemaciclib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_0.pdf@EU-1-18-1317_h_a_dec_0.pdf@2019-06-05 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
ound@Parsed
EU-1-18-1315_h_a_dec_1.pdf@EU-1-18-1315_h_a_dec_1.pdf@2019-10-24 00:00:00@Mektovi@binimetinib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_2.pdf@EU-1-18-1306_h_a_dec_2.pdf@2020-11-02 00:00:00@Symkevi@tezacaftor/ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_3.pdf@EU-1-18-1311_h_a_dec_3.pdf@2020-07-27 00:00:00@Nerlynx@neratinib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_0.pdf@EU-1-18-1297_h_a_dec_0.pdf@2018-08-23 00:00:00@Kymriah@tisagenlecleucel@True@True@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_1.pdf@EU-1-18-1317_h_a_dec_1.pdf@2019-08-07 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-18-1315_h_a_dec_2.pdf@EU-1-18-1315_h_a_dec_2.pdf@2022-06-21 00:00:00@Mektovi@binimetinib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_1.pdf@EU-1-18-1313_h_a_dec_1.pdf@2019-11-03 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_4.pdf@EU-1-18-1311_h_a_dec_4.pdf@2021-10-25 00:00:00@Nerlynx@neratinib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_2.pdf@EU-1-18-1317_h_a_dec_2.pdf@2019-09-12 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_3.pdf@EU-1-18-1306_h_a_dec_3.pdf@2020-11-25 00:00:00@Symkevi@tezacaftor/ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_3.pdf@EU-1-18-1317_h_a_dec_3.pdf@2021-02-26 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-18-1311_h_a_dec_5.pdf@EU-1-18-1311_h_a_dec_5.pdf@2022-04-25 00:00:00@Nerlynx@neratinib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_1.pdf@EU-1-18-1297_h_a_dec_1.pdf@2021-04-03 00:00:00@Kymriah@tisagenlecleucel@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_2.pdf@EU-1-18-1313_h_a_dec_2.pdf@2019-11-22 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1317_h_a_dec_4.pdf@EU-1-18-1317_h_a_dec_4.pdf@2022-05-05 00:00:00@Pazenir@paclitaxel@False@False@OD Not Found@ratiopharm GmbH@CMA Not Found@Parsed
EU-1-18-1308_h_a_dec_0.pdf@EU-1-18-1308_h_a_dec_0.pdf@2018-08-23 00:00:00@Vyxeos@daunorubicin / cytarabine@False@False@adopted@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1306_h_a_dec_4.pdf@EU-1-18-1306_h_a_dec_4.pdf@2022-05-24 00:00:00@Symkevi@tezacaftor/ivacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_3.pdf@EU-1-18-1313_h_a_dec_3.pdf@2021-04-16 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_2.pdf@EU-1-18-1297_h_a_dec_2.pdf@2022-01-24 00:00:00@Kymriah@tisagenlecleucel@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_0.pdf@EU-1-18-1316_h_a_dec_0.pdf@2018-09-20 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1308_h_a_dec_1.pdf@EU-1-18-1308_h_a_dec_1.pdf@2020-08-28 00:00:00@Vyxeos liposomal@daunorubicin / cytarabine@False@False@adopted@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_0.pdf@EU-1-18-1312_h_a_dec_0.pdf@2018-09-20 00:00:00@Xerava@Eravacycline@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1313_h_a_dec_4.pdf@EU-1-18-1313_h_a_dec_4.pdf@2022-06-13 00:00:00@Pelgraz@pegfilgrastim@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_1.pdf@EU-1-18-1316_h_a_dec_1.pdf@2019-01-03 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare Limited@CMA Not Found@Parsed
EU-1-18-1297_h_a_dec_3.pdf@EU-1-18-1297_h_a_dec_3.pdf@2022-04-29 00:00:00@Kymriah@tisagenlecleucel@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_0.pdf@EU-1-18-1318_h_a_dec_0.pdf@2018-09-20 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited,@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_2.pdf@EU-1-18-1316_h_a_dec_2.pdf@2020-03-27 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1308_h_a_dec_2.pdf@EU-1-18-1308_h_a_dec_2.pdf@2022-02-06 00:00:00@Vyxeos liposomal@daunorubicin / cytarabine@False@False@adopted@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_1.pdf@EU-1-18-1312_h_a_dec_1.pdf@2020-02-28 00:00:00@Xerava@Eravacycline@False@False@OD Not Found@Tetraphase Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_0.pdf@EU-1-18-1319_h_a_dec_0.pdf@2018-09-17 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_3.pdf@EU-1-18-1316_h_a_dec_3.pdf@2020-09-24 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_1.pdf@EU-1-18-1318_h_a_dec_1.pdf@2019-11-03 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC Limited@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_1.pdf@EU-1-18-1319_h_a_dec_1.pdf@2019-11-19 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_0.pdf@EU-1-18-1314_h_a_dec_0.pdf@2018-09-20 00:00:00@Braftovi@encorafenib@True@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_4.pdf@EU-1-18-1316_h_a_dec_4.pdf@2020-10-22 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_2.pdf@EU-1-18-1312_h_a_dec_2.pdf@2021-11-02 00:00:00@Xerava@Eravacycline@False@False@OD Not Found@Tetraphase Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_2.pdf@EU-1-18-1318_h_a_dec_2.pdf@2020-02-24 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC SARL@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_2.pdf@EU-1-18-1319_h_a_dec_2.pdf@2020-12-14 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_1.pdf@EU-1-18-1314_h_a_dec_1.pdf@2019-10-29 00:00:00@Braftovi@encorafenib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_5.pdf@EU-1-18-1316_h_a_dec_5.pdf@2021-01-29 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_3.pdf@EU-1-18-1318_h_a_dec_3.pdf@2021-04-21 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC SARL@CMA Not Found@Parsed
EU-1-18-1321_h_a_dec_0.pdf@EU-1-18-1321_h_a_dec_0.pdf@2018-09-27 00:00:00@Gefitinib Mylan@gefitinib@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_3.pdf@EU-1-18-1319_h_a_dec_3.pdf@2021-04-06 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_2.pdf@EU-1-18-1314_h_a_dec_2.pdf@2020-02-06 00:00:00@Braftovi@encorafenib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_6.pdf@EU-1-18-1316_h_a_dec_6.pdf@2021-09-03 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_3.pdf@EU-1-18-1312_h_a_dec_3.pdf@2021-04-16 00:00:00@Xerava@Eravacycline@False@False@OD Not Found@Tetraphase Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1318_h_a_dec_4.pdf@EU-1-18-1318_h_a_dec_4.pdf@2022-02-06 00:00:00@Slenyto@melatonin@False@False@OD Not Found@RAD Neurim Pharmaceuticals EEC SARL@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_0.pdf@EU-1-18-1323_h_a_dec_0.pdf@2018-09-17 00:00:00@Ilumetri@tildrakizumab@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_3.pdf@EU-1-18-1314_h_a_dec_3.pdf@2022-06-01 00:00:00@Braftovi@encorafenib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1316_h_a_dec_7.pdf@EU-1-18-1316_h_a_dec_7.pdf@2021-09-16 00:00:00@Lenalidomide Accord@lenalidomide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-18-1312_h_a_dec_4.pdf@EU-1-18-1312_h_a_dec_4.pdf@2022-06-29 00:00:00@Xerava@Eravacycline@False@False@OD Not Found@PAION Deutschland GmbH@CMA Not Found@Parsed
EU-1-18-1319_h_a_dec_4.pdf@EU-1-18-1319_h_a_dec_4.pdf@2021-11-15 00:00:00@Hulio@adalimumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1321_h_a_dec_1.pdf@EU-1-18-1321_h_a_dec_1.pdf@2021-10-19 00:00:00@Gefitinib Mylan@gefitinib@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1314_h_a_dec_4.pdf@EU-1-18-1314_h_a_dec_4.pdf@2022-07-25 00:00:00@Braftovi@encorafenib@False@False@OD Not Found@Pierre Fabre Médicament@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_1.pdf@EU-1-18-1323_h_a_dec_1.pdf@2020-04-05 00:00:00@Ilumetri@tildrakizumab@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_2.pdf@EU-1-18-1323_h_a_dec_2.pdf@2021-05-07 00:00:00@Ilumetri@tildrakizumab@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-18-1325_h_a_dec_0.pdf@EU-1-18-1325_h_a_dec_0.pdf@2018-12-18 00:00:00@Namuscla@Mexiletine@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_3.pdf@EU-1-18-1323_h_a_dec_3.pdf@2022-04-25 00:00:00@Ilumetri@tildrakizumab@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_0.pdf@EU-1-18-1322_h_a_dec_0.pdf@2018-09-21 00:00:00@Imfinzi@durvalumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1325_h_a_dec_1.pdf@EU-1-18-1325_h_a_dec_1.pdf@2020-07-13 00:00:00@Namuscla@Mexiletine@False@False@adopted@Lupin Europe GmbH@CMA Not Found@Parsed
EU-1-18-1323_h_a_dec_4.pdf@EU-1-18-1323_h_a_dec_4.pdf@2022-06-20 00:00:00@Ilumetri@tildrakizumab@False@False@OD Not Found@Almirall@CMA Not Found@Parsed
EU-1-18-1327_h_a_dec_0.pdf@EU-1-18-1327_h_a_dec_0.pdf@2018-11-22 00:00:00@Ziextenzo@pegfilgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_1.pdf@EU-1-18-1322_h_a_dec_1.pdf@2020-02-21 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed

EU-1-18-1327_h_a_dec_2.pdf@EU-1-18-1327_h_a_dec_2.pdf@2020-12-17 00:00:00@Ziextenzo@pegfilgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_1.pdf@EU-1-18-1329_h_a_dec_1.pdf@2019-11-19 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_0.pdf@EU-1-18-1326_h_a_dec_0.pdf@2018-12-12 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen,  inactivated, prepared in cell cultures)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1324_h_a_dec_0.pdf@EU-1-18-1324_h_a_dec_0.pdf@2018-11-22 00:00:00@Jivi@damoctocog alfa pegol@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-18-1327_h_a_dec_3.pdf@EU-1-18-1327_h_a_dec_3.pdf@2022-05-05 00:00:00@Ziextenzo@pegfilgrastim@False@False@OD Not Found@Sandoz GmbH@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_2.pdf@EU-1-18-1322_h_a_dec_2.pdf@2020-07-27 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_2.pdf@EU-1-18-1329_h_a_dec_2.pdf@2021-09-03 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_0.pdf@EU-1-18-1320_h_a_dec_0.pdf@2018-08-27 00:00:00@Onpattro@patisiran@False@False@adopted@the applicant@CMA Not Found@Parsed
EU-1-18-1324_h_a_dec_1.pdf@EU-1-18-1324_h_a_dec_1.pdf@2019-09-08 00:00:00@Jivi@damoctocog alfa pegol@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_1.pdf@EU-1-18-1326_h_a_dec_1.pdf@2019-08-23 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen, inactivated, prepared in cell  cultures)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_1.pdf@EU-1-18-1320_h_a_dec_1.pdf@2020-09-03 00:00:00@Onpattro@patisiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_2.pdf@EU-1-18-1326_h_a_dec_2.pdf@2020-07-27 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen, inactivated, prepared in cell  cultures)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1324_h_a_dec_2.pdf@EU-1-18-1324_h_a_dec_2.pdf@2020-12-18 00:00:00@Jivi@damoctocog alfa pegol@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_3.pdf@EU-1-18-1322_h_a_dec_3.pdf@2020-08-27 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_3.pdf@EU-1-18-1329_h_a_dec_3.pdf@2021-09-15 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_2.pdf@EU-1-18-1320_h_a_dec_2.pdf@2020-05-20 00:00:00@Onpattro@patisiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_0.pdf@EU-1-18-1328_h_a_dec_0.pdf@2018-11-20 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Cinfa Biotech S.L.@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_3.pdf@EU-1-18-1326_h_a_dec_3.pdf@2020-10-22 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen, inactivated, prepared in cell  cultures)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_0.pdf@EU-1-18-1331_h_a_dec_0.pdf@2018-11-22 00:00:00@Luxturna@voretigene neparvovec@True@True@adopted@Spark Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_1.pdf@EU-1-18-1328_h_a_dec_1.pdf@2019-11-11 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_0.pdf@EU-1-18-1333_h_a_dec_0.pdf@2018-11-22 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir  disoproxil@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_3.pdf@EU-1-18-1320_h_a_dec_3.pdf@2020-11-20 00:00:00@Onpattro@patisiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_4.pdf@EU-1-18-1322_h_a_dec_4.pdf@2021-11-01 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1329_h_a_dec_4.pdf@EU-1-18-1329_h_a_dec_4.pdf@2022-11-03 00:00:00@Fulphila@pegfilgrastim@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_4.pdf@EU-1-18-1326_h_a_dec_4.pdf@2021-07-23 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen, inactivated, prepared in cell  cultures)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_4.pdf@EU-1-18-1320_h_a_dec_4.pdf@2021-11-10 00:00:00@Onpattro@patisiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_1.pdf@EU-1-18-1333_h_a_dec_1.pdf@2020-01-27 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir disoproxil@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_1.pdf@EU-1-18-1331_h_a_dec_1.pdf@2019-01-23 00:00:00@Luxturna@voretigene neparvovec@False@False@adopted@Spark Therapeutics Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1326_h_a_dec_5.pdf@EU-1-18-1326_h_a_dec_5.pdf@2022-07-27 00:00:00@Flucelvax Tetra@influenza vaccine (surface antigen, inactivated, prepared in cell  cultures)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_2.pdf@EU-1-18-1333_h_a_dec_2.pdf@2021-06-17 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir disoproxil@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_2.pdf@EU-1-18-1328_h_a_dec_2.pdf@2020-09-03 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-18-1320_h_a_dec_5.pdf@EU-1-18-1320_h_a_dec_5.pdf@2022-02-16 00:00:00@Onpattro@patisiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_5.pdf@EU-1-18-1322_h_a_dec_5.pdf@2021-10-19 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_0.pdf@EU-1-18-1330_h_a_dec_0.pdf@2018-11-14 00:00:00@Emgality@galcanezumab@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1333_h_a_dec_3.pdf@EU-1-18-1333_h_a_dec_3.pdf@2022-03-28 00:00:00@Delstrigo@doravirine / lamivudine / tenofovir disoproxil@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_2.pdf@EU-1-18-1331_h_a_dec_2.pdf@2020-09-03 00:00:00@Luxturna@voretigene neparvovec@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_1.pdf@EU-1-18-1330_h_a_dec_1.pdf@2019-09-12 00:00:00@Emgality@galcanezumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1328_h_a_dec_3.pdf@EU-1-18-1328_h_a_dec_3.pdf@2022-05-19 00:00:00@Pelmeg@pegfilgrastim@False@False@OD Not Found@Mundipharma Corporation (Ireland) Limited@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_6.pdf@EU-1-18-1322_h_a_dec_6.pdf@2022-02-28 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1337_h_a_dec_0.pdf@EU-1-18-1337_h_a_dec_0.pdf@2019-11-01 00:00:00@Macimorelin Aeterna Zentaris@macimorelin@True@False@OD Not Found@Æterna Zentaris GmbH@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_2.pdf@EU-1-18-1330_h_a_dec_2.pdf@2020-05-20 00:00:00@Emgality@galcanezumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1335_h_a_dec_0.pdf@EU-1-18-1335_h_a_dec_0.pdf@2018-11-22 00:00:00@Poteligeo@Mogamulizumab@True@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_3.pdf@EU-1-18-1331_h_a_dec_3.pdf@2020-11-20 00:00:00@Luxturna@voretigene neparvovec@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_7.pdf@EU-1-18-1322_h_a_dec_7.pdf@2022-06-13 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
ound@Parsed
EU-1-18-1337_h_a_dec_1.pdf@EU-1-18-1337_h_a_dec_1.pdf@2021-04-21 00:00:00@Macimorelin Consilient Health@macimorelin@False@False@OD Not Found@Æterna Zentaris GmbH@CMA Not Found@Parsed
EU-1-18-1335_h_a_dec_1.pdf@EU-1-18-1335_h_a_dec_1.pdf@2020-10-19 00:00:00@Poteligeo@Mogamulizumab@False@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1339_h_a_dec_0.pdf@EU-1-18-1339_h_a_dec_0.pdf@2018-12-18 00:00:00@Bevespi Aerosphere@glycopyrronium bromide /  formoterol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1331_h_a_dec_4.pdf@EU-1-18-1331_h_a_dec_4.pdf@2021-09-11 00:00:00@Luxturna@voretigene  neparvovec@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_4.pdf@EU-1-18-1330_h_a_dec_4.pdf@2021-07-16 00:00:00@Emgality@galcanezumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1322_h_a_dec_8.pdf@EU-1-18-1322_h_a_dec_8.pdf@2022-08-22 00:00:00@Imfinzi@durvalumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1337_h_a_dec_2.pdf@EU-1-18-1337_h_a_dec_2.pdf@2021-04-16 00:00:00@Macimorelin Consilient Health@macimorelin@False@False@OD Not Found@Æterna Zentaris GmbH@CMA Not Found@Parsed
EU-1-18-1339_h_a_dec_1.pdf@EU-1-18-1339_h_a_dec_1.pdf@2020-04-23 00:00:00@Bevespi Aerosphere@glycopyrronium bromide / formoterol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1334_h_a_dec_0.pdf@EU-1-18-1334_h_a_dec_0.pdf@2018-11-20 00:00:00@Vabomere@meropenem/vaborbactam@True@False@OD Not Found@Rempex London Limited@CMA Not Found@Parsed
EU-1-18-1335_h_a_dec_2.pdf@EU-1-18-1335_h_a_dec_2.pdf@2022-04-29 00:00:00@Poteligeo@Mogamulizumab@False@False@adopted@Kyowa Kirin Holdings B.V.@CMA Not Found@Parsed
EU-1-18-1339_h_a_dec_2.pdf@EU-1-18-1339_h_a_dec_2.pdf@2021-07-16 00:00:00@Bevespi Aerosphere@glycopyrronium bromide / formoterol@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-18-1330_h_a_dec_5.pdf@EU-1-18-1330_h_a_dec_5.pdf@2022-07-15 00:00:00@Emgality@galcanezumab@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-18-1334_h_a_dec_1.pdf@EU-1-18-1334_h_a_dec_1.pdf@2019-02-20 00:00:00@Vabomere@meropenem/vaborbactam@False@False@OD Not Found@Rempex London Limited@CMA Not Found@Parsed
EU-1-18-1338_h_a_dec_0.pdf@EU-1-18-1338_h_a_dec_0.pdf@2018-12-12 00:00:00@Dengvaxia@dengue tetravalent vaccine (live,  attenuated)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1332_h_a_dec_0.pdf@EU-1-18-1332_h_a_dec_0.pdf@2018-11-22 00:00:00@Pifeltro@doravirine@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_0.pdf@EU-1-18-1336_h_a_dec_0.pdf@2018-11-20 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1334_h_a_dec_2.pdf@EU-1-18-1334_h_a_dec_2.pdf@2020-03-27 00:00:00@Vaborem@meropenem/vaborbactam@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-18-1338_h_a_dec_1.pdf@EU-1-18-1338_h_a_dec_1.pdf@2020-09-17 00:00:00@Dengvaxia@dengue tetravalent vaccine (live, attenuated)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-18-1332_h_a_dec_1.pdf@EU-1-18-1332_h_a_dec_1.pdf@2020-08-04 00:00:00@Pifeltro@doravirine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_0.pdf@EU-1-18-1341_h_a_dec_0.pdf@2018-12-12 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1334_h_a_dec_3.pdf@EU-1-18-1334_h_a_dec_3.pdf@2021-10-19 00:00:00@Vaborem@meropenem/vaborbactam@False@False@OD Not Found@Menarini International Operations Luxembourg S.A.@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_1.pdf@EU-1-18-1336_h_a_dec_1.pdf@2020-12-06 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1338_h_a_dec_2.pdf@EU-1-18-1338_h_a_dec_2.pdf@2021-09-12 00:00:00@Dengvaxia@dengue tetravalent vaccine (live, attenuated)@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_0.pdf@EU-1-18-1340_h_a_dec_0.pdf@2018-11-22 00:00:00@TAKHZYRO@lanadelumab@True@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1332_h_a_dec_2.pdf@EU-1-18-1332_h_a_dec_2.pdf@2022-07-04 00:00:00@Pifeltro@doravirine@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_1.pdf@EU-1-18-1341_h_a_dec_1.pdf@2020-06-17 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_2.pdf@EU-1-18-1336_h_a_dec_2.pdf@2021-05-19 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_2.pdf@EU-1-18-1341_h_a_dec_2.pdf@2021-06-21 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_1.pdf@EU-1-18-1340_h_a_dec_1.pdf@2020-09-03 00:00:00@TAKHZYRO@lanadelumab@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1336_h_a_dec_3.pdf@EU-1-18-1336_h_a_dec_3.pdf@2022-09-13 00:00:00@Buvidal@buprenorphine@False@False@OD Not Found@Camurus AB@CMA Not Found@Parsed
EU-1-18-1343_h_a_dec_0.pdf@EU-1-18-1343_h_a_dec_0.pdf@2019-07-01 00:00:00@Silodosin Recordati@silodosin@False@False@OD Not Found@Recordati Ireland Ltd@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_0.pdf@EU-1-18-1345_h_a_dec_0.pdf@2019-04-26 00:00:00@Ondexxya@andexanet alfa@True@False@OD Not Found@Portola Netherlands B.V.@conditional@Parsed
EU-1-18-1347_h_a_dec_0.pdf@EU-1-18-1347_h_a_dec_0.pdf@2019-03-28 00:00:00@Febuxostat Krka@febuxostat@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_3.pdf@EU-1-18-1341_h_a_dec_3.pdf@2021-08-18 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_2.pdf@EU-1-18-1340_h_a_dec_2.pdf@2021-02-19 00:00:00@TAKHZYRO@lanadelumab@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1347_h_a_dec_1.pdf@EU-1-18-1347_h_a_dec_1.pdf@2020-09-30 00:00:00@Febuxostat Krka@febuxostat@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-18-1344_h_a_dec_0.pdf@EU-1-18-1344_h_a_dec_0.pdf@2019-02-14 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_1.pdf@EU-1-18-1345_h_a_dec_1.pdf@2020-01-04 00:00:00@Ondexxya@andexanet alfa@False@False@OD Not Found@Portola Netherlands B.V.@conditional@Parsed
EU-1-18-1349_h_a_dec_0.pdf@EU-1-18-1349_h_a_dec_0.pdf@2019-04-26 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@exceptional@Parsed
EU-1-18-1341_h_a_dec_4.pdf@EU-1-18-1341_h_a_dec_4.pdf@2021-11-18 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Viatris Limited@CMA Not Found@Parsed
EU-1-18-1344_h_a_dec_1.pdf@EU-1-18-1344_h_a_dec_1.pdf@2020-01-16 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_3.pdf@EU-1-18-1340_h_a_dec_3.pdf@2021-09-29 00:00:00@TAKHZYRO@lanadelumab@False@False@adopted@Shire Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-18-1351_h_a_dec_0.pdf@EU-1-18-1351_h_a_dec_0.pdf@2019-06-20 00:00:00@Trecondi@treosulfan@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-18-1348_h_a_dec_0.pdf@EU-1-18-1348_h_a_dec_0.pdf@2019-02-18 00:00:00@Lusutrombopag Shionogi@lusutrombopag@True@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_2.pdf@EU-1-18-1345_h_a_dec_2.pdf@2020-11-16 00:00:00@Ondexxya@andexanet alfa@False@False@OD Not Found@Portola Netherlands B.V.@conditional@Parsed
EU-1-18-1344_h_a_dec_2.pdf@EU-1-18-1344_h_a_dec_2.pdf@2020-10-27 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1349_h_a_dec_1.pdf@EU-1-18-1349_h_a_dec_1.pdf@2019-07-19 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@exceptional@Parsed
EU-1-18-1351_h_a_dec_1.pdf@EU-1-18-1351_h_a_dec_1.pdf@2020-01-04 00:00:00@Trecondi@treosulfan@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-18-1348_h_a_dec_1.pdf@EU-1-18-1348_h_a_dec_1.pdf@2020-07-13 00:00:00@Mulpleo@lusutrombopag@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-18-1341_h_a_dec_5.pdf@EU-1-18-1341_h_a_dec_5.pdf@2022-02-21 00:00:00@Ogivri@trastuzumab@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_3.pdf@EU-1-18-1345_h_a_dec_3.pdf@2021-07-01 00:00:00@Ondexxya@andexanet alfa@False@False@OD Not Found@Portola Netherlands B.V.@CMA Not Found@Parsed
EU-1-18-1344_h_a_dec_3.pdf@EU-1-18-1344_h_a_dec_3.pdf@2020-12-22 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1340_h_a_dec_4.pdf@EU-1-18-1340_h_a_dec_4.pdf@2022-09-29 00:00:00@TAKHZYRO@lanadelumab@False@False@adopted@Takeda Pharmaceuticals International AG Ireland Branch@CMA Not Found@Parsed
EU-1-18-1351_h_a_dec_2.pdf@EU-1-18-1351_h_a_dec_2.pdf@2020-10-11 00:00:00@Trecondi@treosulfan@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-18-1348_h_a_dec_2.pdf@EU-1-18-1348_h_a_dec_2.pdf@2022-01-31 00:00:00@Mulpleo@lusutrombopag@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_4.pdf@EU-1-18-1345_h_a_dec_4.pdf@2021-02-19 00:00:00@Ondexxya@andexanet alfa@False@False@OD Not Found@Alexion Europe S.A.S.@conditional@Parsed
EU-1-18-1344_h_a_dec_4.pdf@EU-1-18-1344_h_a_dec_4.pdf@2022-01-07 00:00:00@Zirabev@bevacizumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1349_h_a_dec_2.pdf@EU-1-18-1349_h_a_dec_2.pdf@2020-07-23 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@exceptional@Parsed
EU-1-18-1351_h_a_dec_3.pdf@EU-1-18-1351_h_a_dec_3.pdf@2020-11-24 00:00:00@Trecondi@treosulfan@False@False@adopted@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-18-1345_h_a_dec_5.pdf@EU-1-18-1345_h_a_dec_5.pdf@2022-04-29 00:00:00@Ondexxya@andexanet alfa@False@False@OD Not Found@Alexion Europe S.A.S.@conditional@Parsed
EU-1-18-1349_h_a_dec_3.pdf@EU-1-18-1349_h_a_dec_3.pdf@2022-03-18 00:00:00@Dectova@zanamivir@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@exceptional@Parsed
EU-1-18-1345_h_a_dec_6.pdf@EU-1-18-1345_h_a_dec_6.pdf@2022-07-06 00:00:00@Ondexxya@andexanet alfa@False@False@OD Not Found@Alexion Europe S.A.S.@CMA Not Found@Parsed
EU-1-19-1353_h_a_dec_0.pdf@EU-1-19-1353_h_a_dec_0.pdf@2019-03-25 00:00:00@Atazanavir Krka@atazanavir@False@False@OD Not Found@Krka d. d., Novo mesto@CMA Not Found@Parsed
EU-1-19-1353_h_a_dec_1.pdf@EU-1-19-1353_h_a_dec_1.pdf@2021-11-15 00:00:00@Atazanavir Krka@atazanavir@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_0.pdf@EU-1-19-1355_h_a_dec_0.pdf@2019-06-05 00:00:00@Lorviqua@lorlatinib@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-18-1352_h_a_dec_0.pdf@EU-1-18-1352_h_a_dec_0.pdf@2019-02-15 00:00:00@Besremi@ropeginterferon alfa-2b@True@False@OD Not Found@AOP Orphan Pharmaceuticals AG@CMA Not Found@Parsed
EU-1-18-1342_h_a_dec_0.pdf@EU-1-18-1342_h_a_dec_0.pdf@2019-01-14 00:00:00@Erleada@apalutamide@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_0.pdf@EU-1-19-1358_h_a_dec_0.pdf@2019-03-28 00:00:00@AJOVY@fremanezumab@True@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_1.pdf@EU-1-19-1355_h_a_dec_1.pdf@2020-03-04 00:00:00@Lorviqua@lorlatinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-18-1352_h_a_dec_1.pdf@EU-1-18-1352_h_a_dec_1.pdf@2022-01-31 00:00:00@Besremi@ropeginterferon alfa-2b@False@False@OD Not Found@AOP Orphan Pharmaceuticals GmbH,@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_1.pdf@EU-1-19-1358_h_a_dec_1.pdf@2020-06-26 00:00:00@AJOVY@fremanezumab@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_2.pdf@EU-1-19-1355_h_a_dec_2.pdf@2020-12-17 00:00:00@Lorviqua@lorlatinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1342_h_a_dec_1.pdf@EU-1-18-1342_h_a_dec_1.pdf@2020-01-27 00:00:00@Erleada@apalutamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1354_h_a_dec_0.pdf@EU-1-19-1354_h_a_dec_0.pdf@2019-02-04 00:00:00@Vizimpro@dacomitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1350_h_a_dec_0.pdf@EU-1-18-1350_h_a_dec_0.pdf@2019-02-18 00:00:00@Tobramycin PARI@tobramycin@False@False@adopted@PARI Pharma GmbH@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_2.pdf@EU-1-19-1358_h_a_dec_2.pdf@2021-09-22 00:00:00@AJOVY@fremanezumab@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
Found@Parsed
EU-1-19-1355_h_a_dec_3.pdf@EU-1-19-1355_h_a_dec_3.pdf@2021-09-03 00:00:00@Lorviqua@lorlatinib@False@False@adopted@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-19-1354_h_a_dec_1.pdf@EU-1-19-1354_h_a_dec_1.pdf@2021-01-22 00:00:00@Vizimpro@dacomitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1350_h_a_dec_1.pdf@EU-1-18-1350_h_a_dec_1.pdf@2022-04-02 00:00:00@Vantobra@tobramycin@False@False@OD Not Found@PARI Pharma GmbH@CMA Not Found@Parsed
EU-1-19-1358_h_a_dec_3.pdf@EU-1-19-1358_h_a_dec_3.pdf@2021-12-13 00:00:00@AJOVY@fremanezumab@False@False@OD Not Found@Teva GmbH@CMA Not Found@Parsed
EU-1-18-1342_h_a_dec_2.pdf@EU-1-18-1342_h_a_dec_2.pdf@2021-09-12 00:00:00@Erleada@apalutamide@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_4.pdf@EU-1-19-1355_h_a_dec_4.pdf@2021-03-31 00:00:00@Lorviqua@lorlatinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-19-1354_h_a_dec_2.pdf@EU-1-19-1354_h_a_dec_2.pdf@2022-06-29 00:00:00@Vizimpro@dacomitinib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-18-1346_h_a_dec_1.pdf@EU-1-18-1346_h_a_dec_1.pdf@2019-04-17 00:00:00@Miglustat Dipharma@miglustat@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_5.pdf@EU-1-19-1355_h_a_dec_5.pdf@2021-07-28 00:00:00@Lorviqua@lorlatinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-18-1346_h_a_dec_2.pdf@EU-1-18-1346_h_a_dec_2.pdf@2020-09-12 00:00:00@Miglustat Dipharma@miglustat@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_6.pdf@EU-1-19-1355_h_a_dec_6.pdf@2022-01-27 00:00:00@Lorviqua@lorlatinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-19-1359_h_a_dec_0.pdf@EU-1-19-1359_h_a_dec_0.pdf@2019-09-26 00:00:00@Trogarzo@ibalizumab@True@False@OD Not Found@Theratechnologies International Limited@CMA Not Found@Parsed
EU-1-19-1361_h_a_dec_0.pdf@EU-1-19-1361_h_a_dec_0.pdf@2019-04-26 00:00:00@Skyrizi@risankizumab@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1355_h_a_dec_7.pdf@EU-1-19-1355_h_a_dec_7.pdf@2022-04-04 00:00:00@Lorviqua@lorlatinib@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-18-1346_h_a_dec_3.pdf@EU-1-18-1346_h_a_dec_3.pdf@2022-07-22 00:00:00@Miglustat Dipharma@miglustat@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-19-1365_h_a_dec_0.pdf@EU-1-19-1365_h_a_dec_0.pdf@2019-07-25 00:00:00@Cufence@trientine dihydrochloride@False@False@OD Not Found@Univar BV@CMA Not Found@Parsed
EU-1-19-1361_h_a_dec_1.pdf@EU-1-19-1361_h_a_dec_1.pdf@2020-08-27 00:00:00@Skyrizi@risankizumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1359_h_a_dec_1.pdf@EU-1-19-1359_h_a_dec_1.pdf@2021-04-21 00:00:00@Trogarzo@ibalizumab@False@False@OD Not Found@Theratechnologies Europe Limited@CMA Not Found@Parsed
EU-1-19-1364_h_a_dec_0.pdf@EU-1-19-1364_h_a_dec_0.pdf@2019-09-27 00:00:00@NUCEIVA@botulinum toxin type A@False@False@OD Not Found@Evolus Pharma Limited@CMA Not Found@Parsed
EU-1-19-1365_h_a_dec_1.pdf@EU-1-19-1365_h_a_dec_1.pdf@2020-11-18 00:00:00@Cufence@trientine dihydrochloride@False@False@OD Not Found@Univar Solutions B.V.@CMA Not Found@Parsed
EU-1-19-1368_h_a_dec_0.pdf@EU-1-19-1368_h_a_dec_0.pdf@2019-06-20 00:00:00@Ambrisentan Mylan@ambrisentan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1361_h_a_dec_2.pdf@EU-1-19-1361_h_a_dec_2.pdf@2021-05-21 00:00:00@Skyrizi@risankizumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1369_h_a_dec_0.pdf@EU-1-19-1369_h_a_dec_0.pdf@2019-06-20 00:00:00@Sixmo@buprenorphine@False@False@OD Not Found@L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A,@CMA Not Found@Parsed
EU-1-19-1365_h_a_dec_2.pdf@EU-1-19-1365_h_a_dec_2.pdf@2022-02-06 00:00:00@Cufence@trientine dihydrochloride@False@False@OD Not Found@Univar Solutions B.V.@CMA Not Found@Parsed
EU-1-19-1368_h_a_dec_1.pdf@EU-1-19-1368_h_a_dec_1.pdf@2021-01-29 00:00:00@Ambrisentan Mylan@ambrisentan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1356_h_a_dec_0.pdf@EU-1-19-1356_h_a_dec_0.pdf@2019-02-04 00:00:00@Idacio@adalimumab@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1359_h_a_dec_2.pdf@EU-1-19-1359_h_a_dec_2.pdf@2022-05-19 00:00:00@Trogarzo@ibalizumab@False@False@OD Not Found@Theratechnologies Europe Limited@CMA Not Found@Parsed
EU-1-19-1361_h_a_dec_3.pdf@EU-1-19-1361_h_a_dec_3.pdf@2021-11-15 00:00:00@Skyrizi@risankizumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1364_h_a_dec_1.pdf@EU-1-19-1364_h_a_dec_1.pdf@2021-01-14 00:00:00@NUCEIVA@botulinum toxin type A@False@False@OD Not Found@Evolus Pharma Limited@CMA Not Found@Parsed
EU-1-19-1369_h_a_dec_1.pdf@EU-1-19-1369_h_a_dec_1.pdf@2022-01-25 00:00:00@Sixmo@buprenorphine@False@False@OD Not Found@L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A@CMA Not Found@Parsed
EU-1-19-1356_h_a_dec_1.pdf@EU-1-19-1356_h_a_dec_1.pdf@2020-06-18 00:00:00@Idacio@adalimumab@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1356_h_a_dec_2.pdf@EU-1-19-1356_h_a_dec_2.pdf@2021-10-22 00:00:00@Idacio@adalimumab@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1368_h_a_dec_2.pdf@EU-1-19-1368_h_a_dec_2.pdf@2021-09-29 00:00:00@Ambrisentan Mylan@ambrisentan@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1364_h_a_dec_2.pdf@EU-1-19-1364_h_a_dec_2.pdf@2022-01-24 00:00:00@NUCEIVA@botulinum toxin type A@False@False@OD Not Found@Evolus Pharma Limited@CMA Not Found@Parsed
EU-1-19-1366_h_a_dec_0.pdf@EU-1-19-1366_h_a_dec_0.pdf@2019-01-07 00:00:00@Xromi@hydroxycarbamide@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-19-1370_h_a_dec_0.pdf@EU-1-19-1370_h_a_dec_0.pdf@2019-01-07 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_0.pdf@EU-1-19-1360_h_a_dec_0.pdf@2019-03-05 00:00:00@Waylivra@volanesorsen@True@False@adopted@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1371_h_a_dec_0.pdf@EU-1-19-1371_h_a_dec_0.pdf@2019-02-07 00:00:00@Ultomiris@Ravulizumab@True@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1366_h_a_dec_2.pdf@EU-1-19-1366_h_a_dec_2.pdf@2021-04-15 00:00:00@Xromi@hydroxycarbamide@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-19-1370_h_a_dec_1.pdf@EU-1-19-1370_h_a_dec_1.pdf@2020-01-04 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1362_h_a_dec_0.pdf@EU-1-19-1362_h_a_dec_0.pdf@2019-03-05 00:00:00@Palynziq@pegvaliase@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_1.pdf@EU-1-19-1371_h_a_dec_1.pdf@2020-06-25 00:00:00@similar medicinal product@Active Substance Not Found@False@False@adopted@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_1.pdf@EU-1-19-1360_h_a_dec_1.pdf@2020-03-16 00:00:00@Waylivra@volanesorsen@False@False@OD Not Found@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1370_h_a_dec_2.pdf@EU-1-19-1370_h_a_dec_2.pdf@2020-11-18 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare B.V.@CMA Not Found@Parsed
EU-1-19-1373_h_a_dec_0.pdf@EU-1-19-1373_h_a_dec_0.pdf@2019-06-20 00:00:00@Doptelet@avatrombopag@True@False@OD Not Found@Dova Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_2.pdf@EU-1-19-1371_h_a_dec_2.pdf@2020-11-18 00:00:00@Ultomiris@Ravulizumab@False@False@OD Not Found@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1366_h_a_dec_3.pdf@EU-1-19-1366_h_a_dec_3.pdf@2022-02-14 00:00:00@Xromi@hydroxycarbamide@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-19-1375_h_a_dec_0.pdf@EU-1-19-1375_h_a_dec_0.pdf@2019-06-20 00:00:00@Grasustek@pegfilgrastim@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1370_h_a_dec_3.pdf@EU-1-19-1370_h_a_dec_3.pdf@2021-08-20 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1362_h_a_dec_1.pdf@EU-1-19-1362_h_a_dec_1.pdf@2021-03-26 00:00:00@Palynziq@pegvaliase@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_3.pdf@EU-1-19-1371_h_a_dec_3.pdf@2021-01-09 00:00:00@Ultomiris@Ravulizumab@False@False@OD Not Found@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1373_h_a_dec_1.pdf@EU-1-19-1373_h_a_dec_1.pdf@2020-09-10 00:00:00@Doptelet@avatrombopag@False@False@OD Not Found@Dova Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-19-1375_h_a_dec_1.pdf@EU-1-19-1375_h_a_dec_1.pdf@2021-03-26 00:00:00@Grasustek@pegfilgrastim@False@False@OD Not Found@Juta Pharma GmbH@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_2.pdf@EU-1-19-1360_h_a_dec_2.pdf@2021-04-02 00:00:00@Waylivra@volanesorsen@False@False@OD Not Found@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1370_h_a_dec_4.pdf@EU-1-19-1370_h_a_dec_4.pdf@2021-11-15 00:00:00@Dovato@dolutegravir/lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_4.pdf@EU-1-19-1371_h_a_dec_4.pdf@2022-01-04 00:00:00@Ultomiris@Ravulizumab@False@False@OD Not Found@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1373_h_a_dec_2.pdf@EU-1-19-1373_h_a_dec_2.pdf@2021-01-18 00:00:00@Doptelet@avatrombopag@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-19-1375_h_a_dec_2.pdf@EU-1-19-1375_h_a_dec_2.pdf@2022-08-07 00:00:00@Grasustek@pegfilgrastim@False@False@OD Not Found@Juta Pharma GmbH@CMA Not Found@Parsed
EU-1-19-1362_h_a_dec_2.pdf@EU-1-19-1362_h_a_dec_2.pdf@2021-08-18 00:00:00@Palynziq@pegvaliase@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1371_h_a_dec_5.pdf@EU-1-19-1371_h_a_dec_5.pdf@2022-09-21 00:00:00@Ultomiris@Ravulizumab@False@False@OD Not Found@Alexion Europe SAS@CMA Not Found@Parsed
EU-1-19-1373_h_a_dec_3.pdf@EU-1-19-1373_h_a_dec_3.pdf@2021-03-31 00:00:00@Doptelet@avatrombopag@False@False@OD Not Found@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-19-1377_h_a_dec_0.pdf@EU-1-19-1377_h_a_dec_0.pdf@2019-06-20 00:00:00@Talzenna@talazoparib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1360_h_a_dec_3.pdf@EU-1-19-1360_h_a_dec_3.pdf@2022-02-14 00:00:00@Waylivra@volanesorsen@False@False@OD Not Found@Akcea Therapeutics Ireland Limited@conditional@Parsed
EU-1-19-1377_h_a_dec_1.pdf@EU-1-19-1377_h_a_dec_1.pdf@2020-06-26 00:00:00@Talzenna@talazoparib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1362_h_a_dec_3.pdf@EU-1-19-1362_h_a_dec_3.pdf@2022-03-24 00:00:00@Palynziq@pegvaliase@False@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-19-1377_h_a_dec_2.pdf@EU-1-19-1377_h_a_dec_2.pdf@2021-05-21 00:00:00@Talzenna@talazoparib@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1379_h_a_dec_0.pdf@EU-1-19-1379_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole Accord@posaconazole@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_0.pdf@EU-1-19-1376_h_a_dec_0.pdf@2019-06-28 00:00:00@LIBTAYO@cemiplimab@True@False@OD Not Found@Regeneron Ireland U.C.@conditional@Parsed
EU-1-19-1374_h_a_dec_0.pdf@EU-1-19-1374_h_a_dec_0.pdf@2019-06-20 00:00:00@Esperoct@turoctocog alfa pegol@True@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-19-1379_h_a_dec_1.pdf@EU-1-19-1379_h_a_dec_1.pdf@2021-04-10 00:00:00@Posaconazole Accord@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1381_h_a_dec_0.pdf@EU-1-19-1381_h_a_dec_0.pdf@2019-07-25 00:00:00@LysaKare@arginine / lysine@False@False@OD Not Found@Advanced Accelerator Applications@CMA Not Found@Parsed
EU-1-19-1372_h_a_dec_0.pdf@EU-1-19-1372_h_a_dec_0.pdf@2019-06-25 00:00:00@Striascan@ioflupane ( 123I)@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-19-1374_h_a_dec_1.pdf@EU-1-19-1374_h_a_dec_1.pdf@2020-08-25 00:00:00@Esperoct@turoctocog alfa pegol@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-19-1379_h_a_dec_2.pdf@EU-1-19-1379_h_a_dec_2.pdf@2022-02-06 00:00:00@Posaconazole Accord@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_1.pdf@EU-1-19-1376_h_a_dec_1.pdf@2020-05-20 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity  Company (DAC)@conditional@Parsed
EU-1-19-1372_h_a_dec_1.pdf@EU-1-19-1372_h_a_dec_1.pdf@2022-08-07 00:00:00@Striascan@ioflupane ( 123I)@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-19-1383_h_a_dec_0.pdf@EU-1-19-1383_h_a_dec_0.pdf@2019-08-26 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1385_h_a_dec_0.pdf@EU-1-19-1385_h_a_dec_0.pdf@2019-09-19 00:00:00@VITRAKVI@larotrectinib@True@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1380_h_a_dec_0.pdf@EU-1-19-1380_h_a_dec_0.pdf@2019-07-25 00:00:00@Posaconazole AHCL@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_2.pdf@EU-1-19-1376_h_a_dec_2.pdf@2020-06-26 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@conditional@Parsed
EU-1-19-1383_h_a_dec_1.pdf@EU-1-19-1383_h_a_dec_1.pdf@2020-11-24 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1385_h_a_dec_1.pdf@EU-1-19-1385_h_a_dec_1.pdf@2020-08-25 00:00:00@VITRAKVI@larotrectinib@False@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1389_h_a_dec_0.pdf@EU-1-19-1389_h_a_dec_0.pdf@2019-09-19 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1380_h_a_dec_1.pdf@EU-1-19-1380_h_a_dec_1.pdf@2022-07-15 00:00:00@Posaconazole AHCL@posaconazole@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1387_h_a_dec_0.pdf@EU-1-19-1387_h_a_dec_0.pdf@2019-11-14 00:00:00@Senstend@lidocaine / prilocaine@False@False@OD Not Found@Plethora Pharma Solutions Ltd.@CMA Not Found@Parsed
EU-1-19-1383_h_a_dec_2.pdf@EU-1-19-1383_h_a_dec_2.pdf@2022-02-24 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1392_h_a_dec_0.pdf@EU-1-19-1392_h_a_dec_0.pdf@2019-11-11 00:00:00@Ervebo@ZEBOV-GP, live)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1385_h_a_dec_2.pdf@EU-1-19-1385_h_a_dec_2.pdf@2021-08-18 00:00:00@VITRAKVI@larotrectinib@False@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1389_h_a_dec_1.pdf@EU-1-19-1389_h_a_dec_1.pdf@2020-09-12 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_3.pdf@EU-1-19-1376_h_a_dec_3.pdf@2020-07-31 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@conditional@Parsed
EU-1-19-1383_h_a_dec_3.pdf@EU-1-19-1383_h_a_dec_3.pdf@2022-06-14 00:00:00@Lacosamide UCB@lacosamide@False@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1387_h_a_dec_1.pdf@EU-1-19-1387_h_a_dec_1.pdf@2022-06-24 00:00:00@Senstend@lidocaine / prilocaine@False@False@OD Not Found@Plethora Pharma Solutions Ltd.@CMA Not Found@Parsed
EU-1-19-1394_h_a_dec_0.pdf@EU-1-19-1394_h_a_dec_0.pdf@2020-04-17 00:00:00@Tigecycline Accord@tigecycline@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1385_h_a_dec_3.pdf@EU-1-19-1385_h_a_dec_3.pdf@2022-08-25 00:00:00@VITRAKVI@larotrectinib@False@False@OD Not Found@Bayer AG@conditional@Parsed
EU-1-19-1392_h_a_dec_1.pdf@EU-1-19-1392_h_a_dec_1.pdf@2020-09-15 00:00:00@Ervebo@Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live)@False@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1389_h_a_dec_2.pdf@EU-1-19-1389_h_a_dec_2.pdf@2021-04-16 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1394_h_a_dec_1.pdf@EU-1-19-1394_h_a_dec_1.pdf@2022-09-13 00:00:00@Tigecycline Accord@tigecycline@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
ional@Parsed
EU-1-19-1388_h_a_dec_0.pdf@EU-1-19-1388_h_a_dec_0.pdf@2020-01-16 00:00:00@Polivy@polatuzumab vedotin@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-19-1392_h_a_dec_2.pdf@EU-1-19-1392_h_a_dec_2.pdf@2021-01-14 00:00:00@Ervebo@Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP,  live)@False@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1389_h_a_dec_3.pdf@EU-1-19-1389_h_a_dec_3.pdf@2022-06-29 00:00:00@Epidyolex@cannabidiol@False@False@adopted@GW Pharma (International) B.V.@CMA Not Found@Parsed
EU-1-19-1395_h_a_dec_0.pdf@EU-1-19-1395_h_a_dec_0.pdf@2020-09-01 00:00:00@Clopidogrel/Acetylsalicylic acid Mylan@clopidogrel /  acetylsalicylic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1388_h_a_dec_1.pdf@EU-1-19-1388_h_a_dec_1.pdf@2020-09-12 00:00:00@Polivy@polatuzumab vedotin@False@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-19-1392_h_a_dec_3.pdf@EU-1-19-1392_h_a_dec_3.pdf@2022-01-31 00:00:00@Ervebo@Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live)@False@False@OD Not Found@Merck Sharp & Dohme B.V.@conditional@Parsed
EU-1-19-1376_h_a_dec_5.pdf@EU-1-19-1376_h_a_dec_5.pdf@2021-06-21 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@conditional@Parsed
EU-1-19-1395_h_a_dec_1.pdf@EU-1-19-1395_h_a_dec_1.pdf@2021-02-25 00:00:00@Clopidogrel/Acetylsalicylic acid Mylan@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1384_h_a_dec_0.pdf@EU-1-19-1384_h_a_dec_0.pdf@2019-08-23 00:00:00@Giapreza@angiotensin II acetate@True@False@OD Not Found@La Jolla Pharmaceutical II B.V.@CMA Not Found@Parsed
EU-1-19-1388_h_a_dec_2.pdf@EU-1-19-1388_h_a_dec_2.pdf@2021-03-12 00:00:00@Polivy@polatuzumab vedotin@False@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-19-1386_h_a_dec_0.pdf@EU-1-19-1386_h_a_dec_0.pdf@2019-09-26 00:00:00@Deferasirox Mylan@deferasirox@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1388_h_a_dec_3.pdf@EU-1-19-1388_h_a_dec_3.pdf@2022-05-24 00:00:00@Polivy@polatuzumab vedotin@False@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-19-1384_h_a_dec_1.pdf@EU-1-19-1384_h_a_dec_1.pdf@2021-05-27 00:00:00@Giapreza@angiotensin II acetate@False@False@OD Not Found@La Jolla Pharmaceutical II B.V.@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_6.pdf@EU-1-19-1376_h_a_dec_6.pdf@2021-06-21 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@conditional@Parsed
EU-1-19-1395_h_a_dec_2.pdf@EU-1-19-1395_h_a_dec_2.pdf@2021-10-19 00:00:00@Clopidogrel/Acetylsalicylic acid Mylan@clopidogrel / acetylsalicylic acid@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1384_h_a_dec_2.pdf@EU-1-19-1384_h_a_dec_2.pdf@2022-08-07 00:00:00@Giapreza@angiotensin II acetate@False@False@OD Not Found@PAION Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1393_h_a_dec_0.pdf@EU-1-19-1393_h_a_dec_0.pdf@2019-12-16 00:00:00@Quofenix@delafloxacin@True@False@OD Not Found@A. Menarini - Industrie Farmaceutiche Riunite  - s.r.l.@CMA Not Found@Parsed
EU-1-19-1386_h_a_dec_1.pdf@EU-1-19-1386_h_a_dec_1.pdf@2021-01-09 00:00:00@Deferasirox Mylan@deferasirox@False@False@OD Not Found@Mylan S.A.S.@CMA Not Found@Parsed
EU-1-19-1390_h_a_dec_0.pdf@EU-1-19-1390_h_a_dec_0.pdf@2019-09-19 00:00:00@Inbrija@levodopa@False@False@OD Not Found@Acorda Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_7.pdf@EU-1-19-1376_h_a_dec_7.pdf@2022-07-01 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_0.pdf@EU-1-19-1396_h_a_dec_0.pdf@2019-11-14 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1393_h_a_dec_1.pdf@EU-1-19-1393_h_a_dec_1.pdf@2021-03-26 00:00:00@Quofenix@delafloxacin@False@False@OD Not Found@A. Menarini - Industrie Farmaceutiche Riunite - s.r.l.@CMA Not Found@Parsed
EU-1-19-1398_h_a_dec_0.pdf@EU-1-19-1398_h_a_dec_0.pdf@2019-11-14 00:00:00@Arsenic Trioxide Accord@arsenic trioxide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_1.pdf@EU-1-19-1396_h_a_dec_1.pdf@2020-07-02 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1400_h_a_dec_0.pdf@EU-1-19-1400_h_a_dec_0.pdf@2019-11-19 00:00:00@Rhokiinsa@netarsudil@True@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1390_h_a_dec_1.pdf@EU-1-19-1390_h_a_dec_1.pdf@2020-09-24 00:00:00@Inbrija@levodopa@False@False@OD Not Found@Acorda Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-19-1403_h_a_dec_0.pdf@EU-1-19-1403_h_a_dec_0.pdf@2020-03-04 00:00:00@Budesonide/Formoterol Teva Pharma B.V.@budesonide / formoterol fumarate dihydrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_2.pdf@EU-1-19-1396_h_a_dec_2.pdf@2020-09-17 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_8.pdf@EU-1-19-1376_h_a_dec_8.pdf@2022-06-29 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@conditional@Parsed
EU-1-19-1398_h_a_dec_1.pdf@EU-1-19-1398_h_a_dec_1.pdf@2021-06-21 00:00:00@Arsenic Trioxide Accord@arsenic trioxide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1403_h_a_dec_1.pdf@EU-1-19-1403_h_a_dec_1.pdf@2021-03-18 00:00:00@Budesonide/Formoterol Teva Pharma B.V.@budesonide / formoterol fumarate  dihydrate@False@False@OD Not Found@Teva Pharma B.V.@CMA Not Found@Parsed
EU-1-19-1396_h_a_dec_3.pdf@EU-1-19-1396_h_a_dec_3.pdf@2021-02-12 00:00:00@Ivozall@clofarabine@False@False@OD Not Found@ORPHELIA Pharma SAS@CMA Not Found@Parsed
EU-1-19-1400_h_a_dec_1.pdf@EU-1-19-1400_h_a_dec_1.pdf@2022-01-31 00:00:00@Rhokiinsa@netarsudil@False@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1390_h_a_dec_2.pdf@EU-1-19-1390_h_a_dec_2.pdf@2021-03-26 00:00:00@Inbrija@levodopa@False@False@OD Not Found@Acorda Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_0.pdf@EU-1-19-1405_h_a_dec_0.pdf@2020-09-01 00:00:00@TAVLESSE@fostamatinib@True@False@OD Not Found@Rigel Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-19-1376_h_a_dec_9.pdf@EU-1-19-1376_h_a_dec_9.pdf@2022-01-07 00:00:00@LIBTAYO@cemiplimab@False@False@OD Not Found@Regeneron Ireland Designated Activity Company (DAC)@conditional@Parsed
EU-1-19-1399_h_a_dec_0.pdf@EU-1-19-1399_h_a_dec_0.pdf@2019-10-24 00:00:00@Xospata@gilteritinib@True@False@adopted@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-19-1397_h_a_dec_0.pdf@EU-1-19-1397_h_a_dec_0.pdf@2019-11-14 00:00:00@Bortezomib Fresenius Kabi@bortezomib@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_1.pdf@EU-1-19-1405_h_a_dec_1.pdf@2020-01-04 00:00:00@TAVLESSE@fostamatinib@False@False@OD Not Found@Rigel Pharmaceuticals B.V.@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_0.pdf@EU-1-19-1404_h_a_dec_0.pdf@2019-12-16 00:00:00@Rinvoq@upadacitinib@True@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1407_h_a_dec_0.pdf@EU-1-19-1407_h_a_dec_0.pdf@2020-09-01 00:00:00@Isturisa@osilodrostat@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1397_h_a_dec_1.pdf@EU-1-19-1397_h_a_dec_1.pdf@2021-02-18 00:00:00@Bortezomib Fresenius Kabi@bortezomib@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_2.pdf@EU-1-19-1405_h_a_dec_2.pdf@2021-06-17 00:00:00@TAVLESSE@fostamatinib@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-19-1409_h_a_dec_0.pdf@EU-1-19-1409_h_a_dec_0.pdf@2019-12-19 00:00:00@Pegfilgrastim Mundipharma@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_1.pdf@EU-1-19-1404_h_a_dec_1.pdf@2021-01-22 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1397_h_a_dec_2.pdf@EU-1-19-1397_h_a_dec_2.pdf@2022-07-18 00:00:00@Bortezomib Fresenius Kabi@bortezomib@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_2.pdf@EU-1-19-1404_h_a_dec_2.pdf@2021-05-21 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1405_h_a_dec_3.pdf@EU-1-19-1405_h_a_dec_3.pdf@2021-08-18 00:00:00@TAVLESSE@fostamatinib@False@False@OD Not Found@Instituto Grifols@CMA Not Found@Parsed
EU-1-19-1411_h_a_dec_0.pdf@EU-1-19-1411_h_a_dec_0.pdf@2019-09-12 00:00:00@Evenity@romosozumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-19-1407_h_a_dec_1.pdf@EU-1-19-1407_h_a_dec_1.pdf@2020-01-04 00:00:00@Isturisa@osilodrostat@False@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1413_h_a_dec_0.pdf@EU-1-19-1413_h_a_dec_0.pdf@2020-02-13 00:00:00@Azacitidine Accord@Azacitidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1409_h_a_dec_1.pdf@EU-1-19-1409_h_a_dec_1.pdf@2020-02-28 00:00:00@Cegfila@pegfilgrastim@False@False@OD Not Found@Mundipharma Biologics S.L.@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_3.pdf@EU-1-19-1404_h_a_dec_3.pdf@2021-08-20 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1407_h_a_dec_2.pdf@EU-1-19-1407_h_a_dec_2.pdf@2021-04-06 00:00:00@Isturisa@osilodrostat@False@False@adopted@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_4.pdf@EU-1-19-1404_h_a_dec_4.pdf@2021-12-16 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1415_h_a_dec_0.pdf@EU-1-19-1415_h_a_dec_0.pdf@2020-02-13 00:00:00@Amsparity@adalimumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1413_h_a_dec_1.pdf@EU-1-19-1413_h_a_dec_1.pdf@2022-04-29 00:00:00@Azacitidine Accord@Azacitidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1409_h_a_dec_2.pdf@EU-1-19-1409_h_a_dec_2.pdf@2021-09-29 00:00:00@Cegfila@pegfilgrastim@False@False@OD Not Found@Mundipharma Corporation (Ireland) Limited@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_5.pdf@EU-1-19-1404_h_a_dec_5.pdf@2022-05-30 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1415_h_a_dec_1.pdf@EU-1-19-1415_h_a_dec_1.pdf@2021-05-19 00:00:00@Amsparity@adalimumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1406_h_a_dec_0.pdf@EU-1-19-1406_h_a_dec_0.pdf@2019-12-16 00:00:00@Baqsimi@Glucagon@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1412_h_a_dec_0.pdf@EU-1-19-1412_h_a_dec_0.pdf@2020-09-01 00:00:00@Deferasirox Accord@deferasirox@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1408_h_a_dec_0.pdf@EU-1-19-1408_h_a_dec_0.pdf@2020-01-16 00:00:00@Sunosi@solriamfetol@True@False@OD Not Found@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_6.pdf@EU-1-19-1404_h_a_dec_6.pdf@2022-07-22 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1415_h_a_dec_2.pdf@EU-1-19-1415_h_a_dec_2.pdf@2022-08-07 00:00:00@Amsparity@adalimumab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1412_h_a_dec_1.pdf@EU-1-19-1412_h_a_dec_1.pdf@2022-06-24 00:00:00@Deferasirox Accord@deferasirox@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_0.pdf@EU-1-19-1414_h_a_dec_0.pdf@2020-01-13 00:00:00@Mayzent@siponimod@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1404_h_a_dec_7.pdf@EU-1-19-1404_h_a_dec_7.pdf@2022-07-27 00:00:00@Rinvoq@upadacitinib@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_0.pdf@EU-1-19-1410_h_a_dec_0.pdf@2019-12-18 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1408_h_a_dec_1.pdf@EU-1-19-1408_h_a_dec_1.pdf@2021-10-19 00:00:00@Sunosi@solriamfetol@False@False@OD Not Found@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_1.pdf@EU-1-19-1410_h_a_dec_1.pdf@2021-04-02 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_0.pdf@EU-1-19-1417_h_a_dec_0.pdf@2020-02-13 00:00:00@Beovu@brolucizumab@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_1.pdf@EU-1-19-1414_h_a_dec_1.pdf@2021-07-01 00:00:00@Mayzent@siponimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1419_h_a_dec_1.pdf@EU-1-19-1419_h_a_dec_1.pdf@2022-03-22 00:00:00@Trepulmix@treprostinil sodium@False@False@adopted@SciPharm Sàrl@CMA Not Found@Parsed
EU-1-19-1408_h_a_dec_2.pdf@EU-1-19-1408_h_a_dec_2.pdf@2022-07-10 00:00:00@Sunosi@solriamfetol@False@False@OD Not Found@Jazz Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_2.pdf@EU-1-19-1410_h_a_dec_2.pdf@2021-02-25 00:00:00@Spravato@esketamine@False@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_1.pdf@EU-1-19-1417_h_a_dec_1.pdf@2021-07-19 00:00:00@Beovu@brolucizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_3.pdf@EU-1-19-1410_h_a_dec_3.pdf@2021-02-26 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_2.pdf@EU-1-19-1414_h_a_dec_2.pdf@2022-02-16 00:00:00@Mayzent@siponimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1416_h_a_dec_0.pdf@EU-1-19-1416_h_a_dec_0.pdf@2020-03-24 00:00:00@Azacitidine Betapharm@Azacitidine@False@False@OD Not Found@betapharm Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-19-1410_h_a_dec_4.pdf@EU-1-19-1410_h_a_dec_4.pdf@2022-06-24 00:00:00@Spravato@esketamine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-19-1421_h_a_dec_0.pdf@EU-1-19-1421_h_a_dec_0.pdf@2020-03-27 00:00:00@Staquis@crisaborole@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1416_h_a_dec_1.pdf@EU-1-19-1416_h_a_dec_1.pdf@2022-08-07 00:00:00@Azacitidine Betapharm@Azacitidine@False@False@OD Not Found@betapharm Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_0.pdf@EU-1-19-1420_h_a_dec_0.pdf@2020-02-13 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-19-1414_h_a_dec_3.pdf@EU-1-19-1414_h_a_dec_3.pdf@2022-07-18 00:00:00@Mayzent@siponimod@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_2.pdf@EU-1-19-1417_h_a_dec_2.pdf@2021-11-18 00:00:00@Beovu@brolucizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-19-1421_h_a_dec_1.pdf@EU-1-19-1421_h_a_dec_1.pdf@2022-01-27 00:00:00@Staquis@crisaborole@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1423_h_a_dec_0.pdf@EU-1-20-1423_h_a_dec_0.pdf@2020-01-04 00:00:00@Vaxchora@Cholera vaccine (recombinant, live,  oral)@True@False@OD Not Found@Emergent Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1425_h_a_dec_0.pdf@EU-1-20-1425_h_a_dec_0.pdf@2020-01-04 00:00:00@Nilemdo@bempedoic acid@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-19-1421_h_a_dec_2.pdf@EU-1-19-1421_h_a_dec_2.pdf@2022-01-31 00:00:00@Staquis@crisaborole@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_1.pdf@EU-1-19-1420_h_a_dec_1.pdf@2020-08-04 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-19-1417_h_a_dec_3.pdf@EU-1-19-1417_h_a_dec_3.pdf@2022-03-28 00:00:00@Beovu@brolucizumab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1425_h_a_dec_1.pdf@EU-1-20-1425_h_a_dec_1.pdf@2020-12-06 00:00:00@Nilemdo@bempedoic acid@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1423_h_a_dec_1.pdf@EU-1-20-1423_h_a_dec_1.pdf@2021-02-26 00:00:00@Vaxchora@Cholera vaccine (recombinant, live, oral)@False@False@OD Not Found@Emergent Netherlands B.V.@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_3.pdf@EU-1-19-1420_h_a_dec_3.pdf@2020-11-16 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-20-1425_h_a_dec_2.pdf@EU-1-20-1425_h_a_dec_2.pdf@2021-05-07 00:00:00@Nilemdo@bempedoic acid@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-20-1427_h_a_dec_0.pdf@EU-1-20-1427_h_a_dec_0.pdf@2020-01-04 00:00:00@Arsenic trioxide Mylan@arsenic trioxide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1423_h_a_dec_2.pdf@EU-1-20-1423_h_a_dec_2.pdf@2022-02-08 00:00:00@Vaxchora@Cholera vaccine (recombinant, live, oral)@False@False@OD Not Found@Emergent Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1422_h_a_dec_0.pdf@EU-1-20-1422_h_a_dec_0.pdf@2020-03-24 00:00:00@Liumjev@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1418_h_a_dec_0.pdf@EU-1-19-1418_h_a_dec_0.pdf@2020-02-13 00:00:00@Dexmedetomidine Accord@dexmedetomidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1429_h_a_dec_0.pdf@EU-1-20-1429_h_a_dec_0.pdf@2020-03-04 00:00:00@Cinacalcet Accordpharma@cinacalcet@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-19-1420_h_a_dec_4.pdf@EU-1-19-1420_h_a_dec_4.pdf@2022-03-24 00:00:00@Recarbrio@imipenem / cilastatin / relebactam@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-20-1422_h_a_dec_1.pdf@EU-1-20-1422_h_a_dec_1.pdf@2021-04-21 00:00:00@Lyumjev@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-19-1418_h_a_dec_1.pdf@EU-1-19-1418_h_a_dec_1.pdf@2021-06-17 00:00:00@Dexmedetomidine Accord@dexmedetomidine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1429_h_a_dec_1.pdf@EU-1-20-1429_h_a_dec_1.pdf@2021-12-16 00:00:00@Cinacalcet Accordpharma@cinacalcet@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1427_h_a_dec_1.pdf@EU-1-20-1427_h_a_dec_1.pdf@2022-06-01 00:00:00@Arsenic trioxide Mylan@arsenic trioxide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1422_h_a_dec_2.pdf@EU-1-20-1422_h_a_dec_2.pdf@2022-04-25 00:00:00@Lyumjev@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-20-1424_h_a_dec_0.pdf@EU-1-20-1424_h_a_dec_0.pdf@2020-03-27 00:00:00@Nustendi@bempedoic acid / ezetimibe@True@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1424_h_a_dec_1.pdf@EU-1-20-1424_h_a_dec_1.pdf@2020-02-06 00:00:00@Nustendi@bempedoic acid / ezetimibe@False@False@OD Not Found@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1426_h_a_dec_0.pdf@EU-1-20-1426_h_a_dec_0.pdf@2020-03-27 00:00:00@Azacitidine Mylan@Azacitidine@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1431_h_a_dec_0.pdf@EU-1-20-1431_h_a_dec_0.pdf@2020-01-04 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1428_h_a_dec_0.pdf@EU-1-20-1428_h_a_dec_0.pdf@2020-02-03 00:00:00@Givlaari@givosiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1433_h_a_dec_0.pdf@EU-1-20-1433_h_a_dec_0.pdf@2020-05-20 00:00:00@Fluad Tetra@influenza vaccine (surface antigen,  inactivated, adjuvanted)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1430_h_a_dec_0.pdf@EU-1-20-1430_h_a_dec_0.pdf@2020-03-04 00:00:00@Rybelsus@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1424_h_a_dec_2.pdf@EU-1-20-1424_h_a_dec_2.pdf@2021-06-17 00:00:00@Nustendi@bempedoic acid / ezetimibe@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-20-1431_h_a_dec_1.pdf@EU-1-20-1431_h_a_dec_1.pdf@2020-07-31 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1428_h_a_dec_1.pdf@EU-1-20-1428_h_a_dec_1.pdf@2021-08-18 00:00:00@Givlaari@givosiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1430_h_a_dec_1.pdf@EU-1-20-1430_h_a_dec_1.pdf@2021-08-18 00:00:00@Rybelsus@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1426_h_a_dec_1.pdf@EU-1-20-1426_h_a_dec_1.pdf@2021-12-08 00:00:00@Azacitidine Mylan@Azacitidine@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1433_h_a_dec_1.pdf@EU-1-20-1433_h_a_dec_1.pdf@2021-07-23 00:00:00@Fluad Tetra@influenza vaccine (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1431_h_a_dec_2.pdf@EU-1-20-1431_h_a_dec_2.pdf@2021-08-20 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1433_h_a_dec_2.pdf@EU-1-20-1433_h_a_dec_2.pdf@2022-07-22 00:00:00@Fluad Tetra@influenza vaccine (surface antigen, inactivated, adjuvanted)@False@False@OD Not Found@Seqirus Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1431_h_a_dec_3.pdf@EU-1-20-1431_h_a_dec_3.pdf@2022-08-24 00:00:00@Ruxience@rituximab@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1426_h_a_dec_2.pdf@EU-1-20-1426_h_a_dec_2.pdf@2022-08-07 00:00:00@Azacitidine Mylan@Azacitidine@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1435_h_a_dec_0.pdf@EU-1-20-1435_h_a_dec_0.pdf@2020-05-30 00:00:00@Sarclisa@isatuximab@True@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1435_h_a_dec_1.pdf@EU-1-20-1435_h_a_dec_1.pdf@2021-04-15 00:00:00@Sarclisa@isatuximab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_0.pdf@EU-1-20-1437_h_a_dec_0.pdf@2020-07-31 00:00:00@Pretomanid FGK@pretomanid@True@False@adopted@FGK Representative Service GmbH@conditional@Parsed
EU-1-20-1439_h_a_dec_0.pdf@EU-1-20-1439_h_a_dec_0.pdf@2020-05-30 00:00:00@Atectura Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1435_h_a_dec_2.pdf@EU-1-20-1435_h_a_dec_2.pdf@2021-06-17 00:00:00@Sarclisa@isatuximab@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1434_h_a_dec_0.pdf@EU-1-20-1434_h_a_dec_0.pdf@2020-04-23 00:00:00@Fetcroja@cefiderocol@True@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_1.pdf@EU-1-20-1437_h_a_dec_1.pdf@2021-11-01 00:00:00@Dovprela@pretomanid@False@False@adopted@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1432_h_a_dec_0.pdf@EU-1-20-1432_h_a_dec_0.pdf@2020-03-27 00:00:00@NUBEQA@darolutamide@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-20-1441_h_a_dec_0.pdf@EU-1-20-1441_h_a_dec_0.pdf@2020-05-30 00:00:00@Bemrist Breezhaler@indacaterol / mometasone  furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1434_h_a_dec_1.pdf@EU-1-20-1434_h_a_dec_1.pdf@2021-06-21 00:00:00@Fetcroja@cefiderocol@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
arsed
EU-1-20-1432_h_a_dec_1.pdf@EU-1-20-1432_h_a_dec_1.pdf@2021-04-21 00:00:00@NUBEQA@darolutamide@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_2.pdf@EU-1-20-1437_h_a_dec_2.pdf@2021-01-14 00:00:00@Dovprela@pretomanid@False@False@adopted@FGK Representative Service GmbH@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_0.pdf@EU-1-20-1443_h_a_dec_0.pdf@2020-05-18 00:00:00@Zolgensma@onasemnogene  abeparvovec@True@False@adopted@AveXis EU Limited@conditional@Parsed
EU-1-20-1439_h_a_dec_1.pdf@EU-1-20-1439_h_a_dec_1.pdf@2022-03-24 00:00:00@Atectura Breezhaler@indacaterol / mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1441_h_a_dec_1.pdf@EU-1-20-1441_h_a_dec_1.pdf@2022-04-04 00:00:00@Bemrist Breezhaler@indacaterol / mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1434_h_a_dec_2.pdf@EU-1-20-1434_h_a_dec_2.pdf@2022-08-17 00:00:00@Fetcroja@cefiderocol@False@False@OD Not Found@Shionogi B.V.@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_3.pdf@EU-1-20-1437_h_a_dec_3.pdf@2021-06-17 00:00:00@Dovprela@pretomanid@False@False@OD Not Found@Mylan IRE Healthcare Limited@conditional@Parsed
EU-1-20-1443_h_a_dec_1.pdf@EU-1-20-1443_h_a_dec_1.pdf@2020-10-08 00:00:00@Zolgensma@onasemnogene abeparvovec@False@True@adopted@AveXis EU Limited@conditional@Parsed
EU-1-20-1445_h_a_dec_0.pdf@EU-1-20-1445_h_a_dec_0.pdf@2020-01-07 00:00:00@Mvabea@Ebola vaccine  (MVA-BN-Filo [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1436_h_a_dec_0.pdf@EU-1-20-1436_h_a_dec_0.pdf@2020-05-20 00:00:00@Nepexto@etanercept@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1442_h_a_dec_0.pdf@EU-1-20-1442_h_a_dec_0.pdf@2020-05-20 00:00:00@Zeposia@ozanimod@True@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1437_h_a_dec_4.pdf@EU-1-20-1437_h_a_dec_4.pdf@2022-06-14 00:00:00@Dovprela@pretomanid@False@False@OD Not Found@Mylan IRE Healthcare Limited@conditional@Parsed
EU-1-20-1443_h_a_dec_2.pdf@EU-1-20-1443_h_a_dec_2.pdf@2021-03-26 00:00:00@Zolgensma@onasemnogene  abeparvovec@False@False@OD Not Found@Novartis Gene Therapies EU Limited@conditional@Parsed
EU-1-20-1447_h_a_dec_0.pdf@EU-1-20-1447_h_a_dec_0.pdf@2020-06-25 00:00:00@Insulin aspart Sanofi@insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
opharm Limited@CMA Not Found@Parsed
EU-1-20-1442_h_a_dec_1.pdf@EU-1-20-1442_h_a_dec_1.pdf@2020-09-10 00:00:00@Zeposia@ozanimod@False@False@OD Not Found@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1436_h_a_dec_1.pdf@EU-1-20-1436_h_a_dec_1.pdf@2021-06-21 00:00:00@Nepexto@etanercept@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1447_h_a_dec_1.pdf@EU-1-20-1447_h_a_dec_1.pdf@2021-04-21 00:00:00@Insulin  aspart Sanofi@insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_3.pdf@EU-1-20-1443_h_a_dec_3.pdf@2021-03-31 00:00:00@Zolgensma@onasemnogene abeparvovec@False@False@OD Not Found@Novartis Gene Therapies EU Limited@conditional@Parsed
EU-1-20-1440_h_a_dec_1.pdf@EU-1-20-1440_h_a_dec_1.pdf@2022-05-19 00:00:00@Zimbus Breezhaler@indacaterol / glycopyrronium / mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1446_h_a_dec_0.pdf@EU-1-20-1446_h_a_dec_0.pdf@2020-07-31 00:00:00@Hepcludex@bulevirtide@True@False@adopted@Myr GmbH@conditional@Parsed
EU-1-20-1442_h_a_dec_2.pdf@EU-1-20-1442_h_a_dec_2.pdf@2021-11-18 00:00:00@Zeposia@ozanimod@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-20-1446_h_a_dec_1.pdf@EU-1-20-1446_h_a_dec_1.pdf@2021-02-08 00:00:00@Hepcludex@bulevirtide@False@False@OD Not Found@MYR GmbH@conditional@Parsed
EU-1-20-1443_h_a_dec_4.pdf@EU-1-20-1443_h_a_dec_4.pdf@2021-05-18 00:00:00@Zolgensma@onasemnogene abeparvovec@False@False@OD Not Found@Novartis Gene Therapies EU Limited@conditional@Parsed
EU-1-20-1438_h_a_dec_0.pdf@EU-1-20-1438_h_a_dec_0.pdf@2020-03-07 00:00:00@Enerzair Breezhaler@indacaterol / glycopyrronium /  mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1448_h_a_dec_0.pdf@EU-1-20-1448_h_a_dec_0.pdf@2020-08-28 00:00:00@Cabazitaxel Accord@cabazitaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1452_h_a_dec_0.pdf@EU-1-20-1452_h_a_dec_0.pdf@2020-06-25 00:00:00@Reblozyl@luspatercept@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1450_h_a_dec_0.pdf@EU-1-20-1450_h_a_dec_0.pdf@2020-06-25 00:00:00@Fingolimod Accord@fingolimod@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1448_h_a_dec_2.pdf@EU-1-20-1448_h_a_dec_2.pdf@2022-05-24 00:00:00@Cabazitaxel Accord@cabazitaxel@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_5.pdf@EU-1-20-1443_h_a_dec_5.pdf@2022-04-20 00:00:00@Zolgensma@onasemnogene abeparvovec@False@False@OD Not Found@Novartis Gene Therapies EU Limited@conditional@Parsed
EU-1-20-1438_h_a_dec_1.pdf@EU-1-20-1438_h_a_dec_1.pdf@2022-05-05 00:00:00@Enerzair Breezhaler@indacaterol / glycopyrronium / mometasone furoate@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1450_h_a_dec_1.pdf@EU-1-20-1450_h_a_dec_1.pdf@2022-08-07 00:00:00@Fingolimod Accord@fingolimod@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1452_h_a_dec_1.pdf@EU-1-20-1452_h_a_dec_1.pdf@2021-04-02 00:00:00@Reblozyl@luspatercept@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_6.pdf@EU-1-20-1443_h_a_dec_6.pdf@2022-05-17 00:00:00@Zolgensma@onasemnogene abeparvovec@False@False@adopted@Novartis Gene Therapies EU Limited@conditional@Parsed
EU-1-20-1446_h_a_dec_3.pdf@EU-1-20-1446_h_a_dec_3.pdf@2022-06-21 00:00:00@Hepcludex@bulevirtide@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1454_h_a_dec_0.pdf@EU-1-20-1454_h_a_dec_0.pdf@2020-08-19 00:00:00@Aybintio@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1456_h_a_dec_0.pdf@EU-1-20-1456_h_a_dec_0.pdf@2020-07-27 00:00:00@Zercepac@trastuzumab@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1454_h_a_dec_1.pdf@EU-1-20-1454_h_a_dec_1.pdf@2021-11-18 00:00:00@Aybintio@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1452_h_a_dec_2.pdf@EU-1-20-1452_h_a_dec_2.pdf@2022-09-19 00:00:00@Reblozyl@luspatercept@False@False@adopted@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-20-1458_h_a_dec_0.pdf@EU-1-20-1458_h_a_dec_0.pdf@2020-07-23 00:00:00@Apixaban Accord@apixaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_7.pdf@EU-1-20-1443_h_a_dec_7.pdf@2022-08-25 00:00:00@Zolgensma@onasemnogene  abeparvovec@False@False@adopted@Novartis Gene Therapies EU Limited@CMA Not Found@Parsed
EU-1-20-1451_h_a_dec_0.pdf@EU-1-20-1451_h_a_dec_0.pdf@2020-06-26 00:00:00@Daurismo@glasdegib@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1456_h_a_dec_1.pdf@EU-1-20-1456_h_a_dec_1.pdf@2021-11-15 00:00:00@Zercepac@trastuzumab@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1458_h_a_dec_1.pdf@EU-1-20-1458_h_a_dec_1.pdf@2022-06-29 00:00:00@Apixaban Accord@apixaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1460_h_a_dec_0.pdf@EU-1-20-1460_h_a_dec_0.pdf@2020-07-31 00:00:00@Rozlytrek@entrectinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1451_h_a_dec_1.pdf@EU-1-20-1451_h_a_dec_1.pdf@2022-03-28 00:00:00@Daurismo@glasdegib@False@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1443_h_a_dec_8.pdf@EU-1-20-1443_h_a_dec_8.pdf@2022-02-09 00:00:00@Zolgensma@onasemnogene abeparvovec@False@False@adopted@Novartis Gene Therapies EU Limited@CMA Not Found@Parsed
EU-1-20-1460_h_a_dec_1.pdf@EU-1-20-1460_h_a_dec_1.pdf@2021-06-21 00:00:00@Rozlytrek@entrectinib@False@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1456_h_a_dec_2.pdf@EU-1-20-1456_h_a_dec_2.pdf@2021-11-15 00:00:00@Zercepac@trastuzumab@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1455_h_a_dec_0.pdf@EU-1-20-1455_h_a_dec_0.pdf@2020-07-27 00:00:00@Piqray@alpelisib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1453_h_a_dec_0.pdf@EU-1-20-1453_h_a_dec_0.pdf@2020-06-18 00:00:00@Paliperidone Janssen-Cilag International@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1460_h_a_dec_2.pdf@EU-1-20-1460_h_a_dec_2.pdf@2022-05-30 00:00:00@Rozlytrek@entrectinib@False@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1465_h_a_dec_0.pdf@EU-1-20-1465_h_a_dec_0.pdf@2020-08-19 00:00:00@Gencebok@caffeine citrate@False@False@OD Not Found@Gennisium Pharma@CMA Not Found@Parsed
EU-1-20-1453_h_a_dec_1.pdf@EU-1-20-1453_h_a_dec_1.pdf@2021-11-22 00:00:00@BYANNLI@paliperidone@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1455_h_a_dec_1.pdf@EU-1-20-1455_h_a_dec_1.pdf@2021-05-21 00:00:00@Piqray@alpelisib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1465_h_a_dec_1.pdf@EU-1-20-1465_h_a_dec_1.pdf@2021-10-22 00:00:00@Gencebok@caffeine citrate@False@False@OD Not Found@Gennisium Pharma@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_0.pdf@EU-1-20-1459_h_a_dec_0.pdf@2020-03-07 00:00:00@Veklury@remdesivir@True@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1457_h_a_dec_0.pdf@EU-1-20-1457_h_a_dec_0.pdf@2020-07-27 00:00:00@Xenleta@lefamulin@True@False@OD Not Found@Nabriva Therapeutics Ireland DAC@CMA Not Found@Parsed
EU-1-20-1465_h_a_dec_2.pdf@EU-1-20-1465_h_a_dec_2.pdf@2022-09-26 00:00:00@Gencebok@caffeine citrate@False@False@OD Not Found@Gennisium Pharma@CMA Not Found@Parsed
EU-1-20-1444_h_a_dec_0.pdf@EU-1-20-1444_h_a_dec_0.pdf@2020-01-07 00:00:00@Zabdeno@Ebola vaccine  (Ad26.ZEBOV-GP [recombinant])@True@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1455_h_a_dec_2.pdf@EU-1-20-1455_h_a_dec_2.pdf@2022-08-17 00:00:00@Piqray@alpelisib@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1444_h_a_dec_2.pdf@EU-1-20-1444_h_a_dec_2.pdf@2022-09-21 00:00:00@Zabdeno@Ebola vaccine (Ad26.ZEBOV-GP [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@exceptional@Parsed
EU-1-20-1459_h_a_dec_1.pdf@EU-1-20-1459_h_a_dec_1.pdf@2020-12-18 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1457_h_a_dec_1.pdf@EU-1-20-1457_h_a_dec_1.pdf@2022-08-07 00:00:00@Xenleta@lefamulin@False@False@OD Not Found@Nabriva Therapeutics Ireland DAC@CMA Not Found@Parsed
EU-1-20-1468_h_a_dec_0.pdf@EU-1-20-1468_h_a_dec_0.pdf@2020-08-21 00:00:00@Kaftrio@ivacaftor / tezacaftor / elexacaftor@True@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-20-1462_h_a_dec_0.pdf@EU-1-20-1462_h_a_dec_0.pdf@2020-08-27 00:00:00@Livogiva@teriparatide@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_2.pdf@EU-1-20-1459_h_a_dec_2.pdf@2020-12-21 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1470_h_a_dec_0.pdf@EU-1-20-1470_h_a_dec_0.pdf@2020-08-19 00:00:00@Methylthioninium chloride Cosmo@methylthioninium chloride@False@False@OD Not Found@Cosmo Technologies Ltd@CMA Not Found@Parsed
EU-1-20-1468_h_a_dec_1.pdf@EU-1-20-1468_h_a_dec_1.pdf@2021-04-26 00:00:00@Kaftrio@ivacaftor / tezacaftor / elexacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_3.pdf@EU-1-20-1459_h_a_dec_3.pdf@2021-06-24 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1473_h_a_dec_0.pdf@EU-1-20-1473_h_a_dec_0.pdf@2020-09-24 00:00:00@AYVAKYT@avapritinib@True@False@adopted@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1462_h_a_dec_1.pdf@EU-1-20-1462_h_a_dec_1.pdf@2021-09-12 00:00:00@Livogiva@teriparatide@False@False@OD Not Found@Theramex Ireland Limited@CMA Not Found@Parsed
EU-1-20-1470_h_a_dec_1.pdf@EU-1-20-1470_h_a_dec_1.pdf@2021-05-19 00:00:00@Lumeblue@methylthioninium chloride@False@False@OD Not Found@Cosmo Technologies Ltd@CMA Not Found@Parsed
EU-1-20-1474_h_a_dec_0.pdf@EU-1-20-1474_h_a_dec_0.pdf@2020-08-25 00:00:00@BLENREP@belantamab mafodotin@True@False@adopted@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1476_h_a_dec_0.pdf@EU-1-20-1476_h_a_dec_0.pdf@2020-10-28 00:00:00@Adakveo@crizanlizumab@True@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1473_h_a_dec_1.pdf@EU-1-20-1473_h_a_dec_1.pdf@2021-07-23 00:00:00@AYVAKYT@avapritinib@False@False@OD Not Found@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1459_h_a_dec_4.pdf@EU-1-20-1459_h_a_dec_4.pdf@2021-08-20 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1468_h_a_dec_2.pdf@EU-1-20-1468_h_a_dec_2.pdf@2022-07-01 00:00:00@Kaftrio@ivacaftor / tezacaftor / elexacaftor@False@False@adopted@Vertex Pharmaceuticals (Ireland) Limited@CMA Not Found@Parsed
EU-1-20-1473_h_a_dec_2.pdf@EU-1-20-1473_h_a_dec_2.pdf@2022-03-24 00:00:00@AYVAKYT@avapritinib@False@False@adopted@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1474_h_a_dec_1.pdf@EU-1-20-1474_h_a_dec_1.pdf@2021-06-21 00:00:00@BLENREP@belantamab mafodotin@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1470_h_a_dec_2.pdf@EU-1-20-1470_h_a_dec_2.pdf@2021-05-21 00:00:00@Lumeblue@methylthioninium chloride@False@False@OD Not Found@Cosmo Technologies Ltd@CMA Not Found@Parsed
EU-1-20-1476_h_a_dec_1.pdf@EU-1-20-1476_h_a_dec_1.pdf@2021-08-26 00:00:00@Adakveo@crizanlizumab@False@False@adopted@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1459_h_a_dec_5.pdf@EU-1-20-1459_h_a_dec_5.pdf@2021-12-20 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1473_h_a_dec_3.pdf@EU-1-20-1473_h_a_dec_3.pdf@2022-07-15 00:00:00@AYVAKYT@avapritinib@False@False@OD Not Found@Blueprint Medicines (Netherlands) B.V.@conditional@Parsed
EU-1-20-1478_h_a_dec_0.pdf@EU-1-20-1478_h_a_dec_0.pdf@2020-09-24 00:00:00@Zynrelef@bupivacaine/meloxicam@False@False@OD Not Found@Heron Therapeutics, B.V.@CMA Not Found@Parsed
EU-1-20-1474_h_a_dec_2.pdf@EU-1-20-1474_h_a_dec_2.pdf@2022-05-30 00:00:00@BLENREP@belantamab  mafodotin@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1469_h_a_dec_0.pdf@EU-1-20-1469_h_a_dec_0.pdf@2020-10-27 00:00:00@ARIKAYCE liposomal@amikacin@False@False@adopted@Insmed Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1476_h_a_dec_2.pdf@EU-1-20-1476_h_a_dec_2.pdf@2021-09-29 00:00:00@Adakveo@crizanlizumab@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1459_h_a_dec_6.pdf@EU-1-20-1459_h_a_dec_6.pdf@2022-12-04 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1471_h_a_dec_0.pdf@EU-1-20-1471_h_a_dec_0.pdf@2020-08-25 00:00:00@Idefirix@imlifidase@True@False@adopted@Hansa Biopharma AB@conditional@Parsed
EU-1-20-1471_h_a_dec_1.pdf@EU-1-20-1471_h_a_dec_1.pdf@2021-07-16 00:00:00@Idefirix@imlifidase@False@False@OD Not Found@Hansa Biopharma AB@conditional@Parsed
EU-1-20-1476_h_a_dec_3.pdf@EU-1-20-1476_h_a_dec_3.pdf@2022-12-08 00:00:00@Adakveo@crizanlizumab@False@False@OD Not Found@Novartis Europharm Limited@conditional@Parsed
EU-1-20-1474_h_a_dec_3.pdf@EU-1-20-1474_h_a_dec_3.pdf@2022-06-29 00:00:00@BLENREP@belantamab mafodotin@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1459_h_a_dec_7.pdf@EU-1-20-1459_h_a_dec_7.pdf@2022-07-19 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1479_h_a_dec_0.pdf@EU-1-20-1479_h_a_dec_0.pdf@2020-05-11 00:00:00@Calquence@acalabrutinib@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1471_h_a_dec_2.pdf@EU-1-20-1471_h_a_dec_2.pdf@2022-07-15 00:00:00@Idefirix@imlifidase@False@False@OD Not Found@Hansa Biopharma AB@conditional@Parsed
EU-1-20-1482_h_a_dec_0.pdf@EU-1-20-1482_h_a_dec_0.pdf@2020-12-17 00:00:00@REKAMBYS@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1480_h_a_dec_0.pdf@EU-1-20-1480_h_a_dec_0.pdf@2020-09-24 00:00:00@Jyseleca@filgotinib@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1482_h_a_dec_1.pdf@EU-1-20-1482_h_a_dec_1.pdf@2021-04-02 00:00:00@REKAMBYS@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1479_h_a_dec_1.pdf@EU-1-20-1479_h_a_dec_1.pdf@2022-08-07 00:00:00@Calquence@acalabrutinib@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_8.pdf@EU-1-20-1459_h_a_dec_8.pdf@2022-08-08 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@conditional@Parsed
EU-1-20-1477_h_a_dec_0.pdf@EU-1-20-1477_h_a_dec_0.pdf@2020-09-24 00:00:00@Fampridine Accord@fampridine@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1482_h_a_dec_2.pdf@EU-1-20-1482_h_a_dec_2.pdf@2021-10-19 00:00:00@REKAMBYS@rilpivirine@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1475_h_a_dec_0.pdf@EU-1-20-1475_h_a_dec_0.pdf@2020-09-17 00:00:00@Arsenic trioxide medac@arsenic trioxide@False@False@OD Not Found@medac Gesellschaft für klinische  Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-20-1480_h_a_dec_1.pdf@EU-1-20-1480_h_a_dec_1.pdf@2021-12-11 00:00:00@Jyseleca@filgotinib@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1475_h_a_dec_1.pdf@EU-1-20-1475_h_a_dec_1.pdf@2022-01-27 00:00:00@Arsenic trioxide medac@arsenic trioxide@False@False@OD Not Found@medac Gesellschaft für klinische Spezialpräparate mbH@CMA Not Found@Parsed
EU-1-20-1459_h_a_dec_9.pdf@EU-1-20-1459_h_a_dec_9.pdf@2022-09-16 00:00:00@Veklury@remdesivir@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1484_h_a_dec_0.pdf@EU-1-20-1484_h_a_dec_0.pdf@2020-11-16 00:00:00@Supemtek@quadrivalent influenza vaccine  (recombinant, prepared in cell culture)@True@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1486_h_a_dec_0.pdf@EU-1-20-1486_h_a_dec_0.pdf@2020-11-18 00:00:00@Nyvepria@pegfilgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1480_h_a_dec_2.pdf@EU-1-20-1480_h_a_dec_2.pdf@2021-12-16 00:00:00@Jyseleca@filgotinib@False@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-20-1488_h_a_dec_0.pdf@EU-1-20-1488_h_a_dec_0.pdf@2020-11-16 00:00:00@Rivaroxaban Accord@rivaroxaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1486_h_a_dec_1.pdf@EU-1-20-1486_h_a_dec_1.pdf@2022-06-13 00:00:00@Nyvepria@pegfilgrastim@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-20-1483_h_a_dec_0.pdf@EU-1-20-1483_h_a_dec_0.pdf@2020-11-18 00:00:00@MenQuadfi@Meningococcal group A, C, W and Y  conjugate vaccine@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1488_h_a_dec_1.pdf@EU-1-20-1488_h_a_dec_1.pdf@2021-11-26 00:00:00@Rivaroxaban Accord@rivaroxaban@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1490_h_a_dec_0.pdf@EU-1-20-1490_h_a_dec_0.pdf@2020-12-18 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1483_h_a_dec_1.pdf@EU-1-20-1483_h_a_dec_1.pdf@2022-04-04 00:00:00@MenQuadfi@Meningococcal group A, C, W and Y conjugate vaccine@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1485_h_a_dec_0.pdf@EU-1-20-1485_h_a_dec_0.pdf@2020-11-18 00:00:00@Obiltoxaximab SFL@obiltoxaximab@True@False@adopted@the applicant@exceptional@Parsed
EU-1-20-1487_h_a_dec_0.pdf@EU-1-20-1487_h_a_dec_0.pdf@2020-11-16 00:00:00@PHELINUN@melphalan@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-20-1483_h_a_dec_3.pdf@EU-1-20-1483_h_a_dec_3.pdf@2022-09-29 00:00:00@MenQuadfi@Meningococcal  group A, C, W and Y conjugate vaccine@False@False@OD Not Found@Sanofi Pasteur@CMA Not Found@Parsed
EU-1-20-1490_h_a_dec_1.pdf@EU-1-20-1490_h_a_dec_1.pdf@2020-12-18 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_0.pdf@EU-1-20-1481_h_a_dec_0.pdf@2020-12-17 00:00:00@Vocabria@cabotegravir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1487_h_a_dec_1.pdf@EU-1-20-1487_h_a_dec_1.pdf@2022-09-29 00:00:00@PHELINUN@melphalan@False@False@OD Not Found@ADIENNE S.r.l.S.U.@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_0.pdf@EU-1-20-1492_h_a_dec_0.pdf@2020-12-14 00:00:00@Tecartus@autologous anti-CD19-transduced  CD3+ cells@True@True@adopted@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1490_h_a_dec_2.pdf@EU-1-20-1490_h_a_dec_2.pdf@2021-09-16 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_1.pdf@EU-1-20-1481_h_a_dec_1.pdf@2021-10-19 00:00:00@Vocabria@cabotegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_1.pdf@EU-1-20-1492_h_a_dec_1.pdf@2021-11-18 00:00:00@Tecartus@autologous anti-CD19-transduced CD3+  cells@False@False@OD Not Found@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1489_h_a_dec_0.pdf@EU-1-20-1489_h_a_dec_0.pdf@2020-11-16 00:00:00@EXPAREL liposomal@bupivacaine@False@False@OD Not Found@Pacira Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1496_h_a_dec_0.pdf@EU-1-20-1496_h_a_dec_0.pdf@2020-11-19 00:00:00@Oxlumo@lumasiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_2.pdf@EU-1-20-1492_h_a_dec_2.pdf@2022-01-24 00:00:00@Tecartus@autologous anti-CD19-transduced CD3+ cells@False@False@OD Not Found@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1490_h_a_dec_3.pdf@EU-1-20-1490_h_a_dec_3.pdf@2021-12-08 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1494_h_a_dec_0.pdf@EU-1-20-1494_h_a_dec_0.pdf@2020-09-12 00:00:00@Leqvio@inclisiran@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_2.pdf@EU-1-20-1481_h_a_dec_2.pdf@2021-12-16 00:00:00@Vocabria@cabotegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1492_h_a_dec_3.pdf@EU-1-20-1492_h_a_dec_3.pdf@2022-02-09 00:00:00@Autologous peripheral blood T cells  CD4 and CD 8 selected and CD 3 and CD 28 activated transduced with retroviral  vector expressing anti@CD 19 CD 28/ CD 3-zeta chimeric antigen receptor and  cultured@False@False@adopted@Kite Pharma EU B.V.@conditional@Parsed
EU-1-20-1498_h_a_dec_0.pdf@EU-1-20-1498_h_a_dec_0.pdf@2020-09-12 00:00:00@TRIXEO AEROSPHERE@Formoterol /  glycopyrronium bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1496_h_a_dec_1.pdf@EU-1-20-1496_h_a_dec_1.pdf@2022-09-15 00:00:00@Oxlumo@lumasiran@False@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1500_h_a_dec_0.pdf@EU-1-20-1500_h_a_dec_0.pdf@2021-07-01 00:00:00@Xofluza@baloxavir marboxil@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1481_h_a_dec_3.pdf@EU-1-20-1481_h_a_dec_3.pdf@2022-06-21 00:00:00@Vocabria@cabotegravir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1490_h_a_dec_4.pdf@EU-1-20-1490_h_a_dec_4.pdf@2022-08-07 00:00:00@Lenalidomide Mylan@lenalidomide@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1494_h_a_dec_1.pdf@EU-1-20-1494_h_a_dec_1.pdf@2022-06-13 00:00:00@Afinitor@everolimus@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-20-1498_h_a_dec_1.pdf@EU-1-20-1498_h_a_dec_1.pdf@2022-06-24 00:00:00@TRIXEO AEROSPHERE@Formoterol / glycopyrronium bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-20-1500_h_a_dec_1.pdf@EU-1-20-1500_h_a_dec_1.pdf@2022-04-25 00:00:00@Xofluza@baloxavir marboxil@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1493_h_a_dec_0.pdf@EU-1-20-1493_h_a_dec_0.pdf@2020-12-17 00:00:00@Libmeldy@autologous CD34+ cell enriched population  that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral  vector encoding the human arylsulfatase A gene@True@True@adopted@Orchard Therapeutics (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-20-1497_h_a_dec_0.pdf@EU-1-20-1497_h_a_dec_0.pdf@2020-12-21 00:00:00@Phesgo@pertuzumab / trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1493_h_a_dec_1.pdf@EU-1-20-1493_h_a_dec_1.pdf@2022-01-27 00:00:00@Libmeldy@atidarsagene autotemcel@False@False@adopted@Orchard Therapeutics (Netherlands) B.V.@CMA Not Found@Parsed
EU-1-20-1497_h_a_dec_1.pdf@EU-1-20-1497_h_a_dec_1.pdf@2022-07-27 00:00:00@Phesgo@pertuzumab / trastuzumab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1499_h_a_dec_0.pdf@EU-1-20-1499_h_a_dec_0.pdf@2021-11-01 00:00:00@Onbevzi@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1501_h_a_dec_0.pdf@EU-1-20-1501_h_a_dec_0.pdf@2021-03-31 00:00:00@Sogroya@somapacitan@True@False@adopted@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1499_h_a_dec_1.pdf@EU-1-20-1499_h_a_dec_1.pdf@2022-06-24 00:00:00@Onbevzi@bevacizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-20-1495_h_a_dec_0.pdf@EU-1-20-1495_h_a_dec_0.pdf@2020-12-17 00:00:00@Palforzia@defatted powder  Arachis hypogaea L.,  semen (peanuts)@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-20-1502_h_a_dec_0.pdf@EU-1-20-1502_h_a_dec_0.pdf@2021-07-01 00:00:00@Roclanda@Latanoprost / netarsudil@False@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1491_h_a_dec_0.pdf@EU-1-20-1491_h_a_dec_0.pdf@2020-12-18 00:00:00@Fintepla@fenfluramine@False@False@adopted@Zogenix ROI Limited@CMA Not Found@Parsed
EU-1-20-1501_h_a_dec_1.pdf@EU-1-20-1501_h_a_dec_1.pdf@2022-04-25 00:00:00@Sogroya@somapacitan@False@False@adopted@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-20-1504_h_a_dec_0.pdf@EU-1-20-1504_h_a_dec_0.pdf@2021-07-01 00:00:00@ELZONRIS@tagraxofusp@True@False@adopted@Stemline Therapeutics B.V.@exceptional@Parsed
EU-1-20-1502_h_a_dec_1.pdf@EU-1-20-1502_h_a_dec_1.pdf@2022-04-02 00:00:00@Roclanda@Latanoprost / netarsudil@False@False@OD Not Found@Aerie Pharmaceuticals Ireland Ltd@CMA Not Found@Parsed
EU-1-20-1495_h_a_dec_1.pdf@EU-1-20-1495_h_a_dec_1.pdf@2022-08-07 00:00:00@Palforzia@defatted powder  Arachis hypogaea L., semen (peanuts)@False@False@OD Not Found@Aimmune Therapeutics Ireland Limited@CMA Not Found@Parsed
EU-1-20-1491_h_a_dec_1.pdf@EU-1-20-1491_h_a_dec_1.pdf@2020-12-18 00:00:00@Fintepla@fenfluramine@False@False@adopted@Zogenix ROI Limited@CMA Not Found@Parsed
EU-1-20-1506_h_a_dec_0.pdf@EU-1-20-1506_h_a_dec_0.pdf@2021-05-02 00:00:00@Kixelle@Insulin aspart@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1508_h_a_dec_0.pdf@EU-1-20-1508_h_a_dec_0.pdf@2021-01-18 00:00:00@Enhertu@trastuzumab deruxtecan@True@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1508_h_a_dec_1.pdf@EU-1-20-1508_h_a_dec_1.pdf@2021-12-11 00:00:00@Enhertu@trastuzumab deruxtecan@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1491_h_a_dec_2.pdf@EU-1-20-1491_h_a_dec_2.pdf@2022-06-13 00:00:00@Fintepla@fenfluramine@False@False@adopted@Zogenix ROI Limited@CMA Not Found@Parsed
EU-1-20-1505_h_a_dec_0.pdf@EU-1-20-1505_h_a_dec_0.pdf@2021-03-26 00:00:00@Byfavo@remimazolam@True@False@OD Not Found@PAION Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1506_h_a_dec_1.pdf@EU-1-20-1506_h_a_dec_1.pdf@2022-07-22 00:00:00@Kirsty@Insulin aspart@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1510_h_a_dec_0.pdf@EU-1-20-1510_h_a_dec_0.pdf@2021-03-26 00:00:00@Oyavas@bevacizumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-20-1503_h_a_dec_0.pdf@EU-1-20-1503_h_a_dec_0.pdf@2021-02-18 00:00:00@Heplisav B@hepatitis B surface antigen@False@False@OD Not Found@Dynavax GmbH@CMA Not Found@Parsed
EU-1-20-1512_h_a_dec_0.pdf@EU-1-20-1512_h_a_dec_0.pdf@2021-04-26 00:00:00@Abiraterone Accord@abiraterone acetate@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1508_h_a_dec_2.pdf@EU-1-20-1508_h_a_dec_2.pdf@2022-11-07 00:00:00@Enhertu@trastuzumab deruxtecan@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1505_h_a_dec_1.pdf@EU-1-20-1505_h_a_dec_1.pdf@2022-04-25 00:00:00@Byfavo@remimazolam@False@False@OD Not Found@PAION Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1508_h_a_dec_3.pdf@EU-1-20-1508_h_a_dec_3.pdf@2022-08-25 00:00:00@Enhertu@trastuzumab deruxtecan@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@conditional@Parsed
EU-1-20-1505_h_a_dec_2.pdf@EU-1-20-1505_h_a_dec_2.pdf@2022-07-10 00:00:00@Byfavo@remimazolam@False@False@OD Not Found@PAION Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1513_h_a_dec_0.pdf@EU-1-20-1513_h_a_dec_0.pdf@2021-11-02 00:00:00@Yuflyma@adalimumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-20-1517_h_a_dec_0.pdf@EU-1-20-1517_h_a_dec_0.pdf@2021-04-30 00:00:00@Sibnayal@potassium citrate/potassium hydrogen  carbonate@False@False@OD Not Found@ADVICENNE@CMA Not Found@Parsed
EU-1-20-1514_h_a_dec_0.pdf@EU-1-20-1514_h_a_dec_0.pdf@2021-08-02 00:00:00@Inrebic@fedratinib@True@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1511_h_a_dec_0.pdf@EU-1-20-1511_h_a_dec_0.pdf@2021-11-02 00:00:00@Sunitinib Accord@sunitinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1513_h_a_dec_1.pdf@EU-1-20-1513_h_a_dec_1.pdf@2021-05-19 00:00:00@Yuflyma@adalimumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_0.pdf@EU-1-20-1507_h_a_dec_0.pdf@2021-06-01 00:00:00@COVID-19 Vaccine Moderna@COVID-19 mRNA Vaccine (nucleoside modified)@True@False@OD Not Found@MODERNA BIOTECH SPAIN, S.L.@conditional@Parsed
EU-1-20-1518_h_a_dec_0.pdf@EU-1-20-1518_h_a_dec_0.pdf@2021-04-02 00:00:00@Rukobia@fostemsavir@True@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1520_h_a_dec_0.pdf@EU-1-20-1520_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1514_h_a_dec_1.pdf@EU-1-20-1514_h_a_dec_1.pdf@2021-10-19 00:00:00@Inrebic@fedratinib@False@False@adopted@Celgene Europe B.V.@CMA Not Found@Parsed
EU-1-20-1509_h_a_dec_0.pdf@EU-1-20-1509_h_a_dec_0.pdf@2021-03-26 00:00:00@Alymsys@bevacizumab@False@False@OD Not Found@Mabxience Research SL@CMA Not Found@Parsed
EU-1-20-1518_h_a_dec_1.pdf@EU-1-20-1518_h_a_dec_1.pdf@2022-03-24 00:00:00@Rukobia@fostemsavir@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-20-1513_h_a_dec_2.pdf@EU-1-20-1513_h_a_dec_2.pdf@2022-02-16 00:00:00@Yuflyma@adalimumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-20-1523_h_a_dec_0.pdf@EU-1-20-1523_h_a_dec_0.pdf@2021-11-02 00:00:00@Ogluo@glucagon@False@False@OD Not Found@Xeris Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_1.pdf@EU-1-20-1507_h_a_dec_1.pdf@2021-07-13 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1520_h_a_dec_1.pdf@EU-1-20-1520_h_a_dec_1.pdf@2021-12-02 00:00:00@Lenalidomide Krka@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1509_h_a_dec_1.pdf@EU-1-20-1509_h_a_dec_1.pdf@2022-06-29 00:00:00@Alymsys@bevacizumab@False@False@OD Not Found@Mabxience Research SL@CMA Not Found@Parsed
EU-1-20-1523_h_a_dec_1.pdf@EU-1-20-1523_h_a_dec_1.pdf@2021-09-12 00:00:00@Ogluo@glucagon@False@False@OD Not Found@Xeris Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_10.pdf@EU-1-20-1507_h_a_dec_10.pdf@2022-02-03 00:00:00@Spikevax@elasomeran@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1519_h_a_dec_0.pdf@EU-1-20-1519_h_a_dec_0.pdf@2021-11-02 00:00:00@Lenalidomide Krka d.d. Novo mesto@lenalidomide@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1520_h_a_dec_2.pdf@EU-1-20-1520_h_a_dec_2.pdf@2022-12-08 00:00:00@Lenalidomide Krka d.d. Novo mesto@lenalidomide@False@False@OD Not Found@KRKA d d.@CMA Not Found@Parsed
EU-1-20-1515_h_a_dec_0.pdf@EU-1-20-1515_h_a_dec_0.pdf@2021-04-21 00:00:00@Abevmy@bevacizumab@False@False@OD Not Found@Mylan IRE Healthcare Limited@CMA Not Found@Parsed
EU-1-20-1519_h_a_dec_1.pdf@EU-1-20-1519_h_a_dec_1.pdf@2021-12-02 00:00:00@Lenalidomide Krka d.d. Novo mesto@lenalidomide@False@False@OD Not Found@KRKA, d.d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_11.pdf@EU-1-20-1507_h_a_dec_11.pdf@2022-04-29 00:00:00@Spikevax@elasomeran@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1526_h_a_dec_0.pdf@EU-1-20-1526_h_a_dec_0.pdf@2021-11-02 00:00:00@TUKYSA@tucatinib@False@False@OD Not Found@Seagen B.V.@CMA Not Found@Parsed
EU-1-20-1524_h_a_dec_0.pdf@EU-1-20-1524_h_a_dec_0.pdf@2021-03-26 00:00:00@Vazkepa@icosapent ethyl@True@False@OD Not Found@Amarin Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1526_h_a_dec_1.pdf@EU-1-20-1526_h_a_dec_1.pdf@2022-02-06 00:00:00@TUKYSA@tucatinib@False@False@OD Not Found@Seagen B.V.@CMA Not Found@Parsed
EU-1-21-1530_h_a_dec_0.pdf@EU-1-21-1530_h_a_dec_0.pdf@2021-03-26 00:00:00@Ontozry@cenobamate@True@False@OD Not Found@Arvelle Therapeutics Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1521_h_a_dec_0.pdf@EU-1-20-1521_h_a_dec_0.pdf@2021-12-02 00:00:00@Lenalidomide Krka d.d.@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-20-1519_h_a_dec_2.pdf@EU-1-20-1519_h_a_dec_2.pdf@2022-07-18 00:00:00@Lenalidomide Krka@lenalidomide@False@False@OD Not Found@KRKA@CMA Not Found@Parsed
EU-1-21-1530_h_a_dec_1.pdf@EU-1-21-1530_h_a_dec_1.pdf@2021-10-28 00:00:00@Ontozry@cenobamate@False@False@OD Not Found@Arvelle Therapeutics Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_12.pdf@EU-1-20-1507_h_a_dec_12.pdf@2022-08-16 00:00:00@Spikevax@elasomeran@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1528_h_a_dec_0.pdf@EU-1-20-1528_h_a_dec_0.pdf@2020-12-21 00:00:00@Comirnaty@COVID-19 mRNA  Vaccine (nucleoside modified)@True@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1524_h_a_dec_1.pdf@EU-1-20-1524_h_a_dec_1.pdf@2022-04-25 00:00:00@Vazkepa@icosapent ethyl@False@False@OD Not Found@Amarin Pharmaceuticals Ireland Limited@CMA Not Found@Parsed
EU-1-20-1521_h_a_dec_1.pdf@EU-1-20-1521_h_a_dec_1.pdf@2021-11-02 00:00:00@Lenalidomide Krka d.d.@lenalidomide@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-21-1531_h_a_dec_0.pdf@EU-1-21-1531_h_a_dec_0.pdf@2021-03-26 00:00:00@Evrysdi@risdiplam@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1527_h_a_dec_0.pdf@EU-1-20-1527_h_a_dec_0.pdf@2021-11-02 00:00:00@Retsevmo@selpercatinib@True@False@OD Not Found@Eli Lilly Nederland B.V.@conditional@Parsed
EU-1-20-1507_h_a_dec_13.pdf@EU-1-20-1507_h_a_dec_13.pdf@2022-01-09 00:00:00@Spikevax@elasomeran@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-21-1531_h_a_dec_1.pdf@EU-1-21-1531_h_a_dec_1.pdf@2022-09-21 00:00:00@Evrysdi@risdiplam@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_1.pdf@EU-1-20-1528_h_a_dec_1.pdf@2021-08-01 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1527_h_a_dec_1.pdf@EU-1-20-1527_h_a_dec_1.pdf@2021-12-16 00:00:00@Retsevmo@selpercatinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@conditional@Parsed
EU-1-21-1534_h_a_dec_0.pdf@EU-1-21-1534_h_a_dec_0.pdf@2021-03-26 00:00:00@BroPair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1532_h_a_dec_0.pdf@EU-1-21-1532_h_a_dec_0.pdf@2021-03-26 00:00:00@Kesimpta@ofatumumab@False@False@OD Not Found@Novartis Ireland Limited@CMA Not Found@Parsed
EU-1-21-1536_h_a_dec_0.pdf@EU-1-21-1536_h_a_dec_0.pdf@2021-03-26 00:00:00@Thiotepa Riemser@thiotepa@False@False@OD Not Found@RIEMSER Pharma GmbH@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_14.pdf@EU-1-20-1507_h_a_dec_14.pdf@2022-09-16 00:00:00@Spikevax@elasomeran@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-21-1534_h_a_dec_1.pdf@EU-1-21-1534_h_a_dec_1.pdf@2022-07-27 00:00:00@BroPair Spiromax@salmeterol / fluticasone propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-20-1527_h_a_dec_2.pdf@EU-1-20-1527_h_a_dec_2.pdf@2022-02-28 00:00:00@Retsevmo@selpercatinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-21-1536_h_a_dec_1.pdf@EU-1-21-1536_h_a_dec_1.pdf@2022-08-07 00:00:00@Thiotepa Riemser@thiotepa@False@False@OD Not Found@Esteve Pharmaceuticals GmbH@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_10.pdf@EU-1-20-1528_h_a_dec_10.pdf@2021-09-23 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1525_h_a_dec_0.pdf@EU-1-20-1525_h_a_dec_0.pdf@2021-11-03 00:00:00@COVID-19 Vaccine Janssen@19 vaccine (Ad26.COV2-S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1527_h_a_dec_3.pdf@EU-1-20-1527_h_a_dec_3.pdf@2022-06-21 00:00:00@Retsevmo@selpercatinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-21-1532_h_a_dec_1.pdf@EU-1-21-1532_h_a_dec_1.pdf@2022-05-24 00:00:00@Kesimpta@ofatumumab@False@False@OD Not Found@Novartis Ireland Limited@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_15.pdf@EU-1-20-1507_h_a_dec_15.pdf@2022-03-10 00:00:00@Spikevax@elasomeran@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1527_h_a_dec_4.pdf@EU-1-20-1527_h_a_dec_4.pdf@2022-02-09 00:00:00@Retsevmo@selpercatinib@False@False@OD Not Found@Eli Lilly Nederland B.V.@conditional@Parsed
EU-1-21-1537_h_a_dec_0.pdf@EU-1-21-1537_h_a_dec_0.pdf@2021-03-26 00:00:00@NEXPOVIO@selinexor@True@False@OD Not Found@Karyopharm Europe GmbH@conditional@Parsed
EU-1-20-1528_h_a_dec_11.pdf@EU-1-20-1528_h_a_dec_11.pdf@2021-05-10 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1525_h_a_dec_1.pdf@EU-1-20-1525_h_a_dec_1.pdf@2021-04-22 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1535_h_a_dec_0.pdf@EU-1-21-1535_h_a_dec_0.pdf@2021-03-26 00:00:00@Pemazyre@pemigatinib@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1537_h_a_dec_1.pdf@EU-1-21-1537_h_a_dec_1.pdf@2022-05-13 00:00:00@NEXPOVIO@selinexor@False@False@OD Not Found@Karyopharm Europe GmbH@conditional@Parsed
EU-1-20-1507_h_a_dec_2.pdf@EU-1-20-1507_h_a_dec_2.pdf@2021-07-23 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-21-1533_h_a_dec_0.pdf@EU-1-21-1533_h_a_dec_0.pdf@2021-03-26 00:00:00@Seffalair Spiromax@salmeterol / fluticasone  propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1535_h_a_dec_1.pdf@EU-1-21-1535_h_a_dec_1.pdf@2022-02-16 00:00:00@Pemazyre@pemigatinib@False@False@OD Not Found@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-20-1528_h_a_dec_12.pdf@EU-1-20-1528_h_a_dec_12.pdf@2021-03-11 00:00:00@Comirnaty@tozinameran, COVID-19 mRNA vaccine  (nucleoside-modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1525_h_a_dec_10.pdf@EU-1-20-1525_h_a_dec_10.pdf@2022-03-01 00:00:00@COVID-19 Vaccine Janssen@S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1537_h_a_dec_2.pdf@EU-1-21-1537_h_a_dec_2.pdf@2022-07-18 00:00:00@NEXPOVIO@selinexor@False@False@OD Not Found@Karyopharm Europe GmbH@conditional@Parsed
EU-1-21-1533_h_a_dec_1.pdf@EU-1-21-1533_h_a_dec_1.pdf@2022-07-27 00:00:00@Seffalair Spiromax@salmeterol / fluticasone propionate@False@False@OD Not Found@Teva B.V.@CMA Not Found@Parsed
EU-1-21-1537_h_a_dec_3.pdf@EU-1-21-1537_h_a_dec_3.pdf@2022-07-22 00:00:00@NEXPOVIO@selinexor@False@False@OD Not Found@Karyopharm Europe GmbH@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_3.pdf@EU-1-20-1507_h_a_dec_3.pdf@2021-04-10 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN, S.L.@conditional@Parsed
EU-1-21-1538_h_a_dec_0.pdf@EU-1-21-1538_h_a_dec_0.pdf@2021-04-21 00:00:00@JEMPERLI@dostarlimab@True@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1528_h_a_dec_13.pdf@EU-1-20-1528_h_a_dec_13.pdf@2021-11-18 00:00:00@Comirnaty@tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_11.pdf@EU-1-20-1525_h_a_dec_11.pdf@2022-01-14 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1538_h_a_dec_1.pdf@EU-1-21-1538_h_a_dec_1.pdf@2022-02-16 00:00:00@JEMPERLI@dostarlimab@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-20-1507_h_a_dec_4.pdf@EU-1-20-1507_h_a_dec_4.pdf@2021-05-10 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-21-1542_h_a_dec_0.pdf@EU-1-21-1542_h_a_dec_0.pdf@2021-05-19 00:00:00@Copiktra@duvelisib@True@False@OD Not Found@Verastem Europe GmbH@CMA Not Found@Parsed
EU-1-21-1540_h_a_dec_0.pdf@EU-1-21-1540_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accord@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_12.pdf@EU-1-20-1525_h_a_dec_12.pdf@2022-02-03 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_14.pdf@EU-1-20-1528_h_a_dec_14.pdf@2021-11-26 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1546_h_a_dec_0.pdf@EU-1-21-1546_h_a_dec_0.pdf@2021-07-22 00:00:00@Ozawave@pitolisant@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-21-1538_h_a_dec_2.pdf@EU-1-21-1538_h_a_dec_2.pdf@2022-09-13 00:00:00@JEMPERLI@dostarlimab@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@conditional@Parsed
EU-1-21-1546_h_a_dec_1.pdf@EU-1-21-1546_h_a_dec_1.pdf@2021-07-22 00:00:00@Ozawade@pitolisant@False@False@adopted@Bioprojet Pharma@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_5.pdf@EU-1-20-1507_h_a_dec_5.pdf@2021-10-29 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-21-1542_h_a_dec_1.pdf@EU-1-21-1542_h_a_dec_1.pdf@2021-08-20 00:00:00@Copiktra@duvelisib@False@False@OD Not Found@Verastem Europe GmbH@CMA Not Found@Parsed
EU-1-21-1541_h_a_dec_0.pdf@EU-1-21-1541_h_a_dec_0.pdf@2022-03-24 00:00:00@Dasatinib Accordpharma@dasatinib@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_13.pdf@EU-1-20-1525_h_a_dec_13.pdf@2022-05-17 00:00:00@JCOVDEN@COVID-19 vaccine (Ad26.COV2-S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_15.pdf@EU-1-20-1528_h_a_dec_15.pdf@2021-07-12 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1507_h_a_dec_6.pdf@EU-1-20-1507_h_a_dec_6.pdf@2021-03-11 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-21-1547_h_a_dec_0.pdf@EU-1-21-1547_h_a_dec_0.pdf@2021-05-19 00:00:00@Drovelis@drospirenone / estetrol@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1548_h_a_dec_0.pdf@EU-1-21-1548_h_a_dec_0.pdf@2021-05-19 00:00:00@Lydisilka@drospirenone / estetrol@False@False@OD Not Found@Estetra SRL@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_16.pdf@EU-1-20-1528_h_a_dec_16.pdf@2021-09-12 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1525_h_a_dec_14.pdf@EU-1-20-1525_h_a_dec_14.pdf@2022-05-25 00:00:00@JCOVDEN@COVID-19 vaccine (Ad26.COV2-S [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1539_h_a_dec_0.pdf@EU-1-21-1539_h_a_dec_0.pdf@2021-08-18 00:00:00@Abecma@idecabtagene vicleucel@True@True@adopted@Celgene Europe B.V.@conditional@Parsed
EU-1-21-1544_h_a_dec_0.pdf@EU-1-21-1544_h_a_dec_0.pdf@2021-04-30 00:00:00@Orladeyo@berotralstat@True@False@OD Not Found@Biocryst Ireland Limited@CMA Not Found@Parsed
EU-1-21-1548_h_a_dec_1.pdf@EU-1-21-1548_h_a_dec_1.pdf@2022-09-29 00:00:00@Lydisilka@drospirenone / estetrol@False@False@OD Not Found@Estetra SRL@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_7.pdf@EU-1-20-1507_h_a_dec_7.pdf@2021-11-11 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1528_h_a_dec_17.pdf@EU-1-20-1528_h_a_dec_17.pdf@2022-01-24 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-20-1525_h_a_dec_2.pdf@EU-1-20-1525_h_a_dec_2.pdf@2021-07-05 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1544_h_a_dec_2.pdf@EU-1-21-1544_h_a_dec_2.pdf@2022-01-07 00:00:00@Orladeyo@berotralstat@False@False@OD Not Found@Biocryst Ireland Limited@CMA Not Found@Parsed
EU-1-21-1539_h_a_dec_1.pdf@EU-1-21-1539_h_a_dec_1.pdf@2021-11-18 00:00:00@Abecma@idecabtagene vicleucel@False@False@adopted@Celgene Europe B.V.@conditional@Parsed
EU-1-21-1550_h_a_dec_0.pdf@EU-1-21-1550_h_a_dec_0.pdf@2021-05-19 00:00:00@Ponvory@ponesimod@True@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-20-1507_h_a_dec_8.pdf@EU-1-20-1507_h_a_dec_8.pdf@2021-08-12 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1525_h_a_dec_3.pdf@EU-1-20-1525_h_a_dec_3.pdf@2021-09-07 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_18.pdf@EU-1-20-1528_h_a_dec_18.pdf@2022-04-02 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1549_h_a_dec_0.pdf@EU-1-21-1549_h_a_dec_0.pdf@2021-05-27 00:00:00@Efmody@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
EU-1-21-1539_h_a_dec_2.pdf@EU-1-21-1539_h_a_dec_2.pdf@2022-01-20 00:00:00@Abecma@idecabtagene vicleucel@False@False@adopted@Bristol-Myers Squibb Pharma EEIG@conditional@Parsed
EU-1-21-1549_h_a_dec_1.pdf@EU-1-21-1549_h_a_dec_1.pdf@2022-08-07 00:00:00@Efmody@hydrocortisone@False@False@OD Not Found@Diurnal Europe B.V.@CMA Not Found@Parsed
EU-1-21-1552_h_a_dec_0.pdf@EU-1-21-1552_h_a_dec_0.pdf@2021-06-17 00:00:00@Koselugo@selumetinib@True@False@adopted@AstraZeneca AB@conditional@Parsed
EU-1-20-1507_h_a_dec_9.pdf@EU-1-20-1507_h_a_dec_9.pdf@2022-02-14 00:00:00@Spikevax@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@MODERNA BIOTECH SPAIN@conditional@Parsed
EU-1-20-1525_h_a_dec_4.pdf@EU-1-20-1525_h_a_dec_4.pdf@2021-07-23 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_19.pdf@EU-1-20-1528_h_a_dec_19.pdf@2022-02-28 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1552_h_a_dec_1.pdf@EU-1-21-1552_h_a_dec_1.pdf@2022-04-25 00:00:00@Koselugo@selumetinib@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-21-1539_h_a_dec_3.pdf@EU-1-21-1539_h_a_dec_3.pdf@2022-06-24 00:00:00@Abecma@idecabtagene vicleucel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@conditional@Parsed
EU-1-21-1551_h_a_dec_0.pdf@EU-1-21-1551_h_a_dec_0.pdf@2021-06-17 00:00:00@Evkeeza@evinacumab@True@False@OD Not Found@Regeneron Ireland Designated Activity  Company (DAC)@exceptional@Parsed
EU-1-21-1554_h_a_dec_0.pdf@EU-1-21-1554_h_a_dec_0.pdf@2021-06-17 00:00:00@Adtralza@tralokinumab@True@False@OD Not Found@Leo Pharma A/S@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_5.pdf@EU-1-20-1525_h_a_dec_5.pdf@2021-03-09 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_2.pdf@EU-1-20-1528_h_a_dec_2.pdf@2021-02-02 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1551_h_a_dec_1.pdf@EU-1-21-1551_h_a_dec_1.pdf@2022-04-13 00:00:00@Evkeeza@evinacumab@False@False@OD Not Found@Regeneron Ireland Designated Activity  Company (DAC)@exceptional@Parsed
EU-1-21-1555_h_a_dec_0.pdf@EU-1-21-1555_h_a_dec_0.pdf@2021-11-18 00:00:00@Gavreto@pralsetinib@True@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-21-1553_h_a_dec_0.pdf@EU-1-21-1553_h_a_dec_0.pdf@2021-06-24 00:00:00@Abiraterone Krka@abiraterone acetate@False@False@OD Not Found@KRKA d d., Novo mesto@CMA Not Found@Parsed
EU-1-21-1555_h_a_dec_1.pdf@EU-1-21-1555_h_a_dec_1.pdf@2022-09-13 00:00:00@GAVRETO@pralsetinib@False@False@OD Not Found@Roche Registration GmbH@conditional@Parsed
EU-1-20-1525_h_a_dec_6.pdf@EU-1-20-1525_h_a_dec_6.pdf@2021-09-29 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-20-1528_h_a_dec_20.pdf@EU-1-20-1528_h_a_dec_20.pdf@2022-07-04 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1556_h_a_dec_0.pdf@EU-1-21-1556_h_a_dec_0.pdf@2021-06-17 00:00:00@Onureg@azacitidine@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-21-1558_h_a_dec_0.pdf@EU-1-21-1558_h_a_dec_0.pdf@2021-07-16 00:00:00@Klisyri@tirbanibulin@True@False@OD Not Found@Almirall, S.A.@CMA Not Found@Parsed
EU-1-21-1560_h_a_dec_0.pdf@EU-1-21-1560_h_a_dec_0.pdf@2021-06-17 00:00:00@Celsunax@ioflupane (123I)@False@False@OD Not Found@Pinax Pharma GmbH@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_7.pdf@EU-1-20-1525_h_a_dec_7.pdf@2021-01-10 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1562_h_a_dec_0.pdf@EU-1-21-1562_h_a_dec_0.pdf@2021-12-17 00:00:00@Xevudy@sotrovimab@True@False@OD Not Found@GlaxoSmithKline Trading Services Limited,@CMA Not Found@Parsed
EU-1-21-1559_h_a_dec_0.pdf@EU-1-21-1559_h_a_dec_0.pdf@2021-06-24 00:00:00@Enspryng@satralizumab@True@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_21.pdf@EU-1-20-1528_h_a_dec_21.pdf@2022-04-05 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1561_h_a_dec_0.pdf@EU-1-21-1561_h_a_dec_0.pdf@2021-07-16 00:00:00@Verquvo@vericiguat@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1559_h_a_dec_1.pdf@EU-1-21-1559_h_a_dec_1.pdf@2022-06-30 00:00:00@Enspryng@satralizumab@False@False@adopted@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1556_h_a_dec_1.pdf@EU-1-21-1556_h_a_dec_1.pdf@2022-07-22 00:00:00@Onureg@azacitidine@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-21-1564_h_a_dec_0.pdf@EU-1-21-1564_h_a_dec_0.pdf@2021-07-16 00:00:00@Imcivree@setmelanotide@True@False@adopted@Rhythm Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_8.pdf@EU-1-20-1525_h_a_dec_8.pdf@2021-11-10 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1562_h_a_dec_1.pdf@EU-1-21-1562_h_a_dec_1.pdf@2022-04-29 00:00:00@Xevudy@sotrovimab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_22.pdf@EU-1-20-1528_h_a_dec_22.pdf@2022-05-08 00:00:00@Comirnaty@tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@CMA Not Found@Parsed
EU-1-21-1564_h_a_dec_1.pdf@EU-1-21-1564_h_a_dec_1.pdf@2021-10-22 00:00:00@Imcivree@setmelanotide@False@False@adopted@Rhythm Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-20-1525_h_a_dec_9.pdf@EU-1-20-1525_h_a_dec_9.pdf@2021-12-16 00:00:00@COVID-19 Vaccine Janssen@COVID-19 vaccine (Ad26.COV2-S  [recombinant])@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1562_h_a_dec_2.pdf@EU-1-21-1562_h_a_dec_2.pdf@2022-07-22 00:00:00@Xevudy@sotrovimab@False@False@OD Not Found@GlaxoSmithKline Trading Services Limited@CMA Not Found@Parsed
EU-1-21-1557_h_a_dec_0.pdf@EU-1-21-1557_h_a_dec_0.pdf@2021-06-21 00:00:00@Jayempi@azathioprine@False@False@OD Not Found@Nova Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-21-1566_h_a_dec_0.pdf@EU-1-21-1566_h_a_dec_0.pdf@2021-07-16 00:00:00@Bylvay@odevixibat@True@False@adopted@Albireo AB@exceptional@Parsed
EU-1-21-1564_h_a_dec_2.pdf@EU-1-21-1564_h_a_dec_2.pdf@2022-02-06 00:00:00@Imcivree@setmelanotide@False@False@adopted@Rhythm Pharmaceuticals Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_23.pdf@EU-1-20-1528_h_a_dec_23.pdf@2022-01-09 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1568_h_a_dec_0.pdf@EU-1-21-1568_h_a_dec_0.pdf@2021-09-22 00:00:00@Imatinib Koanaa@imatinib@False@False@OD Not Found@Koanaa Healthcare GmbH@CMA Not Found@Parsed
EU-1-21-1564_h_a_dec_3.pdf@EU-1-21-1564_h_a_dec_3.pdf@2022-02-09 00:00:00@Setmelanotide@Active Substance Not Found@False@False@adopted@Rhythm Pharmaceuticals Netherlands B.V.@CMA Not Found@Parsed
EU-1-21-1572_h_a_dec_0.pdf@EU-1-21-1572_h_a_dec_0.pdf@2021-08-18 00:00:00@Byooviz@ranibizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-21-1569_h_a_dec_0.pdf@EU-1-21-1569_h_a_dec_0.pdf@2021-11-18 00:00:00@QINLOCK@ripretinib@True@False@adopted@Deciphera Pharmaceuticals (Netherlands)  B.V.@CMA Not Found@Parsed
EU-1-21-1570_h_a_dec_0.pdf@EU-1-21-1570_h_a_dec_0.pdf@2021-08-26 00:00:00@Minjuvi@tafasitamab@True@False@adopted@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-20-1528_h_a_dec_24.pdf@EU-1-20-1528_h_a_dec_24.pdf@2022-12-09 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1572_h_a_dec_1.pdf@EU-1-21-1572_h_a_dec_1.pdf@2022-09-29 00:00:00@Byooviz@ranibizumab@False@False@OD Not Found@Samsung Bioepis NL B.V.@CMA Not Found@Parsed
EU-1-21-1570_h_a_dec_1.pdf@EU-1-21-1570_h_a_dec_1.pdf@2022-08-07 00:00:00@Minjuvi@tafasitamab@False@False@OD Not Found@Incyte Biosciences Distribution B.V.@conditional@Parsed
EU-1-21-1567_h_a_dec_0.pdf@EU-1-21-1567_h_a_dec_0.pdf@2021-07-16 00:00:00@Icatibant Accord@icatibant@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_25.pdf@EU-1-20-1528_h_a_dec_25.pdf@2022-09-16 00:00:00@Comirnaty@modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1565_h_a_dec_0.pdf@EU-1-21-1565_h_a_dec_0.pdf@2021-07-16 00:00:00@Ryeqo@relugolix / estradiol / norethisterone  acetate@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1574_h_a_dec_0.pdf@EU-1-21-1574_h_a_dec_0.pdf@2021-08-18 00:00:00@Evrenzo@roxadustat@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1578_h_a_dec_0.pdf@EU-1-21-1578_h_a_dec_0.pdf@2022-02-21 00:00:00@Ontilyv@opicapone@False@False@OD Not Found@Bial - Portela & Cª, SA@CMA Not Found@Parsed
EU-1-21-1576_h_a_dec_0.pdf@EU-1-21-1576_h_a_dec_0.pdf@2021-11-22 00:00:00@Brukinsa@zanubrutinib@True@False@OD Not Found@BeiGene Ireland Limited@CMA Not Found@Parsed
EU-1-21-1565_h_a_dec_1.pdf@EU-1-21-1565_h_a_dec_1.pdf@2021-07-16 00:00:00@Ryeqo@relugolix / estradiol / norethisterone  acetate@True@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1574_h_a_dec_1.pdf@EU-1-21-1574_h_a_dec_1.pdf@2022-09-30 00:00:00@Evrenzo@roxadustat@False@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_26.pdf@EU-1-20-1528_h_a_dec_26.pdf@2022-10-10 00:00:00@Comirnaty@tozinameran, COVID-19 mRNA  vaccine (nucleoside-modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1565_h_a_dec_3.pdf@EU-1-21-1565_h_a_dec_3.pdf@2022-07-22 00:00:00@Ryeqo@relugolix / estradiol / norethisterone acetate@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-21-1573_h_a_dec_0.pdf@EU-1-21-1573_h_a_dec_0.pdf@2021-08-18 00:00:00@Fingolimod Mylan@fingolimod@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1571_h_a_dec_0.pdf@EU-1-21-1571_h_a_dec_0.pdf@2021-08-20 00:00:00@Abiraterone Mylan@abiraterone acetate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1579_h_a_dec_0.pdf@EU-1-21-1579_h_a_dec_0.pdf@2022-06-24 00:00:00@Nexviadyme@avalglucosidase alfa@False@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_4.pdf@EU-1-20-1528_h_a_dec_4.pdf@2021-02-23 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1575_h_a_dec_0.pdf@EU-1-21-1575_h_a_dec_0.pdf@2021-08-20 00:00:00@Bimzelx@bimekizumab@True@False@OD Not Found@UCB Pharma S.A.@CMA Not Found@Parsed
EU-1-21-1577_h_a_dec_0.pdf@EU-1-21-1577_h_a_dec_0.pdf@2021-08-26 00:00:00@Voxzogo@vosoritide@True@False@adopted@BioMarin International Limited@CMA Not Found@Parsed
EU-1-21-1585_h_a_dec_0.pdf@EU-1-21-1585_h_a_dec_0.pdf@2021-11-15 00:00:00@Vumerity@diroximel fumarate@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_5.pdf@EU-1-20-1528_h_a_dec_5.pdf@2021-04-14 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1582_h_a_dec_0.pdf@EU-1-21-1582_h_a_dec_0.pdf@2021-11-22 00:00:00@Artesunate Amivas@artesunate@True@False@adopted@Amivas Ireland Limited@CMA Not Found@Parsed
EU-1-21-1587_h_a_dec_0.pdf@EU-1-21-1587_h_a_dec_0.pdf@2022-08-17 00:00:00@RAYVOW@lasmiditan@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_6.pdf@EU-1-20-1528_h_a_dec_6.pdf@2021-05-31 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1589_h_a_dec_0.pdf@EU-1-21-1589_h_a_dec_0.pdf@2021-11-15 00:00:00@Hukyndra@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-21-1593_h_a_dec_0.pdf@EU-1-21-1593_h_a_dec_0.pdf@2021-09-12 00:00:00@Cibinqo@abrocitinib@True@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1586_h_a_dec_0.pdf@EU-1-21-1586_h_a_dec_0.pdf@2022-11-01 00:00:00@Voraxaze@glucarpidase@True@False@adopted@the applicant@exceptional@Parsed
EU-1-21-1591_h_a_dec_0.pdf@EU-1-21-1591_h_a_dec_0.pdf@2021-12-13 00:00:00@Vaxneuvance@Pneumococcal polysaccharide  conjugate vaccine (15 ‑ valent, adsorbed)@True@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-21-1583_h_a_dec_0.pdf@EU-1-21-1583_h_a_dec_0.pdf@2021-11-15 00:00:00@Sugammadex Mylan@sugammadex@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1588_h_a_dec_0.pdf@EU-1-21-1588_h_a_dec_0.pdf@2021-12-11 00:00:00@Rivaroxaban Mylan@rivaroxaban@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_7.pdf@EU-1-20-1528_h_a_dec_7.pdf@2021-07-13 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1595_h_a_dec_0.pdf@EU-1-21-1595_h_a_dec_0.pdf@2021-12-13 00:00:00@ASPAVELI@pegcetacoplan@True@False@adopted@Swedish Orphan Biovitrum AB (publ)@CMA Not Found@Parsed
EU-1-21-1583_h_a_dec_1.pdf@EU-1-21-1583_h_a_dec_1.pdf@2022-02-06 00:00:00@Sugammadex Mylan@sugammadex@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1590_h_a_dec_0.pdf@EU-1-21-1590_h_a_dec_0.pdf@2021-12-11 00:00:00@Libmyris@adalimumab@False@False@OD Not Found@STADA Arzneimittel AG@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_8.pdf@EU-1-20-1528_h_a_dec_8.pdf@2021-07-23 00:00:00@Comirnaty@COVID-19 mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@conditional@Parsed
EU-1-21-1592_h_a_dec_0.pdf@EU-1-21-1592_h_a_dec_0.pdf@2021-11-22 00:00:00@Trodelvy@sacituzumab govitecan@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-21-1594_h_a_dec_0.pdf@EU-1-21-1594_h_a_dec_0.pdf@2021-09-12 00:00:00@Rybrevant@amivantamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1599_h_a_dec_0.pdf@EU-1-21-1599_h_a_dec_0.pdf@2022-01-24 00:00:00@Vyepti@eptinezumab@True@False@OD Not Found@H. Lundbeck A/S@CMA Not Found@Parsed
EU-1-21-1597_h_a_dec_0.pdf@EU-1-21-1597_h_a_dec_0.pdf@2021-12-11 00:00:00@Regkirona@regdanvimab@True@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-21-1601_h_a_dec_0.pdf@EU-1-21-1601_h_a_dec_0.pdf@2021-12-11 00:00:00@Ronapreve@casirivimab / imdevimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-20-1528_h_a_dec_9.pdf@EU-1-20-1528_h_a_dec_9.pdf@2021-08-26 00:00:00@Comirnaty@COVID-19  mRNA Vaccine (nucleoside modified)@False@False@OD Not Found@BioNTech Manufacturing GmbH@CMA Not Found@Parsed
EU-1-21-1594_h_a_dec_1.pdf@EU-1-21-1594_h_a_dec_1.pdf@2022-09-26 00:00:00@Rybrevant@amivantamab@False@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-21-1596_h_a_dec_0.pdf@EU-1-21-1596_h_a_dec_0.pdf@2022-02-16 00:00:00@Tepmetko@tepotinib@True@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-21-1603_h_a_dec_0.pdf@EU-1-21-1603_h_a_dec_0.pdf@2022-06-01 00:00:00@Lumykras@sotorasib@True@False@OD Not Found@Amgen Europe B.V.@conditional@Parsed
EU-1-21-1601_h_a_dec_1.pdf@EU-1-21-1601_h_a_dec_1.pdf@2021-12-11 00:00:00@Ronapreve@casirivimab / imdevimab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1597_h_a_dec_1.pdf@EU-1-21-1597_h_a_dec_1.pdf@2022-05-25 00:00:00@Regkirona@regdanvimab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-21-1600_h_a_dec_0.pdf@EU-1-21-1600_h_a_dec_0.pdf@2022-06-01 00:00:00@Tecovirimat SIGA@tecovirimat@True@False@OD Not Found@SIGA Technologies Netherlands B.V.@exceptional@Parsed
EU-1-21-1605_h_a_dec_0.pdf@EU-1-21-1605_h_a_dec_0.pdf@2022-11-01 00:00:00@Tavneos@avacopan@True@False@adopted@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-21-1601_h_a_dec_2.pdf@EU-1-21-1601_h_a_dec_2.pdf@2022-07-03 00:00:00@Ronapreve@casirivimab / imdevimab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-21-1604_h_a_dec_0.pdf@EU-1-21-1604_h_a_dec_0.pdf@2022-06-01 00:00:00@Riltrava Aerosphere@formoterol / glycopyrronium  bromide / budesonide@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-21-1607_h_a_dec_0.pdf@EU-1-21-1607_h_a_dec_0.pdf@2022-11-01 00:00:00@Lonapegsomatropin Ascendis Pharma@Lonapegsomatropin@True@False@adopted@Ascendis Pharma Endocrinology Division A/S,@CMA Not Found@Parsed
EU-1-21-1598_h_a_dec_0.pdf@EU-1-21-1598_h_a_dec_0.pdf@2021-09-12 00:00:00@Sitagliptin SUN@sitagliptin fumarate@False@False@OD Not Found@Sun Pharmaceutical Industries Europe BV@CMA Not Found@Parsed
EU-1-21-1611_h_a_dec_0.pdf@EU-1-21-1611_h_a_dec_0.pdf@2022-03-24 00:00:00@Vildagliptin/Metformin hydrochloride Accord@vildagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1615_h_a_dec_0.pdf@EU-1-21-1615_h_a_dec_0.pdf@2022-04-13 00:00:00@Padcev@enfortumab vedotin@True@False@OD Not Found@Astellas Pharma Europe B.V.@CMA Not Found@Parsed
EU-1-21-1606_h_a_dec_0.pdf@EU-1-21-1606_h_a_dec_0.pdf@2022-06-14 00:00:00@Yselty@linzagolix choline@True@False@OD Not Found@ObsEva Ireland Ltd.@CMA Not Found@Parsed
EU-1-21-1617_h_a_dec_0.pdf@EU-1-21-1617_h_a_dec_0.pdf@2022-02-14 00:00:00@Ngenla@somatrogon@True@False@adopted@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1612_h_a_dec_0.pdf@EU-1-21-1612_h_a_dec_0.pdf@2022-02-14 00:00:00@Apexxnar@pneumococcal polysaccharide conjugate  vaccine (20-valent, adsorbed)@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1602_h_a_dec_0.pdf@EU-1-21-1602_h_a_dec_0.pdf@2022-04-25 00:00:00@Uplizna@inebilizumab@True@False@adopted@Viela Bio B.V.@CMA Not Found@Parsed
EU-1-21-1608_h_a_dec_0.pdf@EU-1-21-1608_h_a_dec_0.pdf@2022-06-01 00:00:00@Wegovy@semaglutide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-21-1616_h_a_dec_0.pdf@EU-1-21-1616_h_a_dec_0.pdf@2022-02-16 00:00:00@Kerendia@finerenone@True@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-21-1602_h_a_dec_1.pdf@EU-1-21-1602_h_a_dec_1.pdf@2022-06-29 00:00:00@Uplizna@inebilizumab@False@False@OD Not Found@Viela Bio B.V.@CMA Not Found@Parsed
EU-1-21-1621_h_a_dec_0.pdf@EU-1-21-1621_h_a_dec_0.pdf@2022-02-14 00:00:00@OKEDI@risperidone@False@False@OD Not Found@Laboratorios Farmacéuticos Rovi, S.A.@CMA Not Found@Parsed
EU-1-21-1619_h_a_dec_0.pdf@EU-1-21-1619_h_a_dec_0.pdf@2022-02-16 00:00:00@Sitagliptin/Metformin hydrochloride Mylan@sitagliptin/metformin hydrochloride@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_0.pdf@EU-1-21-1618_h_a_dec_0.pdf@2021-12-20 00:00:00@Nuvaxovid@COVID-19 Vaccine  (recombinant, adjuvanted)@True@False@OD Not Found@Novavax CZ, a.s.@conditional@Parsed
EU-1-21-1623_h_a_dec_0.pdf@EU-1-21-1623_h_a_dec_0.pdf@2022-02-14 00:00:00@Saphnelo@anifrolumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1629_h_a_dec_0.pdf@EU-1-22-1629_h_a_dec_0.pdf@2022-05-31 00:00:00@ZOLSKETIL pegylated liposomal@doxorubicin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1620_h_a_dec_0.pdf@EU-1-21-1620_h_a_dec_0.pdf@2022-02-16 00:00:00@Sapropterin Dipharma@sapropterin@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-22-1625_h_a_dec_0.pdf@EU-1-22-1625_h_a_dec_0.pdf@2022-01-28 00:00:00@Paxlovid@trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide /  ritonavir@True@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-21-1620_h_a_dec_1.pdf@EU-1-21-1620_h_a_dec_1.pdf@2022-05-05 00:00:00@Sapropterin Dipharma@sapropterin@False@False@OD Not Found@Dipharma B.V.@CMA Not Found@Parsed
EU-1-21-1622_h_a_dec_0.pdf@EU-1-21-1622_h_a_dec_0.pdf@2022-02-14 00:00:00@Oxbryta@voxelotor@True@False@adopted@Global Blood Therapeutics Netherlands B.V.,@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_1.pdf@EU-1-21-1618_h_a_dec_1.pdf@2022-12-01 00:00:00@Nuvaxovid@COVID-19 Vaccine (recombinant, adjuvanted)@False@False@OD Not Found@Novavax CZ, a.s.@conditional@Parsed
EU-1-22-1630_h_a_dec_0.pdf@EU-1-22-1630_h_a_dec_0.pdf@2022-01-04 00:00:00@KIMMTRAK@tebentafusp@True@False@adopted@Immunocore Ireland Limited@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_0.pdf@EU-1-21-1529_h_a_dec_0.pdf@2021-01-29 00:00:00@COVID-19 Vaccine AstraZeneca@COVID-19 Vaccine (ChAdOx1-S [recombinant])@True@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1625_h_a_dec_1.pdf@EU-1-22-1625_h_a_dec_1.pdf@2022-01-07 00:00:00@Paxlovid@azabicyclo[3.1.0]hexane-2-carboxamide / ritonavir@False@False@OD Not Found@Pfizer Europe MA EEIG@conditional@Parsed
EU-1-21-1624_h_a_dec_0.pdf@EU-1-21-1624_h_a_dec_0.pdf@2022-06-24 00:00:00@COVID-19 Vaccine (inactivated, adjuvanted)  Valneva@COVID-19 vaccine (inactivated, adjuvanted, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_2.pdf@EU-1-21-1618_h_a_dec_2.pdf@2022-01-07 00:00:00@Nuvaxovid@COVID-19 Vaccine (recombinant, adjuvanted)@False@False@OD Not Found@Novavax CZ@conditional@Parsed
EU-1-22-1635_h_a_dec_0.pdf@EU-1-22-1635_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumerate Polpharma@dimethyl  fumarate@False@False@OD Not Found@Zakłady Farmaceutyczne POLPHARMA S.A.,@CMA Not Found@Parsed
EU-1-22-1631_h_a_dec_0.pdf@EU-1-22-1631_h_a_dec_0.pdf@2022-04-04 00:00:00@Breyanzi@lisocabtagene maraleucel@True@True@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_1.pdf@EU-1-21-1529_h_a_dec_1.pdf@2021-03-19 00:00:00@COVID-19 Vaccine AstraZeneca@COVID-19 Vaccine (ChAdOx1-S  [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1625_h_a_dec_2.pdf@EU-1-22-1625_h_a_dec_2.pdf@2022-09-29 00:00:00@Paxlovid@2-carboxamide / ritonavir@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-21-1624_h_a_dec_1.pdf@EU-1-21-1624_h_a_dec_1.pdf@2022-07-28 00:00:00@COVID-19 Vaccine (inactivated, adjuvanted) Valneva@COVID-19 vaccine  (inactivated, adjuvanted, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-21-1618_h_a_dec_3.pdf@EU-1-21-1618_h_a_dec_3.pdf@2022-06-09 00:00:00@Nuvaxovid@COVID-19 Vaccine (recombinant, adjuvanted)@False@False@OD Not Found@Novavax CZ@conditional@Parsed
EU-1-22-1637_h_a_dec_0.pdf@EU-1-22-1637_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Neuraxpharm@dimethyl  fumarate@False@False@OD Not Found@Laboratorios Lesvi, S.L.@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_10.pdf@EU-1-21-1529_h_a_dec_10.pdf@2022-01-14 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1640_h_a_dec_0.pdf@EU-1-22-1640_h_a_dec_0.pdf@2022-05-05 00:00:00@Amversio@betaine anhydrous@False@False@OD Not Found@the applicant@CMA Not Found@Parsed
EU-1-21-1624_h_a_dec_2.pdf@EU-1-21-1624_h_a_dec_2.pdf@2022-09-27 00:00:00@COVID-19 Vaccine (inactivated, adjuvanted) Valneva@COVID-19 vaccine  (inactivated, adjuvanted, adsorbed)@False@False@OD Not Found@Valneva Austria GmbH@CMA Not Found@Parsed
EU-1-22-1632_h_a_dec_0.pdf@EU-1-22-1632_h_a_dec_0.pdf@2022-03-28 00:00:00@Stimufend@pegfilgrastim@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1628_h_a_dec_0.pdf@EU-1-22-1628_h_a_dec_0.pdf@2022-03-24 00:00:00@Sondelbay@teriparatide@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_11.pdf@EU-1-21-1529_h_a_dec_11.pdf@2022-02-02 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-21-1618_h_a_dec_4.pdf@EU-1-21-1618_h_a_dec_4.pdf@2022-03-10 00:00:00@Nuvaxovid@COVID-19 Vaccine (recombinant, adjuvanted)@False@False@OD Not Found@Novavax CZ, a.s.@conditional@Parsed
EU-1-22-1638_h_a_dec_0.pdf@EU-1-22-1638_h_a_dec_0.pdf@2022-04-29 00:00:00@QUVIVIQ@daridorexant@True@False@OD Not Found@Idorsia Pharmaceuticals Deutschland GmbH,@CMA Not Found@Parsed
EU-1-22-1641_h_a_dec_0.pdf@EU-1-22-1641_h_a_dec_0.pdf@2022-04-25 00:00:00@PreHevbri@Hepatitis B vaccine (recombinant,  adsorbed)@False@False@OD Not Found@VBI Vaccines B.V.@CMA Not Found@Parsed
EU-1-22-1644_h_a_dec_0.pdf@EU-1-22-1644_h_a_dec_0.pdf@2022-04-25 00:00:00@Inpremzia@insulin human (rDNA)@False@False@OD Not Found@Baxter Holding B.V.@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_12.pdf@EU-1-21-1529_h_a_dec_12.pdf@2022-03-31 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1633_h_a_dec_0.pdf@EU-1-22-1633_h_a_dec_0.pdf@2022-04-25 00:00:00@Sitagliptin Accord@Sitagliptin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1648_h_a_dec_0.pdf@EU-1-22-1648_h_a_dec_0.pdf@2022-05-25 00:00:00@CARVYKTI@ciltacabtagene  autoleucel@True@True@adopted@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1639_h_a_dec_0.pdf@EU-1-22-1639_h_a_dec_0.pdf@2022-04-25 00:00:00@Truvelog Mix 30@Insulin aspart@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_13.pdf@EU-1-21-1529_h_a_dec_13.pdf@2022-05-20 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1642_h_a_dec_0.pdf@EU-1-22-1642_h_a_dec_0.pdf@2022-04-29 00:00:00@Orgovyx@relugolix@False@False@OD Not Found@Myovant Sciences Ireland Limited@CMA Not Found@Parsed
EU-1-22-1652_h_a_dec_0.pdf@EU-1-22-1652_h_a_dec_0.pdf@2022-06-21 00:00:00@Filsuvez@birch bark extract@False@False@adopted@Amryt Pharmaceuticals DAC@CMA Not Found@Parsed
EU-1-22-1645_h_a_dec_0.pdf@EU-1-22-1645_h_a_dec_0.pdf@2022-04-25 00:00:00@Vydura@rimegepant@True@False@OD Not Found@Biohaven Pharmaceutical Ireland DAC@CMA Not Found@Parsed
EU-1-22-1649_h_a_dec_0.pdf@EU-1-22-1649_h_a_dec_0.pdf@2022-03-06 00:00:00@Lunsumio@mosunetuzumab@True@False@adopted@Roche Registration GmbH@conditional@Parsed
EU-1-22-1634_h_a_dec_0.pdf@EU-1-22-1634_h_a_dec_0.pdf@2022-05-13 00:00:00@Dimethyl fumarate Mylan@dimethyl fumarate@False@False@OD Not Found@Mylan Ireland Limited@CMA Not Found@Parsed
EU-1-22-1657_h_a_dec_0.pdf@EU-1-22-1657_h_a_dec_0.pdf@2022-07-15 00:00:00@Kinpeygo@budesonide@False@False@adopted@Calliditas Therapeutics AB@conditional@Parsed
EU-1-22-1642_h_a_dec_1.pdf@EU-1-22-1642_h_a_dec_1.pdf@2022-08-07 00:00:00@Orgovyx@relugolix@False@False@OD Not Found@Myovant Sciences Ireland Limited@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_14.pdf@EU-1-21-1529_h_a_dec_14.pdf@2022-08-08 00:00:00@Vaxzevria@COVID-19 Vaccine  (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1646_h_a_dec_0.pdf@EU-1-22-1646_h_a_dec_0.pdf@2022-05-19 00:00:00@Amifampridine SERB@amifampridine@False@False@OD Not Found@SERB S.A.@CMA Not Found@Parsed
EU-1-22-1657_h_a_dec_1.pdf@EU-1-22-1657_h_a_dec_1.pdf@2022-09-15 00:00:00@Kinpeygo@budesonide@False@False@adopted@Calliditas Therapeutics AB@conditional@Parsed
EU-1-21-1529_h_a_dec_2.pdf@EU-1-21-1529_h_a_dec_2.pdf@2021-08-04 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1661_h_a_dec_0.pdf@EU-1-22-1661_h_a_dec_0.pdf@2022-07-22 00:00:00@Sitagliptin/Metformin hydrochloride Accord@sitagliptin / metformin hydrochloride@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1653_h_a_dec_0.pdf@EU-1-22-1653_h_a_dec_0.pdf@2022-07-18 00:00:00@Upstaza@eladocagene  exuparvovec@True@True@adopted@PTC Therapeutics International Limited@exceptional@Parsed
EU-1-22-1647_h_a_dec_0.pdf@EU-1-22-1647_h_a_dec_0.pdf@2022-05-24 00:00:00@Camcevi@leuprorelin@False@False@OD Not Found@Accord Healthcare S.L.U.@CMA Not Found@Parsed
EU-1-22-1650_h_a_dec_0.pdf@EU-1-22-1650_h_a_dec_0.pdf@2022-06-20 00:00:00@Tabrecta@capmatinib@True@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_3.pdf@EU-1-21-1529_h_a_dec_3.pdf@2021-05-21 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1663_h_a_dec_0.pdf@EU-1-22-1663_h_a_dec_0.pdf@2022-07-15 00:00:00@Sugammadex Fresenius Kabi@sugammadex@False@False@OD Not Found@Fresenius Kabi Deutschland GmbH@CMA Not Found@Parsed
EU-1-22-1643_h_a_dec_0.pdf@EU-1-22-1643_h_a_dec_0.pdf@2022-04-25 00:00:00@Kapruvia@difelikefalin@True@False@OD Not Found@Vifor Fresenius Medical Care Renal Pharma  France@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_4.pdf@EU-1-21-1529_h_a_dec_4.pdf@2021-01-07 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1651_h_a_dec_0.pdf@EU-1-22-1651_h_a_dec_0.pdf@2022-03-25 00:00:00@EVUSHELD@tixagevimab / cilgavimab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1655_h_a_dec_0.pdf@EU-1-22-1655_h_a_dec_0.pdf@2022-06-20 00:00:00@Pirfenidone AET@pirfenidone@False@False@OD Not Found@Alfred E. Tiefenbacher (GmbH & Co. KG)@CMA Not Found@Parsed
EU-1-22-1667_h_a_dec_0.pdf@EU-1-22-1667_h_a_dec_0.pdf@2022-08-17 00:00:00@VEGZELMA@bevacizumab@False@False@OD Not Found@Celltrion Healthcare Hungary Kft.@CMA Not Found@Parsed
EU-1-22-1658_h_a_dec_0.pdf@EU-1-22-1658_h_a_dec_0.pdf@2022-07-15 00:00:00@Ganirelix Gedeon Richter@ganirelix@False@False@OD Not Found@Gedeon Richter Plc.@CMA Not Found@Parsed
EU-1-22-1664_h_a_dec_0.pdf@EU-1-22-1664_h_a_dec_0.pdf@2022-07-15 00:00:00@Cevenfacta@eptacog beta (activated)@False@False@OD Not Found@Laboratoire français du Fractionnement et des  Biotechnologies@CMA Not Found@Parsed
EU-1-22-1655_h_a_dec_1.pdf@EU-1-22-1655_h_a_dec_1.pdf@2022-09-26 00:00:00@Pirfenidone axunio@pirfenidone@False@False@OD Not Found@Alfred E. Tiefenbacher (GmbH & Co. KG)@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_5.pdf@EU-1-21-1529_h_a_dec_5.pdf@2021-07-19 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1651_h_a_dec_1.pdf@EU-1-22-1651_h_a_dec_1.pdf@2022-09-16 00:00:00@EVUSHELD@tixagevimab / cilgavimab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-22-1655_h_a_dec_2.pdf@EU-1-22-1655_h_a_dec_2.pdf@2022-07-10 00:00:00@Pirfenidone axunio@pirfenidone@False@False@OD Not Found@Alfred E. Tiefenbacher (GmbH & Co. KG)@CMA Not Found@Parsed
EU-1-22-1666_h_a_dec_0.pdf@EU-1-22-1666_h_a_dec_0.pdf@2022-09-15 00:00:00@Celdoxome pegylated liposomal@doxorubicin  hydrochloride@False@False@OD Not Found@YES Pharmaceutical Development Services  GmbH@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_6.pdf@EU-1-21-1529_h_a_dec_6.pdf@2021-09-14 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1659_h_a_dec_0.pdf@EU-1-22-1659_h_a_dec_0.pdf@2022-06-24 00:00:00@Xenpozyme@olipudase alfa@True@False@adopted@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-22-1671_h_a_dec_0.pdf@EU-1-22-1671_h_a_dec_0.pdf@2022-08-17 00:00:00@Sunlenca@lenacapavir@True@False@OD Not Found@Gilead Sciences Ireland UC@CMA Not Found@Parsed
EU-1-22-1668_h_a_dec_0.pdf@EU-1-22-1668_h_a_dec_0.pdf@2022-08-24 00:00:00@Roctavian@valoctocogene  roxaparvovec@True@True@adopted@BioMarin International Limited@conditional@Parsed
EU-1-21-1529_h_a_dec_7.pdf@EU-1-21-1529_h_a_dec_7.pdf@2021-10-15 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1656_h_a_dec_0.pdf@EU-1-22-1656_h_a_dec_0.pdf@2022-07-15 00:00:00@Ertapenem SUN@ertapenem@False@False@OD Not Found@Sun Pharmaceutical Industries Europe B.V.@CMA Not Found@Parsed
EU-1-22-1676_h_a_dec_0.pdf@EU-1-22-1676_h_a_dec_0.pdf@2022-09-19 00:00:00@Thalidomide Lipomed@Thalidomide@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-22-1673_h_a_dec_0.pdf@EU-1-22-1673_h_a_dec_0.pdf@2022-08-25 00:00:00@Ranivisio@ranibizumab@False@False@OD Not Found@Midas Pharma GmbH@CMA Not Found@Parsed
Found@Parsed
EU-1-22-1676_h_a_dec_1.pdf@EU-1-22-1676_h_a_dec_1.pdf@2022-09-19 00:00:00@Thalidomide Lipomed@Thalidomide@False@False@OD Not Found@Lipomed GmbH@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_8.pdf@EU-1-21-1529_h_a_dec_8.pdf@2021-09-11 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1685_h_a_dec_0.pdf@EU-1-22-1685_h_a_dec_0.pdf@2022-09-15 00:00:00@Mounjaro@tirzepatide@True@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-22-1669_h_a_dec_0.pdf@EU-1-22-1669_h_a_dec_0.pdf@2022-08-17 00:00:00@Pepaxti@melphalan flufenamide@False@False@OD Not Found@Oncopeptides AB (publ)@CMA Not Found@Parsed
EU-1-22-1674_h_a_dec_0.pdf@EU-1-22-1674_h_a_dec_0.pdf@2022-10-08 00:00:00@Vyvgart@efgartigimod alfa@True@False@adopted@argenx BV@CMA Not Found@Parsed
EU-1-22-1681_h_a_dec_0.pdf@EU-1-22-1681_h_a_dec_0.pdf@2022-09-15 00:00:00@Amvuttra@vutrisiran@True@False@adopted@Alnylam Netherlands B.V.@CMA Not Found@Parsed
EU-1-22-1660_h_a_dec_0.pdf@EU-1-22-1660_h_a_dec_0.pdf@2022-07-18 00:00:00@Zokinvy@lonafarnib@True@False@adopted@EigerBio Europe Limited@exceptional@Parsed
EU-1-22-1677_h_a_dec_0.pdf@EU-1-22-1677_h_a_dec_0.pdf@2022-09-19 00:00:00@Tezspire@tezepelumab@True@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-21-1529_h_a_dec_9.pdf@EU-1-21-1529_h_a_dec_9.pdf@2021-11-23 00:00:00@Vaxzevria@COVID-19 Vaccine (ChAdOx1-S [recombinant])@False@False@OD Not Found@AstraZeneca AB@conditional@Parsed
EU-1-22-1683_h_a_dec_0.pdf@EU-1-22-1683_h_a_dec_0.pdf@2022-09-15 00:00:00@Vabysmo@Faricimab@True@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-22-1675_h_a_dec_0.pdf@EU-1-22-1675_h_a_dec_0.pdf@2022-08-23 00:00:00@TECVAYLI@teclistamab@True@False@OD Not Found@Janssen-Cilag International NV@conditional@Parsed
EU-1-22-1670_h_a_dec_0.pdf@EU-1-22-1670_h_a_dec_0.pdf@2022-08-25 00:00:00@Scemblix@asciminib@True@False@adopted@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-22-1678_h_a_dec_0.pdf@EU-1-22-1678_h_a_dec_0.pdf@2022-09-15 00:00:00@Lupkynis@voclosporin@True@False@OD Not Found@Otsuka Pharmaceutical Netherlands B.V.@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_1.pdf@EU-1-95-001_h_a_dec_1.pdf@Date is blank@Gonal-F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_10.pdf@EU-1-95-001_h_a_dec_10.pdf@2000-12-29 00:00:00@GONAL F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@ARES-SERONO (EUROPE)@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_0.pdf@EU-1-96-004_h_a_dec_0.pdf@1996-02-14 00:00:00@FARESTON@toremifene@NAS before 2012@NA before 2012@NA before 2000@Ercopharm A/S@CMA not available before 2006@Parsed
EU-1-22-1684_h_a_dec_0.pdf@EU-1-22-1684_h_a_dec_0.pdf@2022-09-15 00:00:00@NULIBRY@fosdenopterin@True@False@adopted@the applicant@exceptional@Parsed
EU-1-96-004_h_a_dec_1.pdf@EU-1-96-004_h_a_dec_1.pdf@Date is blank@Fareston@Toremifen@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation (Finland) concerning the medicinal product "Fareston -  Toremifen" for which the Commission issued the marketing authorization by its Decision of  14 Februari 1996, and which has been entered in the Community register of medicinal  products@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_11.pdf@EU-1-95-001_h_a_dec_11.pdf@2001-01-29 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@OD Not Found@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-22-1679_h_a_dec_0.pdf@EU-1-22-1679_h_a_dec_0.pdf@2022-09-15 00:00:00@Opdualag@nivolumab/relatlimab@True@False@OD Not Found@Bristol Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_0.pdf@EU-1-96-012_h_a_dec_0.pdf@Date is blank@Bondronat®@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_0.pdf@EU-1-96-008_h_a_dec_0.pdf@1996-05-03 00:00:00@Puregon®@Follitropin ß@NAS before 2012@NA before 2012@NA before 2000@Organon (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_1.pdf@EU-1-96-012_h_a_dec_1.pdf@Date is blank@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_10.pdf@EU-1-96-004_h_a_dec_10.pdf@2006-02-02 00:00:00@Fareston@Toremifene@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_12.pdf@EU-1-95-001_h_a_dec_12.pdf@2001-05-03 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@OD Not Found@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_1.pdf@EU-1-96-008_h_a_dec_1.pdf@1996-11-28 00:00:00@PUREGON@Follitropin beta@NAS before 2012@NA before 2012@NA before 2000@Organon (Ireland) Ltd@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_10.pdf@EU-1-96-012_h_a_dec_10.pdf@2001-12-09 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_13.pdf@EU-1-95-001_h_a_dec_13.pdf@2001-06-20 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@OD Not Found@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_11.pdf@EU-1-96-004_h_a_dec_11.pdf@2006-11-07 00:00:00@Fareston@Toremifene@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_10.pdf@EU-1-96-008_h_a_dec_10.pdf@2000-08-12 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@N.V.Organon@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_0.pdf@EU-1-96-020_h_a_dec_0.pdf@1996-09-20 00:00:00@TWINRIX ADULT@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_0.pdf@EU-1-96-016_h_a_dec_0.pdf@Date is blank@Norvir®@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_11.pdf@EU-1-96-012_h_a_dec_11.pdf@2003-10-24 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_14.pdf@EU-1-95-001_h_a_dec_14.pdf@2001-07-20 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@OD Not Found@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_11.pdf@EU-1-96-008_h_a_dec_11.pdf@2001-01-15 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@N.V.Organon@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_1.pdf@EU-1-96-020_h_a_dec_1.pdf@1997-11-17 00:00:00@TWINRIX Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_12.pdf@EU-1-96-004_h_a_dec_12.pdf@2008-12-17 00:00:00@Fareston@Toremifene@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_12.pdf@EU-1-96-012_h_a_dec_12.pdf@2003-10-31 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_1.pdf@EU-1-96-016_h_a_dec_1.pdf@1997-07-22 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_15.pdf@EU-1-95-001_h_a_dec_15.pdf@2001-07-11 00:00:00@Gonal-F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_12.pdf@EU-1-96-008_h_a_dec_12.pdf@2001-10-04 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@N.V.Organon@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_10.pdf@EU-1-96-020_h_a_dec_10.pdf@2002-10-24 00:00:00@Twinrix Adult Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_10.pdf@EU-1-96-016_h_a_dec_10.pdf@1999-11-29 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_13.pdf@EU-1-96-012_h_a_dec_13.pdf@2003-07-11 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_0.pdf@EU-1-96-026_h_a_dec_0.pdf@Date is blank@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_13.pdf@EU-1-96-004_h_a_dec_13.pdf@2009-02-03 00:00:00@Fareston@Toremifene@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_16.pdf@EU-1-95-001_h_a_dec_16.pdf@2002-01-28 00:00:00@Gonal-F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_11.pdf@EU-1-96-016_h_a_dec_11.pdf@1999-11-29 00:00:00@NORVIR@ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_13.pdf@EU-1-96-008_h_a_dec_13.pdf@2001-07-26 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@N.V.Organon@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_11.pdf@EU-1-96-020_h_a_dec_11.pdf@2004-01-30 00:00:00@Twinrix Adult Adult@Hepatitis A and  Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_1.pdf@EU-1-96-026_h_a_dec_1.pdf@2022-05-12 00:00:00@INVIRASE@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_14.pdf@EU-1-96-012_h_a_dec_14.pdf@2004-10-22 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_17.pdf@EU-1-95-001_h_a_dec_17.pdf@2002-02-19 00:00:00@Gonal-F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_12.pdf@EU-1-96-016_h_a_dec_12.pdf@2000-09-03 00:00:00@Norvir@Ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_14.pdf@EU-1-96-008_h_a_dec_14.pdf@2001-10-18 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@N.V.Organon@CMA not available before 2006@Parsed
6@Parsed
EU-1-96-004_h_a_dec_14.pdf@EU-1-96-004_h_a_dec_14.pdf@2014-08-26 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_18.pdf@EU-1-95-001_h_a_dec_18.pdf@2002-07-06 00:00:00@Gonal-F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_12.pdf@EU-1-96-020_h_a_dec_12.pdf@2006-08-28 00:00:00@Twinrix Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_13.pdf@EU-1-96-016_h_a_dec_13.pdf@2000-03-24 00:00:00@NORVIR@ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_15.pdf@EU-1-96-012_h_a_dec_15.pdf@2006-01-13 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_11.pdf@EU-1-96-026_h_a_dec_11.pdf@2001-12-11 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_19.pdf@EU-1-95-001_h_a_dec_19.pdf@2002-07-06 00:00:00@Gonal-F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_15.pdf@EU-1-96-008_h_a_dec_15.pdf@2002-05-02 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_15.pdf@EU-1-96-004_h_a_dec_15.pdf@2015-08-20 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_14.pdf@EU-1-96-016_h_a_dec_14.pdf@2000-10-24 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_13.pdf@EU-1-96-020_h_a_dec_13.pdf@2007-04-01 00:00:00@Twinrix Adult@Hepatitis A and  Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_16.pdf@EU-1-96-012_h_a_dec_16.pdf@2006-06-26 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_12.pdf@EU-1-96-026_h_a_dec_12.pdf@2002-10-09 00:00:00@Invirase@saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_16.pdf@EU-1-96-008_h_a_dec_16.pdf@2002-08-03 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_15.pdf@EU-1-96-016_h_a_dec_15.pdf@2001-03-13 00:00:00@Norvir@Ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_16.pdf@EU-1-96-004_h_a_dec_16.pdf@2016-12-23 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_14.pdf@EU-1-96-020_h_a_dec_14.pdf@2007-07-24 00:00:00@Twinrix Adult@Hepatitis A and  hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_13.pdf@EU-1-96-026_h_a_dec_13.pdf@2003-09-07 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_17.pdf@EU-1-96-008_h_a_dec_17.pdf@2002-10-28 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_17.pdf@EU-1-96-012_h_a_dec_17.pdf@2007-06-03 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_16.pdf@EU-1-96-016_h_a_dec_16.pdf@2001-06-14 00:00:00@Norvir@Ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_17.pdf@EU-1-96-004_h_a_dec_17.pdf@2018-12-06 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_15.pdf@EU-1-96-020_h_a_dec_15.pdf@2008-01-17 00:00:00@Twinrix Adult@Hepatitis A and  hepatitis B vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_14.pdf@EU-1-96-026_h_a_dec_14.pdf@2004-01-27 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_18.pdf@EU-1-96-008_h_a_dec_18.pdf@2003-08-19 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_17.pdf@EU-1-96-016_h_a_dec_17.pdf@2001-12-11 00:00:00@Norvir@Ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_18.pdf@EU-1-96-004_h_a_dec_18.pdf@2018-07-26 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_18.pdf@EU-1-96-016_h_a_dec_18.pdf@2001-12-17 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_19.pdf@EU-1-96-012_h_a_dec_19.pdf@2009-11-20 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_16.pdf@EU-1-96-020_h_a_dec_16.pdf@2008-06-19 00:00:00@Twinrix Adult@Hepatitis A and  hepatitis B vaccine@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_15.pdf@EU-1-96-026_h_a_dec_15.pdf@2004-10-09 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_19.pdf@EU-1-96-008_h_a_dec_19.pdf@2004-02-08 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_19.pdf@EU-1-96-016_h_a_dec_19.pdf@2002-10-09 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_19.pdf@EU-1-96-004_h_a_dec_19.pdf@2019-10-29 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_2.pdf@EU-1-96-012_h_a_dec_2.pdf@1997-08-27 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_2.pdf@EU-1-96-008_h_a_dec_2.pdf@1997-01-20 00:00:00@holder  the marketing    authorization@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@N.V. Organon@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_2.pdf@EU-1-96-016_h_a_dec_2.pdf@1997-09-30 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_17.pdf@EU-1-96-020_h_a_dec_17.pdf@2010-03-15 00:00:00@Twinrix Adult@Hepatitis A and  hepatitis B vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_16.pdf@EU-1-96-026_h_a_dec_16.pdf@2004-12-17 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_2.pdf@EU-1-96-004_h_a_dec_2.pdf@1998-11-03 00:00:00@FARESTON@torimifen@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_20.pdf@EU-1-96-016_h_a_dec_20.pdf@2002-07-11 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_18.pdf@EU-1-96-020_h_a_dec_18.pdf@2011-06-23 00:00:00@Twinrix Adult@Hepatitis A and hepatitis B vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_20.pdf@EU-1-96-012_h_a_dec_20.pdf@2010-01-25 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_17.pdf@EU-1-96-026_h_a_dec_17.pdf@2005-05-25 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_20.pdf@EU-1-96-004_h_a_dec_20.pdf@2022-01-31 00:00:00@Fareston@Toremifene@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_21.pdf@EU-1-96-016_h_a_dec_21.pdf@2003-07-14 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_19.pdf@EU-1-96-020_h_a_dec_19.pdf@2012-01-13 00:00:00@Twinrix Adult@Hepatitis A and hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_21.pdf@EU-1-96-012_h_a_dec_21.pdf@2011-04-14 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_21.pdf@EU-1-96-008_h_a_dec_21.pdf@2004-10-20 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_3.pdf@EU-1-96-004_h_a_dec_3.pdf@1999-06-18 00:00:00@FARESTON@torimifen@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_18.pdf@EU-1-96-026_h_a_dec_18.pdf@2005-06-28 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_22.pdf@EU-1-96-016_h_a_dec_22.pdf@2004-01-27 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_2.pdf@EU-1-96-020_h_a_dec_2.pdf@1998-12-22 00:00:00@TWINRIX Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_4.pdf@EU-1-96-004_h_a_dec_4.pdf@1999-07-09 00:00:00@FARESTON@torimifen@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_22.pdf@EU-1-96-012_h_a_dec_22.pdf@2011-06-29 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_22.pdf@EU-1-96-008_h_a_dec_22.pdf@2006-05-29 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_23.pdf@EU-1-96-016_h_a_dec_23.pdf@2004-03-25 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_19.pdf@EU-1-96-026_h_a_dec_19.pdf@2005-08-31 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_5.pdf@EU-1-96-004_h_a_dec_5.pdf@2000-01-20 00:00:00@FARESTON@torimifen@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_20.pdf@EU-1-96-020_h_a_dec_20.pdf@2015-02-12 00:00:00@Twinrix  Adult@Hepatitis A and hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_23.pdf@EU-1-96-012_h_a_dec_23.pdf@2011-07-26 00:00:00@Bondronat@Ibandronic acid@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_23.pdf@EU-1-96-008_h_a_dec_23.pdf@2007-09-01 00:00:00@Puregon@follitropin beta@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_2.pdf@EU-1-96-026_h_a_dec_2.pdf@2022-05-13 00:00:00@INVIRASE@Squaninavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_24.pdf@EU-1-96-016_h_a_dec_24.pdf@2004-02-08 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_6.pdf@EU-1-96-004_h_a_dec_6.pdf@2001-03-20 00:00:00@FARESTON@torimifen@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_21.pdf@EU-1-96-020_h_a_dec_21.pdf@2017-04-10 00:00:00@Twinrix  Adult@Hepatitis A and hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_24.pdf@EU-1-96-008_h_a_dec_24.pdf@2008-08-01 00:00:00@Puregon@follitropin beta@NAS before 2012@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_20.pdf@EU-1-96-026_h_a_dec_20.pdf@2005-12-23 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-004_h_a_dec_7.pdf@EU-1-96-004_h_a_dec_7.pdf@2001-05-18 00:00:00@FARESTON@torimifen@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_24.pdf@EU-1-96-012_h_a_dec_24.pdf@2013-03-12 00:00:00@Bondronat@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_25.pdf@EU-1-96-016_h_a_dec_25.pdf@2005-01-20 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_22.pdf@EU-1-96-020_h_a_dec_22.pdf@2019-09-13 00:00:00@Twinrix  Adult@Hepatitis A and hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_25.pdf@EU-1-96-008_h_a_dec_25.pdf@2008-06-20 00:00:00@Puregon@follitropin beta@NAS before 2012@True@OD Not Found@Organon N.V.@CMA Not Found@Parsed
ble before 2006@Parsed
EU-1-96-026_h_a_dec_21.pdf@EU-1-96-026_h_a_dec_21.pdf@2006-11-10 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_26.pdf@EU-1-96-016_h_a_dec_26.pdf@2005-08-31 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-96-020_h_a_dec_23.pdf@EU-1-96-020_h_a_dec_23.pdf@2021-10-03 00:00:00@Twinrix  Adult@Hepatitis A and hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-004_h_a_dec_9.pdf@EU-1-96-004_h_a_dec_9.pdf@2003-12-22 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_25.pdf@EU-1-96-012_h_a_dec_25.pdf@2015-03-26 00:00:00@Bondronat@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_26.pdf@EU-1-96-008_h_a_dec_26.pdf@2008-05-09 00:00:00@Puregon@follitropin beta@NAS before 2012@True@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_22.pdf@EU-1-96-026_h_a_dec_22.pdf@2006-10-27 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_27.pdf@EU-1-96-016_h_a_dec_27.pdf@2006-07-28 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_3.pdf@EU-1-96-020_h_a_dec_3.pdf@1999-01-26 00:00:00@TWINRIX Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_27.pdf@EU-1-96-008_h_a_dec_27.pdf@2009-11-23 00:00:00@Puregon@follitropin beta@NAS before 2012@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_23.pdf@EU-1-96-026_h_a_dec_23.pdf@2006-11-22 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_28.pdf@EU-1-96-016_h_a_dec_28.pdf@2006-11-20 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
ham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_26.pdf@EU-1-96-012_h_a_dec_26.pdf@2016-04-25 00:00:00@Bondronat@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_28.pdf@EU-1-96-008_h_a_dec_28.pdf@2010-10-25 00:00:00@Puregon@follitropin beta@NAS before 2012@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_5.pdf@EU-1-96-020_h_a_dec_5.pdf@2001-05-17 00:00:00@TWINRIX Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_24.pdf@EU-1-96-026_h_a_dec_24.pdf@2007-03-01 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_29.pdf@EU-1-96-016_h_a_dec_29.pdf@2007-12-01 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_3.pdf@EU-1-96-016_h_a_dec_3.pdf@1998-01-15 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_29.pdf@EU-1-96-008_h_a_dec_29.pdf@2010-11-29 00:00:00@Puregon@follitropin beta@NAS before 2012@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_1.pdf@EU-1-96-005_h_a_dec_1.pdf@2022-11-01 00:00:00@CELLCEPT@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration Ltd@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_6.pdf@EU-1-96-020_h_a_dec_6.pdf@2001-08-30 00:00:00@Twinrix Adult@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_25.pdf@EU-1-96-026_h_a_dec_25.pdf@2007-11-01 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_27.pdf@EU-1-96-012_h_a_dec_27.pdf@2018-04-04 00:00:00@Bondronat@Ibandronic acid@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_3.pdf@EU-1-96-008_h_a_dec_3.pdf@1997-03-04 00:00:00@PUREGON@Follitropin beta@NAS before 2012@NA before 2012@NA before 2000@N.V. Organon@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_10.pdf@EU-1-96-005_h_a_dec_10.pdf@2000-09-11 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_30.pdf@EU-1-96-016_h_a_dec_30.pdf@2007-02-27 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_7.pdf@EU-1-96-020_h_a_dec_7.pdf@2001-09-11 00:00:00@Twinrix Adult@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_26.pdf@EU-1-96-026_h_a_dec_26.pdf@2007-03-29 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_11.pdf@EU-1-96-005_h_a_dec_11.pdf@2001-04-27 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_31.pdf@EU-1-96-016_h_a_dec_31.pdf@2007-02-05 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_8.pdf@EU-1-96-020_h_a_dec_8.pdf@2001-12-17 00:00:00@Twinrix Adult@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_28.pdf@EU-1-96-026_h_a_dec_28.pdf@2007-10-19 00:00:00@Invirase@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_30.pdf@EU-1-96-008_h_a_dec_30.pdf@2012-03-26 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_28.pdf@EU-1-96-012_h_a_dec_28.pdf@2019-05-20 00:00:00@Bondronat@Ibandronic acid@False@False@OD Not Found@Atnahs Pharma UK Limited@CMA Not Found@Parsed
EU-1-96-020_h_a_dec_9.pdf@EU-1-96-020_h_a_dec_9.pdf@2002-11-04 00:00:00@Twinrix Adult@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_32.pdf@EU-1-96-016_h_a_dec_32.pdf@2007-10-08 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
ot available before 2006@Parsed
EU-1-96-026_h_a_dec_29.pdf@EU-1-96-026_h_a_dec_29.pdf@2008-07-07 00:00:00@Invirase@Saquinavir@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_29.pdf@EU-1-96-012_h_a_dec_29.pdf@2021-07-16 00:00:00@Bondronat@Ibandronic acid@False@False@OD Not Found@Atnahs Pharma Netherlands B.V.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_13.pdf@EU-1-96-005_h_a_dec_13.pdf@2001-07-16 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_33.pdf@EU-1-96-016_h_a_dec_33.pdf@2007-11-20 00:00:00@Norvir@ritonavir@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_2.pdf@EU-1-95-001_h_a_dec_2.pdf@1995-10-20 00:00:00@Gonal-F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_3.pdf@EU-1-96-026_h_a_dec_3.pdf@1998-11-24 00:00:00@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_31.pdf@EU-1-96-008_h_a_dec_31.pdf@2013-12-09 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Organon N.V.@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_3.pdf@EU-1-96-012_h_a_dec_3.pdf@1998-09-18 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_14.pdf@EU-1-96-005_h_a_dec_14.pdf@2001-07-16 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_30.pdf@EU-1-96-026_h_a_dec_30.pdf@2008-10-31 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_20.pdf@EU-1-95-001_h_a_dec_20.pdf@2002-07-06 00:00:00@Gonal-F@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_4.pdf@EU-1-96-012_h_a_dec_4.pdf@1999-03-29 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_15.pdf@EU-1-96-005_h_a_dec_15.pdf@2001-12-11 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_21.pdf@EU-1-95-001_h_a_dec_21.pdf@2002-02-10 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_35.pdf@EU-1-96-016_h_a_dec_35.pdf@2008-06-18 00:00:00@Norvir@ritonavir@NAS before 2012@True@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_5.pdf@EU-1-96-012_h_a_dec_5.pdf@1999-11-05 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_31.pdf@EU-1-96-026_h_a_dec_31.pdf@2009-01-27 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_16.pdf@EU-1-96-005_h_a_dec_16.pdf@2001-06-12 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_22.pdf@EU-1-95-001_h_a_dec_22.pdf@2003-03-24 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@SERONO EUROPE LIMITED@CMA not available before 2006@Parsed
EU-1-96-012_h_a_dec_6.pdf@EU-1-96-012_h_a_dec_6.pdf@1999-11-16 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_36.pdf@EU-1-96-016_h_a_dec_36.pdf@2008-05-12 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_32.pdf@EU-1-96-026_h_a_dec_32.pdf@2010-03-15 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_17.pdf@EU-1-96-005_h_a_dec_17.pdf@2002-06-02 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_23.pdf@EU-1-95-001_h_a_dec_23.pdf@2004-01-14 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_33.pdf@EU-1-96-008_h_a_dec_33.pdf@2017-04-28 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_7.pdf@EU-1-96-012_h_a_dec_7.pdf@2000-06-27 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_37.pdf@EU-1-96-016_h_a_dec_37.pdf@2009-01-07 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_18.pdf@EU-1-96-005_h_a_dec_18.pdf@2002-05-02 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_33.pdf@EU-1-96-026_h_a_dec_33.pdf@2010-03-26 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_8.pdf@EU-1-96-012_h_a_dec_8.pdf@2001-04-23 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_24.pdf@EU-1-95-001_h_a_dec_24.pdf@2004-02-23 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_38.pdf@EU-1-96-016_h_a_dec_38.pdf@2009-02-09 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_19.pdf@EU-1-96-005_h_a_dec_19.pdf@2002-05-15 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_0.pdf@EU-1-96-022_h_a_dec_0.pdf@1996-09-27 00:00:00@ZYPREXA@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_34.pdf@EU-1-96-026_h_a_dec_34.pdf@2010-07-28 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_34.pdf@EU-1-96-008_h_a_dec_34.pdf@2018-06-07 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-96-012_h_a_dec_9.pdf@EU-1-96-012_h_a_dec_9.pdf@2001-09-13 00:00:00@BONDRONAT@Ibandronic acid@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_25.pdf@EU-1-95-001_h_a_dec_25.pdf@2004-06-17 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_1.pdf@EU-1-96-022_h_a_dec_1.pdf@1998-03-03 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_39.pdf@EU-1-96-016_h_a_dec_39.pdf@2009-10-23 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_35.pdf@EU-1-96-026_h_a_dec_35.pdf@2011-06-01 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_26.pdf@EU-1-95-001_h_a_dec_26.pdf@2005-11-01 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_10.pdf@EU-1-96-022_h_a_dec_10.pdf@2000-12-27 00:00:00@ZYPREXA@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_4.pdf@EU-1-96-016_h_a_dec_4.pdf@1998-01-15 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_35.pdf@EU-1-96-008_h_a_dec_35.pdf@2017-04-28 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_36.pdf@EU-1-96-026_h_a_dec_36.pdf@2011-06-23 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_27.pdf@EU-1-95-001_h_a_dec_27.pdf@2005-04-25 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_11.pdf@EU-1-96-022_h_a_dec_11.pdf@2001-06-14 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_40.pdf@EU-1-96-016_h_a_dec_40.pdf@2010-01-25 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_37.pdf@EU-1-96-026_h_a_dec_37.pdf@2011-11-22 00:00:00@Invirase@Saquinavir@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_28.pdf@EU-1-95-001_h_a_dec_28.pdf@2005-10-19 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_36.pdf@EU-1-96-008_h_a_dec_36.pdf@2020-05-11 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_12.pdf@EU-1-96-022_h_a_dec_12.pdf@2001-06-14 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_41.pdf@EU-1-96-016_h_a_dec_41.pdf@2010-03-15 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_38.pdf@EU-1-96-026_h_a_dec_38.pdf@2012-02-03 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_3.pdf@EU-1-95-001_h_a_dec_3.pdf@1980-01-01 00:00:00@GONAL-F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_39.pdf@EU-1-96-026_h_a_dec_39.pdf@2012-06-27 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_42.pdf@EU-1-96-016_h_a_dec_42.pdf@2010-03-23 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_37.pdf@EU-1-96-008_h_a_dec_37.pdf@2021-04-06 00:00:00@Puregon@follitropin beta@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_13.pdf@EU-1-96-022_h_a_dec_13.pdf@2001-02-07 00:00:00@ZYPREXA@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_30.pdf@EU-1-95-001_h_a_dec_30.pdf@2006-10-05 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_4.pdf@EU-1-96-026_h_a_dec_4.pdf@1999-02-25 00:00:00@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_14.pdf@EU-1-96-022_h_a_dec_14.pdf@2002-09-09 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_43.pdf@EU-1-96-016_h_a_dec_43.pdf@2010-03-11 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_4.pdf@EU-1-96-008_h_a_dec_4.pdf@1998-05-10 00:00:00@PUREGON@follitropin beta@NAS before 2012@NA before 2012@NA before 2000@N.V. Organon@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_40.pdf@EU-1-96-026_h_a_dec_40.pdf@2012-10-24 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_31.pdf@EU-1-95-001_h_a_dec_31.pdf@2006-06-26 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_15.pdf@EU-1-96-022_h_a_dec_15.pdf@2001-10-19 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_44.pdf@EU-1-96-016_h_a_dec_44.pdf@2011-07-06 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_5.pdf@EU-1-96-008_h_a_dec_5.pdf@1999-04-26 00:00:00@Puregon@Follitropin ß@NAS before 2012@NA before 2012@NA before 2000@N.V. Organon@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_32.pdf@EU-1-95-001_h_a_dec_32.pdf@2006-07-20 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_41.pdf@EU-1-96-026_h_a_dec_41.pdf@2013-11-13 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_6.pdf@EU-1-96-008_h_a_dec_6.pdf@1999-08-07 00:00:00@PUREGON@follitropin beta@NAS before 2012@NA before 2012@NA before 2000@N.V. Organon@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_16.pdf@EU-1-96-022_h_a_dec_16.pdf@2001-11-20 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_0.pdf@EU-1-96-015_h_a_dec_0.pdf@1996-08-08 00:00:00@1COMMISSION DECISION   8 August 1996   granting the marketing authorization for the medicinal    product for human use,    “EPIVIR ®”@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo  Group  Ltd.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_45.pdf@EU-1-96-016_h_a_dec_45.pdf@2011-11-22 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_33.pdf@EU-1-95-001_h_a_dec_33.pdf@2007-03-21 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_17.pdf@EU-1-96-022_h_a_dec_17.pdf@2002-04-06 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_7.pdf@EU-1-96-008_h_a_dec_7.pdf@2000-10-02 00:00:00@Puregon@Follitropin ß@NAS before 2012@NA before 2012@OD Not Found@Organon N.V.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_1.pdf@EU-1-96-015_h_a_dec_1.pdf@1997-02-14 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_46.pdf@EU-1-96-016_h_a_dec_46.pdf@2011-12-22 00:00:00@Norvir@ritonavir@NAS before 2012@False@OD Not Found@Abbott  Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_42.pdf@EU-1-96-026_h_a_dec_42.pdf@2014-02-05 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_18.pdf@EU-1-96-022_h_a_dec_18.pdf@2002-10-18 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_34.pdf@EU-1-95-001_h_a_dec_34.pdf@2007-12-21 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-008_h_a_dec_8.pdf@EU-1-96-008_h_a_dec_8.pdf@2000-02-21 00:00:00@PUREGON@follitropin beta@NAS before 2012@NA before 2012@NA before 2000@N.V. Organon@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_10.pdf@EU-1-96-015_h_a_dec_10.pdf@2001-01-22 00:00:00@EPIVIR@lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_47.pdf@EU-1-96-016_h_a_dec_47.pdf@2012-03-19 00:00:00@Norvir@ritonavir@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_19.pdf@EU-1-96-022_h_a_dec_19.pdf@2002-11-20 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-008_h_a_dec_9.pdf@EU-1-96-008_h_a_dec_9.pdf@2000-11-07 00:00:00@PUREGON@Follitropin beta@NAS before 2012@NA before 2012@OD Not Found@N.V. Organon@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_43.pdf@EU-1-96-026_h_a_dec_43.pdf@2015-05-03 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_35.pdf@EU-1-95-001_h_a_dec_35.pdf@2009-09-06 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_48.pdf@EU-1-96-016_h_a_dec_48.pdf@2012-04-20 00:00:00@Norvir@ritonavir@False@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_2.pdf@EU-1-96-022_h_a_dec_2.pdf@2022-03-26 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_11.pdf@EU-1-96-015_h_a_dec_11.pdf@2001-11-07 00:00:00@EPIVIR-lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_36.pdf@EU-1-95-001_h_a_dec_36.pdf@2009-07-24 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_49.pdf@EU-1-96-016_h_a_dec_49.pdf@2012-10-09 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_20.pdf@EU-1-96-022_h_a_dec_20.pdf@2003-08-10 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_44.pdf@EU-1-96-026_h_a_dec_44.pdf@2016-12-23 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_12.pdf@EU-1-96-015_h_a_dec_12.pdf@2001-09-11 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_21.pdf@EU-1-96-022_h_a_dec_21.pdf@2003-10-24 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_5.pdf@EU-1-96-016_h_a_dec_5.pdf@2022-03-17 00:00:00@NORVIR@Ritonavir@False@False@OD Not Found@to Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_37.pdf@EU-1-95-001_h_a_dec_37.pdf@2010-03-15 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_13.pdf@EU-1-96-015_h_a_dec_13.pdf@2001-11-15 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_50.pdf@EU-1-96-016_h_a_dec_50.pdf@2012-10-24 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_22.pdf@EU-1-96-022_h_a_dec_22.pdf@2004-07-13 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_38.pdf@EU-1-95-001_h_a_dec_38.pdf@2010-07-27 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_45.pdf@EU-1-96-026_h_a_dec_45.pdf@2018-03-20 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_14.pdf@EU-1-96-015_h_a_dec_14.pdf@2002-08-21 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_39.pdf@EU-1-95-001_h_a_dec_39.pdf@2011-05-23 00:00:00@GONAL-f@Follitropin alfa@NAS before 2012@False@OD Not Found@Merck Serono Europe  Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_23.pdf@EU-1-96-022_h_a_dec_23.pdf@2004-04-11 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_51.pdf@EU-1-96-016_h_a_dec_51.pdf@2013-12-18 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_15.pdf@EU-1-96-015_h_a_dec_15.pdf@2002-10-17 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_24.pdf@EU-1-96-022_h_a_dec_24.pdf@2005-09-02 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_16.pdf@EU-1-96-015_h_a_dec_16.pdf@2002-12-11 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_46.pdf@EU-1-96-026_h_a_dec_46.pdf@2018-03-23 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_4.pdf@EU-1-95-001_h_a_dec_4.pdf@1997-09-30 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_52.pdf@EU-1-96-016_h_a_dec_52.pdf@2015-05-03 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_40.pdf@EU-1-95-001_h_a_dec_40.pdf@2012-06-28 00:00:00@GONAL-f@Follitropin alfa@False@False@OD Not Found@Merck Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_17.pdf@EU-1-96-015_h_a_dec_17.pdf@2003-05-14 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_47.pdf@EU-1-96-026_h_a_dec_47.pdf@2019-07-31 00:00:00@Invirase@Saquinavir@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_25.pdf@EU-1-96-022_h_a_dec_25.pdf@2005-09-02 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_53.pdf@EU-1-96-016_h_a_dec_53.pdf@2015-08-14 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_18.pdf@EU-1-96-015_h_a_dec_18.pdf@2003-09-07 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_5.pdf@EU-1-96-026_h_a_dec_5.pdf@1999-08-04 00:00:00@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_26.pdf@EU-1-96-022_h_a_dec_26.pdf@2005-08-31 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_41.pdf@EU-1-95-001_h_a_dec_41.pdf@2015-09-04 00:00:00@GONAL-f@Follitropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_19.pdf@EU-1-96-015_h_a_dec_19.pdf@2004-01-29 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-026_h_a_dec_6.pdf@EU-1-96-026_h_a_dec_6.pdf@1999-08-04 00:00:00@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_27.pdf@EU-1-96-022_h_a_dec_27.pdf@2006-03-20 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_2.pdf@EU-1-96-005_h_a_dec_2.pdf@1997-05-13 00:00:00@CELLCEPT@Mycophenolate  mofetiT' (Only the English text is authentic) COMMISSION DECISION  13 May  1997  granting the marketing authorization for the medicinal product for human use,@NAS before 2012@NA before 2012@NA before 2000@Roche  Registration  Limited,@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_54.pdf@EU-1-96-016_h_a_dec_54.pdf@2016-02-05 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_7.pdf@EU-1-96-026_h_a_dec_7.pdf@1999-11-29 00:00:00@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_2.pdf@EU-1-96-015_h_a_dec_2.pdf@1997-04-15 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_42.pdf@EU-1-95-001_h_a_dec_42.pdf@2016-12-13 00:00:00@GONAL-f@Follitropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_20.pdf@EU-1-96-005_h_a_dec_20.pdf@2002-10-18 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_28.pdf@EU-1-96-022_h_a_dec_28.pdf@2006-12-09 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
efore 2006@Parsed
EU-1-96-015_h_a_dec_20.pdf@EU-1-96-015_h_a_dec_20.pdf@2004-01-06 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_21.pdf@EU-1-96-005_h_a_dec_21.pdf@2002-02-12 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_55.pdf@EU-1-96-016_h_a_dec_55.pdf@2017-02-06 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-96-026_h_a_dec_9.pdf@EU-1-96-026_h_a_dec_9.pdf@2000-10-20 00:00:00@INVIRASE@Saquinavir@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_29.pdf@EU-1-96-022_h_a_dec_29.pdf@2006-09-13 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_22.pdf@EU-1-96-005_h_a_dec_22.pdf@2004-02-08 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-001_h_a_dec_43.pdf@EU-1-95-001_h_a_dec_43.pdf@2018-01-03 00:00:00@GONAL-f@Follitropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_21.pdf@EU-1-96-015_h_a_dec_21.pdf@2004-06-12 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_3.pdf@EU-1-96-022_h_a_dec_3.pdf@1998-10-22 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_56.pdf@EU-1-96-016_h_a_dec_56.pdf@2017-08-24 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_23.pdf@EU-1-96-005_h_a_dec_23.pdf@2005-04-27 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_22.pdf@EU-1-96-015_h_a_dec_22.pdf@2004-12-17 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_30.pdf@EU-1-96-022_h_a_dec_30.pdf@2007-09-07 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_44.pdf@EU-1-95-001_h_a_dec_44.pdf@2018-06-08 00:00:00@GONAL-f@Follitropin alfa@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_24.pdf@EU-1-96-005_h_a_dec_24.pdf@2005-11-15 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_23.pdf@EU-1-96-015_h_a_dec_23.pdf@2006-07-28 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_31.pdf@EU-1-96-022_h_a_dec_31.pdf@2007-08-30 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_57.pdf@EU-1-96-016_h_a_dec_57.pdf@2018-05-24 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_45.pdf@EU-1-95-001_h_a_dec_45.pdf@2020-11-24 00:00:00@GONAL- f@Follitropin alfa@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_25.pdf@EU-1-96-005_h_a_dec_25.pdf@2006-03-13 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_24.pdf@EU-1-96-015_h_a_dec_24.pdf@2007-01-25 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_32.pdf@EU-1-96-022_h_a_dec_32.pdf@2007-11-21 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_58.pdf@EU-1-96-016_h_a_dec_58.pdf@2019-04-29 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_5.pdf@EU-1-95-001_h_a_dec_5.pdf@1998-07-17 00:00:00@GONAL F@Follitropin  alpha@NAS before 2012@NA before 2012@NA before 2000@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_26.pdf@EU-1-96-005_h_a_dec_26.pdf@2007-02-07 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_33.pdf@EU-1-96-022_h_a_dec_33.pdf@2008-01-17 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_25.pdf@EU-1-96-015_h_a_dec_25.pdf@2007-01-03 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_6.pdf@EU-1-95-001_h_a_dec_6.pdf@1999-06-18 00:00:00@GONAL F@Follitropin alfa@NAS before 2012@NA before 2012@NA before 2000@ARES-SERONO (EUROPE)@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_59.pdf@EU-1-96-016_h_a_dec_59.pdf@2019-07-18 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_27.pdf@EU-1-96-005_h_a_dec_27.pdf@2007-10-08 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_26.pdf@EU-1-96-015_h_a_dec_26.pdf@2007-08-31 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_7.pdf@EU-1-95-001_h_a_dec_7.pdf@1999-06-16 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_34.pdf@EU-1-96-022_h_a_dec_34.pdf@2008-04-22 00:00:00@Zyprexa@Olanzapine@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_6.pdf@EU-1-96-016_h_a_dec_6.pdf@2022-03-20 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@Abbott Laboratories Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_28.pdf@EU-1-96-005_h_a_dec_28.pdf@2007-10-19 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_8.pdf@EU-1-95-001_h_a_dec_8.pdf@1999-08-12 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_27.pdf@EU-1-96-015_h_a_dec_27.pdf@2007-10-30 00:00:00@Epivir@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_60.pdf@EU-1-96-016_h_a_dec_60.pdf@2022-06-24 00:00:00@Norvir@Ritonavir@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_35.pdf@EU-1-96-022_h_a_dec_35.pdf@2008-07-28 00:00:00@Zyprexa@Olanzapine@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_29.pdf@EU-1-96-005_h_a_dec_29.pdf@2008-02-28 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-001_h_a_dec_9.pdf@EU-1-95-001_h_a_dec_9.pdf@2000-03-16 00:00:00@GONAL F@Follitropin alpha@NAS before 2012@NA before 2012@NA before 2000@ARES-SERONO (EUROPE) Ltd.@CMA not available before 2006@Parsed
EU-1-96-016_h_a_dec_7.pdf@EU-1-96-016_h_a_dec_7.pdf@1999-11-01 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_28.pdf@EU-1-96-015_h_a_dec_28.pdf@2008-02-07 00:00:00@Epivir@Lamivudine@NAS before 2012@True@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_36.pdf@EU-1-96-022_h_a_dec_36.pdf@2009-03-25 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_8.pdf@EU-1-96-016_h_a_dec_8.pdf@1999-02-23 00:00:00@Norvir@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_0.pdf@EU-1-96-010_h_a_dec_0.pdf@Date is blank@Rilutek®@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_29.pdf@EU-1-96-015_h_a_dec_29.pdf@2008-05-09 00:00:00@Epivir@Lamivudine@NAS before 2012@True@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_37.pdf@EU-1-96-022_h_a_dec_37.pdf@2009-03-07 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-016_h_a_dec_9.pdf@EU-1-96-016_h_a_dec_9.pdf@1999-02-26 00:00:00@NORVIR@Ritonavir@NAS before 2012@NA before 2012@NA before 2000@to Abbott Laboratories Limited@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_1.pdf@EU-1-96-010_h_a_dec_1.pdf@1997-08-10 00:00:00@RILUTEK@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.,20 avenue Raymond Aron,92165  Antony Cedex@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_3.pdf@EU-1-96-015_h_a_dec_3.pdf@1997-05-22 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_38.pdf@EU-1-96-022_h_a_dec_38.pdf@2009-12-21 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_10.pdf@EU-1-96-010_h_a_dec_10.pdf@2004-12-17 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_30.pdf@EU-1-96-015_h_a_dec_30.pdf@2009-10-28 00:00:00@Epivir@Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_39.pdf@EU-1-96-022_h_a_dec_39.pdf@2010-06-09 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_11.pdf@EU-1-96-010_h_a_dec_11.pdf@2005-12-23 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_31.pdf@EU-1-96-015_h_a_dec_31.pdf@2010-04-29 00:00:00@Epivir@Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_4.pdf@EU-1-96-022_h_a_dec_4.pdf@1998-12-17 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_0.pdf@EU-1-96-027_h_a_dec_0.pdf@1996-12-11 00:00:00@HYCAMTIN@Topotecan hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_12.pdf@EU-1-96-010_h_a_dec_12.pdf@2006-07-28 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_32.pdf@EU-1-96-015_h_a_dec_32.pdf@2010-10-25 00:00:00@Epivir@Lamivudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_40.pdf@EU-1-96-022_h_a_dec_40.pdf@2010-12-20 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_1.pdf@EU-1-96-027_h_a_dec_1.pdf@1997-04-15 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_13.pdf@EU-1-96-010_h_a_dec_13.pdf@2008-04-22 00:00:00@Rilutek@Riluzole@NAS before 2012@True@OD Not Found@Aventis Pharma S.A@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_33.pdf@EU-1-96-015_h_a_dec_33.pdf@2012-06-15 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_10.pdf@EU-1-96-027_h_a_dec_10.pdf@2001-03-20 00:00:00@HYCAMTIN Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_41.pdf@EU-1-96-022_h_a_dec_41.pdf@2011-02-21 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_14.pdf@EU-1-96-010_h_a_dec_14.pdf@2009-09-01 00:00:00@Rilutek@Riluzole@NAS before 2012@False@OD Not Found@Aventis Pharma S.A@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_34.pdf@EU-1-96-015_h_a_dec_34.pdf@2012-07-23 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK  Ltd@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_11.pdf@EU-1-96-027_h_a_dec_11.pdf@2001-09-13 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_42.pdf@EU-1-96-022_h_a_dec_42.pdf@2011-10-20 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_15.pdf@EU-1-96-010_h_a_dec_15.pdf@2009-05-27 00:00:00@Rilutek@Riluzole@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_35.pdf@EU-1-96-015_h_a_dec_35.pdf@2013-03-26 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_12.pdf@EU-1-96-027_h_a_dec_12.pdf@2002-04-02 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_43.pdf@EU-1-96-022_h_a_dec_43.pdf@2011-11-24 00:00:00@Zyprexa@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_16.pdf@EU-1-96-010_h_a_dec_16.pdf@2014-12-19 00:00:00@Rilutek@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_13.pdf@EU-1-96-027_h_a_dec_13.pdf@2002-07-18 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_36.pdf@EU-1-96-015_h_a_dec_36.pdf@2013-05-30 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_44.pdf@EU-1-96-022_h_a_dec_44.pdf@2012-06-27 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_14.pdf@EU-1-96-027_h_a_dec_14.pdf@2002-07-30 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_17.pdf@EU-1-96-010_h_a_dec_17.pdf@2019-06-06 00:00:00@Rilutek@Riluzole@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_45.pdf@EU-1-96-022_h_a_dec_45.pdf@2013-05-27 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_15.pdf@EU-1-96-027_h_a_dec_15.pdf@2002-11-12 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-010_h_a_dec_18.pdf@EU-1-96-010_h_a_dec_18.pdf@2020-07-27 00:00:00@Rilutek@Riluzole@False@False@OD Not Found@Sanofi Mature IP@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_16.pdf@EU-1-96-027_h_a_dec_16.pdf@2003-06-02 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_46.pdf@EU-1-96-022_h_a_dec_46.pdf@2015-04-13 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_37.pdf@EU-1-96-015_h_a_dec_37.pdf@2015-02-26 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_19.pdf@EU-1-96-010_h_a_dec_19.pdf@2021-11-15 00:00:00@Rilutek@Riluzole@False@False@OD Not Found@Sanofi Mature IP@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_17.pdf@EU-1-96-027_h_a_dec_17.pdf@2003-07-18 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_47.pdf@EU-1-96-022_h_a_dec_47.pdf@2016-08-04 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_2.pdf@EU-1-96-010_h_a_dec_2.pdf@1998-06-15 00:00:00@RILUTEK@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.,20 avenue Raymond Aron,92165  Antony Cedex@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_18.pdf@EU-1-96-027_h_a_dec_18.pdf@2006-01-13 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_3.pdf@EU-1-96-010_h_a_dec_3.pdf@2000-01-31 00:00:00@RILUTEK@Riluzole@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_48.pdf@EU-1-96-022_h_a_dec_48.pdf@2017-11-09 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_38.pdf@EU-1-96-015_h_a_dec_38.pdf@2016-05-17 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_19.pdf@EU-1-96-027_h_a_dec_19.pdf@2006-11-20 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_4.pdf@EU-1-96-010_h_a_dec_4.pdf@2000-12-29 00:00:00@RILUTEK@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_2.pdf@EU-1-96-027_h_a_dec_2.pdf@1999-01-27 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_39.pdf@EU-1-96-015_h_a_dec_39.pdf@2017-05-24 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_5.pdf@EU-1-96-010_h_a_dec_5.pdf@2001-11-07 00:00:00@RILUTEK@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_49.pdf@EU-1-96-022_h_a_dec_49.pdf@2019-02-18 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_20.pdf@EU-1-96-027_h_a_dec_20.pdf@2006-11-22 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_6.pdf@EU-1-96-010_h_a_dec_6.pdf@2002-05-03 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_4.pdf@EU-1-96-015_h_a_dec_4.pdf@1997-12-16 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_5.pdf@EU-1-96-022_h_a_dec_5.pdf@1999-07-19 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_3.pdf@EU-1-96-005_h_a_dec_3.pdf@1997-07-14 00:00:00@CELLCEPT@Mycophenolate  m o f e t i I@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_21.pdf@EU-1-96-027_h_a_dec_21.pdf@2007-02-28 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_7.pdf@EU-1-96-010_h_a_dec_7.pdf@2002-03-22 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_50.pdf@EU-1-96-022_h_a_dec_50.pdf@2020-02-21 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_30.pdf@EU-1-96-005_h_a_dec_30.pdf@2008-10-23 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_22.pdf@EU-1-96-027_h_a_dec_22.pdf@2007-06-21 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_40.pdf@EU-1-96-015_h_a_dec_40.pdf@2018-05-03 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_8.pdf@EU-1-96-010_h_a_dec_8.pdf@2002-11-20 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_23.pdf@EU-1-96-027_h_a_dec_23.pdf@2007-10-24 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_31.pdf@EU-1-96-005_h_a_dec_31.pdf@2009-05-29 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-010_h_a_dec_9.pdf@EU-1-96-010_h_a_dec_9.pdf@2003-06-26 00:00:00@Rilutek@Riluzole@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_51.pdf@EU-1-96-022_h_a_dec_51.pdf@2021-09-12 00:00:00@Zyprexa@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_24.pdf@EU-1-96-027_h_a_dec_24.pdf@2008-03-18 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@False@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_32.pdf@EU-1-96-005_h_a_dec_32.pdf@2009-10-13 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_6.pdf@EU-1-96-022_h_a_dec_6.pdf@2000-12-04 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_41.pdf@EU-1-96-015_h_a_dec_41.pdf@2018-12-17 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_33.pdf@EU-1-96-005_h_a_dec_33.pdf@2011-05-27 00:00:00@CellCept@Mycophenolate mofetil@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_7.pdf@EU-1-96-022_h_a_dec_7.pdf@2000-11-07 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_25.pdf@EU-1-96-027_h_a_dec_25.pdf@2008-10-30 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@False@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_34.pdf@EU-1-96-005_h_a_dec_34.pdf@2012-07-20 00:00:00@CellCept@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-96-022_h_a_dec_8.pdf@EU-1-96-022_h_a_dec_8.pdf@2000-09-25 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_42.pdf@EU-1-96-015_h_a_dec_42.pdf@2019-06-02 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_26.pdf@EU-1-96-027_h_a_dec_26.pdf@2009-03-17 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@False@OD Not Found@SmithKline Beecham plc@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_0.pdf@EU-1-96-011_h_a_dec_0.pdf@1996-06-21 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Sequus Pharmaceuticals, Incorporated@CMA not available before 2006@Parsed
EU-1-96-022_h_a_dec_9.pdf@EU-1-96-022_h_a_dec_9.pdf@1980-01-01 00:00:00@Zyprexa@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_35.pdf@EU-1-96-005_h_a_dec_35.pdf@2014-07-18 00:00:00@CellCept@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_27.pdf@EU-1-96-027_h_a_dec_27.pdf@2010-01-20 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@False@OD Not Found@SmithKline Beecham Ltd.@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_1.pdf@EU-1-96-011_h_a_dec_1.pdf@1997-02-18 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_36.pdf@EU-1-96-005_h_a_dec_36.pdf@2014-12-19 00:00:00@CellCept@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_10.pdf@EU-1-96-011_h_a_dec_10.pdf@2002-02-19 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_43.pdf@EU-1-96-015_h_a_dec_43.pdf@2020-10-03 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_28.pdf@EU-1-96-027_h_a_dec_28.pdf@2010-10-28 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@False@OD Not Found@SmithKline Beecham Ltd.@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_11.pdf@EU-1-96-011_h_a_dec_11.pdf@2003-10-01 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_29.pdf@EU-1-96-027_h_a_dec_29.pdf@2011-05-08 00:00:00@Hycamtin@Topotecan hydrochloride@NAS before 2012@False@OD Not Found@SmithKline Beecham Ltd.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_37.pdf@EU-1-96-005_h_a_dec_37.pdf@2015-11-27 00:00:00@CellCept@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_12.pdf@EU-1-96-011_h_a_dec_12.pdf@2003-03-17 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_1.pdf@EU-1-95-002_h_a_dec_1.pdf@1996-07-10 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_44.pdf@EU-1-96-015_h_a_dec_44.pdf@2021-03-26 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare B.V.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_3.pdf@EU-1-96-027_h_a_dec_3.pdf@1999-03-29 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_13.pdf@EU-1-96-011_h_a_dec_13.pdf@2005-05-01 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_0.pdf@EU-1-96-018_h_a_dec_0.pdf@1996-08-29 00:00:00@Rapilysin®@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_10.pdf@EU-1-95-002_h_a_dec_10.pdf@1998-09-18 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_45.pdf@EU-1-96-015_h_a_dec_45.pdf@2021-09-16 00:00:00@Epivir@Lamivudine@False@False@OD Not Found@ViiV Healthcare B.V.@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_14.pdf@EU-1-96-011_h_a_dec_14.pdf@2005-05-01 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_1.pdf@EU-1-96-018_h_a_dec_1.pdf@1998-03-18 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_38.pdf@EU-1-96-005_h_a_dec_38.pdf@2018-05-03 00:00:00@CellCept@Mycophenolate  mofetil@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_30.pdf@EU-1-96-027_h_a_dec_30.pdf@2013-11-20 00:00:00@Hycamtin@Topotecan hydrochloride@False@False@OD Not Found@SmithKline Beecham Ltd.@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_11.pdf@EU-1-95-002_h_a_dec_11.pdf@1999-06-16 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_5.pdf@EU-1-96-015_h_a_dec_5.pdf@1998-07-01 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_10.pdf@EU-1-96-018_h_a_dec_10.pdf@2003-07-08 00:00:00@Rapilysin@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_15.pdf@EU-1-96-011_h_a_dec_15.pdf@2005-02-17 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_6.pdf@EU-1-96-015_h_a_dec_6.pdf@1998-07-07 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_12.pdf@EU-1-95-002_h_a_dec_12.pdf@1999-05-10 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_39.pdf@EU-1-96-005_h_a_dec_39.pdf@2018-12-03 00:00:00@CellCept@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_31.pdf@EU-1-96-027_h_a_dec_31.pdf@2015-04-24 00:00:00@Hycamtin@Topotecan hydrochloride@False@False@OD Not Found@SmithKline Beecham Ltd@CMA Not Found@Parsed
EU-1-96-018_h_a_dec_11.pdf@EU-1-96-018_h_a_dec_11.pdf@2005-10-27 00:00:00@Rapilysin@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_13.pdf@EU-1-95-002_h_a_dec_13.pdf@2000-01-20 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_16.pdf@EU-1-96-011_h_a_dec_16.pdf@2006-05-19 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_7.pdf@EU-1-96-015_h_a_dec_7.pdf@1998-07-07 00:00:00@EPIVIR Lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_4.pdf@EU-1-96-005_h_a_dec_4.pdf@1998-08-17 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_14.pdf@EU-1-95-002_h_a_dec_14.pdf@2000-08-28 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Avantis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-015_h_a_dec_8.pdf@EU-1-96-015_h_a_dec_8.pdf@1999-10-11 00:00:00@EPIVIR-lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_17.pdf@EU-1-96-011_h_a_dec_17.pdf@2006-10-20 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-96-018_h_a_dec_12.pdf@EU-1-96-018_h_a_dec_12.pdf@2005-10-27 00:00:00@Rapilysin@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_32.pdf@EU-1-96-027_h_a_dec_32.pdf@2016-06-30 00:00:00@Hycamtin@Topotecan hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_40.pdf@EU-1-96-005_h_a_dec_40.pdf@2020-09-15 00:00:00@CellCept@Mycophenolate mofetil@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-96-015_h_a_dec_9.pdf@EU-1-96-015_h_a_dec_9.pdf@2000-07-27 00:00:00@EPIVIR-lamivudine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_15.pdf@EU-1-95-002_h_a_dec_15.pdf@2000-12-28 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_18.pdf@EU-1-96-011_h_a_dec_18.pdf@2007-05-30 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-96-018_h_a_dec_13.pdf@EU-1-96-018_h_a_dec_13.pdf@2006-10-08 00:00:00@Rapilysin@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_41.pdf@EU-1-96-005_h_a_dec_41.pdf@2021-02-18 00:00:00@CellCept@Mycophenolate  mofetil@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_17.pdf@EU-1-95-002_h_a_dec_17.pdf@2001-08-13 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_19.pdf@EU-1-96-011_h_a_dec_19.pdf@2007-12-14 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-96-018_h_a_dec_14.pdf@EU-1-96-018_h_a_dec_14.pdf@2007-06-14 00:00:00@Rapilysin@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_33.pdf@EU-1-96-027_h_a_dec_33.pdf@2018-04-23 00:00:00@Hycamtin@Topotecan hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_18.pdf@EU-1-95-002_h_a_dec_18.pdf@2002-04-16 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_42.pdf@EU-1-96-005_h_a_dec_42.pdf@2022-02-16 00:00:00@CellCept@Mycophenolate  mofetil@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_2.pdf@EU-1-96-011_h_a_dec_2.pdf@1997-05-07 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_15.pdf@EU-1-96-018_h_a_dec_15.pdf@2008-06-20 00:00:00@Rapilysin@Reteplase@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_19.pdf@EU-1-95-002_h_a_dec_19.pdf@2002-04-23 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_5.pdf@EU-1-96-005_h_a_dec_5.pdf@1998-09-18 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_20.pdf@EU-1-96-011_h_a_dec_20.pdf@2010-09-27 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_34.pdf@EU-1-96-027_h_a_dec_34.pdf@2021-01-18 00:00:00@Hycamtin@Topotecan hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_2.pdf@EU-1-95-002_h_a_dec_2.pdf@1997-03-03 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_16.pdf@EU-1-96-018_h_a_dec_16.pdf@2009-03-31 00:00:00@Rapilysin@Reteplase@NAS before 2012@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-96-005_h_a_dec_6.pdf@EU-1-96-005_h_a_dec_6.pdf@1998-10-20 00:00:00@Cellcept@Mycophenolate mofetil@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_20.pdf@EU-1-95-002_h_a_dec_20.pdf@2003-09-01 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_21.pdf@EU-1-96-011_h_a_dec_21.pdf@Date is blank@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Janssen-Cilag International NV@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_7.pdf@EU-1-96-005_h_a_dec_7.pdf@1998-12-17 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_21.pdf@EU-1-95-002_h_a_dec_21.pdf@2003-01-24 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_22.pdf@EU-1-96-011_h_a_dec_22.pdf@2011-11-24 00:00:00@Caelyx@Doxorubicin  hydrochloride@NAS before 2012@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-96-018_h_a_dec_17.pdf@EU-1-96-018_h_a_dec_17.pdf@2016-06-07 00:00:00@Rapilysin@Reteplase@False@False@OD Not Found@Actavis Group PTC ehf.@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_35.pdf@EU-1-96-027_h_a_dec_35.pdf@2022-06-21 00:00:00@Hycamtin@Topotecan hydrochloride@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_22.pdf@EU-1-95-002_h_a_dec_22.pdf@2003-08-10 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_8.pdf@EU-1-96-005_h_a_dec_8.pdf@1999-02-26 00:00:00@Cellcept@Mycophenolate mofetil@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_2.pdf@EU-1-96-018_h_a_dec_2.pdf@1998-04-15 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_23.pdf@EU-1-96-011_h_a_dec_23.pdf@2012-05-25 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_4.pdf@EU-1-96-027_h_a_dec_4.pdf@1999-04-26 00:00:00@HYCAMTIN Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_23.pdf@EU-1-95-002_h_a_dec_23.pdf@2004-05-26 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-005_h_a_dec_9.pdf@EU-1-96-005_h_a_dec_9.pdf@1999-08-12 00:00:00@CELLCEPT@Mycophenolate mofetil@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_3.pdf@EU-1-96-018_h_a_dec_3.pdf@1998-05-10 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_5.pdf@EU-1-96-027_h_a_dec_5.pdf@1999-01-07 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_24.pdf@EU-1-96-011_h_a_dec_24.pdf@2012-10-29 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_24.pdf@EU-1-95-002_h_a_dec_24.pdf@2004-10-20 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_6.pdf@EU-1-96-027_h_a_dec_6.pdf@2000-02-22 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_4.pdf@EU-1-96-018_h_a_dec_4.pdf@1999-03-19 00:00:00@holder  the marketing  authorization@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_25.pdf@EU-1-96-011_h_a_dec_25.pdf@2014-11-09 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-96-027_h_a_dec_7.pdf@EU-1-96-027_h_a_dec_7.pdf@2000-03-16 00:00:00@HYCAMTIN Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_25.pdf@EU-1-95-002_h_a_dec_25.pdf@2004-12-22 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_5.pdf@EU-1-96-018_h_a_dec_5.pdf@1999-08-04 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_6.pdf@EU-1-96-018_h_a_dec_6.pdf@2000-05-29 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_8.pdf@EU-1-96-027_h_a_dec_8.pdf@2000-03-16 00:00:00@HYCAMTIN Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_26.pdf@EU-1-96-011_h_a_dec_26.pdf@2016-03-31 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_26.pdf@EU-1-95-002_h_a_dec_26.pdf@2005-05-01 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-027_h_a_dec_9.pdf@EU-1-96-027_h_a_dec_9.pdf@2000-09-25 00:00:00@HYCAMTIN  Topotecan hydrochloride@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham plc@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_7.pdf@EU-1-96-018_h_a_dec_7.pdf@2001-03-20 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_27.pdf@EU-1-96-011_h_a_dec_27.pdf@2017-03-24 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_27.pdf@EU-1-95-002_h_a_dec_27.pdf@2005-10-06 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_8.pdf@EU-1-96-018_h_a_dec_8.pdf@2001-09-11 00:00:00@RAPILYSIN@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_28.pdf@EU-1-95-002_h_a_dec_28.pdf@2005-06-28 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-96-018_h_a_dec_9.pdf@EU-1-96-018_h_a_dec_9.pdf@2002-03-27 00:00:00@Rapilysin@Reteplase@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_28.pdf@EU-1-96-011_h_a_dec_28.pdf@2019-04-17 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_29.pdf@EU-1-95-002_h_a_dec_29.pdf@2005-11-15 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_3.pdf@EU-1-95-002_h_a_dec_3.pdf@1997-05-22 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_29.pdf@EU-1-96-011_h_a_dec_29.pdf@2019-09-23 00:00:00@Caelyx@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_0.pdf@EU-1-97-029_h_a_dec_0.pdf@1997-02-10 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_30.pdf@EU-1-95-002_h_a_dec_30.pdf@2006-01-24 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_3.pdf@EU-1-96-011_h_a_dec_3.pdf@1997-07-29 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_1.pdf@EU-1-97-029_h_a_dec_1.pdf@1997-11-19 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_31.pdf@EU-1-95-002_h_a_dec_31.pdf@2006-04-27 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_10.pdf@EU-1-97-029_h_a_dec_10.pdf@2002-06-02 00:00:00@Twinrix Paediatric@Hepatitis a and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_30.pdf@EU-1-96-011_h_a_dec_30.pdf@2020-10-19 00:00:00@Caelyx  pegylated liposomal@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_32.pdf@EU-1-95-002_h_a_dec_32.pdf@2006-04-07 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_11.pdf@EU-1-97-029_h_a_dec_11.pdf@2002-11-04 00:00:00@Twinrix Paediatric@Hepatitis a and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_33.pdf@EU-1-95-002_h_a_dec_33.pdf@2006-04-08 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_12.pdf@EU-1-97-029_h_a_dec_12.pdf@2002-10-24 00:00:00@Twinrix Paediatric@Hepatitis a and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_0.pdf@EU-1-97-033_h_a_dec_0.pdf@1997-03-13 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_31.pdf@EU-1-96-011_h_a_dec_31.pdf@2021-01-18 00:00:00@Caelyx  pegylated liposomal@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_0.pdf@EU-1-97-039_h_a_dec_0.pdf@1997-06-23 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_1.pdf@EU-1-97-033_h_a_dec_1.pdf@1997-08-27 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_34.pdf@EU-1-95-002_h_a_dec_34.pdf@2006-10-23 00:00:00@Taxotere@Docetaxel@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_13.pdf@EU-1-97-029_h_a_dec_13.pdf@2003-12-15 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_1.pdf@EU-1-97-039_h_a_dec_1.pdf@1998-03-03 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_10.pdf@EU-1-97-033_h_a_dec_10.pdf@2000-07-27 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_32.pdf@EU-1-96-011_h_a_dec_32.pdf@2021-08-20 00:00:00@Caelyx pegylated liposomal@Doxorubicin hydrochloride@False@False@OD Not Found@Janssen-Cilag International NV@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_10.pdf@EU-1-97-039_h_a_dec_10.pdf@2002-10-10 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_14.pdf@EU-1-97-029_h_a_dec_14.pdf@2006-08-28 00:00:00@Twinrix Paediatric@Hepatitis A and hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_11.pdf@EU-1-97-033_h_a_dec_11.pdf@2000-12-28 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_36.pdf@EU-1-95-002_h_a_dec_36.pdf@2008-11-26 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_0.pdf@EU-1-97-044_h_a_dec_0.pdf@1997-08-27 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_11.pdf@EU-1-97-039_h_a_dec_11.pdf@2003-07-15 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_4.pdf@EU-1-96-011_h_a_dec_4.pdf@1999-07-26 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_1.pdf@EU-1-96-006_h_a_dec_1.pdf@1997-04-12 00:00:00@NOVOSEVEN@Eptacog alfa (activated)@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_12.pdf@EU-1-97-033_h_a_dec_12.pdf@2001-01-22 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_15.pdf@EU-1-97-029_h_a_dec_15.pdf@2007-04-01 00:00:00@Twinrix Paediatric@Hepatitis A and  hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_1.pdf@EU-1-97-044_h_a_dec_1.pdf@1998-01-22 00:00:00@TASMAR@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_5.pdf@EU-1-96-011_h_a_dec_5.pdf@2000-05-29 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_37.pdf@EU-1-95-002_h_a_dec_37.pdf@2009-11-30 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_12.pdf@EU-1-97-039_h_a_dec_12.pdf@2004-09-01 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_13.pdf@EU-1-97-033_h_a_dec_13.pdf@2001-08-06 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_10.pdf@EU-1-96-006_h_a_dec_10.pdf@2005-11-16 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_6.pdf@EU-1-96-011_h_a_dec_6.pdf@2000-10-24 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_16.pdf@EU-1-97-029_h_a_dec_16.pdf@2008-01-22 00:00:00@Twinrix Paediatric@chlorophenyl)propoxy]propyl}piperidine, hydrochloride@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_38.pdf@EU-1-95-002_h_a_dec_38.pdf@2009-12-21 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_10.pdf@EU-1-97-044_h_a_dec_10.pdf@2004-12-22 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_14.pdf@EU-1-97-033_h_a_dec_14.pdf@2001-03-12 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_13.pdf@EU-1-97-039_h_a_dec_13.pdf@2004-08-18 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_11.pdf@EU-1-96-006_h_a_dec_11.pdf@2006-09-02 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-96-011_h_a_dec_7.pdf@EU-1-96-011_h_a_dec_7.pdf@2001-04-27 00:00:00@Caelyx@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_17.pdf@EU-1-97-029_h_a_dec_17.pdf@2008-01-22 00:00:00@Twinrix Paediatric@Hepatitis A and  Hepatitis B vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_15.pdf@EU-1-97-033_h_a_dec_15.pdf@2002-08-03 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_11.pdf@EU-1-97-044_h_a_dec_11.pdf@2006-02-14 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Valeant Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_39.pdf@EU-1-95-002_h_a_dec_39.pdf@2010-04-27 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_14.pdf@EU-1-97-039_h_a_dec_14.pdf@2005-07-07 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-96-011_h_a_dec_8.pdf@EU-1-96-011_h_a_dec_8.pdf@2001-05-07 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_12.pdf@EU-1-96-006_h_a_dec_12.pdf@2006-04-08 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_16.pdf@EU-1-97-033_h_a_dec_16.pdf@2002-07-05 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_18.pdf@EU-1-97-029_h_a_dec_18.pdf@2008-06-19 00:00:00@Twinrix Paediatric@Hepatitis A and  Hepatitis B vaccine@NAS before 2012@True@OD Not Found@GlaxoSmithKline Biologicals s.a.@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_4.pdf@EU-1-95-002_h_a_dec_4.pdf@1997-06-13 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_12.pdf@EU-1-97-044_h_a_dec_12.pdf@2006-04-08 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Valeant Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_15.pdf@EU-1-97-039_h_a_dec_15.pdf@2007-04-17 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@exceptional@Parsed
EU-1-96-011_h_a_dec_9.pdf@EU-1-96-011_h_a_dec_9.pdf@2001-09-24 00:00:00@CAELYX@Doxorubicin hydrochloride@NAS before 2012@NA before 2012@OD Not Found@SP Europe@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_17.pdf@EU-1-97-033_h_a_dec_17.pdf@2002-07-05 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_13.pdf@EU-1-96-006_h_a_dec_13.pdf@2006-08-21 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_13.pdf@EU-1-97-044_h_a_dec_13.pdf@2008-09-10 00:00:00@Tasmar@Tolcapone@NAS before 2012@False@OD Not Found@Valeant Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_19.pdf@EU-1-97-029_h_a_dec_19.pdf@2010-05-11 00:00:00@Twinrix Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_40.pdf@EU-1-95-002_h_a_dec_40.pdf@2010-01-07 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_18.pdf@EU-1-97-033_h_a_dec_18.pdf@2002-06-08 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_14.pdf@EU-1-96-006_h_a_dec_14.pdf@2007-04-01 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_16.pdf@EU-1-97-039_h_a_dec_16.pdf@2007-06-21 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe S.a.r.l.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_2.pdf@EU-1-97-029_h_a_dec_2.pdf@1998-12-22 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_19.pdf@EU-1-97-033_h_a_dec_19.pdf@2003-10-01 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_41.pdf@EU-1-95-002_h_a_dec_41.pdf@2011-09-22 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_14.pdf@EU-1-97-044_h_a_dec_14.pdf@2009-02-13 00:00:00@Tasmar@Tolcapone@NAS before 2012@False@OD Not Found@Valeant Pharmaceuticals Limited@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_17.pdf@EU-1-97-039_h_a_dec_17.pdf@2008-04-25 00:00:00@Cystagon@Mercaptamine bitartrate@NAS before 2012@True@OD Not Found@Orphan Europe S.a.r.l.@CMA Not Found@Parsed
e 2006@Parsed
EU-1-96-006_h_a_dec_15.pdf@EU-1-96-006_h_a_dec_15.pdf@2007-05-03 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_20.pdf@EU-1-97-029_h_a_dec_20.pdf@2012-01-13 00:00:00@Twinrix Paediatric@Hepatitis A and Hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline  Biologicals S.A.@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_42.pdf@EU-1-95-002_h_a_dec_42.pdf@2011-10-27 00:00:00@Taxotere@Docetaxel@NAS before 2012@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_20.pdf@EU-1-97-033_h_a_dec_20.pdf@2003-06-24 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_15.pdf@EU-1-97-044_h_a_dec_15.pdf@2009-02-10 00:00:00@Tasmar@Tolcapone@NAS before 2012@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_18.pdf@EU-1-97-039_h_a_dec_18.pdf@2013-12-09 00:00:00@Cystagon@Mercaptamine  bitartrate@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_21.pdf@EU-1-97-029_h_a_dec_21.pdf@2015-02-12 00:00:00@Twinrix  Paediatric@Hepatitis A and Hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_16.pdf@EU-1-96-006_h_a_dec_16.pdf@2007-03-09 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_21.pdf@EU-1-97-033_h_a_dec_21.pdf@2003-07-30 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_43.pdf@EU-1-95-002_h_a_dec_43.pdf@2012-06-02 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_16.pdf@EU-1-97-044_h_a_dec_16.pdf@2012-03-19 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_22.pdf@EU-1-97-029_h_a_dec_22.pdf@2017-10-13 00:00:00@Twinrix  Paediatric@Hepatitis A and Hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_22.pdf@EU-1-97-033_h_a_dec_22.pdf@2003-08-10 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_17.pdf@EU-1-96-006_h_a_dec_17.pdf@2008-04-25 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_44.pdf@EU-1-95-002_h_a_dec_44.pdf@2012-07-20 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_19.pdf@EU-1-97-039_h_a_dec_19.pdf@2014-05-12 00:00:00@Cystagon@Mercaptamine bitartrate@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_17.pdf@EU-1-97-044_h_a_dec_17.pdf@2012-10-29 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_23.pdf@EU-1-97-029_h_a_dec_23.pdf@2019-09-13 00:00:00@Twinrix  Paediatric@Hepatitis A and Hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_23.pdf@EU-1-97-033_h_a_dec_23.pdf@2003-12-11 00:00:00@Avonex@Interferon beta 1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_2.pdf@EU-1-97-039_h_a_dec_2.pdf@1999-04-19 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_18.pdf@EU-1-96-006_h_a_dec_18.pdf@2008-04-25 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_18.pdf@EU-1-97-044_h_a_dec_18.pdf@2014-05-03 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_24.pdf@EU-1-97-029_h_a_dec_24.pdf@2021-10-03 00:00:00@Twinrix  Paediatric@Hepatitis A and Hepatitis B vaccine@False@False@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_45.pdf@EU-1-95-002_h_a_dec_45.pdf@2014-06-02 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_24.pdf@EU-1-97-033_h_a_dec_24.pdf@2004-12-01 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_20.pdf@EU-1-97-039_h_a_dec_20.pdf@2018-11-01 00:00:00@Cystagon@Mercaptamine bitartrate@False@False@OD Not Found@Orphan Europe S.A.R.L.@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_19.pdf@EU-1-96-006_h_a_dec_19.pdf@2008-08-25 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_3.pdf@EU-1-97-029_h_a_dec_3.pdf@1999-01-26 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@NA before 2000@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_46.pdf@EU-1-95-002_h_a_dec_46.pdf@2015-04-13 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_19.pdf@EU-1-97-044_h_a_dec_19.pdf@2014-07-18 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_21.pdf@EU-1-97-039_h_a_dec_21.pdf@2020-04-17 00:00:00@Cystagon@Mercaptamine bitartrate@False@False@OD Not Found@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_25.pdf@EU-1-97-033_h_a_dec_25.pdf@2004-01-30 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_2.pdf@EU-1-96-006_h_a_dec_2.pdf@1998-07-17 00:00:00@NOVOSEVEN@Eptacog alfa (activated)@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_0.pdf@EU-1-97-049_h_a_dec_0.pdf@1997-08-27 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_47.pdf@EU-1-95-002_h_a_dec_47.pdf@2016-05-26 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_2.pdf@EU-1-97-044_h_a_dec_2.pdf@1998-07-17 00:00:00@TASMAR@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_4.pdf@EU-1-97-029_h_a_dec_4.pdf@2001-05-03 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_22.pdf@EU-1-97-039_h_a_dec_22.pdf@2022-10-14 00:00:00@Cystagon@Mercaptamine bitartrate@False@False@OD Not Found@Recordati Rare Diseases@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_26.pdf@EU-1-97-033_h_a_dec_26.pdf@2004-09-27 00:00:00@Avonex@Interferon beta 1a”, a  medicinal product for human use, granted by Decision C(97)712 final  (Text with EEA relevance)  ONLY THE FRENCH TEXT IS AUTHENTIC  EN     EN   COMMISSION DECISION  27-IX-2004  amending the marketing authorisation for@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec France@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_20.pdf@EU-1-96-006_h_a_dec_20.pdf@2009-03-23 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_48.pdf@EU-1-95-002_h_a_dec_48.pdf@2017-05-18 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_1.pdf@EU-1-97-049_h_a_dec_1.pdf@1999-04-13 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_5.pdf@EU-1-97-029_h_a_dec_5.pdf@2001-03-20 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_20.pdf@EU-1-97-044_h_a_dec_20.pdf@2016-08-22 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_3.pdf@EU-1-97-039_h_a_dec_3.pdf@1999-01-07 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_27.pdf@EU-1-97-033_h_a_dec_27.pdf@2005-02-14 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec France@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_21.pdf@EU-1-96-006_h_a_dec_21.pdf@2009-05-28 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_10.pdf@EU-1-97-049_h_a_dec_10.pdf@2002-08-03 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_4.pdf@EU-1-97-039_h_a_dec_4.pdf@2000-03-16 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_6.pdf@EU-1-97-029_h_a_dec_6.pdf@2001-03-05 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_49.pdf@EU-1-95-002_h_a_dec_49.pdf@2017-11-16 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_11.pdf@EU-1-97-049_h_a_dec_11.pdf@2002-10-04 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_5.pdf@EU-1-97-039_h_a_dec_5.pdf@2000-03-16 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_22.pdf@EU-1-96-006_h_a_dec_22.pdf@2010-09-02 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_28.pdf@EU-1-97-033_h_a_dec_28.pdf@2005-08-31 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA not available before 2006@Parsed
EU-1-97-029_h_a_dec_7.pdf@EU-1-97-029_h_a_dec_7.pdf@2001-08-30 00:00:00@Twinrix Paediatric@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_21.pdf@EU-1-97-044_h_a_dec_21.pdf@2019-08-26 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_5.pdf@EU-1-95-002_h_a_dec_5.pdf@1997-11-10 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_12.pdf@EU-1-97-049_h_a_dec_12.pdf@2002-12-04 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_6.pdf@EU-1-97-039_h_a_dec_6.pdf@2000-11-29 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_50.pdf@EU-1-95-002_h_a_dec_50.pdf@2019-01-31 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_8.pdf@EU-1-97-029_h_a_dec_8.pdf@2001-09-11 00:00:00@Twinrix Paediatric@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@SmithKline Beecham Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_23.pdf@EU-1-96-006_h_a_dec_23.pdf@2010-10-28 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_29.pdf@EU-1-97-033_h_a_dec_29.pdf@2005-08-31 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_13.pdf@EU-1-97-049_h_a_dec_13.pdf@2002-12-06 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_7.pdf@EU-1-97-039_h_a_dec_7.pdf@2001-01-29 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_22.pdf@EU-1-97-044_h_a_dec_22.pdf@2021-10-19 00:00:00@Tasmar@Tolcapone@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-97-029_h_a_dec_9.pdf@EU-1-97-029_h_a_dec_9.pdf@2001-12-18 00:00:00@TWINRIX Paediatric@Hepatitis A and Hepatitis B vaccine@NAS before 2012@NA before 2012@OD Not Found@GlaxoSmithKline Biologicals S.A.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_51.pdf@EU-1-95-002_h_a_dec_51.pdf@2019-11-14 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_24.pdf@EU-1-96-006_h_a_dec_24.pdf@2011-06-23 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_14.pdf@EU-1-97-049_h_a_dec_14.pdf@2002-06-28 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-039_h_a_dec_8.pdf@EU-1-97-039_h_a_dec_8.pdf@2001-03-05 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_3.pdf@EU-1-97-033_h_a_dec_3.pdf@1998-08-17 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_3.pdf@EU-1-97-044_h_a_dec_3.pdf@1998-11-12 00:00:00@TASMAR@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_15.pdf@EU-1-97-049_h_a_dec_15.pdf@2002-10-29 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_25.pdf@EU-1-96-006_h_a_dec_25.pdf@2012-01-13 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_52.pdf@EU-1-95-002_h_a_dec_52.pdf@2020-09-01 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-039_h_a_dec_9.pdf@EU-1-97-039_h_a_dec_9.pdf@2002-01-28 00:00:00@CYSTAGON@Mercaptamine bitartrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe SARL Immeuble “ Le Guillaumet”@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_4.pdf@EU-1-97-044_h_a_dec_4.pdf@2000-01-20 00:00:00@TASMAR@Tolcapone@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_30.pdf@EU-1-97-033_h_a_dec_30.pdf@2006-03-22 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@exceptional@Parsed
EU-1-97-049_h_a_dec_16.pdf@EU-1-97-049_h_a_dec_16.pdf@2003-01-16 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_26.pdf@EU-1-96-006_h_a_dec_26.pdf@2012-10-24 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_53.pdf@EU-1-95-002_h_a_dec_53.pdf@2020-03-03 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Aventis Pharma S.A.@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_5.pdf@EU-1-97-044_h_a_dec_5.pdf@2001-01-29 00:00:00@TASMAR@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_17.pdf@EU-1-97-049_h_a_dec_17.pdf@2003-07-03 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_31.pdf@EU-1-97-033_h_a_dec_31.pdf@2006-07-09 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_18.pdf@EU-1-97-049_h_a_dec_18.pdf@2003-05-19 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_6.pdf@EU-1-97-044_h_a_dec_6.pdf@2001-01-29 00:00:00@TASMAR@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_54.pdf@EU-1-95-002_h_a_dec_54.pdf@2021-04-16 00:00:00@Taxotere@Docetaxel@False@False@OD Not Found@Sanofi Mature IP@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_27.pdf@EU-1-96-006_h_a_dec_27.pdf@2013-12-18 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_32.pdf@EU-1-97-033_h_a_dec_32.pdf@2006-10-20 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-044_h_a_dec_7.pdf@EU-1-97-044_h_a_dec_7.pdf@2003-07-01 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_19.pdf@EU-1-97-049_h_a_dec_19.pdf@2003-07-30 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_6.pdf@EU-1-95-002_h_a_dec_6.pdf@1998-06-09 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_28.pdf@EU-1-96-006_h_a_dec_28.pdf@2017-01-26 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_2.pdf@EU-1-97-049_h_a_dec_2.pdf@1999-06-16 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-044_h_a_dec_8.pdf@EU-1-97-044_h_a_dec_8.pdf@2004-01-14 00:00:00@Tasmar@Tolcapone@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_33.pdf@EU-1-97-033_h_a_dec_33.pdf@2007-01-31 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_7.pdf@EU-1-95-002_h_a_dec_7.pdf@1998-07-07 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_0.pdf@EU-1-97-030_h_a_dec_0.pdf@1997-02-21 00:00:00@INSUMAN@Insulin human@NAS before 2012@NA before 2012@NA before 2000@HOECHST AG@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_0.pdf@EU-1-97-053_h_a_dec_0.pdf@1997-11-17 00:00:00@CEREZYME@imiglucerase@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_29.pdf@EU-1-96-006_h_a_dec_29.pdf@2018-11-20 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
e before 2006@Parsed
EU-1-97-053_h_a_dec_1.pdf@EU-1-97-053_h_a_dec_1.pdf@1980-01-01 00:00:00@CEREZYME@imiglucerase@NAS before 2012@NA before 2012@NA before 2000@MAH Not Found@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_20.pdf@EU-1-97-049_h_a_dec_20.pdf@2004-02-03 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_34.pdf@EU-1-97-033_h_a_dec_34.pdf@2007-02-21 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-95-002_h_a_dec_8.pdf@EU-1-95-002_h_a_dec_8.pdf@1998-07-17 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_3.pdf@EU-1-96-006_h_a_dec_3.pdf@1998-11-19 00:00:00@NOVOSEVEN@Eptacog alfa (activated)@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-95-002_h_a_dec_9.pdf@EU-1-95-002_h_a_dec_9.pdf@1998-08-05 00:00:00@TAXOTERE@Docetaxel@NAS before 2012@NA before 2012@NA before 2000@Rhône-Poulenc Rorer S.A.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_21.pdf@EU-1-97-049_h_a_dec_21.pdf@2004-02-08 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_10.pdf@EU-1-97-053_h_a_dec_10.pdf@2007-09-17 00:00:00@Cerezyme@imiglucerase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_35.pdf@EU-1-97-033_h_a_dec_35.pdf@2007-09-07 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@NA before 2012@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_1.pdf@EU-1-97-030_h_a_dec_1.pdf@1998-11-11 00:00:00@INSUMAN@human insulin@NAS before 2012@NA before 2012@NA before 2000@Hoehst Marion Roussel Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-96-006_h_a_dec_30.pdf@EU-1-96-006_h_a_dec_30.pdf@2020-10-16 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_22.pdf@EU-1-97-049_h_a_dec_22.pdf@2005-02-15 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_11.pdf@EU-1-97-053_h_a_dec_11.pdf@2008-12-22 00:00:00@Cerezyme@imiglucerase@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_36.pdf@EU-1-97-033_h_a_dec_36.pdf@2008-03-03 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_10.pdf@EU-1-97-030_h_a_dec_10.pdf@2004-09-24 00:00:00@Insuman Insuman Basal@human  insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_23.pdf@EU-1-97-049_h_a_dec_23.pdf@2005-09-13 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_12.pdf@EU-1-97-053_h_a_dec_12.pdf@2009-06-30 00:00:00@Cerezyme@imiglucerase@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_37.pdf@EU-1-97-033_h_a_dec_37.pdf@2008-06-20 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@True@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_31.pdf@EU-1-96-006_h_a_dec_31.pdf@2021-09-29 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_11.pdf@EU-1-97-030_h_a_dec_11.pdf@2006-02-14 00:00:00@Insuman Insuman Basal@human  insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_38.pdf@EU-1-97-033_h_a_dec_38.pdf@2008-11-25 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_24.pdf@EU-1-97-049_h_a_dec_24.pdf@2006-09-01 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_13.pdf@EU-1-97-053_h_a_dec_13.pdf@2010-08-26 00:00:00@Cerezyme@imiglucerase@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_12.pdf@EU-1-97-030_h_a_dec_12.pdf@2006-05-05 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_0.pdf@EU-1-97-045_h_a_dec_0.pdf@1997-08-14 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@NA before 2000@INFAI@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_25.pdf@EU-1-97-049_h_a_dec_25.pdf@2006-08-06 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_39.pdf@EU-1-97-033_h_a_dec_39.pdf@2008-12-17 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_32.pdf@EU-1-96-006_h_a_dec_32.pdf@2022-05-24 00:00:00@NovoSeven@Eptacog alfa (activated)@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_14.pdf@EU-1-97-053_h_a_dec_14.pdf@2010-10-25 00:00:00@Cerezyme@imiglucerase@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_1.pdf@EU-1-97-045_h_a_dec_1.pdf@1998-07-17 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@NA before 2000@INFAI@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_13.pdf@EU-1-97-030_h_a_dec_13.pdf@2006-10-31 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_4.pdf@EU-1-97-033_h_a_dec_4.pdf@1998-10-23 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_26.pdf@EU-1-97-049_h_a_dec_26.pdf@2007-06-03 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_5.pdf@EU-1-96-006_h_a_dec_5.pdf@2001-03-05 00:00:00@NOVOSEVEN@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_15.pdf@EU-1-97-053_h_a_dec_15.pdf@2012-01-24 00:00:00@Cerezyme@imiglucerase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_10.pdf@EU-1-97-045_h_a_dec_10.pdf@2008-11-03 00:00:00@Helicobacter test INFAI ¹³C@urea@NAS before 2012@False@OD Not Found@INFAI, Institut für biomedizinische  Analytik & NMR Imaging GmbH@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_14.pdf@EU-1-97-030_h_a_dec_14.pdf@2007-01-16 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_40.pdf@EU-1-97-033_h_a_dec_40.pdf@2010-03-15 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_6.pdf@EU-1-96-006_h_a_dec_6.pdf@2001-06-20 00:00:00@NOVOSEVEN@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_27.pdf@EU-1-97-049_h_a_dec_27.pdf@2007-06-03 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_16.pdf@EU-1-97-053_h_a_dec_16.pdf@2015-10-28 00:00:00@Cerezyme@imiglucerase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_11.pdf@EU-1-97-045_h_a_dec_11.pdf@2012-10-25 00:00:00@Helicobacter test INFAI ¹³C@urea@False@False@OD Not Found@INFAI, Institut für biomedizinische  Analytik & NMR Imaging GmbH@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_7.pdf@EU-1-96-006_h_a_dec_7.pdf@2003-08-10 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_41.pdf@EU-1-97-033_h_a_dec_41.pdf@2011-05-27 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_17.pdf@EU-1-97-053_h_a_dec_17.pdf@2017-02-06 00:00:00@Cerezyme@imiglucerase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_28.pdf@EU-1-97-049_h_a_dec_28.pdf@2007-08-31 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_12.pdf@EU-1-97-045_h_a_dec_12.pdf@2016-04-21 00:00:00@Helicobacter Test INFAI ¹³C@urea@False@False@OD Not Found@INFAI@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_8.pdf@EU-1-96-006_h_a_dec_8.pdf@2004-01-27 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_42.pdf@EU-1-97-033_h_a_dec_42.pdf@2011-10-24 00:00:00@Avonex Interferon Beta@1a@NAS before 2012@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_15.pdf@EU-1-97-030_h_a_dec_15.pdf@2007-12-18 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_18.pdf@EU-1-97-053_h_a_dec_18.pdf@2019-05-12 00:00:00@Cerezyme@imiglucerase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_43.pdf@EU-1-97-033_h_a_dec_43.pdf@2012-07-20 00:00:00@Avonex Interferon Beta@1a@False@False@OD Not Found@Biogen Idec Ltd@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_29.pdf@EU-1-97-049_h_a_dec_29.pdf@2008-10-06 00:00:00@Karvea@Irbesartan@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-96-006_h_a_dec_9.pdf@EU-1-96-006_h_a_dec_9.pdf@2004-01-27 00:00:00@NovoSeven@Eptacog alfa (activated)@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_19.pdf@EU-1-97-053_h_a_dec_19.pdf@2020-12-18 00:00:00@Cerezyme@imiglucerase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_16.pdf@EU-1-97-030_h_a_dec_16.pdf@2008-06-18 00:00:00@Insuman@human insulin@NAS before 2012@True@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_3.pdf@EU-1-97-049_h_a_dec_3.pdf@2000-03-05 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_14.pdf@EU-1-97-045_h_a_dec_14.pdf@2021-05-07 00:00:00@Helicobacter Test INFAI ¹³C@urea@False@False@OD Not Found@INFAI GmbH@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_2.pdf@EU-1-97-053_h_a_dec_2.pdf@1999-06-18 00:00:00@CEREZYME imiglucerase@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@"Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_44.pdf@EU-1-97-033_h_a_dec_44.pdf@2014-08-26 00:00:00@Avonex  Interferon Beta@1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_2.pdf@EU-1-97-045_h_a_dec_2.pdf@1999-11-06 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@NA before 2000@INFAI@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_20.pdf@EU-1-97-053_h_a_dec_20.pdf@2022-06-29 00:00:00@Cerezyme@imiglucerase@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_30.pdf@EU-1-97-049_h_a_dec_30.pdf@2009-02-26 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_17.pdf@EU-1-97-030_h_a_dec_17.pdf@2008-04-11 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_3.pdf@EU-1-97-045_h_a_dec_3.pdf@2000-05-24 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@OD Not Found@INFAI@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_3.pdf@EU-1-97-053_h_a_dec_3.pdf@1999-11-16 00:00:00@CEREZYME imiglucerase@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@"Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_45.pdf@EU-1-97-033_h_a_dec_45.pdf@2016-06-16 00:00:00@Avonex  Interferon Beta@1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_31.pdf@EU-1-97-049_h_a_dec_31.pdf@2009-03-31 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_4.pdf@EU-1-97-045_h_a_dec_4.pdf@2000-11-07 00:00:00@HELICOBACTER test INFAI@13C-urea@NAS before 2012@NA before 2012@OD Not Found@INFAI@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_4.pdf@EU-1-97-053_h_a_dec_4.pdf@2000-01-28 00:00:00@Cerezyme@Imiglucerase@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_5.pdf@EU-1-97-045_h_a_dec_5.pdf@2002-04-23 00:00:00@Helicobacter test INFAI@¹³C-urea@NAS before 2012@NA before 2012@OD Not Found@INFAI@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_18.pdf@EU-1-97-030_h_a_dec_18.pdf@2009-02-19 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_32.pdf@EU-1-97-049_h_a_dec_32.pdf@2010-06-08 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_5.pdf@EU-1-97-053_h_a_dec_5.pdf@2002-03-26 00:00:00@Cerezyme@imiglucerase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe  B.V.@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_6.pdf@EU-1-97-045_h_a_dec_6.pdf@2002-02-05 00:00:00@Helicobacter test INFAI@¹³C-urea@NAS before 2012@NA before 2012@OD Not Found@INFAI@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_46.pdf@EU-1-97-033_h_a_dec_46.pdf@2018-04-26 00:00:00@Avonex  Interferon Beta@1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_6.pdf@EU-1-97-053_h_a_dec_6.pdf@2002-11-12 00:00:00@Cerezyme@imiglucerase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_33.pdf@EU-1-97-049_h_a_dec_33.pdf@2010-10-25 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_19.pdf@EU-1-97-030_h_a_dec_19.pdf@2009-05-29 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-045_h_a_dec_7.pdf@EU-1-97-045_h_a_dec_7.pdf@2002-10-10 00:00:00@Helicobacter test INFAI@13C-urea@NAS before 2012@NA before 2012@OD Not Found@INFAI@CMA not available before 2006@Parsed
EU-1-97-053_h_a_dec_7.pdf@EU-1-97-053_h_a_dec_7.pdf@2003-08-28 00:00:00@Cerezyme@imiglucerase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_8.pdf@EU-1-97-045_h_a_dec_8.pdf@2002-10-29 00:00:00@Helicobacter test INFAI@13C-urea@NAS before 2012@NA before 2012@OD Not Found@INFAI@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_2.pdf@EU-1-97-030_h_a_dec_2.pdf@1999-02-18 00:00:00@INSUMAN@human insulin@NAS before 2012@NA before 2012@NA before 2000@Hoechst Marion Roussel Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_34.pdf@EU-1-97-049_h_a_dec_34.pdf@2011-01-21 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_47.pdf@EU-1-97-033_h_a_dec_47.pdf@2018-02-08 00:00:00@Avonex Interferon Beta@1a@False@False@OD Not Found@Biogen Idec Limited@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_8.pdf@EU-1-97-053_h_a_dec_8.pdf@2005-11-04 00:00:00@Cerezyme@imiglucerase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-97-045_h_a_dec_9.pdf@EU-1-97-045_h_a_dec_9.pdf@2005-02-14 00:00:00@Helicobacter test INFAI ¹³C@urea@NAS before 2012@NA before 2012@OD Not Found@INFAI, Institut für biomedizinische  Analytic und NMR Imaging GmbH@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_35.pdf@EU-1-97-049_h_a_dec_35.pdf@2011-05-18 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_20.pdf@EU-1-97-030_h_a_dec_20.pdf@2009-11-11 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-053_h_a_dec_9.pdf@EU-1-97-053_h_a_dec_9.pdf@2007-04-04 00:00:00@Cerezyme@imiglucerase@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_36.pdf@EU-1-97-049_h_a_dec_36.pdf@2011-06-29 00:00:00@Karvea@Irbesartan@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_21.pdf@EU-1-97-030_h_a_dec_21.pdf@2010-06-09 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_48.pdf@EU-1-97-033_h_a_dec_48.pdf@2020-06-22 00:00:00@Avonex  Interferon Beta@1a@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_37.pdf@EU-1-97-049_h_a_dec_37.pdf@2012-10-10 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_22.pdf@EU-1-97-030_h_a_dec_22.pdf@2011-01-02 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_38.pdf@EU-1-97-049_h_a_dec_38.pdf@2013-02-18 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_49.pdf@EU-1-97-033_h_a_dec_49.pdf@2022-02-17 00:00:00@Avonex  Interferon Beta@1a@False@False@OD Not Found@Biogen Netherlands B.V.@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_39.pdf@EU-1-97-049_h_a_dec_39.pdf@2013-07-31 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_23.pdf@EU-1-97-030_h_a_dec_23.pdf@2011-05-09 00:00:00@Insuman@human insulin@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-033_h_a_dec_5.pdf@EU-1-97-033_h_a_dec_5.pdf@1998-06-11 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_0.pdf@EU-1-97-046_h_a_dec_0.pdf@1997-08-27 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_0.pdf@EU-1-96-007_h_a_dec_0.pdf@1996-04-30 00:00:00@HUMALOG®@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_4.pdf@EU-1-97-049_h_a_dec_4.pdf@2000-07-27 00:00:00@KARVEA@Ibesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol – Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_6.pdf@EU-1-97-033_h_a_dec_6.pdf@1999-03-02 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_24.pdf@EU-1-97-030_h_a_dec_24.pdf@2012-04-20 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_1.pdf@EU-1-97-046_h_a_dec_1.pdf@1999-02-23 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_1.pdf@EU-1-96-007_h_a_dec_1.pdf@Date is blank@Humalog ®@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_7.pdf@EU-1-97-033_h_a_dec_7.pdf@1999-06-18 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_10.pdf@EU-1-97-046_h_a_dec_10.pdf@2002-08-03 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_40.pdf@EU-1-97-049_h_a_dec_40.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(97)2754(final) for “Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_25.pdf@EU-1-97-030_h_a_dec_25.pdf@2012-03-07 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_10.pdf@EU-1-96-007_h_a_dec_10.pdf@1998-11-19 00:00:00@HUMALOG Mix25 100 U/ml suspension for injection in vial, HUMALOG Mix 50 100 U/ml suspension for injection in cartridge,  HUMALOG NPL 100 U/ml suspension for injection in vial,  HUMALOG Mix 25 100 U/ml suspension for injection in cartridge,  HUMALOG Mix50 100 U/ml suspension for injection in vial,  HUMALOG NPL 100 U/ml suspension for injection in cartridge@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_8.pdf@EU-1-97-033_h_a_dec_8.pdf@2000-02-21 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_11.pdf@EU-1-97-046_h_a_dec_11.pdf@2002-10-04 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_0.pdf@EU-1-97-055_h_a_dec_0.pdf@1998-05-02 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_11.pdf@EU-1-96-007_h_a_dec_11.pdf@1999-01-26 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-033_h_a_dec_9.pdf@EU-1-97-033_h_a_dec_9.pdf@2000-09-03 00:00:00@AVONEX@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Biogen France S.A.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_12.pdf@EU-1-97-046_h_a_dec_12.pdf@2002-11-04 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_41.pdf@EU-1-97-049_h_a_dec_41.pdf@2016-06-21 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_26.pdf@EU-1-97-030_h_a_dec_26.pdf@2013-09-19 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_1.pdf@EU-1-97-055_h_a_dec_1.pdf@1998-06-15 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_13.pdf@EU-1-97-046_h_a_dec_13.pdf@2002-12-06 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_12.pdf@EU-1-96-007_h_a_dec_12.pdf@1999-03-06 00:00:00@HUMALOG 40 U/ml solution for injection in vial, HUMALOG 100 U/ml solution for injection in vial,  HUMALOG 100 U/ml solution for injection in cartridge (1.5 ml),  HUMALOG 100 U/ml solution for injection in cartridge (3 ml),  HUMALOG Mix25 100 U/ml suspension for injection in vial,  HUMALOG Mix50 100 U/ml suspension for injection in cartridge,  HUMALOG NPL 100 U/ml suspension for injection in vial,  HUMALOG Mix25 100 U/ml suspension for injection in cartridge,  HUMALOG Mix50 100 U/ml suspension for injection in vial,  HUMALOG NPL 100 U/ml suspension for injection in cartridge@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_42.pdf@EU-1-97-049_h_a_dec_42.pdf@2018-07-13 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_14.pdf@EU-1-97-046_h_a_dec_14.pdf@2002-10-29 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_10.pdf@EU-1-97-055_h_a_dec_10.pdf@2000-11-18 00:00:00@VIRAMUNE@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_13.pdf@EU-1-96-007_h_a_dec_13.pdf@1999-07-30 00:00:00@HUMALOG Mix50 100 U/ml suspension for injection  in vial, Insulin lispro@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_27.pdf@EU-1-97-030_h_a_dec_27.pdf@2014-03-10 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_43.pdf@EU-1-97-049_h_a_dec_43.pdf@2019-02-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 2.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(97)2754(final) for “Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_15.pdf@EU-1-97-046_h_a_dec_15.pdf@2003-07-03 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_14.pdf@EU-1-96-007_h_a_dec_14.pdf@1999-10-11 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_11.pdf@EU-1-97-055_h_a_dec_11.pdf@2001-08-13 00:00:00@VIRAMUNE nevirapine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_16.pdf@EU-1-97-046_h_a_dec_16.pdf@2003-07-28 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_28.pdf@EU-1-97-030_h_a_dec_28.pdf@2018-06-14 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_15.pdf@EU-1-96-007_h_a_dec_15.pdf@2000-04-13 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_44.pdf@EU-1-97-049_h_a_dec_44.pdf@2021-12-02 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_12.pdf@EU-1-97-055_h_a_dec_12.pdf@2001-11-30 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_29.pdf@EU-1-97-030_h_a_dec_29.pdf@2020-08-04 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_13.pdf@EU-1-97-055_h_a_dec_13.pdf@2002-11-07 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_16.pdf@EU-1-96-007_h_a_dec_16.pdf@2001-05-18 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_45.pdf@EU-1-97-049_h_a_dec_45.pdf@2021-10-05 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_17.pdf@EU-1-97-046_h_a_dec_17.pdf@2004-02-03 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_14.pdf@EU-1-97-055_h_a_dec_14.pdf@2002-05-12 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_46.pdf@EU-1-97-049_h_a_dec_46.pdf@2022-09-13 00:00:00@Karvea@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_17.pdf@EU-1-96-007_h_a_dec_17.pdf@2001-06-27 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_18.pdf@EU-1-97-046_h_a_dec_18.pdf@2004-02-08 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_3.pdf@EU-1-97-030_h_a_dec_3.pdf@2000-03-20 00:00:00@Insuman@Human insulin@NAS before 2012@NA before 2012@NA before 2000@Hoechst Marion Roussel Deutschland  GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_15.pdf@EU-1-97-055_h_a_dec_15.pdf@2003-02-17 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_5.pdf@EU-1-97-049_h_a_dec_5.pdf@2000-11-16 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_18.pdf@EU-1-96-007_h_a_dec_18.pdf@2001-09-11 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_19.pdf@EU-1-97-046_h_a_dec_19.pdf@2005-02-15 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_16.pdf@EU-1-97-055_h_a_dec_16.pdf@2003-05-19 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_30.pdf@EU-1-97-030_h_a_dec_30.pdf@2021-08-20 00:00:00@Insuman@human insulin@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_6.pdf@EU-1-97-049_h_a_dec_6.pdf@2001-01-15 00:00:00@Karvea@irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_19.pdf@EU-1-96-007_h_a_dec_19.pdf@2001-05-12 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_2.pdf@EU-1-97-046_h_a_dec_2.pdf@1999-04-13 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_2.pdf@EU-1-96-007_h_a_dec_2.pdf@2022-01-01 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_17.pdf@EU-1-97-055_h_a_dec_17.pdf@2003-09-07 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_20.pdf@EU-1-97-046_h_a_dec_20.pdf@2005-09-13 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_4.pdf@EU-1-97-030_h_a_dec_4.pdf@2000-01-08 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@NA before 2000@Hoechst Marion Roussel Deutschland GmbH.  Done at Brussels@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_20.pdf@EU-1-96-007_h_a_dec_20.pdf@2002-03-21 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_7.pdf@EU-1-97-049_h_a_dec_7.pdf@2001-04-23 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_18.pdf@EU-1-97-055_h_a_dec_18.pdf@2004-04-02 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_5.pdf@EU-1-97-030_h_a_dec_5.pdf@2001-06-14 00:00:00@Insuman@Human insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_21.pdf@EU-1-96-007_h_a_dec_21.pdf@2002-06-17 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_21.pdf@EU-1-97-046_h_a_dec_21.pdf@2006-09-01 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-97-049_h_a_dec_8.pdf@EU-1-97-049_h_a_dec_8.pdf@2001-08-10 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_19.pdf@EU-1-97-055_h_a_dec_19.pdf@2004-07-13 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_6.pdf@EU-1-97-030_h_a_dec_6.pdf@2001-06-14 00:00:00@Insuman@Human insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_22.pdf@EU-1-96-007_h_a_dec_22.pdf@2002-02-10 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_0.pdf@EU-1-97-057_h_a_dec_0.pdf@1998-02-05 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@NA before 2000@CIS bio international@CMA not available before 2006@Parsed
EU-1-97-049_h_a_dec_9.pdf@EU-1-97-049_h_a_dec_9.pdf@2002-02-19 00:00:00@Karvea@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_2.pdf@EU-1-97-055_h_a_dec_2.pdf@1999-01-26 00:00:00@VIRAMUNE@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_7.pdf@EU-1-97-030_h_a_dec_7.pdf@2002-03-22 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_22.pdf@EU-1-97-046_h_a_dec_22.pdf@2006-09-01 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_23.pdf@EU-1-96-007_h_a_dec_23.pdf@2002-11-13 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_1.pdf@EU-1-97-057_h_a_dec_1.pdf@2000-09-10 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA not available before 2006@Parsed
EU-1-97-030_h_a_dec_8.pdf@EU-1-97-030_h_a_dec_8.pdf@2003-10-24 00:00:00@Insuman@human insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_20.pdf@EU-1-97-055_h_a_dec_20.pdf@2004-10-15 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_24.pdf@EU-1-96-007_h_a_dec_24.pdf@2002-12-16 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_10.pdf@EU-1-97-057_h_a_dec_10.pdf@2012-06-14 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@False@False@OD Not Found@CIS bio  international@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_23.pdf@EU-1-97-046_h_a_dec_23.pdf@2006-05-31 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_25.pdf@EU-1-96-007_h_a_dec_25.pdf@2003-07-08 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_11.pdf@EU-1-97-057_h_a_dec_11.pdf@2016-02-05 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@False@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_21.pdf@EU-1-97-055_h_a_dec_21.pdf@2005-05-01 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_24.pdf@EU-1-97-046_h_a_dec_24.pdf@2006-05-31 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-97-030_h_a_dec_9.pdf@EU-1-97-030_h_a_dec_9.pdf@2004-04-08 00:00:00@Insuman Insuman Basal@human  insulin@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_2.pdf@EU-1-97-057_h_a_dec_2.pdf@2001-03-13 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_26.pdf@EU-1-96-007_h_a_dec_26.pdf@2003-11-11 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_22.pdf@EU-1-97-055_h_a_dec_22.pdf@2005-04-20 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_25.pdf@EU-1-97-046_h_a_dec_25.pdf@2007-06-03 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-057_h_a_dec_3.pdf@EU-1-97-057_h_a_dec_3.pdf@2001-12-17 00:00:00@Quadramet@Samarium [ 153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_27.pdf@EU-1-96-007_h_a_dec_27.pdf@2004-02-03 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_23.pdf@EU-1-97-055_h_a_dec_23.pdf@2005-11-15 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_4.pdf@EU-1-97-057_h_a_dec_4.pdf@2002-04-19 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_26.pdf@EU-1-97-046_h_a_dec_26.pdf@2007-08-31 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-97-057_h_a_dec_5.pdf@EU-1-97-057_h_a_dec_5.pdf@2002-06-27 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_28.pdf@EU-1-96-007_h_a_dec_28.pdf@2006-01-13 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_24.pdf@EU-1-97-055_h_a_dec_24.pdf@2006-05-31 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-97-057_h_a_dec_6.pdf@EU-1-97-057_h_a_dec_6.pdf@2003-03-17 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_27.pdf@EU-1-97-046_h_a_dec_27.pdf@2008-10-06 00:00:00@Aprovel@Irbesartan@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_29.pdf@EU-1-96-007_h_a_dec_29.pdf@2006-09-02 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_25.pdf@EU-1-97-055_h_a_dec_25.pdf@2006-01-09 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_3.pdf@EU-1-96-007_h_a_dec_3.pdf@1980-01-01 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-057_h_a_dec_7.pdf@EU-1-97-057_h_a_dec_7.pdf@2007-12-12 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@NAS before 2012@NA before 2012@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_28.pdf@EU-1-97-046_h_a_dec_28.pdf@2009-02-26 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_26.pdf@EU-1-97-055_h_a_dec_26.pdf@2006-10-27 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_0.pdf@EU-1-95-003_h_a_dec_0.pdf@Date is blank@BETAFERON@Interferon beta-lb@NAS before 2012@NA before 2012@NA before 2000@Schering  Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_30.pdf@EU-1-96-007_h_a_dec_30.pdf@2006-01-13 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-057_h_a_dec_8.pdf@EU-1-97-057_h_a_dec_8.pdf@2008-07-23 00:00:00@Quadramet@Samarium [153 Sm]  lexidronam pentasodium@NAS before 2012@True@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_27.pdf@EU-1-97-055_h_a_dec_27.pdf@2007-01-15 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_29.pdf@EU-1-97-046_h_a_dec_29.pdf@2009-03-31 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_1.pdf@EU-1-95-003_h_a_dec_1.pdf@1996-11-21 00:00:00@BETAFERON@Interferon beta-1b@NAS before 2012@NA before 2012@NA before 2000@Schering Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_28.pdf@EU-1-97-055_h_a_dec_28.pdf@2007-02-05 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-97-057_h_a_dec_9.pdf@EU-1-97-057_h_a_dec_9.pdf@2011-02-28 00:00:00@Quadramet@Samarium [153 Sm] lexidronam pentasodium@NAS before 2012@False@OD Not Found@CIS bio international@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_3.pdf@EU-1-97-046_h_a_dec_3.pdf@1999-06-16 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_31.pdf@EU-1-96-007_h_a_dec_31.pdf@2006-09-02 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_10.pdf@EU-1-95-003_h_a_dec_10.pdf@1999-11-05 00:00:00@BETAFERON Interferon beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_30.pdf@EU-1-97-046_h_a_dec_30.pdf@2010-08-23 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_29.pdf@EU-1-97-055_h_a_dec_29.pdf@2007-05-30 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_11.pdf@EU-1-95-003_h_a_dec_11.pdf@1999-09-14 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_3.pdf@EU-1-97-055_h_a_dec_3.pdf@1999-06-18 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_12.pdf@EU-1-95-003_h_a_dec_12.pdf@2000-03-02 00:00:00@Betaferon Interferon beta@1b@NAS before 2012@NA before 2012@NA before 2000@Schering AG Pharma@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_33.pdf@EU-1-96-007_h_a_dec_33.pdf@2006-11-14 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_31.pdf@EU-1-97-046_h_a_dec_31.pdf@2010-10-28 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol- Myers Squibb SNC@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_13.pdf@EU-1-95-003_h_a_dec_13.pdf@2000-11-05 00:00:00@BETAFERON Interferon beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Schering Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_0.pdf@EU-1-98-058_h_a_dec_0.pdf@2022-03-18 00:00:00@COMBIVIR@lamivudine/zidovudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_30.pdf@EU-1-97-055_h_a_dec_30.pdf@2007-06-29 00:00:00@Viramune@nevirapine@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_1.pdf@EU-1-98-058_h_a_dec_1.pdf@1998-08-17 00:00:00@COMBIVIR@lamivudine/zidovudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_32.pdf@EU-1-97-046_h_a_dec_32.pdf@2011-11-02 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_14.pdf@EU-1-95-003_h_a_dec_14.pdf@2001-01-29 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_31.pdf@EU-1-97-055_h_a_dec_31.pdf@2008-10-01 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_35.pdf@EU-1-96-007_h_a_dec_35.pdf@2007-03-29 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_33.pdf@EU-1-97-046_h_a_dec_33.pdf@2011-05-23 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
not available before 2006@Parsed
EU-1-98-058_h_a_dec_10.pdf@EU-1-98-058_h_a_dec_10.pdf@2005-05-01 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_32.pdf@EU-1-97-055_h_a_dec_32.pdf@2008-02-09 00:00:00@Viramune@nevirapine@NAS before 2012@True@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_16.pdf@EU-1-95-003_h_a_dec_16.pdf@2001-11-19 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Schering AG@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_34.pdf@EU-1-97-046_h_a_dec_34.pdf@2011-06-17 00:00:00@Aprovel@Irbesartan@NAS before 2012@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_36.pdf@EU-1-96-007_h_a_dec_36.pdf@2007-03-05 00:00:00@Humalog@Insulin lispro@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_17.pdf@EU-1-95-003_h_a_dec_17.pdf@2003-09-01 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering AG Pharma@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_11.pdf@EU-1-98-058_h_a_dec_11.pdf@2007-01-26 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_35.pdf@EU-1-97-046_h_a_dec_35.pdf@2012-10-10 00:00:00@Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_33.pdf@EU-1-97-055_h_a_dec_33.pdf@2009-01-27 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_37.pdf@EU-1-96-007_h_a_dec_37.pdf@2008-01-31 00:00:00@Humalog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_12.pdf@EU-1-98-058_h_a_dec_12.pdf@2007-03-09 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_18.pdf@EU-1-95-003_h_a_dec_18.pdf@2004-12-07 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering AG Pharma@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_36.pdf@EU-1-97-046_h_a_dec_36.pdf@2013-07-31 00:00:00@Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_34.pdf@EU-1-97-055_h_a_dec_34.pdf@2009-07-05 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_13.pdf@EU-1-98-058_h_a_dec_13.pdf@2007-11-13 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_19.pdf@EU-1-95-003_h_a_dec_19.pdf@2005-10-27 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering AG Pharma@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_38.pdf@EU-1-96-007_h_a_dec_38.pdf@2009-07-01 00:00:00@Humalog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_36.pdf@EU-1-97-055_h_a_dec_36.pdf@2010-08-26 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_37.pdf@EU-1-97-046_h_a_dec_37.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(97)2753(final) for “Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_2.pdf@EU-1-95-003_h_a_dec_2.pdf@1997-02-04 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_14.pdf@EU-1-98-058_h_a_dec_14.pdf@2007-11-23 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_39.pdf@EU-1-96-007_h_a_dec_39.pdf@2009-01-07 00:00:00@Humalog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_0.pdf@EU-1-97-050_h_a_dec_0.pdf@1997-10-14 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_37.pdf@EU-1-97-055_h_a_dec_37.pdf@2011-06-23 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_20.pdf@EU-1-95-003_h_a_dec_20.pdf@2006-01-31 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering AG Pharma@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_38.pdf@EU-1-97-046_h_a_dec_38.pdf@2016-06-24 00:00:00@Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_15.pdf@EU-1-98-058_h_a_dec_15.pdf@2008-02-13 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_4.pdf@EU-1-96-007_h_a_dec_4.pdf@1997-06-16 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_21.pdf@EU-1-95-003_h_a_dec_21.pdf@2006-01-06 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering Aktiengesellschaft@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_1.pdf@EU-1-97-050_h_a_dec_1.pdf@1998-07-24 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_38.pdf@EU-1-97-055_h_a_dec_38.pdf@2011-09-16 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_39.pdf@EU-1-97-046_h_a_dec_39.pdf@2018-07-30 00:00:00@Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_16.pdf@EU-1-98-058_h_a_dec_16.pdf@2008-09-16 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@True@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_40.pdf@EU-1-96-007_h_a_dec_40.pdf@2011-03-24 00:00:00@Humalog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_10.pdf@EU-1-97-050_h_a_dec_10.pdf@2003-02-10 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-046_h_a_dec_4.pdf@EU-1-97-046_h_a_dec_4.pdf@2000-04-25 00:00:00@APROVEL@Irbesartan@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_22.pdf@EU-1-95-003_h_a_dec_22.pdf@2006-01-09 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering Aktiengesellschaft@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_39.pdf@EU-1-97-055_h_a_dec_39.pdf@2011-10-24 00:00:00@Viramune@nevirapine@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_17.pdf@EU-1-98-058_h_a_dec_17.pdf@2009-02-04 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_41.pdf@EU-1-96-007_h_a_dec_41.pdf@2011-04-18 00:00:00@Humalog@Insulin lispro@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_40.pdf@EU-1-97-046_h_a_dec_40.pdf@2019-11-04 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 11.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(97)2753(final) for “Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_11.pdf@EU-1-97-050_h_a_dec_11.pdf@2004-10-22 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_4.pdf@EU-1-97-055_h_a_dec_4.pdf@1999-08-07 00:00:00@VIRAMUNE@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_18.pdf@EU-1-98-058_h_a_dec_18.pdf@2010-01-25 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_42.pdf@EU-1-96-007_h_a_dec_42.pdf@2012-10-25 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_41.pdf@EU-1-97-046_h_a_dec_41.pdf@2019-11-11 00:00:00@Aprovel@Irbesartan@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_24.pdf@EU-1-95-003_h_a_dec_24.pdf@2006-01-09 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Schering Aktiengesellschaft@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_12.pdf@EU-1-97-050_h_a_dec_12.pdf@2005-03-30 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_40.pdf@EU-1-97-055_h_a_dec_40.pdf@2012-04-13 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_19.pdf@EU-1-98-058_h_a_dec_19.pdf@2010-10-05 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_25.pdf@EU-1-95-003_h_a_dec_25.pdf@2007-11-13 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_42.pdf@EU-1-97-046_h_a_dec_42.pdf@2021-02-19 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 19.2.2021 amending Commission Decision C(2019) 2977  11 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(97) 2753 for “Aprovel@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_13.pdf@EU-1-97-050_h_a_dec_13.pdf@2006-06-04 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_2.pdf@EU-1-98-058_h_a_dec_2.pdf@1999-11-16 00:00:00@COMBIVIR lamivudine/zidovudine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_41.pdf@EU-1-97-055_h_a_dec_41.pdf@2012-08-23 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_43.pdf@EU-1-97-046_h_a_dec_43.pdf@2021-10-05 00:00:00@Aprovel@Irbesartan@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_44.pdf@EU-1-96-007_h_a_dec_44.pdf@2016-11-05 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_14.pdf@EU-1-97-050_h_a_dec_14.pdf@2006-07-08 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_26.pdf@EU-1-95-003_h_a_dec_26.pdf@2007-12-18 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@NA before 2012@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_42.pdf@EU-1-97-055_h_a_dec_42.pdf@2012-12-20 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_20.pdf@EU-1-98-058_h_a_dec_20.pdf@2010-03-11 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_45.pdf@EU-1-96-007_h_a_dec_45.pdf@2017-10-19 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_15.pdf@EU-1-97-050_h_a_dec_15.pdf@2007-09-25 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_21.pdf@EU-1-98-058_h_a_dec_21.pdf@2011-02-05 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_27.pdf@EU-1-95-003_h_a_dec_27.pdf@2008-10-29 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_5.pdf@EU-1-97-046_h_a_dec_5.pdf@2000-11-14 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_43.pdf@EU-1-97-055_h_a_dec_43.pdf@2014-10-04 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_46.pdf@EU-1-96-007_h_a_dec_46.pdf@2019-01-21 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_16.pdf@EU-1-97-050_h_a_dec_16.pdf@2008-02-28 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_22.pdf@EU-1-98-058_h_a_dec_22.pdf@2013-03-26 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_28.pdf@EU-1-95-003_h_a_dec_28.pdf@2009-08-31 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_6.pdf@EU-1-97-046_h_a_dec_6.pdf@2001-01-15 00:00:00@Aprovel@irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_44.pdf@EU-1-97-055_h_a_dec_44.pdf@2015-03-07 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_47.pdf@EU-1-96-007_h_a_dec_47.pdf@2020-01-16 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_17.pdf@EU-1-97-050_h_a_dec_17.pdf@2008-08-25 00:00:00@Sifrol@Pramipexole@NAS before 2012@True@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_23.pdf@EU-1-98-058_h_a_dec_23.pdf@2013-05-27 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_29.pdf@EU-1-95-003_h_a_dec_29.pdf@2010-01-25 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_7.pdf@EU-1-97-046_h_a_dec_7.pdf@2001-04-23 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_45.pdf@EU-1-97-055_h_a_dec_45.pdf@2017-09-01 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_18.pdf@EU-1-97-050_h_a_dec_18.pdf@2009-01-30 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_48.pdf@EU-1-96-007_h_a_dec_48.pdf@2021-06-21 00:00:00@Humalog@Insulin lispro@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_8.pdf@EU-1-97-046_h_a_dec_8.pdf@2001-08-10 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_3.pdf@EU-1-95-003_h_a_dec_3.pdf@1997-05-22 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_24.pdf@EU-1-98-058_h_a_dec_24.pdf@2015-04-20 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_46.pdf@EU-1-97-055_h_a_dec_46.pdf@2018-10-29 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_19.pdf@EU-1-97-050_h_a_dec_19.pdf@2009-04-17 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-046_h_a_dec_9.pdf@EU-1-97-046_h_a_dec_9.pdf@2002-02-19 00:00:00@Aprovel@Irbesartan@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_30.pdf@EU-1-95-003_h_a_dec_30.pdf@2011-07-20 00:00:00@Betaferon@Interferon beta-1b@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_5.pdf@EU-1-96-007_h_a_dec_5.pdf@1997-07-29 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_47.pdf@EU-1-97-055_h_a_dec_47.pdf@2020-11-18 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_2.pdf@EU-1-97-050_h_a_dec_2.pdf@1999-11-16 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_25.pdf@EU-1-98-058_h_a_dec_25.pdf@2016-02-05 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_31.pdf@EU-1-95-003_h_a_dec_31.pdf@2012-05-25 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_6.pdf@EU-1-96-007_h_a_dec_6.pdf@1997-11-28 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_48.pdf@EU-1-97-055_h_a_dec_48.pdf@2022-01-07 00:00:00@Viramune@nevirapine@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_7.pdf@EU-1-96-007_h_a_dec_7.pdf@1998-10-03 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_20.pdf@EU-1-97-050_h_a_dec_20.pdf@2009-08-10 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_32.pdf@EU-1-95-003_h_a_dec_32.pdf@2014-08-26 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_5.pdf@EU-1-97-055_h_a_dec_5.pdf@1999-07-29 00:00:00@VIRAMUNE nevirapine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_26.pdf@EU-1-98-058_h_a_dec_26.pdf@2017-03-03 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-96-007_h_a_dec_8.pdf@EU-1-96-007_h_a_dec_8.pdf@1998-11-05 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-055_h_a_dec_6.pdf@EU-1-97-055_h_a_dec_6.pdf@1999-12-28 00:00:00@VIRAMUNE nevirapine@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_21.pdf@EU-1-97-050_h_a_dec_21.pdf@2010-06-14 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_33.pdf@EU-1-95-003_h_a_dec_33.pdf@2015-10-15 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_7.pdf@EU-1-97-055_h_a_dec_7.pdf@2000-03-16 00:00:00@VIRAMUNE@nevirapine@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-96-007_h_a_dec_9.pdf@EU-1-96-007_h_a_dec_9.pdf@1998-06-11 00:00:00@HUMALOG@Insulin lispro@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_22.pdf@EU-1-97-050_h_a_dec_22.pdf@2010-01-07 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_34.pdf@EU-1-95-003_h_a_dec_34.pdf@2016-08-09 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_27.pdf@EU-1-98-058_h_a_dec_27.pdf@2019-01-31 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_8.pdf@EU-1-97-055_h_a_dec_8.pdf@2000-07-27 00:00:00@VIRAMUNE nevirapine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_23.pdf@EU-1-97-050_h_a_dec_23.pdf@2010-02-07 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_35.pdf@EU-1-95-003_h_a_dec_35.pdf@2017-03-22 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_28.pdf@EU-1-98-058_h_a_dec_28.pdf@2021-12-08 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-97-055_h_a_dec_9.pdf@EU-1-97-055_h_a_dec_9.pdf@2000-10-30 00:00:00@VIRAMUNE nevirapine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_24.pdf@EU-1-97-050_h_a_dec_24.pdf@2010-10-25 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_36.pdf@EU-1-95-003_h_a_dec_36.pdf@2018-09-07 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_29.pdf@EU-1-98-058_h_a_dec_29.pdf@2021-08-26 00:00:00@Combivir@lamivudine / zidovudine@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_25.pdf@EU-1-97-050_h_a_dec_25.pdf@2010-12-13 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_37.pdf@EU-1-95-003_h_a_dec_37.pdf@2019-06-06 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_3.pdf@EU-1-98-058_h_a_dec_3.pdf@2000-12-27 00:00:00@ COMBIVIR lamivudine/zidovudine @Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@to Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_26.pdf@EU-1-97-050_h_a_dec_26.pdf@2011-03-18 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_38.pdf@EU-1-95-003_h_a_dec_38.pdf@2020-08-27 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_4.pdf@EU-1-98-058_h_a_dec_4.pdf@2001-07-31 00:00:00@COMBIVIR lamivudine/zidovudine@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_27.pdf@EU-1-97-050_h_a_dec_27.pdf@2011-06-17 00:00:00@Sifrol@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_39.pdf@EU-1-95-003_h_a_dec_39.pdf@2021-10-22 00:00:00@Betaferon@Interferon beta-1b@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_5.pdf@EU-1-98-058_h_a_dec_5.pdf@2002-08-22 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_28.pdf@EU-1-97-050_h_a_dec_28.pdf@2012-11-19 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_4.pdf@EU-1-95-003_h_a_dec_4.pdf@1997-05-22 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_6.pdf@EU-1-98-058_h_a_dec_6.pdf@2003-11-06 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_29.pdf@EU-1-97-050_h_a_dec_29.pdf@2012-10-12 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_5.pdf@EU-1-95-003_h_a_dec_5.pdf@1997-09-07 00:00:00@BETAFERON Interferon beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_7.pdf@EU-1-98-058_h_a_dec_7.pdf@2004-01-14 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_3.pdf@EU-1-97-050_h_a_dec_3.pdf@1999-11-16 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_6.pdf@EU-1-95-003_h_a_dec_6.pdf@1998-05-02 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-98-058_h_a_dec_8.pdf@EU-1-98-058_h_a_dec_8.pdf@2004-05-02 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_7.pdf@EU-1-95-003_h_a_dec_7.pdf@1998-08-07 00:00:00@BETAFERON Interferon beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_30.pdf@EU-1-97-050_h_a_dec_30.pdf@2014-02-28 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-058_h_a_dec_9.pdf@EU-1-98-058_h_a_dec_9.pdf@2004-05-26 00:00:00@Combivir@lamivudine/zidovudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA not available before 2006@Parsed
EU-1-95-003_h_a_dec_8.pdf@EU-1-95-003_h_a_dec_8.pdf@1998-11-11 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_31.pdf@EU-1-97-050_h_a_dec_31.pdf@2015-09-30 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-95-003_h_a_dec_9.pdf@EU-1-95-003_h_a_dec_9.pdf@1999-01-26 00:00:00@BETAFERON Interferon Beta-1b@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering AG@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_32.pdf@EU-1-97-050_h_a_dec_32.pdf@2017-02-16 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_33.pdf@EU-1-97-050_h_a_dec_33.pdf@2017-06-29 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-050_h_a_dec_34.pdf@EU-1-97-050_h_a_dec_34.pdf@2019-07-02 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_0.pdf@EU-1-97-047_h_a_dec_0.pdf@1997-08-27 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe, B.V.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_35.pdf@EU-1-97-050_h_a_dec_35.pdf@2020-02-17 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_1.pdf@EU-1-97-047_h_a_dec_1.pdf@1998-11-11 00:00:00@BENEFIX@nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_36.pdf@EU-1-97-050_h_a_dec_36.pdf@2021-11-10 00:00:00@Sifrol@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_10.pdf@EU-1-97-047_h_a_dec_10.pdf@2003-09-16 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_4.pdf@EU-1-97-050_h_a_dec_4.pdf@1999-11-29 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_11.pdf@EU-1-97-047_h_a_dec_11.pdf@2004-08-18 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_5.pdf@EU-1-97-050_h_a_dec_5.pdf@2000-08-21 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_12.pdf@EU-1-97-047_h_a_dec_12.pdf@2005-08-23 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_0.pdf@EU-1-98-063_h_a_dec_0.pdf@1998-05-04 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_6.pdf@EU-1-97-050_h_a_dec_6.pdf@2000-09-10 00:00:00@SIFROL@pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_13.pdf@EU-1-97-047_h_a_dec_13.pdf@2005-08-24 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_1.pdf@EU-1-98-063_h_a_dec_1.pdf@1999-01-02 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_7.pdf@EU-1-97-050_h_a_dec_7.pdf@2001-12-17 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_10.pdf@EU-1-98-063_h_a_dec_10.pdf@2001-09-18 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_8.pdf@EU-1-97-050_h_a_dec_8.pdf@2002-04-23 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_14.pdf@EU-1-97-047_h_a_dec_14.pdf@2005-12-23 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_11.pdf@EU-1-98-063_h_a_dec_11.pdf@2001-03-10 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-97-050_h_a_dec_9.pdf@EU-1-97-050_h_a_dec_9.pdf@2002-08-11 00:00:00@Sifrol@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_15.pdf@EU-1-97-047_h_a_dec_15.pdf@2006-02-28 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-064_h_a_dec_0.pdf@EU-1-98-064_h_a_dec_0.pdf@1998-07-05 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@NA before 2000@B.S.I.A. Limited@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_12.pdf@EU-1-98-063_h_a_dec_12.pdf@2001-11-20 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_16.pdf@EU-1-97-047_h_a_dec_16.pdf@2007-02-15 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@exceptional@Parsed
EU-1-98-064_h_a_dec_1.pdf@EU-1-98-064_h_a_dec_1.pdf@2001-05-03 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@OD Not Found@Cambridge Export N° 2 Limited@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_13.pdf@EU-1-98-063_h_a_dec_13.pdf@2002-02-04 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_17.pdf@EU-1-97-047_h_a_dec_17.pdf@2007-02-05 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_14.pdf@EU-1-98-063_h_a_dec_14.pdf@2002-05-17 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_18.pdf@EU-1-97-047_h_a_dec_18.pdf@2007-07-30 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_15.pdf@EU-1-98-063_h_a_dec_15.pdf@2003-01-16 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_10.pdf@EU-1-98-064_h_a_dec_10.pdf@2021-11-01 00:00:00@Pylobactell@¹³C-urea@False@False@OD Not Found@Torbet Laboratories Ireland Limited@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_16.pdf@EU-1-98-063_h_a_dec_16.pdf@2003-04-03 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_2.pdf@EU-1-98-064_h_a_dec_2.pdf@1980-01-01 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@NA before 2000@Cambridge Export N° 2 Limited@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_19.pdf@EU-1-97-047_h_a_dec_19.pdf@2007-07-30 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_17.pdf@EU-1-98-063_h_a_dec_17.pdf@2003-04-06 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_3.pdf@EU-1-98-064_h_a_dec_3.pdf@2002-03-10 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@OD Not Found@Torbet Laboratories Limited@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_2.pdf@EU-1-97-047_h_a_dec_2.pdf@1999-11-01 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_18.pdf@EU-1-98-063_h_a_dec_18.pdf@2003-06-25 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_4.pdf@EU-1-98-064_h_a_dec_4.pdf@2003-11-06 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@OD Not Found@Torbet Laboratories Limited@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_0.pdf@EU-1-98-069_h_a_dec_0.pdf@1998-07-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_20.pdf@EU-1-97-047_h_a_dec_20.pdf@2007-07-08 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_19.pdf@EU-1-98-063_h_a_dec_19.pdf@2004-02-23 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_5.pdf@EU-1-98-064_h_a_dec_5.pdf@2005-08-09 00:00:00@Pylobactell@13C-urea@NAS before 2012@NA before 2012@OD Not Found@Torbet Laboratories Limited@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_1.pdf@EU-1-98-069_h_a_dec_1.pdf@1999-01-02 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_21.pdf@EU-1-97-047_h_a_dec_21.pdf@2007-07-30 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_2.pdf@EU-1-98-063_h_a_dec_2.pdf@1999-03-29 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_10.pdf@EU-1-98-069_h_a_dec_10.pdf@2001-03-13 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_6.pdf@EU-1-98-064_h_a_dec_6.pdf@2008-07-29 00:00:00@Pylobactell@13C-urea@NAS before 2012@True@OD Not Found@Torbet Laboratories Limited@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_22.pdf@EU-1-97-047_h_a_dec_22.pdf@2007-07-08 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_20.pdf@EU-1-98-063_h_a_dec_20.pdf@2004-07-20 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_7.pdf@EU-1-98-064_h_a_dec_7.pdf@2012-10-10 00:00:00@Pylobactell@¹³C-urea@False@False@OD Not Found@Torbet Laboratories Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_11.pdf@EU-1-98-069_h_a_dec_11.pdf@2001-07-16 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_23.pdf@EU-1-97-047_h_a_dec_23.pdf@2008-02-14 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@exceptional@Parsed
EU-1-98-063_h_a_dec_21.pdf@EU-1-98-063_h_a_dec_21.pdf@2006-01-19 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_12.pdf@EU-1-98-069_h_a_dec_12.pdf@1980-01-01 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_24.pdf@EU-1-97-047_h_a_dec_24.pdf@2009-02-23 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@exceptional@Parsed
EU-1-98-069_h_a_dec_13.pdf@EU-1-98-069_h_a_dec_13.pdf@2002-01-28 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-064_h_a_dec_8.pdf@EU-1-98-064_h_a_dec_8.pdf@2018-09-07 00:00:00@Pylobactell@¹³C-urea@False@False@OD Not Found@Torbet Laboratories Limited@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_22.pdf@EU-1-98-063_h_a_dec_22.pdf@2006-05-31 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_14.pdf@EU-1-98-069_h_a_dec_14.pdf@2002-02-19 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_25.pdf@EU-1-97-047_h_a_dec_25.pdf@2009-04-22 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_23.pdf@EU-1-98-063_h_a_dec_23.pdf@2006-01-09 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_15.pdf@EU-1-98-069_h_a_dec_15.pdf@2002-06-19 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_26.pdf@EU-1-97-047_h_a_dec_26.pdf@2009-06-30 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-064_h_a_dec_9.pdf@EU-1-98-064_h_a_dec_9.pdf@2019-06-09 00:00:00@Pylobactell@¹³C-urea@False@False@OD Not Found@Torbet Laboratories Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_16.pdf@EU-1-98-069_h_a_dec_16.pdf@2002-09-09 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_24.pdf@EU-1-98-063_h_a_dec_24.pdf@2007-03-28 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_17.pdf@EU-1-98-069_h_a_dec_17.pdf@2003-03-02 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_27.pdf@EU-1-97-047_h_a_dec_27.pdf@2009-10-28 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_25.pdf@EU-1-98-063_h_a_dec_25.pdf@2007-10-08 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_18.pdf@EU-1-98-069_h_a_dec_18.pdf@2003-03-24 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_28.pdf@EU-1-97-047_h_a_dec_28.pdf@2010-03-15 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_0.pdf@EU-1-98-065_h_a_dec_0.pdf@1980-01-01 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@NA before 2000@MAH Not Found@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_19.pdf@EU-1-98-069_h_a_dec_19.pdf@2003-08-10 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_26.pdf@EU-1-98-063_h_a_dec_26.pdf@2007-12-14 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_1.pdf@EU-1-98-065_h_a_dec_1.pdf@1998-11-19 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@NA before 2000@Mallinckrodt  Medical GmbH@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_2.pdf@EU-1-98-069_h_a_dec_2.pdf@1999-06-16 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_29.pdf@EU-1-97-047_h_a_dec_29.pdf@2010-05-05 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@exceptional@Parsed
EU-1-98-063_h_a_dec_27.pdf@EU-1-98-063_h_a_dec_27.pdf@2008-05-20 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@True@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_10.pdf@EU-1-98-065_h_a_dec_10.pdf@2003-03-17 00:00:00@Optison@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Amersham Health AS@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_3.pdf@EU-1-97-047_h_a_dec_3.pdf@1999-03-29 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_20.pdf@EU-1-98-069_h_a_dec_20.pdf@2003-12-22 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_11.pdf@EU-1-98-065_h_a_dec_11.pdf@2003-05-15 00:00:00@Optison@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Amersham Health AS@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_28.pdf@EU-1-98-063_h_a_dec_28.pdf@2009-01-16 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_30.pdf@EU-1-97-047_h_a_dec_30.pdf@2010-07-13 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_21.pdf@EU-1-98-069_h_a_dec_21.pdf@2004-02-08 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_0.pdf@EU-1-97-051_h_a_dec_0.pdf@1998-02-23 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_12.pdf@EU-1-98-065_h_a_dec_12.pdf@2004-12-08 00:00:00@Optison@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Amersham Health AS@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_29.pdf@EU-1-98-063_h_a_dec_29.pdf@2009-04-22 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_1.pdf@EU-1-97-051_h_a_dec_1.pdf@1998-09-16 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_31.pdf@EU-1-97-047_h_a_dec_31.pdf@2011-03-14 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_22.pdf@EU-1-98-069_h_a_dec_22.pdf@2005-05-01 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_3.pdf@EU-1-98-063_h_a_dec_3.pdf@1999-03-12 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_10.pdf@EU-1-97-051_h_a_dec_10.pdf@2002-08-11 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Entreprises S.A.@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_13.pdf@EU-1-98-065_h_a_dec_13.pdf@2006-07-08 00:00:00@Optison@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Amersham Health AS@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_32.pdf@EU-1-97-047_h_a_dec_32.pdf@2011-06-23 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_23.pdf@EU-1-98-069_h_a_dec_23.pdf@2005-09-22 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_30.pdf@EU-1-98-063_h_a_dec_30.pdf@2009-01-07 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_11.pdf@EU-1-97-051_h_a_dec_11.pdf@2004-07-22 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Enterprises SARL@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_14.pdf@EU-1-98-065_h_a_dec_14.pdf@2007-07-20 00:00:00@Optison@Perflutren@NAS before 2012@NA before 2012@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_33.pdf@EU-1-97-047_h_a_dec_33.pdf@2012-07-20 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_24.pdf@EU-1-98-069_h_a_dec_24.pdf@2006-01-20 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_0.pdf@EU-1-98-073_h_a_dec_0.pdf@1998-05-08 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_31.pdf@EU-1-98-063_h_a_dec_31.pdf@2009-10-23 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_12.pdf@EU-1-97-051_h_a_dec_12.pdf@2004-10-28 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pfizer Enterprises SARL@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_34.pdf@EU-1-97-047_h_a_dec_34.pdf@2012-08-23 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_15.pdf@EU-1-98-065_h_a_dec_15.pdf@2008-12-06 00:00:00@Optison@Perflutren@NAS before 2012@True@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_25.pdf@EU-1-98-069_h_a_dec_25.pdf@2006-06-26 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_1.pdf@EU-1-98-073_h_a_dec_1.pdf@2000-01-31 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_13.pdf@EU-1-97-051_h_a_dec_13.pdf@2005-03-29 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_35.pdf@EU-1-97-047_h_a_dec_35.pdf@2013-02-18 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_32.pdf@EU-1-98-063_h_a_dec_32.pdf@2010-02-06 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_16.pdf@EU-1-98-065_h_a_dec_16.pdf@2009-08-10 00:00:00@Optison@Perflutren@NAS before 2012@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_26.pdf@EU-1-98-069_h_a_dec_26.pdf@2006-01-09 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_10.pdf@EU-1-98-073_h_a_dec_10.pdf@2006-10-31 00:00:00@Evista@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_33.pdf@EU-1-98-063_h_a_dec_33.pdf@2010-06-08 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_14.pdf@EU-1-97-051_h_a_dec_14.pdf@2006-06-04 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_27.pdf@EU-1-98-069_h_a_dec_27.pdf@2007-05-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_17.pdf@EU-1-98-065_h_a_dec_17.pdf@2010-12-20 00:00:00@Optison@Perflutren@NAS before 2012@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_36.pdf@EU-1-97-047_h_a_dec_36.pdf@2014-08-26 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
ly Nederland BV@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_34.pdf@EU-1-98-063_h_a_dec_34.pdf@2012-01-20 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Serono Europe  Limited@CMA Not Found@Parsed
 GmbH@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_28.pdf@EU-1-98-069_h_a_dec_28.pdf@2007-06-22 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_12.pdf@EU-1-98-073_h_a_dec_12.pdf@2007-03-28 00:00:00@Evista@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_35.pdf@EU-1-98-063_h_a_dec_35.pdf@2012-06-27 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Serono Europe  Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_16.pdf@EU-1-97-051_h_a_dec_16.pdf@2007-09-17 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_37.pdf@EU-1-97-047_h_a_dec_37.pdf@2015-08-20 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@exceptional@Parsed
EU-1-98-069_h_a_dec_29.pdf@EU-1-98-069_h_a_dec_29.pdf@2008-04-14 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_13.pdf@EU-1-98-073_h_a_dec_13.pdf@2007-11-19 00:00:00@Evista@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_17.pdf@EU-1-97-051_h_a_dec_17.pdf@2008-02-29 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_36.pdf@EU-1-98-063_h_a_dec_36.pdf@2014-02-20 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_3.pdf@EU-1-98-069_h_a_dec_3.pdf@1999-11-06 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_14.pdf@EU-1-98-073_h_a_dec_14.pdf@2008-08-08 00:00:00@Evista@Raloxifene hydrochloride@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_19.pdf@EU-1-98-065_h_a_dec_19.pdf@2019-10-21 00:00:00@Optison@Perflutren@False@False@OD Not Found@GE Healthcare AS@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_38.pdf@EU-1-97-047_h_a_dec_38.pdf@2016-10-21 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_18.pdf@EU-1-97-051_h_a_dec_18.pdf@2008-03-09 00:00:00@Mirapexin@Pramipexole@NAS before 2012@True@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_30.pdf@EU-1-98-069_h_a_dec_30.pdf@2008-06-19 00:00:00@Plavix@Clopidogrel@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_2.pdf@EU-1-98-065_h_a_dec_2.pdf@1999-06-29 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@NA before 2000@Mallinckrodt  Medical GmbH@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_37.pdf@EU-1-98-063_h_a_dec_37.pdf@2014-08-26 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_15.pdf@EU-1-98-073_h_a_dec_15.pdf@2008-08-22 00:00:00@Evista@Raloxifene hydrochloride@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_3.pdf@EU-1-98-065_h_a_dec_3.pdf@2000-10-23 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@OD Not Found@Mallinckrodt  Medical GmbH@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_19.pdf@EU-1-97-051_h_a_dec_19.pdf@2009-01-26 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_31.pdf@EU-1-98-069_h_a_dec_31.pdf@2009-01-26 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_39.pdf@EU-1-97-047_h_a_dec_39.pdf@2017-03-22 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_2.pdf@EU-1-97-051_h_a_dec_2.pdf@1999-01-10 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_4.pdf@EU-1-98-065_h_a_dec_4.pdf@2000-11-29 00:00:00@Optison@octafluoropropane@NAS before 2012@NA before 2012@OD Not Found@Mallinckrodt  Medical GmbH@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_16.pdf@EU-1-98-073_h_a_dec_16.pdf@2012-08-30 00:00:00@Evista@Raloxifene hydrochloride@False@False@OD Not Found@DAIICHI SANKYO  EUROPE GmbH@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_0.pdf@EU-1-97-031_h_a_dec_0.pdf@1998-02-04 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_4.pdf@EU-1-97-047_h_a_dec_4.pdf@1999-08-04 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_38.pdf@EU-1-98-063_h_a_dec_38.pdf@2016-07-22 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_32.pdf@EU-1-98-069_h_a_dec_32.pdf@2009-08-28 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_20.pdf@EU-1-97-051_h_a_dec_20.pdf@2009-04-17 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_5.pdf@EU-1-98-065_h_a_dec_5.pdf@2001-01-08 00:00:00@Optison@perflutren@NAS before 2012@NA before 2012@OD Not Found@Mallinckrodt  Medical GmbH@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_17.pdf@EU-1-98-073_h_a_dec_17.pdf@2018-10-29 00:00:00@Evista@Raloxifene hydrochloride@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
lable before 2006@Parsed
EU-1-98-069_h_a_dec_33.pdf@EU-1-98-069_h_a_dec_33.pdf@2010-03-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_6.pdf@EU-1-98-065_h_a_dec_6.pdf@1980-01-01 00:00:00@Optison@perflutren@NAS before 2012@NA before 2012@NA before 2000@Mallinckrodt  Medical GmbH@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_21.pdf@EU-1-97-051_h_a_dec_21.pdf@2009-08-10 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_10.pdf@EU-1-97-031_h_a_dec_10.pdf@2002-03-12 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_40.pdf@EU-1-97-047_h_a_dec_40.pdf@2018-07-06 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_18.pdf@EU-1-98-073_h_a_dec_18.pdf@2020-07-31 00:00:00@Evista@Raloxifene hydrochloride@False@False@OD Not Found@Daiichi Sankyo Europe GmbH@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_39.pdf@EU-1-98-063_h_a_dec_39.pdf@2018-07-13 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-065_h_a_dec_7.pdf@EU-1-98-065_h_a_dec_7.pdf@2002-04-18 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@OD Not Found@Mallinckrodt Medical GmbH@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_34.pdf@EU-1-98-069_h_a_dec_34.pdf@2010-04-29 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_11.pdf@EU-1-97-031_h_a_dec_11.pdf@2003-03-17 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_22.pdf@EU-1-97-051_h_a_dec_22.pdf@2010-10-06 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_19.pdf@EU-1-98-073_h_a_dec_19.pdf@2022-01-04 00:00:00@Evista@Raloxifene hydrochloride@False@False@OD Not Found@SUBSTIPHARM@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_4.pdf@EU-1-98-063_h_a_dec_4.pdf@1999-12-14 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_8.pdf@EU-1-98-065_h_a_dec_8.pdf@2002-04-29 00:00:00@Optison@Octafluoropropane@NAS before 2012@NA before 2012@OD Not Found@Amersham Health AS@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_41.pdf@EU-1-97-047_h_a_dec_41.pdf@2018-09-27 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_35.pdf@EU-1-98-069_h_a_dec_35.pdf@2010-07-27 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_12.pdf@EU-1-97-031_h_a_dec_12.pdf@2004-02-23 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_2.pdf@EU-1-98-073_h_a_dec_2.pdf@2000-03-24 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-065_h_a_dec_9.pdf@EU-1-98-065_h_a_dec_9.pdf@2002-11-20 00:00:00@Optison@Perflutren@NAS before 2012@NA before 2012@OD Not Found@Amersham Health AS@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_23.pdf@EU-1-97-051_h_a_dec_23.pdf@2010-06-17 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_42.pdf@EU-1-97-047_h_a_dec_42.pdf@2019-11-19 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_3.pdf@EU-1-98-073_h_a_dec_3.pdf@2001-06-03 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_36.pdf@EU-1-98-069_h_a_dec_36.pdf@2011-01-13 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_40.pdf@EU-1-98-063_h_a_dec_40.pdf@2020-10-15 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_13.pdf@EU-1-97-031_h_a_dec_13.pdf@2005-07-13 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_24.pdf@EU-1-97-051_h_a_dec_24.pdf@2010-01-07 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_43.pdf@EU-1-97-047_h_a_dec_43.pdf@2021-09-22 00:00:00@BeneFIX@Nonacog alfa@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_4.pdf@EU-1-98-073_h_a_dec_4.pdf@2001-10-31 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_37.pdf@EU-1-98-069_h_a_dec_37.pdf@2011-05-27 00:00:00@Plavix@Clopidogrel@NAS before 2012@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_14.pdf@EU-1-97-031_h_a_dec_14.pdf@2005-11-17 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_25.pdf@EU-1-97-051_h_a_dec_25.pdf@2010-10-25 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_5.pdf@EU-1-98-073_h_a_dec_5.pdf@2002-07-11 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-97-047_h_a_dec_5.pdf@EU-1-97-047_h_a_dec_5.pdf@2001-04-23 00:00:00@BENEFIX@nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_41.pdf@EU-1-98-063_h_a_dec_41.pdf@2021-12-13 00:00:00@Rebif@Interferon beta-1a@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_6.pdf@EU-1-98-073_h_a_dec_6.pdf@2002-11-20 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_38.pdf@EU-1-98-069_h_a_dec_38.pdf@2012-04-04 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_15.pdf@EU-1-97-031_h_a_dec_15.pdf@2007-04-01 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_26.pdf@EU-1-97-051_h_a_dec_26.pdf@2010-12-20 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_6.pdf@EU-1-97-047_h_a_dec_6.pdf@2001-04-23 00:00:00@BENEFIX@nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_5.pdf@EU-1-98-063_h_a_dec_5.pdf@2000-01-20 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@NA before 2000@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_0.pdf@EU-1-98-066_h_a_dec_0.pdf@2022-05-12 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-073_h_a_dec_7.pdf@EU-1-98-073_h_a_dec_7.pdf@2003-02-14 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_39.pdf@EU-1-98-069_h_a_dec_39.pdf@2012-10-29 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_16.pdf@EU-1-97-031_h_a_dec_16.pdf@2007-06-25 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_6.pdf@EU-1-98-063_h_a_dec_6.pdf@2000-08-12 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_27.pdf@EU-1-97-051_h_a_dec_27.pdf@2011-03-18 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_8.pdf@EU-1-97-047_h_a_dec_8.pdf@2002-05-02 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetic Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_8.pdf@EU-1-98-073_h_a_dec_8.pdf@2003-06-26 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_1.pdf@EU-1-98-066_h_a_dec_1.pdf@1999-02-06 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_4.pdf@EU-1-98-069_h_a_dec_4.pdf@1999-08-07 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-073_h_a_dec_9.pdf@EU-1-98-073_h_a_dec_9.pdf@2003-07-28 00:00:00@EVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_7.pdf@EU-1-98-063_h_a_dec_7.pdf@2001-01-22 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_17.pdf@EU-1-97-031_h_a_dec_17.pdf@2008-02-26 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_28.pdf@EU-1-97-051_h_a_dec_28.pdf@2011-06-17 00:00:00@Mirapexin@Pramipexole@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-97-047_h_a_dec_9.pdf@EU-1-97-047_h_a_dec_9.pdf@2003-03-02 00:00:00@BeneFIX@Nonacog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_10.pdf@EU-1-98-066_h_a_dec_10.pdf@2001-12-17 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_40.pdf@EU-1-98-069_h_a_dec_40.pdf@2013-05-30 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_29.pdf@EU-1-97-051_h_a_dec_29.pdf@2012-11-19 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-98-063_h_a_dec_8.pdf@EU-1-98-063_h_a_dec_8.pdf@2001-03-20 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_11.pdf@EU-1-98-066_h_a_dec_11.pdf@2002-03-13 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_18.pdf@EU-1-97-031_h_a_dec_18.pdf@2008-10-23 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_41.pdf@EU-1-98-069_h_a_dec_41.pdf@2013-07-17 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_3.pdf@EU-1-97-051_h_a_dec_3.pdf@1999-10-26 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_12.pdf@EU-1-98-066_h_a_dec_12.pdf@2002-10-09 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-063_h_a_dec_9.pdf@EU-1-98-063_h_a_dec_9.pdf@2001-07-19 00:00:00@Rebif@Interferon beta-1a@NAS before 2012@NA before 2012@OD Not Found@Ares Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_19.pdf@EU-1-97-031_h_a_dec_19.pdf@2009-11-20 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_42.pdf@EU-1-98-069_h_a_dec_42.pdf@2013-07-26 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_13.pdf@EU-1-98-066_h_a_dec_13.pdf@2003-07-01 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_30.pdf@EU-1-97-051_h_a_dec_30.pdf@2012-11-30 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_14.pdf@EU-1-98-066_h_a_dec_14.pdf@2003-06-30 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_2.pdf@EU-1-97-031_h_a_dec_2.pdf@1998-11-11 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Boehringer Mannheim GmbH@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_0.pdf@EU-1-98-074_h_a_dec_0.pdf@1998-05-08 00:00:00@CELVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_31.pdf@EU-1-97-051_h_a_dec_31.pdf@2014-02-28 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_1.pdf@EU-1-98-074_h_a_dec_1.pdf@1999-11-05 00:00:00@OPTRUMA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_15.pdf@EU-1-98-066_h_a_dec_15.pdf@2004-04-03 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_20.pdf@EU-1-97-031_h_a_dec_20.pdf@2010-01-20 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_10.pdf@EU-1-98-074_h_a_dec_10.pdf@2003-01-31 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_32.pdf@EU-1-97-051_h_a_dec_32.pdf@2015-08-10 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_11.pdf@EU-1-98-074_h_a_dec_11.pdf@2003-02-14 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_21.pdf@EU-1-97-031_h_a_dec_21.pdf@2010-04-29 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_45.pdf@EU-1-98-069_h_a_dec_45.pdf@2017-03-29 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_33.pdf@EU-1-97-051_h_a_dec_33.pdf@2017-02-16 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_12.pdf@EU-1-98-074_h_a_dec_12.pdf@2003-06-26 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_46.pdf@EU-1-98-069_h_a_dec_46.pdf@2018-05-28 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_17.pdf@EU-1-98-066_h_a_dec_17.pdf@2006-02-28 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_13.pdf@EU-1-98-074_h_a_dec_13.pdf@2003-07-28 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_34.pdf@EU-1-97-051_h_a_dec_34.pdf@2017-06-29 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_22.pdf@EU-1-97-031_h_a_dec_22.pdf@2011-06-10 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_47.pdf@EU-1-98-069_h_a_dec_47.pdf@2018-10-25 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_18.pdf@EU-1-98-066_h_a_dec_18.pdf@2006-10-26 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_35.pdf@EU-1-97-051_h_a_dec_35.pdf@2019-06-02 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_14.pdf@EU-1-98-074_h_a_dec_14.pdf@2006-10-31 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_49.pdf@EU-1-98-069_h_a_dec_49.pdf@2019-04-10 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_23.pdf@EU-1-97-031_h_a_dec_23.pdf@2016-07-15 00:00:00@NeoRecormon@Epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_15.pdf@EU-1-98-074_h_a_dec_15.pdf@2006-11-22 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not FoundEU-1-97-051_h_a_dec_36.pdf@EU-1-97-051_h_a_dec_36.pdf@2020-02-21 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_5.pdf@EU-1-98-069_h_a_dec_5.pdf@1999-07-09 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_2.pdf@EU-1-98-066_h_a_dec_2.pdf@1999-08-07 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_37.pdf@EU-1-97-051_h_a_dec_37.pdf@2021-10-19 00:00:00@Mirapexin@pramipexole@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_16.pdf@EU-1-98-074_h_a_dec_16.pdf@2007-03-27 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_4.pdf@EU-1-97-051_h_a_dec_4.pdf@1999-11-29 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@NA before 2000@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_50.pdf@EU-1-98-069_h_a_dec_50.pdf@2019-11-14 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_20.pdf@EU-1-98-066_h_a_dec_20.pdf@2008-05-20 00:00:00@Exelon@Rivastigmine@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_24.pdf@EU-1-97-031_h_a_dec_24.pdf@2018-03-15 00:00:00@NeoRecormon@Epoetin beta@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_17.pdf@EU-1-98-074_h_a_dec_17.pdf@2007-11-19 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_5.pdf@EU-1-97-051_h_a_dec_5.pdf@2000-07-27 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_51.pdf@EU-1-98-069_h_a_dec_51.pdf@2020-11-18 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_25.pdf@EU-1-97-031_h_a_dec_25.pdf@2021-11-26 00:00:00@NeoRecormon@Epoetin beta@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_21.pdf@EU-1-98-066_h_a_dec_21.pdf@2009-01-30 00:00:00@Exelon@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_18.pdf@EU-1-98-074_h_a_dec_18.pdf@2008-11-08 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_6.pdf@EU-1-97-051_h_a_dec_6.pdf@2000-10-20 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pharmacia & Upjohn S.A.@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_52.pdf@EU-1-98-069_h_a_dec_52.pdf@2021-01-29 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_3.pdf@EU-1-97-031_h_a_dec_3.pdf@1999-07-05 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_22.pdf@EU-1-98-066_h_a_dec_22.pdf@2010-03-23 00:00:00@Exelon@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_19.pdf@EU-1-98-074_h_a_dec_19.pdf@2012-08-30 00:00:00@Optruma@Raloxifene hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_7.pdf@EU-1-97-051_h_a_dec_7.pdf@2001-12-11 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Entreprises S.A.@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_53.pdf@EU-1-98-069_h_a_dec_53.pdf@2021-05-21 00:00:00@Plavix@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_4.pdf@EU-1-97-031_h_a_dec_4.pdf@1999-01-07 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_2.pdf@EU-1-98-074_h_a_dec_2.pdf@1999-11-06 00:00:00@CELVISTA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_23.pdf@EU-1-98-066_h_a_dec_23.pdf@2010-04-27 00:00:00@Exelon@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_6.pdf@EU-1-98-069_h_a_dec_6.pdf@2000-03-05 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-97-051_h_a_dec_8.pdf@EU-1-97-051_h_a_dec_8.pdf@2001-11-13 00:00:00@Mirapexin@pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Entreprises S.A.@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_5.pdf@EU-1-97-031_h_a_dec_5.pdf@2000-10-02 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_20.pdf@EU-1-98-074_h_a_dec_20.pdf@2017-08-02 00:00:00@Optruma@Raloxifene hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_7.pdf@EU-1-98-069_h_a_dec_7.pdf@2000-07-13 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_24.pdf@EU-1-98-066_h_a_dec_24.pdf@2011-03-17 00:00:00@Exelon@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-97-051_h_a_dec_9.pdf@EU-1-97-051_h_a_dec_9.pdf@2002-04-18 00:00:00@Mirapexin@Pramipexole@NAS before 2012@NA before 2012@OD Not Found@Pharmacia Entreprises S.A.@CMA not available before 2006@Parsed
EU-1-97-031_h_a_dec_6.pdf@EU-1-97-031_h_a_dec_6.pdf@2000-10-02 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_0.pdf@EU-1-98-076_h_a_dec_0.pdf@1998-08-17 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_21.pdf@EU-1-98-074_h_a_dec_21.pdf@2018-07-19 00:00:00@Optruma@Raloxifene hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-98-069_h_a_dec_8.pdf@EU-1-98-069_h_a_dec_8.pdf@2000-09-25 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_25.pdf@EU-1-98-066_h_a_dec_25.pdf@2011-05-23 00:00:00@Exelon@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_7.pdf@EU-1-97-031_h_a_dec_7.pdf@2001-03-20 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_1.pdf@EU-1-98-076_h_a_dec_1.pdf@2000-01-20 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-069_h_a_dec_9.pdf@EU-1-98-069_h_a_dec_9.pdf@2001-01-15 00:00:00@Plavix@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_26.pdf@EU-1-98-066_h_a_dec_26.pdf@2011-11-16 00:00:00@Exelon@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_8.pdf@EU-1-97-031_h_a_dec_8.pdf@1980-01-01 00:00:00@NEORECORMON@Epoetin beta@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd.@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_10.pdf@EU-1-98-076_h_a_dec_10.pdf@2004-03-31 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_22.pdf@EU-1-98-074_h_a_dec_22.pdf@2022-06-29 00:00:00@Optruma@Raloxifene hydrochloride@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-97-031_h_a_dec_9.pdf@EU-1-97-031_h_a_dec_9.pdf@2002-08-22 00:00:00@NeoRecormon@Epoetin beta@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_27.pdf@EU-1-98-066_h_a_dec_27.pdf@2012-04-20 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_3.pdf@EU-1-98-074_h_a_dec_3.pdf@2000-01-31 00:00:00@OPTRUMA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_11.pdf@EU-1-98-076_h_a_dec_11.pdf@2005-02-02 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_0.pdf@EU-1-98-080_h_a_dec_0.pdf@1998-09-18 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@NA before 2000@Laboratoires 3M Santé@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_28.pdf@EU-1-98-066_h_a_dec_28.pdf@2013-01-14 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_4.pdf@EU-1-98-074_h_a_dec_4.pdf@2000-03-24 00:00:00@OPTRUMA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_1.pdf@EU-1-98-080_h_a_dec_1.pdf@2000-09-03 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_12.pdf@EU-1-98-076_h_a_dec_12.pdf@2006-05-29 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_5.pdf@EU-1-98-074_h_a_dec_5.pdf@2001-06-03 00:00:00@OPTRUMA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_29.pdf@EU-1-98-066_h_a_dec_29.pdf@2014-07-04 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_13.pdf@EU-1-98-076_h_a_dec_13.pdf@2007-06-29 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_10.pdf@EU-1-98-080_h_a_dec_10.pdf@2006-04-27 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@Laboratoires 3M Santé@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_6.pdf@EU-1-98-074_h_a_dec_6.pdf@2001-07-26 00:00:00@OPTRUMA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_3.pdf@EU-1-98-066_h_a_dec_3.pdf@1999-08-07 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_14.pdf@EU-1-98-076_h_a_dec_14.pdf@2007-06-29 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_11.pdf@EU-1-98-080_h_a_dec_11.pdf@2006-01-09 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@Laboratoires 3M Santé@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_7.pdf@EU-1-98-074_h_a_dec_7.pdf@2001-10-31 00:00:00@OPTRUMA@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V@CMA not available before 2006@Parsed
EU-1-98-074_h_a_dec_8.pdf@EU-1-98-074_h_a_dec_8.pdf@2002-04-19 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_15.pdf@EU-1-98-076_h_a_dec_15.pdf@2008-07-23 00:00:00@NovoNorm@Repaglinide@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_12.pdf@EU-1-98-080_h_a_dec_12.pdf@2006-11-29 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@Laboratoires 3M Santé@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_30.pdf@EU-1-98-066_h_a_dec_30.pdf@2015-11-19 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-074_h_a_dec_9.pdf@EU-1-98-074_h_a_dec_9.pdf@2002-07-11 00:00:00@Optruma@Raloxifene hydrochloride@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_16.pdf@EU-1-98-076_h_a_dec_16.pdf@2008-12-17 00:00:00@NovoNorm@Repaglinide@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_13.pdf@EU-1-98-080_h_a_dec_13.pdf@2007-04-24 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@Laboratoires 3M Santé@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_17.pdf@EU-1-98-076_h_a_dec_17.pdf@2012-04-20 00:00:00@NovoNorm@Repaglinide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_31.pdf@EU-1-98-066_h_a_dec_31.pdf@2018-04-23 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_14.pdf@EU-1-98-080_h_a_dec_14.pdf@2007-08-30 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@Laboratoires 3M Santé@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_18.pdf@EU-1-98-076_h_a_dec_18.pdf@2015-11-19 00:00:00@NovoNorm@Repaglinide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_15.pdf@EU-1-98-080_h_a_dec_15.pdf@2008-07-07 00:00:00@Aldara@Imiquimod@NAS before 2012@True@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_0.pdf@EU-1-98-070_h_a_dec_0.pdf@2022-11-15 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_32.pdf@EU-1-98-066_h_a_dec_32.pdf@2020-10-19 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_19.pdf@EU-1-98-076_h_a_dec_19.pdf@2017-04-28 00:00:00@NovoNorm@Repaglinide@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_0.pdf@EU-1-98-084_h_a_dec_0.pdf@1998-09-10 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_1.pdf@EU-1-98-070_h_a_dec_1.pdf@1999-11-06 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_16.pdf@EU-1-98-080_h_a_dec_16.pdf@2008-03-09 00:00:00@Aldara@Imiquimod@NAS before 2012@True@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_2.pdf@EU-1-98-076_h_a_dec_2.pdf@2001-01-22 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_1.pdf@EU-1-98-084_h_a_dec_1.pdf@1999-07-29 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_10.pdf@EU-1-98-070_h_a_dec_10.pdf@2002-01-29 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_33.pdf@EU-1-98-066_h_a_dec_33.pdf@2021-09-12 00:00:00@Exelon@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_17.pdf@EU-1-98-080_h_a_dec_17.pdf@2008-03-09 00:00:00@Aldara@Imiquimod@NAS before 2012@True@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_3.pdf@EU-1-98-076_h_a_dec_3.pdf@2001-01-29 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_11.pdf@EU-1-98-070_h_a_dec_11.pdf@2002-02-19 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_10.pdf@EU-1-98-084_h_a_dec_10.pdf@2003-04-06 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_4.pdf@EU-1-98-066_h_a_dec_4.pdf@2000-12-04 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_18.pdf@EU-1-98-080_h_a_dec_18.pdf@2009-08-28 00:00:00@Aldara@Imiquimod@NAS before 2012@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_4.pdf@EU-1-98-076_h_a_dec_4.pdf@2001-05-03 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_12.pdf@EU-1-98-070_h_a_dec_12.pdf@2002-02-19 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_11.pdf@EU-1-98-084_h_a_dec_11.pdf@2003-10-20 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_5.pdf@EU-1-98-066_h_a_dec_5.pdf@2000-01-12 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_19.pdf@EU-1-98-080_h_a_dec_19.pdf@2010-03-15 00:00:00@Aldara@Imiquimod@NAS before 2012@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_13.pdf@EU-1-98-070_h_a_dec_13.pdf@2002-06-19 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_5.pdf@EU-1-98-076_h_a_dec_5.pdf@2001-09-17 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_6.pdf@EU-1-98-066_h_a_dec_6.pdf@2000-01-12 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_2.pdf@EU-1-98-080_h_a_dec_2.pdf@2000-01-08 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@NA before 2000@3M Santé@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_12.pdf@EU-1-98-084_h_a_dec_12.pdf@2005-08-07 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_14.pdf@EU-1-98-070_h_a_dec_14.pdf@2002-09-09 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_6.pdf@EU-1-98-076_h_a_dec_6.pdf@2002-01-28 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_7.pdf@EU-1-98-066_h_a_dec_7.pdf@2001-03-20 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_15.pdf@EU-1-98-070_h_a_dec_15.pdf@2003-03-02 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_20.pdf@EU-1-98-080_h_a_dec_20.pdf@2010-04-27 00:00:00@Aldara@Imiquimod@NAS before 2012@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-076_h_a_dec_7.pdf@EU-1-98-076_h_a_dec_7.pdf@2002-09-09 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_13.pdf@EU-1-98-084_h_a_dec_13.pdf@2006-01-31 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-066_h_a_dec_8.pdf@EU-1-98-066_h_a_dec_8.pdf@2001-01-08 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_16.pdf@EU-1-98-070_h_a_dec_16.pdf@2003-03-20 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_8.pdf@EU-1-98-076_h_a_dec_8.pdf@2003-01-08 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_21.pdf@EU-1-98-080_h_a_dec_21.pdf@2016-02-18 00:00:00@Aldara@Imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_14.pdf@EU-1-98-084_h_a_dec_14.pdf@2007-09-07 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_17.pdf@EU-1-98-070_h_a_dec_17.pdf@2003-12-05 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-066_h_a_dec_9.pdf@EU-1-98-066_h_a_dec_9.pdf@2001-11-15 00:00:00@Exelon@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-076_h_a_dec_9.pdf@EU-1-98-076_h_a_dec_9.pdf@2003-08-10 00:00:00@NovoNorm@Repaglinide@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_22.pdf@EU-1-98-080_h_a_dec_22.pdf@2016-12-12 00:00:00@Aldara@Imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_18.pdf@EU-1-98-070_h_a_dec_18.pdf@2003-08-10 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_15.pdf@EU-1-98-084_h_a_dec_15.pdf@2008-08-10 00:00:00@Simulect@basiliximab@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_0.pdf@EU-1-98-089_h_a_dec_0.pdf@1998-11-12 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_1.pdf@EU-1-98-089_h_a_dec_1.pdf@1999-06-18 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_19.pdf@EU-1-98-070_h_a_dec_19.pdf@2003-12-22 00:00:00@Brand name Not Found@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_16.pdf@EU-1-98-084_h_a_dec_16.pdf@2011-03-18 00:00:00@Simulect@basiliximab@NAS before 2012@False@OD Not Found@Novartis  Europharm Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_10.pdf@EU-1-98-089_h_a_dec_10.pdf@2003-06-03 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_23.pdf@EU-1-98-080_h_a_dec_23.pdf@2019-12-06 00:00:00@Aldara@Imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_2.pdf@EU-1-98-070_h_a_dec_2.pdf@1999-06-16 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_11.pdf@EU-1-98-089_h_a_dec_11.pdf@2003-07-28 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_17.pdf@EU-1-98-084_h_a_dec_17.pdf@2011-12-14 00:00:00@Simulect@basiliximab@NAS before 2012@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_20.pdf@EU-1-98-070_h_a_dec_20.pdf@2004-02-08 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_12.pdf@EU-1-98-089_h_a_dec_12.pdf@2004-09-01 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_18.pdf@EU-1-98-084_h_a_dec_18.pdf@2012-01-30 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm  Ltd@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_24.pdf@EU-1-98-080_h_a_dec_24.pdf@2020-09-12 00:00:00@Aldara@Imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_21.pdf@EU-1-98-070_h_a_dec_21.pdf@2004-12-22 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_13.pdf@EU-1-98-089_h_a_dec_13.pdf@2004-07-12 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_19.pdf@EU-1-98-084_h_a_dec_19.pdf@2012-06-07 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_2.pdf@EU-1-98-084_h_a_dec_2.pdf@1999-07-29 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_14.pdf@EU-1-98-089_h_a_dec_14.pdf@2006-02-17 00:00:00@Pritor@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_25.pdf@EU-1-98-080_h_a_dec_25.pdf@2022-04-13 00:00:00@Aldara@Imiquimod@False@False@OD Not Found@Meda AB@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_22.pdf@EU-1-98-070_h_a_dec_22.pdf@2005-09-22 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_15.pdf@EU-1-98-089_h_a_dec_15.pdf@2006-03-22 00:00:00@Pritor@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_20.pdf@EU-1-98-084_h_a_dec_20.pdf@2014-04-09 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_0.pdf@EU-1-98-077_h_a_dec_0.pdf@1998-09-14 00:00:00@VIAGRA@sildenafil@NAS before 2012@NA before 2012@NA before 2000@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_16.pdf@EU-1-98-089_h_a_dec_16.pdf@2006-10-27 00:00:00@Pritor@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_3.pdf@EU-1-98-080_h_a_dec_3.pdf@2001-11-21 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@Laboratoires 3M Santé@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_23.pdf@EU-1-98-070_h_a_dec_23.pdf@2006-01-20 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_1.pdf@EU-1-98-077_h_a_dec_1.pdf@1999-09-08 00:00:00@VIAGRA sildenafil@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_17.pdf@EU-1-98-089_h_a_dec_17.pdf@2007-08-01 00:00:00@Pritor@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_21.pdf@EU-1-98-084_h_a_dec_21.pdf@2015-11-19 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_4.pdf@EU-1-98-080_h_a_dec_4.pdf@2003-06-13 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_24.pdf@EU-1-98-070_h_a_dec_24.pdf@2006-06-26 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_10.pdf@EU-1-98-077_h_a_dec_10.pdf@2002-04-12 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_5.pdf@EU-1-98-080_h_a_dec_5.pdf@2003-06-26 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_18.pdf@EU-1-98-089_h_a_dec_18.pdf@2007-02-27 00:00:00@Pritor@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_11.pdf@EU-1-98-077_h_a_dec_11.pdf@2003-07-29 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_25.pdf@EU-1-98-070_h_a_dec_25.pdf@2006-01-09 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-080_h_a_dec_6.pdf@EU-1-98-080_h_a_dec_6.pdf@2003-10-24 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_22.pdf@EU-1-98-084_h_a_dec_22.pdf@2018-02-19 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_19.pdf@EU-1-98-089_h_a_dec_19.pdf@2008-02-07 00:00:00@Pritor@telmisartan@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_12.pdf@EU-1-98-077_h_a_dec_12.pdf@2003-11-11 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_7.pdf@EU-1-98-080_h_a_dec_7.pdf@2004-01-27 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_2.pdf@EU-1-98-089_h_a_dec_2.pdf@1999-09-15 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_26.pdf@EU-1-98-070_h_a_dec_26.pdf@2007-05-15 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_13.pdf@EU-1-98-077_h_a_dec_13.pdf@2004-05-26 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_8.pdf@EU-1-98-080_h_a_dec_8.pdf@2004-07-13 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_23.pdf@EU-1-98-084_h_a_dec_23.pdf@2018-12-04 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_27.pdf@EU-1-98-070_h_a_dec_27.pdf@2007-06-21 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_20.pdf@EU-1-98-089_h_a_dec_20.pdf@2008-11-19 00:00:00@Pritor@telmisartan@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_14.pdf@EU-1-98-077_h_a_dec_14.pdf@2005-03-29 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-080_h_a_dec_9.pdf@EU-1-98-080_h_a_dec_9.pdf@2005-10-28 00:00:00@Aldara@Imiquimod@NAS before 2012@NA before 2012@OD Not Found@3M Santé@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_28.pdf@EU-1-98-070_h_a_dec_28.pdf@2008-04-16 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_21.pdf@EU-1-98-089_h_a_dec_21.pdf@2009-03-17 00:00:00@PritorPlus@Telmisartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_24.pdf@EU-1-98-084_h_a_dec_24.pdf@2020-09-30 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_15.pdf@EU-1-98-077_h_a_dec_15.pdf@2005-04-27 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_29.pdf@EU-1-98-070_h_a_dec_29.pdf@2008-06-19 00:00:00@Iscover@Clopidogrel@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_22.pdf@EU-1-98-089_h_a_dec_22.pdf@2022-12-01 00:00:01@Pritor@telmisartan@False@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_16.pdf@EU-1-98-077_h_a_dec_16.pdf@2005-11-15 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_3.pdf@EU-1-98-070_h_a_dec_3.pdf@1999-08-07 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_23.pdf@EU-1-98-089_h_a_dec_23.pdf@2009-05-26 00:00:00@Pritor@telmisartan@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_25.pdf@EU-1-98-084_h_a_dec_25.pdf@2021-11-29 00:00:00@Simulect@basiliximab@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_17.pdf@EU-1-98-077_h_a_dec_17.pdf@2006-08-06 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_30.pdf@EU-1-98-070_h_a_dec_30.pdf@2009-01-27 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-084_h_a_dec_3.pdf@EU-1-98-084_h_a_dec_3.pdf@2000-08-02 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_24.pdf@EU-1-98-089_h_a_dec_24.pdf@2009-11-23 00:00:00@Pritor@telmisartan@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_0.pdf@EU-1-98-092_h_a_dec_0.pdf@1998-04-12 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_18.pdf@EU-1-98-077_h_a_dec_18.pdf@2008-03-17 00:00:00@Viagra@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Ltd@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_1.pdf@EU-1-98-092_h_a_dec_1.pdf@1999-02-07 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_4.pdf@EU-1-98-084_h_a_dec_4.pdf@2000-11-07 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Ltd@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_31.pdf@EU-1-98-070_h_a_dec_31.pdf@2009-08-27 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_25.pdf@EU-1-98-089_h_a_dec_25.pdf@2011-02-21 00:00:00@Pritor@telmisartan@NAS before 2012@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_0.pdf@EU-1-98-081_h_a_dec_0.pdf@1998-09-22 00:00:00@COMTAN@entacapone@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_10.pdf@EU-1-98-092_h_a_dec_10.pdf@2002-05-03 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_5.pdf@EU-1-98-084_h_a_dec_5.pdf@2000-01-12 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@NA before 2000@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_26.pdf@EU-1-98-089_h_a_dec_26.pdf@2011-02-05 00:00:00@Pritor@telmisartan@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_19.pdf@EU-1-98-077_h_a_dec_19.pdf@2008-08-26 00:00:00@Viagra@sildenafil@NAS before 2012@True@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_32.pdf@EU-1-98-070_h_a_dec_32.pdf@2010-03-15 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_1.pdf@EU-1-98-081_h_a_dec_1.pdf@1980-01-01 00:00:00@COMTAN entacapone@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@"Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_11.pdf@EU-1-98-092_h_a_dec_11.pdf@2002-10-17 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_0.pdf@EU-1-98-067_h_a_dec_0.pdf@1998-02-06 00:00:00@MABTHERA@Rituximab@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_2.pdf@EU-1-98-077_h_a_dec_2.pdf@1999-12-14 00:00:00@VIAGRA sildenafil@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_6.pdf@EU-1-98-084_h_a_dec_6.pdf@2001-03-26 00:00:00@SIMULECT@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_27.pdf@EU-1-98-089_h_a_dec_27.pdf@2012-08-03 00:00:00@Pritor@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_33.pdf@EU-1-98-070_h_a_dec_33.pdf@2010-04-29 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_12.pdf@EU-1-98-092_h_a_dec_12.pdf@2002-12-18 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_10.pdf@EU-1-98-081_h_a_dec_10.pdf@2007-02-27 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_1.pdf@EU-1-98-067_h_a_dec_1.pdf@1999-06-18 00:00:00@MABTHERA rituximab@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd 40 Broadwater Road@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_7.pdf@EU-1-98-084_h_a_dec_7.pdf@2002-02-04 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_28.pdf@EU-1-98-089_h_a_dec_28.pdf@2012-05-25 00:00:00@Pritor@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_34.pdf@EU-1-98-070_h_a_dec_34.pdf@2010-07-27 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_20.pdf@EU-1-98-077_h_a_dec_20.pdf@2010-01-07 00:00:00@Viagra@sildenafil@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
ed@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_11.pdf@EU-1-98-081_h_a_dec_11.pdf@2008-03-09 00:00:00@Comtan@entacapone@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_10.pdf@EU-1-98-067_h_a_dec_10.pdf@2003-07-28 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_14.pdf@EU-1-98-092_h_a_dec_14.pdf@2003-09-22 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-084_h_a_dec_8.pdf@EU-1-98-084_h_a_dec_8.pdf@2003-07-03 00:00:00@Simulect@basiliximab@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_29.pdf@EU-1-98-089_h_a_dec_29.pdf@2012-12-18 00:00:00@Pritor@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_21.pdf@EU-1-98-077_h_a_dec_21.pdf@2013-04-17 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_35.pdf@EU-1-98-070_h_a_dec_35.pdf@2011-01-13 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_11.pdf@EU-1-98-067_h_a_dec_11.pdf@2004-01-14 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_12.pdf@EU-1-98-081_h_a_dec_12.pdf@2010-10-06 00:00:00@Comtan@entacapone@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_15.pdf@EU-1-98-092_h_a_dec_15.pdf@2004-04-03 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_3.pdf@EU-1-98-089_h_a_dec_3.pdf@2000-09-03 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
2006@Parsed
EU-1-98-070_h_a_dec_36.pdf@EU-1-98-070_h_a_dec_36.pdf@2011-05-27 00:00:00@Iscover@Clopidogrel@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_22.pdf@EU-1-98-077_h_a_dec_22.pdf@2014-07-14 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_13.pdf@EU-1-98-081_h_a_dec_13.pdf@2012-08-10 00:00:00@Comtan@entacapone@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_30.pdf@EU-1-98-089_h_a_dec_30.pdf@2013-05-29 00:00:00@Pritor@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_12.pdf@EU-1-98-067_h_a_dec_12.pdf@2004-03-19 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_16.pdf@EU-1-98-092_h_a_dec_16.pdf@2004-04-03 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_37.pdf@EU-1-98-070_h_a_dec_37.pdf@2013-03-13 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_23.pdf@EU-1-98-077_h_a_dec_23.pdf@2015-09-23 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_13.pdf@EU-1-98-067_h_a_dec_13.pdf@2004-02-08 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_38.pdf@EU-1-98-070_h_a_dec_38.pdf@2013-05-30 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_14.pdf@EU-1-98-081_h_a_dec_14.pdf@2013-12-20 00:00:00@Comtan@entacapone@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_31.pdf@EU-1-98-089_h_a_dec_31.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)4288 for “Pritor@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_17.pdf@EU-1-98-092_h_a_dec_17.pdf@2006-02-03 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_14.pdf@EU-1-98-067_h_a_dec_14.pdf@2005-07-03 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_39.pdf@EU-1-98-070_h_a_dec_39.pdf@2013-07-17 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_24.pdf@EU-1-98-077_h_a_dec_24.pdf@2016-01-22 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_32.pdf@EU-1-98-089_h_a_dec_32.pdf@2018-04-13 00:00:00@Pritor@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_18.pdf@EU-1-98-092_h_a_dec_18.pdf@2006-10-24 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_4.pdf@EU-1-98-070_h_a_dec_4.pdf@1999-07-09 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@NA before 2000@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_15.pdf@EU-1-98-081_h_a_dec_15.pdf@2015-11-11 00:00:00@Comtan@entacapone@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_15.pdf@EU-1-98-067_h_a_dec_15.pdf@2005-11-15 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_33.pdf@EU-1-98-089_h_a_dec_33.pdf@2021-11-26 00:00:00@Pritor@telmisartan@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_40.pdf@EU-1-98-070_h_a_dec_40.pdf@2013-07-26 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_25.pdf@EU-1-98-077_h_a_dec_25.pdf@2017-09-01 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_19.pdf@EU-1-98-092_h_a_dec_19.pdf@2007-09-25 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_16.pdf@EU-1-98-067_h_a_dec_16.pdf@2006-03-20 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_4.pdf@EU-1-98-089_h_a_dec_4.pdf@2000-07-27 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_0.pdf@EU-1-98-085_h_a_dec_0.pdf@1998-10-16 00:00:00@KARVEZIDE@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Bristol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_16.pdf@EU-1-98-081_h_a_dec_16.pdf@2018-04-19 00:00:00@Comtan@entacapone@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_17.pdf@EU-1-98-067_h_a_dec_17.pdf@2006-06-07 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_2.pdf@EU-1-98-092_h_a_dec_2.pdf@2000-12-04 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_41.pdf@EU-1-98-070_h_a_dec_41.pdf@2014-01-10 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
tol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_5.pdf@EU-1-98-089_h_a_dec_5.pdf@2001-02-02 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_20.pdf@EU-1-98-092_h_a_dec_20.pdf@2008-05-21 00:00:00@Prometax@Rivastigmine@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_10.pdf@EU-1-98-085_h_a_dec_10.pdf@2002-10-04 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_18.pdf@EU-1-98-067_h_a_dec_18.pdf@2007-12-01 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_26.pdf@EU-1-98-077_h_a_dec_26.pdf@2018-07-30 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_6.pdf@EU-1-98-089_h_a_dec_6.pdf@2001-10-16 00:00:00@PRITOR@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_42.pdf@EU-1-98-070_h_a_dec_42.pdf@2016-08-02 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_11.pdf@EU-1-98-085_h_a_dec_11.pdf@2002-04-18 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_17.pdf@EU-1-98-081_h_a_dec_17.pdf@2019-01-07 00:00:00@Comtan@entacapone@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_7.pdf@EU-1-98-089_h_a_dec_7.pdf@2002-05-30 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_27.pdf@EU-1-98-077_h_a_dec_27.pdf@2019-10-24 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_43.pdf@EU-1-98-070_h_a_dec_43.pdf@2017-03-24 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_19.pdf@EU-1-98-067_h_a_dec_19.pdf@2007-03-27 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_21.pdf@EU-1-98-092_h_a_dec_21.pdf@2008-05-21 00:00:00@Prometax@Rivastigmine@NAS before 2012@True@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_12.pdf@EU-1-98-085_h_a_dec_12.pdf@2002-06-28 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-089_h_a_dec_8.pdf@EU-1-98-089_h_a_dec_8.pdf@2002-08-22 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_2.pdf@EU-1-98-067_h_a_dec_2.pdf@1999-09-09 00:00:00@MABTHERA rituximab@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd 40 Broadwater Road@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_13.pdf@EU-1-98-085_h_a_dec_13.pdf@2003-01-15 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_28.pdf@EU-1-98-077_h_a_dec_28.pdf@2020-02-06 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_22.pdf@EU-1-98-092_h_a_dec_22.pdf@2009-01-26 00:00:00@Prometax@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-089_h_a_dec_9.pdf@EU-1-98-089_h_a_dec_9.pdf@2002-11-12 00:00:00@Pritor@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_14.pdf@EU-1-98-085_h_a_dec_14.pdf@2003-07-03 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_18.pdf@EU-1-98-081_h_a_dec_18.pdf@2019-07-11 00:00:00@Comtan@entacapone@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_45.pdf@EU-1-98-070_h_a_dec_45.pdf@2018-10-25 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_20.pdf@EU-1-98-067_h_a_dec_20.pdf@2007-03-09 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_29.pdf@EU-1-98-077_h_a_dec_29.pdf@2021-12-11 00:00:00@Viagra@sildenafil@False@False@OD Not Found@Upjohn EESV@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_23.pdf@EU-1-98-092_h_a_dec_23.pdf@2010-03-23 00:00:00@Prometax@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_15.pdf@EU-1-98-085_h_a_dec_15.pdf@2003-05-16 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_19.pdf@EU-1-98-081_h_a_dec_19.pdf@2020-11-24 00:00:00@Comtan@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_46.pdf@EU-1-98-070_h_a_dec_46.pdf@2019-04-10 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_21.pdf@EU-1-98-067_h_a_dec_21.pdf@2007-11-19 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_16.pdf@EU-1-98-085_h_a_dec_16.pdf@2003-02-10 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_3.pdf@EU-1-98-077_h_a_dec_3.pdf@2000-10-02 00:00:00@VIAGRA sildenafil@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_2.pdf@EU-1-98-081_h_a_dec_2.pdf@2000-07-27 00:00:00@COMTAN entacapone@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_24.pdf@EU-1-98-092_h_a_dec_24.pdf@2010-04-29 00:00:00@Prometax@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_22.pdf@EU-1-98-067_h_a_dec_22.pdf@2008-01-18 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_47.pdf@EU-1-98-070_h_a_dec_47.pdf@2020-10-15 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_4.pdf@EU-1-98-077_h_a_dec_4.pdf@2000-12-09 00:00:00@VIAGRA sildenafil@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@to Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_17.pdf@EU-1-98-085_h_a_dec_17.pdf@2003-04-12 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_20.pdf@EU-1-98-081_h_a_dec_20.pdf@2022-02-06 00:00:00@Comtan@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_25.pdf@EU-1-98-092_h_a_dec_25.pdf@2011-03-14 00:00:00@Prometax@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_5.pdf@EU-1-98-077_h_a_dec_5.pdf@2000-07-12 00:00:00@VIAGRA sildenafil@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_48.pdf@EU-1-98-070_h_a_dec_48.pdf@2021-01-29 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_23.pdf@EU-1-98-067_h_a_dec_23.pdf@2008-05-20 00:00:00@Mabthera@Rituximab@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_3.pdf@EU-1-98-081_h_a_dec_3.pdf@2001-10-18 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_18.pdf@EU-1-98-085_h_a_dec_18.pdf@2004-02-03 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_26.pdf@EU-1-98-092_h_a_dec_26.pdf@2011-05-23 00:00:00@Prometax@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis Europharm  Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_6.pdf@EU-1-98-077_h_a_dec_6.pdf@2001-11-27 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_49.pdf@EU-1-98-070_h_a_dec_49.pdf@2021-05-21 00:00:00@Iscover@Clopidogrel@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_24.pdf@EU-1-98-067_h_a_dec_24.pdf@2008-04-07 00:00:00@Mabthera@Rituximab@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_4.pdf@EU-1-98-081_h_a_dec_4.pdf@2002-07-02 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_19.pdf@EU-1-98-085_h_a_dec_19.pdf@2004-02-08 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_7.pdf@EU-1-98-077_h_a_dec_7.pdf@2002-05-03 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_27.pdf@EU-1-98-092_h_a_dec_27.pdf@2011-07-12 00:00:00@Prometax@Rivastigmine@NAS before 2012@False@OD Not Found@Novartis  Europharm Ltd@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_5.pdf@EU-1-98-070_h_a_dec_5.pdf@2000-07-13 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_5.pdf@EU-1-98-081_h_a_dec_5.pdf@2002-09-30 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_25.pdf@EU-1-98-067_h_a_dec_25.pdf@2008-11-24 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_2.pdf@EU-1-98-085_h_a_dec_2.pdf@2000-03-02 00:00:00@KARVEZIDE@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Bristol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-077_h_a_dec_8.pdf@EU-1-98-077_h_a_dec_8.pdf@2002-04-18 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_6.pdf@EU-1-98-070_h_a_dec_6.pdf@2000-09-25 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_28.pdf@EU-1-98-092_h_a_dec_28.pdf@2012-04-13 00:00:00@Prometax@Rivastigmine@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_6.pdf@EU-1-98-081_h_a_dec_6.pdf@2003-05-14 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_26.pdf@EU-1-98-067_h_a_dec_26.pdf@2009-02-23 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-077_h_a_dec_9.pdf@EU-1-98-077_h_a_dec_9.pdf@2002-10-24 00:00:00@Viagra@sildenafil@NAS before 2012@NA before 2012@OD Not Found@Pfizer Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_20.pdf@EU-1-98-085_h_a_dec_20.pdf@2004-10-28 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-070_h_a_dec_7.pdf@EU-1-98-070_h_a_dec_7.pdf@2001-01-15 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_29.pdf@EU-1-98-092_h_a_dec_29.pdf@2013-01-14 00:00:00@Prometax@Rivastigmine@False@False@OD Not Found@Novartis Europharm Ltd@CMA Not Found@Parsed
EU-1-98-081_h_a_dec_7.pdf@EU-1-98-081_h_a_dec_7.pdf@2003-10-17 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_27.pdf@EU-1-98-067_h_a_dec_27.pdf@2009-03-25 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_8.pdf@EU-1-98-070_h_a_dec_8.pdf@2001-06-03 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_21.pdf@EU-1-98-085_h_a_dec_21.pdf@2005-08-09 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_3.pdf@EU-1-98-092_h_a_dec_3.pdf@2000-11-05 00:00:00@Prometax@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_8.pdf@EU-1-98-081_h_a_dec_8.pdf@2005-07-03 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_28.pdf@EU-1-98-067_h_a_dec_28.pdf@2009-08-21 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-070_h_a_dec_9.pdf@EU-1-98-070_h_a_dec_9.pdf@2001-07-16 00:00:00@Iscover@Clopidogrel@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_22.pdf@EU-1-98-085_h_a_dec_22.pdf@2006-03-20 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_0.pdf@EU-1-98-090_h_a_dec_0.pdf@1998-12-16 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-081_h_a_dec_9.pdf@EU-1-98-081_h_a_dec_9.pdf@2005-01-08 00:00:00@Comtan@entacapone@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_30.pdf@EU-1-98-092_h_a_dec_30.pdf@2014-07-11 00:00:00@Prometax@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_29.pdf@EU-1-98-067_h_a_dec_29.pdf@2010-03-23 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_1.pdf@EU-1-98-090_h_a_dec_1.pdf@1999-11-06 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_23.pdf@EU-1-98-085_h_a_dec_23.pdf@2006-08-28 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_10.pdf@EU-1-98-090_h_a_dec_10.pdf@2002-09-30 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_3.pdf@EU-1-98-067_h_a_dec_3.pdf@2000-08-02 00:00:00@MABTHERA rituximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd 40 Broadwater Road@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_11.pdf@EU-1-98-090_h_a_dec_11.pdf@2003-03-02 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_24.pdf@EU-1-98-085_h_a_dec_24.pdf@2007-11-01 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_30.pdf@EU-1-98-067_h_a_dec_30.pdf@2010-10-25 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_31.pdf@EU-1-98-092_h_a_dec_31.pdf@2015-11-19 00:00:00@Prometax@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_12.pdf@EU-1-98-090_h_a_dec_12.pdf@2003-05-16 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_25.pdf@EU-1-98-085_h_a_dec_25.pdf@2007-10-15 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_31.pdf@EU-1-98-067_h_a_dec_31.pdf@2010-12-20 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_0.pdf@EU-1-98-082_h_a_dec_0.pdf@1998-09-16 00:00:00@COMTESS@entacapone@NAS before 2012@NA before 2012@NA before 2000@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_13.pdf@EU-1-98-090_h_a_dec_13.pdf@2004-09-01 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_26.pdf@EU-1-98-085_h_a_dec_26.pdf@2008-04-04 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_32.pdf@EU-1-98-067_h_a_dec_32.pdf@2011-06-23 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_1.pdf@EU-1-98-082_h_a_dec_1.pdf@1999-05-18 00:00:00@COMTESS entacapone@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@"Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_32.pdf@EU-1-98-092_h_a_dec_32.pdf@2018-08-05 00:00:00@Prometax@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_14.pdf@EU-1-98-090_h_a_dec_14.pdf@2004-01-12 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_27.pdf@EU-1-98-085_h_a_dec_27.pdf@2008-10-06 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_33.pdf@EU-1-98-067_h_a_dec_33.pdf@2011-12-14 00:00:00@Mabthera@Rituximab@NAS before 2012@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_10.pdf@EU-1-98-082_h_a_dec_10.pdf@2006-11-07 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_15.pdf@EU-1-98-090_h_a_dec_15.pdf@2004-07-12 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_28.pdf@EU-1-98-085_h_a_dec_28.pdf@2008-01-10 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_34.pdf@EU-1-98-067_h_a_dec_34.pdf@2012-05-25 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration  Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_33.pdf@EU-1-98-092_h_a_dec_33.pdf@2020-10-16 00:00:00@Prometax@Rivastigmine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_11.pdf@EU-1-98-082_h_a_dec_11.pdf@2007-01-24 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_16.pdf@EU-1-98-090_h_a_dec_16.pdf@2006-06-26 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_29.pdf@EU-1-98-085_h_a_dec_29.pdf@2009-02-26 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_35.pdf@EU-1-98-067_h_a_dec_35.pdf@2012-03-08 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_0.pdf@EU-1-98-071_h_a_dec_0.pdf@1998-07-29 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_0.pdf@EU-1-99-097_h_a_dec_0.pdf@1999-04-13 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_12.pdf@EU-1-98-082_h_a_dec_12.pdf@2007-02-27 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_3.pdf@EU-1-98-085_h_a_dec_3.pdf@2000-03-24 00:00:00@KARVEZIDE@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Bristol Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_17.pdf@EU-1-98-090_h_a_dec_17.pdf@2007-04-01 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_1.pdf@EU-1-98-071_h_a_dec_1.pdf@1999-11-05 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_36.pdf@EU-1-98-067_h_a_dec_36.pdf@2013-04-22 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
d
EU-1-99-097_h_a_dec_1.pdf@EU-1-99-097_h_a_dec_1.pdf@1999-07-29 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_13.pdf@EU-1-98-082_h_a_dec_13.pdf@2008-03-09 00:00:00@Comtess@entacapone@NAS before 2012@True@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_10.pdf@EU-1-98-071_h_a_dec_10.pdf@2003-04-03 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_30.pdf@EU-1-98-085_h_a_dec_30.pdf@2009-03-27 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_18.pdf@EU-1-98-090_h_a_dec_18.pdf@2007-05-03 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed

EU-1-99-097_h_a_dec_10.pdf@EU-1-99-097_h_a_dec_10.pdf@2011-07-27 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_11.pdf@EU-1-98-071_h_a_dec_11.pdf@2003-08-10 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_5.pdf@EU-1-98-092_h_a_dec_5.pdf@2000-12-18 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_14.pdf@EU-1-98-082_h_a_dec_14.pdf@2010-10-06 00:00:00@Comtess@entacapone@NAS before 2012@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_37.pdf@EU-1-98-067_h_a_dec_37.pdf@2013-11-20 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_31.pdf@EU-1-98-085_h_a_dec_31.pdf@2009-12-21 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_19.pdf@EU-1-98-090_h_a_dec_19.pdf@1980-01-01 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_12.pdf@EU-1-98-071_h_a_dec_12.pdf@2003-08-10 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-092_h_a_dec_6.pdf@EU-1-98-092_h_a_dec_6.pdf@2001-03-20 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
@Parsed
EU-1-98-082_h_a_dec_15.pdf@EU-1-98-082_h_a_dec_15.pdf@2013-01-24 00:00:00@Comtess@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_32.pdf@EU-1-98-085_h_a_dec_32.pdf@2010-03-02 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_2.pdf@EU-1-98-090_h_a_dec_2.pdf@1999-07-09 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_13.pdf@EU-1-98-071_h_a_dec_13.pdf@2004-02-03 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_38.pdf@EU-1-98-067_h_a_dec_38.pdf@2014-03-21 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_7.pdf@EU-1-98-092_h_a_dec_7.pdf@2001-08-13 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_12.pdf@EU-1-99-097_h_a_dec_12.pdf@2017-03-10 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_16.pdf@EU-1-98-082_h_a_dec_16.pdf@2016-01-28 00:00:00@Comtess@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_20.pdf@EU-1-98-090_h_a_dec_20.pdf@2008-11-19 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_33.pdf@EU-1-98-085_h_a_dec_33.pdf@2010-06-08 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_8.pdf@EU-1-98-092_h_a_dec_8.pdf@2001-09-11 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_14.pdf@EU-1-98-071_h_a_dec_14.pdf@2004-09-15 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_13.pdf@EU-1-99-097_h_a_dec_13.pdf@2018-08-23 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_17.pdf@EU-1-98-082_h_a_dec_17.pdf@2018-08-01 00:00:00@Comtess@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_39.pdf@EU-1-98-067_h_a_dec_39.pdf@2014-05-23 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-092_h_a_dec_9.pdf@EU-1-98-092_h_a_dec_9.pdf@2001-11-30 00:00:00@PROMETAX@Rivastigmine@NAS before 2012@NA before 2012@OD Not Found@Novartis Europharm Limited@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_21.pdf@EU-1-98-090_h_a_dec_21.pdf@2009-03-19 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_34.pdf@EU-1-98-085_h_a_dec_34.pdf@2011-09-02 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_15.pdf@EU-1-98-071_h_a_dec_15.pdf@2005-10-06 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_14.pdf@EU-1-99-097_h_a_dec_14.pdf@2021-07-23 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@False@False@OD Not Found@BELPHARMA s.a.@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_4.pdf@EU-1-98-067_h_a_dec_4.pdf@2000-03-05 00:00:00@MABTHERA rituximab@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Ltd 40 Broadwater Road@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_18.pdf@EU-1-98-082_h_a_dec_18.pdf@2022-05-19 00:00:00@Comtess@entacapone@False@False@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_22.pdf@EU-1-98-090_h_a_dec_22.pdf@2009-05-29 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-99-097_h_a_dec_2.pdf@EU-1-99-097_h_a_dec_2.pdf@1999-07-29 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_35.pdf@EU-1-98-085_h_a_dec_35.pdf@2011-05-18 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-097_h_a_dec_3.pdf@EU-1-99-097_h_a_dec_3.pdf@1999-07-29 00:00:00@BEROMUN@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_2.pdf@EU-1-98-082_h_a_dec_2.pdf@2000-07-27 00:00:00@COMTESS entacapone@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_40.pdf@EU-1-98-067_h_a_dec_40.pdf@2015-10-15 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_23.pdf@EU-1-98-090_h_a_dec_23.pdf@2009-11-23 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_36.pdf@EU-1-98-085_h_a_dec_36.pdf@2011-08-18 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-99-097_h_a_dec_4.pdf@EU-1-99-097_h_a_dec_4.pdf@2002-01-28 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_3.pdf@EU-1-98-082_h_a_dec_3.pdf@2000-07-27 00:00:00@COMTESS entacapone@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_37.pdf@EU-1-98-085_h_a_dec_37.pdf@2011-10-20 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_17.pdf@EU-1-98-071_h_a_dec_17.pdf@2008-06-17 00:00:00@Xenical@Orlistat@NAS before 2012@True@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_24.pdf@EU-1-98-090_h_a_dec_24.pdf@2011-02-28 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_41.pdf@EU-1-98-067_h_a_dec_41.pdf@2016-05-26 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_4.pdf@EU-1-98-082_h_a_dec_4.pdf@2001-10-24 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_5.pdf@EU-1-99-097_h_a_dec_5.pdf@2002-12-16 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_38.pdf@EU-1-98-085_h_a_dec_38.pdf@2012-06-27 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Bristol-Myers Squibb  Pharma EEIG@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_18.pdf@EU-1-98-071_h_a_dec_18.pdf@2009-03-25 00:00:00@Xenical@Orlistat@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_25.pdf@EU-1-98-090_h_a_dec_25.pdf@2011-02-05 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_5.pdf@EU-1-98-082_h_a_dec_5.pdf@2002-07-02 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_6.pdf@EU-1-99-097_h_a_dec_6.pdf@2004-01-27 00:00:00@Beromun@Tasonermin (Tumor  Necrosis Factor alfa-1a)@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_39.pdf@EU-1-98-085_h_a_dec_39.pdf@2013-02-18 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_19.pdf@EU-1-98-071_h_a_dec_19.pdf@2011-05-12 00:00:00@Xenical@Orlistat@NAS before 2012@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_26.pdf@EU-1-98-090_h_a_dec_26.pdf@2011-08-24 00:00:00@Micardis@telmisartan@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_42.pdf@EU-1-98-067_h_a_dec_42.pdf@2017-05-16 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_6.pdf@EU-1-98-082_h_a_dec_6.pdf@2002-09-30 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-99-097_h_a_dec_7.pdf@EU-1-99-097_h_a_dec_7.pdf@2004-06-17 00:00:00@Beromun@Tasonermin@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International  GmbH@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_2.pdf@EU-1-98-071_h_a_dec_2.pdf@1999-11-05 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_4.pdf@EU-1-98-085_h_a_dec_4.pdf@2000-11-16 00:00:00@Karvezide@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-082_h_a_dec_7.pdf@EU-1-98-082_h_a_dec_7.pdf@2003-10-17 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_27.pdf@EU-1-98-090_h_a_dec_27.pdf@2012-05-25 00:00:00@Micardis@telmisartan@False@False@OD Not Found@Boehringer  Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-99-097_h_a_dec_8.pdf@EU-1-99-097_h_a_dec_8.pdf@2009-03-25 00:00:00@Beromun@Tasonermin (Tumor Necrosis Factor alfa-1a)@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International  GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_40.pdf@EU-1-98-085_h_a_dec_40.pdf@2013-07-31 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_20.pdf@EU-1-98-071_h_a_dec_20.pdf@2012-04-20 00:00:00@Xenical@Orlistat@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_28.pdf@EU-1-98-090_h_a_dec_28.pdf@2012-12-20 00:00:00@Micardis@telmisartan@False@False@OD Not Found@Boehringer Ingelheim  International GmbH@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_8.pdf@EU-1-98-082_h_a_dec_8.pdf@2005-07-03 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_43.pdf@EU-1-98-067_h_a_dec_43.pdf@2018-03-16 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_21.pdf@EU-1-98-071_h_a_dec_21.pdf@2012-09-24 00:00:00@Xenical@Orlistat@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-99-097_h_a_dec_9.pdf@EU-1-99-097_h_a_dec_9.pdf@2009-10-28 00:00:00@Beromun@Tasonermin (Tumor  Necrosis Factor alfa-1a)@NAS before 2012@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_29.pdf@EU-1-98-090_h_a_dec_29.pdf@2013-05-30 00:00:00@Micardis@telmisartan@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-082_h_a_dec_9.pdf@EU-1-98-082_h_a_dec_9.pdf@2006-04-27 00:00:00@Comtess@entacapone@NAS before 2012@NA before 2012@OD Not Found@Orion Corporation@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_44.pdf@EU-1-98-067_h_a_dec_44.pdf@2018-12-18 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_41.pdf@EU-1-98-085_h_a_dec_41.pdf@2014-04-09 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)3174 for “Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_22.pdf@EU-1-98-071_h_a_dec_22.pdf@2013-06-21 00:00:00@Xenical@Orlistat@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_3.pdf@EU-1-98-090_h_a_dec_3.pdf@2000-09-03 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_45.pdf@EU-1-98-067_h_a_dec_45.pdf@2019-11-03 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_42.pdf@EU-1-98-085_h_a_dec_42.pdf@2017-08-24 00:00:00@Karvezide@Irbesartan /  hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_46.pdf@EU-1-98-067_h_a_dec_46.pdf@2020-03-03 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_23.pdf@EU-1-98-071_h_a_dec_23.pdf@2014-08-26 00:00:00@Xenical@Orlistat@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_43.pdf@EU-1-98-085_h_a_dec_43.pdf@2018-09-20 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)4295 for “Micardis@telmisartan@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_0.pdf@EU-1-99-100_h_a_dec_0.pdf@1999-04-13 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@NA before 2000@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_1.pdf@EU-1-99-100_h_a_dec_1.pdf@1999-09-15 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@NA before 2000@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_47.pdf@EU-1-98-067_h_a_dec_47.pdf@2021-02-18 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_31.pdf@EU-1-98-090_h_a_dec_31.pdf@2018-10-23 00:00:00@Micardis@telmisartan@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_44.pdf@EU-1-98-085_h_a_dec_44.pdf@2019-02-04 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 2.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)3174 for “Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_24.pdf@EU-1-98-071_h_a_dec_24.pdf@2015-11-19 00:00:00@Xenical@Orlistat@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_10.pdf@EU-1-99-100_h_a_dec_10.pdf@2006-10-17 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_48.pdf@EU-1-98-067_h_a_dec_48.pdf@2021-08-26 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_32.pdf@EU-1-98-090_h_a_dec_32.pdf@2021-12-13 00:00:00@Micardis@telmisartan@False@False@OD Not Found@Boehringer Ingelheim International GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_45.pdf@EU-1-98-085_h_a_dec_45.pdf@2021-12-02 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_4.pdf@EU-1-98-090_h_a_dec_4.pdf@1980-01-01 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_49.pdf@EU-1-98-067_h_a_dec_49.pdf@2022-08-07 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_11.pdf@EU-1-99-100_h_a_dec_11.pdf@2008-02-09 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@True@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_25.pdf@EU-1-98-071_h_a_dec_25.pdf@2017-02-05 00:00:00@Xenical@Orlistat@False@False@OD Not Found@Roche Registration Limited@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_0.pdf@EU-1-99-103_h_a_dec_0.pdf@1999-04-13 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_46.pdf@EU-1-98-085_h_a_dec_46.pdf@2021-10-05 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-067_h_a_dec_5.pdf@EU-1-98-067_h_a_dec_5.pdf@2001-06-27 00:00:00@MABTHERA@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Ltd@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_5.pdf@EU-1-98-090_h_a_dec_5.pdf@2000-01-08 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_1.pdf@EU-1-99-103_h_a_dec_1.pdf@2000-01-31 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@NA before 2000@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_12.pdf@EU-1-99-100_h_a_dec_12.pdf@2009-03-25 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@False@OD Not Found@Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_26.pdf@EU-1-98-071_h_a_dec_26.pdf@2019-11-14 00:00:00@Xenical@Orlistat@False@False@OD Not Found@CHEPLAPHARM Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_47.pdf@EU-1-98-085_h_a_dec_47.pdf@2022-09-13 00:00:00@Karvezide@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-98-090_h_a_dec_6.pdf@EU-1-98-090_h_a_dec_6.pdf@2001-01-22 00:00:00@Micardis@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_50.pdf@EU-1-98-067_h_a_dec_50.pdf@2022-08-17 00:00:00@Mabthera@Rituximab@False@False@OD Not Found@Roche Registration GmbH@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_10.pdf@EU-1-99-103_h_a_dec_10.pdf@2002-12-19 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_13.pdf@EU-1-99-100_h_a_dec_13.pdf@2010-03-23 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@False@OD Not Found@SERONO EUROPE LIMITED@CMA Not Found@Parsed
EU-1-98-071_h_a_dec_27.pdf@EU-1-98-071_h_a_dec_27.pdf@2021-03-26 00:00:00@Xenical@Orlistat@False@False@OD Not Found@CHEPLAPHARM Arzneimittel GmbH@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_5.pdf@EU-1-98-085_h_a_dec_5.pdf@2001-04-23 00:00:00@Karvezide@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_0.pdf@EU-1-98-095_h_a_dec_0.pdf@1999-01-27 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@NA before 2000@Alcon Laboratories (UK) Ltd@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_11.pdf@EU-1-99-103_h_a_dec_11.pdf@2003-08-05 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
available before 2006@Parsed
EU-1-98-090_h_a_dec_7.pdf@EU-1-98-090_h_a_dec_7.pdf@2001-10-19 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_3.pdf@EU-1-98-071_h_a_dec_3.pdf@1999-08-12 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@NA before 2000@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_1.pdf@EU-1-98-095_h_a_dec_1.pdf@1999-03-16 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@NA before 2000@Alcon Laboratories (UK) Ltd@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_6.pdf@EU-1-98-085_h_a_dec_6.pdf@2001-06-29 00:00:00@Karvezide@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@MAH Not Found@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_12.pdf@EU-1-99-103_h_a_dec_12.pdf@2003-05-15 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_7.pdf@EU-1-98-067_h_a_dec_7.pdf@2002-02-19 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_8.pdf@EU-1-98-090_h_a_dec_8.pdf@2001-10-19 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_14.pdf@EU-1-99-100_h_a_dec_14.pdf@2014-11-28 00:00:00@Cetrotide@Cetrorelix (as acetate)@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_7.pdf@EU-1-98-085_h_a_dec_7.pdf@2001-08-10 00:00:00@Karvezide@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol - Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-090_h_a_dec_9.pdf@EU-1-98-090_h_a_dec_9.pdf@2002-05-30 00:00:00@Micardis@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_8.pdf@EU-1-98-067_h_a_dec_8.pdf@2002-03-21 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_5.pdf@EU-1-98-071_h_a_dec_5.pdf@2001-03-05 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_13.pdf@EU-1-99-103_h_a_dec_13.pdf@2004-07-20 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_10.pdf@EU-1-98-095_h_a_dec_10.pdf@2015-03-16 00:00:00@Emadine@emedastine@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-98-085_h_a_dec_8.pdf@EU-1-98-085_h_a_dec_8.pdf@2002-02-19 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-067_h_a_dec_9.pdf@EU-1-98-067_h_a_dec_9.pdf@2002-07-15 00:00:00@Mabthera@Rituximab@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_6.pdf@EU-1-98-071_h_a_dec_6.pdf@2001-06-08 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_15.pdf@EU-1-99-100_h_a_dec_15.pdf@2017-04-20 00:00:00@Cetrotide@Cetrorelix (as acetate)@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_14.pdf@EU-1-99-103_h_a_dec_14.pdf@2004-07-29 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_7.pdf@EU-1-98-071_h_a_dec_7.pdf@2001-03-10 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-98-085_h_a_dec_9.pdf@EU-1-98-085_h_a_dec_9.pdf@2002-08-03 00:00:00@Karvezide@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_11.pdf@EU-1-98-095_h_a_dec_11.pdf@2017-04-01 00:00:00@Emadine@emedastine@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_15.pdf@EU-1-99-103_h_a_dec_15.pdf@2004-11-25 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-98-071_h_a_dec_8.pdf@EU-1-98-071_h_a_dec_8.pdf@2001-10-31 00:00:00@XENICAL@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_16.pdf@EU-1-99-100_h_a_dec_16.pdf@2018-03-16 00:00:00@Cetrotide@Cetrorelix (as acetate)@False@False@OD Not Found@Merck Serono Europe Limited@CMA Not Found@Parsed
e 2006@Parsed
EU-1-98-071_h_a_dec_9.pdf@EU-1-98-071_h_a_dec_9.pdf@2002-06-20 00:00:00@Xenical@Orlistat@NAS before 2012@NA before 2012@OD Not Found@Roche Registration Limited@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_18.pdf@EU-1-99-100_h_a_dec_18.pdf@2019-01-07 00:00:00@Cetrotide@Cetrorelix (as acetate)@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-98-095_h_a_dec_12.pdf@EU-1-98-095_h_a_dec_12.pdf@2017-05-16 00:00:00@Emadine@emedastine@False@False@OD Not Found@Alcon Laboratories (UK) Ltd@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_17.pdf@EU-1-99-103_h_a_dec_17.pdf@2007-09-02 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_19.pdf@EU-1-99-100_h_a_dec_19.pdf@2020-11-20 00:00:00@Cetrotide@Cetrorelix (as acetate)@False@False@OD Not Found@Merck Europe B.V.@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_18.pdf@EU-1-99-103_h_a_dec_18.pdf@2007-07-24 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_2.pdf@EU-1-99-100_h_a_dec_2.pdf@2000-05-29 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_13.pdf@EU-1-98-095_h_a_dec_13.pdf@2018-04-23 00:00:00@Emadine@emedastine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_19.pdf@EU-1-99-103_h_a_dec_19.pdf@2009-02-26 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_3.pdf@EU-1-99-100_h_a_dec_3.pdf@2001-03-20 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@ASTA Medica Aktiengesellschaft@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_2.pdf@EU-1-99-103_h_a_dec_2.pdf@2000-06-04 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_4.pdf@EU-1-99-100_h_a_dec_4.pdf@2001-09-20 00:00:00@CETROTIDE@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@Ares-Serono (Europe) Ltd@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_14.pdf@EU-1-98-095_h_a_dec_14.pdf@2019-08-26 00:00:00@Emadine@emedastine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_20.pdf@EU-1-99-103_h_a_dec_20.pdf@2009-02-26 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_5.pdf@EU-1-99-100_h_a_dec_5.pdf@2002-04-19 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_21.pdf@EU-1-99-103_h_a_dec_21.pdf@2009-04-16 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_6.pdf@EU-1-99-100_h_a_dec_6.pdf@2002-04-19 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_0.pdf@EU-1-99-107_h_a_dec_0.pdf@1999-07-05 00:00:00@REBETOL@ribavirin@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_15.pdf@EU-1-98-095_h_a_dec_15.pdf@2021-02-08 00:00:00@Emadine@emedastine@False@False@OD Not Found@Novartis Europharm Limited@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_22.pdf@EU-1-99-103_h_a_dec_22.pdf@2009-01-07 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-99-100_h_a_dec_7.pdf@EU-1-99-100_h_a_dec_7.pdf@2003-01-15 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_0.pdf@EU-1-98-091_h_a_dec_0.pdf@1998-12-16 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_1.pdf@EU-1-99-107_h_a_dec_1.pdf@2000-07-24 00:00:00@REBETOL@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_2.pdf@EU-1-98-095_h_a_dec_2.pdf@2000-05-31 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_8.pdf@EU-1-99-100_h_a_dec_8.pdf@2003-06-03 00:00:00@Cetrotide@Cetrorelix (as acetate)@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_1.pdf@EU-1-98-091_h_a_dec_1.pdf@1999-03-06 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_23.pdf@EU-1-99-103_h_a_dec_23.pdf@2010-08-02 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-095_h_a_dec_3.pdf@EU-1-98-095_h_a_dec_3.pdf@2002-05-30 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_10.pdf@EU-1-99-107_h_a_dec_10.pdf@2005-01-25 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_10.pdf@EU-1-98-091_h_a_dec_10.pdf@2002-02-10 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_4.pdf@EU-1-98-095_h_a_dec_4.pdf@2003-05-19 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-99-100_h_a_dec_9.pdf@EU-1-99-100_h_a_dec_9.pdf@2004-08-17 00:00:00@Cetrotide@Cetrorelix (as  acetate)@NAS before 2012@NA before 2012@OD Not Found@Serono Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_24.pdf@EU-1-99-103_h_a_dec_24.pdf@2010-07-07 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_11.pdf@EU-1-99-107_h_a_dec_11.pdf@2005-03-06 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_11.pdf@EU-1-98-091_h_a_dec_11.pdf@2002-02-12 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_5.pdf@EU-1-98-095_h_a_dec_5.pdf@2003-09-16 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_25.pdf@EU-1-99-103_h_a_dec_25.pdf@2011-06-05 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_12.pdf@EU-1-98-091_h_a_dec_12.pdf@2003-04-16 00:00:00@Kinzalmono@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_12.pdf@EU-1-99-107_h_a_dec_12.pdf@2005-08-30 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-095_h_a_dec_6.pdf@EU-1-98-095_h_a_dec_6.pdf@2004-05-03 00:00:00@Emadine@emedastine@NAS before 2012@NA before 2012@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_26.pdf@EU-1-99-103_h_a_dec_26.pdf@2011-06-05 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_13.pdf@EU-1-98-091_h_a_dec_13.pdf@2004-09-01 00:00:00@Kinzalmono@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_13.pdf@EU-1-99-107_h_a_dec_13.pdf@2005-10-25 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_14.pdf@EU-1-98-091_h_a_dec_14.pdf@2004-07-12 00:00:00@Kinzalmono@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_27.pdf@EU-1-99-103_h_a_dec_27.pdf@2011-07-18 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Wyeth Europa Ltd.@CMA Not Found@Parsed
EU-1-98-095_h_a_dec_7.pdf@EU-1-98-095_h_a_dec_7.pdf@2009-01-13 00:00:00@Emadine@emedastine@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_14.pdf@EU-1-99-107_h_a_dec_14.pdf@2006-03-29 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_0.pdf@EU-1-99-109_h_a_dec_0.pdf@1999-01-07 00:00:00@INTEGRILIN@Eptifibatide@NAS before 2012@NA before 2012@NA before 2000@SP Europe@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_28.pdf@EU-1-99-103_h_a_dec_28.pdf@2011-11-24 00:00:00@ReFacto AF@Moroctocog alfa@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-095_h_a_dec_8.pdf@EU-1-98-095_h_a_dec_8.pdf@2010-06-09 00:00:00@Emadine@emedastine@NAS before 2012@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_15.pdf@EU-1-98-091_h_a_dec_15.pdf@2006-03-22 00:00:00@Kinzalmono@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_1.pdf@EU-1-99-109_h_a_dec_1.pdf@2002-04-19 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_15.pdf@EU-1-99-107_h_a_dec_15.pdf@2006-04-27 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_29.pdf@EU-1-99-103_h_a_dec_29.pdf@2012-08-30 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_16.pdf@EU-1-98-091_h_a_dec_16.pdf@2007-04-01 00:00:00@Kinzalmono@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_10.pdf@EU-1-99-109_h_a_dec_10.pdf@2009-01-07 00:00:00@Integrilin@Eptifibatide@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-095_h_a_dec_9.pdf@EU-1-98-095_h_a_dec_9.pdf@2014-05-03 00:00:00@Emadine@emedastine@False@False@OD Not Found@Alcon Laboratories (UK) Ltd.@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_3.pdf@EU-1-99-103_h_a_dec_3.pdf@2000-11-08 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_16.pdf@EU-1-99-107_h_a_dec_16.pdf@2006-07-25 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_17.pdf@EU-1-98-091_h_a_dec_17.pdf@2007-01-03 00:00:00@Kinzalmono@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_11.pdf@EU-1-99-109_h_a_dec_11.pdf@2009-10-28 00:00:00@Integrilin@Eptifibatide@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_17.pdf@EU-1-99-107_h_a_dec_17.pdf@2006-01-09 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_30.pdf@EU-1-99-103_h_a_dec_30.pdf@2012-10-24 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_18.pdf@EU-1-98-091_h_a_dec_18.pdf@2008-04-07 00:00:00@Kinzalmono@telmisartan@NAS before 2012@True@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_12.pdf@EU-1-99-109_h_a_dec_12.pdf@2010-01-20 00:00:00@Integrilin@Eptifibatide@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_18.pdf@EU-1-99-107_h_a_dec_18.pdf@2006-10-27 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_0.pdf@EU-1-98-086_h_a_dec_0.pdf@1998-10-15 00:00:00@COAPROVEL@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_31.pdf@EU-1-99-103_h_a_dec_31.pdf@2013-11-13 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_19.pdf@EU-1-98-091_h_a_dec_19.pdf@2008-11-19 00:00:00@Kinzalmono@telmisartan@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_1.pdf@EU-1-98-086_h_a_dec_1.pdf@1999-03-29 00:00:00@COAPROVEL@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_13.pdf@EU-1-99-109_h_a_dec_13.pdf@2011-04-14 00:00:00@Integrilin@Eptifibatide@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_19.pdf@EU-1-99-107_h_a_dec_19.pdf@2007-04-01 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_0.pdf@EU-1-98-096_h_a_dec_0.pdf@1999-01-26 00:00:00@TEMODAL@Temozolomide@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_2.pdf@EU-1-98-091_h_a_dec_2.pdf@1999-07-09 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_2.pdf@EU-1-99-107_h_a_dec_2.pdf@2001-03-26 00:00:00@REBETOL@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_14.pdf@EU-1-99-109_h_a_dec_14.pdf@2011-07-27 00:00:00@Integrilin@Eptifibatide@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_32.pdf@EU-1-99-103_h_a_dec_32.pdf@2015-08-04 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_1.pdf@EU-1-98-096_h_a_dec_1.pdf@1980-01-01 00:00:00@TEMODAL temozolomide@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_20.pdf@EU-1-98-091_h_a_dec_20.pdf@2009-03-18 00:00:00@Kinzalmono@telmisartan@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_10.pdf@EU-1-98-086_h_a_dec_10.pdf@2002-04-19 00:00:00@Coaprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_15.pdf@EU-1-99-109_h_a_dec_15.pdf@2012-03-21 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_20.pdf@EU-1-99-107_h_a_dec_20.pdf@2007-01-06 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_10.pdf@EU-1-98-096_h_a_dec_10.pdf@2007-07-25 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_11.pdf@EU-1-98-086_h_a_dec_11.pdf@2003-07-03 00:00:00@Coaprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_21.pdf@EU-1-98-091_h_a_dec_21.pdf@2009-05-05 00:00:00@Kinzalmono@telmisartan@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_33.pdf@EU-1-99-103_h_a_dec_33.pdf@2016-07-29 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_0.pdf@EU-1-99-114_h_a_dec_0.pdf@1999-07-29 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_21.pdf@EU-1-99-107_h_a_dec_21.pdf@2007-09-07 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_11.pdf@EU-1-98-096_h_a_dec_11.pdf@2008-06-25 00:00:00@Temodal@Temozolomide@NAS before 2012@True@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_12.pdf@EU-1-98-086_h_a_dec_12.pdf@2003-02-10 00:00:00@Coaprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_16.pdf@EU-1-99-109_h_a_dec_16.pdf@2014-04-23 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_22.pdf@EU-1-98-091_h_a_dec_22.pdf@2009-05-29 00:00:00@Kinzalmono@telmisartan@NAS before 2012@False@OD Not Found@Bayer HealthCare AG@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_1.pdf@EU-1-99-114_h_a_dec_1.pdf@2001-04-23 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_22.pdf@EU-1-99-107_h_a_dec_22.pdf@2007-10-30 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_12.pdf@EU-1-98-096_h_a_dec_12.pdf@2008-11-25 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_34.pdf@EU-1-99-103_h_a_dec_34.pdf@2017-11-15 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  15.11.2017  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1999)938 for “ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_10.pdf@EU-1-99-114_h_a_dec_10.pdf@2006-04-07 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_13.pdf@EU-1-98-086_h_a_dec_13.pdf@2003-04-12 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_23.pdf@EU-1-98-091_h_a_dec_23.pdf@2009-11-23 00:00:00@Kinzalmono@telmisartan@NAS before 2012@False@OD Not Found@Bayer Schering Pharma AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_17.pdf@EU-1-99-109_h_a_dec_17.pdf@2016-12-05 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_23.pdf@EU-1-99-107_h_a_dec_23.pdf@2008-08-04 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_13.pdf@EU-1-98-096_h_a_dec_13.pdf@2008-12-17 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_11.pdf@EU-1-99-114_h_a_dec_11.pdf@2007-02-27 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_24.pdf@EU-1-98-091_h_a_dec_24.pdf@2022-12-01 00:00:01@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Schering Pharma  AG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_14.pdf@EU-1-98-086_h_a_dec_14.pdf@2004-02-03 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_24.pdf@EU-1-99-107_h_a_dec_24.pdf@2008-10-31 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_35.pdf@EU-1-99-103_h_a_dec_35.pdf@2018-02-08 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_14.pdf@EU-1-98-096_h_a_dec_14.pdf@2009-01-22 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_12.pdf@EU-1-99-114_h_a_dec_12.pdf@2008-07-25 00:00:00@Zeffix@Lamivudine@NAS before 2012@True@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_25.pdf@EU-1-98-091_h_a_dec_25.pdf@2011-02-05 00:00:00@Kinzalmono@telmisartan@NAS before 2012@False@OD Not Found@Bayer Schering  Pharma AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_18.pdf@EU-1-99-109_h_a_dec_18.pdf@2018-03-16 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_36.pdf@EU-1-99-103_h_a_dec_36.pdf@2020-09-30 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_25.pdf@EU-1-99-107_h_a_dec_25.pdf@2008-02-12 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_15.pdf@EU-1-98-086_h_a_dec_15.pdf@2004-02-08 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_15.pdf@EU-1-98-096_h_a_dec_15.pdf@2009-02-17 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_26.pdf@EU-1-98-091_h_a_dec_26.pdf@2012-03-30 00:00:00@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_13.pdf@EU-1-99-114_h_a_dec_13.pdf@2009-08-27 00:00:00@Zeffix@Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_37.pdf@EU-1-99-103_h_a_dec_37.pdf@2021-11-10 00:00:00@ReFacto AF@Moroctocog alfa@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_26.pdf@EU-1-99-107_h_a_dec_26.pdf@2009-04-23 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_27.pdf@EU-1-98-091_h_a_dec_27.pdf@2012-05-25 00:00:00@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_16.pdf@EU-1-98-096_h_a_dec_16.pdf@2010-03-02 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_19.pdf@EU-1-99-109_h_a_dec_19.pdf@2018-10-29 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_14.pdf@EU-1-99-114_h_a_dec_14.pdf@2010-02-07 00:00:00@Zeffix@Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_16.pdf@EU-1-98-086_h_a_dec_16.pdf@2004-10-28 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_4.pdf@EU-1-99-103_h_a_dec_4.pdf@2000-12-27 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_28.pdf@EU-1-98-091_h_a_dec_28.pdf@2012-12-20 00:00:00@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_27.pdf@EU-1-99-107_h_a_dec_27.pdf@2009-11-11 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_2.pdf@EU-1-99-109_h_a_dec_2.pdf@2002-03-10 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_17.pdf@EU-1-98-096_h_a_dec_17.pdf@2010-09-02 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_15.pdf@EU-1-99-114_h_a_dec_15.pdf@2010-11-26 00:00:00@Zeffix@Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_5.pdf@EU-1-99-103_h_a_dec_5.pdf@2001-02-23 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_29.pdf@EU-1-98-091_h_a_dec_29.pdf@2013-05-30 00:00:00@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_17.pdf@EU-1-98-086_h_a_dec_17.pdf@2004-10-28 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_28.pdf@EU-1-99-107_h_a_dec_28.pdf@2010-05-07 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough  Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_18.pdf@EU-1-98-096_h_a_dec_18.pdf@2011-08-02 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_6.pdf@EU-1-99-103_h_a_dec_6.pdf@2002-02-28 00:00:00@ReFacto@Antihaemophilic Factor (Recombinant)@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_16.pdf@EU-1-99-114_h_a_dec_16.pdf@2011-09-12 00:00:00@Zeffix@Lamivudine@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_3.pdf@EU-1-98-091_h_a_dec_3.pdf@2000-09-03 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_20.pdf@EU-1-99-109_h_a_dec_20.pdf@2020-09-03 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_7.pdf@EU-1-99-103_h_a_dec_7.pdf@2002-06-25 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_19.pdf@EU-1-98-096_h_a_dec_19.pdf@2011-06-14 00:00:00@Temodal@Temozolomide@NAS before 2012@False@OD Not Found@Schering Plough  Europe@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_29.pdf@EU-1-99-107_h_a_dec_29.pdf@2011-08-03 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_17.pdf@EU-1-99-114_h_a_dec_17.pdf@2012-06-27 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
nd@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-103_h_a_dec_8.pdf@EU-1-99-103_h_a_dec_8.pdf@2002-08-20 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_2.pdf@EU-1-98-096_h_a_dec_2.pdf@2002-11-04 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_3.pdf@EU-1-99-107_h_a_dec_3.pdf@2002-07-02 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_30.pdf@EU-1-98-091_h_a_dec_30.pdf@2014-04-09 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE GERMAN TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)4330 for “Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-99-103_h_a_dec_9.pdf@EU-1-99-103_h_a_dec_9.pdf@2002-09-18 00:00:00@ReFacto@Moroctocog alfa@NAS before 2012@NA before 2012@OD Not Found@Genetics Institute of Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_21.pdf@EU-1-99-109_h_a_dec_21.pdf@2021-10-19 00:00:00@Integrilin@Eptifibatide@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_20.pdf@EU-1-98-096_h_a_dec_20.pdf@2012-01-13 00:00:00@Temodal@Temozolomide@False@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_19.pdf@EU-1-98-086_h_a_dec_19.pdf@2006-03-20 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_30.pdf@EU-1-99-107_h_a_dec_30.pdf@2011-06-29 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough  Europe@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_31.pdf@EU-1-98-091_h_a_dec_31.pdf@2018-04-04 00:00:00@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer Pharma AG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_2.pdf@EU-1-98-086_h_a_dec_2.pdf@2000-03-24 00:00:00@COAPROVEL@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-109_h_a_dec_3.pdf@EU-1-99-109_h_a_dec_3.pdf@2003-03-24 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_21.pdf@EU-1-98-096_h_a_dec_21.pdf@2012-01-31 00:00:00@Temodal@Temozolomide@False@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_31.pdf@EU-1-99-107_h_a_dec_31.pdf@2011-08-24 00:00:00@Rebetol@ribavirin@NAS before 2012@False@OD Not Found@Schering Plough  Europe@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_19.pdf@EU-1-99-114_h_a_dec_19.pdf@2014-06-23 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_32.pdf@EU-1-98-091_h_a_dec_32.pdf@2021-12-13 00:00:00@Kinzalmono@telmisartan@False@False@OD Not Found@Bayer AG@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_4.pdf@EU-1-99-109_h_a_dec_4.pdf@2004-02-23 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_20.pdf@EU-1-98-086_h_a_dec_20.pdf@2006-08-28 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_32.pdf@EU-1-99-107_h_a_dec_32.pdf@2012-03-30 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Schering Plough  Europe@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_22.pdf@EU-1-98-096_h_a_dec_22.pdf@2012-06-27 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme  Limited@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_2.pdf@EU-1-99-114_h_a_dec_2.pdf@2002-02-04 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_4.pdf@EU-1-98-091_h_a_dec_4.pdf@2000-03-30 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@NA before 2000@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_23.pdf@EU-1-98-096_h_a_dec_23.pdf@2012-11-26 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_5.pdf@EU-1-99-109_h_a_dec_5.pdf@2004-02-09 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_33.pdf@EU-1-99-107_h_a_dec_33.pdf@2012-04-04 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_5.pdf@EU-1-98-091_h_a_dec_5.pdf@2000-07-13 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_21.pdf@EU-1-98-086_h_a_dec_21.pdf@2007-11-01 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_20.pdf@EU-1-99-114_h_a_dec_20.pdf@2016-05-26 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_6.pdf@EU-1-99-109_h_a_dec_6.pdf@2004-06-12 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_6.pdf@EU-1-98-091_h_a_dec_6.pdf@2001-01-22 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_24.pdf@EU-1-98-096_h_a_dec_24.pdf@2013-12-18 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_34.pdf@EU-1-99-107_h_a_dec_34.pdf@2014-04-28 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_22.pdf@EU-1-98-086_h_a_dec_22.pdf@2007-10-15 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_7.pdf@EU-1-99-109_h_a_dec_7.pdf@2005-11-17 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-091_h_a_dec_7.pdf@EU-1-98-091_h_a_dec_7.pdf@2001-10-19 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_21.pdf@EU-1-99-114_h_a_dec_21.pdf@2017-05-22 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_25.pdf@EU-1-98-096_h_a_dec_25.pdf@2015-05-27 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_8.pdf@EU-1-99-109_h_a_dec_8.pdf@2007-01-03 00:00:00@Integrilin@Eptifibatide@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_8.pdf@EU-1-98-091_h_a_dec_8.pdf@2001-10-19 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_23.pdf@EU-1-98-086_h_a_dec_23.pdf@2008-04-04 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_35.pdf@EU-1-99-107_h_a_dec_35.pdf@2015-10-28 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-109_h_a_dec_9.pdf@EU-1-99-109_h_a_dec_9.pdf@2009-07-04 00:00:00@Integrilin@Eptifibatide@NAS before 2012@False@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-98-091_h_a_dec_9.pdf@EU-1-98-091_h_a_dec_9.pdf@2002-05-30 00:00:00@Telmisartan Boehringer Ingelheim Pharma KG@Telmisartan@NAS before 2012@NA before 2012@OD Not Found@Boehringer Ingelheim International GmbH@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_22.pdf@EU-1-99-114_h_a_dec_22.pdf@2018-11-26 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_24.pdf@EU-1-98-086_h_a_dec_24.pdf@2008-10-06 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_26.pdf@EU-1-98-096_h_a_dec_26.pdf@2018-05-28 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_36.pdf@EU-1-99-107_h_a_dec_36.pdf@2018-02-19 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_23.pdf@EU-1-99-114_h_a_dec_23.pdf@2020-11-02 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_25.pdf@EU-1-98-086_h_a_dec_25.pdf@2008-01-10 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@True@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_27.pdf@EU-1-98-096_h_a_dec_27.pdf@2018-08-23 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_37.pdf@EU-1-99-107_h_a_dec_37.pdf@2018-09-28 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_26.pdf@EU-1-98-086_h_a_dec_26.pdf@2009-02-26 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_28.pdf@EU-1-98-096_h_a_dec_28.pdf@2020-11-16 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_0.pdf@EU-1-99-117_h_a_dec_0.pdf@1999-08-13 00:00:00@SYNAGIS@palivizumab@NAS before 2012@NA before 2012@NA before 2000@Abbott Laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_24.pdf@EU-1-99-114_h_a_dec_24.pdf@2021-11-18 00:00:00@Zeffix@Lamivudine@False@False@OD Not Found@GlaxoSmithKline (Ireland) Limited@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_1.pdf@EU-1-99-117_h_a_dec_1.pdf@2022-11-01 00:00:00@SYNAGIS palivizumab@Active Substance Not Found@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_29.pdf@EU-1-98-096_h_a_dec_29.pdf@2022-06-24 00:00:00@Temodal@temozolomide@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_3.pdf@EU-1-99-114_h_a_dec_3.pdf@2002-09-09 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_38.pdf@EU-1-99-107_h_a_dec_38.pdf@2020-11-02 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_27.pdf@EU-1-98-086_h_a_dec_27.pdf@2009-03-31 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_3.pdf@EU-1-98-096_h_a_dec_3.pdf@2003-06-03 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_10.pdf@EU-1-99-117_h_a_dec_10.pdf@2004-03-25 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_4.pdf@EU-1-99-114_h_a_dec_4.pdf@2002-12-19 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_5.pdf@EU-1-99-114_h_a_dec_5.pdf@2003-02-17 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_4.pdf@EU-1-98-096_h_a_dec_4.pdf@2004-05-02 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_11.pdf@EU-1-99-117_h_a_dec_11.pdf@2004-09-09 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_28.pdf@EU-1-98-086_h_a_dec_28.pdf@2010-11-01 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_39.pdf@EU-1-99-107_h_a_dec_39.pdf@2021-01-06 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_0.pdf@EU-1-99-110_h_a_dec_0.pdf@1999-05-28 00:00:00@SUSTIVA@efavirenz@NAS before 2012@NA before 2012@NA before 2000@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_6.pdf@EU-1-99-114_h_a_dec_6.pdf@2004-01-20 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_1.pdf@EU-1-99-110_h_a_dec_1.pdf@1999-08-23 00:00:00@SUSTIVA efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_4.pdf@EU-1-99-107_h_a_dec_4.pdf@2002-12-04 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_5.pdf@EU-1-98-096_h_a_dec_5.pdf@2004-10-03 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_12.pdf@EU-1-99-117_h_a_dec_12.pdf@2006-07-25 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_29.pdf@EU-1-98-086_h_a_dec_29.pdf@2010-03-02 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_10.pdf@EU-1-99-110_h_a_dec_10.pdf@2002-12-04 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma (UK) Limited@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_7.pdf@EU-1-99-114_h_a_dec_7.pdf@2004-09-20 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_13.pdf@EU-1-99-117_h_a_dec_13.pdf@2007-03-14 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-98-096_h_a_dec_6.pdf@EU-1-98-096_h_a_dec_6.pdf@2005-03-06 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_11.pdf@EU-1-99-110_h_a_dec_11.pdf@2002-07-05 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma (UK) Limited@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_3.pdf@EU-1-98-086_h_a_dec_3.pdf@2000-11-16 00:00:00@CoAprovel@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_40.pdf@EU-1-99-107_h_a_dec_40.pdf@2022-07-06 00:00:00@Rebetol@ribavirin@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-114_h_a_dec_8.pdf@EU-1-99-114_h_a_dec_8.pdf@2005-03-29 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_14.pdf@EU-1-99-117_h_a_dec_14.pdf@2007-06-21 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_12.pdf@EU-1-99-110_h_a_dec_12.pdf@2002-06-20 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_7.pdf@EU-1-98-096_h_a_dec_7.pdf@2005-11-15 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_5.pdf@EU-1-99-107_h_a_dec_5.pdf@2003-03-10 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_0.pdf@EU-1-99-122_h_a_dec_0.pdf@2000-09-03 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_30.pdf@EU-1-98-086_h_a_dec_30.pdf@2010-08-23 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_13.pdf@EU-1-99-110_h_a_dec_13.pdf@2002-10-07 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-114_h_a_dec_9.pdf@EU-1-99-114_h_a_dec_9.pdf@2005-04-25 00:00:00@Zeffix@Lamivudine@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_15.pdf@EU-1-99-117_h_a_dec_15.pdf@2009-01-26 00:00:00@Synagis@palivizumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_1.pdf@EU-1-99-122_h_a_dec_1.pdf@2001-10-16 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-107_h_a_dec_6.pdf@EU-1-99-107_h_a_dec_6.pdf@2003-12-12 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_8.pdf@EU-1-98-096_h_a_dec_8.pdf@2007-04-01 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_14.pdf@EU-1-99-110_h_a_dec_14.pdf@2002-08-22 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_16.pdf@EU-1-99-117_h_a_dec_16.pdf@2009-07-27 00:00:00@Synagis@palivizumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_7.pdf@EU-1-99-107_h_a_dec_7.pdf@2004-02-09 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_31.pdf@EU-1-98-086_h_a_dec_31.pdf@2011-11-02 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb  SNC@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_10.pdf@EU-1-99-122_h_a_dec_10.pdf@2009-07-04 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_15.pdf@EU-1-99-110_h_a_dec_15.pdf@2002-08-30 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-096_h_a_dec_9.pdf@EU-1-98-096_h_a_dec_9.pdf@2007-04-23 00:00:00@Temodal@Temozolomide@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_17.pdf@EU-1-99-117_h_a_dec_17.pdf@2009-11-24 00:00:00@Synagis@palivizumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_11.pdf@EU-1-99-122_h_a_dec_11.pdf@2010-01-15 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_8.pdf@EU-1-99-107_h_a_dec_8.pdf@2004-09-09 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_16.pdf@EU-1-99-110_h_a_dec_16.pdf@2002-09-30 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_32.pdf@EU-1-98-086_h_a_dec_32.pdf@2011-05-23 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma  Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_18.pdf@EU-1-99-117_h_a_dec_18.pdf@2010-03-23 00:00:00@Synagis@palivizumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_17.pdf@EU-1-99-110_h_a_dec_17.pdf@2002-04-12 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_12.pdf@EU-1-99-122_h_a_dec_12.pdf@2010-01-20 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-107_h_a_dec_9.pdf@EU-1-99-107_h_a_dec_9.pdf@2005-01-25 00:00:00@Rebetol@ribavirin@NAS before 2012@NA before 2012@OD Not Found@Schering Plough Europe@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_33.pdf@EU-1-98-086_h_a_dec_33.pdf@2011-02-09 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol- Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_18.pdf@EU-1-99-110_h_a_dec_18.pdf@2003-05-19 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_19.pdf@EU-1-99-117_h_a_dec_19.pdf@2011-09-13 00:00:00@Synagis@palivizumab@NAS before 2012@False@OD Not Found@Abbott Laboratories  Ltd@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_13.pdf@EU-1-99-122_h_a_dec_13.pdf@2010-06-09 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_19.pdf@EU-1-99-110_h_a_dec_19.pdf@2003-06-25 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_34.pdf@EU-1-98-086_h_a_dec_34.pdf@2011-10-24 00:00:00@CoAprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@False@OD Not Found@Sanofi Pharma Bristol- Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_2.pdf@EU-1-99-117_h_a_dec_2.pdf@2001-01-06 00:00:00@SYNAGIS@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott Laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_14.pdf@EU-1-99-122_h_a_dec_14.pdf@2011-08-24 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_2.pdf@EU-1-99-110_h_a_dec_2.pdf@1999-01-31 00:00:00@SUSTIVA efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_20.pdf@EU-1-99-117_h_a_dec_20.pdf@2011-12-19 00:00:00@Synagis@palivizumab@NAS before 2012@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_15.pdf@EU-1-99-122_h_a_dec_15.pdf@2012-11-22 00:00:00@Thyrogen@Thyrotropin alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_35.pdf@EU-1-98-086_h_a_dec_35.pdf@2012-10-05 00:00:00@CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_20.pdf@EU-1-99-110_h_a_dec_20.pdf@2003-09-07 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_21.pdf@EU-1-99-117_h_a_dec_21.pdf@2012-06-27 00:00:00@Synagis@palivizumab@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_16.pdf@EU-1-99-122_h_a_dec_16.pdf@2016-07-15 00:00:00@Thyrogen@Thyrotropin alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_36.pdf@EU-1-98-086_h_a_dec_36.pdf@2012-06-28 00:00:00@CoAprovel@Irbesartan /  hydrochlorothiazide@False@False@OD Not Found@Sanofi Pharma Bristol- Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_21.pdf@EU-1-99-110_h_a_dec_21.pdf@2004-05-02 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_22.pdf@EU-1-99-117_h_a_dec_22.pdf@2012-10-10 00:00:00@Synagis@palivizumab@False@False@OD Not Found@Abbott Laboratories Ltd@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_22.pdf@EU-1-99-110_h_a_dec_22.pdf@2004-04-29 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_0.pdf@EU-1-99-116_h_a_dec_0.pdf@1999-08-13 00:00:00@REMICADE@infliximab@NAS before 2012@NA before 2012@NA before 2000@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_37.pdf@EU-1-98-086_h_a_dec_37.pdf@2013-07-31 00:00:00@CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_17.pdf@EU-1-99-122_h_a_dec_17.pdf@2019-09-23 00:00:00@Thyrogen@Thyrotropin alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_1.pdf@EU-1-99-116_h_a_dec_1.pdf@2000-08-02 00:00:00@REMICADE infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_23.pdf@EU-1-99-117_h_a_dec_23.pdf@2013-04-12 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_23.pdf@EU-1-99-110_h_a_dec_23.pdf@2004-07-13 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_10.pdf@EU-1-99-116_h_a_dec_10.pdf@2002-05-17 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_24.pdf@EU-1-99-110_h_a_dec_24.pdf@2004-06-12 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_38.pdf@EU-1-98-086_h_a_dec_38.pdf@2014-04-09 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC)     EN 1    EN COMMISSION IMPLEMENTING DECISION  4.9.2014  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)3106 for “CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_11.pdf@EU-1-99-116_h_a_dec_11.pdf@2002-05-17 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_18.pdf@EU-1-99-122_h_a_dec_18.pdf@2020-12-14 00:00:00@Thyrogen@Thyrotropin alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_24.pdf@EU-1-99-117_h_a_dec_24.pdf@2014-08-22 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_25.pdf@EU-1-99-110_h_a_dec_25.pdf@2005-05-01 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_12.pdf@EU-1-99-116_h_a_dec_12.pdf@2002-06-20 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_39.pdf@EU-1-98-086_h_a_dec_39.pdf@2017-08-22 00:00:00@CoAprovel@Irbesartan /  hydrochlorothiazide@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_13.pdf@EU-1-99-116_h_a_dec_13.pdf@2002-11-07 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_19.pdf@EU-1-99-122_h_a_dec_19.pdf@2021-11-15 00:00:00@Thyrogen@Thyrotropin alfa@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_26.pdf@EU-1-99-110_h_a_dec_26.pdf@2005-07-03 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_25.pdf@EU-1-99-117_h_a_dec_25.pdf@2015-10-12 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_4.pdf@EU-1-98-086_h_a_dec_4.pdf@2001-04-23 00:00:00@CoAprovel@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_14.pdf@EU-1-99-116_h_a_dec_14.pdf@2002-10-14 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_2.pdf@EU-1-99-122_h_a_dec_2.pdf@Date is blank@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_15.pdf@EU-1-99-116_h_a_dec_15.pdf@2003-05-15 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_27.pdf@EU-1-99-110_h_a_dec_27.pdf@2005-09-08 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_40.pdf@EU-1-98-086_h_a_dec_40.pdf@2018-09-28 00:00:00@CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_3.pdf@EU-1-99-122_h_a_dec_3.pdf@2002-02-19 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_16.pdf@EU-1-99-116_h_a_dec_16.pdf@2003-05-15 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_26.pdf@EU-1-99-117_h_a_dec_26.pdf@2018-08-05 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Ltd@CMA Not Found@Parsed
EU-1-99-122_h_a_dec_4.pdf@EU-1-99-122_h_a_dec_4.pdf@2003-06-26 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_28.pdf@EU-1-99-110_h_a_dec_28.pdf@2005-10-25 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_41.pdf@EU-1-98-086_h_a_dec_41.pdf@2019-11-04 00:00:00@, medicinal product for  human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 11.4.2019 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1998)3106 for “CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_17.pdf@EU-1-99-116_h_a_dec_17.pdf@2003-05-15 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_5.pdf@EU-1-99-122_h_a_dec_5.pdf@2003-08-28 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_27.pdf@EU-1-99-117_h_a_dec_27.pdf@2020-11-18 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_18.pdf@EU-1-99-116_h_a_dec_18.pdf@2003-10-07 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_29.pdf@EU-1-99-110_h_a_dec_29.pdf@2005-12-23 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_42.pdf@EU-1-98-086_h_a_dec_42.pdf@2019-11-11 00:00:00@CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi Clir SNC@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_0.pdf@EU-1-99-108_h_a_dec_0.pdf@1999-08-25 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@NA before 2000@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_6.pdf@EU-1-99-122_h_a_dec_6.pdf@2005-02-23 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_28.pdf@EU-1-99-117_h_a_dec_28.pdf@2021-03-18 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_19.pdf@EU-1-99-116_h_a_dec_19.pdf@2003-10-20 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_3.pdf@EU-1-99-110_h_a_dec_3.pdf@2000-05-24 00:00:00@SUSTIVA efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_43.pdf@EU-1-98-086_h_a_dec_43.pdf@2021-02-19 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE FRENCH TEXT IS AUTHENTIC) EN1ENCOMMISSION IMPLEMENTING DECISION 19.2.2021 amending Commission Decision C(2019) 2976  11 April 2019 concerning, in the  framework  Article 31  Directive 2001/83/EC  the European Parliament and  the  Council, the marketing authorisation granted by Decision C(1998) 3106 for “CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_29.pdf@EU-1-99-117_h_a_dec_29.pdf@2021-01-07 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AbbVie Deutschland GmbH & Co. KG@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_2.pdf@EU-1-99-116_h_a_dec_2.pdf@2000-06-27 00:00:00@REMICADE  infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_7.pdf@EU-1-99-122_h_a_dec_7.pdf@2005-03-16 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_30.pdf@EU-1-99-110_h_a_dec_30.pdf@2006-01-09 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_10.pdf@EU-1-99-108_h_a_dec_10.pdf@2004-02-09 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_44.pdf@EU-1-98-086_h_a_dec_44.pdf@2021-10-05 00:00:00@CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_3.pdf@EU-1-99-117_h_a_dec_3.pdf@2001-08-24 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_20.pdf@EU-1-99-116_h_a_dec_20.pdf@2004-08-03 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_8.pdf@EU-1-99-122_h_a_dec_8.pdf@2007-09-01 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_31.pdf@EU-1-99-110_h_a_dec_31.pdf@2006-10-26 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_45.pdf@EU-1-98-086_h_a_dec_45.pdf@2022-02-09 00:00:00@CoAprovel@Irbesartan / hydrochlorothiazide@False@False@OD Not Found@Sanofi-Aventis groupe@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_11.pdf@EU-1-99-108_h_a_dec_11.pdf@2005-08-22 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_30.pdf@EU-1-99-117_h_a_dec_30.pdf@2022-05-08 00:00:00@Synagis@palivizumab@False@False@OD Not Found@AstraZeneca AB@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_21.pdf@EU-1-99-116_h_a_dec_21.pdf@2004-09-03 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-122_h_a_dec_9.pdf@EU-1-99-122_h_a_dec_9.pdf@2007-04-10 00:00:00@Thyrogen@Thyrotropin alfa@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_32.pdf@EU-1-99-110_h_a_dec_32.pdf@2007-01-15 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_5.pdf@EU-1-98-086_h_a_dec_5.pdf@2001-06-29 00:00:00@CoAprovel@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_12.pdf@EU-1-99-108_h_a_dec_12.pdf@2006-01-30 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_4.pdf@EU-1-99-117_h_a_dec_4.pdf@2002-05-03 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_22.pdf@EU-1-99-116_h_a_dec_22.pdf@2004-08-06 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_33.pdf@EU-1-99-110_h_a_dec_33.pdf@2007-02-05 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_0.pdf@EU-1-99-123_h_a_dec_0.pdf@2000-01-28 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@NA before 2000@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_5.pdf@EU-1-99-117_h_a_dec_5.pdf@2002-05-24 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-98-086_h_a_dec_6.pdf@EU-1-98-086_h_a_dec_6.pdf@2001-08-10 00:00:00@CoAprovel@Irbesartan/Hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_13.pdf@EU-1-99-108_h_a_dec_13.pdf@2007-01-26 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_23.pdf@EU-1-99-116_h_a_dec_23.pdf@2004-08-06 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_6.pdf@EU-1-99-117_h_a_dec_6.pdf@2003-03-02 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_34.pdf@EU-1-99-110_h_a_dec_34.pdf@2007-02-07 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_7.pdf@EU-1-98-086_h_a_dec_7.pdf@Date is blank@Coaprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@NA before 2000@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_1.pdf@EU-1-99-123_h_a_dec_1.pdf@2001-04-23 00:00:00@Renagel@sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_14.pdf@EU-1-99-108_h_a_dec_14.pdf@2007-06-29 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA Not Found@Parsed
EU-1-99-117_h_a_dec_7.pdf@EU-1-99-117_h_a_dec_7.pdf@2003-05-15 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_24.pdf@EU-1-99-116_h_a_dec_24.pdf@2004-09-20 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_0.pdf@EU-1-99-124_h_a_dec_0.pdf@2000-01-20 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@NA before 2000@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_35.pdf@EU-1-99-110_h_a_dec_35.pdf@2007-08-23 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_8.pdf@EU-1-98-086_h_a_dec_8.pdf@2002-08-03 00:00:00@Coaprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_10.pdf@EU-1-99-123_h_a_dec_10.pdf@2003-07-14 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_1.pdf@EU-1-99-124_h_a_dec_1.pdf@2000-05-17 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_8.pdf@EU-1-99-117_h_a_dec_8.pdf@2003-06-30 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_15.pdf@EU-1-99-108_h_a_dec_15.pdf@2007-11-19 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-98-086_h_a_dec_9.pdf@EU-1-98-086_h_a_dec_9.pdf@2002-11-04 00:00:00@Coaprovel@Irbesartan/hydrochlorothiazide@NAS before 2012@NA before 2012@OD Not Found@Sanofi Pharma Bristol-Myers Squibb SNC@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_25.pdf@EU-1-99-116_h_a_dec_25.pdf@2004-09-23 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_36.pdf@EU-1-99-110_h_a_dec_36.pdf@2008-11-07 00:00:00@Sustiva@efavirenz@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_11.pdf@EU-1-99-123_h_a_dec_11.pdf@2004-01-27 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-117_h_a_dec_9.pdf@EU-1-99-117_h_a_dec_9.pdf@2003-10-20 00:00:00@Synagis@palivizumab@NAS before 2012@NA before 2012@OD Not Found@Abbott laboratories Ltd@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_10.pdf@EU-1-99-124_h_a_dec_10.pdf@2009-12-23 00:00:00@Tractocile@Atosiban@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_16.pdf@EU-1-99-108_h_a_dec_16.pdf@2008-04-23 00:00:00@Ferriprox@Deferiprone@NAS before 2012@True@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_26.pdf@EU-1-99-116_h_a_dec_26.pdf@2005-10-01 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_37.pdf@EU-1-99-110_h_a_dec_37.pdf@2008-09-15 00:00:00@Sustiva@efavirenz@NAS before 2012@True@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_11.pdf@EU-1-99-124_h_a_dec_11.pdf@2011-07-06 00:00:00@Tractocile@Atosiban@NAS before 2012@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_12.pdf@EU-1-99-123_h_a_dec_12.pdf@2005-01-26 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_27.pdf@EU-1-99-116_h_a_dec_27.pdf@2005-01-26 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_17.pdf@EU-1-99-108_h_a_dec_17.pdf@2009-02-06 00:00:00@Ferriprox@Deferiprone@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_12.pdf@EU-1-99-124_h_a_dec_12.pdf@2012-02-17 00:00:00@Tractocile@Atosiban@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_38.pdf@EU-1-99-110_h_a_dec_38.pdf@2008-01-12 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_13.pdf@EU-1-99-123_h_a_dec_13.pdf@2005-08-31 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_28.pdf@EU-1-99-116_h_a_dec_28.pdf@2005-06-28 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_18.pdf@EU-1-99-108_h_a_dec_18.pdf@2009-09-21 00:00:00@Ferriprox@Deferiprone@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_39.pdf@EU-1-99-110_h_a_dec_39.pdf@2009-09-03 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_14.pdf@EU-1-99-123_h_a_dec_14.pdf@2006-06-26 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@exceptional@Parsed
EU-1-99-124_h_a_dec_13.pdf@EU-1-99-124_h_a_dec_13.pdf@2014-09-01 00:00:00@Tractocile@Atosiban@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_29.pdf@EU-1-99-116_h_a_dec_29.pdf@2005-06-28 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_19.pdf@EU-1-99-108_h_a_dec_19.pdf@2010-05-07 00:00:00@Ferriprox@Deferiprone@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_4.pdf@EU-1-99-110_h_a_dec_4.pdf@2000-10-13 00:00:00@SUSTIVA efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_2.pdf@EU-1-99-108_h_a_dec_2.pdf@2000-01-12 00:00:00@Ferriprox@deferiprone@NAS before 2012@NA before 2012@NA before 2000@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_15.pdf@EU-1-99-123_h_a_dec_15.pdf@2007-01-06 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_3.pdf@EU-1-99-116_h_a_dec_3.pdf@2000-11-16 00:00:00@REMICADE  infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_14.pdf@EU-1-99-124_h_a_dec_14.pdf@2016-12-19 00:00:00@Tractocile@Atosiban@False@False@OD Not Found@Ferring Pharmaceuticals A/S@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_40.pdf@EU-1-99-110_h_a_dec_40.pdf@2009-04-22 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_2.pdf@EU-1-99-124_h_a_dec_2.pdf@2001-02-23 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_20.pdf@EU-1-99-108_h_a_dec_20.pdf@2010-07-28 00:00:00@Ferriprox@Deferiprone@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_30.pdf@EU-1-99-116_h_a_dec_30.pdf@2005-01-08 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_16.pdf@EU-1-99-123_h_a_dec_16.pdf@2008-06-18 00:00:00@Renagel@Sevelamer@NAS before 2012@True@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_3.pdf@EU-1-99-124_h_a_dec_3.pdf@2001-07-19 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_41.pdf@EU-1-99-110_h_a_dec_41.pdf@2009-02-06 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_0.pdf@EU-1-99-118_h_a_dec_0.pdf@1999-02-09 00:00:00@ARAVA@leflunomide@NAS before 2012@NA before 2012@NA before 2000@Hoechst marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_21.pdf@EU-1-99-108_h_a_dec_21.pdf@2010-06-08 00:00:00@Ferriprox@Deferiprone@NAS before 2012@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_17.pdf@EU-1-99-123_h_a_dec_17.pdf@2009-04-21 00:00:00@Renagel@Sevelamer@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_31.pdf@EU-1-99-116_h_a_dec_31.pdf@2005-09-29 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-124_h_a_dec_4.pdf@EU-1-99-124_h_a_dec_4.pdf@2002-10-09 00:00:00@Tractocile@Atociban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_1.pdf@EU-1-99-118_h_a_dec_1.pdf@1999-08-12 00:00:00@ARAVA@leflunomide@NAS before 2012@NA before 2012@NA before 2000@Hoechst Marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_22.pdf@EU-1-99-108_h_a_dec_22.pdf@2012-10-25 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_42.pdf@EU-1-99-110_h_a_dec_42.pdf@2009-09-12 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_18.pdf@EU-1-99-123_h_a_dec_18.pdf@2009-07-27 00:00:00@Renagel@Sevelamer@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_5.pdf@EU-1-99-124_h_a_dec_5.pdf@2003-04-03 00:00:00@Tractocile@Atociban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_32.pdf@EU-1-99-116_h_a_dec_32.pdf@2005-09-29 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_10.pdf@EU-1-99-118_h_a_dec_10.pdf@2002-07-18 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_43.pdf@EU-1-99-110_h_a_dec_43.pdf@2010-03-26 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_19.pdf@EU-1-99-123_h_a_dec_19.pdf@2009-08-12 00:00:00@Renagel@Sevelamer@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_11.pdf@EU-1-99-118_h_a_dec_11.pdf@2003-02-14 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_33.pdf@EU-1-99-116_h_a_dec_33.pdf@2006-02-28 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_6.pdf@EU-1-99-124_h_a_dec_6.pdf@2004-06-17 00:00:00@Tractocile@Atociban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_23.pdf@EU-1-99-108_h_a_dec_23.pdf@2014-04-23 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_44.pdf@EU-1-99-110_h_a_dec_44.pdf@2010-06-08 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_12.pdf@EU-1-99-118_h_a_dec_12.pdf@2003-10-20 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_34.pdf@EU-1-99-116_h_a_dec_34.pdf@2006-04-07 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_20.pdf@EU-1-99-123_h_a_dec_20.pdf@2010-02-06 00:00:00@Renagel@Sevelamer@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_7.pdf@EU-1-99-124_h_a_dec_7.pdf@2005-01-31 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_24.pdf@EU-1-99-108_h_a_dec_24.pdf@2016-05-26 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_45.pdf@EU-1-99-110_h_a_dec_45.pdf@2010-03-11 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_13.pdf@EU-1-99-118_h_a_dec_13.pdf@2004-01-27 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_35.pdf@EU-1-99-116_h_a_dec_35.pdf@2006-01-09 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_21.pdf@EU-1-99-123_h_a_dec_21.pdf@2011-02-18 00:00:00@Renagel@Sevelamer@NAS before 2012@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_8.pdf@EU-1-99-124_h_a_dec_8.pdf@2006-07-20 00:00:00@Tractocile@Atosiban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_25.pdf@EU-1-99-108_h_a_dec_25.pdf@2017-05-24 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_46.pdf@EU-1-99-110_h_a_dec_46.pdf@2011-07-13 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_14.pdf@EU-1-99-118_h_a_dec_14.pdf@2004-10-06 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_22.pdf@EU-1-99-123_h_a_dec_22.pdf@2011-12-22 00:00:00@Renagel@Sevelamer@NAS before 2012@False@OD Not Found@Genzyme Europe  B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_36.pdf@EU-1-99-116_h_a_dec_36.pdf@2006-10-27 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-124_h_a_dec_9.pdf@EU-1-99-124_h_a_dec_9.pdf@2008-04-11 00:00:00@Tractocile@Atosiban@NAS before 2012@False@OD Not Found@Ferring AB@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_47.pdf@EU-1-99-110_h_a_dec_47.pdf@2011-06-10 00:00:00@Sustiva@efavirenz@NAS before 2012@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG,@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_15.pdf@EU-1-99-118_h_a_dec_15.pdf@2004-08-06 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_26.pdf@EU-1-99-108_h_a_dec_26.pdf@2018-12-04 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_37.pdf@EU-1-99-116_h_a_dec_37.pdf@2007-04-01 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_48.pdf@EU-1-99-110_h_a_dec_48.pdf@2012-06-27 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers  Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_23.pdf@EU-1-99-123_h_a_dec_23.pdf@2014-11-19 00:00:00@Renagel@Sevelamer@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_16.pdf@EU-1-99-118_h_a_dec_16.pdf@2004-10-13 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_38.pdf@EU-1-99-116_h_a_dec_38.pdf@2007-03-27 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_49.pdf@EU-1-99-110_h_a_dec_49.pdf@2013-04-29 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_24.pdf@EU-1-99-123_h_a_dec_24.pdf@2015-02-17 00:00:00@Renagel@Sevelamer@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_27.pdf@EU-1-99-108_h_a_dec_27.pdf@2019-11-03 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_17.pdf@EU-1-99-118_h_a_dec_17.pdf@2004-06-12 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_5.pdf@EU-1-99-110_h_a_dec_5.pdf@2001-06-14 00:00:00@SUSTIVA efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_39.pdf@EU-1-99-116_h_a_dec_39.pdf@2007-05-30 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@the Member States. Done at Brussels@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_25.pdf@EU-1-99-123_h_a_dec_25.pdf@2016-08-31 00:00:00@Renagel@Sevelamer@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_18.pdf@EU-1-99-118_h_a_dec_18.pdf@2005-09-19 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_4.pdf@EU-1-99-116_h_a_dec_4.pdf@2001-01-29 00:00:00@REMICADE infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_28.pdf@EU-1-99-108_h_a_dec_28.pdf@2019-05-13 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex Europe B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_0.pdf@EU-1-99-125_h_a_dec_0.pdf@2000-03-02 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@NA before 2000@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_26.pdf@EU-1-99-123_h_a_dec_26.pdf@2019-08-23 00:00:00@Renagel@Sevelamer@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_19.pdf@EU-1-99-118_h_a_dec_19.pdf@2005-11-15 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_50.pdf@EU-1-99-110_h_a_dec_50.pdf@2013-01-07 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_40.pdf@EU-1-99-116_h_a_dec_40.pdf@2007-05-30 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor BV@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_1.pdf@EU-1-99-125_h_a_dec_1.pdf@2000-12-27 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_2.pdf@EU-1-99-118_h_a_dec_2.pdf@2000-03-24 00:00:00@ ARAVA leflunomide @Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Hoechst Marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_41.pdf@EU-1-99-116_h_a_dec_41.pdf@2007-07-24 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_27.pdf@EU-1-99-123_h_a_dec_27.pdf@2021-01-14 00:00:00@Renagel@Sevelamer@False@False@OD Not Found@Genzyme Europe B.V.@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_29.pdf@EU-1-99-108_h_a_dec_29.pdf@2020-04-05 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Apotex B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_10.pdf@EU-1-99-125_h_a_dec_10.pdf@2004-07-13 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_51.pdf@EU-1-99-110_h_a_dec_51.pdf@2014-04-23 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_20.pdf@EU-1-99-118_h_a_dec_20.pdf@2006-09-01 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_3.pdf@EU-1-99-108_h_a_dec_3.pdf@2001-06-03 00:00:00@Ferriprox@deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_3.pdf@EU-1-99-123_h_a_dec_3.pdf@2001-10-15 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_42.pdf@EU-1-99-116_h_a_dec_42.pdf@2007-10-30 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_11.pdf@EU-1-99-125_h_a_dec_11.pdf@2004-04-11 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-123_h_a_dec_4.pdf@EU-1-99-123_h_a_dec_4.pdf@2002-06-02 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme B.V.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_21.pdf@EU-1-99-118_h_a_dec_21.pdf@2006-06-07 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_43.pdf@EU-1-99-116_h_a_dec_43.pdf@2007-11-30 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_0.pdf@EU-1-99-126_h_a_dec_0.pdf@2000-03-02 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@NA before 2000@Wyeth Research (UK) Limited@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_52.pdf@EU-1-99-110_h_a_dec_52.pdf@2015-08-04 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_5.pdf@EU-1-99-123_h_a_dec_5.pdf@2002-02-19 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_12.pdf@EU-1-99-125_h_a_dec_12.pdf@2004-04-11 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_44.pdf@EU-1-99-116_h_a_dec_44.pdf@2007-12-21 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_1.pdf@EU-1-99-126_h_a_dec_1.pdf@2001-03-13 00:00:00@Enbrel@etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_30.pdf@EU-1-99-108_h_a_dec_30.pdf@2022-06-01 00:00:00@Ferriprox@Deferiprone@False@False@OD Not Found@Chiesi Farmaceutici S.p.A.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_22.pdf@EU-1-99-118_h_a_dec_22.pdf@2007-08-11 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_6.pdf@EU-1-99-123_h_a_dec_6.pdf@2002-07-26 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_13.pdf@EU-1-99-125_h_a_dec_13.pdf@2005-09-02 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_53.pdf@EU-1-99-110_h_a_dec_53.pdf@2017-02-13 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_10.pdf@EU-1-99-126_h_a_dec_10.pdf@2003-04-22 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_4.pdf@EU-1-99-108_h_a_dec_4.pdf@2002-05-02 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_23.pdf@EU-1-99-118_h_a_dec_23.pdf@2008-02-26 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_7.pdf@EU-1-99-123_h_a_dec_7.pdf@2002-07-10 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_11.pdf@EU-1-99-126_h_a_dec_11.pdf@2003-04-22 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_14.pdf@EU-1-99-125_h_a_dec_14.pdf@2005-08-31 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_46.pdf@EU-1-99-116_h_a_dec_46.pdf@2008-04-23 00:00:00@Remicade@infliximab@NAS before 2012@True@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_5.pdf@EU-1-99-108_h_a_dec_5.pdf@2002-12-04 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_24.pdf@EU-1-99-118_h_a_dec_24.pdf@2008-02-26 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_8.pdf@EU-1-99-123_h_a_dec_8.pdf@2003-04-03 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_12.pdf@EU-1-99-126_h_a_dec_12.pdf@2003-08-13 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_54.pdf@EU-1-99-110_h_a_dec_54.pdf@2017-12-15 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_6.pdf@EU-1-99-108_h_a_dec_6.pdf@2003-10-04 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_47.pdf@EU-1-99-116_h_a_dec_47.pdf@2008-06-18 00:00:00@Remicade@infliximab@NAS before 2012@True@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_15.pdf@EU-1-99-125_h_a_dec_15.pdf@2006-12-09 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV (the marketing  authorisation holder)@CMA Not Found@Parsed
EU-1-99-123_h_a_dec_9.pdf@EU-1-99-123_h_a_dec_9.pdf@2003-04-22 00:00:00@Renagel@Sevelamer@NAS before 2012@NA before 2012@OD Not Found@Genzyme Europe B.V.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_25.pdf@EU-1-99-118_h_a_dec_25.pdf@2009-10-02 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_7.pdf@EU-1-99-108_h_a_dec_7.pdf@2003-12-05 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_13.pdf@EU-1-99-126_h_a_dec_13.pdf@2003-10-24 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_16.pdf@EU-1-99-125_h_a_dec_16.pdf@2006-09-13 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_48.pdf@EU-1-99-116_h_a_dec_48.pdf@2008-10-07 00:00:00@Remicade@infliximab@NAS before 2012@True@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_26.pdf@EU-1-99-118_h_a_dec_26.pdf@2009-01-07 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-108_h_a_dec_8.pdf@EU-1-99-108_h_a_dec_8.pdf@2003-03-10 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_14.pdf@EU-1-99-126_h_a_dec_14.pdf@2004-01-16 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_55.pdf@EU-1-99-110_h_a_dec_55.pdf@2018-10-25 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_49.pdf@EU-1-99-116_h_a_dec_49.pdf@2008-07-29 00:00:00@Remicade@infliximab@NAS before 2012@True@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_17.pdf@EU-1-99-125_h_a_dec_17.pdf@2007-06-19 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_27.pdf@EU-1-99-118_h_a_dec_27.pdf@2009-10-28 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_15.pdf@EU-1-99-126_h_a_dec_15.pdf@2004-10-05 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-108_h_a_dec_9.pdf@EU-1-99-108_h_a_dec_9.pdf@2004-07-05 00:00:00@Ferriprox@Deferiprone@NAS before 2012@NA before 2012@OD Not Found@Apotex Europe Ltd.@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_5.pdf@EU-1-99-116_h_a_dec_5.pdf@2001-02-23 00:00:00@REMICADE infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_18.pdf@EU-1-99-125_h_a_dec_18.pdf@2007-08-30 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_28.pdf@EU-1-99-118_h_a_dec_28.pdf@2010-01-27 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_56.pdf@EU-1-99-110_h_a_dec_56.pdf@2019-02-20 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_16.pdf@EU-1-99-126_h_a_dec_16.pdf@2004-07-23 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_50.pdf@EU-1-99-116_h_a_dec_50.pdf@2009-06-03 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_19.pdf@EU-1-99-125_h_a_dec_19.pdf@2007-11-21 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_29.pdf@EU-1-99-118_h_a_dec_29.pdf@2010-04-29 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_17.pdf@EU-1-99-126_h_a_dec_17.pdf@2004-07-23 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_2.pdf@EU-1-99-125_h_a_dec_2.pdf@2002-10-09 00:00:00@Tractocile@Atociban@NAS before 2012@NA before 2012@OD Not Found@Ferring AB@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_51.pdf@EU-1-99-116_h_a_dec_51.pdf@2009-03-07 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_3.pdf@EU-1-99-118_h_a_dec_3.pdf@2000-04-07 00:00:00@ ARAVA leflunomide @Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Hoechst Marion Roussel Deuschland GmbH@CMA not available before 2006@Parsed
EU-1-99-110_h_a_dec_57.pdf@EU-1-99-110_h_a_dec_57.pdf@2019-03-28 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_18.pdf@EU-1-99-126_h_a_dec_18.pdf@2004-09-24 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_20.pdf@EU-1-99-125_h_a_dec_20.pdf@2008-01-17 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_30.pdf@EU-1-99-118_h_a_dec_30.pdf@2010-06-08 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_52.pdf@EU-1-99-116_h_a_dec_52.pdf@2009-02-07 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_19.pdf@EU-1-99-126_h_a_dec_19.pdf@2005-10-03 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_21.pdf@EU-1-99-125_h_a_dec_21.pdf@2008-04-23 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_58.pdf@EU-1-99-110_h_a_dec_58.pdf@2020-04-23 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_31.pdf@EU-1-99-118_h_a_dec_31.pdf@2011-04-18 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_53.pdf@EU-1-99-116_h_a_dec_53.pdf@2009-10-29 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_2.pdf@EU-1-99-126_h_a_dec_2.pdf@2001-04-23 00:00:00@Enbrel@etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_32.pdf@EU-1-99-118_h_a_dec_32.pdf@2011-10-08 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_22.pdf@EU-1-99-125_h_a_dec_22.pdf@2008-07-28 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@True@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_54.pdf@EU-1-99-116_h_a_dec_54.pdf@2010-03-15 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_20.pdf@EU-1-99-126_h_a_dec_20.pdf@2005-10-03 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_33.pdf@EU-1-99-118_h_a_dec_33.pdf@2011-10-11 00:00:00@Arava@leflunomide@NAS before 2012@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_59.pdf@EU-1-99-110_h_a_dec_59.pdf@2022-12-08 00:00:00@Sustiva@efavirenz@False@False@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_23.pdf@EU-1-99-125_h_a_dec_23.pdf@2009-03-25 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_55.pdf@EU-1-99-116_h_a_dec_55.pdf@2010-03-26 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_34.pdf@EU-1-99-118_h_a_dec_34.pdf@2012-03-19 00:00:00@Arava@leflunomide@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
maceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_21.pdf@EU-1-99-126_h_a_dec_21.pdf@2005-04-28 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_24.pdf@EU-1-99-125_h_a_dec_24.pdf@2009-07-07 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_56.pdf@EU-1-99-116_h_a_dec_56.pdf@2010-04-27 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_7.pdf@EU-1-99-110_h_a_dec_7.pdf@2001-10-18 00:00:00@SUSTIVA efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@DuPont Pharmaceuticals Limited@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_35.pdf@EU-1-99-118_h_a_dec_35.pdf@2012-12-18 00:00:00@Arava@leflunomide@False@False@OD Not Found@Sanofi-Aventis  Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_22.pdf@EU-1-99-126_h_a_dec_22.pdf@2005-07-22 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_25.pdf@EU-1-99-125_h_a_dec_25.pdf@2009-12-21 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_57.pdf@EU-1-99-116_h_a_dec_57.pdf@2010-11-29 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_8.pdf@EU-1-99-110_h_a_dec_8.pdf@2002-03-21 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma (UK)@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_23.pdf@EU-1-99-126_h_a_dec_23.pdf@2005-01-08 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_36.pdf@EU-1-99-118_h_a_dec_36.pdf@2014-07-11 00:00:00@Arava@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_26.pdf@EU-1-99-125_h_a_dec_26.pdf@2010-06-09 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_58.pdf@EU-1-99-116_h_a_dec_58.pdf@2011-01-27 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Centocor B.V.@CMA Not Found@Parsed
EU-1-99-110_h_a_dec_9.pdf@EU-1-99-110_h_a_dec_9.pdf@2002-02-04 00:00:00@Sustiva@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Bristol-Myers Squibb Pharma EEIG@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_24.pdf@EU-1-99-126_h_a_dec_24.pdf@2006-03-13 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_37.pdf@EU-1-99-118_h_a_dec_37.pdf@2016-09-15 00:00:00@Arava@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_27.pdf@EU-1-99-125_h_a_dec_27.pdf@2010-12-20 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_59.pdf@EU-1-99-116_h_a_dec_59.pdf@2011-02-21 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_38.pdf@EU-1-99-118_h_a_dec_38.pdf@2018-07-30 00:00:00@Arava@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
Parsed
EU-1-99-116_h_a_dec_6.pdf@EU-1-99-116_h_a_dec_6.pdf@2001-06-27 00:00:00@REMICADE infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_28.pdf@EU-1-99-125_h_a_dec_28.pdf@2011-10-20 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_39.pdf@EU-1-99-118_h_a_dec_39.pdf@2022-12-08 00:00:00@Arava@leflunomide@False@False@OD Not Found@Sanofi-Aventis Deutschland GmbH@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_26.pdf@EU-1-99-126_h_a_dec_26.pdf@2006-05-31 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_60.pdf@EU-1-99-116_h_a_dec_60.pdf@2011-04-20 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_29.pdf@EU-1-99-125_h_a_dec_29.pdf@2011-11-24 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_4.pdf@EU-1-99-118_h_a_dec_4.pdf@2000-11-16 00:00:00@ARAVA@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_27.pdf@EU-1-99-126_h_a_dec_27.pdf@2006-04-08 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_61.pdf@EU-1-99-116_h_a_dec_61.pdf@2011-06-17 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_3.pdf@EU-1-99-125_h_a_dec_3.pdf@2001-06-14 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_5.pdf@EU-1-99-118_h_a_dec_5.pdf@2001-07-31 00:00:00@ARAVA leflunomide@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_62.pdf@EU-1-99-116_h_a_dec_62.pdf@2011-07-26 00:00:00@Remicade@infliximab@NAS before 2012@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_30.pdf@EU-1-99-125_h_a_dec_30.pdf@2012-06-27 00:00:00@Zyprexa Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland  B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_28.pdf@EU-1-99-126_h_a_dec_28.pdf@2006-09-26 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_6.pdf@EU-1-99-118_h_a_dec_6.pdf@1980-01-01 00:00:00@ARAVA leflunomide@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_63.pdf@EU-1-99-116_h_a_dec_63.pdf@2012-06-02 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_29.pdf@EU-1-99-126_h_a_dec_29.pdf@2006-10-20 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_31.pdf@EU-1-99-125_h_a_dec_31.pdf@2013-05-27 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_7.pdf@EU-1-99-118_h_a_dec_7.pdf@2002-02-19 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_64.pdf@EU-1-99-116_h_a_dec_64.pdf@2012-02-21 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_3.pdf@EU-1-99-126_h_a_dec_3.pdf@2001-05-17 00:00:00@Enbrel@etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_32.pdf@EU-1-99-125_h_a_dec_32.pdf@2015-04-13 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-118_h_a_dec_8.pdf@EU-1-99-118_h_a_dec_8.pdf@2002-02-19 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-118_h_a_dec_9.pdf@EU-1-99-118_h_a_dec_9.pdf@2002-03-22 00:00:00@Arava@leflunomide@NAS before 2012@NA before 2012@OD Not Found@Aventis Pharma Deutschland GmbH@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_33.pdf@EU-1-99-125_h_a_dec_33.pdf@2017-02-16 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_65.pdf@EU-1-99-116_h_a_dec_65.pdf@2012-03-19 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_30.pdf@EU-1-99-126_h_a_dec_30.pdf@2006-11-29 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_34.pdf@EU-1-99-125_h_a_dec_34.pdf@2018-02-19 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_66.pdf@EU-1-99-116_h_a_dec_66.pdf@2012-11-22 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics  B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_31.pdf@EU-1-99-126_h_a_dec_31.pdf@2007-01-18 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_67.pdf@EU-1-99-116_h_a_dec_67.pdf@2013-07-25 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_32.pdf@EU-1-99-126_h_a_dec_32.pdf@2007-02-04 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_35.pdf@EU-1-99-125_h_a_dec_35.pdf@2019-06-02 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_33.pdf@EU-1-99-126_h_a_dec_33.pdf@2007-08-29 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_68.pdf@EU-1-99-116_h_a_dec_68.pdf@2014-06-19 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_34.pdf@EU-1-99-126_h_a_dec_34.pdf@2007-10-15 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_36.pdf@EU-1-99-125_h_a_dec_36.pdf@2020-02-21 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_69.pdf@EU-1-99-116_h_a_dec_69.pdf@2015-08-07 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_35.pdf@EU-1-99-126_h_a_dec_35.pdf@2007-11-19 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_7.pdf@EU-1-99-116_h_a_dec_7.pdf@2001-07-31 00:00:00@REMICADE infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_36.pdf@EU-1-99-126_h_a_dec_36.pdf@2008-07-07 00:00:00@Enbrel@Etanercept@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_37.pdf@EU-1-99-125_h_a_dec_37.pdf@2021-09-12 00:00:00@Zyprexa  Velotab@Olanzapine@False@False@OD Not Found@Eli Lilly Nederland B.V.@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_70.pdf@EU-1-99-116_h_a_dec_70.pdf@2016-07-15 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_4.pdf@EU-1-99-125_h_a_dec_4.pdf@2001-11-20 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_37.pdf@EU-1-99-126_h_a_dec_37.pdf@2008-08-29 00:00:00@Enbrel@Etanercept@NAS before 2012@True@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_71.pdf@EU-1-99-116_h_a_dec_71.pdf@2019-10-17 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_5.pdf@EU-1-99-125_h_a_dec_5.pdf@2002-04-06 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_38.pdf@EU-1-99-126_h_a_dec_38.pdf@2008-12-22 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_6.pdf@EU-1-99-125_h_a_dec_6.pdf@2002-10-09 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_72.pdf@EU-1-99-116_h_a_dec_72.pdf@2019-10-24 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_7.pdf@EU-1-99-125_h_a_dec_7.pdf@2002-11-20 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_39.pdf@EU-1-99-126_h_a_dec_39.pdf@2009-03-25 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-125_h_a_dec_8.pdf@EU-1-99-125_h_a_dec_8.pdf@2003-08-10 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_4.pdf@EU-1-99-126_h_a_dec_4.pdf@2001-06-08 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Ltd.@CMA not available before 2006@Parsed
EU-1-99-125_h_a_dec_9.pdf@EU-1-99-125_h_a_dec_9.pdf@2003-10-24 00:00:00@Zyprexa Velotab@Olanzapine@NAS before 2012@NA before 2012@OD Not Found@Eli Lilly Nederland BV@CMA not available before 2006@Parsed
EU-1-99-116_h_a_dec_73.pdf@EU-1-99-116_h_a_dec_73.pdf@2021-11-15 00:00:00@Remicade@infliximab@False@False@OD Not Found@Janssen Biologics B.V.@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_40.pdf@EU-1-99-126_h_a_dec_40.pdf@2009-05-29 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_8.pdf@EU-1-99-116_h_a_dec_8.pdf@2001-07-31 00:00:00@REMICADE infliximab@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_41.pdf@EU-1-99-126_h_a_dec_41.pdf@2009-07-16 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-116_h_a_dec_9.pdf@EU-1-99-116_h_a_dec_9.pdf@2002-08-02 00:00:00@Remicade@infliximab@NAS before 2012@NA before 2012@OD Not Found@Centocor B.V.@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_42.pdf@EU-1-99-126_h_a_dec_42.pdf@2009-11-26 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_43.pdf@EU-1-99-126_h_a_dec_43.pdf@2009-11-26 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_0.pdf@EU-1-99-119_h_a_dec_0.pdf@1999-07-09 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_1.pdf@EU-1-99-119_h_a_dec_1.pdf@2000-08-02 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_44.pdf@EU-1-99-126_h_a_dec_44.pdf@2010-05-05 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_10.pdf@EU-1-99-119_h_a_dec_10.pdf@2003-04-06 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_45.pdf@EU-1-99-126_h_a_dec_45.pdf@2010-01-07 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_11.pdf@EU-1-99-119_h_a_dec_11.pdf@2003-04-06 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_46.pdf@EU-1-99-126_h_a_dec_46.pdf@2010-11-26 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_12.pdf@EU-1-99-119_h_a_dec_12.pdf@2003-06-06 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_47.pdf@EU-1-99-126_h_a_dec_47.pdf@2011-01-21 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_13.pdf@EU-1-99-119_h_a_dec_13.pdf@2003-07-18 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_48.pdf@EU-1-99-126_h_a_dec_48.pdf@2011-02-21 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_14.pdf@EU-1-99-119_h_a_dec_14.pdf@2003-08-22 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_49.pdf@EU-1-99-126_h_a_dec_49.pdf@2011-05-27 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa  Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_15.pdf@EU-1-99-119_h_a_dec_15.pdf@2004-07-04 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_5.pdf@EU-1-99-126_h_a_dec_5.pdf@2001-12-17 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_16.pdf@EU-1-99-119_h_a_dec_16.pdf@2004-08-24 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_50.pdf@EU-1-99-126_h_a_dec_50.pdf@2011-06-29 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_17.pdf@EU-1-99-119_h_a_dec_17.pdf@2004-10-13 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_51.pdf@EU-1-99-126_h_a_dec_51.pdf@2011-06-29 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_18.pdf@EU-1-99-119_h_a_dec_18.pdf@2004-10-15 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_52.pdf@EU-1-99-126_h_a_dec_52.pdf@2011-05-08 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Wyeth Europa Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_19.pdf@EU-1-99-119_h_a_dec_19.pdf@2005-03-30 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_53.pdf@EU-1-99-126_h_a_dec_53.pdf@2011-08-24 00:00:00@Enbrel@Etanercept@NAS before 2012@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_2.pdf@EU-1-99-119_h_a_dec_2.pdf@2000-04-13 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@NA before 2000@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_54.pdf@EU-1-99-126_h_a_dec_54.pdf@2012-07-31 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_20.pdf@EU-1-99-119_h_a_dec_20.pdf@2005-08-07 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_55.pdf@EU-1-99-126_h_a_dec_55.pdf@2012-08-30 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_21.pdf@EU-1-99-119_h_a_dec_21.pdf@2006-03-29 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_56.pdf@EU-1-99-126_h_a_dec_56.pdf@2012-10-24 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_22.pdf@EU-1-99-119_h_a_dec_22.pdf@2006-07-20 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_57.pdf@EU-1-99-126_h_a_dec_57.pdf@2013-11-13 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_0.pdf@EU-1-99-111_h_a_dec_0.pdf@1999-05-28 00:00:00@STOCRIN@efavirenz@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_23.pdf@EU-1-99-119_h_a_dec_23.pdf@2007-08-30 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_58.pdf@EU-1-99-126_h_a_dec_58.pdf@2014-07-28 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_1.pdf@EU-1-99-111_h_a_dec_1.pdf@1980-01-01 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_24.pdf@EU-1-99-119_h_a_dec_24.pdf@2008-04-23 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_10.pdf@EU-1-99-111_h_a_dec_10.pdf@2002-08-30 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_11.pdf@EU-1-99-111_h_a_dec_11.pdf@2002-09-30 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_59.pdf@EU-1-99-126_h_a_dec_59.pdf@2015-08-09 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_25.pdf@EU-1-99-119_h_a_dec_25.pdf@2008-04-23 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@True@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_12.pdf@EU-1-99-111_h_a_dec_12.pdf@2003-05-23 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_6.pdf@EU-1-99-126_h_a_dec_6.pdf@2002-06-02 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_26.pdf@EU-1-99-119_h_a_dec_26.pdf@2009-04-30 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_13.pdf@EU-1-99-111_h_a_dec_13.pdf@2003-06-25 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_14.pdf@EU-1-99-111_h_a_dec_14.pdf@2003-09-07 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_27.pdf@EU-1-99-119_h_a_dec_27.pdf@2009-07-27 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_60.pdf@EU-1-99-126_h_a_dec_60.pdf@2016-09-19 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_15.pdf@EU-1-99-111_h_a_dec_15.pdf@2004-06-02 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_28.pdf@EU-1-99-119_h_a_dec_28.pdf@2011-08-04 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_61.pdf@EU-1-99-126_h_a_dec_61.pdf@2017-12-18 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_16.pdf@EU-1-99-111_h_a_dec_16.pdf@2004-04-29 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_29.pdf@EU-1-99-119_h_a_dec_29.pdf@2011-11-07 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_17.pdf@EU-1-99-111_h_a_dec_17.pdf@2004-07-13 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_3.pdf@EU-1-99-119_h_a_dec_3.pdf@2001-01-15 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_62.pdf@EU-1-99-126_h_a_dec_62.pdf@2018-07-30 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_18.pdf@EU-1-99-111_h_a_dec_18.pdf@2004-06-12 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_30.pdf@EU-1-99-119_h_a_dec_30.pdf@2012-07-31 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_63.pdf@EU-1-99-126_h_a_dec_63.pdf@2019-11-14 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_19.pdf@EU-1-99-111_h_a_dec_19.pdf@2005-05-01 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_31.pdf@EU-1-99-119_h_a_dec_31.pdf@2014-10-01 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_2.pdf@EU-1-99-111_h_a_dec_2.pdf@1999-01-31 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@NA before 2000@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-126_h_a_dec_64.pdf@EU-1-99-126_h_a_dec_64.pdf@2021-06-17 00:00:00@Enbrel@Etanercept@False@False@OD Not Found@Pfizer Europe MA EEIG@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_32.pdf@EU-1-99-119_h_a_dec_32.pdf@2016-01-25 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_7.pdf@EU-1-99-126_h_a_dec_7.pdf@2002-09-16 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_20.pdf@EU-1-99-111_h_a_dec_20.pdf@2005-07-03 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_33.pdf@EU-1-99-119_h_a_dec_33.pdf@2016-10-21 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_8.pdf@EU-1-99-126_h_a_dec_8.pdf@2002-09-16 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_21.pdf@EU-1-99-111_h_a_dec_21.pdf@2005-09-08 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_34.pdf@EU-1-99-119_h_a_dec_34.pdf@2017-09-18 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-126_h_a_dec_9.pdf@EU-1-99-126_h_a_dec_9.pdf@2002-05-12 00:00:00@Enbrel@Etanercept@NAS before 2012@NA before 2012@OD Not Found@Wyeth Europa Limited@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_22.pdf@EU-1-99-111_h_a_dec_22.pdf@2005-10-25 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_35.pdf@EU-1-99-119_h_a_dec_35.pdf@2019-03-28 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_36.pdf@EU-1-99-119_h_a_dec_36.pdf@2021-09-22 00:00:00@NovoRapid@Insulin aspart@False@False@OD Not Found@Novo Nordisk A/S@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_23.pdf@EU-1-99-111_h_a_dec_23.pdf@2005-12-23 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-119_h_a_dec_4.pdf@EU-1-99-119_h_a_dec_4.pdf@2001-04-23 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_24.pdf@EU-1-99-111_h_a_dec_24.pdf@2006-01-09 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_5.pdf@EU-1-99-119_h_a_dec_5.pdf@2001-07-26 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_25.pdf@EU-1-99-111_h_a_dec_25.pdf@2006-10-26 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_6.pdf@EU-1-99-119_h_a_dec_6.pdf@2002-02-04 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_26.pdf@EU-1-99-111_h_a_dec_26.pdf@2006-11-24 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_7.pdf@EU-1-99-119_h_a_dec_7.pdf@2002-05-24 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_27.pdf@EU-1-99-111_h_a_dec_27.pdf@2007-01-15 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_8.pdf@EU-1-99-119_h_a_dec_8.pdf@2002-07-15 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_28.pdf@EU-1-99-111_h_a_dec_28.pdf@2007-02-05 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-119_h_a_dec_9.pdf@EU-1-99-119_h_a_dec_9.pdf@2003-04-06 00:00:00@NovoRapid@Insulin aspart@NAS before 2012@NA before 2012@OD Not Found@Novo Nordisk A/S@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_29.pdf@EU-1-99-111_h_a_dec_29.pdf@2007-02-07 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_3.pdf@EU-1-99-111_h_a_dec_3.pdf@2000-05-24 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_30.pdf@EU-1-99-111_h_a_dec_30.pdf@2007-08-23 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_31.pdf@EU-1-99-111_h_a_dec_31.pdf@2008-11-07 00:00:00@Stocrin@efavirenz@NAS before 2012@True@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_32.pdf@EU-1-99-111_h_a_dec_32.pdf@2008-11-28 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_33.pdf@EU-1-99-111_h_a_dec_33.pdf@2009-04-22 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_34.pdf@EU-1-99-111_h_a_dec_34.pdf@2009-02-06 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_35.pdf@EU-1-99-111_h_a_dec_35.pdf@2009-07-17 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_36.pdf@EU-1-99-111_h_a_dec_36.pdf@2009-09-12 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_37.pdf@EU-1-99-111_h_a_dec_37.pdf@2010-03-11 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_38.pdf@EU-1-99-111_h_a_dec_38.pdf@2011-02-21 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp & Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_39.pdf@EU-1-99-111_h_a_dec_39.pdf@2011-07-13 00:00:00@Stocrin@efavirenz@NAS before 2012@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_4.pdf@EU-1-99-111_h_a_dec_4.pdf@2000-10-13 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_40.pdf@EU-1-99-111_h_a_dec_40.pdf@2012-06-27 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp &  Dohme Ltd@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_0.pdf@EU-1-99-120_h_a_dec_0.pdf@1999-08-12 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@NA before 2000@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_41.pdf@EU-1-99-111_h_a_dec_41.pdf@2013-04-29 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_1.pdf@EU-1-99-120_h_a_dec_1.pdf@2001-01-15 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_10.pdf@EU-1-99-120_h_a_dec_10.pdf@2007-02-20 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_42.pdf@EU-1-99-111_h_a_dec_42.pdf@2013-01-07 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_11.pdf@EU-1-99-120_h_a_dec_11.pdf@2007-03-07 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_12.pdf@EU-1-99-120_h_a_dec_12.pdf@2007-10-31 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_43.pdf@EU-1-99-111_h_a_dec_43.pdf@2014-04-23 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_13.pdf@EU-1-99-120_h_a_dec_13.pdf@2008-04-12 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@False@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_14.pdf@EU-1-99-120_h_a_dec_14.pdf@2009-10-14 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@False@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_44.pdf@EU-1-99-111_h_a_dec_44.pdf@2015-03-23 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_15.pdf@EU-1-99-120_h_a_dec_15.pdf@2011-07-07 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@False@OD Not Found@Swedish Orphan Biovitrum International  AB@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_16.pdf@EU-1-99-120_h_a_dec_16.pdf@2011-09-13 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@False@OD Not Found@Swedish Orphan  Biovitrum International AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_45.pdf@EU-1-99-111_h_a_dec_45.pdf@2017-02-16 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_17.pdf@EU-1-99-120_h_a_dec_17.pdf@2015-08-04 00:00:00@Ammonaps@Sodium phenylbutyrate@False@False@OD Not Found@Swedish Orphan International AB@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_18.pdf@EU-1-99-120_h_a_dec_18.pdf@2016-11-29 00:00:00@, medicinal product for human use  (Text with EEA relevance) (ONLY THE SWEDISH TEXT IS AUTHENTIC) EN1  ENCOMMISSION IMPLEMENTING DECISION 29.11.2016 concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(1999)4276 for “Ammonaps@Sodium phenylbutyrate@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_46.pdf@EU-1-99-111_h_a_dec_46.pdf@2017-12-15 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_19.pdf@EU-1-99-120_h_a_dec_19.pdf@2018-06-07 00:00:00@Ammonaps@Sodium phenylbutyrate@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_2.pdf@EU-1-99-120_h_a_dec_2.pdf@2001-06-06 00:00:00@Ammonaps@sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_47.pdf@EU-1-99-111_h_a_dec_47.pdf@2018-04-06 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_48.pdf@EU-1-99-111_h_a_dec_48.pdf@2018-07-30 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_20.pdf@EU-1-99-120_h_a_dec_20.pdf@2019-06-02 00:00:00@Ammonaps@Sodium phenylbutyrate@False@False@OD Not Found@Swedish Orphan Biovitrum International AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_49.pdf@EU-1-99-111_h_a_dec_49.pdf@2019-11-14 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_5.pdf@EU-1-99-111_h_a_dec_5.pdf@2001-06-14 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_22.pdf@EU-1-99-120_h_a_dec_22.pdf@2019-11-07 00:00:00@Ammonaps@Sodium phenylbutyrate@False@False@OD Not Found@Horizon Pharma Ireland Limited@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_50.pdf@EU-1-99-111_h_a_dec_50.pdf@2021-04-21 00:00:00@Stocrin@efavirenz@False@False@OD Not Found@Merck Sharp & Dohme B.V.@CMA Not Found@Parsed
EU-1-99-120_h_a_dec_23.pdf@EU-1-99-120_h_a_dec_23.pdf@2021-10-19 00:00:00@Ammonaps@Sodium phenylbutyrate@False@False@OD Not Found@Immedica Pharma AB@CMA Not Found@Parsed
EU-1-99-111_h_a_dec_6.pdf@EU-1-99-111_h_a_dec_6.pdf@2001-09-20 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_3.pdf@EU-1-99-120_h_a_dec_3.pdf@2002-04-29 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_7.pdf@EU-1-99-111_h_a_dec_7.pdf@2001-10-24 00:00:00@STOCRIN efavirenz@Active Substance Not Found@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dhome Ltd@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_4.pdf@EU-1-99-120_h_a_dec_4.pdf@2003-07-22 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_8.pdf@EU-1-99-111_h_a_dec_8.pdf@2002-12-04 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_5.pdf@EU-1-99-120_h_a_dec_5.pdf@2004-01-27 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-111_h_a_dec_9.pdf@EU-1-99-111_h_a_dec_9.pdf@2002-08-22 00:00:00@Stocrin@efavirenz@NAS before 2012@NA before 2012@OD Not Found@Merck Sharp & Dohme Ltd@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_6.pdf@EU-1-99-120_h_a_dec_6.pdf@2004-06-07 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_7.pdf@EU-1-99-120_h_a_dec_7.pdf@2004-10-28 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_8.pdf@EU-1-99-120_h_a_dec_8.pdf@2005-03-29 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA not available before 2006@Parsed
EU-1-99-120_h_a_dec_9.pdf@EU-1-99-120_h_a_dec_9.pdf@2006-04-24 00:00:00@Ammonaps@Sodium phenylbutyrate@NAS before 2012@NA before 2012@OD Not Found@Orphan Europe@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_0.pdf@EU-1-99-112_h_a_dec_0.pdf@1999-08-07 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_1.pdf@EU-1-99-112_h_a_dec_1.pdf@2000-02-15 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_10.pdf@EU-1-99-112_h_a_dec_10.pdf@2004-05-26 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_11.pdf@EU-1-99-112_h_a_dec_11.pdf@2004-08-18 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_12.pdf@EU-1-99-112_h_a_dec_12.pdf@2004-10-28 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_13.pdf@EU-1-99-112_h_a_dec_13.pdf@2004-10-28 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_14.pdf@EU-1-99-112_h_a_dec_14.pdf@2004-12-17 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_15.pdf@EU-1-99-112_h_a_dec_15.pdf@2005-08-09 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_16.pdf@EU-1-99-112_h_a_dec_16.pdf@Date is blank@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@NA before 2000@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_17.pdf@EU-1-99-112_h_a_dec_17.pdf@2006-08-21 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_18.pdf@EU-1-99-112_h_a_dec_18.pdf@2006-11-28 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_19.pdf@EU-1-99-112_h_a_dec_19.pdf@2007-01-17 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_2.pdf@EU-1-99-112_h_a_dec_2.pdf@2001-02-22 00:00:00@ZIAGEN@abacavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_20.pdf@EU-1-99-112_h_a_dec_20.pdf@2007-05-30 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_21.pdf@EU-1-99-112_h_a_dec_21.pdf@2007-08-27 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_22.pdf@EU-1-99-112_h_a_dec_22.pdf@2007-11-20 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_23.pdf@EU-1-99-112_h_a_dec_23.pdf@2008-02-29 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_24.pdf@EU-1-99-112_h_a_dec_24.pdf@2008-02-09 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@True@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_25.pdf@EU-1-99-112_h_a_dec_25.pdf@2009-07-04 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_26.pdf@EU-1-99-112_h_a_dec_26.pdf@2009-05-29 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_27.pdf@EU-1-99-112_h_a_dec_27.pdf@2009-08-06 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_28.pdf@EU-1-99-112_h_a_dec_28.pdf@2009-11-20 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_29.pdf@EU-1-99-112_h_a_dec_29.pdf@2010-01-20 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_3.pdf@EU-1-99-112_h_a_dec_3.pdf@2001-02-22 00:00:00@ZIAGEN@abacavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_30.pdf@EU-1-99-112_h_a_dec_30.pdf@2010-10-05 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@Glaxo Group Ltd.@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_31.pdf@EU-1-99-112_h_a_dec_31.pdf@2011-06-15 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_32.pdf@EU-1-99-112_h_a_dec_32.pdf@2011-10-24 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_33.pdf@EU-1-99-112_h_a_dec_33.pdf@2012-06-28 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Ltd@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_34.pdf@EU-1-99-112_h_a_dec_34.pdf@2013-03-26 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_35.pdf@EU-1-99-112_h_a_dec_35.pdf@2014-03-21 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_36.pdf@EU-1-99-112_h_a_dec_36.pdf@2015-02-26 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_37.pdf@EU-1-99-112_h_a_dec_37.pdf@2016-07-04 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_38.pdf@EU-1-99-112_h_a_dec_38.pdf@2017-09-03 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_39.pdf@EU-1-99-112_h_a_dec_39.pdf@2018-07-12 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare UK Limited@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_4.pdf@EU-1-99-112_h_a_dec_4.pdf@2001-03-26 00:00:00@ZIAGEN@abacavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_40.pdf@EU-1-99-112_h_a_dec_40.pdf@2020-04-02 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_41.pdf@EU-1-99-112_h_a_dec_41.pdf@2021-09-03 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_42.pdf@EU-1-99-112_h_a_dec_42.pdf@2022-04-03 00:00:00@Ziagen@abacavir sulfate@False@False@OD Not Found@ViiV Healthcare BV@CMA Not Found@Parsed
EU-1-99-112_h_a_dec_5.pdf@EU-1-99-112_h_a_dec_5.pdf@2001-10-24 00:00:00@ZIAGEN@abacavir@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_6.pdf@EU-1-99-112_h_a_dec_6.pdf@2002-10-28 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_7.pdf@EU-1-99-112_h_a_dec_7.pdf@2003-08-04 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_8.pdf@EU-1-99-112_h_a_dec_8.pdf@2003-07-14 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
EU-1-99-112_h_a_dec_9.pdf@EU-1-99-112_h_a_dec_9.pdf@2004-01-30 00:00:00@Ziagen@abacavir sulfate@NAS before 2012@NA before 2012@OD Not Found@Glaxo Group Ltd@CMA not available before 2006@Parsed
